Citrus Sinensis ID: 046275
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1176 | 2.2.26 [Sep-21-2011] | |||||||
| O22476 | 1196 | Protein BRASSINOSTEROID I | yes | no | 0.992 | 0.975 | 0.717 | 0.0 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.978 | 0.953 | 0.706 | 0.0 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.978 | 0.953 | 0.706 | 0.0 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.963 | 0.971 | 0.482 | 0.0 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.913 | 0.922 | 0.498 | 0.0 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.889 | 0.915 | 0.462 | 0.0 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.828 | 0.817 | 0.373 | 1e-162 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.881 | 0.941 | 0.331 | 1e-140 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.892 | 0.839 | 0.309 | 1e-137 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.847 | 0.878 | 0.311 | 1e-136 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1647 bits (4266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 859/1197 (71%), Positives = 986/1197 (82%), Gaps = 30/1197 (2%)
Query: 1 MKAFSLLFLVFSSFISLSLLASA--SSPN----KDLQQLLSFKAALPNPSVLPNWSPNQN 54
MK FS FL ++ S + + +SP+ +++ QL+SFK LP+ ++LP+WS N+N
Sbjct: 1 MKTFSSFFLSVTTLFFFSFFSLSFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKN 60
Query: 55 PCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAG 114
PC F GV+C+ V+SIDLS L+V F V+S LL+L LE+L L NS+I+G++S G
Sbjct: 61 PCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS---G 117
Query: 115 SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKL-SLEV 173
+CS+ L+SLDLS N LSGP++ ++ LGSCS LK LN+SSN LDF G+ +G LKL SLEV
Sbjct: 118 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 177
Query: 174 LDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMA 233
LDLS N ISGANVV W+L +GC ELK LA+ GNK++GD++VS+C NL+FLDVSSNNFS
Sbjct: 178 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTG 237
Query: 234 VPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIP----------- 282
+P GDC AL++LDIS NK +GD AIS C L LN+SSN F GPIP
Sbjct: 238 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS 297
Query: 283 VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP 342
+ N+F GEIP L+ C +L LDLS N+ G VP FGSCS LES +SSN FSGELP
Sbjct: 298 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 357
Query: 343 IEIFLSMSNLKELVLSFNDFTGALPDSLSNLT-NLETLDLSSNNLSGAIPHNLCQGPRNS 401
++ L M LK L LSFN+F+G LP+SL+NL+ +L TLDLSSNN SG I NLCQ P+N+
Sbjct: 358 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 417
Query: 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH 461
L+EL+LQNN G IP TLSNCS+LVSLHLSFNYL+GTIPSSLGSLSKL+DLKLWLN L
Sbjct: 418 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 477
Query: 462 GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSN 521
GEIP EL ++TLETL LDFN+LTG +P+ LSNCTNLNWISLSNN L GEIP WIG+L N
Sbjct: 478 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 537
Query: 522 LAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKY 581
LAILKLSNNSF G IP ELGDCRSLIWLDLNTNLFNG+IP A+FKQSGKIAANFI GK+Y
Sbjct: 538 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRY 597
Query: 582 VYIKNDG-SKECHGAGNLLEFAGIRAERLSRISTRSPCNFT-RVYGGHTQPTFNHNGSMM 639
VYIKNDG KECHGAGNLLEF GIR+E+L+R+STR+PCN T RVYGGHT PTF++NGSMM
Sbjct: 598 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 657
Query: 640 FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGT 699
FLD+SYNMLSG IPKEIGSM YLFILNLGHN++SG IP EVGDLRGLNILDLSSN+L+G
Sbjct: 658 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 717
Query: 700 IPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGAS 759
IP +MS+LT+L EIDL NN L+G IP MGQFETF PAKFLNN GLCG PLP C+ S A
Sbjct: 718 IPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP-SNAD 776
Query: 760 ANSRHQKSH-RRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYIDSRS 818
+ HQ+SH RRPASLAGS+AMGLLFS CIFGLI+V E RKRR+KKE+ L++Y +
Sbjct: 777 GYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHG 836
Query: 819 HSG---TANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGD 875
+SG NT+WKLTG +EALSINLA FEKPLRKLTFADLL+ATNGFHNDSLIGSGGFGD
Sbjct: 837 NSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGD 896
Query: 876 VYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935
VYKA LKDGS VAIKKLIH+SGQGDREF AEMETIGKIKHRNLVPLLGYCKVG+ERLLVY
Sbjct: 897 VYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVY 956
Query: 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVL 995
E+M+YGSLEDVLH+ KK G+KLNW+ RRKIAIGSARGLAFLHHNC PHIIHRDMKSSNVL
Sbjct: 957 EFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVL 1016
Query: 996 LDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1055
LDEN EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL
Sbjct: 1017 LDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1076
Query: 1056 LELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASA 1115
LELLTGKRPTDS DFGDNNLVGWVKQHAKL+ISDVFDPELMKEDP +EIELLQHL VA A
Sbjct: 1077 LELLTGKRPTDSPDFGDNNLVGWVKQHAKLRISDVFDPELMKEDPALEIELLQHLKVAVA 1136
Query: 1116 CLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTI-ATDEGGFGTVEMVEMSIQEAPE 1171
CLDDR WRRPTM+QVMAMFKEIQAGSG+DSQSTI + ++GGF T+EMV+MSI+E PE
Sbjct: 1137 CLDDRAWRRPTMVQVMAMFKEIQAGSGIDSQSTIRSIEDGGFSTIEMVDMSIKEVPE 1193
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1633 bits (4229), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 828/1172 (70%), Positives = 944/1172 (80%), Gaps = 21/1172 (1%)
Query: 21 ASASSPNKDLQQLLSFKAALP-NPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLS 79
AS + KD QQLLSFKAALP P++L NW + +PC F GVSCK + VSSIDLS LS
Sbjct: 35 ASVNGLYKDSQQLLSFKAALPPTPTLLQNWLSSTDPCSFTGVSCKNSRVSSIDLSNTFLS 94
Query: 80 VDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDIS 139
VDF LV S+LL L LE+L LKN+N+SG+++ A S+C L S+DL+ N +SGP+SDIS
Sbjct: 95 VDFSLVTSYLLPLSNLESLVLKNANLSGSLTSAAKSQCGVTLDSIDLAENTISGPISDIS 154
Query: 140 YLGSCSSLKVLNLSSNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198
G CS+LK LNLS N LD G+E SL+VLDLSYN ISG N+ PW+ G EL
Sbjct: 155 SFGVCSNLKSLNLSKNFLDPPGKEMLKGATFSLQVLDLSYNNISGFNLFPWVSSMGFVEL 214
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
+ ++KGNK+ G I KNL +LD+S+NNFS PSF DC L++LD+S+NKF GD+G
Sbjct: 215 EFFSIKGNKLAGSIPELDFKNLSYLDLSANNFSTVFPSFKDCSNLQHLDLSSNKFYGDIG 274
Query: 259 HAISACEHLSFLNVSSNLFSGPIP------VGY-----NEFQGEIPLHLADLCSSLVKLD 307
++S+C LSFLN+++N F G +P + Y N+FQG P LADLC ++V+LD
Sbjct: 275 SSLSSCGKLSFLNLTNNQFVGLVPKLPSESLQYLYLRGNDFQGVYPNQLADLCKTVVELD 334
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
LS NN SG VP G CSSLE DIS+N FSG+LP++ L +SN+K +VLSFN F G LP
Sbjct: 335 LSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGGLP 394
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
DS SNL LETLD+SSNNL+G IP +C+ P N+LK L+LQNNL G IP +LSNCSQLV
Sbjct: 395 DSFSNLPKLETLDMSSNNLTGIIPSGICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLV 454
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT 487
SL LSFNYLTG+IPSSLGSLSKL+DL LWLNQL GEIP EL +Q LE L LDFN+LTG
Sbjct: 455 SLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGP 514
Query: 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
+PA+LSNCT LNWISLSNN L GEIP +G+LSNLAILKL NNS G IP ELG+C+SLI
Sbjct: 515 IPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLI 574
Query: 548 WLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAE 607
WLDLNTN NGSIPP LFKQSG IA + GK+YVYIKNDGSKECHGAGNLLEF GIR E
Sbjct: 575 WLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQE 634
Query: 608 RLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNL 667
+L RISTR PCNFTRVY G TQPTFNHNGSM+FLD+SYN L GSIPKE+G+M YL ILNL
Sbjct: 635 QLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNL 694
Query: 668 GHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM 727
GHN+LSG IP ++G L+ + ILDLS NR GTIP+S++SLTLL EIDL NN L+GMIP
Sbjct: 695 GHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPES 754
Query: 728 GQFETFQPAKFLNNSGLCGLPLP-PCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSL 786
F+TF +F NNS LCG PLP PC + AN +HQKSHRR ASLAGS+AMGLLFSL
Sbjct: 755 APFDTFPDYRFANNS-LCGYPLPLPCSSGPKSDAN-QHQKSHRRQASLAGSVAMGLLFSL 812
Query: 787 FCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKP 846
FCIFGLIIV +ET+KRR+KKE+AL+ Y+D SHS TAN++WK T AREALSINLA FEKP
Sbjct: 813 FCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKP 872
Query: 847 LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAE 906
LRKLTFADLLEATNGFHNDSL+GSGGFGDVYKA+LKDGS VAIKKLIH+SGQGDREFTAE
Sbjct: 873 LRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAE 932
Query: 907 METIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966
METIGKIKHRNLVPLLGYCKVGEERLLVYEYM+YGSLEDVLH++KK GIKLNW ARRKIA
Sbjct: 933 METIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIA 992
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA 1026
IG+ARGLAFLHHNCIPHIIHRDMKSSNVLLDEN EARVSDFGMARLMSAMDTHLSVSTLA
Sbjct: 993 IGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLA 1052
Query: 1027 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086
GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK+PTDSADFGDNNLVGWVK HAK K
Sbjct: 1053 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGK 1112
Query: 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQ 1146
I+DVFD EL+KED +IEIELLQHL VA ACLDDR W+RPTMIQVMAMFKEIQAGSG+DS
Sbjct: 1113 ITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQAGSGMDST 1172
Query: 1147 STIATDEGGFGTVE-MVEM----SIQEAPELS 1173
STI D+ F VE +EM SI+E ELS
Sbjct: 1173 STIGADDVNFSGVEGGIEMGINGSIKEGNELS 1204
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1633 bits (4228), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 828/1172 (70%), Positives = 943/1172 (80%), Gaps = 21/1172 (1%)
Query: 21 ASASSPNKDLQQLLSFKAALP-NPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLS 79
AS + KD QQLLSFKAALP P++L NW + PC F GVSCK + VSSIDLS LS
Sbjct: 35 ASVNGLYKDSQQLLSFKAALPPTPTLLQNWLSSTGPCSFTGVSCKNSRVSSIDLSNTFLS 94
Query: 80 VDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDIS 139
VDF LV S+LL L LE+L LKN+N+SG+++ A S+C L S+DL+ N +SGP+SDIS
Sbjct: 95 VDFSLVTSYLLPLSNLESLVLKNANLSGSLTSAAKSQCGVTLDSIDLAENTISGPISDIS 154
Query: 140 YLGSCSSLKVLNLSSNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198
G CS+LK LNLS N LD G+E + SL+VLDLSYN ISG N+ PW+ G EL
Sbjct: 155 SFGVCSNLKSLNLSKNFLDPPGKEMLKAATFSLQVLDLSYNNISGFNLFPWVSSMGFVEL 214
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
+ +LKGNK+ G I KNL +LD+S+NNFS PSF DC L++LD+S+NKF GD+G
Sbjct: 215 EFFSLKGNKLAGSIPELDFKNLSYLDLSANNFSTVFPSFKDCSNLQHLDLSSNKFYGDIG 274
Query: 259 HAISACEHLSFLNVSSNLFSGPIP------VGY-----NEFQGEIPLHLADLCSSLVKLD 307
++S+C LSFLN+++N F G +P + Y N+FQG P LADLC ++V+LD
Sbjct: 275 SSLSSCGKLSFLNLTNNQFVGLVPKLPSESLQYLYLRGNDFQGVYPNQLADLCKTVVELD 334
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
LS NN SG VP G CSSLE DIS N FSG+LP++ +SN+K +VLSFN F G LP
Sbjct: 335 LSYNNFSGMVPESLGECSSLELVDISYNNFSGKLPVDTLSKLSNIKTMVLSFNKFVGGLP 394
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
DS SNL LETLD+SSNNL+G IP +C+ P N+LK L+LQNNL G IP +LSNCSQLV
Sbjct: 395 DSFSNLLKLETLDMSSNNLTGVIPSGICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLV 454
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT 487
SL LSFNYLTG+IPSSLGSLSKL+DL LWLNQL GEIP EL +Q LE L LDFN+LTG
Sbjct: 455 SLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGP 514
Query: 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
+PA+LSNCT LNWISLSNN L GEIP +G+LSNLAILKL NNS G IP ELG+C+SLI
Sbjct: 515 IPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLI 574
Query: 548 WLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAE 607
WLDLNTN NGSIPP LFKQSG IA + GK+YVYIKNDGSKECHGAGNLLEF GIR E
Sbjct: 575 WLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQE 634
Query: 608 RLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNL 667
+L RISTR PCNFTRVY G TQPTFNHNGSM+FLD+SYN L GSIPKE+G+M YL ILNL
Sbjct: 635 QLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNL 694
Query: 668 GHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM 727
GHN+LSG IP ++G L+ + ILDLS NR GTIP+S++SLTLL EIDL NN L+GMIP
Sbjct: 695 GHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPES 754
Query: 728 GQFETFQPAKFLNNSGLCGLPLP-PCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSL 786
F+TF +F NNS LCG PLP PC + AN +HQKSHRR ASLAGS+AMGLLFSL
Sbjct: 755 APFDTFPDYRFANNS-LCGYPLPIPCSSGPKSDAN-QHQKSHRRQASLAGSVAMGLLFSL 812
Query: 787 FCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKP 846
FCIFGLIIV +ET+KRR+KKE+AL+ Y+D SHS TAN++WK T AREALSINLA FEKP
Sbjct: 813 FCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKP 872
Query: 847 LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAE 906
LRKLTFADLLEATNGFHNDSL+GSGGFGDVYKA+LKDGS VAIKKLIH+SGQGDREFTAE
Sbjct: 873 LRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAE 932
Query: 907 METIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966
METIGKIKHRNLVPLLGYCKVGEERLLVYEYM+YGSLEDVLH++KK+GIKLNW ARRKIA
Sbjct: 933 METIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIA 992
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA 1026
IG+ARGLAFLHHNCIPHIIHRDMKSSNVLLDEN EARVSDFGMARLMSAMDTHLSVSTLA
Sbjct: 993 IGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLA 1052
Query: 1027 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086
GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK+PTDSADFGDNNLVGWVK HAK K
Sbjct: 1053 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGK 1112
Query: 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQ 1146
I+DVFD EL+KED +IEIELLQHL VA ACLDDR W+RPTMIQVMAMFKEIQAGSG+DS
Sbjct: 1113 ITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQAGSGMDST 1172
Query: 1147 STIATDEGGFGTVE-MVEM----SIQEAPELS 1173
STI D+ F VE +EM SI+E ELS
Sbjct: 1173 STIGADDVNFSGVEGGIEMGINGSIKEGNELS 1204
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1006 bits (2600), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 581/1203 (48%), Positives = 780/1203 (64%), Gaps = 70/1203 (5%)
Query: 1 MKAFSLLFLVFSSFISLSLLASASSP---NKDLQQ---LLSFK----AALPNPSVLPNW- 49
MK LL L+ F + SL+ N D + LL+FK + PN +VL NW
Sbjct: 1 MKQRWLLVLILC-FFTTSLVMGIHGKHLINDDFNETALLLAFKQNSVKSDPN-NVLGNWK 58
Query: 50 -SPNQNPCGFKGVSCKA-ASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISG 107
+ C ++GVSC + +DL L+ +LV L L L+ L L+ N
Sbjct: 59 YESGRGSCSWRGVSCSDDGRIVGLDLRNSGLTGTLNLVN--LTALPNLQNLYLQ-GNYFS 115
Query: 108 TISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGS-CSSLKVLNLSSN-LLDFSGREAG 165
+ +GS C +L LDLS N +S S + Y+ S CS+L +N+S+N L+ G
Sbjct: 116 SGGDSSGSDC--YLQVLDLSSNSISD-YSMVDYVFSKCSNLVSVNISNNKLVGKLGFAPS 172
Query: 166 SLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD---INVSKCKNLQF 222
SL+ SL +DLSYN +S + + + LK L L N ++GD ++ C NL F
Sbjct: 173 SLQ-SLTTVDLSYNILS-DKIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGICGNLTF 230
Query: 223 LDVSSNN-----FSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHL-SFLNVSSNL 276
+S NN F + +P +C LE L+IS N G + + E+ SF N+
Sbjct: 231 FSLSQNNLSGDKFPITLP---NCKFLETLNISRNNLAGKIPNG----EYWGSFQNLKQ-- 281
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
+ + +N GEIP L+ LC +LV LDLS N SG++PS+F +C L++ ++ +N
Sbjct: 282 ----LSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNY 337
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
SG+ + ++ + L +++N+ +G++P SL+N +NL LDLSSN +G +P C
Sbjct: 338 LSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCS 397
Query: 397 GPRNS-LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455
+ L+++ + NN L G++P L C L ++ LSFN LTG IP + L L DL +
Sbjct: 398 LQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVM 457
Query: 456 WLNQLHGEIPPEL----GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE 511
W N L G IP + GN LETL L+ N LTG++P ++S CTN+ WISLS+N L G+
Sbjct: 458 WANNLTGTIPEGVCVKGGN---LETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGK 514
Query: 512 IPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKI 571
IP+ IG LS LAIL+L NNS G +P +LG+C+SLIWLDLN+N G +P L Q+G +
Sbjct: 515 IPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLV 574
Query: 572 AANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT 631
+ GK++ +++N+G +C GAG L+EF GIRAERL R+ C TR+Y G T T
Sbjct: 575 MPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMYT 634
Query: 632 FNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDL 691
F+ NGSM++ DISYN +SG IP G+M YL +LNLGHN ++G IP G L+ + +LDL
Sbjct: 635 FSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDL 694
Query: 692 SSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPP 751
S N L+G +P S+ SL+ L+++D+ NN LTG IP GQ TF +++ NNSGLCG+PL P
Sbjct: 695 SHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRP 754
Query: 752 CEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALD 811
C SR H + ++A ++ G+ FS C L++ + RK +KKE +
Sbjct: 755 CGSAPRRPITSR---IHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRK-VQKKEQKRE 810
Query: 812 VYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSG 871
YI+S SG+ SWKL+ E LSIN+ATFEKPLRKLTFA LLEATNGF ++++GSG
Sbjct: 811 KYIESLPTSGSC--SWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSG 868
Query: 872 GFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931
GFG+VYKA+L+DGS VAIKKLI I+GQGDREF AEMETIGKIKHRNLVPLLGYCKVGEER
Sbjct: 869 GFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEER 928
Query: 932 LLVYEYMRYGSLEDVLHNQ--KKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDM 989
LLVYEYM++GSLE VLH + KK GI LNWAAR+KIAIG+ARGLAFLHH+CIPHIIHRDM
Sbjct: 929 LLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDM 988
Query: 990 KSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVY 1049
KSSNVLLDE+FEARVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQSFRC+ KGDVY
Sbjct: 989 KSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY 1048
Query: 1050 SYGVVLLELLTGKRPTDSADFG-DNNLVGWVKQ-HAKLKISDVFDPELMKEDPNIEIELL 1107
SYGV+LLELL+GK+P D +FG DNNLVGW KQ + + + +++ DPEL+ D + ++EL
Sbjct: 1049 SYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVT-DKSGDVELF 1107
Query: 1108 QHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEGGFGTVEMVEMSIQ 1167
+L +AS CLDDRP++RPTMIQ+MAMFKE++A D++ + DE +VE S
Sbjct: 1108 HYLKIASQCLDDRPFKRPTMIQLMAMFKEMKA----DTEEDESLDEFSLKETPLVEESRD 1163
Query: 1168 EAP 1170
+ P
Sbjct: 1164 KEP 1166
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 997 bits (2577), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 580/1163 (49%), Positives = 751/1163 (64%), Gaps = 89/1163 (7%)
Query: 46 LPNW--SPNQNPCGFKGVSCKA-ASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKN 102
L NW ++PC ++GVSC + V +DL L+ +L + L L L +L L+
Sbjct: 53 LGNWRYGSGRDPCTWRGVSCSSDGRVIGLDLRNGGLTGTLNL--NNLTALSNLRSLYLQG 110
Query: 103 SNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYL-GSCSSLKVLNLSSNLLDFSG 161
+N S S S L LDLS N L+ S + Y+ +C +L +N S N L
Sbjct: 111 NNFSSGDSS---SSSGCSLEVLDLSSNSLTDS-SIVDYVFSTCLNLVSVNFSHNKL---- 162
Query: 162 REAGSLKLS-------LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV 214
AG LK S + +DLS N+ S + + + + LK L L GN VTGD
Sbjct: 163 --AGKLKSSPSASNKRITTVDLSNNRFS-DEIPETFIADFPNSLKHLDLSGNNVTGD--- 216
Query: 215 SKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD-VGHAISACEHLSFLNVS 273
FS SFG C L +S N +GD ++S C+ L LN+S
Sbjct: 217 ---------------FSRL--SFGLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLS 259
Query: 274 SNLFSGPIP---------------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVP 318
N G IP + +N + GEIP L+ LC +L LDLS N+L+G++P
Sbjct: 260 RNSLIGKIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLP 319
Query: 319 SRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLET 378
F SC SL+S ++ +NK SG+ + +S + L L FN+ +G++P SL+N +NL
Sbjct: 320 QSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRV 379
Query: 379 LDLSSNNLSGAIPHNLCQGPRNS-LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
LDLSSN +G +P C +S L++L + NN L G++P L C L ++ LSFN LT
Sbjct: 380 LDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALT 439
Query: 438 GTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL----GNIQTLETLFLDFNELTGTLPAALS 493
G IP + +L KL DL +W N L G IP + GN LETL L+ N LTG+LP ++S
Sbjct: 440 GLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGN---LETLILNNNLLTGSLPESIS 496
Query: 494 NCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNT 553
CTN+ WISLS+N L GEIP IG+L LAIL+L NNS G IP ELG+C++LIWLDLN+
Sbjct: 497 KCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNS 556
Query: 554 NLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613
N G++P L Q+G + + GK++ +++N+G +C GAG L+EF GIRAERL
Sbjct: 557 NNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFP 616
Query: 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS 673
C TR+Y G T F+ NGSM++LD+SYN +SGSIP G+M YL +LNLGHN L+
Sbjct: 617 MVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLT 676
Query: 674 GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETF 733
G IP G L+ + +LDLS N L+G +P S+ L+ L+++D+ NN LTG IP GQ TF
Sbjct: 677 GTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTF 736
Query: 734 QPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPA--SLAGSIAMGLLFSLFCIFG 791
++ NNSGLCG+PLPPC S+ SR +SH P S+A ++ G++FS CI
Sbjct: 737 PLTRYANNSGLCGVPLPPC------SSGSRPTRSHAHPKKQSIATGMSAGIVFSFMCIVM 790
Query: 792 LIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLT 851
LI+ + RK +KKE + YI+S SG+++ L+ E LSIN+ATFEKPLRKLT
Sbjct: 791 LIMALYRARK-VQKKEKQREKYIESLPTSGSSSWK--LSSVHEPLSINVATFEKPLRKLT 847
Query: 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIG 911
FA LLEATNGF DS+IGSGGFGDVYKAKL DGS VAIKKLI ++GQGDREF AEMETIG
Sbjct: 848 FAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIG 907
Query: 912 KIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQ-KKVGIKLNWAARRKIAIGSA 970
KIKHRNLVPLLGYCK+GEERLLVYEYM+YGSLE VLH + KK GI L+W+AR+KIAIG+A
Sbjct: 908 KIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAA 967
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
RGLAFLHH+CIPHIIHRDMKSSNVLLD++F ARVSDFGMARL+SA+DTHLSVSTLAGTPG
Sbjct: 968 RGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPG 1027
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG-DNNLVGWVKQ-HAKLKIS 1088
YVPPEYYQSFRC+ KGDVYSYGV+LLELL+GK+P D +FG DNNLVGW KQ + + + +
Sbjct: 1028 YVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGA 1087
Query: 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE-IQAGSGLDSQS 1147
++ DPEL+ D + ++ELL +L +AS CLDDRP++RPTMIQVM MFKE +Q + DS
Sbjct: 1088 EILDPELVT-DKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDS-- 1144
Query: 1148 TIATDEGGFGTVEMVEMSIQEAP 1170
DE +VE S + P
Sbjct: 1145 ---LDEFLLKETPLVEESRDKEP 1164
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 931 bits (2405), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/1158 (46%), Positives = 702/1158 (60%), Gaps = 112/1158 (9%)
Query: 29 DLQQLLSFKAAL---PNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLV 85
D LLSFK + PN ++L NWSP ++PC F GV+C V+ I+LS
Sbjct: 39 DSLSLLSFKTMIQDDPN-NILSNWSPRKSPCQFSGVTCLGGRVTEINLS----------- 86
Query: 86 ASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCS 145
S +SG +S A +SLD
Sbjct: 87 ----------------GSGLSGIVSFNA-------FTSLD-------------------- 103
Query: 146 SLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
SL VL LS N + L L+L L+LS + + G +P F+ L + L
Sbjct: 104 SLSVLKLSENFFVLNSTSLLLLPLTLTHLELSSSGLIGT--LPENFFSKYSNLISITLSY 161
Query: 206 NKVTG----DINVSKCKNLQFLDVSSNNFS-----MAVPSFGDCLALEYLDISANKFTGD 256
N TG D+ +S K LQ LD+S NN + + +P C+++ YLD S N +G
Sbjct: 162 NNFTGKLPNDLFLSS-KKLQTLDLSYNNITGPISGLTIP-LSSCVSMTYLDFSGNSISGY 219
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIP-------------VGYNEFQGEIPLHLADLCSSL 303
+ ++ C +L LN+S N F G IP + +N G IP + D C SL
Sbjct: 220 ISDSLINCTNLKSLNLSYNNFDGQIPKSFGELKLLQSLDLSHNRLTGWIPPEIGDTCRSL 279
Query: 304 VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT 363
L LS NN +G +P SCS L+S D+S+N SG P I S +L+ L+LS N +
Sbjct: 280 QNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILRSFGSLQILLLSNNLIS 339
Query: 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC 423
G P S+S +L D SSN SG IP +LC G SL+EL L +NL+ G IP +S C
Sbjct: 340 GDFPTSISACKSLRIADFSSNRFSGVIPPDLCPGAA-SLEELRLPDNLVTGEIPPAISQC 398
Query: 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
S+L ++ LS NYL GTIP +G+L KL+ W N + GEIPPE+G +Q L+ L L+ N+
Sbjct: 399 SELRTIDLSLNYLNGTIPPEIGNLQKLEQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQ 458
Query: 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543
LTG +P NC+N+ W+S ++N L GE+P G LS LA+L+L NN+F G IPPELG C
Sbjct: 459 LTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDFGILSRLAVLQLGNNNFTGEIPPELGKC 518
Query: 544 RSLIWLDLNTNLFNGSIPPALFKQSG-KIAANFIVGKKYVYIKNDGSKECHGAGNLLEFA 602
+L+WLDLNTN G IPP L +Q G K + + G +++N G+ C G G L+EF+
Sbjct: 519 TTLVWLDLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVGNS-CKGVGGLVEFS 577
Query: 603 GIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYL 662
GIR ERL +I + C+FTR+Y G F ++ +LD+SYN L G IP EIG M L
Sbjct: 578 GIRPERLLQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIAL 637
Query: 663 FILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTG 722
+L L HN LSG IP +G L+ L + D S NRL+G IP S S+L+ L +IDL NN+LTG
Sbjct: 638 QVLELSHNQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTG 697
Query: 723 MIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDS----GASANSRHQKSHRRPASLAGSI 778
IP GQ T ++ NN GLCG+PLP C+ + + + K R AS A SI
Sbjct: 698 PIPQRGQLSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGKRAKHGTRAASWANSI 757
Query: 779 AMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSI 838
+G+L S + LI+ + R RR+ + A ++ +S T+WK+ +E LSI
Sbjct: 758 VLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSA---TTWKIEKEKEPLSI 814
Query: 839 NLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ 898
N+ATF++ LRKL F+ L+EATNGF S+IG GGFG+V+KA LKDGS+VAIKKLI +S Q
Sbjct: 815 NVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQ 874
Query: 899 GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK-- 956
GDREF AEMET+GKIKHRNLVPLLGYCK+GEERLLVYE+M+YGSLE+VLH + G K
Sbjct: 875 GDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHG-PRTGEKRR 933
Query: 957 -LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015
L W R+KIA G+A+GL FLHHNCIPHIIHRDMKSSNVLLD++ EARVSDFGMARL+SA
Sbjct: 934 ILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISA 993
Query: 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNL 1075
+DTHLSVSTLAGTPGYVPPEYYQSFRC+ KGDVYS GVV+LE+L+GKRPTD +FGD NL
Sbjct: 994 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGDTNL 1053
Query: 1076 VGWVKQHAKL-KISDVFDPELMKEDPN-------------IEIELLQHLHVASACLDDRP 1121
VGW K A+ K +V D +L+KE + I E+L++L +A C+DD P
Sbjct: 1054 VGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLRYLEIALRCVDDFP 1113
Query: 1122 WRRPTMIQVMAMFKEIQA 1139
+RP M+QV+A +E++
Sbjct: 1114 SKRPNMLQVVASLRELRG 1131
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1473), Expect = e-162, Method: Compositional matrix adjust.
Identities = 418/1120 (37%), Positives = 583/1120 (52%), Gaps = 146/1120 (13%)
Query: 84 LVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGS 143
L SF ++L L +L + N+++SG I G S LS+L + LN SG + S +G+
Sbjct: 153 LPPSFFISLPALSSLDVSNNSLSGEIPPEIGKL--SNLSNLYMGLNSFSGQIP--SEIGN 208
Query: 144 CSSLKVLNLSSNLLDFSG---REAGSLKLSLEVLDLSYNKISGA---------------- 184
S LK N ++ F+G +E LK L LDLSYN + +
Sbjct: 209 ISLLK--NFAAPSCFFNGPLPKEISKLK-HLAKLDLSYNPLKCSIPKSFGELHNLSILNL 265
Query: 185 ------NVVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVPS 236
++P L N C LK L L N ++G + +S+ L F N S ++PS
Sbjct: 266 VSAELIGLIPPELGN-CKSLKSLMLSFNSLSGPLPLELSEIPLLTF-SAERNQLSGSLPS 323
Query: 237 F-GDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLH 295
+ G L+ L ++ N+F+G++ H I C L L+++SNL SG IP E G L
Sbjct: 324 WMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIP---RELCGSGSLE 380
Query: 296 LADL---------------CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGE 340
DL CSSL +L L++N ++G +P L + D+ SN F+GE
Sbjct: 381 AIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGE 439
Query: 341 LPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN 400
+P ++ S +NL E S+N G LP + N +L+ L LS N L+G IP + G
Sbjct: 440 IPKSLWKS-TNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREI--GKLT 496
Query: 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
SL L L N+ G IP L +C+ L +L L N L G IP + +L++LQ L L N L
Sbjct: 497 SLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNL 556
Query: 461 HGEIP------------PELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
G IP P+L +Q L +N L+G +P L C L ISLSNNHL
Sbjct: 557 SGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHL 616
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQS 568
GEIP + +L+NL IL LS N+ G IP E+G+ L L+L N NG IP +
Sbjct: 617 SGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLG 676
Query: 569 GKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHT 628
+ N K DG GNL E
Sbjct: 677 SLVKLNLTKNKL------DGPVPA-SLGNLKE---------------------------- 701
Query: 629 QPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNI 688
+ +D+S+N LSG + E+ +M L L + N +G IP+E+G+L L
Sbjct: 702 ---------LTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEY 752
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLP 748
LD+S N L G IP+ + L L ++L N L G +P G + A N LCG
Sbjct: 753 LDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG-- 810
Query: 749 LPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFC-IFGLIIVVVETRKRRKK-- 805
++ + + + R A + +G +F +F L + R +++
Sbjct: 811 -------RVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDP 863
Query: 806 ---KESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGF 862
+ES L ++D + + + S RE LSIN+A FE+PL K+ D++EAT+ F
Sbjct: 864 ERMEESRLKGFVDQNLYFLSGSRS------REPLSINIAMFEQPLLKVRLGDIVEATDHF 917
Query: 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
++IG GGFG VYKA L TVA+KKL QG+REF AEMET+GK+KH NLV LL
Sbjct: 918 SKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLL 977
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
GYC EE+LLVYEYM GSL+ L NQ + L+W+ R KIA+G+ARGLAFLHH IP
Sbjct: 978 GYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIP 1037
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
HIIHRD+K+SN+LLD +FE +V+DFG+ARL+SA ++H+S + +AGT GY+PPEY QS R
Sbjct: 1038 HIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVS-TVIAGTFGYIPPEYGQSARA 1096
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDN---NLVGWVKQHA-KLKISDVFDPELMKE 1098
+TKGDVYS+GV+LLEL+TGK PT DF ++ NLVGW Q + K DV DP L+
Sbjct: 1097 TTKGDVYSFGVILLELVTGKEPT-GPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSV 1155
Query: 1099 D-PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
N ++ LLQ +A CL + P +RP M+ V+ KEI
Sbjct: 1156 ALKNSQLRLLQ---IAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 385/1160 (33%), Positives = 588/1160 (50%), Gaps = 123/1160 (10%)
Query: 14 FISLSLLASAS-----SPNKDLQQLLSFKAALPNPS-VLPNWSP-NQNPCGFKGVSCKAA 66
F+++ +L S S S N++ + LL FKA L + + L +W+ + NPC + G++C
Sbjct: 7 FLAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTH- 65
Query: 67 SVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDL 126
L T+ ++ L N+SGT+S P + L L++
Sbjct: 66 -------------------------LRTVTSVDLNGMNLSGTLS-PLICKLHG-LRKLNV 98
Query: 127 SLNILSGPL-SDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGAN 185
S N +SGP+ D+S C SL+VL+L +N ++ ++L+ L L N + G+
Sbjct: 99 STNFISGPIPQDLSL---CRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGS- 154
Query: 186 VVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVPS-FGDCLA 242
+P + N L++L + N +TG I +++K + L+ + N FS +PS C +
Sbjct: 155 -IPRQIGN-LSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCES 212
Query: 243 LEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIP--VG-----------YNEFQ 289
L+ L ++ N G + + ++L+ L + N SG IP VG N F
Sbjct: 213 LKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFT 272
Query: 290 GEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSM 349
G IP + L + + +L L +N L+G++P G+ D S N+ +G +P E F +
Sbjct: 273 GSIPREIGKL-TKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKE-FGHI 330
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
NLK L L N G +P L LT LE LDLS N L+G IP L P L +L L +
Sbjct: 331 LNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPY--LVDLQLFD 388
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
N L G IP + S L +S N L+G IP+ L L L N+L G IP +L
Sbjct: 389 NQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLK 448
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
++L L L N+LTG+LP L N NL + L N L G I +G+L NL L+L+N
Sbjct: 449 TCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLAN 508
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYV-YIKNDG 588
N+F G IPPE+G+ ++ ++++N G IP L I + G K+ YI +
Sbjct: 509 NNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKEL-GSCVTIQRLDLSGNKFSGYIAQEL 567
Query: 589 SKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNML 648
+ + LE + RL+ G +F +M L + N+L
Sbjct: 568 GQLVY-----LEILRLSDNRLT---------------GEIPHSFGDLTRLMELQLGGNLL 607
Query: 649 SGSIPKEIGSMSYLFI-LNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL 707
S +IP E+G ++ L I LN+ HNNLSG IP +G+L+ L IL L+ N+L G IP+S+ +L
Sbjct: 608 SENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNL 667
Query: 708 TLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEK---DSGASANSRH 764
L ++ NN L G +P F+ + F N GLC C+ S + N
Sbjct: 668 MSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLI 727
Query: 765 QKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTAN 824
S R+ I +G +F L GL + K++E A V ++ ++ +
Sbjct: 728 NGSQRQKILTITCIVIGSVF-LITFLGLCWTI-------KRREPAF-VALEDQTKPDVMD 778
Query: 825 TSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDG 884
+ + P + T+ L++AT F D ++G G G VYKA++ G
Sbjct: 779 S-----------------YYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGG 821
Query: 885 STVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941
+A+KKL + G+G D F AE+ T+GKI+HRN+V L G+C LL+YEYM G
Sbjct: 822 EVIAVKKL-NSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKG 880
Query: 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001
SL + L +K + L+W AR +IA+G+A GL +LHH+C P I+HRD+KS+N+LLDE F+
Sbjct: 881 SLGEQLQRGEKNCL-LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQ 939
Query: 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG 1061
A V DFG+A+L+ + S+S +AG+ GY+ PEY + + + K D+YS+GVVLLEL+TG
Sbjct: 940 AHVGDFGLAKLID-LSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITG 998
Query: 1062 KRPTDSADFGDNNLVGWVKQHAKLKIS--DVFDPELMKEDPNIEIELLQHLHVASACLDD 1119
K P + G +LV WV++ + I ++FD L D E+ L +A C +
Sbjct: 999 KPPVQPLEQG-GDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSN 1057
Query: 1120 RPWRRPTMIQVMAMFKEIQA 1139
P RPTM +V+AM E +
Sbjct: 1058 SPASRPTMREVVAMITEARG 1077
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 490 bits (1262), Expect = e-137, Method: Compositional matrix adjust.
Identities = 391/1263 (30%), Positives = 606/1263 (47%), Gaps = 214/1263 (16%)
Query: 27 NKDLQQLLSFKAAL-PNPSV---LPNW-SPNQNPCGFKGVSCKAAS---VSSIDLSPFTL 78
N DLQ LL K +L NP L W S N N C + GV+C V +++L+ L
Sbjct: 24 NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGL 83
Query: 79 SVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDI 138
+ ++ + D L L L ++N+ G I P + L SL L N L+G +
Sbjct: 84 TGS---ISPWFGRFDNLIHLDLSSNNLVGPI--PTALSNLTSLESLFLFSNQLTGEIP-- 136
Query: 139 SYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISG---------ANVVPW 189
S LGS +++ L + N L E ++L++L L+ +++G V
Sbjct: 137 SQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSL 196
Query: 190 IL------------FNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVP 235
IL C +L N + G I + + +NL+ L++++N+ + +P
Sbjct: 197 ILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIP 256
Query: 236 S-FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGY--------- 285
S G+ L+YL + AN+ G + +++ +L L++S+N +G IP +
Sbjct: 257 SQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDL 316
Query: 286 ----NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGEL 341
N G +P + ++L +L LS LSG++P C SL+ D+S+N +G +
Sbjct: 317 VLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSI 376
Query: 342 PIEIFL-----------------------SMSNLKELVLSFNDFTGALPDSLSNLTNLET 378
P +F +++NL+ LVL N+ G LP +S L LE
Sbjct: 377 PEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEV 436
Query: 379 LDLSSNNLSGAIPHNL--CQ--------------------GPRNSLKELFLQNNLLLGSI 416
L L N SG IP + C G L L L+ N L+G +
Sbjct: 437 LFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGL 496
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
P++L NC QL L L+ N L+G+IPSS G L L+ L L+ N L G +P L +++ L
Sbjct: 497 PASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTR 556
Query: 477 LFLDFNELTGTL-----------------------PAALSNCTNLNWISLSNNHLGGEIP 513
+ L N L GT+ P L N NL+ + L N L G+IP
Sbjct: 557 INLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIP 616
Query: 514 TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSG---- 569
+G++ L++L +S+N+ G IP +L C+ L +DLN N +G IPP L K S
Sbjct: 617 WTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGEL 676
Query: 570 KIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629
K+++N V + N +L +S G
Sbjct: 677 KLSSNQFVESLPTELFN-------------------CTKLLVLSLDG-----NSLNGSIP 712
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLN-I 688
+ G++ L++ N SGS+P+ +G +S L+ L L N+L+G IP E+G L+ L
Sbjct: 713 QEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSA 772
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP----------------------V 726
LDLS N G IPS++ +L+ L +DL +NQLTG +P +
Sbjct: 773 LDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL 832
Query: 727 MGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSL 786
QF + FL N+GLCG PL C + +N++ Q R + +I S
Sbjct: 833 KKQFSRWPADSFLGNTGLCGSPLSRCNR---VRSNNKQQGLSARSVVIISAI------SA 883
Query: 787 FCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKP 846
GL+I+V+ +++ + H TA T + S + KP
Sbjct: 884 LTAIGLMILVIALFFKQRHD------FFKKVGHGSTAYT---------SSSSSSQATHKP 928
Query: 847 LRK-------LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG-Q 898
L + + + D++EAT+ + +IGSGG G VYKA+L++G TVA+KK++
Sbjct: 929 LFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLM 988
Query: 899 GDREFTAEMETIGKIKHRNLVPLLGYCKVGEE--RLLVYEYMRYGSLEDVLHNQKKVGIK 956
++ F+ E++T+G+I+HR+LV L+GYC E LL+YEYM+ GS+ D LH K V K
Sbjct: 989 SNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEK 1048
Query: 957 ----LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012
L+W AR +IA+G A+G+ +LHH+C+P I+HRD+KSSNVLLD N EA + DFG+A++
Sbjct: 1049 KKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKV 1108
Query: 1013 MSA-MDTHLSVST-LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF 1070
++ DT+ +T A + GY+ PEY S + + K DVYS G+VL+E++TGK PTDS
Sbjct: 1109 LTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFG 1168
Query: 1071 GDNNLVGWVKQHAKLKIS---DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM 1127
+ ++V WV+ H ++ S + DP+L P E Q L +A C P RP+
Sbjct: 1169 AEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSS 1228
Query: 1128 IQV 1130
Q
Sbjct: 1229 RQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 370/1186 (31%), Positives = 585/1186 (49%), Gaps = 189/1186 (15%)
Query: 4 FSLLFLVFSSFISLSLLASASSPNKDLQQLLSF--KAALPNPSVLPNWSP-NQNPCGFKG 60
FS+ +F +F ++S S+ ++ L+S+ + P PSV W+P + +PC +
Sbjct: 18 FSITLSLFLAF----FISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPY 73
Query: 61 VSCKAAS---VSSIDLSPFTLSVDFHL-VASFLLTLDTLETLSLKNSNISGTISLPAGSR 116
++C ++ V+ I++ L++ F ++SF +L+ L + N+N++G IS
Sbjct: 74 ITCSSSDNKLVTEINVVSVQLALPFPPNISSF----TSLQKLVISNTNLTGAIS------ 123
Query: 117 CSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDL 176
S +G CS L V++LSSN L G + SL L
Sbjct: 124 ----------------------SEIGDCSELIVIDLSSNSL------VGEIPSSLGKLK- 154
Query: 177 SYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAV 234
L++L L N +TG I + C +L+ L++ N S +
Sbjct: 155 --------------------NLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENL 194
Query: 235 P-SFGDCLALEYLDISAN-KFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEI 292
P G LE + N + +G + I C +L L +++ SG +PV +
Sbjct: 195 PLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQL---- 250
Query: 293 PLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL 352
S L L + S LSG++P G+CS L + + N SG LP E+ + NL
Sbjct: 251 --------SKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELG-KLQNL 301
Query: 353 KELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL 412
++++L N+ G +P+ + + +L +DLS N SG IP + G ++L+EL L +N +
Sbjct: 302 EKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSF--GNLSNLQELMLSSNNI 359
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQ 472
GSIPS LSNC++LV + N ++G IP +G L +L W N+L G IP EL Q
Sbjct: 360 TGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQ 419
Query: 473 TLETLFLDFNELTGTLPAAL------------------------SNCTNLNWISLSNNHL 508
L+ L L N LTG+LPA L NCT+L + L NN +
Sbjct: 420 NLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRI 479
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK-- 566
GEIP IG L NL+ L LS N+ G +P E+ +CR L L+L+ N G +P +L
Sbjct: 480 TGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLT 539
Query: 567 --QSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVY 624
Q +++N + GK G+L+ + + S +
Sbjct: 540 KLQVLDVSSNDLTGKIP-----------DSLGHLISLNRLILSKNS-------------F 575
Query: 625 GGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFI-LNLGHNNLSGPIPTEVGDL 683
G + H ++ LD+S N +SG+IP+E+ + L I LNL N+L G IP + L
Sbjct: 576 NGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISAL 635
Query: 684 RGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSG 743
L++LD+S N L G + S++S L L +++ +N+ +G +P F A+ N+G
Sbjct: 636 NRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNG 694
Query: 744 LCGLPLPPC-EKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKR 802
LC C +S R SHR IA+GLL S+ + ++ V+ R +
Sbjct: 695 LCSKGFRSCFVSNSSQLTTQRGVHSHRL------RIAIGLLISVTAVLAVLGVLAVIRAK 748
Query: 803 RKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGF 862
+ ++ D+ S +G +W+ T P +KL F +
Sbjct: 749 QMIRD-------DNDSETGENLWTWQFT---------------PFQKLNFT-VEHVLKCL 785
Query: 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS---------GQGDRE-FTAEMETIGK 912
++IG G G VYKA++ + +A+KKL ++ G R+ F+AE++T+G
Sbjct: 786 VEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGS 845
Query: 913 IKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
I+H+N+V LG C RLL+Y+YM GSL +LH + V L W R KI +G+A+G
Sbjct: 846 IRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGV-CSLGWEVRYKIILGAAQG 904
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
LA+LHH+C+P I+HRD+K++N+L+ +FE + DFG+A+L+ D S +T+AG+ GY+
Sbjct: 905 LAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYI 964
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092
PEY S + + K DVYSYGVV+LE+LTGK+P D ++V WVK+ +++ D
Sbjct: 965 APEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVID--- 1021
Query: 1093 PELMKEDPNIEI-ELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ ++ P E+ E++Q L VA C++ P RPTM V AM EI
Sbjct: 1022 -QGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEI 1066
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1176 | ||||||
| 395335476 | 1184 | brassinosteroid receptor [Fragaria x ana | 0.971 | 0.965 | 0.745 | 0.0 | |
| 359480730 | 1191 | PREDICTED: systemin receptor SR160-like | 0.975 | 0.963 | 0.738 | 0.0 | |
| 449448434 | 1198 | PREDICTED: systemin receptor SR160-like | 0.971 | 0.953 | 0.730 | 0.0 | |
| 351734540 | 1187 | brassinosteroid receptor precursor [Glyc | 0.980 | 0.971 | 0.729 | 0.0 | |
| 255584913 | 1086 | serine/threonine-protein kinase bri1, pu | 0.909 | 0.984 | 0.778 | 0.0 | |
| 449531356 | 1151 | PREDICTED: systemin receptor SR160-like, | 0.964 | 0.985 | 0.731 | 0.0 | |
| 356516311 | 1184 | PREDICTED: brassinosteroid LRR receptor | 0.965 | 0.959 | 0.717 | 0.0 | |
| 224083833 | 1184 | predicted protein [Populus trichocarpa] | 0.974 | 0.967 | 0.743 | 0.0 | |
| 224096434 | 1193 | predicted protein [Populus trichocarpa] | 0.978 | 0.964 | 0.746 | 0.0 | |
| 37693462 | 1188 | brassinosteroid receptor [Pisum sativum] | 0.965 | 0.955 | 0.715 | 0.0 |
| >gi|395335476|gb|AFN54649.1| brassinosteroid receptor [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 1753 bits (4539), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 866/1161 (74%), Positives = 983/1161 (84%), Gaps = 18/1161 (1%)
Query: 22 SASSPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVD 81
S+S+ KD Q LLSFK +LP P++L NW P+QNPC F GV CK VSSIDLS LS +
Sbjct: 27 SSSAAYKDSQNLLSFKYSLPKPTLLSNWLPDQNPCLFSGVFCKQTRVSSIDLSLIPLSTN 86
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYL 141
+V++FL+T+D+L++L+LK + +SG +S PA S+CS L+S+DL+ N LSGP+S +S L
Sbjct: 87 LTVVSTFLMTIDSLQSLTLKTTALSGPVSFPAKSKCSPLLTSIDLAQNTLSGPISTLSNL 146
Query: 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQL 201
GSCS LK LNLSSNLLDF+ +++ LSL VLDLS+NKISG VPWIL NGC EL QL
Sbjct: 147 GSCSGLKSLNLSSNLLDFNVKDSTPFGLSLHVLDLSFNKISGP-AVPWILSNGCAELVQL 205
Query: 202 ALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAI 261
LKGNK+TGD++VS CK L+ LD SSNNF++ +PSFGDCL L+ LDIS NK +GDV +A+
Sbjct: 206 VLKGNKITGDMSVSGCKKLEILDFSSNNFTLEIPSFGDCLVLDRLDISGNKLSGDVANAL 265
Query: 262 SACEHLSFLNVSSNLFSGPIP-----------VGYNEFQGEIPLHLADLCSSLVKLDLSS 310
S+C HL+FLN+S N FSG IP + NEFQG IP L C SL++LDLS
Sbjct: 266 SSCSHLTFLNLSINHFSGQIPAVPAEKLKFLSLSGNEFQGTIPPSLLGSCESLLELDLSM 325
Query: 311 NNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL 370
NNLSG VP SC+SLE+ DIS N F+GELP+E L +S LK + LS NDF G LP SL
Sbjct: 326 NNLSGTVPDALSSCASLETLDISGNFFTGELPVETLLKLSKLKSVSLSLNDFVGTLPRSL 385
Query: 371 SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLH 430
S L +LE+LDLSSNN +G++P LC+GP NS KEL+LQNN G+IP ++SNC+QLV+L
Sbjct: 386 SKLAHLESLDLSSNNFTGSVPSWLCEGPGNSWKELYLQNNKFGGTIPPSISNCTQLVALD 445
Query: 431 LSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA 490
LSFNYLTGTIPSSLGSLSKL+DL LWLNQL GEIP EL + +LE L LDFNELTGT+P
Sbjct: 446 LSFNYLTGTIPSSLGSLSKLRDLILWLNQLSGEIPQELMYLGSLENLILDFNELTGTIPV 505
Query: 491 ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLD 550
LSNCTNL+WISL+NN L GEIP WIG+L LAILKLSNNSFYG IPPELGDC+SLIWLD
Sbjct: 506 GLSNCTNLSWISLANNKLSGEIPAWIGKLPKLAILKLSNNSFYGNIPPELGDCKSLIWLD 565
Query: 551 LNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS 610
LNTNL NGSIPP LFKQSG IA NF+ K YVYIKNDGSKECHGAGNLLEFAGIR E+L+
Sbjct: 566 LNTNLLNGSIPPGLFKQSGNIAVNFVASKTYVYIKNDGSKECHGAGNLLEFAGIRQEQLT 625
Query: 611 RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHN 670
R+STR+PCNFTRVY G QPTFNHNG+M+FLDIS+N LSGSIPKEIGSM YL+ILNLGHN
Sbjct: 626 RLSTRNPCNFTRVYRGILQPTFNHNGTMIFLDISHNRLSGSIPKEIGSMYYLYILNLGHN 685
Query: 671 NLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQF 730
N+SG IP E+G L+ LNILDLSSN L+G+IP ++ L++L EIDL NN L+GMIP GQF
Sbjct: 686 NISGAIPEELGKLKDLNILDLSSNSLDGSIPQTLVGLSMLMEIDLSNNHLSGMIPDSGQF 745
Query: 731 ETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIF 790
ETF +F+NNS LCG PL PC SGA+ N HQKSHR+ ASLAGS+AMGLLFSLFCIF
Sbjct: 746 ETFPAYRFMNNSDLCGYPLNPCGAASGANGNG-HQKSHRQ-ASLAGSVAMGLLFSLFCIF 803
Query: 791 GLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKL 850
GL+IV++ETRKRRKKK+S+LDVY+DSRSHSGTA WKLTGAREALSINL+TFEKPL+KL
Sbjct: 804 GLLIVLIETRKRRKKKDSSLDVYVDSRSHSGTA---WKLTGAREALSINLSTFEKPLQKL 860
Query: 851 TFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETI 910
TFADLLEATNGFHNDSLIGSGGFGDVYKA+LKDGS VAIKKLIHISGQGDREFTAEMETI
Sbjct: 861 TFADLLEATNGFHNDSLIGSGGFGDVYKAQLKDGSIVAIKKLIHISGQGDREFTAEMETI 920
Query: 911 GKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
GKIKHRNLVPLLGYCKVGEERLLVYEYM+YGSL+DVLH+QKK GIKL+W+ARRKIAIGSA
Sbjct: 921 GKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLDDVLHDQKK-GIKLSWSARRKIAIGSA 979
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
RGLAFLHHNCIPHIIHRDMKSSNVL+DEN EARVSDFGMARLMSAMDTHLSVSTLAGTPG
Sbjct: 980 RGLAFLHHNCIPHIIHRDMKSSNVLVDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1039
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090
YVPPEYYQSFRCSTKGDVYSYGVVLLELLTG+RPTDSADFGDNNLVGWVKQHAKLKISDV
Sbjct: 1040 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGRRPTDSADFGDNNLVGWVKQHAKLKISDV 1099
Query: 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIA 1150
FDPELMKEDP +EIELLQHL VA ACLDDRPWRRPTMIQVMAMFKEIQAGSG+DSQSTI
Sbjct: 1100 FDPELMKEDPTLEIELLQHLKVACACLDDRPWRRPTMIQVMAMFKEIQAGSGMDSQSTIG 1159
Query: 1151 TDEGGFGTVEMVEMSIQEAPE 1171
TD+GGFG VEMVEMSI+E PE
Sbjct: 1160 TDDGGFGAVEMVEMSIKEDPE 1180
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480730|ref|XP_002278935.2| PREDICTED: systemin receptor SR160-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1738 bits (4500), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 857/1161 (73%), Positives = 965/1161 (83%), Gaps = 14/1161 (1%)
Query: 28 KDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVAS 87
KD LLSFK +LPNP VL NW ++PC F GV+CK VSS+DL+ L+ + VA+
Sbjct: 32 KDATLLLSFKRSLPNPGVLQNWEEGRDPCYFTGVTCKGGRVSSLDLTSVELNAELRYVAT 91
Query: 88 FLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSL 147
FL+ +D LE LSL+++N++G +S +GSRC + LSSLDL+ N +SG +SD+ L SCSSL
Sbjct: 92 FLMGIDRLEFLSLQSTNLTGAVSSVSGSRCGALLSSLDLANNTVSGSISDLENLVSCSSL 151
Query: 148 KVLNLSSNLLDFSG--REAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
K LNLS N L+F+ R++G + LEVLDLS N+ISG NVV WIL GC +LK LALKG
Sbjct: 152 KSLNLSRNNLEFTAGRRDSGGVFTGLEVLDLSNNRISGENVVGWILSGGCRQLKSLALKG 211
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
N G I +S C NL++LDVS NNFS A PS G C AL YLD+SANKF+G++ + ++ C+
Sbjct: 212 NNANGSIPLSGCGNLEYLDVSFNNFS-AFPSLGRCSALNYLDLSANKFSGEIKNQLAYCQ 270
Query: 266 HLSFLNVSSNLFSGPIP-----------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
L+ LN+SSN F+G IP + N+FQG IPL LAD C +L++L+LSSNNLS
Sbjct: 271 QLNHLNLSSNHFTGAIPALPTANLEYVYLSGNDFQGGIPLLLADACPTLLELNLSSNNLS 330
Query: 315 GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT 374
G VPS F SCSSL S DIS N FSG LPI+ L +NL++L LS+N+F G+LP+SLS L
Sbjct: 331 GTVPSNFQSCSSLVSIDISRNNFSGVLPIDTLLKWTNLRKLSLSYNNFVGSLPESLSKLM 390
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
NLETLD+SSNN SG IP LC PRNSLKEL LQNNL G IP LSNCSQLVSL LSFN
Sbjct: 391 NLETLDVSSNNFSGLIPSGLCGDPRNSLKELHLQNNLFTGRIPEALSNCSQLVSLDLSFN 450
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN 494
YLTGTIPSSLGSL+KLQ L LWLNQLHG+IP EL N++TLE L LDFNELTG +P LSN
Sbjct: 451 YLTGTIPSSLGSLTKLQHLMLWLNQLHGQIPEELMNLKTLENLILDFNELTGPIPDGLSN 510
Query: 495 CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
CTNLNWISLSNN L GEIP WIG+LSNLAILKL NNSFYG IPPELGDCRSLIWLDLNTN
Sbjct: 511 CTNLNWISLSNNRLSGEIPGWIGKLSNLAILKLGNNSFYGSIPPELGDCRSLIWLDLNTN 570
Query: 555 LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST 614
G+IPPALFKQSG IA + GK YVYI+NDGSKECHGAGNLLE+ GIR E + RIST
Sbjct: 571 HLTGTIPPALFKQSGNIAVGLVTGKSYVYIRNDGSKECHGAGNLLEYGGIREEEMDRIST 630
Query: 615 RSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG 674
R+PCNFTRVY G T PTFNHNGS++FLD+SYNML GSIPKE+G+ YL+ILNL HNNLSG
Sbjct: 631 RNPCNFTRVYKGRTNPTFNHNGSLIFLDLSYNMLGGSIPKELGTPYYLYILNLAHNNLSG 690
Query: 675 PIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQ 734
IP E+G L+ +NILD S NRL+GTIP S+S L++LN+IDL NN L+G IP GQF TF
Sbjct: 691 AIPVELGGLKNVNILDFSYNRLQGTIPQSLSGLSMLNDIDLSNNNLSGTIPQSGQFLTFP 750
Query: 735 PAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLII 794
F NNSGLCG PL PC + ++++HQKSHRR ASL GS+AMGLLFSLFCIFGLII
Sbjct: 751 NLSFANNSGLCGFPLSPCGGGPNSISSTQHQKSHRRQASLVGSVAMGLLFSLFCIFGLII 810
Query: 795 VVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFAD 854
V +ETRKRRKKK+S LDVYIDS SHSGTAN SWKLTGAREALSINLATFEKPLRKLTFAD
Sbjct: 811 VAIETRKRRKKKDSTLDVYIDSNSHSGTANVSWKLTGAREALSINLATFEKPLRKLTFAD 870
Query: 855 LLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK 914
LLEATNGFHNDSLIGSGGFGDVY+A+LKDGS VAIKKLIHISGQGDREFTAEMETIGKIK
Sbjct: 871 LLEATNGFHNDSLIGSGGFGDVYRAQLKDGSIVAIKKLIHISGQGDREFTAEMETIGKIK 930
Query: 915 HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
HRNLVPLLGYCKVGEERLLVYEYMR+GSLED+LH++KK GIKLNWAARRKIAIG+ARGLA
Sbjct: 931 HRNLVPLLGYCKVGEERLLVYEYMRFGSLEDILHDRKKAGIKLNWAARRKIAIGAARGLA 990
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP
Sbjct: 991 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1050
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
EYYQSFRCSTKGDVYSYGVVLLELLTGK+PTDSADFGDNNLVGWVKQHAKL+ISDVFDPE
Sbjct: 1051 EYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKQHAKLRISDVFDPE 1110
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEG 1154
LMKEDPN+EIELLQHL VA ACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS STIAT++G
Sbjct: 1111 LMKEDPNLEIELLQHLKVACACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSASTIATEDG 1170
Query: 1155 GFGTVEMVEMSIQEAPELSTK 1175
GF VEMVEMSI+E PE S +
Sbjct: 1171 GFSAVEMVEMSIKEVPEFSKQ 1191
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448434|ref|XP_004141971.1| PREDICTED: systemin receptor SR160-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1714 bits (4440), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 845/1156 (73%), Positives = 972/1156 (84%), Gaps = 14/1156 (1%)
Query: 29 DLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASF 88
D Q+L+SFKA+LPNP++L NW N +PC F G++CK VS+IDLS +LS +F V
Sbjct: 40 DTQKLVSFKASLPNPTLLQNWLSNADPCSFSGITCKETRVSAIDLSFLSLSSNFSHVFPL 99
Query: 89 LLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLK 148
L LD LE+LSLK++N++G+ISLP+G +CS L+S+DLSLN L G +SD+S LG CS++K
Sbjct: 100 LAALDHLESLSLKSTNLTGSISLPSGFKCSPLLASVDLSLNGLFGSVSDVSNLGFCSNVK 159
Query: 149 VLNLSSNLLDFSGRE-AGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNK 207
LNLS N DF ++ A LKL L+VLDLS N+I G+ +VPWI GC L+ LALKGNK
Sbjct: 160 SLNLSFNAFDFPLKDSAPGLKLDLQVLDLSSNRIVGSKLVPWIFSGGCGSLQHLALKGNK 219
Query: 208 VTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHL 267
++G+IN+S C L+ LD+S NNFS+ +PS GDC LE+ DIS NKFTGDVGHA+S+C+ L
Sbjct: 220 ISGEINLSSCNKLEHLDISGNNFSVGIPSLGDCSVLEHFDISGNKFTGDVGHALSSCQQL 279
Query: 268 SFLNVSSNLFSGPIP-----------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+FLN+SSN F GPIP + N+FQGEIP+ +ADLCSSLV+LDLSSN+L G
Sbjct: 280 TFLNLSSNQFGGPIPSFASSNLWFLSLANNDFQGEIPVSIADLCSSLVELDLSSNSLIGA 339
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
VP+ GSC SL++ DIS N +GELPI +F MS+LK+L +S N F G L DSLS L L
Sbjct: 340 VPTALGSCFSLQTLDISKNNLTGELPIAVFAKMSSLKKLSVSDNKFFGVLSDSLSQLAIL 399
Query: 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYL 436
+LDLSSNN SG+IP LC+ P N+LKELFLQNN L G IP+++SNC+QLVSL LSFN+L
Sbjct: 400 NSLDLSSNNFSGSIPAGLCEDPSNNLKELFLQNNWLTGRIPASISNCTQLVSLDLSFNFL 459
Query: 437 TGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT 496
+GTIPSSLGSLSKL++L +WLNQL GEIP + N Q LE L LDFNELTGT+P+ LSNCT
Sbjct: 460 SGTIPSSLGSLSKLKNLIMWLNQLEGEIPSDFSNFQGLENLILDFNELTGTIPSGLSNCT 519
Query: 497 NLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLF 556
NLNWISLSNN L GEIP WIG L NLAILKLSNNSFYGRIP ELGDCRSLIWLDLNTNL
Sbjct: 520 NLNWISLSNNRLKGEIPAWIGSLPNLAILKLSNNSFYGRIPKELGDCRSLIWLDLNTNLL 579
Query: 557 NGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRS 616
NG+IPP LF+QSG IA NFI GK Y YIKNDGSK+CHGAGNLLEFAGIR E+++RIS++S
Sbjct: 580 NGTIPPELFRQSGNIAVNFITGKSYAYIKNDGSKQCHGAGNLLEFAGIRQEQVNRISSKS 639
Query: 617 PCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPI 676
PCNFTRVY G QPTFNHNGSM+FLD+S+NML+GSIPK+IGS +YL+IL+LGHN+LSGPI
Sbjct: 640 PCNFTRVYKGMIQPTFNHNGSMIFLDLSHNMLTGSIPKDIGSTNYLYILDLGHNSLSGPI 699
Query: 677 PTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPA 736
P E+GDL LNILDLS N LEG+IP S++ L+ L EIDL NN L G IP QFETF +
Sbjct: 700 PQELGDLTKLNILDLSGNELEGSIPLSLTGLSSLMEIDLSNNHLNGSIPESAQFETFPAS 759
Query: 737 KFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVV 796
F NNSGLCG PLPPC DS +ANS+HQ+SHR+ ASLAGS+AMGLLFSLFCIFGLIIVV
Sbjct: 760 GFANNSGLCGYPLPPCVVDSAGNANSQHQRSHRKQASLAGSVAMGLLFSLFCIFGLIIVV 819
Query: 797 VETRKRRKKKESALDVYIDSRSHSGTAN-TSWKLTGAREALSINLATFEKPLRKLTFADL 855
+E RKRRKKK+SALD Y++S S SGT +WKLTGAREALSINLATFEKPLRKLTFADL
Sbjct: 820 IEMRKRRKKKDSALDSYVESHSQSGTTTAVNWKLTGAREALSINLATFEKPLRKLTFADL 879
Query: 856 LEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKH 915
LEATNGFHNDSLIGSGGFGDVYKA+LKDGSTVAIKKLIH+SGQGDREFTAEMETIGKIKH
Sbjct: 880 LEATNGFHNDSLIGSGGFGDVYKAQLKDGSTVAIKKLIHVSGQGDREFTAEMETIGKIKH 939
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
RNLVPLLGYCKVGEERLLVYEYM+YGSLEDVLH+QKK GIKLNW+ARRKIAIG+ARGLAF
Sbjct: 940 RNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDQKKGGIKLNWSARRKIAIGAARGLAF 999
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
LHHNCIPHIIHRDMKSSNVLLDEN EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE
Sbjct: 1000 LHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1059
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
YYQSFRCSTKGDVYSYGVV+LELLTGKRPTDSADFGDNNLVGWVKQH KL DVFDPEL
Sbjct: 1060 YYQSFRCSTKGDVYSYGVVMLELLTGKRPTDSADFGDNNLVGWVKQHVKLDPIDVFDPEL 1119
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEGG 1155
+KEDP+++IELL+HL VA ACLDDR WRRPTMIQVM MFKEIQAGSG+DS STI TD GG
Sbjct: 1120 IKEDPSLKIELLEHLKVAVACLDDRSWRRPTMIQVMTMFKEIQAGSGMDSHSTIGTDNGG 1179
Query: 1156 FGTVEMVEMSIQEAPE 1171
F +V+MV+MS++E PE
Sbjct: 1180 F-SVDMVDMSLKEVPE 1194
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351734540|ref|NP_001237411.1| brassinosteroid receptor precursor [Glycine max] gi|212717157|gb|ACJ37420.1| brassinosteroid receptor [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1710 bits (4428), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 859/1177 (72%), Positives = 981/1177 (83%), Gaps = 24/1177 (2%)
Query: 14 FISLSLLASASSPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDL 73
FIS+ AS+SSP QQLLSFK +LPNPS+LPNW PNQ+PC F G+SC ++SIDL
Sbjct: 16 FISVCF-ASSSSPVT--QQLLSFKNSLPNPSLLPNWLPNQSPCTFSGISCNDTELTSIDL 72
Query: 74 SPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLP--AGSRCSSFLSSLDLSLNIL 131
S LS + ++ASFLL+LD L++LSLK++N+SG ++P + S+CSS L+SLDLS N L
Sbjct: 73 SSVPLSTNLTVIASFLLSLDHLQSLSLKSTNLSGPAAMPPLSHSQCSSSLTSLDLSQNSL 132
Query: 132 SGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWIL 191
S L+D+S+L SCS+L+ LNLSSNLL F L L D SYNKISG VV W+L
Sbjct: 133 SASLNDMSFLASCSNLQSLNLSSNLLQFGPPPHWKLH-HLRFADFSYNKISGPGVVSWLL 191
Query: 192 FNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISAN 251
N EL L+LKGNKVTG+ + S +LQ+LD+SSNNFS+ +P+FG+C +LEYLD+SAN
Sbjct: 192 -NPVIEL--LSLKGNKVTGETDFSGSISLQYLDLSSNNFSVTLPTFGECSSLEYLDLSAN 248
Query: 252 KFTGDVGHAISACEHLSFLNVSSNLFSGPIP-----------VGYNEFQGEIPLHLADLC 300
K+ GD+ +S C+ L +LNVSSN FSGP+P + N F G+IPL LADLC
Sbjct: 249 KYLGDIARTLSPCKSLVYLNVSSNQFSGPVPSLPSGSLQFVYLAANHFHGQIPLSLADLC 308
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
S+L++LDLSSNNL+G +P FG+C+SL+S DISSN F+G LP+ + M++LKEL ++FN
Sbjct: 309 STLLQLDLSSNNLTGALPGAFGACTSLQSLDISSNLFAGALPMSVLTQMTSLKELAVAFN 368
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLC----QGPRNSLKELFLQNNLLLGSI 416
F GALP+SLS L+ LE LDLSSNN SG+IP +LC G N+LKEL+LQNN G I
Sbjct: 369 GFLGALPESLSKLSALELLDLSSNNFSGSIPASLCGGGDAGINNNLKELYLQNNRFTGFI 428
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
P TLSNCS LV+L LSFN+LTGTIP SLGSLS L+D +WLNQLHGEIP EL +++LE
Sbjct: 429 PPTLSNCSNLVALDLSFNFLTGTIPPSLGSLSNLKDFIIWLNQLHGEIPQELMYLKSLEN 488
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536
L LDFN+LTG +P+ L NCT LNWISLSNN L GEIP WIG+LSNLAILKLSNNSF GRI
Sbjct: 489 LILDFNDLTGNIPSGLVNCTKLNWISLSNNRLSGEIPPWIGKLSNLAILKLSNNSFSGRI 548
Query: 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAG 596
PPELGDC SLIWLDLNTN+ G IPP LFKQSGKIA NFI GK YVYIKNDGSKECHGAG
Sbjct: 549 PPELGDCTSLIWLDLNTNMLTGPIPPELFKQSGKIAVNFISGKTYVYIKNDGSKECHGAG 608
Query: 597 NLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI 656
NLLEFAGI ++L+RISTR+PCNFTRVYGG QPTFNHNGSM+FLDIS+NMLSGSIPKEI
Sbjct: 609 NLLEFAGISQQQLNRISTRNPCNFTRVYGGKLQPTFNHNGSMIFLDISHNMLSGSIPKEI 668
Query: 657 GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLC 716
G+M YL+ILNLGHNN+SG IP E+G ++ LNILDLS+NRLEG IP S++ L+LL EIDL
Sbjct: 669 GAMYYLYILNLGHNNVSGSIPQELGKMKNLNILDLSNNRLEGQIPQSLTGLSLLTEIDLS 728
Query: 717 NNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAG 776
NN LTG IP GQF+TF AKF NNSGLCG+PL PC + + N++H KSHRR ASLAG
Sbjct: 729 NNLLTGTIPESGQFDTFPAAKFQNNSGLCGVPLGPCGSEPANNGNAQHMKSHRRQASLAG 788
Query: 777 SIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREAL 836
S+AMGLLFSLFC+FGLII+ +ETRKRRKKKE+AL+ Y D SHSG AN SWK T REAL
Sbjct: 789 SVAMGLLFSLFCVFGLIIIAIETRKRRKKKEAALEAYGDGNSHSGPANVSWKHTSTREAL 848
Query: 837 SINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS 896
SINLATFEKPLRKLTFADLL+ATNGFHNDSLIGSGGFGDVYKA+LKDGS VAIKKLIH+S
Sbjct: 849 SINLATFEKPLRKLTFADLLDATNGFHNDSLIGSGGFGDVYKAQLKDGSVVAIKKLIHVS 908
Query: 897 GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK 956
GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM+YGSLEDVLH+QKK GIK
Sbjct: 909 GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDQKKAGIK 968
Query: 957 LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016
LNWA RRKIAIG+ARGLAFLHHNCIPHIIHRDMKSSNVLLDEN EARVSDFGMARLMSAM
Sbjct: 969 LNWAIRRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1028
Query: 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076
DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV
Sbjct: 1029 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1088
Query: 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
GWVKQHAKLKISD+FDPELMKEDPN+E+ELLQHL +A +CLDDRPWRRPTMIQVMAMFKE
Sbjct: 1089 GWVKQHAKLKISDIFDPELMKEDPNLEMELLQHLKIAVSCLDDRPWRRPTMIQVMAMFKE 1148
Query: 1137 IQAGSGLDSQSTIATDEGGFGTVEMVEMSIQEAPELS 1173
IQAGSG+DSQSTIA DE GF VEMVEMSI+EAPELS
Sbjct: 1149 IQAGSGIDSQSTIANDEEGFNAVEMVEMSIKEAPELS 1185
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584913|ref|XP_002533171.1| serine/threonine-protein kinase bri1, putative [Ricinus communis] gi|223527020|gb|EEF29208.1| serine/threonine-protein kinase bri1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1704 bits (4414), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 843/1083 (77%), Positives = 942/1083 (86%), Gaps = 14/1083 (1%)
Query: 103 SNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGS-CSSLKVLNLSSNLLDFSG 161
SNI+G ISLP+GS+CSS LS+LDLS N LSGP+SDI+ L S C SLK LNLS+NLLDFS
Sbjct: 2 SNITGFISLPSGSKCSSVLSNLDLSENGLSGPVSDIAGLVSFCPSLKSLNLSTNLLDFSI 61
Query: 162 REAG--SLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKN 219
+E LKL LE+LD+S+NKISG+NVVP+IL GC+EL LALKGNKV+GD++VS CKN
Sbjct: 62 KEKSFNGLKLGLEILDISFNKISGSNVVPFILSGGCNELVYLALKGNKVSGDLDVSTCKN 121
Query: 220 LQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279
LQFLDVSSNNF++++PSFGDCLALE+LDIS+N+F GD+ HAIS C L+FLNVS+N FSG
Sbjct: 122 LQFLDVSSNNFNISIPSFGDCLALEHLDISSNEFYGDLAHAISDCAKLNFLNVSANDFSG 181
Query: 280 PIPV-----------GYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
+PV N F GEIPLHL D C L++LDLSSNNLSG +PS F +C+SL+
Sbjct: 182 EVPVLPTGSLQYVYLAGNHFHGEIPLHLIDACPGLIQLDLSSNNLSGSIPSSFAACTSLQ 241
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
SFDIS N F+GELPI MS+LK L S+N F G LPDS SNLT+LE LDLSSNNLSG
Sbjct: 242 SFDISINNFAGELPINTIFKMSSLKNLDFSYNFFIGGLPDSFSNLTSLEILDLSSNNLSG 301
Query: 389 AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS 448
IP LC+ P ++LKELFLQNNL GSIP+TLSNCSQL SLHLSFNYLTGTIPSS GSLS
Sbjct: 302 PIPSGLCKDPNSNLKELFLQNNLFTGSIPATLSNCSQLTSLHLSFNYLTGTIPSSFGSLS 361
Query: 449 KLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
KL+DLKLW N LHGEIPPE+ NIQTLETL LDFNELTG +P+ +SNC+ LNWISLSNN L
Sbjct: 362 KLRDLKLWFNLLHGEIPPEITNIQTLETLILDFNELTGVIPSGISNCSKLNWISLSNNRL 421
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQS 568
GEIP IGQLSNLAILKLSNNSFYGRIPPELGDC SLIWLDLNTN NG+IPP LFKQS
Sbjct: 422 TGEIPASIGQLSNLAILKLSNNSFYGRIPPELGDCSSLIWLDLNTNFLNGTIPPELFKQS 481
Query: 569 GKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHT 628
G IA NFI GK+YVY++N+ S+ CHG GNLLEFAGIR+E+L RISTR PC FTRVYGGHT
Sbjct: 482 GNIAVNFITGKRYVYLRNNKSERCHGEGNLLEFAGIRSEQLDRISTRHPCAFTRVYGGHT 541
Query: 629 QPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNI 688
QPTF NGSM+FLD+SYN LSG IPKE+G+M YL+ILNLGHNN++G IP E+G+L GL I
Sbjct: 542 QPTFKDNGSMIFLDLSYNKLSGCIPKEMGTMLYLYILNLGHNNITGSIPQELGNLDGLMI 601
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLP 748
L+LS+N+LEG IP+SM+ L+LL ID+ NN+L+GMIP MGQFETFQ A F NN+GLCG+P
Sbjct: 602 LNLSNNKLEGMIPNSMTRLSLLTAIDMSNNELSGMIPEMGQFETFQAASFANNTGLCGIP 661
Query: 749 LPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKES 808
LPPC G S+NS+HQKSHRR ASL GS+AMGLLFSLFCIF LIIV +ET+KRRKKKES
Sbjct: 662 LPPCGSGLGPSSNSQHQKSHRRQASLVGSVAMGLLFSLFCIFALIIVAIETKKRRKKKES 721
Query: 809 ALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLI 868
LDVY+D+ SHSG +TSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLI
Sbjct: 722 VLDVYMDNNSHSGPTSTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLI 781
Query: 869 GSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG 928
GSGGFGDVYKA+LKDGS VAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG
Sbjct: 782 GSGGFGDVYKAQLKDGSIVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG 841
Query: 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRD 988
EERLLVYEYM++GSLEDVLH+ KK GIKLNW+ARRKIAIG+ARGLAFLHHNCIPHIIHRD
Sbjct: 842 EERLLVYEYMKHGSLEDVLHDPKKSGIKLNWSARRKIAIGAARGLAFLHHNCIPHIIHRD 901
Query: 989 MKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDV 1048
MKSSNVLLDEN EARVSDFGMARLM+A+DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDV
Sbjct: 902 MKSSNVLLDENLEARVSDFGMARLMNAVDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDV 961
Query: 1049 YSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQ 1108
YSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI+DVFDP LMKEDPN++IELL+
Sbjct: 962 YSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKITDVFDPVLMKEDPNLKIELLR 1021
Query: 1109 HLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEGGFGTVEMVEMSIQE 1168
HL VA ACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTI T+E GF V+MVEMSI+E
Sbjct: 1022 HLDVACACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTITTEEDGFSAVQMVEMSIKE 1081
Query: 1169 APE 1171
PE
Sbjct: 1082 DPE 1084
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531356|ref|XP_004172652.1| PREDICTED: systemin receptor SR160-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1704 bits (4412), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 840/1148 (73%), Positives = 965/1148 (84%), Gaps = 14/1148 (1%)
Query: 37 KAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLE 96
KA+LPNP++L NW N +PC F G++CK VS+IDLS +LS +F V L LD LE
Sbjct: 1 KASLPNPTLLQNWLSNADPCSFSGITCKETRVSAIDLSFLSLSSNFSHVFPLLAALDHLE 60
Query: 97 TLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNL 156
+LSLK++N++G+ISLP+G +CS L+S+DLSLN L G +SD+S LG CS++K LNLS N
Sbjct: 61 SLSLKSTNLTGSISLPSGFKCSPLLASVDLSLNGLFGSVSDVSNLGFCSNVKSLNLSFNA 120
Query: 157 LDFSGRE-AGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVS 215
DF ++ A LKL L+VLDLS N+I G+ +VPWI GC L+ LALKGNK++G+IN+S
Sbjct: 121 FDFPLKDSAPGLKLDLQVLDLSSNRIVGSKLVPWIFSGGCGSLQHLALKGNKISGEINLS 180
Query: 216 KCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN 275
C L+ LD+S NNFS+ +PS GDC LE+ DIS NKFTGDVGHA+S+C+ L+FLN+SSN
Sbjct: 181 SCNKLEHLDISGNNFSVGIPSLGDCSVLEHFDISGNKFTGDVGHALSSCQQLTFLNLSSN 240
Query: 276 LFSGPIP-----------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSC 324
F GPIP + N+FQGEIP+ +ADLCSSLV+LDLSSN+L G VP+ GSC
Sbjct: 241 QFGGPIPSFASSNLWFLSLANNDFQGEIPVSIADLCSSLVELDLSSNSLIGAVPTALGSC 300
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
SL++ DIS N +GELPI +F MS+LK+L +S N F G L DSLS L L +LDLSSN
Sbjct: 301 FSLQTLDISKNNLTGELPIAVFAKMSSLKKLSVSDNKFFGVLSDSLSQLAILNSLDLSSN 360
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL 444
N SG+IP LC+ P N+LKELFLQNN L G IP+++SNC+QLVSL LSFN+L+GTIPSSL
Sbjct: 361 NFSGSIPAGLCEDPSNNLKELFLQNNWLTGRIPASISNCTQLVSLDLSFNFLSGTIPSSL 420
Query: 445 GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
GSLSKL++L +WLNQL GEIP + N Q LE L LDFNELTGT+P+ LSNCTNLNWISLS
Sbjct: 421 GSLSKLKNLIMWLNQLEGEIPSDFSNFQGLENLILDFNELTGTIPSGLSNCTNLNWISLS 480
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
NN L GEIP WIG L NLAILKLSNNSFYGRIP ELGDCRSLIWLDLNTNL NG+IPP L
Sbjct: 481 NNRLKGEIPAWIGSLPNLAILKLSNNSFYGRIPKELGDCRSLIWLDLNTNLLNGTIPPEL 540
Query: 565 FKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVY 624
F+QSG IA NFI GK Y YIKNDGSK+CHGAGNLLEFAGIR E+++RIS++SPCNFTRVY
Sbjct: 541 FRQSGNIAVNFITGKSYAYIKNDGSKQCHGAGNLLEFAGIRQEQVNRISSKSPCNFTRVY 600
Query: 625 GGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR 684
G QPTFNHNGSM+FLD+S+NML+GSIPK+IGS +YL+IL+LGHN+LSGPIP E+GDL
Sbjct: 601 KGMIQPTFNHNGSMIFLDLSHNMLTGSIPKDIGSTNYLYILDLGHNSLSGPIPQELGDLT 660
Query: 685 GLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGL 744
LNILDLS N LEG+IP S++ L+ L EIDL NN L G IP QFETF + F NNSGL
Sbjct: 661 KLNILDLSGNELEGSIPLSLTGLSSLMEIDLSNNHLNGSIPESAQFETFPASGFANNSGL 720
Query: 745 CGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKRRK 804
CG PLPPC DS +ANS+HQ+SHR+ ASLAGS+AMGLLFSLFCIFGLIIVV+E RKRRK
Sbjct: 721 CGYPLPPCVVDSAGNANSQHQRSHRKQASLAGSVAMGLLFSLFCIFGLIIVVIEMRKRRK 780
Query: 805 KKESALDVYIDSRSHSGTAN-TSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFH 863
KK+SALD Y++S S SGT +WKLTGAREALSINLATFEKPLRKLTFADLLEATNGFH
Sbjct: 781 KKDSALDSYVESHSQSGTTTAVNWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFH 840
Query: 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
NDSLIGSGGFGDVYKA+LKDGSTVAIKKLIH+SGQGDREFTAEMETIGKIKHRNLVPLLG
Sbjct: 841 NDSLIGSGGFGDVYKAQLKDGSTVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLG 900
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
YCKVGEERLLVYEYM+YGSLEDVLH+QKK GIKLNW+ARRKIAIG+ARGLAFLHHNCIPH
Sbjct: 901 YCKVGEERLLVYEYMKYGSLEDVLHDQKKGGIKLNWSARRKIAIGAARGLAFLHHNCIPH 960
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
IIHRDMKSSNVLLDEN EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS
Sbjct: 961 IIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1020
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
TKGDVYSYGVV+LELLTGKRPTDSADFGDNNLVGWVKQH KL DVFDPEL+KEDP+++
Sbjct: 1021 TKGDVYSYGVVMLELLTGKRPTDSADFGDNNLVGWVKQHVKLDPIDVFDPELIKEDPSLK 1080
Query: 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEGGFGTVEMVE 1163
IELL+HL VA ACLDDR WRRPTMIQVM MFKEIQAGSG+DS STI TD GGF +V+MV+
Sbjct: 1081 IELLEHLKVAVACLDDRSWRRPTMIQVMTMFKEIQAGSGMDSHSTIGTDNGGF-SVDMVD 1139
Query: 1164 MSIQEAPE 1171
MS++E PE
Sbjct: 1140 MSLKEVPE 1147
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516311|ref|XP_003526839.1| PREDICTED: brassinosteroid LRR receptor kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1701 bits (4405), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 832/1160 (71%), Positives = 969/1160 (83%), Gaps = 24/1160 (2%)
Query: 32 QLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCK-AASVSSIDLSPFTLSVDFHLVASFLL 90
QLLSFK +LPNP++LPNW PNQ+PC F G++C ++SIDLS L+ + ++A+FLL
Sbjct: 29 QLLSFKNSLPNPTLLPNWLPNQSPCSFTGITCNDTQHLTSIDLSGVPLTTNLTVIATFLL 88
Query: 91 TLDTLETLSLKNSNISGTISLP---AGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSL 147
TLD L++LSLK++N+SG ++P + S+C+S L+SLDLS N LSG L+D+S+L SCS+L
Sbjct: 89 TLDNLQSLSLKSTNLSGPAAMPPPLSHSKCASTLTSLDLSQNALSGSLNDMSFLSSCSNL 148
Query: 148 KVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNK 207
+ LNLSSNLL+F ++ KL L V D SYNKISG ++PW+L E++ LALKGNK
Sbjct: 149 QSLNLSSNLLEF---DSSHWKLHLLVADFSYNKISGPGILPWLL---NPEIEHLALKGNK 202
Query: 208 VTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHL 267
VTG+ + S +LQFLD+SSNNFS+ +P+FG+C +LEYLD+SANK+ GD+ +S C++L
Sbjct: 203 VTGETDFSGSNSLQFLDLSSNNFSVTLPTFGECSSLEYLDLSANKYFGDIARTLSPCKNL 262
Query: 268 SFLNVSSNLFSGPIP-----------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+LN SSN FSGP+P + N F G+IPL LADLCS+L++LDLSSNNLSG
Sbjct: 263 VYLNFSSNQFSGPVPSLPSGSLQFVYLASNHFHGQIPLPLADLCSTLLQLDLSSNNLSGA 322
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
+P FG+C+SL+SFDISSN F+G LP+++ M +LKEL ++FN F G LP+SL+ L+ L
Sbjct: 323 LPEAFGACTSLQSFDISSNLFAGALPMDVLTQMKSLKELAVAFNAFLGPLPESLTKLSTL 382
Query: 377 ETLDLSSNNLSGAIPHNLC---QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSF 433
E+LDLSSNN SG+IP LC G N LKEL+LQNN G IP TLSNCS LV+L LSF
Sbjct: 383 ESLDLSSNNFSGSIPTTLCGGDAGNNNILKELYLQNNRFTGFIPPTLSNCSNLVALDLSF 442
Query: 434 NYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALS 493
N+LTGTIP SLGSLSKL+DL +WLNQLHGEIP EL +++LE L LDFN+LTG +P+ L
Sbjct: 443 NFLTGTIPPSLGSLSKLKDLIIWLNQLHGEIPQELMYLKSLENLILDFNDLTGNIPSGLV 502
Query: 494 NCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNT 553
NCT LNWISLSNN L GEIP WIG+LSNLAILKLSNNSF GRIPPELGDC SLIWLDLNT
Sbjct: 503 NCTKLNWISLSNNRLSGEIPRWIGKLSNLAILKLSNNSFSGRIPPELGDCTSLIWLDLNT 562
Query: 554 NLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613
N+ G IPP LFKQSGKIA NFI GK YVYIKNDGSKECHGAGNLLEFAGI ++L+RIS
Sbjct: 563 NMLTGPIPPELFKQSGKIAVNFISGKTYVYIKNDGSKECHGAGNLLEFAGISQQQLNRIS 622
Query: 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS 673
TR+PCNFTRVYGG QPTFNHNGSM+FLDIS+NMLSGSIPKEIG+M YL+ILNLGHNN+S
Sbjct: 623 TRNPCNFTRVYGGKLQPTFNHNGSMIFLDISHNMLSGSIPKEIGAMYYLYILNLGHNNVS 682
Query: 674 GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETF 733
G IP E+G ++ LNILDLSSNRLEG IP S++ L+LL EIDL NN LTG IP GQF+TF
Sbjct: 683 GSIPQELGKMKNLNILDLSSNRLEGQIPQSLTGLSLLTEIDLSNNLLTGTIPESGQFDTF 742
Query: 734 QPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLI 793
A+F NNSGLCG+PL PC D + N++H KSHRR ASL GS+AMGLLFSLFC+FGLI
Sbjct: 743 PAARFQNNSGLCGVPLGPCGSDPANNGNAQHMKSHRRQASLVGSVAMGLLFSLFCVFGLI 802
Query: 794 IVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFA 853
I+ +ETRKRRKKKE+AL+ Y D HSG AN SWK T REALSINLATF++PLR+LTFA
Sbjct: 803 IIAIETRKRRKKKEAALEAYADGNLHSGPANVSWKHTSTREALSINLATFKRPLRRLTFA 862
Query: 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI 913
DLL+ATNGFHNDSLIGSGGFGDVYKA+LKDGS VAIKKLIH+SGQGDREFTAEMETIGKI
Sbjct: 863 DLLDATNGFHNDSLIGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKI 922
Query: 914 KHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
KHRNLVPLLGYCKVGEERLLVYEYM+YGSLEDVLH+ KK GIKLNW+ RRKIAIG+ARGL
Sbjct: 923 KHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDPKKAGIKLNWSIRRKIAIGAARGL 982
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
+FLHHNC PHIIHRDMKSSNVLLDEN EARVSDFGMAR MSAMDTHLSVSTLAGTPGYVP
Sbjct: 983 SFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARHMSAMDTHLSVSTLAGTPGYVP 1042
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
PEYY+SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD+FDP
Sbjct: 1043 PEYYESFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDIFDP 1102
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDE 1153
ELMKEDPN+E+ELLQHL +A +CLDDR WRRPTMIQV+ MFKEIQAGSG+DSQSTIA ++
Sbjct: 1103 ELMKEDPNLEMELLQHLKIAVSCLDDRHWRRPTMIQVLTMFKEIQAGSGIDSQSTIANED 1162
Query: 1154 GGFGTVEMVEMSIQEAPELS 1173
F VEMVEMSI+E PELS
Sbjct: 1163 DSFNAVEMVEMSIKETPELS 1182
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224083833|ref|XP_002307140.1| predicted protein [Populus trichocarpa] gi|222856589|gb|EEE94136.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1690 bits (4377), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 866/1164 (74%), Positives = 985/1164 (84%), Gaps = 18/1164 (1%)
Query: 24 SSPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAAS--VSSIDLSPFTLSVD 81
+S NKD Q L++FK L NPS+L NW P+QNPC F GV C+ + VSSIDL+ +L+ D
Sbjct: 22 TSANKDTQNLINFKTTLSNPSLLQNWLPDQNPCIFTGVKCQETTNRVSSIDLTNISLTCD 81
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYL 141
FH VA+FLLTL+ LE+LSLK++NISGTIS P GS+CSS LS+LDLS N LSG +SDI+ L
Sbjct: 82 FHPVAAFLLTLENLESLSLKSANISGTISFPFGSKCSSVLSNLDLSQNSLSGSVSDIAAL 141
Query: 142 GSCSSLKVLNLSSNLLDFS---GREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198
SC +LK L LS N ++FS + +G LS +DLS+NKI G+NVVP+IL GC++L
Sbjct: 142 RSCPALKSLGLSGNSIEFSVPKEKSSGLRGLSFTFIDLSFNKIVGSNVVPFILSGGCNDL 201
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
K LALKGNKV+GD++ S CKNLQ+LDVSSNNFS+ VPSFGDCLALE+LDIS+NKF GD+G
Sbjct: 202 KYLALKGNKVSGDVDFSSCKNLQYLDVSSNNFSVTVPSFGDCLALEHLDISSNKFYGDLG 261
Query: 259 HAISACEHLSFLNVSSNLFSGPIPV-----------GYNEFQGEIPLHLADLCSSLVKLD 307
AI C L+FLN+SSN FSGPIPV G N F+GEIPLHL D C LV LD
Sbjct: 262 RAIGGCVKLNFLNISSNKFSGPIPVFPTGNLQSLSLGGNHFEGEIPLHLMDACPGLVMLD 321
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
LSSNNLSG VP+ FGSC+SLESFDIS+N F+GELP + FL M++LK L L++N F G LP
Sbjct: 322 LSSNNLSGSVPNSFGSCTSLESFDISTNNFTGELPFDTFLKMTSLKRLDLAYNAFMGGLP 381
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
DSLS +LE+LDLSSN+LSG IP LCQ P N+ KEL+LQNN GSIP+TLSNCSQL
Sbjct: 382 DSLSQHASLESLDLSSNSLSGPIPAGLCQVPSNNFKELYLQNNRFTGSIPATLSNCSQLT 441
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT 487
+LHLS+NYLTGTIPSSLG+L+KL+DL LW NQLHGEIP EL NI+ LETL LDFNELTG
Sbjct: 442 ALHLSYNYLTGTIPSSLGTLNKLRDLNLWFNQLHGEIPLELMNIKALETLILDFNELTGV 501
Query: 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
+P+++SNCTNLNWISLSNN L GEIP IGQL +LAILKLSNNSF+GR+PPELGD RSLI
Sbjct: 502 IPSSISNCTNLNWISLSNNRLSGEIPASIGQLWSLAILKLSNNSFHGRVPPELGDSRSLI 561
Query: 548 WLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAE 607
WLDLNTN NG+IPP LFKQSG IA NFI GK+YVY+KN+ S++CHG G+LLEFAGIR+E
Sbjct: 562 WLDLNTNFLNGTIPPELFKQSGSIAVNFIRGKRYVYLKNEKSEQCHGEGDLLEFAGIRSE 621
Query: 608 RLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNL 667
L RIS+R PCNFTRVYG +TQ TFN NGSM+FLD+SYNMLSGSIP IGSMSYL+ILNL
Sbjct: 622 HLIRISSRHPCNFTRVYGDYTQXTFNDNGSMIFLDLSYNMLSGSIPAAIGSMSYLYILNL 681
Query: 668 GHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM 727
GHNNLSG IP E+G L GL+ILDLS+NRLEG IP SM+ L+LL+EID+ NN LTG+IP
Sbjct: 682 GHNNLSGNIPQEIGKLTGLDILDLSNNRLEGMIPQSMTVLSLLSEIDMSNNHLTGIIPEG 741
Query: 728 GQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLF 787
GQF+TF FLNNSGLCG+PLPPC S +S++S H KSHRR ASLA S+AMGLLFSLF
Sbjct: 742 GQFQTFLNRSFLNNSGLCGIPLPPCGSGSASSSSSGHHKSHRRQASLAESVAMGLLFSLF 801
Query: 788 CIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFE-KP 846
C FGLIIV +E +KR+KKKE+ALD+YIDSRSHSGT NT+WKLT AREALSI+LATF+ KP
Sbjct: 802 CFFGLIIVALEMKKRKKKKEAALDIYIDSRSHSGTTNTAWKLT-AREALSISLATFDSKP 860
Query: 847 LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAE 906
LRKLT+ADLLEATNGFHNDSLIGSGGFGDVYKA+LKDGS VAIKKLIHISGQGDREFTAE
Sbjct: 861 LRKLTYADLLEATNGFHNDSLIGSGGFGDVYKAELKDGSVVAIKKLIHISGQGDREFTAE 920
Query: 907 METIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966
METIGKIKH NLVPLLGYCKV EERLLVYEYM+YGSLEDVLHNQKK GIKLNWAARRKIA
Sbjct: 921 METIGKIKHDNLVPLLGYCKVREERLLVYEYMKYGSLEDVLHNQKKTGIKLNWAARRKIA 980
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA 1026
IG+A+GL FLHHNCIP IIHRDMKSSNVLLD N EARVSDFGMARLMS MDTHLSVSTLA
Sbjct: 981 IGAAKGLTFLHHNCIPLIIHRDMKSSNVLLDANLEARVSDFGMARLMSTMDTHLSVSTLA 1040
Query: 1027 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086
GTPGYVPPEYYQSFRCS KGDVYSYGVVLLELLTGKRPTDS+DFGDNNLVGWVKQHAKL+
Sbjct: 1041 GTPGYVPPEYYQSFRCSIKGDVYSYGVVLLELLTGKRPTDSSDFGDNNLVGWVKQHAKLR 1100
Query: 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQ 1146
ISDVFDP L+KEDP++E+ELL+HL VA ACLDDR RRPTMIQVM MFKEI AGSGLDSQ
Sbjct: 1101 ISDVFDPVLLKEDPSLEMELLEHLKVACACLDDRSGRRPTMIQVMTMFKEIHAGSGLDSQ 1160
Query: 1147 STIATDEGGFGTVEMVEMSIQEAP 1170
STIAT++GGF EMVEMSI+E P
Sbjct: 1161 STIATEDGGFSADEMVEMSIREGP 1184
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224096434|ref|XP_002310619.1| predicted protein [Populus trichocarpa] gi|222853522|gb|EEE91069.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1682 bits (4356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 873/1169 (74%), Positives = 989/1169 (84%), Gaps = 18/1169 (1%)
Query: 24 SSPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAAS--VSSIDLSPFTLSVD 81
SS N+D Q L++FK L NPS+L NW PNQNPC F GV C + V+SI L+ +LS D
Sbjct: 26 SSTNEDTQNLINFKTTLSNPSLLQNWLPNQNPCTFTGVKCHETTNRVTSIGLANISLSCD 85
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYL 141
FH VA+FLLTL++LE+LSLK++NISG+IS P GS+CSS LS LDLS + LSG +SDI+ L
Sbjct: 86 FHSVATFLLTLESLESLSLKSANISGSISFPPGSKCSSVLSYLDLSQSSLSGSVSDIATL 145
Query: 142 GSCSSLKVLNLSSNLLDFSGRE---AGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198
SC +LK L+LS N ++FS E +G LS + LDLS+NKI G+N VP+IL GC+EL
Sbjct: 146 RSCPALKSLDLSGNSIEFSVHEEKSSGLRGLSFKFLDLSFNKIVGSNAVPFILSEGCNEL 205
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
K LALKGNK++GDI+ S CKNLQ+LDVS+NNFS +VPSFG CLALE+LDISANKF GD+G
Sbjct: 206 KHLALKGNKLSGDIDFSSCKNLQYLDVSANNFSSSVPSFGKCLALEHLDISANKFYGDLG 265
Query: 259 HAISACEHLSFLNVSSNLFSGPIPV-----------GYNEFQGEIPLHLADLCSSLVKLD 307
HAI AC L+FLNVSSN FSG IPV G N F+G IPLHL D C L LD
Sbjct: 266 HAIGACVKLNFLNVSSNKFSGSIPVLPTASLQSLSLGGNLFEGGIPLHLVDACPGLFMLD 325
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
LSSNNL+G VPS GSC+SLE+ IS N F+GELP++ L M++LK L L++N FTG LP
Sbjct: 326 LSSNNLTGSVPSSLGSCTSLETLHISINNFTGELPVDTLLKMTSLKRLDLAYNAFTGGLP 385
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
DS S +LE+LDLSSN+LSG IP LC+GP N+LKEL+LQNN GS+P+TLSNCSQL
Sbjct: 386 DSFSQHASLESLDLSSNSLSGPIPTGLCRGPSNNLKELYLQNNRFTGSVPATLSNCSQLT 445
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT 487
+LHLSFNYLTGTIPSSLGSL +L+DL LW NQLHGEIPPEL NI+ LETL LDFNELTG
Sbjct: 446 ALHLSFNYLTGTIPSSLGSLYELRDLNLWFNQLHGEIPPELMNIEALETLILDFNELTGV 505
Query: 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
+P+ +SNCTNLNWISLSNN L GEIP IG+L +LAILKLSNNSFYGRIPPELGDCRSLI
Sbjct: 506 IPSGISNCTNLNWISLSNNRLSGEIPASIGKLGSLAILKLSNNSFYGRIPPELGDCRSLI 565
Query: 548 WLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAE 607
WLDLN+N NG+IPP LFKQSG IA NFI GK+YVY+KN S++CHG GNLLEFAGIR E
Sbjct: 566 WLDLNSNFLNGTIPPELFKQSGSIAVNFIRGKRYVYLKNAKSEQCHGEGNLLEFAGIRWE 625
Query: 608 RLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNL 667
+L+RIS+ PCNF+RVYG +TQPTFN NGSM+FLD+SYNMLSGSIP IGSMSYL++L L
Sbjct: 626 QLNRISSSHPCNFSRVYGEYTQPTFNDNGSMIFLDLSYNMLSGSIPAAIGSMSYLYVLIL 685
Query: 668 GHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM 727
GHNN SG IP E+G L GL+ILDLS+NRLEG IP SM+ L+LL+EID+ NN LTGMIP
Sbjct: 686 GHNNFSGNIPQEIGKLTGLDILDLSNNRLEGIIPPSMTGLSLLSEIDMSNNHLTGMIPEG 745
Query: 728 GQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLF 787
GQF TF F+NNSGLCG+PLPPC SG+S+N HQKSHRR ASLAGS+AMGLLFSLF
Sbjct: 746 GQFVTFLNHSFVNNSGLCGIPLPPCGSASGSSSNIEHQKSHRRLASLAGSVAMGLLFSLF 805
Query: 788 CIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFE-KP 846
CIFGL+IVVVE +KR+KKK+SALDVYIDSRSHSGTANT+WKLTG REALSI++ATFE KP
Sbjct: 806 CIFGLLIVVVEMKKRKKKKDSALDVYIDSRSHSGTANTAWKLTG-REALSISIATFESKP 864
Query: 847 LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAE 906
LR LTF DLLEATNGFHNDSLIGSGGFGDVYKA+LKDGS VAIKKLIHISGQGDREFTAE
Sbjct: 865 LRNLTFPDLLEATNGFHNDSLIGSGGFGDVYKAELKDGSIVAIKKLIHISGQGDREFTAE 924
Query: 907 METIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966
METIGKIKHRNLVPLLGYCKVGEER+LVYEYM+YGSLEDVLHNQKK GI+LNWAARRKIA
Sbjct: 925 METIGKIKHRNLVPLLGYCKVGEERILVYEYMKYGSLEDVLHNQKKTGIRLNWAARRKIA 984
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA 1026
IG+ARGL FLHH+CIP IIHRDMKSSNVLLDEN EARVSDFGMARLMS MDTHLSVSTLA
Sbjct: 985 IGAARGLTFLHHSCIPLIIHRDMKSSNVLLDENLEARVSDFGMARLMSTMDTHLSVSTLA 1044
Query: 1027 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086
GTPGYVPPEYYQSFRCS KGDVYS+GVVLLELLTGKRPTDS+DFGDNNLVGWVKQHAKL+
Sbjct: 1045 GTPGYVPPEYYQSFRCSIKGDVYSFGVVLLELLTGKRPTDSSDFGDNNLVGWVKQHAKLR 1104
Query: 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQ 1146
ISDVFDP L+KEDPN+E+ELLQHL VA ACLDDRPWRRPTMIQVMA FKEIQAGSGLDSQ
Sbjct: 1105 ISDVFDPVLLKEDPNLEMELLQHLKVACACLDDRPWRRPTMIQVMATFKEIQAGSGLDSQ 1164
Query: 1147 STIATDEGGFGTVEMVEMSIQEAPELSTK 1175
ST T++GGF VEMVEMSI+E PELS +
Sbjct: 1165 STTGTEDGGFSAVEMVEMSIKEGPELSKQ 1193
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|37693462|dbj|BAC99050.1| brassinosteroid receptor [Pisum sativum] | Back alignment and taxonomy information |
|---|
Score = 1669 bits (4323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 826/1154 (71%), Positives = 964/1154 (83%), Gaps = 19/1154 (1%)
Query: 32 QLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLT 91
QLL FK +LPNPS+L +W P +NPC F G++C +V+SIDL+ L+ + +VA++LLT
Sbjct: 38 QLLYFKQSLPNPSLLHDWLPYKNPCSFTGITCNQTTVTSIDLTSIPLNTNLTVVATYLLT 97
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
LD L+ L+LK+SNI+ + + ++C+S L+++DLS N +S SD+++L SCS LK LN
Sbjct: 98 LDHLQVLTLKSSNITSSPISLSHTKCTSSLTTIDLSQNTISSSFSDLAFLSSCSGLKSLN 157
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
LS+N LDF + +L SL +LD+S NKISG PWIL + EL+ L+L+GNKVTG+
Sbjct: 158 LSNNQLDFDSPKW-TLSSSLRLLDVSDNKISGPGFFPWILNH---ELEFLSLRGNKVTGE 213
Query: 212 INVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
+ S L++LD+SSNNF++++PSFGDC +L++LDISANK+ GD+ +S C++L LN
Sbjct: 214 TDFSGYTTLRYLDISSNNFTVSIPSFGDCSSLQHLDISANKYFGDITRTLSPCKNLLHLN 273
Query: 272 VSSNLFSGPIP-----------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320
+S N F+GP+P + N F G+IP LADLCS+LV+LDLSSNNL+G VP
Sbjct: 274 LSGNQFTGPVPSLPSGSLQFLYLAENHFAGKIPARLADLCSTLVELDLSSNNLTGPVPRE 333
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380
FG+C+S+ SFDISSNKF+GELP+E+ M++LKEL ++FN+F G LP+SLS LT LE+LD
Sbjct: 334 FGACTSVTSFDISSNKFAGELPMEVLTEMNSLKELTVAFNEFAGPLPESLSKLTGLESLD 393
Query: 381 LSSNNLSGAIPHNLC-QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGT 439
LSSNN SG IP LC + N+LK L+LQNN+ G IP TLSNCS LV+L LSFNYLTGT
Sbjct: 394 LSSNNFSGTIPRWLCGEESGNNLKGLYLQNNVFTGFIPPTLSNCSNLVALDLSFNYLTGT 453
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
IP SLGSLSKL+DL +WLNQLHGEIP EL N+++LE L LDFNEL+GT+P+ L NCT LN
Sbjct: 454 IPPSLGSLSKLRDLIMWLNQLHGEIPQELSNMESLENLILDFNELSGTIPSGLVNCTKLN 513
Query: 500 WISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGS 559
WISLSNN L GEIP+WIG+LSNLAILKLSNNSF GRIPPELGDC SLIWLDLNTN G
Sbjct: 514 WISLSNNRLTGEIPSWIGKLSNLAILKLSNNSFSGRIPPELGDCPSLIWLDLNTNFLTGP 573
Query: 560 IPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCN 619
IPP L KQSGK+ NFI GK YVYIKNDGSKECHGAG+LLEFAGI E+L RISTR+PCN
Sbjct: 574 IPPELGKQSGKVVVNFISGKTYVYIKNDGSKECHGAGSLLEFAGINQEQLRRISTRNPCN 633
Query: 620 FTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTE 679
FTRVYGG QPTF NGSM+FLD+S+NMLSG+IPKEIG M+YL++L+L HNNLSG IP E
Sbjct: 634 FTRVYGGKLQPTFTLNGSMIFLDVSHNMLSGTIPKEIGEMTYLYVLHLSHNNLSGSIPQE 693
Query: 680 VGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFL 739
+G ++ LNILDLS N+L+ IP +++ L+LL EID NN L+GMIP GQF+TF KFL
Sbjct: 694 LGKMKNLNILDLSYNKLQDQIPQTLTRLSLLTEIDFSNNCLSGMIPESGQFDTFPVGKFL 753
Query: 740 NNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVET 799
NNSGLCG+PLPPC DSG A S+H +SHRR ASLAGS+AMGLLFSLFC+FGLII+ +ET
Sbjct: 754 NNSGLCGVPLPPCGSDSGGGAGSQH-RSHRRQASLAGSVAMGLLFSLFCVFGLIIIAIET 812
Query: 800 RKRRKKKESALDVYIDSRSHSGTANTS-WKLTGAREALSINLATFEKPLRKLTFADLLEA 858
RKRRKKKE+A+D YID+ SHSG AN S WKLT AREALSINLATFEKPLRKLTFADLL A
Sbjct: 813 RKRRKKKEAAIDGYIDN-SHSGNANNSGWKLTSAREALSINLATFEKPLRKLTFADLLAA 871
Query: 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNL 918
TNGFHNDSLIGSGGFGDVYKA+LKDGS VAIKKLIH+SGQGDREFTAEMETIGKIKHRNL
Sbjct: 872 TNGFHNDSLIGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNL 931
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
VPLLGYCKVGEERLLVYEYM+YGSLEDVLH+ KK GIK+NW+ RRKIAIG+ARGLAFLHH
Sbjct: 932 VPLLGYCKVGEERLLVYEYMKYGSLEDVLHDPKKAGIKMNWSVRRKIAIGAARGLAFLHH 991
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
NCIPHIIHRDMKSSNVLLDEN EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ
Sbjct: 992 NCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1051
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098
SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD ELMKE
Sbjct: 1052 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDKELMKE 1111
Query: 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEGGFGT 1158
DPN+EIELLQHL VA ACLDDRPWRRPTMIQVMA FKEIQAGSG+DSQSTIAT++ GF
Sbjct: 1112 DPNLEIELLQHLKVACACLDDRPWRRPTMIQVMAKFKEIQAGSGMDSQSTIATEDEGFNA 1171
Query: 1159 VEMVEMSIQEAPEL 1172
+EMVEMSI+E PEL
Sbjct: 1172 IEMVEMSIKEVPEL 1185
|
Source: Pisum sativum Species: Pisum sativum Genus: Pisum Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1176 | ||||||
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.957 | 0.941 | 0.646 | 0.0 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.837 | 0.878 | 0.585 | 5e-305 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.822 | 0.830 | 0.518 | 1.1e-264 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.836 | 0.843 | 0.502 | 6.9e-261 | |
| TAIR|locus:2041150 | 1143 | BRL2 "BRI1-like 2" [Arabidopsi | 0.770 | 0.792 | 0.489 | 6.8e-230 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.795 | 0.785 | 0.374 | 2.2e-148 | |
| TAIR|locus:2019255 | 1106 | AT1G74360 [Arabidopsis thalian | 0.426 | 0.452 | 0.370 | 8.4e-136 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.779 | 0.885 | 0.354 | 2.6e-132 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.407 | 0.475 | 0.414 | 1.3e-131 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.812 | 0.738 | 0.357 | 1.3e-130 |
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3710 (1311.0 bits), Expect = 0., P = 0.
Identities = 761/1178 (64%), Positives = 877/1178 (74%)
Query: 28 KDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVAS 87
+++ QL+SFK LP+ ++LP+WS N+NPC F GV+C+ V+SIDLS L+V F V+S
Sbjct: 34 REIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSS 93
Query: 88 FXXXXXXXXXXXXKNSNISGTIS---LPAGXXXXXXXXXXXX---XXXXXXGPLSDISYL 141
NS+I+G++S A G S + +L
Sbjct: 94 SLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 153
Query: 142 --------------GXXXXXXXXXXXXXXXDFSGREAGSLKLSLEVLDLSYNKISGANVV 187
G SG LS +L + ISG +
Sbjct: 154 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 213
Query: 188 PWILFNGCDELKQLALKGNKV-TGDINVSKCKNLQFLDVSSN----NFSMAVPSFGDCLA 242
+ + C L+ L + N TG + C LQ LD+S N +FS A+ + C
Sbjct: 214 GDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAIST---CTE 270
Query: 243 LEYLDISANKFTGDVGHA-ISACEHXXXXXXXXXXXXGPIPVGYNEFQGEIPLHLADLCS 301
L+ L+IS+N+F G + + + ++ + + N+F GEIP L+ C
Sbjct: 271 LKLLNISSNQFVGPIPPLPLKSLQY--------------LSLAENKFTGEIPDFLSGACD 316
Query: 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND 361
+L LDLS N+ G VP FGSCS LES +SSN FSGELP++ L M LK L LSFN+
Sbjct: 317 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 376
Query: 362 FTGALPDSLSNLT-NLETLDLSSNNLSGAIPHNLCQGPRNSXXXXXXXXXXXXGSIPSTL 420
F+G LP+SL+NL+ +L TLDLSSNN SG I NLCQ P+N+ G IP TL
Sbjct: 377 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 436
Query: 421 SNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480
SNCS+LVSLHLSFNYL+GTIPSSLGSLSKL+DLKLWLN L GEIP EL ++TLETL LD
Sbjct: 437 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 496
Query: 481 FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPEL 540
FN+LTG +P+ LSNCTNLNWISLSNN L GEIP WIG+L NLAILKLSNNSF G IP EL
Sbjct: 497 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 556
Query: 541 GDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDG-SKECHGAGNLL 599
GDCRSLIWLDLNTNLFNG+IP A+FKQSGKIAANFI GK+YVYIKNDG KECHGAGNLL
Sbjct: 557 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 616
Query: 600 EFAGIRAERLSRISTRSPCNFT-RVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGS 658
EF GIR+E+L+R+STR+PCN T RVYGGHT PTF++NGSMMFLD+SYNMLSG IPKEIGS
Sbjct: 617 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 676
Query: 659 MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718
M YLFILNLGHN++SG IP EVGDLRGLNILDLSSN+L+G IP +MS+LT+L EIDL NN
Sbjct: 677 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 736
Query: 719 QLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSH-RRPASLAGS 777
L+G IP MGQFETF PAKFLNN GLCG PLP C+ S A + HQ+SH RRPASLAGS
Sbjct: 737 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP-SNADGYAHHQRSHGRRPASLAGS 795
Query: 778 IAMGLLFSLFCIFGLIIVVVETXXXXXXXESALDVYIDSRSHSG--TAN-TSWKLTGARE 834
+AMGLLFS CIFGLI+V E E+ L++Y + +SG TAN T+WKLTG +E
Sbjct: 796 VAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKE 855
Query: 835 ALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIH 894
ALSINLA FEKPLRKLTFADLL+ATNGFHNDSLIGSGGFGDVYKA LKDGS VAIKKLIH
Sbjct: 856 ALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIH 915
Query: 895 ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVG 954
+SGQGDREF AEMETIGKIKHRNLVPLLGYCKVG+ERLLVYE+M+YGSLEDVLH+ KK G
Sbjct: 916 VSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAG 975
Query: 955 IKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014
+KLNW+ RRKIAIGSARGLAFLHHNC PHIIHRDMKSSNVLLDEN EARVSDFGMARLMS
Sbjct: 976 VKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMS 1035
Query: 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDS DFGDNN
Sbjct: 1036 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNN 1095
Query: 1075 LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134
LVGWVKQHAKL+ISDVFDPELMKEDP +EIELLQHL VA ACLDDR WRRPTM+QVMAMF
Sbjct: 1096 LVGWVKQHAKLRISDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRRPTMVQVMAMF 1155
Query: 1135 KEIQAGSGLDSQSTIAT-DEGGFGTVEMVEMSIQEAPE 1171
KEIQAGSG+DSQSTI + ++GGF T+EMV+MSI+E PE
Sbjct: 1156 KEIQAGSGIDSQSTIRSIEDGGFSTIEMVDMSIKEVPE 1193
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2927 (1035.4 bits), Expect = 5.0e-305, P = 5.0e-305
Identities = 605/1033 (58%), Positives = 735/1033 (71%)
Query: 161 GREAGSLKLSLEVLDLSYNK-ISGANVVPWILFNGCDELKQLALKGNKV----TGDINVS 215
G GS L+ LDLS N + G+ L + C LK L L G+ V G
Sbjct: 112 GARCGS---KLQALDLSGNAALRGSVADVAALASACGGLKTLNLSGDAVGAAKVGGGGGP 168
Query: 216 KCKNLQFLDVSSNNFS-------MAVPSFGDCLALEYLDISANKFTGDVGHAISACEHXX 268
L LD+S+N + M G A+ +LD++ N+ +G V + C
Sbjct: 169 GFAGLDSLDLSNNKITDDSDLRWMVDAGVG---AVRWLDLALNRISG-VPE-FTNCSGLQ 223
Query: 269 XXXXXXXXXXGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
G +P G L+D C L L+LS N+L+G P +SL
Sbjct: 224 YLDLSGNLIVGEVPGGA----------LSD-CRGLKVLNLSFNHLAGVFPPDIAGLTSLN 272
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
+ ++S+N FSGELP E F + L L LSFN F G++PD++++L L+ LDLSSN SG
Sbjct: 273 ALNLSNNNFSGELPGEAFAKLQQLTALSLSFNHFNGSIPDTVASLPELQQLDLSSNTFSG 332
Query: 389 AIPHNLCQGPRNSXXXXXXXXXXXXGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS 448
IP +LCQ P + G IP +SNC+ LVSL LS NY+ G+IP+SLG L
Sbjct: 333 TIPSSLCQDPNSKLHLLYLQNNYLTGGIPDAVSNCTSLVSLDLSLNYINGSIPASLGDLG 392
Query: 449 KLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
LQDL LW N+L GEIP L IQ LE L LD+N LTG++P L+ CT LNWISL++N L
Sbjct: 393 NLQDLILWQNELEGEIPASLSRIQGLEHLILDYNGLTGSIPPELAKCTKLNWISLASNRL 452
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQS 568
G IP+W+G+LS LAILKLSNNSF G IPPELGDC+SL+WLDLN+N NGSIP L KQS
Sbjct: 453 SGPIPSWLGKLSYLAILKLSNNSFSGPIPPELGDCQSLVWLDLNSNQLNGSIPKELAKQS 512
Query: 569 GKIAANFIVGKKYVYIKNDG-SKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGH 627
GK+ IVG+ YVY++ND S EC G G+LLEF IR + LSR+ ++ CNFTR+Y G
Sbjct: 513 GKMNVGLIVGRPYVYLRNDELSSECRGKGSLLEFTSIRPDDLSRMPSKKLCNFTRMYVGS 572
Query: 628 TQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLN 687
T+ TFN NGSM+FLD+SYN L +IP E+G M YL I+NLGHN LSG IP+ + + + L
Sbjct: 573 TEYTFNKNGSMIFLDLSYNQLDSAIPGELGDMFYLMIMNLGHNLLSGTIPSRLAEAKKLA 632
Query: 688 ILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGL 747
+LDLS N+LEG IP+S S+L+L +EI+L NNQL G IP +G TF +++ NN+GLCG
Sbjct: 633 VLDLSYNQLEGPIPNSFSALSL-SEINLSNNQLNGTIPELGSLATFPKSQYENNTGLCGF 691
Query: 748 PLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETXXXXXXXE 807
PLPPC+ S S+N HQ SHRR AS+A SIAMGLLFSLFCI +II + E
Sbjct: 692 PLPPCDHSSPRSSND-HQ-SHRRQASMASSIAMGLLFSLFCIIVIIIAIGSKRRRLKNEE 749
Query: 808 SAL--DVYIDSRSHSGTANTSWK--LTGAREALSINLATFEKPLRKLTFADLLEATNGFH 863
++ D+YIDSRSHS T N+ W+ L+G LSINLA FEKPL+ LT ADL+EATNGFH
Sbjct: 750 ASTSRDIYIDSRSHSATMNSDWRQNLSGTN-LLSINLAAFEKPLQNLTLADLVEATNGFH 808
Query: 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IGSGGFGDVYKA+LKDG VAIKKLIH+SGQGDREFTAEMETIGKIKHRNLVPLLG
Sbjct: 809 IACQIGSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLG 868
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
YCK GEERLLVY+YM++GSLEDVLH++KK+G KLNW ARRKIA+G+ARGLAFLHHNCIPH
Sbjct: 869 YCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNCIPH 928
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
IIHRDMKSSNVL+DE EARVSDFGMARLMS +DTHLSVSTLAGTPGYVPPEYYQSFRC+
Sbjct: 929 IIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCT 988
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFG-DNNLVGWVKQHAKLKISDVFDPELMKEDPNI 1102
TKGDVYSYGVVLLELLTGK PTDSADFG DNNLVGWVKQH KLKI+DVFDPEL+KEDP++
Sbjct: 989 TKGDVYSYGVVLLELLTGKPPTDSADFGEDNNLVGWVKQHTKLKITDVFDPELLKEDPSV 1048
Query: 1103 EIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIAT----DEGGFGT 1158
E+ELL+HL +A ACLDDRP RRPTM++VMAMFKEIQAGS +DS+++ A DEGG+G
Sbjct: 1049 ELELLEHLKIACACLDDRPSRRPTMLKVMAMFKEIQAGSTVDSKTSSAAAGSIDEGGYG- 1107
Query: 1159 VEMVEMSIQEAPE 1171
+++M ++EA E
Sbjct: 1108 --VLDMPLREAKE 1118
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2514 (890.0 bits), Expect = 1.1e-264, Sum P(2) = 1.1e-264
Identities = 524/1010 (51%), Positives = 680/1010 (67%)
Query: 158 DFSGRE-AGSLKLS-------LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT 209
+FS + AG LK S + +DLS N+ S + + + + LK L L GN VT
Sbjct: 156 NFSHNKLAGKLKSSPSASNKRITTVDLSNNRFSD-EIPETFIADFPNSLKHLDLSGNNVT 214
Query: 210 GD---INVSKCKNLQFLDVSSNNFSM-AVP-SFGDCLALEYLDISANKFTGDVGHAISAC 264
GD ++ C+NL +S N+ S P S +C LE L++S N G I
Sbjct: 215 GDFSRLSFGLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSLIGK----IPGD 270
Query: 265 EHXXXXXXXXXXXXGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSC 324
++ + + +N + GEIP L+ LC +L LDLS N+L+G++P F SC
Sbjct: 271 DYWGNFQNLRQ-----LSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSC 325
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
SL+S ++ +NK SG+ + +S + L L FN+ +G++P SL+N +NL LDLSSN
Sbjct: 326 GSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSN 385
Query: 385 NLSGAIPHNLCQGPRNSXXXXXXXXXXX-XGSIPSTLSNCSQLVSLHLSFNYLTGTIPSS 443
+G +P C +S G++P L C L ++ LSFN LTG IP
Sbjct: 386 EFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKE 445
Query: 444 LGSLSKLQDLKLWLNQLHGEIPPEL----GNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
+ +L KL DL +W N L G IP + GN LETL L+ N LTG+LP ++S CTN+
Sbjct: 446 IWTLPKLSDLVMWANNLTGGIPESICVDGGN---LETLILNNNLLTGSLPESISKCTNML 502
Query: 500 WISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGS 559
WISLS+N L GEIP IG+L LAIL+L NNS G IP ELG+C++LIWLDLN+N G+
Sbjct: 503 WISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGN 562
Query: 560 IPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCN 619
+P L Q+G + + GK++ +++N+G +C GAG L+EF GIRAERL C
Sbjct: 563 LPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCP 622
Query: 620 FTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTE 679
TR+Y G T F+ NGSM++LD+SYN +SGSIP G+M YL +LNLGHN L+G IP
Sbjct: 623 KTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDS 682
Query: 680 VGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFL 739
G L+ + +LDLS N L+G +P S+ L+ L+++D+ NN LTG IP GQ TF ++
Sbjct: 683 FGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYA 742
Query: 740 NNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVET 799
NNSGLCG+PLPPC SG+ H +H + S+A ++ G++FS CI ++I+ +
Sbjct: 743 NNSGLCGVPLPPCS--SGSRPTRSH--AHPKKQSIATGMSAGIVFSFMCIV-MLIMALYR 797
Query: 800 XXXXXXXESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEAT 859
E + YI+S SG++ SWKL+ E LSIN+ATFEKPLRKLTFA LLEAT
Sbjct: 798 ARKVQKKEKQREKYIESLPTSGSS--SWKLSSVHEPLSINVATFEKPLRKLTFAHLLEAT 855
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLV 919
NGF DS+IGSGGFGDVYKAKL DGS VAIKKLI ++GQGDREF AEMETIGKIKHRNLV
Sbjct: 856 NGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLV 915
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQ-KKVGIKLNWAARRKIAIGSARGLAFLHH 978
PLLGYCK+GEERLLVYEYM+YGSLE VLH + KK GI L+W+AR+KIAIG+ARGLAFLHH
Sbjct: 916 PLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHH 975
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+CIPHIIHRDMKSSNVLLD++F ARVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQ
Sbjct: 976 SCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQ 1035
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG-DNNLVGWVKQ-HAKLKISDVFDPELM 1096
SFRC+ KGDVYSYGV+LLELL+GK+P D +FG DNNLVGW KQ + + + +++ DPEL+
Sbjct: 1036 SFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELV 1095
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE-IQAGSGLDS 1145
D + ++ELL +L +AS CLDDRP++RPTMIQVM MFKE +Q + DS
Sbjct: 1096 T-DKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDS 1144
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2477 (877.0 bits), Expect = 6.9e-261, Sum P(2) = 6.9e-261
Identities = 515/1025 (50%), Positives = 682/1025 (66%)
Query: 161 GREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCD-ELKQLALKGNKVTGD---INVSK 216
G SL+ SL +DLSYN +S + +P + LK L L N ++GD ++
Sbjct: 168 GFAPSSLQ-SLTTVDLSYNILS--DKIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGI 224
Query: 217 CKNLQFLDVSSNNFSM-AVP-SFGDCLALEYLDISANKFTGDVGHAISACEHXXXXXXXX 274
C NL F +S NN S P + +C LE L+IS N G + + E+
Sbjct: 225 CGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNG----EYWGSFQNLK 280
Query: 275 XXXXGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISS 334
+ + +N GEIP L+ LC +LV LDLS N SG++PS+F +C L++ ++ +
Sbjct: 281 Q-----LSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGN 335
Query: 335 NKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNL 394
N SG+ + ++ + L +++N+ +G++P SL+N +NL LDLSSN +G +P
Sbjct: 336 NYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGF 395
Query: 395 CQGPRNSXXXXXXXXXXX-XGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453
C + G++P L C L ++ LSFN LTG IP + L L DL
Sbjct: 396 CSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDL 455
Query: 454 KLWLNQLHGEIPPEL----GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG 509
+W N L G IP + GN LETL L+ N LTG++P ++S CTN+ WISLS+N L
Sbjct: 456 VMWANNLTGTIPEGVCVKGGN---LETLILNNNLLTGSIPESISRCTNMIWISLSSNRLT 512
Query: 510 GEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSG 569
G+IP+ IG LS LAIL+L NNS G +P +LG+C+SLIWLDLN+N G +P L Q+G
Sbjct: 513 GKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAG 572
Query: 570 KIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629
+ + GK++ +++N+G +C GAG L+EF GIRAERL R+ C TR+Y G T
Sbjct: 573 LVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTM 632
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNIL 689
TF+ NGSM++ DISYN +SG IP G+M YL +LNLGHN ++G IP G L+ + +L
Sbjct: 633 YTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVL 692
Query: 690 DLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPL 749
DLS N L+G +P S+ SL+ L+++D+ NN LTG IP GQ TF +++ NNSGLCG+PL
Sbjct: 693 DLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPL 752
Query: 750 PPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETXXXXXXXESA 809
PC SR H + ++A ++ G+ FS C F ++++ + E
Sbjct: 753 RPCGSAPRRPITSR---IHAKKQTVATAVIAGIAFSFMC-FVMLVMALYRVRKVQKKEQK 808
Query: 810 LDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIG 869
+ YI+S SG+ SWKL+ E LSIN+ATFEKPLRKLTFA LLEATNGF ++++G
Sbjct: 809 REKYIESLPTSGSC--SWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVG 866
Query: 870 SGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929
SGGFG+VYKA+L+DGS VAIKKLI I+GQGDREF AEMETIGKIKHRNLVPLLGYCKVGE
Sbjct: 867 SGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGE 926
Query: 930 ERLLVYEYMRYGSLEDVLHNQ--KKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
ERLLVYEYM++GSLE VLH + KK GI LNWAAR+KIAIG+ARGLAFLHH+CIPHIIHR
Sbjct: 927 ERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHR 986
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGD 1047
DMKSSNVLLDE+FEARVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQSFRC+ KGD
Sbjct: 987 DMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGD 1046
Query: 1048 VYSYGVVLLELLTGKRPTDSADFG-DNNLVGWVKQ-HAKLKISDVFDPELMKEDPNIEIE 1105
VYSYGV+LLELL+GK+P D +FG DNNLVGW KQ + + + +++ DPEL+ D + ++E
Sbjct: 1047 VYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVT-DKSGDVE 1105
Query: 1106 LLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATDEGGFGTVEMVEMS 1165
L +L +AS CLDDRP++RPTMIQ+MAMFKE++A D++ + DE +VE S
Sbjct: 1106 LFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMKA----DTEEDESLDEFSLKETPLVEES 1161
Query: 1166 IQEAP 1170
+ P
Sbjct: 1162 RDKEP 1166
|
|
| TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2218 (785.8 bits), Expect = 6.8e-230, P = 6.8e-230
Identities = 460/940 (48%), Positives = 598/940 (63%)
Query: 174 LDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDIN-----VSKCKNLQFLDVSSN 228
+ LSYN +G +P LF +L+ L L N +TG I+ +S C ++ +LD S N
Sbjct: 157 ITLSYNNFTGK--LPNDLFLSSKKLQTLDLSYNNITGPISGLTIPLSSCVSMTYLDFSGN 214
Query: 229 NFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHXXXXXXXXXXXXGPIPVGYNE 287
+ S + S +C L+ L++S N F G + + + + + +N
Sbjct: 215 SISGYISDSLINCTNLKSLNLSYNNFDGQIPKSFGELKLLQS-----------LDLSHNR 263
Query: 288 FQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFL 347
G IP + D C SL L LS NN +G +P SCS L+S D+S+N SG P I
Sbjct: 264 LTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILR 323
Query: 348 SMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSXXXXXX 407
S +L+ L+LS N +G P S+S +L D SSN SG IP +LC G S
Sbjct: 324 SFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIPPDLCPGAA-SLEELRL 382
Query: 408 XXXXXXGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE 467
G IP +S CS+L ++ LS NYL GTIP +G+L KL+ W N + GEIPPE
Sbjct: 383 PDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQFIAWYNNIAGEIPPE 442
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
+G +Q L+ L L+ N+LTG +P NC+N+ W+S ++N L GE+P G LS LA+L+L
Sbjct: 443 IGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDFGILSRLAVLQL 502
Query: 528 SNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSG-KIAANFIVGKKYVYIKN 586
NN+F G IPPELG C +L+WLDLNTN G IPP L +Q G K + + G +++N
Sbjct: 503 GNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRN 562
Query: 587 DGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYN 646
G+ C G G L+EF+GIR ERL +I + C+FTR+Y G F ++ +LD+SYN
Sbjct: 563 VGNS-CKGVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYN 621
Query: 647 MLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSS 706
L G IP EIG M L +L L HN LSG IP +G L+ L + D S NRL+G IP S S+
Sbjct: 622 QLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSN 681
Query: 707 LTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSG----ASANS 762
L+ L +IDL NN+LTG IP GQ T ++ NN GLCG+PLP C+ + +
Sbjct: 682 LSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEG 741
Query: 763 RHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETXXXXXXXESALDVYIDSRSHSGT 822
+ K R AS A SI +G+L S + LI+ + + A ++ +S T
Sbjct: 742 KRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSAT 801
Query: 823 ANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK 882
+WK+ +E LSIN+ATF++ LRKL F+ L+EATNGF S+IG GGFG+V+KA LK
Sbjct: 802 ---TWKIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLK 858
Query: 883 DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942
DGS+VAIKKLI +S QGDREF AEMET+GKIKHRNLVPLLGYCK+GEERLLVYE+M+YGS
Sbjct: 859 DGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGS 918
Query: 943 LEDVLHNQKKVGIK---LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN 999
LE+VLH + G K L W R+KIA G+A+GL FLHHNCIPHIIHRDMKSSNVLLD++
Sbjct: 919 LEEVLHGPR-TGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQD 977
Query: 1000 FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1059
EARVSDFGMARL+SA+DTHLSVSTLAGTPGYVPPEYYQSFRC+ KGDVYS GVV+LE+L
Sbjct: 978 MEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEIL 1037
Query: 1060 TGKRPTDSADFGDNNLVGWVKQHAKL-KISDVFDPELMKE 1098
+GKRPTD +FGD NLVGW K A+ K +V D +L+KE
Sbjct: 1038 SGKRPTDKEEFGDTNLVGWSKMKAREGKHMEVIDEDLLKE 1077
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1380 (490.8 bits), Expect = 2.2e-148, Sum P(2) = 2.2e-148
Identities = 376/1005 (37%), Positives = 530/1005 (52%)
Query: 162 REAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKN 219
+E LK L LDLSYN + + +P F L L L ++ G I + CK+
Sbjct: 228 KEISKLK-HLAKLDLSYNPLKCS--IPKS-FGELHNLSILNLVSAELIGLIPPELGNCKS 283
Query: 220 LQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHXXXXXXXXXXXXG 279
L+ L +S N+ S +P LE +I F+ + + +S
Sbjct: 284 LKSLMLSFNSLSGPLP-------LELSEIPLLTFSAE-RNQLSG---SLPSWMGKWKVLD 332
Query: 280 PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSG 339
+ + N F GEIP + D C L L L+SN LSG +P SLE+ D+S N SG
Sbjct: 333 SLLLANNRFSGEIPHEIED-CPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSG 391
Query: 340 ELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPR 399
+ E+F S+L EL+L+ N G++P+ L L L LDL SNN +G IP +L +
Sbjct: 392 TIE-EVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIPKSLWKS-- 447
Query: 400 NSXXXXXXXXXXXXGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
+ G +P+ + N + L L LS N LTG IP +G L+ L L L N
Sbjct: 448 TNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANM 507
Query: 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPT----W 515
G+IP ELG+ +L TL L N L G +P ++ L + LS N+L G IP+ +
Sbjct: 508 FQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAY 567
Query: 516 IGQLS--NLAILK------LSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567
Q+ +L+ L+ LS N G IP ELG+C L+ + L+ N +G IP +L +
Sbjct: 568 FHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRL 627
Query: 568 SG----KIAANFIVGKKYVYIKNDGSKECHGAGNLL--EFAGIRAERLSRISTRSPCNFT 621
+ ++ N + G + N S + G NL + G E + + N T
Sbjct: 628 TNLTILDLSGNALTGSIPKEMGN--SLKLQGL-NLANNQLNGHIPESFGLLGSLVKLNLT 684
Query: 622 R-VYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV 680
+ G + + + +D+S+N LSG + E+ +M L L + N +G IP+E+
Sbjct: 685 KNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSEL 744
Query: 681 GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLN 740
G+L L LD+S N L G IP+ + L L ++L N L G +P G + A
Sbjct: 745 GNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSG 804
Query: 741 NSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFC-IFGLIIVVVET 799
N LCG + K G S +AG + +G +F +F L +
Sbjct: 805 NKELCGRVVGSDCKIEGTKLRSAW--------GIAG-LMLGFTIIVFVFVFSLRRWAMTK 855
Query: 800 XXXXXXXESALDVYIDSRSHSGTANTSWKLTGAR--EALSINLATFEKPLRKLTFADLLE 857
++ +SR + L+G+R E LSIN+A FE+PL K+ D++E
Sbjct: 856 RVKQRDDPERME---ESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVE 912
Query: 858 ATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN 917
AT+ F ++IG GGFG VYKA L TVA+KKL QG+REF AEMET+GK+KH N
Sbjct: 913 ATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPN 972
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
LV LLGYC EE+LLVYEYM GSL+ L NQ + L+W+ R KIA+G+ARGLAFLH
Sbjct: 973 LVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLH 1032
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
H IPHIIHRD+K+SN+LLD +FE +V+DFG+ARL+SA ++H+S + +AGT GY+PPEY
Sbjct: 1033 HGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVS-TVIAGTFGYIPPEYG 1091
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN---NLVGWVKQHAKL-KISDVFDP 1093
QS R +TKGDVYS+GV+LLEL+TGK PT DF ++ NLVGW Q K DV DP
Sbjct: 1092 QSARATTKGDVYSFGVILLELVTGKEPT-GPDFKESEGGNLVGWAIQKINQGKAVDVIDP 1150
Query: 1094 ELMKED-PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
L+ N ++ LLQ +A CL + P +RP M+ V+ KEI
Sbjct: 1151 LLVSVALKNSQLRLLQ---IAMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| TAIR|locus:2019255 AT1G74360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 807 (289.1 bits), Expect = 8.4e-136, Sum P(2) = 8.4e-136
Identities = 203/548 (37%), Positives = 306/548 (55%)
Query: 624 YGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDL 683
+ G + + + L + +N G +P EIG + F LNL NN SG IP E+G+L
Sbjct: 582 FSGEIPASISQMDRLSTLHLGFNEFEGKLPPEIGQLPLAF-LNLTRNNFSGEIPQEIGNL 640
Query: 684 RGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQ-LTGMIPVMGQFETFQPAKFLNNS 742
+ L LDLS N G P+S++ L L++ ++ N ++G IP GQ TF FL N
Sbjct: 641 KCLQNLDLSFNNFSGNFPTSLNDLNELSKFNISYNPFISGAIPTTGQVATFDKDSFLGNP 700
Query: 743 GLCGLPLPPCEKDSGASANS-RHQKSHRRPASLAG---SIAMGLLF-SLFCIFGLIIVVV 797
L L P SG + +Q RP +L S+A+ L F + + G++++VV
Sbjct: 701 -L--LRFPSFFNQSGNNTRKISNQVLGNRPRTLLLIWISLALALAFIACLVVSGIVLMVV 757
Query: 798 ETXXXXXXXESALDVYIDSRS-HSGTANTS----WKLTGAREALSINLATFEKPLRKLTF 852
+ E+ +D+ S++ H T+++ W L+G + + ++ +TF T+
Sbjct: 758 KASR-----EAEIDLLDGSKTRHDMTSSSGGSSPW-LSGKIKVIRLDKSTF-------TY 804
Query: 853 ADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETI-- 910
AD+L+AT+ F + ++G GG+G VY+ L DG VA+KKL + ++EF AEME +
Sbjct: 805 ADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQREGTEAEKEFRAEMEVLSA 864
Query: 911 ---GKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI 967
G H NLV L G+C G E++LV+EYM GSLE+++ ++ K L W R IA
Sbjct: 865 NAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITDKTK----LQWKKRIDIAT 920
Query: 968 GSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG 1027
ARGL FLHH C P I+HRD+K+SNVLLD++ ARV+DFG+ARL++ D+H+S + +AG
Sbjct: 921 DVARGLVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDFGLARLLNVGDSHVS-TVIAG 979
Query: 1028 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087
T GYV PEY Q+++ +T+GDVYSYGV+ +EL TG+R D G+ LV W ++ +
Sbjct: 980 TIGYVAPEYGQTWQATTRGDVYSYGVLTMELATGRRAVDG---GEECLVEWARRVMTGNM 1036
Query: 1088 SDVFDP-ELMKEDP-NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS---- 1141
+ P L P N ++ + L + C D P RP M +V+AM +I +
Sbjct: 1037 TAKGSPITLSGTKPGNGAEQMTELLKIGVKCTADHPQARPNMKEVLAMLVKISGKAELFN 1096
Query: 1142 GLDSQSTI 1149
GL SQ I
Sbjct: 1097 GLSSQGYI 1104
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 2.6e-132, Sum P(2) = 2.6e-132
Identities = 342/964 (35%), Positives = 499/964 (51%)
Query: 197 ELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVPSFGDCLAL-EYLDISANKF 253
EL+ L L N++ G++ +SK + LQ LD+S N S +V L L + L+IS+N
Sbjct: 89 ELRVLDLSRNQLKGEVPAEISKLEQLQVLDLSHNLLSGSVLGVVSGLKLIQSLNISSNSL 148
Query: 254 TG---DVGHA-------ISACEHXXXXXXXXXXXXGPIPV---GYNEFQGEIPLHLADLC 300
+G DVG +S G I V N G + L +
Sbjct: 149 SGKLSDVGVFPGLVMLNVSNNLFEGEIHPELCSSSGGIQVLDLSMNRLVGNLD-GLYNCS 207
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
S+ +L + SN L+G++P S LE +S N SGEL + ++S LK L++S N
Sbjct: 208 KSIQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLS-NLSGLKSLLISEN 266
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSXXXXXXXXXXXXGSIPSTL 420
F+ +PD NLT LE LD+SSN SG P +L Q + GSI
Sbjct: 267 RFSDVIPDVFGNLTQLEHLDVSSNKFSGRFPPSLSQCSK--LRVLDLRNNSLSGSINLNF 324
Query: 421 SNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480
+ + L L L+ N+ +G +P SLG K++ L L N+ G+IP N+Q+L L L
Sbjct: 325 TGFTDLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLFLSLS 384
Query: 481 FN---ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537
N + + T+ L +C NL+ + LS N +G EIP + NLAIL L N G+IP
Sbjct: 385 NNSFVDFSETMNV-LQHCRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRGQIP 443
Query: 538 PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGN 597
L +C+ L LDL+ N F G+IP + GK+ + F + + N
Sbjct: 444 SWLLNCKKLEVLDLSWNHFYGTIPHWI----GKMESLFYIDFSNNTLTGAIPVAITELKN 499
Query: 598 LLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIG 657
L+ G ++ S+ P R + P + + ++ N L+G+I EIG
Sbjct: 500 LIRLNGTASQMTD--SSGIPLYVKRNKSSNGLPYNQVSRFPPSIYLNNNRLNGTILPEIG 557
Query: 658 SMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCN 717
+ L +L+L NN +G IP + L L +LDLS N L G+IP S SLT L+ +
Sbjct: 558 RLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAY 617
Query: 718 NQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRRPASLAGS 777
N+LTG IP GQF +F + F N GLC PC+ +N + K R + G
Sbjct: 618 NRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDV---LMSNMLNPKGSSRRNNNGGK 674
Query: 778 IAMGLLFSLFCIFGLIIVVVETXXXXXXXESALDVYIDSRSHSGTANTSWKLTGAREALS 837
+ L L I + S DV D R + T ++G +AL
Sbjct: 675 FGRSSIVVL--TISLAIGITLLLSVILLRISRKDV--DDRINDVDEET---ISGVSKALG 727
Query: 838 IN-LATFEK-PLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHI 895
+ + F + L+ +LL++TN F ++IG GGFG VYKA DGS A+K+L
Sbjct: 728 PSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGD 787
Query: 896 SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGI 955
GQ +REF AE+E + + +H+NLV L GYCK G +RLL+Y +M GSL+ LH + +
Sbjct: 788 CGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNM 847
Query: 956 KLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015
L W R KIA G+ARGLA+LH C P++IHRD+KSSN+LLDE FEA ++DFG+ARL+
Sbjct: 848 TLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRP 907
Query: 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-NN 1074
DTH++ L GT GY+PPEY QS + +GDVYS+GVVLLEL+TG+RP + +
Sbjct: 908 YDTHVTTD-LVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRD 966
Query: 1075 LVGWVKQ-HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
LV V Q A+ + +++ D + +E+ N E +L+ L +A C+D P RRP + +V+
Sbjct: 967 LVSRVFQMKAEKREAELIDTTI-RENVN-ERTVLEMLEIACKCIDHEPRRRPLIEEVVTW 1024
Query: 1134 FKEI 1137
+++
Sbjct: 1025 LEDL 1028
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 910 (325.4 bits), Expect = 1.3e-131, Sum P(3) = 1.3e-131
Identities = 207/499 (41%), Positives = 301/499 (60%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
+++ +N LSG I +E G++ L + +L N LSG IP+ + + L LDLS+NRL G+I
Sbjct: 528 IELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSI 587
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASA 760
P S+ L+ L++ + N L+G+IP GQF+TF + F +N LCG PC + + ++
Sbjct: 588 PVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNH-LCGEHRFPCSEGTESAL 646
Query: 761 NSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETXXXXXXXESALDVYIDSRSHS 820
R ++S +A IA G +F L + LI++ +D I+ S
Sbjct: 647 IKRSRRSRGGDIGMAIGIAFGSVF-LLTLLSLIVL------RARRRSGEVDPEIEE---S 696
Query: 821 GTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK 880
+ N K G E S + F+ ++L++ DLL++TN F ++IG GGFG VYKA
Sbjct: 697 ESMNR--KELG--EIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKAT 752
Query: 881 LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940
L DG VAIKKL GQ +REF AE+ET+ + +H NLV L G+C +RLL+Y YM
Sbjct: 753 LPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMEN 812
Query: 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF 1000
GSL+ LH + L W R +IA G+A+GL +LH C PHI+HRD+KSSN+LLDENF
Sbjct: 813 GSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENF 872
Query: 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
+ ++DFG+ARLMS +TH+S L GT GY+PPEY Q+ + KGDVYS+GVVLLELLT
Sbjct: 873 NSHLADFGLARLMSPYETHVSTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 931
Query: 1061 GKRPTDSAD-FGDNNLVGWV-KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLD 1118
KRP D G +L+ WV K + + S+VFDP + ++ N + E+ + L +A CL
Sbjct: 932 DKRPVDMCKPKGCRDLISWVVKMKHESRASEVFDPLIYSKE-N-DKEMFRVLEIACLCLS 989
Query: 1119 DRPWRRPTMIQVMAMFKEI 1137
+ P +RPT Q+++ ++
Sbjct: 990 ENPKQRPTTQQLVSWLDDV 1008
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 370/1035 (35%), Positives = 527/1035 (50%)
Query: 159 FSGREAGSLK--LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI--NV 214
F+G+ S+ SL LD+S N +P + L QL K ++G++ +
Sbjct: 293 FTGKIPWSISGLSSLTELDISDNNFDAE--LPSSM-GELGNLTQLIAKNAGLSGNMPKEL 349
Query: 215 SKCKNLQFLDVSSNNFSMAVPS-FGDCLALEYLDISANKFTGDVGHAISACEHXXXXXXX 273
CK L +++S N +P F D A+ + NK +G V I ++
Sbjct: 350 GNCKKLTVINLSFNALIGPIPEEFADLEAIVSFFVEGNKLSGRVPDWIQKWKNARSIRLG 409
Query: 274 XXXXXGPIPV-------GY----NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFG 322
GP+PV + N G IP H+ +SL L L NNL+G + F
Sbjct: 410 QNKFSGPLPVLPLQHLLSFAAESNLLSGSIPSHICQ-ANSLHSLLLHHNNLTGTIDEAFK 468
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
C++L ++ N GE+P +L+ L L LS N F G LP L L + LS
Sbjct: 469 GCTNLTELNLLDNHIHGEVPG--YLAELPLVTLELSQNKFAGMLPAELWESKTLLEISLS 526
Query: 383 SNNLSGAIPHNLCQGPRNSXXXXXXXXXXXXGSIPSTLSNCSQLVSLHLSFNYLTGTIPS 442
+N ++G IP ++ G + G IP ++ + L +L L N L+G IP
Sbjct: 527 NNEITGPIPESI--GKLSVLQRLHIDNNLLEGPIPQSVGDLRNLTNLSLRGNRLSGIIPL 584
Query: 443 SLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAAL----SN---- 494
+L + KL L L N L G IP + ++ L++L L N+L+G++PA + N
Sbjct: 585 ALFNCRKLATLDLSYNNLTGNIPSAISHLTLLDSLILSSNQLSGSIPAEICVGFENEAHP 644
Query: 495 ----CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLD 550
+ + LS N L G+IPT I + + +L L N G IP ELG+ +L ++
Sbjct: 645 DSEFLQHHGLLDLSYNQLTGQIPTSIKNCAMVMVLNLQGNLLNGTIPVELGELTNLTSIN 704
Query: 551 LNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS 610
L+ N F G + P SG + + G + + N+ H G++ G +++
Sbjct: 705 LSFNEFVGPMLP----WSGPLVQ--LQG---LILSNN-----HLDGSIPAKIGQILPKIA 750
Query: 611 RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSI----PKEIGSMSYLFILN 666
+ S G + N + LD+S N LSG I P S L N
Sbjct: 751 VLDLSS-----NALTGTLPQSLLCNNYLNHLDVSNNHLSGHIQFSCPDGKEYSSTLLFFN 805
Query: 667 LGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV 726
N+ SG + + + L+ LD+ +N L G +PS++S L+ LN +DL +N L G IP
Sbjct: 806 SSSNHFSGSLDESISNFTQLSTLDIHNNSLTGRLPSALSDLSSLNYLDLSSNNLYGAIPC 865
Query: 727 MGQFETFQPAKFLNNSG--LCGLPLPPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLF 784
G F F N SG + L C S N K+ + +I + F
Sbjct: 866 -GICNIFG-LSFANFSGNYIDMYSLADCAAGGICSTNGTDHKALHPYHRVRRAITI-CAF 922
Query: 785 SLFCIFGLIIVVVETXXXXXXXESALDVYIDSRSHSGTANTSW-KLTG--AREALSINLA 841
+ I L+++ V L S++ + TS +L G +RE LSINLA
Sbjct: 923 TFVIIIVLVLLAVYLRRKLVRSRP-LAFESASKAKATVEPTSTDELLGKKSREPLSINLA 981
Query: 842 TFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG---Q 898
TFE L ++T D+L+AT F +IG GGFG VYKA L +G VAIK+L H G Q
Sbjct: 982 TFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRL-H-GGHQFQ 1039
Query: 899 GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN 958
GDREF AEMETIGK+KH NLVPLLGYC G+ER L+YEYM GSLE L N+ L
Sbjct: 1040 GDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALG 1099
Query: 959 WAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018
W R KI +GSARGLAFLHH +PHIIHRDMKSSN+LLDENFE RVSDFG+AR++SA +T
Sbjct: 1100 WPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACET 1159
Query: 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF-GDNNLVG 1077
H+S +AGT GY+PPEY + + +TKGDVYS+GVV+LELLTG+ PT + G NLVG
Sbjct: 1160 HVSTD-IAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVG 1218
Query: 1078 WVK-QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
WV+ A+ K +++FDP L E ++ + L +A C D P++RPTM++V+ K
Sbjct: 1219 WVRWMIARGKQNELFDPCLPVSSVWRE-QMARVLAIARDCTADEPFKRPTMLEVV---KG 1274
Query: 1137 IQAGSGLDSQSTIAT 1151
++ G++ + T
Sbjct: 1275 LKMTHGMECGPLVVT 1289
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GUQ5 | BRI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.7064 | 0.9787 | 0.9536 | N/A | no |
| Q8L899 | BRI1_SOLPE | 2, ., 7, ., 1, 1, ., 1 | 0.7064 | 0.9787 | 0.9536 | N/A | no |
| O22476 | BRI1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7176 | 0.9923 | 0.9757 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | 0.983 |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1176 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-112 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 372 bits (957), Expect = e-112
Identities = 326/1134 (28%), Positives = 505/1134 (44%), Gaps = 220/1134 (19%)
Query: 6 LLFLVFSSFISLSLLASASSPNKDLQQLLSFKAALPNPS-VLPNWSPNQNPCGFKGVSCK 64
L+F++F F++ S+L + ++L+ LLSFK+++ +P L NW+ + + C ++G++C
Sbjct: 12 LIFMLFFLFLNFSMLHA-----EELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCN 66
Query: 65 AAS-VSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTIS-----LPAGSRCS 118
+S V SIDLS NISG IS LP
Sbjct: 67 NSSRVVSIDLS---------------------------GKNISGKISSAIFRLP------ 93
Query: 119 SFLSSLDLSLNILSGPL-SDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLS 177
++ +++LS N LSGP+ DI + SSL+ LNLS+N +F+G +LE LDLS
Sbjct: 94 -YIQTINLSNNQLSGPIPDDIFT--TSSSLRYLNLSNN--NFTGSIPRGSIPNLETLDLS 148
Query: 178 YNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP-S 236
N +SG ++ DI +L+ LD+ N +P S
Sbjct: 149 NNMLSG-----------------------EIPNDIGSFS--SLKVLDLGGNVLVGKIPNS 183
Query: 237 FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHL 296
+ +LE+L +++N+ G + + + L + I +GYN GEIP +
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKW-----------IYLGYNNLSGEIPYEI 232
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
L +SL LDL NNL+G +PS G+ +L+ + NK SG +P IF S+ L L
Sbjct: 233 GGL-TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLD 290
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
LS N +G +P+ + L NLE L L SNN +G IP L PR L+ L L +N G I
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR--LQVLQLWSNKFSGEI 348
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
P L + L L LS N LTG IP L S L L L+ N L GEIP LG
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA------ 402
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536
C +L + L +N GE+P+ +L + L +SNN+ GRI
Sbjct: 403 ------------------CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
Query: 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAG 596
D SL L L N F G +P + GSK
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLPDSF-----------------------GSKR----- 476
Query: 597 NLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI 656
LE + + S R + + +M L +S N LSG IP E+
Sbjct: 477 --LENLDLSRNQFSGAVPRKLGSLSE---------------LMQLKLSENKLSGEIPDEL 519
Query: 657 GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLC 716
S L L+L HN LSG IP ++ L+ LDLS N+L G IP ++ ++ L ++++
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
Query: 717 NNQLTGMIPVMGQFETFQPAKFLNNSGLCG----LPLPPCEKDSGASANSRHQKSHRRPA 772
+N L G +P G F + N LCG LPPC+ R +K+
Sbjct: 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK---------RVRKTPSWWF 630
Query: 773 SLAGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGA 832
+ ++ L+ +L FG + + K+ E+ GT W+L
Sbjct: 631 YITCTLGAFLVLALVA-FGFVFIRGRNNLELKRVEN----------EDGT----WELQFF 675
Query: 833 REALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKL 892
+S + +T D+L + +++I G G YK K + K
Sbjct: 676 DSKVS----------KSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKE 722
Query: 893 IHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKK 952
I+ A+M GK++H N+V L+G C+ + L++EY+ +L +VL N
Sbjct: 723 INDVNSIPSSEIADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 953 VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012
L+W RRKIAIG A+ L FLH C P ++ ++ +++D E + + L
Sbjct: 777 ----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831
Query: 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD 1072
+ DT +S+ YV PE ++ + K D+Y +G++L+ELLTGK P D+
Sbjct: 832 L-CTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885
Query: 1073 NNLVGWVKQ-HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP 1125
++V W + ++ + DP + + + E+++ +++A C P RP
Sbjct: 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 868 IGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+G G FG+VYK KLK VA+K L + + EF E + K+ H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
LG C E +V EYM G L L + KL+ + A+ ARG+ +L
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK-- 121
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEY 1036
+ IHRD+ + N L+ EN ++SDFG++R + D + G +P PE
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK------RGGKLPIRWMAPES 174
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ + ++K DV+S+GV+L E+ T G++P + ++ ++K +L PEL
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP--GMSNEEVLEYLKNGYRLPQPPNCPPEL 232
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134
+ C + P RPT +++ +
Sbjct: 233 YD--------------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 8e-49
Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 39/282 (13%)
Query: 865 DSLIGSGGFGDVYKAKLKDGS-----TVAIKKL-IHISGQGDREFTAEMETIGKIKHRNL 918
+G G FG+VYK LK VA+K L S Q EF E + K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
V LLG C E ++V EYM G L D L + + + + A+ ARG+ +L
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL--SLSDLLSFALQIARGMEYLES 121
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP----- 1033
+ IHRD+ + N L+ EN ++SDFG++R + D + G +P
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV------KGGKLPIRWMA 172
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092
PE + + ++K DV+S+GV+L E+ T G+ P + ++ ++K+ +L
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEVLEYLKKGYRLPKPPNCP 230
Query: 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134
PEL K + C + P RPT +++ +
Sbjct: 231 PELYK--------------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 83/275 (30%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
+ +G G FG VY A+ K G VAIK + + DRE E++ + K+KH N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L + ++ LV EY G L D+L + + + + A R L +LH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEA--RFYLRQILSALEYLHSK 116
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
I+HRD+K N+LLDE+ +++DFG+AR +D ++T GTP Y+ PE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADF-GDNNLVGWVKQHAKLKISDVFDPELMKE 1098
D++S GV+L ELLTGK P F GD+ L+ K+ K K +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ +L++ L P +R T + +
Sbjct: 226 E---AKDLIRK------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 5e-47
Identities = 89/279 (31%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNL 918
+ +GSG FG VYKAK K G VA+K L + D+ E+ + ++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
V L+ + + LV EY G L D L L+ +KIA+ RGL +LH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS 116
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE--- 1035
N IIHRD+K N+LLDEN +++DFG+A+ + + L +T GTP Y+ PE
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLL 171
Query: 1036 ---YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092
Y K DV+S GV+L ELLTGK P + D + L+ +
Sbjct: 172 GGNGY-----GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+E + L CL+ P +RPT +++
Sbjct: 227 SSGSEE--------AKDL--IKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-46
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKH 915
+G G FG+VYK LK VA+K L + + +R EF E + K+ H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
N+V LLG C GE +V EYM G L D L + KL ++A+ A+G+ +
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEY 117
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-- 1033
L + +HRD+ + N L+ EN ++SDFG++R + D G +P
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-----YRKRGGGKLPIK 169
Query: 1034 ---PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE + + ++K DV+S+GV+L E+ T G++P
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 868 IGSGGFGDVYKAKLKDGST----VAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLL 922
+G G FG+VYK KLK VA+K L + + +R +F E + K+ H N+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK-----LNWAARRKIAIGSARGLAFLH 977
G C E LV EYM G L D L + V L+ AI A+G+ +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
+HRD+ + N L+ E+ ++SDFG++R + D + T G +P
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK-----KTGGKLPIRWM 174
Query: 1034 -PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
PE + ++K DV+S+GV+L E+ T G P + ++ ++++ +L +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEVLEYLRKGYRLPKPEYC 232
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQV 1130
EL EL+ C P RPT ++
Sbjct: 233 PDEL--------YELMLS------CWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 71/195 (36%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
+G GGFG VY A+ K G VAIK + E E+E + K+ H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ LV EY GSL+D+L + KL+ +I + GL +LH N II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 986 HRDMKSSNVLLDE-NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCS 1043
HRD+K N+LLD N + +++DFG+++L++ + T+ GTP Y+ PE S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 1044 TKGDVYSYGVVLLEL 1058
K D++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 12/205 (5%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
F IG GGFG+VYKA+ + G VAIK + S + + E++ + K KH N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
G +E +V E+ GSL+D+L + + + + A + +GL +LH N
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIA--YVCKELLKGLEYLHSN- 117
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
IIHRD+K++N+LL + E ++ DFG++ +L + T+ GTP ++ PE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN----TMVGTPYWMAPEVING 171
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
K D++S G+ +EL GK P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 44/280 (15%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISG--QGDREFT-AEMETIGKIKHRNLVPLL 922
IG G FG VY + DG +K+ I +S + +RE E++ + K+ H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNII--- 62
Query: 923 GYCKVGEER---LLVYEYMRYGSLEDVLHNQKKVGIK------LNWAARRKIAIGSARGL 973
Y + EE+ +V EY G L + QKK G L+W ++ + L
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----L 116
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
+LH I+HRD+K N+ L N ++ DFG+++++S T T+ GTP Y+
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLS 171
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
PE Q+ + K D++S G VL EL T K P + + L + + I +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKILKGQYPPIPSQYSS 229
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
EL L+ S+ L P RP++ Q++
Sbjct: 230 EL--------RNLV------SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKK--LIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
L+G G FG VY A KD G +A+K L S + E+ + ++H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 924 YCKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
+ EE+ + EY+ GSL +L KK G KL RK GLA+LH N
Sbjct: 67 -SERDEEKNTLNIFLEYVSGGSLSSLL---KKFG-KLPEPVIRKYTRQILEGLAYLHSN- 120
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
I+HRD+K +N+L+D + +++DFG A+ + ++T ++ GTP ++ PE +
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP 1064
D++S G ++E+ TGK P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 86/265 (32%), Positives = 128/265 (48%), Gaps = 26/265 (9%)
Query: 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGD--REFTAEMETIGKIKHRNLVPLL 922
++G G G VYK + K G A+KK IH+ G + ++ E++T+ + +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKK-IHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 923 G-YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G + K GE + V EYM GSL D+L KKVG K+ IA +GL +LH
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLL---KKVG-KIPEPVLAYIARQILKGLDYLHTK-- 118
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
HIIHRD+K SN+L++ E +++DFG+++++ +T GT Y+ PE Q
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGES 176
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101
S D++S G+ LLE GK P F + + I D P L E+ +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP-----FLPPGQPSFFEL--MQAICDGPPPSLPAEEFS 229
Query: 1102 IEIELLQHLHVASACLDDRPWRRPT 1126
E SACL P +RP+
Sbjct: 230 PEFR-----DFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 868 IGSGGFGDVYKAKLK-DGST----VAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPL 921
+GSG FG VYK +G VAIK L + + ++E E + + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQK-KVGIK--LNWAARRKIAIGSARGLAFLHH 978
LG C + + L+ + M G L D + N K +G + LNW +IA +G+++L
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIA----KGMSYLEE 127
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP----- 1033
++HRD+ + NVL+ +++DFG+A+L+ + G VP
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG-----GKVPIKWMA 179
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSAD 1069
E + K DV+SYGV + EL+T G +P +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 5e-30
Identities = 77/284 (27%), Positives = 120/284 (42%), Gaps = 22/284 (7%)
Query: 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIH---ISGQGDREFTAEMETIGKIKH-R 916
+ +G G FG+VY A+ + VA+K L + F E++ + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
N+V L + + LV EY+ GSLED+L + G L+ + I L +L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG-PLSESEALFILAQILSALEYL 117
Query: 977 HHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLSV----STLAGTPGY 1031
H IIHRD+K N+LLD + ++ DFG+A+L+ + S+ ST GTPGY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 1032 VPPEYYQSFRC---STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088
+ PE S+ D++S G+ L ELLTG P + + +K +L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK-NSSATSQTLKIILELPTP 233
Query: 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ P I L L P R + ++
Sbjct: 234 SLASPLSPSNPELISKAASDLL---KKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 867 LIGSGGFGDVYKA-KLKDGSTVAIKK--LIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
LIG G FG VYK L+ G VAIK+ L I + + E++ + +KH N+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA---RGLAFLHHNC 980
+ + ++ EY GSL ++ L +A+ +GLA+LH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLHEQ- 118
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
+IHRD+K++N+L ++ +++DFG+A ++ + +++ GTP ++ PE +
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEMS 174
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP 1064
ST D++S G ++ELLTG P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
IG G G+VYKA G VAIKK + + Q E+ + KH N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
VG+E +V EYM GSL D++ Q V + A + +GL +LH ++IH
Sbjct: 86 VGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAY--VCREVLQGLEYLHSQ---NVIH 139
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG 1046
RD+KS N+LL ++ +++DFG A ++ +++ GTP ++ PE + K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTK--EKSKRNSVVGTPYWMAPEVIKRKDYGPKV 197
Query: 1047 DVYSYGVVLLELLTGKRP 1064
D++S G++ +E+ G+ P
Sbjct: 198 DIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+GSG FG+V++ K+ VAIK L ++F E++ + +++H++L+ L C V
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
GE ++ E M GSL L + + G L A+ +A A G+A+L + IHR
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128
Query: 988 DMKSSNVLLDENFEARVSDFGMARLM-----SAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
D+ + N+L+ E+ +V+DFG+ARL+ + D + A PE
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA-------PEAASHGTF 181
Query: 1043 STKGDVYSYGVVLLELLT-GKRP 1064
STK DV+S+G++L E+ T G+ P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
IG G FGDVYK LK + VA+K + F E E + + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCIPHI 984
+ +V E + GSL L +KK + + ++++ +A G+ +L NCI
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVK--KLLQMSLDAAAGMEYLESKNCI--- 115
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEYYQS 1039
HRD+ + N L+ EN ++SDFGM+R + + T++ +P PE
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD---PELM 1096
R +++ DV+SYG++L E + GD G Q + +I + P+L
Sbjct: 170 GRYTSESDVWSYGILLWETFS---------LGDTPYPGMSNQQTRERIESGYRMPAPQLC 220
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
E+ L+ C P RP+ ++ + E+Q
Sbjct: 221 PEEIY---RLMLQ------CWAYDPENRPSFSEI---YNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 80/272 (29%), Positives = 126/272 (46%), Gaps = 39/272 (14%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+ IG G FGDV + G VA+K L S F AE + ++H NLV LLG
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVV 69
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
G +V EYM GSL D L ++ + I A + A+ G+ +L + +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVI--TLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEYYQSF 1040
HRD+ + NVL+ E+ A+VSDFG+A+ ++ G +P PE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----------EASQGQDSGKLPVKWTAPEALREK 174
Query: 1041 RCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099
+ STK DV+S+G++L E+ + G+ P D +V V++ +++ + PE+ K
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYRMEAPEGCPPEVYK-- 230
Query: 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
V C + P +RPT Q+
Sbjct: 231 ------------VMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 73/206 (35%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKL-IHISGQGD-REFTAEMETIGKIKHRNLVPLLGY 924
IG G FG VY A L G +A+K++ I + +E EM+ + +KH NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 925 CKVGEERLLVY-EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+V E++ ++ EY G+LE++L + G L+ R + GLA+LH +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT--HLSVSTLAGTPGYVPPEYYQSFR 1041
I+HRD+K +N+ LD N ++ DFG A + T V +LAGTP Y+ PE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 1042 CSTKG---DVYSYGVVLLELLTGKRP 1064
G D++S G V+LE+ TGKRP
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 12/200 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD-REFTAEMETIGKIKHRNLVPLLGYCK 926
+G+G FG+V++ + + VA+K L G D ++F AE + + K++H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK--PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
+ E +V E M+YGSL + L +KL +A A G+A+L + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTK 1045
RD+ + NVL+ EN +V+DFG+AR++ + A P + PE R S K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 1046 GDVYSYGVVLLELLT-GKRP 1064
DV+S+G++L E++T G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYCK 926
+G+G FG+V+ + VA+K L G E F E + + K++H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK--PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
E +V EYM GSL D L + + G KL +A A G+A+L + IH
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTK 1045
RD+ + N+L+ EN +++DFG+ARL+ D + A P + PE R + K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 1046 GDVYSYGVVLLELLT-GKRP 1064
DV+S+G++L E++T G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+GSG FG V+ K + VAIK +I + +F E + + K+ H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
+V EYM G L + L +K KL + + +L N IHR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNGF---IHR 124
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTKG 1046
D+ + N L+ E+ +VSDFG+AR + +D + S P + PPE + R S+K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 1047 DVYSYGVVLLELLT-GKRPTD 1066
DV+S+GV++ E+ + GK P +
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 868 IGSGGFGDVYKAKL-----KDGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V + G VA+K L H Q +F E+E + + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 922 LGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C+ R L+ EY+ GSL D L + ++N + +G+ +L
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ 128
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG-YVPPEYYQ 1038
IHRD+ + N+L++ ++SDFG+A+++ + V +P + PE +
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDS 1067
+ + S+ DV+S+GV L EL T P+ S
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 32/276 (11%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA---EMETIGKIKHRNL 918
F + IG G FG V+K K V K I +S RE E + K+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLN--WAARRKIAIGSARGLAF 975
+ + + +L +V EY G L +L Q+ + + W + I GLA
Sbjct: 62 IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
LH I+HRD+KS N+ LD ++ D G+A+L+S D +T+ GTP Y+ PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPE 171
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ + K DV++ GVVL E TGK P D+ NN + + + VF P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-----NNQGALILKIIR----GVFPPVS 222
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ +L+ CL +RP Q++
Sbjct: 223 QMYSQQL-AQLID------QCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
IGSG FG V+ + VAIK I + +F E + + K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
LV+E+M +G L D L Q+ K + + + G+A+L + +IHR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTKG 1046
D+ + N L+ EN +VSDFGM R + +D + ST P + PE + + S+K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 1047 DVYSYGVVLLELLT-GKRPTDS 1067
DV+S+GV++ E+ + GK P ++
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 33/213 (15%)
Query: 868 IGSGGFGDVYKA--KLKDGS--TVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V K +K G VA+K L HI+ G +EF E + ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK--LNWAARRKIAIGSARGLAFLHHN 979
+G CK GE +LV E G L L ++++ + A + A G+A+L
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLESK 114
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----P 1034
H +HRD+ + NVLL +A++SDFGM+R + A + A T G P P
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR----ATTAGRWPLKWYAP 167
Query: 1035 E--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E Y F S+K DV+SYGV L E + G +P
Sbjct: 168 ECINYGKF--SSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 75/229 (32%), Positives = 111/229 (48%), Gaps = 31/229 (13%)
Query: 855 LLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKI 913
L + T F +IG G +G VYKA+ K G VAIK ++ I + E E + K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 914 -KHRNLVPLLG-YCK----VGEERL-LVYEYMRYGSLEDVLHNQKKVG--IKLNWAARRK 964
H N+ G + K +++L LV E GS+ D++ +K G +K W A
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
I + RGLA+LH N +IHRD+K N+LL +N E ++ DFG++ + + T +T
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNT 172
Query: 1025 LAGTPGYVPPE---------YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
GTP ++ PE R DV+S G+ +EL GK P
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARS----DVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 868 IGSGGFGDVYKAKL------KDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
+G G FG V+ + D VA+K L + R+ F E E + +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLH----------NQKKVGIKLNWAARRKIAIGSA 970
G C G+ ++V+EYM +G L L + +L + +IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD-------THLSVS 1023
G+ +L H +HRD+ + N L+ + ++ DFGM+R + D T L +
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++PPE + +T+ DV+S+GVVL E+ T GK+P
Sbjct: 190 -------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 31/273 (11%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G+G G V K + + K I + ++ E++ + K +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ + EYM GSL+ +L K+V ++ KIA+ +GL +LH II
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KII 123
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS-TLAGTPGYVPPEYYQSFRCST 1044
HRD+K SN+L++ + ++ DFG++ + S++ T GT Y+ PE Q S
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVN-----SLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 1045 KGDVYSYGVVLLELLTGKRPTDSADFGDNN----LVGWVKQHAKLKISDVFDPELMKEDP 1100
K D++S G+ L+EL TG+ P + + L V + S F P+
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ---- 234
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ CL P RP+ +++
Sbjct: 235 ----------DFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 81/301 (26%), Positives = 132/301 (43%), Gaps = 62/301 (20%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
IG G +G VYKA+ K G VA+KK I + ++E TA E++ + K++H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK---IRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 922 LGYCKVGEER---LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
+ + +V+EYM + L +L + +K + + GL +LH
Sbjct: 64 KEIV-TSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM-DTHLS--VSTLAGTPGYVPPE 1035
N I+HRD+K SN+L++ + +++DFG+AR + + V TL Y PPE
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL----WYRPPE 171
Query: 1036 -YYQSFRCSTKGDVYSYGVVLLELLTGK--------------------RPTDSADFGDNN 1074
+ R + D++S G +L EL GK PTD G +
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 1075 LVGW----VKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQV 1130
L + K+ K ++ + F ++LL L LD P +R + Q
Sbjct: 232 LPWFENLKPKKPYKRRLREFFK----HLIDPSALDLLDKL----LTLD--PKKRISADQA 281
Query: 1131 M 1131
+
Sbjct: 282 L 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 26/275 (9%)
Query: 861 GFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKL-IHISGQGDREFTA-EMETIGKIKHRN 917
F +G G +G VYK K L D A+K++ + Q +RE E+ + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
++ G + +V EY +G L + +KK + +I I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
I+HRD+KS+N+LL N ++ D G+++++ T GTP Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPHYMAPEVW 173
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097
+ S K D++S G +L E+ T P ++ D V++ I ++ +L
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK--VQRGKYPPIPPIYSQDLQN 231
Query: 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ L +P RP +++A
Sbjct: 232 --------------FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 9/207 (4%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G +G+VY+ K TVA+K L + + + EF E + +IKH NLV LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
++ E+M YG+L D L + ++N +A + + +L + IH
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQ--EVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG 1046
RD+ + N L+ EN +V+DFG++RLM+ DT+ + + + PE + S K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 1047 DVYSYGVVLLELLT-GKRPTDSADFGD 1072
DV+++GV+L E+ T G P D
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 868 IGSGGFGDVYKAKL------KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V+ A+ +D VA+K L S ++F E E + ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 922 LGYCKVGEERLLVYEYMRYGSL---------EDVLHNQKKVGIKLNWAARRKIAIGSARG 972
G C G+ ++V+EYM++G L + VL + +L + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ +L H +HRD+ + N L+ EN ++ DFGM+R + + D + ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PPE + +T+ DV+S GVVL E+ T GK+P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 865 DSLIGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLV 919
+ +IG G FG+V + +LK VAIK L S R +F E +G+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVL--HNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
L G +++ EYM GSL+ L ++ K +L + G A G+ +L
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-----VGMLRGIASGMKYLS 123
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
+HRD+ + N+L++ N +VSDFG++R + + + T G G +P
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKG--GKIPIRWT 175
Query: 1034 -PEY--YQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE Y+ F ++ DV+S+G+V+ E+++ G+RP
Sbjct: 176 APEAIAYRKF--TSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 9e-23
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 868 IGSGGFGDVYKAKL------KDGSTVAIKKLIH-ISGQGDREFTAEMETIGKIKHRNLVP 920
IG G FG V++A+ + + VA+K L S +F E + + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL-----HNQKKVG-------------IKLNWAAR 962
LLG C VG+ L++EYM YG L + L Q + + L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 963 RKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV 1022
IA A G+A+L +HRD+ + N L+ EN +++DFG++R + + D + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 1023 STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
A ++PPE R +T+ DV++YGVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 868 IGSGGFGDVYKAKL------KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V+ A+ +D VA+K L S ++F E E + ++H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHN-----------QKKVGIKLNWAARRKIAIGSA 970
G C G L+V+EYMR+G L L + + +L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP- 1029
G+ +L H +HRD+ + N L+ + ++ DFGM+R + + D + V P
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPI 188
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++PPE + +T+ D++S+GVVL E+ T GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 17/207 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
F +G G +G VYKA K+ G VAIK + + +E E+ + + +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKV-VPVEE-DLQEIIKEISILKQCDSPYIVK 62
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGLAFLH 977
G + +V EY GS+ D++ K L +IA + +GL +LH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLT---EEEIAAILYQTLKGLEYLH 116
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
N IHRD+K+ N+LL+E +A+++DFG++ ++ DT +T+ GTP ++ PE
Sbjct: 117 SN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVI 171
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
Q + K D++S G+ +E+ GK P
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTV-AIKKL----IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G G FG V + KD + A+K L I + + T E + +I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
Y EE+L LV EY G L L + + + AR A I A L +LH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE---RARFYAAEIVLA--LEYLHSL- 112
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
II+RD+K N+LLD + +++DFG+A+ +S +T GTP Y+ PE
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
D +S GV+L E+LTGK P + D
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKL--IHISGQGDREF-TAEMETIGKIK-HRNLVPL 921
+IG G F V AK K AIK L + + ++ E E + ++ H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHN 979
Y EE L V EY G L + + K R A I A L +LH
Sbjct: 68 Y-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC---TRFYAAEILLA--LEYLHSK 121
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV----------------- 1022
IIHRD+K N+LLD++ +++DFG A+++ + S
Sbjct: 122 ---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 1023 -STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
++ GT YV PE D+++ G ++ ++LTGK P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 3e-22
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA----EMETIGKIKHR 916
+ +G G +G VYKA+ K G VA+KK+ + + E+ + ++KH
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 917 NLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
N+V LL E +L LV+EY L+ L + + N + I RGLA+
Sbjct: 59 NIVKLLDVI-HTERKLYLVFEYCDM-DLKKYLDK-RPGPLSPNLI--KSIMYQLLRGLAY 113
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----MSAMDTHLSVSTLAGTPGY 1031
H + I+HRD+K N+L++ + +++DFG+AR + TH V T Y
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-----TLWY 164
Query: 1032 VPPE------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
PE +Y ST D++S G + E++TGK
Sbjct: 165 RAPEILLGSKHY-----STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 31/212 (14%)
Query: 867 LIGSGGFGDVYKA-KLKDGSTVAIKK-LIHISGQGDREFTAEMET----IGKIKHRNLVP 920
L+GSG FG VY+ L DG A+K+ + GQ +E ++E + K++H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 921 LLGYCKVGEERLLVY-EYMRYGSLEDVLHNQKKVG------IKLNWAARRKIAIGSARGL 973
LG + E+ L ++ E + GSL +L KK G I+L R+I +G L
Sbjct: 67 YLGTERE-EDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRL---YTRQILLG----L 115
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
+LH + +HRD+K +N+L+D N +++DFGMA+ + S G+P ++
Sbjct: 116 EYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMA 169
Query: 1034 PEYY-QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
PE Q D++S G +LE+ TGK P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-22
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 23/217 (10%)
Query: 868 IGSGGFGDVYKAKL------KDGSTVAIKKLI-HISGQGDREFTAEMETIGKIKHRNLVP 920
+G G FG VYK +L ++VAIK L + + +EF E E + ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 921 LLGYCKVGEERLLVYEYMRYGSL----------EDVLHNQKKVGIK--LNWAARRKIAIG 968
LLG C + +++EY+ +G L DV +K L+ + IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A G+ +L + H +HRD+ + N L+ E ++SDFG++R + + D + S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++PPE + +T+ D++S+GVVL E+ + G +P
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 868 IGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG VY+ K + VAIK + + +R EF E + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQK-------KVGI-----KLNWAARRKIAIG 968
LLG G+ L+V E M G L+ L +++ +G + AA
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A G+A+L +HRD+ + N ++ E+ ++ DFGM R + D + G
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK-----GG 179
Query: 1029 PGYVP-----PEYYQSFRCSTKGDVYSYGVVLLELLT 1060
G +P PE + +TK DV+S+GVVL E+ T
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G+G FG V K + VAIK +I + EF E + + K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
+V EYM G L + L K + + ++ G+A+L IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTKG 1046
D+ + N L+D+ +VSDFG++R + +D + S + P + PPE + S+K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 1047 DVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIE 1105
DV+++GV++ E+ + GK P + F ++ V V Q +L + P L E
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER--FNNSETVEKVSQGLRL-----YRPHLASE------- 228
Query: 1106 LLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ + +C ++ RPT Q+++
Sbjct: 229 --KVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 14/201 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTV-AIK---KLIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IG G FG V + +D + A+K K + R E + ++ H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ E LV + + G L H +KV K + + L +LH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKV--KFSEEQVKFWICEIVLALEYLHSK---G 120
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
IIHRD+K N+LLDE ++DF +A ++ L+ ST +GTPGY+ PE S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTST-SGTPGYMAPEVLCRQGYS 177
Query: 1044 TKGDVYSYGVVLLELLTGKRP 1064
D +S GV E L GKRP
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 868 IGSGGFGDVYKAK------LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V+ A+ KD VA+K L + ++F E E + ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQ------------KKVGIKLNWAARRKIAIGS 969
G C G+ ++V+EYM++G L L ++ +L + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
A G+ +L H +HRD+ + N L+ N ++ DFGM+R + + D +
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++PPE + +T+ DV+S+GV+L E+ T GK+P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 74/274 (27%), Positives = 132/274 (48%), Gaps = 33/274 (12%)
Query: 867 LIGSGGFGDVYKA-KLKDGSTVAIKKL---IHISGQGD-------REFTAEMETIGKIKH 915
LIG G +G VY A + G +A+K++ I+G+ D + +E+ET+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 916 RNLVPLLGYCKVGEERLLVY-EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
N+V LG + EE L ++ EY+ GS+ L + +L ++ GLA
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLA 122
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
+LH I+HRD+K+ N+L+D + ++SDFG+++ + + ++ G+ ++ P
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 1035 EYYQSFRC--STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092
E S+ S K D++S G V+LE+ G+RP + D + + + + +
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-----WSDEEAIAAMFKLGNKRSAPPIP 234
Query: 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126
P++ N+ L L+ AC P RPT
Sbjct: 235 PDVS---MNLSPVALDFLN---ACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 26/208 (12%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
IGSG +GDVYKA+ + G VAIK +I + D E E+ + + +H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGLAFLHHNCIP 982
++ +V EY GSL+D+ L+ +IA + +GLA+LH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLS---ELQIAYVCRETLKGLAYLHET--- 120
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS---TLAGTPGYVPPEYYQS 1039
IHRD+K +N+LL E+ + +++DFG++ ++A +++ + GTP ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAAV 175
Query: 1040 FRCS---TKGDVYSYGVVLLELLTGKRP 1064
R K D+++ G+ +EL + P
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 868 IGSGGFGD--VYKAKLKDGSTVAIKK--LIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
+G G FG+ +Y+ + +D S V K+ L +S + R+ E+ + ++H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ L+ EY G+L D + QK + I SA ++++H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA---G 121
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
I+HRD+K+ N+ L + ++ DFG+++++ + T+ GTP Y+ PE Q + +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDN--NLVGWVKQHAKLKISDVFDPELMKEDPN 1101
K D+++ G VL ELLT KR D N NLV + Q + V+ EL+
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD----ATNPLNLVVKIVQGNYTPVVSVYSSELIS---- 231
Query: 1102 IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ + L P +RPT +V+
Sbjct: 232 ----------LVHSLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 867 LIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLV 919
+G G FG+V+ AK K + V +K L + EF E++ K+ H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK-----LNWAARRKIAIGSARGLA 974
LLG C+ E ++ EY G L+ L K K L+ + + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVP 1033
L + +HRD+ + N L+ E +VS +++ + + + + L P ++
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLA 186
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE Q STK DV+S+GV++ E+ T G+ P
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 33/270 (12%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHRNLVPLLG 923
IG G FG V K + K DG + K+ I ++E +E+ + ++KH N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKE-IDYGNMTEKEKQQLVSEVNILRELKHPNIV---R 63
Query: 924 YCK--VGEERLLVYEYMRY---GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
Y + +Y M Y G L ++ KK + +I L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 979 NCIPH--IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
P ++HRD+K +N+ LD N ++ DFG+A+++ T GTP Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKTYVGTPYYMSPEQ 181
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096
K D++S G ++ EL P + + L +K+ +I + EL
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKIKEGKFRRIPYRYSSELN 239
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPT 1126
+ V + L+ P +RP+
Sbjct: 240 E--------------VIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 865 DSLIGSGGFGDVYKAKLKDGS----TVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLV 919
+ +IG+G FG+V +LK VAIK L + + R+F +E +G+ H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVL--HNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
L G + ++V EYM GSL+ L H+ + I+L R G A G+ +L
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYLS 123
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
+HRD+ + N+L++ N +VSDFG++R++ D + T G G +P
Sbjct: 124 DM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRG--GKIPIRWT 176
Query: 1034 -PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE + ++ DV+SYG+V+ E+++ G+RP
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 865 DSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGD-REFTAEMETIGKI-KHR 916
+G G FG V KA+ STVA+K L + + D + +EME + I KH+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI----------- 965
N++ LLG C +V EY +G+L D L ++ G + R
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 966 -AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD------- 1017
A ARG+ FL IHRD+ + NVL+ E+ +++DFG+AR + +D
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
L V +A PE + + DV+S+GV+L E+ T
Sbjct: 194 GRLPVKWMA-------PEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G G FG+V+ + VAIK L F E + + K++H LV L Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 928 GEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
EE + +V EYM GSL D L + ++L I S G+A++ + +H
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS--GMAYVERM---NYVH 125
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTK 1045
RD++++N+L+ EN +V+DFG+ARL+ D + A P + PE R + K
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1046 GDVYSYGVVLLELLTGKR 1063
DV+S+G++L EL T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 75/315 (23%), Positives = 126/315 (40%), Gaps = 71/315 (22%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA--EMETIGKIKHR 916
N + ++G G +G V K + K G VAIKK D + TA E++ + +++H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
N+V L + LV+EY+ LE + + + A R + +A+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPP----DAVRSYIWQLLQAIAYC 116
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA-MDTHLS--VST--------L 1025
H + +IIHRD+K N+L+ E+ ++ DFG AR + A + L+ V+T L
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 1026 AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKR--PTDS---------------- 1067
G Y P DV++ G ++ ELL G+ P DS
Sbjct: 174 VGDTNYGKPV-----------DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP 222
Query: 1068 ----ADFGDNNLVGWVKQHAKLKISDVFDPELMKE-----DPNIEIELLQHLHVASACLD 1118
F N + A + + PE ++ + ++ L+ ACL
Sbjct: 223 PSHQELFSSN------PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLK------ACLR 270
Query: 1119 DRPWRRPTMIQVMAM 1133
P R T +++
Sbjct: 271 MDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 865 DSLIGSGGFGDVYKAK-LKDGSTVAIKK--LIHISGQGDR-EFTA--EMETIGKIKHRNL 918
+G G + VYKA+ + G VAIKK L D FTA E++ + ++KH N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 919 VPLLG-YCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
+ LL + + + LV+E+M LE V+ ++ I L A + + + RGL +L
Sbjct: 65 IGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYL 118
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H N I+HRD+K +N+L+ + +++DFG+AR + + + + T Y PE
Sbjct: 119 HSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTRWYRAPEL 173
Query: 1037 YQSFRCSTKG-DVYSYGVVLLELLTGK 1062
R G D++S G + ELL
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
D +G G FG+V+ + VAIK L F E + + K++H LVPL Y
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 925 CKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
V EE + +V E+M GSL D L ++ G L +A A G+A++ +
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRC 1042
IHRD++++N+L+ +N +++DFG+ARL+ D + A P + PE R
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 1043 STKGDVYSYGVVLLELLTGKR 1063
+ K DV+S+G++L EL+T R
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 23/203 (11%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
IG G FGDV + G+ VA+K + + + + F AE + +++H NLV LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV--I 68
Query: 928 GEER---LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
EE+ +V EYM GSL D L ++ + L K ++ + +L N +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAM-DT-HLSVSTLAGTPGYVPPEYYQSFRC 1042
+HRD+ + NVL+ E+ A+VSDFG+ + S+ DT L V + PE + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKF 176
Query: 1043 STKGDVYSYGVVLLELLT-GKRP 1064
STK DV+S+G++L E+ + G+ P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 56/300 (18%)
Query: 865 DSLIGSGGFGDVYKAKLK-DGS--TVAIKKLIHISGQGD-REFTAEMETIGKI-KHRNLV 919
+ +IG G FG V +A +K DG AIK L + + D R+F E+E + K+ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQ----------KKVGIKLNWAARR--KIAI 967
LLG C+ + EY YG+L D L K+ G +++ + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 968 GSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG 1027
A G+ +L IHRD+ + NVL+ EN ++++DFG++R +
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 1028 TPGYVPPEYY--QSFRCS---TKGDVYSYGVVLLELLT-GKRP---TDSADFGDNNLVGW 1078
T G +P + +S S TK DV+S+GV+L E+++ G P A+ + G+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235
Query: 1079 VKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
+ + +V+ ELM++ C DRP+ RP Q+ +
Sbjct: 236 RMEKPRNCDDEVY--ELMRQ-----------------CWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD--REFTAEMETIGKIKHRNLVPLLG 923
S +G G G V K +LK+ + K I D ++ E+E K +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 924 YCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ EY GSL+ + KK G ++ KIA +GL++LH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
IIHRD+K SN+LL + ++ DFG++ L++++ T GT Y+ PE Q
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----GTFTGTSFYMAPERIQGK 178
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP---TDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097
S DV+S G+ LLE+ + P G L+ + I ++ +PEL K
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------IVNMPNPEL-K 229
Query: 1098 EDPNIEIELLQHL-HVASACLDDRPWRRPT 1126
++P I+ + CL+ P RRPT
Sbjct: 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKK--LIHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
IG G G V+KAK + G TVA+KK L + G + E++ + +H +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR--------GLAFL 976
G +LV EYM L +VL + R + + G+A++
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD-----------EERPLPEAQVKSYMRMLLKGVAYM 115
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE- 1035
H N I+HRD+K +N+L+ + +++DFG+ARL S + S T Y PE
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE-EEPRLYSHQVATRWYRAPEL 171
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTG 1061
Y + + D+++ G + ELL G
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+GSG FG V+ K + VAIK I+ + +F E + + K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
+ +V E+M G L + L ++ KL+ + G+ +L N IHR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTKG 1046
D+ + N L+ +VSDFGM R + +D + S+ A P + PPE + + S+K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 1047 DVYSYGVVLLELLT-GKRPTDS 1067
DV+S+GV++ E+ T GK P +
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLLGYC 925
L+G G FG+V+K LKD + VA+K Q + +F +E + + H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCIPHI 984
+R +Y M D L +K +L K A+ +A G+A+L NCI
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI--- 115
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCS 1043
HRD+ + N L+ EN ++SDFGM+R D S S L P + PE R S
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 1044 TKGDVYSYGVVLLELLT 1060
++ DV+SYG++L E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 25/211 (11%)
Query: 867 LIGSGGFGDVYKAKLK----DGSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+IG+G FG+V++ LK VAIK L + R +F +E +G+ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVL--HNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G + +++ EYM G+L+ L H+ + +L R G A G+ +L
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLSDM 126
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----P 1034
+ +HRD+ + N+L++ N E +VSDFG++R++ D T +G G +P P
Sbjct: 127 ---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSG--GKIPIRWTAP 179
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E + ++ DV+S+G+V+ E+++ G+RP
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 75/234 (32%), Positives = 109/234 (46%), Gaps = 29/234 (12%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA---EMETIGKIKHRNL 918
+ IG G FG +Y AK K S + K I ++ +E A E+ + K+KH N+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK----LNWAARRKIAIGSARGLA 974
V + +V EY G L ++ Q+ V L+W +I++G
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG------ 113
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
L H I+HRD+KS N+ L +N A++ DFG+AR ++ D+ T GTP Y+
Sbjct: 114 -LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLS 170
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087
PE Q+ + K D++S G VL EL T K P F NNL LKI
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP-----FEGNNL-----HQLVLKI 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 866 SLIGSGGFGDVYKAK---LKD--GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G FG V + L+D G VA+KKL H + + R+F E+E + ++H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 921 LLGYC-KVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS--ARGLAFL 976
G C G L LV EY+ YGSL D L ++ +L+ R+ + S +G+ +L
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE---RLD--HRKLLLYASQICKGMEYL 124
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP--- 1033
+HRD+ + N+L++ ++ DFG+ +++ + V PG P
Sbjct: 125 G---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESPIFW 177
Query: 1034 --PEYYQSFRCSTKGDVYSYGVVLLELLT 1060
PE + S DV+S+GVVL EL T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 69/205 (33%), Positives = 109/205 (53%), Gaps = 23/205 (11%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHRNLVPLLGY 924
+G+G FG+V+ + VAIK L QG F AE + +++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRL--Y 67
Query: 925 CKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
V +E + ++ EYM GSL D L + GIKL +A A G+AF+ +
Sbjct: 68 AVVTQEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---N 122
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEY--YQSF 1040
IHRD++++N+L+ E +++DFG+ARL+ D + A P + PE Y +F
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 1041 RCSTKGDVYSYGVVLLELLT-GKRP 1064
+ K DV+S+G++L E++T G+ P
Sbjct: 181 --TIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA---EMETIGKIKHRNLVPLLG 923
++G G FG V+ + K + I K I + E A E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ ++V EY G+L + + + + I + L LHH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCN-----SLLDEDTILHFFVQILLALHHVHTKL 121
Query: 984 IIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
I+HRD+K+ N+LLD++ ++ DFG+++++S + T+ GTP Y+ PE +
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPY 178
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNI 1102
+ K D+++ G VL EL + KR ++A+ LV + ISD + P+L +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANL--PALVLKIMSGTFAPISDRYSPDLRQ----- 231
Query: 1103 EIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
I + +L P +RP + Q+MA
Sbjct: 232 LILSMLNLD---------PSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 77/290 (26%), Positives = 134/290 (46%), Gaps = 56/290 (19%)
Query: 867 LIGSGGFGDVYKAKLK-DG--STVAIKKLIHISGQGD-REFTAEMETIGKIKHR-NLVPL 921
+IG G FG V KA++K DG AIK++ + + D R+F E+E + K+ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV----------GIKLNWAARR--KIAIGS 969
LG C+ L EY +G+L D L + + ++++ A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
ARG+ +L IHRD+ + N+L+ EN+ A+++DFG++R + T
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKTM 170
Query: 1030 GYVPPEYY--QSFRCS---TKGDVYSYGVVLLELLT-GKRP---TDSADFGDNNLVGWVK 1080
G +P + +S S T DV+SYGV+L E+++ G P A+ + G+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230
Query: 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQV 1130
+ +V+ +LM++ C ++P+ RP+ Q+
Sbjct: 231 EKPLNCDDEVY--DLMRQ-----------------CWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 74/222 (33%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 852 FADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE----FTAE 906
F DL E IG G FG VY A+ ++ VAIKK+ + SG+ E E
Sbjct: 17 FTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSY-SGKQSNEKWQDIIKE 65
Query: 907 METIGKIKHRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI 965
+ + +++H N + G C + E LV EY GS D+L KK ++ AA I
Sbjct: 66 VRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAA---I 120
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
G+ +GLA+LH + IHRD+K+ N+LL E +++DFG A L+S ++
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS------PANSF 171
Query: 1026 AGTPGYVPPEYYQSF---RCSTKGDVYSYGVVLLELLTGKRP 1064
GTP ++ PE + + K DV+S G+ +EL K P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 72/211 (34%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDREFT-AEMETIGKIKHRNLVPLLG 923
+G GGFG V K+K T A+K + HI G +E +E E + + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 924 YCKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHN 979
K ++ +Y EY G L +L G+ + AR IA + A +LH+
Sbjct: 61 TFK---DKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLA--FEYLHNR 112
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
II+RD+K N+LLD N ++ DFG A+ L S T T GTP YV PE
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPEIIL 165
Query: 1039 SFRCSTKG-----DVYSYGVVLLELLTGKRP 1064
+ KG D +S G++L ELLTG+ P
Sbjct: 166 N-----KGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
IG G G VY A + G VAIK+ +++ Q +E E+ + + KH N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQ-MNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V EY+ GSL DV+ ++ R + + L FLH N +I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 137
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS N+LL + +++DFG ++ + ST+ GTP ++ PE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG G VY A L + VAIK++ + E E++ + + H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E LV Y+ GSL D++ + G L+ A + +GL +LH N I
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSN---GQI 124
Query: 986 HRDMKSSNVLLDENFEARVSDFGM-ARLMSAMD-THLSVSTLAGTPGYVPPEYYQSFRCS 1043
HRD+K+ N+LL E+ +++DFG+ A L D T T GTP ++ PE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 1044 T-KGDVYSYGVVLLELLTGKRP 1064
K D++S+G+ +EL TG P
Sbjct: 185 DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
IG G FG V + + G VA+K + ++ Q F E + K+ H+NLV LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI- 68
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
+ +V E M G+L + L + + + + + ++ A G+ +L ++H
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 987 RDMKSSNVLLDENFEARVSDFGMARL--MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST 1044
RD+ + N+L+ E+ A+VSDFG+AR+ M ++ L V + PE + + S+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSS 176
Query: 1045 KGDVYSYGVVLLELLT-GKRP 1064
K DV+SYGV+L E+ + G+ P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G+G FG+V+ + VA+K L F E + + K++H LV L Y V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 928 GEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
EE + +V EYM GSL D L + + +KL +A A G+A++ + IH
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERM---NYIH 125
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTK 1045
RD++S+N+L+ + +++DFG+ARL+ D + A P + PE R + K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1046 GDVYSYGVVLLELLTGKR 1063
DV+S+G++L EL+T R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 69/237 (29%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 845 KPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREF 903
+ L + + L + F ++G+G +G VYK + +K G AIK ++ ++ + E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59
Query: 904 TAEMETIGKIKH-RNLVPLLG-YCKVG-----EERLLVYEYMRYGSLEDVLHNQKKVGIK 956
E+ + K H RN+ G + K ++ LV E+ GS+ D++ N K +K
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 957 LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016
+W A I RGLA LH +IHRD+K NVLL EN E ++ DFG++ + +
Sbjct: 120 EDWIAY--ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQL 171
Query: 1017 DTHLS-VSTLAGTPGYVPPEYYQSFRCST--------KGDVYSYGVVLLELLTGKRP 1064
D + +T GTP ++ PE C + D++S G+ +E+ G P
Sbjct: 172 DRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKH-RNLVPLLG- 923
L+G+G +G VYK + +K G AIK ++ ++G + E E+ + K H RN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 924 YCK-----VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFL 976
+ K + ++ LV E+ GS+ D++ N K +K W A R+I RGL+ L
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL----RGLSHL 127
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS-VSTLAGTPGYVPPE 1035
H + +IHRD+K NVLL EN E ++ DFG++ + +D + +T GTP ++ PE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPYWMAPE 181
Query: 1036 YYQSFRCST--------KGDVYSYGVVLLELLTGKRP 1064
C K D++S G+ +E+ G P
Sbjct: 182 V---IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 34/222 (15%)
Query: 852 FADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD---REFTAEM 907
F+DL E IG G FG VY A+ +++ VAIKK+ + Q + ++ E+
Sbjct: 17 FSDLRE----------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 908 ETIGKIKHRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966
+ K++H N + G C + E LV EY GS D+L KK ++ AA +
Sbjct: 67 RFLQKLRHPNTIQYRG-CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---VT 121
Query: 967 IGSARGLAFLH-HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
G+ +GLA+LH HN +IHRD+K+ N+LL E ++ DFG A +M+ +
Sbjct: 122 HGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXF 171
Query: 1026 AGTPGYVPPEYYQSF---RCSTKGDVYSYGVVLLELLTGKRP 1064
GTP ++ PE + + K DV+S G+ +EL K P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-19
Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 54/290 (18%)
Query: 867 LIGSGGFGDVYKAKL-KDG--STVAIKKLIHISGQGD-REFTAEMETIGKI-KHRNLVPL 921
+IG G FG V KA++ KDG AIK++ + + D R+F E+E + K+ H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA------------IGS 969
LG C+ L EY +G+L D L + + +A A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
ARG+ +L IHRD+ + N+L+ EN+ A+++DFG++R + T
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKTM 182
Query: 1030 GYVPPEYY--QSFRCS---TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV--KQH 1082
G +P + +S S T DV+SYGV+L E+++ G G + +
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELY 233
Query: 1083 AKLKISDVFDPELMKEDPNIEI-ELLQHLHVASACLDDRPWRRPTMIQVM 1131
KL + L +D E+ +L++ C ++P+ RP+ Q++
Sbjct: 234 EKLPQGYRLEKPLNCDD---EVYDLMRQ------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKL--IHISGQGDREFTA---EMETIGKIKHRNLVP 920
L+G G FG VY D G +A+K++ S + +E A E++ + ++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 921 LLGYCKVGEERLLVY-EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C +E L ++ EYM GS++D L K G L RK G+ +LH N
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYG-ALTETVTRKYTRQILEGVEYLHSN 123
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS-VSTLAGTPGYVPPEYYQ 1038
I+HRD+K +N+L D ++ DFG ++ + + + + + ++ GTP ++ PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRP 1064
K DV+S G ++E+LT K P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 865 DSLIGSGGFGDVYKA-----KLKDG-STVAIKKLIHISGQGD-REFTAEMETIGKIKHRN 917
+G G FG V KA K + G +TVA+K L + + R+ +E + ++ H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVG------------IKLNWAARRKI 965
++ L G C LL+ EY +YGSL L +KVG L+ R +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 966 AIGS--------ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017
+G +RG+ +L ++HRD+ + NVL+ E + ++SDFG++R + D
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
+++ S ++ E +T+ DV+S+GV+L E++T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 63/234 (26%), Positives = 122/234 (52%), Gaps = 25/234 (10%)
Query: 865 DSLIGSGGFGDVYKAKLK----DGSTVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLV 919
+ +IG+G FG+V + +LK VAIK L + + R+F +E +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVL--HNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
L G +++ E+M G+L+ L ++ + I+L R G A G+ +L
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS 123
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
+ +HRD+ + N+L++ N +VSDFG++R + + + ++ G G +P
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWT 178
Query: 1034 -PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKL 1085
PE + ++ DV+SYG+V+ E+++ G+RP D + +++ ++Q +L
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVINAIEQDYRL 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 41/293 (13%)
Query: 864 NDSL-----IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD--REFTAEMETIGKIKHR 916
N+ L +G+G G V K K TV KK++HI + ++ E++ + + +
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVG-IKLNWAARRKIAIGSARGLAF 975
+V G + E+M GSL+ + KK G I + KIA+ GL +
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILG--KIAVAVVEGLTY 118
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPP 1034
L++ + I+HRD+K SN+L++ + ++ DFG++ L++++ T GT Y+ P
Sbjct: 119 LYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADTFVGTSTYMSP 171
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD-- 1092
E Q + + K DV+S G+ ++EL GK P ++ D+ Q + I D+
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQI 225
Query: 1093 -----PELMKED-PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
P L D P + + ACL P RPT Q+ AM IQA
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVD------ACLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKL-IHISGQ--GDREFTAEMETIG---KIKHRNLVP 920
++G G +G VY G +A+K++ + S ++E+ E + +KH N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
LG C + E++ GS+ +L + G L K G+A+LH+NC
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL---NRFG-PLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS----TLAGTPGYVPPEY 1036
+ +HRD+K +NV+L N ++ DFG AR ++ + H + S ++ GTP ++ PE
Sbjct: 123 V---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
K D++S G + E+ TGK P S D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL------HHNCIPHIIH 986
LV +Y G L + ++ K R A GL F+ HH H+IH
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTN--------RTFREHEA-GLLFIQVLLAVHHVHSKHMIH 166
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG 1046
RD+KS+N+LL N ++ DFG +++ +A + T GTP YV PE ++ S K
Sbjct: 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226
Query: 1047 DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIEL 1106
D++S GV+L ELLT KRP D + + V ++ +DP P+I E+
Sbjct: 227 DMFSLGVLLYELLTLKRPFDGENMEE------VMHKT---LAGRYDP----LPPSISPEM 273
Query: 1107 LQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ + +A L P RRP+ +++ M
Sbjct: 274 QE---IVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 37/283 (13%)
Query: 867 LIGSGGFGDVYKAKLKDGST----VAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPL 921
+IG G FG VY L D A+K L I+ + E F E + H N++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 922 LGYCKVGE-ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG--SARGLAFLHH 978
LG C E L+V YM++G L + + ++ N + I G A+G+ +L
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLAS 116
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV--STLAGTP-GYVPPE 1035
+HRD+ + N +LDE+F +V+DFG+AR + + + SV T A P ++ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE-YYSVHNHTGAKLPVKWMALE 172
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
Q+ + +TK DV+S+GV+L EL+T G P D D + ++ Q +L PE
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQGRRLL-----QPE 225
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
DP E+ L +C +P RPT ++++ ++I
Sbjct: 226 YCP-DPLYEVML--------SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 26/283 (9%)
Query: 868 IGSGGFGDV----YKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPL 921
+G G FG V Y G VA+K L GQ + + E+ + + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 922 LGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C + L+ EY+ GSL D L K LN A A G+A+LH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY-VPPEYYQ 1038
H IHRD+ + NVLLD + ++ DFG+A+ + + V +P + E +
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK-QHAKLKISDVFDPELMK 1097
+ S DV+S+GV L ELLT S ++G + Q +++ ++ + +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243
Query: 1098 EDPN---IEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
P E+ + C + RPT ++ + KE+
Sbjct: 244 PCPKNCPQEVY-----ILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-18
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGST----VAIKKLIH-ISGQGDREFTAEMETIGKIKH 915
F ++GSG FG VYK + +G VAIK+L S + ++E E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLED-VLHNQKKVGIK--LNWAARRKIAIGSARG 972
++ LLG C +L + + M +G L D V ++ +G + LNW + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ +L ++HRD+ + NVL+ +++DFG+A+L+ A + ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTD 1066
E + + DV+SYGV + EL+T G +P D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-18
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 867 LIGSGGFGDVYKAK-LKDGST----VAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVP 920
L+GSG FG V+K + +G + VAIK + SG Q +E T M +G + H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLED-VLHNQKKVGIK--LNWAARRKIAIGSARGLAFLH 977
LLG C G LV + GSL D V ++ + + LNW + A+G+ +L
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+ + +HR++ + N+LL + +++DFG+A L+ D S ++ E
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 1038 QSFRCSTKGDVYSYGVVLLELLT-------GKRPTDSADF 1070
R + + DV+SYGV + E+++ G RP + D
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLL-GYC 925
+G G FG VYKA+ K+ A K+I I + + E F E++ + + KH N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY- 71
Query: 926 KVGEERLLVY-EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
E +L + E+ G+L+ ++ ++ L R + L FLH + +
Sbjct: 72 -FYENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 985 IHRDMKSSNVLLDENFEARVSDFGM-ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
IHRD+K+ N+LL + + +++DFG+ A+ S + T GTP ++ PE C
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEV---VACE 178
Query: 1044 T--------KGDVYSYGVVLLELLTGKRP 1064
T K D++S G+ L+EL + P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-18
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTV----AIKKLIHISG-QGDREFTAEMETIGKIKHRNLVP 920
++GSG FG VYK + +G TV AIK L +G + + EF E + + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQK-KVG--IKLNWAARRKIAIGSARGLAFLH 977
LLG C + LV + M +G L D +H K +G + LNW + A+G+ +L
Sbjct: 74 LLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
++HRD+ + NVL+ +++DFG+ARL+ + + ++ E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 1038 QSFRCSTKGDVYSYGVVLLELLT-GKRPTD 1066
+ + + DV+SYGV + EL+T G +P D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 868 IGSGGFGDVYKA------KLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKI-KHRNLV 919
+G+G FG V +A K VA+K L + +RE +E++ + + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HH 978
LLG C +G L++ EY YG L + L +++ + L + A+G+AFL
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE--DLLSFSYQVAKGMAFLASK 160
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLAGTP-GYVPPEY 1036
NC IHRD+ + NVLL ++ DFG+AR +M+ D++ V A P ++ PE
Sbjct: 161 NC----IHRDLAARNVLLTHGKIVKICDFGLARDIMN--DSNYVVKGNARLPVKWMAPE- 213
Query: 1037 YQSFRC--STKGDVYSYGVVLLELLT 1060
F C + + DV+SYG++L E+ +
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-17
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD---REFTAEMETIGKIKHRNLVPLLG 923
IG G FG VY A+ ++ VAIKK+ + Q + ++ E++ + +IKH N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 924 YCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCI 981
C + E LV EY GS D+L KK ++ AA I G+ +GLA+LH HN
Sbjct: 93 -CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHN-- 145
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF- 1040
+IHRD+K+ N+LL E + +++DFG A + S ++ GTP ++ PE +
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVILAMD 197
Query: 1041 --RCSTKGDVYSYGVVLLELLTGKRP 1064
+ K DV+S G+ +EL K P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLI-HISGQGDREF--TA--EMETIGKIKHRNLVPL 921
+G G FG+VYKA ++K G VA+KK++ H G F TA E++ + K+KH N+VPL
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPL 72
Query: 922 LGYC-----KVGEERLLVYEYMRY--GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
+ K +R VY Y L +L N +KL + + + G+
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS---VKLTESQIKCYMLQLLEGIN 129
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM----------SAMDTHLSVST 1024
+LH N HI+HRD+K++N+L+D +++DFG+AR T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR-KYTN 185
Query: 1025 LAGTPGYVPPEY-YQSFRCSTKGDVYSYGVVLLELLTGK 1062
L T Y PPE R +T D++ G V E+ T +
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
IG G G V+ A + G VAIK+ I++ Q +E E+ + ++K+ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V EY+ GSL DV+ ++ R + + L FLH N +I
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS NVLL + +++DFG ++ + ST+ GTP ++ PE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 73/213 (34%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 868 IGSGGFGDVYK-AKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLG-Y 924
IG G +G VYK KDGS A+K L IS D E AE + + H N+V G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 925 CK----VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
K VG + LV E GS+ +++ G +L+ A I G+ GL LH+N
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE----- 1035
IIHRD+K +N+LL ++ DFG++ +++ T L +T GTP ++ PE
Sbjct: 148 --RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACE 203
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
Y RC DV+S G+ +EL G P
Sbjct: 204 QQYDYSYDARC----DVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGY 924
IG G FG+VYKA K VAIK + + + E E++ + + + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66
Query: 925 CKVGEERL-LVYEYMRYGSLEDVLH----NQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
+ +L ++ EY GS D+L ++ + L R++ GL +LH
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL-----REVL----LGLEYLHEE 117
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
IHRD+K++N+LL E + +++DFG++ ++ T +T GTP ++ PE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMAPEVIKQ 172
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
K D++S G+ +EL G+ P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIH--ISGQGDREFTAEMETIGKIKHRNLV 919
F S +G+G G V K + K + +KLIH I + E++ + + +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G E + E+M GSL+ VL K++ ++ K++I RGLA+L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREK 122
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
I+HRD+K SN+L++ E ++ DFG++ +L+ +M ++ GT Y+ PE Q
Sbjct: 123 --HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQ 175
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
S + D++S G+ L+EL G+ P D
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G+G FG+V+ + + VA+K L + F E + ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
E ++ EYM GSL D L + + G K+ + A G+A++ + IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEY--YQSFRCST 1044
D++++NVL+ E+ +++DFG+AR++ D + A P + PE + SF +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSF--TI 183
Query: 1045 KGDVYSYGVVLLELLT-GKRP 1064
K DV+S+G++L E++T GK P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 29/269 (10%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G +G+V + + DG IKKL + S + + E + + ++KH N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 925 CKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
+ GE+ LL V + G L L QK + N + I A L +LH
Sbjct: 68 WE-GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI--AMALQYLHEK--- 121
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
HI+HRD+K+ NV L +V D G+AR++ STL GTP Y+ PE + +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPY 179
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNI 1102
+ K DV++ G + E+ T K ++ D N+LV + + + + PEL
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDM--NSLVYRIIEGKLPPMPKDYSPEL------- 230
Query: 1103 EIELLQHLHVASACLDDRPWRRPTMIQVM 1131
EL+ + L RP +RP++ ++
Sbjct: 231 -GELIATM------LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 37/223 (16%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNL 918
+ N L+G G +G V K K K+ G VAIKK + + A E+ + +++H NL
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
V L+ + + LV+E++ + L+D+ + RK RG+ F H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV----RKYLFQILRGIEFCHS 118
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG-----YVP 1033
+ +IIHRD+K N+L+ ++ ++ DFG AR TLA PG YV
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFAR------------TLAA-PGEVYTDYVA 162
Query: 1034 PEYYQS-------FRCSTKGDVYSYGVVLLELLTGKR--PTDS 1067
+Y++ + D+++ G ++ E+LTG+ P DS
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 23/214 (10%)
Query: 866 SLIGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDRE---------FTAEMETIGKIKH 915
+LIGSG FG VY G +A+K++ S + E+ + +++H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 916 RNLVPLLGYCKVGEERLLVY-EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
N+V LG + + L ++ EY+ GS+ +L+N L R+I +GL
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLN 120
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA----MDTHLSVSTLAGTPG 1030
+LH+ IIHRD+K +N+L+D ++SDFG+++ + A T+ + +L G+
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
++ PE + + K D++S G +++E+LTGK P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLI------HISGQGDREFTAEMETIGKIKHRNLVP 920
IG G +G V+K + ++ G VAIKK + I RE + + ++KH NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HN 979
L+ + + LV+EY + L ++ N + V +KI + + + F H HN
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV----PEHLIKKIIWQTLQAVNFCHKHN 120
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS--VST--------LAGTP 1029
CI HRD+K N+L+ + + ++ DFG AR+++ + V+T L G
Sbjct: 121 CI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG 1061
Y PP DV++ G V ELLTG
Sbjct: 177 QYGPPV-----------DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 868 IGSGGFGDVY--------KAKLKDGSTVAIKKLIHISGQGD-REFTAEMETIGKI-KHRN 917
+G G FG V K K K+ TVA+K L + + D + +EME + I KH+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KI 965
++ LLG C ++ EY G+L + L ++ G++ ++ R
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 966 AIGSARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
ARG+ +L CI HRD+ + NVL+ EN +++DFG+AR ++ +D + +
Sbjct: 143 TYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
++ PE + + DV+S+GV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-17
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGD---REFTAEMETIGKIKHRNLVPLLG 923
IG G FG VY A VA+KK+ + Q + ++ E++ + ++KH N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 924 YCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
C + E LV EY GS D+L KK ++ AA I G+ +GLA+LH + +
Sbjct: 89 -CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHNM- 142
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-- 1040
IHRD+K+ N+LL E + +++DFG A S ++ GTP ++ PE +
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDE 194
Query: 1041 -RCSTKGDVYSYGVVLLELLTGKRP 1064
+ K DV+S G+ +EL K P
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-16
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIH-ISGQGD-----RE--FTAEMETIGKIKHRNL 918
+G G +G V+KA + VA+KK+ D RE F E+ H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNI 69
Query: 919 VPLLGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
V LL K ++ LV+EYM E LH + I L +R I + L ++
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANI-LEDVHKRYIMYQLLKALKYI 123
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA---GTPGYVP 1033
H ++IHRD+K SN+LL+ + +++DFG+AR +S ++ + L T Y
Sbjct: 124 HSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 1034 PEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
PE TKG D++S G +L E+L GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-16
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 20/178 (11%)
Query: 648 LSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL 707
L G IP +I + +L +NL N++ G IP +G + L +LDLS N G+IP S+ L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 708 TLLNEIDLCNNQLTGMIP--VMGQFETFQPAKFLNNSGLCGLP-LPPCEKDSGASANSRH 764
T L ++L N L+G +P + G+ F +N+GLCG+P L C
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC------------ 537
Query: 765 QKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRK--RRKKKESALDV-YIDSRSH 819
H IA G+ + + + + R+ R ++ +A + Y +R+H
Sbjct: 538 -GPH-LSVGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQRIAAREAPYAKARTH 593
|
Length = 623 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHI-----SGQGDREFTAEMETIGKIKHRNLVP 920
++GSG FG VYK + DG V I I + S + ++E E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLED-VLHNQKKVGIK--LNWAARRKIAIGSARGLAFLH 977
LLG C +L V + M YG L D V N+ ++G + LNW + A+G+++L
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
++HRD+ + NVL+ +++DFG+ARL+ +T G VP ++
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG-----GKVPIKWM 178
Query: 1038 --QSF---RCSTKGDVYSYGVVLLELLT-GKRPTDS 1067
+S R + + DV+SYGV + EL+T G +P D
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 51/280 (18%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD----REFTAEMETIGKIKHRNLVPLLG 923
IGSG G VYK + + K+I+ G + R+ E+E + + H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
E ++ E+M GSLE ++ L AR+ ++ G+A+LH H
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQ---FLADVARQILS-----GIAYLHRR---H 188
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMS-AMD-THLSVSTLAGTPGYVPPEYYQSFR 1041
I+HRD+K SN+L++ +++DFG++R+++ MD + SV T+A Y+ PE R
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA----YMSPE-----R 239
Query: 1042 CSTK----------GDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+T GD++S GV +LE G+ P GD W + +S
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMSQ-- 292
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
PE E H S CL P +R + +Q++
Sbjct: 293 PPE---APATASREF---RHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 867 LIGSGGFGDVYKA-KLKDGSTVAIKKLIHI--SGQGDREFTA---EMETIGKIKHRNLVP 920
L+G G FG VY + G +A K++ S + +E +A E++ + ++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 921 LLGYCKVGEERLLV--YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
G + E+ L EYM GS++D Q K L + RK G+++LH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKD----QLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
N I +HRD+K +N+L D ++ DFG + RL + + + ++ GTP ++ PE
Sbjct: 125 NMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
K DV+S G ++E+LT K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
IG G G VY A + G VAIK++ ++ Q +E E+ + + K+ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V EY+ GSL DV+ ++ R + + L FLH N +I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS N+LL + +++DFG ++ + ST+ GTP ++ PE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA--------EMETIGKIK-HRN 917
+G G FG VY A+ K+ G VAIKK+ ++F + E++++ K+ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+V L + +E V+EYM G+L ++ ++K G + + R I +GLA +H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIH 116
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS-VSTLAGTPGYVPPE- 1035
+ HRD+K N+L+ +++DFG+AR + + + VS T Y PE
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS----TRWYRAPEI 169
Query: 1036 -----YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y S+ D+++ G ++ EL T +
Sbjct: 170 LLRSTSY-----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDREFT-AEMETIGKIKHRNLVPLLGYC 925
IG G G V A G VA+KK+ + Q RE E+ + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V E++ G+L D++ + ++N + + + L+FLH +I
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 986 HRDMKSSNVLLDENFEARVSDFGM-ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST 1044
HRD+KS ++LL + ++SDFG A++ + S L GTP ++ PE T
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPEVISRLPYGT 194
Query: 1045 KGDVYSYGVVLLELLTGKRP 1064
+ D++S G++++E++ G+ P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKL--------IHISGQGDREFTAEMETIGKIKHRNL 918
IG G +G VY+A+ G VA+KK+ I IS RE T + ++H N+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL--REITL----LLNLRHPNI 68
Query: 919 VPLLGYCKVG---EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
V L VG + LV EY L +L N + + + + + RGL +
Sbjct: 69 VELKEVV-VGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQY 123
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVP 1033
LH N I IHRD+K SN+LL + +++DFG+AR ++ V TL Y
Sbjct: 124 LHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL----WYRA 176
Query: 1034 PEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
PE T D+++ G +L ELL K
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
IG G +G VYKA+ G VAIKK+ TA E++ + ++ H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+ + LV+E+M D+ K L + + +GLAF H + I
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-- 1042
+HRD+K N+L++ +++DFG+AR T YV +Y++
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARS-------FGSPVRPYTH-YVVTRWYRAPELLL 171
Query: 1043 -----STKGDVYSYGVVLLELLTGK 1062
ST D++S G + ELL+ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHISG--QGDREFTA---EMETIGKIKHRNLVP 920
L+G G FG+VY D G +A+K++ + +E A E++ + ++H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 921 LLGYCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
G + EE+ L EYM GS++D L + + R+I +G+++LH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHS 124
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
N I +HRD+K +N+L D ++ DFG + R+ + + + ++ GTP ++ PE
Sbjct: 125 NMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
K DV+S ++E+LT K P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 867 LIGSGGFGDVYKAKLKD-------GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNL 918
+GSG FG+VY+ D VA+K L + Q +EF E + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAF 975
V LLG C + E + ++ E M G L L + + L I + A+G +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEAR-----VSDFGMARLMSAMDTH-------LSVS 1023
L H IHRD+ + N L+ E + DFG+AR + D + L V
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+A PE + +T+ DV+S+GV++ E+LT G++P
Sbjct: 179 WMA-------PESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 71/278 (25%), Positives = 127/278 (45%), Gaps = 35/278 (12%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHI-SGQGDREFTAE--METI---GKIKHRNLV 919
+G+G F Y+A+ +K G+ +A+K++ ++ + ++E E + I ++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
+LG L E+M GS+ +L + ++ RGL++LH N
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHEN 122
Query: 980 CIPHIIHRDMKSSNVLLDENFE-ARVSDFGMARLMSAMDTH--LSVSTLAGTPGYVPPEY 1036
IIHRD+K +N+L+D + R++DFG A ++A T L GT ++ PE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--KISDVFDPE 1094
+ + DV+S G V++E+ T K P ++ H L KI+
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK---------HSNHLALIFKIASATTA- 229
Query: 1095 LMKEDPNIEIELLQHLH-VASACLDDRPWRRPTMIQVM 1131
P+I L L V CL+ +P RP +++
Sbjct: 230 -----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD--REFTAEMETIGKIKH---RNLVP 920
LIG G +G VY+ K + G VA+K +I++ D + E+ + +++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAA--RRKIAIGSARGLAFLHH 978
G G ++ EY GS+ ++ I + + R++ + L ++H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVA----LKYIHK 119
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+IHRD+K++N+L+ ++ DFG+A L++ ST GTP ++ PE
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVIT 174
Query: 1039 SFRC-STKGDVYSYGVVLLELLTGKRP 1064
+ TK D++S G+ + E+ TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL----IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
I G +G V+ AK K G AIK + + Q D+ T E + + + + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVKLY 59
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
Y G++ L LV EY+ G L +L N VG AR IA I L +LH N
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDVARIYIAEI--VLALEYLHSN- 112
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LMSAMDTHLSVST----LAGTPGYVPP 1034
IIHRD+K N+L+D N +++DFG+++ L+ + GTP Y+ P
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
E S D +S G +L E L G P F
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDR--EFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG+V+K V K+I + D + E+ + + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 926 KVGEERLLVYEYMRYGSLEDVLH----NQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G + ++ EY+ GS D+L ++ ++ L ++I +GL +LH
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML-----KEIL----KGLDYLHSE-- 120
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
IHRD+K++NVLL E + +++DFG+A ++ DT + +T GTP ++ PE Q
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
+K D++S G+ +EL G+ P
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 20/246 (8%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLG 923
+G GGFG+V ++K G A KKL +G++ E + + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ ++ LV M G L+ ++N + G A A GL LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQR---R 115
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
I++RD+K NVLLD++ R+SD G+A + + AGTPGY+ PE Q
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYD 172
Query: 1044 TKGDVYSYGVVLLELLTGKRP-TDSADFGDNNLVGWVKQHAKLKISDVFDPE-------L 1095
D ++ G L E++ G+ P + + + ++ D F PE L
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 1096 MKEDPN 1101
+++DP
Sbjct: 233 LQKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-15
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETIGKIKHRNLV 919
IGSG +G V A + G VAIKK+ ++ D A E++ + ++H N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENII 62
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDV----------LHNQKKVGIKLNWAARRKIAIGS 969
LL + DV LH K L +
Sbjct: 63 GLL----------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
RGL +LH ++IHRD+K SN+L++ N + ++ DFG+AR + + T
Sbjct: 113 LRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT----- 164
Query: 1030 GYVPPEYY-------QSFRCSTKGDVYSYGVVLLELLTGK 1062
YV +Y S R + D++S G + ELLT K
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHI--SGQGDREFTA---EMETIGKIKHRNLVP 920
L+G G FG VY D G +A+K++ S + +E A E++ + + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 921 LLGYCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
G + ER L E+M GS++D L + + + R+I G+++LH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
N I +HRD+K +N+L D ++ DFG + RL + + + ++ GTP ++ PE
Sbjct: 125 NMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
K D++S G ++E+LT K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDR--EFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG+VYK V K+I + D + E+ + + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
G + ++ EY+ GS D+L K G L I +GL +LH I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL----KPG-PLEETYIATILREILKGLDYLHSE---RKI 123
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+K++NVLL E + +++DFG+A ++ DT + +T GTP ++ PE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G+ +EL G+ P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETI--GKIKHRNLVPLLGY 924
++G G FG + + K I + + E + K+KH N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQK----KVGIKLNWAARRKIAIGSARGLAFLHHNC 980
+ +V EY G L + Q+ L W + + + H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV---------QHIH 117
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
++HRD+KS N+ L +N + ++ DFG ARL+++ + T GTP YVPPE +++
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENM 175
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP 1064
+ K D++S G +L EL T K P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
IG G G VY A + G VAI+++ ++ Q +E E+ + + K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V EY+ GSL DV+ ++ R + + L FLH N +I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS N+LL + +++DFG ++ + ST+ GTP ++ PE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++ +E++ G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKLIH--ISGQGDREFT-AEMETIG-KIKHRNLVPL 921
++G G FG V A+LK + AIK L + D E T E + +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ E V EY+ G L + H Q + + A R A GL FLH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL--MFHIQSS--GRFDEARARFYAAEIICGLQFLHKK-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
II+RD+K NVLLD++ +++DFGM + + ST GTP Y+ PE + +
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQK 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
+ D +S+GV+L E+L G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 866 SLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLV 919
IG G +G VYKA+ KD G VA+KK + ++E TA E++ + ++ HRN+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 920 PL----------LGYCKVGEERLLVYEYMR---YGSLEDVLHNQKKVGIKLNWAARRKIA 966
L L + K LV+EYM G LE L + + IK
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SFM 122
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA 1026
GL + H + +HRD+K SN+LL+ + +++DFG+ARL ++ ++ + +
Sbjct: 123 KQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 1027 GTPGYVPPE-YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
T Y PPE R DV+S G +L EL T K+P A+
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIH--ISGQGDREFTAEMETIGKIKHRNLV 919
F S +G+G G V+K K + +KLIH I + E++ + + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G E + E+M GSL+ VL KK G ++ K++I +GL +L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAG-RIPEQILGKVSIAVIKGLTYLREK 122
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
I+HRD+K SN+L++ E ++ DFG++ +L+ +M ++ GT Y+ PE Q
Sbjct: 123 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQ 175
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
S + D++S G+ L+E+ G+ P D
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFT-AEMETIGKIKHRNLVPLLGYC 925
IG G G V A K G VA+KK+ + Q RE E+ + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V E++ G+L D++ + + +N + + R L++LH+ +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS ++LL + ++SDFG +S +L GTP ++ PE T+
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++++E++ G+ P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 868 IGSGGFGDVYKAKL-----KDGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPL 921
+G FG +YK L VAIK L I+ Q EF E + ++ H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVL-------------HNQKKVGIKLNWAARRKIAIG 968
LG + +++EY+ G L + L V L+ IAI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A G+ +L + +H+D+ + N+L+ E ++SD G++R + + D +
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKI 1087
++PPE + S+ D++S+GVVL E+ + G +P F + ++ V++ L
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY--YGFSNQEVIEMVRKRQLLPC 247
Query: 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP 1125
S+ P + + + C + P RRP
Sbjct: 248 SEDCPPRMYS--------------LMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 54/172 (31%), Positives = 93/172 (54%), Gaps = 16/172 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFT---AEMETIGKIKHRNLVPLLGY 924
+GSG +GDVYKA+ +A K+I + GD +F+ E+ + + KH N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE-PGD-DFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVG-IKLNWAARRKIAIGSARGLAFLHHNCIPH 983
E+ + EY GSL+D+ H + +++ + R + +GLA+LH
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK-- 127
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
+HRD+K +N+LL +N + +++DFG+A ++A T + GTP ++ PE
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIH--ISGQGDREFT-AEMETIGKIKHRNLVPL 921
++G G FG V A+ K AIK L + D E T E + +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
L C +RL Y M Y + D++++ ++VG K A + GL FLH
Sbjct: 66 LHSCFQTVDRL--YFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR-- 120
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY--YQS 1039
II+RD+K NV+LD +++DFGM + M ++ T GTP Y+ PE YQ
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ S D ++YGV+L E+L G+ P D D
Sbjct: 178 YGKSV--DWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 67/203 (33%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIH--ISGQGDREFTAEMETIGKIKHRN-LVPLL 922
++G G FG V A+LK G A+K L I D E T + I + + + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 923 GYCKVGEERLL-VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
C +RL V E++ G L + H QK A I SA L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSA--LMFLHDK-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
II+RD+K NVLLD +++DFGM + + + ST GTP Y+ PE Q
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
D ++ GV+L E+L G P
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIH-ISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG+V+ +L+ D + VA+K + +F E + + H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ +V E ++ G L + G +L ++ +A G+ +L H I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCI 116
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCST 1044
HRD+ + N L+ E ++SDFGM+R + S + P + PE R S+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 1045 KGDVYSYGVVLLE 1057
+ DV+S+G++L E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 74/255 (29%), Positives = 112/255 (43%), Gaps = 38/255 (14%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIG---KIKHRNLVPLL 922
++G G +G VY A+ L +AIK+ I + R E I +KHRN+V L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKE---IPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVG-IKLNWAARRKIAIGSARGLAFLHHNCI 981
G + E + GSL +L + K G +K N GL +LH N
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 982 PHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY-QS 1039
I+HRD+K NVL++ + ++SDFG ++ ++ ++ T GT Y+ PE +
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKG 184
Query: 1040 FRCSTK-GDVYSYGVVLLELLTGKRP------TDSADFGDNNLVGWVKQH---------- 1082
R D++S G ++E+ TGK P +A F VG K H
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK----VGMFKIHPEIPESLSAE 240
Query: 1083 AKLKISDVFDPELMK 1097
AK I F+P+ K
Sbjct: 241 AKNFILRCFEPDPDK 255
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFT-AEMETIGKIKHRNLVPLLGYC 925
IG G G V A+ K G VA+K ++ + Q RE E+ + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VGEE ++ E+++ G+L D++ +LN + + L +LH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS ++LL + ++SDFG +S D S L GTP ++ PE T+
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKS-LVGTPYWMAPEVISRTPYGTE 197
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++++E++ G+ P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA---EMETIGKIKHRNLVPLLGY 924
IG G FG K K+ + K I+IS +E E+ + +KH N+V Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---Y 64
Query: 925 CKVGEERLLVYEYMRY---GSLEDVLHNQKKVGIK----LNWAARRKIAIGSARGLAFLH 977
+ EE +Y M Y G L ++ Q+ V L+W + +A L
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LK 115
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
H I+HRD+KS N+ L ++ ++ DFG+AR++++ T T GTP Y+ PE
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEIC 173
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076
++ + K D+++ G VL E+ T K ++ + NLV
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDREFTA-----EMETIGKIKHRNLVPL 921
IGSG +G V A + G VAIKK+ H D A E++ + KH N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---DVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 922 LGYCKV----GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+ ++ +V + M L ++H+ + L R RGL ++H
Sbjct: 70 RDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIH 124
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVST-LAGTPGYVPPE 1035
+ IHRD+K SN+L++E+ E R+ DFGMAR L S+ H T T Y PE
Sbjct: 125 SANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 1036 YYQSF-RCSTKGDVYSYGVVLLELLTGKRP 1064
S +T D++S G + E+L G+R
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 38/271 (14%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDR--EFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG+V+K V K+I + D + E+ + + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 926 KVGEERLLVYEYMRYGSLEDVLH----NQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ ++ EY+ GS D+L ++ ++ L R+I +GL +LH
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL-----REIL----KGLDYLHSE-- 120
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
IHRD+K++NVLL E+ E +++DFG+A ++ DT + +T GTP ++ PE +
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101
+K D++S G+ +EL G+ P H++L V P
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP-----------------HSELHPMKVLFLIPKNNPPT 220
Query: 1102 IEIELLQHL-HVASACLDDRPWRRPTMIQVM 1131
+E + L ACL+ P RPT +++
Sbjct: 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-15
Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIH--ISGQGDREFTAEMETIGKIKHRNLVPLLG 923
++G G FG V A+LK G A+K L + D E T + + + N P L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN--PFLT 59
Query: 924 --YC--KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
YC + E V E++ G L + H Q K L A I GL FLH
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVC--GLQFLHSK 115
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
II+RD+K NV+LD + +++DFGM + D ST GTP Y+ PE Q
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQG 170
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ + D +S+GV+L E+L G+ P D
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 34/273 (12%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYCK 926
+G G FG VYKAK K+ +A K+I + + E + E+E + H +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
+ ++ E+ G+++ ++ + L + I L +LH IIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST-- 1044
RD+K+ NVLL + + +++DFG++ + T + GTP ++ PE C T
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVM---CETMK 188
Query: 1045 ------KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098
K D++S G+ L+E+ + P + LKI+ +P + +
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELN----------PMRVLLKIAKS-EPPTLSQ 237
Query: 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+E L A LD P RP+ Q++
Sbjct: 238 PSKWSMEFRDFLKTA---LDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 868 IGSGGFGDVYKAKL--KDGST----VAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVP 920
+G G FG+VY+ +DG VA+K L S Q + +F E + K H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL-HNQKKVGIKLNWAARR--KIAIGSARGLAFLH 977
L+G R ++ E M G L+ L N+ + + + A A+G +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARV---SDFGMARLMSAMDTHLSVSTLAGTP-GYVP 1033
N H IHRD+ + N LL RV +DFGMAR + + A P ++P
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS-YYRKGGRAMLPIKWMP 189
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT 1060
PE + ++K DV+S+GV+L E+ +
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 861 GFHNDSLIGSGGFGDVYKAKLKDGST---VAIKKLIHISGQGD-------REFTAEMETI 910
+ + IG G +G VYKAK K+G AIKK Q RE E
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE-- 58
Query: 911 GKIKHRNLVPLLGYCKVGEERL--LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
+KH N+V L+ ++ L+++Y + + + +++ + + + + +
Sbjct: 59 --LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLM-SAMDTHLSVS 1023
G+ +LH N ++HRD+K +N+L+ E ++ D G+ARL + + +
Sbjct: 117 ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 1024 TLAGTPGYVPPEYYQSFRCSTKG-DVYSYGVVLLELLT 1060
+ T Y PE R TK D+++ G + ELLT
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFT-AEMETIGKIKHRNLVPLLGYC 925
IG G G V A +K G VA+KK+ + Q RE E+ + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V E++ G+L D++ + + +N + + + L+ LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS ++LL + ++SDFG +S +L GTP ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPE 196
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D++S G++++E++ G+ P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 868 IGSGGFGDVY----KAKLKDG--STVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG VY K +KD + VAIK + + +R EF E + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHN-----QKKVGIKLNWAARR-KIAIGSARGLA 974
LLG G+ L++ E M G L+ L + + + ++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP- 1033
+L+ N +HRD+ + N ++ E+F ++ DFGM R + D + G G +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185
Query: 1034 ----PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKIS 1088
PE + +T DV+S+GVVL E+ T ++P + ++ +V + L
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--MSNEQVLRFVMEGGLLDKP 243
Query: 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
D P++ EL++ C P RP+ +++++ KE
Sbjct: 244 D--------NCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 62/261 (23%), Positives = 101/261 (38%), Gaps = 54/261 (20%)
Query: 868 IGSGGFGDVYKAK------------LKDGSTVAIKKLIHISG-------QGDREFTAEME 908
I G FG VY AK LK +A ++ ++ QG+ + A+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK-- 61
Query: 909 TIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
L + + LV EY+ G ++ + G+ +WA ++
Sbjct: 62 ------------LYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWA--KQYIAE 105
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
G+ LH IIHRD+K N+L+D+ +++DFG++R L GT
Sbjct: 106 VVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGT 156
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP----TDSADFGD--NNLVGWVKQH 1082
P Y+ PE D +S G V+ E L G P T A F + + + W ++
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV 216
Query: 1083 AKLKISDVFD--PELMKEDPN 1101
+ + D L+ DP
Sbjct: 217 KEFCSPEAVDLINRLLCMDPA 237
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 868 IGSGGFGDVY--------KAKLKDGSTVAIKKLIHISGQGD-REFTAEMETIGKI-KHRN 917
+G G FG V K K TVA+K L + D + +EME + I KH+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KI 965
++ LLG C ++ EY G+L + L ++ G+ ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 966 AIGSARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
A ARG+ +L CI HRD+ + NVL+ E+ +++DFG+AR + +D + +
Sbjct: 140 AYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
++ PE + + DV+S+GV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 38/213 (17%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKL-IHISGQGD-----REFTAEMETIGKIKHRNL 918
+ IG G +G VYKA+ L G VA+KK+ + +S +G RE A ++ + +H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFEHPNI 63
Query: 919 VPLLGYCKVGE-ER----LLVYEYMRYGSLEDVLHNQKKVGI---KLNWAARRKIAIGSA 970
V LL C +R LV+E++ L L K G+ + R+ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL----- 117
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
RG+ FLH + I +HRD+K N+L+ + + +++DFG+AR+ ++++++ T
Sbjct: 118 RGVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLW 171
Query: 1031 YVPPE-----YYQSFRCSTKGDVYSYGVVLLEL 1058
Y PE Y +T D++S G + EL
Sbjct: 172 YRAPEVLLQSSY-----ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 24/286 (8%)
Query: 859 TNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKK--LIHISGQGDRE-FTAEMETIGKIK 914
F + IG G F VYKA L DG VA+KK + + R+ E++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 915 HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
H N++ L E +V E G L ++ + KK + K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
+H I+HRD+K +NV + ++ D G+ R S+ T + +L GTP Y+ P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP 175
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-NLVGWVKQHAKLKISDVFDP 1093
E + K D++S G +L E+ + P +GD NL K KI P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCK-----KIEKCDYP 226
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
L + + E+ + S C++ P +RP + V+ + KE+ A
Sbjct: 227 PLPADHYSEELR-----DLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 868 IGSGGFGDVYKA---KLKDGSTVAIKKLIHISGQG--DREFTAEMETIGKIKHRNLVPLL 922
+GSG FG V K K TVA+K L + + E E + ++ + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
G C+ E +LV E G L L K V K ++++G + +L
Sbjct: 63 GICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEET--- 114
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFR 1041
+ +HRD+ + NVLL A++SDFG+++ + A + + T P + PE ++
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 1042 CSTKGDVYSYGVVLLELLT-GKRP 1064
S+K DV+S+GV++ E + G++P
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
IGSG +GDVYKA+ + G AIK + G+ E+ + KH N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVG-IKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
++ + E+ GSL+D+ H + ++ + +R + +GL +LH +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK---GKM 128
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+K +N+LL +N +++DFG++ ++A T + GTP ++ PE R K
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVER---K 183
Query: 1046 G------DVYSYGVVLLELLTGKRP 1064
G D+++ G+ +EL + P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 24/283 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLI---HISGQGDREFTAEMETIGKIKHRN 917
F + IG G F +VY+A L DG VA+KK+ + + + E++ + ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
++ E +V E G L ++ + KK + K + L +H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
++HRD+K +NV + ++ D G+ R S+ T + +L GTP Y+ PE
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERI 178
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-NLVGWVKQHAKLKISDVFDPELM 1096
+ K D++S G +L E+ + P +GD NL K KI P L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCK-----KIEQCDYPPLP 229
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
+ + E+ L ++ C++ P +RP + V + K + A
Sbjct: 230 SDHYSEELRQLVNM-----CINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIH--ISGQGDREFTAEMETIGKIKHRNLVPLLG-Y 924
+G+G G V K + + +KLIH I + E++ + + +V G +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVG-IKLNWAARRKIAIGSARGLAFLHHNCIPH 983
GE + + E+M GSL+ VL KK G I N KI+I RGL +L
Sbjct: 69 YSDGEISICM-EHMDGGSLDQVL---KKAGRIPENILG--KISIAVLRGLTYLREK--HK 120
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
I+HRD+K SN+L++ E ++ DFG++ +L+ +M ++ GT Y+ PE Q
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTHY 175
Query: 1043 STKGDVYSYGVVLLELLTGKRP 1064
+ + D++S G+ L+E+ G+ P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-14
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 19/192 (9%)
Query: 884 GSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHRNLVPLLGYCKVGEERLL-VYEYMR 939
G VAIK L + + + + F E ++ H N+V LL + L V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL--- 996
+L +VL L ++ + LA H+ I+HRD+K N+++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 997 DENFEARVSDFGMARLMS----AMDTHLSVST-LAGTPGYVPPEYYQSFRCSTKGDVYSY 1051
A+V DFG+ L+ A L+ +T + GTP Y PE + + D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 1052 GVVLLELLTGKR 1063
G++ LE LTG+R
Sbjct: 176 GLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 21/209 (10%)
Query: 867 LIGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGD-REFTAEMETIGKIKHRNLVPL 921
+G G FG V + + VA+K L +F E + + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKK----VGIKLNWAARRKIAIGSARGLAFLH 977
G + ++V E GSL D L + ++A + I A G+ +L
Sbjct: 62 YGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA----VQI--ANGMRYLE 114
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEY 1036
IHRD+ + N+LL + + ++ DFG+ R + + H + P + PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++ S DV+ +GV L E+ T G+ P
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 48/219 (21%)
Query: 866 SLIGSGGFGDVYKAKLKD-GSTVAIKKL-------IHISGQGDREFTAEMETIGKIKHRN 917
S +GSG +G V A G VAIKKL IH R + E+ + + H N
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH----AKRTYR-ELRLLKHMDHEN 75
Query: 918 LVPLLGYCKVGEER------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR 971
++ LL LV M L +++ QK L+ + + R
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQK-----LSDDHIQFLVYQILR 129
Query: 972 GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA-MDTHLSVSTLAGTPG 1030
GL ++H IIHRD+K SN+ ++E+ E ++ DFG+AR M ++ T
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV------ATRW 180
Query: 1031 YVPPE-------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y PE Y Q+ D++S G ++ ELLTGK
Sbjct: 181 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 9e-14
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDREFT-AEMETIGKIKHRNLVP 920
+G+G FG V + K G A+K K++ E E + I+H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVN 65
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN--WAARRKIAIGSARGLAFLHH 978
L G + LV EY+ G L L + + +AA+ +A L +LH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA------LEYLHS 119
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
I++RD+K N+LLD + +++DFG A+ + T+ TL GTP Y+ PE
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-RTY----TLCGTPEYLAPEIIL 171
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
S D ++ G+++ E+L G P F D+N
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPP-----FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 867 LIGSGGFGDVYKAKLK--DGST--VAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVP 920
++G G FG V + +L DGS VA+K KL + EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 921 LLGYCKVGEER------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR--KIAIGSARG 972
L+G C +++ +M++G L L + G+ + K + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GY 1031
+ +L + + IHRD+ + N +L E+ V+DFG+++ + + D + +A P +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ-GRIAKMPVKW 181
Query: 1032 VPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+ E ++K DV+++GV + E+ T G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 436 LTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC 495
L G IP+ + L LQ + L N + G IPP LG+I +LE L L +N G++P +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 496 TNLNWISLSNNHLGGEIPTWIG-QLSNLAILKLSNNSFYGRIP 537
T+L ++L+ N L G +P +G +L + A ++N+ IP
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 24/202 (11%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYCK 926
+G G FG VYKA+ K+ +A K+I + + E + E++ + H N+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
++ E+ G+++ V+ ++ L R + + L +LH N IIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSFRCST 1044
RD+K+ N+L + + +++DFG +SA +T + GTP ++ PE C T
Sbjct: 127 RDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAPEVVM---CET 179
Query: 1045 --------KGDVYSYGVVLLEL 1058
K DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 24/282 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLI---HISGQGDREFTAEMETIGKIKHRN 917
F + IG G F +VY+A L D VA+KK+ + + ++ E++ + ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
++ L E +V E G L ++ KK + R + + + +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVE 120
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
H ++HRD+K +NV + ++ D G+ R S+ T + +L GTP Y+ PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERI 178
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-NLVGWVKQHAKLKISDVFDPELM 1096
+ K D++S G +L E+ + P +GD NL + KI P L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLFSLCQ-----KIEQCDYPPLP 229
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
E + E L+ L S C+ P +RP + V + K++
Sbjct: 230 TEHYS---EKLREL--VSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
IG G +G VYKA+ G VA+KK+ + TA E+ + ++ H N+V LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+ LV+E++ L+ + GI L + +GLAF H + +
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSH---RV 121
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSA---MDTHLSVSTLAGTPGYVPPE------ 1035
+HRD+K N+L++ +++DFG+AR TH V TL Y PE
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTL----WYRAPEILLGCK 176
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKR--PTDS 1067
YY ST D++S G + E++T + P DS
Sbjct: 177 YY-----STAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 89/256 (34%), Positives = 129/256 (50%), Gaps = 12/256 (4%)
Query: 309 SSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPD 368
S+N +PS SL+ S E L++ L L L+ N
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDG--SENLLNLLPLPSLDLNLNRLRS-NIS 110
Query: 369 SLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVS 428
L LTNL +LDL +NN++ IP + +++LKEL L +N + S+PS L N L +
Sbjct: 111 ELLELTNLTSLDLDNNNIT-DIPPLIGL-LKSNLKELDLSDNKIE-SLPSPLRNLPNLKN 167
Query: 429 LHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTL 488
L LSFN L+ +P L +LS L +L L N++ ++PPE+ + LE L L N + L
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL 224
Query: 489 PAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIW 548
++LSN NL+ + LSNN ++P IG LSNL L LSNN LG +L
Sbjct: 225 LSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRE 281
Query: 549 LDLNTNLFNGSIPPAL 564
LDL+ N + ++P
Sbjct: 282 LDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIH--ISGQGDREFTAEMETIGKI--KHRNLVPL 921
++G G FG V+ A+LK AIK L + D E T + + + +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ E V EY+ G L + H Q L A I GL FLH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEI--ICGLQFLHSK-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
I++RD+K N+LLD + +++DFGM + M T GTP Y+ PE +
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+T D +S+GV+L E+L G+ P D
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+ +G+G FG+V+ A + VA+K + F AE + ++H LV L +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--H 67
Query: 925 CKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
V +E + ++ E+M GSL D L + + G K + A G+AF+ +
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---N 122
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEY--YQSF 1040
IHRD++++N+L+ + +++DFG+AR++ D + A P + PE + SF
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 1041 RCSTKGDVYSYGVVLLELLT-GKRP 1064
+ K DV+S+G++L+E++T G+ P
Sbjct: 181 --TIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTV-AIKKLIH--ISGQGDREFT-AEMETIGKIKHRNLVPL 921
++G G FG V A+ K + AIK L I D E T E + +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVG-----IKLNWAARRKIAIGSARGLAF 975
L C +RL V EY+ G D++++ ++VG + +AA +IAIG L F
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGKFKEPHAVFYAA--EIAIG----LFF 116
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
LH II+RD+K NV+LD +++DFGM + + + T GTP Y+ PE
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPE 171
Query: 1036 Y--YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
YQ + S D +++GV+L E+L G+ P D D
Sbjct: 172 IIAYQPYGKSV--DWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 868 IGSGGFGDVYKAKL------KDGSTVAIKKLI-HISGQGDREFTAEMETIGKIKHRNLVP 920
+G FG VYK L + VAIK L G EF E +++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL------------HNQKKVGIKLNWAARRKIAIG 968
LLG + +++ Y + L + L + K V L A I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A G+ FL + H++H+D+ + NVL+ + ++SD G+ R + A D + +
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++ PE + S D++SYGVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLG 923
+G GGFG+V ++K+ G A KKL G++ E E + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ LV M G L+ ++N + G+++ R I + LH + +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME----RVIHYSAQITCGILHLHSM-D 115
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
I++RDMK NVLLD+ R+SD G+A + T ++ AGT GY+ PE + S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYS 172
Query: 1044 TKGDVYSYGVVLLELLTGKRP 1064
D ++ G + E++ G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 16/210 (7%)
Query: 868 IGSGGFGDVYKAKLKDGSTVA---IKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLG 923
IG+G FG V + G + A +K+L + F E++ ++ H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLH-NQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
C LLV E+ G L++ L N+ V +++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-- 1040
IH D+ N L + ++ D+G+A D +++ A ++ PE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 1041 -----RCSTKGDVYSYGVVLLELLT-GKRP 1064
+ K +++S GV + EL T +P
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 868 IGSGGFG----DVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHR----NLV 919
+GSG FG VYK + K VAIK L + + + R+ EM +I H+ +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
++G C+ E +LV E G L L +K N ++ + G+ +L
Sbjct: 59 RMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVV---ELMHQVSMGMKYLEGK 114
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQ 1038
+ +HRD+ + NVLL A++SDFG+++ + A D++ + P + PE
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 1039 SFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+ S++ DV+SYG+ + E + G++P
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 70/251 (27%), Positives = 109/251 (43%), Gaps = 47/251 (18%)
Query: 867 LIGSGGFGDVY-------------------KAKLKDGSTVAIKKLIHIS--GQGDREFTA 905
+IG GGFG+VY + K+K G T+A+ + I +S GD F
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 906 EMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI 965
M T L +L G+ L Y ++G + ++K++ R
Sbjct: 61 CM-TYAFHTPDKLCFILDLMNGGD---LHYHLSQHG-----VFSEKEM---------RFY 102
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
A GL +H+ +++RD+K +N+LLDE+ R+SD G+A S H SV
Sbjct: 103 ATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 1026 AGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
GT GY+ PE Q + D +S G +L +LL G P D + + +
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215
Query: 1085 LKISDVFDPEL 1095
+++ D F PEL
Sbjct: 216 VELPDSFSPEL 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKLIH--ISGQGDREFTAEMETIGKI--KHRNLVPL 921
++G G FG V A+LK V AIK L I D + T + I + KH L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ + V EY+ G L + Q+ K + R A L FLH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL--MFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+I+RD+K N+LLD +++DFGM + + ++ +T GTP Y+ PE Q
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
D ++ GV++ E++ G+ P
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001
SL+ G+ + KIA+ + L +LH +IHRD+K SNVL++ N +
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQ 142
Query: 1002 ARVSDFGMA-RLMSAMDTHLSVSTL-AGTPGYVPPEY------YQSFRCSTKGDVYSYGV 1053
++ DFG++ L+ ++ T+ AG Y+ PE + + K DV+S G+
Sbjct: 143 VKLCDFGISGYLVDSV-----AKTIDAGCKPYMAPERINPELNQKGY--DVKSDVWSLGI 195
Query: 1054 VLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK-ISDVFDPELMKEDPNIEIELLQHLHV 1112
++EL TG+ P DS W +LK + + P+L E + E +
Sbjct: 196 TMIELATGRFPYDS----------WKTPFQQLKQVVEEPSPQLPAEKFSPEFQ-----DF 240
Query: 1113 ASACLDDRPWRRPTMIQVMAM-FKEIQAGSGLDSQSTIAT 1151
+ CL RP +++ F E+ D S ++
Sbjct: 241 VNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-13
Identities = 39/88 (44%), Positives = 53/88 (60%)
Query: 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464
L L N L G IP+ +S L S++LS N + G IP SLGS++ L+ L L N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 465 PPELGNIQTLETLFLDFNELTGTLPAAL 492
P LG + +L L L+ N L+G +PAAL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEM---ETIGKIKHRNLVPLLG 923
+G GGFG+V +++ G A KKL + + + M + K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHN--QKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ + LV M G L ++N ++ G A I S GL LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS--GLEHLHQR-- 116
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
II+RD+K NVLLD + R+SD G+A + D AGTPG++ PE Q
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
D ++ GV L E++ + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE------------FTA--EMETIGK 912
+G G +G V KA G VAIKK+ I D FT E++ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 913 IKHRNLVPLLG-YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR 971
IKH N++ L+ Y + G+ LV + M L+ V+ + I+L + + I +
Sbjct: 77 IKHENIMGLVDVYVE-GDFINLVMDIMAS-DLKKVVDRK----IRLTESQVKCILLQILN 130
Query: 972 GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-------LMSAMDTHLSVST 1024
GL LH + +HRD+ +N+ ++ +++DFG+AR +
Sbjct: 131 GLNVLH-KW--YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 1025 LAGTPG-----YVPPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
T Y PE D++S G + ELLTGK
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 46/227 (20%)
Query: 868 IGSGGFGDVYKA----------------KLKDGST-VAIKKLIHISGQGDR-EFTAEMET 909
+G G FG+V+ D VA+K L + R +F E++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 910 IGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK----- 964
+ ++ N+ LLG C V ++ EYM G L L QK V A K
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL--QKHVAETSGLACNSKSLSFS 130
Query: 965 ----IAIGSARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019
+A A G+ +L N +HRD+ + N L+ +N+ +++DFGM+R + + D
Sbjct: 131 TLLYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD-- 184
Query: 1020 LSVSTLAGTPGYVPPEYYQSFRC------STKGDVYSYGVVLLELLT 1060
+ G P + ++ +TK DV+++GV L E+LT
Sbjct: 185 --YYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 868 IGSGGFGDVY--------KAKLKDGSTVAIKKLIHISGQGD-REFTAEMETIGKI-KHRN 917
+G G FG V K K + VA+K L + + D + +EME + I KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK------------LNWAARRKI 965
++ LLG C ++ EY G+L + L ++ G++ L++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR + +D + +
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 1026 AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
++ PE + + DV+S+GV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD------REFTAEMETIGKIKHRNLVP 920
IG G +G VYKA+ G VA+K + + + RE A ++ + H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66
Query: 921 LLGYCKVGE-----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
L+ C + LV+E++ L L G+ + + RGL F
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDF 123
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
LH NCI +HRD+K N+L+ + +++DFG+AR+ S ++++ + T Y PE
Sbjct: 124 LHANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPE 177
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
+T D++S G + E+ K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 41/284 (14%)
Query: 867 LIGSGGFGDVYKAKLKDGST--VAIKKL-IH--ISGQGDRE-------FTAEMETIGK-I 913
+GSG FG VYK + K+ +A+K++ +H G+ RE +E+ I + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 914 KHRNLVPLLGYCKV---GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
+H N+V Y K + +V + + L + ++ K+ + I +
Sbjct: 67 RHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
L +LH I+HRD+ +N++L E+ + ++DFG+A+ SV GT
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV---VGTIL 178
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD- 1089
Y PE ++ K DV+++G +L ++ T + P F N++ KI +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP-----FYSTNMLSLA-----TKIVEA 228
Query: 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
V++P + E + E + V ++CL RP +IQV AM
Sbjct: 229 VYEP--LPEG--MYSEDVT--DVITSCLTPDAEARPDIIQVSAM 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGYC 925
+G G + VYK + + + K IH+ + TA E+ + ++KH N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ +LV+EYM L+ + G L+ + +G+AF H N ++
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG---TPGYVPPEYYQSFRC 1042
HRD+K N+L+++ E +++DFG+AR + V+T + T Y P+ R
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFG-----IPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 1043 -STKGDVYSYGVVLLELLTGK---RPTDSAD 1069
ST D++S G ++ E++TG+ T++ D
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-13
Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIK---KLIHISGQGDREFTAEMETIGK-IKHRNLVPL 921
+IG G FG V AK K DGS A+K K + + AE + K +KH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ E+ V +Y+ G L H Q++ A R A A + +LH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRA--RFYAAEVASAIGYLHSL-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+II+RD+K N+LLD ++DFG+ + ++ + ST GTP Y+ PE +
Sbjct: 116 -NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFG 1071
D + G VL E+L G P S D
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKL--IHISGQGDREFTAEMETIGKIK-HRNLVPLLG 923
IG G +G V+K K+GS A+K L IH D E AE + + H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 924 Y-----CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
K G++ LV E GS+ D++ K G ++ I + GL LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY- 1037
N IHRD+K +N+LL ++ DFG++ +++ T L +T GTP ++ PE
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIA 197
Query: 1038 --QSFRCS--TKGDVYSYGVVLLELLTGKRP 1064
Q + + DV+S G+ +EL G P
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 868 IGSGGFGDVYKAKL--------KDGSTVAIKKLIHISGQGD-REFTAEMETIGKI-KHRN 917
+G G FG V +A+ TVA+K L + D + +EME + I KH+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGI------------KLNWAARRKI 965
++ LLG C ++ EY G+L + L ++ G +L++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR + +D + S
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 1026 AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
++ PE + + DV+S+G+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-13
Identities = 70/211 (33%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKLIH--ISGQGDREFTAEMETIGKI--KHRNLVPL 921
++G G FG V A+LK + A+K L I D E T + + + KH L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
C ++RL V EY+ G L + H Q+ A R A GL FLH
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRA--RFYAAEIVLGLQFLHER- 115
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY--YQ 1038
II+RD+K NVLLD +++DFGM + + ++ ST GTP Y+ PE YQ
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ + D ++ GV+L E+L G+ P + D
Sbjct: 172 PYGPAV--DWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 868 IGSGGFGDVYKAKLKDGST-------VAIKKLIHISGQGDREFTAEMETIG---KIKHRN 917
+G G F ++YK L+ S + ++ + G R+ A ET ++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
LV L G C V +E ++V EY+++G L+ LH +K + L+W + +A A L +L
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKN-NVSLHW--KLDVAKQLASALHYLE 118
Query: 978 HNCIPHIIHRDMKSSNVLL---DENFE----ARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
++H ++ N+L+ N ++SD G+ T LS
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIP 169
Query: 1031 YVPPEYYQSFRCSTK--GDVYSYGVVLLEL 1058
++ PE ++ + S D +S+G LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 18/159 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
IG G FG+V+KA+ K VA+KK++ + + TA E++ + +KH N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 925 C---KVGEER-----LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
C R LV+E+ + L +L N+ +K + +K+ GL ++
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYI 135
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015
H N I+HRDMK++N+L+ ++ +++DFG+AR S
Sbjct: 136 HRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFTAEMETIGKIKHRN- 917
F +IG G FG+V + K V A+K L + + D F E I + H N
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANS 102
Query: 918 --LVPLLGYCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWA----ARRKIAIGS 969
+V L + +++ L V EYM G L +++ N I WA A +A+ +
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDA 157
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
+ F IHRD+K N+LLD++ +++DFG M A + + T GTP
Sbjct: 158 IHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGTP 207
Query: 1030 GYVPPEYYQSFRCST----KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077
Y+ PE +S + D +S GV L E+L G P F ++LVG
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-----FYADSLVG 254
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 49/291 (16%)
Query: 868 IGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG VY+ +D + VA+K + + +R EF E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL--------HNQKKVGIKLNWAARRKIAIGSARG 972
LLG G+ L+V E M +G L+ L +N + L + I A G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI--ADG 131
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+A+L+ +HRD+ + N ++ +F ++ DFGM R + D + G G +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLL 183
Query: 1033 P-----PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLK 1086
P PE + +T D++S+GVVL E+ + ++P G +N +Q K
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ----GLSN-----EQVLKF- 233
Query: 1087 ISDVFDPELMKEDPNIEIELLQHLH-VASACLDDRPWRRPTMIQVMAMFKE 1136
V D + + N + + + C P RPT ++++ + K+
Sbjct: 234 ---VMDGGYLDQPDNCP----ERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 865 DSLIGSGGFGDVYKAKLKDGST----VAIKKL-IHISGQGDREFTAEMETIGKIKHRNLV 919
+ ++G+G FG++ + LK S VAI L S + R F AE T+G+ H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L G G ++V EYM G+L+ L + +L + G A G+ +L
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEM 126
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----MSAMDTHLSVSTLAGTPGYVPPE 1035
+H+ + + VL++ + ++S F RL A+ T +S + + PE
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV---LWAAPE 178
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
Q S+ DV+S+G+V+ E+++ G+RP
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTA--EMETIGKIK 914
A + N +G G + VYK + +G VA+K +I + + FTA E + +K
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLK 61
Query: 915 HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
H N+V L E V+EYM D+ + L+ R RGLA
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
++H HI+HRD+K N+L+ E +++DFG+AR S S + T Y PP
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPP 172
Query: 1035 EYYQ-SFRCSTKGDVYSYGVVLLELLTGK 1062
+ + S+ D++ G + +E+L G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE----FTAEMETIGKIKHRNLVPLL 922
+IG G + V +LK + K++ D E E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
C RL LV EY+ G L + H Q++ KL R A L FLH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFHMQRQR--KLPEEHARFYAAEICIALNFLHER-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
II+RD+K NVLLD + +++D+GM + + + ST GTP Y+ PE +
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTD 1066
D ++ GV++ E++ G+ P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 852 FADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIH------ISGQGDREFT 904
F + E TN + + +G G FG V A+ G VAIKK++ ++ + RE
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-- 59
Query: 905 AEMETIGKIKHRNLVPLLG-YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR 963
++ + ++H N++ L + E+ V E + LH L +
Sbjct: 60 --LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTD-----LHRLLTSR-PLEKQFIQ 111
Query: 964 KIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023
RGL ++H ++HRD+K SN+L++EN + ++ DFG+AR+ D ++
Sbjct: 112 YFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMT-- 163
Query: 1024 TLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLTGK 1062
GYV YY++ + + D++S G + E+L GK
Sbjct: 164 ------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
+G G + VYK K K +G VA+K +I + + FTA E + +KH N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
E LV+EY+ D+ K L+ + RGL+++H +I
Sbjct: 72 IHTKETLTLVFEYVH----TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YI 124
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE-YYQSFRCS 1043
+HRD+K N+L+ + E +++DFG+AR S + +H + S T Y PP+ S S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKS-VPSH-TYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 1044 TKGDVYSYGVVLLELLTG 1061
T D++ G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIK---KLIHISGQGDREFTAEMETIGK-IKHRNLVPL 921
+IG G FG V AK K DG A+K K I ++ + + AE + K +KH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ E+ V +++ G L H Q++ A I SA L +LH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASA--LGYLHS--- 114
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
+I++RD+K N+LLD ++DFG+ + ++ DT +T GTP Y+ PE +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIRKQ 171
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP---TDSADFGDNNL 1075
D + G VL E+L G P D A+ DN L
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRN 917
F ++G GGFG+V +++ G A KKL +G+ E + + K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+V L + + LV M G L+ +++ + G + A I GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC--GLEDLH 119
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
I++RD+K N+LLD++ R+SD G+A + T + GT GY+ PE
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVV 173
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
++ R + D ++ G +L E++ G+ P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 71/252 (28%), Positives = 107/252 (42%), Gaps = 49/252 (19%)
Query: 867 LIGSGGFGDVY-------------------KAKLKDGSTVAIKKLIHIS--GQGDREFTA 905
+IG GGFG+VY + K+K G T+A+ + I +S GD F
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 906 EMETIGKIKHRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
M Y ++L + + M G L L +Q V + A R
Sbjct: 61 CMS---------------YAFHTPDKLSFILDLMNGGDLHYHL-SQHGV---FSEAEMRF 101
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
A GL +H+ +++RD+K +N+LLDE+ R+SD G+A S H SV
Sbjct: 102 YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 156
Query: 1025 LAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083
GT GY+ PE Q + D +S G +L +LL G P D + + +
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214
Query: 1084 KLKISDVFDPEL 1095
+++ D F PEL
Sbjct: 215 AVELPDSFSPEL 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-12
Identities = 85/267 (31%), Positives = 119/267 (44%), Gaps = 38/267 (14%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
L LDL+ N L + ++L S D+ +N + ++P I L SNLKEL LS N
Sbjct: 93 LPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDN 150
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL 420
+LP L NL NL+ LDLS N+LS +P L
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDLS---------------------------DLPKLL 182
Query: 421 SNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG-EIPPELGNIQTLETLFL 479
SN S L +L LS N +P + LS L+ +L L+ E+ L N++ L L L
Sbjct: 183 SNLSNLNNLDLSGN-KISDLPPEIELLSALE--ELDLSNNSIIELLSSLSNLKNLSGLEL 239
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539
N+L LP ++ N +NL + LSNN + +G L+NL L LS NS P
Sbjct: 240 SNNKLE-DLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLS-NALPL 295
Query: 540 LGDCRSLIWLDLNTNLFNGSIPPALFK 566
+ L+ L LN L ++ L
Sbjct: 296 IALLLLLLELLLNLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 868 IGSGGFGDVYKAKL-----KDGSTVAIKKLIHISGQGD-REFTAEMETIGKIKHRNLVPL 921
+G G FG V + G VA+K L SG + E+E + + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 922 LGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C L+ E++ GSL++ L K K+N + K A+ +G+ +L
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR 128
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY-VPPEYYQ 1038
+HRD+ + NVL++ + ++ DFG+ + + + +V +P + PE
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 1039 SFRCSTKGDVYSYGVVLLELLT 1060
+ DV+S+GV L ELLT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-12
Identities = 95/347 (27%), Positives = 137/347 (39%), Gaps = 56/347 (16%)
Query: 89 LLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLK 148
LL +L L + IS GS L L L+ S+IS L ++L
Sbjct: 60 LLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLT 119
Query: 149 VLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKV 208
L+L +N + G LK +L+ LDLS NKI
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-------------------------- 153
Query: 209 TGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLS 268
+ + NL+ LD+S N+ S + L LD+S NK + D+ I L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
L++S+N E+ L++L +L L+L SNN +P G+ S+LE
Sbjct: 213 ELDLSNNS------------IIELLSSLSNL-KNLSGLEL-SNNKLEDLPESIGNLSNLE 258
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL--------- 379
+ D+S+N+ S I S++NL+EL LS N + ALP L LE L
Sbjct: 259 TLDLSNNQISS---ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315
Query: 380 ---DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC 423
L+S L+ I N +L L NNL SN
Sbjct: 316 LELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNL 362
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 38/88 (43%), Positives = 51/88 (57%)
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536
L LD L G +P +S +L I+LS N + G IP +G +++L +L LS NSF G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 537 PPELGDCRSLIWLDLNTNLFNGSIPPAL 564
P LG SL L+LN N +G +P AL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G G G VYKA L +A+K + + I+ + ++ +E+E + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
V + E+M GSL+ V K+ +IA+ +GL +L I+
Sbjct: 69 FVENRISICTEFMDGGSLD--------VYRKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 986 HRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST 1044
HRD+K SN+L++ + ++ DFG++ L++++ T GT Y+ PE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-----TYVGTNAYMAPERISGEQYGI 172
Query: 1045 KGDVYSYGVVLLELLTGKRP 1064
DV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 866 SLIGSGGFGDVYKAKLKDGST-VAIKKLIH---ISGQGDREFTAEMETIGKIKHRNLVPL 921
+G+G FG V+ + + A+K + I + ++ E + ++ H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 922 LGYCKVGEERLL--VYEYMRYGSLEDVLHNQKKV--GIKLNWAARRKIAIGSARGLAFLH 977
+ ++R L + EY+ G L L N + L +A+ I A L +LH
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE----IVCA--LEYLH 118
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
I++RD+K N+LLD+ +++DFG A+ TL GTP Y+ PE
Sbjct: 119 SK---EIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVI 170
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077
QS + D ++ G+++ E+L G P F D+N G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP-----FFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIH---ISGQGDREFT-AEMETIGKIKHRNLVPLL 922
++G G FG V A+ K + K++ + D E T E + + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGI-----KLNWAARRKIAIGSARGLAFL 976
C +RL V EY+ G D+++ ++VG + +AA +IAIG L FL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAA--EIAIG----LFFL 117
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H II+RD+K NV+LD +++DFGM + M ++ T GTP Y+ PE
Sbjct: 118 HSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEI 172
Query: 1037 --YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
YQ + S D +++GV+L E+L G+ P + D
Sbjct: 173 IAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 37/212 (17%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKL-IHISGQGDREF--TA--EMETIGKIKHRNLVPL 921
I G +G VY+A+ K G VA+KKL + +G F T+ E+ + K++H N+V
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV-- 67
Query: 922 LGYCKVGE--------ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
V E + +V EY+ + L+ ++ K+ + + + + G+
Sbjct: 68 ----TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGV 119
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS--VSTLAGTPGY 1031
A LH N I+HRD+K+SN+LL+ ++ DFG+AR + + V TL Y
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL----WY 172
Query: 1032 VPPEYYQSFRC-STKGDVYSYGVVLLELLTGK 1062
PE + ST D++S G + ELLT K
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 37/213 (17%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
+G G + VYK + K G VA+K+ I + + FTA E + +KH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKE-IRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 925 CKVGEERLLVYEYM---------RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
+ LV+EY+ G +HN + +L RGLA+
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLS-MHNVRLFLFQL------------LRGLAY 118
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVP 1033
H ++HRD+K N+L+ E E +++DFG+AR S S V TL Y P
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL----WYRP 171
Query: 1034 PEYYQSFRC-STKGDVYSYGVVLLELLTGKRPT 1065
P+ ST D++ G + E+ TG RP
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 73/254 (28%), Positives = 108/254 (42%), Gaps = 40/254 (15%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLI---HISGQGDREFTAEMETIGKIKHRNLVPLLG 923
+IG G FG+V + K V KL+ + + D F E I + V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 924 YCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWA----ARRKIAIGSARGLAFLHH 978
Y + L +V EYM G L +++ N WA A +A+ + + F
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLALDAIHSMGF--- 163
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
IHRD+K N+LLD++ +++DFG M+ + + T GTP Y+ PE +
Sbjct: 164 ------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLK 216
Query: 1039 SFRCSTKGDVY--------SYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090
S GD Y S GV L E+L G P F ++LVG + K S
Sbjct: 217 ----SQGGDGYYGRECDWWSVGVFLYEMLVGDTP-----FYADSLVGTYSKIMNHKNSLT 267
Query: 1091 F--DPELMKEDPNI 1102
F D ++ KE N+
Sbjct: 268 FPDDNDISKEAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRN 917
F ++G GGFG+V +++ G A K+L +G+ E + + K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+V L + + LV M G L+ ++N G + + +A L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE-----EERALFYAAEILCGLE 116
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+ ++RD+K N+LLD+ R+SD G+A + + S+ GT GY+ PE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVL 173
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ R + D + G ++ E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGST-VAIKKL-IHISGQGD-----REFTAEMETIGKIKHRNLV 919
IG G +G V+KA+ LK+G VA+K++ + +G RE A + + +H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 67
Query: 920 PLLGYCKVG----EERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
L C V E +L LV+E++ L L + G+ + + RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLD 124
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
FLH + ++HRD+K N+L+ + + +++DFG+AR+ S ++++++ T Y P
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAP 178
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
E +T D++S G + E+ ++P
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLI---HISGQGDREFT-AEMETIGKIKHRNLVPLLG 923
IG G FG V + + +D + K I HI + + T AE + ++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ E+ LV ++ G L H+ ++ G AR +A L L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRAR----FYTAELLCALENLHKFN 113
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
+I+RD+K N+LLD + DFG+ +L M D +T GTP Y+ PE
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELLLGHGY 170
Query: 1043 STKGDVYSYGVVLLELLTGKRP 1064
+ D ++ GV+L E+LTG P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 867 LIGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGD----REFTAEMETIGKIKHRNLVPL 921
+GSG +G V A + G VAIKKL Q + R + E+ + ++H N++ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL 79
Query: 922 LGYCKVG------EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
L ++ LV YM+ D+ QK +G L+ + + GL +
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQ----TDL---QKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
+H IIHRD+K N+ ++E+ E ++ DFG+AR A T V T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAPE 184
Query: 1036 YYQSFRCSTKG-DVYSYGVVLLELLTGKRPTDSADFGD 1072
++ + D++S G ++ E+LTGK D+ D
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 21/234 (8%)
Query: 868 IGSGGFGDVYKAKLKDGST---VAIKKL-IHISGQGDRE-FTAEMETIGKIKHRNLVPLL 922
+G G FG V + +L + VA+K + I I + + E F +E + + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 923 GYCKVGEER------LLVYEYMRYGSLEDVLHNQK--KVGIKLNWAARRKIAIGSARGLA 974
G C E +++ +M++G L L + L K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVP 1033
+L IHRD+ + N +L+EN V+DFG+++ + D + +A P ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ-GRIAKMPVKWIA 182
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLK 1086
E +TK DV+S+GV + E+ T G+ P + ++ + +++Q +LK
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYLRQGNRLK 234
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 14/212 (6%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE----FTAEMETIGKIKHRNLVPLL 922
+IG G + V +LK + K++ D E E + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 923 GYCKVGEERLL-VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
C E RL V EY+ G L + H Q++ KL R + + L +LH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQR--KLPEEHARFYSAEISLALNYLHER-- 115
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
II+RD+K NVLLD +++D+GM + + + ST GTP Y+ PE +
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDN 1073
D ++ GV++ E++ G+ P D DN
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI---KH-----RNL 918
+IG G + V +LK + K+I +E + E I + KH N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVI------KKELVNDDEDIDWVQTEKHVFETASNH 55
Query: 919 VPLLGY--CKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR---- 971
L+G C E RL V E++ G L + H Q++ RK+ AR
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQ----------RKLPEEHARFYSA 103
Query: 972 ----GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLA 1026
L FLH II+RD+K NVLLD +++D+GM + + DT ST
Sbjct: 104 EISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFC 157
Query: 1027 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN 1073
GTP Y+ PE + D ++ GV++ E++ G+ P D DN
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
IG G +G VYKA+ G VA+KK I + + E TA E+ + ++ H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK---IRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 922 LG--YCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
L + E +L LV+E++ L+ + L+ + +G+A+ H
Sbjct: 64 LDVVHS---ENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA---MDTHLSVSTLAGTPGYVPPE 1035
+ ++HRD+K N+L+D +++DFG+AR TH V TL Y PE
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH-EVVTL----WYRAPE 169
Query: 1036 ------YYQSFRCSTKGDVYSYGVVLLELLTGKR--PTDS 1067
Y ST D++S G + E++ + P DS
Sbjct: 170 ILLGSRQY-----STPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 868 IGSGGFGDVY---KAKLKDGSTVAIKKLIHISGQGDREF---TAEMETIGKIKHRNLVPL 921
+G G FG VY K + + K I + E E + + K+ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ ++ EY L+ L K G L+ + I G+ ++H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-- 125
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
I+HRD+K+ N+ L N ++ DFG++R LM + D +T GTP Y+ PE +
Sbjct: 126 -RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATTFTGTPYYMSPEALKHQ 180
Query: 1041 RCSTKGDVYSYGVVLLEL 1058
+K D++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 63/280 (22%), Positives = 115/280 (41%), Gaps = 32/280 (11%)
Query: 865 DSLIGSGGFGDVYKA---KLKDGS-TVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
IG G FGDVY+ ++ VA+K + + RE F E + + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH- 978
L+G +V E G L L K L+ A+ + + LA+L
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK 126
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+ HRD+ + NVL+ ++ DFG++R + +++ S ++ PE
Sbjct: 127 RFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPESIN 181
Query: 1039 SFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097
R ++ DV+ +GV + E+L G +P +N+++G ++ +L + P L
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENGERLPMPPNCPPTLY- 238
Query: 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ + C P +RP ++ A +I
Sbjct: 239 -------------SLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 867 LIGSGGFGDVYKAKLKDGST-----VAIKKLI-HISG-QGDREFTAEMETIGKIKHRNLV 919
L+ G FG ++ L D V +K + H S Q G + H+N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNIL 71
Query: 920 PLLGYC-KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK----IAIGSARGLA 974
P+L C + GE ++Y YM +G+L+ L + A + +AI A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP- 1033
+LH +IH+D+ + N ++DE + +++D ++R + MD H G P
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-----CLGDNENRPV 183
Query: 1034 ----PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E + S+ DV+S+GV+L EL+T G+ P
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 868 IGSGGFGDVYKAKLKDGST---VAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IG+G FG V ++ G T V +K+L + S Q +F E + ++H NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKV-GIKLNWAARRKIAIGSARGLAFLHHNCIP 982
C LLV E+ G L+ L + +K + + +++A A GL LH N
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
+ IH D+ N LL + ++ D+G++ D +++ L ++ PE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 1043 -------STKGDVYSYGVVLLELLT-GKRP 1064
+ + +V+S GV + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGYC 925
+G G + VYK + K + K I + + TA E+ + +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ LV+EY+ +D+ G +N + RGL + H ++
Sbjct: 74 HTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVL 126
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE-YYQSFRCST 1044
HRD+K N+L++E E +++DFG+AR S S + T Y PP+ S ST
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 1045 KGDVYSYGVVLLELLTGKRP 1064
+ D++ G + E+ TG RP
Sbjct: 185 QIDMWGVGCIFYEMSTG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA---EMETIGKIKHRNLVPLLG 923
+IG G FG+V KLK+ V K+++ R TA E + + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 924 YCKVGEERL-LVYEYMRYGSLEDVL---HNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
Y E L LV +Y G L +L ++ + + A IAI S L
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL------ 121
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
H +HRD+K N+L+D N R++DFG +LM D + S GTP Y+ PE Q
Sbjct: 122 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPEILQ 176
Query: 1039 SF-----RCSTKGDVYSYGVVLLELLTGKRP 1064
+ + + D +S GV + E+L G+ P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-11
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 2/91 (2%)
Query: 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438
L L + L G IP+++ + L+ + L N + G+IP +L + + L L LS+N G
Sbjct: 423 LGLDNQGLRGFIPNDISK--LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 439 TIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
+IP SLG L+ L+ L L N L G +P LG
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD--REFTAEMETIGKIKHR- 916
N N IGSG G VYK + K V K + +G + + +++ + K H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDC 73
Query: 917 -NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
+V GY + + E M + D L + + I + + +AI A
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKA----- 126
Query: 976 LHHNCIPH-IIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVP 1033
LH+ H +IHRD+K SN+LLD + ++ DFG++ RL+ + + + AG Y+
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK----AKTRSAGCAAYMA 182
Query: 1034 PEYYQSFRCSTK----GDVYSYGVVLLELLTGKRP 1064
PE + K DV+S G+ L+EL TG+ P
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL--IHISGQGD-REFTAEMETIGK-IKHRNLVPLL 922
IG G FG V AK K DG A+K L I + + + AE + K +KH LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
+ ++ V +Y+ G L H Q++ A I SA L +LH
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASA--LGYLHSL--- 115
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
+II+RD+K N+LLD ++DFG+ + ++ + ST GTP Y+ PE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 1043 STKGDVYSYGVVLLELLTGKRP---TDSADFGDNNL 1075
D + G VL E+L G P D+A+ DN L
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 855 LLEATNGFHNDSLIGSGGFGDVYKA-KLKDGSTVAIKKL-------IHISGQGDREFTAE 906
+ E + N S +GSG +G V A K G VA+KKL IH R + E
Sbjct: 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYR-E 66
Query: 907 METIGKIKHRNLVPLLGY---CKVGEERLLVY--EYMRYGSLEDVLHNQKKVGIKLNWAA 961
+ + +KH N++ LL + EE VY ++ L +++ QK + +
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 962 RRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021
+ + RGL ++H IIHRD+K SN+ ++E+ E ++ DFG+AR T
Sbjct: 127 YQIL-----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDE 173
Query: 1022 VSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGK 1062
++ T Y PE ++ + D++S G ++ ELLTG+
Sbjct: 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 866 SLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEM------ETIGKIKHRNL 918
+++G G FG V A+ K G AIK L E + M ET +H L
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI--AIGSARGLAF 975
V L C E+ + V EY G L ++H V ++ R + A GL +
Sbjct: 65 VNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV-----FSEPRAVFYAACVVLGLQY 116
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPP 1034
LH N I++RD+K N+LLD +++DFG+ + M D ST GTP ++ P
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAP 170
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
E + D + GV++ E+L G+ P
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA-----EMETIGKIKHRNLVPL 921
IG G +G V+KAK ++ VA+K+ + D E E+ + ++KH+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
++ LV+EY +D+ ++ + +GLAF H +
Sbjct: 65 YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQS 1039
+++HRD+K N+L+++N E +++DFG+AR S V TL Y PP+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL----WYRPPDVLFG 173
Query: 1040 FRC-STKGDVYSYGVVLLELLTGKRP 1064
+ ST D++S G + EL RP
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
+G G + V+K + K + VA+K+ I + + TA E+ + +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKE-IRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
LV+EY+ D+ G ++ + RGL++ H I
Sbjct: 72 IHTERCLTLVFEYLD----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE-YYQSFRCS 1043
+HRD+K N+L++E E +++DFG+AR S S + T Y PP+ S S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 1044 TKGDVYSYGVVLLELLTGKRP 1064
T D++ G +L E+ TG RP
Sbjct: 183 TPIDMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 72/255 (28%), Positives = 108/255 (42%), Gaps = 42/255 (16%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLI---HISGQGDREFTAEMETIGKIKHRNLVPLLG 923
+IG G FG+V + K V KL+ + + D F E I + V L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108
Query: 924 YCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWA----ARRKIAIGSARGLAFLH 977
+C +++ L V EYM G L +++ N + WA A +A+ + +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSMG--- 162
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+IHRD+K N+LLD++ +++DFG M + T GTP Y+ PE
Sbjct: 163 ------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVL 215
Query: 1038 QSFRCSTKGDVY--------SYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089
+ S GD Y S GV L E+L G P F ++LVG + K S
Sbjct: 216 K----SQGGDGYYGRECDWWSVGVFLFEMLVGDTP-----FYADSLVGTYSKIMDHKNSL 266
Query: 1090 VF--DPELMKEDPNI 1102
F D E+ K N+
Sbjct: 267 NFPEDVEISKHAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-10
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 905 AEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
+E+ + H +V K ++ LL+ M YGS D L+ Q K +K + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLI---MEYGSGGD-LNKQIKQRLKEHLPFQEY 169
Query: 965 IAIGSARGLAF---------LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015
GL F +H + +HRD+KS+N+ L ++ DFG ++ S
Sbjct: 170 EV-----GLLFYQIVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ S+ GTP Y+ PE ++ R S K D++S GV+L ELLT RP
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 49/216 (22%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 868 IGSGGFGDVYKAK-------LKDGST--------VAIKKL-IHISGQGDREFTAEMETIG 911
+G G FG+V+ + L +G+ VA+K L ++ +F E++ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 912 KIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWA------ARRKI 965
++K+ N++ LLG C + ++ EYM G L L +Q+++ A + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-SQREIESTFTHANNIPSVSIANL 131
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
+ + + + + + +HRD+ + N L+ ++ +++DFGM+R + + D + +
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD-YYRIQGR 190
Query: 1026 AGTP-GYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
A P ++ E + +T DV+++GV L E+ T
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 868 IGSGGFGDVYKAKLKDGS--TVAIKKL----IHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G+G FG V A K+ VAIK+ I Q D F+ E + + I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV--GIKLNWAARRKIAIGSARGLAFLHHN 979
G K LV E++ G L K+ + +AA+ + + L
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL------ 150
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+I++RD+K N+LLD++ +++DFG A+++ TL GTP Y+ PE +
Sbjct: 151 ---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLN 202
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
D ++ G+ + E+L G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-10
Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 1/89 (1%)
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA 365
L L + L G +P+ L+S ++S N G +P S+++L+ L LS+N F G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGS 481
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNL 394
+P+SL LT+L L+L+ N+LSG +P L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 27/217 (12%)
Query: 865 DSLIG----SGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFT---AEMETIGKIKHRN 917
+LIG + K K + VA+KK I++ + E+ T +++H N
Sbjct: 3 LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
++P + V E +V M YGS ED+L G L A I L ++H
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIH 118
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH---------LSVSTLAGT 1028
IHR +K+S++LL + + +S R +M H S++
Sbjct: 119 SK---GFIHRSVKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 1029 PGYVPPEYYQSFRCST-KGDVYSYGVVLLELLTGKRP 1064
P P Q+ + K D+YS G+ EL G P
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 48/238 (20%)
Query: 857 EATNGFHNDSLIGSGGFGDV---YKAKLKDGSTVAIKKL-------IHISGQGDREFTAE 906
E + N + +GSG +G V Y +L+ VA+KKL IH R E
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIH-----ARRTYRE 64
Query: 907 METIGKIKHRNLVPLLGY---CKVGEERLLVY--EYMRYGSLEDVLHNQKKVGIKLNWAA 961
+ + +KH N++ LL E VY + L +++ QK + +
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124
Query: 962 RRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021
+ + RGL ++H IIHRD+K SNV ++E+ E R+ DFG+AR D ++
Sbjct: 125 YQLL-----RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT 173
Query: 1022 VSTLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD 1072
GYV +Y++ + D++S G ++ ELL GK D+ D
Sbjct: 174 --------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGY 924
IG G +G VYK + K G VA+KK+ S + TA E+ + +++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 925 CKVGEERL-LVYEY--MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ E RL L++E+ M D L + + +L + +I +G+ F H
Sbjct: 68 L-MQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA---MDTHLSVSTLAGTPGYVPPE-YY 1037
++HRD+K N+L+D +++DFG+AR + TH V TL Y PE
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-EVVTL----WYRAPEVLL 174
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
S R ST D++S G + E+ T K+P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKLIHISGQGD-REFTAEMETIGK-------IKHRN 917
IG G FG V K K T+ A+K++ + + + +++ + + +K
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLED---VLHNQKKVGIKLNWAARRKIAIGSARGLA 974
+ G C + E M SL+ ++ K I KIA+ + + L
Sbjct: 71 ALFREGDC------WICMELMDI-SLDKFYKYVYEVLKSVIPEEILG--KIAVATVKALN 121
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL----AGTPG 1030
+L IIHRD+K SN+LLD N ++ DFG++ L S AG
Sbjct: 122 YLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSIAKTRDAGCRP 172
Query: 1031 YVPPEYYQSFRCS---TKGDVYSYGVVLLELLTGKRP 1064
Y+ PE + DV+S G+ L E+ TGK P
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHR 916
F SL+G G FG+V + K + K++ S +E F E I I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 917 NLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLH---NQKKVGIKLNWAARRKIAIGSARG 972
+P L Y ++ L LV EY G L +L+ +Q + + A +AI S
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ + +HRD+K NVL+D +++DFG A ++A + ++ GTP Y+
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYI 170
Query: 1033 PPEYYQSFRCSTKG------DVYSYGVVLLELLTGKRP 1064
PE + KG D +S GV+ E++ G+ P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGYC 925
+G G + V+K + K + K I + + TA E+ + +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ LV+EY+ +D+ G ++ + RGLA+ H ++
Sbjct: 74 HTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE-YYQSFRCST 1044
HRD+K N+L++E E +++DFG+AR S S + T Y PP+ S ST
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 1045 KGDVYSYGVVLLELLTGK 1062
+ D++ G + E+ +G+
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL----IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G+G FG V AK K G AIK L I Q E + ++ H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSHPFIVNMM 84
Query: 923 -GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HN 979
+ E R+ + E++ G L L +K G N A+ A LAF + H+
Sbjct: 85 CSF--QDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHA---ELVLAFEYLHS 136
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
II+RD+K N+LLD +V+DFG A+ + TL GTP Y+ PE QS
Sbjct: 137 K--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQS 189
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
D ++ GV+L E + G P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 31/195 (15%)
Query: 887 VAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLED 945
VA+K L + + R +F E++ + ++K N++ LLG C + ++ EYM G L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 946 VLHN---------------QKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMK 990
L + +++++ +A+ A G+ +L + +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA 165
Query: 991 SSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC------ST 1044
+ N L+ EN +++DFGM+R + A D + + A V P + ++ C +T
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRA-----VLPIRWMAWECILMGKFTT 219
Query: 1045 KGDVYSYGVVLLELL 1059
DV+++GV L E+L
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G G +G VYK + G T+A+K++ + + + E++ + K +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL--HHNCIPH 983
+ + EYM GSL D L+ + R+I +GL FL HN
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---- 123
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS-TLAGTPGYVPPEYYQSFRC 1042
IIHRD+K +NVL++ N + ++ DFG++ + A S++ T G Y+ PE +S
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-----SLAKTNIGCQSYMAPERIKSGGP 178
Query: 1043 STKG------DVYSYGVVLLELLTGKRP 1064
+ DV+S G+ +LE+ G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNL-------- 918
+IG G FG+V K+K + K+++ E ET + RN+
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILN-----KWEMLKRAETACFREERNVLVNGDCQW 62
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVL---HNQKKVGIKLNWAARRKIAIGSARGLA 974
+ L Y E L LV +Y G L +L ++ + + A +AI S L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL- 121
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
H +HRD+K NVLLD N R++DFG M+ D + S GTP Y+ P
Sbjct: 122 --------HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ-DGTVQSSVAVGTPDYISP 172
Query: 1035 EYYQSF-----RCSTKGDVYSYGVVLLELLTGKRP 1064
E Q+ + + D +S GV + E+L G+ P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA---EMETIGKIKHRNLVPLLG 923
+IG G FG+V K+K+ V K+++ R TA E + R + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN------WAARRKIAIGSARGLAFLH 977
Y E L Y M Y D+L K +L + A +AI S L
Sbjct: 68 YAFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---- 121
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+HRD+K NVLLD+N R++DFG + A T S + GTP Y+ PE
Sbjct: 122 -----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS-NVAVGTPDYISPEIL 175
Query: 1038 QSF-----RCSTKGDVYSYGVVLLELLTGKRP 1064
Q+ R + D +S GV + E+L G+ P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-10
Identities = 32/84 (38%), Positives = 52/84 (61%), Gaps = 2/84 (2%)
Query: 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC 423
G +P+ +S L +L++++LS N++ G IP +L G SL+ L L N GSIP +L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSL--GSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 424 SQLVSLHLSFNYLTGTIPSSLGSL 447
+ L L+L+ N L+G +P++LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRN 917
F + ++G GGFG+V +++ G A KKL +G+ E + + K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+V L + + LV M G L+ ++N G A I GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI--TCGLEDLH 119
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
I++RD+K N+LLD+ R+SD G+A + +T + GT GY+ PE
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVV 173
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
++ R + D + G ++ E++ GK P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G +G VYKAK KDG L I G G E+ + ++KH N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 927 VGEER--LLVYEYMRYGSLEDV-LHNQKKVG---IKLNWAARRKIAIGSARGLAFLHHNC 980
+R L+++Y + + H K ++L + + G+ +LH N
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 981 IPHIIHRDMKSSNVLL----DENFEARVSDFGMARLM-SAMDTHLSVSTLAGTPGYVPPE 1035
++HRD+K +N+L+ E +++D G ARL S + + + T Y PE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1036 YYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
R TK D+++ G + ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRN 917
F + ++G GGFG+V +++ G A KKL +G+ E + K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 918 LVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI--AIGSARGLA 974
+V L Y ++ L LV M G L+ ++N G + +R I A GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FDEQRAIFYAAELCCGLE 116
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
L I++RD+K N+LLD+ R+SD G+A + +T V GT GY+ P
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAP 170
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
E + + + D + G ++ E++ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTV-------AIKKLIHISGQGDREFT-AEMETIGKIKHRN 917
++G GG+G V++ + G+ +KK + Q D T AE + +KH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFL 976
+V L+ + G + L+ EY+ G L +H +++ GI + A ++ I A L L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLERE-GIFMEDTACFYLSEISLA--LEHL 116
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LMSAMDTHLSVSTLAGTPGYVPP 1034
H II+RD+K N+LLD +++DFG+ + + TH T GT Y+ P
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TFCGTIEYMAP 169
Query: 1035 EYYQSFRCSTKGDV--YSYGVVLLELLTGKRP 1064
E R V +S G ++ ++LTG P
Sbjct: 170 EILM--RSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 61/264 (23%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 844 EKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVY-----------------KAKLKDGST 886
E P ++LTF + L G G FG+V+
Sbjct: 1 EFPRKRLTFKEKL------------GEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVL 48
Query: 887 VAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLED 945
VA+K L + + R +F E++ + ++K N++ LL C + ++ EYM G L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 946 VL--HNQKKVGIK-----LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE 998
L H ++ K ++++ +A A G+ +L + +HRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGK 165
Query: 999 NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF------RCSTKGDVYSYG 1052
N+ +++DFGM+R + + D + + G V P + S+ + +T DV+++G
Sbjct: 166 NYTIKIADFGMSRNLYSGDYY----RIQGRA--VLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 1053 VVLLELLTGKRPTDSADFGDNNLV 1076
V L E+LT + + D ++
Sbjct: 220 VTLWEILTLCKEQPYSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G +G VYKAK KDG L I G G E+ + ++KH N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 927 VGEER--LLVYEYMRYGSLEDV-LHNQKKVG---IKLNWAARRKIAIGSARGLAFLHHNC 980
+R L+++Y + + H K ++L + + + G+ +LH N
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 981 IPHIIHRDMKSSNVLL----DENFEARVSDFGMARLM-SAMDTHLSVSTLAGTPGYVPPE 1035
++HRD+K +N+L+ E +++D G ARL S + + + T Y PE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1036 YYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
R TK D+++ G + ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 867 LIGSGGFGDVYKAKLK--DGS--TVAIKKL-IHISGQGD-REFTAEMETIGKIKHRNLVP 920
++G G FG V +A+LK DGS VA+K L I D EF E + + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 921 LLGYC--KVGEERL----LVYEYMRYGSLEDVLHNQKKVG---IKLNWAARRKIAIGSAR 971
L+G + RL ++ +M++G L L ++G L + I A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 972 GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY 1031
G+ +L + IHRD+ + N +L+EN V+DFG+++ + + D + +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 1032 VPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+ E +T DV+++GV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 867 LIGSGGFGDVY---KAKLKDGSTV-AIKKLIHISGQ-GDREFTA-EMETIGKIKHRNLVP 920
++G G FG V+ K D + A+K L + + DR T E + + ++ H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 921 LLGYCKVGEERL-LVYEYMRYGSL-----EDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
L Y E +L L+ +++R G L ++V+ ++ V L A +A+ L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---AELALALDHLHSLG 118
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
II+RD+K N+LLDE +++DFG+++ ++D + GT Y+ P
Sbjct: 119 ---------IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAP 167
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
E + D +S+GV++ E+LTG P D
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 53/289 (18%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK----KLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G GG+G V+ AK KD G VA+K L+ + R E + + K LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI-----AIGSARGLAFLH 977
+ E L EY+ G +L+N +G+ AR + A+ + L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG--- 121
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
IHRD+K N L+D + +++DFG+++ + +++ G+P Y+ PE
Sbjct: 122 ------YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVL 170
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP--TDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ D +S G +L E L G P + + NL W + +
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE---------TLQRPV 221
Query: 1096 MKEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEI 1137
+DP + +L+ ++D R ++ + FKE+
Sbjct: 222 -YDDPRFNLSDEAWDLITK------LINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 64/247 (25%), Positives = 97/247 (39%), Gaps = 60/247 (24%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKL----IHISGQGDREFTAEMETIGKIK 914
+ F +IG G FG+V+ + KD G A+K L + Q AE + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 915 HRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLN-----WA----ARRK 964
+V L Y EE L LV EYM G L ++L I+ + A A
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL-------IRKDVFPEETARFYIAELV 111
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS- 1023
+A+ S L F IHRD+K N+L+D + +++DFG+ + M+
Sbjct: 112 LALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 1024 --------------------------TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLE 1057
+ GTP Y+ PE + + D +S GV+L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 1058 LLTGKRP 1064
+L G P
Sbjct: 223 MLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK------ 914
+ N S IG G +G V A K G VAIKK+ Q T T+ +IK
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFK 61
Query: 915 HRNLVPLLGYCKVG-----EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS 969
H N++ +L + + +V E M L ++ Q + + + +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQIL---- 116
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST-LAGT 1028
RGL ++H +++HRD+K SN+LL+ N + ++ DFG+AR+ H T T
Sbjct: 117 -RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 1029 PGYVPPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
Y PE + + TK D++S G +L E+L+ +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 868 IGSGGFGDV-YKAKLKDGSTVAIKKLIHISGQGD---REFTAEMETIGKIKHRNLVPLLG 923
+GSG +G V + G+ VAIKKL + Q + + E+ + +KH N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 924 YCKVGE------ERLLVYEYMRYGS-LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
+ LV +M G+ L ++ ++K ++ + + + +GL ++
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKYI 134
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H IIHRD+K N+ ++E+ E ++ DFG+AR + T V T Y PE
Sbjct: 135 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEV 186
Query: 1037 YQSFRCSTKG-DVYSYGVVLLELLTGK 1062
++ T+ D++S G ++ E+LTGK
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKLI----HISGQGD--REFTA----EMETIGKIK 914
+IG G +G V A G VAIKK+ H+S RE I +IK
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 915 HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
H L P K + +V+E M E LH K L + R L
Sbjct: 66 HIMLPPSRREFK---DIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV--STLAGTPGYV 1032
++H ++ HRD+K N+L + + + ++ DFG+AR+ DT ++ + T Y
Sbjct: 118 YIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN-DTPTAIFWTDYVATRWYR 173
Query: 1033 PPEYYQSF--RCSTKGDVYSYGVVLLELLTGK 1062
PE SF + + D++S G + E+LTGK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-09
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 29/173 (16%)
Query: 970 ARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLAG 1027
A+G+ FL NCI HRD+ + NVLL + A++ DFG+AR +M+ D++ V A
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMN--DSNYVVKGNAR 275
Query: 1028 TP-GYVPPEYYQSFRC--STKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHA 1083
P ++ PE F C + + DV+SYG++L E+ + GK P ++ VK+
Sbjct: 276 LPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI-LVNSKFYKMVKRGY 332
Query: 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
++ D PE+ + C + P RPT Q+ + +
Sbjct: 333 QMSRPDFAPPEIYS--------------IMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G G V+ A D VA+KK++ Q + E++ I ++ H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 927 VGEERL--------------LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
L +V EYM L +VL + A R RG
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGP---LSEEHA--RLFMYQLLRG 126
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLS----VSTLAG 1027
L ++H +++HRD+K +NV ++ E+ ++ DFG+AR+ +D H S +S
Sbjct: 127 LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI---VDPHYSHKGYLSEGLV 180
Query: 1028 TPGYVPPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
T Y P S TK D+++ G + E+LTGK
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 62/213 (29%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN--------- 917
IG G FG VY+ + KD A+K L +E A+ E I RN
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 918 ---LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS-ARGL 973
+V L + + LV +YM G L H QK+ R K I L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFS---EDRAKFYIAELVLAL 109
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYV 1032
LH I++RD+K N+LLD + DFG+++ ++ T +T GT Y+
Sbjct: 110 EHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYL 163
Query: 1033 PPEYYQSFRCSTKG-DVYSYGVVLLELLTGKRP 1064
PE + TK D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-08
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 50/235 (21%)
Query: 867 LIGSGGFGDVYKA-KLKDGSTVAIKK---------LIHISGQGDREFTAEMETIGKIKHR 916
LIG GG G+VY A VA+KK L+ + F E + + H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK------KRFLREAKIAADLIHP 62
Query: 917 NLVPLLGYCKVGEERLLVYEYMRY---GSLEDVLHN-------QKKVGIKLNWAARRKIA 966
+VP+ C G+ VY M Y +L+ +L + K++ K + A I
Sbjct: 63 GIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM--DTHLSVST 1024
+ ++H ++HRD+K N+LL E + D+G A + + + L +
Sbjct: 120 HKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDV 175
Query: 1025 ---------------LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ GTP Y+ PE S D+Y+ GV+L ++LT P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 867 LIGSGGFGDVY----KAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
L+G G FG V KA K + +KK + I+ E + +H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
+ + V EY+ G L H ++ + I SA L +LH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSG--- 114
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
I++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+ PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSAD 1069
D + GVV+ E++ G+ P + D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 43/221 (19%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREF--TA--EMETIGKIKHRNLVPL- 921
IG G +G VYKA+ + T+A+KK I + Q D TA E+ + +++H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKK-IRLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 922 -LGYCKVGEERL-LVYEYM------RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
+ + E+RL LV+EY+ S D N + + L + RG+
Sbjct: 68 DVVHS---EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-YQI--------LRGI 115
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEA-RVSDFGMARLMSA---MDTHLSVSTLAGTP 1029
A+ H + ++HRD+K N+L+D A +++DFG+AR TH V TL
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH-EVVTL---- 167
Query: 1030 GYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKR--PTDS 1067
Y PE R ST D++S G + E++ K P DS
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
|
Length = 294 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 17/217 (7%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIH---ISGQGDREFTAEMETIGK-IKHRNLVPL 921
+IG G FG V A+ K + A+K L + + ++ +E + K +KH LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ ++ V +Y+ G L H Q++ A I SA L +LH
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASA--LGYLHS--- 114
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+I++RD+K N+LLD ++DFG+ + ++ + + ST GTP Y+ PE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP---TDSADFGDNNL 1075
D + G VL E+L G P ++A+ DN L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
RGL ++H +++HRD+K SN+LL+ N + ++ DFG+AR S + ++ T
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--EKGDFMTEYVVTRW 173
Query: 1031 YVPPEYYQSFRCSTKG---DVYSYGVVLLELLTGK 1062
Y PE + CS DV+S G + ELL K
Sbjct: 174 YRAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 868 IGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQGDREFTAEM---ETIGKIK------- 914
+G G +G V A+ + TVAIKK+ ++ F+ ++ + ++K
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFRG 60
Query: 915 HRNLVPLLG-----YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS 969
H+N+ L E +Y Y +E LH + G L A +
Sbjct: 61 HKNITCLYDMDIVFPGNFNE----LYLYEEL--MEADLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA----MDTHLSVSTL 1025
GL ++H +++HRD+K N+L++ + E ++ DFG+AR S + +
Sbjct: 115 LCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEY 169
Query: 1026 AGTPGYVPPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
T Y PE SF+ TK DV+S G +L ELL K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 26/140 (18%)
Query: 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKS 991
+L+ +Y++ G L D+L + K L+ A +KI L LH + +IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLKKEGK----LSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKL 137
Query: 992 SNVLLDEN-FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE------YYQSFRCST 1044
NVL D + D+G+ +++ + S GT Y PE Y SF
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSF---- 187
Query: 1045 KGDVYSYGVVLLELLTGKRP 1064
D ++ GV+ ELLTGK P
Sbjct: 188 --DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
GL +LH IIHRD+K+ N+ +++ + + D G A+ L LAGT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVE 221
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELL 1059
PE + ++K D++S G+VL E+L
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 33/82 (40%), Positives = 50/82 (60%), Gaps = 3/82 (3%)
Query: 339 GELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGP 398
G +P +I + +L+ + LS N G +P SL ++T+LE LDLS N+ +G+IP +L G
Sbjct: 432 GFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL--GQ 488
Query: 399 RNSLKELFLQNNLLLGSIPSTL 420
SL+ L L N L G +P+ L
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIK---KLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
L+G G FG V + K G A+K K + I+ E + +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
Y +RL V EY G L H ++ A I SA L +LH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSA--LEYLHSR-- 114
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+ PE +
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
D + GVV+ E++ G+ P + D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 6e-08
Identities = 26/61 (42%), Positives = 39/61 (63%), Gaps = 1/61 (1%)
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
+L+S D+S+N+ + +P F + NLK L LS N+ T P++ S L +L +LDLS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 386 L 386
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 12/207 (5%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVA---IKKLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
L+G G FG V K K G A +KK + ++ E + +H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
+ + V EY G L H ++ + A I SA L +LH
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSA--LDYLHSE--K 115
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
++++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+ PE +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSAD 1069
D + GVV+ E++ G+ P + D
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
II+RD+K N+LLD ++DFG+++ A + + S GT Y+ PE R
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEV---IRGG 181
Query: 1044 TKG-----DVYSYGVVLLELLTGKRP 1064
+ G D +S GV+ ELLTG P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 83/266 (31%)
Query: 868 IGSGGFGDVYKA------KLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-----KHR 916
+G G FG V +A K TVA+K L G E+ A M + KI H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLK--EGATASEYKALMTEL-KILIHIGHHL 71
Query: 917 NLVPLLGYC-KVGEERLLVYEYMRYGSLEDVLHN-------------QKKVGIKLNWAAR 962
N+V LLG C K G +++ EY ++G+L + L + +K+ + +
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 963 RKIAIGSARGLA---FLHHNCIPHI----------------------------------- 984
R ++ S++ A F+ + +
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191
Query: 985 ---IHRDMKSSNVLLDENFEARVSDFGMAR-------LMSAMDTHLSVSTLAGTPGYVPP 1034
IHRD+ + N+LL EN ++ DFG+AR + D L + +A P
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA-------P 244
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLT 1060
E +T+ DV+S+GV+L E+ +
Sbjct: 245 ESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 53/223 (23%), Positives = 81/223 (36%), Gaps = 30/223 (13%)
Query: 237 FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHL 296
L+ LD+S N D + + S L + + N L
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQE--------LKLNNNGLGDRGLRLL 128
Query: 297 A----DLCSSLVKLDLSSNNLSGK----VPSRFGSCSSLESFDISSNKFSGELPI---EI 345
A DL +L KL L N L G + + L+ ++++N E
Sbjct: 129 AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188
Query: 346 FLSMSNLKELVLSFNDFT----GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG---P 398
+ NL+ L L+ N T AL ++L++L +LE L+L NNL+ A L P
Sbjct: 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSP 248
Query: 399 RNSLKELFLQNNLL----LGSIPSTLSNCSQLVSLHLSFNYLT 437
SL L L N + + L+ L+ L L N
Sbjct: 249 NISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-07
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNL 918
D IG G FG V+ +DG VA+KK+ ++ + + E++ + KH N+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 919 VPLLGYCKVG-----EERLLVYEYMRYGSLEDVLHNQKKVG---IKLNWAARRKIAIGSA 970
+ L + EE +V E M+ L ++ + + + +K+
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKV-------FLYQIL 113
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
RGL +LH I+HRD+K N+L++ N ++ DFG+AR+ D ++ T
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169
Query: 1031 YVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGK 1062
Y PE S ++ D++S G + ELL +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 27/172 (15%)
Query: 970 ARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A+G++FL NCI HRD+ + N+LL ++ DFG+AR + D++ V A
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRN-DSNYVVKGNARL 278
Query: 1029 P-GYVPPEYYQSFRC--STKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAK 1084
P ++ PE F C + + DV+SYG++L E+ + G P D+ +K+ +
Sbjct: 279 PVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIKEGYR 335
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
+ +S P M + + +C D P +RPT Q++ + ++
Sbjct: 336 M-LSPECAPSEMYD-------------IMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-07
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHRNLVPLLG- 923
IG+G FG+V+ K K K I G +RE E+ + ++KH+N+V +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 924 -YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCI 981
K ++ ++ E+ G L + K+ K+ A I LA+ H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 982 PH---IIHRDMKSSNVLLDENFE-----------------ARVSDFGMARLMSAMDTHLS 1021
P+ ++HRD+K N+ L A++ DFG+++ ++
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-------NIG 193
Query: 1022 VSTLA----GTPGYVPPEY--YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ ++A GTP Y PE +++ K D+++ G ++ EL +GK P A+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 57/259 (22%), Positives = 115/259 (44%), Gaps = 48/259 (18%)
Query: 889 IKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGY---CKVGEERL-LVYEYMRYGSLE 944
K LI I E++ + +I N++ + G+ RL L+ EY G L
Sbjct: 58 HKVLIDI-------TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLR 110
Query: 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCIPHIIHRDMKSSNVLLDENFEAR 1003
+VL +K L++ + +AI +GL L+ + P+ +++ S + L+ EN++ +
Sbjct: 111 EVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLK 163
Query: 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCST-KGDVYSYGVVLLELLTG 1061
+ G+ +++S+ +V+ + Y + F T K D+YS GVVL E+ TG
Sbjct: 164 IICHGLEKILSSPPFK-NVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
Query: 1062 KRPTDSADFGD--NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDD 1119
K P ++ + + + + ++ LK+ + P +K + AC
Sbjct: 219 KIPFENLTTKEIYDLI---INKNNSLKL-PLDCPLEIK-------------CIVEACTSH 261
Query: 1120 RPWRRPT---MIQVMAMFK 1135
+RP ++ ++++K
Sbjct: 262 DSIKRPNIKEILYNLSLYK 280
|
Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
L +LH +++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
PE + D + GVV+ E++ G+ P + D
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 12/88 (13%)
Query: 255 GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
G + + IS HL +N+S N G IP G I +SL LDLS N+ +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSL----GSI--------TSLEVLDLSYNSFN 479
Query: 315 GKVPSRFGSCSSLESFDISSNKFSGELP 342
G +P G +SL +++ N SG +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 11/206 (5%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA--EMETIGKIKHR 916
N F ++G G +G V K + K+ VAIKK + + T E++ + +K
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
N+V L + + LV+EY+ LE L + G+ R + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKV--RSYIYQLIKAIHWC 116
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H N I+HRD+K N+L+ N ++ DFG AR +S ++ + + T Y PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPEL 172
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGK 1062
D++S G +L EL G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 35/208 (16%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHI--SGQGDREFTAEMETIGKIK-HRNLVPLLG 923
IG G F +V KA+ K G AIK + S + E++ + ++ H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL-- 63
Query: 924 YCKVGEERL-----LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
+V +R LV+E M +L +++ +K+ L + + L +H
Sbjct: 64 -IEVLFDRKTGRLALVFELMD-MNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHR 118
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE--- 1035
N I HRD+K N+L+ ++ +++DFG R + + + T Y PE
Sbjct: 119 N---GIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171
Query: 1036 ---YYQSFRCSTKGDVYSYGVVLLELLT 1060
YY K D+++ G V E+L+
Sbjct: 172 TDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-07
Identities = 26/62 (41%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
NLK L LS N T + L NL+ LDLS NNL+ I G SL+ L L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLP-SLRSLDLSGN 58
Query: 411 LL 412
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 31/277 (11%)
Query: 868 IGSGGFGDVYKAKLKDGSTVA---IKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IG+G FG V +++ + VA +K+L + S + EF + + ++H N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
C LLV+EY G L+ L ++ +++A A G+ +H + +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC- 1042
+H D+ N L + +V D+G+ D + ++ PE F
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 1043 -----STK-GDVYSYGVVLLELL-TGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
TK +V++ GV L EL +P + D ++ V + ++K+ F P+L
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPY--SHLSDREVLNHVIKDQQVKL---FKPQL 234
Query: 1096 MKEDPNIE--IELLQHLHVASACLDDRPWRRPTMIQV 1130
E P E E+LQ ++ P +R T +V
Sbjct: 235 --ELPYSERWYEVLQFCWLS-------PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 50/243 (20%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE----FTAEMETIGKIKHRN 917
F + +IG G FG+V + KD V K++ + ++E AE + + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN--WAARRKIAIGSARGLAF 975
+V + + L+ E++ G + +L + + + + A +AI S L F
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDT---------------- 1018
IHRD+K N+LLD ++SDFG+ L A T
Sbjct: 123 ---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 1019 -----------------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG 1061
L+ ST+ GTP Y+ PE + + D +S GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 1062 KRP 1064
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 66/262 (25%), Positives = 102/262 (38%), Gaps = 81/262 (30%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKL-----------IHISGQGDREFTAEM 907
+ F + +IG G FG+V + KD G A+KKL H+ + +R+ AE
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHV--RAERDILAE- 57
Query: 908 ETIGKIKHRNLVPLLGYCKVGEERL-LVYEYMRYGSL------EDVL-HNQKKVGIKLNW 959
V L Y E L L+ EY+ G + +D + + I
Sbjct: 58 ------ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI---- 107
Query: 960 AARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM---------- 1009
A +AI S L + IHRD+K N+LLD ++SDFG+
Sbjct: 108 -AETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 1010 ------------------ARLMSAMDT---------HLSVSTLAGTPGYVPPEYYQSFRC 1042
++ MS+ L+ ST+ GTP Y+ PE +
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGY 216
Query: 1043 STKGDVYSYGVVLLELLTGKRP 1064
+ + D +S GV++ E+L G P
Sbjct: 217 NKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-06
Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 26 PNKDLQQLLSFKAALPNPS--VLPNWSPNQ-NPCGFKGVSC 63
N D LL+FK++L L +W+P+ +PC + GV+C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 867 LIGSGGFGDVYKAKLKDG-------STVAIKKLIHISGQGDREFT-AEMETIGKIKHRNL 918
++G+G +G V+ + G + +KK + E T E + + I+
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+ L Y + +L L+ +Y+ G L H ++ K ++ I S + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQ-----EVQIYSGEIVLALE 119
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
H II+RD+K N+LLD N ++DFG+++ + + S GT Y+ P+
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDI- 177
Query: 1038 QSFRCSTKG-----DVYSYGVVLLELLTGKRP 1064
R G D +S GV++ ELLTG P
Sbjct: 178 --VRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 56/243 (23%), Positives = 97/243 (39%), Gaps = 50/243 (20%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE----FTAEMETIGKIKHRN 917
F + +IG G FG+V + KD + K++ + ++E AE + + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN--WAARRKIAIGSARGLAF 975
+V + + L+ E++ G + +L + + + + A +AI + L F
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDT---------------- 1018
IHRD+K N+LLD ++SDFG+ L A T
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 1019 -----------------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG 1061
L+ ST+ GTP Y+ PE + + D +S GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 1062 KRP 1064
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 44/186 (23%), Positives = 69/186 (37%), Gaps = 30/186 (16%)
Query: 890 KKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG-------- 941
KK+I + G + E++ + I HR ++ L+ + +V +
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS 179
Query: 942 ---SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE 998
LE + Q+ LA+LH IIHRD+K+ N+ LDE
Sbjct: 180 GPLPLEQAITIQR----------------RLLEALAYLHGR---GIIHRDVKTENIFLDE 220
Query: 999 NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLEL 1058
A + DFG A + A +GT PE K D++S G+VL E+
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 1059 LTGKRP 1064
Sbjct: 281 SVKNVT 286
|
Length = 392 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRN-LVPLLG 923
IG G +G VYKA+ G VA+KK + TA E+ + + +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 924 YCKVGEER-----LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
V E+ LV+EY+ + + N + G L + +G+A H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 979 NCIPHIIHRDMKSSNVLLDENFEA-RVSDFGMARLMS---AMDTHLSVSTLAGTPGYVPP 1034
+ ++HRD+K N+L+D+ +++D G+ R S TH V T Y P
Sbjct: 129 H---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----TLWYRAP 180
Query: 1035 E-YYQSFRCSTKGDVYSYGVVLLELLTG 1061
E S ST D++S G + E+
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 36/234 (15%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKDGST-VAIKKL----IHISGQGDREFTAEMETIGKIK 914
F LI +G +G VY + K+ A+KK+ + + Q + F E + + +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 915 HRNLVPLLGYCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+ +V + +C +R L V EY+ G +L N + + + AR A +
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM---ARMYFA-ETVLA 113
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LMSAMDT-----HLSVST- 1024
L +LH+ I+HRD+K N+L+ +++DFG+++ LMS + T H+ T
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS-LTTNLYEGHIEKDTR 169
Query: 1025 ------LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD 1072
+ GTP Y+ PE D ++ G++L E L G P FGD
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF----FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 868 IGSGGFGDVYKAK---LKDG-----STVAIKKLIHISGQGDREFTAEMETIGKIKHRNLV 919
+G G F ++K + D + V +K L F + ++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C G+E ++V EY+++GSL+ L KK +N + + ++A A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG------TPGYVP 1033
+ H ++ + NVLL E R + G + D +S++ L P +VP
Sbjct: 120 GLT---HGNVCAKNVLLIRE-EDRKT--GNPPFIKLSDPGISITVLPKEILLERIP-WVP 172
Query: 1034 PEYYQSFR-CSTKGDVYSYGVVLLELLTG 1061
PE ++ + S D +S+G L E+ +G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 970 ARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
ARG+ FL CI HRD+ + N+LL EN ++ DFG+AR + ++ +
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++ PE +T+ DV+S+GV+L E+ + G P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 21/135 (15%)
Query: 970 ARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-------LMSAMDTHLS 1021
A+G+ FL CI HRD+ + N+LL EN ++ DFG+AR + D L
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVK 1080
+ +A PE + + DV+S+GV+L E+ + G P D +K
Sbjct: 245 LKWMA-------PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLK 296
Query: 1081 QHAKLKISDVFDPEL 1095
+ +++ D PE+
Sbjct: 297 EGTRMRAPDYTTPEM 311
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 866 SLIGSGGFGDVYKAKLKDGS-TVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
++IG+G FG VY+A D S VAIKK++ +RE + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDY 127
Query: 925 -----CKVGEERLL-----------VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
K E+ + V++YM++ + + H +KL +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN--HALPLFLVKL-------YSYQ 178
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA-RVSDFGMARLMSAMDTHLSVSTLAG 1027
R LA++H I HRD+K N+L+D N ++ DFG A+ + + SVS +
Sbjct: 179 LCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICS 233
Query: 1028 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG 1061
P + +T D++S G ++ E++ G
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 213 NVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
++SK ++LQ +++S N+ +P S G +LE LD+S N F G + ++ L LN
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496
Query: 272 VSSNLFSGPIPVGYNEFQGEIPLHLA 297
++ N SG +P G LH A
Sbjct: 497 LNGNSLSGRVPAAL----GGRLLHRA 518
|
Length = 623 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-05
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 970 ARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
ARG+ FL NC+ HRD+ + NVLL + ++ DFG+AR + ++S +
Sbjct: 247 ARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
++ PE +T DV+SYG++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 27/82 (32%), Positives = 45/82 (54%), Gaps = 2/82 (2%)
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
I++RD+K N+LLD ++DFG+++ + + + S GT Y+ PE +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGH 184
Query: 1044 TKG-DVYSYGVVLLELLTGKRP 1064
K D +S G+++ ELLTG P
Sbjct: 185 GKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 22/163 (13%)
Query: 914 KHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
+H N++ G ++ +M YGS +L G ++ A I G+ RGL
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGL 114
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT-----------HLSV 1022
+LH N IHR++K+S++L+ + VS G++ L S + S
Sbjct: 115 NYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 1023 STLAGTPGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRP 1064
S L P P Q + K D+YS G+ EL TG+ P
Sbjct: 170 SVL---PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 13/229 (5%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
S LL L L +L L N+NI+ L S L LDLS N + S + L +
Sbjct: 110 SELLELTNLTSLDLDNNNITDIPPLIGLL--KSNLKELDLSDNKIESLPSPLRNL---PN 164
Query: 147 LKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
LK L+LS N L + +L +L LDLS NKIS +P L++L L N
Sbjct: 165 LKNLDLSFNDLSDLPKLLSNLS-NLNNLDLSGNKIS---DLP-PEIELLSALEELDLSNN 219
Query: 207 KVTGDIN-VSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
+ ++ +S KNL L++S+N S G+ LE LD+S N+ + ++ +
Sbjct: 220 SIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSI--SSLGSLT 277
Query: 266 HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
+L L++S N S +P+ L L ++L L+S L+
Sbjct: 278 NLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326
|
Length = 394 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 970 ARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A G+ FL NC+ HRD+ + NVL+ E ++ DFG+AR + ++S +
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
++ PE + +T DV+S+G++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKL---IHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IGSG G V A G VA+KKL R + E+ + + H+N++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 924 YC---KVGEERLLVYEYMRY--GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
K EE VY M +L V+H ++L+ + G+ LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS 141
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
IIHRD+K SN+++ + ++ DFG+AR T+ ++ T Y PE
Sbjct: 142 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVIL 195
Query: 1039 SFRCSTKGDVYSYGVVLLELLTG 1061
D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 27/62 (43%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
NL++LDLS+N L+ IP +G N LK L L N L P S L SL LS N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPN-LKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
Query: 435 YL 436
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 12/111 (10%)
Query: 960 AARRKIAI--------GSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011
AA+R IAI R + +LH N IIHRD+K+ N+ ++ + + DFG A
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
++ + AGT PE D++S G+VL E+ T
Sbjct: 231 FPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 1e-04
Identities = 20/59 (33%), Positives = 26/59 (44%)
Query: 474 LETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
L++L L N LT A NL + LS N+L P L +L L LS N+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 58/262 (22%), Positives = 93/262 (35%), Gaps = 47/262 (17%)
Query: 106 SGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISY-LGSCSSLKVLNLSSNLLD-----F 159
G SL G L LDLS N L + L SSL+ L L++N L
Sbjct: 68 RGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRL 127
Query: 160 SGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKN 219
+ L +LE L L N++ GA C+ L + ++
Sbjct: 128 LAKGLKDLPPALEKLVLGRNRLEGA---------SCEALAKAL------------RANRD 166
Query: 220 LQFLDVSSNNFSMA-----VPSFGDCLALEYLDISANKFT----GDVGHAISACEHLSFL 270
L+ L++++N A LE LD++ N T + +++ + L L
Sbjct: 167 LKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVL 226
Query: 271 NVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK-VPSRFGSCS---S 326
N+ N + + + L SL+ L LS N+++ + S
Sbjct: 227 NLGDNNLT-------DAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKES 279
Query: 327 LESFDISSNKFSGELPIEIFLS 348
L D+ NKF E + S
Sbjct: 280 LLELDLRGNKFGEEGAQLLAES 301
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 21/60 (35%), Positives = 24/60 (40%)
Query: 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
+LK L L NN L L L LS N LT P + L L+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDRE-FTAEMETIGKI-KHRNLV 919
+GSG FG V +A S VA+K L + +++ +E++ + + H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQK 951
LLG C G ++ EY RYG L D LH K
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 67/246 (27%), Positives = 100/246 (40%), Gaps = 29/246 (11%)
Query: 862 FHNDSLIGSGGFGDV---YKAKLKDGSTVAIKKL---IHISGQGDREFTAEMETIGKIKH 915
+ N IGSG G V Y A L VAIKKL R + E+ + + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 916 RNLVPLLGYC---KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+N++ LL K EE VY M L D Q + ++L+ + G
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVME---LMDANLCQV-IQMELDHERMSYLLYQMLCG 131
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ LH IIHRD+K SN+++ + ++ DFG+AR T ++ T Y
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092
PE D++S G ++ E++ K D+ D W K +L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ----WNKVIEQLGTP---C 238
Query: 1093 PELMKE 1098
PE MK+
Sbjct: 239 PEFMKK 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 28/136 (20%), Positives = 54/136 (39%), Gaps = 16/136 (11%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVP-LLG 923
L+ G VY KD V K+ S + + E+ + + + VP +L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVL--KINP-SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ L+ E++ +L++V +K+ ++A LA LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKE-------DIAEQLA----ELLAKLHQLPLLV 109
Query: 984 IIHRDMKSSNVLLDEN 999
+ H D+ N+L+D+
Sbjct: 110 LCHGDLHPGNILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 20/117 (17%)
Query: 843 FEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKA------KLKDGSTVAIKKLIHIS 896
+E P +L+F L G+G FG V +A K TVA+K L +
Sbjct: 30 WEFPRNRLSFGKTL------------GAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA 77
Query: 897 GQGDRE-FTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQK 951
+RE +E++ + + H N+V LLG C VG L++ EY YG L + L ++
Sbjct: 78 HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKR 134
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 63/262 (24%), Positives = 98/262 (37%), Gaps = 92/262 (35%)
Query: 868 IGSGGFGDVYKAKLKDGSTV-AIKKL-----------IHISGQGDREFTAEMETIGKIKH 915
IG G FG+V + D + + A+K L H+ + +R+ AE +
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHV--KAERDILAEADN------ 60
Query: 916 RNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-----IGS 969
V L Y ++ L V +Y+ G + +L ++GI AR IA I S
Sbjct: 61 -EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIAELTCAIES 116
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM------------------AR 1011
+ F IHRD+K N+L+D + +++DFG+ R
Sbjct: 117 VHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 1012 L--MSAMDTHLSVS---------------------TLAGTPGYVPPE------YYQSFRC 1042
M + + +L GTP Y+ PE Y Q C
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL--C 225
Query: 1043 STKGDVYSYGVVLLELLTGKRP 1064
D +S GV+L E+L G+ P
Sbjct: 226 ----DWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-04
Identities = 70/270 (25%), Positives = 110/270 (40%), Gaps = 45/270 (16%)
Query: 294 LHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSN-------KFSGELPIEIF 346
L L+D CSSLV+L S L+ C +LE N SG ++ F
Sbjct: 662 LKLSD-CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSF 720
Query: 347 LSMS-NLKELVL---SFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP--HNLCQGPRN 400
+S N+ L L + +F L L NL L ++ S L + L
Sbjct: 721 PDISTNISWLDLDETAIEEFPSNLR--LENLDELILCEMKSEKLWERVQPLTPLMTMLSP 778
Query: 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
SL LFL + L +PS++ N L KL+ L++ N +
Sbjct: 779 SLTRLFLSDIPSLVELPSSIQN------------------------LHKLEHLEIE-NCI 813
Query: 461 HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLS 520
+ E P N+++LE+L L T P +N ++LN LS + E+P WI + S
Sbjct: 814 NLETLPTGINLESLESLDLSGCSRLRTFPDISTNISDLN---LSRTGI-EEVPWWIEKFS 869
Query: 521 NLAILKLSNNSFYGRIPPELGDCRSLIWLD 550
NL+ L ++ + R+ + + L +D
Sbjct: 870 NLSFLDMNGCNNLQRVSLNISKLKHLETVD 899
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 146 SLKVLNLSSNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
+LK L+LS+N L A L +L+VLDLS N ++ + F+G L+ L L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLP-NLKVLDLSGNNLT---SISPEAFSGLPSLRSLDLS 56
Query: 205 GNK 207
GN
Sbjct: 57 GNN 59
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
LD+S N + S+P + ++ L L+L N+LS +P + +L LN LDLS N++ +
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DL 201
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQP 735
P + L+ L E+DL NN + ++ + +
Sbjct: 202 PPEIELLSALEELDLSNNSIIELLSSLSNLKNLSG 236
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 23/63 (36%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVS--KCKNLQFLDVSS 227
+L+ LDLS N+++ V+P F G LK L L GN +T + +L+ LD+S
Sbjct: 1 NLKSLDLSNNRLT---VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
Query: 228 NNF 230
NN
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 862 FHNDSLIGSGGFGDV---YKAKLKDGSTVAIKKL---IHISGQGDREFTAEMETIGKIKH 915
+ N IGSG G V Y A L+ VAIKKL R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 916 RNLVPLLGYC---KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+N++ LL K EE VY M L D Q + ++L+ + G
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVME---LMDANLCQV-IQMELDHERMSYLLYQMLCG 138
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ LH IIHRD+K SN+++ + ++ DFG+AR T ++ T Y
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
PE D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 862 FHNDSLIGSGGFGDVYKA-KLKDGSTVAIKKL-------IHISGQGDREFTAEMETIGKI 913
+ N IGSG G V A G VAIKKL H + + RE M+ +
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH-AKRAYRELVL-MKLV--- 72
Query: 914 KHRNLVPLLGYC---KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
H+N++ LL K EE VY M L D N +V I+++ R
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVME---LMD--ANLCQV-IQMDLDHER------- 119
Query: 971 RGLAFLHHN--C-IPH-----IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV 1022
+++L + C I H IIHRD+K SN+++ + ++ DFG+AR T +
Sbjct: 120 --MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMM 174
Query: 1023 STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
+ T Y PE D++S G ++ E++ G
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 868 IGSGGFGDVYKAKLKDGSTV----AIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
I G FG VY + K+ S + +KK I+ + AE + + K +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ LV EY+ G ++ +LH G A + I+ A L +LH +
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH---IYGYFDEEMAVKYIS-EVALALDYLHRH---G 124
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
IIHRD+K N+L+ +++DFG++++ ++ L++ + TP P
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV--TLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.002
Identities = 20/37 (54%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS 387
NL+ L LS N T LSNL NLETLDLS N ++
Sbjct: 2 NLETLDLSNNQITDL--PPLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 23/145 (15%)
Query: 827 WKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSL-----IGSGGFGDVYKA-- 879
WK+ A E N TF P +L + + E F D+L +G+G FG V +A
Sbjct: 8 WKIIEAAEG---NNYTFIDP-TQLPYNEKWE----FPRDNLQFGKTLGAGAFGKVVEATA 59
Query: 880 ----KLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKI-KHRNLVPLLGYCKVGEERLL 933
K + VA+K L + +RE +E++ + + +H+N+V LLG C G L+
Sbjct: 60 FGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119
Query: 934 VYEYMRYGSLEDVLHNQKKVGIKLN 958
+ EY YG L + L +KK LN
Sbjct: 120 ITEYCCYGDLLNFL--RKKAETFLN 142
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 22/58 (37%), Positives = 28/58 (48%), Gaps = 2/58 (3%)
Query: 664 ILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
L+L +N L+ IP L L +LDLS N L P + S L L +DL N L
Sbjct: 4 SLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 1/60 (1%)
Query: 219 NLQFLDVSSNNF-SMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
NL+ LD+S+N + +F L+ LD+S N T A S L L++S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.004
Identities = 59/259 (22%), Positives = 95/259 (36%), Gaps = 82/259 (31%)
Query: 868 IGSGGFGDVYKA-KLKDGSTVAIKKL-----------IHISGQGDREFTAEMETIGKIKH 915
+G G FG+V A K+ + A+K L H+ + D A+ E + K+ +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 916 R-----NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
NL ++ Y G+ L+ +R +VL + A +AI S
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRMEVFPEVLAR--------FYIAELTLAIESV 117
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-------------------- 1010
+ F IHRD+K N+L+D + +++DFG+
Sbjct: 118 HKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 1011 -------------------RLMS----AMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTK 1045
RL + A H +L GTP Y+ PE +
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 1046 GDVYSYGVVLLELLTGKRP 1064
D +S GV+L E+L G+ P
Sbjct: 229 CDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 32/142 (22%), Positives = 63/142 (44%), Gaps = 19/142 (13%)
Query: 868 IGSGGFGDVYKAKLKD---------GSTVAIKKLIHISGQGDREFT-AEMET---IGKIK 914
+G G +Y L IK ++ + R+ + A ET + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 915 HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
H+++V L G C E ++V E++ +G L+ +H + V L + K+A A L+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV---LTTPWKFKVAKQLASALS 119
Query: 975 FLHHNCIPHIIHRDMKSSNVLL 996
+L ++H ++ + N+LL
Sbjct: 120 YLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1176 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.3 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.29 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.83 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.75 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.61 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.6 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.45 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-111 Score=1103.87 Aligned_cols=920 Identities=32% Similarity=0.536 Sum_probs=716.2
Q ss_pred ChHHHHHHHHHHhcCCCCC-CCCCCCCCCCCcccceeEeCC-CcEEEEecCCccccccchhhhhhhcCcccccccccCCC
Q 046275 26 PNKDLQQLLSFKAALPNPS-VLPNWSPNQNPCGFKGVSCKA-ASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNS 103 (1176)
Q Consensus 26 ~~~~~~~ll~~k~~~~~~~-~l~~w~~~~~cC~W~gv~C~~-~~v~~l~L~~~~~~~~~~~~~~~l~~~~~L~~L~L~~n 103 (1176)
.++|+.||++||+++.+|. .+++|..+.+||.|.||+|++ ++|+.|||++..+.+ .++..+..+++|+.|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~---~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISG---KISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccc---cCChHHhCCCCCCEEECCCC
Confidence 4689999999999998774 789999889999999999986 589888888765543 23445666677777777777
Q ss_pred CCCCcccCCCCC-ccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCC
Q 046275 104 NISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKIS 182 (1176)
Q Consensus 104 ~l~g~~~~~~~~-~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~ 182 (1176)
+++|.+ |..+ ..+++|++|||++|.+++..+ . ..+++|++|+|++|.++
T Consensus 104 ~~~~~i--p~~~~~~l~~L~~L~Ls~n~l~~~~p-------------------------~---~~l~~L~~L~Ls~n~~~ 153 (968)
T PLN00113 104 QLSGPI--PDDIFTTSSSLRYLNLSNNNFTGSIP-------------------------R---GSIPNLETLDLSNNMLS 153 (968)
T ss_pred ccCCcC--ChHHhccCCCCCEEECcCCccccccC-------------------------c---cccCCCCEEECcCCccc
Confidence 666532 3222 244555555555555543222 1 12346677777777765
Q ss_pred CCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCccccc-CCCccCCCCCcEEEcCCCcCCCCcChhh
Q 046275 183 GANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMA-VPSFGDCLALEYLDISANKFTGDVGHAI 261 (1176)
Q Consensus 183 ~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~N~l~~~~~~~l 261 (1176)
+. +|. .+..+++|++|++++|.+.+. +..+.++++|++|+|++|++++..|..+
T Consensus 154 ~~--~p~-----------------------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l 208 (968)
T PLN00113 154 GE--IPN-----------------------DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL 208 (968)
T ss_pred cc--CCh-----------------------HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHH
Confidence 41 221 134556666777777766543 3457778888888888888887788888
Q ss_pred hccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccC
Q 046275 262 SACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGEL 341 (1176)
Q Consensus 262 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i 341 (1176)
.++++|++|+|++|.+++.+|..+. .+++|++|+|++|++++.+|..++++++|++|++++|.+++.+
T Consensus 209 ~~l~~L~~L~L~~n~l~~~~p~~l~------------~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 276 (968)
T PLN00113 209 GQMKSLKWIYLGYNNLSGEIPYEIG------------GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276 (968)
T ss_pred cCcCCccEEECcCCccCCcCChhHh------------cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccC
Confidence 8888888888888888766655433 2468888888888888888888889999999999999988777
Q ss_pred CHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcccc
Q 046275 342 PIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS 421 (1176)
Q Consensus 342 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~ 421 (1176)
|..+ ..+++|++|+|++|.+++.+|..+.++++|+.|++++|.+++.+|..+ ..+++|+.|+|++|.+++.+|..++
T Consensus 277 p~~l-~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~--~~l~~L~~L~L~~n~l~~~~p~~l~ 353 (968)
T PLN00113 277 PPSI-FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL--TSLPRLQVLQLWSNKFSGEIPKNLG 353 (968)
T ss_pred chhH-hhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH--hcCCCCCEEECcCCCCcCcCChHHh
Confidence 7664 678899999999999988888888899999999999999988888776 3467899999999999989999999
Q ss_pred ccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCee
Q 046275 422 NCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501 (1176)
Q Consensus 422 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 501 (1176)
.+++|+.|++++|++++.+|.++..+++|+.|++++|.+.+.+|..++.+++|+.|+|++|++++.+|..|.++++|+.|
T Consensus 354 ~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 433 (968)
T PLN00113 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433 (968)
T ss_pred CCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccce
Q 046275 502 SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKY 581 (1176)
Q Consensus 502 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~ 581 (1176)
++++|++++.+|..+..+++|+.|+|++|++.|.+|..++ +++|+.|++++|+++|.+|..+.
T Consensus 434 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~---------------- 496 (968)
T PLN00113 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLG---------------- 496 (968)
T ss_pred ECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhh----------------
Confidence 9999999999999999999999999999999999888764 58999999999999988775431
Q ss_pred eeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcccccccc
Q 046275 582 VYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSY 661 (1176)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~ 661 (1176)
.+.+|+.|+|++|+++|.+|..++++++
T Consensus 497 ----------------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 524 (968)
T PLN00113 497 ----------------------------------------------------SLSELMQLKLSENKLSGEIPDELSSCKK 524 (968)
T ss_pred ----------------------------------------------------hhhccCEEECcCCcceeeCChHHcCccC
Confidence 2246889999999999999999999999
Q ss_pred ceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCCCccccCCccccCC
Q 046275 662 LFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNN 741 (1176)
Q Consensus 662 L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n 741 (1176)
|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|..+++.++....+.+|
T Consensus 525 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n 604 (968)
T PLN00113 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN 604 (968)
T ss_pred CCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC----CCCCCCCCCCCCccccCCCCCCccccchhhhhHHHHhhhhhhhhhhhhhhhhhccccccccccccccc
Q 046275 742 SGLCGLPL----PPCEKDSGASANSRHQKSHRRPASLAGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYIDSR 817 (1176)
Q Consensus 742 ~~l~~~~~----~~c~~~~~~~~~s~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (1176)
+++||.+. ++|... .+ .....+++++++++++ ++++++++++.+|+|++.+.+..+ .
T Consensus 605 ~~lc~~~~~~~~~~c~~~---------~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~---~-- 665 (968)
T PLN00113 605 IDLCGGDTTSGLPPCKRV---------RK--TPSWWFYITCTLGAFL---VLALVAFGFVFIRGRNNLELKRVE---N-- 665 (968)
T ss_pred ccccCCccccCCCCCccc---------cc--cceeeeehhHHHHHHH---HHHHHHHHHHHHHhhhcccccccc---c--
Confidence 99999653 456321 00 1111112222222211 111112222222222221111100 0
Q ss_pred CCCCCcccccccccchhhhccccccccccccccCHHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC
Q 046275 818 SHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS 896 (1176)
Q Consensus 818 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~ 896 (1176)
....|...... ....+.+++.++ ...|...++||+|+||.||+|++. ++..||||++....
T Consensus 666 -----~~~~~~~~~~~----------~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~ 727 (968)
T PLN00113 666 -----EDGTWELQFFD----------SKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727 (968)
T ss_pred -----ccccccccccc----------cccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc
Confidence 00112111000 001122344443 345778889999999999999874 78999999885432
Q ss_pred CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHH
Q 046275 897 GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976 (1176)
Q Consensus 897 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 976 (1176)
.. ...|++++++++|||||+++++|.++...|+||||+++|+|.++++ .++|.++.+++.|+|+|++||
T Consensus 728 ~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yL 796 (968)
T PLN00113 728 SI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFL 796 (968)
T ss_pred cc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHh
Confidence 22 2356889999999999999999999999999999999999999996 378999999999999999999
Q ss_pred HhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHH
Q 046275 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLL 1056 (1176)
Q Consensus 977 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 1056 (1176)
|..+.++|+||||||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 797 H~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ 869 (968)
T PLN00113 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILI 869 (968)
T ss_pred ccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHH
Confidence 97666699999999999999999888875 6665432211 2236889999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCccHHHHHHHhh-ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1057 ELLTGKRPTDSADFGDNNLVGWVKQHA-KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1057 elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
||+||+.||...........+|..... .......+++.+....+....+..++.+++.+||+.||++||||+||+++|+
T Consensus 870 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 870 ELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred HHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 999999999654444455677764432 2233445566555444444556778889999999999999999999999999
Q ss_pred HHhhCCC
Q 046275 1136 EIQAGSG 1142 (1176)
Q Consensus 1136 ~i~~~~~ 1142 (1176)
++.+...
T Consensus 950 ~~~~~~~ 956 (968)
T PLN00113 950 SASRSSS 956 (968)
T ss_pred Hhhcccc
Confidence 9976543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-60 Score=621.97 Aligned_cols=517 Identities=35% Similarity=0.522 Sum_probs=454.4
Q ss_pred CCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeec
Q 046275 146 SLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDV 225 (1176)
Q Consensus 146 ~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L 225 (1176)
.++.|+|++|.++......+..+++|+.|+|++|++++ .+|...|..+++|++|+|++|.+++..+...+++|++|+|
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~--~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~L 147 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG--PIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDL 147 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCC--cCChHHhccCCCCCEEECcCCccccccCccccCCCCEEEC
Confidence 34444444444443333444455566666666666653 2566666677777777777777776555667899999999
Q ss_pred cCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCcc
Q 046275 226 SSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLV 304 (1176)
Q Consensus 226 s~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~ 304 (1176)
++|.+++..+ .++++++|++|+|++|.+.+..|..+.++++|++|+|++|.+++.+|..+.. +++|+
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~------------l~~L~ 215 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ------------MKSLK 215 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcC------------cCCcc
Confidence 9999986544 6999999999999999999999999999999999999999998777665443 47999
Q ss_pred EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC
Q 046275 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384 (1176)
Q Consensus 305 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 384 (1176)
+|+|++|++++.+|..++++++|++|++++|.+++.+|.. |..+++|++|+|++|.+++.+|..+.++++|+.|+|++|
T Consensus 216 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 216 WIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294 (968)
T ss_pred EEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh-HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence 9999999999999999999999999999999999888866 689999999999999999999999999999999999999
Q ss_pred cCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCC
Q 046275 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464 (1176)
Q Consensus 385 ~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 464 (1176)
.+.+.+|..+ ..+++|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..++.+++|+.|++++|++.+.+
T Consensus 295 ~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~ 372 (968)
T PLN00113 295 SLSGEIPELV--IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372 (968)
T ss_pred eeccCCChhH--cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeC
Confidence 9999999877 45789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCC
Q 046275 465 PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR 544 (1176)
Q Consensus 465 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 544 (1176)
|..+..+++|+.|++++|++++.+|..+.++++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..++
T Consensus 373 p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 452 (968)
T PLN00113 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452 (968)
T ss_pred ChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCcccccc
Q 046275 545 SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVY 624 (1176)
Q Consensus 545 ~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 624 (1176)
+|+.|+|++|++.|.+|..+.
T Consensus 453 ~L~~L~L~~n~~~~~~p~~~~----------------------------------------------------------- 473 (968)
T PLN00113 453 SLQMLSLARNKFFGGLPDSFG----------------------------------------------------------- 473 (968)
T ss_pred CCcEEECcCceeeeecCcccc-----------------------------------------------------------
Confidence 999999999999987775320
Q ss_pred CCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCc
Q 046275 625 GGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSM 704 (1176)
Q Consensus 625 ~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l 704 (1176)
..+|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+
T Consensus 474 ----------~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (968)
T PLN00113 474 ----------SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543 (968)
T ss_pred ----------cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhH
Confidence 1358899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccCCCCCC-CCccccCCccccCCCCCCCCC
Q 046275 705 SSLTLLNEIDLCNNQLTGMIPVM-GQFETFQPAKFLNNSGLCGLP 748 (1176)
Q Consensus 705 ~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~~~~ 748 (1176)
..+++|+.|||++|+++|.+|.. ..+..+....+.+|.-.+..|
T Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred hCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999963 455556666777776555444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=441.53 Aligned_cols=290 Identities=51% Similarity=0.847 Sum_probs=250.8
Q ss_pred cccccCHHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEE
Q 046275 846 PLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925 (1176)
Q Consensus 846 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 925 (1176)
+.+.|++.++..||++|...+.||+|+||.||+|...+|+.||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999987654333156699999999999999999999999
Q ss_pred eeCC-eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 926 KVGE-ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 926 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
.+.+ +.++|||||++|+|.++++..... +++|.+|.+||.++|+||+|||+.+.++||||||||+|||+|+++.+||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999986543 7899999999999999999999999889999999999999999999999
Q ss_pred Eeecccccccccccccccccc-ccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-CCCccHHHHH-HH
Q 046275 1005 SDFGMARLMSAMDTHLSVSTL-AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD-FGDNNLVGWV-KQ 1081 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~-~~~~~~~~~~-~~ 1081 (1176)
+|||+|+........ .... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... ....++..|+ ..
T Consensus 219 sDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999765431111 1222 89999999999999999999999999999999999999887543 3445688997 44
Q ss_pred hhccccccccCccccc-CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1082 HAKLKISDVFDPELMK-EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.....+.+.+|+.+.. ..+. ..++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 5556889999999873 3332 25777788999999999999999999999999766544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=387.65 Aligned_cols=251 Identities=29% Similarity=0.441 Sum_probs=209.5
Q ss_pred CCCceEeEeCceEEEEEEEC-CCCEEEEEEeec-cCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-eeEEEEeecc
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIH-ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE-ERLLVYEYMR 939 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~ 939 (1176)
+..+.||+|..|+|||++++ +++.+|+|.+.. ......+++.+|++++++.+||+||+++|.|..+. ..+++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34679999999999999998 678889998843 23344678999999999999999999999999988 5999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|++++...+ ++++...-+|+.++++||.|||+.. +||||||||+|||++..|.|||||||.+..+...
T Consensus 162 gGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999998775 6899999999999999999999732 8999999999999999999999999999876443
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
...+..||..|||||.+.+..|+.++||||||++++|+.+|++||........+..+....+..... |.+...
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-----P~lP~~- 305 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-----PRLPEG- 305 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-----CCCCcc-
Confidence 2367889999999999999999999999999999999999999998753333344444444443332 222221
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. -.++..|+..||+.||.+|||++|+++|
T Consensus 306 -~f---S~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EF---SPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cC---CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01 1246679999999999999999999988
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=395.17 Aligned_cols=258 Identities=32% Similarity=0.518 Sum_probs=208.4
Q ss_pred CCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC--HHHHHHHHHHHHhcCCCCcccceeEEeeCC-eeEEEEeeccC
Q 046275 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG--DREFTAEMETIGKIKHRNLVPLLGYCKVGE-ERLLVYEYMRY 940 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~~ 940 (1176)
..+.||+|+||+||+|.+.....||||++....... .++|.+|+.++.+++|||||+++|+|.+.. ...+||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999844449999986543222 458999999999999999999999999887 79999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEECCCC-cEEEEeeccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH-IIHRDMKSSNVLLDENF-EARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 1018 (1176)
|+|.++++.. ....+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999884 123799999999999999999999999 6 99999999999999997 99999999998654322
Q ss_pred cccccccccCCcccCccccC--CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ--SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... .+.+....... ..+.+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~----~Rp~~p 268 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGG----LRPPIP 268 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC----CCCCCC
Confidence 2334478999999999999 56999999999999999999999999976542 11222111111 112222
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
...+. .+..++..||+.||++||++.+++..|+.+......
T Consensus 269 ~~~~~------~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 269 KECPP------HLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ccCCH------HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 22222 344588899999999999999999999999765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.82 Aligned_cols=201 Identities=35% Similarity=0.535 Sum_probs=181.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
..+|...+.||+|+||+||+|+++ ++..||||++.+. .....+-+..|+++++.++|||||.+++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999987 5899999999765 3444556789999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC------CcEEEEeecc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN------FEARVSDFGM 1009 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGl 1009 (1176)
|||+||+|.++++..+ .+++++++.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999886 699999999999999999999999 99999999999999764 4589999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
|+.+.... ...+.+|+|.|||||+++..+|+.|+|+||+|+++|+|++|+.||....
T Consensus 162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99886433 2367899999999999999999999999999999999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=376.47 Aligned_cols=254 Identities=29% Similarity=0.397 Sum_probs=206.7
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-------CHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-------GDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||.+.+.... ....+.+|+++|++++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456888999999999999999765 7999999998653211 1234679999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEe
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN---FEARVSD 1006 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 1006 (1176)
..||||||++||+|.+.+-..+ .+.+..-+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999998776 577788899999999999999999 99999999999999765 6799999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCC---CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC---STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
||+|+..+. ...+.+.+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||..... +. ...+++.
T Consensus 323 FGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-~~---sl~eQI~ 395 (475)
T KOG0615|consen 323 FGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-DP---SLKEQIL 395 (475)
T ss_pred cchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-Cc---cHHHHHh
Confidence 999998753 334678999999999999976543 3478999999999999999999975432 21 1233444
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++.. +-|..|.+ --.+.+++|.+||..||++|||++|+++|
T Consensus 396 ~G~y~--f~p~~w~~------Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYA--FGPLQWDR------ISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCccc--ccChhhhh------hhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 44432 11222221 22356779999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=361.51 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=213.6
Q ss_pred CCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCccccee-EEeeCCe-eEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLG-YCKVGEE-RLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV~ 935 (1176)
+|.+.++||+|.||+|||+.. .+|..||.|++... +....++...|+.++++++|||||++++ .+.++.. .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 477888999999999999975 48999999998632 2233456889999999999999999999 4544444 89999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP-HIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+.|+|..+++..+.....+++.++++++.|+++||.++|...+. -|+||||||.||+++.+|.+|++|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999998877777899999999999999999999994321 39999999999999999999999999999886
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... .....+|||.||+||++...+|+.||||||+||++|||+.-+.||.+. ++.+..+.+..++.+.
T Consensus 180 s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~~~----- 247 (375)
T KOG0591|consen 180 SKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDYPP----- 247 (375)
T ss_pred chhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCCCC-----
Confidence 5333 235678999999999999999999999999999999999999999765 5666776666664321
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
+++ +.-...+..+|..|+.+||+.||+.-.+++.+..
T Consensus 248 ~p~-----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPD-----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcH-----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111 1122345669999999999999996666555544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=388.93 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=211.2
Q ss_pred cCCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.+|...+.||+|+|++||.+++ .+|+.||+|.+.+. .....+.+.+|+++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999998 68999999999663 3334566889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|+|+.|+|..++++.+ ++++.+++.++.||+.||.|||+. +|+|||||-.|++++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998655 799999999999999999999999 999999999999999999999999999998865
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.+.. ..+.+|||.|+|||++....++..+||||+||++|-|+.|++||+..+ +.+....+... +..-|+.
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~---~Y~~P~~ 240 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLN---EYSMPSH 240 (592)
T ss_pred cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhc---Ccccccc
Confidence 4322 367899999999999999999999999999999999999999997654 22222222221 1111111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-..++.++|.++|+.+|.+|||+++|+.+
T Consensus 241 ---------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 ---------LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---------cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11245579999999999999999999988
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=367.09 Aligned_cols=242 Identities=29% Similarity=0.400 Sum_probs=203.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.++||+|+||+||.++.+ +++.+|+|++.+.. ..+.+...+|..++.+++||+||+++..|++.+..|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 46899999999999999999876 58899999886532 234567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+.||.|+.++.+.+ .+++..++.++.+|+.||.|||+. +|||||+||+|||+|++|+++|+|||+++..-.
T Consensus 105 d~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999876 689999999999999999999999 999999999999999999999999999985433
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. .....+.+||+.|||||++.+..|+.++|+||+|+++|||++|.+||...+ ...+.+.+...+.. ..+..
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k~~--~~p~~ 248 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGKLP--LPPGY 248 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCcCC--CCCcc
Confidence 2 223456899999999999999999999999999999999999999997654 44455544444411 11111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCC
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt 1126 (1176)
.. ....+++.+.+..||++|..
T Consensus 249 ls---------~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 249 LS---------EEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CC---------HHHHHHHHHHhccCHHHhcC
Confidence 11 13456999999999999963
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=375.10 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=209.0
Q ss_pred CCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
...+.||+|.||.||.|++.....||+|.+... ....++|.+|+++|++++|++||+++|+|..++..|||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 346789999999999999997779999998754 3445788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccc
Q 046275 943 LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV 1022 (1176)
Q Consensus 943 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 1022 (1176)
|.++++... +..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...+.. ....
T Consensus 288 Ll~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~ 361 (468)
T KOG0197|consen 288 LLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTAS 361 (468)
T ss_pred HHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc-eeec
Confidence 999999733 34788999999999999999999999 99999999999999999999999999999544332 2222
Q ss_pred cccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCc
Q 046275 1023 STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101 (1176)
Q Consensus 1023 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1176)
....-...|.|||.+....++.|||||||||+||||+| |+.||.... ..+.++...++. .... +...|.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~~~le~Gy--Rlp~---P~~CP~ 431 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVLELLERGY--RLPR---PEGCPD 431 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHHHHHhccC--cCCC---CCCCCH
Confidence 33334668999999999999999999999999999999 999976543 222333322221 0111 111222
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1102 IEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1102 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.+.+++..||+.+|++|||++.+...++++....
T Consensus 432 ------~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 432 ------EVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ------HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 2445899999999999999999999999887543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=362.77 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=209.2
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
+...+|..++.||+|+|++||+|+.+ +++.||||++.+. .....+.+.+|-.+|.+| .||.|++++..|.++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34467899999999999999999876 6899999988542 222334577899999999 899999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+|+||+++|+|.++|++.+ .+++...+.++.+|+.||+|||++ |||||||||+|||+|+++++||+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999887 799999999999999999999999 99999999999999999999999999999
Q ss_pred cccccccc---------cc--ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1012 LMSAMDTH---------LS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1012 ~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
.+...... .. ....+||..|.+||++.....++.+|+|+||||+|+|+.|++||.... .+..+.+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliFqk 298 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIFQK 298 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHHHH
Confidence 87643221 11 145789999999999999999999999999999999999999997543 2333322
Q ss_pred Hh-hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1081 QH-AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ....+++.+++ .+.++|.+.|..||.+|+|.++|-+|
T Consensus 299 I~~l~y~fp~~fp~--------------~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQALDYEFPEGFPE--------------DARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHhcccCCCCCCH--------------HHHHHHHHHHccCccccccHHHHhhC
Confidence 11 12233333331 34569999999999999999777665
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=337.48 Aligned_cols=261 Identities=26% Similarity=0.349 Sum_probs=204.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
+.|+...++|+|+||+|||++++ +|+.||||++..... .-.+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999987 599999999975432 223446799999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
||+. ++.+-+..... -++...+.+++.|++.|+.|+|++ ++|||||||+|||++.+|.+|+||||.|+.+...
T Consensus 82 ~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 66666655432 478899999999999999999999 9999999999999999999999999999988743
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH-----------hhc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ-----------HAK 1084 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~-----------~~~ 1084 (1176)
.. .++.++.|..|.|||.+.+ .+|..++|||++||++.||++|.+-|.+.+.-++-+ ...+. +..
T Consensus 155 gd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy-~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 155 GD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY-LIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH-HHHHHHcccCHHHHHHhcc
Confidence 22 2356678999999999987 689999999999999999999999997765333211 11111 111
Q ss_pred c------ccccccCccc-ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 L------KISDVFDPEL-MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~------~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. .+++.-+++. ....|.. ...+++++.+|++.||.+|++-++++.+
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~---s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKI---SNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccc---hHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 1111111111 1122222 1245789999999999999999999865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=384.11 Aligned_cols=266 Identities=27% Similarity=0.467 Sum_probs=218.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
.+....+.||+|+||+||+|+.. +...||||.+++.+.. ..++|++|++.+..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34556789999999999999853 3567999999876655 5678999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhcccc------C----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 933 LVYEYMRYGSLEDVLHNQKKV------G----IKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~------~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
+|+|||+.|+|.+++...... + .+++..+.+.||.|||.||+||-++ .+|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999765321 1 2388999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||+++.....+.+.......=..+|||||.+..++|+.+||||||||++||+++ |+.||.+.. .+.+.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--n~EVIe~--- 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--NQEVIEC--- 717 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--hHHHHHH---
Confidence 9999999997776666544334444679999999999999999999999999999999 999998654 2223333
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
+..+.+.+ .....|. ++.+++..||+..|++||+++||-..|+.....++..
T Consensus 718 i~~g~lL~-----~Pe~CP~------~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 718 IRAGQLLS-----CPENCPT------EVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred HHcCCccc-----CCCCCCH------HHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 33333311 1112222 3456999999999999999999999999887665543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=355.81 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=203.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC--eeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE--ERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 936 (1176)
.+|...+.||+|+||+||++..++ |+..|||.+...+....+.+.+|+.++++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 357778899999999999998874 8999999886543333566899999999999999999999754444 6899999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeecccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 1015 (1176)
|+++|+|.+++.+.+. ++++..++++..||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999998752 699999999999999999999999 9999999999999999 79999999999987653
Q ss_pred ccc-cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1016 MDT-HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1016 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
... ........||+.|||||++..+ ....++||||+||++.||+||+.||... .....+.-...... .-|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~----~~P 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED----SLP 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC----CCC
Confidence 111 1122457899999999999853 3445999999999999999999999753 11222222222211 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.+....+ ....+|+.+|+..+|++||||.+++++--.
T Consensus 243 ~ip~~ls------~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLS------DEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccC------HHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2222111 134569999999999999999999998543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=376.47 Aligned_cols=492 Identities=30% Similarity=0.371 Sum_probs=318.9
Q ss_pred CccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCcc
Q 046275 120 FLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELK 199 (1176)
Q Consensus 120 ~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~ 199 (1176)
.|+.|++++|.+.-..++ +.++..|.+|++++|++...++++.+.. .++.|++|+|+++. +|..
T Consensus 46 ~l~~lils~N~l~~l~~d---l~nL~~l~vl~~~~n~l~~lp~aig~l~-~l~~l~vs~n~ls~---lp~~--------- 109 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLRED---LKNLACLTVLNVHDNKLSQLPAAIGELE-ALKSLNVSHNKLSE---LPEQ--------- 109 (565)
T ss_pred chhhhhhccCchhhccHh---hhcccceeEEEeccchhhhCCHHHHHHH-HHHHhhcccchHhh---ccHH---------
Confidence 466777777777654444 5677788888888888888877666554 67778888888875 4432
Q ss_pred EEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccC
Q 046275 200 QLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279 (1176)
Q Consensus 200 ~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (1176)
+..+.+|+.|++++|.+...+++++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|.++.
T Consensus 110 --------------i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~ 174 (565)
T KOG0472|consen 110 --------------IGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA 174 (565)
T ss_pred --------------HhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh
Confidence 23445555666666666666666666666666666666665 334455566666666666666552
Q ss_pred ccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccC
Q 046275 280 PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359 (1176)
Q Consensus 280 ~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~ 359 (1176)
.|..... ++.|++||...|-++ .+|+.++.+.+|+.|+|.+|+|. .+| + |.++..|++|+++.
T Consensus 175 ------------l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-e-f~gcs~L~Elh~g~ 237 (565)
T KOG0472|consen 175 ------------LPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-E-FPGCSLLKELHVGE 237 (565)
T ss_pred ------------CCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-C-CCccHHHHHHHhcc
Confidence 2222222 355666666666665 56666666666666666666665 566 2 56666666666666
Q ss_pred cccCCCCccccc-CCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccC
Q 046275 360 NDFTGALPDSLS-NLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438 (1176)
Q Consensus 360 N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 438 (1176)
|+|. .+|.+.. ++.+|.+|||.+|+++ ..|+.+|. +.+|.+||+++|.++ .+|..++++ .|+.|-+.+|.+.
T Consensus 238 N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl--LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr- 310 (565)
T KOG0472|consen 238 NQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL--LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR- 310 (565)
T ss_pred cHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH--hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-
Confidence 6666 4444443 6666666666666666 56666643 456666666666666 456667777 6777777777765
Q ss_pred CCCccccCCC---ccCeee-------cccccc----cCC----CCCCCCCccccceeecccccccCccccccccCCC---
Q 046275 439 TIPSSLGSLS---KLQDLK-------LWLNQL----HGE----IPPELGNIQTLETLFLDFNELTGTLPAALSNCTN--- 497 (1176)
Q Consensus 439 ~~p~~~~~l~---~L~~L~-------L~~N~l----~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--- 497 (1176)
++-..+-+.. -|++|. ++.-.= .+. .-.....+.+.+.|+++.-+++ .+|.....-..
T Consensus 311 TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~ 389 (565)
T KOG0472|consen 311 TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEI 389 (565)
T ss_pred HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcc
Confidence 2222221111 122221 111000 001 1112234567788888888888 55554443333
Q ss_pred CCeeeccccccCCCCCccccCCCCCCeE-EccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhc
Q 046275 498 LNWISLSNNHLGGEIPTWIGQLSNLAIL-KLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFI 576 (1176)
Q Consensus 498 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~ 576 (1176)
....+++.|++. ++|..+..++.+.+. .+++|.+ +-+|..++.+++|..|+|++|.+. .+|.+.|.
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~---------- 456 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS---------- 456 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhh----------
Confidence 778888999888 788887777776544 4444444 488888888899999999888876 57766543
Q ss_pred cccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccc
Q 046275 577 VGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI 656 (1176)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~ 656 (1176)
+..|+.||+|.|+|. .+|+++
T Consensus 457 ----------------------------------------------------------lv~Lq~LnlS~NrFr-~lP~~~ 477 (565)
T KOG0472|consen 457 ----------------------------------------------------------LVRLQTLNLSFNRFR-MLPECL 477 (565)
T ss_pred ----------------------------------------------------------hhhhheecccccccc-cchHHH
Confidence 124778899999888 789888
Q ss_pred cccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCC-CccccCC
Q 046275 657 GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMG-QFETFQP 735 (1176)
Q Consensus 657 ~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~-~~~~~~~ 735 (1176)
-.+..|+.+-.++|++...-|+.+++|.+|.+|||.+|.|. +||+.+++|++|++|+|++|++. .+|..+ -..|...
T Consensus 478 y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~ai 555 (565)
T KOG0472|consen 478 YELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAI 555 (565)
T ss_pred hhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHH
Confidence 88888888888889998444455999999999999999998 89999999999999999999998 333322 2233334
Q ss_pred ccccCC
Q 046275 736 AKFLNN 741 (1176)
Q Consensus 736 ~~~~~n 741 (1176)
.+|.++
T Consensus 556 L~ylrd 561 (565)
T KOG0472|consen 556 LSYLRD 561 (565)
T ss_pred HHHhcc
Confidence 455554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=354.55 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=208.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC-HHHHHHHHHHHHhcC-CCCcccceeEEeeCC-eeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG-DREFTAEMETIGKIK-HRNLVPLLGYCKVGE-ERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 934 (1176)
.++|.+.+.||.|.||.||+|+.+ +|+.||||++.+.-... +..-.||+..++++. |||||++.+++.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 457889999999999999999865 68999999986543333 233568999999998 999999999998888 89999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
||||+. +|++++++++ ..+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999976 9999998774 4799999999999999999999999 99999999999999999999999999999775
Q ss_pred cccccccccccccCCcccCcccc-CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh----------
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYY-QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA---------- 1083 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~---------- 1083 (1176)
.... ++.++.|..|.|||++ +...|+.+.|+|++|||++|+.+-++-|.+.+..++ +........
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccchhH
Confidence 5433 4667889999999987 567899999999999999999999988877553221 111111111
Q ss_pred -------ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 -------KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...++....-.+..-.|. ...++++++.+|+.+||.+||||.+++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~---~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN---ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc---cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111222222222222222 22345679999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=329.58 Aligned_cols=234 Identities=28% Similarity=0.366 Sum_probs=198.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|+..+.||.|+||+|.+++.+ +|..+|+|.+.+..-- ..+....|..+++++.||+++++++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35778899999999999999987 5889999988653322 2345678999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||++||.|++++++.+ ++++..++.+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999999887 799999999999999999999999 999999999999999999999999999997754
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc--ccccCc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI--SDVFDP 1093 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1093 (1176)
. .-+.+|||.|+|||++...+|..++|+|+|||++|||+.|.+||..... .+..+.+..+++ +..+.+
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI~~~~v~fP~~fs~ 266 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKILEGKVKFPSYFSS 266 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHHHhCcccCCcccCH
Confidence 2 2567999999999999999999999999999999999999999975432 333344444332 222222
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCC
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRR 1124 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 1124 (1176)
.+.+++.+.++.|-.+|
T Consensus 267 --------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 --------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------------HHHHHHHHHHhhhhHhh
Confidence 23458888899998888
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=344.23 Aligned_cols=258 Identities=25% Similarity=0.335 Sum_probs=204.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC-HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.|++.++||.|..++||+|+.. .++.||||++....-.. .+.+.+|+..|+.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 56889999999999999999865 68999999996433222 47899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|.+||+.++++..-.. -+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 106 Ma~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999876543 489999999999999999999999 99999999999999999999999999765443322
Q ss_pred c-cccc-cccccCCcccCccccC--CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc----c
Q 046275 1018 T-HLSV-STLAGTPGYVPPEYYQ--SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS----D 1089 (1176)
Q Consensus 1018 ~-~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----~ 1089 (1176)
. .... .+..||+.|||||++. ...|+.|+||||||++..|+.+|..||...... +..........+ .
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHHHHhcCCCCCcccc
Confidence 1 1111 5678999999999954 347999999999999999999999999754311 111111111111 1
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.+-... --..+.+++..||+.||++|||+++++++
T Consensus 256 ~~~~d~~k~------~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKK------FSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhh------hcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111111 11245679999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.97 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=209.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
..|...++||+|+-|.||.|+.. +++.||||++........+-+.+|+.+|+..+|+|||++++.|...+..|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35777789999999999999765 68999999997766666667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+||+|.|.+... .+++.++..|..++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999765 589999999999999999999999 999999999999999999999999999987765443
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
...+.+|||.|||||+.....|++|+||||||++++||+.|.+||-..+ .......+.....++.-.++..
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyLIa~ng~P~lk~~~kl-- 495 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYLIATNGTPKLKNPEKL-- 495 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHHHhhcCCCCcCCcccc--
Confidence 3367899999999999999999999999999999999999999986532 2222222222222222111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-..+.+|+.+||+.|+++||++.|+++|
T Consensus 496 -------S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 -------SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -------CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1245679999999999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=354.74 Aligned_cols=247 Identities=29% Similarity=0.420 Sum_probs=208.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+... .+.+.+.+|++++++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999877 578899998865332 334568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+.| +|+.++...+ .++++.+..++.+++.||.|||+. +|.|||+||.||+++.++++|++|||+|+-+...
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 9999998765 699999999999999999999999 9999999999999999999999999999977642
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
....+...|||-|||||...+.+|+..+|.||+||++|||++|++||.... +.+.++.+..... .+
T Consensus 154 --t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d~v-------~~ 219 (808)
T KOG0597|consen 154 --TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKDPV-------KP 219 (808)
T ss_pred --ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcCCC-------CC
Confidence 223467789999999999999999999999999999999999999986432 3334443333221 11
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. . --..+..|+...|..||.+|.|..+++.|
T Consensus 220 p~--~---~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 PS--T---ASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cc--c---ccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 10 1 11245669999999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=360.23 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=208.4
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc----CC-cCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI----SG-QGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 930 (1176)
..++|.+.+.||+|+||+|+.|++. +|+.||+|.+.+. .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999765 6899999955432 11 23456778999999998 9999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeecc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGM 1009 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 1009 (1176)
.|+||||+.||+|++++...+ ++.+..+++++.|++.|++|+|+. +|+||||||+||+++.+ +.+||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999854 688899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCC-CC-chhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc-
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR-CS-TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK- 1086 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~- 1086 (1176)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||... +.......+..+.
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKGEF 240 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcCCc
Confidence 98764 2223356789999999999999877 75 7899999999999999999999752 2233333333322
Q ss_pred -cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1087 -ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1087 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
++..++ -..+..++.+|+..||.+|+|+.+++++ .-++.
T Consensus 241 ~~p~~~~-------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h-~w~~~ 280 (370)
T KOG0583|consen 241 KIPSYLL-------------SPEARSLIEKMLVPDPSTRITLLEILEH-PWFQK 280 (370)
T ss_pred cCCCCcC-------------CHHHHHHHHHHcCCCcccCCCHHHHhhC-hhhcc
Confidence 222221 1245569999999999999999999944 44443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.78 Aligned_cols=248 Identities=24% Similarity=0.284 Sum_probs=199.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
..++|+..++||+|+||.||+|+-+ +|..+|+|++.+... ...+.+..|-.+|...++|+||+++..|++.+..|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4467999999999999999999876 699999999976433 334567889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||++||++..++.+.+ .+++..++.++.+++-|++.+|+. |+|||||||+|+|||..|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999876 799999999999999999999999 9999999999999999999999999998422
Q ss_pred ccc----------------------ccc-----cc------------------ccccccCCcccCccccCCCCCCchhhh
Q 046275 1014 SAM----------------------DTH-----LS------------------VSTLAGTPGYVPPEYYQSFRCSTKGDV 1048 (1176)
Q Consensus 1014 ~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv 1048 (1176)
... +.. .. ....+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 110 000 00 012469999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC
Q 046275 1049 YSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126 (1176)
Q Consensus 1049 wSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt 1126 (1176)
||+|||+|||+.|.+||.+.+.. ..|.+....... -.++.+.. ...++.++|.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~----~T~rkI~nwr~~-l~fP~~~~--------~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQ----ETYRKIVNWRET-LKFPEEVD--------LSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhhh-ccCCCcCc--------ccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999865422 233322211111 01111111 11356679999999 9999987
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=361.45 Aligned_cols=402 Identities=25% Similarity=0.231 Sum_probs=274.1
Q ss_pred CccccccCCcccCCCCCcccccCCC--CCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCC
Q 046275 120 FLSSLDLSLNILSGPLSDISYLGSC--SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDE 197 (1176)
Q Consensus 120 ~L~~LdLs~N~l~~~~~~~~~l~~l--~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~ 197 (1176)
+-..||++++.+.... -+.+.++ +.-+.|++++|+|.++....|...++|+++++.+|.++. +|... +...+
T Consensus 53 ~~~lldcs~~~lea~~--~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~---IP~f~-~~sgh 126 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAID--KSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR---IPRFG-HESGH 126 (873)
T ss_pred CceeeecCcccccccc--ccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh---ccccc-ccccc
Confidence 4566777877775321 1223333 233457777777777777777777777777777777775 33211 23345
Q ss_pred ccEEEeCCCccccc--ccCCCCCccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecc
Q 046275 198 LKQLALKGNKVTGD--INVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSS 274 (1176)
Q Consensus 198 L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (1176)
|+.|+|.+|.|++. ..++.++.|+.||||.|.|+.++. +|..-.++++|+|++|.|+......|.++.+|..|.|+.
T Consensus 127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr 206 (873)
T KOG4194|consen 127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR 206 (873)
T ss_pred eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence 77777777777753 346667777777777777776654 466666777777777777777777777777777777777
Q ss_pred ccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCE
Q 046275 275 NLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKE 354 (1176)
Q Consensus 275 N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~ 354 (1176)
|+|+ .+|...|+.+++|+.|+|..|+|.-.---.|..+++|+.|.|..|.|+ .+..++|-.+.++++
T Consensus 207 Nrit------------tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~ 273 (873)
T KOG4194|consen 207 NRIT------------TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEH 273 (873)
T ss_pred Cccc------------ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccce
Confidence 7776 455566666677777777777776222345677777777777777776 666666777777777
Q ss_pred EEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCc
Q 046275 355 LVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434 (1176)
Q Consensus 355 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 434 (1176)
|+|+.|+++..-..++.+|+.|+.|+||+|.|.. ..++..+..++|++|||++|
T Consensus 274 l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r--------------------------ih~d~WsftqkL~~LdLs~N 327 (873)
T KOG4194|consen 274 LNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR--------------------------IHIDSWSFTQKLKELDLSSN 327 (873)
T ss_pred eecccchhhhhhcccccccchhhhhccchhhhhe--------------------------eecchhhhcccceeEecccc
Confidence 7777777766556666677777777777766653 33344445566666667766
Q ss_pred cccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccc---cccccCCCCCeeeccccccCCC
Q 046275 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLP---AALSNCTNLNWISLSNNHLGGE 511 (1176)
Q Consensus 435 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~ 511 (1176)
+|+...+.+|..|+.|+.|+|++|.+...--..|..+++|++|||++|.|+..+- ..|.+|+.|+.|+|.+|+|..+
T Consensus 328 ~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I 407 (873)
T KOG4194|consen 328 RITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI 407 (873)
T ss_pred ccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence 6665566666667777777777777665555567777777777777777775553 3477888888888888888865
Q ss_pred CCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhh
Q 046275 512 IPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567 (1176)
Q Consensus 512 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~ 567 (1176)
.-.+|..+..|++|||.+|.|...-|.+|..+ .|+.|.+..-.|-+.+--.++.+
T Consensus 408 ~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~q 462 (873)
T KOG4194|consen 408 PKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQ 462 (873)
T ss_pred chhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHH
Confidence 56778888888888888888887778888888 88888887766666554444443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.71 Aligned_cols=248 Identities=27% Similarity=0.343 Sum_probs=210.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
-|..++.||+|+.|.|..|++. +|+.+|||.+.+.. ......+.+|+-+|+.+.||||+++++++++.++.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4677889999999999999875 79999999986542 2234568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|.|++++-..+ ++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|..-..
T Consensus 93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 999999999998877 789999999999999999999999 999999999999999999999999999975432
Q ss_pred cccccccccccCCcccCccccCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCS-TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
..-..+.||+|+|.|||++.+.+|+ .++||||+|||+|.++||+.||+ ++++.........+.+. +
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLlKV~~G~f~------M 231 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLLKVQRGVFE------M 231 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHHHHHcCccc------C
Confidence 2234678999999999999998874 68999999999999999999985 45565565555554431 1
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
....+. ++.+++.+|++.||++|.|++||++|--
T Consensus 232 Ps~Is~------eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 232 PSNISS------EAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CCcCCH------HHHHHHHHHhccCccccccHHHHhhCch
Confidence 111121 3456999999999999999999999854
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.95 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=203.8
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 935 (1176)
.|+..++||+|.||.||+|++. +|+.||+||+.... ........+|+.+|++++||||+++.+...+. ...|+|+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 4666789999999999999875 79999999997654 33456688999999999999999999988766 7899999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|||+. +|.-++... +..+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 198 eYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99987 888888754 35799999999999999999999999 999999999999999999999999999998765
Q ss_pred ccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH--------hhccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ--------HAKLK 1086 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~--------~~~~~ 1086 (1176)
.... .++..+-|..|.|||.+.+. .|+.++|+||.|||+.||++|++.|.+...- ..+....+. |...+
T Consensus 271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhcccccc
Confidence 4432 34666779999999998764 7999999999999999999999998775421 111111111 11111
Q ss_pred cc--cccCcccccCCCchHHHH-----HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 IS--DVFDPELMKEDPNIEIEL-----LQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~--~~~~~~~~~~~~~~~~~~-----~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
++ ..+.+.-. ......|. ...++++..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~--y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQP--YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCc--ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 11111100 01111111 234679999999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.71 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=205.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.+|...+++|+|.||.||+|++. +|+.|||||+...... -.....+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999999999999875 7999999999754332 24567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
||+. +|+..+++.. ..++..++..++.++.+|++|||.+ .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 9999998764 4799999999999999999999999 8999999999999999999999999999988765
Q ss_pred cccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh---ccccccc--
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA---KLKISDV-- 1090 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 1090 (1176)
..... ..+-|..|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+...-+ .+........ ...+++.
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCCCcccCccccc
Confidence 54332 33678899999988764 78999999999999999999887766543211 1111111111 1111111
Q ss_pred ---------cC-cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 ---------FD-PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ---------~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
++ +....-.+.+. ..+++++.+|+..||.+|+|+.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas---~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAAS---SDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCcccccccccc---HHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 11111222222 234779999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=361.08 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=204.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeC-C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVG-E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 929 (1176)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357899999999999999999742 356899998864322 2235688999999999 899999999988764 4
Q ss_pred eeEEEEeeccCCCHHHHHhhcccc--------------------------------------------------------
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKV-------------------------------------------------------- 953 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 953 (1176)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999999754210
Q ss_pred --CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcc
Q 046275 954 --GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY 1031 (1176)
Q Consensus 954 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 1031 (1176)
..++++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12478889999999999999999999 9999999999999999999999999999865433222222334567889
Q ss_pred cCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHH
Q 046275 1032 VPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHL 1110 (1176)
Q Consensus 1032 ~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1110 (1176)
+|||++.+..++.++|||||||++|||++ |..||....... .+......... .......+ ..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~-----~~~~~~~~------~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGTR-----MRAPENAT------PEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCCC-----CCCCCCCC------HHHH
Confidence 99999998899999999999999999997 999997643211 11111111111 11111111 2356
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1111 HVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1111 ~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
+++.+||+.||++|||+.|+++.|+++..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 79999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.75 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=209.1
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.-+.+.+.+.||+|.||+||+|+|. ..||||.+..... +..+.|+.|+.++++-+|.||+-+.|||..+.. .||+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3345667889999999999999986 5699998865433 344679999999999999999999999998887 9999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
.+|+|.+|+.++|..+ .+++..+.+.||.|||+|+.|||.+ +|||||||..||++.+++.|||+|||++.....
T Consensus 467 qwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred hhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999999876 4799999999999999999999999 999999999999999999999999999976544
Q ss_pred ccccccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...........|...|||||+++. .+|++.+||||||+++|||+||..||.... .+ ++..+......-
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~d--------qIifmVGrG~l~ 611 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RD--------QIIFMVGRGYLM 611 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hh--------heEEEecccccC
Confidence 433334456678889999999853 478999999999999999999999997322 11 111111111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+++..-......+ +.+++..||..++++||.+.+|+..|+.+..+
T Consensus 612 pd~s~~~s~~pk~---mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 PDLSKIRSNCPKA---MKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccchhhhccCHHH---HHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 2222211122223 44589999999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.70 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=213.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeeccCCcCHH---HHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHISGQGDR---EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
..+|++.+.||+|.||.|-+|.. +.|+.||||.+.+....+++ .+.+|+++|..++||||+.++++|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999975 67999999988765544444 478899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||..+|.|+|++...+ .+++.+++.+++||+.|+.|+|.+ +|+|||+|.+|||+|+++.+||+|||++-.+.
T Consensus 132 MEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999886 799999999999999999999999 99999999999999999999999999998775
Q ss_pred cccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
... ...+++|+|-|.+||++.+.+| .+.+|-||+||++|-++.|..||++.+. -..+.++..+...+.-.|
T Consensus 205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs~GaYrEP~~P 276 (668)
T KOG0611|consen 205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQISRGAYREPETP 276 (668)
T ss_pred ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhhcccccCCCCC
Confidence 432 3467899999999999999887 4789999999999999999999987652 334455555554332111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
. .+.-+|++||..+|++|.|..+|..|+.
T Consensus 277 S-------------dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 277 S-------------DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred c-------------hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1 1234899999999999999999999873
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.72 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=209.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.|+..+.||+|.||.||+|.+. +++.||+|.+... ......++.+|+.++.+++++||.++|+.+..+...+++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666789999999999999875 6889999988543 3344578999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
.||++.+.++... .+++....-+++++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||++..+.....
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998664 457888888999999999999999 899999999999999999999999999987654332
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
. ..+.+|||.|||||++....|+.|+||||||++.|||.+|.+||...... ..-..+++..+|.+.+.
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------rvlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------RVLFLIPKSAPPRLDGD 234 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------eEEEeccCCCCCccccc
Confidence 2 26789999999999999989999999999999999999999998765421 11223444555555543
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... .+.+|+..||+.||+.||+|.++++|
T Consensus 235 ~S~------~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSP------PFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCH------HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 322 35569999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=364.47 Aligned_cols=280 Identities=25% Similarity=0.440 Sum_probs=220.0
Q ss_pred cccccccccccccCHHHHHHHhcCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccC-CcCHHHHHHHHHHHHh
Q 046275 838 INLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHIS-GQGDREFTAEMETIGK 912 (1176)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~ 912 (1176)
++..++|.|.+...-...+.......+.++||.|.||.||+|+++. ...||||.++... +...++|..|..||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 4445555554433322222333456788999999999999999872 3579999987543 3445679999999999
Q ss_pred cCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 046275 913 IKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSS 992 (1176)
Q Consensus 913 l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 992 (1176)
++||||+++.|+.......+||.|||++|+|+.+++... ..+++.+...++++||.|+.||.++ ++|||||.++
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR 760 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR 760 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence 999999999999999999999999999999999998775 3699999999999999999999999 9999999999
Q ss_pred CEEECCCCcEEEEeecccccccccccccccccccc--CCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCC
Q 046275 993 NVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG--TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSAD 1069 (1176)
Q Consensus 993 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~ 1069 (1176)
|||++.+..+|++|||+++.+.++. ...+++..| ..+|.|||.+...+++.++|||||||++||.++ |.+||-..
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm- 838 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM- 838 (996)
T ss_pred heeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-
Confidence 9999999999999999999775543 222233333 468999999999999999999999999999887 99996432
Q ss_pred CCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1070 FGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
..+++...++ +.+.-....+.|.. +.+++..||+.|-.+||++.+|+.+|+++...
T Consensus 839 -SNQdVIkaIe--------~gyRLPpPmDCP~a------L~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 839 -SNQDVIKAIE--------QGYRLPPPMDCPAA------LYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -chHHHHHHHH--------hccCCCCCCCCcHH------HHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2222222221 11221222334443 44588999999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.34 Aligned_cols=241 Identities=29% Similarity=0.473 Sum_probs=199.5
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHH
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLE 944 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 944 (1176)
.+-||.|+.|.||.|+.+ ++.|||||+... -..+++.++.++||||+.|.|+|.....++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 467999999999999997 899999987432 235788899999999999999999999999999999999999
Q ss_pred HHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccc
Q 046275 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024 (1176)
Q Consensus 945 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 1024 (1176)
..++... +++......+..+||.|+.|||.+ .|||||||.-||||..+..|||+|||-++......+ ...
T Consensus 201 ~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMS 270 (904)
T KOG4721|consen 201 EVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMS 270 (904)
T ss_pred HHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhh
Confidence 9998765 678888999999999999999999 899999999999999999999999999987765433 356
Q ss_pred cccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHH
Q 046275 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEI 1104 (1176)
Q Consensus 1025 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1176)
++||..|||||+++..+.++|+||||||||+|||+||..||...+... +..+.....+.-.+....|..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------IIwGVGsNsL~LpvPstcP~G-- 339 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------IIWGVGSNSLHLPVPSTCPDG-- 339 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------eEEeccCCcccccCcccCchH--
Confidence 799999999999999999999999999999999999999987543211 111111111222222233322
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1105 ELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1105 ~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
+.-++.+||+-.|..||++.+++.||+-..
T Consensus 340 ----fklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 340 ----FKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ----HHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 233889999999999999999999997544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=353.53 Aligned_cols=388 Identities=24% Similarity=0.241 Sum_probs=304.4
Q ss_pred cccccccCCCCCCCcccCCCCCc-cccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCc
Q 046275 94 TLETLSLKNSNISGTISLPAGSR-CSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLE 172 (1176)
Q Consensus 94 ~L~~L~L~~n~l~g~~~~~~~~~-~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~ 172 (1176)
.-+.||.+++.+... ....... ..+.-+.||+|+|+++.. ++..+-++++|+.++|.+|.++.||.. .....+|+
T Consensus 53 ~~~lldcs~~~lea~-~~~~l~g~lp~~t~~LdlsnNkl~~i--d~~~f~nl~nLq~v~l~~N~Lt~IP~f-~~~sghl~ 128 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAI-DKSRLKGFLPSQTQTLDLSNNKLSHI--DFEFFYNLPNLQEVNLNKNELTRIPRF-GHESGHLE 128 (873)
T ss_pred CceeeecCccccccc-cccccCCcCccceeeeeccccccccC--cHHHHhcCCcceeeeeccchhhhcccc-ccccccee
Confidence 345688899988731 1111111 224467899999999865 445678999999999999999999743 33344799
Q ss_pred EEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccc--cCCCCCccceeeccCCcccccCC-CccCCCCCcEEEcC
Q 046275 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDIS 249 (1176)
Q Consensus 173 ~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls 249 (1176)
.|+|.+|.|++ +......-++.|+.|+|+.|.|+... .+..-.++++|+|++|+|+.+.. .|.++.+|..|.|+
T Consensus 129 ~L~L~~N~I~s---v~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLs 205 (873)
T KOG4194|consen 129 KLDLRHNLISS---VTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLS 205 (873)
T ss_pred EEeeecccccc---ccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecc
Confidence 99999999997 55566778899999999999999743 46666899999999999997755 58999999999999
Q ss_pred CCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcE
Q 046275 250 ANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLES 329 (1176)
Q Consensus 250 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 329 (1176)
+|+++...+..|.++++|+.|+|..|+|. .+.-..|..+++|+.|.|..|.++..-...|..+.++++
T Consensus 206 rNrittLp~r~Fk~L~~L~~LdLnrN~ir------------ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~ 273 (873)
T KOG4194|consen 206 RNRITTLPQRSFKRLPKLESLDLNRNRIR------------IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEH 273 (873)
T ss_pred cCcccccCHHHhhhcchhhhhhcccccee------------eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccce
Confidence 99999999999999999999999999997 222234666899999999999999777889999999999
Q ss_pred EEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccC
Q 046275 330 FDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409 (1176)
Q Consensus 330 L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~ 409 (1176)
|+|+.|+++ .+..+.+-+++.|+.|+||+|.|..+-+++....++|+.|+|++|+|+..-+..+ ..+..|++|+|++
T Consensus 274 l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf--~~L~~Le~LnLs~ 350 (873)
T KOG4194|consen 274 LNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF--RVLSQLEELNLSH 350 (873)
T ss_pred eecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH--HHHHHhhhhcccc
Confidence 999999998 6776666789999999999999998889999999999999999999984444333 2356678888888
Q ss_pred ccccCCCCccccccccCcEEEcCCccccCCCCc---cccCCCccCeeecccccccCCCCCCCCCccccceeecccccccC
Q 046275 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPS---SLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTG 486 (1176)
Q Consensus 410 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 486 (1176)
|.+...--..|..+++|+.|||++|.++..+.+ .|..|++|+.|.|.+|++..+....|.++..|++|||.+|.|..
T Consensus 351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee
Confidence 887765566777778888888888877755543 35556667777777777665445566666666666666666666
Q ss_pred ccccccccCCCCCeeecc
Q 046275 487 TLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 487 ~~p~~~~~l~~L~~L~Ls 504 (1176)
+-|.+|..+ +|++|.+.
T Consensus 431 Iq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 431 IQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecccccccc-hhhhhhhc
Confidence 666666666 66666544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.64 Aligned_cols=472 Identities=27% Similarity=0.397 Sum_probs=357.4
Q ss_pred CCccEEEeCCCcccc-cccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecc
Q 046275 196 DELKQLALKGNKVTG-DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSS 274 (1176)
Q Consensus 196 ~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~ 274 (1176)
..|..|.+++|.++. ..++.++..|.+|++++|++...+++++.+..++.|+.++|++. ..|..+..+.+|+.|++++
T Consensus 45 v~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 45 VDLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred cchhhhhhccCchhhccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 345566666666654 34567788888999999999888888888889999999999887 6777888888999999999
Q ss_pred ccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCE
Q 046275 275 NLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKE 354 (1176)
Q Consensus 275 N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~ 354 (1176)
|.+. ++|..++. +..|+.|+..+|+++ ..|..+.++.+|..|++.+|++. .+|+.... ++.|++
T Consensus 124 n~~~------------el~~~i~~-~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ 187 (565)
T KOG0472|consen 124 NELK------------ELPDSIGR-LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKH 187 (565)
T ss_pred ccee------------ecCchHHH-Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHh
Confidence 9887 33333333 357888888899988 67888888889999999999988 77777654 888999
Q ss_pred EEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccc-cccccCcEEEcCC
Q 046275 355 LVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL-SNCSQLVSLHLSF 433 (1176)
Q Consensus 355 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~ 433 (1176)
||..+|-++ .+|..++.+.+|+.|+|.+|++. .+| .| ..+..|++|+++.|++. .+|... .++.+|.+|||..
T Consensus 188 ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef--~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRd 261 (565)
T KOG0472|consen 188 LDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EF--PGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRD 261 (565)
T ss_pred cccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CC--CccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccc
Confidence 999988888 78888999999999999999887 666 33 34567888888888887 555544 4888888888888
Q ss_pred ccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCC---CCCeee-------c
Q 046275 434 NYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT---NLNWIS-------L 503 (1176)
Q Consensus 434 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~-------L 503 (1176)
|+++ ..|+.+..+.+|.+||+|+|.++ .+|.+++++ .|+.|-+.+|.+. ++-..+-+.. -|++|. +
T Consensus 262 Nklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dgl 337 (565)
T KOG0472|consen 262 NKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGL 337 (565)
T ss_pred cccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCC
Confidence 8888 78888888888888888888888 678888888 8888888888876 3333322211 122221 1
Q ss_pred ccccc----CCCCCc----cccCCCCCCeEEccCCcccccCCCCCCCCCC---CCEEEccCCCCcccCChhHHhhcccch
Q 046275 504 SNNHL----GGEIPT----WIGQLSNLAILKLSNNSFYGRIPPELGDCRS---LIWLDLNTNLFNGSIPPALFKQSGKIA 572 (1176)
Q Consensus 504 s~N~l----~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~g~ip~~~~~~~~~l~ 572 (1176)
+.-.= .+..|. ....+.+.+.|+++.=+++ .+|.+...-.. .+.++++.|+++ ++|..+-.......
T Consensus 338 S~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT 415 (565)
T KOG0472|consen 338 SQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVT 415 (565)
T ss_pred CCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHH
Confidence 11100 011111 1234567889999999998 78887665544 788999999997 78876544322111
Q ss_pred hhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCC
Q 046275 573 ANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSI 652 (1176)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~i 652 (1176)
...+.. +...|. ...++....|++|+|++|-+. .+
T Consensus 416 ~l~lsn------------------n~isfv--------------------------~~~l~~l~kLt~L~L~NN~Ln-~L 450 (565)
T KOG0472|consen 416 DLVLSN------------------NKISFV--------------------------PLELSQLQKLTFLDLSNNLLN-DL 450 (565)
T ss_pred HHHhhc------------------Cccccc--------------------------hHHHHhhhcceeeecccchhh-hc
Confidence 111111 111111 112344567899999999998 89
Q ss_pred CccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCCCccc
Q 046275 653 PKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFET 732 (1176)
Q Consensus 653 P~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~ 732 (1176)
|.+++.+..||.||+|+|+|. .+|..+-.+..|+.+-.++|++...-|..+.+|..|..|||.+|.|...+|..|.+..
T Consensus 451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lgnmtn 529 (565)
T KOG0472|consen 451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTN 529 (565)
T ss_pred chhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccc
Confidence 999999999999999999999 9999999999999999999999844444599999999999999999999999999999
Q ss_pred cCCccccCCC
Q 046275 733 FQPAKFLNNS 742 (1176)
Q Consensus 733 ~~~~~~~~n~ 742 (1176)
+......||+
T Consensus 530 L~hLeL~gNp 539 (565)
T KOG0472|consen 530 LRHLELDGNP 539 (565)
T ss_pred eeEEEecCCc
Confidence 9888888884
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=337.42 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=199.1
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEee----CCeeEEEEee
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKV----GEERLLVYEY 937 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~ 937 (1176)
...||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 58999999986543333 3567799999999999999999999876 3467899999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++...+ .+++.....++.+++.|+.|||+.. +++||||||+||++++++.+|++|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999998654 6889999999999999999999842 78899999999999999999999999988654321
Q ss_pred ccccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+ .............. +..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~----~~~ 243 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYDLIINKNNS----LKL 243 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCC----CCC
Confidence 23468899999999976 688999999999999999999999997543 12222222111111 111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
....+ ..+.+++.+||+.||++|||++|+++.|++++.
T Consensus 244 ~~~~~------~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 PLDCP------LEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCcCc------HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111 135579999999999999999999999998864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=330.95 Aligned_cols=260 Identities=25% Similarity=0.282 Sum_probs=201.2
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--------------cCHHHHHHHHHHHHhcCCCCcccc
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--------------QGDREFTAEMETIGKIKHRNLVPL 921 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 921 (1176)
...++|++.+.||+|.||.|-+|+.. +++.||+|.+.+... ...+.+.+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999876 689999998854211 112468899999999999999999
Q ss_pred eeEEee--CCeeEEEEeeccCCCHHHHHhhccccCcc-cCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 046275 922 LGYCKV--GEERLLVYEYMRYGSLEDVLHNQKKVGIK-LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE 998 (1176)
Q Consensus 922 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 998 (1176)
+++..+ .+..|||+|||..|.+...-. ..+ +++.++++++.+++.||+|||.+ +||||||||+|+|+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 999876 457899999999988753222 223 89999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccccccccc---cccccccccccCCcccCccccCCCC----CCchhhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046275 999 NFEARVSDFGMARLMSAM---DTHLSVSTLAGTPGYVPPEYYQSFR----CSTKGDVYSYGVVLLELLTGKRPTDSADFG 1071 (1176)
Q Consensus 999 ~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~ 1071 (1176)
+|++||+|||.+...... +........+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 999999999999866322 1222334578999999999987632 3568899999999999999999985422
Q ss_pred CccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1072 DNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.......+....+. .|...+.-..+.++|.++|+.||++|.+..+|..|...-+.
T Consensus 324 ---~~~l~~KIvn~pL~----------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ---ELELFDKIVNDPLE----------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---HHHHHHHHhcCccc----------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 22222222222211 11111223345679999999999999999999888665443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=326.18 Aligned_cols=266 Identities=29% Similarity=0.379 Sum_probs=203.3
Q ss_pred CCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHh--cCCCCcccceeEEeeCC----eeEEEEee
Q 046275 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGK--IKHRNLVPLLGYCKVGE----ERLLVYEY 937 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lV~E~ 937 (1176)
..++||+|.||.||||.+. ++.||||++.. +..+.|..|-++.+. ++|+||++++++-+..+ ++++|+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4568999999999999987 69999999843 455678888887765 58999999999876555 88999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC------IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
.+.|+|.+++... ..+|....+|+..+++||+|||+.. .|+|+|||||..|||+..|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999876 6999999999999999999999864 4689999999999999999999999999999
Q ss_pred ccccccccccccccccCCcccCccccCCCC-C-----CchhhhHHHHHHHHHHHcCCCCCCCCC-------CC-----Cc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFR-C-----STKGDVYSYGVVLLELLTGKRPTDSAD-------FG-----DN 1073 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGvil~elltg~~P~~~~~-------~~-----~~ 1073 (1176)
.+............+||.+|||||++++.- + -.+.||||+|.|+|||++...-+.... ++ ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 887655544445578999999999997642 1 236899999999999998544332100 00 01
Q ss_pred cHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1074 NLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1074 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.+.++.......+ ..|.+....-.. ..+..+.+.+..||+.||+.|.|+.=|.+.+.++....+.
T Consensus 445 t~e~mq~~VV~kK----~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKK----QRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhc----cCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1112211111111 112221111111 2345667899999999999999999999999999877655
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=342.84 Aligned_cols=265 Identities=22% Similarity=0.351 Sum_probs=201.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-----------------CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-----------------GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPL 921 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 921 (1176)
++|.+.+.||+|+||.||+|++.+ +..||+|.+..... ....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468889999999999999997532 33699998764322 224568899999999999999999
Q ss_pred eeEEeeCCeeEEEEeeccCCCHHHHHhhcccc---------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 046275 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV---------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986 (1176)
Q Consensus 922 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 986 (1176)
++++.+....++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999998654211 12478899999999999999999999 9999
Q ss_pred CCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc--CCCC
Q 046275 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT--GKRP 1064 (1176)
Q Consensus 987 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P 1064 (1176)
|||||+||+++.++.+||+|||+++.....+.........++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544333222234456889999999988899999999999999999987 5567
Q ss_pred CCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1065 TDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
|.... ..................... ......| ..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT--DEQVIENAGEFFRDQGRQVYL-FRPPPCP------QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC--HHHHHHHHHHHhhhccccccc-cCCCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 76432 222222222111111111100 0001111 135679999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=306.92 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=208.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++++.||+|.||.||.|+.+ ++..||+|++.+.. ....+++.+|+++-..++||||.++++||.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 46899999999999999999876 57889999987532 344678999999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||..+|+++..+..++. .++++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..|++|||-+...+
T Consensus 102 Eya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999985542 3688899999999999999999999 99999999999999999999999999775433
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.... .+ +..+.+...+ ..+|+.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~----etYkrI~k~~---~~~p~~ 244 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HS----ETYKRIRKVD---LKFPST 244 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hH----HHHHHHHHcc---ccCCcc
Confidence 122367899999999999999999999999999999999999999997654 11 1222222222 222222
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.. ..+.++|.+|+..+|.+|.+..|++++-
T Consensus 245 is---------~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 245 IS---------GGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred cC---------hhHHHHHHHHhccCccccccHHHHhhhH
Confidence 11 1355699999999999999999999884
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=305.68 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=210.9
Q ss_pred HhcCCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----Cee
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EER 931 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 931 (1176)
..++|++.+.+|+|||+.||.++. .+++.+|+|++.....++.+...+|++..++++||||++++++...+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 346899999999999999999984 47899999999877777778899999999999999999999987443 348
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|++++|+..|+|.+.+...+..+..+++.+.+.|+.++++||.+||+.. +++.||||||.||++.+.+.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999988777778999999999999999999999983 359999999999999999999999999987
Q ss_pred cccccccc-------ccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 046275 1012 LMSAMDTH-------LSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1012 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
...-.-.. ........|..|.|||.+. +...++++|||||||++|+|+.|..||+..-....++ ..+-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-aLAv~ 256 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-ALAVQ 256 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-EEeee
Confidence 55321110 0112335789999999984 4567899999999999999999999997543211111 11110
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
..... ++ ..+... ..+.+++.+|+++||.+||++.+++..++.+.
T Consensus 257 n~q~s--------~P-~~~~ys---e~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 257 NAQIS--------IP-NSSRYS---EALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ccccc--------cC-CCCCcc---HHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00111 11 111122 23456999999999999999999999988654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.32 Aligned_cols=274 Identities=25% Similarity=0.369 Sum_probs=209.7
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEee--ccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee-----C
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV-----G 928 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 928 (1176)
+....|...+.||+|+||.|++|.++ +|+.||+||+. ..+....++..+|+++++.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456666789999999999999886 69999999997 3444455678899999999999999999998865 4
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
...|+|+|+|+. +|...++.+. .++......++.|+++||.|+|+. +|+|||+||+|++++.+..+||+|||
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 578999999965 9999998764 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc-------------c
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-------------N 1074 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~-------------~ 1074 (1176)
+|+..........++...-|..|.|||+.. ...|+.+.||||+|||+.||++|++-|.+.+.-.+ .
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999876543333456778899999999874 56899999999999999999999999977552110 0
Q ss_pred HHHHHH-Hhhcc---ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhCC
Q 046275 1075 LVGWVK-QHAKL---KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAGS 1141 (1176)
Q Consensus 1075 ~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~~ 1141 (1176)
....+. ..... ..+..-...+..-.|... ..+++++.+||..||.+|+|++|+++| ++......
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC---HHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 000000 00000 000000011111112111 235679999999999999999999998 56555443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=346.31 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=198.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|...++||+|.||+|+++..+ +++.+|||.+.+.. ..+.+..+.|.+++... +||++++++.+|...++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457999999999999999999987 58899999887643 34456678888888877 59999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+.||++..+.+.. .+++..++.++..|+.||.|||++ +|||||||-+|||+|.+|++||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999955444432 699999999999999999999999 9999999999999999999999999999854
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
-. .....++.+|||.|||||++.+..|+.++|+|||||++|||+.|..||.+.+.++ ....+...+ ...|
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----~FdsI~~d~---~~yP 588 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----VFDSIVNDE---VRYP 588 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHhcCC---CCCC
Confidence 32 2224578999999999999999999999999999999999999999998765221 222222211 1111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM 1127 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~ 1127 (1176)
... ..+.+.++.++|..+|++|..+
T Consensus 589 ~~l---------s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 RFL---------SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred Ccc---------cHHHHHHHHHHhccCcccccCC
Confidence 111 1245569999999999999976
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.79 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=207.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECC--C---CEEEEEEeec---cCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD--G---STVAIKKLIH---ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
++....++||+|+||.||+|+++. + ..||||.... .......+|.+|.++|+.++|||||+++|++...+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445556899999999999998763 2 2378887763 2334456799999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+|||+|+||+|.++++..+. .++..++..++.+.|+||+|||++ ++|||||.++|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999998753 589999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ .....-...|+|||.+....|+.++|||||||++||+++ |..||.+.. ..+....+.....
T Consensus 311 ~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-----~~~v~~kI~~~~~--- 380 (474)
T KOG0194|consen 311 AGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-----NYEVKAKIVKNGY--- 380 (474)
T ss_pred CCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-----HHHHHHHHHhcCc---
Confidence 54311111 111224578999999999999999999999999999999 888987543 1112222211111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
........|. .+..++.+||..+|++||||.++.+.++.+......++
T Consensus 381 -r~~~~~~~p~------~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 381 -RMPIPSKTPK------ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred -cCCCCCCCHH------HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence 1111112221 23447789999999999999999999999987766543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.87 Aligned_cols=245 Identities=23% Similarity=0.290 Sum_probs=200.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999986 68999999885432 123456888999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997654 688999999999999999999999 999999999999999999999999999876532
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............. .++..
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~--~~~~~- 220 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFGIYEKILAGKL--EFPRH- 220 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCc--CCCcc-
Confidence 1 123568999999999999899999999999999999999999997543 1222222222211 01111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||.+||+ +++++++
T Consensus 221 ---~~------~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 ---LD------LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CC------HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 13557999999999999995 8887766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=351.95 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=203.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEE------CCCCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL------KDGSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
.++|++.+.||+|+||.||+|++ .++..||||++.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999974 235689999885432 22345688999999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccc----------------------------------------------------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKK---------------------------------------------------------- 952 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 952 (1176)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975321
Q ss_pred -------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 953 -------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 953 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012578999999999999999999999 9999999999999999999999999999865433222
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+. .... .+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~---~~~~-----~~~~~~~ 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMI---KEGY-----RMLSPEC 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHH---HhCc-----cCCCCCC
Confidence 12223345678999999999999999999999999999998 88898654321 1112221 1111 0001111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+ .++.+++.+||+.||++|||+.|+++.|++.
T Consensus 342 ~~------~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 AP------SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC------HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11 2456799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=342.20 Aligned_cols=200 Identities=29% Similarity=0.422 Sum_probs=175.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+++++ +|..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999987 57888888775432 2234568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.... .+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997654 5889999999999999999999863 6999999999999999999999999998755322
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 23456899999999999989999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.26 Aligned_cols=265 Identities=24% Similarity=0.364 Sum_probs=215.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC-HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+....+.++||+|.||.|.++....+..||||++...+... .++|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44567889999999999999999888999999997654443 47899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|++|+|.+++..+... ....+...+|+.|||.|++||.+. ++||||+.+.|+|+|.++++||+|||+++-+...+
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999887532 245566778999999999999999 99999999999999999999999999999776666
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc--CCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT--GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.+.......-..+|||||.+.-++++.++|||+||+++||+++ ...||.... +++.++.............+.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~~~l--- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQVVL--- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcceec---
Confidence 6655555666789999999999999999999999999999865 788986543 222333333222222222221
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
...+....+ +.+++..||..|.++||+++++...|.+.
T Consensus 767 -~~P~~cp~~---lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -SRPPACPQG---LYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -cCCCcCcHH---HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112222223 34699999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=366.19 Aligned_cols=266 Identities=27% Similarity=0.441 Sum_probs=212.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECC--CC----EEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD--GS----TVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
.+.+..+.||+|+||.||.|...+ |. .||+|++.+. +.+...+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345667899999999999998753 43 4899988664 3445678999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhcccc---CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
+++|||.+|+|..++++.+.. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999877322 23588999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
|+.+...+.+.......-...|||||.++.+.++.|+|||||||++||++| |..||...+ ...+...+..-.+...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHHHHhCCccCCC
Confidence 996655444333222223468999999999999999999999999999999 999986543 11122211111111111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
...|. .+.+++.+||+.+|++||++..+++.+..+....-.+
T Consensus 927 --------~~CP~------~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 927 --------SYCPE------KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred --------CCCCh------HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 11222 3446999999999999999999999999988665443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=337.50 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=199.4
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.|+..+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.++++++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999875 78999999886432 1223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886543 22589999999999999999999999 9999999999999999999999999999765332
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............. ..+.
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~--~~~~---- 225 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKEDQ--EEYS---- 225 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhhccc--ccCC----
Confidence 21 234578999999999999999999999999999999999999997654211 1111111111100 0111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++||+ +++++++
T Consensus 226 ~~~s------~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 EKFS------EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCC------HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1111 13456999999999999997 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=351.10 Aligned_cols=261 Identities=25% Similarity=0.416 Sum_probs=203.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
++|.+.+.||+|+||.||+|++. ++..||+|++...... ....+.+|+.+++.+ +|||||++++++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46889999999999999999753 2457999988643222 234578999999999 899999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccc-----------------------------------------------------------
Q 046275 932 LLVYEYMRYGSLEDVLHNQKK----------------------------------------------------------- 952 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 952 (1176)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999865321
Q ss_pred -------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccccc
Q 046275 953 -------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025 (1176)
Q Consensus 953 -------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 1025 (1176)
...++++.++++++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 012478899999999999999999999 9999999999999999999999999999765432222122233
Q ss_pred ccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHH
Q 046275 1026 AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEI 1104 (1176)
Q Consensus 1026 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1176)
.+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ....... ..+......+
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~---~~~~~~~-----~~~~~~~~~~---- 341 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF---YKMVKRG-----YQMSRPDFAP---- 341 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH---HHHHHcc-----cCccCCCCCC----
Confidence 45678999999998899999999999999999997 999987543211 11 1111111 0111111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1105 ELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1105 ~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 342 --~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 --PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23556999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=344.14 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=195.9
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999876 68999999886432 222345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
+|.+++...+ .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 9999997654 689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCc
Q 046275 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101 (1176)
Q Consensus 1022 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1176)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. ......+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~------~~p~~~~- 219 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEI------RFPRTLS- 219 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCC------CCCCCCC-
Confidence 244579999999999999999999999999999999999999996543 1112222211111 1111111
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1102 IEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1102 ~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+.+++.+||+.||++|| ++.+++++
T Consensus 220 -----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 220 -----PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -----HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1355699999999999999 79999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=344.96 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=200.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888999999999999999986 58999999886432 223456889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999998654 578899999999999999999999 999999999999999999999999999976533
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. ++
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~--~p--- 235 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEKILAGRLK--FP--- 235 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHHHhcCCcC--CC---
Confidence 21 23579999999999999999999999999999999999999986432 11222222222110 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||.+||+ ++++++|
T Consensus 236 -~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 -NWFD------GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1011 13457999999999999997 6777766
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.68 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=204.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEee--ccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++.|++.+.||+|+|+.||++.+. +|+.+|+|.+. +.+..+.+++.+|+++-+.++|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356788889999999999999765 68999988773 234446778999999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 1012 (1176)
|+|+|++|..-+-.+. .+++..+-.++.||+++|+|+|.+ +|||||+||+|+++.. .-.+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999987665442 588899999999999999999999 9999999999999953 34599999999998
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
+... ......+|||+|||||+.+..+|+.++|||+.||++|-++.|++||...+. ....+.+..+.. .++
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~rlye~I~~g~y--d~~ 232 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYEQIKAGAY--DYP 232 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HHHHHHHhcccc--CCC
Confidence 7732 223567899999999999999999999999999999999999999975431 222233333221 233
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.-|..... .+.+++++||..||.+|.|+.|+++|
T Consensus 233 ~~~w~~is~------~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SPEWDTVTP------EAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcccCcCCH------HHHHHHHHHhccChhhhccHHHHhCC
Confidence 333332222 34569999999999999999998765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=344.60 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=202.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++..++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999987 58999999986432 223456788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997654 588999999999999999999999 999999999999999999999999999975543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC-cc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD-PE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1094 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .......... ..+. +.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~--~~~~~~~ 221 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----ETWENLKYWK--ETLQRPV 221 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----HHHHHHHhcc--ccccCCC
Confidence 123457999999999999989999999999999999999999999754311 1111111100 0010 10
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....... ....+.+++.+||..+|++||++++++++
T Consensus 222 ~~~~~~~---~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFN---LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccc---cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001 11245569999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=323.55 Aligned_cols=268 Identities=28% Similarity=0.398 Sum_probs=202.4
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe-----eEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE-----RLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lV 934 (1176)
.|+..+++|.|+||.||+|... +++.||||+..... +.-.+|+++|+.++|||||+++-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3566789999999999999875 57999999986422 233579999999999999999998865332 2489
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeecccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLM 1013 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~ 1013 (1176)
||||+. +|.+.++..-..+..++...++-+..||++|++|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 99999986544455788899999999999999999998 99999999999999975 89999999999988
Q ss_pred ccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh--------c
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA--------K 1084 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~--------~ 1084 (1176)
...+.. ..+..|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+ ....+...++... .
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhh
Confidence 766554 34456889999999876 479999999999999999999999998754 2223333332221 1
Q ss_pred cccc--cccCcccccCCC---chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhC
Q 046275 1085 LKIS--DVFDPELMKEDP---NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAG 1140 (1176)
Q Consensus 1085 ~~~~--~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 1140 (1176)
+... +.-.|.+..... .....-.+.++++.+++..+|.+|.++.|++++ +.+++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111 111122211110 000112245679999999999999999999876 5555533
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.70 Aligned_cols=265 Identities=23% Similarity=0.263 Sum_probs=199.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999987 57889999886432 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++++.+..+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987666544322 2588999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH-----------h-hc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ-----------H-AK 1084 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~-----------~-~~ 1084 (1176)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+. ....... . ..
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhcc
Confidence 22 122345789999999999988899999999999999999999999975432110 1000000 0 00
Q ss_pred cccccccCcccccCCCchH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIE----IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+.......... .--..+.+++.+||+.||++|||++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000000 011246789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=346.28 Aligned_cols=260 Identities=19% Similarity=0.194 Sum_probs=197.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
..+|++.+.||+|+||.||+|++. +++.||+|+.. ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999876 68899999642 23567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+. ++|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 68998887653 588999999999999999999999 99999999999999999999999999997543222
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc---HHHHHHHhhc-cccccccC-
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN---LVGWVKQHAK-LKISDVFD- 1092 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~- 1092 (1176)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.. .......... +.....+.
T Consensus 237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 A-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred c-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1 1223457999999999999989999999999999999999999887543211100 0000000000 00000000
Q ss_pred -----------------cccccCCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 -----------------PELMKEDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 -----------------~~~~~~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.......+... ..-..+.+++.+||+.||++|||++|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000011100 112246679999999999999999999975
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=357.76 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=203.2
Q ss_pred CCCCCceEeEeCceEEEEEEEC-C-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-D-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.|.+.+.||+|+||.||+|... + ++.||+|++..........+.+|+.+++.++|||||++++++..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999765 3 5778888765443333456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.++++.......++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999875433344689999999999999999999999 999999999999999999999999999986643322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .............. + ....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~~~----~-~~~~ 294 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYGKYD----P-FPCP 294 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC----C-CCcc
Confidence 222345679999999999999999999999999999999999999986533 12222222222111 0 0011
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||++||++++++++
T Consensus 295 ~s------~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 295 VS------SGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC------HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11 235669999999999999999998754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=350.30 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=211.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCC-CEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCccccee-EEee------CC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDG-STVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLG-YCKV------GE 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~ 929 (1176)
..++++.++|.+|||+.||.|.+..+ ..||+|++...++...+.+.+|+++|+.|+ |+|||.+++ .... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35678889999999999999998765 999999998877777888999999999997 999999999 3321 24
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
++++.||||.||.|-|++..+... .|++.++++|+.|+++|+++||.. .++|||||||-+|||++.++..||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 678999999999999999876543 599999999999999999999997 46799999999999999999999999999
Q ss_pred cccccccc-ccccc------cccccCCcccCcccc---CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 046275 1010 ARLMSAMD-THLSV------STLAGTPGYVPPEYY---QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV 1079 (1176)
Q Consensus 1010 a~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~ 1079 (1176)
|.-.-... ..... -....|+.|+|||++ .+...++|+|||+|||+||-++....||+....-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 86322111 11100 123579999999987 5778999999999999999999999999754210
Q ss_pred HHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1080 KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
.+..++. ..|........+.+||..||++||++||++.+|+.++-+++...-+-.
T Consensus 265 -aIlng~Y----------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 265 -AILNGNY----------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred -eEEeccc----------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 1111111 111112233456679999999999999999999999999986654433
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=333.97 Aligned_cols=263 Identities=26% Similarity=0.434 Sum_probs=209.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999752 345688888765544445678999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccc---------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 934 VYEYMRYGSLEDVLHNQKK---------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
||||+++++|.+++...+. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+|+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 9999999999999976532 122489999999999999999999999 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |+.||..... ........
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~~~~~~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIECIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 99999976543332222233446788999999998889999999999999999998 8999865431 11222222
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
...... .....+ ..+.+++.+||+.+|.+|||+.++.+.|+++...+
T Consensus 237 ~~~~~~-----~~~~~~------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGRVLQ-----RPRTCP------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCcCC-----CCCCCC------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 221111 111111 23567999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=342.68 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=199.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECC--CCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD--GSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|.+.+.||+|+||.||+|+++. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468899999999999999998653 3689999885432 22345678899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+.+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998654 689999999999999999999999 99999999999999999999999999997653
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. .+++.
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~i~~~~~--~~p~~ 250 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQKILEGII--YFPKF 250 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHHHHhcCCC--CCCCC
Confidence 21 134579999999999998889999999999999999999999997543 1111222222111 11111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
. + ..+.+++.+|++.||++|+ ++++++++
T Consensus 251 ~----~------~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 L----D------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----C------HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 1 1345699999999999995 88888876
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=336.32 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=211.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe-eEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE-RLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 935 (1176)
++|...+.+|+|+||.++.++++ ++..+|+|++.... ....+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999887 68899999986433 3334467889999999999999999999998888 89999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
+|++||++.+.+.+++ +.-++++.+..++.|++.|+.|||+. .|+|||||+.||+++.++.||++|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999876 45799999999999999999999988 999999999999999999999999999998876
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ...+..|||.||.||.+.+.+|..|+||||+||++|||++-+++|...+ +...+..+.... ++|-
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~----~~Pl- 226 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL----YSPL- 226 (426)
T ss_pred chh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc----CCCC-
Confidence 542 2356789999999999999999999999999999999999999987654 333333322222 1111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .....+..+|..|++.+|+.||++.+++.+
T Consensus 227 p~------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PS------MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Cc------cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 122245569999999999999999999987
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=337.26 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=174.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+|+++ ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999987 57788888775432 2233568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++...+ .+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997654 5888999999999999999999852 7999999999999999999999999998755322
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 13456899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=332.80 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=198.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999876 688999998864322 2345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++ +|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 9999887553 2578899999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh------------c
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA------------K 1084 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~------------~ 1084 (1176)
. ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||...+... .+........ .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccc
Confidence 1 1234568999999999865 568999999999999999999999997643211 0110000000 0
Q ss_pred cccccccCcccc-----cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELM-----KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+... ...+.. -....+++.+||+.||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRL---DTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCC---CHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000111100 000111 1235679999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=325.17 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=209.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|++++++++||||+++++++.+....++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999876 689999998754222 22346788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999875443334688999999999999999999999 999999999999999999999999999886543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... +...+......... .+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~~ 229 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIEQCDY----PPLP 229 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHhcCCC----CCCC
Confidence 221 12345688999999999888899999999999999999999999865432 12223222221111 1111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
... ....+.+++.+||+.+|++||++.+|++.+++++
T Consensus 230 ~~~------~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 TEH------YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhh------cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111 1124567999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=338.75 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=195.2
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
+.||+|+||.||+++.+ +|+.||+|++.... ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999876 68999999986432 223345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 9999887654 689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCc
Q 046275 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101 (1176)
Q Consensus 1022 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1176)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........... .++ ...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~--~~p----~~~~- 219 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEI--RFP----RTLS- 219 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC--CCC----CCCC-
Confidence 23457999999999999989999999999999999999999999654311 11111111111 011 1111
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1102 IEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1102 ~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+.+++.+||+.||++|| ++.+++++
T Consensus 220 -----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 220 -----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1345699999999999998 89988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.06 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=201.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|.++ .+..||+|.+..... ...+.+.+|+.++++++||||+++++++..+...++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999764 356899998864322 2235688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999997643 2689999999999999999999999 99999999999999999999999999876432
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
... ........++..|+|||++.+..++.++|||||||++||+++ |+.||..... ....+...... ..
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~~~~-----~~ 227 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAVEDGF-----RL 227 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHCCC-----CC
Confidence 211 111122345678999999999999999999999999999875 9999865431 12222222111 11
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
......| ..+.+++.+||+.+|++||+++++.+.|+++
T Consensus 228 ~~~~~~~------~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PAPRNCP------NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCC------HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111112 1355699999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.97 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=202.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|+++++..+|+|.+.. .....+++.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEeccc-CCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 35788899999999999999998888999998753 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999997543 2588999999999999999999999 9999999999999999999999999998765332211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...+ ..+.......... ...+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~--~~~~~~--- 225 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISRGFR--LYRPKL--- 225 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCCCC--CCCCCC---
Confidence 1122345678999999988889999999999999999999 899986543 1222222222111 111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
. ...+.+++.+||+.+|++||+++++++.|
T Consensus 226 ~------~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 A------SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C------CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 12456799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=344.46 Aligned_cols=263 Identities=23% Similarity=0.393 Sum_probs=205.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcC-CCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIK-HRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 930 (1176)
.++|.+.+.||+|+||.||+|++. .+..||||++...... ..+.+.+|++++++++ ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467889999999999999999863 1346999988643322 2456889999999996 9999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc---------------------------------------------------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV--------------------------------------------------------- 953 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 953 (1176)
.|+||||+++|+|.++++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999998754210
Q ss_pred -----------------------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 046275 954 -----------------------------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE 998 (1176)
Q Consensus 954 -----------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 998 (1176)
...+++..+..++.|+++|+.|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12478888999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHH
Q 046275 999 NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 999 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~ 1077 (1176)
++.+|++|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~-- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TF-- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HH--
Confidence 99999999999986543322222233457788999999998899999999999999999997 999986532111 11
Q ss_pred HHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1078 WVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1078 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
....... .........+ ..+.+++.+||+.||++|||+.++.++|+++..
T Consensus 350 -~~~~~~~-----~~~~~~~~~~------~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 -YNKIKSG-----YRMAKPDHAT------QEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHHHhcC-----CCCCCCccCC------HHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111111 0111111111 245679999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=331.92 Aligned_cols=266 Identities=24% Similarity=0.301 Sum_probs=198.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|.+.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999987 689999998864332 223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 58888886543 2588899999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---ccc----
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---KIS---- 1088 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~---- 1088 (1176)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+.......... .+.
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1 12234568999999999865 4578899999999999999999999975431111111111100000 000
Q ss_pred -cccCcccc-cCCCchHH-------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 -DVFDPELM-KEDPNIEI-------ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 -~~~~~~~~-~~~~~~~~-------~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.++.. ...+.... ....+.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00011100 00010000 01245679999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=313.48 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=206.2
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
|.+.++||+|+||.||||.++ .|+.+|+|++.. ..+.+++..|+.+|++.+.|+||++||.|......|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 456679999999999999876 699999998853 34567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+..|.++.+.+ ++++.++..++...+.||+|||.. .-||||||+.|||++-+|.+|++|||.|..+.+ +-.
T Consensus 113 GSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 113 GSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999987653 799999999999999999999998 789999999999999999999999999976542 333
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
...+..|||.|||||+++.-.|+.++||||+|++..||..|++||....... ...-++..-+|.+.+ |
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------AIFMIPT~PPPTF~K--P 252 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------AIFMIPTKPPPTFKK--P 252 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------eeEeccCCCCCCCCC--h
Confidence 3467789999999999999999999999999999999999999987543211 011111112222221 2
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.....+-+|+++||-..|++|.|+-++++|
T Consensus 253 --E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 --EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1233456789999999999999999998876
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=353.50 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=205.0
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-----
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE----- 929 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 929 (1176)
..++|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.++..++|+|++++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999875 68999999885432 223446788999999999999999988765432
Q ss_pred ---eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 930 ---ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 930 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
..++||||+++|+|.++++........+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 36899999999999999987654455789999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ............
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~~~ 261 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLAGR 261 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcCC
Confidence 999987654322222345679999999999999999999999999999999999999996543 222332222221
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .+++ ..+ ..+.+++.+||+.||.+||++.+++++
T Consensus 262 ~~-~~~~----~~~------~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YD-PLPP----SIS------PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC-CCCC----CCC------HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 1111 111 135569999999999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=337.95 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=196.1
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999876 68999999986432 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 9999987654 689999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCc
Q 046275 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101 (1176)
Q Consensus 1022 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1176)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ............ .+++ ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~--~~p~----~~~- 219 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDI--KFPR----TLS- 219 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCc--cCCC----CCC-
Confidence 2345799999999999988999999999999999999999999965431 122222211111 1111 111
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1102 IEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1102 ~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+.+++.+||+.||++|| ++.+++++
T Consensus 220 -----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 -----ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1345699999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=314.79 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=201.5
Q ss_pred CCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|++.+.||.|.-|+||+++.++ +..+|+|++.+..... ..+...|-+||+.++||.++.+|+.|+.+...++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 5567899999999999999874 6899999996543332 34567799999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc-
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM- 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~- 1016 (1176)
|+||+|..+.+++. +..+++..++.++.+++-||+|||.. |||+|||||+|||+.++|++-++||.++......
T Consensus 159 CpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred CCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999998775 45799999999999999999999999 9999999999999999999999999986433110
Q ss_pred --------------------------------ccc---------------------ccccccccCCcccCccccCCCCCC
Q 046275 1017 --------------------------------DTH---------------------LSVSTLAGTPGYVPPEYYQSFRCS 1043 (1176)
Q Consensus 1017 --------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~ 1043 (1176)
... ......+||..|+|||++.+..++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011235699999999999999999
Q ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCC
Q 046275 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWR 1123 (1176)
Q Consensus 1044 ~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 1123 (1176)
.++|+|+|||++|||+.|+.||.+.+... +....... . ..+.. .+ .-...+.++|++.|..||++
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~----Tl~NIv~~-~------l~Fp~-~~---~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE----TLRNIVGQ-P------LKFPE-EP---EVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchh----hHHHHhcC-C------CcCCC-CC---cchhHHHHHHHHHhccChhh
Confidence 99999999999999999999998765322 22221111 1 11111 11 12345678999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 046275 1124 RPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1124 RPt~~evl~~L~~i 1137 (1176)
|...+.=+++++++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 99943333344433
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=338.35 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=203.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhc-CCCCcccceeEEee-CCe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKI-KHRNLVPLLGYCKV-GEE 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 930 (1176)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.+++++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999642 3578999988543222 234577899999999 89999999998764 456
Q ss_pred eEEEEeeccCCCHHHHHhhcccc---------------------------------------------------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV--------------------------------------------------------- 953 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 953 (1176)
.++||||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999998653210
Q ss_pred CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccC
Q 046275 954 GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033 (1176)
Q Consensus 954 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 1033 (1176)
..++++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12689999999999999999999999 999999999999999999999999999987644332222234456788999
Q ss_pred ccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHH
Q 046275 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHV 1112 (1176)
Q Consensus 1034 PE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1112 (1176)
||++.+..++.++|||||||++|||++ |+.||...... ..+ .......... ..... ....+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~---~~~~~~~~~~-----~~~~~------~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEF---CRRLKEGTRM-----RAPEY------ATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHH---HHHHhccCCC-----CCCcc------CCHHHHHH
Confidence 999999999999999999999999998 99998653321 111 1111111110 00010 11245679
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1113 ASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1113 i~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
+.+||+.+|++||++.|++++|+++.+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=330.23 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=204.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|.+.+.||+|+||.||+|+..+ ++.||+|.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998643 478999988654333 3467899999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccc----------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 933 LVYEYMRYGSLEDVLHNQKK----------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
+||||+++|+|.++++..+. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999976531 123578999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
|++|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||...+. ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EEVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Confidence 9999999875533222111233446788999999999999999999999999999998 9999865431 122222
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
........ .....+ ..+.+++.+||+.||++|||++|+++.|+
T Consensus 237 ~~~~~~~~-----~~~~~~------~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQ-----RPRTCP------SEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCC-----CCCCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 22222111 011111 24567999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.55 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=203.9
Q ss_pred CCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
+|++.+.||+|+||.||+|.... ...|++|.+..... ....++.+|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57888999999999999998653 25789998754322 223568899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 046275 934 VYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 1001 (1176)
+|||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 99999999999999764221 13588999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 046275 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1002 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~ 1080 (1176)
+||+|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~~~~ 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QEVIE 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence 99999999976544333222334456889999999988899999999999999999998 9999875431 11222
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
........ ......+ ..+.+++.+||+.||.+||++.+|+++|+.
T Consensus 238 ~i~~~~~~-----~~~~~~~------~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLL-----PCPEDCP------ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcC-----CCcccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 22221111 1111112 245679999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=336.30 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=193.4
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||+|+||.||+|++. +++.||+|++... .......+.+|+.++++++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999986 5889999988643 223345678899999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 99997654 589999999999999999999999 999999999999999999999999999875432221 224
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. ......+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~------~~~~~~~--- 217 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPL------RFPDGFD--- 217 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCC------CCCCcCC---
Confidence 4579999999999999999999999999999999999999996532 2222222222111 1111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRPT---MIQVMAM 1133 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt---~~evl~~ 1133 (1176)
..+.+++.+||+.||++||+ +.+++++
T Consensus 218 ---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 ---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 13456999999999999975 6666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.52 Aligned_cols=250 Identities=33% Similarity=0.514 Sum_probs=191.7
Q ss_pred CCceEeEeCceEEEEEEEC-----CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 864 NDSLIGSGGFGDVYKAKLK-----DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.+.||.|+||.||+|++. .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999887 256799998854322 2356799999999999999999999999988889999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.++++... ...+++.++..++.||++||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 23689999999999999999999999 89999999999999999999999999998663322
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.........+...|+|||.+....++.++||||||+++||+++ |+.||...+ ...+........... ..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~~~~~~~~~~~~-----~~ 227 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEIIEKLKQGQRLP-----IP 227 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHHHHHHHTTEETT-----SB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccccccce-----ec
Confidence 2222234456789999999988889999999999999999999 788875432 222222222221111 11
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
...+ ..+.+++.+||+.+|++|||+.++++.|
T Consensus 228 ~~~~------~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCP------KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSB------HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchh------HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111 1345699999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=327.47 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=208.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
..+|++.+.||.|+||.||+|.+++++.+++|.+.........++.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999999889999999987655545677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++.... +..+++.++..++.|++.|++|||+. +|+||||||+||++++++.+|++|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998653 33689999999999999999999999 899999999999999999999999999976543211
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
......++..|+|||++....++.++||||||+++|+|++ |+.||...+ . .......... ..+....
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~---~~~~~~~~~~-----~~~~~~~ 227 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--N---HEVYDQITAG-----YRMPCPA 227 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--H---HHHHHHHHhC-----CcCCCCC
Confidence 1123346778999999988889999999999999999998 899986543 1 1111111111 1111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
..+ ..+.+++.+|++.||++|||++++++.|+.+
T Consensus 228 ~~~------~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 228 KCP------QEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111 2355799999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=331.07 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=208.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778899999999999999753 345688888765444445678999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccc------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 046275 934 VYEYMRYGSLEDVLHNQKK------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 1001 (1176)
||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999976432 123489999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 046275 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1002 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~ 1080 (1176)
+|++|||++................+++.|+|||++.+..++.++||||||+++|||+| |+.||...+. .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 99999999976543322222234456788999999998899999999999999999999 9999865431 11222
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
........+ .....+ ..+.+++.+||+.+|++|||+++|++.|+++.+.
T Consensus 237 ~~~~~~~~~-----~~~~~~------~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQGRVLE-----RPRVCP------KEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCCCCCC-----CCccCC------HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 222221111 111111 2456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.82 Aligned_cols=263 Identities=26% Similarity=0.276 Sum_probs=203.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC--HHHHHHHHHHHHhcCCCCcccceeEEee--CCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG--DREFTAEMETIGKIKHRNLVPLLGYCKV--GEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 934 (1176)
++|+..+.|++|.||.||+|+++ +++.||+|++....... .-.-.+|+.++.+++|||||.+-++... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45888899999999999999987 68899999986432111 2235789999999999999999998754 4579999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
||||+. +|.++++..+ .++...+++.++.|+++|++|||.. .|+|||+||+|+|++..|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 9999998775 4799999999999999999999999 89999999999999999999999999999887
Q ss_pred cccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh---hccccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH---AKLKISDV 1090 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~ 1090 (1176)
..-. .++..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....++ +...++.. ....++..
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCc
Confidence 6432 34566779999999998764 689999999999999999999998877543221 11111111 11111111
Q ss_pred cCcc--------------cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPE--------------LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... +.+..+... --..-++++...+..||.+|.|+.|.+++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111 111111110 01234679999999999999999999987
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=325.31 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=205.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.++||+|+||.||+|...++..||+|++... ....+.+.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 468889999999999999999888889999987542 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.++++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.........
T Consensus 85 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999997643 23688999999999999999999998 9999999999999999999999999999865432211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||++....++.++|||||||++|+|++ |+.||..... . .......... .......
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~---~~~~~~~~~~-----~~~~~~~ 228 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--S---DVMSALQRGY-----RMPRMEN 228 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--H---HHHHHHHcCC-----CCCCCCC
Confidence 1123345678999999988889999999999999999998 9999865321 1 1111111111 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+ ..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 229 ~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 229 CP------DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CC------HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11 2356699999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=328.38 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=203.0
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
+.++|++.+.||+|+||.||+|.++ ++..||+|++..... ....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999764 256799998753221 223468899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
.++||||+++|+|.+++...+.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999764321 12467889999999999999999998 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence 99999876543322222223345788999999998889999999999999999999 788886432 112222222
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
...... .....+ ..+.+++.+|++.+|++|||+.|+++.+++
T Consensus 236 ~~~~~~-----~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLD-----KPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCC-----CCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 211111 111111 245679999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=338.70 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=175.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|+.++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999876 58899999886432 222345788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999998654 689999999999999999999999 999999999999999999999999999875432
Q ss_pred cccc---------------------------------ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCC
Q 046275 1016 MDTH---------------------------------LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062 (1176)
Q Consensus 1016 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 1062 (1176)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 046275 1063 RPTDSA 1068 (1176)
Q Consensus 1063 ~P~~~~ 1068 (1176)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=337.40 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=195.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----CeeE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EERL 932 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 932 (1176)
+|++.+.||+|+||.||+|+++ +|+.||+|++... .......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999876 6899999988642 222345688999999999999999999987543 2479
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 69999987654 589999999999999999999999 999999999999999999999999999975
Q ss_pred cccccc-cccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHH----------
Q 046275 1013 MSAMDT-HLSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV---------- 1079 (1176)
Q Consensus 1013 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~---------- 1079 (1176)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+... .....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~ 230 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPE 230 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHH
Confidence 432211 111234578999999999865 578999999999999999999999996543110 00000
Q ss_pred --HHhhccc-------cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1080 --KQHAKLK-------ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1080 --~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....... .............+... ..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNAD---PLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCC---hHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 00000000000011111 234579999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.95 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=211.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++|+|++++++++..+...++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999887 78999999875322 222457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.........+++.++..++.+++.|++|||+. +|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999976544445689999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .+.............. +..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~----~~~ 229 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYP----PLP 229 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCC----CCC
Confidence 221 1133468889999999998889999999999999999999999986543 2222222222221111 100
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
... ....+.+++.+||+.+|++|||+.+|++.++++++
T Consensus 230 ~~~------~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 230 ADH------YSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred hhh------cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 001 11245679999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=333.50 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=202.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC----EEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS----TVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.+|++.+.||+|+||.||+|++. +++ .||+|.+.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 35889999999999999999864 333 38888875432 23345788999999999999999999998764 5789
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998653 2588999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~---~- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGER---L- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhCCCC---C-
Confidence 54333222223345678999999999999999999999999999998 999986432 1112211111110 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
+. ....+ ..+.+++.+||+.+|++||++.++++.+.++.+..
T Consensus 231 ~~-~~~~~------~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 PQ-PPICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CC-CCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00 01111 23556999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.33 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=209.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+.. +++.++||++..... ....++.+|+.+++.++||||+++++++..+...++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999865 789999998754322 22346888999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++.........+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999976443344689999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ...+.+....... +..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~-----~~~ 228 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCDY-----PPL 228 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhcCCC-----CCC
Confidence 221 123446889999999998888999999999999999999999998654322 1222222211111 111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
... .....+.+++.+||+.+|++|||+.+|++.++++.+
T Consensus 229 ~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 267 (267)
T cd08229 229 PSD-----HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267 (267)
T ss_pred Ccc-----cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhcC
Confidence 100 011245679999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.35 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=202.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC----cCH----HHHHHHHHHHHhc-CCCCcccceeEEeeCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG----QGD----REFTAEMETIGKI-KHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 929 (1176)
+.|.-.+.+|.|..++|..+.++ +|..+|+|++..... +.. +.-.+|+.+++++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777789999999999988765 689999998854221 112 2356799999998 6999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++|+|.|+.|.|+|++...- .++++..++|++|+.+|++|||.. .|||||+||+|||+|++..+||+|||.
T Consensus 97 F~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999998653 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
|+.+.+.+. ....+|||+|.|||.++. ..|+..+|+|++||++|-++.|.+||..... .-+...+.
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----mlMLR~Im 241 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----MLMLRMIM 241 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HHHHHHHH
Confidence 998765443 467899999999999853 3678899999999999999999999864320 11112233
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++. +.-.|+ |.+ ....+.++|.+||+.||.+|.|++|+++|
T Consensus 242 eGky-qF~spe-Wad------is~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 242 EGKY-QFRSPE-WAD------ISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hccc-ccCCcc-hhh------ccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 3322 111222 221 22245579999999999999999999987
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=363.66 Aligned_cols=482 Identities=28% Similarity=0.339 Sum_probs=380.1
Q ss_pred ccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEE
Q 046275 123 SLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLA 202 (1176)
Q Consensus 123 ~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~ 202 (1176)
.+|+|++++.-.+..+ -.-..++.|++++|-+-..|-.....+-+|+.||+|+|+++. +|.. ...+.+|+.|+
T Consensus 2 ~vd~s~~~l~~ip~~i---~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~---fp~~-it~l~~L~~ln 74 (1081)
T KOG0618|consen 2 HVDASDEQLELIPEQI---LNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS---FPIQ-ITLLSHLRQLN 74 (1081)
T ss_pred CcccccccCcccchhh---ccHHHHHhhhccccccccCchHHhhheeeeEEeecccccccc---CCch-hhhHHHHhhcc
Confidence 4677777776443322 222338888888887666554444555568899999998876 3332 25567888888
Q ss_pred eCCCcccc-cccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCcc
Q 046275 203 LKGNKVTG-DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPI 281 (1176)
Q Consensus 203 L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 281 (1176)
++.|-|.. +....++++|++|.|.+|.+..+|.++..+.+|++|+++.|++. .+|..+..+..+..+..++|.-....
T Consensus 75 ~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l 153 (1081)
T KOG0618|consen 75 LSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL 153 (1081)
T ss_pred cchhhHhhCchhhhhhhcchhheeccchhhcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh
Confidence 88888876 45567788888888888888888888888888888888888887 56677888888888888888221110
Q ss_pred CCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcc
Q 046275 282 PVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND 361 (1176)
Q Consensus 282 p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~ 361 (1176)
+ . ..++.++|..|.+.+.++..+.+++. .|+|++|.+. .+. ...+.+|+.|....|+
T Consensus 154 g----------------~-~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~d---ls~~~~l~~l~c~rn~ 210 (1081)
T KOG0618|consen 154 G----------------Q-TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLD---LSNLANLEVLHCERNQ 210 (1081)
T ss_pred c----------------c-ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhh---hhhccchhhhhhhhcc
Confidence 0 0 23788999999999888888888877 7999999986 333 4678899999999999
Q ss_pred cCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCC
Q 046275 362 FTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441 (1176)
Q Consensus 362 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 441 (1176)
+... --..++|+.|+.++|.++...+. ....+|+++++++|+++ .+|++++.+.+|+.|+..+|+|+ .+|
T Consensus 211 ls~l----~~~g~~l~~L~a~~n~l~~~~~~----p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp 280 (1081)
T KOG0618|consen 211 LSEL----EISGPSLTALYADHNPLTTLDVH----PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALP 280 (1081)
T ss_pred cceE----EecCcchheeeeccCcceeeccc----cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhH
Confidence 8732 22347899999999999843332 23467999999999999 56799999999999999999997 889
Q ss_pred ccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCC-CCeeeccccccCCCCCcccc--C
Q 046275 442 SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTN-LNWISLSNNHLGGEIPTWIG--Q 518 (1176)
Q Consensus 442 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~--~ 518 (1176)
..+....+|+.|.+..|.+. -+|+....+++|++|+|..|+|...++..|.-+.. |+.|+.+.|++. ..| .++ .
T Consensus 281 ~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp-~~~e~~ 357 (1081)
T KOG0618|consen 281 LRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLP-SYEENN 357 (1081)
T ss_pred HHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccc-cccchh
Confidence 99999999999999999999 78888999999999999999999444444444444 888999999998 444 233 3
Q ss_pred CCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCc
Q 046275 519 LSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL 598 (1176)
Q Consensus 519 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (1176)
++.|+.|++.+|.++...=+.+-+...|+.|+|++|++. ++|+..+..
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~k------------------------------- 405 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRK------------------------------- 405 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhc-------------------------------
Confidence 678999999999999888888999999999999999996 688765432
Q ss_pred hhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCc
Q 046275 599 LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPT 678 (1176)
Q Consensus 599 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~ 678 (1176)
+..|+.|+||+|+|+ .+|.++.++..|++|...+|++. ..|
T Consensus 406 ------------------------------------le~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP- 446 (1081)
T KOG0618|consen 406 ------------------------------------LEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP- 446 (1081)
T ss_pred ------------------------------------hHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-
Confidence 235778999999999 89999999999999999999999 888
Q ss_pred cccCcCcccEEEccCccccc-cCCCCccccccccccccccccc
Q 046275 679 EVGDLRGLNILDLSSNRLEG-TIPSSMSSLTLLNEIDLCNNQL 720 (1176)
Q Consensus 679 ~~~~L~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~l~ls~N~l 720 (1176)
++..+++|+.+|||.|+|+- .+|...-. +.|++|||++|.-
T Consensus 447 e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence 89999999999999999974 34444333 8899999999974
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=341.40 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=195.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.|++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999876 58899999986532 2233568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999998654 588999999999999999999999 9999999999999999999999999997543110
Q ss_pred ccc---------------------------------------------ccccccccCCcccCccccCCCCCCchhhhHHH
Q 046275 1017 DTH---------------------------------------------LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSY 1051 (1176)
Q Consensus 1017 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 1051 (1176)
... .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 00123469999999999998899999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHH--hccCCCCCCCCHHH
Q 046275 1052 GVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASA--CLDDRPWRRPTMIQ 1129 (1176)
Q Consensus 1052 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dp~~RPt~~e 1129 (1176)
||++|||++|+.||...+... ...........-.+++. ... . .++.+++.+ |+..+|..||++++
T Consensus 235 G~il~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~--~~~---s---~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTE-----TQLKVINWENTLHIPPQ--VKL---S---PEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHH-----HHHHHHccccccCCCCC--CCC---C---HHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999997543111 11111100000000100 001 1 134457777 55666667999999
Q ss_pred HHHH
Q 046275 1130 VMAM 1133 (1176)
Q Consensus 1130 vl~~ 1133 (1176)
+++|
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.03 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=204.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|++.+.||+|+||.||+|.+.+++.||+|.+... ....+++.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4568889999999999999999887888999987543 234567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++.... +..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997653 34689999999999999999999999 999999999999999999999999999987653211
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. .......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ........... . .....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~-~----~~~~~ 227 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQVDQGY-R----MPCPP 227 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC-C----CCCCC
Confidence 1 1111223457999999998899999999999999999999 9999865321 11111111111 0 00011
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.. ...+.+++.+|++.+|++||+++++++.|++
T Consensus 228 ~~------~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GC------PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cC------CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11 1245679999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=354.75 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=204.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.++||+|+||.||+|++. +|+.||+|++...... ..+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999886 5899999998643222 2356889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccc-------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 936 EYMRYGSLEDVLHNQKK-------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
||++||+|.+++..... .....++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999875321 123467788899999999999999999 99999999999999999999999999
Q ss_pred cccccccccc----------------cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 046275 1009 MARLMSAMDT----------------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD 1072 (1176)
Q Consensus 1009 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~ 1072 (1176)
+++....... ........||+.|+|||++.+..++.++||||+||++|||+||+.||...+...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001123469999999999999999999999999999999999999997533111
Q ss_pred ccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhhCC
Q 046275 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-TMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~ 1141 (1176)
. .+..... . .....+ ....| ..+.+++.+|++.||++|| +++++++.|+...+..
T Consensus 239 i---~~~~~i~--~-P~~~~p--~~~iP------~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 I---SYRDVIL--S-PIEVAP--YREIP------PFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred h---hhhhhcc--C-hhhccc--cccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 0000000 0 000000 01111 1345689999999999996 6777788888886643
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.85 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=201.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC----EEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS----TVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||.||+|++. +++ .+++|++..... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35778899999999999999875 344 366776643222 12345777888899999999999999875 455788
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997653 2589999999999999999999999 8999999999999999999999999999866
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............++..|+|||++.+..++.++|||||||++||+++ |+.||..... ............. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~--~~ 232 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLLEKGERL--AQ 232 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCcC--CC
Confidence 54333323344567789999999998899999999999999999998 9999865431 1111111111111 01
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
+.. .+ ..+.+++.+||..+|++|||+.|+++.+..+....+
T Consensus 233 ~~~---~~------~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 233 PQI---CT------IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred CCC---CC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 111 11 134558999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=333.63 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=194.7
Q ss_pred ceEeEeCceEEEEEEEC----CCCEEEEEEeeccC----CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 866 SLIGSGGFGDVYKAKLK----DGSTVAIKKLIHIS----GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 58999999999999863 57899999886422 22234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999997654 578889999999999999999999 99999999999999999999999999987432222
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ............ .+++.+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~~--~~~~~~-- 223 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGKL--NLPPYL-- 223 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC--CCCCCC--
Confidence 1 12345799999999999988899999999999999999999999975431 122222222111 111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
+ ..+.+++.+||+.||++|| ++++++++
T Consensus 224 --~------~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 224 --T------PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --C------HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 1355799999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=331.40 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=211.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcC---HHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQG---DREFTAEMETIGKIK-HRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 932 (1176)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+..... ...+.+|+.+|+++. |||||.++++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578889999999999999999874 9999999997654433 357999999999998 999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEEeec
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN----FEARVSDFG 1008 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG 1008 (1176)
+|||++.||.|++.+... .+++..+..++.|++.++.|||+. +|+|||+||+|+++... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999865 289999999999999999999998 99999999999999543 479999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||........ ...+..+++
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-----~~~i~~~~~- 255 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-----FLAILRGDF- 255 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-----HHHHHcCCC-
Confidence 9998765 2335678999999999999999999999999999999999999999976542211 112333332
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++...|..... .+-+++..|+..||.+|+|+.++++|
T Consensus 256 -~f~~~~w~~is~------~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPWDDISE------SAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCccccCH------HHHHHHHHhcccCcccCCCHHHHhcC
Confidence 233344433322 34569999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.83 Aligned_cols=268 Identities=25% Similarity=0.402 Sum_probs=209.8
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHh--cCCCCcccceeEEeeCC----ee
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGK--IKHRNLVPLLGYCKVGE----ER 931 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~ 931 (1176)
...+..+.+.||+|.||.||+|++. |+.||||.+.. .+++.+.+|.++.+. ++|+||..+++.-..+. ..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3456778899999999999999997 99999999864 345667778777776 49999999999765443 57
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN-----CIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
|+|.+|.+.|||+|++.+. .++....++++..+|.||+|||.+ +.|.|.|||||+.|||+..++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999975 689999999999999999999964 568899999999999999999999999
Q ss_pred eccccccccccc--cccccccccCCcccCccccCCC------CCCchhhhHHHHHHHHHHHc----C------CCCCCCC
Q 046275 1007 FGMARLMSAMDT--HLSVSTLAGTPGYVPPEYYQSF------RCSTKGDVYSYGVVLLELLT----G------KRPTDSA 1068 (1176)
Q Consensus 1007 fGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~ellt----g------~~P~~~~ 1068 (1176)
+|+|-....... .......+||.+|||||++... ..-..+||||||.|+||+.. | +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 999987655422 2233567899999999998543 11236899999999999874 2 4577665
Q ss_pred CCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1069 DFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
-..+.++.++.+..-..++. |.+.... ...+.+..+.++++.||..+|..|-|+-.+-+.|.++..
T Consensus 440 Vp~DPs~eeMrkVVCv~~~R----P~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLR----PNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhcceeecccC----CCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 55555555554433322222 2222211 122356677789999999999999999999999998875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=335.76 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=198.0
Q ss_pred CCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccC----CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHIS----GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
+|++.+.||+|+||+||+++.. +++.||+|.+.+.. ....+.+.+|+.+++.+ +||+|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999763 58899999886422 12234577899999999 599999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999997654 588999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ............
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~----- 226 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRILKC----- 226 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHhcC-----
Confidence 65332221 12345799999999999765 47889999999999999999999997543221 111121211111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
++......+ ..+.+++.+||+.||++|| ++++++++
T Consensus 227 -~~~~~~~~~------~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -DPPFPSFIG------PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCCCC------HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111111 1345699999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.07 Aligned_cols=270 Identities=24% Similarity=0.313 Sum_probs=204.2
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCC-cccceeEEeeCC------e
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRN-LVPLLGYCKVGE------E 930 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 930 (1176)
.|...++||+|+||+||+|+.+ +|+.||+|++...... ......+|+.++++++|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4555678999999999999876 6899999999754432 3456789999999999999 999999998877 7
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++|+||++. +|.+++.........++...++.++.||++||+|||++ +|+||||||.||+++++|.+|++|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999976 99999987764323466688999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh---ccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA---KLK 1086 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~ 1086 (1176)
+...-... ..+...+|..|.|||++.+. .|+...||||+|||++||++++.-|.+....+ .+........ ...
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCccC
Confidence 96653222 24566789999999999776 78999999999999999999988887644211 1111111111 111
Q ss_pred cccc-----cCcccccCC-CchHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 046275 1087 ISDV-----FDPELMKED-PNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEI 1137 (1176)
Q Consensus 1087 ~~~~-----~~~~~~~~~-~~~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i 1137 (1176)
++.. +.+...... +.... ......+++.+|++.+|.+|.|++.+++| +.++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111 111111111 11000 01245689999999999999999999987 5544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.55 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=203.7
Q ss_pred cCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|+++. ...||+|.+..... ....++.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998752 45789998754322 2345688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++..... .+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999976532 689999999999999999999998 99999999999999999999999999998765
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... . ............. +
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~---~~~~~~~~~~~~~----~ 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--N---QDVIKAVEDGYRL----P 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--H---HHHHHHHHcCCCC----C
Confidence 2222222223345678999999998899999999999999999998 999985432 1 1112222111100 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.....+ ..+.+++.+|++.+|++||++.+++++|+++
T Consensus 229 -~~~~~~------~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -PPMDCP------SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011111 2456799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=336.47 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=194.6
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
+.||+|+||.||++++. +|+.||+|.+.... ......+.+|+++++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 68999999986432 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
+|.+++...+ .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 9999887654 68999999999999999999997 6 899999999999999999999999999875322211
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ............ .++ ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~~--~~p----~~~~ 220 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEI--RFP----RTLS 220 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCCC--CCC----CCCC
Confidence 22345799999999999998999999999999999999999999965431 112222111111 011 1111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+.+++.+||+.||++|+ ++++++++
T Consensus 221 ------~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 221 ------PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ------HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1345699999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=339.91 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+++++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999986 68999999986432 223345788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999998654 589999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccc------------------------------------cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHH
Q 046275 1016 MDTHL------------------------------------SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1059 (1176)
Q Consensus 1016 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 1059 (1176)
..... ......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11100 001246999999999999989999999999999999999
Q ss_pred cCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 046275 1060 TGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT---MIQVMAM 1133 (1176)
Q Consensus 1060 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~evl~~ 1133 (1176)
+|+.||...+. .............-.++.. .+ .. ..+.+++.+|+. +|.+|++ +++++++
T Consensus 234 ~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~----~~-~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNP-----QETYRKIINWKETLQFPDE----VP-LS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCH-----HHHHHHHHcCCCccCCCCC----CC-CC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999975431 1111111111100001111 00 11 134568888996 9999998 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.62 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=201.5
Q ss_pred cCCCCCceEeEeCceEEEEEEE-----CCCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL-----KDGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.+|++.+.||+|+||+||+|+. .++..|++|.+..... .....+.+|+.++++++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577889999999999999985 2467899998864322 223568899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccc-------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 046275 934 VYEYMRYGSLEDVLHNQKK-------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF 1000 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 1000 (1176)
||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 122478999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHH
Q 046275 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWV 1079 (1176)
Q Consensus 1001 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~ 1079 (1176)
.+|++|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----NQEVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Confidence 999999999976543322222233456778999999988889999999999999999998 999986532 11122
Q ss_pred HHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1080 KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
......... ......+ ..+.+++.+|++.||++||++.++.++++.
T Consensus 237 ~~~~~~~~~-----~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLL-----PCSEDCP------PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcC-----CCCCCCC------HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 221111111 1111111 135569999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=341.91 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=202.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+|++. +|+.||+|++.... ......+.+|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999987 68999999986432 233456888999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998663 689999999999999999999998 999999999999999999999999999976543
Q ss_pred cc---------------------------ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1016 MD---------------------------THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1016 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 001123457999999999999999999999999999999999999999754
Q ss_pred CCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 046275 1069 DFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-MIQVMAM 1133 (1176)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-~~evl~~ 1133 (1176)
.. ...............++... ..+ ..+.+++.+|+. ||.+||+ +++++++
T Consensus 234 ~~-----~~~~~~i~~~~~~~~~p~~~--~~~------~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TL-----QETYNKIINWKESLRFPPDP--PVS------PEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CH-----HHHHHHHhccCCcccCCCCC--CCC------HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 31 11111111100000011100 011 234568999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=345.10 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=196.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--------C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--------E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 929 (1176)
..+|.+.+.||+|+||+||+|... +++.||||++... .....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999875 6899999988532 23345799999999999999999876432 2
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeec
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFG 1008 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG 1008 (1176)
..++||||+++ ++.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 88888765443445789999999999999999999999 999999999999998664 69999999
Q ss_pred cccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc---
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK--- 1084 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~--- 1084 (1176)
+|+....... .....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.... ..+.........
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence 9986543222 234578999999999865 46899999999999999999999999764321 111111111100
Q ss_pred ------------cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHh
Q 046275 1085 ------------LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138 (1176)
Q Consensus 1085 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 1138 (1176)
..........+....|.. .-..+.+++.+||+.||.+|||+.|+++| ++.++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~--~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKG--TPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccC--CCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000000000010000100 11246789999999999999999999977 45544
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=325.94 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=193.9
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||+|+||+||++.++ +|+.||+|++...... ..+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999876 6899999998643221 224567899999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988865433344689999999999999999999999 999999999999999999999999999876543222 123
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ .......+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~--- 225 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDS------VTYPDKFS--- 225 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccC------CCCcccCC---
Confidence 45789999999999999999999999999999999999999975432111 111111111100 00111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+.+++.+||+.||++|| |+++++++
T Consensus 226 ---~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 ---PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2355699999999999999 66666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=342.34 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=196.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999876 68999999886432 222356788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997654 588999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccc---------------------------------------------cccccccCCcccCccccCCCCCCchhhhHH
Q 046275 1016 MDTHL---------------------------------------------SVSTLAGTPGYVPPEYYQSFRCSTKGDVYS 1050 (1176)
Q Consensus 1016 ~~~~~---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 1050 (1176)
..... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 10000 001246999999999999989999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCC---CCH
Q 046275 1051 YGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRR---PTM 1127 (1176)
Q Consensus 1051 lGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---Pt~ 1127 (1176)
|||++|||++|+.||...+. ........... ..+ ..... ... ...+.+++.+|+. +|.+| +|+
T Consensus 234 lGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~--~~~--~~p~~-~~~---s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS-----HETYRKIINWR--ETL--YFPDD-IHL---SVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH-----HHHHHHHHccC--Ccc--CCCCC-CCC---CHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999965431 11111111100 000 00000 000 1235569999997 66665 699
Q ss_pred HHHHHH
Q 046275 1128 IQVMAM 1133 (1176)
Q Consensus 1128 ~evl~~ 1133 (1176)
.|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=337.45 Aligned_cols=253 Identities=28% Similarity=0.347 Sum_probs=199.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457999999999999999999886 58899999886421 22334577899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998754 478888999999999999999999 99999999999999999999999999997654
Q ss_pred cccccccccccccCCcccCccccCCC----CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSF----RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ......+......-.
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSLT 267 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCcCC
Confidence 3221 112345799999999998653 478899999999999999999999975432 112222211111001
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~ 1133 (1176)
++. .+.. -..+.+++.+||+.+|++ |||+++++++
T Consensus 268 ~~~-----~~~~---s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-----DIEI---SKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-----cCCC---CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 0011 124556999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=326.44 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=203.3
Q ss_pred CCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
+|++.+.||+|+||.||+|+... ...+++|.+..... ...+++.+|+.+++.++||||+++++++..+...++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998642 24677777654322 223568899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccc--------------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 046275 934 VYEYMRYGSLEDVLHNQKK--------------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSN 993 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 993 (1176)
|+||+.+|+|.+++..... ...++++.+++.++.|++.|++|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999875321 123588999999999999999999998 99999999999
Q ss_pred EEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 046275 994 VLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGD 1072 (1176)
Q Consensus 994 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 1072 (1176)
|++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999976543332222233456778999999988889999999999999999998 999986432
Q ss_pred ccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
........... .........+ ..+.+++.+|++.+|++||+++++++.|+++..+
T Consensus 235 --~~~~~~~~~~~-----~~~~~~~~~~------~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 --PERLFNLLKTG-----YRMERPENCS------EEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHHHHHHhCC-----CCCCCCCCCC------HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11222111111 1111111111 2456799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=332.90 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=193.3
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|+.++.++ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 57899999886532 22334577888888776 899999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 99999887654 689999999999999999999999 999999999999999999999999999875322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC---CccHHHHHHH-hhccccccccCcccc
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG---DNNLVGWVKQ-HAKLKISDVFDPELM 1096 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~ 1096 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+... ...... .++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p---- 225 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIP---- 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCC----
Confidence 123457999999999999999999999999999999999999999642211 1112222211 111111 011
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPT------MIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt------~~evl~~ 1133 (1176)
... ...+.+++.+||+.||++||| +.++++|
T Consensus 226 ~~~------~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 226 RSL------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCC------CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111 123557999999999999998 4677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.80 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=203.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
+|++.+.||+|+||.||+|.++ +++.||+|.+.. ......++.+|++++++++||||+++++++..+...++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4778889999999999999876 588899998753 33345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+|++|||++.........
T Consensus 86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999997643 23589999999999999999999999 9999999999999999999999999999765432211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......+++.|+|||++.+..++.++|||||||++|||++ |..||...+. .......... ..+.....
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~~~ 229 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKG-----YRMERPEG 229 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC-----CCCCCCCC
Confidence 1122334678999999998899999999999999999998 9999865431 2222222111 11111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+ ..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~------~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 230 CP------PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC------HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12 2456699999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.78 Aligned_cols=252 Identities=26% Similarity=0.410 Sum_probs=201.5
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|++.++..+|+|.+... .....++.+|+.++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357888999999999999999887778999987643 2345678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++..... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++........
T Consensus 83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999976432 589999999999999999999999 9999999999999999999999999998765432211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ............. ..+..
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~--~~~~~--- 225 (256)
T cd05113 157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SETVEKVSQGLRL--YRPHL--- 225 (256)
T ss_pred -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHhcCCCC--CCCCC---
Confidence 1122345678999999988889999999999999999999 9999864331 1111111111110 00110
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
. ...+.+++.+||+.+|.+|||+.++++.++
T Consensus 226 ~------~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 A------SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C------CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1 124567999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=331.67 Aligned_cols=242 Identities=26% Similarity=0.359 Sum_probs=193.5
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||+||+|+++ +++.||+|++... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999986 5889999988642 223345567888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 99999987654 689999999999999999999999 99999999999999999999999999987532211 1
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. ..+. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~---~~~~---~~~ 220 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDEV---VYPT---WLS 220 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCCC---CCCC---CCC
Confidence 2234579999999999999899999999999999999999999997543 1222222222111 0111 011
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTM------IQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~------~evl~~ 1133 (1176)
..+.+++.+||+.||++||++ ++++++
T Consensus 221 ------~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 221 ------QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ------HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 135679999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=330.48 Aligned_cols=241 Identities=27% Similarity=0.372 Sum_probs=189.6
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|++. +++.||+|.+.... ....+.+..|..++... +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 57899999886432 22234456677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 99999997654 689999999999999999999999 99999999999999999999999999997543222 1
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ........... +......+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~------~~~~~~~~ 220 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDR------PHFPRWIS 220 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC------CCCCCCCC
Confidence 22455799999999999998999999999999999999999999975431 11222211111 11111111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMI-QVMA 1132 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~-evl~ 1132 (1176)
..+.+++.+||+.||++||++. ++++
T Consensus 221 ------~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 221 ------KEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ------HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1345699999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=331.50 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=194.7
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
++||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|..++.++ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999876 68899999986532 22234578899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 99999987654 689999999999999999999999 99999999999999999999999999987432211 1
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC---CccHHHHH-HHhhccccccccCcccc
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG---DNNLVGWV-KQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~ 1096 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+. +....... .++..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~-- 227 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRS-- 227 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCC--
Confidence 224567999999999999999999999999999999999999999643221 11122222 11111111 01111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPT------MIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt------~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||.+||| +++++++
T Consensus 228 --~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 228 --LS------VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CC------HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 13566999999999999997 6777655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=331.94 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=193.4
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHH---HhcCCCCcccceeEEeeCCeeEEE
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETI---GKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999876 68999999986432 22234566676655 566899999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|..+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888643 589999999999999999999999 99999999999999999999999999987432
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+ .............. +++.
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~~~~--~p~~ 223 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-----EEEVFDSIVNDEVR--YPRF 223 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--CCCC
Confidence 221 12245679999999999999899999999999999999999999997543 12222222221110 1111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||.+|| ++.+++++
T Consensus 224 ----~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 ----LS------REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CC------HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11 1345699999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=336.70 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=198.5
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
...++|++.+.||+|+||.||+|+++ +++.||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.++...|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34568999999999999999999987 57889999885421 223445788999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+|..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999754 478899999999999999999999 999999999999999999999999999986
Q ss_pred cccccccccccccccCCcccCccccCCC----CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSF----RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+. .............
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~ 265 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNS 265 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcc
Confidence 543221 122456799999999998654 378899999999999999999999975431 1122222111100
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~ 1133 (1176)
-.++... .. ...+.+++.+|++.++.+ |||+.|+++|
T Consensus 266 ~~~p~~~-----~~---s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFPEDV-----EI---SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCCCcc-----cC---CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011100 00 113446888899865544 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=335.86 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=191.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+|+..+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566789999999999999876 689999998854322 22456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986432 356678889999999999999999 999999999999999999999999999986543211
Q ss_pred cccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ............. .+
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-----~~ 294 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ-----PP 294 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC-----CC
Confidence 1234579999999998743 23456899999999999999999999743221 1111111111111 01
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...... -..+.+++.+||+.||++|||+.|++++
T Consensus 295 ~~~~~~------~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATA------SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCcc------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1245679999999999999999999987
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=325.38 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=199.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
+|++.+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999875 68999999886422 1223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999887543 23589999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ............. ....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~------~~~~ 225 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVKEDQ------EEYS 225 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhhhcc------cccC
Confidence 21 234468999999999998889999999999999999999999997543211 1111111111100 0111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
... ...+.+++.+||+.||++|| ++++++++
T Consensus 226 ~~~------~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKF------SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccc------CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111 11345699999999999999 78888766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=331.25 Aligned_cols=247 Identities=25% Similarity=0.311 Sum_probs=195.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCC-CCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKH-RNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 935 (1176)
+|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999876 57899999886432 2334567789999999976 56888999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999997654 588999999999999999999999 999999999999999999999999999864322
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+. ............ ..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~~~~------~~ 220 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQSIMEHNV------SY 220 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC------CC
Confidence 111 12345799999999999999999999999999999999999999975431 111222221111 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTM-----IQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~-----~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|++. +++.++
T Consensus 221 ~~~~~------~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 PKSLS------KEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 135569999999999999986 555544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=325.15 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=193.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC--CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhc---CCCCcccceeEEe-----e
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK--DGSTVAIKKLIHISG--QGDREFTAEMETIGKI---KHRNLVPLLGYCK-----V 927 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 927 (1176)
++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999874 467899998854322 2234566788777766 6999999999885 2
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 599999976432 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..............
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCC
Confidence 999765432 1224457899999999998888999999999999999999999999764321 11111110000000
Q ss_pred ccccC------cccc-cCCCchHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 SDVFD------PELM-KEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~~~~~------~~~~-~~~~~~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+..+ .... ...+.... .-..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 0000 00000000 01234579999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=336.99 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=203.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCcC-HHHHHHHHHHHHhcC-CCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQG-DREFTAEMETIGKIK-HRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 931 (1176)
++|.+.+.||+|+||.||+|++. .+..||+|++....... .+.+.+|++++.++. |||||++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46788899999999999999864 34689999986532222 346889999999997 99999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccc-----------------------------------------------------------
Q 046275 932 LLVYEYMRYGSLEDVLHNQKK----------------------------------------------------------- 952 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 952 (1176)
++||||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred -----------------------------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 953 -----------------------------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 953 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
....+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 012367888999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 1076 (1176)
+++.+|++|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---- 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---- 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence 999999999999976533222112233457889999999998889999999999999999998 899986543111
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
.......... .+......+ ..+.+++.+||+.+|++||+++++++.|+++.
T Consensus 350 ~~~~~~~~~~-----~~~~p~~~~------~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFYNAIKRGY-----RMAKPAHAS------DEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCC-----CCCCCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111 111111111 24567999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=319.40 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=200.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..+...++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46999999999999999999975 68889999886554445566888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.++++..+ ++++..+..++.|++.|+.|||+. +|+|||+||+||+++.++.+|++|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999997553 588999999999999999999999 999999999999999999999999999976532211
Q ss_pred cccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
......|++.|+|||.+. ...++.++||||+||++|||++|+.||........ ....... ....+..
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-----~~~~~~~---~~~~~~~ 231 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LFLMSKS---NFQPPKL 231 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-----heeeecC---CCCCCCC
Confidence 113446889999999874 34578899999999999999999999854321110 0000000 0011111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.. ... ....+.+++.+||+.+|++|||++++++++
T Consensus 232 ~~-~~~---~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD-KTK---WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc-ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 001 112456799999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=321.61 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=209.3
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC---CCC--EEEEEEeec-cCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK---DGS--TVAIKKLIH-ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
..++..+..++||.|.||.||+|... .|+ .||||..+. ......+.|..|..+|+.++|||||+++|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34445666789999999999999864 344 477776654 344556779999999999999999999999864 57
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+|||.++-|.|..+++..+. .++......++.||..||+|||+. .+|||||.++|||+.....||++|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 8999999999999999987753 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
+.+.....+.. +...-...|||||.+.-..++.++|||.|||.+||++. |..||.+-...+. + +.+..
T Consensus 539 R~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------I--~~iEn 607 (974)
T KOG4257|consen 539 RYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------I--GHIEN 607 (974)
T ss_pred hhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------E--EEecC
Confidence 98876544332 33344668999999999999999999999999999887 9999987543321 1 11111
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.-........|. .+..++.+||+.+|.+||++.++...|.++....
T Consensus 608 GeRlP~P~nCPp------~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 608 GERLPCPPNCPP------ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCCCCCCCCCh------HHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 111222233333 2345899999999999999999999999887643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=322.08 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=198.6
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||+|+||.||+++.+ +|+.||+|++.... ....+.+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999876 58999999885422 12234456799999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 998875542 3588999999999999999999999 99999999999999999999999999987654322 123
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
...|++.|+|||++.+..++.++||||+||++|||++|+.||....... ............... .. ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~----~~----~~~~- 222 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVK----FE----HQNF- 222 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccc----cc----cccC-
Confidence 4568999999999998889999999999999999999999986533111 111111111111110 00 0001
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
...+.+++.+||+.||++||+++|+++.+.......+
T Consensus 223 --~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 223 --TEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred --CHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 1135679999999999999999888877666554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=327.99 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=204.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC--------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 929 (1176)
++|.+.+.||+|+||.||+|++. ++..+|+|.+.... .....++.+|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46899999999999999999753 23568999876432 22345688899999999 7999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
..|+||||+++|+|.+++...+.. ...+++.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999999999999865321 23589999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 1076 (1176)
+++.+|++|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||.... ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----~~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VE 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----HH
Confidence 999999999999876543222111122234578999999988889999999999999999998 888885432 22
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
........... ....... ...+.+++.+|++.+|++|||+.++++.|+++.+.
T Consensus 250 ~~~~~~~~~~~-----~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLLKEGHR-----MDKPSNC------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHcCCC-----CCCCCcC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 22222221111 0111111 12455699999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.52 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=204.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
.++|++.+.||+|+||.||+|.... ...+|+|.+.... ......+.+|+++++++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3568889999999999999998642 3578888875422 22334688899999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcc------------ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 046275 931 RLLVYEYMRYGSLEDVLHNQK------------KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE 998 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 998 (1176)
.++||||+++|+|.++++... .....+++..++.++.|++.|++|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999997532 2234689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHH
Q 046275 999 NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 999 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~ 1077 (1176)
++.+|++|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~ 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VEE 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----HHH
Confidence 99999999999987654332222223345678999999988899999999999999999998 999986433 111
Q ss_pred HHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1078 WVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1078 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
........... ...... ...+.+++.+|++.+|++|||++|+++.|+.+.
T Consensus 243 ~~~~~~~~~~~-----~~~~~~------~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGYRM-----EKPQNC------TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCCcC-----CCCCCC------CHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 22221111110 011111 124567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=320.95 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=200.1
Q ss_pred CCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe-----
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE----- 930 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 930 (1176)
|.+.+.||+|+||.||+|.+.. +..||+|++..... .....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998752 36799998864322 223568899999999999999999998866554
Q ss_pred -eEEEEeeccCCCHHHHHhhccc--cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 931 -RLLVYEYMRYGSLEDVLHNQKK--VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 931 -~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
.++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865431 223689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... . .+.........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~---~~~~~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--N---HEIYDYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--H---HHHHHHHHcCC
Confidence 99986644332222223345678999999988889999999999999999999 888886432 1 12222222111
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.. ...... ...+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ~~-----~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RL-----KQPEDC------LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-----CCCcCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 111111 12456799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=334.13 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=200.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+|+.+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999876 689999999865322 23456788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999998753 2689999999999999999999999 999999999999999999999999999986643
Q ss_pred ccccccccccccCCcccCccccC------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQ------SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..............
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQRFL 228 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCCcc
Confidence 3222 223457899999999986 45678899999999999999999999965431 11222211111000
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++ ..+... ..+.+++.+|++ +|.+|||+++++++
T Consensus 229 ~~~-----~~~~~~---~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFP-----EDPKVS---SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC-----CCCCCC---HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 011 011111 234568899998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=326.33 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=202.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+|++.+.||+|+||.||+|++. +++.|++|.+..........+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888999999999999999875 68999999887655555667889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998643 478899999999999999999999 999999999999999999999999999876533221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.... ......... ...
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~~-~~~~~~~~~---~~~ 241 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIA-TNGTPELQN---PEK 241 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHHh-cCCCCCCCC---ccc
Confidence 123446889999999998888899999999999999999999999654321 1111111 111100000 010
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ...+.+++.+||+.+|++|||+.+++++
T Consensus 242 ~------~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 L------SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred c------CHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1 1235569999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=328.54 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=190.5
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|+++ +|+.||+|.+.... ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999987 58899999886432 22334566788787754 899999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 99999987653 588999999999999999999999 999999999999999999999999999874322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ........... +......+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~~------~~~~~~~~ 220 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVDT------PHYPRWIT 220 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC------CCCCCCCC
Confidence 12456799999999999999999999999999999999999999965431 12222211111 11111111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMI-QVMA 1132 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~-evl~ 1132 (1176)
..+.+++.+||+.||++||++. ++++
T Consensus 221 ------~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 221 ------KESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ------HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1345699999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=327.23 Aligned_cols=241 Identities=26% Similarity=0.353 Sum_probs=190.8
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|+++ +++.||+|.+.... ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999986 57899999886431 22334566788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 99999997653 588999999999999999999999 999999999999999999999999999874322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ............ .+++. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~~--~~~~~----~~ 220 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIRMDNP--CYPRW----LT 220 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC--CCCcc----CC
Confidence 12345789999999999998999999999999999999999999975431 112221111110 01111 11
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMI-QVMA 1132 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~-evl~ 1132 (1176)
..+.+++.+||+.||++||++. ++.+
T Consensus 221 ------~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 221 ------REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ------HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1345699999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=326.02 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=207.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC--------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVG 928 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 928 (1176)
.++|.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356888999999999999999742 24578888875432 23346788999999999 899999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
...|+||||+++|+|.+++...... ...+++.++..++.|++.||.|||+. +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999999999999865321 23578899999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNL 1075 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~ 1075 (1176)
++++.+|++|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence 9999999999999986654333222233446778999999998889999999999999999998 788875432 2
Q ss_pred HHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1076 VGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
..+.......... ......+ ..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 246 ~~~~~~~~~~~~~-----~~~~~~~------~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 EELFKLLKEGHRM-----DKPANCT------NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHcCCcC-----CCCCCCC------HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 2333222211110 0111111 23556999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=330.68 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=201.7
Q ss_pred cCCCCCceEeEeCceEEEEEEE------CCCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeC-Ce
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL------KDGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVG-EE 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 930 (1176)
++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4689999999999999999974 2478899998864322 2235688899999999 689999999987654 56
Q ss_pred eEEEEeeccCCCHHHHHhhcccc---------------------------------------------------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV--------------------------------------------------------- 953 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 953 (1176)
.++||||+++|+|.++++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999999753210
Q ss_pred ------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccccccc
Q 046275 954 ------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG 1027 (1176)
Q Consensus 954 ------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 1027 (1176)
...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12478889999999999999999999 999999999999999999999999999976543222222233446
Q ss_pred CCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHH
Q 046275 1028 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIEL 1106 (1176)
Q Consensus 1028 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1106 (1176)
++.|+|||++.+..++.++||||||+++|+|++ |..||....... ........... .......+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~-----~~~~~~~~------ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTR-----MRAPDYTT------ 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccCC-----CCCCCCCC------
Confidence 678999999988889999999999999999997 999986543211 11111111110 00000011
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1107 LQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1107 ~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
..+.+++.+||+.+|++|||+.|++++|+++.+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1356789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=337.91 Aligned_cols=262 Identities=22% Similarity=0.232 Sum_probs=196.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
..+|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999886 47889999642 23457899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+. ++|.+++.... ..+++.+++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 69998886543 2689999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC--CccH-HHHHHHhhccccc-cccCc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG--DNNL-VGWVKQHAKLKIS-DVFDP 1093 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~--~~~~-~~~~~~~~~~~~~-~~~~~ 1093 (1176)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+...... .... ....+........ ..+.+
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 221223457999999999999999999999999999999999988765432211 1111 1111111111110 00000
Q ss_pred c----c--------------ccCCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 E----L--------------MKEDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~----~--------------~~~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. + ....+... .--..+.+|+.+||+.||++|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0 00000000 001135679999999999999999999986
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=330.23 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=193.8
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
++||+|+||.||+|+++ +++.||+|.+.... ....+.+..|.+++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999886 57899999886432 22334577888888866 799999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 99999987654 688999999999999999999999 999999999999999999999999999875432211
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. ..+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~~~---~~p~~---~~ 220 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHDDV---LYPVW---LS 220 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCC---CCCCC---CC
Confidence 2234579999999999999899999999999999999999999997543 1122222222111 01110 11
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRP-------TMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RP-------t~~evl~~ 1133 (1176)
..+.+++.+||+.||++|| ++.+++++
T Consensus 221 ------~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 221 ------KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1355799999999999999 78888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.25 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=194.0
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
+.||+|+||.||+|+++ +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999876 68899999875432 22345688999999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++...+ ..+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+|++|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997543 2588999999999999999999999 99999999999999999999999999987543211111111
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCch
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNI 1102 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1102 (1176)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... . ......... . ........+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~---~~~~~~~~~-~----~~~~~~~~~-- 222 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--Q---QTREAIEQG-V----RLPCPELCP-- 222 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--H---HHHHHHHcC-C----CCCCcccCC--
Confidence 1223457999999998889999999999999999998 8888864321 1 111111111 0 111111111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1103 EIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1103 ~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
..+.+++.+|++.+|++|||+.++++.|+
T Consensus 223 ----~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 ----DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 24567999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.60 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=200.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-----CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-----GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47889999999999999999875 6899999987543211 22467889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+++++|.+++...+ .+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999997654 578899999999999999999999 9999999999999999999999999998765
Q ss_pred cccccccc-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLS-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
........ .....|+..|+|||++.+..++.++||||+|+++|||++|+.||.... ....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~-~~~~~~~---- 225 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----AMAAIFK-IATQPTN---- 225 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----hHHHHHH-HhccCCC----
Confidence 43221111 123467889999999999889999999999999999999999986432 1111111 1111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+......+ ..+.+++.+||..+|++|||+.+++++
T Consensus 226 ~~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQLPSHVS------PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCccCC------HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111111 134569999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.96 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=200.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
+++|.+.+.||+|+||.||+|.+.. +..|++|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999998753 5678888765332 22345688999999999999999999999998999
Q ss_pred EEEEeeccCCCHHHHHhhcccc---CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEE
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF---EARVS 1005 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 1005 (1176)
++||||+++|+|.++++..+.. ...+++.+++.++.||+.|++|||+. +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999765421 23589999999999999999999999 899999999999998654 59999
Q ss_pred eeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~~ 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVMEFVTG 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHc
Confidence 9999986533222111122334568999999998899999999999999999997 99998754321 12222111
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
.... ......+ ..+.+++.+|++.+|++|||+.+|+++|.
T Consensus 237 ~~~~-----~~~~~~~------~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGRL-----DPPKGCP------GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCcC-----CCCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1100 0111111 24566999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.19 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=199.7
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+|++.+.||+|+||.||+|+++++..+|+|.+... ......+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47788999999999999999887788999987533 23445788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
++|.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++........
T Consensus 84 ~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 84 GCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999999976432 689999999999999999999999 8999999999999999999999999998765432111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. ......... .........
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~-----~~~~~~~~~ 226 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVESVSAG-----YRLYRPKLA 226 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHHHHcC-----CcCCCCCCC
Confidence 1112234567999999998899999999999999999999 89998654311 111111111 111111111
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
+ .++.+++.+||..+|++|||+.++++.|
T Consensus 227 ~------~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 P------TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C------HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1 2456799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=319.45 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=196.4
Q ss_pred CCCCceEeEeCceEEEEEEECCC-C--EEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------Ce
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKDG-S--TVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------EE 930 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 930 (1176)
|.+.+.||+|+||.||+|++... . .||+|.+... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 45678999999999999987643 3 5888877542 223345688899999999999999999987432 24
Q ss_pred eEEEEeeccCCCHHHHHhhcc--ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 931 RLLVYEYMRYGSLEDVLHNQK--KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
.++||||+.+|+|.+++.... .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885332 1223589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||.... . ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~---~~~~~~~~~~~~ 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--N---SEIYDYLRQGNR 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--H---HHHHHHHHcCCC
Confidence 9987644332211223356778999999999899999999999999999999 888986532 1 112222222111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.. .. ... ...+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 ~~-~~----~~~------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK-QP----PDC------LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CC----CCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 01 111 12356799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=327.30 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=200.4
Q ss_pred ceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHH
Q 046275 866 SLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLE 944 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 944 (1176)
-+||+|.||+||-|++.+ ...+|||.+.....+..+-+..|+..-++++|.|||+++|.+.+++..-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999874 6678999987766666677899999999999999999999999999999999999999999
Q ss_pred HHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEEeecccccccccccccccc
Q 046275 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 945 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
++++..-. +.+-.+.+.-.+-+||++||.|||+. .|||||||.+|||++ -.|.+||+|||-++++..... ...
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE 734 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE 734 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence 99986532 12237888999999999999999999 899999999999996 578999999999987765433 235
Q ss_pred ccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCc
Q 046275 1024 TLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1176)
+..||..|||||++..+ .|+.++|||||||++.||.||++||....... ..+-.. .+.+..|.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AAMFkV-----------GmyKvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AAMFKV-----------GMYKVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hhhhhh-----------cceecCCC
Confidence 67899999999999765 58889999999999999999999996543221 111011 11122222
Q ss_pred hHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1102 IEIE-LLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1102 ~~~~-~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..++..||.+|+.+||.+||++.++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2222 2345679999999999999999999864
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.12 Aligned_cols=244 Identities=30% Similarity=0.432 Sum_probs=199.4
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|.-.+.||.|+||.||.|++. +.+.|||||+.-.. .+...++..|+.++++++|||++.+.|||-.+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444567999999999999876 67899999996433 33356799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|- |+-.|++.-.++ ++.+..+..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|.++.+.
T Consensus 108 Cl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 96 588999887654 788999999999999999999999 8999999999999999999999999999876543
Q ss_pred ccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
..++|||.|||||++. .+.|+-|+||||+|++..|+...++|.... +.......+...+ .|.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----NAMSALYHIAQNe-----sPt 244 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNE-----SPT 244 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----hHHHHHHHHHhcC-----CCC
Confidence 4578999999999984 568999999999999999999999996432 2222222222222 122
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+... .....+..|+..||+.-|++|||.+++++|
T Consensus 245 Lqs~-----eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQSN-----EWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCc-----hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2211 123356789999999999999999998776
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.12 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=204.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
=|...+.||+|.|..|-+|++- +|++||||++.+.. ......+..|+++|+.++|||||++|++...+...|+|+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4677789999999999999875 89999999986532 33345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-CCCCcEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL-DENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~~~ 1016 (1176)
=++|+|+|++.++.. -+.+.-..+++.||++|+.|+|+. .|||||+||+||.+ ..-|-||++|||++-.+.+.
T Consensus 99 GD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999987753 589999999999999999999999 89999999999877 55788999999998766543
Q ss_pred cccccccccccCCcccCccccCCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCST-KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
+ ...+.+|+..|-|||++.+..|+. ++||||+|||+|.+++|+.||+.+...+. .. .+...+.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--LT---mImDCKY-------- 236 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--LT---MIMDCKY-------- 236 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--hh---hhhcccc--------
Confidence 3 357789999999999999988864 78999999999999999999987653321 11 1111110
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..|. .--.++.++|..||..||.+|.+.+||+.+
T Consensus 237 --tvPs--hvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 --TVPS--HVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cCch--hhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 0111 123367789999999999999999998765
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=317.21 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=201.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|..+++..||+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4688899999999999999998888899999886433 34567899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.++++... ...+++.+++.++.|++.|++|||+. +|+||||||+||++++++.++++|||.+.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999997643 23589999999999999999999999 8999999999999999999999999999765432221
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+ ............ .......
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~~ 227 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLEQVERGY-----RMPCPQD 227 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC-----CCCCCCc
Confidence 1122345678999999988889999999999999999999 889986432 112222221111 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.+ ..+.+++.+|++.+|++|||++++.+.|++
T Consensus 228 ~~------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CP------ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CC------HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 246679999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=339.29 Aligned_cols=252 Identities=20% Similarity=0.242 Sum_probs=193.8
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999876 58899999886432 1223467889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.+.+ .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997654 578899999999999999999999 9999999999999999999999999997532110
Q ss_pred cc---------------------------------------------cccccccccCCcccCccccCCCCCCchhhhHHH
Q 046275 1017 DT---------------------------------------------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSY 1051 (1176)
Q Consensus 1017 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 1051 (1176)
.. ........||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 000123469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC---HH
Q 046275 1052 GVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT---MI 1128 (1176)
Q Consensus 1052 Gvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~ 1128 (1176)
||++|||++|+.||...+. ...............++ .. .... ..+.+++.+|+ .+|++|++ ++
T Consensus 235 Gvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~p-~~----~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP-----LETQMKVINWQTSLHIP-PQ----AKLS---PEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH-----HHHHHHHHccCCCcCCC-Cc----ccCC---HHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999999975431 11111111110000000 00 0011 12345666665 59999997 88
Q ss_pred HHHHH
Q 046275 1129 QVMAM 1133 (1176)
Q Consensus 1129 evl~~ 1133 (1176)
++++|
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 88765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=338.40 Aligned_cols=253 Identities=19% Similarity=0.225 Sum_probs=196.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+.. +++.||+|.+.+.. ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 58999999885422 223456788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997654 578899999999999999999999 999999999999999999999999999753210
Q ss_pred ccc-----------------------------------------cccccccccCCcccCccccCCCCCCchhhhHHHHHH
Q 046275 1016 MDT-----------------------------------------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVV 1054 (1176)
Q Consensus 1016 ~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 1054 (1176)
... ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 000123479999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC---CHHHHH
Q 046275 1055 LLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP---TMIQVM 1131 (1176)
Q Consensus 1055 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP---t~~evl 1131 (1176)
+|||++|+.||..... ...............+.. ....+ ..+.+++.+|+ .+|.+|+ |+.+++
T Consensus 234 lyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~--~~~~s------~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTP-----AETQLKVINWETTLHIPS--QAKLS------REASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCH-----HHHHHHHhccCccccCCC--CCCCC------HHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999999975431 111111111110000000 01111 12345777766 5999999 899998
Q ss_pred HH
Q 046275 1132 AM 1133 (1176)
Q Consensus 1132 ~~ 1133 (1176)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 87
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=322.91 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=202.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.+|...+.||+|+||.||+|... ++..+++|.+..........+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35777899999999999999642 356788888765555555679999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhcccc-----------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 934 VYEYMRYGSLEDVLHNQKKV-----------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
||||+++|+|.+++...+.. ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999999765321 12488999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-----TEAIEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-----HHHHHH
Confidence 9999999875543222222223345788999999998899999999999999999998 8999864321 111111
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
....... ......+ ..+.+++.+||+.||++||++++|++.|+
T Consensus 237 ~~~~~~~-----~~~~~~~------~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGREL-----ERPRTCP------PEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccC-----CCCCCCC------HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111110 1111111 13456999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=323.34 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=203.4
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
..++|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999754 245799997753321 223457789999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
.++||||+++|+|.+++...+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999764321 12457788899999999999999999 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...+. .+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 99999886543332222223345778999999998899999999999999999998 7889865331 12222221
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
...... .....+ ..+.+++.+|++.||++|||+.++++.+++..
T Consensus 236 ~~~~~~-----~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGYLD-----QPDNCP------ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCCCC-----CCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111110 111111 24567999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=323.90 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=201.9
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CC--EEEEEEeecc-CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GS--TVAIKKLIHI-SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|..++ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478899999999999999998764 33 4677776532 222345688999999999 799999999999999999999
Q ss_pred EeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 935 YEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
|||+++|+|.++++..... ...+++..++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999999764311 12488999999999999999999998 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||..... ......
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AELYEK 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 99999998643211 11112233567999999988889999999999999999997 9999865431 112222
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.... ..+......+ ..+.+++.+|++.+|.+|||++++++.|+.+....
T Consensus 231 ~~~~-----~~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQG-----YRMEKPRNCD------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcC-----CCCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 1111111111 23557999999999999999999999999988655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=316.01 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=202.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|++|.||+|+.+ +++.|++|.+... .....+.+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999876 6899999987532 233455688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.++++... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998652 23689999999999999999999998 99999999999999999999999999988654332
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+. ............ +....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-----~~~~~ 223 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRGVF-----PPVSQ 223 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC-----CCCcc
Confidence 21 2345688999999999998899999999999999999999999975431 111111111111 11111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ...+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~------~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MY------SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cc------CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 1245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=316.97 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=203.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|++.++||+|+||.||+|..++++.||+|.+... .....++.+|+.++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 3568889999999999999999888999999988643 334567899999999999999999999874 45689999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
.+|+|.+++.... +..+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999987543 33689999999999999999999998 999999999999999999999999999876542221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||...+ . ........... ......
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~---~~~~~~~~~~~-----~~~~~~ 226 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--N---PEVIQNLERGY-----RMPRPD 226 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--h---HHHHHHHHcCC-----CCCCCC
Confidence 1 1123345778999999988889999999999999999999 999986533 1 11121111111 111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
..+ .++.+++.+|++.+|++|||++++++.|+.
T Consensus 227 ~~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCP------EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC------HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 246679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=321.41 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=206.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC-----CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEee-CCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD-----GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKV-GEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 931 (1176)
.++|.+.+.||+|+||.||+|.+.. +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999998865 6788888875432 2234568889999999999999999998765 5678
Q ss_pred EEEEeeccCCCHHHHHhhcccc----CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKV----GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
++++||+++|+|.+++...... +..+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999765322 14689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|+++.+...+.........++..|+|||++.+..++.++||||||+++||+++ |+.||...+ ...+........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~ 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLKDGY 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHcCC
Confidence 99986544333222233456778999999988889999999999999999999 999986432 122222222111
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
........+ ..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 237 -----~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 -----RLAQPINCP------DELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----CCCCCCcCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111111 135679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=321.68 Aligned_cols=267 Identities=27% Similarity=0.401 Sum_probs=199.2
Q ss_pred CCCCceEeEeCceEEEEEEE-----CCCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEE
Q 046275 862 FHNDSLIGSGGFGDVYKAKL-----KDGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLL 933 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 933 (1176)
|.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 3578899998864322 2345688999999999999999999987653 46789
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++... .+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999754 489999999999999999999999 9999999999999999999999999999866
Q ss_pred cccccccc-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH-Hhhcccccccc
Q 046275 1014 SAMDTHLS-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK-QHAKLKISDVF 1091 (1176)
Q Consensus 1014 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 1091 (1176)
........ .....++..|+|||++....++.++||||||+++|||++|+.||............... ........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 44322111 12234566799999998888999999999999999999999998653311111110000 00000000000
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
+.......+.. ....+.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~~~~~~~~--~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKN--CPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCC--CCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000000000 1124667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=328.92 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=195.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+|.+.+.||+|+||.||+|+++ +++.||+|.+.+.. ....+.+..|..++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999877 57899999886432 12234466788888777 5899999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987654 588999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......+..... .++..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~i~~~~~--~~p~~- 223 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHNV--AYPKS- 223 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC--CCCCc-
Confidence 111 12356799999999999999999999999999999999999999975431 112222222111 11111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTM-----IQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~-----~evl~~ 1133 (1176)
.+ ..+.+++.+|++.||++|++. .++.++
T Consensus 224 ---~s------~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 224 ---MS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---CC------HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11 235669999999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=327.49 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=194.2
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||+||+|+++ +++.||+|.+.+.. ......+.+|..+++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999886 57899999886532 22344567888888887 799999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 99999987654 689999999999999999999999 999999999999999999999999999864322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+ ............. .++ ...+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~~~--~~~----~~~~ 220 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILEDEV--RYP----RWLS 220 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCC--CCC----CcCC
Confidence 1234568999999999999999999999999999999999999996543 1122222221111 011 1111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTM-----IQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~-----~evl~~ 1133 (1176)
..+.+++.+||+.||.+|||+ .+++++
T Consensus 221 ------~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 221 ------KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ------HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 235679999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.23 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=201.4
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|++.++..||+|++... ....+.+.+|++++++++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 468999999999999999999887778999988642 234567899999999999999999999875 456799999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... +..+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+|||.++........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997643 23578999999999999999999999 9999999999999999999999999999765433221
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||+..+..++.++||||||+++|||++ |+.||..... ........... .......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~~~~~~~~~~~-----~~~~~~~ 227 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGY-----RMPCPPE 227 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----HHHHHHHhcCC-----CCCCccc
Confidence 1123456778999999988889999999999999999999 8888864321 11111111110 0011111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
....+.+++.+|++.+|++||+++++++.|++.
T Consensus 228 ------~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 228 ------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ------cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 112456799999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=323.97 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=202.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
++|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46889999999999999999752 345789998764322 2234688999999999 799999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+.+|+|.++++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+|++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 2489999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
...............+++.|+|||++.+..++.++||||+||++|||++ |+.||....... ..........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~~~~~---- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLIKEGY---- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHHHcCC----
Confidence 6543322111223456788999999998889999999999999999998 999986543211 1111111110
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+...... ..++.+++.+|++.+|++|||+.++++.|++.
T Consensus 262 -~~~~~~~~------~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -RMAQPEHA------PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -cCCCCCCC------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011111 12466799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=327.82 Aligned_cols=238 Identities=28% Similarity=0.374 Sum_probs=188.6
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHH-HHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEME-TIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||+||+|+++ +|+.||+|++..... ...+.+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999986 689999999864321 22234455554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 99999997654 688999999999999999999999 99999999999999999999999999987532211 1
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ..+.......... .+.+.. +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~--~~~~~~----~ 220 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPL--RLKPNI----S 220 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCC--CCCCCC----C
Confidence 2244579999999999999999999999999999999999999997543 2222222222111 111111 1
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQ 1129 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~e 1129 (1176)
..+.+++.+|++.||++||++++
T Consensus 221 ------~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 221 ------VSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred ------HHHHHHHHHHhhcCHHhCCCCCC
Confidence 13556999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.97 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=202.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||.||+|.+++ +..||+|.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 578889999999999999998752 36899998754322 22346889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhcccc------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 933 LVYEYMRYGSLEDVLHNQKKV------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
+||||+++|+|.+++...... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+|++|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999999754321 12478899999999999999999998 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcc
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
||+++.....+.........++..|+|||++.+..++.++|||||||++||+++ |+.||...+ . ....+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~---~~~~~~~~~~ 237 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--N---EEVLKFVIDG 237 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--H---HHHHHHHhcC
Confidence 999876544332222234456889999999988889999999999999999998 999986432 1 1122222211
Q ss_pred ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
... ......+ ..+.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~-----~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHL-----DLPENCP------DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC-----CCCCCCC------HHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111 1111111 24567999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=334.28 Aligned_cols=259 Identities=27% Similarity=0.342 Sum_probs=199.5
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
+.....++|++.+.||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445578999999999999999999987 57889999885422 222345778999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998754 478889999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCC----CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF----RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+. ......+...
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNH 262 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC
Confidence 986543221 122356799999999998654 378899999999999999999999975431 1222222211
Q ss_pred ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 046275 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAMF 1134 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~L 1134 (1176)
...-.++ . .+.. ...+.+++.+|+..++.+ ||++++++++.
T Consensus 263 ~~~~~~~----~-~~~~---s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFP----D-DNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCC----C-cCCC---CHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1000010 0 0111 113456899999844443 78999998873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.97 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=201.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC----EEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS----TVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||+||+|++. +|+ .||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46888899999999999999864 444 47888875432 2234568889999999999999999999865 45789
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
++||+++|+|.++++... ..+++.+++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999997643 2589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............+++.|+|||+..+..++.++|||||||++|||++ |..||.... ......+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~---~~~~~---- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLE---KGERL---- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH---CCCcC----
Confidence 53322222223345678999999998899999999999999999998 899986432 111222221 11110
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
...... ...+.+++.+||+.||++||++.++++.++++....
T Consensus 231 -~~~~~~------~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -PQPPIC------TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -CCCccC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 001111 123556999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=327.30 Aligned_cols=248 Identities=26% Similarity=0.323 Sum_probs=193.2
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++.++ +||+|+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999876 578999999865322 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 99999887654 689999999999999999999999 999999999999999999999999999874322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC-CccHHHHHHHhhccccccccCcccccCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG-DNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+......... ..++ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~p----~~~ 226 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IRIP----RFL 226 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CCCC----CCC
Confidence 123467999999999999999999999999999999999999999653321 1112222211111110 0011 111
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTM------IQVMAM 1133 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~------~evl~~ 1133 (1176)
+ ..+.+++.+||+.||++|+++ .++.+|
T Consensus 227 ~------~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 227 S------VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred C------HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1 134569999999999999985 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=325.29 Aligned_cols=261 Identities=27% Similarity=0.469 Sum_probs=202.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC--EEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS--TVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|+++ ++. .+++|++.... ....+.+.+|+.++.++ +||||+++++++..++..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888999999999999999875 454 35777664322 22345688999999999 899999999999999999999
Q ss_pred EeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 935 YEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
|||+++|+|.++++..+.. ...+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 9999999999999765321 23578999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||...+. .+....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK 235 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHHHHH
Confidence 99999998632211 11112234678999999988889999999999999999998 9999864331 112221
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
.... .........+ ..+.+++.+||+.+|++||+++++++.++++.....
T Consensus 236 ~~~~-----~~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 236 LPQG-----YRLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HhcC-----CcCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1111 1111111111 135679999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.14 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=196.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.++||+|+||.||+|++. +++.||+|.+... .....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999875 6889999988543 222345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|..+. .+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999996542 467888999999999999999999 99999999999999999999999999987553321
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc--HHHHHHHhhccccccccCccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN--LVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ............ .+..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 220 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL 220 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC
Confidence 23457899999999999888999999999999999999999999754322111 111111111111 1111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... . ....+.+++.+|++.+|++||+++|++++
T Consensus 221 ~~~--~---~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVG--Q---FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC--c---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 100 0 11235679999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=323.15 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=201.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
+|.+.+.||+|+||.||+|++. ++..||+|++...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999864 2478999988643322 23568889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhcc------------ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 046275 934 VYEYMRYGSLEDVLHNQK------------KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 1001 (1176)
++||+++++|.+++.... .....+++..+..++.|++.||+|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999986321 1122588899999999999999999999 9999999999999999999
Q ss_pred EEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 046275 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1002 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~ 1080 (1176)
+|++|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |..||.... ...+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Confidence 99999999886543332222234456789999999988889999999999999999998 888886432 122333
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
........ ......+. .+.+++.+||+.+|++||++++|++.|+.
T Consensus 238 ~i~~~~~~-----~~~~~~~~------~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVL-----PCPDDCPA------WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcC-----CCCCCCCH------HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222211 11111221 35569999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=339.31 Aligned_cols=370 Identities=28% Similarity=0.385 Sum_probs=249.3
Q ss_pred CCcEEEcCCCcCC-CCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCcc
Q 046275 242 ALEYLDISANKFT-GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320 (1176)
Q Consensus 242 ~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 320 (1176)
-.+-.|+++|.++ +..|.....+++++.|.|....+. ++|.++.. +.+|++|.+++|++. .+-..
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~------------~vPeEL~~-lqkLEHLs~~HN~L~-~vhGE 73 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE------------QVPEELSR-LQKLEHLSMAHNQLI-SVHGE 73 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh------------hChHHHHH-HhhhhhhhhhhhhhH-hhhhh
Confidence 3444566666665 345666666666666666665554 44444432 355666666666665 34455
Q ss_pred ccCCCCCcEEEccCCcCc-ccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCC
Q 046275 321 FGSCSSLESFDISSNKFS-GELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPR 399 (1176)
Q Consensus 321 ~~~l~~L~~L~Ls~N~l~-~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 399 (1176)
+..++.|+.+.+.+|++. .-||.++| .+..|..||||+|+++ ..|..+..-+++-.|+||+|+|. .||..+|. .+
T Consensus 74 Ls~Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfi-nL 149 (1255)
T KOG0444|consen 74 LSDLPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFI-NL 149 (1255)
T ss_pred hccchhhHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHH-hh
Confidence 666666777777776664 24666666 5677777777777776 56666766677777777777776 66665543 34
Q ss_pred CCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccc-cCCCCCCCCCccccceee
Q 046275 400 NSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL-HGEIPPELGNIQTLETLF 478 (1176)
Q Consensus 400 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~ 478 (1176)
..|-.|+|++|++. .+|..+..+..|++|+|++|.+.-.--..+..+++|+.|.+++.+= ...+|.++..+.+|..+|
T Consensus 150 tDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvD 228 (1255)
T KOG0444|consen 150 TDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVD 228 (1255)
T ss_pred HhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcc
Confidence 55666677777776 5666677777777777777776532223344556666677765432 235677777777777777
Q ss_pred cccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcc
Q 046275 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 479 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 558 (1176)
||.|.+. ..|+.+.++.+|+.|+||+|+|+ ++....+...+|++|+||+|+++ .+|..++.+++|+.|.+.+|+++
T Consensus 229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~- 304 (1255)
T KOG0444|consen 229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT- 304 (1255)
T ss_pred ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc-
Confidence 7777777 67777777777777777777777 55556666777777777777777 67777777777777777777664
Q ss_pred cCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCc
Q 046275 559 SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSM 638 (1176)
Q Consensus 559 ~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 638 (1176)
T Consensus 305 -------------------------------------------------------------------------------- 304 (1255)
T KOG0444|consen 305 -------------------------------------------------------------------------------- 304 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccc
Q 046275 639 MFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718 (1176)
Q Consensus 639 ~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N 718 (1176)
+. -||+.||.|.+|+++.+++|+|. .+|+.+..+..|+.|.|++|+|- ++|..+.-|+.|+.|||..|
T Consensus 305 ---------Fe-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 305 ---------FE-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred ---------cc-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence 11 36777777888888888888877 77888888888888888888887 78888877888888888877
Q ss_pred cccCCCCC
Q 046275 719 QLTGMIPV 726 (1176)
Q Consensus 719 ~l~g~~p~ 726 (1176)
+=--.+|.
T Consensus 373 pnLVMPPK 380 (1255)
T KOG0444|consen 373 PNLVMPPK 380 (1255)
T ss_pred cCccCCCC
Confidence 65555553
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=325.54 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=195.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+++++ +++.+|+|.+.+.. ......+.+|+.++..++|++|+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999987 47889999885421 222345788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ ..+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999998643 2589999999999999999999999 999999999999999999999999999875433
Q ss_pred ccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+ ................
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERFQ 228 (332)
T ss_pred CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCcccc
Confidence 222 1123457999999999986 3467889999999999999999999996543 2222222221111111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~ 1133 (1176)
++... ...+ ..+.+++.+|+..++++ |+++++++++
T Consensus 229 ~p~~~-~~~s------~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQV-TDVS------EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCcc-ccCC------HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111 1111 13456888888654444 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=334.76 Aligned_cols=262 Identities=20% Similarity=0.221 Sum_probs=199.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC---CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
..+|.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999754 3578898877432 34568999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|++. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 166 e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9996 58999885433 689999999999999999999999 999999999999999999999999999976654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc--cHHHHHHHhhccc--cccc-
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN--NLVGWVKQHAKLK--ISDV- 1090 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~--~~~~- 1090 (1176)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+........... ....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3332223456799999999999999999999999999999999999999976543211 1111111100000 0000
Q ss_pred ----------cCccccc--CCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 ----------FDPELMK--EDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ----------~~~~~~~--~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+...... ..+... ..-..+.+++.+||+.||++|||+.|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 000000 011245678999999999999999999987
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=322.46 Aligned_cols=264 Identities=21% Similarity=0.335 Sum_probs=199.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECC---------------CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCccccee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD---------------GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
++|++.+.||+|+||.||+++... ...||+|++.... ......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468899999999999999997642 2348888875432 222356889999999999999999999
Q ss_pred EEeeCCeeEEEEeeccCCCHHHHHhhcccc--------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 046275 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKV--------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVL 995 (1176)
Q Consensus 924 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 995 (1176)
++......++||||+++++|.+++...... ...+++..+..++.|+++|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999999654211 12378899999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc--CCCCCCCCCCCCc
Q 046275 996 LDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT--GKRPTDSADFGDN 1073 (1176)
Q Consensus 996 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~~~~~~ 1073 (1176)
+++++.+|++|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence 99999999999999876543322222233445778999999988889999999999999999998 5667654321 1
Q ss_pred cHHHHH-HHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1074 NLVGWV-KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1074 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
...... +...... ..... ......| ..+.+++.+|++.||++||++++|++.|++
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~------~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQG-RQIYL-SQTPLCP------SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhcc-ccccC-CCCCCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111 1111100 00000 0001111 246679999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.94 Aligned_cols=264 Identities=25% Similarity=0.439 Sum_probs=199.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-----CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-----DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 932 (1176)
..|++.+.||+|+||+||+|..+ +++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999742 588999999865544445678899999999999999999998754 34678
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997543 2589999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccccc-cccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc---
Q 046275 1013 MSAMDTHLSV-STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS--- 1088 (1176)
Q Consensus 1013 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 1088 (1176)
.......... ....++..|+|||++.+..++.++|||||||++|||++|..|+...... +..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 231 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQMI 231 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhcccccccccc
Confidence 6443221111 1223345699999998888999999999999999999988776432210 11000000000
Q ss_pred -----cccCcc-cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1089 -----DVFDPE-LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1089 -----~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
+.+... .....+.. ...+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGC---PAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000000 00000111 124567999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=323.02 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=202.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+|++.+.||.|+||.||+|.+. +++.|++|.+........+.+.+|+.+++.++|||++++++++......|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 36888999999999999999875 68999999987655555667889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988643 589999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ................ ...
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~---~~~ 240 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNGTPELQN---PEK 240 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCCcccCC---ccc
Confidence 1 23456889999999999888999999999999999999999999654321 1111111111100000 011
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+++.+||..||++|||+.+++++
T Consensus 241 ~~------~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 241 LS------PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CC------HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11 134569999999999999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=317.17 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
+.+++++.....||+|+||.||+|++. ++..|++|.+........+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345566666789999999999999876 5788999988665555566789999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeecccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLM 1013 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~ 1013 (1176)
+||+++++|.+++..... ....++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999986421 11227888999999999999999999 9999999999999976 678999999998765
Q ss_pred ccccccccccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
..... ......|++.|+|||++.+. .++.++||||+|+++|+|++|+.||....... ...+..... . .
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~--~----~ 229 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMF--K----I 229 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhh--c----c
Confidence 33221 12334688999999998654 37889999999999999999999986432111 111111000 0 0
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.+.... ...+.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 HPEIPESL------SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCCccc------CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11111111 1235569999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.74 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=202.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57899999999999999999875 69999999987655555567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++++|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998653 478899999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .............. ...
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-----~~~~~~~~~~~~~~---~~~ 240 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGTPELQN---PER 240 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-----eeeeccCCCCCCCC---ccc
Confidence 12345688999999999988899999999999999999999999965432111 00000000000000 010
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ...+.+++.+||+.+|++||++++++++
T Consensus 241 ~------~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 L------SAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred c------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1234569999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=325.60 Aligned_cols=255 Identities=25% Similarity=0.304 Sum_probs=195.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+++.+ +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999976 5899999998642 1223345788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997542 2588999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+.............
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCccc
Confidence 2221 1123469999999999863 457889999999999999999999986532 1222222211111011
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPW--RRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~--~RPt~~evl~~ 1133 (1176)
+++.. +... ..+.+++.+|+..+++ .||++++++++
T Consensus 229 ~~~~~----~~~~---~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDV----TDVS---EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCcc----CCCC---HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111 1111 1345577787755443 48899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=330.46 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=191.0
Q ss_pred ceEeEeCceEEEEEEEC----CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 866 SLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
+.||+|+||.||+++.. +|+.||+|++..... .....+.+|++++++++||||+++++++..+...|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999999752 588999998865322 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999997643 689999999999999999999999 999999999999999999999999999876533211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ............. .+++. .
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~~~--~~p~~----~ 221 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKAKL--GMPQF----L 221 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcCCC--CCCCC----C
Confidence 1234578999999999998889999999999999999999999997543 1112222222111 01111 1
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQ 1129 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~e 1129 (1176)
+ ..+.+++.+||+.||++||++.+
T Consensus 222 ~------~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 S------PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C------HHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 13456999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=326.82 Aligned_cols=246 Identities=25% Similarity=0.341 Sum_probs=191.2
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHH-HHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEME-TIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||+||+|+++ +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999987 57889999886432 122234444544 56778999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999997654 578889999999999999999999 999999999999999999999999999875322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. .+.+.+ +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~--~~~~~~----~ 220 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNKPL--QLKPNI----T 220 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----HHHHHHHHHhCCc--CCCCCC----C
Confidence 2245579999999999999999999999999999999999999996533 1222222211111 111111 1
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
..+.+++.+|++.||.+||++.+.+..+.+.
T Consensus 221 ------~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 221 ------NSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred ------HHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 1345699999999999999988655554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.96 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=199.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999876 57778888765322 22235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.++++..+ .+++..+..++.|+++||.|||+.. +++||||||+||+++.++.+|++|||++.......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999998654 5889999999999999999999742 89999999999999999999999999987543221
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-cccccc------
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK-LKISDV------ 1090 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~------ 1090 (1176)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+. .....+...... ......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccC
Confidence 1345789999999999888899999999999999999999999865431 111111100000 000000
Q ss_pred cCc-----------------ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1091 FDP-----------------ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1091 ~~~-----------------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
... ......|.. ..-..+.+++.+||+.+|++|||+++++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCc-ccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 000000000 0112356799999999999999999999883
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=331.99 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=196.4
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-----eeE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE-----ERL 932 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 932 (1176)
+|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999975 68999999885432 223456889999999999999999999998776 789
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888886543 689999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh--------
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA-------- 1083 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 1083 (1176)
...... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...+... .+........
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHH
Confidence 543222 122345678999999998764 47899999999999999999999997643211 0000000000
Q ss_pred ------cccc-ccccC-cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 ------KLKI-SDVFD-PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ------~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..... +...............+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 00000 00000000000011245679999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.95 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=200.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|.+.+.||+|+||.||+|.++.+..+|+|++... ....+.+.+|++++++++|||++++++++. ....++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 458888999999999999999887778999987532 234467889999999999999999999875 456789999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999997643 23588999999999999999999999 9999999999999999999999999999765432211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||+..+..++.++||||||+++|||++ |+.||..... . ......... ..+.....
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~---~~~~~~~~~-----~~~~~~~~ 227 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--R---EVLEQVERG-----YRMPCPQG 227 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--H---HHHHHHHcC-----CCCCCCcc
Confidence 1123346778999999988889999999999999999999 8999865321 1 111111111 01111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.+ ..+.+++.+||+.+|++||+++++++.|++
T Consensus 228 ~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CP------ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cC------HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 245679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=323.17 Aligned_cols=261 Identities=21% Similarity=0.338 Sum_probs=198.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|.+.+.||+|+||.||+|+++ +++.||+|++..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999876 578899998864332 2334677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++ +|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888887553 2578999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc------------
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK------------ 1084 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~------------ 1084 (1176)
. ......+|+.|+|||++.+ ..++.++||||+||++|+|+||+.||...+..+. +.........
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcch
Confidence 1 1234467899999998865 4688999999999999999999999976542210 1111000000
Q ss_pred -----cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 -----LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...............+... ..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLD---TEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCC---HHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000011111 234679999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.54 Aligned_cols=265 Identities=22% Similarity=0.356 Sum_probs=200.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-----------------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-----------------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPL 921 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 921 (1176)
++|++.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998643 23468888876432 2234578899999999999999999
Q ss_pred eeEEeeCCeeEEEEeeccCCCHHHHHhhcccc-------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 046275 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV-------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNV 994 (1176)
Q Consensus 922 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 994 (1176)
++++..+...++||||+++|+|.+++...... ...+++.++..++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999999765321 12478889999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc--CCCCCCCCCCCC
Q 046275 995 LLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT--GKRPTDSADFGD 1072 (1176)
Q Consensus 995 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~~~~~ 1072 (1176)
+++.++.++++|||+++.+.............+++.|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999976543222111223345678999999888889999999999999999998 77888643321
Q ss_pred ccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.........-.........+.. ...+ ..+.+++.+||+.||++||++.+|++.|++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 -QVIENTGEFFRDQGRQVYLPKP-ALCP------DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHhhccccccCCCC-CCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111100000000111110 1111 245679999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.12 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=201.7
Q ss_pred ceEeEeCceEEEEEEECC----CCEEEEEEeeccCCcC-HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++++++++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998764 7889999886543332 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcccc-----CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 941 GSLEDVLHNQKKV-----GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 941 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
++|.+++...... ...+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875211 24689999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
...........+++.|+|||.+....++.++||||+|+++|||++ |+.||.... ............ ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~ 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLRKGY-----RLP 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC-----CCC
Confidence 432222344567889999999988889999999999999999999 699987542 122222222211 001
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
..... -.++.+++.+|++.+|++|||+.+++++|+
T Consensus 228 ~~~~~------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 KPEYC------PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCccC------ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111 124567999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=325.85 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=209.3
Q ss_pred CCCceEeEeCceEEEEEEEC-CC----CEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DG----STVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
...++||.|+||+||+|.+- +| -+||+|.+.... .+...++.+|+.+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34679999999999999763 34 367888876533 334567999999999999999999999997766 889999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++.|+|.|+++..+. ++-....+.+..|||+||.|||.+ ++|||||.++|||+..-..+||+|||+|+....+
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999998753 678889999999999999999999 9999999999999999999999999999998877
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
+..+......-.+.|||-|.+....|++++|||||||++||++| |..|+.+....+ ..... ..+ +.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--I~dll---e~g---eR----- 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--IPDLL---EKG---ER----- 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--hhHHH---hcc---cc-----
Confidence 77666555566788999999999999999999999999999999 999987654211 11111 111 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
....|.-..++.. ++.+||..|+..||+++++...+.++..-..
T Consensus 919 LsqPpiCtiDVy~---~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 919 LSQPPICTIDVYM---VMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred CCCCCCccHHHHH---HHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 1223333334443 8889999999999999999999998875443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=330.52 Aligned_cols=245 Identities=23% Similarity=0.381 Sum_probs=198.8
Q ss_pred CCceEeEeCceEEEEEEEC-CCCEEEEEEe--ec--cCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe--eEEEEe
Q 046275 864 NDSLIGSGGFGDVYKAKLK-DGSTVAIKKL--IH--ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE--RLLVYE 936 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~E 936 (1176)
...+||+|+|-+||+|.+. +|-.||.-.+ .+ .++...+.|..|+.+++.|+|||||+++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999876 5777876433 22 233334779999999999999999999999977655 778999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeecccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 1015 (1176)
.+..|+|..|+++.+ ..+....+.|++||++||.|||++ .|+|||||||-+||+|+. .|.|||+|.|+|.....
T Consensus 124 L~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999887 578889999999999999999998 568999999999999976 58999999999987654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ....|||.|||||++. ..|++.+||||||+.++||.|+.+||..- .+..+..+....+..+..+..--
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----TNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh----CCHHHHHHHHHcCCCHHHhhccC
Confidence 222 3468999999999998 58999999999999999999999998643 34455555555554433332111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-.++.+||.+|+.. ..+|||+.|++++
T Consensus 270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 ----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 12345699999999 9999999999986
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=324.68 Aligned_cols=241 Identities=25% Similarity=0.338 Sum_probs=191.9
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+|...+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999876 68999999886432 223345778888888885 578889999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999997654 689999999999999999999999 999999999999999999999999999875332
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ .++
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~i~~~~~--~~p--- 221 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQSIMEHNV--SYP--- 221 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC--CCC---
Confidence 211 12345699999999999998999999999999999999999999975431 112222222111 011
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTM 1127 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~ 1127 (1176)
...+ ..+.+++.+||+.+|.+|++.
T Consensus 222 -~~~~------~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 -KSLS------KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -ccCC------HHHHHHHHHHcccCHhhCCCC
Confidence 1111 134669999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=316.86 Aligned_cols=253 Identities=31% Similarity=0.494 Sum_probs=199.3
Q ss_pred CCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHH--HHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDR--EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
|++.+.||+|+||+||+++... ++.||+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999874 568999998754433222 2356999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++.... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN 151 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999998433 689999999999999999999999 99999999999999999999999999987541 11
Q ss_pred cccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
........++..|+|||++. +..++.++||||+|+++|+|++|..||..... .+............... ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~----~~~~ 225 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKRPLPS----SSQQ 225 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHTHHHH----HTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccccccc----cccc
Confidence 22234567899999999998 88899999999999999999999999875411 11111111111111100 0000
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ....+.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~----~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SRE----KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTT----SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cch----hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 01456779999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.17 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=199.8
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ------GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
+|++.+.||+|+||.||+|...+++.+|+|.+...... ..+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999999888999999987543211 124578899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++.+.. ++++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+|++|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997654 578999999999999999999999 89999999999999999999999999987653
Q ss_pred cccc----cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1015 AMDT----HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1015 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
.... ........|+..|+|||++.+..++.++||||+|+++|+|++|+.||...+. ..... ..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~-~~~~~---~~ 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMF-YIGAH---RG 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHH-Hhhhc---cC
Confidence 2111 1112345689999999999988899999999999999999999999965321 11111 11110 00
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+......+ ..+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~------~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMPRLPDSFS------AAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCCCCC------HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111111111 234669999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.64 Aligned_cols=250 Identities=31% Similarity=0.466 Sum_probs=202.9
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||.|+||.||+|... |+.||+|++..... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46888999999999999999876 89999999865433 45678999999999999999999999998999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999976542 2589999999999999999999999 99999999999999999999999999998653211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .......... . .......
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~-~----~~~~~~~ 223 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPHVEKG-Y----RMEAPEG 223 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHhcC-C----CCCCccC
Confidence 12334668999999988889999999999999999997 9999865431 1111111111 0 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+ ..+.+++.+||..+|++|||+++++++|+++
T Consensus 224 ~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 224 CP------PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CC------HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11 2455699999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=332.03 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=196.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|+.++..++||+|+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 58999999886422 223456788999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997654 689999999999999999999999 999999999999999999999999999875432
Q ss_pred cccc---------------------------------ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCC
Q 046275 1016 MDTH---------------------------------LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062 (1176)
Q Consensus 1016 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 1062 (1176)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0011346999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 046275 1063 RPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT---MIQVMAM 1133 (1176)
Q Consensus 1063 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~evl~~ 1133 (1176)
.||...+. ...............+++.. +. . ..+.+++.+|+ .||.+|++ +.++++|
T Consensus 234 ~Pf~~~~~-----~~~~~~i~~~~~~~~~p~~~----~~-s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETP-----QETYRKVMNWKETLVFPPEV----PI-S---EKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCH-----HHHHHHHHcCCCceecCCCC----CC-C---HHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99975431 11212111111111111111 11 1 13445777766 49999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=328.45 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=191.7
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHH-HHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEME-TIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||+||+|+.+ +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 68999999886432 222334555655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ ++++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99999887654 689999999999999999999999 999999999999999999999999999875322111
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. .+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~~~--~~~~~------ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHKPL--VLRPG------ 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcCCc--cCCCC------
Confidence 1234579999999999999999999999999999999999999997543 1122222221111 11111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
. ...+.+++.+|++.+|++||++++.++.+.+
T Consensus 219 -~---~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 219 -A---SLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred -C---CHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 1 1234569999999999999998755544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.29 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=205.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|++.+.||+|+||.||+|..++++.||+|.+... ....+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4678999999999999999999888889999987643 344567999999999999999999999999889999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++.... +..+++.++..++.+++.|++|||+. +++|+||||+||++++++.+|++|||.+........
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999997643 23689999999999999999999999 899999999999999999999999999876543211
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.......++..|+|||.+.+..++.++||||+|+++|++++ |+.||..... .......... +......
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~-----~~~~~~~ 227 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLEQVERG-----YRMPRPP 227 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC-----CCCCCCC
Confidence 11122334678999999998889999999999999999998 9999864321 1111111111 0011111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
..+ ..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 228 ~~~------~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCP------EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCC------HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111 245679999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=324.90 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=197.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+++++ +++.||+|.+.+.. ......+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999986 57889999885421 222345778999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998643 2588999999999999999999999 999999999999999999999999999976543
Q ss_pred ccccccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+ ..............-.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEERFQ 228 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCCccc
Confidence 2221 1234579999999999875 467889999999999999999999996543 1122222211110001
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~ 1133 (1176)
+++.. ... ...+.+++.+|+..++++ |+++++++++
T Consensus 229 ~p~~~-~~~------~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHI-TDV------SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcc-ccC------CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 111 124556888988866554 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.10 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=198.0
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|+..+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++++++|++++++++++.+....++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999876 6889999988643222 234567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+.+|+|.+++...+. ..+++.++..++.|++.||.|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999865432 3589999999999999999999998 99999999999999999999999999987553322
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||....... .......... ... .....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~~~~~--~~~----~~~~~ 226 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVK--EVQ----EEYSE 226 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHhhhh--hhh----hhcCc
Confidence 1 233478999999999999899999999999999999999999997543211 0111111000 000 11111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++||| ++|++++
T Consensus 227 ~~~------~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KFS------PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCC------HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111 13456999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.28 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=203.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC--------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 929 (1176)
++|.+.+.||+|+||.||+|+.. .+..+|+|.+.... ......+.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888999999999999999752 24568888775432 22345688899999999 6999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccc------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKK------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
..++||||+++|+|.+++..... ....+++.++..++.|++.||.|||+. +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999976432 123589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 1076 (1176)
+++.+|++|||.++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~ 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----VE 243 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----HH
Confidence 999999999999986543222211122334568999999988889999999999999999999 888985432 11
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
............ ......+ ..+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 244 ~~~~~~~~~~~~-----~~~~~~~------~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFKLLREGHRM-----DKPSNCT------HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHcCCCC-----CCCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 222222111110 1111111 1355699999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.32 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=194.0
Q ss_pred eEeEeCceEEEEEEEC---CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 867 LIGSGGFGDVYKAKLK---DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
.||+|+||.||+|.++ ++..+|+|++..... ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578899998753322 22456889999999999999999999875 45678999999999
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997553 589999999999999999999999 999999999999999999999999999986644322111
Q ss_pred -ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1022 -VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1022 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
.....+++.|+|||.+....++.++|||||||++|||++ |+.||.... ...+......... +......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~i~~~~~-----~~~~~~~ 223 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GNEVTQMIESGER-----MECPQRC 223 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCCCC-----CCCCCCC
Confidence 122344678999999988889999999999999999998 999986532 1122222222111 1111111
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
+ ..+.+++.+||+.||++||++.+|.+.|+++
T Consensus 224 ~------~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 P------PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C------HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 1345699999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=319.24 Aligned_cols=265 Identities=22% Similarity=0.361 Sum_probs=202.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC-----------------CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCccc
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD-----------------GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVP 920 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 920 (1176)
.++|++.+.||+|+||.||+|++.. +..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999997652 24578888764322 23456889999999999999999
Q ss_pred ceeEEeeCCeeEEEEeeccCCCHHHHHhhcccc-------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 046275 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV-------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSN 993 (1176)
Q Consensus 921 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 993 (1176)
+++++..+...++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 999999999999999999999999999765411 12589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc--CCCCCCCCCCC
Q 046275 994 VLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT--GKRPTDSADFG 1071 (1176)
Q Consensus 994 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~P~~~~~~~ 1071 (1176)
|+++.++.++++|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999876543332222234456789999999988889999999999999999998 677875432
Q ss_pred CccHHHHHHHh-hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1072 DNNLVGWVKQH-AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1072 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
........... ......... ...+.. ...+.+++.+|++.||++|||+.++++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL-----PRPPNC---PKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccC-----CCccCC---CHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111 000000000 001111 1246679999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=312.18 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=191.3
Q ss_pred ceEeEeCceEEEEEEECC---CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 866 SLIGSGGFGDVYKAKLKD---GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
+.||+|+||.||+|.+.+ +..+|+|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45789998754332 23346888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcccc-CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 942 SLEDVLHNQKKV-GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 942 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
+|.++++..... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999765322 23567788889999999999999999 99999999999999999999999999987543322222
Q ss_pred cccccccCCcccCccccCCC-------CCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSF-------RCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
......|++.|+|||++.+. .++.++||||||+++|||++ |+.||...... ....+. . ........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~--~-~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYT--V-REQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHH--h-hcccCCCCC
Confidence 22344678899999998642 35789999999999999996 99999654311 111111 1 111111112
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
+......+ ..+.+++..|+ .+|++|||++||++.|+
T Consensus 233 ~~~~~~~~------~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLKLPLS------DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccCCCCC------hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22211111 12455888998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.63 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=201.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+|++.+.||+|+||.||++.+. +++.+|+|.+... .....+.+.+|+.++++++||||+++++++..+...|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999876 6889999987542 2233456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++.... +..+++..++.++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999987543 23578999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+ .............. .++ ..
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~-~~~----~~ 223 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSYK-PLP----SH 223 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCCC-CCC----cc
Confidence 1234568999999999999889999999999999999999999996533 11122222111111 011 11
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||++|||+.+++..
T Consensus 224 ~~------~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YS------YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cC------HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 135579999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=331.24 Aligned_cols=259 Identities=24% Similarity=0.303 Sum_probs=195.7
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-----
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE----- 929 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 929 (1176)
..++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999876 5899999998543 2233456788999999999999999999886543
Q ss_pred -eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 930 -ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 930 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
..|+||||+++ ++.+.++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999975 67766642 478889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh-----
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA----- 1083 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~----- 1083 (1176)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.. ..|.....
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~~~ 241 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI----DQWNKVIEQLGTP 241 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCC
Confidence 997543211 123457899999999999999999999999999999999999999765321 11110000
Q ss_pred ----------------cc--cc-----ccccCcccccCCC-chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 ----------------KL--KI-----SDVFDPELMKEDP-NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ----------------~~--~~-----~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .. .+.++........ ........+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00 0000000000000 000011345679999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=323.06 Aligned_cols=265 Identities=25% Similarity=0.371 Sum_probs=206.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECC--------CCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD--------GSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 929 (1176)
.+|++.+.||+|+||.||+|++.. +..||+|.+.... ....+++.+|+++++++ +||||+++++++..+.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999997531 2368888765322 22345788999999999 7999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccc------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKK------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999976431 123588999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 1076 (1176)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...+ ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence 999999999999976543322211222334568999999999899999999999999999998 888886432 22
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.+.......... ......+ ..+.+++.+|++.+|++|||+.+++++|+++....+.
T Consensus 244 ~~~~~~~~~~~~-----~~~~~~~------~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 244 ELFKLLKEGHRM-----DKPANCT------HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHcCCCC-----CCCCCCC------HHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 233222221111 1111111 2455799999999999999999999999999865544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=319.60 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=203.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
.++|++.+.||+|+||.||+|++. ++..||+|.+..... ...+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999864 467899998754322 2345688999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccc------------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 046275 932 LLVYEYMRYGSLEDVLHNQKK------------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSN 993 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 993 (1176)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999975321 112478899999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 046275 994 VLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGD 1072 (1176)
Q Consensus 994 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~ 1072 (1176)
|++++++.+|++|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999875543322111223345678999999998899999999999999999998 888886432
Q ss_pred ccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
..+............ ..... ..++.+++.+|++.||++|||+.|+++.|++
T Consensus 238 --~~~~~~~~~~~~~~~-----~~~~~------~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVIYYVRDGNVLS-----CPDNC------PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHHhcCCCCC-----CCCCC------CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222222222110 00111 1245679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.06 Aligned_cols=249 Identities=29% Similarity=0.425 Sum_probs=199.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEE-eeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC-KVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~E~~ 938 (1176)
.+|.+.+.||+|+||.||+|... |..||+|.+... ...+.+.+|+.++++++|+|++++++++ ..+...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999875 888999987532 3345788999999999999999999975 4556789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999999976542 2588999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .+....
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~ 222 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGY-----KMDAPD 222 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCC-----CCCCCC
Confidence 22345678999999998889999999999999999997 999986432 222222222211 111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
..+ ..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 223 ~~~------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCP------PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112 2355699999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=320.18 Aligned_cols=199 Identities=24% Similarity=0.389 Sum_probs=162.4
Q ss_pred CceEeEeCceEEEEEEEC---CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeEEEEeecc
Q 046275 865 DSLIGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERLLVYEYMR 939 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 939 (1176)
.++||+|+||+||+|+.+ +++.||+|++... .....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 4678999988532 223457889999999999999999998854 456789999996
Q ss_pred CCCHHHHHhhccc-----cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEeeccc
Q 046275 940 YGSLEDVLHNQKK-----VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMA 1010 (1176)
Q Consensus 940 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 1010 (1176)
++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 489888764321 123589999999999999999999999 99999999999999 45678999999999
Q ss_pred ccccccccc-ccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1011 RLMSAMDTH-LSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1011 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 866432211 12245678999999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.23 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=199.0
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---------HHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---------DREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
+|.+.+.||+|+||.||+|.+. +++.||+|.+....... .+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999875 58899999885433221 1457889999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++||||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997654 588899999999999999999998 9999999999999999999999999998
Q ss_pred cccccccccc----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1011 RLMSAMDTHL----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1011 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
+......... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ..... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~-- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIF-KIGE-- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHHH-HHhc--
Confidence 7664211110 11234588999999999988899999999999999999999999975321 11111 1111
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+......+ ..+.+++.+||+.||.+||++.+++++
T Consensus 227 ---~~~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ---NASPEIPSNIS------SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---cCCCcCCcccC------HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11122211111 235569999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=346.84 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=198.2
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCee
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEER 931 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 931 (1176)
...++|.+.+.||+|+||+||+|++. ++..||+|.+... .......+..|+.++++++|||||+++++|.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999987 4677888877532 22234568899999999999999999998854 4568
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCC----CCeeeCCCCCCCEEECC---------
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI----PHIIHRDMKSSNVLLDE--------- 998 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~--------- 998 (1176)
|+||||+++|+|.+++.........+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999998654333469999999999999999999998531 25999999999999964
Q ss_pred --------CCcEEEEeeccccccccccccccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 999 --------NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 999 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 33489999999976543221 234579999999999854 45889999999999999999999999643
Q ss_pred CCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1069 DFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+ ....+........ +... ...+ ..+.+||..||+.+|.+||++.+++++
T Consensus 247 ~----~~~qli~~lk~~p-----~lpi-~~~S------~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 N----NFSQLISELKRGP-----DLPI-KGKS------KELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred C----cHHHHHHHHhcCC-----CCCc-CCCC------HHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 2 2222222222111 0000 0011 235669999999999999999999964
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.73 Aligned_cols=247 Identities=29% Similarity=0.396 Sum_probs=195.7
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHH
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLE 944 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 944 (1176)
++||+|+||.||+|...+++.+|+|.+...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999987643322 2346889999999999999999999999999999999999999999
Q ss_pred HHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccc
Q 046275 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024 (1176)
Q Consensus 945 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 1024 (1176)
+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++......... ....
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence 9987543 2578999999999999999999998 9999999999999999999999999998754322111 1122
Q ss_pred cccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1025 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
..+++.|+|||++.+..++.++||||||+++|++++ |..||..... ........... ........+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~--- 220 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQVEKGY-----RMSCPQKCP--- 220 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHHcCC-----CCCCCCCCC---
Confidence 344678999999998889999999999999999998 9999864321 11111111111 111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
..+.+++.+|++.+|++||++.+++++|+
T Consensus 221 ---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 ---DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 24567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.65 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=199.4
Q ss_pred CCCCCceEeEeCceEEEEEEECC-C---CEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD-G---STVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+|.+.+.||+|+||.||+|+++. + ..||+|.+... ......++..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999998753 3 36999987543 2223457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999997643 2589999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccccc-cc--cCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1016 MDTHLSVST-LA--GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1016 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
......... .. .+..|+|||++.+..++.++||||+||++|||++ |..||...+. .....+. ... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i---~~~-----~ 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI---EQD-----Y 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH---HcC-----C
Confidence 222111111 11 2457999999998899999999999999999887 9999865331 1122221 111 0
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
........+ ..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 ~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLPPPMDCP------TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCCcccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 101111112 1345699999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=325.02 Aligned_cols=237 Identities=28% Similarity=0.350 Sum_probs=187.0
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHH-HHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEME-TIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
++||+|+||.||+|++. +++.||+|.+..... .....+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999986 588999998864321 22334555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 99999887543 588899999999999999999999 99999999999999999999999999987532211 1
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ............. .+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~------~~~~~~- 219 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPL------QLPGGK- 219 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCCC------CCCCCC-
Confidence 2244578999999999999899999999999999999999999997543 2222222211110 111111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMI 1128 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~ 1128 (1176)
...+.+++.+||+.||.+||++.
T Consensus 220 -----~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 -----TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CHHHHHHHHHHccCCHhhcCCCC
Confidence 12456799999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.14 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=198.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|.+.+.||+|+||.||+|++. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999875 58899999886544444456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++...+ .+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999987654 689999999999999999999999 99999999999999999999999999987553221
Q ss_pred cccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.......|++.|+|||++. ...++.++||||+||++|+|++|+.||....... ........... .+..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~---~~~~ 231 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALFLMTKSNFQ---PPKL 231 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----hHHhhhccCCC---CCcc
Confidence 1123457899999999974 4567889999999999999999999986433111 01111111110 1111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....... ..+.+++.+|++.+|++|||+++++++
T Consensus 232 -~~~~~~~---~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 -KDKMKWS---NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -cccCCCC---HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1000011 135569999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=314.77 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=197.0
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|+..+.||+|+||+||+|++. +++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999876 688999998854321 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++...+. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+|++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998875432 3689999999999999999999999 99999999999999999999999999987553222
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+........ ..+. .
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~~--~~~~----~ 226 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLETE--EVYS----A 226 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhccc--cccC----c
Confidence 1 234578999999999998899999999999999999999999997543111 1111111111111 1111 1
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
..+ ..+.+++.+|++.||++||+ +.+++++
T Consensus 227 ~~~------~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 KFS------EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCC------HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111 13456999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.98 Aligned_cols=249 Identities=29% Similarity=0.450 Sum_probs=195.5
Q ss_pred ceEeEeCceEEEEEEECC----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|++.. +..+|+|.+..... ...+++.+|++++++++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997642 26899998864333 23457889999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998654 689999999999999999999999 89999999999999999999999999998664433221
Q ss_pred c-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1021 S-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1021 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+ . .+........... .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~---~~~~~~~~~~~~~-----~~~~~ 222 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--G---AEVIAMLESGERL-----PRPEE 222 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--H---HHHHHHHHcCCcC-----CCCCC
Confidence 1 112223568999999998899999999999999999998 999986543 1 1222222111110 01111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
.+ ..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 223 ~~------~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CP------QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11 24567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=314.02 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=201.4
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CC---EEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GS---TVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|+..+.||+|+||.||+|+.+. +. .+++|++.... ....+++..|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999998763 33 68888875432 22345688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999997543 2689999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccccc-cccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTHLSV-STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
........ .....++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~~~~~---~- 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFR---L- 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhcCCC---C-
Confidence 32221111 11223457999999988889999999999999999997 9999864331 122222221110 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
+. ....+ ..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 ~~-~~~~~------~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PA-PMDCP------SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC-CCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 11111 2456799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=330.06 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=196.3
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------ 928 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 928 (1176)
..++|.+.+.||+|+||.||+|.+. .++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4468999999999999999999876 58899999886432 22235677899999999999999999988643
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 356999999975 67776642 478899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh------
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH------ 1082 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~------ 1082 (1176)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ........
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 240 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPE 240 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence 997643221 12345789999999999998999999999999999999999999976442110 00000000
Q ss_pred ------------hc--cc-----cccccCcccccCCCch-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1083 ------------AK--LK-----ISDVFDPELMKEDPNI-EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1083 ------------~~--~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .. ....+........... ......+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 00 0000000000000000 0012345689999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.48 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=201.7
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++||||+++++++.++...|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999875 78999998854322 668999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++...+ ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999997543 3689999999999999999999999 999999999999999999999999999886543321
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... ......... .+... .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~-----~~~~~-~ 221 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIFMIPNKP-----PPTLS-D 221 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhhhhccCC-----CCCCC-c
Confidence 1234458899999999998899999999999999999999999987543111 011110100 00000 0
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+. --..+.+++.+|++.+|++|||+.|++++
T Consensus 222 ~~~---~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEK---WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhh---cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 000 11245679999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=316.24 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=201.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999876 58889998875433 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++...+ ++++..+..++.+++.|+.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999987654 5899999999999999999999742 79999999999999999999999999986542211
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC------ccHHHHHHHhhcccccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD------NNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 1091 (1176)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .....+........
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 124568999999999988889999999999999999999999997543211 01111221111111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.+.+... .-...+.+++.+|++.||++|||+.|++++.
T Consensus 230 ~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPSS-----DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCch-----hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111100 0112356799999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=312.96 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=197.8
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeC------C
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVG------E 929 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 929 (1176)
+++.|++.+.||+|+||.||+|+.. +++.||+|.+... ......+..|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5567888999999999999999876 5788999987543 34456788999999998 799999999998653 4
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+++|+|.+++...+ ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 5799999999999999998643 23688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
+........ ......|++.|+|||++. ...++.++||||+||++|||++|+.||..... ........ .
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~~~~-~ 230 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIP-R 230 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHHHHh-c
Confidence 876533221 224467899999999986 34578899999999999999999999864321 11111111 1
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .+...... . ...+.+++.+||..+|.+|||+.+++++
T Consensus 231 ~~-----~~~~~~~~--~---~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NP-----APRLKSKK--W---SKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC-----CCCCCCCC--c---CHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 01111000 0 1245679999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.34 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=192.9
Q ss_pred eEeEeCceEEEEEEEC---CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 867 LIGSGGFGDVYKAKLK---DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355689998754332 22356889999999999999999999875 457899999999999
Q ss_pred HHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc-
Q 046275 943 LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS- 1021 (1176)
Q Consensus 943 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 1021 (1176)
|.+++.... ..+++.++++++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987543 2689999999999999999999999 999999999999999999999999999976543322111
Q ss_pred ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1022 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
.....+++.|+|||++.+..++.++|||||||++||+++ |+.||.... ...+......+... ..+ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~~-~~~----~~~- 223 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----GPEVMSFIEQGKRL-DCP----AEC- 223 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHCCCCC-CCC----CCC-
Confidence 122234678999999988889999999999999999996 999986542 11222222221111 011 111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 224 -----~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 224 -----PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -----CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12455699999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=315.54 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=193.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhc---CCCCcccceeEEee-----CC
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKI---KHRNLVPLLGYCKV-----GE 929 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 929 (1176)
+|++.+.||+|+||+||+|+++ +++.||+|.+..... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999886 688999998864322 2234566788777765 69999999998764 34
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++||||+++ +|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 89998876432 2589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh---ccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA---KLK 1086 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~ 1086 (1176)
++....... .....||+.|+|||++.+..++.++||||+||++|+|++|++||...... ..+........ ...
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 986543221 23456899999999999889999999999999999999999998654311 11111111100 000
Q ss_pred ccc-------ccCccc----ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISD-------VFDPEL----MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~-------~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... .+.+.. ....+.. ...+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEI---EESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCc---CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000 0000111 1235679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.73 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=205.8
Q ss_pred CCCCceEeEeCceEEEEEEECCC-CEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKDG-STVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
|.++..||.|+||.||+|..++. -..|.|.+...+....+++.-|++++..++||+||++++.|..+...||..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44567899999999999988754 44566777666777778899999999999999999999999889999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|-++..+-.-+ ..+++.++..+++|++.||.|||++ .|||||+|+.|||++.+|.++++|||.+..... +..
T Consensus 114 GAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 114 GAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred chHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 99999887664 3799999999999999999999999 999999999999999999999999998753321 112
Q ss_pred cccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1021 SVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
....+.|||.|||||+.. ..+|+.++||||||+++.||..+.+|-.. .+.....-.+.....+-...|..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-----lnpMRVllKiaKSePPTLlqPS~ 260 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-----LNPMRVLLKIAKSEPPTLLQPSH 260 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-----cchHHHHHHHhhcCCCcccCcch
Confidence 235678999999999864 56899999999999999999999999542 22333333444445555555555
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
|. ..+-+|+.+||..+|+.||++.++++|
T Consensus 261 Ws---------~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 261 WS---------RSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hh---------hHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 53 246679999999999999999999865
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=319.38 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=202.2
Q ss_pred HHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEe---
Q 046275 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCK--- 926 (1176)
Q Consensus 852 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 926 (1176)
+.++..+.++|++.+.||+|+||.||+|+++ +++.+|+|.+... .....++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567789999999999999999999876 5788999976532 22345688899999999 6999999999874
Q ss_pred --eCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 927 --VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 927 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
.+...++||||+++++|.++++........+++..+..++.|+++|+.|||+. +|+||||||+||++++++.+|+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999998875433334688999999999999999999999 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHH
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV 1079 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~ 1079 (1176)
+|||+++....... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||...... ..+.
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RALF 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHHh
Confidence 99999876543221 1234568999999998753 45788999999999999999999998654311 1111
Q ss_pred HHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1080 KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
. ..........++... ...+.+++.+||+.||++|||+.|++++.
T Consensus 240 ~-~~~~~~~~~~~~~~~---------~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 K-IPRNPPPTLHQPELW---------SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h-ccccCCCcccCCCCc---------CHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1 111111111111110 11356799999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=313.12 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=200.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-C---CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-D---GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|.+.+.||+|+||.||+|++. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999864 2 3378888875422 22245688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997653 2589999999999999999999999 99999999999999999999999999998664
Q ss_pred ccccccc-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTHLS-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ... ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~---~~~~~~~~-----~ 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDV---IKAIEEGY-----R 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHH---HHHHhCCC-----c
Confidence 4322111 112233568999999998889999999999999999887 9999865431 111 11111110 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.......+ ..+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 ~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 LPAPMDCP------AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCC------HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11111111 2345799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=311.00 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=202.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|.+.+.||+|+||.||+|.+.++..+++|.+... ....+.+.+|++++++++|+||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578899999999999999999887888999987542 2234678899999999999999999999877 7789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++.... +..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999997643 33688999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......++..|+|||++....++.++|||||||++|++++ |+.||...+. .....+ ..... ......
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~---~~~~~-----~~~~~~ 226 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRA---LERGY-----RMPRPE 226 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHH---HhCCC-----CCCCcc
Confidence 1 1123345678999999998889999999999999999999 8999865331 111111 11111 111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
..+ ..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 227 ~~~------~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCP------EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCC------HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 245679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.54 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=196.6
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
|++.+.||.|+||.||+|.+. ++..+++|.+........+.+.+|+++++.++|||++++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999887 4677888887554444456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
++|.+++.... .++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|++|||++....... .
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 99999887532 2689999999999999999999999 99999999999999999999999999987543221 1
Q ss_pred cccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1021 SVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
......|++.|+|||++. +..++.++||||+||++|||++|+.||...+. .................+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~-- 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLAQP-- 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHHHhhcCCCCCCCc--
Confidence 123456899999999984 44577899999999999999999999865331 111111111111111111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.+|++||++.+++++
T Consensus 232 -~~~~------~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 -SRWS------SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -cccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 245679999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=326.18 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=195.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 929 (1176)
.++|.+.+.||+|+||.||+|.+. .++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999876 58899999886432 23345678899999999999999999987543 3
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999975 77777742 478899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh------
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA------ 1083 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~------ 1083 (1176)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+... .+........
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEF 248 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 97653321 1234578999999999999999999999999999999999999997643211 0000000000
Q ss_pred ------------cc--cc-----ccccCcccccCCCc-hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 ------------KL--KI-----SDVFDPELMKEDPN-IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ------------~~--~~-----~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .. .+.+........+. .......+.+++.+|++.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00 00000000000000 00012356789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=309.49 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=203.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999876 57889999887655555677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++.... ..+++.++..++.|++.|+.|||+. +|+|+||||+||++++++.+|++|||.+........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999987652 2689999999999999999999998 999999999999999999999999999876543211
Q ss_pred cccccccccCCcccCccccCCC---CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSF---RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+... -........ +.+..
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-----~~~~~~~~~----~~~~~ 225 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-----ALFLISKSN----FPPPK 225 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc----CCCcc
Confidence 12345688899999999776 78999999999999999999999986543111 111111110 11111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ .....+.+++.+||+.+|.+|||+.+++.+
T Consensus 226 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKE---KWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchh---hhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111 112345679999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=310.77 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=198.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc----------CHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ----------GDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
+|.+.+.||.|+||.||+|... +|+.||+|.+...... ..+.+.+|+.++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999875 6899999987532111 1235778999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++||||+++|+|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999998663 688999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR--CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
+................|+..|+|||++.... ++.++||||+|+++|++++|+.||...+ ....+.. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~-~~~~~~ 229 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFK-LGNKRS 229 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHH-hhcccc
Confidence 87654322222223456889999999987654 7889999999999999999999985322 1111111 111111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+++......+ ..+.+++.+|++.+|++|||+++++++
T Consensus 230 ~~~~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDVSMNLS------PVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCccccccCC------HHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1112222211111 245669999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=315.64 Aligned_cols=263 Identities=27% Similarity=0.457 Sum_probs=215.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+.+..++||-|.||.||.|.|+. .-.||||.+.. +....++|..|..+|+.++|||+|+++|+|.-+...|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345567899999999999999874 67899998754 3455678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
..|+|.++++...+. .++....+.++-||+.|++||..+ ++|||||.++|.|+.++..|||+|||+++++..+ +
T Consensus 346 ~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-T 419 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-T 419 (1157)
T ss_pred cCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC-c
Confidence 999999999987643 467778889999999999999999 8999999999999999999999999999987543 2
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
+..-....-...|.|||-+....++.|+|||+|||++||+.| |..||.+.+. .++....+.-.+++-++..++.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--SqVY~LLEkgyRM~~PeGCPpk--- 494 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYGLLEKGYRMDGPEGCPPK--- 494 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHHhccccccCCCCCCHH---
Confidence 222222334668999999999999999999999999999998 8889876542 2233333333333444443333
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
+.++++.||++.|.+||+++|+-+.++.+...+..++
T Consensus 495 -----------VYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisd 531 (1157)
T KOG4278|consen 495 -----------VYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISD 531 (1157)
T ss_pred -----------HHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccH
Confidence 3458999999999999999999999999987765544
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=312.37 Aligned_cols=257 Identities=22% Similarity=0.341 Sum_probs=201.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999998653 2468888775443 2334578899999999999999999998875 557899
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.... ..+++.+++.++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997643 2589999999999999999999998 99999999999999999999999999987654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..... ......+++.|+|||.+....++.++||||||+++||+++ |+.||...... +.......... .
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~~-----~ 227 (270)
T cd05056 159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRIENGER-----L 227 (270)
T ss_pred cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHcCCc-----C
Confidence 33221 1122334568999999988889999999999999999986 99998654321 11111111110 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
......+ ..+.+++.+|+..+|++|||+.++++.|++++..
T Consensus 228 ~~~~~~~------~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 PMPPNCP------PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111 1455699999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=323.77 Aligned_cols=193 Identities=23% Similarity=0.298 Sum_probs=165.3
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
....+|++.+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34468999999999999999999886 467888886432 22356899999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+. ++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 58998887543 3689999999999999999999999 999999999999999999999999999875322
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCC
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT 1065 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~ 1065 (1176)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11 123456899999999999989999999999999999999865554
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=309.38 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=201.4
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
.+|++.+.||+|+||.||+|.+.+++.+|+|++... .....++.+|++++++++|||++++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 357788999999999999999887889999987532 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++.... ..+++..++.++.+++.|++|||+. +++||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 999999997543 2578999999999999999999999 899999999999999999999999999875533211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......++.+|+|||++.+..++.++||||+|+++|||++ |+.||.... ............ ....+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~--~~~~~~~--- 225 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETINAGF--RLYKPRL--- 225 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHhCCC--CCCCCCC---
Confidence 11122335678999999998889999999999999999998 999986433 112222221110 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
. ...+.+++.+||+.+|++|||+.+++++|
T Consensus 226 ~------~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 A------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C------CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 12466799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=308.09 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=197.5
Q ss_pred ceEeEeCceEEEEEEECC--C--CEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLKD--G--STVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3689998865444 445678999999999999999999999888 889999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987542 3689999999999999999999999 99999999999999999999999999998765433221
Q ss_pred c-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1021 S-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1021 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..+........ ......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~----~~~~~~ 225 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKIDKEGER----LERPEA 225 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcCCc----CCCCcc
Confidence 1 123457789999999998899999999999999999998 999986432 11122211111100 000011
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
.| ..+.+++.+|++.+|++||++.++++.|.
T Consensus 226 ~~------~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CP------QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CC------HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11 24567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=313.19 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=199.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+.|++.+.||.|+||.||+|++. +++.|++|.+........+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888999999999999999886 48889999886555445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|..++.... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998886543 2589999999999999999999998 99999999999999999999999999886543211
Q ss_pred cccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.......+++.|+|||++. ...++.++|||||||++|||++|+.||...+. .................+
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCCCccCCCC
Confidence 1123456889999999984 34567899999999999999999999864331 111111111111110000
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ....+.+++.+||+.+|++||++++++++
T Consensus 239 ------~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 ------SK---WSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------cc---cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 11235679999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.75 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=201.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|...++||+|.||+|.+++.+ +|+.+|+|.+.+.- ......-..|-++++..+||++..+...|+..++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356888899999999999999877 68999999886532 23334456788999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||..||.|+-++.+.+ .+++...+.+...|+.||.|||++ +||+||+|.+|.|+|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999998765 689999999999999999999999 99999999999999999999999999997432
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.....+.+.+|||.|+|||++....|+.++|+|.+||++|||++|+.||...+.+. +.+.+ .....+++..+.+
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLI-l~ed~kFPr~ls~- 393 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELI-LMEDLKFPRTLSP- 393 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHH-HhhhccCCccCCH-
Confidence 23344678999999999999999999999999999999999999999998755221 11111 1111222222221
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
++..++...|..||.+|. .++||.++
T Consensus 394 -------------eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 394 -------------EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -------------HHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 223477888999999997 35555544
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.52 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=194.5
Q ss_pred CCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeecc
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
+....||.|..|+||+++.+ +|..+|||.+... +.+..+++...++++..- ++|+||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999876 5889999999754 333445677777776665 48999999999999999999999996
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
. ..+.++++-+. ++++...-++...++.||.||.+++ +|+|||+||+|||+|+.|.+|++|||.+-++-+...+
T Consensus 175 ~-C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 T-CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 4 66677765543 6888888899999999999999987 9999999999999999999999999999766433222
Q ss_pred ccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1020 LSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
+..+|.+.|||||.+.- .+|+.++||||||+.++|+.||++||...+.+.+ ...+ +.. +. +|.+.
T Consensus 249 ---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---~ltk-vln-~e----PP~L~ 316 (391)
T KOG0983|consen 249 ---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---VLTK-VLN-EE----PPLLP 316 (391)
T ss_pred ---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH---HHHH-HHh-cC----CCCCC
Confidence 45689999999999854 4788999999999999999999999987543321 1111 111 11 12222
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... .. ..+++|+..||+.|+.+||...++++|
T Consensus 317 ~~~g-FS---p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHMG-FS---PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cccC-cC---HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2111 11 135669999999999999999999987
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=309.46 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=199.0
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-----cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-----QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
+|+..+.||+|+||.||+|... +++.|++|.+..... +..+.+.+|++++++++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999887 789999998864332 2345688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997653 588999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccccccccccCCcccCccccCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
... ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||.... -............. +
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~----~ 221 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGRSKEL----P 221 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHhcccC----C
Confidence 322 123456889999999987766 8999999999999999999999986533 11111111110100 1
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...... ...+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 PIPDHL------SDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CcCCCc------CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111111 1234569999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=313.06 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=200.3
Q ss_pred CCCCCceEeEeCceEEEEEEE-----CCCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKL-----KDGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERL 932 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 932 (1176)
.|++.+.||+|+||.||.++. .++..||+|.+.... ......+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 257889999875432 22345688999999999999999999998775 5689
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999997543 2589999999999999999999999 999999999999999999999999999986
Q ss_pred cccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----------CCccHHHHHHH
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF----------GDNNLVGWVKQ 1081 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~----------~~~~~~~~~~~ 1081 (1176)
........ ......++..|+|||++.+..++.++||||||+++|||++++.|+..... .......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 64332211 11234567789999999888899999999999999999998876432110 01111111111
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
...... ....... ...+.+++.+|++.+|++|||++++++.++++
T Consensus 239 ~~~~~~-----~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR-----LPRPPNC------PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc-----CCCCCCC------CHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0011111 12466799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=313.13 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=203.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC----EEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS----TVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.+|++.+.||+|+||+||+|.++ +|+ .||+|....... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999865 333 578887654332 233568899999999999999999999877 78899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999986532 589999999999999999999998 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............++..|+|||.+....++.++||||||+++||+++ |+.||.... ...+.......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~~--~~ 232 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIPDLLEKGERL--PQ 232 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhCCCCC--CC
Confidence 54333222222334678999999988889999999999999999998 999986543 12222222221110 00
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+ ... ...+.+++.+||..+|.+|||+.++++.++++.+.
T Consensus 233 ~---~~~------~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 233 P---PIC------TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C---CCC------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 001 12355689999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=311.86 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=193.8
Q ss_pred ceEeEeCceEEEEEEECC-CC--EEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLKD-GS--TVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|++++ +. .+++|.+.... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998864 43 46777765322 23345688999999999 899999999999999999999999999
Q ss_pred CCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 941 GSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 941 gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
|+|.+++...+.. ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999999764311 12478999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||...+. ...........
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~~~- 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQGY- 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HHHHHHHhCCC-
Confidence 98532211 11112234567999999988889999999999999999997 9999865331 11122111110
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
..+.....+ ..+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 229 ----~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 ----RLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----CCCCCCcCC------HHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111111 13567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=309.07 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=188.0
Q ss_pred eEeEeCceEEEEEEECCCC---EEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 867 LIGSGGFGDVYKAKLKDGS---TVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
.||+|+||.||+|+..++. .+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6899999999999765433 45566554322 2334678999999999999999999999999999999999999999
Q ss_pred HHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccc
Q 046275 943 LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV 1022 (1176)
Q Consensus 943 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 1022 (1176)
|.++++.........++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986543333567788889999999999999998 9999999999999999999999999998643221111112
Q ss_pred cccccCCcccCccccCC-------CCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1023 STLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1023 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||.... .................++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-----DREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhhcccccCCCc
Confidence 34567899999998753 245789999999999999997 566775432 11222222222222233333
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
+....+ ..+.+++..|| .+|++||++++|++.|.
T Consensus 234 ~~~~~~------~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPYS------ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCCc------HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322211 13445888899 57999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=311.34 Aligned_cols=262 Identities=27% Similarity=0.343 Sum_probs=202.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 935 (1176)
++|+..+.||.|++|.||+|.++ +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999986 578899998764322 2345688999999999999999999988653 4689999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998875443344689999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...........+........... .+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 228 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-----EL 228 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-----hh
Confidence 211 234578899999999988999999999999999999999999976532222222222222221111 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+........+.+++.+||+.+|++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11111000112346689999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=309.29 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=201.2
Q ss_pred CCCCCceEeEeCceEEEEEEECC--CCEEEEEEeeccCC----------cCHHHHHHHHHHHHh-cCCCCcccceeEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD--GSTVAIKKLIHISG----------QGDREFTAEMETIGK-IKHRNLVPLLGYCKV 927 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 927 (1176)
+|++.+.||+|+||.||+|.++. ++.+|+|.+..... ....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999875 68899998753211 122446778887765 799999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
+...++||||+++++|.+++.........+++..++.++.|++.|+.|||+.. +++|+||+|+||+++.++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999998654433457899999999999999999999632 7999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
|.+....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+ .............
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKIVEAVY 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHHhhccC
Confidence 9998654432 2245568999999999998889999999999999999999999986432 2222222222111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
. +...... ...+.+++.+||+.||++||++.|+.++++
T Consensus 231 ~----~~~~~~~------~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 E----PLPEGMY------SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----cCCcccC------CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 1110011 124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=313.59 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=200.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||.|+||.||+|++. ++..||+|.+........+.+.+|++++++++||||+++++++..+...|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888899999999999999875 68899999886544444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++...+ ..+++..++.++.|++.|+.|||+. +|+|+||||+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999987653 2689999999999999999999999 999999999999999999999999998865432211
Q ss_pred cccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
......|++.|+|||++. ...++.++||||||+++|||++|+.||...+. .................+
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~ 231 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLKILKSEPPTLDQP 231 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHHHhcCCCCCcCCc
Confidence 123456899999999874 34567899999999999999999999865421 111111111111110001
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .+ ..+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~---~~------~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 SK---WS------SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cc---CC------HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 11 135569999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=316.22 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=197.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||.||+|+++ +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46889999999999999999876 58899999885432 22344677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 59999887653 2578999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc----ccccccC
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL----KISDVFD 1092 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 1092 (1176)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...+... ........... .+.....
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhc
Confidence 1 1233457889999998865 357889999999999999999999997543211 11111110000 0000000
Q ss_pred ---------cccc-----cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 ---------PELM-----KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ---------~~~~-----~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+... ...+.. ...+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRL---DSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCC---CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000111 1134579999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.27 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=199.8
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEee-CCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKV-GEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 936 (1176)
+|++.+.||+|++|.||+++++ +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999876 57889999985432 2334568889999999999999999998764 446799999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.+++.... ...+++.++..++.+++.|++|||+. +|+||||||+||+++.++.++++|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998643 23589999999999999999999999 9999999999999999999999999999766432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||...+ ..........+... ...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~-----~~~ 223 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEGKLP-----PMP 223 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcCCC-----CCc
Confidence 22 1234568999999999999899999999999999999999999986433 12222222222111 111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... ...+.+++.+|++.+|++|||+.+++++
T Consensus 224 ~~~------~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDY------SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccc------CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 1245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=312.28 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=201.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||.|+||.||+|++. +++.||+|.+.... ......+.+|+++++.++|||++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999876 58899999885432 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++... ++++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999999754 689999999999999999999999 89999999999999999999999999998765432
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+. .......... ..+.+..
T Consensus 153 ~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~-----~~~~~~~ 220 (274)
T cd06609 153 S--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFLIPKN-----NPPSLEG 220 (274)
T ss_pred c--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHHhhhc-----CCCCCcc
Confidence 1 12345688899999999988899999999999999999999999865431 1111111111 1111111
Q ss_pred C-CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 E-DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~-~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. .+ ..+.+++.+||..+|++|||+++++++
T Consensus 221 ~~~~------~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 NKFS------KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccC------HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 11 135569999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.21 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=196.5
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHH
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLE 944 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 944 (1176)
++||+|+||.||+|.+.+++.|++|++...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999988654333 3457889999999999999999999999999999999999999999
Q ss_pred HHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccc
Q 046275 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024 (1176)
Q Consensus 945 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 1024 (1176)
+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|||.+..............
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9997543 2578999999999999999999999 999999999999999999999999999875532211111112
Q ss_pred cccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1025 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
..++..|+|||.+.+..++.++|||||||++|||++ |..||..... ........... ........
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~~~~~~~~~-----~~~~~~~~---- 220 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIESGY-----RMPAPQLC---- 220 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHHHHHHhcCC-----CCCCCccC----
Confidence 234667999999988889999999999999999999 8888865431 11111111110 00011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
...+.+++.+|+..+|++|||+.|+++.|+
T Consensus 221 --~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 --PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 124667999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=310.08 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=204.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|+..+.||.|+||.||+|.++ +++.|++|.+.... ....+++.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999887 58899999886543 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
+++++|.+++.... .++++..+..++.|++.|++|+|+ . +++||||||+||++++++.++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999998653 368899999999999999999999 7 9999999999999999999999999998755322
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ....++..|+|||++.+..++.++||||+|+++|+|++|+.||...+.................. +...
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 225 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-----PRLP 225 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-----CCCC
Confidence 11 12568899999999998899999999999999999999999997654333333333332222211 1111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... --..+.+++.+||..+|++|||+.+++++
T Consensus 226 ~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SGK-----FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhh-----cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 100 11235679999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=309.20 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=191.3
Q ss_pred ceEeEeCceEEEEEEECC----CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEe-eCCeeEEEEeecc
Q 046275 866 SLIGSGGFGDVYKAKLKD----GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCK-VGEERLLVYEYMR 939 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 939 (1176)
+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 3578999875322 223456888999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++..... ..++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976432 467788899999999999999998 9999999999999999999999999998754322111
Q ss_pred --ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCC-CCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1020 --LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK-RPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1020 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.......++..|+|||++.+..++.++|||||||++|||++|. .||...+ ............. +...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~~~~-----~~~~ 224 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLLQGRR-----LLQP 224 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhcCCC-----CCCC
Confidence 1112334677899999998889999999999999999999954 4554321 1222222211110 0001
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
...+ ..+.+++.+||+.+|++||++.++++.++++..
T Consensus 225 ~~~~------~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 225 EYCP------DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CcCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1111 135579999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=309.92 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=201.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 935 (1176)
+|++.+.||.|+||.||+|.+. +++.||+|.+.... ....+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999875 67889999875432 2234568889999999999999999998753 45679999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-----HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
||+++++|.+++........++++..++.++.|++.|++||| +. +++|+||||+||+++.++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999876444457999999999999999999999 66 8999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+ ...+.........
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--- 227 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKEGKF--- 227 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhcCCC---
Confidence 86654322 1234568999999999998889999999999999999999999997543 1222222222221
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.+.... ...+.+++.+|++.+|++|||+++|+++
T Consensus 228 --~~~~~~~------~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --RRIPYRY------SSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCCcccc------CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111111 1245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.88 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=193.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-----cCHHHHHHHHHHHHhcCCCCcccceeEEee--CCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-----QGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 931 (1176)
.+|+..+.||+|+||.||+|.+. +++.|++|++..... .....+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999875 589999998754321 122457889999999999999999998865 3567
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++|+||+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997654 578999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccc-cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1012 LMSAMDT-HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1012 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
....... ........++..|+|||++.+..++.++||||+||++|||++|+.||...+. .......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~-----~ 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQ-----P 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcC-----C
Confidence 6532211 1111234588999999999988899999999999999999999999864321 1111111110 0
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.+....+ ..+.+++ +||..+|++||+++|++++
T Consensus 226 ~~~~~~~~~~------~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNPQLPSHIS------EHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCCchhcC------HHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111111111 1223355 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=310.76 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=185.8
Q ss_pred ceEeEeCceEEEEEEECC-------------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 866 SLIGSGGFGDVYKAKLKD-------------GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2257788765443334456888999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-------EEEE
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE-------ARVS 1005 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~ 1005 (1176)
+||||+++|+|..++.... ..+++..++.++.||++|++|||+. +|+||||||+||+++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999887543 2589999999999999999999999 9999999999999986654 8999
Q ss_pred eeccccccccccccccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHH-cCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELL-TGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||....... ... ..
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~-~~ 222 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KER-FY 222 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHH-HH
Confidence 99998654321 2345788999999886 567899999999999999998 5888876433111 111 11
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.... .. ..+. ...+.+++.+||+.||++||++.++++++
T Consensus 223 ~~~~-~~-------~~~~----~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-ML-------VTPS----CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-cC-------CCCC----hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1110 00 0111 12456799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=309.87 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=199.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999987 58999999886432 2233567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++++++..+..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765433 589999999999999999999998 9999999999999999999999999999866443
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-----------
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK----------- 1084 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~----------- 1084 (1176)
.. ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||......+ ...........
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhccc
Confidence 22 1234467889999999876 457889999999999999999999997543211 11111110000
Q ss_pred ccc-ccccCcccccCCCch---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKI-SDVFDPELMKEDPNI---EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... .....+......+.. ...-..+.+++.+||+.+|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 000000100000000 0011345679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=316.26 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=199.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC----EEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS----TVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778899999999999999864 344 467777654322 1233678899999999999999999998654 4678
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987653 2588999999999999999999999 9999999999999999999999999999866
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ......+. ..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~---~~~~~---~~ 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLL---EKGER---LP 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---HCCCC---CC
Confidence 54332222233446778999999998899999999999999999997 999986532 11122221 11111 00
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
..... ...+.+++.+||..+|++||+++++++.++++...
T Consensus 232 --~~~~~------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 --QPPIC------TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111 12456699999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=322.09 Aligned_cols=261 Identities=26% Similarity=0.328 Sum_probs=195.1
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG----- 928 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 928 (1176)
+..++|.+.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45578999999999999999999875 68899999885422 12234577899999999999999999987543
Q ss_pred -CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 929 -EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 929 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
...|+++|++ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999998 67998887643 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+ .+..+...... .
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~-~ 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGT-P 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCC-C
Confidence 999865332 234568999999999876 568899999999999999999999996543111 11111110000 0
Q ss_pred cccc---cC--------cccccCCCchHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDV---FD--------PELMKEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~---~~--------~~~~~~~~~~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+. +. ..+......... .-..+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00 000000000000 01135679999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.78 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=195.4
Q ss_pred ceEeEeCceEEEEEEECC-------CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 866 SLIGSGGFGDVYKAKLKD-------GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.||+|+||.||+|+.++ +..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2578888775432 23355788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhcccc---CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-----cEEEEeecc
Q 046275 938 MRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-----EARVSDFGM 1009 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl 1009 (1176)
+++|+|.+++...... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999764321 23478999999999999999999998 899999999999999877 899999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~~~~- 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QEVLQHVTAGGR- 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HHHHHHHhcCCc-
Confidence 876543322222223345788999999999899999999999999999998 9999864321 111111111110
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.......+ ..+.+++.+||..+|++||+++++++.|.+
T Consensus 232 ----~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 ----LQKPENCP------DKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----cCCcccch------HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01111111 234579999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=337.34 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=193.4
Q ss_pred HHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC------CCcccceeEEee
Q 046275 855 LLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKH------RNLVPLLGYCKV 927 (1176)
Q Consensus 855 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 927 (1176)
+...+++|++.+.||+|+||+||+|++. +++.||||++.... ...+++..|+.+++.++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999876 57889999885422 223456678888777754 458889888875
Q ss_pred C-CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC------
Q 046275 928 G-EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF------ 1000 (1176)
Q Consensus 928 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------ 1000 (1176)
+ ...++|||++ +++|.+++...+ .+++..+..++.||+.||+|||++. +||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 4 5678999988 679999987654 6899999999999999999999732 899999999999998765
Q ss_pred ----------cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Q 046275 1001 ----------EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF 1070 (1176)
Q Consensus 1001 ----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~ 1070 (1176)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998754221 12356799999999999999999999999999999999999999976431
Q ss_pred CCccHHHHH-HHhhc---------------------cccccccCcccc----cCCCc-hHHHHHHHHHHHHHhccCCCCC
Q 046275 1071 GDNNLVGWV-KQHAK---------------------LKISDVFDPELM----KEDPN-IEIELLQHLHVASACLDDRPWR 1123 (1176)
Q Consensus 1071 ~~~~~~~~~-~~~~~---------------------~~~~~~~~~~~~----~~~~~-~~~~~~~~~~li~~cl~~dp~~ 1123 (1176)
. .....+ ..... .......++... ...+. ...+...+.+|+.+||+.||++
T Consensus 351 ~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 351 L--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred H--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 1 111100 00000 000000000000 00000 0011234678999999999999
Q ss_pred CCCHHHHHHH
Q 046275 1124 RPTMIQVMAM 1133 (1176)
Q Consensus 1124 RPt~~evl~~ 1133 (1176)
|||++|+++|
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999986
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=313.42 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=202.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeec--cCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIH--ISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 934 (1176)
....|++.+.||+||-+.||++...+.+.+|+|++.. .+.+...-|..|+..|.+++ |.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456889999999999999999998888999998754 23344566999999999995 99999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||=+. +|..+++.... ....| .++.+..|++.|+.++|.+ ||||.||||.|+++-. |.+||+|||.|.-+.
T Consensus 439 mE~Gd~-DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecccc-cHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999754 99999987653 23445 7889999999999999999 9999999999999965 589999999999887
Q ss_pred cccccccccccccCCcccCccccCCC-----------CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSF-----------RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
.+.+.......+||+.||+||.+... +.+.++||||+|||+|+|+.|+.||.... -.|.+...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~aKl~a 584 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIAKLHA 584 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHHHHHh
Confidence 76666666678999999999998432 35679999999999999999999986321 12332222
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+|...-..|... +-.++++++..||..||.+|||..+++++
T Consensus 585 ------I~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ------ITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------hcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222111111111 11127789999999999999999999987
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=304.03 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=203.0
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|+..+.||.|+||.||.++.. +++.+++|++... .....+++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4888999999999999999865 5889999987543 233446688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++.... +..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999998653 23689999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......|++.|+|||+..+..++.++||||+|+++|||++|+.||.... ..+............ .. .
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~~----~~-~ 223 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQGNYTP----VV-S 223 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCCC----Cc-c
Confidence 1 2234568999999999988888999999999999999999999986432 222222222222111 10 1
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ...+.+++.+||+.+|++||++++++++
T Consensus 224 ---~~---~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 224 ---VY---SSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---cc---CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11 1235569999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=313.05 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=194.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHH-HHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMET-IGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|+++ +|+.||+|++.... .....++..|+.. ++..+||||+++++++..+...|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999886 69999999886432 2233456666665 566789999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++ |+|.+++.........+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6898888764333457899999999999999999999853 7999999999999999999999999998765322
Q ss_pred cccccccccccCCcccCccccCC----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
. ......|+..|+|||++.+ ..++.++|+||+|+++|+|++|+.||..... ........ .... .
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~-~~~~-----~ 225 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLKQV-VEEP-----S 225 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHHHH-HhcC-----C
Confidence 1 1123468899999998865 4568899999999999999999999864321 11111111 1111 1
Q ss_pred ccccc-CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMK-EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.... ..+ ..+.+++.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~------~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 PQLPAEKFS------PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCccccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 111 135569999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.93 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=200.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ....+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888999999999999999864 2467888877543322 2456899999999999999999999999989999
Q ss_pred EEEeeccCCCHHHHHhhccccC-----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVG-----IKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654211 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .. ..........
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~---~~~~~~~~~~ 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DE---EVLNRLQAGK 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hH---HHHHHHHcCC
Confidence 9986443221 112233456778999999988888999999999999999999 788885432 11 1222222112
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
...... ...| ..+.+++.+||+.+|++|||+.+++++|.
T Consensus 236 ~~~~~~----~~~~------~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVP----EGCP------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCC----CCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111 1111 14567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=319.84 Aligned_cols=199 Identities=23% Similarity=0.306 Sum_probs=164.6
Q ss_pred CCceEeEe--CceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 864 NDSLIGSG--GFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 864 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+.++||+| +|++||+++.+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 68899999875 689999998854322 22345778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999975432 2588999999999999999999999 999999999999999999999999986543321111
Q ss_pred cc-----cccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCC
Q 046275 1019 HL-----SVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDS 1067 (1176)
Q Consensus 1019 ~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~ 1067 (1176)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 00 0122356788999999875 4688999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.63 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=186.2
Q ss_pred eEeEeCceEEEEEEECC---CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 867 LIGSGGFGDVYKAKLKD---GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34677777643222 223467889999999999999999999999999999999999999
Q ss_pred HHHHHhhcccc-CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc
Q 046275 943 LEDVLHNQKKV-GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 943 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+|++|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765421 22356788899999999999999999 999999999999999999999999999875433222111
Q ss_pred ccccccCCcccCccccCC-------CCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1022 VSTLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1022 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.....+++.|+|||++.. ..++.++||||+||++|||++ |..||..... ........... ......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~~-~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVLKQVVREQ-DIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhhcc-CccCCCC
Confidence 233456778999998742 356789999999999999999 7888764321 11111111111 1111122
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
......+. .+.+++..|+ .||++|||+++|++.+
T Consensus 234 ~~~~~~~~------~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLDLKYSD------RWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccccCCH------HHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 22211111 2334777888 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.94 Aligned_cols=264 Identities=28% Similarity=0.391 Sum_probs=203.6
Q ss_pred cCHHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEee
Q 046275 850 LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKV 927 (1176)
Q Consensus 850 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 927 (1176)
++..++..+.++|.+.+.||+|+||.||+|..+ +++.+|+|.+... ......+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344555667889999999999999999999885 6889999987543 22345678899999999 89999999999865
Q ss_pred C-----CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 928 G-----EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 928 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
. ...++||||+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 358999999999999999875433344689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCC-----CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-----RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~ 1077 (1176)
|++|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...+.. ..
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----~~ 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KT 241 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----HH
Confidence 99999998765432211 1334688999999997543 3678999999999999999999998653211 11
Q ss_pred HHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1078 WVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1078 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ............++. . ....+.+++.+|++.+|++||++.+++++
T Consensus 242 ~-~~~~~~~~~~~~~~~------~---~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 L-FKIPRNPPPTLLHPE------K---WCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HHHhcCCCCCCCccc------c---cCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111111111111110 0 11245679999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=312.60 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=203.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-----CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEee--CCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-----DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKV--GEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 931 (1176)
+.|++.+.||+|+||.||+|++. ++..||+|.+...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777889999999999999864 3688999988654332 35679999999999999999999999877 5578
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999986542 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccccc-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc----------cHHHHHH
Q 046275 1012 LMSAMDTHLS-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN----------NLVGWVK 1080 (1176)
Q Consensus 1012 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~----------~~~~~~~ 1080 (1176)
.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653222111 1123456679999999888899999999999999999999999764321110 0111111
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
...... ... .....+ .++.+++.+|++.+|++|||+.||+++|+.++
T Consensus 238 ~~~~~~---~~~--~~~~~~------~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGE---RLP--RPPSCP------DEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCC---cCC--CCccCC------HHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111100 000 001111 34667999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.82 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=199.8
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
+|+..+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999874 6899999988643211 23568899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARL 1012 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 1012 (1176)
||||+++++|.+++...+ ++++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+|++|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997654 688999999999999999999999 999999999999998775 599999999876
Q ss_pred cccccccc--cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1013 MSAMDTHL--SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1013 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASATT--- 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhccCC---
Confidence 64432111 1123468899999999988889999999999999999999999986543221 1111111111111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+..... ....+.+++.+|++.+|++|||+.+++++
T Consensus 229 -~~~~~~~------~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 -APSIPEH------LSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -CCCCchh------hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111111 11245569999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=322.50 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=186.0
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhc---CCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKI---KHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
||+|+||+||+|+++ +++.||+|++...... ....+..|..++.+. +||||+++++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 5899999998643221 223345566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 99999987654 689999999999999999999999 999999999999999999999999999875322211
Q ss_pred cccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+ ..+.......... .++...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~--~~~~~~---- 220 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGKV--RFPKNV---- 220 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCCC--CCCCcc----
Confidence 12356799999999998754 47899999999999999999999986543 1222222222111 011100
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRP----TMIQVMAM 1133 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RP----t~~evl~~ 1133 (1176)
. ...+.+++.+||+.||++|| ++.+++++
T Consensus 221 --~---~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 221 --L---SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --C---CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 11345699999999999998 45666553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=316.23 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=197.6
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
|.....||+|+||.||++... ++..||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344467999999999999875 5889999988654444456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 104 ~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 104 GALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999988543 478999999999999999999999 999999999999999999999999999875533221
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...+. ......... .+++......
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~-----~~~~~~~~~~- 242 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAMRRIRD-----NLPPRVKDSH- 242 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-----cCCCcccccc-
Confidence 12345689999999999888899999999999999999999999864321 111111111 1111111111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ....+.+++.+|+..||++|||+++++++
T Consensus 243 ~---~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 K---VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c---cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 11134568999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=310.52 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=196.4
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|++|.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999876 68999999885432 22345688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
++ ++|.+++..... +..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 589998875432 23689999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc-----------
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL----------- 1085 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~----------- 1085 (1176)
. ......+++.|+|||++.+. .++.++||||||+++|+|+||+.||......+ ............
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhh
Confidence 1 12334578899999988654 57889999999999999999999997543111 011110000000
Q ss_pred -----ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 -----KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
................. -.++.+++.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNL---DEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCC---CHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000001 1234579999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=311.32 Aligned_cols=246 Identities=27% Similarity=0.389 Sum_probs=197.2
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556678999999999999876 57889999875332 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++... .+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998643 588999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...+.....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~-----~~~~~~~~~- 224 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFLIPK-----NSPPTLEGQ- 224 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhhhhc-----CCCCCCCcc-
Confidence 123346888999999999988999999999999999999999998643211 11111111 111111111
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+.+++.+|++.+|++||++.+++++
T Consensus 225 -----~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 225 -----YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -----cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11245679999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=313.85 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=201.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|.+.+.||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++||||+++++++......|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999865 68899999886544445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998754 478899999999999999999999 999999999999999999999999998875543322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......|++.|+|||.+....++.++||||||+++|++++|+.||........ ......... +...
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~~~-----~~~~-- 236 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGT-----PELQ-- 236 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eeehhcCCC-----CCCC--
Confidence 12344688999999999888899999999999999999999999975432110 000000000 0000
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+. .....+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPE--KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred Ccc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011235569999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=311.82 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=198.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||.||+|++. +|..||+|.+... .......+.+|+.++++++||||+++++++..+...|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999986 6899999987543 222235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++..... ...+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999998876421 236899999999999999999999742 89999999999999999999999999987553221
Q ss_pred ccccccccccCCcccCccccCCCC------CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFR------CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
.....|++.|+|||++.+.. ++.++||||+||++|+|++|+.||...... .............
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~----- 226 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVDGD----- 226 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHhhcC-----
Confidence 13446888999999985543 478999999999999999999999654311 1111111111111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+...... ...+.+++.+|++.+|++||++++++++
T Consensus 227 ~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPSGY------SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCccc------CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111 1234569999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.22 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=199.8
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++|||++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999875 68899999886432 23345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~ 1016 (1176)
+++++|.+++.... +..+++..+..++.+++.|++|||+. +|+||||||+||+++++ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997653 23589999999999999999999999 99999999999999865 46899999999866432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ............. ..
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~-----~~ 222 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGTFAP-----IS 222 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHhcCCCC-----CC
Confidence 22 13356889999999999888899999999999999999999998654321 1222221111111 11
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.+|++|||+.|++++
T Consensus 223 ~~~~------~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYS------PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcC------HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 134569999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=318.70 Aligned_cols=197 Identities=30% Similarity=0.391 Sum_probs=170.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-C-----CCcccceeEEeeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-H-----RNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 933 (1176)
+|++.++||+|+||.|.+|.+. +++.||||.+... ..-.++-..|+.++..++ | -|+|++++||.-..+.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7999999999999999999875 6999999988642 233456677999999996 4 489999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CcEEEEeecccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN--FEARVSDFGMAR 1011 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~ 1011 (1176)
|+|.++. +|+++++..+.. .++...++.++.||+.||..||+. +|||+||||+|||+.+. ..+||+|||.|+
T Consensus 266 VfELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999965 999999987654 488899999999999999999999 99999999999999653 469999999998
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
+....- ..+..+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 754321 25667899999999999999999999999999999999987776644
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=334.30 Aligned_cols=281 Identities=25% Similarity=0.246 Sum_probs=222.8
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeec---cCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIH---ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
++.-..++|.+.++||+|+||.|..++++ +++.||+|++.+ ........|..|-++|..-+.+.||+++..|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445578999999999999999999987 578889998865 22344567889999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
+.|+|||||+||+|-.++.+.+ ++++.-++.++..|+-||.-+|+. |+|||||||+|||+|..|++|++|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999998775 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccC----C-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQ----S-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
+-.+...... .....+|||.|++||+++ + +.|+..+|+||+||++|||+.|..||+... ++.-...+..
T Consensus 222 Clkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHhc
Confidence 8777654443 346789999999999984 2 578999999999999999999999997543 3333322222
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH-------HHHHhhCCCCCCCCcccccCC
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT---MIQVMAM-------FKEIQAGSGLDSQSTIATDEG 1154 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt---~~evl~~-------L~~i~~~~~~~~~~~~~~~~~ 1154 (1176)
.+-.-.|++... . ..++.++|++.+. +|+.|.. ++++-.| +..|+...++-.|...+.++.
T Consensus 296 hk~~l~FP~~~~--V------SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DT 366 (1317)
T KOG0612|consen 296 HKESLSFPDETD--V------SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDT 366 (1317)
T ss_pred hhhhcCCCcccc--c------CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcc
Confidence 211111221111 1 1134457777665 7888988 8888776 377777777777777777655
Q ss_pred CC
Q 046275 1155 GF 1156 (1176)
Q Consensus 1155 ~~ 1156 (1176)
+-
T Consensus 367 sn 368 (1317)
T KOG0612|consen 367 SN 368 (1317)
T ss_pred cc
Confidence 43
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.67 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=195.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--c---CHHHHHHHHHHHHhcCCCCcccceeEEeeC--Cee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--Q---GDREFTAEMETIGKIKHRNLVPLLGYCKVG--EER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 931 (1176)
++|++.+.||+|+||.||+|.+. +++.||+|++..... . ..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999876 589999998753221 1 124678899999999999999999988663 467
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999997654 578889999999999999999999 99999999999999999999999999987
Q ss_pred cccccccc-ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1012 LMSAMDTH-LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1012 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+ ....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~-~~~~~---- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAAIFK-IATQP---- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHHHHH-HhcCC----
Confidence 55322111 11233468899999999988889999999999999999999999986432 1111111 11111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.. |. .....+.+++.+|+. +|++||+++|++++
T Consensus 226 ~~~~~----~~--~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 TNPVL----PP--HVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCC----ch--hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11111 11 112345678889985 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=310.43 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=199.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999876 58999999886432 123456888999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997664 689999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...+ .....+....... .+++.
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--~~~~~- 220 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILEGKV--RFPSF- 220 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCc--cCCcc-
Confidence 2 234568999999999988888999999999999999999999986543 1111111111111 01111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.+|.+|| +++|++++
T Consensus 221 ---~~------~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 221 ---FS------PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CC------HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11 2345699999999999999 66676654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=309.21 Aligned_cols=239 Identities=23% Similarity=0.403 Sum_probs=186.1
Q ss_pred ceEeEeCceEEEEEEECC--------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 866 SLIGSGGFGDVYKAKLKD--------GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.||+|+||.||+|..+. ..+|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998642 234777776543333445688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------EEEEeecc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE--------ARVSDFGM 1009 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfGl 1009 (1176)
+++|+|.++++..+. .+++..++.++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999986542 588999999999999999999999 9999999999999987665 69999998
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCC-CCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGK-RPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
+...... ....+++.|+|||++.+ ..++.++||||||+++|||++|. .||...+. ......... .
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~-~- 221 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----QKKLQFYED-R- 221 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----HHHHHHHHc-c-
Confidence 8654321 23467889999999976 45789999999999999999985 55543221 111111110 0
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
..+++.. ..++.+++.+||+.||++|||++++++.|
T Consensus 222 -~~~~~~~----------~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 -HQLPAPK----------WTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -ccCCCCC----------cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111111 12456799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.46 Aligned_cols=251 Identities=29% Similarity=0.443 Sum_probs=199.4
Q ss_pred CCCCceEeEeCceEEEEEEECC-----CCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKD-----GSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+++.+.||.|+||.||++++.+ +..||+|++...... ..+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998764 388999988544332 4567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999986542 1289999999999999999999999 999999999999999999999999999976654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
...... ....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...+ ...............
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~~----- 224 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEYLKKGYRLP----- 224 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCCCCC-----
Confidence 322211 12336789999999988889999999999999999998 788876432 122222222211111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
..... ..++.+++.+|+..+|++|||+.++++.|
T Consensus 225 ~~~~~------~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENC------PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcC------CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111 12456699999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=312.90 Aligned_cols=198 Identities=24% Similarity=0.386 Sum_probs=161.2
Q ss_pred CceEeEeCceEEEEEEEC---CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeEEEEeecc
Q 046275 865 DSLIGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERLLVYEYMR 939 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 939 (1176)
..+||+|+||.||+|+.+ ++..||+|.+... .....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999875 3578999987542 223467889999999999999999998853 567799999986
Q ss_pred CCCHHHHHhhccc-----cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEeeccc
Q 046275 940 YGSLEDVLHNQKK-----VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMA 1010 (1176)
Q Consensus 940 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla 1010 (1176)
+ +|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 88888753321 123588999999999999999999999 99999999999999 56678999999999
Q ss_pred ccccccccc-ccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1011 RLMSAMDTH-LSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1011 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 866432221 12234578999999999876 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.39 Aligned_cols=237 Identities=22% Similarity=0.386 Sum_probs=187.3
Q ss_pred ceEeEeCceEEEEEEECCCC-----------EEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 866 SLIGSGGFGDVYKAKLKDGS-----------TVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999986433 4667765433222 5778899999999999999999999887 778999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-------cEEEEee
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-------EARVSDF 1007 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df 1007 (1176)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999986542 588999999999999999999998 999999999999999887 7999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
|++..... .....++..|+|||++... .++.++||||||+++|||++ |..||...+. . .+......
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~---~~~~~~~~ 221 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--S---EKERFYQD 221 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--h---hHHHHHhc
Confidence 99876543 1234567789999999876 78899999999999999999 5777765431 1 11111111
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.. .. . .+. ...+.+++.+||+.+|++|||+.++++.|
T Consensus 222 ~~---~~-----~-~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QH---RL-----P-MPD----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC---CC-----C-CCC----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 00 0 000 13566799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=302.39 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=201.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|+||.||+++.. +|+.||+|++... .....+++.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999876 6899999988643 223345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+.+++|.+++.... ...+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999997543 22578999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......|++.|+|||+..+..++.++|||||||++|+|++|+.||...+ .............. ....
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~-----~~~~ 223 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGSYP-----PVSS 223 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCCCC-----CCcc
Confidence 1 1233468899999999998889999999999999999999999986432 22222222222111 1111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ...+.+++.+||+.+|.+||++.+|+++
T Consensus 224 ~~------~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HY------SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cC------CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 1235669999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=314.26 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=198.2
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..+...++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999876 6899999998654445556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
++|.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 9999987543 588999999999999999999999 999999999999999999999999999875433221
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ............ +. ....+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~-----~~-~~~~~ 241 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRDSPP-----PK-LKNAH 241 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhccCC-----CC-ccccC
Confidence 12345689999999999988899999999999999999999999864321 111111111110 00 00001
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ...+.+++.+|++.+|++||++++++++
T Consensus 242 ~~---~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KI---SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CC---CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11 1235569999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=307.71 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=199.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.|+..+.||.|+||.||+|.++ +++.||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999876 58889999875432 233456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++... ++++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998743 578899999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......++..|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...+....
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~-----~~~~~~~~- 223 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLIPK-----NNPPTLTG- 223 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhhhc-----CCCCCCch-
Confidence 123346788999999998888999999999999999999999998643311 11111111 11111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+.+++.+||+.+|++||++.+++++
T Consensus 224 -----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 -----EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 122345679999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=310.40 Aligned_cols=267 Identities=24% Similarity=0.279 Sum_probs=196.6
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++++|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3568999999999999999999875 689999998864332 22346778999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+. +++.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 68877775432 2478888999999999999999999 999999999999999999999999999875433
Q ss_pred ccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc---------c
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK---------L 1085 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~---------~ 1085 (1176)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+......... .
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 221 12334578999999998753 57889999999999999999999997543211111100000000 0
Q ss_pred ccccccCcccccCCCch-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 KISDVFDPELMKEDPNI-------EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..............+.. ......+.+++.+|++.||.+|||++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000 0012345679999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=345.73 Aligned_cols=481 Identities=30% Similarity=0.376 Sum_probs=310.2
Q ss_pred ccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccE
Q 046275 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200 (1176)
Q Consensus 121 L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~ 200 (1176)
++.|+++.|.+-..+ +.+..++-+|+.|+|++|++...|..+-. ..+|+.|+++.|-|.. +| .....+.+|++
T Consensus 23 ~~~ln~~~N~~l~~p--l~~~~~~v~L~~l~lsnn~~~~fp~~it~-l~~L~~ln~s~n~i~~---vp-~s~~~~~~l~~ 95 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRP--LEFVEKRVKLKSLDLSNNQISSFPIQITL-LSHLRQLNLSRNYIRS---VP-SSCSNMRNLQY 95 (1081)
T ss_pred HHhhhccccccccCc--hHHhhheeeeEEeeccccccccCCchhhh-HHHHhhcccchhhHhh---Cc-hhhhhhhcchh
Confidence 444555555443322 22333444455555555555544433222 2355555555555554 22 22244556666
Q ss_pred EEeCCCcccc-cccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccC
Q 046275 201 LALKGNKVTG-DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279 (1176)
Q Consensus 201 L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (1176)
|+|.+|.+.. +..+..+++|++|++|.|++...|.-+..++.++.+..++|..... ++... ++.+++..|.+.+
T Consensus 96 lnL~~n~l~~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~ 170 (1081)
T KOG0618|consen 96 LNLKNNRLQSLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGG 170 (1081)
T ss_pred heeccchhhcCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhccc
Confidence 6666666654 3456677777888888888777777777777777777777722211 22222 6777777777665
Q ss_pred ccCCCCccccCcchhhhhhcCCCcc-EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEcc
Q 046275 280 PIPVGYNEFQGEIPLHLADLCSSLV-KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358 (1176)
Q Consensus 280 ~~p~~~~~l~~~i~~~~~~~l~~L~-~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls 358 (1176)
.++.+.. .++ .|+|++|.+. . -.+.++.+|+.|....|+++ .+. -.-++|+.|+.+
T Consensus 171 ~~~~~i~---------------~l~~~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls-~l~----~~g~~l~~L~a~ 227 (1081)
T KOG0618|consen 171 SFLIDIY---------------NLTHQLDLRYNEME-V--LDLSNLANLEVLHCERNQLS-ELE----ISGPSLTALYAD 227 (1081)
T ss_pred chhcchh---------------hhheeeecccchhh-h--hhhhhccchhhhhhhhcccc-eEE----ecCcchheeeec
Confidence 5444332 233 4777777776 2 34566777777777777776 332 234677778888
Q ss_pred CcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccC
Q 046275 359 FNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438 (1176)
Q Consensus 359 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 438 (1176)
+|.++...+. ..-.+|+++++++|+++ .+|+.+ ..+.+|+.|...+|+|+ .+|..+...++|+.|++.+|.+.
T Consensus 228 ~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi--~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~- 300 (1081)
T KOG0618|consen 228 HNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWI--GACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE- 300 (1081)
T ss_pred cCcceeeccc--cccccceeeecchhhhh-cchHHH--HhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-
Confidence 8877743322 22356778888888777 566555 34567788888888885 67777777788888888888887
Q ss_pred CCCccccCCCccCeeecccccccCCCCCCC-CCcc-ccceeecccccccCcccc-ccccCCCCCeeeccccccCCCCCcc
Q 046275 439 TIPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQ-TLETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTW 515 (1176)
Q Consensus 439 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~ 515 (1176)
.+|.....++.|+.|+|..|+|. .+|+.+ .-+. +|+.|..+.|++. ..|. .=..+..|+.|++.+|.|+...-..
T Consensus 301 yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 301 YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhh
Confidence 67777777888888888888877 444433 3333 3677777777777 3441 2234567888888888888766667
Q ss_pred ccCCCCCCeEEccCCcccccCCC-CCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccC
Q 046275 516 IGQLSNLAILKLSNNSFYGRIPP-ELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHG 594 (1176)
Q Consensus 516 ~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 594 (1176)
+-+.++|+.|+|++|++. .+|. .+.++..|+.|+||+|+|+ .+|.++-.
T Consensus 379 l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~---------------------------- 428 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVAN---------------------------- 428 (1081)
T ss_pred hccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHh----------------------------
Confidence 778888888888888887 4554 5777888888888888887 56654421
Q ss_pred CCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccc
Q 046275 595 AGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG 674 (1176)
Q Consensus 595 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g 674 (1176)
++.|++|...+|++. ..| ++..++.|+.+|+|.|+|+-
T Consensus 429 ----------------------------------------~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 429 ----------------------------------------LGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred ----------------------------------------hhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 123566777778887 677 88888899999999998873
Q ss_pred c-CCccccCcCcccEEEccCccccccCCCCccccccccccccccc
Q 046275 675 P-IPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718 (1176)
Q Consensus 675 ~-iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N 718 (1176)
. +|...-. ++|++|||++|.=.-.--..|..+.++..++++-|
T Consensus 467 ~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 467 VTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 3 4443333 89999999999832133445666777777777766
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.70 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=194.8
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|+||.||+|++. +|+.||+|++..... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999986 689999998854322 2235677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
++ ++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 58888876543 2589999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc------cccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK------ISDV 1090 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~ 1090 (1176)
. ......+++.|+|||++.+. .++.++||||+||++|+|+||+.|+.........+........... ..+.
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 1 12334678899999998664 4689999999999999999999986433211111100000000000 0000
Q ss_pred cCcccccCCCch-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNI-------EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.......+.. ..-...+.+++.+||+.||.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000000 0011245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.68 Aligned_cols=238 Identities=22% Similarity=0.341 Sum_probs=183.9
Q ss_pred eEeEeCceEEEEEEECC-------------------------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccc
Q 046275 867 LIGSGGFGDVYKAKLKD-------------------------GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 921 (1176)
.||+|+||.||+|.... ...|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997521 13477887754333334568889999999999999999
Q ss_pred eeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-
Q 046275 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF- 1000 (1176)
Q Consensus 922 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 1000 (1176)
++++.++...++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999987532 2588999999999999999999999 999999999999997643
Q ss_pred ------cEEEEeeccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHH-cCCCCCCCCCCCC
Q 046275 1001 ------EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELL-TGKRPTDSADFGD 1072 (1176)
Q Consensus 1001 ------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~P~~~~~~~~ 1072 (1176)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999987643221 22357888999998865 56899999999999999985 6999986543111
Q ss_pred ccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
...+... ... ++. +. ...+.+++.+||+.+|++|||++++++.|
T Consensus 230 --~~~~~~~--~~~----~~~------~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 --KERFYEK--KHR----LPE------PS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HHHHHHh--ccC----CCC------CC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111110 000 110 00 01356799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=304.07 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=202.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+..+...++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999875 57889999885432 22456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++..... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 13589999999999999999999999 99999999999999999999999999987665433
Q ss_pred ccc--cccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THL--SVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... ......|+..|+|||++... .++.++|||||||++|+|++|+.||....... ........ . ++.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~-~-----~~~ 226 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQN-D-----PPS 226 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcC-C-----CCC
Confidence 221 11334689999999998776 78999999999999999999999996543211 11111111 1 011
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+ ...-...+.+++.+|++.||++|||+++++++
T Consensus 227 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGAD-YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccc-cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 110000 00011245679999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=313.12 Aligned_cols=256 Identities=22% Similarity=0.291 Sum_probs=198.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||++.+. +++.|++|.+..... ...+.+.+|+++++.++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999886 578999998864332 22346778999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++...+ .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997654 589999999999999999999999 999999999999999999999999998864211
Q ss_pred ccc-------------cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1016 MDT-------------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1016 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
... ........|+..|+|||++.+..++.++||||||+++|||++|+.||.+.. ..++....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~~~ 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQV 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence 000 001112457889999999988889999999999999999999999986432 12222222
Q ss_pred hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
...... .+......+ ..+.+++.+||+.+|++||++.++.+.++.
T Consensus 229 ~~~~~~---~~~~~~~~~------~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDIE---WPEGDEALP------ADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HhcccC---CCCccccCC------HHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 221111 011101111 134569999999999999996555555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=307.87 Aligned_cols=261 Identities=25% Similarity=0.340 Sum_probs=199.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||.|+||.||+|++. +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999876 68999999986543 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+ +++|.+++.... .++++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++++|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987654 3689999999999999999999999 99999999999999999999999999988665432
Q ss_pred ccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc------cccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK------ISDV 1090 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~ 1090 (1176)
. .......|+..|+|||++.+. .++.++||||+|+++|||++|+.||..... ...+........ ..+.
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHHhhc
Confidence 2 112345689999999998654 468899999999999999999887754321 111111100000 0000
Q ss_pred -----cCcc-cccCCCch-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 -----FDPE-LMKEDPNI-----EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 -----~~~~-~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... .....+.. ......+.+++.+|++.+|++|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000 0011456679999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=303.61 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=200.9
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|.+.+.||+|+||.||+|... +++.|++|.+...... ..+.+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999875 6889999988654433 456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++.... .+++..+..++.++++|++|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997653 578899999999999999999999 99999999999999999999999999988765433
Q ss_pred cccc--ccccccCCcccCccccCCCC---CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1018 THLS--VSTLAGTPGYVPPEYYQSFR---CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1018 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.. .......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~~~~~-----~~ 224 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVGAG-----HK 224 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHHHhcC-----CC
Confidence 2211 12356789999999998766 889999999999999999999999754311 1111111111 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.+.... . -...+.+++.+|++.+|++|||+.+++++
T Consensus 225 ~~~~~~~-~---~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIPDSL-Q---LSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCccc-c---cCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111 0 01234569999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=311.16 Aligned_cols=261 Identities=26% Similarity=0.382 Sum_probs=198.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|.++ +++.||+|++...... ..+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 5899999987543222 24568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++++++.++..... .+++.+++.++.|++.|++|||+. +++||||+|+||++++++.++++|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999888776432 589999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-cccc----c-
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK-LKIS----D- 1089 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~----~- 1089 (1176)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+...... .... +
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHH
Confidence 22 2234567899999999865 4567899999999999999999999864331 1111111000 0000 0
Q ss_pred ---------ccCcccccCCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 ---------VFDPELMKEDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ---------~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+......+... .....+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000000 012346679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.86 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=197.1
Q ss_pred CCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ 929 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 929 (1176)
|.+.+.||+|+||.||+|.++ +++.||+|.+.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999764 36889999885422 223456889999999999999999999875432
Q ss_pred eeEEEEeeccCCCHHHHHhhcc--ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQK--KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
..++++||+.+|+|.+++.... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875432 1123578999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|.++...............+++.|++||.+....++.++||||||+++|||++ |+.||...+. ...........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~~~~~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYNYLIKGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHHHHHcCC
Confidence 99986543322222223345678999999988889999999999999999999 8888864321 11111111111
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.. ... +. ....+.+++.+|++.+|++||++.++++.|+++
T Consensus 233 ~~-----~~~---~~---~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RL-----KQP---PD---CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC-----CCC---CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 000 11 112466799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=308.72 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=197.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-----CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-----GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
+|++.+.||+|+||.||+|.+. +|+.||+|++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999876 6899999998654322 234567899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+ +|+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997653 2689999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc--------
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL-------- 1085 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------- 1085 (1176)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+..........
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhc
Confidence 4322 1233456888999998854 46788999999999999999997777643311 1011110000000
Q ss_pred -ccccccCcccccCCCc---hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 -KISDVFDPELMKEDPN---IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 -~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..............+. .......+.+++.+||+.+|++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000000 00112356689999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.73 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=200.4
Q ss_pred cCHHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEee
Q 046275 850 LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKV 927 (1176)
Q Consensus 850 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 927 (1176)
.+..++....+.|++.+.||.|+||.||+|++. +++.+|+|.+... .....++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 344555566788999999999999999999885 5788999987543 23345688899999998 79999999999853
Q ss_pred ------CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 046275 928 ------GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001 (1176)
Q Consensus 928 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 1001 (1176)
....++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 457899999999999999997644 23578889999999999999999999 9999999999999999999
Q ss_pred EEEEeeccccccccccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH
Q 046275 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 1002 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 1076 (1176)
++|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||...... .
T Consensus 160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~ 233 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----R 233 (282)
T ss_pred EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----h
Confidence 99999999875432211 123456899999999875 346788999999999999999999998643211 1
Q ss_pred HHHHHhhccccccccCcccc-cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1077 GWVKQHAKLKISDVFDPELM-KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ... ...+... ...+ ..+.+++.+||+.||.+|||+.|++++
T Consensus 234 ~~~~-~~~-----~~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 234 ALFL-IPR-----NPPPKLKSKKWS------KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhh-Hhh-----CCCCCCcccccC------HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1100 000 0111111 1111 245679999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=300.98 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=205.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|++|.||+|++. +++.|++|++..... ...+.+.+|++++.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999887 589999998865433 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
+++++|.+++.... ++++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999998653 68999999999999999999999 8 9999999999999999999999999998766432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+.......... +...
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~-----~~~~ 224 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPP-----PSLP 224 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCC-----CCCC
Confidence 221 1245678999999999998999999999999999999999999876532 112222222221111 1111
Q ss_pred cC-CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KE-DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~-~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .+ ..+.+++.+|++.+|++|||+.+++++
T Consensus 225 ~~~~~------~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFS------PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCC------HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 11 245569999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.43 Aligned_cols=371 Identities=26% Similarity=0.391 Sum_probs=303.0
Q ss_pred CCccEEEccCCccc-ccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEE
Q 046275 301 SSLVKLDLSSNNLS-GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 379 (1176)
+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|.++ +.+.+|++|.+++|++. .+-..++.++.|+.+
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL-~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEEL-SRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHH-HHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 44566777888877 467777888888888888888886 778774 67888888888888887 555667778888888
Q ss_pred EccCCcCCC-CCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCc-cccCCCccCeeeccc
Q 046275 380 DLSSNNLSG-AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPS-SLGSLSKLQDLKLWL 457 (1176)
Q Consensus 380 ~Ls~N~l~~-~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~ 457 (1176)
++..|++.. -+|..++. +..|+.|+|++|++. +.|..+...+++..|+||+|+|. +||. -|-+|+.|-.|+||+
T Consensus 84 ~~R~N~LKnsGiP~diF~--l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFR--LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred hhhccccccCCCCchhcc--cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 888887752 35666643 567888888888888 67888888888888999999888 5565 456888888899999
Q ss_pred ccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccC-CCCCccccCCCCCCeEEccCCcccccC
Q 046275 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG-GEIPTWIGQLSNLAILKLSNNSFYGRI 536 (1176)
Q Consensus 458 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~ 536 (1176)
|++. .+|+.+..+..|++|+|++|.+..---..+-.+++|++|.+++.+-+ ..+|.++..+.+|..+|||.|.+. .+
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 9888 78888888888999999998876444455567788888899887643 368888999999999999999998 88
Q ss_pred CCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCC
Q 046275 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRS 616 (1176)
Q Consensus 537 p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 616 (1176)
|..+.++++|+.|+||+|+++. +-...
T Consensus 238 Pecly~l~~LrrLNLS~N~ite-L~~~~---------------------------------------------------- 264 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKITE-LNMTE---------------------------------------------------- 264 (1255)
T ss_pred hHHHhhhhhhheeccCcCceee-eeccH----------------------------------------------------
Confidence 9999999999999999998872 11000
Q ss_pred CCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCcccccc-CCccccCcCcccEEEccCcc
Q 046275 617 PCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGP-IPTEVGDLRGLNILDLSSNR 695 (1176)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~-iP~~~~~L~~L~~L~Ls~N~ 695 (1176)
..-.+|+.|+||.|+|+ .+|..++.|+.|+.|++.+|+|+-. ||..||+|.+|+.+..++|.
T Consensus 265 ----------------~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 265 ----------------GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNK 327 (1255)
T ss_pred ----------------HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence 00024778999999999 8999999999999999999999754 99999999999999999999
Q ss_pred ccccCCCCccccccccccccccccccCCCCCCCCccccCCccccCCCCCCCCCCCC
Q 046275 696 LEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPP 751 (1176)
Q Consensus 696 l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~~~~~~~ 751 (1176)
|+ -+|..++.+..|+.|.|+.|+|-..+-.+-.+..+..+....|+.|.-+|.|.
T Consensus 328 LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPKP~ 382 (1255)
T KOG0444|consen 328 LE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPKPN 382 (1255)
T ss_pred cc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCCcc
Confidence 99 89999999999999999999999887777778888899999999988776553
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=316.49 Aligned_cols=272 Identities=26% Similarity=0.340 Sum_probs=205.4
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------eeEE
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ERLL 933 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 933 (1176)
|...+.||+|+||.||+|+++ +|+.||||.+.... ....+...+|++++++++|||||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 79999999886543 333456789999999999999999999765443 4689
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCC--cEEEEeecc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD--ENF--EARVSDFGM 1009 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfGl 1009 (1176)
|||||.||+|+..+++.+. ..-+++.+.+.++.+++.||.|||++ +||||||||.||++- ++| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999987543 34599999999999999999999998 999999999999983 333 479999999
Q ss_pred ccccccccccccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc--c
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--K 1086 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~ 1086 (1176)
|+..++.. .....+||+.|.+||.+. ...|+..+|.|||||++|++.||..||.+..-+..+.........+. .
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99876544 456789999999999998 48899999999999999999999999987654432222221111110 0
Q ss_pred cccc----------cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHhhC
Q 046275 1087 ISDV----------FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP--TMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1087 ~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP--t~~evl~~L~~i~~~ 1140 (1176)
+... ....++...........++-+....+|..+|++|- ...+....+..|...
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0000 11111111112223444556778888999999999 777777777666544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.72 Aligned_cols=248 Identities=24% Similarity=0.299 Sum_probs=200.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
+|++.+.||.|+||.||+|+++ +++.||+|.+..... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999986 589999998865322 335678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+.+++|.+++.... ++++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999997653 688999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
. ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||...+.. ........... .....++.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~--~~~~~~~~-- 224 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET--ADVLYPAT-- 224 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc--ccccCccc--
Confidence 2 123456888999999998888999999999999999999999999765422 11111111111 11111111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTM--IQVMA 1132 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~--~evl~ 1132 (1176)
.+ ..+.+++.+||+.||.+||++ +|+++
T Consensus 225 --~~------~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 --WS------TEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred --Cc------HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11 245579999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.88 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=196.7
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|.. +++.||+|++... .....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 5888999987532 2345788999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999997653 23578999999999999999999998 99999999999999999999999999987543211
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .+.....
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~~ 221 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVEKGY-----RMEPPEG 221 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHhCCC-----CCCCCCc
Confidence 22234578999999988899999999999999999997 999986543 222222222211 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.+ ..+.+++.+||+.+|++||+++++++.|++
T Consensus 222 ~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CP------ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CC------HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 245579999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=308.61 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=196.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999886 689999998864322 2234567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++ +|.+++..... .+++...+.++.|++.||.|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 99998876532 588999999999999999999999 99999999999999999999999999986543211
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc---ccc------
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK---LKI------ 1087 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~---~~~------ 1087 (1176)
. ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.........+......... ...
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1122346889999999865 457899999999999999999999996543111111000000000 000
Q ss_pred --------ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 --------SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+..+....+.. .....+.+++.+|++.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000000000 011345679999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=312.43 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=199.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999886 4899999988654322 3356888999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+.+++|.+++.... +..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987543 23689999999999999999999999 999999999999999999999999999875432
Q ss_pred cccc---------------------------ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1016 MDTH---------------------------LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1016 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
.... .......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0112346889999999999888999999999999999999999999754
Q ss_pred CCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 046275 1069 DFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT----MIQVMAM 1133 (1176)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt----~~evl~~ 1133 (1176)
+.. ..+.... .... ...... . .-..+.+++.+|++.||++||| +++++++
T Consensus 236 ~~~----~~~~~~~-~~~~------~~~~~~-~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRD----ETFSNIL-KKEV------TFPGSP-P---VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chH----HHHHHHh-cCCc------cCCCcc-c---cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 321 1111111 1110 000000 0 1124567999999999999999 5555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.32 Aligned_cols=256 Identities=30% Similarity=0.431 Sum_probs=199.6
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCC------
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGE------ 929 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 929 (1176)
++++|++.+.||+|+||.||+|..+ +++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999986 57889999875433 3456789999999999 7999999999996644
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++||||+++++|.+++......+..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+|++|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999876543344789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
+........ ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||...... .. ......
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~ 232 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RA-LFKIPR 232 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HH-HHHhhc
Confidence 876543221 2234568999999998753 34678999999999999999999998643211 11 111111
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .+.... + ......+.+++.+||..||++|||+.+++++
T Consensus 233 ~~-----~~~~~~--~--~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NP-----PPTLKS--P--ENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cC-----CCCCCc--h--hhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111110 0 0011245579999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=305.75 Aligned_cols=242 Identities=25% Similarity=0.304 Sum_probs=185.3
Q ss_pred eEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHh---cCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGK---IKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
.||+|+||.||+++.. +++.+|+|.+..... .....+.+|..+++. .+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999886 588999998854321 112334445444443 479999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999987654 689999999999999999999999 899999999999999999999999999875433221
Q ss_pred ccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
....|++.|+|||.+. +..++.++||||+||++|+|++|+.||....... ......... . .+..+...
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~--~----~~~~~~~~ 221 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTL--T----VNVELPDS 221 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHhh--c----CCcCCccc
Confidence 2346899999999986 4568899999999999999999999997543221 111111110 0 11111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||++|| |+++++++
T Consensus 222 ~~------~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 FS------PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cC------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 2455699999999999999 58888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=313.18 Aligned_cols=205 Identities=24% Similarity=0.384 Sum_probs=170.9
Q ss_pred CCCCCceEeEeCceEEEEEEECC---CCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD---GSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERL 932 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 932 (1176)
+|.+.+.||+|+||.||+|..+. ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999986532 33345678899999999999999999999888 7899
Q ss_pred EEEeeccCCCHHHHHhhccccC-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC----CCcEEEEee
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVG-IKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE----NFEARVSDF 1007 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 1007 (1176)
+||||+++ ++.+++....... ..+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7877776443322 3689999999999999999999999 8999999999999999 899999999
Q ss_pred ccccccccccc-cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1008 GMARLMSAMDT-HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1008 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
|++........ ........+++.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543222 1122345678999999988664 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=303.25 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=198.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
-|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677889999999999999875 68899999875332 223356888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998743 588999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.... ............ .+.+...
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~~ 224 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFLIPKNN-----PPTLEGN 224 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHHHhcCC-----CCCCCcc
Confidence 1233468889999999988888999999999999999999999986432 111111111111 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~------~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YS------KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cC------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 235569999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=303.01 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=198.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcC---CCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIK---HRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.|+..+.||+|+||.||+|.+. +++.||+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999875 6899999987543 2334456888999999996 999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++... .+++..++.++.|++.|+.|||+. +|+||||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998643 588999999999999999999999 999999999999999999999999999986654
Q ss_pred ccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .......... ..+.
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~-----~~~~ 221 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLIPKS-----KPPR 221 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhccccC-----CCCC
Confidence 332 1234568999999998865 4568899999999999999999999965431 1111111111 1122
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.... ....+.+++.+||+.||++||++.+++++
T Consensus 222 ~~~~~-----~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDNG-----YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCccc-----CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 21110 11245679999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=312.69 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=199.4
Q ss_pred CCceEeEeCceEEEEEEEC--CCC--EEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 864 NDSLIGSGGFGDVYKAKLK--DGS--TVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
..++||+|.||.|+.|.|+ .|+ .||||.+...... ...+|.+|+.+|.+++|||++++||++.+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4568999999999999886 344 5799988654333 56789999999999999999999999877 7789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+.|+|.+.+++.. ...+.......++.|||.||.||..+ +.||||+.++|+++-....|||+|||+.+-++..+.
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999833 23678889999999999999999999 999999999999999999999999999998877666
Q ss_pred cccccc-cccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1019 HLSVST-LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1019 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
++.+.. ..-...|.|||.+...+++.++|||+|||++|||+| |..||-+.. -.+..+.+..+ +.+.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~qIL~~iD~~---erLp---- 335 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQILKNIDAG---ERLP---- 335 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHHHHHhcccc---ccCC----
Confidence 554432 233567999999999999999999999999999999 899997643 11112211111 1111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
+.+... ..+.+++..||..+|++|||+..+.+.+
T Consensus 336 -RPk~cs---edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 -RPKYCS---EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -CCCCCh---HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111111 2355699999999999999999998554
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.43 Aligned_cols=202 Identities=28% Similarity=0.398 Sum_probs=180.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.+.|+.-++||+|+||.||-++.+ +|+.+|.|++.+. ....+.....|-.++.++..++||.+-..|+..+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 346788899999999999999765 6999999987442 234455678899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
+..|.||+|.-++...+. .-+++..++.++.+|+.||++||.. +||+||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999987764 3589999999999999999999999 99999999999999999999999999999876
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
..+.. ...+||.+|||||++....|+...|+||+||++|||+.|+.||...
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 65443 4458999999999999999999999999999999999999999754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=285.00 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=204.6
Q ss_pred ceEeEeCceEEEEEE-ECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
+.||+|+|+.|--+. ..+|..+|||++.+........+.+|++++... .|+||++++++|++++..|+|||.|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999999886 568999999999888777788899999999998 599999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEEeecccccccccc---
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF---EARVSDFGMARLMSAMD--- 1017 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~--- 1017 (1176)
.++++.++ -+++.++.++.++||.||.+||.+ ||.|||+||+|||..... .+||+||.++.-.....
T Consensus 164 LshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99999876 589999999999999999999999 999999999999997654 38999999875332111
Q ss_pred --ccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----CCccHHHHH-----H
Q 046275 1018 --THLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADF-----GDNNLVGWV-----K 1080 (1176)
Q Consensus 1018 --~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~-----~~~~~~~~~-----~ 1080 (1176)
......+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||.+..- +.+...... +
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 111234678999999999863 44789999999999999999999999976432 122222222 2
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhCCCCCC
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAGSGLDS 1145 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~~~ 1145 (1176)
.++.+.. ++ +..-|.. -..+.-+++...+..|+.+|.++.+++++ ...++.....++
T Consensus 317 sIQEGkY-eF-PdkdWah------IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 317 SIQEGKY-EF-PDKDWAH------ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred HHhccCC-cC-ChhhhHH------hhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 2222221 11 1111211 11234468888899999999999999884 444444444443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=305.77 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=196.2
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|+..+.||.|++|.||+|+++ +|+.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999886 68999999885432 22235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 58999887643 23689999999999999999999999 99999999999999999999999999987554322
Q ss_pred ccccccccccCCcccCccccCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc-----------
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL----------- 1085 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~----------- 1085 (1176)
. ......+++.|+|||++.+.. ++.++||||||+++|||+||+.||...+... ............
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHH
Confidence 1 123345788999999886644 5889999999999999999999997543211 111111100000
Q ss_pred -----ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 -----KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..............+... ..+.+++.+|++.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLD---EDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCC---HHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000001111 234579999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=296.93 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=203.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 935 (1176)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++++... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999987 689999998865432 3456788999999999999999999999888 8899999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998654 689999999999999999999998 999999999999999999999999999887654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
...........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+ +.............. +.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~----~~~ 225 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSSGEP----PEI 225 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccccCCC----cCC
Confidence 432111234568899999999988889999999999999999999999997654 111111111110111 111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... -..+.+++.+|++.+|++||++.+++++
T Consensus 226 ~~~~------~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHL------SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred Cccc------CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111 1245669999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=302.19 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=198.9
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
|...+.||+|++|.||+|... +++.+++|++........+.+.+|+.+++.++||||+++++++......++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999875 6889999988654444456688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
++|.+++... ++++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+........
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998762 588999999999999999999999 999999999999999999999999998865433211
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+ ............ .+.... .+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~-~~ 239 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIRDNL-----PPKLKN-LH 239 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHhcC-----CCCCcc-cc
Confidence 1133568999999999988889999999999999999999999986432 122222222111 111110 00
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. -..+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~---~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KV---SPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cC---CHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 01 1245679999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=340.41 Aligned_cols=253 Identities=28% Similarity=0.384 Sum_probs=199.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+-+|.....||.|.||.||-|..- +|+-.|+|.+..... .....+.+|+.++..++|||+|+++|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346778899999999999999764 688899997754322 23345789999999999999999999988889999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|||++|+|.+.+...+ ..++.....+-.|++.|++|||+. |||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999998664 467777778889999999999999 999999999999999999999999999987654
Q ss_pred ccc--cccccccccCCcccCccccCCC---CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1016 MDT--HLSVSTLAGTPGYVPPEYYQSF---RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1016 ~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
.-. ........||+.|||||++.+. ...-+.||||+|||+.||+||++||...+.... .+....-+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVAAGHK--- 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHhccCC---
Confidence 321 1123467899999999999653 456789999999999999999999987653221 1111112221
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
|.++... -.+-.+|+..||+.||.+|.++.|++++
T Consensus 1460 --Pq~P~~l------s~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --PQIPERL------SSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --CCCchhh------hHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111110 1123469999999999999999877765
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=308.95 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=205.7
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC--HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG--DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
-...|.+...||+|.|+.|.+|++. ++..||+|.+.+..... .+.+.+|+++|..++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467899999999999999999876 69999999886543332 24588999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+.+|.+++++...+ +..+..++.++.|+.+|++|||++ .|||||||++||+++.+..+||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999876 456688899999999999999999 89999999999999999999999999998776
Q ss_pred cccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc--cccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--KISDVF 1091 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1091 (1176)
... ...+.+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++..... .......+ .+...+
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----LRPRVLRGKYRIPFYM 278 (596)
T ss_pred ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----ccchheeeeeccccee
Confidence 322 3467899999999999998776 578999999999999999999997654321 11111111 111111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
. ..+-+++++++-.+|.+|++.+++.++-
T Consensus 279 s--------------~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 279 S--------------CDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred e--------------chhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1 1234589999999999999999998764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=298.13 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=200.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|+++++.++|+||+++++++..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999886 58889999885432 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 1016 (1176)
+++++|.+++.... +..+++..++.++.|+++|+.|||+. +++|+||||+||++++++ .+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997643 23579999999999999999999999 999999999999999875 4699999998765432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ...+........... ..
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~-~~---- 223 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAP-IS---- 223 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCC-CC----
Confidence 21 1233468999999999988889999999999999999999999986432 222332222221111 11
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+... ..+.+++.+|++.+|++|||+.|++++
T Consensus 224 ---~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 ---PNFS---RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111 135569999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=307.87 Aligned_cols=263 Identities=26% Similarity=0.337 Sum_probs=198.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|.++ +++.|++|++... .......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999887 5889999987543 22334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++++.+..+..... .+++.++..++.|++.|++|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877666554332 589999999999999999999999 9999999999999999999999999998876543
Q ss_pred cccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-----------
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK----------- 1084 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~----------- 1084 (1176)
... ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+ .+.........
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhccc
Confidence 321 22345678899999999887 88999999999999999999999986542111 00000000000
Q ss_pred -c-----ccccccCcccc-cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 -L-----KISDVFDPELM-KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 -~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ...+..++... ...+.. .-..+.+++.+||+.+|++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGK--VSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCc--cchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000000000 000000 02346779999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=299.14 Aligned_cols=251 Identities=24% Similarity=0.292 Sum_probs=192.5
Q ss_pred HHHHHHHhcCCCCCceE--eEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEee
Q 046275 852 FADLLEATNGFHNDSLI--GSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKV 927 (1176)
Q Consensus 852 ~~~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 927 (1176)
..+.....++|++.+.+ |.|+||.||+++.+ ++..+|+|.+....... .|+.....+ +|||++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34444555677777776 99999999999876 57888888875432111 122222222 79999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEe
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSD 1006 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 1006 (1176)
+...++||||+++|+|.+++.... ++++.++..++.|+++|+.|||+. +++||||||+||+++.++ .++++|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 999999999999999999998654 689999999999999999999999 899999999999999988 999999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
||++...... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||............+.... ...
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 226 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK 226 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc
Confidence 9998755321 234688999999999988999999999999999999999999975432222222232211 100
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-MIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-~~evl~~ 1133 (1176)
...... .-..+.+++.+||+.+|++||+ +++++++
T Consensus 227 ------~~~~~~------~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 ------LPFIKN------VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ------CCcccc------cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 011111 1124567999999999999996 5888764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=305.81 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=203.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++.|+..+.||.|+||.||+|.+. ++..|++|++..... ..+.+.+|++++++++|+|++++++++......|+|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999887 689999998865433 45678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998754 3689999999999999999999998 9999999999999999999999999988655432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+. .................+.
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~-- 240 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LRALFLITTKGIPPLKNPE-- 240 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCCCCcchh--
Confidence 21 12334578899999999888899999999999999999999999864321 1111111111111111110
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+|++.+|.+|||+.+++++
T Consensus 241 -~~~------~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 241 -KWS------PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -hCC------HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011 235569999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=304.00 Aligned_cols=247 Identities=30% Similarity=0.399 Sum_probs=195.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
..|...+.||+|+||+||+|+.. +++.||+|++...... ..+++.+|+++++.++||||+++++++..+...|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999876 6899999988643322 2346889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||++ |++.+++.... .++++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 58877776433 2589999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
. ....|++.|+|||++. ...++.++||||||+++|||++|+.||...+. ............
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~----- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNDS----- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHHHHHHhcCCC-----
Confidence 2 2346788999999874 45688899999999999999999999864321 111111111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
+..... .....+.+++.+||+.+|++||++.+++++-
T Consensus 232 ~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 PTLSSN-----DWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCCch-----hhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 111000 0112456799999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=302.04 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=182.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCC----CEEEEEEeeccCCcCH-----------HHHHHHHHHHHhcCCCCccccee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDG----STVAIKKLIHISGQGD-----------REFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
.++|.+.+.||+|+||+||+|.+.++ ..+|+|.......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999987643 4455554322111110 01223334556678999999999
Q ss_pred EEeeCC----eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 046275 924 YCKVGE----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN 999 (1176)
Q Consensus 924 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 999 (1176)
++.... ..++++|++.. ++.+.+.... ..++..+..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 765543 34788888754 7777766443 357888999999999999999999 99999999999999999
Q ss_pred CcEEEEeecccccccccccc-----ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 046275 1000 FEARVSDFGMARLMSAMDTH-----LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074 (1176)
Q Consensus 1000 ~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~ 1074 (1176)
+.++|+|||+|+.+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999866432211 1112346999999999999999999999999999999999999999765322111
Q ss_pred HH----HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1075 LV----GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1075 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.. .+......... . . ...+ ..+.+++..|++.+|++||++.++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~----~--~-~~~~------~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI----K--I-KNAN------KFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhhh----c--c-CCCC------HHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 11111111110 0 0 1111 2355799999999999999999999876
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=329.19 Aligned_cols=270 Identities=16% Similarity=0.191 Sum_probs=188.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECC--CCEEEEEE--------------ee---ccCCcCHHHHHHHHHHHHhcCCCCc
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKD--GSTVAIKK--------------LI---HISGQGDREFTAEMETIGKIKHRNL 918 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni 918 (1176)
..++|++.+.||+|+||+||++..+. +..++.|. +. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45689999999999999999987642 22222221 10 1111223457899999999999999
Q ss_pred ccceeEEeeCCeeEEEEeeccCCCHHHHHhhcccc-CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKV-GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 919 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
+++++++...+..|+|+|++. +++.+++...... .......+.+.++.|++.||+|||+. +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999995 5788877543211 11234567788999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~ 1077 (1176)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..++...... .....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHH
Confidence 9999999999999866433221 123457999999999999999999999999999999999988654322211 11111
Q ss_pred HHHHhhcccc-ccccCc-----------ccccCCCchHHH-------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1078 WVKQHAKLKI-SDVFDP-----------ELMKEDPNIEIE-------LLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1078 ~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~-------~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+....... .+.++. ......+..... -..+.+++.+||+.||++|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111000 000000 000000000000 0134567899999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=297.87 Aligned_cols=250 Identities=31% Similarity=0.454 Sum_probs=203.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
+|+..+.||+|++|.||++.+. +++.+++|++........+.+.+|++++++++||+++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 688999999866544456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++.... ..+++..+..++.|++.|+.|||.. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987653 2689999999999999999999998 999999999999999999999999999876654321
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||...+. .................+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~---- 222 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIATNGPPGLRNPEK---- 222 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhcCCCCcCcccc----
Confidence 2345688999999999888899999999999999999999999875431 11111111111111111000
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-...+.+++.+|++.||++|||+.+++++
T Consensus 223 -----~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 -----WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01245679999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=329.38 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=189.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC--------
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE-------- 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 929 (1176)
.+|+..++||+||||.|||++.+ ||+.|||||+.... ......+.+|+.++.+++|||||+++..+.+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 45777889999999999999988 89999999996543 333456889999999999999999975432100
Q ss_pred --------------------------------------------------------------------------------
Q 046275 930 -------------------------------------------------------------------------------- 929 (1176)
Q Consensus 930 -------------------------------------------------------------------------------- 929 (1176)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred -------------------------------eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHh
Q 046275 930 -------------------------------ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978 (1176)
Q Consensus 930 -------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 978 (1176)
..||=||||+.-++.+++++.... -.....++++.+|++||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHHh
Confidence 037889999987777777655321 1467889999999999999999
Q ss_pred cCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc----cc------------cccccccccccCCcccCccccCCC--
Q 046275 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS----AM------------DTHLSVSTLAGTPGYVPPEYYQSF-- 1040 (1176)
Q Consensus 979 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~----~~------------~~~~~~~~~~gt~~y~aPE~~~~~-- 1040 (1176)
+ |||||||||.||++|++..|||+|||+|.... .. ......+..+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998621 00 001123467899999999999765
Q ss_pred -CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccC
Q 046275 1041 -RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDD 1119 (1176)
Q Consensus 1041 -~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 1119 (1176)
.|+.|+|+||+|||++||+. ||... ..-+........+.+++. +.+.. .+...-.++|++|++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR~g~iP~~--~~f~~------~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLRKGSIPEP--ADFFD------PEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcccCCCCCC--ccccc------ccchHHHHHHHHHhcC
Confidence 49999999999999999984 55321 112222233334444433 22211 1222345699999999
Q ss_pred CCCCCCCHHHHHHH
Q 046275 1120 RPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1120 dp~~RPt~~evl~~ 1133 (1176)
||.+||||.|+++.
T Consensus 858 dP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 858 DPSKRPTATELLNS 871 (1351)
T ss_pred CCccCCCHHHHhhc
Confidence 99999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=304.33 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=194.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCe-----
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEE----- 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 930 (1176)
++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999876 689999998754322 22356888999999995 6999999999877665
Q ss_pred eEEEEeeccCCCHHHHHhhcccc-CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeec
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV-GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFG 1008 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 1008 (1176)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+|++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899988765432 34689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc-
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK- 1086 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~- 1086 (1176)
.+........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+. ............
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhCC
Confidence 9875533211 1123356889999998865 4578999999999999999999999865331 111111111000
Q ss_pred -ccccc----------------CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 -ISDVF----------------DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 -~~~~~----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.. +..+....+. .-..+.+++.+||+.||.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccc---cCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000000011 11235679999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=297.19 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=205.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|.+.+.||.|+||.||++.+. +++.|++|++..... ...+.+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999886 688999998865432 3456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++......+..+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987643345799999999999999999999999 99999999999999999999999999987654432
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||...+ .............. .+..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~-----~~~~ 225 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQYP-----PIPS 225 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCCCC-----CCCC
Confidence 12234568899999999988889999999999999999999999986543 22222222222111 1111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+||..+|++|||+.+++++
T Consensus 226 ~~~------~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYS------SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCC------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=298.63 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=203.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|+||.||+++.+ +++.+++|++.... ......+.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999876 68899999886432 22345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++.........+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999987544445789999999999999999999999 99999999999999999999999999998765431
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+. .............. ...
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~ 223 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQRGKYPP-----IPP 223 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCCCC-----Cch
Confidence 1334688999999999998899999999999999999999999975431 11222222211111 111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+.+++.+|++.+|++|||+.+++++
T Consensus 224 ------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 ------IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ------hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112346679999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=300.79 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=196.2
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
|++.+.||.|++|.||+|.++ +|..||+|++.... ....+.+.+|++++++++|||++++++++.++...++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999876 69999999886432 222356888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999876542 3589999999999999999999998 999999999999999999999999999875533211
Q ss_pred cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc------------
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL------------ 1085 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------ 1085 (1176)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+... .+..........
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhch
Confidence 11233568899999987654 56889999999999999999999986543211 111111100000
Q ss_pred ----ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 ----KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.......+......+.. ...+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNL---DEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCC---CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000111101111 1245679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=295.65 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=201.2
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|++.+.||+|++|.||+|+.. +++.|++|.+..... ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999876 578999998865443 3345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999997653 689999999999999999999999 99999999999999999999999999998665433
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||...+ ......... ... . +....
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~-~~~-~----~~~~~ 221 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIV-QDD-H----PPLPE 221 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh-ccC-C----CCCCC
Confidence 21 234568899999999988888999999999999999999999986433 111111111 111 0 11111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.+|++|||+.+++.+
T Consensus 222 ~~~------~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 GIS------PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCC------HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 111 234569999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=296.68 Aligned_cols=242 Identities=26% Similarity=0.312 Sum_probs=193.8
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||.|+||.||+|++. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 489999998864322 2345688999999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....... ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 99998654 588999999999999999999998 99999999999999999999999999998664432 113
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
...|++.|+|||++....++.++|+||+|+++|+|++|+.||.....+ ................++...
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-------- 219 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILKGNGKLEFPNYI-------- 219 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhccCCCCCCCccc--------
Confidence 346889999999998888999999999999999999999999765421 122222222111110111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRPT-----MIQVMA 1132 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt-----~~evl~ 1132 (1176)
-..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 --~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 --DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred --CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 124567999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=312.27 Aligned_cols=270 Identities=24% Similarity=0.345 Sum_probs=198.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----Cee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 931 (1176)
+++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999875 68999999885422 22345678899999999999999999987554 357
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+|+||+.+ ++.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 888887643 589999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccc-cccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1012 LMSAMDTHL-SVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1012 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
......... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ..............+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQE 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHH
Confidence 654322211 1133568999999998754 468899999999999999999999996543110 000000000000000
Q ss_pred c----cC-------cccccCC--Cch---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhh
Q 046275 1090 V----FD-------PELMKED--PNI---EIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQA 1139 (1176)
Q Consensus 1090 ~----~~-------~~~~~~~--~~~---~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 1139 (1176)
. .+ ....... +.. .....++.+++.+||+.||++|||+.+++++ +++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 00 0000000 000 0012346689999999999999999999998 665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=304.79 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=195.4
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHH
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLE 944 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 944 (1176)
..||+|+||.||+|..+ +++.||+|++..........+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 68999999886544444567889999999999999999999999999999999999999999
Q ss_pred HHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccc
Q 046275 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024 (1176)
Q Consensus 945 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 1024 (1176)
+++... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++++|||++........ ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 987543 478999999999999999999999 999999999999999999999999998875543221 1234
Q ss_pred cccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHH
Q 046275 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEI 1104 (1176)
Q Consensus 1025 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1104 (1176)
..|++.|+|||++.+..++.++||||+|+++|+|++|+.||...+. ......... . .++.... ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~~-~----~~~~~~~-~~~~-- 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRD-N----LPPKLKN-LHKV-- 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-h----CCcccCC-cccC--
Confidence 5688999999999888889999999999999999999999865321 111111111 1 1111100 0011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1105 ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1105 ~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-..+.+++.+||+.+|.+||++.+++++
T Consensus 243 -~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 -SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1134568999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=301.32 Aligned_cols=244 Identities=27% Similarity=0.344 Sum_probs=190.7
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||+|+||+||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68999999885422 22244567899999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+....... ...
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 999976542 3589999999999999999999999 99999999999999999999999999987654311 123
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
...++..|+|||++.+..++.++||||+|+++|+|++|+.||....... ........... .........
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~---- 221 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLE------MAVEYPDKF---- 221 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcccc------ccccCCccC----
Confidence 4567889999999988889999999999999999999999997654211 11111111100 011111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRP-----TMIQVMA 1132 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RP-----t~~evl~ 1132 (1176)
-..+.+++.+||+.+|++|| ++.++++
T Consensus 222 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 --SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11345699999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=294.78 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=195.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-----CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--Cee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-----GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 931 (1176)
.+|++.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999875 58999999874321 12234688899999999999999999998664 457
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++|+||+++++|.+++...+ .+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999997654 578899999999999999999999 99999999999999999999999999997
Q ss_pred ccccccc-cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1012 LMSAMDT-HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1012 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.... .... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~-~~~~~~~~~~~~ 229 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AMAA-IFKIATQPTKPM 229 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HHHH-HHHHHcCCCCCC
Confidence 6532111 111233568899999999998888999999999999999999999986432 1111 111111111111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+++.+ ...+.+++.+|++ +|.+|||+.+++.|
T Consensus 230 ~p~~~----------~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 LPDGV----------SDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCccc----------CHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11111 1235569999999 57999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=304.06 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=194.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 929 (1176)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999876 689999998854322 22335678999999999999999999886654
Q ss_pred --eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 930 --ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 930 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
..++||||+.+ ++.+.+.... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999964 8888886543 2589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccc--ccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1008 GMARLMSAMDTH--LSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1008 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...+.. ..........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~- 240 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLC- 240 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHh-
Confidence 999766433221 112234578899999988664 4688999999999999999999998654311 1111111100
Q ss_pred cccccccCccc-----------ccCCC-chH------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPEL-----------MKEDP-NIE------IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~-----------~~~~~-~~~------~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.......+.. ..... ... .+...+.+++.+||+.||++|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000000 00000 000 011245679999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-34 Score=285.08 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=195.2
Q ss_pred CceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHH-HhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 865 DSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETI-GKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
...||.|+||+|+|-.++ .|+..|||++..... .+.+++..|.++. +.-+.||||+++|.+..++..|+.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 357999999999999887 699999999976444 4456678888754 445799999999999999999999999975
Q ss_pred CHHHHHhhcc-ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 942 SLEDVLHNQK-KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 942 sL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|++.+.+... .....+++...-.|....+.||.||.+.. .|||||+||+|||++..|.+|+||||.+-.+.. ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence 7776654321 11235888888889889999999999875 899999999999999999999999999865432 22
Q ss_pred cccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1021 SVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
..+..+|...|||||.+.. ..|+.+|||||+|+++||+.||+.|+...+ +..+.......+..+....+.-
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----svfeql~~Vv~gdpp~l~~~~~--- 295 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----SVFEQLCQVVIGDPPILLFDKE--- 295 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----HHHHHHHHHHcCCCCeecCccc---
Confidence 3356689999999999954 358999999999999999999999987654 2333333333443332222111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...--..+.++|.-|+..|-..||.+.++.++
T Consensus 296 ---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 ---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 01122346679999999999999999999876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=299.20 Aligned_cols=259 Identities=21% Similarity=0.236 Sum_probs=191.9
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcC-CCCcccceeEEeeC--CeeEEEEe
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIK-HRNLVPLLGYCKVG--EERLLVYE 936 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 936 (1176)
|++.+.||+|+||.||+|+.. +++.||+|++..... .......+|+.+++++. |||++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667889999999999999876 688999998864322 22234457888999885 99999999999887 88999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|++ |++.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 58888887543 2689999999999999999999999 9999999999999999 99999999999765432
Q ss_pred cccccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh------------
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA------------ 1083 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~------------ 1083 (1176)
.. .....+++.|+|||++. +..++.++||||+||++|||++|+.||...+.. ....+.....
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhc
Confidence 22 12345789999999764 455788999999999999999999999654321 1111111100
Q ss_pred ccccccc-cCcccccCC-CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDV-FDPELMKED-PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....... +++...... +........+.+++.+||+.+|++|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 000000000 0000112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=302.26 Aligned_cols=263 Identities=25% Similarity=0.306 Sum_probs=196.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 934 (1176)
++|++.+.||.|+||.||+|.++ +++.+++|++..... .....+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999987 588999998864322 2233567899999999999999999998877 889999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++ +|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 99999876542 589999999999999999999999 99999999999999999999999999988665
Q ss_pred cccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHH------------HHHH
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG------------WVKQ 1081 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~------------~~~~ 1081 (1176)
.... ......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||....... .... |...
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHh
Confidence 4321 12344578899999998654 46889999999999999999999997543110 0000 1000
Q ss_pred --h---hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1082 --H---AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1082 --~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ............+....+.. .....+.+++.+||+.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000000000111111111 001235579999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=302.58 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=192.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|...+.||+|+||.||++++. +++.||+|++..... .....+.+|+.++.++. ||||+++++++..+...++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3555678999999999999876 589999998864332 23456888999999996 99999999999999999999999
Q ss_pred ccCCCHHHHHhhc-cccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQ-KKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
+.. ++.++.... ......+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 666554321 111236899999999999999999999743 8999999999999999999999999999765432
Q ss_pred cccccccccccCCcccCccccCCC---CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSF---RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.. .....|++.|+|||++.+. .++.++||||+||++|||++|+.||.... ............. .+
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-----~~ 229 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD-----PP 229 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-----CC
Confidence 21 1234688999999998765 68899999999999999999999986532 1111111111111 11
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+....+ ......+.+++.+||+.+|++|||+++|+++
T Consensus 230 ~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEE--REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCC--CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 0011245679999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=308.66 Aligned_cols=259 Identities=24% Similarity=0.315 Sum_probs=196.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------ 928 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 928 (1176)
..++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3468999999999999999999876 6899999987542 222334677899999999999999999988643
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 356999999964 88888753 278889999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh-----
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA----- 1083 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~----- 1083 (1176)
+++....... .....+++.|+|||++.+..++.++||||+||++|+|++|+.||...+.. ..|.....
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~ 236 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI----DQWNKIIEQLGTP 236 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHhcCCC
Confidence 9986543211 23346789999999999999999999999999999999999999754311 11111000
Q ss_pred ----------------c-c------ccccccCcccccCC-Cc-hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 ----------------K-L------KISDVFDPELMKED-PN-IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ----------------~-~------~~~~~~~~~~~~~~-~~-~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. . .+.+.++....... +. .......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 00000000000000 00 00112345689999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=301.31 Aligned_cols=249 Identities=30% Similarity=0.411 Sum_probs=195.7
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|...+.||+|+||.||+|++. ++..||+|++...... ....+.+|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999875 6889999988643222 234688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+. |++.+.+.... .++++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+|++|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 48888776543 2589999999999999999999999 9999999999999999999999999988654321
Q ss_pred ccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
....|++.|+|||++. ...++.++|||||||++|||++|+.||...+. ...............
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~---- 244 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESPTL---- 244 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhccCCCC----
Confidence 2346888999999973 45688999999999999999999999864321 111111111111000
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
.... ....+.+++.+|++.+|++||++.+++++...+.
T Consensus 245 ~~~~------~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 QSNE------WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCcc------ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 1123567999999999999999999999866544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=303.45 Aligned_cols=264 Identities=25% Similarity=0.310 Sum_probs=195.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 933 (1176)
.++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357999999999999999999986 5899999988643222 223466899999999999999999998654 56899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+.+ +|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8988887543 3689999999999999999999999 9999999999999999999999999999866
Q ss_pred ccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc-
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF- 1091 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1091 (1176)
..... ......+++.|+|||++.+ ..++.++||||+|+++|||++|+.||...+.. ..................
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhch
Confidence 43321 1223345788999999865 45789999999999999999999999754311 111111110000000000
Q ss_pred -----C---c-ccccCC-CchHH----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 -----D---P-ELMKED-PNIEI----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 -----~---~-~~~~~~-~~~~~----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+ . ...... ..... ....+.+++.+|++.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0 000000 00000 12234679999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=308.52 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=199.3
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeC--Cee
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVG--EER 931 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 931 (1176)
..++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999876 5889999988542 222334577899999999 999999999998653 367
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5999888653 578899999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc---ccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh----
Q 046275 1012 LMSAMDTH---LSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA---- 1083 (1176)
Q Consensus 1012 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~---- 1083 (1176)
........ .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~ 234 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 65433221 12234568999999998754 457889999999999999999999986533111 0000000000
Q ss_pred ----------ccccccccC----cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhC
Q 046275 1084 ----------KLKISDVFD----PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAG 1140 (1176)
Q Consensus 1084 ----------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 1140 (1176)
.....+.+. .......+. .-..+.+++.+||+.||++|||+.+++++ +.++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPK---ASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccC---CCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000000000 000000011 11345679999999999999999999987 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=298.18 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=185.8
Q ss_pred eEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHH---HHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEME---TIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
.||+|+||.||+|+.. +++.||+|.+...... ....+..|.. .++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5889999988653221 1222334433 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++...+ .+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999987543 689999999999999999999998 899999999999999999999999999875533221
Q ss_pred ccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
....|+..|+|||++.+. .++.++||||+||++|||++|+.||........ ......... .++.....
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~------~~~~~~~~ 221 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------MAVELPDS 221 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc------cCCCCCCc
Confidence 234689999999998754 688999999999999999999999975432211 111111110 11111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
.+ ..+.+++.+|+..+|.+|| ++.+++++
T Consensus 222 ~s------~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 222 FS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CC------HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 2456699999999999999 99999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=306.80 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=197.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 931 (1176)
.++|++.+.||.|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999876 69999999886532 2234567789999999999999999998753 3467
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+. |+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58999887554 589999999999999999999999 99999999999999999999999999987
Q ss_pred cccccccc--ccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---
Q 046275 1012 LMSAMDTH--LSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--- 1085 (1176)
Q Consensus 1012 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 1085 (1176)
........ .......|+..|+|||++.+ ..++.++||||+||++|||++|+.||...+... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~ 233 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSE 233 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChh
Confidence 65432211 11134578899999999865 468899999999999999999999996543210 01110000000
Q ss_pred ---------ccccccCcccccCCCch-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 ---------KISDVFDPELMKEDPNI-----EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ---------~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.+..+ ......+.. ......+.+++.+||+.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 000000000 0012346779999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=296.42 Aligned_cols=265 Identities=22% Similarity=0.338 Sum_probs=197.9
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+|++.+.||.|++|.||+|++. +|+.||+|++...... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999986 5889999988654322 3456778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89988875542 23689999999999999999999999 999999999999999999999999999875533211
Q ss_pred cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc--------ccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK--------LKISD 1089 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~ 1089 (1176)
......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...+... ........... .....
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCc
Confidence 11334578899999988653 56889999999999999999999997654211 11111100000 00000
Q ss_pred ccCcccccCCCchH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIE-----IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+............ ..-..+.+++.+|++.||.+||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000000 011345679999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=299.69 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=194.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|++|.||+|+++ +|+.||+|++..... ...+.+.+|++++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999886 688999998754322 233568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeecccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~ 1015 (1176)
|++ +++.+++.... ...+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+|++|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888886543 23468889999999999999999999 9999999999999985 56799999999975432
Q ss_pred ccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc---
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF--- 1091 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1091 (1176)
... ......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...+..+ ........... ...+..
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~-~~~~~~~~~ 231 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGT-PNEETWPGV 231 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC-CChhhcccc
Confidence 211 1233457889999998866 457889999999999999999999997543211 11111010000 000000
Q ss_pred --------------CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 --------------DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 --------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+.. ...+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTL---EPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCC---ChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000001111 1235679999999999999999999975
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=309.00 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=202.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----Ce
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 930 (1176)
.++|.+.+.||+|+||+||+|++. +++.||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999875 6899999988642 222345677899999999999999999987654 34
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||+. ++|.+++...+ ++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68999887553 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh------
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA------ 1083 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~------ 1083 (1176)
........ ......++..|+|||++.. ..++.++|||||||++|+|++|+.||...+... ..........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEED 232 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHH
Confidence 86543221 1234567889999998764 468899999999999999999999996543110 0000000000
Q ss_pred -----ccc-------cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhCCCC
Q 046275 1084 -----KLK-------ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAGSGL 1143 (1176)
Q Consensus 1084 -----~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~ 1143 (1176)
... .....++......+. ....+.+++.+||+.+|++|||+++++++ ++.+......
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPH---ANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHccc---CCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 000 000000000000011 12345679999999999999999999999 7777655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=301.95 Aligned_cols=262 Identities=23% Similarity=0.249 Sum_probs=189.5
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
.+.+|.|+++.||+++. +++.||+|++... .....+.+.+|++++++++||||+++++++.++...+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 5899999998653 23345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc---
Q 046275 943 LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH--- 1019 (1176)
Q Consensus 943 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--- 1019 (1176)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.........
T Consensus 86 l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999986532 2588999999999999999999999 9999999999999999999999999988654322111
Q ss_pred --ccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc---------
Q 046275 1020 --LSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK--------- 1086 (1176)
Q Consensus 1020 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------- 1086 (1176)
.......++..|+|||++.. ..++.++||||+||++|||++|+.||....... .............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhh
Confidence 11133457788999999865 357889999999999999999999997543111 0111000000000
Q ss_pred ---ccc----ccCccccc--CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ---ISD----VFDPELMK--EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ---~~~----~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... ..++.... ..+....-...+.+++.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000000 000001112356789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=297.29 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=200.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 934 (1176)
++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999876 68999999875422 223456888999999998 99999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998664 689999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccc------------------ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH
Q 046275 1015 AMDTH------------------LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 1015 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 1076 (1176)
..... .......|+..|+|||+.....++.++||||+|+++|++++|+.||...+. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~ 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YL 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HH
Confidence 32211 112344678999999999888899999999999999999999999875541 11
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM----IQVMAM 1133 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~----~evl~~ 1133 (1176)
....... ....+.+.+ -..+.+++.+||+.+|++|||+ ++++++
T Consensus 230 -~~~~~~~--~~~~~~~~~----------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 -TFQKILK--LEYSFPPNF----------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -HHHHHHh--cCCCCCCcc----------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111111 111111111 1135569999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=299.16 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=193.1
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|.+.+ ++.||||.+..... .....+.+|+.++.+. .||||+++++++.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999874 89999999865332 2234566777777676 49999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+. +++.+++.... .++++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 ~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 47887776533 26899999999999999999999732 8999999999999999999999999998765432
Q ss_pred cccccccccccCCcccCccccCCCC----CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFR----CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.. .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... .+............
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~--- 238 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEEPPS--- 238 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCCCCC---
Confidence 22 12345788999999987553 788999999999999999999998643211 11111111111110
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
..... .. ...+.+++.+||+.||++||++.+++++-
T Consensus 239 --~~~~~-~~---~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 --LPPNE-GF---SPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCCC-CC---CHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 10000 01 12456799999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=296.31 Aligned_cols=244 Identities=29% Similarity=0.401 Sum_probs=192.4
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|...+.||+|+||+||+|+.. +++.|++|++...... ..+.+.+|++++++++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566778999999999999875 6889999988643322 224578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+. |++.+++.... .++++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+|++|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 58888876543 2689999999999999999999999 999999999999999999999999998864321
Q ss_pred ccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.....|+..|+|||++. ...++.++|||||||++|+|++|+.||...+. .................
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~-- 242 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNDSPTLQS-- 242 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCCCCCCc--
Confidence 13456889999999984 45688899999999999999999999865421 11111111111111111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.+|.+||++.+++++
T Consensus 243 --~~~~------~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 --NEWT------DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --cccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 135569999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=292.46 Aligned_cols=245 Identities=26% Similarity=0.341 Sum_probs=193.3
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||+|+||.||++++. +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999987 489999998854332 2345688899999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc-----
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT----- 1018 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~----- 1018 (1176)
.+++.+.+ .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99998654 689999999999999999999999 999999999999999999999999999875433211
Q ss_pred -cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 -HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
........++..|+|||......++.++||||||+++|++++|+.||.... .............. .+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~---~~~~~~ 225 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILNGKIE---WPEDVE 225 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCcC---CCcccc
Confidence 112234567889999999988888999999999999999999999986543 11222222211110 000000
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
....+.+++.+|++.+|.+|||+.++.+.+
T Consensus 226 -------~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 226 -------VSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -------CCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 012455799999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=303.96 Aligned_cols=266 Identities=24% Similarity=0.340 Sum_probs=197.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 929 (1176)
.++|.+.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999875 68999999886432 22234578899999999999999999998654 3
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 7776542 2578999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH-------
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ------- 1081 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~------- 1081 (1176)
++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...+... .+......
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 237 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPE 237 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 8754321 123467889999999866 468899999999999999999999997543111 01000000
Q ss_pred ----hhcc---cc----ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhCCCC
Q 046275 1082 ----HAKL---KI----SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAGSGL 1143 (1176)
Q Consensus 1082 ----~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~ 1143 (1176)
.... .. ............+.. -..+.+++.+||+.||++||++++++++ ++.+++..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKA---SPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCC---CHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 0000 00 000000000000111 1235679999999999999999999977 8887765433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=303.00 Aligned_cols=271 Identities=23% Similarity=0.349 Sum_probs=200.4
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEee-CC
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKV-GE 929 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 929 (1176)
++..++++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557789999999999999999999876 7899999987542 22234568889999999999999999998865 56
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++|+||+ +++|.++++.. ++++.....++.|++.||+|||+. +|+||||+|+||++++++.+|++|||.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999999 56898888643 578888899999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH-----------H
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV-----------G 1077 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~-----------~ 1077 (1176)
+...... .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||....... ... +
T Consensus 155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~ 228 (328)
T cd07856 155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDD 228 (328)
T ss_pred ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 8754321 123457889999998765 568999999999999999999999986543100 000 0
Q ss_pred HHHHhhccccccccCcccccCC--CchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhC
Q 046275 1078 WVKQHAKLKISDVFDPELMKED--PNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAG 1140 (1176)
Q Consensus 1078 ~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 1140 (1176)
+..........+.+. ...... +... .....+.+++.+|++.+|++|||+++++.+ +++.+..
T Consensus 229 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 229 VINTICSENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhccchhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 110000000000000 000000 0000 011346679999999999999999999888 4444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=277.96 Aligned_cols=254 Identities=23% Similarity=0.273 Sum_probs=196.2
Q ss_pred HhcCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHh-cCCCCcccceeEEee----CCe
Q 046275 858 ATNGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGK-IKHRNLVPLLGYCKV----GEE 930 (1176)
Q Consensus 858 ~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~ 930 (1176)
.+++|++. ++||-|--|.|..+.++ +|+++|+|.+.. ....++|++.--. -.|||||.++++|+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566654 58999999999999876 799999998753 2345677775433 379999999998854 345
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEee
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDF 1007 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 1007 (1176)
..+|||.|+||.|++.+..++. ..+++.++-.|+.||+.|+.|||+. +|.||||||+|+|+.. +..+|++||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 6899999999999999998773 4799999999999999999999999 9999999999999964 456999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
|+|+.... .....+.+.||.|.|||++...+|+..+|+||+||++|-|++|.+||.+..- ..--..+...+..+.
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gq- 283 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQ- 283 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccC-
Confidence 99986432 3345677889999999999999999999999999999999999999986432 110111112222211
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++-+++ |. .-.....++|+.+|..+|.+|.|+.+++.+
T Consensus 284 y~FP~pE-Ws------~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YEFPEPE-WS------CVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCChh-Hh------HHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111111 11 112234579999999999999999999987
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=296.82 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=197.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCC----cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISG----QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
+|++.+.||+|+||.||+++.. +++.||+|.+.+... ...+.+.+|++++.++ +||+|+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999753 578899998864321 2234578899999999 599999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++++|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999987543 588999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccccccccCCcccCccccCCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFR--CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
......... .....|+..|+|||.+.+.. .+.++||||||+++|||++|+.||...... .....+.+......
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~--- 228 (288)
T cd05583 154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccC---
Confidence 654332211 12346889999999987654 788999999999999999999998643211 11112222111111
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
+......+ ..+.+++.+||+.||++|||++++.+.++.
T Consensus 229 ---~~~~~~~~------~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ---PPFPKTMS------AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCCCcccC------HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11111111 134569999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=296.89 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=196.7
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEEEEe
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLLVYE 936 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 936 (1176)
|++.+.||.|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999887 48899999987543 23345688999999999999999999999888 88999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++ +|.+++.... ..+++.+++.++.|+++|++|||+. +++|+||||+||++++++.+|++|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8998887552 2689999999999999999999999 9999999999999999999999999999866543
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---cccc---
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---KISD--- 1089 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~--- 1089 (1176)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+... .+.......... ....
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhcccccc
Confidence 21 11233456888999997754 457899999999999999999999987543211 011100100000 0000
Q ss_pred -----ccCcccccCC--CchHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 -----VFDPELMKED--PNIEI--ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 -----~~~~~~~~~~--~~~~~--~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+...... ..... ....+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 00000 12356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=302.31 Aligned_cols=267 Identities=25% Similarity=0.308 Sum_probs=199.2
Q ss_pred ccCHHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEE
Q 046275 849 KLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYC 925 (1176)
Q Consensus 849 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 925 (1176)
+....++..++++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3445667778899999999999999999999865 68999999886432 22245677899999999999999999988
Q ss_pred eeC------CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 046275 926 KVG------EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN 999 (1176)
Q Consensus 926 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 999 (1176)
... ...+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence 543 3467888887 77998887643 589999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHH
Q 046275 1000 FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGW 1078 (1176)
Q Consensus 1000 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~ 1078 (1176)
+.+|++|||+++..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.. ..+...
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~ 230 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLI 230 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999999998754321 234567899999999866 46788999999999999999999998643311 111110
Q ss_pred HHHhhc--cccccccC----------------cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1079 VKQHAK--LKISDVFD----------------PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1079 ~~~~~~--~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...... ......+. ......... .-..+.+++.+|++.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG---ANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCC---CCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 00000000 000000000 11235679999999999999999999988
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=298.00 Aligned_cols=248 Identities=29% Similarity=0.381 Sum_probs=193.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.|+..+.||+|+||.||+|++. +++.+|+|++..... ...+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999976 578899998854222 223467789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+. |++.+.+.... .++++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 58888776443 2588999999999999999999999 9999999999999999999999999998755321
Q ss_pred cccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
....|++.|+|||++. ...++.++|||||||++|+|++|+.||...+. .............
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~----- 232 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNESP----- 232 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HHHHHHHhhcCCC-----
Confidence 2346889999999974 34678899999999999999999999854321 1111111111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~ 1136 (1176)
.... .. ....+.+++.+||+.+|++||++.+++++-..
T Consensus 233 ~~~~--~~---~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 ALQS--GH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred CcCc--cc---ccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 1100 00 11234569999999999999999999988443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=298.26 Aligned_cols=264 Identities=27% Similarity=0.340 Sum_probs=196.6
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC----
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE---- 929 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 929 (1176)
...++|++.+.||+|+||.||+|.++ +|+.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578999999999999999999986 58899999886432 223356788999999999999999999887654
Q ss_pred ------eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 930 ------ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 930 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
..++|+||+++ ++.+.+.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 7777776542 2689999999999999999999999 999999999999999999999
Q ss_pred EEeeccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1004 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
|+|||++........ .......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+..... .
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~-~ 233 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISR-L 233 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-H
Confidence 999999976643322 11123346788999998864 3578899999999999999999999865331 111111111 1
Q ss_pred hcccccccc------------Cc------ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1083 AKLKISDVF------------DP------ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1083 ~~~~~~~~~------------~~------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
......... ++ ......... -..+.+++.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI---PTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCC---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100000000 00 000000001 1245679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=295.39 Aligned_cols=262 Identities=26% Similarity=0.316 Sum_probs=198.0
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
|++.+.||.|++|.||+|... +++.+++|++...... ....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999876 6889999988643322 3456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++ ++.+++.... ..+++.++..++.|++.|+.|||+. +|+|+||||+||+++.++.+|++|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8988887643 3689999999999999999999999 99999999999999999999999999987665432
Q ss_pred cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---cccccc---
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---KISDVF--- 1091 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 1091 (1176)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+ .+.......... ......
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhh
Confidence 112334678899999998776 78999999999999999999999986543211 000000000000 000000
Q ss_pred ---CcccccCCCc-----hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 ---DPELMKEDPN-----IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ---~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.......... ...-...+.+++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000 00112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=290.84 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=186.1
Q ss_pred ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHH-HhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETI-GKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|+.. +|+.||+|.+...... ....+..|..++ ...+|||++++++++..++..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 5899999988543221 122344555444 445899999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
++|.+++...+ .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+|++|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997654 588999999999999999999999 999999999999999999999999999875432
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
.....|++.|+|||.+.+..++.++||||+|+++|+|++|..||...+. ............. ..+......+
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~ 221 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRIN--WPEEVKEFCS 221 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccC--CCCcccccCC
Confidence 1234688999999999888889999999999999999999999965431 1122221111110 1111111111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.+++.+||+.+|++||++.++.+.
T Consensus 222 ------~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 222 ------PEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ------HHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 235679999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=293.87 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=194.6
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhc---CCCCcccceeEEeeCCe-----
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKI---KHRNLVPLLGYCKVGEE----- 930 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 930 (1176)
|++.+.||+|+||.||+|+++ +++.||+|++...... ....+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999987 4899999988643222 234566788777666 59999999999988776
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.+++|||+++ +|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+|++|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 89998876542 2589999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---cc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---KI 1087 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~ 1087 (1176)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....... ..
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhc
Confidence 76543222 1234578899999999988899999999999999999999999865331 11111111111000 00
Q ss_pred c-------cccCcccccCCCch-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 S-------DVFDPELMKEDPNI-EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~-------~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ..+........... ..-...+.+++.+||+.||.+||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00000000000000 0112345679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=295.40 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=194.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCC----cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISG----QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
+|++.+.||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999863 688999998864221 2235678899999999 599999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997654 588899999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
....... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......+........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE--- 228 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC---
Confidence 6543221 112245688999999998653 467899999999999999999999864321 112222222211111
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
+......+ ..+.+++.+|++.||++|| ++++++.+
T Consensus 229 ---~~~~~~~~------~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---PPYPQEMS------ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCCccCC------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111111 1345699999999999997 66666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=291.38 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=195.0
Q ss_pred CCCCCceEeEeCceEEEEEEECC-CCEEEEEEeecc-----CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHI-----SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
+|.+.+.||+|+||.||++++.. +..+++|..... ......++.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998763 444555544321 122334567899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++.........+++.+++.++.|++.|+.|||+. +++|+||||+||++++ +.+|++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999976544445799999999999999999999999 9999999999999976 569999999987654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ............ .+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~-----~~~ 224 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGP-----TPS 224 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCC-----CCC
Confidence 3221 1234568899999999988888999999999999999999999985322 222222221111 111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..... -..+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 LPETY------SRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred Ccchh------cHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11111 1245669999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=272.12 Aligned_cols=205 Identities=25% Similarity=0.384 Sum_probs=169.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-----CCEEEEEEeeccCCc-C-HHHHHHHHHHHHhcCCCCcccceeEEee-CCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-----GSTVAIKKLIHISGQ-G-DREFTAEMETIGKIKHRNLVPLLGYCKV-GEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 931 (1176)
..|+....||+|.||.||||..++ ...+|+|++...... + ....-+|+..++.++|||++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468999999999999999996542 236899988643221 1 2346789999999999999999999877 7889
Q ss_pred EEEEeeccCCCHHHHHhhcccc-CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEEe
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKV-GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN----FEARVSD 1006 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 1006 (1176)
++++||.+. +|++.++-++.. ...++...++.|+.||+.|+.|||+. =|+|||+||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 999999765432 24688899999999999999999999 69999999999999877 8999999
Q ss_pred eccccccccccccc-cccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCC
Q 046275 1007 FGMARLMSAMDTHL-SVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSA 1068 (1176)
Q Consensus 1007 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~ 1068 (1176)
||+|+.+...-... .....+-|.-|.|||.+.+. .||.+.|||+.|||+.||+|-++-|.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999876532221 23445678899999998765 6899999999999999999998888653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=291.82 Aligned_cols=259 Identities=26% Similarity=0.372 Sum_probs=195.2
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEeec
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
|++.+.||+|+||.||+|+.. +++.|++|++..... .......+|+..+++++ |||++++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999986 478899998864322 22334567999999998 999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+|+|.+++.... +..+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999987654 23689999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH------------HHHHHhhcc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV------------GWVKQHAKL 1085 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~------------~~~~~~~~~ 1085 (1176)
.....++..|+|||++. ...++.++||||||+++|||++|+.||......+ .+. .|.....
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-- 228 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYK-- 228 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhh--
Confidence 13346788999999874 4557899999999999999999999986543111 000 0110000
Q ss_pred ccccccCcccccCCCchH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 KISDVFDPELMKEDPNIE-----IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.............+... .....+.+++.+||+.+|++|||++|++.+
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 -LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred -hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000000000 012346689999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=294.20 Aligned_cols=245 Identities=23% Similarity=0.403 Sum_probs=200.8
Q ss_pred CceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 865 DSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
.++||.|.||+||-|+++ +|+.||||.+.+. ....+.++++|+.+++.++||.||.+-..|+..+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 479999999999999875 7999999998653 344567899999999999999999999999999999999999966
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEeeccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN---FEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~ 1018 (1176)
+..+++-..++ .++++..-..++.||+.||+|||.+ +|||+|+||+|||+... -.+|++|||.|++.+....
T Consensus 648 DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 66666654443 2789999999999999999999999 99999999999999653 3599999999998865333
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.....|||.|.|||+++.+.|...-|+||+|||+|.-++|..||.... +.. .+++.. .-++++..|.+
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIn---dQIQNA--aFMyPp~PW~e 790 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DIN---DQIQNA--AFMYPPNPWSE 790 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chh---HHhhcc--ccccCCCchhh
Confidence 356789999999999999999999999999999999999999996432 221 122222 22456666664
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... .++++|...|+..-++|-+++..+.+
T Consensus 791 is~------~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 791 ISP------EAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cCH------HHHHHHHHHHHHHHHHhcchHhhccc
Confidence 433 45678999999999999999877544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=303.16 Aligned_cols=241 Identities=22% Similarity=0.252 Sum_probs=196.3
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++.|.....+|.|+|+.|-.+.+. +++..+||.+.+. ..+..+|+.++.+. +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888889999999999999876 6889999988654 23344677666665 7999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-CCCCcEEEEeeccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL-DENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~~~~ 1014 (1176)
|++.||-+.+.+...+ .....+..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999999888887654 22277888999999999999999 99999999999999 589999999999998765
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. ....+-|..|.|||+.....|++++||||||+++|+|++|+.||.....+ .+.......+...+.+
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s~~v--- 535 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFSECV--- 535 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCcccccc---
Confidence 43 33456788999999999999999999999999999999999999876433 2222333333222111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-..+.+++.+||+.||.+||+|.++..+
T Consensus 536 -----------S~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 536 -----------SDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----------CHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1234569999999999999999999887
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=298.50 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=192.0
Q ss_pred eEeEe--CceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 867 LIGSG--GFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 867 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
.||+| +||+||+|++. +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 99999999885 699999998754322 22356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+...........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886542 2588999999999999999999998 999999999999999999999999986543322111100
Q ss_pred -----ccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc----------
Q 046275 1022 -----VSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK---------- 1084 (1176)
Q Consensus 1022 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~---------- 1084 (1176)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||....... ...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCccccccch
Confidence 0112346679999998763 47899999999999999999999996543110 00000000000
Q ss_pred ---------cc----ccccc-C----ccc---ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhh
Q 046275 1085 ---------LK----ISDVF-D----PEL---MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQA 1139 (1176)
Q Consensus 1085 ---------~~----~~~~~-~----~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 1139 (1176)
.. +.+.. . ... ....+........+.+++.+||+.||++|||++|++++ ++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00 00000 0 000 00011111233456789999999999999999999876 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=301.80 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=194.5
Q ss_pred cCCC-CCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC--------------HHHHHHHHHHHHhcCCCCccccee
Q 046275 860 NGFH-NDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG--------------DREFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 860 ~~y~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
++|. +.+.||.|+||+||+|+++ +++.||+|++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 4578999999999999876 68999999885432221 124678999999999999999999
Q ss_pred EEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 924 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
++..+...++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +|+||||+|+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 59999987543 588999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccccc------------ccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Q 046275 1004 VSDFGMARLMSAMD------------THLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADF 1070 (1176)
Q Consensus 1004 l~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~ 1070 (1176)
++|||.+....... .........+++.|+|||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987654110 01111233568899999998764 468899999999999999999999975432
Q ss_pred CCccHHHHHHHhhcc---ccccc------------cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1071 GDNNLVGWVKQHAKL---KISDV------------FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1071 ~~~~~~~~~~~~~~~---~~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ .+.......... .+.+. .++......+. ....+.+++.+|++.+|++|||++|++.+
T Consensus 240 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN---ASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcC---CChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11 111111110000 00000 00000000011 12345679999999999999999999975
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=298.95 Aligned_cols=267 Identities=27% Similarity=0.377 Sum_probs=193.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCC------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 929 (1176)
.++|++.+.||+|+||.||+|+++ +++.||+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999876 5899999988643322 2345778999999999999999999875433
Q ss_pred --eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 930 --ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 930 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
..++||||+.+ ++.+.+.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+|++||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999975 7777776532 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccc---------cccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHH
Q 046275 1008 GMARLMSAMDTHL---------SVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 1008 Gla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~ 1077 (1176)
|+++......... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHL 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 9997654322111 1123456888999998765 457899999999999999999999986543211 0111
Q ss_pred HHHHhhc---------cccccccCcccccCCCc-hHH----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1078 WVKQHAK---------LKISDVFDPELMKEDPN-IEI----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1078 ~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....... .......+.......+. ... ....+.+++.+|++.||++|||+.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000 00000000000000110 000 11345689999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=300.05 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=202.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-----eeE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE-----ERL 932 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 932 (1176)
+|.+.+.||.|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999986 48999999886533 334467889999999999999999999987765 789
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+. ++|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 48999887653 689999999999999999999999 999999999999999999999999999987
Q ss_pred ccccccc-ccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc-----
Q 046275 1013 MSAMDTH-LSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL----- 1085 (1176)
Q Consensus 1013 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~----- 1085 (1176)
....... .......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...+... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEED 230 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChhH
Confidence 6543210 112345678899999999887 78999999999999999999999997543210 00000000000
Q ss_pred -------ccccccCcccccCCCchHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhh
Q 046275 1086 -------KISDVFDPELMKEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQA 1139 (1176)
Q Consensus 1086 -------~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 1139 (1176)
...+.+.. .....+.... .-..+.+++.+||+.+|++|||+++++++ ++++..
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 0000000000 11245679999999999999999999987 666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=302.93 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=193.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC---------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--------- 928 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 928 (1176)
..+|.+.+.||.|+||.||+|..+ +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999876 5899999998765555567788999999999999999999876543
Q ss_pred -----CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcE
Q 046275 929 -----EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEA 1002 (1176)
Q Consensus 929 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 1002 (1176)
...++||||++ ++|.+++... .+++..++.++.|++.|+.|||+. +|+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 5898888643 588999999999999999999999 9999999999999974 5678
Q ss_pred EEEeeccccccccccccc-cccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHL-SVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
|++|||.++......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....... .......
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999999997653321111 1123457889999998644 567889999999999999999999996543110 0000000
Q ss_pred Hhhc------c----ccccccC-cccccCCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1081 QHAK------L----KISDVFD-PELMKEDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~~~------~----~~~~~~~-~~~~~~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... . ....... .......+... .....+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 0 0000000 00000000000 011245679999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=317.83 Aligned_cols=260 Identities=26% Similarity=0.444 Sum_probs=205.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC----C----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK----D----GSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 929 (1176)
++..+.+.+|+|+||.|++|... . ...||||....... .+.+.+..|+++|+.+ +||||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34456679999999999999743 1 45689998865433 3456799999999998 6999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhcc---ccC---------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQK---KVG---------IKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
..++|+||+..|+|.++++..+ ... ..++..+.+.++.|||.|++||++. ++||||+.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999998776 111 1388999999999999999999999 899999999999999
Q ss_pred CCCcEEEEeecccccccccccccccccccc--CCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAG--TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNN 1074 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~ 1074 (1176)
++..+||+|||+|+.....+.... ....| ...|||||.+....|+.++|||||||++||++| |..||.+.. ...+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~ 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEE 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHH
Confidence 999999999999996654443321 22222 345999999999999999999999999999999 899986522 1223
Q ss_pred HHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1075 LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1075 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
+.++.+.-.+...++...+ ++.+++..||+.+|++||++.++.+.++.+.
T Consensus 531 l~~~l~~G~r~~~P~~c~~--------------eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQPEHCSD--------------EIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHhcCCCCCCCCCCCH--------------HHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 3333332222222222111 3345999999999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=302.05 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=195.3
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe---
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE--- 930 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 930 (1176)
+..++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34578999999999999999999986 5789999987542 12233557789999999999999999998866554
Q ss_pred ---eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 931 ---RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 931 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
.++|+||+ +++|.+++... ++++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 56999988753 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh----
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH---- 1082 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~---- 1082 (1176)
|++...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.......
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~ 236 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCC
Confidence 998765332 234467889999998865 36788999999999999999999999653311 0000000000
Q ss_pred -------hccccccccCcccccCCCchH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1083 -------AKLKISDVFDPELMKEDPNIE----IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1083 -------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+........+... .....+.+++.+|++.+|++|||+.+|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000000000 012356789999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=299.01 Aligned_cols=267 Identities=25% Similarity=0.346 Sum_probs=197.0
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC----
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE---- 929 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 929 (1176)
...++|++.+.||+|+||.||+|... +|..||+|++..... .....+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999865 689999998854221 12345788999999999999999999886543
Q ss_pred --eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 930 --ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 930 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
..++||||+ +++|.+++... .+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 67999888643 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHH---------
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG--------- 1077 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~--------- 1077 (1176)
|++...... .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||...+... .+..
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence 998755321 123467889999999876 457889999999999999999999997543110 0000
Q ss_pred --HHHHhhccccccccCcccccCCCchH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhh
Q 046275 1078 --WVKQHAKLKISDVFDPELMKEDPNIE-----IELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQA 1139 (1176)
Q Consensus 1078 --~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 1139 (1176)
+........... +...+....+... .....+.+++.+|++.||++|||+.+++++ ++.+..
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 237 KEFVQKLQSEDAKN-YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHHhhcchhHHH-HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000000000000 0000000000000 011235679999999999999999999965 555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=298.78 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=191.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-C--CCEEEEEEeeccC--CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeC----Ce
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-D--GSTVAIKKLIHIS--GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVG----EE 930 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 930 (1176)
+|++.+.||+|+||.||+|+.. + +..||+|++.... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999976 3 7789999875422 12245678899999999 599999999875432 45
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+++||+. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899986 69999987543 689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccc--ccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH-----------
Q 046275 1011 RLMSAMDTH--LSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV----------- 1076 (1176)
Q Consensus 1011 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~----------- 1076 (1176)
+........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 231 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDE 231 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCH
Confidence 765432211 11233568999999998765 468899999999999999999999987543210 000
Q ss_pred HHHHHhhccc-------cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1077 GWVKQHAKLK-------ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1077 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+........ ....-...+....+.. -..+.+++.+|++.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA---NPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCC---CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0000000000000111 1245679999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=283.82 Aligned_cols=236 Identities=28% Similarity=0.330 Sum_probs=190.8
Q ss_pred EeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
||+|+||.||++... +++.+++|.+...... ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999886 5899999988653322 344688899999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS 1023 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 1023 (1176)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 99998654 589999999999999999999998 99999999999999999999999999987654321 1224
Q ss_pred ccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1024 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
...++..|+|||...+...+.++|+||||+++|++++|+.||...+. ........... .......+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~------~~~~~~~~--- 217 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDP------LRFPEFLS--- 217 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC------CCCCCCCC---
Confidence 45688999999999888889999999999999999999999965432 11112111111 01111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRPTMIQ 1129 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt~~e 1129 (1176)
..+.+++.+||..||++|||+++
T Consensus 218 ---~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 ---PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---HHHHHHHHHHhcCCHhhCCCccc
Confidence 23456999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=288.70 Aligned_cols=259 Identities=27% Similarity=0.357 Sum_probs=197.3
Q ss_pred CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999887 48999999886543 233456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999998653 2589999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh-----------hccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH-----------AKLK 1086 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~~~ 1086 (1176)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+....... ....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCcHHHHHhhcccc
Confidence 12234567789999998766 78999999999999999999999986543110 000000000 0000
Q ss_pred -cccccC----cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 -ISDVFD----PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 -~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+. .......+.. -..+.+++.+||+.||++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRL---DPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccc---cHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 0000001111 2346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=321.11 Aligned_cols=145 Identities=26% Similarity=0.362 Sum_probs=130.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+|++. +++.||+|++...... ....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999987 6899999998643222 2356888999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
||+.+++|.+++...+ .+++..++.++.||+.||+|||.. +||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 578899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=256.72 Aligned_cols=201 Identities=25% Similarity=0.388 Sum_probs=170.8
Q ss_pred CCCceEeEeCceEEEEEEEC-CCCEEEEEEeec-cCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeecc
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIH-ISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
.....||+|++|.|-+.++. +|...|+|++.. .+.+..++..+|+++..+. .+|++|.++|....+...|+.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 34567999999999999876 799999999864 3444556678888876664 79999999999999999999999998
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
. ||+.+.+..-+.+...++...-+|+..+.+||.|||++. .|||||+||+|||++.+|.+|+||||.+-.+.+ .
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---S 202 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD---S 202 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh---h
Confidence 6 898888766566678999999999999999999999985 899999999999999999999999999876532 1
Q ss_pred ccccccccCCcccCccccCC----CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQS----FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
...+..+|...|||||.+.. ..|+-|+||||+|+.+.||.++++||....
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 22244678899999999843 478899999999999999999999997654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.51 Aligned_cols=240 Identities=24% Similarity=0.314 Sum_probs=195.7
Q ss_pred CCCCceEeEeCceEEEEEEECCCC-EEEEEEeec---cCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKDGS-TVAIKKLIH---ISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.....||-|+||+|-++..+... .+|+|.+.+ ......+.+..|-.+|...+.|+||++|..|.+++..|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 444668999999999999877433 377776644 3444456688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|-||.++..+++.+ .++..+.+.++..+.+|++|||++ +||+||+||+|.++|.+|-+|+.|||.|+.+....
T Consensus 502 ClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999887 688889999999999999999999 99999999999999999999999999999876544
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. .-+.+|||.|.|||++....++.++|.||+|+++||+++|.+||.+.+. +..| ..+.++--.-.++..+.+
T Consensus 575 K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktY-n~ILkGid~i~~Pr~I~k 646 (732)
T KOG0614|consen 575 K---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTY-NLILKGIDKIEFPRRITK 646 (732)
T ss_pred c---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHH-HHHHhhhhhhhcccccch
Confidence 3 3467999999999999999999999999999999999999999987652 2222 222221111111222211
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPT 1126 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt 1126 (1176)
...++|.+....+|.+|..
T Consensus 647 ----------~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 647 ----------TATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----------hHHHHHHHHHhcCcHhhhc
Confidence 3445888889999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=279.73 Aligned_cols=240 Identities=27% Similarity=0.351 Sum_probs=190.1
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+|....+||+|+||.|.+|..+ +.+.+|||++.+.- ..+.+--..|-+++... +-|.+++++.+|..-++.|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 5778899999999999999776 56789999875421 11222234466666655 6789999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+.||+|-.+++..+ ++-+..+..+|.+||-||-+||++ +||+||+|.+|||+|.+|++||+|||+++.--.
T Consensus 430 EyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999998876 577788999999999999999999 999999999999999999999999999974322
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
......+.+|||.|+|||++...+|+..+|+|||||++|||+.|+.||++.+.+ +....+.... -.++..+
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-----elF~aI~ehn--vsyPKsl 573 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQAIMEHN--VSYPKSL 573 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHcc--CcCcccc
Confidence 122346789999999999999999999999999999999999999999876522 1222222211 1122222
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCC
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt 1126 (1176)
.. +++.+....+...|.+|..
T Consensus 574 Sk----------EAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 574 SK----------EAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cH----------HHHHHHHHHhhcCCccccC
Confidence 21 3445778888899998863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=297.77 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=205.7
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEee-----C
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKV-----G 928 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~ 928 (1176)
...++.|++.+.||.|.+|.||+++.. +|+.+|+|++. .....++++..|+++++.. +|||++.++|+|.. +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~-~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMD-PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeec-CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 334567889999999999999999876 57778887664 3445567788899999988 69999999999854 5
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
+..|+|||||.+||.-|+++... +.++.|+.+..|++.+++|+.+||.. .++|||||-.|||++.++.||++|||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence 68899999999999999999876 66899999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
++..+... .....+..|||.|||||++.. ..|+.++|+||+|++..||--|.+|+..... + ..
T Consensus 169 vSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----m------ra 236 (953)
T KOG0587|consen 169 VSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----M------RA 236 (953)
T ss_pred eeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----h------hh
Confidence 98766432 223357789999999999854 3577899999999999999999999753221 1 11
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-..++..-+|.+.. | .....++.+||..||..|-++||++.++++|
T Consensus 237 LF~IpRNPPPkLkr--p--~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 LFLIPRNPPPKLKR--P--KKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hccCCCCCCccccc--h--hhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11222222333321 1 1234567889999999999999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=273.13 Aligned_cols=270 Identities=21% Similarity=0.315 Sum_probs=210.7
Q ss_pred CHHHHHHHhcCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCccccee
Q 046275 851 TFADLLEATNGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 851 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
...++....++++...++-+|.||+||.|.+.+ .+.|.+|.+... +.-....+..|--.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345555666788888899999999999997642 345666655432 2223345777888888889999999999
Q ss_pred EEee-CCeeEEEEeeccCCCHHHHHhhccc----cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 046275 924 YCKV-GEERLLVYEYMRYGSLEDVLHNQKK----VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE 998 (1176)
Q Consensus 924 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 998 (1176)
++.+ .+..+.+|.++.-|+|..++...+. ....++..+...++.|++.|++|||.. +|||.||.++|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 8865 4567899999999999999984331 123577788999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHH
Q 046275 999 NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 999 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~ 1077 (1176)
...+|++|=.+++..-+.+.+.-.........||+||.+....|+.++|||||||++|||+| |+.|+...|. ..+..
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--fEm~~ 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--FEMEH 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--HHHHH
Confidence 99999999999998776666655555567889999999999999999999999999999999 9999876542 22333
Q ss_pred HHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1078 WVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1078 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
+.+.-.+...+ ...|. ++..++.-||..+|++||++++++..|.++..
T Consensus 510 ylkdGyRlaQP--------~NCPD------eLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 510 YLKDGYRLAQP--------FNCPD------ELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHhccceecCC--------CCCcH------HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 33322221111 11221 35558899999999999999999999998764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=279.74 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=193.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCH--------HHHHHHHHHHHhcCCCCcccceeEEeeC-C
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGD--------REFTAEMETIGKIKHRNLVPLLGYCKVG-E 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 929 (1176)
++|-..++||+|+|+.||||.+- ..+.||||.-. .+..+. +...+|.++-+.++||.||++|+||.-+ +
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHq-lNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQ-LNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeeh-hccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46778899999999999999764 56777887542 222221 2356799999999999999999999755 4
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEe
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD---ENFEARVSD 1006 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 1006 (1176)
..+-|+|||+|.+|+-+++..+ .+++++++.|++||+.||.||.+. .++|||-|+||.|||+. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 5678999999999999998775 689999999999999999999987 46899999999999994 357899999
Q ss_pred eccccccccccccc-----cccccccCCcccCccccCC----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHH
Q 046275 1007 FGMARLMSAMDTHL-----SVSTLAGTPGYVPPEYYQS----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077 (1176)
Q Consensus 1007 fGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~ 1077 (1176)
||+++.+....... -.+..+||..|++||.+.- .+.+.|+||||+|||+|+++.|+.||.... ...++.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq-sQQdIL- 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ-SQQDIL- 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-hHHHHH-
Confidence 99999887644332 1246789999999998843 356789999999999999999999997542 222221
Q ss_pred HHHHhhccccccc-cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1078 WVKQHAKLKISDV-FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1078 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
......+..+. |++ .|.... ++..||++||++.-++|..+.++..+
T Consensus 695 --qeNTIlkAtEVqFP~-----KPvVss---eAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 695 --QENTILKATEVQFPP-----KPVVSS---EAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred --hhhchhcceeccCCC-----CCccCH---HHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 21111121121 111 122212 23459999999999999988887654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=278.62 Aligned_cols=262 Identities=25% Similarity=0.317 Sum_probs=200.8
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-C-C----CcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-H-R----NLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 930 (1176)
.+++|.+...+|+|.||.|-.+.+. .+..||+|++....... +...-|+++++++. + | -+|++.+||+-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3678999999999999999999875 47899999886544332 33566999999993 2 3 37888899999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD------------- 997 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~------------- 997 (1176)
.++|+|.+ |-|+++++..... .+++..+++.++.|+++++++||+. +++|.|+||+||++.
T Consensus 166 iCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999999 4599999987653 4789999999999999999999999 999999999999993
Q ss_pred -------CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Q 046275 998 -------ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF 1070 (1176)
Q Consensus 998 -------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~ 1070 (1176)
....+|++|||.|+.-.... ...+.|..|.|||++.+.+++.++||||+|||++|+.||..-|...+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 13358999999998644322 456789999999999999999999999999999999999999876541
Q ss_pred CCccHHHHHHHhhc--------------------cccccccCc-----------ccccCCCchHHHHHHHHHHHHHhccC
Q 046275 1071 GDNNLVGWVKQHAK--------------------LKISDVFDP-----------ELMKEDPNIEIELLQHLHVASACLDD 1119 (1176)
Q Consensus 1071 ~~~~~~~~~~~~~~--------------------~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~ 1119 (1176)
.+.+ .+++.+.. .++.+...+ .+.........+..++++++++||..
T Consensus 315 -~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 315 -LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred -HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 1111 11111110 011110000 00111112234677889999999999
Q ss_pred CCCCCCCHHHHHHH
Q 046275 1120 RPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1120 dp~~RPt~~evl~~ 1133 (1176)
||.+|+|+.|+++|
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999976
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=277.78 Aligned_cols=220 Identities=22% Similarity=0.180 Sum_probs=174.2
Q ss_pred eCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhh
Q 046275 871 GGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHN 949 (1176)
Q Consensus 871 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 949 (1176)
|.||.||+++++ +++.||+|++.... .+.+|...+....||||+++++++......++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999886 68999999986432 233455555566799999999999999999999999999999999976
Q ss_pred ccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCC
Q 046275 950 QKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029 (1176)
Q Consensus 950 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 1029 (1176)
.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 FL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred hc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 54 589999999999999999999999 9999999999999999999999999987654322 12334677
Q ss_pred cccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHH
Q 046275 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQH 1109 (1176)
Q Consensus 1030 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1109 (1176)
.|+|||++.+..++.++||||+|+++|||++|+.|+....... ..... ..+.... ...+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~~~--------~~~~~~~------~~~~ 205 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTHTT--------LNIPEWV------SEEA 205 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccccc--------cCCcccC------CHHH
Confidence 8999999988888999999999999999999998864321100 00000 0011111 1235
Q ss_pred HHHHHHhccCCCCCCCCHH
Q 046275 1110 LHVASACLDDRPWRRPTMI 1128 (1176)
Q Consensus 1110 ~~li~~cl~~dp~~RPt~~ 1128 (1176)
.+++.+|++.||++|||+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 5699999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=263.89 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=196.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEee--------C
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKV--------G 928 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 928 (1176)
..|....+||+|.||.||+|+.+ +|+.||+|++...++. -.....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666779999999999999876 5788999987543222 13456789999999999999999998743 2
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
...|+||++|+. +|.-++.+.. .+++..++.+++.++..||.|+|.. .|+|||+||.||||+.+|.+|++|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999987 8988887653 3789999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccccc--cccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH---HHHHHh
Q 046275 1009 MARLMSAMDTHL--SVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV---GWVKQH 1082 (1176)
Q Consensus 1009 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~---~~~~~~ 1082 (1176)
+|+.+...+... .++..+-|..|.+||.+.+ ..|+++.|||.-|||+.||+|+.+-+.+.... ..+. .....+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~Is~LcGs~ 248 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLISQLCGSI 248 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHHHHHhccC
Confidence 998665443322 2344556999999999866 47899999999999999999999888754311 1110 000111
Q ss_pred hccccccccCcccc----------cCCCchHHHH------HHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1083 AKLKISDVFDPELM----------KEDPNIEIEL------LQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~----------~~~~~~~~~~------~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
....+++.-.-+++ +........+ ...++++.+++..||.+|+++++++.+-
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11111111110000 0000011111 1456799999999999999999998873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=304.35 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=170.7
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-C----CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeE------Ee
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-D----GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGY------CK 926 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 926 (1176)
..++|.+.+.||+|+||.||+|++. + +..||+|++..... .+....| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999986 4 68999998753221 1111111 1222223333333222 24
Q ss_pred eCCeeEEEEeeccCCCHHHHHhhcccc----------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 046275 927 VGEERLLVYEYMRYGSLEDVLHNQKKV----------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMK 990 (1176)
Q Consensus 927 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 990 (1176)
.+...++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999999754210 00112344668999999999999999 99999999
Q ss_pred CCCEEECC-CCcEEEEeeccccccccccccccccccccCCcccCccccCCC----------------------CCCchhh
Q 046275 991 SSNVLLDE-NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF----------------------RCSTKGD 1047 (1176)
Q Consensus 991 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 1047 (1176)
|+|||+++ ++.+||+|||+|+........ ......||+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 578999999999865432221 22456789999999965322 2345679
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC--------CCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccC
Q 046275 1048 VYSYGVVLLELLTGKRPTDSAD--------FGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDD 1119 (1176)
Q Consensus 1048 vwSlGvil~elltg~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 1119 (1176)
|||+||++|||+++..|+.... ....+...|....... ..++..........+.....+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-----ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-----cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999776643210 0011112222111100 01110000000000111234799999999
Q ss_pred CCCCCCCHHHHHHH
Q 046275 1120 RPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1120 dp~~RPt~~evl~~ 1133 (1176)
||++|||++++++|
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=261.72 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=195.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|...++||+|+|++|-.++++ +.+.+|+|.+.+. ..++...++.|-.+..+. +||++|-+..+|..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 47889999999999999999876 5778898877653 333445577788777776 799999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
.||++||+|--++.+++ +++++.++.+...|.-||.|||++ |||+||+|..||++|..|++|++|+|+++.--
T Consensus 330 ieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999988888776 699999999999999999999999 99999999999999999999999999987532
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CCCccHHHHH-HHhhcccccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD--FGDNNLVGWV-KQHAKLKISDVF 1091 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~--~~~~~~~~~~-~~~~~~~~~~~~ 1091 (1176)
. .....++.+|||.|+|||++++..|...+|+|++||+++||+.|+.||+-.. .++++-..+. +.+....+ .+
T Consensus 403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--ri 478 (593)
T KOG0695|consen 403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RI 478 (593)
T ss_pred C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cc
Confidence 2 2233578899999999999999999999999999999999999999997533 2333333333 22222111 11
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCC
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRP 1125 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP 1125 (1176)
+.++. .++..++..-+..||.+|.
T Consensus 479 prsls----------vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLS----------VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceee----------hhhHHHHHHhhcCCcHHhc
Confidence 11111 1223366677889998875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=237.20 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=196.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|...++||+|.||+||||+.. +++.||+|++.... +.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556679999999999999866 58889999886432 22345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|+. +|..+..... ..++.+..+.++.|+.+|+.++|++ ++.|||+||.|.+|+.+|+.|++|||+|+-++-.-
T Consensus 83 cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 975 8888887653 2588999999999999999999999 89999999999999999999999999998665322
Q ss_pred ccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHh---hccccccc--
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQH---AKLKISDV-- 1090 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 1090 (1176)
...+...-|..|.+|.++.+. -|+...|+||-||++.|+.. |++-|.+.+.+++ +....... .+..++.+
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCcccc
Confidence 122445668899999998775 47889999999999999988 5555655543332 22222111 11122211
Q ss_pred -cCcccccCCCch---HHHHHH----HHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 -FDPELMKEDPNI---EIELLQ----HLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 -~~~~~~~~~~~~---~~~~~~----~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-|-....-.|.. .+-+.+ =.++.++.+.-+|.+|.++++++++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111111111 111111 1478889999999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=290.00 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=181.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEE-----------------CCCCEEEEEEeeccCCcCHHH--------------HHHH
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKL-----------------KDGSTVAIKKLIHISGQGDRE--------------FTAE 906 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 906 (1176)
..++|++.++||+|+||+||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 235689999985432222222 3346
Q ss_pred HHHHHhcCCCCc-----ccceeEEee--------CCeeEEEEeeccCCCHHHHHhhccc--------------------c
Q 046275 907 METIGKIKHRNL-----VPLLGYCKV--------GEERLLVYEYMRYGSLEDVLHNQKK--------------------V 953 (1176)
Q Consensus 907 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~ 953 (1176)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876554 677787753 3467999999999999999975321 0
Q ss_pred CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccC
Q 046275 954 GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033 (1176)
Q Consensus 954 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 1033 (1176)
...+++..++.++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 12357788999999999999999999 899999999999999999999999999975533211 11122345889999
Q ss_pred ccccCCCC----------------------CCchhhhHHHHHHHHHHHcCCC-CCCCCCCCC-------ccHHHHHHHhh
Q 046275 1034 PEYYQSFR----------------------CSTKGDVYSYGVVLLELLTGKR-PTDSADFGD-------NNLVGWVKQHA 1083 (1176)
Q Consensus 1034 PE~~~~~~----------------------~~~~~DvwSlGvil~elltg~~-P~~~~~~~~-------~~~~~~~~~~~ 1083 (1176)
||.+.... ...+.||||+||++|+|++|.. ||....... .+...|... .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-K 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-c
Confidence 99875322 1234799999999999999875 665322111 111222211 0
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRP---WRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp---~~RPt~~evl~~ 1133 (1176)
. ..++-...+.. -....+++.+|+..+| .+|+|++|+++|
T Consensus 458 ~----~~~~~~~~d~~------s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 G----QKYDFSLLDRN------KEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred c----cCCCccccccc------ChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 11111111111 1234568999999766 689999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=294.69 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=188.9
Q ss_pred CCCCceEeEeCceE-EEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeecc
Q 046275 862 FHNDSLIGSGGFGD-VYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 862 y~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
|.-.+++|.|+-|+ ||+|... |+.||||++.. +-.....+|++.++.- +|||||++++.-.++...||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34456899999875 6999986 89999998853 2234567899999998 59999999999899999999999996
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---C--CcEEEEeeccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---N--FEARVSDFGMARLMS 1014 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfGla~~~~ 1014 (1176)
. +|.+++...............+.++.|++.||+|||+. +||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999987421111122245678899999999999998 9999999999999975 3 468999999999887
Q ss_pred ccccccc-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcC-CCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTHLS-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG-KRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
....... .....||-+|+|||++....-+.++||||+||++|+.++| .+||...-..+.+ +..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~----- 730 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNY----- 730 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCcc-----
Confidence 6544322 3567899999999999988888899999999999999985 9998643211111 111110
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+..-.+... . .+.++|.+|++++|..||++.+|+.|
T Consensus 731 -~L~~L~~~~d-~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 731 -TLVHLEPLPD-C--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -ceeeeccCch-H--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0111011111 1 56679999999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-28 Score=263.45 Aligned_cols=239 Identities=33% Similarity=0.428 Sum_probs=192.5
Q ss_pred CceEEEEEEEC-CCCEEEEEEeeccCCcC-HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhh
Q 046275 872 GFGDVYKAKLK-DGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHN 949 (1176)
Q Consensus 872 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 949 (1176)
+||.||+|+.. +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999987654444 67899999999999999999999999999999999999999999999976
Q ss_pred ccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCC
Q 046275 950 QKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029 (1176)
Q Consensus 950 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 1029 (1176)
.. .+++..+..++.++++++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 54 388999999999999999999999 99999999999999999999999999998765432 224456888
Q ss_pred cccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHH
Q 046275 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQH 1109 (1176)
Q Consensus 1030 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1109 (1176)
.|++||......++.++||||+|+++|++++|..||.... ................ . ......+ ..+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~~~~~~~~--~-~~~~~~~------~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKIGKPKPPF--P-PPEWKIS------PEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhccCCCC--c-cccccCC------HHH
Confidence 9999999988888999999999999999999999986532 1111222111111110 0 0000011 245
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1110 LHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1110 ~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+++.+|+..+|++||++.+++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhhC
Confidence 669999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=276.30 Aligned_cols=205 Identities=24% Similarity=0.351 Sum_probs=173.5
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
-|..++.||-|+||.|.+++-. +...+|.|.+.+.+- .....++.|.+||...+.+.||+++..|.+.+..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4778899999999999999754 456788887765432 233457889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc---
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM--- 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~--- 1013 (1176)
|++||++-+++.+.+ .+++.-++.++.++..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+
T Consensus 710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999998876 688899999999999999999999 9999999999999999999999999997422
Q ss_pred ------ccccccc-------------------------------cccccccCCcccCccccCCCCCCchhhhHHHHHHHH
Q 046275 1014 ------SAMDTHL-------------------------------SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLL 1056 (1176)
Q Consensus 1014 ------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 1056 (1176)
...+.+. .....+||+.|+|||++....|+.-+|+||.|||+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1111000 001346999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCC
Q 046275 1057 ELLTGKRPTDSADFGD 1072 (1176)
Q Consensus 1057 elltg~~P~~~~~~~~ 1072 (1176)
||+.|+.||-......
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999997655443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=247.06 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=197.7
Q ss_pred hcCCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeC--CeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVG--EERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 934 (1176)
.++|++.+++|+|.|+.||.|.. .+.++++||.+.. ...+.+.+|+.+++.++ ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45788999999999999999974 4688899998753 34567899999999997 99999999998764 456899
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeecccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLM 1013 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~ 1013 (1176)
+||+++.+...+.. .++...++.++.+++.||.|+|++ ||+|||+||.||+||.. -..+++|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999977776654 577788999999999999999999 99999999999999964 56999999999988
Q ss_pred ccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc----
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS---- 1088 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 1088 (1176)
.+.... .....+..|--||.+.. ..|+..-|+|||||++..|+..+.||.........++..++.....++.
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 664432 34455677889998854 4678899999999999999999999876544433444444322211111
Q ss_pred ---cccCccccc-----------CC-Cch-HH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 ---DVFDPELMK-----------ED-PNI-EI-ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ---~~~~~~~~~-----------~~-~~~-~~-~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-.+||...+ .. +.. .. -..++++++.+.|..|-++|||++|+++|
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 112222111 00 000 00 11456789999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=265.43 Aligned_cols=197 Identities=22% Similarity=0.345 Sum_probs=168.4
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcC--------HHHHHHHHHHHHhcC---CCCcccceeEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQG--------DREFTAEMETIGKIK---HRNLVPLLGYCKV 927 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 927 (1176)
.+|+..+.+|+|+||.|+.|.++. ...|++|.+.+...-. .-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999999885 4567777665422111 112567999999997 9999999999999
Q ss_pred CCeeEEEEeecc-CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 928 GEERLLVYEYMR-YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 928 ~~~~~lV~E~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
++.+|++||-.. |-+|++++.... .+++..+..|++|++.|+++||++ +|||||||-+||.++.+|.+|++|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 999999999754 459999998765 689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCC
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDS 1067 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~ 1067 (1176)
||.|....... .....||..|.|||++.+.+| ...-|||++|+++|-++....||..
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99987654433 356789999999999998876 4568999999999999999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=255.45 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=193.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-----C---CCcccceeEEee--
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-----H---RNLVPLLGYCKV-- 927 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 927 (1176)
..+|.+.++||+|.|++||++.+. ..+.||+|+... ...-.+....|++++++++ | .+||+++++|.-
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999886 467788887642 3333455678999999983 3 479999999854
Q ss_pred --CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC------
Q 046275 928 --GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN------ 999 (1176)
Q Consensus 928 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------ 999 (1176)
+.+++||+|++ |.+|..+|......+ ++...++.|++||+.||.|||.+| +|||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhh
Confidence 56789999999 569999998876654 677899999999999999999998 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 046275 1000 -------------------------------------------------------------------------------- 999 (1176)
Q Consensus 1000 -------------------------------------------------------------------------------- 999 (1176)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 046275 1000 -------------------------------------------------------------------------------- 999 (1176)
Q Consensus 1000 -------------------------------------------------------------------------------- 999 (1176)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred CcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC-----Ccc
Q 046275 1000 FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG-----DNN 1074 (1176)
Q Consensus 1000 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~-----~~~ 1074 (1176)
-.+||+|||-|+.+.. ..+....|..|.|||++.+..|+..+||||++|+++|+.||.+-|+...-. +..
T Consensus 391 i~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred eeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0134455554443211 112334788999999999999999999999999999999999988764321 111
Q ss_pred HHHHHHHhh--------cccc-ccccCc-----------------ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHH
Q 046275 1075 LVGWVKQHA--------KLKI-SDVFDP-----------------ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMI 1128 (1176)
Q Consensus 1075 ~~~~~~~~~--------~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~ 1128 (1176)
+...++... .++. .++|+. -+...+.-..++..++.+|+.-||+.+|++||||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 222221111 1111 112221 11222223345777888999999999999999999
Q ss_pred HHHHH
Q 046275 1129 QVMAM 1133 (1176)
Q Consensus 1129 evl~~ 1133 (1176)
+.+++
T Consensus 546 ~cl~h 550 (590)
T KOG1290|consen 546 QCLKH 550 (590)
T ss_pred HHhcC
Confidence 99987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=248.58 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=191.1
Q ss_pred CCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----CeeEEEE
Q 046275 864 NDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EERLLVY 935 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~ 935 (1176)
-.+.||-|+||.||.+++. +|+.||.||+... +-...+.+.+|++++..++|.|+...++...-. ++.|.|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3578999999999999875 7999999998643 223456788999999999999999998876443 3568899
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|.|.. +|...+-.-. .++.+.++-+++||++||.|||+. +|.||||||.|.+++.+...||+|||+|+....
T Consensus 137 ELmQS-DLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHh-hhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 99965 8887776443 688889999999999999999999 999999999999999999999999999986544
Q ss_pred ccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC-----------ccHHHHH---H
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-----------NNLVGWV---K 1080 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~-----------~~~~~~~---~ 1080 (1176)
.+ ...++...-|..|.|||.+.+. .|+.+.||||+|||+.|++..+.-|....... ..+..+. +
T Consensus 209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 33 2334555668889999999875 68899999999999999998888876543211 0011111 0
Q ss_pred ---H-hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1081 ---Q-HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1081 ---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
. ..++.....--+.+..-..... .-.+.+.+.+.++..||++|.+..+++.+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~-~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDD-KNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcc-cchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 0011110000011111111111 112334578899999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-28 Score=250.14 Aligned_cols=259 Identities=25% Similarity=0.291 Sum_probs=197.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------ee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ER 931 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 931 (1176)
+|...+.+|.|+- .|..|.+. .+++||+|+.... .....+...+|..++..+.|+||++++.+|...+ +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5667788899988 66666554 6899999988542 2334466789999999999999999999986543 56
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+|||||+. +|...+.. .++..+...+..|+..|+.|||+. +|+||||||+||++..+..+||.|||+|+
T Consensus 97 y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 999999975 99988872 478899999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC-------------ccHH--
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-------------NNLV-- 1076 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~-------------~~~~-- 1076 (1176)
..... ..++.+..|..|.|||++-+..+.+.+||||+||++.||++|+.-|.+.+.-+ ..+.
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 54332 34566788999999999998889999999999999999999999887543211 1110
Q ss_pred ---------HHHHHhhccccccccCcccccCCCch-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1077 ---------GWVKQHAKLKISDVFDPELMKEDPNI-EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1077 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
............+.++...+...... ..+...+.+++.+||-.+|++|-+++++++|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00011111222233333322211111 1244456789999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=237.21 Aligned_cols=248 Identities=20% Similarity=0.365 Sum_probs=190.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeE-EeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGY-CKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~E 936 (1176)
+.|.+.+.+|+|.||.+-+++++. .+.+++|.+.. .....++|.+|..---.+ .|.||+.-++. |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 358899999999999999999874 66777776643 334567899998765555 58999998874 677788899999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-C-CCCcEEEEeeccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL-D-ENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~DfGla~~~~ 1014 (1176)
|++.|+|.+-+...+ +-+..-.+++.|++.|+.|+|++ .+||||||.+|||| + +...+|+||||..+..+
T Consensus 103 ~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999887654 67788899999999999999999 99999999999999 3 33479999999987554
Q ss_pred cccccccccccccCCcccCccccCCC-----CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSF-----RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
.. ......+..|.+||..... ...+.+|||.||+++|.++||+.||+.+...+..+..|.+...+...
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 32 1233346679999987432 45678999999999999999999999888888888888765544321
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQV 1130 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~ev 1130 (1176)
.+++...... .+++++..+-+.++|++|=...++
T Consensus 248 ----~~P~~F~~fs---~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 248 ----ALPKKFNPFS---EKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred ----cCchhhcccC---HHHHHHHHHhcCCcccccchhHHH
Confidence 1111111111 134557788899999999333333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=267.08 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=203.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|+....+|.|.||.|||++++ +++..|+|.+.........-+..|+-+++..+|||||.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 357888999999999999999987 6899999998777767777788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|.+|+|.+..+-.+ ++++.++..+.+...+|+.|||++ +=+|||||-.||++++.|.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999988665 799999999999999999999999 77899999999999999999999999986554321
Q ss_pred ccccccccccCCcccCcccc---CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THLSVSTLAGTPGYVPPEYY---QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.......||+.|||||+. +.+.|...+|||++|+...|+-.-+.|... -..+... ..-....++|.
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd----lhpmr~l-----~LmTkS~~qpp 235 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD----LHPMRAL-----FLMTKSGFQPP 235 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc----cchHHHH-----HHhhccCCCCC
Confidence 123567899999999986 456789999999999999999877777321 1111111 11112223333
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
-.++...- -..+-+|++.|+..+|.+|||++.+++|
T Consensus 236 ~lkDk~kw---s~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 236 TLKDKTKW---SEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cccCCccc---hHHHHHHHHHHhcCCCccCCChhhheec
Confidence 22222211 1234569999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=237.63 Aligned_cols=211 Identities=36% Similarity=0.576 Sum_probs=182.4
Q ss_pred EeEeCceEEEEEEECC-CCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHHH
Q 046275 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLED 945 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 945 (1176)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5899999999999864 899999988643322 24678999999999999999999999999999999999999999999
Q ss_pred HHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeeccccccccccccccccc
Q 046275 946 VLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMSAMDTHLSVST 1024 (1176)
Q Consensus 946 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 1024 (1176)
++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++++|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 997652 2588999999999999999999999 9999999999999999 89999999999876544321 1233
Q ss_pred cccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchH
Q 046275 1025 LAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103 (1176)
Q Consensus 1025 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1103 (1176)
..+...|++||..... .++.+.|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5678899999999887 788999999999999999
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1104 ~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2455699999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=246.68 Aligned_cols=268 Identities=26% Similarity=0.379 Sum_probs=200.7
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeC
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVG 928 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 928 (1176)
++....+.|..+++||+|.|++||++.+. .++.||+|.+... +....+..|++++.++ .+.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678999999999999999999754 4688999998643 3456789999999999 599999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEee
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDF 1007 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 1007 (1176)
+...+|+||++.....++.. .++...+..+++.+..||.++|.. |||||||||+|++++. .+...|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 99999999999999888886 356788999999999999999999 9999999999999975 577899999
Q ss_pred cccccccccc-------------cc-----------------------------ccccccccCCcccCccccC-CCCCCc
Q 046275 1008 GMARLMSAMD-------------TH-----------------------------LSVSTLAGTPGYVPPEYYQ-SFRCST 1044 (1176)
Q Consensus 1008 Gla~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~ 1044 (1176)
|+|....... .. ......+||+||.|||++. ....+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9987321100 00 0001346999999999985 456788
Q ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc----------cc--ccc---------------ccC-cccc
Q 046275 1045 KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK----------LK--ISD---------------VFD-PELM 1096 (1176)
Q Consensus 1045 ~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~----------~~--~~~---------------~~~-~~~~ 1096 (1176)
++||||.|||+.-++++++||.....+...+.+.+..... +. +.+ .++ ....
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999997765444443333211110 01 000 010 0111
Q ss_pred c-CCC------chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 K-EDP------NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~-~~~------~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+ +.+ ..+.--..+.+++.+|++.||.+|.|++++++|
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1 000 000011256789999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=253.37 Aligned_cols=265 Identities=24% Similarity=0.277 Sum_probs=203.7
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC------CCCcccceeEEeeCC
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK------HRNLVPLLGYCKVGE 929 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~ 929 (1176)
....+|.+....|+|-|++|..|.+. .|..||||++... ....+.=..|+++|++|. .-|.++++..|.-..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34578999999999999999999876 4889999998642 223344567999999994 358999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeec
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFG 1008 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 1008 (1176)
+.++|+|-+.- +|.+.++..+.. .-+...+++.++.|+.-||..|... +|+|.||||.|||+++. ..+||||||
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 99999999865 999999988653 4588899999999999999999998 99999999999999875 458999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh-----
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA----- 1083 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~----- 1083 (1176)
.|......+. +.+.-+..|.|||++.+.+|+...|+||+||++||+.||+.-|.+... ..+..+.....
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN--N~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN--NQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc--HHHHHHHHHhcCCCcH
Confidence 9987765443 333456789999999999999999999999999999999998876431 12222221100
Q ss_pred ----ccccc-cccC--------------------------c------ccccC--CCch-HHHHHHHHHHHHHhccCCCCC
Q 046275 1084 ----KLKIS-DVFD--------------------------P------ELMKE--DPNI-EIELLQHLHVASACLDDRPWR 1123 (1176)
Q Consensus 1084 ----~~~~~-~~~~--------------------------~------~~~~~--~~~~-~~~~~~~~~li~~cl~~dp~~ 1123 (1176)
.+.+. +-|| | .+... .|.. ...+.++.+++.+|+..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 00000 0011 1 11111 1222 235566789999999999999
Q ss_pred CCCHHHHHHH
Q 046275 1124 RPTMIQVMAM 1133 (1176)
Q Consensus 1124 RPt~~evl~~ 1133 (1176)
|.|..++++|
T Consensus 737 Rit~nqAL~H 746 (752)
T KOG0670|consen 737 RITVNQALKH 746 (752)
T ss_pred cCCHHHHhcC
Confidence 9999999876
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-28 Score=256.08 Aligned_cols=444 Identities=21% Similarity=0.216 Sum_probs=297.0
Q ss_pred eeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCC
Q 046275 223 LDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSS 302 (1176)
Q Consensus 223 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~ 302 (1176)
.+.++-.++.+|..+. +.-.+++|..|+|+.+.+.+|+.+++|+.||||+|.|+. |..+.|..+++
T Consensus 51 VdCr~~GL~eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~------------I~p~AF~GL~~ 116 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISF------------IAPDAFKGLAS 116 (498)
T ss_pred EEccCCCcccCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhh------------cChHhhhhhHh
Confidence 4566666666666543 456789999999999999999999999999999999883 33444555566
Q ss_pred ccEEEccC-CcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 303 LVKLDLSS-NNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 303 L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
|..|-+.+ |+|+......|+++.+|+.|.+.-|++. -++.+.|..+++|..|.+.+|.+..+--..|..+..++++.+
T Consensus 117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhl 195 (498)
T KOG4237|consen 117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHL 195 (498)
T ss_pred hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhh
Confidence 66665544 7888666677888888888888888886 777788888888888888888887433347778888888888
Q ss_pred cCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCC-CccCeeecccccc
Q 046275 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSL-SKLQDLKLWLNQL 460 (1176)
Q Consensus 382 s~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l 460 (1176)
..|.+... |. ++.+.. ++. ..|..++...-..-..+.++++..+-+..|..- .++..=-.+.+..
T Consensus 196 A~np~icd-----Cn--L~wla~-~~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~ 261 (498)
T KOG4237|consen 196 AQNPFICD-----CN--LPWLAD-DLA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFP 261 (498)
T ss_pred hcCccccc-----cc--cchhhh-HHh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCc
Confidence 88764311 11 111110 111 223344455555555666677665544444332 2222111222223
Q ss_pred cCCCC-CCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 461 HGEIP-PELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 461 ~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
.++-| ..|.++++|++|+|++|+|+++-+.+|.++..+++|.|..|+|...--..|.++..|++|+|.+|+|+..-|..
T Consensus 262 d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~a 341 (498)
T KOG4237|consen 262 DSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGA 341 (498)
T ss_pred CCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccc
Confidence 33333 35889999999999999999999999999999999999999998776778999999999999999999999999
Q ss_pred CCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCc
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCN 619 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 619 (1176)
|..+.+|..|.|-.|+|.+..--.++..|- .++. ..+...|+.++-+.+ ..+......+..+..+..
T Consensus 342 F~~~~~l~~l~l~~Np~~CnC~l~wl~~Wl-------r~~~-----~~~~~~Cq~p~~~~~-~~~~dv~~~~~~c~~~ee 408 (498)
T KOG4237|consen 342 FQTLFSLSTLNLLSNPFNCNCRLAWLGEWL-------RKKS-----VVGNPRCQSPGFVRQ-IPISDVAFGDFRCGGPEE 408 (498)
T ss_pred ccccceeeeeehccCcccCccchHHHHHHH-------hhCC-----CCCCCCCCCCchhcc-ccchhccccccccCCccc
Confidence 999999999999999999877655554331 1111 223345665543322 112222222222211111
Q ss_pred cccccCCCCCCCcCCCCCcc-EEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccc
Q 046275 620 FTRVYGGHTQPTFNHNGSMM-FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEG 698 (1176)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~l~-~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g 698 (1176)
..-...+.-++. .+-+. +..-|++.+. .+|+.|-. .-..|+|.+|.++ .+|.+ .+++| .+|||+|+++-
T Consensus 409 ~~~~~s~~cP~~---c~c~~tVvRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~ 478 (498)
T KOG4237|consen 409 LGCLTSSPCPPP---CTCLDTVVRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISS 478 (498)
T ss_pred cCCCCCCCCCCC---cchhhhhHhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceeh
Confidence 100000111111 11111 2334555555 56655432 3567899999999 89988 78889 99999999995
Q ss_pred cCCCCccccccccccccccc
Q 046275 699 TIPSSMSSLTLLNEIDLCNN 718 (1176)
Q Consensus 699 ~iP~~l~~l~~L~~l~ls~N 718 (1176)
---..|+++++|..|-||||
T Consensus 479 Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 479 LSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhcccccchhhhheeEEecC
Confidence 55567899999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=235.95 Aligned_cols=199 Identities=34% Similarity=0.492 Sum_probs=173.2
Q ss_pred CCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
|.+.+.||.|++|.||+|...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999875 899999998755444 56678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++..... .+++..+..++.++++++.+||+. +++|+|++|+||+++.++.++++|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999987542 178999999999999999999999 9999999999999999999999999998876543211
Q ss_pred ccccccccCCcccCcccc-CCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Q 046275 1020 LSVSTLAGTPGYVPPEYY-QSFRCSTKGDVYSYGVVLLELLTGKRPTDS 1067 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~P~~~ 1067 (1176)
......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=277.05 Aligned_cols=256 Identities=23% Similarity=0.248 Sum_probs=109.5
Q ss_pred ChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcC
Q 046275 258 GHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKF 337 (1176)
Q Consensus 258 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 337 (1176)
+.+|.++.+|+.|.+..+.... .......+|..+...+.+|+.|++.++.+. .+|..| ...+|+.|+|++|++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~-----~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l 623 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQ-----KKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKL 623 (1153)
T ss_pred HHHHhcCccccEEEEecccccc-----cccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccc
Confidence 3445566666666665543220 000111122222222234555555555544 344444 234555555555555
Q ss_pred cccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCC
Q 046275 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP 417 (1176)
Q Consensus 338 ~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p 417 (1176)
. .++.++ ..+++|++|+|+++.....+|. ++.+++|++|+|++|.....+ |
T Consensus 624 ~-~L~~~~-~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~l--------------------------p 674 (1153)
T PLN03210 624 E-KLWDGV-HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVEL--------------------------P 674 (1153)
T ss_pred c-cccccc-ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCcccc--------------------------c
Confidence 4 444332 3445555555554432223332 444445555555444333344 4
Q ss_pred ccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCC
Q 046275 418 STLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTN 497 (1176)
Q Consensus 418 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 497 (1176)
..+.++++|+.|++++|..-+.+|..+ ++++|+.|++++|...+.+|.. ..+|++|+|++|.++ .+|..+ .+++
T Consensus 675 ~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~ 748 (1153)
T PLN03210 675 SSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLEN 748 (1153)
T ss_pred hhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccc
Confidence 444444444444444433222334333 3444444444444333333322 123444444444444 333332 3444
Q ss_pred CCeeecccccc-------CCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCC
Q 046275 498 LNWISLSNNHL-------GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNL 555 (1176)
Q Consensus 498 L~~L~Ls~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 555 (1176)
|+.|++.++.. ....|..+...++|+.|+|++|...+.+|.+++++++|+.|+|++|.
T Consensus 749 L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 749 LDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred cccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 44444444221 11111112223455555555555444555555555555555555543
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=275.08 Aligned_cols=236 Identities=23% Similarity=0.259 Sum_probs=187.0
Q ss_pred CCccccCCCCCcEEEccCCcC------cccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCC
Q 046275 317 VPSRFGSCSSLESFDISSNKF------SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAI 390 (1176)
Q Consensus 317 ~p~~~~~l~~L~~L~Ls~N~l------~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 390 (1176)
.+.+|..+++|+.|.+..+.. ...+|.++..-..+|+.|++.++.++ .+|..+ ...+|+.|+|++|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 456788899999999976642 23466654332356999999999987 677777 5789999999999987 66
Q ss_pred CccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCC
Q 046275 391 PHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGN 470 (1176)
Q Consensus 391 p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 470 (1176)
+..+ ..+++|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ +
T Consensus 627 ~~~~--~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~ 702 (1153)
T PLN03210 627 WDGV--HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-N 702 (1153)
T ss_pred cccc--ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-C
Confidence 7665 4578899999998875557774 8889999999999988767899999999999999999986666888776 7
Q ss_pred ccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcc-------cccCCCCCCCC
Q 046275 471 IQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF-------YGRIPPELGDC 543 (1176)
Q Consensus 471 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~p~~~~~l 543 (1176)
+++|+.|+|++|...+.+|.. ..+|++|+|++|.+. .+|..+ .+++|++|++.++.. ....|..+...
T Consensus 703 l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 703 LKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred CCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcc
Confidence 999999999999876677753 468999999999997 678765 688999999987542 21222233345
Q ss_pred CCCCEEEccCCCCcccCChhH
Q 046275 544 RSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 544 ~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
++|+.|+|++|+..+.+|..+
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si 798 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSI 798 (1153)
T ss_pred ccchheeCCCCCCccccChhh
Confidence 789999999999888888764
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=259.22 Aligned_cols=74 Identities=26% Similarity=0.376 Sum_probs=40.6
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
.-..|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|. ..++|++|+|++|+|+ .+|.. .++|+.|+|
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 4556677777776 4565554 35666666666666 4553 2355556666555555 23321 234455555
Q ss_pred cCCcCC
Q 046275 382 SSNNLS 387 (1176)
Q Consensus 382 s~N~l~ 387 (1176)
++|.++
T Consensus 270 s~N~L~ 275 (788)
T PRK15387 270 FSNPLT 275 (788)
T ss_pred cCCchh
Confidence 555544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=257.22 Aligned_cols=263 Identities=28% Similarity=0.325 Sum_probs=141.1
Q ss_pred CCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccE
Q 046275 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKE 404 (1176)
Q Consensus 325 ~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~ 404 (1176)
..-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l-----p~sL~~ 266 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL-----PPGLLE 266 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc-----ccccce
Confidence 34567788888887 7776553 36777888888777 34532 466777777777776 44431 245666
Q ss_pred EEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccc
Q 046275 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNEL 484 (1176)
Q Consensus 405 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 484 (1176)
|+|++|.++ .+|..+ ++|+.|++++|+++ .+|.. +++|+.|+|++|++++ +|... .+
T Consensus 267 L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~----------- 323 (788)
T PRK15387 267 LSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SE----------- 323 (788)
T ss_pred eeccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---cc-----------
Confidence 666666665 333322 34555666666665 33331 2345555555555552 23211 23
Q ss_pred cCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhH
Q 046275 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 485 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
|+.|++++|+|+ .+|.. ..+|++|+|++|+|+ .+|... .+|+.|++++|.+++ +|..
T Consensus 324 -------------L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l- 380 (788)
T PRK15387 324 -------------LCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL- 380 (788)
T ss_pred -------------ccccccccCccc-ccccc---ccccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc-
Confidence 444444444444 23321 124555555555554 334322 244455555555542 3310
Q ss_pred HhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcc
Q 046275 565 FKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644 (1176)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs 644 (1176)
..+|+.|||+
T Consensus 381 ----------------------------------------------------------------------~~~L~~LdLs 390 (788)
T PRK15387 381 ----------------------------------------------------------------------PSGLKELIVS 390 (788)
T ss_pred ----------------------------------------------------------------------ccccceEEec
Confidence 0124455666
Q ss_pred cCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCC
Q 046275 645 YNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMI 724 (1176)
Q Consensus 645 ~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~ 724 (1176)
+|+|++ +|... ++|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .||..+.++++|+.|+|++|+|+|.+
T Consensus 391 ~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 391 GNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred CCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchH
Confidence 666653 44332 34556666666666 355432 34556666666666 56666666666666666666666665
Q ss_pred CC
Q 046275 725 PV 726 (1176)
Q Consensus 725 p~ 726 (1176)
|.
T Consensus 462 ~~ 463 (788)
T PRK15387 462 LQ 463 (788)
T ss_pred HH
Confidence 54
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-26 Score=240.53 Aligned_cols=413 Identities=20% Similarity=0.207 Sum_probs=269.9
Q ss_pred CccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecc-ccccCccCCCCccccCcchhh
Q 046275 218 KNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSS-NLFSGPIPVGYNEFQGEIPLH 295 (1176)
Q Consensus 218 ~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~~i~~~ 295 (1176)
+.-+.++|..|+|+.+|+ +|+.+.+|+.||||+|+|+.+.|.+|.++.+|..|-+.+ |+|+ .+|..
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~------------~l~k~ 134 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT------------DLPKG 134 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh------------hhhhh
Confidence 466778888888888877 588899999999999999988889999998887777766 8887 67778
Q ss_pred hhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccC------------
Q 046275 296 LADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT------------ 363 (1176)
Q Consensus 296 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~------------ 363 (1176)
.|..+..|+.|.+.-|++.-...+.|..+++|..|.+..|.+. .++...|..+..++.+.+..|.+.
T Consensus 135 ~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~ 213 (498)
T KOG4237|consen 135 AFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDL 213 (498)
T ss_pred HhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHH
Confidence 8888888899999989888777788999999999999999987 788878888899999999888742
Q ss_pred CCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCC-ccccccccCcEEEcCCccccCCCCc
Q 046275 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHLSFNYLTGTIPS 442 (1176)
Q Consensus 364 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~ 442 (1176)
...|..+++..-..-..+.++++...-+..+. -...++..=..+.+...+.-| ..|..+++|+.|+|++|+++++-+.
T Consensus 214 a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~-c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~ 292 (498)
T KOG4237|consen 214 AMNPIETSGARCVSPYRLYYKRINQEDARKFL-CSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDG 292 (498)
T ss_pred hhchhhcccceecchHHHHHHHhcccchhhhh-hhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhh
Confidence 12344455555555555566655422222221 111112111222232333333 3567788888888888888877778
Q ss_pred cccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCC-CCccccCCCC
Q 046275 443 SLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE-IPTWIGQLSN 521 (1176)
Q Consensus 443 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~ 521 (1176)
+|..+.++++|.|..|++...-...|.++..|++|+|.+|+|+-..|.+|..+..|..|+|-.|.+.-. --.|++.
T Consensus 293 aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~--- 369 (498)
T KOG4237|consen 293 AFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE--- 369 (498)
T ss_pred hhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH---
Confidence 888888888888888888766666777788888888888888877778888888888888877766421 0112221
Q ss_pred CCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCc---ccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCc
Q 046275 522 LAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFN---GSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL 598 (1176)
Q Consensus 522 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (1176)
.|..+...|..| . ..-..++.++++++.+. +.-|++... .-+...+..|......
T Consensus 370 ----Wlr~~~~~~~~~-C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~----------------~~s~~cP~~c~c~~tV 427 (498)
T KOG4237|consen 370 ----WLRKKSVVGNPR-C-QSPGFVRQIPISDVAFGDFRCGGPEELGC----------------LTSSPCPPPCTCLDTV 427 (498)
T ss_pred ----HHhhCCCCCCCC-C-CCCchhccccchhccccccccCCccccCC----------------CCCCCCCCCcchhhhh
Confidence 112222222221 1 11123445555555442 222322111 0111222223222211
Q ss_pred hhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCc
Q 046275 599 LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPT 678 (1176)
Q Consensus 599 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~ 678 (1176)
....+ ..+..++... ...-.+|.|.+|.++ .+|.+ .+++| .++||+|+++-.--.
T Consensus 428 vRcSn---k~lk~lp~~i------------------P~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~ 482 (498)
T KOG4237|consen 428 VRCSN---KLLKLLPRGI------------------PVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNY 482 (498)
T ss_pred Hhhcc---cchhhcCCCC------------------CchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcc
Confidence 11111 0011111110 123457889999999 78988 78889 999999999955557
Q ss_pred cccCcCcccEEEccCc
Q 046275 679 EVGDLRGLNILDLSSN 694 (1176)
Q Consensus 679 ~~~~L~~L~~L~Ls~N 694 (1176)
.|.++++|.+|-||+|
T Consensus 483 tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 483 TFSNMTQLSTLILSYN 498 (498)
T ss_pred cccchhhhheeEEecC
Confidence 8999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=215.12 Aligned_cols=171 Identities=22% Similarity=0.209 Sum_probs=128.2
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.++++..+ ..+++.+++.++.|+++||+|||+. + ||+||+++.++.+|+ ||.+......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 68999998653 2699999999999999999999998 4 999999999999999 9998765432
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
...||+.|||||++.+..++.++|||||||++|||+||+.||.........+..+........ +... ..+
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~ 132 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PRDR-SNL 132 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------cccc-ccH
Confidence 125899999999999999999999999999999999999998654322211222211111100 0000 001
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
....+...+.+++.+||+.+|.+|||+.++++++..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 111111257789999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=267.28 Aligned_cols=197 Identities=16% Similarity=0.190 Sum_probs=139.2
Q ss_pred hcCC-CCcccceeEE-------eeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046275 912 KIKH-RNLVPLLGYC-------KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983 (1176)
Q Consensus 912 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 983 (1176)
.++| +||++++++| ......+.++||+ +++|+++++... ..+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5788888877 2234567788988 559999997542 3589999999999999999999999 9
Q ss_pred eeeCCCCCCCEEECCC-------------------CcEEEEeeccccccccccc--------------cccccccccCCc
Q 046275 984 IIHRDMKSSNVLLDEN-------------------FEARVSDFGMARLMSAMDT--------------HLSVSTLAGTPG 1030 (1176)
Q Consensus 984 ivH~Dlkp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~ 1030 (1176)
|+||||||+|||++.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666653211000 000112458889
Q ss_pred ccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHH
Q 046275 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHL 1110 (1176)
Q Consensus 1031 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1110 (1176)
|||||++.+..++.++|||||||++|||++|..|+.... ......... ..++.... ......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~~----~~~~~~~~-------~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRHR----VLPPQILL-------NWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHHh----hcChhhhh-------cCHHHH
Confidence 999999999999999999999999999999988864211 111111111 11111111 122344
Q ss_pred HHHHHhccCCCCCCCCHHHHHHH
Q 046275 1111 HVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1111 ~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++.+||+.+|.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 68889999999999999999876
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=246.44 Aligned_cols=61 Identities=13% Similarity=0.159 Sum_probs=47.5
Q ss_pred HHHHhhhcCCCChHHHHHHHHHHhcCCCCCCCCC----CCCCCCCcccce----------------eEeCCCcEEEEecC
Q 046275 15 ISLSLLASASSPNKDLQQLLSFKAALPNPSVLPN----WSPNQNPCGFKG----------------VSCKAASVSSIDLS 74 (1176)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~ll~~k~~~~~~~~l~~----w~~~~~cC~W~g----------------v~C~~~~v~~l~L~ 74 (1176)
+.-.|+-+.+-.++|...+++....+.-|+.+++ |..+++.|-=.. |.|.+..||.+...
T Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~ 129 (754)
T PRK15370 50 IAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVT 129 (754)
T ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccc
Confidence 3444666777789999999999999998887777 999999996655 77877777766554
Q ss_pred C
Q 046275 75 P 75 (1176)
Q Consensus 75 ~ 75 (1176)
+
T Consensus 130 g 130 (754)
T PRK15370 130 E 130 (754)
T ss_pred c
Confidence 3
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-21 Score=217.32 Aligned_cols=266 Identities=22% Similarity=0.259 Sum_probs=197.9
Q ss_pred CCCCCceEeEeCceEEEEEEECCC--CEEEEEEeeccCCcCHHHHHHHHHHHHhcCC----CCcccceeEE-eeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDG--STVAIKKLIHISGQGDREFTAEMETIGKIKH----RNLVPLLGYC-KVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 933 (1176)
+|.+.+.||+|+||.||+|..... ..+|+|............+..|..++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998754 4677776654433333378889999998863 6899999988 47778999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CcEEEEeec
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-----FEARVSDFG 1008 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfG 1008 (1176)
||+.+ |.+|.++..... ...++..+...|+.|++.+|+++|+. |++||||||.|+.+... ..+.+.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 679999887665 34799999999999999999999999 99999999999999765 459999999
Q ss_pred ccc--cccccccc--c---c-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1009 MAR--LMSAMDTH--L---S-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1009 la~--~~~~~~~~--~---~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
+|+ .+...... . . .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ......
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~ 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEK 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHH
Confidence 998 33222211 1 1 1235599999999999999999999999999999999999999976542221 111111
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
......... ..... ..++.. +...+-..+...+|....+...+++.....+..
T Consensus 252 ~~~~~~~~~-----~~~~~---~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 252 DPRKLLTDR-----FGDLK---PEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred Hhhhhcccc-----ccCCC---hHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 111111110 11111 123333 444445588999999999999999888776433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=220.13 Aligned_cols=167 Identities=18% Similarity=0.190 Sum_probs=129.7
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC--CCCEEEEEEeeccC-----CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK--DGSTVAIKKLIHIS-----GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
...++|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999875 47778999875321 1124458999999999999999863332 24
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCcEEEEeec
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDM-KSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG 1008 (1176)
..|+||||++|++|.. ... .. ...++.++++||.|||+. +|+|||| ||+||+++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5799999999999963 211 11 146788999999999999 9999999 9999999999999999999
Q ss_pred ccccccccccccc------ccccccCCcccCccccCCC
Q 046275 1009 MARLMSAMDTHLS------VSTLAGTPGYVPPEYYQSF 1040 (1176)
Q Consensus 1009 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 1040 (1176)
+|+.+........ .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987654332211 2456788999999998543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=242.44 Aligned_cols=203 Identities=25% Similarity=0.429 Sum_probs=101.9
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
.+...|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..++ ++|++|++++|+++ .+|..+. .+|+.|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 45677777777777 4555443 46777777777776 6666543 46777777777766 3454432 3466666
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 460 (1176)
|++|++. .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++| ++
T Consensus 248 Ls~N~L~-~LP~~l~----s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N------------------------~L 295 (754)
T PRK15370 248 LSINRIT-ELPERLP----SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDN------------------------SI 295 (754)
T ss_pred CcCCccC-cCChhHh----CCCCEEECcCCccC-ccccccC--CCCcEEECCCC------------------------cc
Confidence 6666655 4444331 23444444444444 2333222 23444444444 43
Q ss_pred cCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCC
Q 046275 461 HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPEL 540 (1176)
Q Consensus 461 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 540 (1176)
+ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+
T Consensus 296 t-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l 365 (754)
T PRK15370 296 R-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL 365 (754)
T ss_pred c-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh
Confidence 3 2222221 234455555555542 332221 345555555555552 443332 34555555555554 344433
Q ss_pred CCCCCCCEEEccCCCCc
Q 046275 541 GDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 541 ~~l~~L~~L~L~~N~l~ 557 (1176)
. ++|+.|+|++|+|+
T Consensus 366 p--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 366 P--PTITTLDVSRNALT 380 (754)
T ss_pred c--CCcCEEECCCCcCC
Confidence 2 34555555555554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-20 Score=196.49 Aligned_cols=264 Identities=20% Similarity=0.236 Sum_probs=203.0
Q ss_pred CCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.|.++++||+|.||.++.|+. -++++||||.-. ......++..|.+..+.+ ..++|...+.+..++.+-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 689999999999999999974 479999999532 233445788899999988 4699999988888888889999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CcEEEEeecccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-----FEARVSDFGMARLM 1013 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGla~~~ 1013 (1176)
|.||+|++.-++ .+++.+++..+|.|++.-++|+|++ ..|.|||||+|+||... ..+.++|||+|+.+
T Consensus 107 -GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 679999998775 3799999999999999999999999 89999999999999643 35899999999988
Q ss_pred cccccccc-----ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1014 SAMDTHLS-----VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1014 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
.+.++... .....||.+||+--...+...+.+.|.-|+|-++.+++-|..||.+...+ .+-..+.+ + ++..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~kYeK-I--Ge~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNKEKYEK-I--GETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chHHHHHH-h--cccc
Confidence 76655332 24567999999999999999999999999999999999999999875422 22222211 1 1111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
...+.+ .-......|+.+.++.++. .+-.+-|..+-+...+..+....+
T Consensus 256 r~T~i~--~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 256 RSTPIE--VLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred ccCCHH--HHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcC
Confidence 111111 1112233466666666655 466678999998888888865543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-22 Score=200.62 Aligned_cols=248 Identities=23% Similarity=0.433 Sum_probs=185.1
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEee--ccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
..+|.+...|..|+|+++ |..+++|.+. .......++|..|.-.++-+.||||..++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457888899999999997 6666666553 3344456789999999999999999999999999999999999999999
Q ss_pred HHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccc
Q 046275 943 LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV 1022 (1176)
Q Consensus 943 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 1022 (1176)
|+..++.+. +...+..++.+++.++|+|++|||+.. +-|..--+....|++|++.+.+|+- +-++ .....
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~k------fsfqe 343 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTK------FSFQE 343 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccce------eeeec
Confidence 999999765 346788899999999999999999974 2233445889999999999888752 1111 11111
Q ss_pred cccccCCcccCccccCCCCCC---chhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1023 STLAGTPGYVPPEYYQSFRCS---TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1023 ~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......|.||+||.++..+-+ .++|+|||++++||+.|...||......+-.+ + +. .+.+...+..
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----k-ia----leglrv~ipp-- 412 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----K-IA----LEGLRVHIPP-- 412 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----h-hh----hccccccCCC--
Confidence 233457899999999776543 47899999999999999999997544221100 0 00 1222222221
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
.... .+.+++.-|+..||.+||.++.|+-.|++++
T Consensus 413 -gis~---hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 -GISR---HMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -CccH---HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1222 3445888899999999999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=235.31 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=188.2
Q ss_pred CCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHH----HHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 864 NDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDR----EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
..+++|.|++|.|+.+... .....+.|..... .....+ .+..|+-+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988887654 3444444433210 112222 25567888888999999999888877777777799
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++ +|+.++.... .+...++..++.|+.+|++|+|+. ||.|||+|++|++++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999998763 578889999999999999999999 9999999999999999999999999998766443
Q ss_pred ccc--ccccccccCCcccCccccCCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1017 DTH--LSVSTLAGTPGYVPPEYYQSFRCST-KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1017 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
... .......|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||..+...+..+.... ..........+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---~~~~~~~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---YSDQRNIFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc---cccccccccCh
Confidence 332 3446778999999999999988876 58999999999999999999987765544331100 00000000000
Q ss_pred -ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 -ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 -~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.. ..-.+...++.+||++||.+|.|+++|++.
T Consensus 551 ~~~~~------~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLS------LLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHH------hchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0111 112234568999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=187.86 Aligned_cols=266 Identities=21% Similarity=0.242 Sum_probs=199.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEE-CCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC-CCcccceeEEeeCCeeEEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKL-KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKH-RNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 935 (1176)
..++|.+.++||.|+||.+|.|.. .+|+.||+|.-... ....++..|..+.+.+++ ..|..+..|..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 346899999999999999999975 57999999975432 233467889999999975 67888888888888899999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 1012 (1176)
|.+ |.||.+++.-... .++.++++-++.|++.-++|+|.+ ++|||||||+|+|+.- ...+.++|||+|+.
T Consensus 91 dLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 999 6799999987753 699999999999999999999999 8999999999999964 34589999999998
Q ss_pred cccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1013 MSAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1013 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
+.+..+.. ......||..|.+--...+...+.+.|+-|+|.++.++-.|..||.+.... .-.+-.+.+.+.+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~--tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA--TKKQKYEKISEKKM 241 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh--hHHHHHHHHHHhhc
Confidence 76544322 124567999999988888778889999999999999999999999875321 11111112221111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.- ....+-...|. | +.-.+.-|=...-++-|...-+.+.++.+..+.
T Consensus 242 s~-~ie~LC~G~P~---E---F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 242 ST-PIEVLCKGFPA---E---FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CC-CHHHHhCCCcH---H---HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 10 11112222222 2 222556677777778888888888877776554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-19 Score=205.03 Aligned_cols=262 Identities=29% Similarity=0.408 Sum_probs=198.0
Q ss_pred CCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcCCC-CcccceeEEeeCCeeEEEEee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ---GDREFTAEMETIGKIKHR-NLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 937 (1176)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999987 88888988654333 356789999999999988 799999999777778999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~ 1016 (1176)
+.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654321 2588899999999999999999999 899999999999999988 7999999999855443
Q ss_pred cccc----cccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1017 DTHL----SVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1017 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
.... ......||..|+|||.+.+ ..+....|+||+|++++++++|..||...... ................
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence 3221 2356789999999999987 57888999999999999999999996654321 0011111111111100
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..........+ ......+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00111111100 1122345678999999999999999998876
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=222.85 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=182.1
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccC-CcCHHHHHHHHHH--HHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS-GQGDREFTAEMET--IGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+|...+.||.+.|=+|.+|++.+|. |+||++.+.. .-..+.+.++++- ...++|||.+++.-+-..+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998777 8999887654 3334444443332 4456899999999988888889999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc--cc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM--SA 1015 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~--~~ 1015 (1176)
+.. +|+|.+..+. -+...+.+.|+.|++.|+..+|.. +|+|||||.+|||++.-..+.++||..-+-. +.
T Consensus 103 vkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 976 9999998764 477888999999999999999999 9999999999999999999999999765422 11
Q ss_pred ccc---cccccccccCCcccCccccCCC----------C-CCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 046275 1016 MDT---HLSVSTLAGTPGYVPPEYYQSF----------R-CSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1016 ~~~---~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~ 1080 (1176)
++. .....+...-..|.|||.+... . .+++-||||+||++.|+++ |++||.-. .+..|..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~ 249 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRS 249 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhc
Confidence 111 1112233445579999998431 1 5678899999999999998 78887421 1222211
Q ss_pred HhhccccccccCccc-ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1081 QHAKLKISDVFDPEL-MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
.. ..+++. .... +-..++.++..|++.||++|-++++.++.-
T Consensus 250 ---~~----~~~~e~~Le~I-----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 250 ---GN----ADDPEQLLEKI-----EDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ---cC----ccCHHHHHHhC-----cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 10 111110 0000 111345699999999999999999999884
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=184.16 Aligned_cols=139 Identities=16% Similarity=0.170 Sum_probs=109.0
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCc--C-------H-----------------HHHHHHHHHHHhcCCCCc
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ--G-------D-----------------REFTAEMETIGKIKHRNL 918 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 918 (1176)
...||+|+||.||+|.+.+|+.||||++...... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998643211 1 0 122349999999988887
Q ss_pred ccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEEC
Q 046275 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 919 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 997 (1176)
.....+.. ...++||||++++++........ ++++.+...++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 55444322 23489999999887765433222 588899999999999999999 677 999999999999998
Q ss_pred CCCcEEEEeecccccc
Q 046275 998 ENFEARVSDFGMARLM 1013 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~ 1013 (1176)
++.++++|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=187.83 Aligned_cols=171 Identities=13% Similarity=0.157 Sum_probs=133.1
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHH---------HHHHHHHHHhcCCCCcccceeEEeeC
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE---------FTAEMETIGKIKHRNLVPLLGYCKVG 928 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 928 (1176)
..++|.+.+++|.|+||.||.+.. ++..+|+|.+.......++. +.+|++.+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467999999999999999999766 57789999886544333332 67899999999999999999986543
Q ss_pred --------CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 046275 929 --------EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF 1000 (1176)
Q Consensus 929 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 1000 (1176)
...++||||++|.+|.++.. ++. ....+++.++..+|.. +++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999988732 222 2455889999999999 999999999999999988
Q ss_pred cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHH
Q 046275 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1059 (1176)
Q Consensus 1001 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 1059 (1176)
++++|||........... ..+.....+..++|+|+||+++....
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654221110 01233345667899999999887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=176.78 Aligned_cols=188 Identities=15% Similarity=0.102 Sum_probs=141.4
Q ss_pred CCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCH----HHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEee
Q 046275 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD----REFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.+...|++|+||+||.+.. .+.+++.+.+........ ..+.+|++++++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998766 578888777654322111 24789999999995 5889999886 447999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCcEEEEeeccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDM-KSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
+.|.+|.+.... ....++.|+++++.++|+. ||+|||| ||+||+++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 1134678999999999999 9999999 799999999999999999999865433
Q ss_pred ccc----c--c-----ccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1017 DTH----L--S-----VSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1017 ~~~----~--~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
... . . .....+++.|++|+...-. +--.+.+.++-|.-+|.++|++.|.....
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 0 0 0122368889999865432 22357899999999999999999865443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-20 Score=178.35 Aligned_cols=167 Identities=34% Similarity=0.540 Sum_probs=128.4
Q ss_pred CccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEE
Q 046275 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549 (1176)
Q Consensus 470 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 549 (1176)
++...+.|.||+|+++ .+|..++.+.+|+.|++++|++. ++|..+..+++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4566777888888888 67777888888888888888887 78888888888888888888887 788888888888888
Q ss_pred EccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCC
Q 046275 550 DLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629 (1176)
Q Consensus 550 ~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 629 (1176)
||++|+++.
T Consensus 108 dltynnl~e----------------------------------------------------------------------- 116 (264)
T KOG0617|consen 108 DLTYNNLNE----------------------------------------------------------------------- 116 (264)
T ss_pred hcccccccc-----------------------------------------------------------------------
Confidence 888887752
Q ss_pred CCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccc
Q 046275 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTL 709 (1176)
Q Consensus 630 ~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~ 709 (1176)
..+|..|..|+.|+.|+|+.|.|. .+|.++|+|++||.|.+.+|.|- ++|.+++.|+.
T Consensus 117 --------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~ 174 (264)
T KOG0617|consen 117 --------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTR 174 (264)
T ss_pred --------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHH
Confidence 134555555666777777777777 77777777777777777777777 67777777777
Q ss_pred ccccccccccccCCCCCCCCccc
Q 046275 710 LNEIDLCNNQLTGMIPVMGQFET 732 (1176)
Q Consensus 710 L~~l~ls~N~l~g~~p~~~~~~~ 732 (1176)
|++|.+.+|+|+-.+|+.+++..
T Consensus 175 lrelhiqgnrl~vlppel~~l~l 197 (264)
T KOG0617|consen 175 LRELHIQGNRLTVLPPELANLDL 197 (264)
T ss_pred HHHHhcccceeeecChhhhhhhh
Confidence 77777777777777777665544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-18 Score=177.47 Aligned_cols=139 Identities=16% Similarity=0.183 Sum_probs=111.1
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCc---------------------C-----HHHHHHHHHHHHhcCCCCc
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ---------------------G-----DREFTAEMETIGKIKHRNL 918 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 918 (1176)
...||+|+||+||+|++.+|+.||||.+...... . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999888999999988643211 0 1123578999999999988
Q ss_pred ccceeEEeeCCeeEEEEeeccCCCHHHH-HhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEE
Q 046275 919 VPLLGYCKVGEERLLVYEYMRYGSLEDV-LHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 919 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 996 (1176)
.....+... ..++||||++|+++... +.. .+++..+...++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655554433 34899999998865443 332 257788999999999999999999 7 99999999999999
Q ss_pred CCCCcEEEEeeccccccc
Q 046275 997 DENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~ 1014 (1176)
+ ++.++++|||+|....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-20 Score=177.72 Aligned_cols=183 Identities=28% Similarity=0.492 Sum_probs=131.6
Q ss_pred CCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeE
Q 046275 446 SLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAIL 525 (1176)
Q Consensus 446 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 525 (1176)
+++..+.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..||.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3455566666666666 66666777777777777777777 67777777777777777777777 677777778888888
Q ss_pred EccCCcccc-cCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhh
Q 046275 526 KLSNNSFYG-RIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGI 604 (1176)
Q Consensus 526 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (1176)
||.+|++.. .+|..|..++.|+
T Consensus 108 dltynnl~e~~lpgnff~m~tlr--------------------------------------------------------- 130 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLR--------------------------------------------------------- 130 (264)
T ss_pred hccccccccccCCcchhHHHHHH---------------------------------------------------------
Confidence 887777653 3444444333333
Q ss_pred hhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcC
Q 046275 605 RAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR 684 (1176)
Q Consensus 605 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~ 684 (1176)
.|.|++|.|. .+|..+|+|++||.|.+..|.+- ++|.++|.|+
T Consensus 131 -----------------------------------alyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt 173 (264)
T KOG0617|consen 131 -----------------------------------ALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLT 173 (264)
T ss_pred -----------------------------------HHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHH
Confidence 3445555555 67888899999999999999988 8999999999
Q ss_pred cccEEEccCccccccCCCCccccccc---cccccccccccCCCCC
Q 046275 685 GLNILDLSSNRLEGTIPSSMSSLTLL---NEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 685 ~L~~L~Ls~N~l~g~iP~~l~~l~~L---~~l~ls~N~l~g~~p~ 726 (1176)
+|+.|.+.+|+|+ .+|++++++.-+ +.+.+.+|++...|.+
T Consensus 174 ~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 174 RLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred HHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 9999999999998 889888877543 3455666666555543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-17 Score=179.18 Aligned_cols=232 Identities=21% Similarity=0.300 Sum_probs=146.4
Q ss_pred CCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc---CHHHHHHHHHHHHhcC----------CCCcccceeEEee-
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ---GDREFTAEMETIGKIK----------HRNLVPLLGYCKV- 927 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------h~niv~l~~~~~~- 927 (1176)
...+.||.|+++.||.+++. +|+++|+|.+...... ..+++++|.-....+. |-.++..++....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44679999999999999987 5899999988654322 2345666654444432 2223333332221
Q ss_pred --------C---C-----eeEEEEeeccCCCHHHHHhh---ccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 046275 928 --------G---E-----ERLLVYEYMRYGSLEDVLHN---QKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRD 988 (1176)
Q Consensus 928 --------~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 988 (1176)
. . ..+++|+-+. ++|.+++.. .......+....+..+-.|+++.+++||+. |+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1 1 2267888875 488888653 222122355667778889999999999999 999999
Q ss_pred CCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCC--------CCCCchhhhHHHHHHHHHHHc
Q 046275 989 MKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS--------FRCSTKGDVYSYGVVLLELLT 1060 (1176)
Q Consensus 989 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt 1060 (1176)
|||+|++++++|.++++||+.....+..- .....+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999998776543211 11334578999997643 357889999999999999999
Q ss_pred CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCC
Q 046275 1061 GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRR 1124 (1176)
Q Consensus 1061 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 1124 (1176)
|+.||......... +.....+... .+ .+..+|..+|+.+|++|
T Consensus 246 ~~lPf~~~~~~~~~------------------~~~f~~C~~~-Pe--~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADP------------------EWDFSRCRDM-PE--PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTS------------------GGGGTTSS----H--HHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccc------------------cccchhcCCc-CH--HHHHHHHHHccCCcccC
Confidence 99999754322110 0011222211 12 34459999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-18 Score=193.14 Aligned_cols=220 Identities=26% Similarity=0.460 Sum_probs=167.8
Q ss_pred HHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeCC
Q 046275 910 IGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI-IHRD 988 (1176)
Q Consensus 910 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~D 988 (1176)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+... ...++|.....++++|+.||+|+|.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 35678999999999999999999999999999999999874 34799999999999999999999998 44 9999
Q ss_pred CCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCC-------CCCchhhhHHHHHHHHHHHcC
Q 046275 989 MKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-------RCSTKGDVYSYGVVLLELLTG 1061 (1176)
Q Consensus 989 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~elltg 1061 (1176)
+++.|.++|....+|++|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766431111111122234579999998663 146789999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1062 KRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1062 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
+.||......... .+.+..... .....+.|.+.... .....+..++..||..+|++||++++|-..++.+....
T Consensus 155 ~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cCccccccccCCh-HHHHHHHHh-cCCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9999875433322 222222222 22333445544322 11114667999999999999999999999998887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-19 Score=203.71 Aligned_cols=234 Identities=23% Similarity=0.258 Sum_probs=178.9
Q ss_pred EeEeCceEEEEEEE----CCCCEEEEEEeeccCCcC--HHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEeeccC
Q 046275 868 IGSGGFGDVYKAKL----KDGSTVAIKKLIHISGQG--DREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 868 lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+|.|+||.|+.++- ..|.-+|.|...+..... ......|..++..++ ||++|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998753 236777887665432221 113456788888887 99999999999999999999999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|.+...+.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-..+.
T Consensus 82 g~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred chhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99999887665 577888888889999999999999 999999999999999999999999999986543322
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1100 (1176)
.+||..|||||++. .+...+|.||||++++||+||..||.. +..+.+...+. .++..+
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~~~~--~~p~~l----- 210 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILKAEL--EMPREL----- 210 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhhhcc--CCchhh-----
Confidence 28999999999998 567899999999999999999999875 11222222111 111111
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHHHHHH
Q 046275 1101 NIEIELLQHLHVASACLDDRPWRRPTMI-QVMAMFKEI 1137 (1176)
Q Consensus 1101 ~~~~~~~~~~~li~~cl~~dp~~RPt~~-evl~~L~~i 1137 (1176)
...+.+++..++..+|..|.-.. +.+..+++.
T Consensus 211 -----~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 211 -----SAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred -----hHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 12334578888889999888663 444444433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-18 Score=181.92 Aligned_cols=205 Identities=20% Similarity=0.234 Sum_probs=143.3
Q ss_pred CCCCcccceeEEeeC---------------------------CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHH
Q 046275 914 KHRNLVPLLGYCKVG---------------------------EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966 (1176)
Q Consensus 914 ~h~niv~l~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 966 (1176)
+|||||++.++|.+. ...|+||..++. +|.+++..+. .+...+.-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 599999999887552 245899998865 9999998663 4556777788
Q ss_pred HHHHHHHHHHHhcCCCCeeeCCCCCCCEEE--CCCCc--EEEEeeccccccccc----cccccccccccCCcccCccccC
Q 046275 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLL--DENFE--ARVSDFGMARLMSAM----DTHLSVSTLAGTPGYVPPEYYQ 1038 (1176)
Q Consensus 967 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~--~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 1038 (1176)
.|+++|+.|||.+ +|.|||+|.+|||+ |+|+. ..|+|||++---... ..........|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 8999999999999 99999999999999 34433 688999986421110 0111112345788899999986
Q ss_pred CCCC------CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHH
Q 046275 1039 SFRC------STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHV 1112 (1176)
Q Consensus 1039 ~~~~------~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1112 (1176)
..+- -.|+|.|+.|.+.||+++...||.+.....-+...|. +.. -|.+....|.. +.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq----e~q-----LPalp~~vpp~------~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ----ESQ-----LPALPSRVPPV------ARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh----hhh-----CCCCcccCChH------HHHH
Confidence 5321 2489999999999999999999987442221222221 111 13333334432 3347
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1113 ASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1113 i~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
+...|+.||.+|++..-+...+.=.....+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLNLSLWRMG 519 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHHHHHhcCc
Confidence 788899999999998887777654444433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.7e-18 Score=206.41 Aligned_cols=252 Identities=20% Similarity=0.238 Sum_probs=187.0
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC---CCCcccceeEEeeCCeeEE
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK---HRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 933 (1176)
.-.+.|.|.+.||+|+||+||+|...+|+.||+|.-......+ |.-=.+++.||+ -+.|+.+..++.-.+.-++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3456788999999999999999999889999999765433332 222233455555 3457777777777888899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-------CCCcEEEEe
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-------ENFEARVSD 1006 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~D 1006 (1176)
|+||.+.|+|.+++...+ .++|.-.+.+..|+++.+++||.. +|||+||||+|.++. +...++|+|
T Consensus 772 v~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 999999999999998544 689999999999999999999999 999999999999994 234589999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
||.+..+............++|-.+-.+|+..+..+++.+|.|.++.+++.|+.|++-=.. .+ ..|. ...+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~---~g---~~~~---~~~~ 915 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVK---NG---SSWM---VKTN 915 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhc---CC---ccee---cccc
Confidence 9999766554444455677899999999999999999999999999999999999853100 00 0000 0000
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+.+.++. +++ -+|+..+|..|-..=|...++...++++.+.
T Consensus 916 ~~Ry~~~-----------~~W--~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 916 FPRYWKR-----------DMW--NKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred chhhhhH-----------HHH--HHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1111122 222 2466667776766667777777777776543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-19 Score=207.66 Aligned_cols=280 Identities=26% Similarity=0.269 Sum_probs=138.2
Q ss_pred EEEccCcccCC-CCcccccCCCCCCEEEccCCcCCCC----CCccccCCCCCCccEEEccCccccC------CCCccccc
Q 046275 354 ELVLSFNDFTG-ALPDSLSNLTNLETLDLSSNNLSGA----IPHNLCQGPRNSLKELFLQNNLLLG------SIPSTLSN 422 (1176)
Q Consensus 354 ~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~~~~~~L~~L~L~~N~l~~------~~p~~l~~ 422 (1176)
.|+|..+.+++ .....+..+..|+.|+++++.++.. ++..+ ...+++++|+++++.+.+ .++..+..
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l--~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~ 79 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASAL--RPQPSLKELCLSLNETGRIPRGLQSLLQGLTK 79 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHH--hhCCCceEEeccccccCCcchHHHHHHHHHHh
Confidence 46677777763 3344455666677777777776532 11111 122345555555555541 11223333
Q ss_pred cccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccC----ccccccccC-CC
Q 046275 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTG----TLPAALSNC-TN 497 (1176)
Q Consensus 423 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l-~~ 497 (1176)
+++|+.|++++|.+.+..+..+..+.+ . ++|++|++++|++++ .+...+..+ ++
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~ 138 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPA 138 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCC
Confidence 444444444444444333333322222 0 115555555555542 122233344 55
Q ss_pred CCeeeccccccCCC----CCccccCCCCCCeEEccCCcccc----cCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcc
Q 046275 498 LNWISLSNNHLGGE----IPTWIGQLSNLAILKLSNNSFYG----RIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSG 569 (1176)
Q Consensus 498 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~ 569 (1176)
|+.|++++|.+++. ++..+..+++|++|+|++|.+++ .++..+..+++|+.|+|++|.+++.-+..+..
T Consensus 139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--- 215 (319)
T cd00116 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE--- 215 (319)
T ss_pred ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH---
Confidence 55555555555522 22334444556666666665553 12233344456666666666554211111000
Q ss_pred cchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCc
Q 046275 570 KIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS 649 (1176)
Q Consensus 570 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~ 649 (1176)
.+..+++|++||+++|.++
T Consensus 216 -------------------------------------------------------------~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 216 -------------------------------------------------------------TLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred -------------------------------------------------------------HhcccCCCCEEecCCCcCc
Confidence 0112235666666666666
Q ss_pred cCCCccccc-----cccceeeeccCcccc----ccCCccccCcCcccEEEccCcccccc----CCCCcccc-cccccccc
Q 046275 650 GSIPKEIGS-----MSYLFILNLGHNNLS----GPIPTEVGDLRGLNILDLSSNRLEGT----IPSSMSSL-TLLNEIDL 715 (1176)
Q Consensus 650 g~iP~~~~~-----l~~L~~L~L~~N~l~----g~iP~~~~~L~~L~~L~Ls~N~l~g~----iP~~l~~l-~~L~~l~l 715 (1176)
+..+..+.. ...|+.|++++|.++ ..+++.+..+++|++||+++|+++.. +...+... +.|+++|+
T Consensus 235 ~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~ 314 (319)
T cd00116 235 DAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWV 314 (319)
T ss_pred hHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhccc
Confidence 432222222 256677777777665 23445555667777777777777743 44444444 56777777
Q ss_pred ccccc
Q 046275 716 CNNQL 720 (1176)
Q Consensus 716 s~N~l 720 (1176)
.+|++
T Consensus 315 ~~~~~ 319 (319)
T cd00116 315 KDDSF 319 (319)
T ss_pred CCCCC
Confidence 77654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-17 Score=168.89 Aligned_cols=136 Identities=16% Similarity=0.220 Sum_probs=105.8
Q ss_pred CCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-----CCCCcccceeEEeeCC---eeE-E
Q 046275 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-----KHRNLVPLLGYCKVGE---ERL-L 933 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 933 (1176)
.-.+.||+|+||.||. +.+....+||++........+++.+|+.+++.+ +||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 443333478888654444567899999999999 5799999999998874 333 7
Q ss_pred EEee--ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCCEEECC----CCcEEEEe
Q 046275 934 VYEY--MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL-AFLHHNCIPHIIHRDMKSSNVLLDE----NFEARVSD 1006 (1176)
Q Consensus 934 V~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D 1006 (1176)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999653 24444 35577777777 999999 9999999999999974 34799999
Q ss_pred eccc
Q 046275 1007 FGMA 1010 (1176)
Q Consensus 1007 fGla 1010 (1176)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-19 Score=201.39 Aligned_cols=217 Identities=29% Similarity=0.314 Sum_probs=92.9
Q ss_pred ccccCCCCCcEEEccCCcCcccCCHHHHhcCCC---CCEEEccCcccCC----CCcccccCC-CCCCEEEccCCcCCCCC
Q 046275 319 SRFGSCSSLESFDISSNKFSGELPIEIFLSMSN---LKELVLSFNDFTG----ALPDSLSNL-TNLETLDLSSNNLSGAI 390 (1176)
Q Consensus 319 ~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~---L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~Ls~N~l~~~~ 390 (1176)
..+..+++|+.|++++|.+.+.. ...+..+.+ |++|++++|.+++ .+...+..+ ++|+.|++++|.+++..
T Consensus 75 ~~l~~~~~L~~L~l~~~~~~~~~-~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 153 (319)
T cd00116 75 QGLTKGCGLQELDLSDNALGPDG-CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGAS 153 (319)
T ss_pred HHHHhcCceeEEEccCCCCChhH-HHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchH
Confidence 34444555555555555554222 222233333 5555555555542 122233344 55555555555555322
Q ss_pred CccccC--CCCCCccEEEccCccccCC----CCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCC
Q 046275 391 PHNLCQ--GPRNSLKELFLQNNLLLGS----IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464 (1176)
Q Consensus 391 p~~~~~--~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 464 (1176)
...+.. ....+|++|+|++|.+++. ++..+..+++|+.|++++|.+++.... .+
T Consensus 154 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------------~l 213 (319)
T cd00116 154 CEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------------------AL 213 (319)
T ss_pred HHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------------------HH
Confidence 111100 0112344444444444321 122233334555555555555422111 11
Q ss_pred CCCCCCccccceeecccccccCccccccc-----cCCCCCeeeccccccCC----CCCccccCCCCCCeEEccCCccccc
Q 046275 465 PPELGNIQTLETLFLDFNELTGTLPAALS-----NCTNLNWISLSNNHLGG----EIPTWIGQLSNLAILKLSNNSFYGR 535 (1176)
Q Consensus 465 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~ 535 (1176)
+..+..+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .++..+..+++|+++++++|.+...
T Consensus 214 ~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 214 AETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 22233344455555555554432222221 12455556666555541 1223344445566666666665532
Q ss_pred ----CCCCCCCC-CCCCEEEccCCCC
Q 046275 536 ----IPPELGDC-RSLIWLDLNTNLF 556 (1176)
Q Consensus 536 ----~p~~~~~l-~~L~~L~L~~N~l 556 (1176)
+...+... +.|+.|++.+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 294 GAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHHHHhhcCCchhhcccCCCCC
Confidence 22233333 4566666665543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=168.13 Aligned_cols=144 Identities=13% Similarity=0.101 Sum_probs=111.6
Q ss_pred HhcCCCCCceEeEeCceEEEEEE--ECCCCEEEEEEeeccCCc-------------------C-----HHHHHHHHHHHH
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAK--LKDGSTVAIKKLIHISGQ-------------------G-----DREFTAEMETIG 911 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------~-----~~~~~~E~~~l~ 911 (1176)
.+.-|.+.+.||+|+||.||+|+ ..+|+.||+|.+...... . ...+.+|+..+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33458889999999999999998 457999999988643210 0 123568999999
Q ss_pred hcCCC--CcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCC
Q 046275 912 KIKHR--NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH-IIHRD 988 (1176)
Q Consensus 912 ~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~D 988 (1176)
++.+. .+.+++++ ...++||||++++++........ .+...+...++.|++.++.+||+. + |+|||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D 174 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGD 174 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence 99753 23344432 23589999999988876543222 455667789999999999999999 8 99999
Q ss_pred CCCCCEEECCCCcEEEEeecccccc
Q 046275 989 MKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 989 lkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|||+||+++ ++.++++|||.|...
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999 789999999988754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9e-17 Score=191.59 Aligned_cols=210 Identities=22% Similarity=0.318 Sum_probs=143.1
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+|..++.|-.|+||.||.++++. .+.+|. ++.+.+ .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee-------------------
Confidence 578889999999999999999874 667787 443321 11110 33333444444
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc-
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD- 1017 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~- 1017 (1176)
|+=.+.++..+ +++... +.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+++.....-
T Consensus 136 --gDc~tllk~~g----~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNIG----PLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccCC----CCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 34344444433 232222 6789999999 99999999999999999999999999986532110
Q ss_pred -----------c-cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-
Q 046275 1018 -----------T-HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK- 1084 (1176)
Q Consensus 1018 -----------~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~- 1084 (1176)
. .......+|||.|.|||++..+.|...+|+|++|+|+||++-|..||.+...+ +.+.....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-----elfg~visd 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVISD 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-----HHHhhhhhh
Confidence 0 01124568999999999999999999999999999999999999999765422 12221111
Q ss_pred -cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 046275 1085 -LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQ 1129 (1176)
Q Consensus 1085 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~e 1129 (1176)
..+.|. |.... .++.+++.+.|+.+|..|--...
T Consensus 274 ~i~wpE~-dea~p----------~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 274 DIEWPEE-DEALP----------PEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hcccccc-CcCCC----------HHHHHHHHHHHHhChHhhcccch
Confidence 112222 21111 13455888889999999975443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9e-17 Score=179.98 Aligned_cols=176 Identities=23% Similarity=0.369 Sum_probs=134.8
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..||.|++|...+|.+|+.+.+. ....++.....++.|++.|+.| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46899999999999999986543 3467889999999999999999 5 789999999999999999999999999
Q ss_pred cccccccc----ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1010 ARLMSAMD----THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1010 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
........ .....+...||..||+||.+.+..|+.++||||+|++++|++. =..+++.. .....+..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------~t~~d~r~ 474 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------ATLTDIRD 474 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------Hhhhhhhc
Confidence 88766554 2223456789999999999999999999999999999999997 22222110 11112222
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl 1131 (1176)
+ .++|....+.|. -..|+.+++...|.+||++.++.
T Consensus 475 g----~ip~~~~~d~p~-------e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 475 G----IIPPEFLQDYPE-------EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred C----CCChHHhhcCcH-------HHHHHHHhcCCCcccCchHHHHh
Confidence 2 234444444443 23488899999999999555543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=160.78 Aligned_cols=134 Identities=22% Similarity=0.306 Sum_probs=113.8
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC--------HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG--------DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.||+|++|.||+|++ .|..|++|+........ ...+.+|+.++..++|++++....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 57889999765322211 13477899999999999998888888788889999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
++|++|.+++.... + .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 1 7889999999999999999 999999999999999 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=158.95 Aligned_cols=131 Identities=21% Similarity=0.322 Sum_probs=108.0
Q ss_pred eEeEeCceEEEEEEECCCCEEEEEEeeccCCcC--------HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG--------DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.||+|+||.||+|.+ +|..|++|+........ ...+.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 47889999865322111 245678999999999988776666666777789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
+|++|.+++.... . .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998876432 1 7899999999999999 999999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.3e-15 Score=157.95 Aligned_cols=145 Identities=19% Similarity=0.138 Sum_probs=112.5
Q ss_pred HHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCc----------------------CHHHHHHHHHHH
Q 046275 853 ADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ----------------------GDREFTAEMETI 910 (1176)
Q Consensus 853 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 910 (1176)
+++......|.+.+.||+|+||.||+|...+|+.||||++...... ......+|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444555558889999999999999999888999999986532100 011356788899
Q ss_pred HhcCCCC--cccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 046275 911 GKIKHRN--LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRD 988 (1176)
Q Consensus 911 ~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 988 (1176)
..+.|++ +++.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+|||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 9988774 444443 2456899999999998765321 23457888999999999998 999999
Q ss_pred CCCCCEEECCCCcEEEEeeccccccc
Q 046275 989 MKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 989 lkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+||++++++.++++|||.+....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-15 Score=181.24 Aligned_cols=137 Identities=23% Similarity=0.312 Sum_probs=111.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccC-C-------cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS-G-------QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
...|...+.||+|+||+||+|.+... .+++|+..... . ...+.+.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456788999999999999987643 44444432211 1 112457889999999999999988888877778
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++++|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999998875 3467899999999999999 99999999999999 5778999999998
Q ss_pred cc
Q 046275 1011 RL 1012 (1176)
Q Consensus 1011 ~~ 1012 (1176)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.6e-16 Score=188.40 Aligned_cols=117 Identities=34% Similarity=0.594 Sum_probs=105.8
Q ss_pred CccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccc
Q 046275 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLC 716 (1176)
Q Consensus 637 ~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls 716 (1176)
.++.|+|++|.++|.+|..|+.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+++|++|+.|||+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCC--CccccCCccccCCCCCCCCCC-CCCC
Q 046275 717 NNQLTGMIPVMG--QFETFQPAKFLNNSGLCGLPL-PPCE 753 (1176)
Q Consensus 717 ~N~l~g~~p~~~--~~~~~~~~~~~~n~~l~~~~~-~~c~ 753 (1176)
+|+|+|.+|..- .+..+....+.+|..+||.|. ++|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999999642 123344567899999999874 6785
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.5e-16 Score=187.36 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=192.7
Q ss_pred CCCCCceEeEeCceEEEEEEECC--CCEEEEEEeeccC--CcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD--GSTVAIKKLIHIS--GQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46677789999999998886643 4456666554332 222334455777777775 999999999999999999999
Q ss_pred eeccCCCHHHHH-hhccccCcccCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccc
Q 046275 936 EYMRYGSLEDVL-HNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 1012 (1176)
+|.++|++++-+ +... ...+....-.++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999888 3321 13455667778999999999999 76 899999999999999999 999999999987
Q ss_pred ccc-cccccccccccc-CCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1013 MSA-MDTHLSVSTLAG-TPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1013 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......+..+..|......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----- 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR----- 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc-----
Confidence 766 444444556778 9999999998874 55678999999999999999999998877666656666533211
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+..... ...++..+++..+|..|.+.+++...
T Consensus 250 -~~~~~~~~~~~------~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 250 -FTQLPWNSISD------QAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -cccCccccCCh------hhhhcccccccCCchhcccccccccc
Confidence 11112221111 23447778888999999998887543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-15 Score=170.93 Aligned_cols=175 Identities=29% Similarity=0.383 Sum_probs=110.2
Q ss_pred ceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCC
Q 046275 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554 (1176)
Q Consensus 475 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 554 (1176)
...||+.|++. .+|..+..+-.|+.+.|..|.+. .+|..++++..|.+|||+.|+++ .+|..++.|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 34455555555 45555555555555555555554 45555555555555555555555 5555555553 555555555
Q ss_pred CCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCC
Q 046275 555 LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNH 634 (1176)
Q Consensus 555 ~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (1176)
+++ .+|+.+. .
T Consensus 154 kl~-~lp~~ig--------------------------------------------------------------------~ 164 (722)
T KOG0532|consen 154 KLT-SLPEEIG--------------------------------------------------------------------L 164 (722)
T ss_pred ccc-cCCcccc--------------------------------------------------------------------c
Confidence 554 3443321 1
Q ss_pred CCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccc
Q 046275 635 NGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEID 714 (1176)
Q Consensus 635 ~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ 714 (1176)
...|..||.|+|.+. .+|..++++.+|+.|++++|++. .+|++++.|+ |..||+|.|+++ .||-.|.+|+.|++|-
T Consensus 165 ~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~ 240 (722)
T KOG0532|consen 165 LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQ 240 (722)
T ss_pred chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeee
Confidence 123455666777766 67777888888888888888887 7777777664 778888888887 7888888888888888
Q ss_pred cccccccCCCCC
Q 046275 715 LCNNQLTGMIPV 726 (1176)
Q Consensus 715 ls~N~l~g~~p~ 726 (1176)
|.+|+|...+.+
T Consensus 241 LenNPLqSPPAq 252 (722)
T KOG0532|consen 241 LENNPLQSPPAQ 252 (722)
T ss_pred eccCCCCCChHH
Confidence 888888766554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=144.80 Aligned_cols=136 Identities=19% Similarity=0.225 Sum_probs=98.2
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC--HHH----------------------HHHHHHHHHhcCCCC--c
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG--DRE----------------------FTAEMETIGKIKHRN--L 918 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i 918 (1176)
.+.||+|+||+||+|++.+|+.||||.+....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999998889999999875422111 111 134666666664433 4
Q ss_pred ccceeEEeeCCeeEEEEeeccCCCHHH-HHhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEE
Q 046275 919 VPLLGYCKVGEERLLVYEYMRYGSLED-VLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 919 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 996 (1176)
.+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 24589999999854321 111111 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCcEEEEeeccccccc
Q 046275 997 DENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~ 1014 (1176)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=138.63 Aligned_cols=135 Identities=20% Similarity=0.198 Sum_probs=113.5
Q ss_pred CCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC--CCcccceeEEeeCCeeEEEEeeccCC
Q 046275 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKH--RNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
+.+.||.|.++.||+++..+ ..+++|....... ...+.+|+.+++.++| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999864 7889998754322 4678899999999976 58999999888888899999999987
Q ss_pred CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 942 SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 942 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4466778899999999999997545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.5e-13 Score=144.94 Aligned_cols=135 Identities=18% Similarity=0.221 Sum_probs=105.0
Q ss_pred CceEe-EeCceEEEEEEECCCCEEEEEEeeccC-------------CcCHHHHHHHHHHHHhcCCCCc--ccceeEEeeC
Q 046275 865 DSLIG-SGGFGDVYKAKLKDGSTVAIKKLIHIS-------------GQGDREFTAEMETIGKIKHRNL--VPLLGYCKVG 928 (1176)
Q Consensus 865 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 928 (1176)
...|| .|+.|+||.+... +..+++|.+.... ......+.+|+.++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999875 7889998774211 1223457889999999998775 6777764432
Q ss_pred C----eeEEEEeeccC-CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 929 E----ERLLVYEYMRY-GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 929 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
. ..++||||++| .+|.+++... +++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 22599999997 6999888643 34443 356889999999999 999999999999999988999
Q ss_pred EEeeccccc
Q 046275 1004 VSDFGMARL 1012 (1176)
Q Consensus 1004 l~DfGla~~ 1012 (1176)
++|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.4e-15 Score=155.39 Aligned_cols=240 Identities=21% Similarity=0.292 Sum_probs=146.8
Q ss_pred CcEEEEecCCccccccchh-hhhhhcCcccccccccCCCCCCCc--ccCC-------CCCccccCccccccCCcccCCC-
Q 046275 66 ASVSSIDLSPFTLSVDFHL-VASFLLTLDTLETLSLKNSNISGT--ISLP-------AGSRCSSFLSSLDLSLNILSGP- 134 (1176)
Q Consensus 66 ~~v~~l~L~~~~~~~~~~~-~~~~l~~~~~L~~L~L~~n~l~g~--~~~~-------~~~~~~~~L~~LdLs~N~l~~~- 134 (1176)
..++.|+|+++..+.+... ++..|...++|+..++|+- ++|+ ..+| .++..+++|++||||+|.+...
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 4799999999998877665 7788999999999999987 4443 1222 3345667999999999999742
Q ss_pred -CCcccccCCCCCCcEEecCCCCCCcccccc-------------ccccCCCcEEEccCCCCCCCCccc-cccccCCCCcc
Q 046275 135 -LSDISYLGSCSSLKVLNLSSNLLDFSGREA-------------GSLKLSLEVLDLSYNKISGANVVP-WILFNGCDELK 199 (1176)
Q Consensus 135 -~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~-------------~~~~~~L~~LdLs~N~i~~~~~~~-~~~f~~~~~L~ 199 (1176)
..-...+++|..|++|+|.+|.+...+... ....+.|++++.++|++.+.+... ..+|+.++.|+
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~le 188 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLE 188 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccc
Confidence 222256788999999999999998665333 223446777777777775543332 22356666666
Q ss_pred EEEeCCCccccc------ccCCCCCccceeeccCCcccc-----cCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCC
Q 046275 200 QLALKGNKVTGD------INVSKCKNLQFLDVSSNNFSM-----AVPSFGDCLALEYLDISANKFTGDVGHAISACEHLS 268 (1176)
Q Consensus 200 ~L~L~~n~l~~~------~~~~~l~~L~~L~Ls~N~l~~-----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 268 (1176)
.+.++.|.|... ..+..|++|+.|||.+|-++. +...+..+++|++|++++|.+......+|.
T Consensus 189 evr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~------ 262 (382)
T KOG1909|consen 189 EVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV------ 262 (382)
T ss_pred eEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH------
Confidence 666666666531 234555555555555555541 122344455555555555555443322221
Q ss_pred eEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccc----cCCccccCCCCCcEEEccCCcC
Q 046275 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG----KVPSRFGSCSSLESFDISSNKF 337 (1176)
Q Consensus 269 ~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l 337 (1176)
..+-...++|+.|.|.+|.++. .+...+...+.|+.|+|++|++
T Consensus 263 -------------------------~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 263 -------------------------DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred -------------------------HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 1111223455555555555541 1223344456677777777776
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-14 Score=162.24 Aligned_cols=212 Identities=34% Similarity=0.497 Sum_probs=171.8
Q ss_pred EEccCCcccccCCc--cccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccC
Q 046275 306 LDLSSNNLSGKVPS--RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSS 383 (1176)
Q Consensus 306 L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 383 (1176)
|.|++-+++ ..|. +=..++--...||+.|++. .+|.++ ..+..|+.+.|++|.+. .+|..++++..|+.|||+.
T Consensus 55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~-~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEA-CAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred cccccchhh-cCCCccccccccchhhhhccccccc-cCchHH-HHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 455555555 2221 1134555667899999998 889875 66788999999999998 8899999999999999999
Q ss_pred CcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC
Q 046275 384 NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463 (1176)
Q Consensus 384 N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 463 (1176)
|+++ .+|..+|..+ |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .
T Consensus 131 NqlS-~lp~~lC~lp---Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP---LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D 203 (722)
T ss_pred chhh-cCChhhhcCc---ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence 9998 8899888754 889999999998 78888888889999999999998 78888999999999999999988 7
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccC---CCCCCeEEccCCc
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ---LSNLAILKLSNNS 531 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---l~~L~~L~L~~N~ 531 (1176)
+|.+++.| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|+ ..|..|+. ..-.++|+..-++
T Consensus 204 lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 204 LPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred CCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 78778744 5888999999998 88888999999999999999988 56666643 3334667666664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.3e-13 Score=140.02 Aligned_cols=208 Identities=19% Similarity=0.306 Sum_probs=146.6
Q ss_pred HHHHHhcCCCCcccceeEEeeCC-----eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCC
Q 046275 907 METIGKIKHRNLVPLLGYCKVGE-----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981 (1176)
Q Consensus 907 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 981 (1176)
..-+-++.|.|+|+++.|+.+.+ +..++.|||..|++.+++++.++....+......++.-||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34456667999999999986543 46789999999999999999888888899999999999999999999995 6
Q ss_pred CCeeeCCCCCCCEEECCCCcEEEEeecccccccccc--ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHH
Q 046275 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD--THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1059 (1176)
Q Consensus 982 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 1059 (1176)
|+|+|+++..+-|++..+|-+|+.----........ .........+-++|.|||+-.....+.++|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 789999999999999999988874321111100000 001113345788999999887777788999999999999998
Q ss_pred cCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1060 TGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1060 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
-+..--.... + .+... +.+...+...... .-.+++.+|++..|..||+|.+++.|.
T Consensus 277 ilEiq~tnse----S--~~~~e-------e~ia~~i~~len~------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSE----S--KVEVE-------ENIANVIIGLENG------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCc----c--eeehh-------hhhhhheeeccCc------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 7764311110 0 00000 0000000000000 012377899999999999999998764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.8e-13 Score=157.90 Aligned_cols=85 Identities=35% Similarity=0.580 Sum_probs=45.3
Q ss_pred ccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccccccccccc
Q 046275 638 MMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCN 717 (1176)
Q Consensus 638 l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~ 717 (1176)
|.+|++++|.+. .+|..+.++.++..|.+.+|++. .+|..++.+++|++|++++|+++ .++. +..+.+|+.||+++
T Consensus 211 L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~ 286 (394)
T COG4886 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSG 286 (394)
T ss_pred hhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccC
Confidence 334444444322 34444555555555555555555 34555555555666666666655 4444 55555566666666
Q ss_pred ccccCCCCC
Q 046275 718 NQLTGMIPV 726 (1176)
Q Consensus 718 N~l~g~~p~ 726 (1176)
|.++..+|.
T Consensus 287 n~~~~~~~~ 295 (394)
T COG4886 287 NSLSNALPL 295 (394)
T ss_pred ccccccchh
Confidence 666555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.5e-13 Score=155.38 Aligned_cols=200 Identities=41% Similarity=0.568 Sum_probs=144.0
Q ss_pred EEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCC-CccEEEccCccccCCCCccccccccCcEEEcC
Q 046275 354 ELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN-SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS 432 (1176)
Q Consensus 354 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 432 (1176)
.|++..|.+. .....+..++.++.|++.+|.++ .+|... .... +|+.|++++|.+. .+|..+..+++|+.|+++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~--~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~ 171 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLI--GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCcccc--ccchhhcccccccccchh-hhhhhhhccccccccccC
Confidence 4555555543 12233344455666666666665 344333 2222 5666667766666 455667778888888888
Q ss_pred CccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCC
Q 046275 433 FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEI 512 (1176)
Q Consensus 433 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 512 (1176)
+|+++ .+|...+.++.|+.|++++|++. .+|..+.....|++|++++|++. ..+..+.++.++..|.+.+|++. .+
T Consensus 172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~ 247 (394)
T COG4886 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL 247 (394)
T ss_pred Cchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ec
Confidence 88888 66666667788888888888888 77777666777888888888655 57778888888888889999887 45
Q ss_pred CccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhH
Q 046275 513 PTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 513 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
+..++.++++++|++++|+++ .++. ++.+.+|+.|++++|.++..+|...
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence 778888899999999999998 5555 8888999999999999886655443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.2e-12 Score=146.51 Aligned_cols=142 Identities=21% Similarity=0.273 Sum_probs=100.2
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC--------------------------H--------------HHHH
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG--------------------------D--------------REFT 904 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~ 904 (1176)
.+.||.|++|+||+|+.++|+.||||+........ . -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46899999999999999999999999874321000 0 0244
Q ss_pred HHHHHHHhcC-----CCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHH-HHHHHHh
Q 046275 905 AEMETIGKIK-----HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR-GLAFLHH 978 (1176)
Q Consensus 905 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 978 (1176)
+|...+.+++ ++++.-..-|....+..++||||++|++|.++...... .. .+..++..+++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 4555555552 33332222222334567999999999999887653211 11 23456666665 4678898
Q ss_pred cCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 979 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
. |++|+|++|.||+++.++.++++|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=5e-12 Score=155.72 Aligned_cols=91 Identities=30% Similarity=0.525 Sum_probs=82.4
Q ss_pred CCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccc-ccccccc
Q 046275 636 GSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL-TLLNEID 714 (1176)
Q Consensus 636 ~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l-~~L~~l~ 714 (1176)
.+|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|+.+++|++|+.|||++|+|+|.+|..+..+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 468899999999999999999999999999999999999999999999999999999999999999998764 4677899
Q ss_pred cccccccCCCCC
Q 046275 715 LCNNQLTGMIPV 726 (1176)
Q Consensus 715 ls~N~l~g~~p~ 726 (1176)
+++|+....+|.
T Consensus 522 ~~~N~~lc~~p~ 533 (623)
T PLN03150 522 FTDNAGLCGIPG 533 (623)
T ss_pred ecCCccccCCCC
Confidence 999975444453
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.4e-13 Score=146.87 Aligned_cols=228 Identities=23% Similarity=0.212 Sum_probs=127.3
Q ss_pred ccchhhhhhhcCcccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCc
Q 046275 80 VDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDF 159 (1176)
Q Consensus 80 ~~~~~~~~~l~~~~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~ 159 (1176)
.++..+++-.+++..|+...|.+..+..+. ...-.+.|++++.||||.|-+..+.+.+..+..+++|+.|+|+.|++..
T Consensus 108 iGfDki~akQsn~kkL~~IsLdn~~V~~~~-~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~ 186 (505)
T KOG3207|consen 108 IGFDKIAAKQSNLKKLREISLDNYRVEDAG-IEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSN 186 (505)
T ss_pred ecHHHHHHHhhhHHhhhheeecCccccccc-hhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccC
Confidence 455667777888888888888888776321 1134567788888888888888887777777888888888888887653
Q ss_pred cc-cccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCc-ccccCCCc
Q 046275 160 SG-REAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNN-FSMAVPSF 237 (1176)
Q Consensus 160 ~~-~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~l 237 (1176)
.. ...-...+.|+.|.|+.|.++.. .+.+ .+..+++|+.|+|..|. +.......
T Consensus 187 ~~~s~~~~~l~~lK~L~l~~CGls~k-~V~~-----------------------~~~~fPsl~~L~L~~N~~~~~~~~~~ 242 (505)
T KOG3207|consen 187 FISSNTTLLLSHLKQLVLNSCGLSWK-DVQW-----------------------ILLTFPSLEVLYLEANEIILIKATST 242 (505)
T ss_pred CccccchhhhhhhheEEeccCCCCHH-HHHH-----------------------HHHhCCcHHHhhhhcccccceecchh
Confidence 32 11111334455555555555421 1111 12344555555555553 11111123
Q ss_pred cCCCCCcEEEcCCCcCCCCc-ChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCccccc
Q 046275 238 GDCLALEYLDISANKFTGDV-GHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316 (1176)
Q Consensus 238 ~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~ 316 (1176)
..+..|++|||++|++-+.. ....+.++.|..|+++.+.|+..--... -........++|++|+++.|++...
T Consensus 243 ~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~------~s~~kt~~f~kL~~L~i~~N~I~~w 316 (505)
T KOG3207|consen 243 KILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDV------ESLDKTHTFPKLEYLNISENNIRDW 316 (505)
T ss_pred hhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCc------cchhhhcccccceeeecccCccccc
Confidence 44455666666666554322 2344555666666666665542110000 0011123346777777777777521
Q ss_pred -CCccccCCCCCcEEEccCCcCc
Q 046275 317 -VPSRFGSCSSLESFDISSNKFS 338 (1176)
Q Consensus 317 -~p~~~~~l~~L~~L~Ls~N~l~ 338 (1176)
.-..+..+.+|+.|.+-.|.++
T Consensus 317 ~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 317 RSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccchhhccchhhhhhccccccc
Confidence 1134455667777777777775
|
|
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-13 Score=147.41 Aligned_cols=329 Identities=26% Similarity=0.273 Sum_probs=222.8
Q ss_pred CCCCCC--CCCCCc-ccceeEeCCCcEEEEecCCccccccchhhhhhhcCc-ccccccccCCCCCCCcccCCCCCccccC
Q 046275 45 VLPNWS--PNQNPC-GFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTL-DTLETLSLKNSNISGTISLPAGSRCSSF 120 (1176)
Q Consensus 45 ~l~~w~--~~~~cC-~W~gv~C~~~~v~~l~L~~~~~~~~~~~~~~~l~~~-~~L~~L~L~~n~l~g~~~~~~~~~~~~~ 120 (1176)
+|..|. ..+.|| .|++-.=++..++.+||..++.+++.+.++.++... .+|+.|.|+++.=.+..++-.+...+++
T Consensus 86 ~LDtksl~r~a~~c~~~n~~AlD~~~~q~idL~t~~rDv~g~VV~~~~~Rcgg~lk~LSlrG~r~v~~sslrt~~~~Cpn 165 (483)
T KOG4341|consen 86 MLDTKSLCRAAQCCTMWNKLALDGSCWQHIDLFTFQRDVDGGVVENMISRCGGFLKELSLRGCRAVGDSSLRTFASNCPN 165 (483)
T ss_pred HHhHHHHHHHHHHHHHhhhhhhccccceeeehhcchhcCCCcceehHhhhhccccccccccccccCCcchhhHHhhhCCc
Confidence 344454 234556 899988888899999999999999999888888777 7999999999987777777778889999
Q ss_pred ccccccCCcccCCCCCcccccCCCCCCcEEecCCC-CCCccc-cccccccCCCcEEEccCC-CCCCCCccccccccCCCC
Q 046275 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSN-LLDFSG-REAGSLKLSLEVLDLSYN-KISGANVVPWILFNGCDE 197 (1176)
Q Consensus 121 L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n-~i~~~~-~~~~~~~~~L~~LdLs~N-~i~~~~~~~~~~f~~~~~ 197 (1176)
+++|++.+|....+..-...-..|++|++|+|..| .|++.. ......|++|++|++|++ .|++. .+ ...+.++.+
T Consensus 166 IehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL~~lNlSwc~qi~~~-gv-~~~~rG~~~ 243 (483)
T KOG4341|consen 166 IEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKLKYLNLSWCPQISGN-GV-QALQRGCKE 243 (483)
T ss_pred hhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhHHHhhhccCchhhcC-cc-hHHhccchh
Confidence 99999999986554444455678999999999996 677666 347788999999999998 56552 22 234688988
Q ss_pred ccEEEeCCCcccccccC----CCCCccceeeccCCc-ccccC--CCccCCCCCcEEEcCCC-cCCCCcChhh-hccccCC
Q 046275 198 LKQLALKGNKVTGDINV----SKCKNLQFLDVSSNN-FSMAV--PSFGDCLALEYLDISAN-KFTGDVGHAI-SACEHLS 268 (1176)
Q Consensus 198 L~~L~L~~n~l~~~~~~----~~l~~L~~L~Ls~N~-l~~~~--~~l~~l~~L~~L~Ls~N-~l~~~~~~~l-~~l~~L~ 268 (1176)
++.+.+.+|.-.....+ ..+..+..+++.++. ++... ..-..+..|+.|+.+++ .+++..-.++ .++.+|+
T Consensus 244 l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~ 323 (483)
T KOG4341|consen 244 LEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHALQVLCYSSCTDITDEVLWALGQHCHNLQ 323 (483)
T ss_pred hhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHhhhhcccCCCCCchHHHHHHhcCCCceE
Confidence 99998888765543322 345566677766653 33211 11245778888888887 4444333333 3667888
Q ss_pred eEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCccc--ccCCccccCCCCCcEEEccCCcCcccCCHHHH
Q 046275 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS--GKVPSRFGSCSSLESFDISSNKFSGELPIEIF 346 (1176)
Q Consensus 269 ~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~ 346 (1176)
.|-++.++- |++.--..+...++.|+.+++..+... +.+...-.+++.|+.|.|+++..........+
T Consensus 324 ~l~l~~c~~----------fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~lslshce~itD~gi~~l 393 (483)
T KOG4341|consen 324 VLELSGCQQ----------FSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLSLSHCELITDEGIRHL 393 (483)
T ss_pred EEeccccch----------hhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCChhhhhhhhhhhhhhh
Confidence 888888762 111222345556778888888877654 22333345667888888887755312211122
Q ss_pred ----hcCCCCCEEEccCcccC-CCCcccccCCCCCCEEEccCCc
Q 046275 347 ----LSMSNLKELVLSFNDFT-GALPDSLSNLTNLETLDLSSNN 385 (1176)
Q Consensus 347 ----~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~ 385 (1176)
..+..|+.|.|+++..+ ...-..+..+++|+.++|-+++
T Consensus 394 ~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q 437 (483)
T KOG4341|consen 394 SSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQ 437 (483)
T ss_pred hhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechh
Confidence 23556777777776543 2223345556666666666554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.7e-10 Score=130.87 Aligned_cols=167 Identities=19% Similarity=0.281 Sum_probs=128.7
Q ss_pred ECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHH
Q 046275 881 LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWA 960 (1176)
Q Consensus 881 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 960 (1176)
..++.+|.|......+........+-++.++.+|||+|+++++.++.++..|+|+|-+. -|..+++..+ ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------KE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------HH
Confidence 34688888887765554334556778889999999999999999999999999999985 5777787543 45
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCC
Q 046275 961 ARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040 (1176)
Q Consensus 961 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 1040 (1176)
.....+.||+.||.+||+.+ +++|++|.-..|+++..|..||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 66777899999999999876 899999999999999999999999998765433221 00111122246677755433
Q ss_pred CCCchhhhHHHHHHHHHHHcCC
Q 046275 1041 RCSTKGDVYSYGVVLLELLTGK 1062 (1176)
Q Consensus 1041 ~~~~~~DvwSlGvil~elltg~ 1062 (1176)
. -..|.|.||++++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-11 Score=140.93 Aligned_cols=249 Identities=22% Similarity=0.245 Sum_probs=180.4
Q ss_pred CCCCCceEeE--eCceEEEEEEE---CCCCEEEEEEeecc--CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeE
Q 046275 861 GFHNDSLIGS--GGFGDVYKAKL---KDGSTVAIKKLIHI--SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 861 ~y~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 932 (1176)
.|.+.+.+|. |.+|.||.++. .++..+|+|+-... .......-.+|+..-..+ .|++.++.+..+...+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999986 36888999974322 223333345667666666 4999999989999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEee
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR----GLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDF 1007 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 1007 (1176)
+-+|++. .++.++.+.... .++....+.+..+..+ |+.++|.. +++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999996 588887775432 3667777778888878 99999999 99999999999999999 88999999
Q ss_pred ccccccccccccccc---cccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1008 GMARLMSAMDTHLSV---STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
|+...+......... ....|...|++||...+ -++...|+|++|.++.+..++..+...... ..|.+....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~~r~~ 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQLRQG 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-----CCccccccc
Confidence 999877665432221 22357788999999876 568899999999999999998776543311 123221111
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. +..+...... ..+...+..|++.+|..|++.+.+..+
T Consensus 342 ~-----ip~e~~~~~s------~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 342 Y-----IPLEFCEGGS------SSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred c-----CchhhhcCcc------hhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1 1111111111 112237788999999999999888654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.2e-12 Score=129.55 Aligned_cols=84 Identities=27% Similarity=0.397 Sum_probs=53.1
Q ss_pred ccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccC--CCCcccccccccccc
Q 046275 638 MMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI--PSSMSSLTLLNEIDL 715 (1176)
Q Consensus 638 l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~i--P~~l~~l~~L~~l~l 715 (1176)
|+.||||+|.++ .+-.+--.|.+.+.|+|+.|.+. .+ ..+++|.+|..||+++|+|. .+ -..+++|+.|+.+.|
T Consensus 331 L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L 406 (490)
T KOG1259|consen 331 LQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRL 406 (490)
T ss_pred ceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhh
Confidence 333444444433 22333333445555666666655 22 25677778888888888886 33 256788889999999
Q ss_pred ccccccCCCC
Q 046275 716 CNNQLTGMIP 725 (1176)
Q Consensus 716 s~N~l~g~~p 725 (1176)
.+|+|.+.+-
T Consensus 407 ~~NPl~~~vd 416 (490)
T KOG1259|consen 407 TGNPLAGSVD 416 (490)
T ss_pred cCCCccccch
Confidence 9999988765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-11 Score=141.26 Aligned_cols=145 Identities=18% Similarity=0.189 Sum_probs=94.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCc--------------------------C--------HH---
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQ--------------------------G--------DR--- 901 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~--- 901 (1176)
..|+. +.||+|++|+||+|++++ |+.||||+....-.. . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 999999988532100 0 01
Q ss_pred ---HHHHHHHHHHhcC----CCCcccceeEEee-CCeeEEEEeeccCCCHHHHH--hhccccCcccCHHHHHHHHHHHHH
Q 046275 902 ---EFTAEMETIGKIK----HRNLVPLLGYCKV-GEERLLVYEYMRYGSLEDVL--HNQKKVGIKLNWAARRKIAIGSAR 971 (1176)
Q Consensus 902 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~ 971 (1176)
++.+|...+.+++ +...+.+-.++.+ .+..++||||++|+.+.+.- ...+.....+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1334444444442 3333443343332 45678999999999998753 2221100112233333333333
Q ss_pred HHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEeecccccccc
Q 046275 972 GLAFLHHNCIPHIIHRDMKSSNVLLDENF----EARVSDFGMARLMSA 1015 (1176)
Q Consensus 972 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~ 1015 (1176)
... |++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 899999999999999888 899999999877654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-11 Score=134.85 Aligned_cols=64 Identities=27% Similarity=0.134 Sum_probs=40.6
Q ss_pred CCCCccceeeccCCcccccCC--CccCCCCCcEEEcCCCcCCCC--cChhhhccccCCeEeecccccc
Q 046275 215 SKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISANKFTGD--VGHAISACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~Ls~N~l~ 278 (1176)
+++++|+...|.+..+..... ....|++++.|||++|-+... +......+++|+.|+|+.|++.
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~ 185 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS 185 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc
Confidence 456777777777777664332 356677777777777766533 2234456677777777777665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3e-11 Score=121.84 Aligned_cols=127 Identities=27% Similarity=0.224 Sum_probs=35.3
Q ss_pred CcccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCC
Q 046275 91 TLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLS 170 (1176)
Q Consensus 91 ~~~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~ 170 (1176)
+...+++|+|++|.|+ .+......+.+|+.||||+|.|+. +..+..++.|+.|++++|+|+.++....+.+++
T Consensus 17 n~~~~~~L~L~~n~I~---~Ie~L~~~l~~L~~L~Ls~N~I~~----l~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~ 89 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS---TIENLGATLDKLEVLDLSNNQITK----LEGLPGLPRLKTLDLSNNRISSISEGLDKNLPN 89 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S------TT----TT--EEE--SS---S-CHHHHHH-TT
T ss_pred cccccccccccccccc---cccchhhhhcCCCEEECCCCCCcc----ccCccChhhhhhcccCCCCCCccccchHHhCCc
Confidence 3344566666666665 222111234556666666666653 223455566666666666666554333334555
Q ss_pred CcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCC----CccCCCCCcEE
Q 046275 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP----SFGDCLALEYL 246 (1176)
Q Consensus 171 L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~l~~l~~L~~L 246 (1176)
|++|+|++|+|.+...+ ..++.+++|+.|+|.+|.++.... .+..+|+|+.|
T Consensus 90 L~~L~L~~N~I~~l~~l------------------------~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~L 145 (175)
T PF14580_consen 90 LQELYLSNNKISDLNEL------------------------EPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVL 145 (175)
T ss_dssp --EEE-TTS---SCCCC------------------------GGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEE
T ss_pred CCEEECcCCcCCChHHh------------------------HHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhee
Confidence 66666666666553322 223445555555555555543322 13455666666
Q ss_pred Ec
Q 046275 247 DI 248 (1176)
Q Consensus 247 ~L 248 (1176)
|-
T Consensus 146 D~ 147 (175)
T PF14580_consen 146 DG 147 (175)
T ss_dssp TT
T ss_pred CC
Confidence 54
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3e-12 Score=136.22 Aligned_cols=199 Identities=24% Similarity=0.264 Sum_probs=94.6
Q ss_pred ccCCCCCcEEEcCCCcCCCCcCh----hhhccccCCeEeeccccccCccCCCCccccCcc----hhhhhhcCCCccEEEc
Q 046275 237 FGDCLALEYLDISANKFTGDVGH----AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEI----PLHLADLCSSLVKLDL 308 (1176)
Q Consensus 237 l~~l~~L~~L~Ls~N~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i----~~~~~~~l~~L~~L~L 308 (1176)
+..+++|++||||+|-|....+. .++.+..|++|.|.+|.+. |.+-..+...+ -.......+.|+.+..
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~ 164 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG---PEAGGRLGRALFELAVNKKAASKPKLRVFIC 164 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC---hhHHHHHHHHHHHHHHHhccCCCcceEEEEe
Confidence 34455666666666655533222 2345555666666666543 11111100000 0001112345666666
Q ss_pred cCCcccc----cCCccccCCCCCcEEEccCCcCc--c-cCCHHHHhcCCCCCEEEccCcccCCC----CcccccCCCCCC
Q 046275 309 SSNNLSG----KVPSRFGSCSSLESFDISSNKFS--G-ELPIEIFLSMSNLKELVLSFNDFTGA----LPDSLSNLTNLE 377 (1176)
Q Consensus 309 ~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~--~-~i~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~ 377 (1176)
.+|++.. .+...|...+.|+.+.++.|.|. | .+-...|..+++|+.|||.+|.++.. +...++.+++|+
T Consensus 165 ~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~ 244 (382)
T KOG1909|consen 165 GRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLR 244 (382)
T ss_pred eccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhe
Confidence 6666542 12334555566666666666654 1 12223345566666666666666532 234455555666
Q ss_pred EEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccc-cccccCcEEEcCCccccC----CCCccccCCCccCe
Q 046275 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL-SNCSQLVSLHLSFNYLTG----TIPSSLGSLSKLQD 452 (1176)
Q Consensus 378 ~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~ 452 (1176)
.|++++|.+.......+.. .+ ...++|+.|.|.+|.++. .+...+...+.|..
T Consensus 245 El~l~dcll~~~Ga~a~~~----------------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~k 302 (382)
T KOG1909|consen 245 ELNLGDCLLENEGAIAFVD----------------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEK 302 (382)
T ss_pred eecccccccccccHHHHHH----------------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHH
Confidence 6666666555433332211 11 123455666666665541 12223344556666
Q ss_pred eecccccc
Q 046275 453 LKLWLNQL 460 (1176)
Q Consensus 453 L~L~~N~l 460 (1176)
|+|+.|.+
T Consensus 303 LnLngN~l 310 (382)
T KOG1909|consen 303 LNLNGNRL 310 (382)
T ss_pred hcCCcccc
Confidence 66666665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.9e-10 Score=118.50 Aligned_cols=130 Identities=17% Similarity=0.073 Sum_probs=95.6
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcc-cceeEEeeCCeeEEEEeeccCCCH
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLV-PLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
.+.++.|.++.||+++.. ++.|++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999876 78899997643321 233567899999998655544 444433 3345899999999877
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC--IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
.+. . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~----~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 111345678999999999983 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=117.19 Aligned_cols=85 Identities=26% Similarity=0.310 Sum_probs=18.5
Q ss_pred cCCCCccEEEeCCCcccccccCC-CCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEe
Q 046275 193 NGCDELKQLALKGNKVTGDINVS-KCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271 (1176)
Q Consensus 193 ~~~~~L~~L~L~~n~l~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 271 (1176)
.++.++++|+|++|.|+.+..++ .+.+|+.|+|++|.|+.+ +.+..++.|++|++++|+|+.+.+.....+++|++|+
T Consensus 16 ~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccccccccchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 44455666666666666655554 355666666666666543 2345556666666666666543222123455555555
Q ss_pred ecccccc
Q 046275 272 VSSNLFS 278 (1176)
Q Consensus 272 Ls~N~l~ 278 (1176)
|++|+|.
T Consensus 95 L~~N~I~ 101 (175)
T PF14580_consen 95 LSNNKIS 101 (175)
T ss_dssp -TTS---
T ss_pred CcCCcCC
Confidence 5555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-11 Score=125.44 Aligned_cols=135 Identities=26% Similarity=0.252 Sum_probs=106.7
Q ss_pred cccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCC
Q 046275 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNL 498 (1176)
Q Consensus 419 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 498 (1176)
.+.....|+.+|||+|.|+ .+.+++.-+++++.|++|+|.+.. + ..+..+.+|+.||||+|.++ .+..+-..+.+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444567888888888888 677778888888999999998873 3 23778889999999999988 566666778889
Q ss_pred CeeeccccccCCCCCccccCCCCCCeEEccCCcccccC-CCCCCCCCCCCEEEccCCCCccc
Q 046275 499 NWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI-PPELGDCRSLIWLDLNTNLFNGS 559 (1176)
Q Consensus 499 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~ 559 (1176)
+.|.|++|.|.. -..+++|-+|..||+++|+|...- -..+++++-|+.|.|.+|++.+.
T Consensus 355 KtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 355 KTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 999999998852 234778889999999999987321 24688999999999999999863
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.1e-09 Score=110.78 Aligned_cols=136 Identities=15% Similarity=0.165 Sum_probs=98.0
Q ss_pred CceEeEeCceEEEEEEECC-------CCEEEEEEeeccC------------C---------cC-HHHH----HHHHHHHH
Q 046275 865 DSLIGSGGFGDVYKAKLKD-------GSTVAIKKLIHIS------------G---------QG-DREF----TAEMETIG 911 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~---------~~-~~~~----~~E~~~l~ 911 (1176)
...||.|..+.||.|...+ +..+|||...... . .. .+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997653 4799999663210 0 01 1123 37999999
Q ss_pred hcCC--CCcccceeEEeeCCeeEEEEeeccCCCHHH-HHhhccccCcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeC
Q 046275 912 KIKH--RNLVPLLGYCKVGEERLLVYEYMRYGSLED-VLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHNCIPHIIHR 987 (1176)
Q Consensus 912 ~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~ 987 (1176)
++.. -++.+++++ ...++||||+.++.+.. .+++. .++..+...+..+++.++..+ |.. ++|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9853 466677664 56789999997654322 22221 344556677889999999999 777 99999
Q ss_pred CCCCCCEEECCCCcEEEEeecccccc
Q 046275 988 DMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 988 Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+++.||++++ +.+.++|||.|...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999974 67999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.1e-11 Score=140.71 Aligned_cols=264 Identities=27% Similarity=0.301 Sum_probs=155.2
Q ss_pred ccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCc
Q 046275 93 DTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLE 172 (1176)
Q Consensus 93 ~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~ 172 (1176)
+.++.++...+.+.+.... ...+..++.+++..|.+... ...+..+.+|+.|++.+|+|..+... ...+.+|+
T Consensus 49 ~~~~~~~~~~~~~~~~~~~---~~~l~~l~~l~l~~n~i~~~---~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~ 121 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL---VESLTSLKELNLRQNLIAKI---LNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQ 121 (414)
T ss_pred chhhhhcchhccccchhhh---HHHhHhHHhhccchhhhhhh---hcccccccceeeeeccccchhhcccc-hhhhhcch
Confidence 3444555555544321110 13455666777777777531 12367777888888888877766422 45566778
Q ss_pred EEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCC-ccCCCCCcEEEcCCC
Q 046275 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS-FGDCLALEYLDISAN 251 (1176)
Q Consensus 173 ~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N 251 (1176)
+|||++|+|+.+..+ ..++.|+.|++++|.|.....+..++.|+.+++++|.+..+... ...+.+++.+++.+|
T Consensus 122 ~L~ls~N~I~~i~~l-----~~l~~L~~L~l~~N~i~~~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n 196 (414)
T KOG0531|consen 122 VLDLSFNKITKLEGL-----STLTLLKELNLSGNLISDISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGN 196 (414)
T ss_pred heeccccccccccch-----hhccchhhheeccCcchhccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCC
Confidence 888888888765443 34555777778888777777777777888888888877755443 466777777777777
Q ss_pred cCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCC--CccEEEccCCcccccCCccccCCCCCcE
Q 046275 252 KFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS--SLVKLDLSSNNLSGKVPSRFGSCSSLES 329 (1176)
Q Consensus 252 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~--~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 329 (1176)
.+.... .+..+..+..+++..|.++..-+.. .+. .|+.+++++|++. .++..+..+..+..
T Consensus 197 ~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~l~--------------~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~ 259 (414)
T KOG0531|consen 197 SIREIE--GLDLLKKLVLLSLLDNKISKLEGLN--------------ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPV 259 (414)
T ss_pred chhccc--chHHHHHHHHhhcccccceeccCcc--------------cchhHHHHHHhcccCccc-cccccccccccccc
Confidence 776442 2444455555577777765211110 011 2667777777776 33355666667777
Q ss_pred EEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCC---Cccc-ccCCCCCCEEEccCCcCCC
Q 046275 330 FDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA---LPDS-LSNLTNLETLDLSSNNLSG 388 (1176)
Q Consensus 330 L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~-l~~l~~L~~L~Ls~N~l~~ 388 (1176)
|++++|++.. + ..+...+.+..+.+..|.+... .... ......++...+..|.+..
T Consensus 260 l~~~~n~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 260 LDLSSNRISN-L--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred cchhhccccc-c--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccc
Confidence 7777777652 1 1133455566666666655421 1111 3444555555555555543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3e-10 Score=130.91 Aligned_cols=251 Identities=19% Similarity=0.218 Sum_probs=177.0
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC--CCCEEEEEEeeccCCcCHHH--HHHHHHHHHhc-CCCCcccceeEEeeCCeeE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK--DGSTVAIKKLIHISGQGDRE--FTAEMETIGKI-KHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 932 (1176)
-+.+|..+..||.|.|+.|++.... ++..+++|...........+ -..|+.+...+ .|.+++.....+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4457888999999999999998643 57889998775433322222 23456555555 5888998888887778888
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeecccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMAR 1011 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~ 1011 (1176)
+=-||++++++.....-. ..+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||++.
T Consensus 343 ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 999999999888776322 2578889999999999999999998 89999999999999876 788999999986
Q ss_pred ccccccccccccccccCCccc--CccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYV--PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
.+.... ....+.-+++ +|+......+-.+.|+||||.-+++..+|..--... ..|.. +..+..
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~~~-i~~~~~-- 480 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQSLT-IRSGDT-- 480 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-------cccee-eecccc--
Confidence 432111 1222333444 555556677888999999999999999986532111 11211 011110
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+.. +. ...++..+...+...++..||.+.+...+.+-.++.
T Consensus 481 ---p~~----~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 481 ---PNL----PG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred ---cCC----Cc---hHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 111 11 112344467778999999999999998887666544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.3e-09 Score=103.89 Aligned_cols=130 Identities=24% Similarity=0.336 Sum_probs=100.5
Q ss_pred eEeEeCceEEEEEEECCCCEEEEEEeeccCCcC---H-----HHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG---D-----REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+++|+-+.+|.+.+. |.++++|.-....-.. + ....+|..++.+++--.|...+=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 5557777543322111 1 23567999999987767776666777888889999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+|..|.+.+... +..++..+-+-+.-||.. +|||+|+.++||++..+. +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998888888754 234566667777889999 999999999999998765 99999999874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.9e-11 Score=139.10 Aligned_cols=216 Identities=31% Similarity=0.340 Sum_probs=101.6
Q ss_pred CCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccccc-ccCCCCCccceeeccCCcccccCCCccCCCCCcEEE
Q 046275 169 LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD-INVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLD 247 (1176)
Q Consensus 169 ~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~ 247 (1176)
+.++.++..++.+...... . ..+..++.+.++.|.+... ..+..+++|+.|++.+|+|..+...+..+++|++|+
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~---~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ 124 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-V---ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLD 124 (414)
T ss_pred chhhhhcchhccccchhhh-H---HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccchhhhhcchhee
Confidence 3556666666655432111 0 2334444444555555542 224444555555555555544333344444444444
Q ss_pred cCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCC
Q 046275 248 ISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSL 327 (1176)
Q Consensus 248 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 327 (1176)
|++|+|+.+.+ +..++. |+.|++++|.|+.. ..+..++.|
T Consensus 125 ls~N~I~~i~~--l~~l~~------------------------------------L~~L~l~~N~i~~~--~~~~~l~~L 164 (414)
T KOG0531|consen 125 LSFNKITKLEG--LSTLTL------------------------------------LKELNLSGNLISDI--SGLESLKSL 164 (414)
T ss_pred ccccccccccc--hhhccc------------------------------------hhhheeccCcchhc--cCCccchhh
Confidence 44444443322 333333 44455555554421 234445666
Q ss_pred cEEEccCCcCcccCCH-HHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCC--CccE
Q 046275 328 ESFDISSNKFSGELPI-EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN--SLKE 404 (1176)
Q Consensus 328 ~~L~Ls~N~l~~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~--~L~~ 404 (1176)
+.+++++|++. .+.. . ...+.+++.+++.+|.+... ..+..+..+..+++..|.++..-+.. ... .|+.
T Consensus 165 ~~l~l~~n~i~-~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l~----~~~~~~L~~ 236 (414)
T KOG0531|consen 165 KLLDLSYNRIV-DIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEGLN----ELVMLHLRE 236 (414)
T ss_pred hcccCCcchhh-hhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccCcc----cchhHHHHH
Confidence 66666666665 3332 1 24556666666666665522 23333344444466666555221110 011 1555
Q ss_pred EEccCccccCCCCccccccccCcEEEcCCcccc
Q 046275 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437 (1176)
Q Consensus 405 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 437 (1176)
+++++|++. ..+..+..+..+..|++..|++.
T Consensus 237 l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 237 LYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred HhcccCccc-cccccccccccccccchhhcccc
Confidence 555555554 22234445555666666666655
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.4e-09 Score=112.83 Aligned_cols=142 Identities=21% Similarity=0.237 Sum_probs=109.0
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCC--CCcccceeEEeeCC---eeEEEEeecc
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG-QGDREFTAEMETIGKIKH--RNLVPLLGYCKVGE---ERLLVYEYMR 939 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lV~E~~~ 939 (1176)
+.|+.|..+.||+++..+|+.+++|....... ....++.+|+++++.+++ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999998754322 134578899999999975 34677777765532 5689999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC--------------------------------------- 980 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 980 (1176)
|+++.+.+.. ..++..++..++.++++++.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765531 14677778888888888888888531
Q ss_pred --------------CCCeeeCCCCCCCEEECC--CCcEEEEeeccccc
Q 046275 981 --------------IPHIIHRDMKSSNVLLDE--NFEARVSDFGMARL 1012 (1176)
Q Consensus 981 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~ 1012 (1176)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-08 Score=98.46 Aligned_cols=143 Identities=18% Similarity=0.205 Sum_probs=106.6
Q ss_pred CCceEeEeCceEEEEEEECCCCEEEEEEeeccCCc--------CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ--------GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
....+-+|+.++|+++.+. |+..+||.-....-. ..+...+|.+.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568899999999999986 888888754321111 1234678999999887666666666777777788999
Q ss_pred eeccC-CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEEeecccc
Q 046275 936 EYMRY-GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF---EARVSDFGMAR 1011 (1176)
Q Consensus 936 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~ 1011 (1176)
||++| .++.+++...-.. .........++..|-+.+.-||.. +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 4888888765321 122223367888888999999999 999999999999996544 36899999975
Q ss_pred c
Q 046275 1012 L 1012 (1176)
Q Consensus 1012 ~ 1012 (1176)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.8e-10 Score=133.85 Aligned_cols=249 Identities=21% Similarity=0.241 Sum_probs=166.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.+.+.+.+-+-+|.++.++.++-. .|...+.|..... .....+....+-.+.-..++|.++.....+.-....++|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 356777788999999999988643 3433343322211 111122222333333333567777666665666788999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
++|+.+++|...++..+ ..+.+..+.....+..+.+|||.. .+.|||++|.|.++..++..+++|||.....+
T Consensus 883 ~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999998775 355555666666788899999998 79999999999999999999999998443221
Q ss_pred cc---------------------cc--------cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCC
Q 046275 1015 AM---------------------DT--------HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT 1065 (1176)
Q Consensus 1015 ~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~ 1065 (1176)
.. .. ........||+.|.+||...+......+|+|+.|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 11 00 01123456899999999999999999999999999999999999998
Q ss_pred CCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHH
Q 046275 1066 DSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMI 1128 (1176)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~ 1128 (1176)
...... +..+.+..+.+....-+.. .-..+.+++...+..+|.+|-.|.
T Consensus 1036 na~tpq-----~~f~ni~~~~~~~p~g~~~---------~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQ-----QIFENILNRDIPWPEGPEE---------GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchh-----hhhhccccCCCCCCCCccc---------cChhhhhhhhhhhccCchhccCcc
Confidence 654321 1122222222211111111 111233466677888888888776
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-09 Score=80.31 Aligned_cols=38 Identities=47% Similarity=1.095 Sum_probs=30.8
Q ss_pred hHHHHHHHHHHhcCC-CC-CCCCCCCCC--CCCcccceeEeC
Q 046275 27 NKDLQQLLSFKAALP-NP-SVLPNWSPN--QNPCGFKGVSCK 64 (1176)
Q Consensus 27 ~~~~~~ll~~k~~~~-~~-~~l~~w~~~--~~cC~W~gv~C~ 64 (1176)
++|++|||+||+++. ++ ..+.+|... ++||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999999 45 589999987 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-10 Score=119.48 Aligned_cols=211 Identities=21% Similarity=0.195 Sum_probs=126.8
Q ss_pred CcccceeEeCCCcEEEEecCCccccccchhhhhhhcCcccccccccCCCCCCCcccCCCCCc----cccCccccccCCcc
Q 046275 55 PCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSR----CSSFLSSLDLSLNI 130 (1176)
Q Consensus 55 cC~W~gv~C~~~~v~~l~L~~~~~~~~~~~~~~~l~~~~~L~~L~L~~n~l~g~~~~~~~~~----~~~~L~~LdLs~N~ 130 (1176)
|-+|+|..-+..-|+.+||.+..+..+.-. ..++ ..+..+.+....... |...+ .-++||+||||+-.
T Consensus 125 C~Rfyr~~~de~lW~~lDl~~r~i~p~~l~--~l~~--rgV~v~Rlar~~~~~----prlae~~~~frsRlq~lDLS~s~ 196 (419)
T KOG2120|consen 125 CKRFYRLASDESLWQTLDLTGRNIHPDVLG--RLLS--RGVIVFRLARSFMDQ----PRLAEHFSPFRSRLQHLDLSNSV 196 (419)
T ss_pred HHHHhhccccccceeeeccCCCccChhHHH--HHHh--CCeEEEEcchhhhcC----chhhhhhhhhhhhhHHhhcchhh
Confidence 458999888878899999998766543211 1010 223334444333321 21221 12569999999988
Q ss_pred cCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCC-CCCCCCccccccccCCCCccEEEeCCCccc
Q 046275 131 LSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYN-KISGANVVPWILFNGCDELKQLALKGNKVT 209 (1176)
Q Consensus 131 l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N-~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~ 209 (1176)
|+-... ...|+.|++|+.|.|.++++.+--........+|+.|||+.+ .++.. -...+|.+|+.|..|+|+.|.+.
T Consensus 197 it~stl-~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n--~~~ll~~scs~L~~LNlsWc~l~ 273 (419)
T KOG2120|consen 197 ITVSTL-HGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTEN--ALQLLLSSCSRLDELNLSWCFLF 273 (419)
T ss_pred eeHHHH-HHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchh--HHHHHHHhhhhHhhcCchHhhcc
Confidence 863211 135788999999999999988765555566678999999986 45432 22345778888888888888777
Q ss_pred ccc---cC-CCCCccceeeccCCccc----ccCCCccCCCCCcEEEcCCC-cCCCCcChhhhccccCCeEeecccc
Q 046275 210 GDI---NV-SKCKNLQFLDVSSNNFS----MAVPSFGDCLALEYLDISAN-KFTGDVGHAISACEHLSFLNVSSNL 276 (1176)
Q Consensus 210 ~~~---~~-~~l~~L~~L~Ls~N~l~----~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~Ls~N~ 276 (1176)
.+. .+ .--++|+.|+|++..-. .+.--...+++|.+||||+| .++......|.+++.|++|.|+.|.
T Consensus 274 ~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY 349 (419)
T KOG2120|consen 274 TEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCY 349 (419)
T ss_pred chhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhc
Confidence 532 11 12356777777765321 11111356667777777766 4443333445555566666665554
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-09 Score=112.20 Aligned_cols=213 Identities=16% Similarity=0.169 Sum_probs=142.1
Q ss_pred CcEEEEecCCccccccchh-hhhhhcCcccccccccCCCCCCC-cccC-------CCCCccccCccccccCCcccCCCCC
Q 046275 66 ASVSSIDLSPFTLSVDFHL-VASFLLTLDTLETLSLKNSNISG-TISL-------PAGSRCSSFLSSLDLSLNILSGPLS 136 (1176)
Q Consensus 66 ~~v~~l~L~~~~~~~~~~~-~~~~l~~~~~L~~L~L~~n~l~g-~~~~-------~~~~~~~~~L~~LdLs~N~l~~~~~ 136 (1176)
..++++||+|+.++-+... ++..+.+-.+|+..++++-..+- ...+ ...+-.|++|+..|||+|.+....+
T Consensus 30 d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~ 109 (388)
T COG5238 30 DELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFP 109 (388)
T ss_pred cceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccc
Confidence 4689999999887754432 66777888889988888764431 1111 2234578999999999999975322
Q ss_pred --cccccCCCCCCcEEecCCCCCCccccc-c------------ccccCCCcEEEccCCCCCCCCcccccc-ccCCCCccE
Q 046275 137 --DISYLGSCSSLKVLNLSSNLLDFSGRE-A------------GSLKLSLEVLDLSYNKISGANVVPWIL-FNGCDELKQ 200 (1176)
Q Consensus 137 --~~~~l~~l~~L~~L~Ls~n~i~~~~~~-~------------~~~~~~L~~LdLs~N~i~~~~~~~~~~-f~~~~~L~~ 200 (1176)
....++.-..|++|.|++|.+..+... + .+..+.|++.+..+|++...+..-+.+ |+....|+.
T Consensus 110 e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~ 189 (388)
T COG5238 110 EELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLKE 189 (388)
T ss_pred hHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCcee
Confidence 225678889999999999999866421 1 233468999999999987644433333 566677888
Q ss_pred EEeCCCccccc-------ccCCCCCccceeeccCCccccc-----CCCccCCCCCcEEEcCCCcCCCCcChhhh------
Q 046275 201 LALKGNKVTGD-------INVSKCKNLQFLDVSSNNFSMA-----VPSFGDCLALEYLDISANKFTGDVGHAIS------ 262 (1176)
Q Consensus 201 L~L~~n~l~~~-------~~~~~l~~L~~L~Ls~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~------ 262 (1176)
+.+..|.|... ..+..+++|+.|||.+|-++.. ...+...+.|++|.+.+|-++.....++-
T Consensus 190 vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~ 269 (388)
T COG5238 190 VKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEK 269 (388)
T ss_pred EEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhh
Confidence 88888888742 2345677888888888877622 22345556677788877777654332221
Q ss_pred ccccCCeEeecccccc
Q 046275 263 ACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 263 ~l~~L~~L~Ls~N~l~ 278 (1176)
..++|..|-..+|.+.
T Consensus 270 ~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 270 FVPNLMPLPGDYNERR 285 (388)
T ss_pred cCCCccccccchhhhc
Confidence 2345566655555544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.5e-07 Score=99.32 Aligned_cols=261 Identities=14% Similarity=0.163 Sum_probs=156.7
Q ss_pred CCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEE-------eeCCeeEEE
Q 046275 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYC-------KVGEERLLV 934 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-------~~~~~~~lV 934 (1176)
...+.||+|+.+.+|-.-.- .-.+.|++.........+... .|... .||-+-.-+.|= ..+....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34678999999999975321 122445554433333333222 23333 455433312111 122336788
Q ss_pred EeeccCC-CHHHHHhhc--cccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 935 YEYMRYG-SLEDVLHNQ--KKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 935 ~E~~~~g-sL~~~l~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|..+.+. -..+++... +..-.-.+|...+++++.+|.+.+.||.. |.+-+|+.++|+|+.+++.+.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8887763 233333211 11112378999999999999999999999 88999999999999999999998865433
Q ss_pred ccccccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcC-CCCCCCCCCCC--cc-HH------
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTG-KRPTDSADFGD--NN-LV------ 1076 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~--~~-~~------ 1076 (1176)
.. ..........|...|.+||.-. +...+...|-|.+||++++++.| ++||.+..... .+ +.
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 22 2222335667899999999753 44567789999999999999885 99998743211 11 11
Q ss_pred --HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCC--CCCCCCHHHHHHHHHHHhhCC
Q 046275 1077 --GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDR--PWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1077 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--p~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.+......+..+.. ...|-. .--..+..+..+|+... +.-|||++..+..|.++++..
T Consensus 243 ~f~ya~~~~~g~~p~P------~~~P~~-~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKPPP------RSIPLS-MLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCCCC------CCCChh-hcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11111111111100 001110 00011223556677653 568999999988888776553
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-08 Score=128.03 Aligned_cols=249 Identities=25% Similarity=0.249 Sum_probs=108.2
Q ss_pred hhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCC
Q 046275 296 LADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTN 375 (1176)
Q Consensus 296 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 375 (1176)
.+..++.|+.|||++|.=-+.+|+.++.+-+|++|++++..++ .+|.++ .++..|.+|++..+.-...+|.....+++
T Consensus 566 ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l-~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~ 643 (889)
T KOG4658|consen 566 FFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGL-GNLKKLIYLNLEVTGRLESIPGILLELQS 643 (889)
T ss_pred HHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHH-HHHHhhheeccccccccccccchhhhccc
Confidence 3334444455555544433345555555555555555555554 455442 44555555555544433333444444555
Q ss_pred CCEEEccCCcCCC--CCCccccCCCCCCccEEEccCccccCCCCccccccccC----cEEEcCCccccCCCCccccCCCc
Q 046275 376 LETLDLSSNNLSG--AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL----VSLHLSFNYLTGTIPSSLGSLSK 449 (1176)
Q Consensus 376 L~~L~Ls~N~l~~--~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~ 449 (1176)
|++|.+....... ..-..+ ..+.+|+.+....... .+-..+..+..| +.+.+.++... ..+..++.+.+
T Consensus 644 Lr~L~l~~s~~~~~~~~l~el--~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~ 718 (889)
T KOG4658|consen 644 LRVLRLPRSALSNDKLLLKEL--ENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGN 718 (889)
T ss_pred ccEEEeeccccccchhhHHhh--hcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccC
Confidence 5555544332110 000001 1122222222221111 000111111211 12222222222 34455666666
Q ss_pred cCeeecccccccCCCCCCCCCc------cccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCC
Q 046275 450 LQDLKLWLNQLHGEIPPELGNI------QTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523 (1176)
Q Consensus 450 L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 523 (1176)
|+.|.+.++.+........... +++..+...++... ..+.+..-.++|+.|++..+.....+.+....+..+.
T Consensus 719 L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~ 797 (889)
T KOG4658|consen 719 LEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELK 797 (889)
T ss_pred cceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcc
Confidence 7777776666653222221111 12222222222111 2233333456778888877776666665666666666
Q ss_pred eEEccCCccccc-CCCCCCCCCCCCEEEcc
Q 046275 524 ILKLSNNSFYGR-IPPELGDCRSLIWLDLN 552 (1176)
Q Consensus 524 ~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~ 552 (1176)
.+-+..+.+.+. .-...++++++..+.++
T Consensus 798 ~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 798 ELILPFNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred cEEecccccccceeeecCCCCceeEecccC
Confidence 666666666654 33444455555544443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.9e-08 Score=83.55 Aligned_cols=60 Identities=35% Similarity=0.485 Sum_probs=39.2
Q ss_pred CccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccc
Q 046275 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRL 696 (1176)
Q Consensus 637 ~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l 696 (1176)
+|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 466677777777654445666666777777777776655556666666666666666654
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.4e-07 Score=99.30 Aligned_cols=141 Identities=16% Similarity=0.095 Sum_probs=101.7
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCC-----------cCHHHHHHHHHHHHhcCC--CCcccceeEEee-----
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG-----------QGDREFTAEMETIGKIKH--RNLVPLLGYCKV----- 927 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----- 927 (1176)
+.+-......|+++.. +|+.|.||+...... .....+.+|...+.++.. -..++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556777766 478899997632221 111247789999988843 334455666543
Q ss_pred CCeeEEEEeeccCC-CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------C
Q 046275 928 GEERLLVYEYMRYG-SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-------N 999 (1176)
Q Consensus 928 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 999 (1176)
....++|+|++++- +|.+++..... .+.+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999875 89998864321 2456677889999999999999999 9999999999999975 4
Q ss_pred CcEEEEeeccccc
Q 046275 1000 FEARVSDFGMARL 1012 (1176)
Q Consensus 1000 ~~~kl~DfGla~~ 1012 (1176)
+.+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999997753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-07 Score=98.42 Aligned_cols=135 Identities=21% Similarity=0.179 Sum_probs=98.7
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC------------------c----CHHHHHHHHHHHHhcCCC--
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG------------------Q----GDREFTAEMETIGKIKHR-- 916 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h~-- 916 (1176)
=+.++..||.|.-+.||.|....|.++|||.-..... . ......+|+++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3556789999999999999999999999993311000 0 012367899999999654
Q ss_pred CcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 917 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
.|.+.+++ +...+||||++|-.|...- ++......++..|.+-+...-.. ||||+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 67777765 5678999999986654322 22333444555555555555566 99999999999999
Q ss_pred CCCCcEEEEeecccc
Q 046275 997 DENFEARVSDFGMAR 1011 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~ 1011 (1176)
+++|.+.++||-.+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.7e-08 Score=125.28 Aligned_cols=126 Identities=30% Similarity=0.368 Sum_probs=70.3
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCc--CcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEE
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK--FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 379 (1176)
..+.+.+-+|.+. .++.... .+.|++|-+..|. +. .++.++|..++.|++|||++|.=-+.+|..++.|-+|++|
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 4555555555554 2333322 2356666666665 43 5666666667777777777665445666666666666666
Q ss_pred EccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCC
Q 046275 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSF 433 (1176)
Q Consensus 380 ~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 433 (1176)
+|++..++ .+|..+ ..++.|.+|++..+.-...+|.....+++|++|.+..
T Consensus 601 ~L~~t~I~-~LP~~l--~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGL--GNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccCCCcc-ccchHH--HHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence 66666665 455544 2234455555554444333344444455555555443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-07 Score=96.72 Aligned_cols=125 Identities=22% Similarity=0.283 Sum_probs=81.2
Q ss_pred EEEEEEECCCCEEEEEEeeccCC-------------c--------C-----HHHHHHHHHHHHhcCCC--CcccceeEEe
Q 046275 875 DVYKAKLKDGSTVAIKKLIHISG-------------Q--------G-----DREFTAEMETIGKIKHR--NLVPLLGYCK 926 (1176)
Q Consensus 875 ~Vy~~~~~~~~~vavK~~~~~~~-------------~--------~-----~~~~~~E~~~l~~l~h~--niv~l~~~~~ 926 (1176)
-||.|...+|..+|+|....... . . .....+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999998899999997632110 0 0 12367799999999765 566666542
Q ss_pred eCCeeEEEEeecc--CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 927 VGEERLLVYEYMR--YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 927 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
...+||||++ |..+..+.... ++......++.+++..+..+ |.. +|||+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4589999998 54554433221 11234556777777755554 676 99999999999999988 899
Q ss_pred EEeecccccc
Q 046275 1004 VSDFGMARLM 1013 (1176)
Q Consensus 1004 l~DfGla~~~ 1013 (1176)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.7e-07 Score=102.80 Aligned_cols=168 Identities=23% Similarity=0.301 Sum_probs=127.0
Q ss_pred eEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCeeEEEEeeccC-CCHHHHH
Q 046275 874 GDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEERLLVYEYMRY-GSLEDVL 947 (1176)
Q Consensus 874 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~l 947 (1176)
.+.||+... +|..|++|++..........-..-+++.+++.|+|||++.+++.. +...++||+|+++ ++|.+..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999765 799999999943332333233456788999999999999998863 4467899999886 6787776
Q ss_pred hhccc-----------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 948 HNQKK-----------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 948 ~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
-.... .+...++...|.++.|++.||.++|+. |...+-+.+.+|+++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 43221 123478899999999999999999999 8888999999999999999999888876544332
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKR 1063 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 1063 (1176)
.. |-++. -.+-|.=.||.++..+.||..
T Consensus 447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 20 11112 236788999999999999954
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.1e-09 Score=109.01 Aligned_cols=81 Identities=15% Similarity=0.237 Sum_probs=48.8
Q ss_pred CCCccEEEccCCccccc-CCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcc------cccC
Q 046275 300 CSSLVKLDLSSNNLSGK-VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPD------SLSN 372 (1176)
Q Consensus 300 l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~------~l~~ 372 (1176)
.+++..+-+..|.+... ..+.+..++.+..|+|+.|+|..--..+.+.++++|..|.+++|.+...+.. -++.
T Consensus 198 Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaR 277 (418)
T KOG2982|consen 198 FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIAR 277 (418)
T ss_pred cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEee
Confidence 35666677777766532 2345555666777778887775333344456777777888777777543221 1355
Q ss_pred CCCCCEEE
Q 046275 373 LTNLETLD 380 (1176)
Q Consensus 373 l~~L~~L~ 380 (1176)
+++++.|+
T Consensus 278 L~~v~vLN 285 (418)
T KOG2982|consen 278 LTKVQVLN 285 (418)
T ss_pred ccceEEec
Confidence 66666655
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.6e-08 Score=82.65 Aligned_cols=61 Identities=38% Similarity=0.509 Sum_probs=55.7
Q ss_pred ccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccc
Q 046275 660 SYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720 (1176)
Q Consensus 660 ~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l 720 (1176)
++|+.|++++|+++...+..|..+++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4689999999999955557999999999999999999977788999999999999999986
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.5e-09 Score=125.14 Aligned_cols=126 Identities=29% Similarity=0.253 Sum_probs=83.9
Q ss_pred CccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCcc
Q 046275 120 FLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELK 199 (1176)
Q Consensus 120 ~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~ 199 (1176)
.|...+.|+|.+.-.. +.|.-++.|+.|||++|+++.+. ..+.++.|+.|||++|.+.. +|...-.+|. |.
T Consensus 165 ~L~~a~fsyN~L~~mD---~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~---vp~l~~~gc~-L~ 235 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMD---ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRH---VPQLSMVGCK-LQ 235 (1096)
T ss_pred hHhhhhcchhhHHhHH---HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcc---ccccchhhhh-he
Confidence 4566666777665332 23566677777888888777664 66677778888888887775 4433334454 77
Q ss_pred EEEeCCCcccccccCCCCCccceeeccCCcccccCC--CccCCCCCcEEEcCCCcCC
Q 046275 200 QLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISANKFT 254 (1176)
Q Consensus 200 ~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~ 254 (1176)
.|++++|.++...++.++++|+.||+++|-|.+... .+..+..|+.|+|.+|.+-
T Consensus 236 ~L~lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 236 LLNLRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eeeecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 777777777777777777777777777777664433 2455666777777777664
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.8e-09 Score=120.97 Aligned_cols=128 Identities=29% Similarity=0.277 Sum_probs=74.1
Q ss_pred ccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhh
Q 046275 219 NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~ 298 (1176)
.|...+.+.|.+.....++.-++.|+.|||++|+++... .+..|++|++|||++|.++ .+|..-..
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~------------~vp~l~~~ 230 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR------------HVPQLSMV 230 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc------------cccccchh
Confidence 455566666666655555666666777777777776443 5666777777777777665 12211111
Q ss_pred cCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccC
Q 046275 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT 363 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~ 363 (1176)
.| .|..|+|++|.++.. ..+.++.+|+.||+++|-|.+.-..+.+..+..|+.|+|.+|.+-
T Consensus 231 gc-~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 231 GC-KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hh-hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 22 366666666666532 345566666666666666654322333344556666666666654
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-08 Score=103.52 Aligned_cols=230 Identities=23% Similarity=0.243 Sum_probs=128.5
Q ss_pred ccCCCCCcEEEcCCCcCCCC----cChhhhccccCCeEeeccccccCccCCCCccccCcchhhh------hhcCCCccEE
Q 046275 237 FGDCLALEYLDISANKFTGD----VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHL------ADLCSSLVKL 306 (1176)
Q Consensus 237 l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~------~~~l~~L~~L 306 (1176)
+..+..+++++||+|.|... +...+++-.+|+..++|.-- +| ...++++..+ .-.|+.|+..
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~f-tg-------r~kde~~~~L~~Ll~aLlkcp~l~~v 97 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAF-TG-------RDKDELYSNLVMLLKALLKCPRLQKV 97 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhh-hc-------ccHHHHHHHHHHHHHHHhcCCcceee
Confidence 34466777788888877644 33445566777777777532 11 2222333322 2235677777
Q ss_pred EccCCcccccCCc----cccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEcc
Q 046275 307 DLSSNNLSGKVPS----RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382 (1176)
Q Consensus 307 ~L~~n~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 382 (1176)
+||+|.+....|. .++.-+.|++|.|++|.+. .+.-+-.+. .|. .|..|+ ...+-+.|++....
T Consensus 98 ~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rigk--al~--~la~nK-------Kaa~kp~Le~vicg 165 (388)
T COG5238 98 DLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIGK--ALF--HLAYNK-------KAADKPKLEVVICG 165 (388)
T ss_pred eccccccCcccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHHH--HHH--HHHHHh-------hhccCCCceEEEec
Confidence 7777776654443 3344566777777777663 322111110 000 011111 12233667777777
Q ss_pred CCcCCCCCCccccCC---CCCCccEEEccCccccCCC-----CccccccccCcEEEcCCccccCC----CCccccCCCcc
Q 046275 383 SNNLSGAIPHNLCQG---PRNSLKELFLQNNLLLGSI-----PSTLSNCSQLVSLHLSFNYLTGT----IPSSLGSLSKL 450 (1176)
Q Consensus 383 ~N~l~~~~p~~~~~~---~~~~L~~L~L~~N~l~~~~-----p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 450 (1176)
.|++. ..|...... .-..|+++.+..|.|.... -..+..+.+|+.|||..|.++.. +...+..++.|
T Consensus 166 rNRle-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~l 244 (388)
T COG5238 166 RNRLE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLL 244 (388)
T ss_pred cchhc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchh
Confidence 77775 333222111 1135777888888776321 12234567899999999988732 33455667778
Q ss_pred CeeecccccccCCCCCCC----C--CccccceeecccccccCc
Q 046275 451 QDLKLWLNQLHGEIPPEL----G--NIQTLETLFLDFNELTGT 487 (1176)
Q Consensus 451 ~~L~L~~N~l~~~~p~~~----~--~l~~L~~L~L~~N~l~~~ 487 (1176)
+.|.+.+|-++..-..++ . ..++|..|-+.+|.+.+.
T Consensus 245 rEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~ 287 (388)
T COG5238 245 RELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGG 287 (388)
T ss_pred hhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCc
Confidence 888888888875443322 1 245677777777777643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1176 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 0.0 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 0.0 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-07 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 4e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 738 bits (1908), Expect = 0.0
Identities = 505/769 (65%), Positives = 598/769 (77%), Gaps = 20/769 (2%)
Query: 18 SLLASAS-SPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPF 76
S AS S S +++ QL+SFK LP+ ++LP+WS N+NPC F GV+C+ V+SIDLS
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSK 60
Query: 77 TLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLS 136
L+V F V+S LL+L LE+L L NS+I+G++ +S L+SLDLS N LSGP++
Sbjct: 61 PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV--SGFKCSAS-LTSLDLSRNSLSGPVT 117
Query: 137 DISYLGSCSSLKVLNLSSNLLDFSGREAGSLKL-SLEVLDLSYNKISGANVVPWILFNGC 195
++ LGSCS LK LN+SSN LDF G+ +G LKL SLEVLDLS N ISGANVV W+L +GC
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177
Query: 196 DELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTG 255
ELK LA+ GNK++GD++VS+C NL+FLDVSSNNFS +P GDC AL++LDIS NK +G
Sbjct: 178 GELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSG 237
Query: 256 DVGHAISACEHLSFLNVSSNLFSGPIP-----------VGYNEFQGEIPLHLADLCSSLV 304
D AIS C L LN+SSN F GPIP + N+F GEIP L+ C +L
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
LDLS N+ G VP FGSCS LES +SSN FSGELP++ L M LK L LSFN+F+G
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 365 ALPDSLSNLT-NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC 423
LP+SL+NL+ +L TLDLSSNN SG I NLCQ P+N+L+EL+LQNN G IP TLSNC
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417
Query: 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
S+LVSLHLSFNYL+GTIPSSLGSLSKL+DLKLWLN L GEIP EL ++TLETL LDFN+
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543
LTG +P+ LSNCTNLNWISLSNN L GEIP WIG+L NLAILKLSNNSF G IP ELGDC
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 544 RSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS-KECHGAGNLLEFA 602
RSLIWLDLNTNLFNG+IP A+FKQSGKIAANFI GK+YVYIKNDG KECHGAGNLLEF
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 603 GIRAERLSRISTRSPCNFT-RVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSY 661
GIR+E+L+R+STR+PCN T RVYGGHT PTF++NGSMMFLD+SYNMLSG IPKEIGSM Y
Sbjct: 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY 657
Query: 662 LFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
LFILNLGHN++SG IP EVGDLRGLNILDLSSN+L+G IP +MS+LT+L EIDL NN L+
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 722 GMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANSRHQKSHRR 770
G IP MGQFETF PAKFLNN GLCG PLP C+ + + HQ+SH
Sbjct: 718 GPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA-DGYAHHQRSHHH 765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 406 bits (1045), Expect = e-132
Identities = 126/295 (42%), Positives = 182/295 (61%), Gaps = 10/295 (3%)
Query: 847 LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG-DREFTA 905
L++ + +L A++ F N +++G GGFG VYK +L DG+ VA+K+L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 906 EMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI 965
E+E I HRNL+ L G+C ERLLVY YM GS+ L + + L+W R++I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST- 1024
A+GSARGLA+LH +C P IIHRD+K++N+LLDE FEA V DFG+A+LM DTH V+T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTA 194
Query: 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN---NLVGWVKQ 1081
+ GT G++ PEY + + S K DV+ YGV+LLEL+TG+R D A ++ L+ WVK
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 1082 -HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135
+ K+ + D +L + E+ Q + VA C P RP M +V+ M +
Sbjct: 255 LLKEKKLEALVDVDLQGNYK--DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-121
Identities = 115/316 (36%), Positives = 169/316 (53%), Gaps = 11/316 (3%)
Query: 828 KLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTV 887
K T + + ++ DL EATN F + LIG G FG VYK L+DG+ V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 888 AIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVL 947
A+K+ S QG EF E+ET+ +H +LV L+G+C E +L+Y+YM G+L+ L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 948 HNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007
+ + ++W R +I IG+ARGL +LH IIHRD+KS N+LLDENF +++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 1008 GMARLMSAMD-THLSVST-LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT 1065
G+++ + +D TH +ST + GT GY+ PEY+ R + K DVYS+GVVL E+L +
Sbjct: 184 GISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 1066 D-SADFGDNNLVGWVKQ-HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWR 1123
S NL W + H ++ + DP L + E L + A CL
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-ADKIRPE-SLRKFGDTAVKCLALSSED 299
Query: 1124 RPTMIQVMAMFKEIQA 1139
RP+M V+ +
Sbjct: 300 RPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-113
Identities = 106/307 (34%), Positives = 161/307 (52%), Gaps = 26/307 (8%)
Query: 847 LRKLTFADLLEATNGFH------NDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHI----S 896
+F +L TN F + +G GGFG VYK + + +TVA+KKL + +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 897 GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK 956
+ ++F E++ + K +H NLV LLG+ G++ LVY YM GSL D L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-P 129
Query: 957 LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016
L+W R KIA G+A G+ FLH N IHRD+KS+N+LLDE F A++SDFG+AR
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 1017 D-THLSVST-LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
T +++ + GT Y+ PE + + K D+YS+GVVLLE++TG D
Sbjct: 187 AQTV--MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQL 242
Query: 1075 LVGWVKQH--AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
L+ ++ + I D D ++ D + VAS CL ++ +RP + +V
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 1133 MFKEIQA 1139
+ +E+ A
Sbjct: 300 LLQEMTA 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = 1e-93
Identities = 132/698 (18%), Positives = 236/698 (33%), Gaps = 91/698 (13%)
Query: 94 TLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS 153
+ E + ++ +P + ++ L+L+ N L + + S L L++
Sbjct: 5 SHEVADCSHLKLT---QVPDDL--PTNITVLNLTHNQLRRLPA--ANFTRYSQLTSLDVG 57
Query: 154 SNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG-- 210
N + E L L+VL+L +N++S + F C L +L L N +
Sbjct: 58 FNTISKLEPELCQKLP-MLKVLNLQHNELSQ---LSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 211 DINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEH--L 267
+ K KNL LD+S N S + L+ L +S NK + + L
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 268 SFLNVSSNLFSGPIP-------------VGYNEFQGEIPLHLADLC--SSLVKLDLSSNN 312
L +SSN P + + + L +S+ L LS++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 313 LSGKVPSRFGSC--SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL 370
LS + F ++L D+S N + + + F + L+ L +N+ SL
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 371 SNLTNLETLDLSSNNLSGAIPHNLCQGPRN-------SLKELFLQNNLLLGSIPSTLSNC 423
L N+ L+L + +I + L+ L +++N + G + +
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 424 SQLVSLHLSFNYLTGTIPSSLG----SLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479
L L LS ++ + ++ + S L L L N++ + LE L L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 480 DFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG--RI 536
NE+ L N+ I LS N + +L L L +
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS 472
Query: 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAG 596
P R+L LDL+ N I + + K+ + + +
Sbjct: 473 PSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKL--------EILDL----------QH 513
Query: 597 NLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI 656
N L+R+ + G + L++ N +
Sbjct: 514 N----------NLARLWKHA-------NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556
Query: 657 GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMS-SLTLLNEIDL 715
+ L I++LG NNL+ + + L L+L N + + L E+D+
Sbjct: 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616
Query: 716 CNNQLTGMIPVMGQF-----ETFQPAKFLNNSGLCGLP 748
N + F ET L++ LC P
Sbjct: 617 RFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 1e-85
Identities = 129/644 (20%), Positives = 220/644 (34%), Gaps = 77/644 (11%)
Query: 116 RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREA-GSLKLSLEVL 174
+C+ D S L+ D+ +++ VLNL+ N L L L
Sbjct: 1 KCTVSHEVADCSHLKLTQVPDDLP-----TNITVLNLTHNQLRRLPAANFTRYS-QLTSL 54
Query: 175 DLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDIN--VSKCKNLQFLDVSSNNFSM 232
D+ +N IS + L LK L L+ N+++ + + C NL L + SN+
Sbjct: 55 DVGFNTISK---LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 233 AVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGE 291
F L LD+S N + E+L L +S+N + F
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA-- 169
Query: 292 IPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIF--LSM 349
SSL KL+LSSN + P F + L +++ + L ++ L+
Sbjct: 170 --------NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221
Query: 350 SNLKELVLSFNDFTGALPDSLSNL--TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFL 407
++++ L LS + + + L TNL LDLS NNL+ + P L+ FL
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP--QLEYFFL 279
Query: 408 QNNLLLGSIPSTLSNCSQLVSLHL---------SFNYLTGTIPSSLGSLSKLQDLKLWLN 458
+ N + +L + L+L S L S L L+ L + N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339
Query: 459 QLHGEIPPELGNIQTLETLFLDFNELTGT--LPAALSNCTN--LNWISLSNNHLGGEIPT 514
+ G + L+ L L + + + + L+ ++L+ N +
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 515 WIGQLSNLAILKLSNNSFYGRIPP-ELGDCRSLIWLDLNTNLFNGSIPPALFKQSG---- 569
L +L +L L N + E ++ + L+ N + +
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 570 KIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629
+ + + NL LS N +
Sbjct: 460 MLRRVALKN------VDSSPSPFQPLRNLTIL------DLSN------NNIANI----ND 497
Query: 630 PTFNHNGSMMFLDISYNMLS--------GSIPKEIGSMSYLFILNLGHNNLSGPIPTEVG 681
+ LD+ +N L+ G + +S+L ILNL N
Sbjct: 498 DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557
Query: 682 DLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
DL L I+DL N L S ++ L ++L N +T +
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 4e-82
Identities = 133/656 (20%), Positives = 226/656 (34%), Gaps = 83/656 (12%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLG 142
L A+ L +L + + IS + L L+L N LS
Sbjct: 39 RLPAANFTRYSQLTSLDVGFNTISKLEP-ELCQKLPM-LKVLNLQHNELSQLSDKT--FA 94
Query: 143 SCSSLKVLNLSSNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQL 201
C++L L+L SN + K +L LDLS+N +S + L++L
Sbjct: 95 FCTNLTELHLMSNSIQKIKNNPFVKQK-NLITLDLSHNGLSS---TKLGTQVQLENLQEL 150
Query: 202 ALKGNKVTG----DINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGD 256
L NK+ ++++ +L+ L++SSN P F L L ++ +
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPS 210
Query: 257 VGHAISACE---HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNL 313
+ + + L++S++ S F G ++L LDLS NNL
Sbjct: 211 LTEKLCLELANTSIRNLSLSNSQLSTTSN---TTFLGLK-------WTNLTMLDLSYNNL 260
Query: 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVL---------SFNDFTG 364
+ F LE F + N + N++ L L S
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFS-HSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL-LGSIPS-TLSN 422
S L LE L++ N++ G + +LK L L N+ L ++ + T +
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI--NLKYLSLSNSFTSLRTLTNETFVS 377
Query: 423 C--SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP-ELGNIQTLETLFL 479
S L L+L+ N ++ + L L+ L L LN++ E+ E ++ + ++L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGG--EIPTWIGQLSNLAILKLSNNSFYGRIP 537
+N+ + + +L + L L P+ L NL IL LSNN+
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497
Query: 538 PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGN 597
L L LDL N ++ + G ++K
Sbjct: 498 DMLEGLEKLEILDLQHNNLA------------RLWKHANPGGPIYFLKGLSH-------- 537
Query: 598 LLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIG 657
L + + I F + +D+ N L+
Sbjct: 538 -LHILNLESNGFDEIPVEV---------------FKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 658 SMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGTIPSSMSSLTLLNE 712
+ L LNL N ++ G R L LD+ N + T S + +NE
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 4e-77
Identities = 101/534 (18%), Positives = 173/534 (32%), Gaps = 77/534 (14%)
Query: 216 KCK-NLQFLDVSSNNFSMAVPSFGDCLA-LEYLDISANKFTGDVGHAISACEHLSFLNVS 273
KC + + D S + VP D + L+++ N+ + L+ L+V
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 274 SNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDIS 333
N S P Q L L+L N LS F C++L +
Sbjct: 58 FNTISKLEP---ELCQK---------LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 334 SNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHN 393
SN + F+ NL L LS N + + L NL+ L LS+N +
Sbjct: 106 SNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLG---SLSKL 450
L +SLK+L L +N + P +L L L+ L ++ L + + +
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224
Query: 451 QDLKLWLNQLHGEIPPELGNIQ--TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
++L L +QL ++ L L L +N L + + L + L N++
Sbjct: 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRI---------PPELGDCRSLIWLDLNTNLFNGS 559
+ L N+ L L + I + L L++ N G
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 560 IPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS--RISTRSP 617
G NL LS S R+
Sbjct: 345 KSNMF----------------------------TGLINLKYL------SLSNSFTSLRTL 370
Query: 618 CNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIP 677
N T + + L+++ N +S + +L +L+LG N + +
Sbjct: 371 TNET--------FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 678 TEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQF 730
+ L + + LS N+ +S + + L + L L + F
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-52
Identities = 81/409 (19%), Positives = 138/409 (33%), Gaps = 41/409 (10%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDIS--- 139
+ L LE L+ +NI + + + + L+L + +S S
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFN-VRYLNLKRSFTKQSISLASLPK 319
Query: 140 ----YLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFN-G 194
L+ LN+ N + + ++L+ L LS + S + +
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 195 CDELKQLALKGNKVTGDINV--SKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISA 250
L L L NK++ + S +L+ LD+ N + + + + +S
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 251 NKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSS 310
NK+ ++ + L L + + + FQ +L LDLS+
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQP---------LRNLTILDLSN 489
Query: 311 NNLSGKVPSRFGSCSSLESFDISSNKFS-------GELPIEIFLSMSNLKELVLSFNDFT 363
NN++ LE D+ N + PI +S+L L L N F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS-N 422
+ +L L+ +DL NNL+ SLK L LQ NL+
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV--SLKSLNLQKNLITSVEKKVFGPA 607
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNI 471
L L + FN T S + W+N+ H IP +
Sbjct: 608 FRNLTELDMRFNPFDCTCES-------IAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-10
Identities = 45/230 (19%), Positives = 75/230 (32%), Gaps = 56/230 (24%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLG 142
++ L L+ LE L L+++N++ L + P I +L
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLA--------------------RLWKHANPGGPIYFLK 533
Query: 143 SCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLA 202
S L +LNL SN D E L+++DL N ++ + + N
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT--LPASVFNN--------- 582
Query: 203 LKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS-FGDCL-ALEYLDISANKFTGDVGHA 260
+L+ L++ N + FG L LD+ N F
Sbjct: 583 --------------QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT---- 624
Query: 261 ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSS 310
CE +++ N IP + + P H + D SS
Sbjct: 625 ---CESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF--PVRLFDTSS 669
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 5e-80
Identities = 97/586 (16%), Positives = 179/586 (30%), Gaps = 55/586 (9%)
Query: 19 LLASASSPNKDLQQLLSFKAALPNPS---------VLPNWSPNQNPC---GFKGVSCKAA 66
L+ + KD L AL + NW+ N+ GVS +
Sbjct: 21 KLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN 80
Query: 67 S-VSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGT--ISLPAGSRCSSFLSS 123
V+ + L F S V + L LE L+L + + P G +
Sbjct: 81 GRVTGLSLEGFGAS---GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 124 LDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISG 183
D S L ++S+ S +++ + L + N I+
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 184 ANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLAL 243
V + +L+Q + + + +N + + + + L
Sbjct: 198 ---VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSE--YAQQYKTEDLKWDNLKDL 251
Query: 244 EYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSL 303
+++ + + A + +NV+ N + + + + +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD---WQALADA-PVGEKI 307
Query: 304 VKLDLSSNNL-SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
+ + NNL + V + L + N+ G+LP S L L L++N
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG-SEIKLASLNLAYNQI 365
Query: 363 TGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL-------LGS 415
T + +E L + N L IP+ + + + N +
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 416 IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG-------EIPPEL 468
+ T + S++LS N ++ + S L + L N L +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 469 GNIQTLETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
N L ++ L FN+LT + L I LS N PT S L +
Sbjct: 485 KNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543
Query: 528 SN------NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567
N N P + C SL L + +N + +
Sbjct: 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPN 588
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 5e-79
Identities = 86/616 (13%), Positives = 180/616 (29%), Gaps = 107/616 (17%)
Query: 118 SSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKL----SLEV 173
+ ++ L L SG + D +G + L+VL L S+ + R G + S E
Sbjct: 80 NGRVTGLSLEGFGASGRVPD--AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 174 LDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSK--CKNLQFLDVSSNNFS 231
V + +L + + + I S + SNN +
Sbjct: 138 KQKMRMHYQK-TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 232 MAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGE 291
+ L + + F + CE N + ++
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDN---- 247
Query: 292 IPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLS--- 348
L +++ + K+P+ + ++ +++ N+ ++
Sbjct: 248 --------LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 349 ----MSNLKELVLSFNDF-TGALPDSLSNLTNLETLDLSSNNLSGAIP--HNLCQGPRNS 401
++ + + +N+ T + SL + L L+ N L G +P +
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSE-----IK 354
Query: 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL--GSLSKLQDLKLWLNQ 459
L L L N + + Q+ +L + N L IP+ S+S + + N+
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413
Query: 460 LHG-------EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGG-- 510
+ + P + ++ L N+++ S + L+ I+L N L
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 511 -----EIPTWIGQLSNLAILKLSNNSFYGRIPPEL--GDCRSLIWLDLNTNLFNGSIPPA 563
+ L + L N ++ + L+ +DL+ N F+ P
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531
Query: 564 LFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS--RISTRSPCNFT 621
S L F R P
Sbjct: 532 PLNSS----------------------------TLKGFGIRNQRDAQGNRTLREWP---- 559
Query: 622 RVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVG 681
S+ L I N + + ++I + +L++ N + V
Sbjct: 560 --------EGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVC 608
Query: 682 DLRGLNILDLSSNRLE 697
+ L ++ +
Sbjct: 609 PYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 7e-74
Identities = 77/521 (14%), Positives = 150/521 (28%), Gaps = 79/521 (15%)
Query: 236 SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLH 295
S + L + +G V AI L L + S+ P
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER-------LFGPKG 128
Query: 296 LADLCSSLVKLDLSSNNLSGKVPSRFG--SCSSLESFDISSNKFSGELPIEIFLSMSNLK 353
++ S + + S L I+S+ + +
Sbjct: 129 ISAN-MSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI-TLKDT 186
Query: 354 ELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLL 413
++ N+ T + ++ LT L + ++ + + +
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI-------CEAWENENSEYAQQY 238
Query: 414 GSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH--------GEIP 465
+ N L + + +P+ L +L ++Q + + N+ +
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 466 PELGNIQTLETLFLDFNEL-TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAI 524
+ + ++ +++ +N L T + +L L + N L G++P G LA
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLAS 357
Query: 525 LKLSNNSFYGRIPPEL-GDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
L L+ N IP G + L N IP +S
Sbjct: 358 LNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS------------- 402
Query: 584 IKNDGSKECHGAGNLLEFAGIRAERLS--RISTRSPCNFTRVYGGHTQPTFNHNGSMMFL 641
+ S I + NF + PT ++ +
Sbjct: 403 -------------VMSAI------DFSYNEIGSVDGKNFDPLD-----PTPFKGINVSSI 438
Query: 642 DISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG-------PIPTEVGDLRGLNILDLSSN 694
++S N +S + + S L +NL N L+ + L +DL N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 695 RLEGTIPS-SMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQ 734
+L ++L L IDL N + T +
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLK 539
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 5e-63
Identities = 66/445 (14%), Positives = 141/445 (31%), Gaps = 60/445 (13%)
Query: 95 LETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSS 154
L + NS A + + + + L + L + + +
Sbjct: 208 LRQFYMGNSPFVAENICEAWE-----NENSEYAQQYKTEDLK----WDNLKDLTDVEVYN 258
Query: 155 NLLDFSGR---EAGSLKLSLEVLDLSYNKISGANVVPWILFN-----GCDELKQLALKGN 206
+ +L +++++++ N+ + ++++ + + N
Sbjct: 259 CPN--LTKLPTFLKALP-EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 207 K-VTGDINVS--KCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISA 263
T + S K K L L+ N +P+FG + L L+++ N+ T +
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 264 CEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG-------K 316
E + L+ + N IP + A S + +D S N +
Sbjct: 376 TEQVENLSFAHNKLKY-IP----------NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG-------ALPDS 369
+ ++ S ++S+N+ S P E+F + S L + L N T ++
Sbjct: 425 LDPTPFKGINVSSINLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
Query: 370 LSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSL 429
N L ++DL N L+ + + L + L N P+ N S L
Sbjct: 484 FKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGF 541
Query: 430 HL------SFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
+ N P + L L++ N + + ++ + L + N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNP 598
Query: 484 LTGTLPAALSNCTNLNWISLSNNHL 508
+ + L +
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-51
Identities = 61/370 (16%), Positives = 131/370 (35%), Gaps = 47/370 (12%)
Query: 95 LETLSLKNSNISGTISLP------AGSRCSSFLSSLDLSLN-ILSGPLSDISYLGSCSSL 147
++ +++ + L A + + + + N + + P+ + L L
Sbjct: 275 MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE--TSLQKMKKL 332
Query: 148 KVLNLSSNLLDFSG--REAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
+L N L G GS L L+L+YN+I+ +P ++++ L+
Sbjct: 333 GMLECLYNQL--EGKLPAFGSEI-KLASLNLAYNQITE---IPANFCGFTEQVENLSFAH 386
Query: 206 NKVTG---DINVSKCKNLQFLDVSSNNFSMAV--------PSFGDCLALEYLDISANKFT 254
NK+ + + +D S N P+ + + +++S N+ +
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
Query: 255 GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
S LS +N+ N+ + IP + + + L +DL N L+
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTE-IP---KNSLKDENENFKNT-YLLTSIDLRFNKLT 501
Query: 315 GKVPS-RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVL------SFNDFTGALP 367
R + L D+S N FS P + + S LK + N P
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL-NSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
+ ++ +L L + SN++ + + ++ L +++N + S + +
Sbjct: 560 EGITLCPSLTQLQIGSNDIRK-VNEKITP----NISVLDIKDNPNISIDLSYVCPYIEAG 614
Query: 428 SLHLSFNYLT 437
L ++
Sbjct: 615 MYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-40
Identities = 32/335 (9%), Positives = 91/335 (27%), Gaps = 65/335 (19%)
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG----EIP 465
++ +L++ ++ L L +G +P ++G L++L+ L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 466 PELGNIQTLETLFLDFNELTGTLPAALS--NCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523
+ + E T + ++L ++++ I
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 524 ILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
+ +N+ + + L + + F
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA------------------- 226
Query: 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643
++ +++ + +++
Sbjct: 227 ------------WENENS------EYAQQYKTED------------LKWDNLKDLTDVEV 256
Query: 644 SYNMLSGSIPKEIGSMSYLFILNLGHNNL--------SGPIPTEVGDLRGLNILDLSSNR 695
+P + ++ + ++N+ N + + I+ + N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 696 L-EGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQ 729
L + +S+ + L ++ NQL G +P G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS 351
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-36
Identities = 55/320 (17%), Positives = 105/320 (32%), Gaps = 48/320 (15%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
+ L L + + G + PA L+SL+L+ N ++ ++ G ++ L+
Sbjct: 329 MKKLGMLECLYNQLEGKL--PAFGSEIK-LASLNLAYNQITEIPANF--CGFTEQVENLS 383
Query: 152 LSSNLLDF--SGREAGSLKLSLEVLDLSYNKISGANVV-----PWILFNGCDELKQLALK 204
+ N L + + +A S+ + +D SYN+I + F + + L
Sbjct: 384 FAHNKLKYIPNIFDAKSVS-VMSAIDFSYNEIGSVDGKNFDPLDPTPFK-GINVSSINLS 441
Query: 205 GNKVTGDIN--VSKCKNLQFLDVSSNNFS--------MAVPSFGDCLALEYLDISANKFT 254
N+++ S L +++ N + +F + L +D+ NK T
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
Query: 255 G-DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKL------D 307
+ +L +++S N FS P + S+L D
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSK------------FPTQPLNS-STLKGFGIRNQRD 548
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
N + P C SL I SN + +I N+ L + N
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT---PNISVLDIKDNPNISIDL 604
Query: 368 DSLSNLTNLETLDLSSNNLS 387
+ L +
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-24
Identities = 26/285 (9%), Positives = 77/285 (27%), Gaps = 66/285 (23%)
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG----R 535
+ + +L++ + +SL G +P IGQL+ L +L L ++
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 536 IPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGA 595
P + S + +
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYD------------------------------- 153
Query: 596 GNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE 655
+F+ + + ++ + + + N ++ + K
Sbjct: 154 -PREDFSDLIKDCINSDPQQKSIK----------KSSRITLKDTQIGQLSNNIT-FVSKA 201
Query: 656 IGSMSYLFILNLGHNNLSGP-------------------IPTEVGDLRGLNILDLSSNRL 696
+ ++ L +G++ + +L+ L +++ +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261
Query: 697 EGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNN 741
+P+ + +L + I++ N+ + ++ A
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-24
Identities = 37/300 (12%), Positives = 88/300 (29%), Gaps = 42/300 (14%)
Query: 436 LTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC 495
G + + ++L +W Q L + + L L+ +G +P A+
Sbjct: 49 QQGFGTQPGANWNFNKELDMWGAQ----PGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104
Query: 496 TNLNWISLSNNHLGG----EIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDL 551
T L ++L ++ P I + + + + DL
Sbjct: 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP---REDFSDL 161
Query: 552 NTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSR 611
+ N Q I + + K I N + + + R
Sbjct: 162 IKDCINSD------PQQKSIKKSSRITLKDTQI--------GQLSNNIT--FVSKA-VMR 204
Query: 612 ISTRSPCNFTRVYGGHTQ-PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHN 670
++ + Y G++ N + + Y + + ++ L + + +
Sbjct: 205 LT-----KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259
Query: 671 NLSGPIPTEVGDLRGLNILDLSSNRL--------EGTIPSSMSSLTLLNEIDLCNNQLTG 722
+PT + L + +++++ NR + + + I + N L
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-14
Identities = 17/95 (17%), Positives = 35/95 (36%), Gaps = 10/95 (10%)
Query: 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGH------NNLSGPIPTEVGDLRGLNILD 690
++ +D+SYN S P + + S L + + N P + L L
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 691 LSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
+ SN + ++++L D+ +N +
Sbjct: 573 IGSNDIRKVNEKITPNISVL---DIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-13
Identities = 16/124 (12%), Positives = 36/124 (29%), Gaps = 6/124 (4%)
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGP----IPTEVGDLRGL 686
+ N NG + L + SG +P IG ++ L +L LG + P +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 687 NILDLSSNRLEGTIPSSMSSLTLLN--EIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGL 744
+ T + + + ++ I + ++ +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 745 CGLP 748
+
Sbjct: 196 TFVS 199
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 13/81 (16%), Positives = 27/81 (33%), Gaps = 3/81 (3%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
D N P+ I L L +G N++ + ++ +++LD+ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603
Query: 701 PSSMSSLTLLNEIDLCNNQLT 721
S + L ++
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 1e-78
Identities = 81/315 (25%), Positives = 124/315 (39%), Gaps = 37/315 (11%)
Query: 850 LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEME- 908
L +L + + G FG V+KA+L VA+K Q + + E E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF---PIQDKQSWQNEYEV 69
Query: 909 -TIGKIKHRNLVPLLGYCKVGE----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR 963
++ +KH N++ +G K G + L+ + GSL D L ++W
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELC 124
Query: 964 KIAIGSARGLAFLHHNCI-------PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016
IA ARGLA+LH + P I HRD+KS NVLL N A ++DFG+A A
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 1017 DTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDS-ADF 1070
+ GT Y+ PE + + D+Y+ G+VL EL + D D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 1071 GDNNLVGWVKQHAKL-KISDVFDPELMKEDPNIEIELLQH------LHVASACLDDRPWR 1123
+ QH L + +V + K+ P + +H C D
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHK--KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 1124 RPTMIQVMAMFKEIQ 1138
R + V ++Q
Sbjct: 303 RLSAGCVGERITQMQ 317
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-77
Identities = 118/628 (18%), Positives = 202/628 (32%), Gaps = 88/628 (14%)
Query: 118 SSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREA-GSLKLSLEVLDL 176
+LDLS N L S S L+VL+LS + A SL L L L
Sbjct: 27 PFSTKNLDLSFNPLRHLGS--YSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLIL 83
Query: 177 SYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVS--KCKNLQFLDVSSNNFSMAV 234
+ N I + F+G L++L + N K L+ L+V+ N
Sbjct: 84 TGNPIQS---LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 235 P--SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEI 292
F + LE+LD+S+NK + + LN+S +L N
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL-------SLNPMNFIQ 193
Query: 293 PLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFSGELPIE--IFLSM 349
P ++ L KL L +N S V + LE + +F E +E ++
Sbjct: 194 PGAFKEI--RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 350 SNLKELVLSFND------FTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
L L + + + D + LTN+ + L S + + +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN----FGWQ 307
Query: 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH-- 461
L L N L + L+F G S L L+ L L N L
Sbjct: 308 HLELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 462 GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLS 520
G +L+ L L FN + T+ + L + +++L + L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 521 NLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKK 580
NL L +S+ SL L + N F + P +F + +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL--------T 473
Query: 581 YVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMF 640
++ + + LE + FN S+
Sbjct: 474 FLDL----------SQCQLE-------------------------QLSPTAFNSLSSLQV 498
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDL-RGLNILDLSSNRLEGT 699
L++S+N ++ L +L+ N++ E+ L L+L+ N T
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 700 IPSS--MSSLTLLNEIDLCNNQLTGMIP 725
+ + ++ + ++ P
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 2e-70
Identities = 102/538 (18%), Positives = 183/538 (34%), Gaps = 66/538 (12%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLG 142
HL + + L+ L L I A S LS+L L+ N +
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIED-GAYQSLSH-LSTLILTGNPIQSLALGA--FS 97
Query: 143 SCSSLKVLNLSSNLLDFSGREAGSLKL--SLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
SSL+ L L + E + +L+ L++++N I F+ L+
Sbjct: 98 GLSSLQKLVAVETNL--ASLENFPIGHLKTLKELNVAHNLIQSFK--LPEYFSNLTNLEH 153
Query: 201 LALKGNKVTGDI--NVSKCKNLQF----LDVSSNNFSMAVPSFGDCLALEYLDISANKFT 254
L L NK+ ++ + LD+S N + P + L L + N +
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDS 213
Query: 255 GDV-GHAISACEHLSFLNVSSNLFSGPIPVG---YNEFQGEIPLHLADL----------- 299
+V I L + F + + +G L + +
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 300 -------CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI------- 345
+++ L S + + + ++ + KF +++
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 346 -----------FLSMSNLKELVLSFND--FTGALPDSLSNLTNLETLDLSSNNLSGAIPH 392
+ + +L+ L LS N F G S T+L+ LDLS N + +
Sbjct: 332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390
Query: 393 NLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQ 451
N L+ L Q++ L S + L+ L +S + LS L+
Sbjct: 391 NFLGLE--QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 452 DLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGG 510
LK+ N P+ ++ L L L +L P A ++ ++L +++S+N+
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 511 EIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC-RSLIWLDLNTNLFNGSIPPALFKQ 567
L++L +L S N EL SL +L+L N F + F Q
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 566
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-62
Identities = 97/498 (19%), Positives = 170/498 (34%), Gaps = 43/498 (8%)
Query: 84 LVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPL-SDISYLG 142
L + L TL+ L++ ++ I S ++ L LDLS N + +D+ L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLH 173
Query: 143 SCSSLKV-LNLSSNLLDFSGREAGSLK-LSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
L + L+LS N + + + G+ K + L L L N S V G L+
Sbjct: 174 QMPLLNLSLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLN--VMKTCIQGLAGLEV 229
Query: 201 LALKGNKVTGDINV-----SKCKNLQFLDVSSNNFSM-------AVPSFGDCLALEYLDI 248
L + + N+ S + L L + + + F + +
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 249 SANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVG--------YNEFQGEIPLHLADLC 300
+ S L + + F + + +G DL
Sbjct: 290 VSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL- 346
Query: 301 SSLVKLDLSSNNLS--GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358
SL LDLS N LS G +SL+ D+S N FL + L+ L
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT--MSSNFLGLEQLEHLDFQ 404
Query: 359 FNDFTGALPDS-LSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI- 416
++ S +L NL LD+S + A SL+ L + N +
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS--SLEVLKMAGNSFQENFL 462
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
P + L L LS L P++ SLS LQ L + N + +L+
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522
Query: 477 LFLDFNELTGTLPAALSNC-TNLNWISLSNNHLGGEIPT--WIGQLSNLAILKLSNNSFY 533
L N + + L + ++L +++L+ N ++ + + L +
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 582
Query: 534 GRIPPELGDCRSLIWLDL 551
P + ++ L++
Sbjct: 583 CATPSDKQG-MPVLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-61
Identities = 87/479 (18%), Positives = 155/479 (32%), Gaps = 47/479 (9%)
Query: 264 CEHLSFLNVSSNLFSG--PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRF 321
C L+F + NL + + +N + L LDLS + +
Sbjct: 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSF-PELQVLDLSRCEIQTIEDGAY 72
Query: 322 GSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
S S L + ++ N L + F +S+L++LV + + +L L+ L++
Sbjct: 73 QSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL----VSLHLSFNYLT 437
+ N + N L+ L L +N + + L Q+ +SL LS N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 438 GTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTL------PA 490
P + + L L L N + + + LE L E +
Sbjct: 191 FIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 491 ALSNCTNLNWISLSNNHL---GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
AL NL +L +I L+N++ L + + +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQ 307
Query: 548 WLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAE 607
L+L F P K ++ G GN + +
Sbjct: 308 HLELVNCKFGQ-FPTLKLKSLKRLTFTSNKG-----------------GNAFSEVDLPSL 349
Query: 608 RLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNL 667
+S R+ +F G + S+ +LD+S+N + + + L L+
Sbjct: 350 EFLDLS-RNGLSFK----GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403
Query: 668 GHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
H+NL V LR L LD+S + L+ L + + N
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-54
Identities = 82/405 (20%), Positives = 141/405 (34%), Gaps = 33/405 (8%)
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCS----SFLSSLDLSLNILSGPLSD 137
+++ + + L LE L +L + + L+ + L L L D
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 138 ISYL-GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCD 196
I L +++ +L S + + S + L+L K
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ------FPTLKLK 325
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAV---PSFGDCLALEYLDISANKF 253
LK+L NK + +L+FLD+S N S S +L+YLD+S N
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 254 TGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNL 313
+ E L L+ + F +L+ LD+S +
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV--FLS---------LRNLIYLDISHTHT 433
Query: 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNL 373
F SSLE ++ N F +IF + NL L LS P + ++L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 374 TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC-SQLVSLHLS 432
++L+ L++S NN SL+ L N ++ S L + S L L+L+
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLN--SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 433 FNYLTGTIPSS--LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLE 475
N T L + + L + + ++ P + + L
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS 596
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-52
Identities = 96/473 (20%), Positives = 154/473 (32%), Gaps = 71/473 (15%)
Query: 261 ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320
+ ++++ + N + IP +L S LDLS N L
Sbjct: 4 VEVVPNITYQCMELNFYK-------------IP---DNLPFSTKNLDLSFNPLRHLGSYS 47
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380
F S L+ D+S + + + S+S+L L+L+ N + S L++L+ L
Sbjct: 48 FFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
Query: 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLG-SIPSTLSNCSQLVSLHLSFNYLTGT 439
NL+ + G +LKEL + +NL+ +P SN + L L LS N +
Sbjct: 107 AVETNLASLENFPI--GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
+ L L ++ L L L+ L N + P A L+
Sbjct: 165 YCTDLRVLHQMPLLNLSLD--------------------LSLNPMNFIQPGAFKE-IRLH 203
Query: 500 WISLSNNHLGGEIP-TWIGQLSNLAILKLSNNSFYGRI---PPELGDCRSLIWLDLNTNL 555
++L NN + T I L+ L + +L F + L L +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 556 FNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTR 615
L I F C + + ER+ S
Sbjct: 264 LAY-----LDYYLDDIIDLF---------------NCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 616 SPCNFTRVYG-GHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS- 673
+ Q S+ L + N G + L L+L N LS
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 674 -GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
G L LDLS N + T+ S+ L L +D ++ L M
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 8e-74
Identities = 84/301 (27%), Positives = 127/301 (42%), Gaps = 20/301 (6%)
Query: 236 SFGDCLAL----EYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGE 291
G+ L D + G + + ++ L++S P P
Sbjct: 17 DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP--------- 67
Query: 292 IPLHLADLCSSLVKLDLSS-NNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
IP LA+L L L + NNL G +P + L I+ SG +P + +
Sbjct: 68 IPSSLANL-PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-QIK 125
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L L S+N +G LP S+S+L NL + N +SGAIP + + + N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS-KLFTSMTISRN 184
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGN 470
L G IP T +N + L + LS N L G GS Q + L N L ++ ++G
Sbjct: 185 RLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGL 242
Query: 471 IQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530
+ L L L N + GTLP L+ L+ +++S N+L GEIP G L + +NN
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301
Query: 531 S 531
Sbjct: 302 K 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 3e-73
Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 13/288 (4%)
Query: 281 IPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG--KVPSRFGSCSSLESFDISS-NKF 337
+ G + + LDLS NL +PS + L I N
Sbjct: 31 TDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG 397
G +P I ++ L L ++ + +GA+PD LS + L TLD S N LSG +P ++
Sbjct: 90 VGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLV-SLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
P +L + N + G+IP + + S+L S+ +S N LTG IP + +L+ L + L
Sbjct: 149 P--NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI 516
N L G+ G+ + + + L N L L + NLN + L NN + G +P +
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 517 GQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDL--NTNLFNGSIPP 562
QL L L +S N+ G I P+ G+ + N L +P
Sbjct: 265 TQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 4e-69
Identities = 73/269 (27%), Positives = 115/269 (42%), Gaps = 31/269 (11%)
Query: 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLS-MSNLKELVL 357
L S L D + G + + + D+S PI L+ + L L +
Sbjct: 24 LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI 83
Query: 358 S-FNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
N+ G +P +++ LT L L ++ N+SG +I
Sbjct: 84 GGINNLVGPIPPAIAKLTQLHYLYITHTNVSG--------------------------AI 117
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
P LS LV+L S+N L+GT+P S+ SL L + N++ G IP G+ L T
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 477 -LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR 535
+ + N LTG +P +N NL ++ LS N L G+ G N + L+ NS
Sbjct: 178 SMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 536 IPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
+ ++G ++L LDL N G++P L
Sbjct: 237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-65
Identities = 79/288 (27%), Positives = 116/288 (40%), Gaps = 23/288 (7%)
Query: 213 NVSKCKNLQFLDVSSNNFSMAV---PSFGDCLALEYLDIS-ANKFTGDVGHAISACEHLS 268
++ + LD+S N S + L +L I N G + AI+ L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
+L ++ SG IP +F + +LV LD S N LSG +P S +L
Sbjct: 105 YLYITHTNVSGAIP----DFLSQ--------IKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
N+ SG +P + +S N TG +P + +NL NL +DLS N L G
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG 211
Query: 389 AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS 448
G + +++ L N L + + L L L N + GT+P L L
Sbjct: 212 DASVLF--GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 449 KLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT 496
L L + N L GEI P+ GN+Q + N+ P L CT
Sbjct: 269 FLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-58
Identities = 90/404 (22%), Positives = 136/404 (33%), Gaps = 101/404 (25%)
Query: 27 NKDLQQLLSFKAALPNPSVLPNWSPNQNPC--GFKGVSCKAASVSSIDLSPFTLSVDFHL 84
+D Q LL K L NP+ L +W P + C + GV C + +
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY-------------- 50
Query: 85 VASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSC 144
+ L L N+ +P S L +
Sbjct: 51 ---------RVNNLDLSGLNLPKPYPIP--------------------------SSLANL 75
Query: 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
L L + N + G +P + +L L +
Sbjct: 76 PYLNFLYIG-----------------------GINNLVG--PIPPAIAK-LTQLHYLYIT 109
Query: 205 GNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAI 261
V+G I +S+ K L LD S N S +P S L + N+ +G + +
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 262 SACEHLS-FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320
+ L + +S N +G IP A+L +L +DLS N L G
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPT-----------FANL--NLAFVDLSRNMLEGDASVL 216
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380
FGS + + ++ N + +L ++ NL L L N G LP L+ L L +L+
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLG-KVG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
+S NNL G IP G NN L P L C+
Sbjct: 275 VSFNNLCGEIPQG---GNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-54
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
+ G L D+ + + LDLS NL P I
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP------------------------I 68
Query: 417 PSTLSNCSQLVSLHLS-FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLE 475
PS+L+N L L++ N L G IP ++ L++L L + + G IP L I+TL
Sbjct: 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 476 TLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA-ILKLSNNSFYG 534
TL +N L+GTLP ++S+ NL I+ N + G IP G S L + +S N G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 535 RIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566
+IPP + +L ++DL+ N+ G
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 3e-38
Identities = 43/118 (36%), Positives = 66/118 (55%), Gaps = 1/118 (0%)
Query: 635 NGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSN 694
N ++ F+D+S NML G GS ++L N+L+ + +VG + LN LDL +N
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254
Query: 695 RLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPC 752
R+ GT+P ++ L L+ +++ N L G IP G + F + + NN LCG PLP C
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 43/202 (21%), Positives = 69/202 (34%), Gaps = 46/202 (22%)
Query: 527 LSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGS--IPPALFKQSGKIAANFIVGKKYVYI 584
N ++ G + + LDL+ IP +L
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL-------------------- 72
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644
NL L+ + N G P + +L I+
Sbjct: 73 -----------ANL--------PYLNFLYIGGINNLV----GPIPPAIAKLTQLHYLYIT 109
Query: 645 YNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSM 704
+ +SG+IP + + L L+ +N LSG +P + L L + NR+ G IP S
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 705 SSLT-LLNEIDLCNNQLTGMIP 725
S + L + + N+LTG IP
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-16
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG--PIPTEVGDLRGLNILDLSS-NRLE 697
D G + + L+L NL PIP+ + +L LN L + N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 698 GTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
G IP +++ LT L+ + + + ++G IP
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIP 118
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 9e-70
Identities = 110/641 (17%), Positives = 216/641 (33%), Gaps = 108/641 (16%)
Query: 96 ETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSN 155
+T + +N ++ +P + L+ S N+L + +L L+L+
Sbjct: 15 KTYNCENLGLN---EIPGT--LPNSTECLEFSFNVLPTIQNTT--FSRLINLTFLDLTRC 67
Query: 156 LLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV 214
+ + + S L+ L L+ N + + +G LK L ++ +
Sbjct: 68 QIYWIHEDTFQSQH-RLDTLVLTANPLIF---MAETALSGPKALKHLFFIQTGISSIDFI 123
Query: 215 --SKCKNLQFLDVSSNNF-SMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLS--F 269
K L+ L + SN+ S+ +P L+ LD N +S+ + +
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183
Query: 270 LNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS--RFGSCSSL 327
LN++ N +G I G A + L+ + + + SL
Sbjct: 184 LNLNGNDIAG-IEPG------------AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 328 ESFDISSNKFSGELPIEIF--LSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
++ +F L +++ + L + F ++ + L+ LDL++ +
Sbjct: 231 WLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289
Query: 386 LSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLG 445
LS +PS L S L L LS N S
Sbjct: 290 LS---------------------------ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 446 SLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELT--GTLPAALSNCTNLNWIS 502
+ L L + N E+ L N++ L L L +++ L N ++L ++
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 503 LSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNGSIP 561
LS N + L +L L+ + + L L+L+ +L +
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD-ISS 441
Query: 562 PALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFT 621
LF + +++ + GN + + +
Sbjct: 442 EQLFDGLPAL--------QHLNL----------QGN----------HFPKGNIQKT---- 469
Query: 622 RVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVG 681
+ G + L +S+ LS S+ + ++L HN L+ +
Sbjct: 470 --------NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 682 DLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTG 722
L+G+ L+L+SN + +PS + L+ I+L N L
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-67
Identities = 101/569 (17%), Positives = 184/569 (32%), Gaps = 75/569 (13%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVS--KCKNLQFLDVSS 227
S E L+ S+N + + F+ L L L ++ + L L +++
Sbjct: 34 STECLEFSFNVLPT---IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA 90
Query: 228 NNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYN 286
N + AL++L + + + L L + SN S
Sbjct: 91 NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL---P 147
Query: 287 EFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE--SFDISSNKFSGELPIE 344
+ L LD +N + S S +++ N + +
Sbjct: 148 KGFP---------TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPG 197
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSLSN--LTNLETLDLSSNNLSGAIPHNLCQGPRNSL 402
F + + L + L N + +L + P S+
Sbjct: 198 AF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 403 KELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG 462
+ + LQ + +T S L L L+ +L+ +PS L LS L+ L L N+
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 463 EIPPELGNIQTLETLFLDFNELTGTL-PAALSNCTNLNWISLSNNHLG--GEIPTWIGQL 519
N +L L + N L L N NL + LS++ + + L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 520 SNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGK 579
S+L L LS N +C L LDL + F+ +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL-------- 427
Query: 580 KYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMM 639
K + + + + L S + F+ ++
Sbjct: 428 KVLNLSH----------S----------LLDISSEQ---------------LFDGLPALQ 452
Query: 640 FLDISYNMLSGSIPKEIGS---MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRL 696
L++ N ++ S + L IL L +LS L+ +N +DLS NRL
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 697 EGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
+ ++S L + ++L +N ++ ++P
Sbjct: 513 TSSSIEALSHLKGI-YLNLASNHISIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-65
Identities = 106/499 (21%), Positives = 173/499 (34%), Gaps = 40/499 (8%)
Query: 95 LETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS 153
L L L I + + + L +L L+ N L L +LK L
Sbjct: 59 LTFLDLTRCQIY---WIHEDTFQSQHRLDTLVLTANPLIFMAETA--LSGPKALKHLFFI 113
Query: 154 SNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT---- 209
+ + +LE L L N IS + ++LK L + N +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISS---IKLPKGFPTEKLKVLDFQNNAIHYLSK 170
Query: 210 GDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANK-----FTGDVGHAISAC 264
D++ + L+++ N+ + P D + L+ + F G I +
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 265 EHLSFLNVSSNLFSGPIPVG------------YNEFQGEIPLHLADLCSSLVKLDLSSNN 312
+F ++ S + G + F S L +LDL++ +
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF-SGLQELDLTATH 289
Query: 313 LSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL-PDSLS 371
LS ++PS S+L+ +S+NKF L + +L L + N L L
Sbjct: 290 LS-ELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
Query: 372 NLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHL 431
NL NL LDLS +++ + NL + L+ L L N L C QL L L
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407
Query: 432 SFNYLTGTIP-SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT--- 487
+F L S +L L+ L L + L + L+ L L N
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467
Query: 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
+L L + LS L L + + LS+N L + +
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY 527
Query: 548 WLDLNTNLFNGSIPPALFK 566
L+L +N + I P+L
Sbjct: 528 -LNLASNHIS-IILPSLLP 544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 3e-63
Identities = 110/493 (22%), Positives = 179/493 (36%), Gaps = 41/493 (8%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYL 141
+ + L L+ L + IS S+ L SL L N +S
Sbjct: 95 FMAETALSGPKALKHLFFIQTGIS---SIDFIPLHNQKTLESLYLGSNHISSIKLPK--G 149
Query: 142 GSCSSLKVLNLSSNLL-DFSGREAGSL-KLSLEVLDLSYNKISGANVVPWILFNGCDELK 199
LKVL+ +N + S + SL + + L+L+ N I+G + F+ +
Sbjct: 150 FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG---IEPGAFD-SAVFQ 205
Query: 200 QLALKGNKVTGDI-------NVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANK 252
L G + I + F D+ + S AV +++E +++ +
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265
Query: 253 FTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNN 312
F + L L++++ S E+P L L S+L KL LS+N
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS------------ELPSGLVGL-STLKKLVLSANK 312
Query: 313 LSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT--GALPDSL 370
+ SL I N EL ++ NL+EL LS +D L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 371 SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSL 429
NL++L++L+LS N + P L+ L L L S N L L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECP--QLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 430 HLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI---PPELGNIQTLETLFLDFNELTG 486
+LS + L + L LQ L L N L + LE L L F +L+
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 487 TLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSL 546
A ++ +N + LS+N L + L + L L++N +P L
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ 549
Query: 547 IWLDLNTNLFNGS 559
++L N + +
Sbjct: 550 RTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 5e-60
Identities = 74/490 (15%), Positives = 142/490 (28%), Gaps = 61/490 (12%)
Query: 243 LEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSS 302
E L+ S N S +L+FL+++ + FQ
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE---DTFQS---------QHR 82
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
L L L++N L + +L+ S + + L+ L L N
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHI 141
Query: 363 TGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSN 422
+ L+ LD +N + ++ + + L L N + I +
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN-DIAGIEPGAFD 200
Query: 423 CSQLVSLHLSFNYLTGTIPSSLG--SLSKLQDLKLWLNQLHGEIPPELGNIQ--TLETLF 478
+ SL+ I L ++ L P + ++E++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
L + + L + L+ HL E+P+ + LS L L LS N F
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 539 ELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL 598
+ SL L + N + + + + + + + +
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENL--------RELDL----------SHDD 361
Query: 599 LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGS 658
+E + + + L++SYN +
Sbjct: 362 IETSDCCNL-----------------------QLRNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 659 MSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCN 717
L +L+L L +L L +L+LS + L+ + L L ++L
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 718 NQLTGMIPVM 727
N
Sbjct: 459 NHFPKGNIQK 468
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-56
Identities = 87/449 (19%), Positives = 158/449 (35%), Gaps = 35/449 (7%)
Query: 94 TLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS 153
T +L+L ++I+ + G+ S+ SL+ + + SL +
Sbjct: 180 TNLSLNLNGNDIA---GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFE 236
Query: 154 SNLLDFSGREA--GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG- 210
+ G ++S+E ++L + + F+ L++L L ++
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFN---ISSNTFHCFSGLQELDLTATHLSEL 293
Query: 211 DINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVG-HAISACEHLS 268
+ L+ L +S+N F S + +L +L I N ++G + E+L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
L++S + + + S L L+LS N F C LE
Sbjct: 354 ELDLSHDDIET-SDCCNLQLRN---------LSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
D++ + + F ++ LK L LS + + L L+ L+L N+
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 389 AIPH--NLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS 446
N Q L+ L L L ++ + + LS N LT + +L
Sbjct: 464 GNIQKTNSLQTLGR-LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 447 LSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTN---LNWISL 503
L + L L N + +P L + T+ L N L T C+N L W
Sbjct: 523 LKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT-------CSNIYFLEWYKE 574
Query: 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+ L T L ++LS+ +
Sbjct: 575 NMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-56
Identities = 79/443 (17%), Positives = 139/443 (31%), Gaps = 59/443 (13%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
EIP L +S L+ S N L + F +L D++ + + + F S
Sbjct: 26 EIP---GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQH 81
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L LVL+ N +LS L+ L +S L +L+ L+L +N
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK--TLESLYLGSN 139
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH-GEIPPELG 469
+ +L L N + + SL + +L L LN I P
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCT--NLNWISLSNNHLGGEIPTWIGQLSNLAI--L 525
+ ++L + + L N T +L + + P L +++ +
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 526 KLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIK 585
L + F+ L LDL + +P L
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV-------------------- 298
Query: 586 NDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY 645
G L + LS F + + ++ S+ L I
Sbjct: 299 --------GLSTLKKL------VLSA------NKFENLCQI----SASNFPSLTHLSIKG 334
Query: 646 NMLSGSIPKE-IGSMSYLFILNLGHNNL--SGPIPTEVGDLRGLNILDLSSNRLEGTIPS 702
N + + ++ L L+L H+++ S ++ +L L L+LS N
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 703 SMSSLTLLNEIDLCNNQLTGMIP 725
+ L +DL +L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDA 417
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-50
Identities = 70/429 (16%), Positives = 136/429 (31%), Gaps = 61/429 (14%)
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA 365
+ + L+ ++P + S E + S N + F + NL L L+
Sbjct: 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ 425
D+ + L+TL L++N L + GP+ LK LF + L N
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKA-LKHLFFIQTGISSIDFIPLHNQKT 130
Query: 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD--FNE 483
L SL+L N+++ KL+ L N +H ++ ++Q L L+ N+
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIG--QLSNLAILKLSNNSFYGRIPPELG 541
+ + + ++ I + + +L + + P
Sbjct: 191 IA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 542 DCR--SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLL 599
S+ ++L + F +I F H L
Sbjct: 250 GLCEMSVESINLQKHYFF-NISSNTF---------------------------HCFSGLQ 281
Query: 600 EFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSM 659
E L+ + + + ++ L +S N +
Sbjct: 282 EL------DLTA------THLSEL-----PSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 660 SYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLE--GTIPSSMSSLTLLNEIDLC 716
L L++ N + T +L L LDLS + +E + +L+ L ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 717 NNQLTGMIP 725
N+ +
Sbjct: 385 YNEPLSLKT 393
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-48
Identities = 70/409 (17%), Positives = 128/409 (31%), Gaps = 55/409 (13%)
Query: 328 ESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS 387
++++ + + E+P + ++ + L SFN + S L NL LDL+ +
Sbjct: 15 KTYNCENLGLN-EIPGTLP---NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 388 GAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSL 447
I + Q L L L N L+ + LS L L ++ L +
Sbjct: 71 W-IHEDTFQSQHR-LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128
Query: 448 SKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL--SN 505
L+ L L N + P+ + L+ L N + +S+ +SL +
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC--RSLIWLDLNTNLFNGSIPPA 563
N + I + L I L + +SL I PA
Sbjct: 189 NDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPA 246
Query: 564 LFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRV 623
+F+ ++ ++ L + F +
Sbjct: 247 VFEGLCEM-------------------------SVESI------NLQK------HYFFNI 269
Query: 624 YGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDL 683
TF+ + LD++ LS +P + +S L L L N +
Sbjct: 270 SSN----TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 684 RGLNILDLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLTGMIPVMGQFE 731
L L + N + + +L L E+DL ++ + Q
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-38
Identities = 68/312 (21%), Positives = 111/312 (35%), Gaps = 22/312 (7%)
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYL 141
F++ ++ L+ L L +++S LP+G S L L LS N
Sbjct: 267 FNISSNTFHCFSGLQELDLTATHLS---ELPSGLVGLSTLKKLVLSANKFENLCQIS--A 321
Query: 142 GSCSSLKVLNLSSNLLDFSGREAGSLKL-SLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
+ SL L++ N L +L LDLS++ I ++ + L+
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN-LQLRNLSHLQS 380
Query: 201 LALKGNKVTGDINV--SKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISANKFTGD 256
L L N+ +C L+ LD++ + F + L+ L++S +
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
L LN+ N F N Q L L LS +LS
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT---------LGRLEILVLSFCDLSSI 491
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
F S + D+S N+ + IE + + L L+ N + LP L L+
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ 549
Query: 377 ETLDLSSNNLSG 388
T++L N L
Sbjct: 550 RTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-23
Identities = 61/312 (19%), Positives = 106/312 (33%), Gaps = 52/312 (16%)
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYL 141
L L L+ L L L + +I + R S L SL+LS N ++
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA--F 396
Query: 142 GSCSSLKVLNLSSNLLDFSGREAGSLKL-SLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
C L++L+L+ L ++ L L+VL+LS++ + LF+G
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI---SSEQLFDG------ 447
Query: 201 LALKGNKVTGDINVSKCKNLQFLDVSSNNFS----MAVPSFGDCLALEYLDISANKFTGD 256
LQ L++ N+F S LE L +S +
Sbjct: 448 ----------------LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
HA ++ + ++ +++S N + + L+L+SN++S
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSI---EALSH----------LKGIYLNLASNHISII 538
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL-KELVLSFNDFTGALPDSLSNLTN 375
+PS S + ++ N FL + + D P L
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRG--- 595
Query: 376 LETLDLSSNNLS 387
+ LS LS
Sbjct: 596 ---VRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-15
Identities = 36/275 (13%), Positives = 71/275 (25%), Gaps = 50/275 (18%)
Query: 472 QTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNS 531
+ +T + L +P L N + + S N L T +L NL L L+
Sbjct: 12 EVNKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQ 68
Query: 532 FYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKE 591
Y L L L N +
Sbjct: 69 IYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALS------------------------- 102
Query: 592 CHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGS 651
G L + + + ++ ++ L + N +S
Sbjct: 103 --GPKALKHL------FFIQ------TGISSIDFI----PLHNQKTLESLYLGSNHISSI 144
Query: 652 IPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNI--LDLSSNRLEGTIPSSMSSLTL 709
+ L +L+ +N + ++ L+ L+L+ N + I +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203
Query: 710 LNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGL 744
++ Q +I + T Q +
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-13
Identities = 41/257 (15%), Positives = 74/257 (28%), Gaps = 50/257 (19%)
Query: 495 CTNLNWI-SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNT 553
+N + N L EIP + ++ L+ S N +L +LDL
Sbjct: 10 EKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTR 66
Query: 554 NLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613
I F+ ++ + + N L ++
Sbjct: 67 CQIY-WIHEDTFQSQHRL--------DTLVL----------TAN----------PLIFMA 97
Query: 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS 673
+ + ++ L +S + + L L LG N++S
Sbjct: 98 ---------------ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 674 GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLN--EIDLCNNQLTGMIPVMGQFE 731
+ L +LD +N + MSSL ++L N + G+ P
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA 202
Query: 732 TFQPAKFLNNSGLCGLP 748
FQ F L +
Sbjct: 203 VFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 7/107 (6%)
Query: 78 LSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLS 136
+ L TL LE L L ++S S+ + ++ +DLS N L+
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLS---SIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 137 DISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISG 183
+ L + LNL+SN + + ++L N +
Sbjct: 518 EA--LSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 2e-68
Identities = 85/563 (15%), Positives = 171/563 (30%), Gaps = 51/563 (9%)
Query: 35 SFKAALPNPSVLP-NWSPNQNPC---GFKGVSCKAAS-VSSIDLSPFTLSVDFHLVASFL 89
+ + N ++ NW+ N+ GV V+ + L+ F V +
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAK---GRVPDAI 343
Query: 90 LTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKV 149
L L+ LS + + + L + +S + + Y + +
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403
Query: 150 L-NLSSNLLDFSGREAGS-LKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNK 207
L + + + + S + L + N+I+ + + +L+ + +
Sbjct: 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF---ISKAIQR-LTKLQIIYFANSP 459
Query: 208 VTGDINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEH 266
T D + + + S+ + L +++ + +
Sbjct: 460 FTYDNI---AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 267 LSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG-KVPSRFGSCS 325
L LN++ N + + + + + NNL +
Sbjct: 517 LQSLNIACNRGISAAQLKAD--WTRLADDEDTG-PKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL-SNLTNLETLDLSSN 384
L D NK +E F + L +L L +N +P+ + +E L S N
Sbjct: 574 KLGLLDCVHNKVRH---LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHN 629
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS-----NCSQLVSLHLSFNYLTGT 439
L IP+ + + N + + ++ LS+N +
Sbjct: 630 KLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKF 688
Query: 440 IPSSLGSLSKLQDLKLWLNQL-------HGEIPPELGNIQTLETLFLDFNELTGTLPA-- 490
+ S + + L N + N L T+ L FN+LT +L
Sbjct: 689 PTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDF 747
Query: 491 ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL------SNNSFYGRIPPELGDCR 544
+ L+ + +S N PT S L + N + P + C
Sbjct: 748 RATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806
Query: 545 SLIWLDLNTNLFNGSIPPALFKQ 567
SLI L + +N + L Q
Sbjct: 807 SLIQLQIGSNDIR-KVDEKLTPQ 828
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-68
Identities = 90/625 (14%), Positives = 178/625 (28%), Gaps = 123/625 (19%)
Query: 118 SSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLS 177
+ ++ L L+ G + D +G + LKVL+ ++ SGR G +L+ ++ +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDA--IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 178 YNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAV--- 234
++I + + L L + + + + K + +
Sbjct: 380 KHRIRMH--YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 235 ----PSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQG 290
+ L+ + + + FT + N +
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEE---LSWSN 489
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
L ++L + ++P L+S +I+ N+ ++ +
Sbjct: 490 ---------LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT-- 538
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L D ++ + NNL P + L L +N
Sbjct: 539 --------------RLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHN 583
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS-LSKLQDLKLWLNQLHGEIPPELG 469
+ +L L L +N + IP + +++ L N+L IP
Sbjct: 584 KV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTW-----IGQLSNLAI 524
+ + + S N +G E + N +
Sbjct: 640 ----------------------AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 525 LKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584
+ LS N + + L+ NL SIP K N
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPKDGNYKNT--------- 727
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644
LL +R +L+ +S + +D+S
Sbjct: 728 ------------YLLTTIDLRFNKLTSLSD--------------DFRATTLPYLSNMDVS 761
Query: 645 YNMLSGSIPKEIGSMSYLFILNLGH------NNLSGPIPTEVGDLRGLNILDLSSNRLEG 698
YN S S P + + S L + H N + PT + L L + SN +
Sbjct: 762 YNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR- 819
Query: 699 TIPSSMSSLTLLNEIDLCNNQLTGM 723
+ + L +D+ +N +
Sbjct: 820 KVDEKL--TPQLYILDIADNPNISI 842
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 3e-67
Identities = 80/566 (14%), Positives = 181/566 (31%), Gaps = 89/566 (15%)
Query: 187 VPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVPSFGD-CLAL 243
P + + + L+L G G + + + L+ L +++ +++ FGD L
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373
Query: 244 EYLDISANKFTGDVGH-AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSS 302
+ + ++ + + L+ ++ + + E + L
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-----NPEMKPIKKDSRISL--K 426
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
++ +N ++ + + L+ +++ F+ I + +N +
Sbjct: 427 DTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANS-----DYAKQ 479
Query: 363 TGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL---------L 413
S SNL +L ++L + +P L P L+ L + N
Sbjct: 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP--ELQSLNIACNRGISAAQLKADW 537
Query: 414 GSIPSTLSNCSQLVSLHLSFNYLTGTIPS-SLGSLSKLQDLKLWLNQLHGEIPPELGNIQ 472
+ ++ ++ +N L S SL + KL L N++ G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNV 595
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTW--IGQLSNLAILKLSNN 530
L L LD+N++ + + + S+N L IP + + + S N
Sbjct: 596 KLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYN 654
Query: 531 SFYGRIPPELGD------CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584
+ + + L+ N P LF I + +
Sbjct: 655 KIGS-EGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPI--------STIIL 704
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644
N N ++ I S Y + +D+
Sbjct: 705 SN----------N----------LMTSIPENSLKPKDGNYKNTY--------LLTTIDLR 736
Query: 645 YNMLSGSIPKEI--GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDL------SSNRL 696
+N L+ S+ + ++ YL +++ +N S PT+ + L + NR+
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794
Query: 697 EGTIPSSMSSLTLLNEIDLCNNQLTG 722
P+ +++ L ++ + +N +
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-60
Identities = 66/521 (12%), Positives = 151/521 (28%), Gaps = 81/521 (15%)
Query: 236 SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLH 295
+ + L ++ G V AI L L+ ++ + + E+
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRL---FGDEELTPD 374
Query: 296 LADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKEL 355
+++ +++ L + + S L I+ N + + +S+ + ++
Sbjct: 375 MSEERKHRIRMHYKKMFLD---YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT-QI 430
Query: 356 VLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGS 415
N T + ++ LT L+ + +++ + ++ +
Sbjct: 431 GNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-------DWEDANSDYAKQYEN 482
Query: 416 IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG---------EIPP 466
+ SN L + L +P L L +LQ L + N+ +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 467 ELGNIQTLETLFLDFNELTG-TLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAIL 525
+ ++ ++ +N L A+L L + +N + + G L L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDL 600
Query: 526 KLSNNSFYGRIPPELG-DCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584
KL N IP + + L + N IP
Sbjct: 601 KLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN------------------- 639
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLS--RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLD 642
+ S +I + + +
Sbjct: 640 -------AKSVYVMGSV------DFSYNKIGSEGRNISC-------SMDDYKGINASTVT 679
Query: 643 ISYNMLSGSIPKEIGSMSYLFILNLGHNNLS-------GPIPTEVGDLRGLNILDLSSNR 695
+SYN + + + S + + L +N ++ P + L +DL N+
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739
Query: 696 LEGTIPSSM--SSLTLLNEIDLCNNQLTGMIPVMGQFETFQ 734
L ++ ++L L+ +D+ N + +
Sbjct: 740 LT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLK 779
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-51
Identities = 63/435 (14%), Positives = 129/435 (29%), Gaps = 58/435 (13%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
L L+ + NS + + + + L +
Sbjct: 447 LTKLQIIYFANSPFTYDNI-------AVDWEDANSDYAKQYENEELS--WSNLKDLTDVE 497
Query: 152 LSS-NLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWIL------FNGCDELKQLALK 204
L + + L L+ L+++ N+ A + + +++ +
Sbjct: 498 LYNCPNMTQLPDFLYDLP-ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 205 GNKVTG---DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAI 261
N + ++ K L LD N + +FG + L L + N+
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEEIPEDFC 615
Query: 262 SACEHLSFLNVSSNLFSGPIP---------------VGYNEFQGEIPLHLADL----CSS 302
+ + + L S N IP YN+ E + +
Sbjct: 616 AFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFS------GELPIEIFLSMSNLKELV 356
+ LS N + F + S + + +S+N + + + + L +
Sbjct: 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID 734
Query: 357 LSFNDFTGALPDSL--SNLTNLETLDLSSNNLSGAIPHNLCQGPR----NSLKELFLQNN 410
L FN T L D + L L +D+S N S P + + + N
Sbjct: 735 LRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGN 470
+L P+ ++ C L+ L + N + + L +L L + N +
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCP 849
Query: 471 IQTLETLFLDFNELT 485
L +++
Sbjct: 850 YIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-41
Identities = 58/444 (13%), Positives = 132/444 (29%), Gaps = 69/444 (15%)
Query: 281 IPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGE 340
+P+ E I + A L + LD + + + +F+ + + +
Sbjct: 257 VPIQLKETAEYIKDYKA-LKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQ 314
Query: 341 LPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN 400
+++ + + L L+ G +PD++ LT L+ L +++ + + +
Sbjct: 315 PGVDL-DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373
Query: 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
+ E ++ + + L +L L + + + + K + L Q+
Sbjct: 374 DMSEE-RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQI 430
Query: 461 HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLS 520
N +T + A+ T L I +N+ +
Sbjct: 431 G-----------------NLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIA-----V 467
Query: 521 NLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKK 580
+ Y + + L ++L +P L+
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD-------------- 513
Query: 581 YVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMF 640
+ L+ I R + + ++TR+ + +
Sbjct: 514 ---LPE------------LQSLNIACNRGISAA-QLKADWTRLA-----DDEDTGPKIQI 552
Query: 641 LDISYNMLSGSIPKE--IGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEG 698
+ YN L P + M L +L+ HN + G L L L N++E
Sbjct: 553 FYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE 609
Query: 699 TIPSSMSSLTLLNEIDLCNNQLTG 722
+ + + +N+L
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY 633
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-39
Identities = 56/366 (15%), Positives = 114/366 (31%), Gaps = 46/366 (12%)
Query: 74 SPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSG 133
S L D+ +A T ++ + +N+ + + + L LD N
Sbjct: 529 SAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK-LGLLDCVHN---- 583
Query: 134 PLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFN 193
+ + G+ L L L N ++ + + +E L S+NK+ +
Sbjct: 584 KVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY--IPNIFNAK 641
Query: 194 GCDELKQLALKGNKVTG-------DINVSKCKNLQFLDVSSNNFSMAVPS-FGDCLALEY 245
+ + NK+ ++ K N + +S N F +
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701
Query: 246 LDISANKFT-------GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLA- 297
+ +S N T L+ +++ N + +
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT------------SLSDDFRA 749
Query: 298 DLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDI------SSNKFSGELPIEIFLSMSN 351
L +D+S N S P++ + S L++F I N+ + P I + +
Sbjct: 750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT-TCPS 807
Query: 352 LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL 411
L +L + ND + + L L LD++ N ++C + L
Sbjct: 808 LIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
Query: 412 LLGSIP 417
+
Sbjct: 865 DIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-31
Identities = 60/470 (12%), Positives = 137/470 (29%), Gaps = 59/470 (12%)
Query: 281 IPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK---- 336
+ V Y E E + + + +++ + + +P+ + ++ S K
Sbjct: 176 MKVTYKEDSKEHQNPD-NANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQSGIKRSEL 234
Query: 337 FSGELPIEIFLSMSN----LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPH 392
+ + E F + N + + + + D + E LD + +
Sbjct: 235 ETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTIN 294
Query: 393 NLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQD 452
N + + ++ L N ++ L L+ G +P ++G L++L+
Sbjct: 295 NTIHSLNWNFNKEL---DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKV 351
Query: 453 LKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLP-AALSNCTNLNWISLSNNHLGGE 511
L + T + + + L LN L + +
Sbjct: 352 LSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-R 410
Query: 512 IPTWIGQLSNLAILKLSNNSFYG------RIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565
P + + + + L + I + L + + F +
Sbjct: 411 NPE-MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDW 469
Query: 566 KQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYG 625
+ + A E NL + L+ + + C
Sbjct: 470 EDANSDYAKQY------------ENEELSWSNL--------KDLTDVELYN-CPNM---- 504
Query: 626 GHTQPTFNHNGSMMFLDISYNMLSG---------SIPKEIGSMSYLFILNLGHNNLSG-P 675
+ L+I+ N + + + + I +G+NNL P
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFP 564
Query: 676 IPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
+ + L +LD N++ + + L ++ L NQ+ IP
Sbjct: 565 ASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IP 611
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-20
Identities = 32/309 (10%), Positives = 78/309 (25%), Gaps = 18/309 (5%)
Query: 446 SLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505
L+K ++ + L + I E L + N N+ +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKEL 308
Query: 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565
+ G + + + L L+ GR+P +G L L T+ S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 566 KQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYG 625
++ + + ++ K NL + R + + +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQ-RLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 626 GHTQPTFNHNGS----------MMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGP 675
N + + + + + N +
Sbjct: 428 TQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482
Query: 676 IPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQP 735
+L+ L ++L + +P + L L +++ N+ + +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL-A 541
Query: 736 AKFLNNSGL 744
+
Sbjct: 542 DDEDTGPKI 550
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-68
Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 26/272 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G G FG V KAK + VAIK++ S + F E+ + ++ H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
LV EY GSL +VLH + + A + ++G+A+LH +IHR
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPL-PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 988 DMKSSNVLLDENFE-ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG 1046
D+K N+LL ++ DFG A + T G+ ++ PE ++ S K
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFEGSNYSEKC 184
Query: 1047 DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIEL 1106
DV+S+G++L E++T ++P D ++ V + + + L
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--------ESL 236
Query: 1107 LQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
+ C P +RP+M +++ + +
Sbjct: 237 MT------RCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 6e-68
Identities = 83/284 (29%), Positives = 146/284 (51%), Gaps = 24/284 (8%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG+G FG V++A+ GS VA+K L+ + EF E+ + +++H N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+V EY+ GSL +LH +L+ R +A A+G+ +LH N P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HR++KS N+L+D+ + +V DFG++RL + T LS + AGTP ++ PE + + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 1046 GDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV-KQHAKLKISDVFDPELMKEDPNIEI 1104
DVYS+GV+L EL T ++P + +V V + +L+I +P++
Sbjct: 220 SDVYSFGVILWELATLQQPWG--NLNPAQVVAAVGFKCKRLEIPRNLNPQV--------A 269
Query: 1105 ELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQST 1148
+++ C + PW+RP+ +M + + + + +
Sbjct: 270 AIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-66
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGD-------REFTAEMETIGKIKHRNLV 919
IG GGFG V+K +L D S VAIK LI +G+ +EF E+ + + H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L G +V E++ G L L ++ + W+ + ++ + A G+ ++ N
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 980 CIPHIIHRDMKSSNVLLDENFE-----ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
P I+HRD++S N+ L E A+V+DFG+++ + L G ++ P
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-----GLLGNFQWMAP 195
Query: 1035 E--YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV-KQHAKLKISDVF 1091
E + + K D YS+ ++L +LTG+ P D +G + + ++ + I +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
P L +++ C P +RP ++ E+
Sbjct: 256 PPRL--------RNVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-64
Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+ G+++K + + G+ + +K L S + R+F E + H N++P+LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 926 KVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ + +M YGSL +VLH ++ + K A+ ARG+AFLH P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLH-TLEPL 133
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ---SF 1040
I + S +V++DE+ AR+S + + P +V PE Q
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPED 186
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN----LVGWVKQHAKLKISDVFDPELM 1096
D++S+ V+L EL+T + P F D + + + + I P +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKVALEGLRPTIPPGISPHV- 240
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
+L++ C+++ P +RP ++ + +++Q
Sbjct: 241 -------SKLMK------ICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-63
Identities = 80/283 (28%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKL----IHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IG GGFG VY+A G VA+K Q E + +KH N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
C LV E+ R G L VL ++ + A+ ARG+ +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 984 IIHRDMKSSNVLLDENFEAR--------VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
IIHRD+KSSN+L+ + E ++DFG+AR + + AG ++ PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKMSAAGAYAWMAPE 184
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV-KQHAKLKISDVFDPE 1094
++ S DV+SYGV+L ELLTG+ P D + V L I
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--VAYGVAMNKLALPIPSTCPEP 242
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+L++ C + P RP+ ++ I
Sbjct: 243 F--------AKLME------DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 9e-62
Identities = 89/513 (17%), Positives = 162/513 (31%), Gaps = 45/513 (8%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYL 141
L + L+ L L I ++ + LS+L L+ N +
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIE---TIEDKAWHGLHHLSNLILTGNPIQSFSPGS--F 100
Query: 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQL 201
+SL+ L L ++L+ L++++N I + F+ L +
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA--YFSNLTNLVHV 158
Query: 202 ALKGNKVTG------DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTG 255
L N + + LD+S N + L L + N +
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSS 218
Query: 256 DV-GHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS-SLVKLDLSSNNL 313
++ + L + F + P + LC ++ + L+ N
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKD-----ERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIE------------------IFLSMSNLKEL 355
+F +++ + ++ + L + LK L
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL 333
Query: 356 VLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGS 415
L+ N + + L +L LDLS N LS + + NSL+ L L N +
Sbjct: 334 TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-I 390
Query: 416 IPSTLSNCSQLVSLHLSFNYLTGTIP-SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTL 474
+ + +L L + L S+ SL KL L + + + +L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 475 ETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY 533
TL + N + +N TNL ++ LS L L L +L +S+N+
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 534 GRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566
SL LD + N + L
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQH 542
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-61
Identities = 108/622 (17%), Positives = 193/622 (31%), Gaps = 85/622 (13%)
Query: 115 SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVL 174
+ LS DI SS K ++LS N L + S L+ L
Sbjct: 7 CIEVVPNITYQCMDQKLSKVPDDIP-----SSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 175 DLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG--DINVSKCKNLQFLDVSSNNFS- 231
DLS +I + ++G L L L GN + + S +L+ L +
Sbjct: 62 DLSRCEIET---IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 232 MAVPSFGDCLALEYLDISANKFTG-DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQG 290
+ G + L+ L+++ N + S +L +++S N N+ Q
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV---NDLQF 175
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
L + + LD+S N + + + L + N S + +++
Sbjct: 176 -----LRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229
Query: 351 NLKELVLSFNDFTGAL------PDSLSNLTNL--ETLDLSSNNLSGAIPHNLCQGPRNSL 402
L L +F P + L ++ + L+ N +
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN--V 287
Query: 403 KELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG 462
+ L + + + SL + L L L L L G
Sbjct: 288 SAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL-----TLTMNKG 340
Query: 463 EIPPELGNIQTLETLFLDFNELTGTLPAALSN--CTNLNWISLSNNHLGGEIPTWIGQLS 520
I + + +L L L N L+ + + S+ +L + LS N + L
Sbjct: 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE 399
Query: 521 NLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGK 579
L L +++ L++LD++ +F +
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK-IDFDGIFLGLTSL-------- 450
Query: 580 KYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMM 639
+ + AGN + N F + ++
Sbjct: 451 NTLKM----------AGN-------------SFKDNTLSNV-----------FANTTNLT 476
Query: 640 FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGT 699
FLD+S L ++ L +LN+ HNNL + L L+ LD S NR+E +
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 700 IPSSMSSLTLLNEIDLCNNQLT 721
L +L NN +
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-57
Identities = 88/487 (18%), Positives = 164/487 (33%), Gaps = 52/487 (10%)
Query: 92 LDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
L +LE L + ++ SL + L L+++ N + +Y + ++L +
Sbjct: 103 LTSLENLVAVETKLA---SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTNLVHV 158
Query: 151 NLSSNLL----DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
+LS N + + LD+S N I + F G +L +L L+GN
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF---IQDQAFQGI-KLHELTLRGN 214
Query: 207 KVTGDINVSKCKNLQFLDVSS-------NNFSMAVPSFG-----DCLALEYLDISANKFT 254
+ +I + +NL L V + ++ + + ++ ++
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 255 GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
D ++S ++++ L L + L
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--------------LEDVPKHFKWQSLSIIRCQLK 320
Query: 315 GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNL- 373
L+S ++ NK S +++ +L L LS N + + S S+L
Sbjct: 321 Q---FPTLDLPFLKSLTLTMNKGSI---SFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 374 -TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHL 431
+L LDLS N + N L+ L Q++ L S + +L+ L +
Sbjct: 375 TNSLRHLDLSFNGAII-MSANFMGLE--ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPA 490
S+ L+ L LK+ N N L L L +L
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 491 ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLD 550
L +++S+N+L + QL +L+ L S N +SL + +
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551
Query: 551 LNTNLFN 557
L N
Sbjct: 552 LTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 8e-57
Identities = 96/524 (18%), Positives = 173/524 (33%), Gaps = 59/524 (11%)
Query: 219 NLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
+ + +D+S N + SF + L++LD+S + A HLS L ++ N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKF 337
P F G +SL L L+ G +L+ +++ N
Sbjct: 93 QSFSP---GSFSG---------LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL----ETLDLSSNNLSGAIPHN 393
F +++NL + LS+N + L L +LD+S N + I
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQ 199
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPST-LSNCSQLVSLHLSFNYLTGTI------PSSLGS 446
QG L EL L+ N +I T L N + L L PS +
Sbjct: 200 AFQGI--KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG 257
Query: 447 LSKLQ--DLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
L + + +L + + + + + L + + +S+
Sbjct: 258 LCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSII 315
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
L + PT L L L L+ N G I + SL +LDL+ N +
Sbjct: 316 RCQL-KQFPT--LDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALS-FSGCCS 369
Query: 565 FKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS--RISTRSPCNFTR 622
+ G ++ + + N + ++ + + +
Sbjct: 370 YSDLG--------TNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA-- 419
Query: 623 VYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV-G 681
F +++LDISY ++ L L + N+ + V
Sbjct: 420 ---------FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 682 DLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
+ L LDLS +LE +L L +++ +N L +
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-56
Identities = 90/487 (18%), Positives = 152/487 (31%), Gaps = 46/487 (9%)
Query: 97 TLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNL 156
T + +S +P S ++DLS N L S + S L+ L+LS
Sbjct: 15 TYQCMDQKLS---KVPDDI--PSSTKNIDLSFNPLKILKSYS--FSNFSELQWLDLSRCE 67
Query: 157 LDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG--DIN 213
++ +A L L L L+ N I F+G L+ L K+
Sbjct: 68 IETIEDKAWHGLH-HLSNLILTGNPIQS---FSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 214 VSKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
+ + L+ L+V+ N F + L ++D+S N + + +N
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183
Query: 272 VSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESF 330
+S ++ N + L +L L N S + + + L
Sbjct: 184 LSLDM-------SLNPIDFIQDQAFQGI--KLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
Query: 331 DISSNKFSGELPIEIF-------LSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSS 383
+ +F E +EIF L + E L++ + L N+ + L+
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294
Query: 384 NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSS 443
++ + L + L L L SL L+ N + I
Sbjct: 295 VSIKYLEDVPKH----FKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGS--ISFK 345
Query: 444 LGSLSKLQDLKLWLNQLH--GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501
+L L L L N L G +L L L FN + A L +
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHL 404
Query: 502 SLSNNHLGGEIPTW-IGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSI 560
++ L L L L +S + SL L + N F +
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 561 PPALFKQ 567
+F
Sbjct: 465 LSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-47
Identities = 87/456 (19%), Positives = 152/456 (33%), Gaps = 60/456 (13%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
++P D+ SS +DLS N L F + S L+ D+S + + + + +
Sbjct: 25 KVP---DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLH 80
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
+L L+L+ N P S S LT+LE L L+ + Q +LK+L + +N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLI--TLKKLNVAHN 138
Query: 411 LLLG-SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL----NQLHGEIP 465
+ +P+ SN + LV + LS+NY+ + L L + + L L N + I
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQ 197
Query: 466 PELGNIQTLETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEI------PTWIGQ 518
+ L L L N + + L N L+ L E P+ +
Sbjct: 198 DQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG 257
Query: 519 LSNLAI--LKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFI 576
L ++ I +L+ + + + ++ + L +
Sbjct: 258 LCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFK-------- 308
Query: 577 VGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVY----GGHTQPTF 632
+ I +L + T + G
Sbjct: 309 ----------------------WQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKK 346
Query: 633 NHNGSMMFLDISYNMLSGSIPK--EIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILD 690
S+ +LD+S N LS S + L L+L N + L L LD
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLD 405
Query: 691 LSSNRLEGTIP-SSMSSLTLLNEIDLCNNQLTGMIP 725
+ L+ S+ SL L +D+
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-46
Identities = 67/391 (17%), Positives = 119/391 (30%), Gaps = 37/391 (9%)
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCS----SFLSSLDLSLNILSGPLSD 137
+++ + L L L L +L ++ + L + D
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277
Query: 138 ISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDE 197
I +++ ++L+ + E + L + ++
Sbjct: 278 IVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ------FPTLDLPF 329
Query: 198 LKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSM---AVPSFGDCLALEYLDISANKFT 254
LK L L NK + +L +LD+S N S S +L +LD+S N
Sbjct: 330 LKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 255 GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
+ E L L+ + F L+ LD+S N
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFS--AFLS---------LEKLLYLDISYTNTK 437
Query: 315 GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT 374
F +SL + ++ N F +F + +NL L LS L
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
L+ L++S NNL + Q SL L N + S L +L+ N
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLY--SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIP 465
+ + + Q W+ + +
Sbjct: 556 SVA--------CICEHQKFLQWVKEQKQFLV 578
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-45
Identities = 83/419 (19%), Positives = 140/419 (33%), Gaps = 39/419 (9%)
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
++ K S ++P +I S+ K + LSFN S SN + L+ LDLS +
Sbjct: 15 TYQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 389 AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS 448
I G + L L L N + P + S + L +L L +G L
Sbjct: 71 -IEDKAWHGLHH-LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLI 128
Query: 449 KLQDLKLWLNQLHG-EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNW----ISL 503
L+ L + N +H ++P N+ L + L +N + L + +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNG---- 558
S N + I Q L L L N I L + L L F
Sbjct: 189 SLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 559 -SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSP 617
P++ + + + Y +D + H N+ L+ +S +
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLT-YTNDFSDDIVKFHCLANVSAM------SLAGVSIKYL 300
Query: 618 CNFTRVYGGH---------TQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLG 668
+ + + Q + L ++ N S I + ++ L L+L
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLS 358
Query: 669 HNNLS--GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
N LS G L LDLS N + ++ L L +D ++ L +
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 60/377 (15%), Positives = 116/377 (30%), Gaps = 81/377 (21%)
Query: 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC 423
G+L + + N+ T LS +P ++ P + K + L N L + SN
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI---PSS-TKNIDLSFNPLKILKSYSFSNF 55
Query: 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
S+L L LS + + L L L L N
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLS------------------------NLILTGNP 91
Query: 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG-RIPPELGD 542
+ P + S T+L + L IGQL L L +++N + ++P +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 543 CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFA 602
+L+ +DL+ N +I + + + + N ++F
Sbjct: 152 LTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNL--------------SLDMSLNPIDFI 196
Query: 603 GIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE-IGSMSY 661
+A + ++ L + N S +I K + +++
Sbjct: 197 QDQAFQGIKLHE--------------------------LTLRGNFNSSNIMKTCLQNLAG 230
Query: 662 LFILNLGHNNLSGPIPTEVGD---LRGL-----NILDLSSNRLEGTIPSSMSSLTLLNEI 713
L + L E+ + + GL + L+ L ++ +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
Query: 714 DLCNNQLTGMIPVMGQF 730
L + + V F
Sbjct: 291 SLAGVSIKYLEDVPKHF 307
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-61
Identities = 73/309 (23%), Positives = 126/309 (40%), Gaps = 45/309 (14%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G FG K ++ G + +K+LI + R F E++ + ++H N++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
+ + EY++ G+L ++ + + W+ R A A G+A+LH +IIH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTH------------LSVSTLAGTPGYVPP 1034
RD+ S N L+ EN V+DFG+ARLM T T+ G P ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTD-----SADFGDNNLVGWVKQHAKLKISD 1089
E K DV+S+G+VL E++ + DFG N V+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLDRYCPP 246
Query: 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA--GSGLDSQS 1147
P + C D P +RP+ +++ + ++ L
Sbjct: 247 NCPPSF--------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
Query: 1148 TIATDEGGF 1156
+ + GF
Sbjct: 293 QLEQLDRGF 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 2e-60
Identities = 69/326 (21%), Positives = 115/326 (35%), Gaps = 48/326 (14%)
Query: 850 LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEME- 908
++ + LIG G +G VYK L D VA+K S + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 909 -TIGKIKHRNLVPLLGYCKVGE-----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR 962
+ ++H N+ + + E LLV EY GSL L +W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113
Query: 963 RKIAIGSARGLAFLH------HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA- 1015
++A RGLA+LH + P I HRD+ S NVL+ + +SDFG++ ++
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 1016 -----MDTHLSVSTLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLTGKR 1063
+ + + GT Y+ PE + + D+Y+ G++ E+ R
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM--R 231
Query: 1064 PTDSADFGDNN--------LVGWVKQHAKLKISDVFD---PELMKEDPNIEIELLQHLHV 1112
TD VG +++ + P+ + + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 1113 ASACLDDRPWRRPTMIQVMAMFKEIQ 1138
C D R T E+
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELM 317
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-60
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IGSG FG VYK K VA+K L + Q + F E+ + K +H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 926 KVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+L +V ++ SL LH + K IA +ARG+ +LH I
Sbjct: 90 T--APQLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE---YYQSFR 1041
IHRD+KS+N+ L E+ ++ DFG+A S L+G+ ++ PE S
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101
S + DVY++G+VL EL+TG+ P + + N + I V L +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQI-------IEMVGRGSLSPDLSK 249
Query: 1102 IEIELLQHL-HVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
+ + + + + CL + RP+ +++A +E+
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-59
Identities = 97/458 (21%), Positives = 183/458 (39%), Gaps = 57/458 (12%)
Query: 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYN 179
L ++D + L + G L +L ++ S N
Sbjct: 26 KMKTVLGKT----NVTDTVSQTDLDQVTTLQADRLGIKSIDG--VEYLN-NLTQINFSNN 78
Query: 180 KISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGD 239
+++ +L + + N++ ++ NL L + +N + + +
Sbjct: 79 QLTDI-----TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD-IDPLKN 132
Query: 240 CLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL 299
L L++S+N + A+S L L+ + + + P+
Sbjct: 133 LTNLNRLELSSNTISDIS--ALSGLTSLQQLSFGNQV-TDLKPLAN-------------- 175
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
++L +LD+SSN +S S ++LES ++N+ S P+ ++NL EL L+
Sbjct: 176 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNG 230
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPS 418
N +L++LTNL LDL++N +S P L L EL L N + P
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGL-----TKLTELKLGANQISNISP- 282
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
L+ + L +L L+ N L P + +L L L L+ N + P + ++ L+ LF
Sbjct: 283 -LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
N+++ ++L+N TN+NW+S +N + P + L+ + L L++ ++ P
Sbjct: 338 FYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APV 392
Query: 539 ELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFI 576
++ + N+ I PA G I
Sbjct: 393 NY--KANVSIPNTVKNVTGALIAPATISDGGSYTEPDI 428
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-53
Identities = 94/453 (20%), Positives = 175/453 (38%), Gaps = 55/453 (12%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
+ L+ L ++ N+ ++ L + L + ++ N ++DI+ L + ++
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITPL---KNLTK-LVDILMNNN----QIADITPLANLTN 113
Query: 147 LKVLNLSSNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
L L L +N + + + +L +L L+LS N IS + +G L+QL+ G
Sbjct: 114 LTGLTLFNNQI--TDIDPLKNLT-NLNRLELSSNTISDISA-----LSGLTSLQQLSF-G 164
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
N+VT ++ L+ LD+SSN S + LE L + N+ + +
Sbjct: 165 NQVTDLKPLANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDI--TPLGILT 221
Query: 266 HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCS 325
+L L+++ N + ++L LDL++N +S P +
Sbjct: 222 NLDELSLNGNQLKDIGTLAS--------------LTNLTDLDLANNQISNLAP--LSGLT 265
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
L + +N+ S I ++ L L L+ N +SNL NL L L NN
Sbjct: 266 KLTELKLGANQISN---ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNN 320
Query: 386 LSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL 444
+S P +L L+ LF NN + S S+L+N + + L N ++ P L
Sbjct: 321 ISDISPVSSL-----TKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--L 371
Query: 445 GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
+L+++ L L P ++ + PA +S+ + ++
Sbjct: 372 ANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDIT 429
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537
N S + +F G +
Sbjct: 430 WNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-46
Identities = 92/529 (17%), Positives = 184/529 (34%), Gaps = 82/529 (15%)
Query: 203 LKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAIS 262
+ + + + N + S D + L G +
Sbjct: 9 TQDTPINQIFTDTALAEKMKTVLGKTNVT-DTVSQTDLDQVTTLQADRLGIKSIDG--VE 65
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFG 322
+L+ +N S+N + P+ + LV + +++N ++ P
Sbjct: 66 YLNNLTQINFSNNQLTDITPLKN--------------LTKLVDILMNNNQIADITP--LA 109
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
+ ++L + +N+ + I+ +++NL L LS N + +LS LT+L+ L
Sbjct: 110 NLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG 164
Query: 383 SNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441
N ++ P NL +L+ L + +N + S S L+ + L SL + N ++ P
Sbjct: 165 -NQVTDLKPLANL-----TTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP 216
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501
LG L+ L +L L NQL + L ++ L L L N+++ P LS T L +
Sbjct: 217 --LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 502 SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561
L N + P + L+ L L+L+ N + + ++L +L L N + P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP 326
Query: 562 PALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST-RSPCNF 620
+ + L+ ++S +S+ + N
Sbjct: 327 VSSLTK-------------------------------LQRLFFYNNKVSDVSSLANLTNI 355
Query: 621 TRVYGGHTQ----PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPI 676
+ GH Q + + L ++ + + ++S + L
Sbjct: 356 NWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--A 413
Query: 677 PTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
P + D D++ N + + I +G +
Sbjct: 414 PATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-36
Identities = 83/426 (19%), Positives = 150/426 (35%), Gaps = 81/426 (19%)
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
L S I+ + + I +++ + VL + T + ++L + TL
Sbjct: 2 PLGSATITQDTPINQ--IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 386 LSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLG 445
+ +L ++ NN L P L N ++LV + ++ N + P L
Sbjct: 58 IKSIDGVEYLN----NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LA 109
Query: 446 SLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505
+L+ L L L+ NQ+ P L N+ L L L N ++ +ALS T+L +S N
Sbjct: 110 NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGN 165
Query: 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565
+ + L+ L L +S+N L +L L N + P +
Sbjct: 166 QVTDLKP---LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGIL 220
Query: 566 KQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPC-NFTRVY 624
L+ + +L I T + N T +
Sbjct: 221 TN-------------------------------LDELSLNGNQLKDIGTLASLTNLTDLD 249
Query: 625 GGHTQ----PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV 680
+ Q + + L + N +S P + ++ L L L N L P +
Sbjct: 250 LANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--I 305
Query: 681 GDLRGLNILDLSSNRLEGTIP--------------------SSMSSLTLLNEIDLCNNQL 720
+L+ L L L N + P SS+++LT +N + +NQ+
Sbjct: 306 SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQI 365
Query: 721 TGMIPV 726
+ + P+
Sbjct: 366 SDLTPL 371
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-08
Identities = 18/100 (18%), Positives = 43/100 (43%), Gaps = 6/100 (6%)
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNIL 689
++ ++ +L + +N +S P + S++ L L +N +S + +L +N L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWL 358
Query: 690 DLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQ 729
N++ P +++LT + ++ L + T
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 5/91 (5%)
Query: 636 GSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNR 695
G + I+ + I +++ LG N++ + DL + L
Sbjct: 1 GPLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 696 LEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV 726
+ + L L +I+ NNQLT + P+
Sbjct: 58 I--KSIDGVEYLNNLTQINFSNNQLTDITPL 86
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-58
Identities = 59/288 (20%), Positives = 109/288 (37%), Gaps = 44/288 (15%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG VY + VAI+ + + + F E+ + +H N+V +G C
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
++ + +L V+ + K L+ R+IA +G+ +LH I+
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMS---AMDTHLSVSTLAGTPGYVPPEYYQSFR- 1041
H+D+KS NV D + ++DFG+ + A + G ++ PE +
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 1042 --------CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNL---VGWVKQHAKLKISDV 1090
S DV++ G + EL + P F + + K +S +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP-----FKTQPAEAIIWQMGTGMKPNLSQI 266
Query: 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
+ + ++L C RPT ++M M +++
Sbjct: 267 GMGKEIS-------DILL------FCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-56
Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 49/303 (16%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEME--TIGKIKHRNLVPLLGY 924
+G G +G+V++ + G VA+K S + ++ + E E ++H N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 925 CKVGE----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--- 977
+ L+ Y GSL D L L+ + +I + A GLA LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 978 --HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH--LSVSTLAGTPGYVP 1033
P I HRD+KS N+L+ +N + ++D G+A + S + + GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 1034 PE------YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD-----FGDNNLVGWVKQH 1082
PE F + D++++G+VL E+ + F D +V
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD--VVPNDPSF 243
Query: 1083 AKLKISDVFD------PELMKEDPNIE--IELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134
++ D P DP + +L++ C P R T +++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK------ECWYQNPSARLTALRIKKTL 297
Query: 1135 KEI 1137
+I
Sbjct: 298 TKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-55
Identities = 67/302 (22%), Positives = 116/302 (38%), Gaps = 45/302 (14%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEME--TIGKIKHRNLVPLLGY 924
IG G +G+V+ K + G VA+K + + E E ++H N++ +
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 925 CKVGEER----LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--- 977
G L+ +Y GSL D L + L+ + K+A S GL LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 978 --HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA--MDTHLSVSTLAGTPGYVP 1033
P I HRD+KS N+L+ +N ++D G+A + + + +T GT Y+P
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 1034 PE------YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD---NNLVGWVKQHAK 1084
PE F+ D+YS+G++L E+ + ++LV +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 1085 LKISDVFD---PELMKEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
++ P + E +L+ C P R T ++V +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMT------ECWAHNPASRLTALRVKKTLAK 328
Query: 1137 IQ 1138
+
Sbjct: 329 MS 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 9e-54
Identities = 64/307 (20%), Positives = 119/307 (38%), Gaps = 45/307 (14%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEME--TIGKIKHRNLVPLLGY 924
IG G FG+V++ K + G VA+K S + +R + E E ++H N++ +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 925 CKVGE----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--- 977
+ LV +Y +GSL D L+ + K+A+ +A GLA LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEI 159
Query: 978 --HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA--MDTHLSVSTLAGTPGYVP 1033
P I HRD+KS N+L+ +N ++D G+A + ++ + GT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 1034 PE------YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK- 1086
PE + F + D+Y+ G+V E+ + V ++
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 1087 -ISDVFD-------PELMKEDPNIE--IELLQHLHVASACLDDRPWRRPTMIQVMAMFKE 1136
V + P + + ++++ C R T +++ +
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR------ECWYANGAARLTALRIKKTLSQ 333
Query: 1137 IQAGSGL 1143
+ G+
Sbjct: 334 LSQQEGI 340
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-53
Identities = 72/383 (18%), Positives = 151/383 (39%), Gaps = 42/383 (10%)
Query: 127 SLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANV 186
+L L P++ I + L + + S+ L ++ K++
Sbjct: 4 TLATLPAPINQIFPDADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVASIQG 61
Query: 187 VPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYL 246
L+ L L GN++T +S L L + +N + + + + L L
Sbjct: 62 -----IEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITD-ISALQNLTNLREL 115
Query: 247 DISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKL 306
++ + + ++ + LN+ +N + L+++ + L L
Sbjct: 116 YLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS------------PLSNM-TGLNYL 160
Query: 307 DLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL 366
++ + + P + + L S ++ N+ I S+++L N T
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED---ISPLASLTSLHYFTAYVNQITD-- 213
Query: 367 PDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ 425
++N+T L +L + +N ++ P NL + L L + N + S + + + ++
Sbjct: 214 ITPVANMTRLNSLKIGNNKITDLSPLANL-----SQLTWLEIGTNQI--SDINAVKDLTK 266
Query: 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485
L L++ N ++ S L +LS+L L L NQL E +G + L TLFL N +T
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 486 GTLPAALSNCTNLNWISLSNNHL 508
P L++ + ++ +N +
Sbjct: 325 DIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-53
Identities = 83/385 (21%), Positives = 157/385 (40%), Gaps = 44/385 (11%)
Query: 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNF 230
L I+ E + L+ VT + + +++ L V+
Sbjct: 2 AATLATLPAPINQ-----IFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKV 56
Query: 231 SMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQG 290
+ + LEYL+++ N+ T +S L+ L + +N + +
Sbjct: 57 AS-IQGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKITDISALQN----- 108
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
++L +L L+ +N+S S + + + S ++ +N + + +M+
Sbjct: 109 ---------LTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD--LSPLSNMT 155
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQN 409
L L ++ + P ++NLT+L +L L+ N + P +L SL
Sbjct: 156 GLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASL-----TSLHYFTAYV 208
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
N + P ++N ++L SL + N +T P L +LS+L L++ NQ+ +
Sbjct: 209 NQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVK 262
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
++ L+ L + N+++ + L+N + LN + L+NN LG E IG L+NL L LS
Sbjct: 263 DLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTN 554
N I P L + D
Sbjct: 321 NHITD-IRP-LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-49
Identities = 71/375 (18%), Positives = 146/375 (38%), Gaps = 46/375 (12%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
L L+ ++++ ++ S ++ L ++ ++ I + ++
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQ---EELES-ITKLVVAGE----KVASIQGIEYLTN 67
Query: 147 LKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
L+ LNL+ N + + S + L L + NKI+ + L++L L +
Sbjct: 68 LEYLNLNGNQI--TDISPLSNLVKLTNLYIGTNKITDISA-----LQNLTNLRELYLNED 120
Query: 207 KVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEH 266
++ ++ + L++ +N+ + + L YL ++ +K I+
Sbjct: 121 NISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDV--TPIANLTD 178
Query: 267 LSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS 326
L L+++ N P+ +SL N ++ P + +
Sbjct: 179 LYSLSLNYNQIEDISPLAS--------------LTSLHYFTAYVNQITDITP--VANMTR 222
Query: 327 LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
L S I +NK + + ++S L L + N + +++ +LT L+ L++ SN +
Sbjct: 223 LNSLKIGNNKITD---LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
Query: 387 SGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLG 445
S +NL + L LFL NN L + + L +L LS N++T P L
Sbjct: 278 SDISVLNNL-----SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330
Query: 446 SLSKLQDLKLWLNQL 460
SLSK+ +
Sbjct: 331 SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-49
Identities = 67/365 (18%), Positives = 133/365 (36%), Gaps = 39/365 (10%)
Query: 198 LKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDV 257
LA + + + + + V + + ++ L ++ K
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASI- 59
Query: 258 GHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKV 317
I +L +LN++ N + P+ L L + +N ++
Sbjct: 60 -QGIEYLTNLEYLNLNGNQITDISPLSN--------------LVKLTNLYIGTNKITD-- 102
Query: 318 PSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE 377
S + ++L ++ + S I +++ + L L N LSN+T L
Sbjct: 103 ISALQNLTNLRELYLNEDNISD---ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 378 TLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYL 436
L ++ + + P NL L L L N + P L++ + L N +
Sbjct: 159 YLTVTESKVKDVTPIANL-----TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211
Query: 437 TGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT 496
T P + ++++L LK+ N++ P L N+ L L + N+++ A+ + T
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLT 265
Query: 497 NLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLF 556
L +++ +N + + LS L L L+NN +G +L L L+ N
Sbjct: 266 KLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 557 NGSIP 561
P
Sbjct: 324 TDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-49
Identities = 82/393 (20%), Positives = 150/393 (38%), Gaps = 50/393 (12%)
Query: 95 LETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSS 154
TL+ + I+ + L ++D+ S+ L ++
Sbjct: 2 AATLATLPAPINQIFPDADLAE----GIRAVLQKA----SVTDVVTQEELESITKLVVAG 53
Query: 155 NLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDIN 213
+ G L +LE L+L+ N+I+ + + +L L + NK+T
Sbjct: 54 EKVASIQG--IEYLT-NLEYLNLNGNQITDISP-----LSNLVKLTNLYIGTNKITDISA 105
Query: 214 VSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVS 273
+ NL+ L ++ +N S + + + L++ AN D+ +S L++L V+
Sbjct: 106 LQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVT 163
Query: 274 SNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDIS 333
+ P+ + L L L+ N + S S +SL F
Sbjct: 164 ESKVKDVTPIAN--------------LTDLYSLSLNYNQIED--ISPLASLTSLHYFTAY 207
Query: 334 SNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-H 392
N+ + I +M+ L L + N T L+NL+ L L++ +N +S
Sbjct: 208 VNQITD---ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINAVK 262
Query: 393 NLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQD 452
+L LK L + +N + S S L+N SQL SL L+ N L +G L+ L
Sbjct: 263 DL-----TKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 453 LKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485
L L N + P L ++ +++ +
Sbjct: 316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-40
Identities = 75/400 (18%), Positives = 140/400 (35%), Gaps = 60/400 (15%)
Query: 327 LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
+ + P ++ VL T + L ++ L ++ +
Sbjct: 2 AATLATLPAPINQIFPDA---DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV 56
Query: 387 SGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS 446
+ +L+ L L N + P LSN +L +L++ N +T S+L +
Sbjct: 57 ASIQGIEYL----TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQN 108
Query: 447 LSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506
L+ L++L L + + L N+ + +L L N + + LSN T LN+++++ +
Sbjct: 109 LTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTES 165
Query: 507 HLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566
+ P I L++L L L+ N L SL + N P A
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITDITPVANMT 221
Query: 567 QSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPC-NFTRVYG 625
+ L I +++ +S + T +
Sbjct: 222 R-------------------------------LNSLKIGNNKITDLSPLANLSQLTWLEI 250
Query: 626 GHTQ----PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVG 681
G Q + L++ N +S + ++S L L L +N L +G
Sbjct: 251 GTNQISDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 682 DLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
L L L LS N + P ++SL+ ++ D N +
Sbjct: 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 61/301 (20%), Positives = 119/301 (39%), Gaps = 36/301 (11%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
S L L L L + + I+ + A ++ L L L+ + +SDIS L + +
Sbjct: 82 SPLSNLVKLTNLYIGTNKIT---DISALQNLTN-LRELYLNED----NISDISPLANLTK 133
Query: 147 LKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
+ LNL +N ++ L L ++ +K+ +L L+L N
Sbjct: 134 MYSLNLGANHNLSDLSPLSNMT-GLNYLTVTESKVKDVTP-----IANLTDLYSLSLNYN 187
Query: 207 KVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEH 266
++ ++ +L + N + + + L L I NK T ++
Sbjct: 188 QIEDISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDL--SPLANLSQ 244
Query: 267 LSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS 326
L++L + +N S V + L L++ SN +S S + S
Sbjct: 245 LTWLEIGTNQISDINAVKD--------------LTKLKMLNVGSNQISD--ISVLNNLSQ 288
Query: 327 LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
L S +++N+ +E+ ++NL L LS N T P L++L+ +++ D ++ +
Sbjct: 289 LNSLFLNNNQLGN-EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
Query: 387 S 387
Sbjct: 346 K 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 51/327 (15%), Positives = 112/327 (34%), Gaps = 69/327 (21%)
Query: 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH 461
L + I ++ ++ + L +T + L + L + ++
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 462 GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSN 521
+ + LE L L+ N++T P LSN L + + N + + + L+N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 522 LAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKY 581
L L L+ ++ L + + L+L N N S L
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANH-NLSDLSPL----------------- 151
Query: 582 VYIKNDGSKECHGAGNL--LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMM 639
N+ L + + ++ + + +
Sbjct: 152 --------------SNMTGLNYLTVTESKVKDV-----------------TPIANLTDLY 180
Query: 640 FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGT 699
L ++YN + P + S++ L N ++ P V ++ LN L + +N++
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236
Query: 700 IPSSMSSLTLLNEIDLCNNQLTGMIPV 726
P +++L+ L +++ NQ++ + V
Sbjct: 237 SP--LANLSQLTWLEIGTNQISDINAV 261
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 1e-09
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 4/86 (4%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
L+I N +S + ++ L +LN+G N +S + +L LN L L++N+L
Sbjct: 248 LEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNED 303
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPV 726
+ LT L + L N +T + P+
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRPL 329
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-52
Identities = 111/508 (21%), Positives = 195/508 (38%), Gaps = 40/508 (7%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLG 142
+ AS L+ L+ L L + TI A + L LDL + + D
Sbjct: 38 TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN-LRILDLGSSKIYFLHPDA--FQ 94
Query: 143 SCSSLKVLNLSSNLLDFSGREAGSLK--LSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
L L L L + + G + +L LDLS N+I ++ F + LK
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR--SLYLHPSFGKLNSLKS 152
Query: 201 LALKGNKVT----GDINVSKCKNLQFLDVSSNNFSMAVP-SFGDC------LALEYLDIS 249
+ N++ ++ + K L F +++N+ V +G C + LE LD+S
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212
Query: 250 ANKFTGDVGHA-ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLC-SSLVKLD 307
N +T D+ +A ++ G++ + A L SS+ LD
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
LS + F + L+ +++ NK + ++ E F + NL+ L LS+N
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYS 331
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
+ L + +DL N+++ I + L+ L L++N L +T+ +
Sbjct: 332 SNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEK-LQTLDLRDNAL-----TTIHFIPSIP 384
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT 487
+ LS N L T+P + + + + L L I L + L+ L L+ N +
Sbjct: 385 DIFLSGNKLV-TLPKINLTANLIHLSENRLENLD--ILYFLLRVPHLQILILNQNRFSSC 441
Query: 488 LP-AALSNCTNLNWISLSNNHLGGEIPTWI-----GQLSNLAILKLSNNSFYGRIPPE-L 540
S +L + L N L T + LS+L +L L++N +PP
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVF 500
Query: 541 GDCRSLIWLDLNTNLFNGSIPPALFKQS 568
+L L LN+N + +
Sbjct: 501 SHLTALRGLSLNSNRLT-VLSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-47
Identities = 121/653 (18%), Positives = 211/653 (32%), Gaps = 105/653 (16%)
Query: 117 CSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDL 176
CS L+ ++ + + L LS N + + L++L+L
Sbjct: 2 CSFDGRIAFYRFCNLTQVPQVLN------TTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 177 SYNKISGANVVPWILFNGCDELKQLALKGNKVTG-DINV-SKCKNLQFLDVSSNNFSMAV 234
+ F L+ L L +K+ + +L L + S AV
Sbjct: 56 GSQYTP--LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 235 PS---FGDCLALEYLDISANKFTG-DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQG 290
F + AL LD+S N+ + + L ++ SSN V +E +
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL---VCEHELEP 170
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCS------SLESFDISSNKFSGELPIE 344
L +L L++N+L +V +G C LE D+S N ++ ++
Sbjct: 171 ---LQG----KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT-- 221
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKE 404
N + + SL ++ +N+ + R+S++
Sbjct: 222 -----------GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464
L L + + L L+L++N + + L LQ L L N L E+
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-EL 329
Query: 465 PPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523
+ + + L N + L + L +N L T I + ++
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIP 384
Query: 524 ILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
+ LS N +L ++L NL + S
Sbjct: 385 DIFLSGNKL-----------VTLPKINLTANLIHLS---------------------ENR 412
Query: 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643
++N L+ + R S S T + N S+ L +
Sbjct: 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQ--------------TPSENPSLEQLFL 458
Query: 644 SYNMLSGSIPKEI-----GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEG 698
NML + E+ +S+L +L L HN L+ P L L L L+SNRL
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT- 517
Query: 699 TIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPP 751
+ + L +D+ NQL P F + +N +C L
Sbjct: 518 VLSHN-DLPANLEILDISRNQLLAPNP--DVFVSLSVLDITHNKFICECELST 567
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-34
Identities = 89/437 (20%), Positives = 158/437 (36%), Gaps = 57/437 (13%)
Query: 67 SVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGT-ISLPAGSRCSSFLSS-- 123
++S L+ +L + + ++ + L+ ++SG ++ S+ +S
Sbjct: 175 TLSFFSLAANSLYSRVSV--DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 124 ------------LDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSL 171
+ + P + + SS++ L+LS + L
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL 292
Query: 172 EVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT--GDINVSKCKNLQFLDVSSNN 229
+VL+L+YNKI+ + F G D L+ L L N + N + ++D+ N+
Sbjct: 293 KVLNLAYNKINK---IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 230 FSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN---------LFSG 279
++ +F L+ LD+ N T I + + +S N L +
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTAN 404
Query: 280 PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFS 338
I + N + L+ L L L+ N S + SLE + N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 339 G----ELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNL 394
EL ++F +S+L+ L L+ N P S+LT L L L+SN L+ + HN
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND 523
Query: 395 CQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLK 454
+L+ L + N LL P + L L ++ N L
Sbjct: 524 LPA---NLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECE--------LSTFI 569
Query: 455 LWLNQLHGEIPPELGNI 471
WLN + I +I
Sbjct: 570 NWLNHTNVTIAGPPADI 586
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-48
Identities = 58/342 (16%), Positives = 106/342 (30%), Gaps = 43/342 (12%)
Query: 217 CKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN 275
+ L + D + + + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-------AWRQANSNNPQIETR 63
Query: 276 LFSGPIPVGYNEFQGEIPLHLADLCS-SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISS 334
+ L D V L+L S L + P + S L+ I +
Sbjct: 64 --------TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 335 NKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNL 394
ELP + + L+ L L+ N ALP S+++L L L + + +P L
Sbjct: 114 AGLM-ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
Query: 395 CQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLK 454
L SL L + + ++P+S+ +L L+ LK
Sbjct: 171 AST-----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 455 LWLNQLHGEIPPELGNIQTLETLFL-DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIP 513
+ + L + P + ++ LE L L L P L + L + +P
Sbjct: 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 514 TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNL 555
I +L+ L L L R+P + + + + +L
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-40
Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 24/281 (8%)
Query: 295 HLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKE 354
H S L + + D + + + +N +
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-----NSNNPQI 60
Query: 355 LVLSFNDFTGALPDSLSNLT--NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL 412
+ A D L + T L+L S L P + + L+ + +
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFR--LSHLQHMTIDAA-G 115
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQ 472
L +P T+ + L +L L+ N L +P+S+ SL++L++L + E+P L +
Sbjct: 116 LMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 473 T---------LETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523
L++L L++ + +LPA+++N NL + + N+ L + I L L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLE 232
Query: 524 ILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
L L + PP G L L L ++P +
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 55/341 (16%), Positives = 105/341 (30%), Gaps = 39/341 (11%)
Query: 140 YLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELK 199
+ S + L + L YN W N + +
Sbjct: 7 HHHHSSGRENLYFQGS------TALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-NNPQ 59
Query: 200 QLALKGNKVT---GDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
G + + + L++ S L+++ I A +
Sbjct: 60 IETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+ + L L ++ N +P +A L + L +L + + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR------------ALPASIASL-NRLRELSIRACPELTE 165
Query: 317 VPSRFGSCS---------SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
+P S +L+S + LP I ++ NLK L + + + AL
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLS-ALG 222
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
++ +L LE LDL P R LK L L++ L ++P + +QL
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGG--RAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL 468
L L +PS + L + + + ++
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ-AQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 54/353 (15%), Positives = 104/353 (29%), Gaps = 64/353 (18%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI-NVSKCKNLQFLDVSSN 228
E L + + + ++ + N Q +
Sbjct: 13 GRENLYFQGSTALRP------YHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 229 NFSMAVPSFGDC--LALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYN 286
D L++ + HL + + +
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-------- 117
Query: 287 EFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI- 345
E+P + + L L L+ N L +P+ S + L I + ELP +
Sbjct: 118 ----ELPDTMQQF-AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 346 -------FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGP 398
+ NL+ L L + +LP S++NL NL++L + ++ LS
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS----------- 219
Query: 399 RNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS-FNYLTGTIPSSLGSLSKLQDLKL-W 456
++ + + +L L L L P G + L+ L L
Sbjct: 220 ----------------ALGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKD 262
Query: 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG 509
+ L +P ++ + LE L L LP+ ++ I + +
Sbjct: 263 CSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-33
Identities = 47/355 (13%), Positives = 102/355 (28%), Gaps = 44/355 (12%)
Query: 94 TLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS 153
E L + S LS N + ++ ++ +
Sbjct: 13 GRENLYFQGST--ALRPYH------DVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT 64
Query: 154 SNLLDFSGREAGSLKL-SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI 212
L + L+L + P D+ +L
Sbjct: 65 GRALKATADLLEDATQPGRVALELRSVPLP---QFP-------DQAFRL----------- 103
Query: 213 NVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNV 272
+LQ + + + + LE L ++ N + +I++ L L++
Sbjct: 104 -----SHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157
Query: 273 SSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDI 332
+ +P +L L L + +P+ + +L+S I
Sbjct: 158 RACPELTELP---EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 333 SSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPH 392
++ S L I + L+EL L P L+ L L + +P
Sbjct: 214 RNSPLS-ALGPAIH-HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
Query: 393 NLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSL 447
++ + L++L L+ + L +PS ++ + + + +
Sbjct: 272 DIHR--LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 46/319 (14%), Positives = 98/319 (30%), Gaps = 37/319 (11%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
L + + N + A S + + L + L
Sbjct: 32 LSQWQRHYNADRNRWHSAWRQANS---NNPQIETRTGRALKATADLLEDATQ-PGRVALE 87
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
L S L +A L L+ + + + +P + L+ L L N +
Sbjct: 88 LRSVPLPQFPDQAFRLS-HLQHMTIDAAGLM---ELPDTMQQ-FAGLETLTLARNPLR-A 141
Query: 212 I--NVSKCKNLQFLDVSSNNFSMAVP----------SFGDCLALEYLDISANKFTGDVGH 259
+ +++ L+ L + + +P + L+ L + +
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 260 AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS 319
+I+ ++L L + ++ S + + L L +LDL P
Sbjct: 201 SIANLQNLKSLKIRNSPLS------------ALGPAIHHL-PKLEELDLRGCTALRNYPP 247
Query: 320 RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379
FG + L+ + LP++I ++ L++L L LP ++ L +
Sbjct: 248 IFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306
Query: 380 DLSSNNLSGAIPHNLCQGP 398
+ + + H P
Sbjct: 307 LVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 44/229 (19%), Positives = 81/229 (35%), Gaps = 33/229 (14%)
Query: 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ-----------------GPRNSLKELF 406
G+ + + E L + L Q ++ ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 407 LQNNLLLGSIPSTLSNCSQ--LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464
+ L + L + +Q V+L L L P LS LQ + + L E+
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 465 PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ------ 518
P + LETL L N L LPA++++ L +S+ E+P +
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 519 ---LSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
L NL L+L +P + + ++L L + + + ++ PA+
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-16
Identities = 25/173 (14%), Positives = 47/173 (27%), Gaps = 24/173 (13%)
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL---------------KLWL 457
+GS + S +L+ + L + + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 458 NQLHG----EIPPELGNIQ--TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE 511
G L + L L L P ++L +++ L E
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-ME 118
Query: 512 IPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
+P + Q + L L L+ N +P + L L + +P L
Sbjct: 119 LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 4/102 (3%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
L++ L P + +S+L + + L +P + GL L L+ N L +
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-AL 142
Query: 701 PSSMSSLTLLNEIDL-CNNQLTGMIPVMGQFETFQPAKFLNN 741
P+S++SL L E+ + +LT + + + + L N
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 3/86 (3%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSS-NRLEGT 699
L I + LS ++ I + L L+L P G L L L + L T
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-T 268
Query: 700 IPSSMSSLTLLNEIDLCNNQLTGMIP 725
+P + LT L ++DL +P
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 17/85 (20%), Positives = 30/85 (35%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
LD+ + P G + L L L + +P ++ L L LDL +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIP 725
PS ++ L I + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 20/98 (20%), Positives = 43/98 (43%), Gaps = 11/98 (11%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVG---------DLRGLNILDL 691
L ++ N L ++P I S++ L L++ +P + L L L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 692 SSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQ 729
+ ++P+S+++L L + + N+ L+ + P +
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHH 227
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 16/94 (17%), Positives = 29/94 (30%), Gaps = 11/94 (11%)
Query: 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRL 696
+ + I L +P + + L L L N L +P + L L L + +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162
Query: 697 EGTIPSSMSSLTLLNEI---------DLCNNQLT 721
+P ++S E L +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 12/91 (13%)
Query: 641 LDISYNMLSGSIPKEIGS---------MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDL 691
L I +P+ + S + L L L + +P + +L+ L L +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKI 213
Query: 692 SSNRLEGTIPSSMSSLTLLNEIDLC-NNQLT 721
++ L + ++ L L E+DL L
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 12/73 (16%), Positives = 19/73 (26%), Gaps = 4/73 (5%)
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR--GLNILDLSSNRLEGTIPSSMSSLT 708
+ + I L + D G L+L S L P L+
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104
Query: 709 LLNEIDLCNNQLT 721
L + + L
Sbjct: 105 HLQHMTIDAAGLM 117
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-47
Identities = 104/504 (20%), Positives = 174/504 (34%), Gaps = 45/504 (8%)
Query: 92 LDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
L+ L L I ++ G+ + S LS+L L+ N + SSL+ L
Sbjct: 51 FPELQVLDLSRCEIQ---TIEDGAYQSLSHLSTLILTGNPIQSLALGA--FSGLSSLQKL 105
Query: 151 NLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT 209
L G LK +L+ L++++N I + F+ L+ L L NK+
Sbjct: 106 VAVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPE--YFSNLTNLEHLDLSSNKIQ 162
Query: 210 G--DINVSKCKNLQF----LDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDV-GHAIS 262
++ + LD+S N + P + L L + N + +V I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS-SLVKLDLSSNNLSG-KVPSR 320
L + F + L LC+ ++ + L+ + +
Sbjct: 223 GLAGLEVHRLVLGEFRN-----EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL---------- 370
F +++ SF + S +L+ + F F SL
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
Query: 371 ------SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
+L +LE LDLS N LS + SLK L L N ++ ++ S
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 396
Query: 425 QLVSLHLSFNYLTGTIPSS-LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
QL L + L S SL L L + + +LE L + N
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456
Query: 484 LTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LG 541
+ NL ++ LS L PT LS+L +L +++N +P
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFD 515
Query: 542 DCRSLIWLDLNTNLFNGSIPPALF 565
SL + L+TN ++ S P +
Sbjct: 516 RLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-46
Identities = 101/483 (20%), Positives = 167/483 (34%), Gaps = 50/483 (10%)
Query: 118 SSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREA-GSLKLSLEVLDL 176
+LDLS N L S S L+VL+LS + A SL L L L
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYS--FFSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLIL 83
Query: 177 SYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV--SKCKNLQFLDVSSNNFSMA- 233
+ N I + F+G L++L + N K L+ L+V+ N
Sbjct: 84 TGNPIQS---LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 234 -VPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIP---------- 282
F + LE+LD+S+NK + + LN+S +L P+
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 283 ------VGYNEFQGEIPLHLADLCSSLVKLDL------SSNNLSGKVPSRFGSCSSL--E 328
+ N + + L L + NL S +L E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
F ++ + + I++F ++N+ L S + L+L +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF-- 316
Query: 389 AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT--GTIPSSLGS 446
SLK L +N + + + L L LS N L+ G S
Sbjct: 317 ---GQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 447 LSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA-ALSNCTNLNWISLSN 505
+ L+ L L N + + ++ LE L + L + NL ++ +S+
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPAL 564
H LS+L +LK++ NSF P+ + R+L +LDL+ + P
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 489
Query: 565 FKQ 567
F
Sbjct: 490 FNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-45
Identities = 104/587 (17%), Positives = 177/587 (30%), Gaps = 95/587 (16%)
Query: 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
S K L+LS N L G + L+VLDLS +I + + L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ---TIEDGAYQSLSHLSTLILT 84
Query: 205 GNKVTG--DINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFT-GDVGHA 260
GN + S +LQ L N + G L+ L+++ N +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 261 ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320
S +L L++SSN L + + LDLS N ++ +
Sbjct: 145 FSNLTNLEHLDLSSNKIQ--------SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA---LPDSLSNLTNLE 377
L + +N S + ++ L+ L +F S L L
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
L + L+ + L I + + + S L +
Sbjct: 256 NLTIEEFRLA--------------------YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 438 GTIPSS-LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT 496
S L+ + Q +++L+ L N+ + +
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAF--SEVDLP 347
Query: 497 NLNWISLSNNHLG--GEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
+L ++ LS N L G ++L L LS N + L LD +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406
Query: 555 LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST 614
++F + Y+ I +
Sbjct: 407 NLKQMSEFSVFLSLRNL--------IYLDISH---------------------------- 430
Query: 615 RSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLS 673
+ + G FN S+ L ++ N + +I + L L+L L
Sbjct: 431 ---THTRVAFNG----IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 674 GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
PT L L +L+++SN+L+ LT L +I L N
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-45
Identities = 110/522 (21%), Positives = 187/522 (35%), Gaps = 62/522 (11%)
Query: 219 NLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
+ + LD+S N SF L+ LD+S + A + HLS L ++ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKF 337
+ L SSL KL NL+ G +L+ +++ N
Sbjct: 89 Q------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE----TLDLSSNNLSGAIPHN 393
E F +++NL+ L LS N L L + +LDLS N ++ I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPG 195
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPST-LSNCSQLVSLHL------SFNYLTGTIPSSLGS 446
+ L +L L+NN ++ T + + L L + L S+L
Sbjct: 196 AFKEI--RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
Query: 447 LSKLQDLKLWLNQLHG---EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL 503
L L + L L +I + + + L + S + L
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLEL 311
Query: 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN-LFNGSIPP 562
N G+ PT +L +L L ++N D SL +LDL+ N L
Sbjct: 312 VNCKF-GQFPTL--KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 563 ALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL--LEFAGIRAERLSRISTRSPCNF 620
+ + + + + S G L L+F S + S +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVITM----SSNFLGLEQLEHLDFQH------SNLKQMSEFSV 416
Query: 621 TRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV 680
F ++++LDIS+ + +S L +L + N+ ++
Sbjct: 417 -----------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 681 -GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
+LR L LDLS +LE P++ +SL+ L +++ +NQL
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-43
Identities = 91/454 (20%), Positives = 158/454 (34%), Gaps = 41/454 (9%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYL 141
L L +L+ L +N++ SL L L+++ N++ Y
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA---SLENFPIGHLKTLKELNVAHNLIQS-FKLPEYF 145
Query: 142 GSCSSLKVLNLSSNLLDFSGREA----GSLKLSLEVLDLSYNKISGANVVPWILFNGCDE 197
+ ++L+ L+LSSN + + L LDLS N ++ + F
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF---IQPGAFKEI-R 201
Query: 198 LKQLALKGNKVTGDINVSKCKNLQFLDV---------SSNNFSMAVPSFGD---CLALEY 245
L +L L+ N + ++ + + L L+V + N S + L +E
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 246 LDISANK-FTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS--- 301
++ + D+ + ++S ++ S YN + L
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 302 ----SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSG-ELPIEIFLSMSNLKELV 356
SL +L +SN SLE D+S N S + ++LK L
Sbjct: 322 LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
LSFN + + L LE LD +NL ++ RN L L + + +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-LIYLDISHTHTRVAF 437
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPS-SLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTL 474
+ S L L ++ N L L L L QL ++ P ++ +L
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSL 496
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
+ L + N+L T+L I L N
Sbjct: 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-42
Identities = 87/454 (19%), Positives = 154/454 (33%), Gaps = 40/454 (8%)
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
+L S LDLS N L F S L+ D+S + + + S+S+L L+
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLL-GS 415
L+ N + S L++L+ L NL+ + +LKEL + +NL+
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK--TLKELNVAHNLIQSFK 140
Query: 416 IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL----NQLHGEIPPELGNI 471
+P SN + L L LS N + + L L ++ L L L N ++ I P
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 472 QTLETLFLDFNELTGTLPA-ALSNCTNLNWISL------SNNHLGGEIPTWIGQLSNLAI 524
L L L N + + + L L + +L + + L NL I
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 525 LKL---SNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKY 581
+ + + I ++ L + + + ++
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 582 VYIKNDGSKECHGAGNLLE--FAGIRAERLS-------RISTRSPCNFTRVYGGHTQPTF 632
+K K N F+ + L +S + C+ +
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ----------SD 369
Query: 633 NHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDL 691
S+ +LD+S+N + ++ + L L+ H+NL V LR L LD+
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 692 SSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
S + L+ L + + N
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-38
Identities = 80/414 (19%), Positives = 130/414 (31%), Gaps = 28/414 (6%)
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
++ F ++P + + K L LSFN S + L+ LDLS +
Sbjct: 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 389 AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS 448
I Q + L L L N + S S L L L +G L
Sbjct: 66 TIEDGAYQSLSH-LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 449 KLQDLKLWLNQL-HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNW----ISL 503
L++L + N + ++P N+ LE L L N++ L + + L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNG---- 558
S N + I + L L L NN + + L L F
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 559 -SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSP 617
+ + + Y +D + N + + + + R+ S
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIERVKDFSY 302
Query: 618 CNFTRV----YGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS 673
+ Q S+ L + N + E+ + L L+L N LS
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLS 360
Query: 674 --GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
G L LDLS N + T+ S+ L L +D ++ L M
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 83/417 (19%), Positives = 145/417 (34%), Gaps = 63/417 (15%)
Query: 95 LETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSS 154
+L L + ++ + G+ L L L N S + + + + L+V L
Sbjct: 179 NLSLDLSLNPMN---FIQPGAFKEIRLHKLTLRNNFDSLNVMK-TCIQGLAGLEVHRLVL 234
Query: 155 NLLDFSGR----EAGSLK----LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
G + +L+ L++E L+Y +++ LFN + +L
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID--LFNCLTNVSSFSLVSV 292
Query: 207 KVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEH 266
+ + S Q L++ + F +L+ L ++NK +
Sbjct: 293 TIERVKDFSYNFGWQHLELVNCKFGQ--FPTLKLKSLKRLTFTSNKGGNA--FSEVDLPS 348
Query: 267 LSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS 326
L FL++S N S G +SL LDLS N + + S F
Sbjct: 349 LEFLDLSRNGLSF-KGCCSQSDFG---------TTSLKYLDLSFNGVI-TMSSNFLGLEQ 397
Query: 327 LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
LE D + +FLS+ NL L +S A + L++LE L ++ N+
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 387 SGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS 446
P + L L LS L P++ S
Sbjct: 458 QENFL-------------------------PDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 447 LSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWIS 502
LS LQ L + NQL +P + +L+ ++L N + C ++++S
Sbjct: 493 LSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS-------CPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 73/335 (21%), Positives = 122/335 (36%), Gaps = 27/335 (8%)
Query: 90 LTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSC-SSLK 148
L + L +N A + L+ + L L L DI L +C +++
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCN-LTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 149 VLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKV 208
+L S + + S + L+L K LK+L NK
Sbjct: 286 SFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFG------QFPTLKLKSLKRLTFTSNKG 337
Query: 209 TGDINVSKCKNLQFLDVSSNNFSM---AVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
+ +L+FLD+S N S S +L+YLD+S N + E
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 396
Query: 266 HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCS 325
L L+ + F +L+ LD+S + F S
Sbjct: 397 QLEHLDFQHSNLKQMSEFSV--FLS---------LRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
SLE ++ N F +IF + NL L LS P + ++L++L+ L+++SN
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 386 LSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL 420
L ++P + SL++++L N S P
Sbjct: 506 LK-SVPDGIFDRLT-SLQKIWLHTNPWDCSCPRID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 74/392 (18%), Positives = 118/392 (30%), Gaps = 53/392 (13%)
Query: 372 NLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHL 431
+ N+ T N IP NL S K L L N L + + +L L L
Sbjct: 6 VVPNI-TYQCMELNFY-KIPDNLP----FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAA 491
S + + SLS L L L N + + +L+ L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 492 LSNCTNLNWISLSNNHLG-GEIPTWIGQLSNLAILKLSNNSF------------------ 532
+ + L +++++N + ++P + L+NL L LS+N
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 533 ---------YGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
I P L L L N + ++ + + + +V ++
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 584 IKNDGSKECHGAGNL--LEFAGIRAERLSRISTRSPCNFTRVYGGHTQ----------PT 631
N + L L R L F + +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 632 FNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDL 691
F++N L++ P + L L N +EV L L LDL
Sbjct: 300 FSYNFGWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDL 354
Query: 692 SSNRLE--GTIPSSMSSLTLLNEIDLCNNQLT 721
S N L G S T L +DL N +
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 9e-45
Identities = 73/453 (16%), Positives = 146/453 (32%), Gaps = 39/453 (8%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
EI + + ++ ++L + S S +++ D+S N S ++ +
Sbjct: 4 EIKQNG----NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFT 58
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L+ L LS N D L +L+ L TLDL++N + L GP S++ L NN
Sbjct: 59 KLELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQ-----ELLVGP--SIETLHAANN 109
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG-EIPPELG 469
+ S +++L+ N +T G S++Q L L LN++
Sbjct: 110 NISRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
+ TLE L L +N + + L + LS+N L + + + + L N
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589
N I L ++L DL N F+ F ++ ++ + + +
Sbjct: 224 NKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNE 280
Query: 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS 649
+EC + A + + L +
Sbjct: 281 EEC----TVPTLGHYGAYCCEDLPAPFADRLIAL----------KRKEHALLSGQGSETE 326
Query: 650 GSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTL 709
+ E + + ++ I + L+ L+ + + +
Sbjct: 327 -RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 710 LNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNS 742
L+ + + Q + +
Sbjct: 386 LDGTLQQAVGQIELQHATEEQSPLQLLRAIVKR 418
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-41
Identities = 58/446 (13%), Positives = 123/446 (27%), Gaps = 64/446 (14%)
Query: 135 LSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNG 194
+ +I + + K+ ++ + L + +++ LDLS N +S +
Sbjct: 2 IHEIK--QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ---ISAADLAP 56
Query: 195 CDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFT 254
L+ L++SSN L LD++ N
Sbjct: 57 ----------------------FTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93
Query: 255 GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
+ + L+ ++N S + + L++N ++
Sbjct: 94 -----ELLVGPSIETLHAANNNIS------------RVS---CSRGQGKKNIYLANNKIT 133
Query: 315 GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT 374
G S ++ D+ N+ E+ S L+ L L +N + +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
L+TLDLSSN L+ + + + L+NN L I L L L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAA--GVTWISLRNN-KLVLIEKALRFSQNLEHFDLRGN 247
Query: 435 YL-TGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALS 493
GT+ ++Q + +
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 494 NCTNLNWISLSNNHLGG----EIPTWIGQLSNLAILKLSNNSFYGRIPPELG-DCRSLIW 548
L + G + + + + + ++ ++ I
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY-RTVIDQVTLRKQAKIT 364
Query: 549 LDLNTNLFNGSIPPALFKQSGKIAAN 574
L+ + + ++
Sbjct: 365 LEQKKKALD-EQVSNGRRAHAELDGT 389
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-38
Identities = 78/472 (16%), Positives = 158/472 (33%), Gaps = 47/472 (9%)
Query: 92 LDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
+ + + +S++ A + + + LDLS N LS + L + L++L
Sbjct: 9 GNRYKIEKVTDSSLK---QALASLRQSAWNVKELDLSGNPLSQISAAD--LAPFTKLELL 63
Query: 151 NLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
NLSSN+L + SL +L LDL+ N + ++ L N ++
Sbjct: 64 NLSSNVLY-ETLDLESLS-TLRTLDLNNNYVQE--------LLVGPSIETLHAANNNIS- 112
Query: 211 DINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTG-DVGHAISACEHLS 268
++ S+ + + + +++N +M G ++YLD+ N+ + ++ + L
Sbjct: 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
LN+ N + +G++ + L LDLSSN L+ + F S + +
Sbjct: 173 HLNLQYNFIY--------DVKGQVVF------AKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF-TGALPDSLSNLTNLETLDLSSNNLS 387
+ +NK + + NL+ L N F G L D S ++T+ +
Sbjct: 218 WISLRNNKLV-LIE-KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 388 GAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG----TIPSS 443
C P L + G +
Sbjct: 276 TGQNEEECTVP----TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 444 LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL 503
+ ++ +++ Q I Q TL L + L+
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
Query: 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSF-YGRIPPELGDCRSLIWLDLNTN 554
E+ + S L +L+ + + + ++ D+ +
Sbjct: 392 QAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 59/358 (16%), Positives = 107/358 (29%), Gaps = 62/358 (17%)
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
A+ + N + ++ ++L +L Q N +KEL L N L + L+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWN-VKELDLSGNPLSQISAADLAPFT 58
Query: 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNEL 484
+L L+LS N L L SLS L+ L L N + EL ++ETL N +
Sbjct: 59 KLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG-RIPPELGDC 543
+ + S I L+NN + G S + L L N
Sbjct: 112 S-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 544 RSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAG 603
+L L+L N + + L+
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAK------------------------------LKTLD 197
Query: 604 IRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLF 663
+ + +L+ + P F + ++ + N L I K + L
Sbjct: 198 LSSNKLAFMG----------------PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
+L N + + ++ ++ + T+
Sbjct: 241 HFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 51/340 (15%), Positives = 107/340 (31%), Gaps = 58/340 (17%)
Query: 415 SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTL 474
+I N ++ ++ + L + S S +++L L N L +L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534
E L L N L L + + L + L+NN++ + ++ L +NN+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 535 RIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHG 594
R+ G + + L N + ++ +
Sbjct: 113 RVSCSRG--QGKKNIYLANNKIT-MLRDLDEGCRSRV------------------QYLDL 151
Query: 595 AGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPK 654
N + ++ + ++ L++ YN + +
Sbjct: 152 KLN----------EIDTVNFAE--------------LAASSDTLEHLNLQYNFIY-DVKG 186
Query: 655 EIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEID 714
++ + L L+L N L+ + E G+ + L +N+L I ++ L D
Sbjct: 187 QV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243
Query: 715 LCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEK 754
L N + F Q + + + L E+
Sbjct: 244 LRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 19/110 (17%), Positives = 33/110 (30%), Gaps = 5/110 (4%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
LD+S N L+ + E S + + ++L +N L I + + L DL N
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CG 252
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLP 750
+ + + E + C LP
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTG--QNEEECTVPTLGHYGAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 63/282 (22%), Positives = 113/282 (40%), Gaps = 22/282 (7%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
EI + + ++ ++L + S S +++ D+S N S ++ +
Sbjct: 4 EIKQNG----NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFT 58
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L+ L LS N D L +L+ L TLDL++N + L GP S++ L NN
Sbjct: 59 KLELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQ-----ELLVGP--SIETLHAANN 109
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG-EIPPELG 469
+ + S +++L+ N +T G S++Q L L LN++
Sbjct: 110 NI-SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
+ TLE L L +N + + L + LS+N L + + + + L N
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKI 571
N I L ++L DL N F+ F ++ ++
Sbjct: 224 NKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 54/361 (14%), Positives = 105/361 (29%), Gaps = 67/361 (18%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG--DINVSKCKNLQFLDVSS 227
++ ++ + + L +K+L L GN ++ +++ L+ L++SS
Sbjct: 11 RYKIEKVTDSSLKQ---ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 228 NNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNE 287
N L LD++ N + + L+ ++N S
Sbjct: 68 NVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS--------- 112
Query: 288 FQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFL 347
+ + L++N ++ L
Sbjct: 113 ---RVS---CSRGQGKKNIYLANNKIT-------------------------MLRDLDEG 141
Query: 348 SMSNLKELVLSFNDFTG-ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELF 406
S ++ L L N+ + ++ LE L+L N + + + LK L
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV---FAKLKTLD 197
Query: 407 LQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP 466
L +N L + + + + + L N L I +L L+ L N H
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH----- 250
Query: 467 ELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILK 526
TL F + + T N + LG L +
Sbjct: 251 ----CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 527 L 527
L
Sbjct: 307 L 307
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 52/337 (15%), Positives = 109/337 (32%), Gaps = 58/337 (17%)
Query: 415 SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTL 474
+I N ++ ++ + L + S S +++L L N L +L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534
E L L N L L + + L + L+NN++ + ++ L +NN+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 535 RIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHG 594
R+ G + + L N + ++ +Y+ +K
Sbjct: 113 RVSCSRG--QGKKNIYLANNKIT-MLRDLDEGCRSRV--------QYLDLKL-------- 153
Query: 595 AGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPK 654
N + ++ + ++ L++ YN + +
Sbjct: 154 --N----------EIDTVNFAE--------------LAASSDTLEHLNLQYNFIY-DVKG 186
Query: 655 EIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEID 714
++ + L L+L N L+ + E G+ + L +N+L I ++ L D
Sbjct: 187 QV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243
Query: 715 LCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPP 751
L N + F Q + + + L
Sbjct: 244 LRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 41/218 (18%), Positives = 76/218 (34%), Gaps = 26/218 (11%)
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
A+ + N + ++ ++L +L Q N +KEL L N L + L+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWN-VKELDLSGNPLSQISAADLAPFT 58
Query: 425 QLVSLHLSFNYLTGTIP-----------------SSLGSLSKLQDLKLWLNQLHGEIPPE 467
+L L+LS N L T+ L ++ L N + +
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCS 117
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGG-EIPTWIGQLSNLAILK 526
G Q + ++L N++T + + ++ L N + L L
Sbjct: 118 RG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 527 LSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
L N Y + ++ L LDL++N + P
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEF 210
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 19/114 (16%), Positives = 35/114 (30%), Gaps = 3/114 (2%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
LD+S N L+ + E S + + ++L +N L I + + L DL N
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CG 252
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEK 754
+ + + + T LP P ++
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-43
Identities = 108/481 (22%), Positives = 178/481 (37%), Gaps = 40/481 (8%)
Query: 95 LETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS 153
L+ L LK+S I+ ++ + L LDLS N LS LS S+ G SSLK LNL
Sbjct: 52 LQVLILKSSRIN---TIEGDAFYSLGSLEHLDLSDNHLSS-LSS-SWFGPLSSLKYLNLM 106
Query: 154 SNLLDFSGREAGSLKL-SLEVLDLS-YNKISGANVVPWILFNGCDELKQLALKGNKVTG- 210
N G + L +L+ L + S + I F G L +L +K +
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFS---EIRRIDFAGLTSLNELEIKALSLRNY 163
Query: 211 -DINVSKCKNLQFLDVSSNNFSMAVPSFGDCL-ALEYLDISANKFTGDVGHAISACEHLS 268
++ +++ L + + + + F D L ++ YL++ + E S
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS----- 323
+ + S +NE + L S + D + N L PS
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILE--LSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 324 ---CSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380
++ I ++ + +K + + + +L +LE LD
Sbjct: 282 KVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLD 340
Query: 381 LSSNNLSGAIPHN-LCQGPRNSLKELFLQNNLL--LGSIPSTLSNCSQLVSLHLSFNYLT 437
LS N + N C+G SL+ L L N L + L L SL +S N
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
Query: 438 GTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTN 497
+P S K++ L L + + + QTLE L + N L + L
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL---PR 452
Query: 498 LNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLF 556
L + +S N L +P L ++K+S N +P SL + L+TN +
Sbjct: 453 LQELYISRNKL-KTLPDA-SLFPVLLVMKISRNQL-KSVPDGIFDRLTSLQKIWLHTNPW 509
Query: 557 N 557
+
Sbjct: 510 D 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-41
Identities = 84/506 (16%), Positives = 166/506 (32%), Gaps = 71/506 (14%)
Query: 219 NLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
++ LD+S N + C L+ L + +++ G A + L L++S N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG-KVPSRFGSCSSLESFDISSNK 336
S + SSL L+L N V S F + ++L++ I + +
Sbjct: 87 S------------SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
E+ F +++L EL + SL ++ ++ L L + + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFAD 193
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
+ ++ L L++ L S L + + S L KL L
Sbjct: 194 ILSS-VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI 516
L+++ + + +E + + + +L ++ T
Sbjct: 253 LSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 517 GQLSNLAILKLSNNSFYGRIPPELGD-CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANF 575
L + + + N+ + +P +SL +LDL+ NL
Sbjct: 307 SLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM------------------- 346
Query: 576 IVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHN 635
V S +L LS+ + + T
Sbjct: 347 ------VEEYLKNSACKGAWPSLQTL------VLSQ------NHLRSM--QKTGEILLTL 386
Query: 636 GSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNR 695
++ LDIS N +P + LNL + + T + + L +LD+S+N
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNN 442
Query: 696 LEGTIPSSMSSLTLLNEIDLCNNQLT 721
L+ + + L E+ + N+L
Sbjct: 443 LD-SFSLFLPRLQ---ELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-40
Identities = 107/606 (17%), Positives = 203/606 (33%), Gaps = 127/606 (20%)
Query: 143 SCSSLKVLNLSSNLLDF--SGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
SC + V + S SG L +++ LDLS+NKI+ +
Sbjct: 3 SCDASGVCDGRSRSFTSIPSG-----LTAAMKSLDLSFNKIT--------------YIGH 43
Query: 201 LALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGH 259
L+ C NLQ L + S+ + +F +LE+LD+S N +
Sbjct: 44 GDLRA-----------CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS 92
Query: 260 AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS 319
L +LN+ N + + V + F ++L L + + ++
Sbjct: 93 WFGPLSSLKYLNLMGNPYQT-LGVT-SLFPN---------LTNLQTLRIGNVETFSEIRR 141
Query: 320 R-FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLET 378
F +SL +I + + S+ ++ L L ++ L L+++
Sbjct: 142 IDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 379 LDLSSNNLSGAIPHNLCQGPRNS-LKELFLQNNLL-------LGSIPSTLSNCSQLVSLH 430
L+L NL+ L +S +K+L + ++L L + + S++
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 431 LSFNYLTGTIPSSLGSLSKLQDLK------LWL--NQLHGEIPPELGNIQTLETLFLDFN 482
+ N L PS +S+L ++ L + L ++ ++ ++ + ++ +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEI---PTWIGQLSNLAILKLSNNSFYGRIPPE 539
++ + + +L ++ LS N + E G +L L LS N +
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKT 379
Query: 540 LGDC---RSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAG 596
++L LD++ N F+ +P C
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPD----------------------------SCQWPE 410
Query: 597 NLLEFAGIRAERLS--RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPK 654
+ LS I C + LD+S N L S
Sbjct: 411 KMRFL------NLSSTGIRVVKTCIPQTLE---------------VLDVSNNNLD-SFSL 448
Query: 655 EIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEID 714
+ L L + N L +P L ++ +S N+L+ LT L +I
Sbjct: 449 FLPR---LQELYISRNKLKT-LPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 715 LCNNQL 720
L N
Sbjct: 504 LHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-40
Identities = 68/413 (16%), Positives = 132/413 (31%), Gaps = 37/413 (8%)
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
SC + D S F+ +P + + +K L LSFN T L NL+ L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG-TIP 441
S+ ++ I + + L+ L L +N L S S L L+L N +
Sbjct: 59 SSRIN-TIEGDAFYSLGS-LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNW 500
S +L+ LQ L++ + EI + +L L + L +L + +++
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 501 ISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSI 560
++L + + + LS++ L+L + + R + +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 561 PPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNF 620
F + K+ + +EF L +
Sbjct: 236 TDESFNELLKL------------------LRYILELSEVEFDDCTLNGLGDFNPSESDVV 277
Query: 621 TRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV 680
+ + ++ L I L + + + + + ++ + +
Sbjct: 278 S-------ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330
Query: 681 GDLRGLNILDLSSNRLEGTI---PSSMSSLTLLNEIDLCNNQLTGMIPVMGQF 730
L+ L LDLS N + + + L + L N L M
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 78/489 (15%), Positives = 155/489 (31%), Gaps = 77/489 (15%)
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFG 322
+C+ + S F+ IP + L +++ LDLS N ++
Sbjct: 3 SCDASGVCDGRSRSFT------------SIP---SGLTAAMKSLDLSFNKITYIGHGDLR 47
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
+C++L+ + S++ + + + F S+ +L+ L LS N + L++L+ L+L
Sbjct: 48 ACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHLSFNYLTGTIP 441
N + +L+ L + N I + + L L + L
Sbjct: 107 GNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501
SL S+ + L L L++ + + ++ L L L + L + +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 502 SLSNNHLGG----------EIPTWIGQLSNLAILKLSNNSFYGRIPPELGD--------- 542
++ +I +LS + + N G P D
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL-GDFNPSESDVVSELGKVE 284
Query: 543 CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY-----IKNDGSKECHGAGN 597
++ L + ++ K+ K + + +
Sbjct: 285 TVTIRRLHIPQFYLF-YDLSTVYSLLEKV--------KRITVENSKVFLVPCSFSQHLKS 335
Query: 598 LLEFAGIRAERLS--RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE 655
L LS + N S+ L +S N L S+ K
Sbjct: 336 LEFL------DLSENLMVEEYLKNSA---------CKGAWPSLQTLVLSQNHLR-SMQKT 379
Query: 656 IG---SMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNE 712
++ L L++ N P+P + L+LSS + + + L
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEV 435
Query: 713 IDLCNNQLT 721
+D+ NN L
Sbjct: 436 LDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 62/320 (19%), Positives = 113/320 (35%), Gaps = 34/320 (10%)
Query: 50 SPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLD-TLETLSLKNSNISGT 108
++ K ++ + + ++ + + + L S + D TL L N + S
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 109 ISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK 168
+S + + L + L LS + +K + + ++ +
Sbjct: 277 VSELGKVETVT-IRRLHIPQFYLFYDLSTV--YSLLEKVKRITVENSKVFLVPCSFSQHL 333
Query: 169 LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT----GDINVSKCKNLQFLD 224
SLE LDLS N + + L+ L L N + + KNL LD
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393
Query: 225 VSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISAC--EHLSFLNVSSNLFSGPIP 282
+S N F S + +L++S+ + C + L L+VS+N
Sbjct: 394 ISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-----VVKTCIPQTLEVLDVSNNNLD---- 444
Query: 283 VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP 342
L L L +L +S N L +P L IS N+ +P
Sbjct: 445 --------SFSLFL----PRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLK-SVP 489
Query: 343 IEIFLSMSNLKELVLSFNDF 362
IF +++L+++ L N +
Sbjct: 490 DGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-12
Identities = 36/186 (19%), Positives = 67/186 (36%), Gaps = 23/186 (12%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCS 145
+ +L+TL L +++ ++ L+SLD+S N +
Sbjct: 355 ACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWP---E 410
Query: 146 SLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
++ LNLSS + +LEVLD+S N + L L++L +
Sbjct: 411 KMRFLNLSSTGIRVVKTCIPQ---TLEVLDVSNNNLD---SFSLFLPR----LQELYISR 460
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPS-FGDCLALEYLDISANKFTGDVGHAISAC 264
NK+ + S L + +S N F +L+ + + N + C
Sbjct: 461 NKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS-------C 513
Query: 265 EHLSFL 270
+ +L
Sbjct: 514 PRIDYL 519
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 23/93 (24%), Positives = 40/93 (43%), Gaps = 9/93 (9%)
Query: 629 QPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNI 688
+ M FL++S + + I L +L++ +NNL L L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FSL---FLPRLQE 455
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
L +S N+L+ T+P + S +L + + NQL
Sbjct: 456 LYISRNKLK-TLPDA-SLFPVLLVMKISRNQLK 486
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-42
Identities = 83/507 (16%), Positives = 161/507 (31%), Gaps = 95/507 (18%)
Query: 69 SSIDLSPFTLS--VDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDL 126
+ + + + +++ S + +S L+L
Sbjct: 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----AHELEL 78
Query: 127 SLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANV 186
+ LS + L+ L S N L SLK SL V + + +S
Sbjct: 79 NNL----GLSSLP--ELPPHLESLVASCNSLTELPELPQSLK-SLLVDNNNLKALSDL-- 129
Query: 187 VPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYL 246
L+ L + N++ + L+ +DV +N+ +LE++
Sbjct: 130 --------PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPP---SLEFI 178
Query: 247 DISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKL 306
N+ + L+ + +N ++P DL SL +
Sbjct: 179 AAGNNQLE--ELPELQNLPFLTAIYADNNSLK------------KLP----DLPLSLESI 220
Query: 307 DLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL 366
+N L ++P + L + +N LP +L+ L + N T L
Sbjct: 221 VAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLP----PSLEALNVRDNYLT-DL 272
Query: 367 PDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL 426
P+ +LT L+ + + LS P +L L +N + S+ + L
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPP---------NLYYLNASSNEI-RSLCDLPPS---L 319
Query: 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTG 486
L++S N L +P+ +L+ L N L E+P N L+ L +++N L
Sbjct: 320 EELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR- 370
Query: 487 TLPAALSNCTNLN----------------WISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530
P + +L + + N L E P + +L ++++
Sbjct: 371 EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSE 426
Query: 531 SFYGRIPPELGDCRSLIWLDLNTNLFN 557
L + +
Sbjct: 427 RVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-40
Identities = 88/448 (19%), Positives = 146/448 (32%), Gaps = 100/448 (22%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS-------------CSSLESFDISSNKF 337
E+P+ ++ S + + + P G ++++
Sbjct: 25 EMPVEAENV-KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG 397
S LP +L+ LV S N T LP+ +L +L + + LS P
Sbjct: 84 S-SLPELP----PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP------ 131
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457
L+ L + NN L +P L N S L + + N L +P SL + +
Sbjct: 132 ---LLEYLGVSNNQL-EKLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSL---EFIAAGN 182
Query: 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIG 517
NQL E PEL N+ L ++ D N L LP + ++ NN L E +
Sbjct: 183 NQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNIL--EELPELQ 234
Query: 518 QLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIV 577
L L + NN +P SL L++ N +P
Sbjct: 235 NLPFLTTIYADNNLL-KTLPDLPP---SLEALNVRDNYLT-DLPELP------------- 276
Query: 578 GKKYVYIKNDGSKECHGAGNL--LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT--FN 633
+L L+ + L + P N + + +
Sbjct: 277 ------------------QSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCD 314
Query: 634 HNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSS 693
S+ L++S N L +P + L N+L+ +P +L+ L +
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPELPQNLK---QLHVEY 366
Query: 694 NRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
N L P S+ L N+ L
Sbjct: 367 NPLR-EFPDIPESVEDLR----MNSHLA 389
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 79/481 (16%), Positives = 147/481 (30%), Gaps = 115/481 (23%)
Query: 90 LTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKV 149
++ L+ +SN++ +P + + + + G + V
Sbjct: 8 VSNTFLQEPLRHSSNLT---EMPVEAENVKSKTEYYNAWSEWERNAPPG--NGEQREMAV 62
Query: 150 LNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT 209
L L L+L+ +S +P
Sbjct: 63 SRLRDCLD-----------RQAHELELNNLGLS---SLP--------------------- 87
Query: 210 GDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTG--------DVGH-- 259
+L+ L S N+ + +L + + + V +
Sbjct: 88 -----ELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ 142
Query: 260 -----AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
+ L ++V +N ++P DL SL + +N L
Sbjct: 143 LEKLPELQNSSFLKIIDVDNNSLK------------KLP----DLPPSLEFIAAGNNQLE 186
Query: 315 GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT 374
++P + L + +N ++ +L+ +V N L NL
Sbjct: 187 -ELPE-LQNLPFLTAIYADNNSLK-----KLPDLPLSLESIVAGNNILE--ELPELQNLP 237
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
L T+ +N L +P SL+ L +++N L +P + + L F+
Sbjct: 238 FLTTIYADNNLLK-TLPDLPP-----SLEALNVRDN-YLTDLPELPQSLTFLDVSENIFS 290
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN 494
L+ P+ L L N++ + + LE L + N+L LPA
Sbjct: 291 GLSELPPN-------LYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPPR 338
Query: 495 CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
L S NHL E+P NL L + N P S+ L +N++
Sbjct: 339 LERLI---ASFNHL-AEVPELPQ---NLKQLHVEYNPLR-EFPDIPE---SVEDLRMNSH 387
Query: 555 L 555
L
Sbjct: 388 L 388
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-37
Identities = 90/504 (17%), Positives = 159/504 (31%), Gaps = 68/504 (13%)
Query: 241 LALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD-L 299
L+ ++ T ++ + + + + + P G E + L D L
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+L+L++ LS +P LES S N + ELP S+ +L +
Sbjct: 70 DRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQ-SLKSLLVDNNNL 123
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
+ LE L +S+N L +P + LK + + NN L +P
Sbjct: 124 KALS-------DLPPLLEYLGVSNNQLE-KLPEL---QNSSFLKIIDVDNNSL-KKLPDL 171
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479
+ L + N L +P L +L L + N L ++P + LE++
Sbjct: 172 PPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVA 222
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539
N L LP L N L I NN L +P L L + +P
Sbjct: 223 GNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTD----LPEL 275
Query: 540 LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLL 599
L + + + +PP L N+ C +L
Sbjct: 276 PQSLTFLDVSENIFSGLS-ELPPNL--------------YYLNASSNEIRSLCDLPPSLE 320
Query: 600 EFAGIRAERLSRISTRSPCNFTRVYGGHTQPTF--NHNGSMMFLDISYNMLSGSIPKEIG 657
E + +L + P R+ ++ L + YN L P
Sbjct: 321 EL-NVSNNKLIELPA-LPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPE 377
Query: 658 SMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCN 717
S+ +L N+ +P +L+ L + +N L P S+ L + +
Sbjct: 378 SVE-----DLRMNSHLAEVPELPQNLK---QLHVETNPLR-EFPDIPESVEDL---RMNS 425
Query: 718 NQLTGMIPVMGQFETFQPAKFLNN 741
++ + +
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEH 449
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 81/390 (20%), Positives = 130/390 (33%), Gaps = 62/390 (15%)
Query: 347 LSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG--------- 397
+S + L+E + ++ T +P N+ + + + P +
Sbjct: 8 VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 398 --PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455
EL L N L S+P + L SL S N LT +P SL L
Sbjct: 67 DCLDRQAHELELNNL-GLSSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTW 515
L L P LE L + N+L LP L N + L I + NN L ++P
Sbjct: 122 NLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL-KKLP-- 169
Query: 516 IGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANF 575
+L + NN PEL + L + + N +P
Sbjct: 170 -DLPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSL-------- 217
Query: 576 IVGKKYVYIKNDGSKECHGAGNL--LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTF- 632
+ + N+ +E NL L L + P + + T
Sbjct: 218 ----ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD-LPPSLEALNVRDNYLTDL 272
Query: 633 -NHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDL 691
S+ FLD+S N+ S + + + L+ LN N + + L L++
Sbjct: 273 PELPQSLTFLDVSENIFS-GLSELPPN---LYYLNASSNEIRS-LCDL---PPSLEELNV 324
Query: 692 SSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
S+N+L +P+ L L N L
Sbjct: 325 SNNKLI-ELPALPPRLERL---IASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-21
Identities = 58/309 (18%), Positives = 108/309 (34%), Gaps = 52/309 (16%)
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN----- 494
I S + LQ+ + L E+P E N+++ + ++E P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 495 --------CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSL 546
+ + L+N L +P L + L S NS +P +SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGL-SSLPELPPHLES---LVASCNSL-TELPELPQSLKSL 116
Query: 547 IWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL--LEFAGI 604
+ + N + +PP L +Y+ + N+ ++ N L+ +
Sbjct: 117 LVDNNNLKALS-DLPPLL---------------EYLGVSNNQLEKLPELQNSSFLKIIDV 160
Query: 605 RAERLSRISTRSPCNFTRVYGGHTQ----PTFNHNGSMMFLDISYNMLSGSIPKEIGSMS 660
L ++ P + + G+ Q P + + + N L +P S
Sbjct: 161 DNNSLKKLP-DLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLS-- 216
Query: 661 YLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
L + G+N L E+ +L L + +N L+ T+P SL LN + +N L
Sbjct: 217 -LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYL 269
Query: 721 TGMIPVMGQ 729
T + +
Sbjct: 270 TDLPELPQS 278
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-41
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 868 IGSGGFGDVYKAKLKDGST-VAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG+V+ +L+ +T VA+K + +F E + + H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ +V E ++ G L + +L ++ +A G+ +L I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEYYQSF 1040
HRD+ + N L+ E ++SDFGM+R + V +G VP PE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQVPVKWTAPEALNYG 290
Query: 1041 RCSTKGDVYSYGVVLLELLT-GKRP 1064
R S++ DV+S+G++L E + G P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 5e-41
Identities = 69/418 (16%), Positives = 146/418 (34%), Gaps = 81/418 (19%)
Query: 115 SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVL 174
S D+ +++ + + + ++ K++ ++ + +E+L
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80
Query: 175 DLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAV 234
+L+ +I + F +++L + N + +
Sbjct: 81 NLNDLQIE---EIDTYAFAYAHTIQKLYMGFNAIR---------------------YLPP 116
Query: 235 PSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPL 294
F + L L + N + ++ +F
Sbjct: 117 HVFQNVPLLTVLVLERNDLS----------------SLPRGIFHN--------------- 145
Query: 295 HLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKE 354
L L +S+NNL F + +SL++ +SSN+ + + + + +L
Sbjct: 146 -----TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI---PSLFH 196
Query: 355 LVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLG 414
+S+N + +L+ +E LD S N+++ + + L L LQ+N L
Sbjct: 197 ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV----ELTILKLQHNNL-- 244
Query: 415 SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTL 474
+ + L N LV + LS+N L + + +L+ L + N+L + I TL
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+ L L N L + L + L +N + + + L L LS+N +
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 88/477 (18%), Positives = 164/477 (34%), Gaps = 62/477 (12%)
Query: 70 SIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCS-SFLSSLDLSL 128
ID+ + F +TL+ + ++ KNS + LPA S + L+L+
Sbjct: 33 HIDMQTQDVYFGFED-----ITLNNQKIVTFKNSTMR---KLPAALLDSFRQVELLNLND 84
Query: 129 NILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVP 188
+ + +++ L + N + + L VL L N +S +P
Sbjct: 85 LQIEEIDTYA--FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS---SLP 139
Query: 189 WILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVSSNNFSMAVPSFGDCLALEY 245
+F+ +L L++ N + I +LQ L +SSN + +L +
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHV--DLSLIPSLFH 196
Query: 246 LDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVK 305
++S N + ++ + L+ S N + + + L
Sbjct: 197 ANVSYNLLS-----TLAIPIAVEELDASHNSIN------------VVR---GPVNVELTI 236
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA 365
L L NNL+ + L D+S N+ ++ F+ M L+ L +S N A
Sbjct: 237 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ 425
L + L+ LDLS N+L + N Q L+ L+L +N + ++ LS
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD--RLENLYLDHN-SIVTLK--LSTHHT 346
Query: 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGN----------IQTLE 475
L +L LS N S + + H +I +L +
Sbjct: 347 LKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404
Query: 476 TLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
++ + + A C+ + I+ + L L+ N
Sbjct: 405 LQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-35
Identities = 71/408 (17%), Positives = 139/408 (34%), Gaps = 68/408 (16%)
Query: 291 EIPLHLADLCSSL-VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSM 349
I +L C V +D+ + ++ + ++ + ++ +LP + S
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYF--GFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
++ L L+ + + ++ L + N + +P ++ Q L L L+
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL-LTVLVLER 132
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
N L N +L +L +S N L + + + LQ+L+L N+L +
Sbjct: 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--S 189
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
I +L + +N L+ L+ + + S+N + + L ILKL +
Sbjct: 190 LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQH 241
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589
N+ L + L+ +DL+ N I F + +
Sbjct: 242 NNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQR------------------- 279
Query: 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS 649
LE I RL ++ ++ LD+S+N L
Sbjct: 280 ---------LERLYISNNRLVALN----------------LYGQPIPTLKVLDLSHNHLL 314
Query: 650 GSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLE 697
+ + L L L HN++ + + L L LS N +
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-32
Identities = 71/451 (15%), Positives = 136/451 (30%), Gaps = 80/451 (17%)
Query: 310 SNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIF-----LSMSNLKELVLSFNDFTG 364
N+ + P S+L+ + + +++ ++++N K + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
L + +E L+L+ + I +
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIE-EID-------------------------TYAFAYAH 99
Query: 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNE 483
+ L++ FN + P ++ L L L N L +P + N L TL + N
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158
Query: 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543
L T+L + LS+N L + + + +L +S N L
Sbjct: 159 LERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIP 210
Query: 544 RSLIWLDLNTNLFNGSIPPALFK--QSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEF 601
++ LD + N N + + K+ N + LL +
Sbjct: 211 IAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTD----------------TAWLLNY 253
Query: 602 AGIRAERLS--RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSM 659
G+ LS + F + L IS N L ++ +
Sbjct: 254 PGLVEVDLSYNELEKIMYH------------PFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 660 SYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQ 719
L +L+L HN+L + L L L N + T+ +S+ L + L +N
Sbjct: 301 PTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 356
Query: 720 LTGMIPVMGQFETFQPAKFLNNSGLCGLPLP 750
+ F + C +
Sbjct: 357 WDC-NSLRALFRNVARPAVDDADQHCKIDYQ 386
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-39
Identities = 85/455 (18%), Positives = 161/455 (35%), Gaps = 79/455 (17%)
Query: 93 DTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNL 152
D + + T ++ + ++ L+SLD + ++D++ + + L L
Sbjct: 18 DNFASEVAAAFEMQATDTISE-EQLAT-LTSLDCHNS----SITDMTGIEKLTGLTKLIC 71
Query: 153 SSNLLDFSGREAGSLKLS----LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKV 208
+SN + +L LS L L NK++ + +L L NK+
Sbjct: 72 TSNNIT-------TLDLSQNTNLTYLACDSNKLTN------LDVTPLTKLTYLNCDTNKL 118
Query: 209 TGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLS 268
T ++VS+ L +L+ + N + L LD NK + ++ L+
Sbjct: 119 T-KLDVSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
L+ S N + E+ + L +L+ +NN++ K+ L
Sbjct: 174 TLDCSFNKIT------------ELDVS---QNKLLNRLNCDTNNIT-KLD--LNQNIQLT 215
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG 388
D SSNK + E+ + ++ L S N T L +S L+ L TL +L
Sbjct: 216 FLDCSSNKLT-EIDVT---PLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL- 267
Query: 389 AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS 448
+ L + + + +++ +QL L +T + L
Sbjct: 268 ----EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNP 318
Query: 449 KLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
KL L L +L E+ + + L++L + ++ LN +
Sbjct: 319 KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEG-- 371
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543
Q + L+NNS + P+L D
Sbjct: 372 ---------QTITMPKETLTNNSLTIAVSPDLLDQ 397
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-38
Identities = 89/424 (20%), Positives = 148/424 (34%), Gaps = 69/424 (16%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
L TL +L NS+I+ + + + L+ L + N ++ + L ++L L
Sbjct: 41 LATLTSLDCHNSSIT---DMTGIEKLTG-LTKLICTSN----NITTLD-LSQNTNLTYLA 91
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
SN L + + L L L+ NK++ + + L L N +T +
Sbjct: 92 CDSNKL--TNLDVTPLT-KLTYLNCDTNKLTKLD------VSQNPLLTYLNCARNTLT-E 141
Query: 212 INVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
I+VS L LD N L LD S NK T +S + L+ LN
Sbjct: 142 IDVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLN 197
Query: 272 VSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFD 331
+N + ++ L + L LD SSN L+ ++ + L FD
Sbjct: 198 CDTNNIT------------KLDL---NQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 332 ISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL--SGA 389
S N + EL + S L L D + L++ T L
Sbjct: 240 CSVNPLT-ELDVSTL---SKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD 292
Query: 390 IPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSK 449
+ HN L L Q + + LS +LV L+L+ LT + + +K
Sbjct: 293 VTHN------TQLYLLDCQAA-GITELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 450 LQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN-----CTNLNWISLS 504
L+ L + + +G I L F + L+N + + +
Sbjct: 341 LKSLSCVNAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 505 NNHL 508
N +
Sbjct: 399 GNPM 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-34
Identities = 77/390 (19%), Positives = 126/390 (32%), Gaps = 47/390 (12%)
Query: 172 EVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFS 231
+ ++ I L L + +T + K L L +SNN +
Sbjct: 22 SEVAAAFEM----QATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT 77
Query: 232 MAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGE 291
L YL +NK T ++ L++LN +N + + V N
Sbjct: 78 T--LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLDVSQNPLLTY 131
Query: 292 IPLH---LADL----CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIE 344
+ L ++ + L +LD N K+ + L + D S NK + EL +
Sbjct: 132 LNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVS 188
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKE 404
L L N+ T L L+ L LD SSN L+ L L
Sbjct: 189 ---QNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEIDVTPL-----TQLTY 237
Query: 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464
N L + +S S+L +LH L I L ++L +
Sbjct: 238 FDCSVN-PLTELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQL--IYFQAEGCRKIK 289
Query: 465 PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAI 524
++ + L L +T L LS L ++ L+N L E+ + + L
Sbjct: 290 ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL-TELD--VSHNTKLKS 343
Query: 525 LKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
L N + +G +L
Sbjct: 344 LSCVNAHI--QDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 75/459 (16%), Positives = 136/459 (29%), Gaps = 72/459 (15%)
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
++ + ++L S D ++ + + ++ L +L+ + N+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNI 76
Query: 363 TGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSN 422
T L LS TNL L SN L+ L L L N L + +S
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLTNLDVTPL-----TKLTYLNCDTNKL-TKLD--VSQ 125
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482
L L+ + N LT I + ++L +L + ++ L TL FN
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLT--ELDCHLNKKITKLDVTPQTQLTTLDCSFN 180
Query: 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGD 542
++T L +S LN ++ N++ ++ + Q L L S+N I +
Sbjct: 181 KIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTP 231
Query: 543 CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFA 602
L + D + N + + + L
Sbjct: 232 LTQLTYFDCSVNPLT-ELDVSTLSK-------------------------------LTTL 259
Query: 603 GIRAERLSRISTRSPCNFTRVYGGH----TQPTFNHNGSMMFLDISYNMLSGSIPKEIGS 658
L I + HN + LD ++ + +
Sbjct: 260 HCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQ 316
Query: 659 MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718
L L L + L+ + V L L + ++ S + + LN
Sbjct: 317 NPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEG 371
Query: 719 QLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSG 757
Q M + A + G P+ D G
Sbjct: 372 QTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 62/385 (16%), Positives = 114/385 (29%), Gaps = 68/385 (17%)
Query: 342 PIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG--AIPHNLCQGPR 399
+ N V + + S L L +LD +++++ I
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKL------ 63
Query: 400 NSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
L +L +N + ++ LS + L L N LT + + L+KL L N+
Sbjct: 64 TGLTKLICTSN-NITTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNK 117
Query: 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQL 519
L ++ + L L N LT + +S+ T L + N ++ +
Sbjct: 118 LT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQ 169
Query: 520 SNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGK 579
+ L L S N ++ + L L+ +TN + Q
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQ------------ 213
Query: 580 KYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT---FNHNG 636
L F + +L+ I T T +
Sbjct: 214 -------------------LTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELDVSTLS 254
Query: 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRL 696
+ L L I + + L + +V L +LD + +
Sbjct: 255 KLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGI 309
Query: 697 EGTIPSSMSSLTLLNEIDLCNNQLT 721
+ +S L + L N +LT
Sbjct: 310 T-ELD--LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 54/332 (16%), Positives = 100/332 (30%), Gaps = 57/332 (17%)
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457
P ++ + + + + L SL + +T + + L+ L L
Sbjct: 16 PDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73
Query: 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIG 517
N + + L L L D N+LT L ++ T L +++ N L ++ +
Sbjct: 74 NNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VS 124
Query: 518 QLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIV 577
Q L L + N+ ++ L LD + N + Q
Sbjct: 125 QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQ---------- 171
Query: 578 GKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGH---TQPTFNH 634
L +++ + R+ T+ N
Sbjct: 172 ---------------------LTTLDCSFNKITELDVSQNKLLNRLNCDTNNITKLDLNQ 210
Query: 635 NGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSN 694
N + FLD S N L+ I + ++ L + N L+ + V L L L
Sbjct: 211 NIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQT 264
Query: 695 RLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV 726
L I ++ T L + + V
Sbjct: 265 DLL-EID--LTHNTQLIYFQAEGCRKIKELDV 293
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 74/353 (20%), Positives = 137/353 (38%), Gaps = 38/353 (10%)
Query: 218 KNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN 275
N + + ++ +P+ +E L+++ + +A + + L + N
Sbjct: 45 NNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103
Query: 276 LFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSN 335
+P H+ L L L N+LS F + L + +S+N
Sbjct: 104 AIR------------YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 151
Query: 336 KFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLC 395
+ + F + ++L+ L LS N T + LS + +L ++S N LS + +
Sbjct: 152 NLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI- 205
Query: 396 QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455
+++EL +N + + + +L L L N LT + L + L ++ L
Sbjct: 206 -----AVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDL 255
Query: 456 WLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPT 514
N+L +I +Q LE L++ N L L L + LS+NHL +
Sbjct: 256 SYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVER 312
Query: 515 WIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567
Q L L L +NS + +L L L+ N ++ + ALF+
Sbjct: 313 NQPQFDRLENLYLDHNSI-VTLKL--STHHTLKNLTLSHNDWDCNSLRALFRN 362
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-37
Identities = 69/406 (16%), Positives = 134/406 (33%), Gaps = 66/406 (16%)
Query: 292 IPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSN 351
I +L C + + + ++ + ++ +LP + S
Sbjct: 13 IDSNLQYDCV-FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 352 LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL 411
++ L L+ + + ++ L + N + +P ++ Q L L L+ N
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL-LTVLVLERND 128
Query: 412 LLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNI 471
L N +L +L +S N L + + + LQ+L+L N+L + I
Sbjct: 129 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLI 185
Query: 472 QTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNS 531
+L + +N L+ L+ + + S+N + + L ILKL +N+
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNN 237
Query: 532 FYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKE 591
L + L+ +DL+ N I F + +
Sbjct: 238 L--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQR--------------------- 273
Query: 592 CHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGS 651
LE I RL ++ ++ LD+S+N L
Sbjct: 274 -------LERLYISNNRLVALN----------------LYGQPIPTLKVLDLSHNHLL-H 309
Query: 652 IPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLE 697
+ + L L L HN++ + + L L LS N +
Sbjct: 310 VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 61/372 (16%), Positives = 114/372 (30%), Gaps = 65/372 (17%)
Query: 352 LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL 411
++ + L N + + ++ + +P L R ++ L L +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ-VELLNLNDLQ 80
Query: 412 LLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GN 470
+ + + L++ FN + P ++ L L L N L +P + N
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
Query: 471 IQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530
L TL + N L T+L + LS+N L + + + +L +S N
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196
Query: 531 SFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSK 590
L ++ LD + N N + +
Sbjct: 197 LL-----STLAIPIAVEELDASHNSIN-VVRGPV-------------------------- 224
Query: 591 ECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
+ +L N T + ++ +D+SYN L
Sbjct: 225 ----------NVELTILKLQHN------NLTDT------AWLLNYPGLVEVDLSYNELE- 261
Query: 651 SIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTL 709
I M L L + +N L + + L +LDLS N L + +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 710 LNEIDLCNNQLT 721
L + L +N +
Sbjct: 320 LENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 62/317 (19%), Positives = 110/317 (34%), Gaps = 38/317 (11%)
Query: 267 LSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS 326
F +V ++ + + + G + L ++ + ++ + + S
Sbjct: 21 CVFYDVHIDMQTQ------DVYFGFEDITL----NNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 327 LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
+E +++ + E+ F +++L + FN P N+ L L L N+L
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 387 SGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS 446
S ++P + L L + NN L T + L +L LS N LT + L
Sbjct: 130 S-SLPRGIFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSL 184
Query: 447 LSKLQDLKLWLNQLHGEIPPELG---------NIQT--------LETLFLDFNELTGTLP 489
+ L + N L + + +I L L L N LT
Sbjct: 185 IPSLFHANVSYNLLS-TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--T 241
Query: 490 AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549
A L N L + LS N L + ++ L L +SNN + +L L
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVL 300
Query: 550 DLNTNLFNGSIPPALFK 566
DL+ N + +
Sbjct: 301 DLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 71/331 (21%), Positives = 115/331 (34%), Gaps = 43/331 (12%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCS-SFLSSLDLSLNILSGPLSDISYL 141
L A+ L + +E L+L + I + + + L + N + +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIE---EIDTYAFAYAHTIQKLYMGFNAIRYLPPHV--F 113
Query: 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQL 201
+ L VL L N L R L L +S N + + F L+ L
Sbjct: 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE---RIEDDTFQATTSLQNL 170
Query: 202 ALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAI 261
L N++T +++S +L +VS N S + +A+E LD S N +
Sbjct: 171 QLSSNRLT-HVDLSLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSIN-----VV 220
Query: 262 S--ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS 319
L+ L + N + LV++DLS N L +
Sbjct: 221 RGPVNVELTILKLQHNNLTDT-----AWLLN---------YPGLVEVDLSYNELEKIMYH 266
Query: 320 RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379
F LE IS+N+ L + LK L LS N + + LE L
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALN-LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L N++ + + +LK L L +N
Sbjct: 324 YLDHNSIV-TLKLSTHH----TLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-22
Identities = 51/318 (16%), Positives = 107/318 (33%), Gaps = 41/318 (12%)
Query: 408 QNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE 467
I S L +H+ +L+ + + + + ++P
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63
Query: 468 -LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ-LSNLAIL 525
L + + +E L L+ ++ A + + + + N + +P + Q + L +L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVL 122
Query: 526 KLSNNSFYGRIPPEL-GDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584
L N +P + + L L ++ N I F+ + + + + +
Sbjct: 123 VLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL--------QNLQL 172
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT-FNHNGSMMFLDI 643
+ N RL+ + + + + ++ LD
Sbjct: 173 SS----------N----------RLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDA 212
Query: 644 SYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSS 703
S+N ++ + L IL L HNNL+ + GL +DLS N LE +
Sbjct: 213 SHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHP 267
Query: 704 MSSLTLLNEIDLCNNQLT 721
+ L + + NN+L
Sbjct: 268 FVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 41/226 (18%), Positives = 76/226 (33%), Gaps = 40/226 (17%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
+L+ L L ++ ++ + S L ++S N +S L +++ L+
Sbjct: 164 TTSLQNLQLSSNRLT---HVDLSLIPS--LFHANVSYN-------LLSTLAIPIAVEELD 211
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
S N ++ L +L L +N ++ W L ++ L N++
Sbjct: 212 ASHNSINVVRGPVNV---ELTILKLQHNNLTD---TAW--LLNYPGLVEVDLSYNELE-K 262
Query: 212 INV---SKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLS 268
I K + L+ L +S+N L+ LD+S N V + L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE 321
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS 314
L + N + L +L L LS N+
Sbjct: 322 NLYLDHNSIV------------TLKL---STHHTLKNLTLSHNDWD 352
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 868 IGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+GSG FG VYK VAIK+L + E E + + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQK-KVGIK--LNWAARRKIAIGSARGLAFL-H 977
LG C L+ + M +G L D + K +G + LNW A+G+ +L
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
+ HRD+ + NVL+ +++DFG+A+L+ A + G VP
Sbjct: 136 RRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWM 186
Query: 1034 -PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E ++ + + + DV+SYGV + EL+T G +P
Sbjct: 187 ALESILHRIY--THQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 868 IGSGGFGDVYKAKLK-----DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G G FG V + G+ VA+K+L H R+F E++ + + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 923 GYCKVGEER--LLVYEYMRYGSLEDVL-HNQKKVGIK--LNWAARRKIAIGSARGLAFLH 977
G + LV EY+ G L D L ++ ++ L +++ +G+ +L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGMEYLG 144
Query: 978 -HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---P 1033
C +HRD+ + N+L++ +++DFG+A+L+ + V +P +
Sbjct: 145 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IFWYA 198
Query: 1034 PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE F S + DV+S+GVVL EL T +
Sbjct: 199 PESLSDNIF--SRQSDVWSFGVVLYELFTYCDKS 230
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 26/279 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD----REFTAEMETIGKIKHRNLVPL 921
IG G F +VY+A L DG VA+KK + I D + E++ + ++ H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
E +V E G L ++ + KK + K + L +H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-- 155
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
++HRD+K +NV + ++ D G+ R S+ T +L GTP Y+ PE
Sbjct: 156 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENG 212
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI-SDVFDPELMKEDP 1100
+ K D++S G +L E+ + P +L ++Q + SD + EL
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR---- 268
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
+ + C++ P +RP + V + K + A
Sbjct: 269 ----------QLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
IGSG FG V+ + VAIK + + +F E E + K+ H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
LV E+M +G L D L Q+ + + G+A+L +IHR
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHR 128
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE--YYQSFRC 1042
D+ + N L+ EN +VSDFGM R + D + ST P V PE + +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFP--VKWASPEVFSFSRY-- 182
Query: 1043 STKGDVYSYGVVLLELLT-GKRP 1064
S+K DV+S+GV++ E+ + GK P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+GSG FG V K K VA+K + + EF E +T+ K+ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
+V EY+ G L + L + K L + ++ G+AFL + IHR
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE--YYQSFRC 1042
D+ + N L+D + +VSDFGM R + D S P V PE +Y +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFP--VKWSAPEVFHYFKY-- 182
Query: 1043 STKGDVYSYGVVLLELLT-GKRP 1064
S+K DV+++G+++ E+ + GK P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 863 HNDSLIGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRN 917
H+D +IG G FG VY + D + AIK L I+ F E + + H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 918 LVPLLGYCKVGEERLL-VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
++ L+G E + YM +G L + + ++ + ARG+ +L
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL 140
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP--- 1033
+HRD+ + N +LDE+F +V+DFG+AR + + + S +P
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKW 194
Query: 1034 --PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E F +TK DV+S+GV+L ELLT G P
Sbjct: 195 TALESLQTYRF--TTKSDVWSFGVLLWELLTRGAPP 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 868 IGSGGFGDVYKAKLK-----DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G G FG V + G VA+KKL H + + R+F E+E + ++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 923 GYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
G C R L+ EY+ YGSL D L K+ +++ + +G+ +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE 1035
IHRD+ + N+L++ ++ DFG+ +++ V PG P PE
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 1036 --YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077
F S DV+S+GVVL EL T + S ++G
Sbjct: 188 SLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-37
Identities = 72/343 (20%), Positives = 107/343 (31%), Gaps = 82/343 (23%)
Query: 212 INVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
+ L+V + + + L I N T
Sbjct: 34 MRACLNNGNAVLNVGESGLTTLPDCLPAH--ITTLVIPDNNLT----------------- 74
Query: 272 VSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFD 331
+P L L++S N L+ +P L F
Sbjct: 75 -------------------SLPALP----PELRTLEVSGNQLT-SLPVLPPGLLELSIFS 110
Query: 332 ISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP 391
LP S L +L + N T +LP L L +S N L+ ++P
Sbjct: 111 NPLTHLP-ALP-------SGLCKLWIFGNQLT-SLPVLPPGLQE---LSVSDNQLA-SLP 157
Query: 392 HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQ 451
+ L +L+ NN L S+P S L L +S N L ++P+ L KL
Sbjct: 158 ALPSE-----LCKLWAYNN-QLTSLPMLPSG---LQELSVSDNQLA-SLPTLPSELYKLW 207
Query: 452 DLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE 511
L L P L+ L + N LT +LP S L +S N L
Sbjct: 208 AYNNRLTSL----PALPSG---LKELIVSGNRLT-SLPVLPSELKELM---VSGNRL-TS 255
Query: 512 IPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
+P L + L + N R+P L S ++L N
Sbjct: 256 LPMLPSGLLS---LSVYRNQL-TRLPESLIHLSSETTVNLEGN 294
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-29
Identities = 71/381 (18%), Positives = 120/381 (31%), Gaps = 73/381 (19%)
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
+ L + + T LPD L ++ TL + NNL+ ++P + L+ L +
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPE-----LRTLEVSG 90
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
N L S+P +L +L S L L ++ NQL +P
Sbjct: 91 NQL-TSLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLPVLPP 141
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
L+ L + N+L +LPA S L NN L +P L L +S+
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQEL---SVSD 190
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589
N +P L L N S+P
Sbjct: 191 NQL-ASLPTLPS---ELYKLWAYNNRLT-SLPALP------------------------- 220
Query: 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTF--NHNGSMMFLDISYNM 647
L E + RL+ + P + + T ++ L + N
Sbjct: 221 ------SGLKELI-VSGNRLTSLPV-LPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQ 272
Query: 648 LSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILD---LSSNRLEGTIPSSM 704
L+ +P+ + +S +NL N LS + ++ + + + P
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRET 331
Query: 705 SSLTLLNEIDLCNNQLTGMIP 725
+L L L + P
Sbjct: 332 RALHLAAADWLVPAREGEPAP 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 83/476 (17%), Positives = 153/476 (32%), Gaps = 90/476 (18%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
+ L++ S ++ +LP + +++L + N L+ + L+ L
Sbjct: 39 NNGNAVLNVGESGLT---TLPDCL--PAHITTLVIPDN----NLTSLP--ALPPELRTLE 87
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
+S N L L L + + L +L + GN++T
Sbjct: 88 VSGNQLTSLPVLPPGLL-ELSIFSNPLTHLP----------ALPSGLCKLWIFGNQLT-S 135
Query: 212 INVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
+ V LQ L VS N + + L L N+ T + S L L+
Sbjct: 136 LPVL-PPGLQELSVSDNQLASLPALPSE---LCKLWAYNNQLT-SLPMLPS---GLQELS 187
Query: 272 VSSNLFSGPIP----------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRF 321
VS N + +P N L L S L +L +S N L+ +P
Sbjct: 188 VSDNQLAS-LPTLPSELYKLWAYNNRLT-----SLPALPSGLKELIVSGNRLTS-LPV-- 238
Query: 322 GSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
S L+ +S N+ + LP+ S L L + N T LP+SL +L++ T++L
Sbjct: 239 -LPSELKELMVSGNRLT-SLPMLP----SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS-FNYLTGTI 440
N LS + + + ++ + S + +LHL+ ++L
Sbjct: 292 EGNPLS-ERTLQALR----EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
Query: 441 PSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNW 500
+ G + L + L+ T
Sbjct: 347 EGEPAPADRWH---------------MFGQEDNADAFSLFLDRLSETENFI--------- 382
Query: 501 ISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLF 556
+ +I +W+ QL+ L+ + + D + +
Sbjct: 383 ---KDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQMKNVQL 435
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 5e-19
Identities = 60/342 (17%), Positives = 103/342 (30%), Gaps = 103/342 (30%)
Query: 399 RNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLN 458
R + E ++ + + L + L++ + LT
Sbjct: 17 RAAPAEESRGRAAVVQKMRACL--NNGNAVLNVGESGLT--------------------- 53
Query: 459 QLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ 518
+P L + TL + N LT +LPA L +S N L +P
Sbjct: 54 ----TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPG 102
Query: 519 LSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVG 578
L L+I +P L L + N S+P
Sbjct: 103 LLELSIFSNPLTH----LPALPS---GLCKLWIFGNQLT-SLPVLPPG------------ 142
Query: 579 KKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTF--NHNG 636
L+ + +L+ + P +++ + Q T
Sbjct: 143 --------------------LQELSVSDNQLASL-PALPSELCKLWAYNNQLTSLPMLPS 181
Query: 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILN-----------------LGHNNLSGPIPTE 679
+ L +S N L+ S+P + L+ N + N L+ +P
Sbjct: 182 GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVL 239
Query: 680 VGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
+L+ L +S NRL ++P S L L + NQLT
Sbjct: 240 PSELK---ELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT 274
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 4e-15
Identities = 49/277 (17%), Positives = 88/277 (31%), Gaps = 63/277 (22%)
Query: 474 LETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY 533
L + + LT TLP L ++ + + +N+L +P +L L ++S N
Sbjct: 42 NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT 94
Query: 534 GRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECH 593
+P L ++P L K
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK--------------------------- 125
Query: 594 GAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTF--NHNGSMMFLDISYNMLSGS 651
L G + L P + Q + L N L+ S
Sbjct: 126 -----LWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLT-S 175
Query: 652 IPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLN 711
+P + L ++ N L+ +PT +L L + NRL ++P+ S L L
Sbjct: 176 LPMLPSGLQEL---SVSDNQLAS-LPTLPSELYKLWAYN---NRLT-SLPALPSGLKEL- 226
Query: 712 EIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLP 748
+ N+LT + + + + ++ + L LP
Sbjct: 227 --IVSGNRLTSLPVLPSELKEL----MVSGNRLTSLP 257
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IG G F VYK + VA + ++ + F E E + ++H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 924 YCKV---GEERLLVY-EYMRYGSLEDVLHNQKKVGIKL--NWAARRKIAIGSARGLAFLH 977
+ G++ +++ E M G+L+ L K + IK+ +W R+I +GL FLH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC--RQIL----KGLQFLH 146
Query: 978 HNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
P IIHRD+K N+ + ++ D G+A L A + GTP ++ PE
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM 201
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
Y+ + DVY++G+ +LE+ T + P
Sbjct: 202 YEE-KYDESVDVYAFGMCMLEMATSEYP 228
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-37
Identities = 77/399 (19%), Positives = 136/399 (34%), Gaps = 72/399 (18%)
Query: 112 PAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSL 171
P CS+ ++ I + ++L+L N + ++ + L
Sbjct: 4 PPRCECSAQDRAVLCHRKRFVAVPEGIP-----TETRLLDLGKNRIKTLNQDEFASFPHL 58
Query: 172 EVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFS 231
E L+L+ N +S V FN L+ L L+ N++
Sbjct: 59 EELELNENIVS---AVEPGAFNNLFNLRTLGLRSNRLK---------------------L 94
Query: 232 MAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGE 291
+ + F L LDIS NK + +F
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIV----------------ILLDYMFQD------------ 126
Query: 292 IPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSN 351
+L L++ N+L F +SLE + + +P E +
Sbjct: 127 --------LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
Query: 352 LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL 411
L L L + S L L+ L++S + N G +L L + +
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL--NLTSLSITHCN 235
Query: 412 LLGSIPS-TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LG 469
L ++P + + L L+LS+N ++ S L L +LQ+++L QL + P
Sbjct: 236 L-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
+ L L + N+LT + + NL + L +N L
Sbjct: 294 GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 62/269 (23%), Positives = 117/269 (43%), Gaps = 8/269 (2%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
L +L+L+ N +S P F + +L + + SN+ +P+ +F +SNL +L +S N
Sbjct: 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISEN 114
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-T 419
L +L NL++L++ N+L I H G + L++L L+ L SIP+
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS-LEQLTLEKCNL-TSIPTEA 171
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479
LS+ L+ L L + S L +L+ L++ + P L +L +
Sbjct: 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539
LT A+ + L +++LS N + + + +L L ++L + P
Sbjct: 232 THCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPY 290
Query: 540 -LGDCRSLIWLDLNTNLFNGSIPPALFKQ 567
L L+++ N ++ ++F
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 77/404 (19%), Positives = 136/404 (33%), Gaps = 85/404 (21%)
Query: 323 SCS-SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
CS + +F +P I + + L L N D ++ +LE L+L
Sbjct: 8 ECSAQDRAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELEL 63
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441
+ N +S A+ P +N L +L L N L
Sbjct: 64 NENIVS-AVE-------------------------PGAFNNLFNLRTLGLRSNRLKLIPL 97
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPAALSNCTNLNW 500
LS L L + N++ + + ++ L++L + N+L A S +L
Sbjct: 98 GVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQ 156
Query: 501 ISLSNNHLGGEIPT-WIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNG 558
++L +L IPT + L L +L+L + + I L L+++ +
Sbjct: 157 LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 559 SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPC 618
++ P NL ++ C
Sbjct: 215 TMTPNCLYGL----------------------------NLTSL------SITH------C 234
Query: 619 NFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIP 677
N T V H + FL++SYN +S +I + + L + L L+ +
Sbjct: 235 NLTAVPYL----AVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VE 288
Query: 678 TEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
L L +L++S N+L S S+ L + L +N L
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 61/314 (19%), Positives = 106/314 (33%), Gaps = 33/314 (10%)
Query: 94 TLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISY--LGSCSSLKVL 150
L L + I +L L L+L+ N +S + + +L+ L
Sbjct: 33 ETRLLDLGKNRIK---TLNQDEFASFPHLEELELNEN----IVSAVEPGAFNNLFNLRTL 85
Query: 151 NLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
L SN L + +L LD+S NKI ++ +F LK L + N +
Sbjct: 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIV---ILLDYMFQDLYNLKSLEVGDNDLV- 141
Query: 211 DINV---SKCKNLQFLDVSSNNFSM-AVPSFGDCLALEYLDISANKFTGDVGHAISACEH 266
I+ S +L+ L + N + + L L + ++
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 267 LSFLNVSSNLFSGPIPVG-------------YNEFQGEIPLHLADLCSSLVKLDLSSNNL 313
L L +S + + + +P L L+LS N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
Query: 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNL 373
S S L+ + + + + F ++ L+ L +S N T ++
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 374 TNLETLDLSSNNLS 387
NLETL L SN L+
Sbjct: 320 GNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 70/349 (20%), Positives = 119/349 (34%), Gaps = 59/349 (16%)
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
+ A+P + P + L L N + ++ L L L+ N ++
Sbjct: 15 AVLCHRKRFV-AVPEGI---PTE-TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 438 GTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCT 496
P + +L L+ L L N+L IP + L L + N++ L +
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 497 NLNWISLSNNHLGGEIPT-WIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTN 554
NL + + +N L I L++L L L + IP E L LI L L
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHL 186
Query: 555 LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST 614
N +I FK L ++
Sbjct: 187 NIN-AIRDYSFK---------------------------RLYRL------------KVLE 206
Query: 615 RSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE-IGSMSYLFILNLGHNNLS 673
S + P + ++ L I++ L+ ++P + + YL LNL +N +S
Sbjct: 207 ISHWPYLD----TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 674 GPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
I + +L L + L +L P + L L +++ NQLT
Sbjct: 262 T-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-10
Identities = 42/253 (16%), Positives = 72/253 (28%), Gaps = 53/253 (20%)
Query: 476 TLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR 535
+ +P + T + L N + +L L+L+ N
Sbjct: 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SA 70
Query: 536 IPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHG 594
+ P + +L L L +N IP +F G
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT---------------------------G 102
Query: 595 AGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPK 654
NL + +S + F ++ L++ N L I
Sbjct: 103 LSNLTKL------DISE------NKIVILLDY----MFQDLYNLKSLEVGDNDLV-YISH 145
Query: 655 EI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNE 712
++ L L L NL+ IPTE L GL +L L + S L L
Sbjct: 146 RAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKV 204
Query: 713 IDLCNNQLTGMIP 725
+++ + +
Sbjct: 205 LEISHWPYLDTMT 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-37
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLL 922
IG G FG VY L D A+K L I+ G+ +F E + H N++ LL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 923 GYCKVGEE-RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G C E L+V YM++G L + + N+ + A+G+ +L
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE- 1035
+HRD+ + N +LDE F +V+DFG+AR M + + + T +P E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMALES 203
Query: 1036 -YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
Q F +TK DV+S+GV+L EL+T G P
Sbjct: 204 LQTQKF--TTKSDVWSFGVLLWELMTRGAPP 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G+G FG V K + VAIK + S D EF E + + + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
++ EYM G L + L + + ++ + +L +HR
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE--YYQSFRC 1042
D+ + N L+++ +VSDFG++R + +D + S + P V PPE Y F
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFP--VRWSPPEVLMYSKF-- 198
Query: 1043 STKGDVYSYGVVLLELLT-GKRP 1064
S+K D++++GV++ E+ + GK P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-37
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 868 IGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+GSG FG V+K V IK + SG+ T M IG + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLH-NQKKVGIK--LNWAARRKIAIGSARGLAFLHH 978
LG C G LV +Y+ GSL D + ++ +G + LNW A+G+ +L
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYYLEE 133
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP----- 1033
+ ++HR++ + NVLL + +V+DFG+A L+ D L + P
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEAKTPIKWMA 185
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E + + + DV+SYGV + EL+T G P
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-36
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 868 IGSGGFGDVYKAKLKDGST-VAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G +G+VY+ K S VA+K L + + + EF E + +IKH NLV LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
++ E+M YG+L D L +++ +A + + +L + IH
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLM------SAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
R++ + N L+ EN +V+DFG++RLM + + A PE
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA-------PESLAYN 394
Query: 1041 RCSTKGDVYSYGVVLLELLT-GKRP 1064
+ S K DV+++GV+L E+ T G P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 868 IGSGGFGDVYKAKL-----KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G G FG V + G VA+KKL H + + R+F E+E + ++H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 923 GYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
G C R L+ EY+ YGSL D L K+ +++ + +G+ +L
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK- 164
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE 1035
IHRD+ + N+L++ ++ DFG+ +++ + V PG P PE
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 1036 --YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077
F S DV+S+GVVL EL T + S ++G
Sbjct: 219 SLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 33/278 (11%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHRNLVPLL 922
IG+G +G K + DG + K+ + + E +E+ + ++KH N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKE-LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 923 G--YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--H 978
+ +V EY G L V+ K L+ ++ L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+ ++HRD+K +NV LD ++ DFG+AR+++ T GTP Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMN 189
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK---LKISDVFDPEL 1095
+ K D++S G +L EL P F + + + +I + EL
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKELAGKIREGKFRRIPYRYSDEL 244
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ + L+ + + RP++ +++
Sbjct: 245 N--------------EIITRMLNLKDYHRPSVEEILEN 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 28/271 (10%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTAEMETIGKIKHRNLVPLL 922
IG G FG K +DG IK+ I+IS +E E+ + +KH N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
+ +V +Y G L ++ QK V + + + L +H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQICLALKHVHDR--- 144
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
I+HRD+KS N+ L ++ ++ DFG+AR++++ T GTP Y+ PE ++
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPY 202
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNI 1102
+ K D+++ G VL EL T K ++ NLV + + +S + +L
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKIISGSFPPVSLHYSYDLR------ 254
Query: 1103 EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ S P RP++ ++
Sbjct: 255 --------SLVSQLFKRNPRDRPSVNSILEK 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-36
Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLL 922
IG G FG VY L D A+K L I+ G+ +F E + H N++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 923 GYCKVGEE-RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G C E L+V YM++G L + + N+ + A+G+ FL
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK-- 211
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE- 1035
+HRD+ + N +LDE F +V+DFG+AR M + S T +P E
Sbjct: 212 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVKWMALES 267
Query: 1036 -YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
Q F +TK DV+S+GV+L EL+T G P
Sbjct: 268 LQTQKF--TTKSDVWSFGVLLWELMTRGAPP 296
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 868 IGSGGFGDVYKAKLKDGST-VAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
+G G +G+VY+ K S VA+K L + E F E + +IKH NLV LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHNCIPHI 984
++ E+M YG+L D L +++ +A + + +L N
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF---- 132
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE--YY 1037
IHRD+ + N L+ EN +V+DFG++RLM+ DT+ A P PE Y
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY-----TAHAGAKFPIKWTAPESLAY 186
Query: 1038 QSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
F S K DV+++GV+L E+ T G P
Sbjct: 187 NKF--SIKSDVWAFGVLLWEIATYGMSP 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYCK 926
+G+G FG+V+ + VA+K L G + F AE + +++H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
E ++ EYM GSL D L GIKL +A A G+AF+ + IH
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE--YYQSFR 1041
RD++++N+L+ + +++DFG+ARL+ D + A P + PE Y +F
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFP--IKWTAPEAINYGTF- 187
Query: 1042 CSTKGDVYSYGVVLLELLT-GKRP 1064
+ K DV+S+G++L E++T G+ P
Sbjct: 188 -TIKSDVWSFGILLTEIVTHGRIP 210
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 868 IGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+GSG FG VYK VAIK+L + E E + + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLH-NQKKVGIK--LNWAARRKIAIGSARGLAFL-H 977
LG C + L+ + M +G L D + ++ +G + LNW A+G+ +L
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYLED 135
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
+ HRD+ + NVL+ +++DFG+A+L+ A + G VP
Sbjct: 136 RRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWM 186
Query: 1034 -PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E ++ + + + DV+SYGV + EL+T G +P
Sbjct: 187 ALESILHRIY--THQSDVWSYGVTVWELMTFGSKP 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 31/207 (14%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
IG G FGDV + G+ VA+K + + + F AE + +++H NLV LLG
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 928 GEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHNCIPHII 985
+ L +V EYM GSL D L + + L K ++ + +L +N +
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---- 139
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE--YYQ 1038
HRD+ + NVL+ E+ A+VSDFG+ + + + T G +P PE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT-----GKLPVKWTAPEALREK 189
Query: 1039 SFRCSTKGDVYSYGVVLLELLT-GKRP 1064
F STK DV+S+G++L E+ + G+ P
Sbjct: 190 KF--STKSDVWSFGILLWEIYSFGRVP 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 868 IGSGGFGDVYKAKLK-----DGSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+G G FG V + G VA+K L SG + E+E + + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 922 LGYC--KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C G L+ E++ GSL++ L K K+N + K A+ +G+ +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR 145
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE- 1035
+HRD+ + NVL++ + ++ DFG+ + + + +V +P V PE
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP--VFWYAPEC 200
Query: 1036 -YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
F DV+S+GV L ELLT
Sbjct: 201 LMQSKF--YIASDVWSFGVTLHELLTYCDSD 229
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 36/223 (16%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V+ A+ + S VA+K L + ++F E E + ++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KIAIGS 969
G C G+ ++V+EYM++G L L + L R IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
A G+ +L H +HRD+ + N L+ N ++ DFGM+R + + D + G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGGH 194
Query: 1030 GYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+P PE Y+ F +T+ DV+S+GV+L E+ T GK+P
Sbjct: 195 TMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFTYGKQP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 32/287 (11%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G GGF V + L DG A+K+++ Q E E + H N++ L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 926 KV----GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
E L+ + + G+L + + K G L + +G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLA------GTPGYVPP 1034
HRD+K +N+LL + + + D G ++ TL T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 1035 E---YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
E + DV+S G VL ++ G+ P D +++ V+ + S
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
L +LL ++ + P +RP + +++ + +Q
Sbjct: 273 SSAL--------WQLL------NSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 50/287 (17%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLV- 919
F LIGSGGFG V+KAK DG T IK+ + + + E++ + K+ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAER---EVKALAKLDHVNIVH 68
Query: 920 ------------PLLGYCKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
+ ++ E+ G+LE + ++ + A +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA--LE 126
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ +G+ ++H +I+RD+K SN+ L + + ++ DFG+ + +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TR 180
Query: 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
GT Y+ PE S + D+Y+ G++L ELL F + ++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----FETSKFFTDLR---D 233
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
ISD+FD + LLQ L +P RP +++
Sbjct: 234 GIISDIFDKKEK--------TLLQ------KLLSKKPEDRPNTSEIL 266
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 868 IGSGGFGDVYKAKLKDGS---TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLLG 923
+G G FG V + + VAIK L + + D E E + + ++ + +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
C+ E +LV E G L L +++ ++ + ++ + G+ +L +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE--YYQ 1038
+HRD+ + NVLL A++SDFG+++ + A D++ + + P + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP--LKWYAPECINFR 188
Query: 1039 SFRCSTKGDVYSYGVVLLELLT-GKRP 1064
F S++ DV+SYGV + E L+ G++P
Sbjct: 189 KF--SSRSDVWSYGVTMWEALSYGQKP 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V+ A+ + VA+K L S ++F E E + ++H+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVL-----------HNQKKVGIKLNWAARRKIAIGSA 970
G C G L+V+EYMR+G L L + L +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
G+ +L H +HRD+ + N L+ + ++ DFGM+R + + D G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YRVGGRT 220
Query: 1031 YVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+P PE Y+ F +T+ DV+S+GVVL E+ T GK+P
Sbjct: 221 MLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFTYGKQP 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 867 LIGSGGFGDVYKAKLKDGS---TVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRNLVPL 921
+IG G FG V KA++K AIK++ + + D +F E+E + K+ H N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KIAIGS 969
LG C+ L EY +G+L D L + + +A A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
ARG+ +L IHRD+ + N+L+ EN+ A+++DFG++R + V T
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKK---TM 200
Query: 1030 GYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
G +P E Y + +T DV+SYGV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG VY+ K VAIK + + +R EF E + + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL------HNQKKVGIKLNWAARRKIAIGSARGLA 974
LLG G+ L++ E M G L+ L V + + ++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP- 1033
+L+ N +HRD+ + N ++ E+F ++ DFGM R + D G G +P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPV 204
Query: 1034 ----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE F +T DV+S+GVVL E+ T ++P
Sbjct: 205 RWMSPESLKDGVF--TTYSDVWSFGVVLWEIATLAEQP 240
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G G FG+V+ + VAIK L + + F E + + K++H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS- 249
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
E +V EYM GSL D L + + G L +A A G+A++ + +HR
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTKG 1046
D++++N+L+ EN +V+DFG+ARL+ D + A P + PE R + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 1047 DVYSYGVVLLELLT-GKRP 1064
DV+S+G++L EL T G+ P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 865 DSLIGSGGFGDVYKAKLKDGS---TVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLV 919
D +GSG FG V K + TVA+K K E AE + ++ + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK--LNWAARRKIAIGSARGLAFL- 976
++G C+ E +LV E G L L + V K + + G+ +L
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH------QVSMGMKYLE 134
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP--- 1033
N + HRD+ + NVLL A++SDFG+++ + A + + A T G P
Sbjct: 135 ESNFV----HRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKW 186
Query: 1034 --PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE Y F S+K DV+S+GV++ E + G++P
Sbjct: 187 YAPECINYYKF--SSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V + LK VA+K KL + S + EF +E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 922 LGYC-----KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR--KIAIGSARGLA 974
LG C + + +++ +M+YG L L + + + K + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP- 1033
+L + + +HRD+ + N +L ++ V+DFG+++ + + D + G +P
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPV 213
Query: 1034 ----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E + + ++K DV+++GV + E+ T G P
Sbjct: 214 KWIAIESLADRVY--TSKSDVWAFGVTMWEIATRGMTP 249
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 865 DSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA----EMETIGKIKHRNLV 919
+G GG VY A+ VAIK I I + E E+ ++ H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 920 PLLGYCKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
++ V EE Y EY+ +L + + + L+ G+
Sbjct: 75 SMI---DVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHA 127
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H I+HRD+K N+L+D N ++ DFG+A+ +S + + + GT Y PE
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPEQ 183
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ D+YS G+VL E+L G+ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLL 922
IGSG G+V +L+ VAIK L + R +F +E +G+ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
G G ++V EYM GSL+ L + + G G+ +L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPE--YY 1037
+HRD+ + NVL+D N +VSDFG++R++ +T P + PE +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP--IRWTAPEAIAF 228
Query: 1038 QSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++F S+ DV+S+GVV+ E+L G+RP
Sbjct: 229 RTF--SSASDVWSFGVVMWEVLAYGERP 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-35
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
IG G FGDV + G+ VA+K + + + F AE + +++H NLV LLG
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 928 GEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
+ L +V EYM GSL D L + + L K ++ + +L N + +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEYYQSFR 1041
RD+ + NVL+ E+ A+VSDFG+ + S+ G +P PE + +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----------GKLPVKWTAPEALREKK 362
Query: 1042 CSTKGDVYSYGVVLLELLT-GKRP 1064
STK DV+S+G++L E+ + G+ P
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 38/280 (13%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNL--VPLL 922
IGSGG V++ + AIK L Q + E+ + K++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
Y + +V E L L +K ++ R+ + +H +
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE------- 1035
I+H D+K +N L+ + ++ DFG+A M T + + GT Y+PPE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+ S K DV+S G +L + GK P + L + + +++ D+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ +L ++L+ CL P +R ++ +++
Sbjct: 266 EKDL--------QDVLKC------CLKRDPKQRISIPELL 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-35
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G+G FG+V+ A + VA+K + S + F AE + ++H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
E ++ E+M GSL D L + + G K + A G+AF+ + IHR
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV---PPEYYQSFRCST 1044
D++++N+L+ + +++DFG+AR++ D + A P + PE +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFP--IKWTAPEAINFGSFTI 364
Query: 1045 KGDVYSYGVVLLELLT-GKRP 1064
K DV+S+G++L+E++T G+ P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 868 IGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
IG+G FG+VYK LK S VAIK L + R +F E +G+ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G + +++ EYM G+L+ L + + + + G A G+ +L +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM-- 166
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE- 1035
+ +HRD+ + N+L++ N +VSDFG++R++ D + T +G G +P PE
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSG--GKIPIRWTAPEA 221
Query: 1036 -YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
Y+ F ++ DV+S+G+V+ E++T G+RP
Sbjct: 222 ISYRKF--TSASDVWSFGIVMWEVMTYGERP 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG+VY+ ++ VA+K L + + D +F E I K H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHN---QKKVGIKLNWAARRKIAIGSARGLAFLH 977
+G R ++ E M G L+ L + L +A A G +L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 978 HNCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP- 1033
N H IHRD+ + N LL A++ DFGMAR D + + G +P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 1034 ----PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE + ++K D +S+GV+L E+ + G P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 865 DSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA----EMETIGKIKHRNLV 919
L+G GG GDVY+A+ VA+K L+ + D F E T G+++ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 920 PLLGYCKVGEERLLVYEYMRY---GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
P+ + GE +Y MR L +L Q + A I L
Sbjct: 98 PIHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP--RAVA--IVRQIGSALDAA 150
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL-SVSTLAGTPGYVPPE 1035
H HRD+K N+L+ + A + DFG+A + D L + GT Y+ PE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPE 205
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ + + D+Y+ VL E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 61/213 (28%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 868 IGSGGFGDVYKAKLKD-----GSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPL 921
+G G FG V G VA+K L +G R + E++ + + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 922 LGYC--KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C LV EY+ GSL D L + A A G+A+LH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ 153
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----P 1034
H IHRD+ + NVLLD + ++ DFG+A+ + + V G P P
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPVFWYAP 206
Query: 1035 E--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E F DV+S+GV L ELLT
Sbjct: 207 ECLKEYKF--YYASDVWSFGVTLYELLTHCDSS 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/232 (24%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 868 IGSGGFGDVYKAKLKDG------STVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG V KA +TVA+K L + + + +E + ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS----------- 969
L G C LL+ EY +YGSL L +KVG + + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 970 ---------ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020
++G+ +L ++HRD+ + N+L+ E + ++SDFG++R + D++
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 1021 SVSTLAGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+ + G +P E + + +T+ DV+S+GV+L E++T G P
Sbjct: 207 ----VKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 40/227 (17%)
Query: 868 IGSGGFGDVYKAKLKD--------GSTVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRN 917
+G G FG V A+ TVA+K L + + D + +EME + I KH+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KI 965
++ LLG C ++ EY G+L + L ++ G++ ++ R
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
ARG+ +L IHRD+ + NVL+ EN +++DFG+AR ++ +D +
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 214
Query: 1026 AGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
T G +P PE + + + + + DV+S+GV++ E+ T G P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSP 259
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-34
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G G FG+V+ + VAIK L + + F E + + K++H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
E +V EYM GSL D L + + G L +A A G+A++ + +HR
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQSFRCSTKG 1046
D++++N+L+ EN +V+DFG+ARL+ D + A P + PE R + K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 1047 DVYSYGVVLLELLT-GKRP 1064
DV+S+G++L EL T G+ P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G FG VYK L + VAIK L + R EF E +++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL------------HNQKKVGIKLNWAARRKIAIG 968
LLG + +++ Y +G L + L + + V L +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
A G+ +L + H++H+D+ + NVL+ + ++SD G+ R + A D
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-----YKLLG 188
Query: 1029 PGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+P PE Y F S D++SYGVVL E+ + G +P
Sbjct: 189 NSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 64/305 (20%), Positives = 98/305 (32%), Gaps = 43/305 (14%)
Query: 264 CEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS 323
+ ++S N F I K L N + S
Sbjct: 5 LPINNNFSLSQNSFYNTIS--------GTYADYFSAWDKWEKQALPGENR-NEAVSLLKE 55
Query: 324 C--SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
C + ++ S LP + + L ++ N +LP+ +LE LD
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELP---ASLEYLDA 107
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441
N LS +P SLK L + NN L +P + L ++ N LT +P
Sbjct: 108 CDNRLS-TLPELPA-----SLKHLDVDNNQL-TMLPELPAL---LEYINADNNQLT-MLP 156
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNL--- 498
SL + L + NQL +P + LE L + N L +LPA +
Sbjct: 157 ELPTSL---EVLSVRNNQL-TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEET 208
Query: 499 -NWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFN 557
+ N + IP I L + L +N RI L + F+
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
Query: 558 GSIPP 562
S
Sbjct: 268 MSDGQ 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 52/258 (20%), Positives = 89/258 (34%), Gaps = 32/258 (12%)
Query: 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358
L + +L L+ NLS +P + +I+ N LP ++L+ L
Sbjct: 57 LINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELP----ASLEYLDAC 108
Query: 359 FNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS 418
N + LP+ ++L +L D+ +N L+ +P L+ + NN L +P
Sbjct: 109 DNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL-----LEYINADNNQL-TMLPE 157
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET-- 476
++ L L + N LT +P SL + L + N L +P E
Sbjct: 158 LPTS---LEVLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETE 209
Query: 477 --LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534
N +T +P + + I L +N L I + Q + F
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 535 RIPPELGDCRSLIWLDLN 552
+ R L
Sbjct: 269 SDGQQNTLHRPLADAVTA 286
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-26
Identities = 74/408 (18%), Positives = 143/408 (35%), Gaps = 68/408 (16%)
Query: 174 LDLSYNKISGANVVPWILFNGCDELKQLALKG---NKVTGDINVSKCKNLQFLDVSSNNF 230
+ YN ISG F+ D+ ++ AL G N+ + L ++ N
Sbjct: 15 QNSFYNTISG---TYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL 71
Query: 231 SMAVPSFGDCLALEYLDISANKFTGDVGHAI-SACEHLSFLNVSSNLFSGPIPVGYNEFQ 289
S ++P + L+I+ N ++ L +L+ N S
Sbjct: 72 S-SLPD-NLPPQITVLEITQNALI-----SLPELPASLEYLDACDNRLS----------- 113
Query: 290 GEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSM 349
+P +L +SL LD+ +N L+ +P + LE + +N+ + LP
Sbjct: 114 -TLP----ELPASLKHLDVDNNQLT-MLPE---LPALLEYINADNNQLT-MLPELP---- 159
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGP--RNSLKELFL 407
++L+ L + N T LP+ +L E LD+S+N L ++P + +
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 408 QNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE 467
+ N + IP + + ++ L N L+ I SL + D +
Sbjct: 215 RENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTN--------------LNWISLSNNH-----L 508
+ L + + +S + L+ +S + +
Sbjct: 274 NTLHRPLADAVTAW--FPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGF 331
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLF 556
++ W+ +LS A L+ + + D +L W +L L
Sbjct: 332 REQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-20
Identities = 56/330 (16%), Positives = 94/330 (28%), Gaps = 76/330 (23%)
Query: 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQ--TLETLFLDFNEL 484
+S + +N ++GT + K + L E L L L+ L
Sbjct: 13 LSQNSFYNTISGTYADYFSAWDKWEKQALPGEN-RNEAVSLLKECLINQFSELQLNRLNL 71
Query: 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR 544
+ +LP L + + ++ N L +P L L +N +P
Sbjct: 72 S-SLPDNL--PPQITVLEITQNALI-SLPELPASLEYL---DACDNRL-STLPELPA--- 120
Query: 545 SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGI 604
SL LD++ N +P LLE+
Sbjct: 121 SLKHLDVDNNQLT-MLPELP--------------------------------ALLEYINA 147
Query: 605 RAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFI 664
+L+ + P + L + N L+ +P+ S L
Sbjct: 148 DNNQLTMLPE-LPTSLEV------------------LSVRNNQLT-FLPELPES---LEA 184
Query: 665 LNLGHNNLSGPIPTEVGDLRGL----NILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
L++ N L +P NR+ IP ++ SL I L +N L
Sbjct: 185 LDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 721 TGMIPVMGQFETFQPAKFLNNSGLCGLPLP 750
+ I +T QP
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 6e-10
Identities = 41/242 (16%), Positives = 73/242 (30%), Gaps = 72/242 (29%)
Query: 495 CTNLNWISLSNN-------HLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
N SLS N + + + A+ + N + L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 548 WLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAE 607
L LN + S+P L + I
Sbjct: 63 ELQLNRLNLS-SLPDNL-------------------------------PPQITVLEITQN 90
Query: 608 RLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNL 667
L + P S+ +LD N LS ++P+ S+ +L ++
Sbjct: 91 ALISL----PELP---------------ASLEYLDACDNRLS-TLPELPASLKHL---DV 127
Query: 668 GHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM 727
+N L+ +P L ++ +N+L +P +SL +L + NNQLT + +
Sbjct: 128 DNNQLTM-LPELPALLE---YINADNNQLT-MLPELPTSLEVL---SVRNNQLTFLPELP 179
Query: 728 GQ 729
Sbjct: 180 ES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 5e-09
Identities = 57/411 (13%), Positives = 112/411 (27%), Gaps = 105/411 (25%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILS------GPLS--DISYL-- 141
++ L L N+S SLP ++ L+++ N L L D
Sbjct: 58 INQFSELQLNRLNLS---SLPDNL--PPQITVLEITQNALISLPELPASLEYLDACDNRL 112
Query: 142 ----GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDE 197
+SLK L++ +N L L E ++ N+++ ++P
Sbjct: 113 STLPELPASLKHLDVDNNQLTMLPELPALL----EYINADNNQLT---MLP--------- 156
Query: 198 LKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDV 257
+L+ L V +N + +LE LD+S N
Sbjct: 157 -----------------ELPTSLEVLSVRNNQLTFLPELPE---SLEALDVSTNLLES-- 194
Query: 258 GHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKV 317
+P +P+ + + N ++ +
Sbjct: 195 -----------------------LP--------AVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 318 PSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE 377
P S + + N S E + + F+ D N +
Sbjct: 223 PENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSM--SDGQQNTLHRP 279
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
D + ++ Q + + +T S +S +S +
Sbjct: 280 LADAVTAWFPENKQSDVSQ----------IWHAFEHEEHANTFSAFLDRLSDTVSARNTS 329
Query: 438 GT---IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485
G + + L LS +L+ + + + L L L
Sbjct: 330 GFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 39/297 (13%), Positives = 88/297 (29%), Gaps = 55/297 (18%)
Query: 95 LETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSS 154
LE ++ N+ ++ LP +S L L + N L+ + SL+ L++S+
Sbjct: 142 LEYINADNNQLT---MLPE--LPTS-LEVLSVRNN----QLTFLP--ELPESLEALDVST 189
Query: 155 NLLDFSGREAG---SLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
NLL+ + + N+I+ +P + + L
Sbjct: 190 NLLESLPAVPVRNHHSEETEIFFRCRENRIT---HIP-------ENILSL---------- 229
Query: 212 INVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271
+ + N S + + + +
Sbjct: 230 ------DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADA 283
Query: 272 VSSNL---FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSN-----NLSGKVPSRFGS 323
V++ + ++ F+ E H + L +L + + +V +
Sbjct: 284 VTAWFPENKQSDVSQIWHAFEHEE--HANTFSAFLDRLSDTVSARNTSGFREQVAAWLEK 341
Query: 324 CSSLESFDISSNKFSGELPIEI----FLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
S+ S + + L+ +NL++ +L G + L +L
Sbjct: 342 LSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 38/280 (13%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNL--VPLL 922
IGSGG V++ + AIK L Q + E+ + K++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
Y + +V E L L +K ++ R+ + +H +
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE------- 1035
I+H D+K +N L+ + ++ DFG+A M T + + GT Y+PPE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+ S K DV+S G +L + GK P + L + + +++ D+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ +L ++L+ CL P +R ++ +++
Sbjct: 247 EKDL--------QDVLKC------CLKRDPKQRISIPELL 272
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 23/277 (8%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
LDL +N ++ F + +L + + +NK S ++ F + L+ L LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN 110
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI--PS 418
LP+ + L+ L + N ++ + ++ G + + L N L S
Sbjct: 111 QLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQ-MIVVELGTNPLKSSGIENG 165
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETL 477
+L + ++ +T TIP G L +L L N++ ++ L + L L
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 478 FLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537
L FN ++ +L+N +L + L+NN L ++P + + ++ L NN+ I
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNI-SAIG 279
Query: 538 PE-------LGDCRSLIWLDLNTN-LFNGSIPPALFK 566
S + L +N + I P+ F+
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 68/326 (20%), Positives = 130/326 (39%), Gaps = 42/326 (12%)
Query: 219 NLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
+L+ + S VP D LD+ NK T ++L L + +N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
S I G F L +L LS N L ++P +L+ + N+
Sbjct: 88 ISK-ISPG--AFAP---------LVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENE 132
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGAL--PDSLSNLTNLETLDLSSNNLSGAIPHNL 394
+ ++ +F ++ + + L N + + + L + ++ N++ IP L
Sbjct: 133 IT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 190
Query: 395 CQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453
SL EL L N + + + +L + L L LSFN ++ SL + L++L
Sbjct: 191 PP----SLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245
Query: 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELTG------TLPAALSNCTNLNWISLSNNH 507
L N+L ++P L + + ++ ++L N ++ P + + + +SL +N
Sbjct: 246 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304
Query: 508 LG-GEIP--TWIGQLSNLAILKLSNN 530
+ EI T+ + A ++L N
Sbjct: 305 VQYWEIQPSTFRC-VYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 58/301 (19%), Positives = 104/301 (34%), Gaps = 35/301 (11%)
Query: 218 KNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
+ LD+ +N + F + L L + NK + A + L L +S N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSN 335
E+P + +L +L + N ++ KV F + + ++ +N
Sbjct: 112 LK------------ELP---EKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTN 155
Query: 336 KF-SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNL 394
S + F M L + ++ + T +P L +L L L N ++ +
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAAS 211
Query: 395 CQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLK 454
+G N L +L L N + +L+N L LHL+ N L +P L +Q +
Sbjct: 212 LKGLNN-LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 455 LWLNQLHGEIPPE-------LGNIQTLETLFLDFNELTGTL--PAALSNCTNLNWISLSN 505
L N + I + + L N + P+ + L N
Sbjct: 270 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 506 N 506
Sbjct: 329 Y 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 71/357 (19%), Positives = 125/357 (35%), Gaps = 73/357 (20%)
Query: 115 SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL------DFSGREAGSLK 168
RC L + S L D+ +L+L +N + DF LK
Sbjct: 27 FRCQCHLRVVQCSDLGLEKVPKDLP-----PDTALLDLQNNKITEIKDGDFKN-----LK 76
Query: 169 LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSN 228
+L L L NKIS + F +L++L L N++ ++ K LQ L V N
Sbjct: 77 -NLHTLILINNKIS---KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 131
Query: 229 NFSMAVP--SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYN 286
+ V F + +++ N L + + F G
Sbjct: 132 EITK-VRKSVFNGLNQMIVVELGTNP--------------LKSSGIENGAFQG------- 169
Query: 287 EFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIF 346
L + ++ N++ +P G SL + NK + ++
Sbjct: 170 -------------MKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASL 212
Query: 347 LSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELF 406
++NL +L LSFN + SL+N +L L L++N L +P L ++ ++
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK--YIQVVY 269
Query: 407 LQNNLL------LGSIPSTLSNCSQLVSLHLSFNYLTGTI--PSSLGSLSKLQDLKL 455
L NN + P + + + L N + PS+ + ++L
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 67/354 (18%), Positives = 122/354 (34%), Gaps = 66/354 (18%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
+L + S L +P +L P + L LQNN + N L +L L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL---PPD-TALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN 494
++ P + L KL+ L L NQL E+P ++ +TL+ L + NE+T + +
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNG 143
Query: 495 CTNLNWISLSNNHLGGEI--PTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLN 552
+ + L N L + L+ +++++ + IP L SL L L+
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLD 200
Query: 553 TNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRI 612
N + A K L G+ +S +
Sbjct: 201 GNKIT-KVDAASLKGLNN----------------------------LAKLGLSFNSISAV 231
Query: 613 STRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNL 672
+ + + L ++ N L +P + Y+ ++ L +NN+
Sbjct: 232 DNG---------------SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 673 SG------PIPTEVGDLRGLNILDLSSNRLEGTI--PSSMSSLTLLNEIDLCNN 718
S P + + L SN ++ PS+ + + + L N
Sbjct: 276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 59/387 (15%), Positives = 117/387 (30%), Gaps = 98/387 (25%)
Query: 323 SCS-SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
C L S ++P ++ + L L N T NL NL TL L
Sbjct: 28 RCQCHLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 83
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441
+N +S I P + +L L+LS N L +P
Sbjct: 84 INNKIS-KIS-------------------------PGAFAPLVKLERLYLSKNQLK-ELP 116
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTL--PAALSNCTNL 498
+ LQ+L++ N++ ++ + + + L N L + A L
Sbjct: 117 EKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 499 NWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFN 557
++I +++ ++ IP G +L L L N ++ L +L L L+ N +
Sbjct: 174 SYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS 229
Query: 558 GSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSP 617
++ + + +E H N +L ++
Sbjct: 230 -AVDNGSLANTPHL------------------RELHLNNN----------KLVKVP---- 256
Query: 618 CNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE-------IGSMSYLFILNLGHN 670
+ + + + N +S +I + ++L N
Sbjct: 257 ------------GGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 671 NLS-GPIPTEV-GDLRGLNILDLSSNR 695
+ I + + L + +
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 60/303 (19%), Positives = 109/303 (35%), Gaps = 38/303 (12%)
Query: 94 TLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNL 152
L L+N+ I+ + G + L +L L N +S +S + L+ L L
Sbjct: 53 DTALLDLQNNKIT---EIKDGDFKNLKNLHTLILINNKISK-ISPGA-FAPLVKLERLYL 107
Query: 153 SSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT-GD 211
S N L K +L+ L + N+I+ V +FNG +++ + L N +
Sbjct: 108 SKNQL--KELPEKMPK-TLQELRVHENEIT---KVRKSVFNGLNQMIVVELGTNPLKSSG 161
Query: 212 INV---SKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLS 268
I K L ++ ++ N + +P G +L L + NK T ++ +L+
Sbjct: 162 IENGAFQGMKKLSYIRIADTNIT-TIPQ-GLPPSLTELHLDGNKITKVDAASLKGLNNLA 219
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
L +S N S V L +L L++N L KVP ++
Sbjct: 220 KLGLSFNSISA---VDNGSLAN---------TPHLRELHLNNNKLV-KVPGGLADHKYIQ 266
Query: 329 SFDISSNKFS-----GELPIEIFLSMSNLKELVLSFN--DFTGALPDSLSNLTNLETLDL 381
+ +N S P ++ + L N + P + + + L
Sbjct: 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326
Query: 382 SSN 384
+
Sbjct: 327 GNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 59/307 (19%), Positives = 105/307 (34%), Gaps = 63/307 (20%)
Query: 421 SNCS-QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLF 478
C L + S L +P L L L N++ EI N++ L TL
Sbjct: 27 FRCQCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKIT-EIKDGDFKNLKNLHTLI 82
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
L N+++ P A + L + LS N L E+P L L++ N ++
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRK 138
Query: 539 E-LGDCRSLIWLDLNTN-LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAG 596
+I ++L TN L + I F+ K+ Y+ I A
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL--------SYIRI----------AD 180
Query: 597 NLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI 656
++ I P + T L + N ++ +
Sbjct: 181 T----------NITTIPQGLPPSLTE------------------LHLDGNKIT-KVDAAS 211
Query: 657 -GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEID 714
++ L L L N++S + + L L L++N+L +P ++ + +
Sbjct: 212 LKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 715 LCNNQLT 721
L NN ++
Sbjct: 270 LHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 52/264 (19%), Positives = 94/264 (35%), Gaps = 53/264 (20%)
Query: 463 EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNL 522
++P +L L L N++T N NL+ + L NN + P L L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 523 AILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYV 582
L LS N +P ++ ++L L ++ N + ++F ++ V
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQM--------IVV 150
Query: 583 YIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLD 642
+ N L+ +GI F + ++
Sbjct: 151 EL----------GTNPLKSSGIENG-----------------------AFQGMKKLSYIR 177
Query: 643 ISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIP 701
I+ ++ +IP+ G L L+L N ++ + L L L LS N +
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDN 233
Query: 702 SSMSSLTLLNEIDLCNNQLTGMIP 725
S+++ L E+ L NN+L +P
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVP 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 9/98 (9%)
Query: 89 LLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLN----ILSGPLSDISYLGSC 144
L L L L N+ + +P G ++ + L N I S Y
Sbjct: 236 LANTPHLRELHLNNNKLV---KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 145 SSLKVLNLSSNLLDFSGREAGSLK--LSLEVLDLSYNK 180
+S ++L SN + + + + + + L K
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG+VY+ ++ VA+K L + + D +F E I K H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVL-HNQKKVGIKLNWAARR--KIAIGSARGLAFLH 977
+G R ++ E M G L+ L + + + A +A A G +L
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 978 HNCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP- 1033
N H IHRD+ + N LL A++ DFGMAR D + + G +P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 1034 ----PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE + ++K D +S+GV+L E+ + G P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 865 DSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA----EMETIGKIKHRNLV 919
++G GG +V+ A+ L+D VA+K L D F E + + H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 920 PLLGYCKVGEERL-------LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+ GE +V EY+ +L D++H + + ++ + +
Sbjct: 76 AVY---DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQA 128
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL-SVSTLAGTPGY 1031
L F H N IIHRD+K +N+++ +V DFG+AR ++ + + + GT Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 1032 VPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ PE + + DVYS G VL E+LTG+ P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 30/213 (14%)
Query: 868 IGSGGFGDVYKAKLKDGST----VAIKKL---IHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G FG V + + S VA+K L + + +F E+ + + HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQK---KVGIKLNWAARRKIAIGSARGLAFLH 977
L G + +V E GSL D L + +G +A A G+ +L
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYLE 138
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP---- 1033
IHRD+ + N+LL ++ DFG+ R + D H + VP
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWC 191
Query: 1034 -PEYYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
PE ++ S D + +GV L E+ T G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG V +A+LK VA+K K I+ EF E + + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 922 LGYCKVGEER------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR--KIAIGSARGL 973
+G + +++ +M++G L L + N + + + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
+L + IHRD+ + N +L E+ V+DFG++R + + D + G +P
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGCASKLP 202
Query: 1034 -----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
E + + DV+++GV + E++T G+ P
Sbjct: 203 VKWLALESLADNLY--TVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-34
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 36/223 (16%)
Query: 868 IGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRNLV 919
+G+G FG V +A VA+K L + ++ +E++ + + +H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR----------KIAIGS 969
LLG C G L++ EY YG L + L + +V A +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
A+G+AFL + IHRD+ + NVLL A++ DFG+AR + + +
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IVKGN 225
Query: 1030 GYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+P PE + + + + DV+SYG++L E+ + G P
Sbjct: 226 ARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFSLGLNP 266
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 46/223 (20%)
Query: 868 IGSGGFGDVYKAKLKDGS--------TVAIKKLIHISGQGDREFTAEMETIGKIKHRNLV 919
+G G F ++K ++ V +K L F + K+ H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G C G+E +LV E++++GSL+ L K +N + ++A A + FL N
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN 132
Query: 980 CIPHIIHRDMKSSNVLLD--------ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY 1031
+IH ++ + N+LL ++SD G++ + D
Sbjct: 133 ---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------IL 177
Query: 1032 ------VPPE---YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
VPPE ++ + D +S+G L E+ + G +P
Sbjct: 178 QERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKP 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 79/253 (31%), Positives = 125/253 (49%), Gaps = 25/253 (9%)
Query: 824 NTSWKLTGAREALSINLATFEKPLRKL-TFADLLEATNGFHNDSLIGSGGFGDVYKAKLK 882
N KL G R ++ TFE P + + FA L+ATN D ++G+G FG+V +LK
Sbjct: 11 NGHLKLPGLRT--FVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLK 67
Query: 883 DGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937
S +VAIK L + R +F E +G+ H N++ L G + ++V EY
Sbjct: 68 LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997
M GSL+ L + + G A G+ +L +HRD+ + N+L++
Sbjct: 128 MENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILIN 181
Query: 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEYYQSFRCSTKGDVYSYG 1052
N +VSDFG+ R++ D + T G G +P PE + ++ DV+SYG
Sbjct: 182 SNLVCKVSDFGLGRVLE--DDPEAAYTTRG--GKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 1053 VVLLELLT-GKRP 1064
+VL E+++ G+RP
Sbjct: 238 IVLWEVMSYGERP 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 40/227 (17%)
Query: 868 IGSGGFGDVYKAKLKD--------GSTVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRN 917
+G G FG V A+ TVA+K L + + D + +EME + I KH+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KI 965
++ LLG C ++ EY G+L + L ++ G++ ++ R
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
ARG+ +L IHRD+ + NVL+ EN +++DFG+AR ++ +D +
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 260
Query: 1026 AGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
T G +P PE + + + + + DV+S+GV++ E+ T G P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSP 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 868 IGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRNLV 919
+G+G FG V +A TVA+K L + +R +E++ + + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR--------------KI 965
LLG C +G L++ EY YG L + L ++ I +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
+ A+G+AFL + IHRD+ + N+LL ++ DFG+AR + + +
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-----V 202
Query: 1026 AGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+P PE + + + + DV+SYG+ L EL + G P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
IG G FGDV++ VAIK S +F E T+ + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHNCI 981
G ++ E G L L +K L+ A+ A + LA+L +
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKRFV 138
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEY 1036
HRD+ + NVL+ N ++ DFG++R M + + G +P PE
Sbjct: 139 ----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPES 188
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
R ++ DV+ +GV + E+L G +P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 57/263 (21%), Positives = 96/263 (36%), Gaps = 31/263 (11%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI----KHR 916
F S +G G +G+V+K + K DG A+K+ +G ++ ++ +G +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
V L + G L E SL+ + G L A + LA L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H ++H D+K +N+ L ++ DFG+ + G P Y+ PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG---EVQEGDPRYMAPEL 227
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL- 1095
Q T DV+S G+ +LE+ G + + + + EL
Sbjct: 228 LQG-SYGTAADVFSLGLTILEVACNMELP----HGGEGWQQLRQGYLPPEFTAGLSSELR 282
Query: 1096 ------MKEDPNIEI---ELLQH 1109
++ DP + LL
Sbjct: 283 SVLVMMLEPDPKLRATAEALLAL 305
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 2e-33
Identities = 30/301 (9%), Positives = 67/301 (22%), Gaps = 52/301 (17%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLI---HISGQGDREFTAEMETIGKIKHRNLVPLL 922
+ G V+ + + A+K S ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 923 GYCKVG--------------------------EERLLVYEYMRYGSLEDVLHNQKKVGIK 956
++ LL+ LE + V +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 957 ---LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013
A + R A L ++H N+ + + + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRC--STKGDVYSYGVVLLELLTGKRPTDSADFG 1071
+ Y P E+ + + + + G+ + + P FG
Sbjct: 245 GT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP-----FG 294
Query: 1072 DNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
D + + ++ L L+ RR ++ M
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP-DFVKTL--IGRFLNFDRRRRLLPLEAM 351
Query: 1132 A 1132
Sbjct: 352 E 352
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 868 IGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRNLV 919
+G G FG V +A TVA+K L + + +E++ + I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 920 PLLGYC-KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KIA 966
LLG C K G +++ E+ ++G+L L +++ + A +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLA 1026
A+G+ FL IHRD+ + N+LL E ++ DFG+AR + + +
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----VR 206
Query: 1027 GTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+P PE + + + + + DV+S+GV+L E+ + G P
Sbjct: 207 KGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASP 250
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 38/280 (13%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNL--VPLL 922
IGSGG V++ + AIK L Q + E+ + K++ + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
Y + +V E L L +K ++ R+ + +H +
Sbjct: 123 DYEITDQYIYMVMECGN-IDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE------- 1035
I+H D+K +N L+ + ++ DFG+A M T + + G Y+PPE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+ S K DV+S G +L + GK P + L + + +++ D+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ +L ++L+ CL P +R ++ +++
Sbjct: 294 EKDL--------QDVLKC------CLKRDPKQRISIPELL 319
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 45/232 (19%)
Query: 868 IGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRNLV 919
+GSG FG V A S VA+K L + +R +E++ + ++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS---------- 969
LLG C + L++EY YG L + L ++++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 970 ---------ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020
A+G+ FL +HRD+ + NVL+ ++ DFG+AR + + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 1021 SVSTLAGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+ +P PE + + + K DV+SYG++L E+ + G P
Sbjct: 229 ----VVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFSLGVNP 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 40/227 (17%)
Query: 868 IGSGGFGDVYKAKLKD--------GSTVAIKKLIHISGQGDR-EFTAEMETIGKI-KHRN 917
+G G FG V A+ + VA+K L + + D + +EME + I KH+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR------------KI 965
++ LLG C ++ EY G+L + L ++ G++ ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR + +D +
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-----K 248
Query: 1026 AGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
T G +P PE + + + + + DV+S+GV+L E+ T G P
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSP 293
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLL 922
+G G FG+VY+ + VA+K ++ +F +E + + H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
G + E ++ E YG L L K L ++ + +A+L
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI--- 132
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PE-- 1035
+ +HRD+ N+L+ ++ DFG++R + D + + +P PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY------KASVTRLPIKWMSPESI 186
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
++ F +T DV+ + V + E+L+ GK+P
Sbjct: 187 NFRRF--TTASDVWMFAVCMWEILSFGKQP 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 9/237 (3%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFS-GELPIEIFLSMSNLKELVLSF 359
SS +L+L SN L F + L +SSN S + ++LK L LSF
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
N + + L LE LD +NL ++ RN L L + + +
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-LIYLDISHTHTRVAFNGI 145
Query: 420 LSNCSQLVSLHLSFN-YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETL 477
+ S L L ++ N + +P L L L L QL ++ P ++ +L+ L
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVL 204
Query: 478 FLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIP--TWIGQLSNLAILKLSNNSF 532
+ N +L + S NH+ S+LA L L+ N F
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 59/248 (23%), Positives = 87/248 (35%), Gaps = 15/248 (6%)
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
SCS +S + +P I S+ L L N LT L L LS
Sbjct: 6 SCSG-TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLS 60
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPS 442
SN LS + SLK L L N ++ ++ S QL L + L
Sbjct: 61 SNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 119
Query: 443 SL-GSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFN-ELTGTLPAALSNCTNLN 499
S+ SL L L + + +LE L + N LP + NL
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178
Query: 500 WISLSNNHLGGEIPT-WIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFN 557
++ LS L ++ LS+L +L +S+N+F + SL LD + N
Sbjct: 179 FLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIM 236
Query: 558 GSIPPALF 565
+
Sbjct: 237 -TSKKQEL 243
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 71/352 (20%), Positives = 115/352 (32%), Gaps = 74/352 (21%)
Query: 115 SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVL 174
SRCS + + + L+ + I SS L L SN L L L
Sbjct: 3 SRCSCSGTEIRCNSKGLTSVPTGIP-----SSATRLELESNKLQSLPHGVFDKLTQLTKL 57
Query: 175 DLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAV 234
LS N +S F +L++LD+S N
Sbjct: 58 SLSSNGLSFKGCCSQSDFG-----------------------TTSLKYLDLSFNGVITMS 94
Query: 235 PSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPL 294
+F LE+LD + +S ++F
Sbjct: 95 SNFLGLEQLEHLDFQHSNLK-----QMS----------EFSVFLS--------------- 124
Query: 295 HLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKE 354
+L+ LD+S + F SSLE ++ N F +IF + NL
Sbjct: 125 -----LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 355 LVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLG 414
L LS P + ++L++L+ L++S NN ++ + SL+ L N ++
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLN-SLQVLDYSLNHIMT 237
Query: 415 SIPSTLSN-CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIP 465
S L + S L L+L+ N T + Q W+ +
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDFACT--------CEHQSFLQWIKDQRQLLV 281
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 68/306 (22%), Positives = 104/306 (33%), Gaps = 73/306 (23%)
Query: 110 SLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK- 168
S+P G S + L+L N L + + L L+LSSN L F G + S
Sbjct: 21 SVPTG--IPSSATRLELESNKLQSLPHGV--FDKLTQLTKLSLSSNGLSFKGCCSQSDFG 76
Query: 169 -LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSS 227
SL+ LDLS+N + ++ + + L+ LD
Sbjct: 77 TTSLKYLDLSFNGVI------------------------TMSSNF--LGLEQLEHLDFQH 110
Query: 228 NNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGY 285
+N F L YLDIS + +F+G
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTR----------------VAFNGIFNG------ 148
Query: 286 NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFSGELPIE 344
SSL L ++ N+ F +L D+S + +L
Sbjct: 149 --------------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKE 404
F S+S+L+ L +S N+F L +L+ LD S N++ Q +SL
Sbjct: 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAF 252
Query: 405 LFLQNN 410
L L N
Sbjct: 253 LNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 58/329 (17%), Positives = 103/329 (31%), Gaps = 83/329 (25%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
+ + +S L+ ++P + P + L L++N L +QL L LS N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI---PSS-ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 435 YLT--GTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA-- 490
L+ G S + L+ L L N + + ++ LE L + L +
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS 120
Query: 491 ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLD 550
+ NL ++ +S+ H N F G SL L
Sbjct: 121 VFLSLRNLIYLDISHTHTR----------------VAFNGIFNG--------LSSLEVLK 156
Query: 551 LNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS 610
+ N F + P +F NL LS
Sbjct: 157 MAGNSFQENFLPDIFT---------------------------ELRNLTFL------DLS 183
Query: 611 RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGH 669
+ C ++ FN S+ L++S+N S+ ++ L +L+
Sbjct: 184 Q------CQLEQLSPT----AFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSL 232
Query: 670 NNLSGPIPTEV--GDLRGLNILDLSSNRL 696
N++ + L L+L+ N
Sbjct: 233 NHIMT-SKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 42/253 (16%), Positives = 67/253 (26%), Gaps = 49/253 (19%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL--GGEIPTWIGQLSNLAILKLSNN 530
+ L L+ N+L T L +SLS+N L G ++L L LS N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 531 SFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSK 590
+ L LD + ++F
Sbjct: 89 GV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN-------------------- 127
Query: 591 ECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
L + I FN S+ L ++ N
Sbjct: 128 --------LIYLDISHTHTRVAFNG---------------IFNGLSSLEVLKMAGNSFQE 164
Query: 651 SIPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLT 708
+ +I + L L+L L + L L +L++S N L
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 709 LLNEIDLCNNQLT 721
L +D N +
Sbjct: 224 SLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 45/229 (19%), Positives = 77/229 (33%), Gaps = 50/229 (21%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
+L+ L L + + ++ + L LD + L +S SL+
Sbjct: 77 TTSLKYLDLSFNGVI---TMSSNFLGLEQLEHLDFQHS----NLKQMSEFSVFLSLR--- 126
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD 211
+L LD+S+ V +FNG L+ L + GN +
Sbjct: 127 ------------------NLIYLDISHTHTR---VAFNGIFNGLSSLEVLKMAGNSFQEN 165
Query: 212 INV---SKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISANKFTGDVGHAISACEH 266
++ +NL FLD+S + +F +L+ L++S N F
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224
Query: 267 LSFLNVSSNLFSGPIPVGYNEFQGEIPLH-LADLCSSLVKLDLSSNNLS 314
L L+ S N L SSL L+L+ N+ +
Sbjct: 225 LQVLDYSLNHIM------------TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 4/97 (4%)
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNIL 689
+ S+ +LD+S+N + ++ + L L+ H+NL V LR L L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 690 DLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLTGMIP 725
D+S + + + L+ L + + N
Sbjct: 132 DISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 6e-33
Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 865 DSLIGSGGFGDVYKAKLKDGS---TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
D +G G FG V + + VAIK L + + D E E + + ++ + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL-HHN 979
L+G C+ E +LV E G L L +++ ++ + ++ + G+ +L N
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP-GYVPPEYYQ 1038
+ HR++ + NVLL A++SDFG+++ + A D++ + + P + PE
Sbjct: 457 FV----HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 1039 SFRCSTKGDVYSYGVVLLELLT-GKRP 1064
+ S++ DV+SYGV + E L+ G++P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-33
Identities = 41/315 (13%), Positives = 91/315 (28%), Gaps = 69/315 (21%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD------REFTAEMETIGKIKH---- 915
++G +A + G + + +E + + IK+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 916 ---------RNLVPLLGYCKVGE-----------ERLLVYEYMRYGSLEDV---LHNQKK 952
+LV K+ R +Y M +L+ L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS 203
Query: 953 VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012
L AR ++ + R LA LHH ++H ++ +++LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG-----DVYSYGVVLLELLTGKRPTDS 1067
A + P + D ++ G+ + + P
Sbjct: 261 DGA-SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--- 316
Query: 1068 ADFGDNNLVGWVKQHAKLKISDVFD-PELMKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126
D+ +G + + P+ ++ LL+ L R
Sbjct: 317 --NTDDAALGGSEWI----FRSCKNIPQPVR-------ALLEGF------LRYPKEDRLL 357
Query: 1127 MIQVM--AMFKEIQA 1139
+Q M +++++
Sbjct: 358 PLQAMETPEYEQLRT 372
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 64/277 (23%), Positives = 107/277 (38%), Gaps = 24/277 (8%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
LDL +N++S F L + + +NK S ++ + F + L++L +S N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI--PS 418
+P +L ++L L + N + +P + G RN + + + N L S P
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRN-MNCIEMGGNPLENSGFEPG 167
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETL 477
L L +S LT IP L L +L L N++ I E L L L
Sbjct: 168 AFDGLK-LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222
Query: 478 FLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537
L N++ +LS L + L NN L +P + L L ++ L N+ ++
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNI-TKVG 280
Query: 538 PE-------LGDCRSLIWLDLNTN-LFNGSIPPALFK 566
+ L N + + PA F+
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 70/326 (21%), Positives = 120/326 (36%), Gaps = 62/326 (19%)
Query: 218 KNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
+ LD+ +N+ S F L L + NK + +
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS----------------KIHEKA 97
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
FS L KL +S N+L P+ SSL I N+
Sbjct: 98 FSP--------------------LRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNR 134
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGAL--PDSLSNLTNLETLDLSSNNLSGAIPHNL 394
++P +F + N+ + + N + P + L L L +S L+ IP +L
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL 191
Query: 395 CQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453
+ +L EL L +N + +I L S+L L L N + SL L L++L
Sbjct: 192 PE----TLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL 246
Query: 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA-------ALSNCTNLNWISLSNN 506
L N+L +P L +++ L+ ++L N +T + N ISL NN
Sbjct: 247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNN 304
Query: 507 HLG-GEIPTWIGQ-LSNLAILKLSNN 530
+ E+ + +++ ++ N
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 69/345 (20%), Positives = 104/345 (30%), Gaps = 77/345 (22%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVS 226
+LDL N IS + F G L L L NK++ I+ S + LQ L +S
Sbjct: 55 DTTLLDLQNNDIS---ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYIS 110
Query: 227 SNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN-LFSGPIPV 283
N+ +P L L I N+ S +++ + + N L +
Sbjct: 111 KNHLV-EIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 284 GYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPI 343
G F G L L +S L+ +P +L + NK + +
Sbjct: 167 GA--FDG----------LKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIEL 210
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
E L S L L L N SLS L L L L +N LS
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS---------------- 254
Query: 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463
+P+ L + L ++L N +T + +
Sbjct: 255 -----------RVPAGLPDLKLLQVVYLHTNNIT-KVGV--NDFCPVGFGVKRAY----- 295
Query: 464 IPPELGNIQTLETLFLDFNELTGTL--PAALSNCTNLNWISLSNN 506
+ L N + PA T+ I N
Sbjct: 296 ----------YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 69/386 (17%), Positives = 120/386 (31%), Gaps = 72/386 (18%)
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
E + +L L +++ P +L + S L A+P + +
Sbjct: 8 ETTSGIPDLDSLPPTYS---AMCPFGCHC--HLRVVQCSDLGLK-AVPKEI---SPD-TT 57
Query: 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463
L LQNN + L +L L N ++ + L KLQ L + N L E
Sbjct: 58 LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-E 116
Query: 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG-GEIPTWIGQLSNL 522
IPP L +L L + N + S N+N I + N L L
Sbjct: 117 IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 523 AILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYV 582
L++S IP +L +L L L+ N +I + K
Sbjct: 175 NYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSK------------ 218
Query: 583 YIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLD 642
L G+ ++ I + + ++ L
Sbjct: 219 ----------------LYRLGLGHNQIRMIENG---------------SLSFLPTLRELH 247
Query: 643 ISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV-------GDLRGLNILDLSSNR 695
+ N LS +P + + L ++ L NN++ + N + L +N
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 696 LE-GTIPSSM-SSLTLLNEIDLCNNQ 719
+ + + +T I N +
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 66/372 (17%), Positives = 123/372 (33%), Gaps = 88/372 (23%)
Query: 367 PDSLSNLTNLETLDLSSNNLSGAIPHNLC-QGPRNSLKELFLQNNLLLGSIPSTLSNCSQ 425
++ S + +L++L + + + C G L+ + + L ++P +S
Sbjct: 7 AETTSGIPDLDSLPPTYSAM--------CPFGCHCHLRVVQCSDLGLK-AVPKEIS--PD 55
Query: 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485
L L N ++ L L L L N++ +I +
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEK------------------ 96
Query: 486 GTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCR 544
A S L + +S NHL EIP S+L L++ +N ++P R
Sbjct: 97 -----AFSPLRKLQKLYISKNHL-VEIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLR 147
Query: 545 SLIWLDLNTN-LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAG 603
++ +++ N L N P F G L +
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFD-----------------------------GLKLNYLR 178
Query: 604 IRAERLSRISTRSPCNFTRVYGGHTQ------PTFNHNGSMMFLDISYNMLSGSIPKEI- 656
I +L+ I P ++ H + + L + +N + I
Sbjct: 179 ISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSL 237
Query: 657 GSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSM-------SSLTL 709
+ L L+L +N LS +P + DL+ L ++ L +N + + +
Sbjct: 238 SFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY 295
Query: 710 LNEIDLCNNQLT 721
N I L NN +
Sbjct: 296 YNGISLFNNPVP 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G G FG+V++ K + G A+KK + + E + + +VPL G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ G + E + GSL ++ K++G L + GL +LH I+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI---KQMG-CLPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 986 HRDMKSSNVLLDEN-FEARVSDFGMARLMSAM---DTHLSVSTLAGTPGYVPPEYYQSFR 1041
H D+K+ NVLL + A + DFG A + + L+ + GT ++ PE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
C K D++S ++L +L G P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-32
Identities = 88/477 (18%), Positives = 166/477 (34%), Gaps = 64/477 (13%)
Query: 124 LDLSLNILSG-PLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--LSLEVLDLSYNK 180
L++S N +S SDI L S L++L +S N + + K LE LDLS+NK
Sbjct: 26 LNISQNYISELWTSDILSL---SKLRILIISHNRI--QYLDISVFKFNQELEYLDLSHNK 80
Query: 181 ISGANVVPWILFNGCDELKQLALKGNK---VTGDINVSKCKNLQFLDVSSNNFSMAVPSF 237
+ I + LK L L N + L+FL +S+ + +
Sbjct: 81 LVK------ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 238 GDCLALEYL----------------------------DISANKFTGDVGHAISACEHLSF 269
L + + + +F + ++ +L
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 270 LNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLES 329
N+ L + +L ++ + N+ + +++
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKL-SNLTLNNIETTWNSFIR--ILQLVWHTTVWY 251
Query: 330 FDISSNKFSGELPIEIF----LSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
F IS+ K G+L F S+ L + + F +N+ + + +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 386 LSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLG 445
+ H LC + L NNLL ++ + ++L +L L N L +
Sbjct: 312 TR--MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAE 368
Query: 446 ---SLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501
+ LQ L + N + + ++L +L + N LT T+ L + +
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVL 426
Query: 502 SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFN 557
L +N + IP + +L L L +++N +P SL + L+TN ++
Sbjct: 427 DLHSNKI-KSIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 89/456 (19%), Positives = 154/456 (33%), Gaps = 34/456 (7%)
Query: 92 LDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
L L L + ++ I L + + L LDLS N L +LK L
Sbjct: 44 LSKLRILIISHNRIQ---YLDISVFKFNQELEYLDLSHNKLVKISCH-----PTVNLKHL 95
Query: 151 NLSSNLLDFSGREAGSLKL-SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT 209
+LS N D + L+ L LS + + + L L
Sbjct: 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE--KSSVLPIAHLNISKVLLVLGETYGE 153
Query: 210 GDINVSKCK----NLQFLDVSSNNFSMAV-PSFGDCLALEYLDISANKFTGDVGHAISAC 264
+ +L + ++ F + S LE +I + +S
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
Query: 265 EHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRF--G 322
L SNL I +N F L L +++ +S+ L G++ R
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWH-TTVWYFSISNVKLQGQLDFRDFDY 270
Query: 323 SCSSLESF---DISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379
S +SL++ + S+ F I+ SN+ + + S ++ L
Sbjct: 271 SGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329
Query: 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL--LGSIPSTLSNCSQLVSLHLSFNYLT 437
D S+N L+ C L+ L LQ N L L I + L L +S N ++
Sbjct: 330 DFSNNLLT-DTVFENCGHL-TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387
Query: 438 GTIPSSL-GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT 496
L L + N L I L ++ L L N++ ++P +
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLE 444
Query: 497 NLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
L +++++N L +L++L + L N +
Sbjct: 445 ALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 90/467 (19%), Positives = 148/467 (31%), Gaps = 65/467 (13%)
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA 365
+D S N L VP +IS N S EL LS+S L+ L++S N
Sbjct: 5 VDRSKNGLI-HVPK--DLSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYL 60
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP--STLSNC 423
LE LDLS N L H +LK L L N ++P N
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKISCHPT-----VNLKHLDLSFNAFD-ALPICKEFGNM 114
Query: 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
SQL L LS +L + + L+ + L + + P +Q T L
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVF 172
Query: 484 LTGTLPAALSNCTNLNWISLSNNHLGG-----------EIPTWIGQLSNLAILKLSNNSF 532
T + + + +L +++ I + L+ L L+N
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 533 YGRIPPELGDC---RSLIWLDLNTNLFNGSIPPALFKQSG-KIAANFI--VGKKYVYIKN 586
+ ++ + ++ G + F SG + A I V
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 587 DGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT------FNHNGSMMF 640
E N+ F + + F + + T H +
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 641 LDISYNMLSGSIPKEIG---SMSYLFILNLGHNNLSGPIPTEVGD--------------- 682
L + N L + K M L L++ N++S
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 683 --------LRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
+ +LDL SN+++ +IP + L L E+++ +NQL
Sbjct: 412 TDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 78/431 (18%), Positives = 140/431 (32%), Gaps = 41/431 (9%)
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
DL L++S N +S S S S L IS N+ L I +F L+ L
Sbjct: 17 KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLD 75
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
LS N + NL+ LDLS N A+P G + LK L L L S
Sbjct: 76 LSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
+++ + L + L L + + + ++
Sbjct: 132 VLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536
L+ + + + + + + L+ L ++ + NSF
Sbjct: 190 ANLELSNIKC-------VLEDNKCSYFLSILAKLQTNPKLSNLT-LNNIETTWNSFIR-- 239
Query: 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHG-- 594
+L ++ + ++ G + F SG K + I S
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG-------TSLKALSIHQVVSDVFGFPQ 292
Query: 595 AGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPK 654
+ F+ + + + TR + + LD S N+L+ ++ +
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMV----------HMLCPSKISPFLHLDFSNNLLTDTVFE 342
Query: 655 EIGSMSYLFILNLGHNNLSGPIPTEVG---DLRGLNILDLSSNRLEGTIPSSM-SSLTLL 710
G ++ L L L N L + ++ L LD+S N + S L
Sbjct: 343 NCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 711 NEIDLCNNQLT 721
+++ +N LT
Sbjct: 402 LSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 77/431 (17%), Positives = 139/431 (32%), Gaps = 37/431 (8%)
Query: 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
+LN+S N + L +L +S+N+I + +F EL+ L L
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY---LDISVFKFNQELEYLDLS 77
Query: 205 GNKVTGDINVSKCKNLQFLDVSSNNF-SMAVPSFGDCLA-LEYLDISANKFTGDVGHAIS 262
NK+ I+ NL+ LD+S N F ++ + ++ L++L +S I+
Sbjct: 78 HNKLVK-ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVK--LDLSSNNLSGKVPSR 320
L V + + LH+ + LD+S ++ S
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380
+ + +L LS L + ++N F L L T +
Sbjct: 197 IKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFS 253
Query: 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTI 440
+S+ L G + SLK L + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSI---------------------HQVVSDVFGFPQ 292
Query: 441 PSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNW 500
S + ++ I L N LT T+ + T L
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 501 ISLSNNHLGGEIPTWIG---QLSNLAILKLSNNSFYGRIPPELGDC-RSLIWLDLNTNLF 556
+ L N L E+ Q+ +L L +S NS +SL+ L++++N+
Sbjct: 353 LILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 557 NGSIPPALFKQ 567
+I L +
Sbjct: 412 TDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 92/525 (17%), Positives = 164/525 (31%), Gaps = 74/525 (14%)
Query: 222 FLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPI 281
+D S N VP L+IS N + I + L L +S N
Sbjct: 4 LVDRSKNGLI-HVPK-DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ--- 58
Query: 282 PVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGEL 341
+ + + L LDLS N L K+ +L+ D+S N F
Sbjct: 59 ---------YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALP 106
Query: 342 PIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE-TLDLSSNNLSGAIPHNLCQGPRN 400
+ F +MS LK L LS + +++L + L L P L
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
SL +F N + ++ + L ++ L L+KLQ N
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 461 HG-------EIPPELGNIQTLETLFLDFNELT-------GTLPAALSNCTNLNWISLSNN 506
L + + + + + ++ L+ + ++
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286
Query: 507 HLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566
G SN+ I + + + LD + NL
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL-TDTVF---- 341
Query: 567 QSGKIAANFIVGKKYVYIKNDGSKECHGAGNL--LEFAGIRAERLSRIS--TRSPCNFTR 622
+ C L L + + LS+I+ T + +
Sbjct: 342 -----------------------ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 623 VYGGHTQ-------PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGP 675
+ + S++ L++S N+L+ +I + + + +L+L N +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS- 435
Query: 676 IPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
IP +V L L L+++SN+L+ LT L +I L N
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 54/367 (14%), Positives = 116/367 (31%), Gaps = 22/367 (5%)
Query: 27 NKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVA 86
+ + + + + ++P G + + ++ + F +D +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
L L ++ + N L + ++ I L ++
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 147 LKVLNLSSNLLDFSG--REAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
+ ++S+ L R+ SL+ L + ++ +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 205 GNKVTG-DINV-SKCKNLQFLDVSSNNF-SMAVPSFGDCLALEYLDISANKFT--GDVGH 259
+ + SK LD S+N + G LE L + N+ +
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368
Query: 260 AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS 319
+ + L L++S N S G SL+ L++SSN L+ +
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKG-----------DCSWTKSLLSLNMSSNILTDTIFR 417
Query: 320 RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379
++ D+ SNK +P ++ + L+EL ++ N LT+L+ +
Sbjct: 418 CLPP--RIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473
Query: 380 DLSSNNL 386
L +N
Sbjct: 474 WLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 640 FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGT 699
+D S N L +PK++ ILN+ N +S +++ L L IL +S NR++
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 700 IPSSMSSLTLLNEIDLCNNQLT 721
S L +DL +N+L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV 82
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 868 IGSGGFGDVYKAKLKDG------STVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
IG G FG V++A+ + VA+K L + + +F E + + + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARR----------------- 963
LLG C VG+ L++EYM YG L + L + + +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 964 ---KIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020
IA A G+A+L +HRD+ + N L+ EN +++DFG++R + + D +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 1021 SVSTLAGTPGYVP-----PE--YYQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
A +P PE +Y + +T+ DV++YGVVL E+ + G +P
Sbjct: 231 ----KADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGLQP 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 71/275 (25%), Positives = 111/275 (40%), Gaps = 42/275 (15%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKL----IHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G G FG+VY A+ K +A+K L + +G + E+E ++H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRL 74
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHN 979
GY R+ L+ EY G++ L K I + +A L++ H
Sbjct: 75 YGYFH-DATRVYLILEYAPLGTVYRELQKLSKFD---EQRTATYITELANA--LSYCHSK 128
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+IHRD+K N+LL E +++DFG S + L GT Y+PPE +
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK--QHAKLKISDVFDPELMK 1097
K D++S GV+ E L GK P F N K + D
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGA-- 234
Query: 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+L+ L L P +RP + +V+
Sbjct: 235 ------RDLISRL------LKHNPSQRPMLREVLE 257
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 38/318 (11%), Positives = 92/318 (28%), Gaps = 76/318 (23%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK----------- 914
++G +A + G + + E + +++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 915 -----------------HRNLVPLLGYCKVGEERLLVYEYMR-YGSLEDV---LHNQKKV 953
+ ++ + + + Y R +L+ L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 954 GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013
L AR ++ + R LA LHH ++H ++ +++LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG-----------DVYSYGVVLLELLTGK 1062
A + + G+ PPE + D ++ G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 1063 RPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPW 1122
P + +G + + NI + ++ L L
Sbjct: 311 LP-----ITKDAALGGSEWI-------------FRSCKNIP-QPVRAL--LEGFLRYPKE 349
Query: 1123 RRPTMIQVMAM--FKEIQ 1138
R +Q M +++++
Sbjct: 350 DRLLPLQAMETPEYEQLR 367
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 65/299 (21%), Positives = 113/299 (37%), Gaps = 54/299 (18%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGD--REFTAEMETIGKIKHRNL 918
F +G GGFG V++AK K D AIK+ I + + + E++ + K++H +
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 919 V---------PLLGYCKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAARRKIA 966
V + ++ +Y + R +L+D ++ + + + + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHIF 124
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS----------AM 1016
+ A + FLH ++HRD+K SN+ + +V DFG+ M M
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076
+ + GT Y+ PE S K D++S G++L ELL V
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------PFSTQMERV 234
Query: 1077 GWVKQHAKLKISDVFD---PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ LK +F P ++Q L P RP I ++
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYV--------MVQ------DMLSPSPMERPEAINIIE 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 55/251 (21%), Positives = 98/251 (39%), Gaps = 16/251 (6%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
S+ L+L NN+ F LE + N ++ + F +++L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-T 419
T + L+ L L L +N + +IP + L L L L I
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPS-LMRLDLGELKKLEYISEGA 191
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLF 478
L L+L + +P+ L L L++L++ N EI P + +L+ L+
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLW 248
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
+ ++++ A +L ++L++N+L L L L L +N +
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW------ 302
Query: 539 ELGDCRSLIWL 549
DC ++WL
Sbjct: 303 -NCDCD-ILWL 311
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 59/257 (22%), Positives = 105/257 (40%), Gaps = 13/257 (5%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
+ K+ + LS +VP S + ++ N + + F + +L+ L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-T 419
+ + L +L TL+L N L+ IP + L+EL+L+NN + SIPS
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSK-LRELWLRNNPI-ESIPSYA 166
Query: 420 LSNCSQLVSLHLS-FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
+ L+ L L L + L L+ L L + + P L + LE L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELE 224
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
+ N P + ++L + + N+ + L++L L L++N+ +P
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-SSLPH 283
Query: 539 E-LGDCRSLIWLDLNTN 554
+ R L+ L L+ N
Sbjct: 284 DLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 74/305 (24%), Positives = 114/305 (37%), Gaps = 57/305 (18%)
Query: 112 PAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSL 171
P+ CS+ S + + LS I S+ + LNL N + + L
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLSEVPQGIP-----SNTRYLNLMENNIQMIQADTFRHLHHL 101
Query: 172 EVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVSSN 228
EVL L N I + FNG L L L N +T I L+ L + +N
Sbjct: 102 EVLQLGRNSIR---QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNN 157
Query: 229 NFSMAVPS--FGDCLALEYLDIS-ANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGY 285
+PS F +L LD+ K +S F G
Sbjct: 158 PIES-IPSYAFNRVPSLMRLDLGELKKLE----------------YISEGAFEG------ 194
Query: 286 NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI 345
+L L+L N+ +P+ LE ++S N F E+
Sbjct: 195 --------------LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGS 237
Query: 346 FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKEL 405
F +S+LK+L + + + ++ L +L L+L+ NNLS ++PH+L R L EL
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRY-LVEL 295
Query: 406 FLQNN 410
L +N
Sbjct: 296 HLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 61/245 (24%), Positives = 98/245 (40%), Gaps = 19/245 (7%)
Query: 219 NLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
N ++L++ NN M +F LE L + N A + L+ L + N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNK 336
+ IP G L S L +L L +N + +PS F SL D+ K
Sbjct: 136 TV-IPSG----------AFEYL-SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
+ F + NLK L L + +P+ L+ L LE L++S N+ I
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFH 239
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
G + LK+L++ N+ + + + LV L+L+ N L+ L L +L L
Sbjct: 240 GLSS-LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLH 298
Query: 457 LNQLH 461
N +
Sbjct: 299 HNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 43/194 (22%), Positives = 66/194 (34%), Gaps = 11/194 (5%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
+ + LS +P + P N + L L N + T + L L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI---PSN-TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALS 493
+ + L+ L L+L+ N L IP + L L+L N + A +
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 494 NCTNLNWISLS-NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLN 552
+L + L L L NL L L + + P L L L+++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMS 226
Query: 553 TNLFNGSIPPALFK 566
N F I P F
Sbjct: 227 GNHFP-EIRPGSFH 239
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 60/324 (18%), Positives = 94/324 (29%), Gaps = 78/324 (24%)
Query: 400 NSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
N ++ L +P + S L+L N + + L L+ L+L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 460 LHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ 518
+ +I + +L TL L N LT A + L + L NN +
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE--------- 160
Query: 519 LSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVG 578
+ + +F SL+ LDL I F
Sbjct: 161 -------SIPSYAFNR--------VPSLMRLDLGELKKLEYISEGAF------------- 192
Query: 579 KKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSM 638
G NL L CN + P +
Sbjct: 193 --------------EGLFNLKYL------NLGM------CNIKDM------PNLTPLVGL 220
Query: 639 MFLDISYNMLSGSIPKE-IGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRL 696
L++S N I +S L L + ++ +S I L L L+L+ N L
Sbjct: 221 EELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNL 278
Query: 697 EGTIPSSMSSLTLLNEIDLCNNQL 720
+ L L E+ L +N
Sbjct: 279 SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 64/313 (20%), Positives = 104/313 (33%), Gaps = 84/313 (26%)
Query: 61 VSCKAASVSSI--DLSPFTLSVDFH------LVASFLLTLDTLETLSLKNSNISGTISLP 112
V C +S + + T ++ + A L LE L L ++I +
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR---QIE 115
Query: 113 AGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--LS 170
G+ +SL L L N L + +G+ +
Sbjct: 116 VGA-------------------------FNGLASLNTLELFDNWL--TVIPSGAFEYLSK 148
Query: 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVSS 227
L L L N I +P FN L +L L K I+ NL++L++
Sbjct: 149 LRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 228 NNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNE 287
N +P+ + LE L++S N F + F G
Sbjct: 206 CNIKD-MPNLTPLVGLEELEMSGNHFP----------------EIRPGSFHG-------- 240
Query: 288 FQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFL 347
SSL KL + ++ +S + F +SL +++ N S LP ++F
Sbjct: 241 ------------LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
Query: 348 SMSNLKELVLSFN 360
+ L EL L N
Sbjct: 288 PLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 42/251 (16%), Positives = 79/251 (31%), Gaps = 49/251 (19%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNS 531
L L N + + +L + L N + +I L++L L+L +N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 532 FYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSK 590
IP L L L N SIP F
Sbjct: 135 L-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF------------------------- 167
Query: 591 ECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
+ +L+ ++L IS F ++ +L++ +
Sbjct: 168 --NRVPSLMRLDLGELKKLEYISEG---------------AFEGLFNLKYLNLGMCNIK- 209
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLL 710
+P + + L L + N+ P L L L + ++++ ++ L L
Sbjct: 210 DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268
Query: 711 NEIDLCNNQLT 721
E++L +N L+
Sbjct: 269 VELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 22/87 (25%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 635 NGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSN 694
+ + + LS +P+ I S LNL NN+ L L +L L N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 695 RLEGTIPSSMSSLTLLNEIDLCNNQLT 721
+ + + L LN ++L +N LT
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT 136
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-31
Identities = 57/280 (20%), Positives = 102/280 (36%), Gaps = 56/280 (20%)
Query: 865 DSLIGSGGFGDVYKAK---LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
I GG G +Y A + +G V +K L+H + AE + + ++ H ++V
Sbjct: 85 KGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 921 LLGYCKVGEERL--------LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+ + E +V EY+ SL+ KL A +
Sbjct: 144 IFNF---VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPA 194
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
L++LH +++ D+K N++L E + ++ D G ++ S L GTPG+
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQ 244
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092
PE ++ + D+Y+ G L L + G + LK D +
Sbjct: 245 APEIVRT-GPTVATDIYTVGRTLAALTLDLPT-----RNGRYVDGLPEDDPVLKTYDSYG 298
Query: 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
L + +D P +R T + M+
Sbjct: 299 RLLRR------------------AIDPDPRQRFTTAEEMS 320
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 868 IGSGGFGDVYKAKLKDGS----TVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVPLL 922
IG G FGDV++ VAIK + + R +F E T+ + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCI 981
G ++ E G L L +K L+ A+ A + LA+L +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKRFV 513
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEY 1036
HRD+ + NVL+ N ++ DFG++R M + + G +P PE
Sbjct: 514 ----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPES 563
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLT-GKRP 1064
R ++ DV+ +GV + E+L G +P
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 61/303 (20%), Positives = 119/303 (39%), Gaps = 61/303 (20%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
F +++G G FG V KA+ D AIKK I + + +E+ + + H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 921 LLG----------YCKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI 967
+++ ++ EY G+L D++ + ++
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFR 123
Query: 968 GSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV----- 1022
L+++H IIHRD+K N+ +DE+ ++ DFG+A+ + L +
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 1023 -------STLAGTPGYVPPE------YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
++ GT YV E +Y + K D+YS G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYPF------- 228
Query: 1070 FGDNNLVGWVKQHAKLKISDV-FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMI 1128
V +K KL+ + F P+ +E ++++ +D P +RP
Sbjct: 229 STGMERVNILK---KLRSVSIEFPPDFDDNKMKVEKKIIRL------LIDHDPNKRPGAR 279
Query: 1129 QVM 1131
++
Sbjct: 280 TLL 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 39/274 (14%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK----KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
L+G G F VY+A+ + G VAIK K ++ +G R E++ ++KH +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN-WAARRKIA-IGSARGLAFLHHN 979
Y + LV E G + L N+ K + AR + I G+ +LH +
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQI--ITGMLYLHSH 131
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
I+HRD+ SN+LL N +++DFG+A + TL GTP Y+ PE
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATR 186
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK--QHAKLKISDVFDPELMK 1097
+ DV+S G + LL G+ P F + + + A ++ E
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP-----FDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241
Query: 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
L+ L L P R ++ V+
Sbjct: 242 --------LIHQL------LRRNPADRLSLSSVL 261
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 61/251 (24%), Positives = 101/251 (40%), Gaps = 16/251 (6%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
++ L+L N + + F LE +S N + I F ++NL L L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-T 419
T + L+ L+ L L +N + +IP + L+ L L L I
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS-LRRLDLGELKRLSYISEGA 180
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLF 478
S L L+L+ L IP+ L L KL +L L N L I P + L+ L+
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
+ +++ A N +L I+L++N+L L +L + L +N +
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW------ 291
Query: 539 ELGDCRSLIWL 549
+C ++WL
Sbjct: 292 -NCNCD-ILWL 300
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 13/257 (5%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
+ K+ NL +VP + + ++ N+ + + F + +L+ L LS N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-T 419
+ + L NL TL+L N L+ IP+ LKEL+L+NN + SIPS
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSK-LKELWLRNNPI-ESIPSYA 155
Query: 420 LSNCSQLVSLHLS-FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
+ L L L L+ + LS L+ L L + L P L + L+ L
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELD 213
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
L N L+ P + +L + + + + L +L + L++N+ +P
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TLLPH 272
Query: 539 E-LGDCRSLIWLDLNTN 554
+ L + L+ N
Sbjct: 273 DLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 67/305 (21%), Positives = 118/305 (38%), Gaps = 57/305 (18%)
Query: 112 PAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSL 171
P+ CS+ S + L IS ++ ++LNL N + + L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLREVPDGIS-----TNTRLLNLHENQIQIIKVNSFKHLRHL 90
Query: 172 EVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVSSN 228
E+L LS N I + FNG L L L N++T I L+ L + +N
Sbjct: 91 EILQLSRNHIR---TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNN 146
Query: 229 NFSMAVPS--FGDCLALEYLDIS-ANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGY 285
++PS F +L LD+ + + +S F G
Sbjct: 147 PIE-SIPSYAFNRIPSLRRLDLGELKRLS----------------YISEGAFEG------ 183
Query: 286 NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI 345
S+L L+L+ NL ++P+ L+ D+S N S +
Sbjct: 184 --------------LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGS 226
Query: 346 FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKEL 405
F + +L++L + + ++ NL +L ++L+ NNL+ +PH+L + L+ +
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPL-HHLERI 284
Query: 406 FLQNN 410
L +N
Sbjct: 285 HLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 19/245 (7%)
Query: 219 NLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
N + L++ N + SF LE L +S N A + +L+ L + N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNK 336
+ IP G L S L +L L +N + +PS F SL D+ K
Sbjct: 125 TT-IPNG----------AFVYL-SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
+ F +SNL+ L L+ + +P+ L+ L L+ LDLS N+LS AI Q
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQ 228
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
G + L++L++ + + + N LV ++L+ N LT L L+ + L
Sbjct: 229 GLMH-LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287
Query: 457 LNQLH 461
N +
Sbjct: 288 HNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 46/195 (23%), Positives = 74/195 (37%), Gaps = 13/195 (6%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
+ NL +P + N + L L N + ++ + L L LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI---STN-TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALS 493
++ + L+ L L+L+ N+L IP + L+ L+L N + A +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 494 NCTNLNWISLS-NNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDL 551
+L + L L I LSNL L L+ + R P L L LDL
Sbjct: 158 RIPSLRRLDLGELKRL-SYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDELDL 214
Query: 552 NTNLFNGSIPPALFK 566
+ N + +I P F+
Sbjct: 215 SGNHLS-AIRPGSFQ 228
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 63/301 (20%), Positives = 94/301 (31%), Gaps = 56/301 (18%)
Query: 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFN 482
+Q + L +P + + + L L NQ+ I +++ LE L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPEL-G 541
+ A + NLN + L +N L LS L L L NN IP
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFN 157
Query: 542 DCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEF 601
SL LDL I F G NL
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAF---------------------------EGLSNLRYL 190
Query: 602 AGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMS 660
L+ CN + P + LD+S N LS +I +
Sbjct: 191 ------NLAM------CNLREI------PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLM 231
Query: 661 YLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQ 719
+L L + + + I +L+ L ++L+ N L + L L I L +N
Sbjct: 232 HLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNP 290
Query: 720 L 720
Sbjct: 291 W 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 61/338 (18%), Positives = 105/338 (31%), Gaps = 106/338 (31%)
Query: 61 VSCKAASVSSI--DLSPFTLSVDFH------LVASFLLTLDTLETLSLKNSNISGTISLP 112
V C ++ + +S T ++ H + + L LE L L ++I ++
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR---TIE 104
Query: 113 AGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--LS 170
G+ ++L L L N L + G+
Sbjct: 105 IGA-------------------------FNGLANLNTLELFDNRL--TTIPNGAFVYLSK 137
Query: 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNF 230
L+ L L N I +P FN +L+ LD+
Sbjct: 138 LKELWLRNNPIE---SIPSYAFNR----------------------IPSLRRLDLGELKR 172
Query: 231 SMAVP--SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEF 288
+ +F L YL+++
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR---------------------------------- 198
Query: 289 QGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLS 348
EIP +L L L +LDLS N+LS P F L+ + ++ + F +
Sbjct: 199 --EIP-NLTPL-IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
Query: 349 MSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
+ +L E+ L+ N+ T D + L +LE + L N
Sbjct: 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 53/250 (21%), Positives = 86/250 (34%), Gaps = 47/250 (18%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
L L N++ + + +L + LS NH+ L+NL L+L +N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 533 YGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKE 591
IP L L L N SIP F
Sbjct: 125 -TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF-------------------------- 156
Query: 592 CHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGS 651
+ +L +RLS IS F ++ +L+++ L
Sbjct: 157 -NRIPSLRRLDLGELKRLSYISEG---------------AFEGLSNLRYLNLAMCNLR-E 199
Query: 652 IPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLN 711
IP + + L L+L N+LS P L L L + ++++ ++ +L L
Sbjct: 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258
Query: 712 EIDLCNNQLT 721
EI+L +N LT
Sbjct: 259 EINLAHNNLT 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 72/301 (23%), Positives = 114/301 (37%), Gaps = 49/301 (16%)
Query: 841 ATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKL----IHI 895
A E P RK T D F +G G FG+VY A+ K +A+K L +
Sbjct: 2 ALAEMPKRKFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK 54
Query: 896 SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVG 954
G + E+E ++H N++ + Y +R+ L+ E+ G L L +
Sbjct: 55 EGVEHQ-LRREIEIQSHLRHPNILRMYNYFH-DRKRIYLMLEFAPRGELYKELQKHGRFD 112
Query: 955 IKLNWAARRKIA-IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013
+ + + A L + H +IHRD+K N+L+ E +++DFG
Sbjct: 113 ---EQRSATFMEELADA--LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----W 160
Query: 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN 1073
S L T+ GT Y+PPE + K D++ GV+ E L G P F
Sbjct: 161 SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP-----FDSP 215
Query: 1074 NLVGWVK--QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ + + LK +L+ L L P +R + VM
Sbjct: 216 SHTETHRRIVNVDLKFPPFLSDGS--------KDLISKL------LRYHPPQRLPLKGVM 261
Query: 1132 A 1132
Sbjct: 262 E 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 71/305 (23%), Positives = 120/305 (39%), Gaps = 43/305 (14%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGY 924
++ GGF VY+A+ + G A+K+L+ + +R E+ + K+ H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 925 CKVGEER-------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+G+E L+ + G L + L + G L+ KI + R + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG-PLSCDTVLKIFYQTCRAVQHMH 153
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVS----------TLAG 1027
P IIHRD+K N+LL ++ DFG A +S + + T
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 1028 TPGYVPPE---YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
TP Y PE Y +F K D+++ G +L L + P F D + V
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----FEDGAKLRIVNGKYS 267
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144
+ D L++ L P R ++ +V+ +EI A ++
Sbjct: 268 IPPHDTQYTVF--------HSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARNVN 313
Query: 1145 SQSTI 1149
+S I
Sbjct: 314 PKSPI 318
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 89/406 (21%), Positives = 141/406 (34%), Gaps = 37/406 (9%)
Query: 56 CGFKGVSCKAASVSSI-DLSPFTLSVDFH------LVASFLLTLDTLETLSLKNSNISGT 108
C + + +L VD L + L L+ L ++
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 109 ISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK 168
I SS L L L N + ++L+VL L+ LD + K
Sbjct: 70 IRNNTFRGLSS-LIILKLDYNQFLQLETGA--FNGLANLEVLTLTQCNLDGAVLSGNFFK 126
Query: 169 --LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT----GDINVSKCKNLQF 222
SLE+L L N I + P F L L NKV D+ + K+
Sbjct: 127 PLTSLEMLVLRDNNIK--KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184
Query: 223 LDVSSNNF---------SMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN-- 271
L +SS + ++ LD+S N F + + +
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244
Query: 272 VSSNLFSGPIPVGYNEFQGEIPLHLADL-CSSLVKLDLSSNNLSGKVPSR-FGSCSSLES 329
+ SN ++ G+ F+ L S + DLS + + + F + LE
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQ 303
Query: 330 FDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGA 389
++ N+ + ++ F +++L +L LS N NL LE LDLS N++ A
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-A 361
Query: 390 IPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFN 434
+ G N LKEL L N L S+P + L + L N
Sbjct: 362 LGDQSFLGLPN-LKELALDTN-QLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 77/436 (17%), Positives = 148/436 (33%), Gaps = 74/436 (16%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
+ + +DLS N+++ + F L+ + + F +S+L L L +N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNL-SGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
F + + L NLE L L+ NL + N + + L+ L L++N + P++
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPAS 148
Query: 420 L-SNCSQLVSLHLSFNYLTGTIPSSLGSLSK--LQDLKLWLNQLH--------GEIPPEL 468
N + L L+FN + L + L+L L E
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 469 GNIQTLETLFLDFNELTGTLPAALSNCTNLNWI-SLSNNHLGGEIPTWIGQLSNLAILKL 527
++ TL L N ++ + I SL ++ +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM----GSSFGHTNFKDP 264
Query: 528 SNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKND 587
N +F G + DL+ + ++ ++F
Sbjct: 265 DNFTFKGLEAS------GVKTCDLSKSKIF-ALLKSVFSHFTD----------------- 300
Query: 588 GSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNM 647
LE + +++I F ++ L++S N
Sbjct: 301 -----------LEQLTLAQNEINKIDDN---------------AFWGLTHLLKLNLSQNF 334
Query: 648 LSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGTIPSSM- 704
L SI + ++ L +L+L +N++ + + L L L L +N+L+ ++P +
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIF 391
Query: 705 SSLTLLNEIDLCNNQL 720
LT L +I L N
Sbjct: 392 DRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 78/380 (20%), Positives = 129/380 (33%), Gaps = 57/380 (15%)
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
+++ + LS N S S L +L+ L + I +N +G + L L L
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS-LIILKLDY 88
Query: 410 NLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTI--PSSLGSLSKLQDLKLWLNQLHGEIPP 466
N L + + + + L L L+ L G + + L+ L+ L L N + +I P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQP 146
Query: 467 E--LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAI 524
N++ L L FN++ L N ++ L LS++ +
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITL 192
Query: 525 LKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584
++ S+ LDL+ N F S+ F IA I
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF---DAIAGTKIQSLILSNS 249
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644
N GS H F + + D+S
Sbjct: 250 YNMGSSFGHTN----------------FKDPDNFTFKGLEASGVK----------TCDLS 283
Query: 645 YNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGTIPS 702
+ + ++ K + + L L L N ++ I L L L+LS N L G+I S
Sbjct: 284 KSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDS 340
Query: 703 SM-SSLTLLNEIDLCNNQLT 721
M +L L +DL N +
Sbjct: 341 RMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 77/412 (18%), Positives = 142/412 (34%), Gaps = 57/412 (13%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVS 226
+ +DLS N I+ + F+ +L+ L ++ I +L L +
Sbjct: 31 HVNYVDLSLNSIA---ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87
Query: 227 SNNFSMAVPS--FGDCLALEYLDISANKFTGDV--GHAISACEHLSFLNVSSNLFSGPIP 282
N F + + F LE L ++ G V G+ L L + N P
Sbjct: 88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 283 VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS--LESFDISSNKFS-- 338
+ F LDL+ N + + +SS
Sbjct: 147 ASF--FLNM---------RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 339 -----GELPIEIFLSMSNLKELVLSFNDFTGALP---DSLSNLTNLETLDLSSNNLSGA- 389
G +++ L LS N F ++ T +++L LS++ G+
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 390 --------IPHNLCQG-PRNSLKELFLQNNLLLGSIPSTL-SNCSQLVSLHLSFNYLTGT 439
+ +G + +K L + + ++ ++ S+ + L L L+ N +
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKI 314
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPAALSNCTNL 498
++ L+ L L L N L G I + N+ LE L L +N + + NL
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373
Query: 499 NWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549
++L N L +P I +L++L + L N + C + +L
Sbjct: 374 KELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYL 417
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-18
Identities = 64/310 (20%), Positives = 104/310 (33%), Gaps = 19/310 (6%)
Query: 92 LDTLETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
L LE L+L N+ G + L + + L L L N + + S+ + VL
Sbjct: 102 LANLEVLTLTQCNLDGAV-LSGNFFKPLTSLEMLVLRDNNIKK-IQPASFFLNMRRFHVL 159
Query: 151 NLSSNLLDFSGREA--GSLKLSLEVLDLSYNKIS--GANVVPWI---LFNGCDELKQLAL 203
+L+ N + E +L LS + + W + L L
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219
Query: 204 KGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISA 263
GN + + + S S + + D F G +
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT 279
Query: 264 --CEHLSFLNVSSNLFSG-----PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+ ++FS + + NE +I + + L+KL+LS N L
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSI 338
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
F + LE D+S N L + FL + NLKEL L N LT+L
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397
Query: 377 ETLDLSSNNL 386
+ + L +N
Sbjct: 398 QKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-09
Identities = 54/351 (15%), Positives = 95/351 (27%), Gaps = 102/351 (29%)
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GNI 471
L +P ++ + + LS N + +S L LQ LK+ I +
Sbjct: 22 LHQVPELPAH---VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL 78
Query: 472 QTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNS 531
+L L LD+N+ A + NL ++L+ +L G + LS N
Sbjct: 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAV--------------LSGNF 124
Query: 532 FYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI-KNDGSK 590
F SL L L N P + F + + + N
Sbjct: 125 F--------KPLTSLEMLVLRDNNIKKIQPASFFLNMRRF--------HVLDLTFNKVKS 168
Query: 591 ECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
C + + T S+ D++ L
Sbjct: 169 ICEED-----LLNFQGKHF---------------------TLLRLSSITLQDMNEYWLGW 202
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDL--------------------------- 683
+ + L+L N + D
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 684 ------------RGLNILDLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLT 721
G+ DLS +++ + S+ S T L ++ L N++
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNR 695
+ ++D+S N ++ + L L + I L L IL L N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 696 LEGTIPSSM-SSLTLLNEIDLCNNQLTGMIPVMGQF 730
+ + + L L + L L G + F
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 36/242 (14%), Positives = 69/242 (28%), Gaps = 54/242 (22%)
Query: 496 TNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGD-CRSLIWLDLNTN 554
++N++ LS N + T +L +L LK+ + I SLI L L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 555 LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST 614
F + F + + + + L+ A +
Sbjct: 90 QF-LQLETGAFNGLANL--------EVLTLTQ----------CNLDGAVLSGN------- 123
Query: 615 RSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLS 673
F S+ L + N + P +M +L+L N +
Sbjct: 124 ----------------FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
Query: 674 ----------GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGM 723
+ L + + D++ L + T + +DL N
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227
Query: 724 IP 725
+
Sbjct: 228 MA 229
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 93/465 (20%), Positives = 155/465 (33%), Gaps = 83/465 (17%)
Query: 121 LSSLDLSLNILSGPLSDISYLGSC-SSLKVLNLSSNLLDFSGREAGSLKL----SLEVLD 175
+ SLD+ LS + + L +V+ L L + + S L +L L+
Sbjct: 5 IQSLDIQCEELSD--ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 176 LSYNKI--SGANVVPWILFNGCDELKQLALKGNKVTGD------INVSKCKNLQFLDVSS 227
L N++ G + V L ++++L+L+ +TG + LQ L +S
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 228 NNFS-MAVPSFGDCL-----ALEYLDISANKFT----GDVGHAISACEHLSFLNVSSNLF 277
N + + L LE L + + + + A L VS+N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 278 SGPIPVGYNEFQG--EIPLHLADLCSSLVKLDLSSNNLSGK----VPSRFGSCSSLESFD 331
+ G + L D L L L S ++ + S +SL
Sbjct: 183 NE---------AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 332 ISSNKFSGE----LPIEIFLSMSNLKELVLSFNDFT----GALPDSLSNLTNLETLDLSS 383
+ SNK L + S L+ L + T G L L +L+ L L+
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 384 NNLSGAIPHNLCQG---PRNSLKELFLQNNLL----LGSIPSTLSNCSQLVSLHLSFNYL 436
N L LC+ P L+ L++++ S L+ L+ L +S N L
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353
Query: 437 TGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT----GTLPAAL 492
L L Q L L+L +++ +L A L
Sbjct: 354 EDAGVRELCQG---------LGQPG----------SVLRVLWLADCDVSDSSCSSLAATL 394
Query: 493 SNCTNLNWISLSNNHLGGEIPTWIGQL-----SNLAILKLSNNSF 532
+L + LSNN LG + + L L L + +
Sbjct: 395 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 84/459 (18%), Positives = 137/459 (29%), Gaps = 102/459 (22%)
Query: 145 SSLKVLNLSSNLLDFSG-REAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLAL 203
++ L++ L + E L +V+ L ++ A C ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA---------RCKDISSA-- 51
Query: 204 KGNKVTGDINVSKCKNLQFLDVSSNNFS-MAVPSFGDCLA-----LEYLDISANKFT--- 254
+ L L++ SN + V L ++ L + T
Sbjct: 52 ----------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 101
Query: 255 -GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPL--HLADLCSSLVKLDLSSN 311
G + + L L++S NL G L L D L KL L
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLLGD---------AGLQLLCEGLLDPQCRLEKLQLEYC 152
Query: 312 NLSGKVPSRFGS----CSSLESFDISSNKFSGE----LPIEIFLSMSNLKELVLSFNDFT 363
+LS S + +S+N + L + S L+ L L T
Sbjct: 153 SLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
Query: 364 ----GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG---PRNSLKELFLQNNLL---- 412
L +++ +L L L SN L LC G P + L+ L++ +
Sbjct: 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG 272
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQ 472
G + L L L L+ N L L
Sbjct: 273 CGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC------------------- 313
Query: 473 TLETLFLDFNELTGT----LPAALSNCTNLNWISLSNNHLGGEIPTWIGQL-----SNLA 523
LE+L++ T + L+ L + +SNN L + Q S L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 524 ILKLSNNSFYGRIPPE--------LGDCRSLIWLDLNTN 554
+L L++ + L SL LDL+ N
Sbjct: 374 VLWLADCD----VSDSSCSSLAATLLANHSLRELDLSNN 408
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 76/383 (19%), Positives = 127/383 (33%), Gaps = 67/383 (17%)
Query: 86 ASFLLTLDTLETLSLKNSNI--SGTISLPAGSR-CSSFLSSLDLSLNILSGP-LSDI-SY 140
+S L TL TL+ L L ++ + +G L G L L L LS + S
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165
Query: 141 LGSCSSLKVLNLSSNLLDFSGREA-----GSLKLSLEVLDLSYNKISGANVVPWILFNGC 195
L + K L +S+N ++ +G LE L L ++ C
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD---------NC 216
Query: 196 DELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFS------MAVPSFGDCLALEYLDIS 249
+L + +L+ L + SN + L L I
Sbjct: 217 RDLCG-IVASK-----------ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264
Query: 250 ANKFTGD----VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVK 305
T + + A E L L+++ N +E + L + L
Sbjct: 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELG-------DEGARLLCETLLEPGCQLES 317
Query: 306 LDLSSNNLSGKVPSRFGS----CSSLESFDISSNKF--SGELPIEIFLSMSN--LKELVL 357
L + S + + S F S L IS+N+ +G + L L+ L L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 358 SFNDFT----GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG---PRNSLKELFLQNN 410
+ D + +L +L +L LDLS+N L A L + P L++L L +
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 411 LL----LGSIPSTLSNCSQLVSL 429
+ + + L +
Sbjct: 438 YWSEEMEDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-19
Identities = 81/435 (18%), Positives = 135/435 (31%), Gaps = 92/435 (21%)
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT----GALPDSLSNLTNLETLD 380
++S DI + S E+ + + + L T + +L L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 381 LSSNNLSGAIPHNLCQG---PRNSLKELFLQNNLL----LGSIPSTLSNCSQLVSLHLSF 433
L SN L H + QG P +++L LQN L G + STL L LHLS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 434 NYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT----LP 489
N L + L L + L LE L L++ L+ L
Sbjct: 123 NLLG---DAGLQLLCEGL----------------LDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 490 AALSNCTNLNWISLSNNHLGGEIPTWIGQL-----SNLAILKLSNNSFYGR----IPPEL 540
+ L + +++SNN + + Q L LKL + + +
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 541 GDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLE 600
SL L L +N + + G E G L
Sbjct: 224 ASKASLRELALGSN----------------------------KLGDVGMAE-LCPGLLHP 254
Query: 601 FAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSM- 659
+ +R + C T G S+ L ++ N L + +
Sbjct: 255 SSRLRTLWIWE------CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL 308
Query: 660 ----SYLFILNLGHNNLSGPIPTEVGDL----RGLNILDLSSNRL--EGTIPSS---MSS 706
L L + + + + + R L L +S+NRL G
Sbjct: 309 LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP 368
Query: 707 LTLLNEIDLCNNQLT 721
++L + L + ++
Sbjct: 369 GSVLRVLWLADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-09
Identities = 41/218 (18%), Positives = 70/218 (32%), Gaps = 31/218 (14%)
Query: 83 HLVASFLLTLDTLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILSGPLSDISY 140
L L L TL + I+ G L R L L L+ N L
Sbjct: 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD--EGARL 303
Query: 141 LG-----SCSSLKVLNLSSNLLDFSGREAGSLKL----SLEVLDLSYNKI--SGANVVPW 189
L L+ L + S + S L L L +S N++ +G +
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363
Query: 190 ILFNGCDELKQLALKGNKVTGD------INVSKCKNLQFLDVSSNNFSMA-VPSFGDCLA 242
L L+ L L V+ + +L+ LD+S+N A + + +
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423
Query: 243 -----LEYLDISANKFTGDVGHAISA----CEHLSFLN 271
LE L + ++ ++ + A L ++
Sbjct: 424 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 71/244 (29%), Positives = 114/244 (46%), Gaps = 29/244 (11%)
Query: 839 NLATFEKP--LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHI 895
++A+ L ++ + L + F L+G+G +G VYK + +K G AIK + +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDV 59
Query: 896 SGQGDREFTAEMETIGKI-KHRNLVPLLG-YCKVGEERL-----LVYEYMRYGSLEDVLH 948
+G + E E+ + K HRN+ G + K + LV E+ GS+ D++
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 949 NQKKVGIKLNWAARRKIAI---GSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVS 1005
N K +K W IA RGL+ LH + +IHRD+K NVLL EN E ++
Sbjct: 120 NTKGNTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171
Query: 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS-----TKGDVYSYGVVLLELLT 1060
DFG++ + T +T GTP ++ PE K D++S G+ +E+
Sbjct: 172 DFGVSAQLD--RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 1061 GKRP 1064
G P
Sbjct: 230 GAPP 233
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-30
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 39/300 (13%)
Query: 865 DSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLL 922
+G+GGFG V + +D G VAIK+ +RE + E++ + K+ H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 923 ------GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN-WAARRKIA-IGSARGLA 974
+ LL EY G L L NQ + L R ++ I SA L
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSA--LR 135
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEAR---VSDFGMARLMSAMDTHLSVSTLAGTPGY 1031
+LH N IIHRD+K N++L + + D G A+ + L + GT Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGEL-CTEFVGTLQY 189
Query: 1032 VPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+ PE + + + D +S+G + E +TG RP + V W + + +
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL----PNWQPVQWHGKVREKSNEHIV 245
Query: 1092 DPELMKEDPNIEIELLQHLHVASAC-----------LDDRPWRRPTMIQVMAM--FKEIQ 1138
+ + L H++ L +R T Q + F+ +
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
++G G +G VY + L + +AIK++ + + E+ +KH+N+V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ E + GSL +L ++ +K N GL +LH N I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 986 HRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR--C 1042
HRD+K NVL++ + ++SDFG ++ ++ ++ T GT Y+ PE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGY 202
Query: 1043 STKGDVYSYGVVLLELLTGKRP 1064
D++S G ++E+ TGK P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 25/230 (10%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
+ ++G G +V++ + K G AIK +IS + E E + K+ H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 920 PLLGYCKVGEERL--LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFL 976
L + R L+ E+ GSL VL + + + L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHL 128
Query: 977 HHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
N I+HR++K N++ D +++DFG AR + D +L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFV--SLYGTEEYL 182
Query: 1033 PPEYYQSFRCSTKG--------DVYSYGVVLLELLTGKRPTDSADFGDNN 1074
P+ Y+ D++S GV TG P + N
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 57/269 (21%), Positives = 107/269 (39%), Gaps = 16/269 (5%)
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
+ L ++ LDLS+N ++ S C +L++ ++SN + + + F S+ +L+ L
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLD 106
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
LS+N + L++L L+L N + L+ L + N I
Sbjct: 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 417 PS-TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQTL 474
+ + L L + + L P SL S+ + L L + Q + ++
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSV 224
Query: 475 ETLFLD--------FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILK 526
E L L F+EL+ +L + +++ L ++ + Q+S L L+
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 527 LSNNSFYGRIPPE-LGDCRSLIWLDLNTN 554
S N +P SL + L+TN
Sbjct: 284 FSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 56/292 (19%), Positives = 107/292 (36%), Gaps = 33/292 (11%)
Query: 219 NLQFLDVSSNNFSMAVPS-FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
++ LD+S+N + S C+ L+ L +++N + S+ L L++S N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNK 336
S + + F+ SSL L+L N + F + L+ + +
Sbjct: 113 SN-LSSSW--FKP---------LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
++ + F ++ L+EL + +D P SL ++ N+ L L +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
+S++ L L++ L F+ L+ +SL +++K+
Sbjct: 220 V-TSSVECLELRDTDL----------------DTFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHL 508
L ++ L I L L N+L T+L I L N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 57/245 (23%), Positives = 93/245 (37%), Gaps = 14/245 (5%)
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
SC SS + +P + +K L LS N T L NL+ L L+
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIP 441
SN ++ I + + L+ L L N L ++ S S L L+L N
Sbjct: 85 SNGIN-TIEEDSFSSLGS-LEHLDLSYN-YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGE 141
Query: 442 SSL-GSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
+SL L+KLQ L++ +I + + LE L +D ++L P +L + N++
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 500 WISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPEL--GDCRSLIWLDLNTNLF 556
+ L + S++ L+L + EL G+ SLI N+
Sbjct: 202 HLILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260
Query: 557 NGSIP 561
Sbjct: 261 ITDES 265
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 67/333 (20%), Positives = 115/333 (34%), Gaps = 61/333 (18%)
Query: 143 SCSSLKVLNLSSNLLD--FSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
SC + SS L+ SG L +++ LDLS N+I+ + C L+
Sbjct: 29 SCDRNGICKGSSGSLNSIPSG-----LTEAVKSLDLSNNRIT---YISNSDLQRCVNLQA 80
Query: 201 LALKGNKVTGDINV---SKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTG 255
L L N + I S +L+ LD+S N S + S F +L +L++ N +
Sbjct: 81 LVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK- 137
Query: 256 DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG 315
+ S L L L + + +
Sbjct: 138 ----TLGETSLFSHLT------------------------------KLQILRVGNMDTFT 163
Query: 316 KVPSR-FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT 374
K+ + F + LE +I ++ + S+ N+ L+L L + +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNS------LKELFLQNNLLLGSIPSTLSNCSQLVS 428
++E L+L +L L G NS + + + + L + L+ S L+
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281
Query: 429 LHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH 461
L S N L L+ LQ + L N
Sbjct: 282 LEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 67/308 (21%), Positives = 121/308 (39%), Gaps = 48/308 (15%)
Query: 110 SLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK- 168
S+P+G + + SLDLS N ++ + L C +L+ L L+SN + + E S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSD--LQRCVNLQALVLTSNGI--NTIEEDSFSS 98
Query: 169 -LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT--GDINV-SKCKNLQFLD 224
SLE LDLSYN +S + F L L L GN G+ ++ S LQ L
Sbjct: 99 LGSLEHLDLSYNYLS---NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 225 VSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIP 282
V + + + F LE L+I A+ ++ + +++S L +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI---- 211
Query: 283 VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP 342
+ D+ SS+ L+L +L S +S+ + +
Sbjct: 212 --------LLLEIFVDVTSSVECLELRDTDLDTFHFSE-----------LSTGETNS--- 249
Query: 343 IEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSL 402
+ + + ++ + L+ ++ L L+ S N L +P + SL
Sbjct: 250 ---LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT-SL 303
Query: 403 KELFLQNN 410
++++L N
Sbjct: 304 QKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 57/322 (17%), Positives = 110/322 (34%), Gaps = 61/322 (18%)
Query: 409 NNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL 468
++ L SIPS L+ + SL LS N +T S L LQ L L N ++ I +
Sbjct: 39 SSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95
Query: 469 -GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIP--TWIGQLSNLAIL 525
++ +LE L L +N L+ + ++L +++L N + + L+ L IL
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154
Query: 526 KLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584
++ N + +I + L L+++ + S P K + ++ +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNV--------SHLIL 205
Query: 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644
+ + + S+ L++
Sbjct: 206 HM----------K----------QHILLLEIF---------------VDVTSSVECLELR 230
Query: 645 YNMLSGSIPKEIGS--------MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRL 696
L E+ + + + +L + + + GL L+ S N+L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 697 EGTIPSSMSSLTLLNEIDLCNN 718
+ LT L +I L N
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 55/319 (17%), Positives = 96/319 (30%), Gaps = 65/319 (20%)
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLE 475
++LS C + S L +IPS L ++ L L N++ I L L+
Sbjct: 25 QASLS-CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQ 79
Query: 476 TLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534
L L N + T+ + S+ +L + LS N+L +W LS+L L L N +
Sbjct: 80 ALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-K 137
Query: 535 RIPPE--LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKEC 592
+ L L + I F
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF--------------------------- 170
Query: 593 HGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSI 652
G L E I A L +S ++ L + +
Sbjct: 171 AGLTFL-EELEIDASDLQSYEPKS---------------LKSIQNVSHLILHMKQHI-LL 213
Query: 653 PKEI-GSMSYLFILNLGHNNLSGPIPTEV--------GDLRGLNILDLSSNRLEGTIPSS 703
+ S + L L +L +E+ + ++ L +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKL 272
Query: 704 MSSLTLLNEIDLCNNQLTG 722
++ ++ L E++ NQL
Sbjct: 273 LNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 36/285 (12%), Positives = 80/285 (28%), Gaps = 77/285 (27%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+++L L N +T + L C NL + L++N + + +SF
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN----------------TIEEDSF 96
Query: 533 YGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKEC 592
SL LDL+ N ++ + F
Sbjct: 97 SS--------LGSLEHLDLSYNYL-SNLSSSWF--------------------------- 120
Query: 593 HGAGNLLEFAGIRAERLS--RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
+L L T + F+H + L +
Sbjct: 121 KPLSSLTFL------NLLGNPYKTLGETSL-----------FSHLTKLQILRVGNMDTFT 163
Query: 651 SIPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLT 708
I ++ +++L L + ++L + ++ ++ L L + + + +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 709 LLNEIDLCNNQLTGMIPVM---GQFETFQPAKFLNNSGLCGLPLP 750
+ ++L + L G+ + N + L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 45/240 (18%), Positives = 80/240 (33%), Gaps = 53/240 (22%)
Query: 486 GTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCR 544
+ A +C S+ L IP+ + + L LSNN I L C
Sbjct: 21 ESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRI-TYISNSDLQRCV 76
Query: 545 SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGI 604
+L L L +N N +I F G+L +
Sbjct: 77 NLQALVLTSNGIN-TIEEDSF---------------------------SSLGSLEHL-DL 107
Query: 605 RAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI--GSMSYL 662
LS +S+ F S+ FL++ N ++ + ++ L
Sbjct: 108 SYNYLSNLSSS---------------WFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKL 151
Query: 663 FILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
IL +G+ + I + L L L++ ++ L+ P S+ S+ ++ + L Q
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 27/187 (14%), Positives = 54/187 (28%), Gaps = 44/187 (23%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
L LE L + S++ S S L S ++ L
Sbjct: 173 LTFLEELEIDASDLQ---SYEPKS-------------------------LKSIQNVSHLI 204
Query: 152 LSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANV--VPWILFNGCD---ELKQLALKGN 206
L + S+E L+L + + + N + + +
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264
Query: 207 KVTGDINV-SKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISA 263
+ + + ++ L L+ S N VP F +L+ + + N +
Sbjct: 265 SLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS------- 316
Query: 264 CEHLSFL 270
C + +L
Sbjct: 317 CPRIDYL 323
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
+ IG G G VY A + G VAI++ +++ Q +E E+ + + K+ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L VG+E +V EY+ GSL DV+ ++ + + L FLH N
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN 135
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+IHRD+KS N+LL + +++DFG ++ ST+ GTP ++ PE
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTR 190
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
K D++S G++ +E++ G+ P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 56/295 (18%), Positives = 103/295 (34%), Gaps = 54/295 (18%)
Query: 862 FHNDSLIGSGGFGDVYKA-KLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI----KHR 916
FH IGSG FG V+K K DG AIK+ G + + + +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
++V + L+ EY GSL D + ++ A + + + RGL ++
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 977 HHNCIPHIIHRDMKSSNVLLDEN-------------------FEARVSDFGMARLMSAMD 1017
H ++H D+K SN+ + ++ D G +S
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185
Query: 1018 THLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076
S G ++ E Q ++ K D+++ + ++ + + +
Sbjct: 186 ---SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQW 237
Query: 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
++Q +I V E ELL + P RRP+ + ++
Sbjct: 238 HEIRQGRLPRIPQVLSQEF--------TELL------KVMIHPDPERRPSAMALV 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
+ IG G G V A+ G VA+K + + Q RE E+ + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVV 105
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
+ VGEE ++ E+++ G+L D++ ++LN + + LA+LH
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+IHRD+KS ++LL + ++SDFG +S +L GTP ++ PE
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKSLVGTPYWMAPEVISR 215
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
+T+ D++S G++++E++ G+ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
++ ++ L N +S + F +C +L + SN + + F ++ L++L LS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
Query: 361 DFTGALP-DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS- 418
++ + L L TL L L + L +G L+ L+LQ+N L ++P
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA-LQYLYLQDN-ALQALPDD 147
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETL 477
T + L L L N ++ + L L L L N++ + P ++ L TL
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTL 206
Query: 478 FLDFNELTGTLPAALSNCTNLNWISLSNN 506
+L N L+ AL+ L ++ L++N
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 58/236 (24%), Positives = 88/236 (37%), Gaps = 13/236 (5%)
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
+ +P+ I + + + L N + S NL L L
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIP 441
SN L+ I G L++L L +N L S+ T +L +LHL L +
Sbjct: 65 SNVLA-RIDAAAFTGLAL-LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG 121
Query: 442 S-SLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
L+ LQ L L N L +P + ++ L LFL N ++ A +L+
Sbjct: 122 PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 500 WISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTN 554
+ L N + P L L L L N+ +P E L R+L +L LN N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 13/231 (5%)
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA 365
L VP + + + + N+ S +P F + NL L L N
Sbjct: 16 TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARI 71
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCS 424
+ + L LE LDLS N ++ G L L L L + +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGR-LHTLHLDRCGL-QELGPGLFRGLA 129
Query: 425 QLVSLHLSFNYLTGTIPS-SLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFN 482
L L+L N L +P + L L L L N++ +P + +L+ L L N
Sbjct: 130 ALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQN 187
Query: 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSF 532
+ P A + L + L N+L +PT L L L+L++N +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 47/219 (21%), Positives = 78/219 (35%), Gaps = 19/219 (8%)
Query: 219 NLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
Q + + N S SF C L L + +N A + L L++S N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNK 336
+ F G L L L L ++ F ++L+ + N
Sbjct: 93 LRSVDPA--TFHG---------LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
LP + F + NL L L N + + L +L+ L L N ++ + + +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR 198
Query: 397 GPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFN 434
L L+L N L ++P+ L+ L L L+ N
Sbjct: 199 DLGR-LMTLYLFAN-NLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 53/269 (19%), Positives = 86/269 (31%), Gaps = 68/269 (25%)
Query: 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
++ + + L N + + +L +L L N ++ + A
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA--------------RIDAAAFT 77
Query: 205 GNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAIS 262
G L+ LD+S N +V F L L +
Sbjct: 78 GL-----------ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-------- 118
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-F 321
+ LF G ++L L L N L +P F
Sbjct: 119 --------ELGPGLFRG--------------------LAALQYLYLQDNALQ-ALPDDTF 149
Query: 322 GSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
+L + N+ S +P F + +L L+L N P + +L L TL L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
+NNLS A+P R +L+ L L +N
Sbjct: 209 FANNLS-ALPTEALAPLR-ALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 50/251 (19%), Positives = 87/251 (34%), Gaps = 49/251 (19%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+ +FL N ++ A+ C NL + L +N L L+ L L LS+N+
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 533 YGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKE 591
+ P L L L+ + P LF+ + +Y+Y+++
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL--------QYLYLQD----- 138
Query: 592 CHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGS 651
N L + TF G++ L + N +S S
Sbjct: 139 -----N----------ALQALPDD---------------TFRDLGNLTHLFLHGNRIS-S 167
Query: 652 IPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTL 709
+P+ + L L L N ++ + DL L L L +N L +++ L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 710 LNEIDLCNNQL 720
L + L +N
Sbjct: 227 LQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/251 (21%), Positives = 89/251 (35%), Gaps = 54/251 (21%)
Query: 118 SSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--LSLEVLD 175
+ + L N +S + +C +L +L L SN+L + +A + LE LD
Sbjct: 31 PAASQRIFLHGNRISHVPAAS--FRACRNLTILWLHSNVL--ARIDAAAFTGLALLEQLD 86
Query: 176 LSYN-KISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVSSNNFS 231
LS N ++ V F+G L L L + ++ LQ+L + N
Sbjct: 87 LSDNAQLR---SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 232 MAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQ 289
A+P F D L +L + N+ + +V F G
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRIS----------------SVPERAFRG---------- 175
Query: 290 GEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSM 349
SL +L L N ++ P F L + + +N S LP E +
Sbjct: 176 ----------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPL 224
Query: 350 SNLKELVLSFN 360
L+ L L+ N
Sbjct: 225 RALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 44/230 (19%), Positives = 81/230 (35%), Gaps = 25/230 (10%)
Query: 61 VSCKAASVSSI--DLSPFTLSVDFH------LVASFLLTLDTLETLSLKNSNISGTISLP 112
SC + ++ + + + H + A+ L L L ++ ++ +
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA---RID 72
Query: 113 AGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--L 169
A + + L LDLS N + + L L+L L G +
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDP-ATFHGLGRLHTLHLDRCGL--QELGPGLFRGLA 129
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG--DINVSKCKNLQFLDVSS 227
+L+ L L N + +P F L L L GN+++ + +L L +
Sbjct: 130 ALQYLYLQDNALQ---ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 228 NNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN 275
N + V F D L L + AN + A++ L +L ++ N
Sbjct: 187 NRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 4/93 (4%)
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNI 688
TF+ G + L + L + + ++ L L L N L +P + DL L
Sbjct: 100 TFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTH 157
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
L L NR+ + L L+ + L N++
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 61/309 (19%), Positives = 106/309 (34%), Gaps = 43/309 (13%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
+ ++G G +V++ + K G AIK +IS + E E + K+ H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 920 PLLGYCKVGEERL--LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFL 976
L + R L+ E+ GSL VL + + + L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHL 128
Query: 977 HHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
N I+HR++K N++ D +++DFG AR + D +L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFV--SLYGTEEYL 182
Query: 1033 PPEYYQSFRCSTKG--------DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
P+ Y+ D++S GV TG P + N K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK---I 239
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHL---------------HVASACLDDRPWRRPTMIQ 1129
+ +++ N I+ + V + L+ + Q
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 1130 VMAMFKEIQ 1138
A +I
Sbjct: 300 FFAETSDIL 308
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 41/300 (13%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD--REFTAEMETIGKIKHRNLV 919
F S +G+G G V+K K V +KLIH+ + + E++ + + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
G E + E+M GSL+ VL ++ ++ K++I +GL +L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 150
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
I+HRD+K SN+L++ E ++ DFG++ +L+ +M ++ GT Y+ PE Q
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQ 203
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098
S + D++S G+ L+E+ G+ P D + L+ + + +
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 1099 DPNIE---------IELLQHL------------------HVASACLDDRPWRRPTMIQVM 1131
ELL ++ + CL P R + Q+M
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 47/270 (17%), Positives = 87/270 (32%), Gaps = 24/270 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQGDREFTAEMETIGKIKH 915
+ L+G G F VY+A D +K + T ME +
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK-LNWAARRKIAIGSARGLA 974
+ +LV E YG+L + ++ K K + A+ +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 975 FLHHNCIPHIIHRDMKSSNVLL-----------DENFEARVSDFGMARLMSAMDTHLSVS 1023
+H IIH D+K N +L D + + D G + M +
Sbjct: 187 QVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083
T G+ E + + + D + + +L G + G+ G ++
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 1084 KLKI-SDVFDPELMKEDPNI--EIELLQHL 1110
L + ++ F L D + ++LL+
Sbjct: 304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 36/272 (13%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK----KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G GGF ++ A K L+ Q ++ + E+ + H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G+ + + +V E R SL ++ +K L R G +LH N
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN-- 134
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+IHRD+K N+ L+E+ E ++ DFG+A + L GTP Y+ PE
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKG 191
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK--QHAKLKISDVFDPELMKED 1099
S + DV+S G ++ LL GK P F + L + + I +P
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP-----FETSCLKETYLRIKKNEYSIPKHINPVAAS-- 244
Query: 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
L+Q + L P RPT+ +++
Sbjct: 245 ------LIQKM------LQTDPTARPTINELL 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK----KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+G GGF ++ A K L+ Q ++ + E+ + H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
G+ + + +V E R SL ++ +K L R G +LH N
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN-- 160
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+IHRD+K N+ L+E+ E ++ DFG+A + L GTP Y+ PE
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKG 217
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
S + DV+S G ++ LL GK P +++
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSC 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 23/218 (10%)
Query: 862 FHNDSLIGSG--GFGDVYKAK-LKDGSTVAIKK--LIHISGQGDREFTAEMETIGKIKHR 916
+ ++IG G V A+ G V +++ L S + E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGL 973
N+VP E +V +M YGS +D++ G+ IA G + L
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKAL 141
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG-MARLMSAMD----THLSVSTLAGT 1028
++HH +HR +K+S++L+ + + +S ++S H
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 1029 PGYVPPEYYQSFRC--STKGDVYSYGVVLLELLTGKRP 1064
++ PE Q K D+YS G+ EL G P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
+ +G G FG VYKAK + G+ A K I + + E + E+E + H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGLAFL 976
LLG + ++ E+ G+++ ++ + L +I + L FL
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLT---EPQIQVVCRQMLEALNFL 133
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE- 1035
H IIHRD+K+ NVL+ + R++DFG++ T + GTP ++ PE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAPEV 188
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ K D++S G+ L+E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 55/301 (18%), Positives = 101/301 (33%), Gaps = 55/301 (18%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIK--------KLIHISGQGDREFTA---------EMETI 910
+ G F + + KD A+K K + + + + E++ I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 911 GKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKL-----NWAARRKI 965
IK+ + G +E ++YEYM S+ + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 966 A-IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ +++H+ +I HRD+K SN+L+D+N ++SDFG + M D +
Sbjct: 158 KSV--LNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKI--KG 209
Query: 1025 LAGTPGYVPPEYYQSFRCSTKG-------DVYSYGVVLLELLTGKRPTDSADFGDNNLVG 1077
GT ++PPE+ S + D++S G+ L + P +LV
Sbjct: 210 SRGTYEFMPPEF-----FSNESSYNGAKVDIWSLGICLYVMFYNVVPFS----LKISLVE 260
Query: 1078 WVK--QHAKLKISDVFDPELMKEDPNIEIELLQHLHVA-----SACLDDRPWRRPTMIQV 1130
+ ++ + L L L P R T
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 1131 M 1131
+
Sbjct: 321 L 321
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 41/285 (14%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVP 920
F ++G G G + + D VA+K+ I + E++ + + +H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVIR 82
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR---RKIAIGSARGLAFLH 977
K + + + E +L++ + ++K L ++ GLA LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQT----TSGLAHLH 135
Query: 978 HNCIPHIIHRDMKSSNVLLDENFE-----ARVSDFGMARLMSAMDTHLSV-STLAGTPGY 1031
+I+HRD+K N+L+ A +SDFG+ + ++ S S + GT G+
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 1032 VPPEYYQSF---RCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKI 1087
+ PE + D++S G V +++ G P FG + + + L
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-----FGKSLQ---RQANILLGA 244
Query: 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ K + I EL++ + P +RP+ V+
Sbjct: 245 CSLDCLHPEKHEDVIARELIEK------MIAMDPQKRPSAKHVLK 283
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
F IG G FG+V+K + VAIK + + + E E+ + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGLAFL 976
G + ++ EY+ GS D+L L+ +IA +GL +L
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LD---ETQIATILREILKGLDYL 135
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H IHRD+K++NVLL E+ E +++DFG+A ++ DT + +T GTP ++ PE
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEV 190
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ +K D++S G+ +EL G+ P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
F +G G +G VYKA + G VAIK+ + + E E+ + + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-VPVESDLQ-EIIKEISIMQQCDSPHVVK 88
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGLAFLH 977
G + +V EY GS+ D++ + K L +IA + +GL +LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLT---EDEIATILQSTLKGLEYLH 142
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
IHRD+K+ N+LL+ A+++DFG+A ++ DT +T+ GTP ++ PE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVI 197
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRP 1064
Q + D++S G+ +E+ GK P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 11/212 (5%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
S LDLS N L F S L+ D+S + + + S+S+L L+L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-- 418
+ S L++L+ L NL+ ++ + + LKEL + +NL+ S
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKT-LKELNVAHNLIQ-SFKLPE 143
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQ--DLKLWL--NQLHGEIPPELGNIQTL 474
SN + L L LS N + + L L ++ +L L L N ++ I P L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506
+ L LD N+L T+L I L N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/241 (22%), Positives = 89/241 (36%), Gaps = 21/241 (8%)
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
++ ++ F ++P + + K L LSFN S + L+ LDLS
Sbjct: 6 VVPNI-TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIP 441
+ I Q + L L L N + S+ S S L L L ++
Sbjct: 61 RCEIQ-TIEDGAYQSLSH-LSTLILTGN-PIQSLALGAFSGLSSLQKLVAVETNLA-SLE 116
Query: 442 SSL-GSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPA-ALSNCTNL 498
+ G L L++L + N + PE N+ LE L L N++ ++ L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQM 175
Query: 499 NWI----SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGD-CRSLIWLDLNT 553
+ LS N + I + L L L N +P + D SL + L+T
Sbjct: 176 PLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHT 233
Query: 554 N 554
N
Sbjct: 234 N 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 57/273 (20%), Positives = 88/273 (32%), Gaps = 75/273 (27%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNN 229
S + LDLS+N + L + LQ LD+S
Sbjct: 29 STKNLDLSFNPLR--------------HLGSYSF-----------FSFPELQVLDLSRCE 63
Query: 230 FSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNE 287
+ + L L ++ N +++ FSG
Sbjct: 64 IQ-TIEDGAYQSLSHLSTLILTGNPIQ----------------SLALGAFSG-------- 98
Query: 288 FQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPI-EIF 346
SSL KL NL+ G +L+ +++ N + E F
Sbjct: 99 ------------LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145
Query: 347 LSMSNLKELVLSFNDFTGALPDSLSNLTNLE----TLDLSSNNLSGAIPHNLCQGPRNSL 402
+++NL+ L LS N L L + +LDLS N ++ I + R L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR--L 202
Query: 403 KELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFN 434
KEL L N L S+P + L + L N
Sbjct: 203 KELALDTN-QLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 57/272 (20%), Positives = 90/272 (33%), Gaps = 79/272 (29%)
Query: 123 SLDLSLNILSGPLSDISY--LGSCSSLKVLNLSSNLLDFSGREAG---SLKLSLEVLDLS 177
+LDLS N PL + S L+VL+LS + E G SL L L L+
Sbjct: 32 NLDLSFN----PLRHLGSYSFFSFPELQVLDLSRCEI--QTIEDGAYQSLS-HLSTLILT 84
Query: 178 YNKISGANVVPWILFNGCDELKQLALKGNKVTG--DINVSKCKNLQFLDVSSNNFSMAVP 235
N I + F+G L++L + + + K L+ L+V+ N +
Sbjct: 85 GNPIQ---SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK 140
Query: 236 S---FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEI 292
F + LE+LD+S+NK ++
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ----------------SIYCTDLRV------------- 171
Query: 293 PLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL 352
L + + LDLS N ++ + F + L
Sbjct: 172 ---LHQMPLLNLSLDLSLNPMN-------------------------FIQPGAFKEI-RL 202
Query: 353 KELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
KEL L N LT+L+ + L +N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 20/95 (21%), Positives = 41/95 (43%), Gaps = 7/95 (7%)
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNI 688
+ + L ++ N + S+ +S L L NL+ + G L+ L
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKE 128
Query: 689 LDLSSNRLEGTIPSS--MSSLTLLNEIDLCNNQLT 721
L+++ N ++ + S+LT L +DL +N++
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 46/171 (26%), Positives = 67/171 (39%), Gaps = 22/171 (12%)
Query: 92 LDTLETLSLKNSNISGTISLPAG--SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKV 149
L L TL L + I SL G S SS L L L+ L + +G +LK
Sbjct: 75 LSHLSTLILTGNPIQ---SLALGAFSGLSS-LQKLVAVETNLAS-LENFP-IGHLKTLKE 128
Query: 150 LNLSSNLLDFSGREAGSL-KL-SLEVLDLSYNKISGANVVPWILFNGCDELK----QLAL 203
LN++ NL+ S + L +LE LDLS NKI + ++ L L
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ---SIYCTDLRVLHQMPLLNLSLDL 184
Query: 204 KGNKVTG-DINVSKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISAN 251
N + K L+ L + +N VP F +L+ + + N
Sbjct: 185 SLNPMNFIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 63/312 (20%), Positives = 104/312 (33%), Gaps = 28/312 (8%)
Query: 117 CSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK-LSLEVLD 175
C+ D S +D+ G SL+ L + G+ +K LSL+ L
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74
Query: 176 LSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVS----KCKNLQFLDVSSNNFS 231
+ +I + + G L++L L+ +VTG +L L++ + +++
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 232 MAVPSFGDC-----LALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYN 286
+ L+ L I+ + LS L++S N G +
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 287 EFQGEIPLHLADLCSSLVKLDLSSNN---LSGKVPSRFGSCSSLESFDISSNKFSGELPI 343
+ P +L L L + SG + + L+ D+S N
Sbjct: 195 LCPLKFP--------TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
S L L LSF +P L L LDLS N L + +
Sbjct: 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDELP----QVG 299
Query: 404 ELFLQNNLLLGS 415
L L+ N L S
Sbjct: 300 NLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 62/305 (20%), Positives = 95/305 (31%), Gaps = 44/305 (14%)
Query: 237 FGDCLALEYLDISANKFTGDVGHA-ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLH 295
+G +LEYL + I L L V + I G G
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG----- 93
Query: 296 LADLCSSLVKLDLSSNNLSGKVPSRFGSCS--SLESFDISSNKFSG---ELPIEIFLSMS 350
S L +L L + ++G P + L ++ + ++ L
Sbjct: 94 ----ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSG--AIPHNLCQGPRNSLKELFLQ 408
LK L ++ + + L TLDLS N G + LC +L+ L L+
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 409 NNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL 468
N +G + + +LQ L L N L
Sbjct: 210 NA---------------------GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 469 -GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
L +L L F L +P L L+ + LS N L P+ +L + L L
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRL-DRNPS-PDELPQVGNLSL 303
Query: 528 SNNSF 532
N F
Sbjct: 304 KGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 5e-21
Identities = 51/265 (19%), Positives = 87/265 (32%), Gaps = 33/265 (12%)
Query: 64 KAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSS 123
K+ S+ + + + A +L + L+ L+L+N ++GT P L+
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 124 LDLSLNILSGPLSDISYLGSCS--SLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKI 181
L+L + + ++ L LKVL+++ E + +L LDLS N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 182 SGANVVPWILFNGC-DELKQLALKGNKVT-----GDINVSKCKNLQFLDVSSNNFSMAVP 235
G + L L+ LAL+ + + LQ LD+S N+
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR-DAA 244
Query: 236 SFGDCL---ALEYLDISANKFTGDVGHAISAC--EHLSFLNVSSNLFSGPIPVGYNEFQG 290
C L L++S + LS L++S N
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-----QVPKGLPAKLSVLDLSYNRLD------------ 287
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSG 315
P + L L N
Sbjct: 288 RNPSPDE--LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 43/258 (16%), Positives = 72/258 (27%), Gaps = 32/258 (12%)
Query: 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLS---NLTNLE 377
+G SLE + + + +LK L + + ++ L+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
L L + ++G P L + L L L+N + L+ Q + L +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIA 157
Query: 438 GTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC-- 495
++ L TL L N G + C
Sbjct: 158 Q-------------------AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 496 --TNLNWISLSNNH---LGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGD-CRSLIWL 549
L ++L N G L L LS+NS D L L
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 550 DLNTNLFNGSIPPALFKQ 567
+L+ +P L +
Sbjct: 259 NLSFTGLK-QVPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 64/359 (17%), Positives = 106/359 (29%), Gaps = 64/359 (17%)
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
N ++ + S+ N GA L G R+ L + + + L
Sbjct: 12 SCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLK 71
Query: 428 SLHLSFNYLTGTIPSS---LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNEL 484
L + + I + +S LQ+L L ++ G PP L + L+ +
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR 544
+ T W++ L L +L ++ ++
Sbjct: 132 SWA--------TRDAWLAELQQWL----------KPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 545 SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGI 604
+L LDL+ N G S C L+ +
Sbjct: 174 ALSTLDLSDNPELGERGLI-------------------------SALCPLKFPTLQVLAL 208
Query: 605 RAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGS-MSYLF 663
R + S G + LD+S+N L + S L
Sbjct: 209 RNAGMETPS------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTG 722
LNL L +P + L++LDLS NRL+ PS L + + L N
Sbjct: 257 SLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLD-RNPSP-DELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS-GPIPTEVGDL-----RGLNILDLSSN 694
L + ++G+ P + + + L N+S + +L GL +L ++
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 695 RLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM 727
+ L+ +DL +N G ++
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-27
Identities = 57/256 (22%), Positives = 105/256 (41%), Gaps = 21/256 (8%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+ +K +L +++ V +S++ +++ ++ + N+ +L L+
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---VQGIQYLPNVTKLFLNG 74
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
N T P L+NL NL L L N + LK L L++N + S +
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLKDL----KKLKSLSLEHNGI--SDING 126
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479
L + QL SL+L N +T + L L+KL L L NQ+ +I P L + L+ L+L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539
N ++ L+ NL+ + L + + L +K ++ S P
Sbjct: 183 SKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEI 238
Query: 540 LGDCRSLIWLDLNTNL 555
+ D ++ +L
Sbjct: 239 ISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-23
Identities = 50/256 (19%), Positives = 104/256 (40%), Gaps = 23/256 (8%)
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
+ + S + P + + ++ + + ++++ +++ + +D
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDI 55
Query: 363 TGALPDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLS 421
+ L N+ L L+ N L+ P NL +L LFL N + S+L
Sbjct: 56 KSV--QGIQYLPNVTKLFLNGNKLTDIKPLTNL-----KNLGWLFLDENKI--KDLSSLK 106
Query: 422 NCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDF 481
+ +L SL L N ++ I + L L +L+ L L N++ +I L + L+TL L+
Sbjct: 107 DLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLED 162
Query: 482 NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELG 541
N+++ + L+ T L + LS NH+ ++ + L NL +L+L + +
Sbjct: 163 NQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQS 218
Query: 542 DCRSLIWLDLNTNLFN 557
+ +
Sbjct: 219 NLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.8 bits (248), Expect = 1e-21
Identities = 53/316 (16%), Positives = 96/316 (30%), Gaps = 61/316 (19%)
Query: 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNF 230
+ I + P + E + LK VT + ++ ++ + ++++
Sbjct: 1 MGETITVSTPIK--QIFP---DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI 55
Query: 231 SMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQG 290
V + L ++ NK ++ + L+ L
Sbjct: 56 KS-VQGIQYLPNVTKLFLNGNK--------LTDIKPLTNL-------------------- 86
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
+L L L N + L+S + N S I + +
Sbjct: 87 ----------KNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD---INGLVHLP 131
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQN 409
L+ L L N T LS LT L+TL L N +S +P L L+ L+L
Sbjct: 132 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGL-----TKLQNLYLSK 184
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
N + S L+ L L L + +L +K L P +
Sbjct: 185 NHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIIS 240
Query: 470 NIQTLETLFLDFNELT 485
+ E + ++
Sbjct: 241 DDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 4e-21
Identities = 55/318 (17%), Positives = 104/318 (32%), Gaps = 59/318 (18%)
Query: 128 LNILSGPLSDISYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANV 186
+S P+ I + + NL + D + L S++ + + + I +V
Sbjct: 4 TITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQN--ELN-SIDQIIANNSDIK--SV 58
Query: 187 VPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYL 246
+ +L L GNK+T ++ KNL +L + N + S D L+ L
Sbjct: 59 QG---IQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSL 114
Query: 247 DISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKL 306
+ N IS L L L L
Sbjct: 115 SLEHNG--------ISDINGLVHL------------------------------PQLESL 136
Query: 307 DLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL 366
L +N ++ + + L++ + N+ S I ++ L+ L LS N +
Sbjct: 137 YLGNNKIT--DITVLSRLTKLDTLSLEDNQISD---IVPLAGLTKLQNLYLSKNHISDL- 190
Query: 367 PDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL 426
+L+ L NL+ L+L S ++ + + L P +S+
Sbjct: 191 -RALAGLKNLDVLELFSQECLNKPINHQS--NLVVPNTVKNTDGSL--VTPEIISDDGDY 245
Query: 427 VSLHLSFNYLTGTIPSSL 444
++ ++ T S
Sbjct: 246 EKPNVKWHLPEFTNEVSF 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 44/264 (16%), Positives = 93/264 (35%), Gaps = 36/264 (13%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
+LK +++ ++ + +S + + + + + + + ++ L
Sbjct: 20 FAETIKDNLKKKSVTDAVTQ---NELNS-IDQIIANNS----DIKSVQGIQYLPNVTKLF 71
Query: 152 LSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
L+ N L D +LK +L L L NKI ++ +LK L+L+ N ++
Sbjct: 72 LNGNKLTDIKPLT--NLK-NLGWLFLDENKIK--DLSS---LKDLKKLKSLSLEHNGIS- 122
Query: 211 DI-NVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSF 269
DI + L+ L + +N + + L+ L + N+ + D+ ++ L
Sbjct: 123 DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQN 179
Query: 270 LNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLES 329
L +S N S ++ LA L +L L+L S K + + +
Sbjct: 180 LYLSKNHIS------------DLR-ALAGL-KNLDVLELFSQECLNKPINHQSNLVVPNT 225
Query: 330 FDISSNKFSGELPIEIFLSMSNLK 353
+ I
Sbjct: 226 VKNTDGSLVTPEIISDDGDYEKPN 249
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 7e-13
Identities = 39/195 (20%), Positives = 78/195 (40%), Gaps = 18/195 (9%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
+ L + L L + ++ + + + L L L N + D+S L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLT---DIKPLTNLKN-LGWLFLDEN----KIKDLSSLKDLKK 110
Query: 147 LKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
LK L+L N + D +G L LE L L NKI+ ++ + +L L+L+
Sbjct: 111 LKSLSLEHNGISDINGLV--HLP-QLESLYLGNNKIT--DITV---LSRLTKLDTLSLED 162
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
N+++ + ++ LQ L +S N+ S + + L+ L++ + + + S
Sbjct: 163 NQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 266 HLSFLNVSSNLFSGP 280
+ + + P
Sbjct: 222 VPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 2e-11
Identities = 48/327 (14%), Positives = 100/327 (30%), Gaps = 68/327 (20%)
Query: 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH 461
+ E + + I ++ + +L +T + L+ + + + +
Sbjct: 1 MGETITVSTPI-KQI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 462 GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSN 521
+ + + + LFL+ N+LT P L+N NL W+ L N
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK-------------- 98
Query: 522 LAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKY 581
I LS+ L D + L L L N + I ++ +
Sbjct: 99 --IKDLSS----------LKDLKKLKSLSLEHNGIS-DING--LVHLPQL--------ES 135
Query: 582 VYIKNDGSKECHGAGNL--LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMM 639
+Y+ N+ + L L+ + ++S I +
Sbjct: 136 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-----------------LAGLTKLQ 178
Query: 640 FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGT 699
L +S N +S + + + + L +L L +L N + + L
Sbjct: 179 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-- 234
Query: 700 IPSSMSSLTLLNEIDLCNNQLTGMIPV 726
P +S + ++ + V
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 6e-08
Identities = 43/206 (20%), Positives = 69/206 (33%), Gaps = 44/206 (21%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
S L L L++LSL+++ IS + L SL L N ++DI+ L +
Sbjct: 103 SSLKDLKKLKSLSLEHNGIS---DINGLVHLPQ-LESLYLGNN----KITDITVLSRLTK 154
Query: 147 LKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
L L+L N + D L L+ L LS N IS
Sbjct: 155 LDTLSLEDNQISDIVPLA--GLT-KLQNLYLSKNHIS----------------------- 188
Query: 206 NKVTGDI-NVSKCKNLQFLDVSSNNFSMAVPS-FGDCLALEYLDISANKFTGDVGHAISA 263
D+ ++ KNL L++ S + + + + + IS
Sbjct: 189 -----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP--EIISD 241
Query: 264 CEHLSFLNVSSNLFSGPIPVGYNEFQ 289
NV +L V + +Q
Sbjct: 242 DGDYEKPNVKWHLPEFTNEVSFIFYQ 267
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 35/283 (12%), Positives = 90/283 (31%), Gaps = 36/283 (12%)
Query: 474 LETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY 533
+ + P +L + + +L+++ + +N+
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI- 55
Query: 534 GRIPPELGDCRSLIWLDLNTN----LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589
+ + ++ L LN N + + L ++++ +
Sbjct: 56 KSVQG-IQYLPNVTKLFLNGNKLTDIKPLTNLKNL---------------GWLFLDENKI 99
Query: 590 KECHGAGNL--LEFAGIRAERLSRISTRSPC-NFTRVYGGHTQ----PTFNHNGSMMFLD 642
K+ +L L+ + +S I+ +Y G+ + + + L
Sbjct: 100 KDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS 159
Query: 643 ISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPS 702
+ N +S I + ++ L L L N++S + L+ L++L+L S +
Sbjct: 160 LEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPIN 215
Query: 703 SMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLC 745
S+L + N + + L + + +P +
Sbjct: 216 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 258
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
IGSG V A VAIK++ Q + E++ + + H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR-RKIAI---GSARGLAFLHHNCI 981
V +E LV + + GS+ D++ + G + IA GL +LH N
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGM-ARLMSAMDTHLSVS--TLAGTPGYVPPEYYQ 1038
IHRD+K+ N+LL E+ +++DFG+ A L + D + T GTP ++ PE +
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 1039 SFRC-STKGDVYSYGVVLLELLTGKRP 1064
R K D++S+G+ +EL TG P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 13/204 (6%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD--REFTAEMETIGK-IKHRNLVPLLGY 924
+G G +G V K + + K I + + +++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+ + E M SL+ G + KIA+ + L LH +
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE----YYQSF 1040
IHRD+K SNVL++ + ++ DFG++ + D ++ AG Y+ PE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV--DD-VAKDIDAGCKPYMAPERINPELNQK 188
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP 1064
S K D++S G+ ++EL + P
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFP 212
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 22/248 (8%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
++G GGFG+V +++ + A KKL I + E + + K+ R +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
Y ++ L LV M G L+ +++ + G A A GL LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA--VFYAAEICCGLEDLHRE-- 305
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
I++RD+K N+LLD++ R+SD G+A + T + GT GY+ PE ++ R
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNER 361
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSAD-FGDNNLVGWVKQHAKLKISDVFDPE------ 1094
+ D ++ G +L E++ G+ P V + + + S+ F P+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 1095 -LMKEDPN 1101
L+ +DP
Sbjct: 422 QLLCKDPA 429
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 46/298 (15%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVP 920
++ ++G G G V G VA+K+ + E++ + + H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR---RKIAIGSARGLAFLH 977
+ E +L+D++ ++ L + A G+A LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 978 HNCIPHIIHRDMKSSNVLLD-------------ENFEARVSDFGMARLMSAMDTHLS--V 1022
IIHRD+K N+L+ EN +SDFG+ + + + + +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 1023 STLAGTPGYVPPE-------YYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNN 1074
+ +GT G+ PE R + D++S G V +L+ GK P FGD
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP-----FGDKY 244
Query: 1075 LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
++ ++ D D ++ I L S +D P +RPT ++V+
Sbjct: 245 S----RESNIIRGIFSLDEMKCLHDRSL-IAEATDL--ISQMIDHDPLKRPTAMKVLR 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 59/252 (23%), Positives = 103/252 (40%), Gaps = 32/252 (12%)
Query: 821 GTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK 880
G++ +S K TG L+I ++ + L + L +GSG G V+K +
Sbjct: 1 GSSGSSGKQTGY---LTIGGQRYQAEINDL---ENLGE---------MGSGTCGQVWKMR 45
Query: 881 LKDGSTVAIKKLIHISGQGD--REFTAEMETIGK-IKHRNLVPLLGYCKVGEERLLVYEY 937
+ V K + SG + + +++ + K +V G + + E
Sbjct: 46 FRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997
M + + Q I K+ + + L +L +IHRD+K SN+LLD
Sbjct: 106 MGTCAEKLKKRMQG--PIPERILG--KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLD 159
Query: 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-----STKGDVYSYG 1052
E + ++ DFG++ + D + AG Y+ PE + DV+S G
Sbjct: 160 ERGQIKLCDFGISGRLV--DD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 1053 VVLLELLTGKRP 1064
+ L+EL TG+ P
Sbjct: 217 ISLVELATGQFP 228
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 71/299 (23%), Positives = 119/299 (39%), Gaps = 61/299 (20%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK-----KLIHISGQGDREFTAEMETIG--------- 911
IG G +G V A D + A+K KLI +G R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 912 ------------KIKHRNLVPLLGYC---KVGEERL-LVYEYMRYGSLEDVLHNQKKVGI 955
K+ H N+V L E+ L +V+E + G + +V +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 956 KLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015
L+ R +G+ +LH+ IIHRD+K SN+L+ E+ +++DFG++
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG---DVYSYGVVLLELLTGKRPTDSADFGD 1072
D L S GTP ++ PE R G DV++ GV L + G+ P F D
Sbjct: 190 SDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP-----FMD 242
Query: 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ + H+K+K + P+ +++ +L+ + LD P R + ++
Sbjct: 243 ERI---MCLHSKIKSQALEFPDQPDIAEDLK-DLITRM------LDKNPESRIVVPEIK 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE----FTAEMETIGKIKHR 916
F + IG G FG VY A+ +++ VAIKK + SG+ E E+ + K++H
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKK-MSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI---GSARGL 973
N + G LV EY GS D+L KK L +IA G+ +GL
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQ---EVEIAAVTHGALQGL 167
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
A+LH + ++IHRD+K+ N+LL E ++ DFG A +M+ + + GTP ++
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMA 218
Query: 1034 PEYYQSFRCST---KGDVYSYGVVLLELLTGKRP 1064
PE + K DV+S G+ +EL K P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 87/440 (19%), Positives = 155/440 (35%), Gaps = 77/440 (17%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSF-----LSSLDLSLN-ILSGPLSDISYLGSCS 145
+ +L L L ++ LP C F L+ L LS L +++L
Sbjct: 120 MASLRHLDLSFNDFD---VLP---VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL---- 169
Query: 146 SLKVLNLSSNLLDFSGREAGSL-KLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
L + L G E SL + VL L ++ S +V + N L+ +K
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 205 GNK---------VTGDINVSKCKNLQFLDVSSNNFSM-AVPSFGDCLALEYLDISANKFT 254
N ++ N+ + + + F +EYL+I T
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 255 G-----DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLS 309
+ ++ +A + L +V + +F Y+ F + + LS
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF------------AEMNIKMLS 337
Query: 310 SNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP-- 367
++ S SS + + N F+ + + ++ L+ L+L N
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NFFKV 395
Query: 368 -DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL 426
N+++LETLD+S N+L+ C + + L L +N+L GS+ L ++
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES-ILVLNLSSNMLTGSVFRCLP--PKV 452
Query: 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTG 486
L L N + +IP + L LQ+L + NQL +P
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG------------------- 491
Query: 487 TLPAALSNCTNLNWISLSNN 506
T+L +I L +N
Sbjct: 492 ----VFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 86/452 (19%), Positives = 163/452 (36%), Gaps = 34/452 (7%)
Query: 95 LETLSLKNSNISGTISLPAGS-RCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS 153
L L L ++ I SL + L LD+S N L +IS +SL+ L+LS
Sbjct: 78 LRVLRLSHNRIR---SLDFHVFLFNQDLEYLDVSHN----RLQNISC-CPMASLRHLDLS 129
Query: 154 SNLLDFSGREAGSLKL-SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT-GD 211
N D L L L LS K +++P + + L L + G+
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP--VAHLHLSCILLDLVSYHIKGGE 187
Query: 212 INVSKCKNLQFLDVSSN-NFSMAVPSFGDCLALEYLDISANKFTG-DVGHAISACEHLSF 269
+ N L + + N +V AL +L +S K + ++ L+
Sbjct: 188 TESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247
Query: 270 LNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCS---- 325
N+ I + + L + L++ + ++ ++ + S
Sbjct: 248 GPTLLNVTLQHIETTWKCS---VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 326 -SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
SL + + F ++ + + +LS +D + ++ L+ + N
Sbjct: 305 KSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNNLL--LGSIPSTLSNCSQLVSLHLSFNYLTGTIPS 442
+ C L+ L LQ N L + N S L +L +S N L
Sbjct: 364 VFT-DSVFQGCST-LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 443 SL-GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501
+ L L N L G + L ++ L L N + ++P +++ L +
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQEL 478
Query: 502 SLSNNHLGGEIPT-WIGQLSNLAILKLSNNSF 532
++++N L +P +L++L + L +N +
Sbjct: 479 NVASNQL-KSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 74/444 (16%), Positives = 140/444 (31%), Gaps = 40/444 (9%)
Query: 143 SCSSLKVLNLSSNLLD--FSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
S +++ S+ L L + L LS N IS + + EL+
Sbjct: 29 SNELESMVDYSNRNLTHVPKD-----LPPRTKALSLSQNSIS---ELRMPDISFLSELRV 80
Query: 201 LALKGNKVTG-DINV-SKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTG-DV 257
L L N++ D +V ++L++LDVS N + +L +LD+S N F V
Sbjct: 81 LRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS-CCPMASLRHLDLSFNDFDVLPV 138
Query: 258 GHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKV 317
L+FL +S+ F + LHL+ + LV + G+
Sbjct: 139 CKEFGNLTKLTFLGLSAAKFR------QLDLLPVAHLHLSCILLDLVSYHIKG----GET 188
Query: 318 PSRFGSCSSLESFDISSNKFSGELPIEIF-----LSMSNLKELVLSFNDFTGALPDSLSN 372
S +++ N L +SN+K + L +
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
Query: 373 LTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-----STLSNCSQLV 427
T L ++ L + N + I + + L+
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGT 487
H+ + + +++ L ++ + + L N T +
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF----YGRIPPELGDC 543
+ S L + L N L N++ L+ + S
Sbjct: 369 VFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 544 RSLIWLDLNTNLFNGSIPPALFKQ 567
S++ L+L++N+ GS+ L +
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLPPK 451
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 87/519 (16%), Positives = 169/519 (32%), Gaps = 76/519 (14%)
Query: 217 CKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
+ +D S+ N + VP + L +S N + IS L L +S N
Sbjct: 30 NELESMVDYSNRNLT-HVPK-DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
+ H+ L LD+S N L + +SL D+S N
Sbjct: 88 IR------------SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFND 132
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNL-TNLETLDLSSNNLSGAIPHNLC 395
F + F +++ L L LS F +++L + LDL S ++ G +L
Sbjct: 133 FDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192
Query: 396 QGPRNSLKELFLQNNLLLGSIPSTLSNCS--QLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453
L +F N+L + +++ QL ++ L+ + L
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252
Query: 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELT----------GTLPAALSNCTNLNWISL 503
+ L + + Q +++ + + + +L +
Sbjct: 253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV 312
Query: 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPA 563
N + + I LS + S +L+ N+F
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF-TDSVFQ 371
Query: 564 LFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRV 623
+ + + ++ N L+ +++ N + +
Sbjct: 372 GCST--------LKRLQTLILQR----------NGLK-------NFFKVA-LMTKNMSSL 405
Query: 624 YGGHTQPTFNHNGSMMFLDISYNML-SGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD 682
LD+S N L S + + + +LNL N L+G + +
Sbjct: 406 E---------------TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-- 448
Query: 683 LRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
+ +LDL +NR+ +IP ++ L L E+++ +NQL
Sbjct: 449 PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 6e-21
Identities = 67/444 (15%), Positives = 121/444 (27%), Gaps = 63/444 (14%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+D S+ NL+ VP ++ +S N S EL + +S L+ L LS
Sbjct: 30 NELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSH 85
Query: 360 NDFTGALPDSL-SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS 418
N +L + +LE LD+S N L + SL+ L L N
Sbjct: 86 NRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPM-----ASLRHLDLSFN-------- 131
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
L + G+L+KL L L + ++ L +
Sbjct: 132 ------DFDVL---------PVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCIL 175
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
L +L + Q+ N +L L +
Sbjct: 176 L-----------------DLVSYHIKGGETE------SLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 539 ELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL 598
+L L L+ N L ++ + + K
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 599 LEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGS 658
+ + ++ + T S+M + + S
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALK-----SLMIEHVKNQVFLFSKEALYSV 327
Query: 659 MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718
+ + I L ++ L+ + N ++ S+L L + L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 719 QLTGMIPVMGQFETFQPAKFLNNS 742
L V + + L+ S
Sbjct: 388 GLKNFFKVALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 54/324 (16%), Positives = 108/324 (33%), Gaps = 23/324 (7%)
Query: 70 SIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDL-SL 128
+ P +L ++ L L + L + N ++ + L ++ L +
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 129 NILSGPLSDISYLGSCSSLKVLNLSSNLLD--FSGREAGSLKLSLEVLDLSYNKISGANV 186
+ ++ LN+ + + E + +L+ L + + K
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 187 VPWILFNGCDELKQLALKGNKVTGDINV--SKCKNLQFLDVSSNNFSMAVPSFGDCLA-L 243
L++ E+ L + V + FL+ + N F+ +V L L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 244 EYLDISANKFT--GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS 301
+ L + N V L L+VS N +
Sbjct: 380 QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL----NSHAYD-------RTCAWAE 428
Query: 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND 361
S++ L+LSSN L+G V ++ D+ +N+ +P + + L+EL ++ N
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKD-VTHLQALQELNVASNQ 484
Query: 362 FTGALPDSLSNLTNLETLDLSSNN 385
LT+L+ + L N
Sbjct: 485 LKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD--REFTAEMETIGK-IKHRNLVPLLGY 924
IG G +G V K K + K I + ++ +++ + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ + E M S + V I KI + + + L L N
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILG--KITLATVKALNHLKENL- 145
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGM-ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
IIHRD+K SN+LLD + ++ DFG+ +L+ ++ + AG Y+ PE
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERIDPS 200
Query: 1041 RC----STKGDVYSYGVVLLELLTGKRP 1064
+ DV+S G+ L EL TG+ P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 52/284 (18%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK----KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
L+G G +G V + + A+K K + G+ E++ + +++H+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 922 LGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR-------- 971
+ E++ +V EY G E L+ ++ + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 972 GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY 1031
GL +LH I+H+D+K N+LL ++S G+A + + T G+P +
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 1032 VPPEYYQSFRC--STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK--QHAKLKI 1087
PPE K D++S GV L + TG P F +N+ + I
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-----FEGDNIYKLFENIGKGSYAI 232
Query: 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
P L LL+ + L+ P +R ++ Q+
Sbjct: 233 PGDCGPPLSD--------LLKGM------LEYEPAKRFSIRQIR 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 48/240 (20%), Positives = 102/240 (42%), Gaps = 22/240 (9%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+ L ++ ++L ++ N+ + + +++ + EL LS
Sbjct: 40 LDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITD---LAPLKNLTKITELELSG 94
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
N +++ L +++TLDL+S ++ P +L+ L+L N + + S
Sbjct: 95 NPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLAGLS----NLQVLYLDLNQI--TNISP 146
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479
L+ + L L + ++ + L +LSKL LK N++ +I P L ++ L + L
Sbjct: 147 LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHL 202
Query: 480 DFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539
N+++ P L+N +NL ++L+N + + +NL + + I P
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF---YNNNLVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/325 (16%), Positives = 115/325 (35%), Gaps = 63/325 (19%)
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
++A + VT + + + L + + L L++ N+ T
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITD- 77
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
++ ++L + + +L+LS N L K
Sbjct: 78 ----LAPLKNL---------------------------------TKITELELSGNPL--K 98
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
S S+++ D++S + + + +SNL+ L L N T L+ LTNL
Sbjct: 99 NVSAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNL 153
Query: 377 ETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNY 435
+ L + + +S P NL + L L +N + I L++ L+ +HL N
Sbjct: 154 QYLSIGNAQVSDLTPLANL-----SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQ 206
Query: 436 LTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC 495
++ S L + S L + L + + N+ + ++
Sbjct: 207 ISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP-------IAPA 257
Query: 496 TNLNWISLSNNHLGGEIPTWIGQLS 520
T + + ++ +L + ++I +S
Sbjct: 258 TISDNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 45/253 (17%)
Query: 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND 361
+ +K+ +N++ V + + + IE ++NL L L N
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKDNQ 74
Query: 362 FTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS 421
T P L NLT + L+LS N L S ++
Sbjct: 75 ITDLAP--LKNLTKITELELSGNPLK----------------------------NVSAIA 104
Query: 422 NCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDF 481
+ +L L+ +T P L LS LQ L L LNQ+ I P L + L+ L +
Sbjct: 105 GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGN 160
Query: 482 NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELG 541
+++ P L+N + L + +N + +I + L NL + L NN + P L
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKI-SDISP-LASLPNLIEVHLKNNQI-SDVSP-LA 214
Query: 542 DCRSLIWLDLNTN 554
+ +L + L
Sbjct: 215 NTSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 49/306 (16%), Positives = 108/306 (35%), Gaps = 35/306 (11%)
Query: 134 PLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFN 193
++ I + ++ + + + L + L ++
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVT-DTVTQADLD-GITTLSAFGTGVTTIEG-----VQ 60
Query: 194 GCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKF 253
+ L L LK N++T + + L++S N V + +++ LD+++ +
Sbjct: 61 YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119
Query: 254 TGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNL 313
T ++ +L L + N + P+ ++L L + + +
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQITNISPLAG--------------LTNLQYLSIGNAQV 163
Query: 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNL 373
S P + S L + NK S I S+ NL E+ L N + P L+N
Sbjct: 164 SDLTP--LANLSKLTTLKADDNKISD---ISPLASLPNLIEVHLKNNQISDVSP--LANT 216
Query: 374 TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSF 433
+NL + L++ ++ N + ++ P+T+S+ S +L++
Sbjct: 217 SNLFIVTLTNQTITNQPVFYN----NNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTW 272
Query: 434 NYLTGT 439
N +
Sbjct: 273 NLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 40/185 (21%), Positives = 77/185 (41%), Gaps = 16/185 (8%)
Query: 370 LSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSL 429
L N + +N++ + Q + + L + +I + + L+ L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT----QADLDGITTLSAFGT-GVTTIEG-VQYLNNLIGL 68
Query: 430 HLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLP 489
L N +T + L +L+K+ +L+L N L + + +Q+++TL L ++T P
Sbjct: 69 ELKDNQITD--LAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP 124
Query: 490 AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549
L+ +NL + L N + I + L+NL L + N + P L + L L
Sbjct: 125 --LAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTL 178
Query: 550 DLNTN 554
+ N
Sbjct: 179 KADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 55/302 (18%), Positives = 112/302 (37%), Gaps = 61/302 (20%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
LD + TLS + ++ ++ ++ L L+L N ++D++ L + +
Sbjct: 35 VTQADLDGITTLSAFGTGVT---TIEGVQYLNN-LIGLELKDN----QITDLAPLKNLTK 86
Query: 147 LKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
+ L LS N L + S L+ S++ LDL+ +I+ G L+ L L
Sbjct: 87 ITELELSGNPLKNVSAIA--GLQ-SIKTLDLTSTQITD-----VTPLAGLSNLQVLYLDL 138
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
N++T ++ NLQ+L + + S + + L L NK + IS
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKISD-----ISPLA 192
Query: 266 HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCS 325
L +L+++ L +N +S P + S
Sbjct: 193 SL---------------------------------PNLIEVHLKNNQISDVSP--LANTS 217
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN 385
+L +++ + +F + + + V+ P ++S+ + +L+ N
Sbjct: 218 NLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNL 274
Query: 386 LS 387
S
Sbjct: 275 TS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 10/137 (7%)
Query: 418 STLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETL 477
+ + + + +T + L + L + + I + + L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 478 FLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537
L N++T P L N T + + LS N L + I L ++ L L++
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPL-KNVSA-IAGLQSIKTLDLTSTQI--TDV 122
Query: 538 PELGDCRSLIWLDLNTN 554
L +L L L+ N
Sbjct: 123 TPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 20/86 (23%), Positives = 39/86 (45%), Gaps = 6/86 (6%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
L++S N L I + + L+L ++ P + L L +L L N++
Sbjct: 90 LELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI- 144
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPV 726
S ++ LT L + + N Q++ + P+
Sbjct: 145 -SPLAGLTNLQYLSIGNAQVSDLTPL 169
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 22/99 (22%), Positives = 46/99 (46%), Gaps = 6/99 (6%)
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNIL 689
++ L + N ++ +I + ++ L L++G+ +S P + +L L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 690 DLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMG 728
N++ S ++SL L E+ L NNQ++ + P+
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLAN 215
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 28/251 (11%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
IG G FG V + D A+K + + + E++ + ++H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
Y EE + +V + + G L H Q+ V K + I + A L +L +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFK-EETVKLFICELVMA--LDYLQNQ- 134
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
IIHRDMK N+LLDE+ ++DF +A ++ +T+AGT Y+ PE + S
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSR 189
Query: 1041 RCSTKG---DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE--- 1094
+ + D +S GV ELL G+RP + + + + + E
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249
Query: 1095 ----LMKEDPN 1101
L++ +P+
Sbjct: 250 LLKKLLEPNPD 260
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 21/234 (8%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+ +K +L +++ V +S++ +++ ++ + N+ +L L+
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---VQGIQYLPNVTKLFLNG 77
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFLQNNLLLGSIPS 418
N T P L+NL NL L L N + +L LK L L++N + S +
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDL-----KKLKSLSLEHNGI--SDIN 128
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
L + QL SL+L N +T + L L+KL L L NQ+ +I P L + L+ L+
Sbjct: 129 GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 184
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
L N ++ L+ NL+ + L + + L +K ++ S
Sbjct: 185 LSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 52/307 (16%), Positives = 103/307 (33%), Gaps = 59/307 (19%)
Query: 134 PLSDISYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILF 192
P+ I + + NL + D + L S++ + + + I +V
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELN-SIDQIIANNSDIK--SVQG---I 64
Query: 193 NGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANK 252
+ +L L GNK+T ++ KNL +L + N + S D L+ L + N
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNG 123
Query: 253 FTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNN 312
+ I+ HL L L L +N
Sbjct: 124 IS-----DINGLVHL---------------------------------PQLESLYLGNNK 145
Query: 313 LSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSN 372
++ + + L++ + N+ S I ++ L+ L LS N + +L+
Sbjct: 146 ITD--ITVLSRLTKLDTLSLEDNQISD---IVPLAGLTKLQNLYLSKNHISDL--RALAG 198
Query: 373 LTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS 432
L NL+ L+L S ++ + + L+ P +S+ ++
Sbjct: 199 LKNLDVLELFSQECLNKPINHQS--NLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVK 254
Query: 433 FNYLTGT 439
++ T
Sbjct: 255 WHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 48/284 (16%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
+ + + ++ + + + + +++ + + + V
Sbjct: 5 SETITVPTPIKQIFSDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SV- 61
Query: 259 HAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVP 318
I +++ L ++ N + +I LA+L +L L L N +
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT------------DIK-PLANL-KNLGWLFLDENKVK--DL 105
Query: 319 SRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLET 378
S L+S + N S I + + L+ L L N T LS LT L+T
Sbjct: 106 SSLKDLKKLKSLSLEHNGISD---INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDT 160
Query: 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438
L L N +S +P L+ L+L N + S L+ L L L
Sbjct: 161 LSLEDNQISDIVPLAGL----TKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLN 214
Query: 439 TIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482
+ +L +K L P + + E + ++
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 50/267 (18%), Positives = 88/267 (32%), Gaps = 57/267 (21%)
Query: 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYN 179
+L ++D +S+ + +++ + G + L ++ L L+ N
Sbjct: 26 TIKDNLKKK----SVTDAVTQNELNSIDQIIANNSDIKSVQGIQ--YLP-NVTKLFLNGN 78
Query: 180 KISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGD 239
K++ ++ P L L L NKV ++ K L+ L + N S +
Sbjct: 79 KLT--DIKP---LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD-INGLVH 132
Query: 240 CLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL 299
LE L + NK I+ LS L
Sbjct: 133 LPQLESLYLGNNK--------ITDITVLSRL----------------------------- 155
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+ L L L N +S VP + L++ +S N S + + NL L L
Sbjct: 156 -TKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD---LRALAGLKNLDVLELFS 209
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNL 386
+ + SNL T+ + +L
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 20/190 (10%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
L++++ + NS+I S+ + ++ L L+ N L+DI L + +
Sbjct: 40 VTQNELNSIDQIIANNSDIK---SVQGIQYLPN-VTKLFLNGN----KLTDIKPLANLKN 91
Query: 147 LKVLNLSSN-LLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
L L L N + D S + LK L+ L L +N IS ++ +L+ L L
Sbjct: 92 LGWLFLDENKVKDLSSLK--DLK-KLKSLSLEHNGIS--DING---LVHLPQLESLYLGN 143
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
NK+T +S+ L L + N S + L+ L +S N + D+ A++ +
Sbjct: 144 NKITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLK 200
Query: 266 HLSFLNVSSN 275
+L L + S
Sbjct: 201 NLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 33/241 (13%), Positives = 82/241 (34%), Gaps = 34/241 (14%)
Query: 492 LSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDL 551
+L + + +L+++ + +N+ + + ++ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFL 75
Query: 552 NTN----LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNL--LEFAGIR 605
N N + + L ++++ + K+ +L L+ +
Sbjct: 76 NGNKLTDIKPLANLKNL---------------GWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 606 AERLSRISTRSPC-NFTRVYGGHTQ----PTFNHNGSMMFLDISYNMLSGSIPKEIGSMS 660
+S I+ +Y G+ + + + L + N +S I + ++
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLT 178
Query: 661 YLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQL 720
L L L N++S + L+ L++L+L S + S+L + N + + L
Sbjct: 179 KLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 721 T 721
Sbjct: 237 V 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 68/315 (21%), Positives = 108/315 (34%), Gaps = 70/315 (22%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
IG G +G V A + AIK K+ I+ + E+ + K+ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR---------- 971
+ + LV E G L D L+ K I
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 972 --------------------------GLAFLHHNCIPHIIHRDMKSSNVLL--DENFEAR 1003
L +LH+ I HRD+K N L +++FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 1004 VSDFGMARLMSAMDTH--LSVSTLAGTPGYVPPE--YYQSFRCSTKGDVYSYGVVLLELL 1059
+ DFG+++ ++ ++T AGTP +V PE + K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 1060 TGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIE---LLQHLHVASAC 1116
G P F N + Q K+ F+ + LL +L
Sbjct: 271 MGAVP-----FPGVNDADTISQVLNKKLC--FENP---NYNVLSPLARDLLSNL------ 314
Query: 1117 LDDRPWRRPTMIQVM 1131
L+ R ++ +
Sbjct: 315 LNRNVDERFDAMRAL 329
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 43/276 (15%), Positives = 72/276 (26%), Gaps = 58/276 (21%)
Query: 865 DSLIGSGGFGDVYKAKLKD---GSTVAIKKLIHISGQGDREFTA----EMETIGKIKHRN 917
G ++A D VA+ + G + + +I
Sbjct: 36 LIFHGGVPPLQFWQAL--DTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+ +L L+V E++R GSL++V A R A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIR--AMQSLAAAADAAH 146
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+ S V VS G L P +P
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDANP 181
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097
Q D+ G L LL + P A + + ++ + E
Sbjct: 182 QD-------DIRGIGASLYALLVNRWPLPEAG--VRSGLAPAERDTAGQP-----IEPAD 227
Query: 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
D +I ++ VA+ + R + M
Sbjct: 228 IDRDIPFQISA---VAARSVQGDGGIRSASTLLNLM 260
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 63/250 (25%), Positives = 105/250 (42%), Gaps = 29/250 (11%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
++G G F V A+ S AIK L HI + + E + + ++ H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
+ +E+L Y + G L + +K+G R A I SA L +LH
Sbjct: 97 FTFQ-DDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSA--LEYLHGK- 149
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
IIHRD+K N+LL+E+ +++DFG A+++S ++ GT YV PE
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ--HAKLKISDVFDPE---- 1094
D+++ G ++ +L+ G P F N ++ + + F P+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262
Query: 1095 ---LMKEDPN 1101
L+ D
Sbjct: 263 VEKLLVLDAT 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 52/281 (18%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKL----IHISGQGDREFTAEMETI-------GKIK 914
L+G GGFG V+ L D VAIK + + T +E +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE-VALLWKVGAGGG 96
Query: 915 HRNLVPLLGYCKVGEERLLVYEY-MRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARG 972
H ++ LL + + E +LV E + L D + + +G +R + +A
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---SRCFFGQVVAA-- 151
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGY 1031
+ H ++HRD+K N+L+D A++ DFG L+ D + GT Y
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPY--TDFDGTRVY 204
Query: 1032 VPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090
PPE+ + + V+S G++L +++ G P F + + A+L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-----FERDQEI----LEAELHFPAH 255
Query: 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
P+ L++ CL +P RP++ +++
Sbjct: 256 VSPDC--------CALIRR------CLAPKPSSRPSLEEIL 282
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-23
Identities = 67/266 (25%), Positives = 103/266 (38%), Gaps = 45/266 (16%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKL--IHISGQGDREFT-AEMETIGKIKHRN 917
F + ++G GGFG+V+ ++K G A KKL + + + E + + K+ R
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 918 LVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSAR----- 971
+V L Y + L LV M G + H I A
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDI--RYH------IYNVDEDNPGFQEPRAIFYTAQ 297
Query: 972 ---GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
GL LH +II+RD+K NVLLD++ R+SD G+A + AGT
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL--KAGQTKTKGYAGT 352
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ------H 1082
PG++ PE D ++ GV L E++ + P F K+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP-----FRARGEKVENKELKQRVLE 407
Query: 1083 AKLKISDVFDPE-------LMKEDPN 1101
+ D F P L+++DP
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQKDPE 433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 42/215 (19%), Positives = 81/215 (37%), Gaps = 13/215 (6%)
Query: 301 SSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
S L L +L +PS F + ++ +S + +L F ++S + + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 360 NDFTGALP-DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS 418
+ D+L L L+ L + + L P + L + +N + SIP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 419 TL--SNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL--GNIQTL 474
C++ ++L L N T ++ + +KL + L N+ I + G
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 475 ETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHL 508
L + +T LP+ L + L I+ + L
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKEL--IARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 44/222 (19%), Positives = 73/222 (32%), Gaps = 27/222 (12%)
Query: 323 SCSSLESFDISSNKFSG--ELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380
C E F ++ LP + + L L + SNL N+ +
Sbjct: 9 ECHQEEDFRVTCKDIQRIPSLP-------PSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 381 LSSNNLSGAIP----HNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNY 435
+S + + +NL + + + ++N L I L L L +
Sbjct: 62 VSIDVTLQQLESHSFYNL-----SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG 116
Query: 436 LTGTIP--SSLGSLSKLQDLKLWLNQLHGEIPPEL--GNIQTLETLFLDFNELTGTLPAA 491
L P + + S L++ N IP G TL L N T ++
Sbjct: 117 LK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174
Query: 492 LSNCTNLNWISLSNNHLGGEIPTWI--GQLSNLAILKLSNNS 531
N T L+ + L+ N I G S ++L +S S
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 42/267 (15%), Positives = 88/267 (32%), Gaps = 48/267 (17%)
Query: 217 CKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
C + V+ + +PS + + L + + S+
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPSLPP--STQTLKLIETHLR----------------TIPSHA 50
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSN 335
FS ++ ++ +S + ++ S F + S + +I +
Sbjct: 51 FSN--------------------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 336 KFSGELPIEIFLSMSNLKELVLSFNDFTGALPD--SLSNLTNLETLDLSSNNLSGAIPHN 393
+ + + + LK L + PD + + L+++ N +IP N
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL--GSLSKLQ 451
QG N L L NN S+ N ++L +++L+ N I G S
Sbjct: 150 AFQGLCNETLTLKLYNN-GFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 452 DLKLWLNQLHGEIPPE-LGNIQTLETL 477
L + + +P + L +++ L
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 42/295 (14%), Positives = 92/295 (31%), Gaps = 73/295 (24%)
Query: 143 SCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLA 202
C + ++ + + SL S + L L + +P F+
Sbjct: 9 ECHQEEDFRVTCKDI----QRIPSLPPSTQTLKLIETHLR---TIPSHAFSN-------- 53
Query: 203 LKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHA 260
N+ + VS + + S F + + +++I +
Sbjct: 54 --------------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR-------- 91
Query: 261 ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVP-- 318
+L+++ + L L + + L P
Sbjct: 92 -----NLTYI--DPDALKE--------------------LPLLKFLGIFNTGLK-MFPDL 123
Query: 319 SRFGSCSSLESFDISSNKFSGELPIEIFLSMSN-LKELVLSFNDFTGALPDSLSNLTNLE 377
++ S +I+ N + +P+ F + N L L N FT ++ N T L+
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHL 431
+ L+ N I + G + L + + ++PS L + +L++ +
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 30/149 (20%), Positives = 52/149 (34%), Gaps = 11/149 (7%)
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDF 481
C Q ++ + IPS S Q LKL L IP N+ + +++
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPSLPPST---QTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 482 NELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPT-WIGQLSNLAILKLSNNSFYGRIPPE 539
+ L + + N + + I + N I + +L L L + N P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDL 123
Query: 540 --LGDCRSLIWLDLNTNLFNGSIPPALFK 566
+ L++ N + SIP F+
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 36/247 (14%), Positives = 71/247 (28%), Gaps = 51/247 (20%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNS 531
+ +TL L L A SN N++ I +S + ++ + LS + +++ N
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 532 FYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSK 590
I P+ L + L +L + P
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK------------------------- 125
Query: 591 ECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
+ ++ I + + L + N +
Sbjct: 126 -VYSTDIFFILEITDNPYMTSIPVNAFQGLCN--------------ETLTLKLYNNGFT- 169
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEV--GDLRGLNILDLSSNRLEGTIPS----SM 704
S+ + + L + L N I + G G ++LD+S + +PS +
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHL 228
Query: 705 SSLTLLN 711
L N
Sbjct: 229 KELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 30/151 (19%), Positives = 48/151 (31%), Gaps = 22/151 (14%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
L + + ++N+ I A L L + L D++ + S +L
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPL-LKFLGIFNTGLKM-FPDLTKVYSTDIFFILE 136
Query: 152 LSSNLL-------DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
++ N F G L L L N + V FNG +L + L
Sbjct: 137 ITDNPYMTSIPVNAFQG-----LCNETLTLKLYNNGFT---SVQGYAFNGT-KLDAVYLN 187
Query: 205 GNK----VTGDINVSKCKNLQFLDVSSNNFS 231
NK + D LDVS + +
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 36/238 (15%), Positives = 66/238 (27%), Gaps = 58/238 (24%)
Query: 495 CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNT 553
C ++ + IP + LKL IP + ++ + ++
Sbjct: 10 CHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSI 64
Query: 554 NLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613
++ + F K+ ++ I+N L+ I
Sbjct: 65 DVTLQQLESHSFYNLSKV--------THIEIRN-------------------TRNLTYID 97
Query: 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE--IGSMSYLFILNLGHNN 671
+ FL I L P + S FIL + N
Sbjct: 98 PD---------------ALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNP 141
Query: 672 LSGPIPTEVGDLRGLN----ILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIP 725
IP +GL L L +N ++ + T L+ + L N+ +I
Sbjct: 142 YMTSIPV--NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID 196
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 15/103 (14%), Positives = 36/103 (34%), Gaps = 5/103 (4%)
Query: 641 LDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEG 698
L + L +IP ++ + + + + + + +L + +++ + R
Sbjct: 36 LKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 699 TIPSSM-SSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLN 740
I L LL + + N L M P + + + L
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILE 136
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 48/278 (17%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKL----IHISGQGDREFTAEME--TIGKIKHR--N 917
L+GSGGFG VY + D VAIK + I G+ ME + K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 918 LVPLLGYCKVGEERLLVYEYMR-YGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAF 975
++ LL + + + +L+ E L D + + + +L AR + A +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARSFFWQVLEA--VRH 164
Query: 976 LHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
H+ ++HRD+K N+L+D N E ++ DFG L+ DT + GT Y PP
Sbjct: 165 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVY--TDFDGTRVYSPP 217
Query: 1035 EYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
E+ + R V+S G++L +++ G P F + + ++
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEI----IRGQVFFRQRVSS 268
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
E L++ CL RP RPT ++
Sbjct: 269 ECQH--------LIRW------CLALRPSDRPTFEEIQ 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPLL 922
+G G +G VYKAK G VA+K+ I + + E TA E+ + ++ H N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR-IRL--DAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
E L LV+E+M L+ VL K L + + RG+A H +
Sbjct: 86 DVI-HSERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPPE--- 1035
I+HRD+K N+L++ + +++DFG+AR TH V TL Y P+
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE-VVTL----WYRAPDVLM 192
Query: 1036 ---YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y ST D++S G + E++TGK
Sbjct: 193 GSKKY-----STSVDIWSIGCIFAEMITGK 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+GSG +G+V + K AIK + +S + + E+ + + H N++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNCIP 982
+ LV E + G L D + ++ K AA +++ G+ +LH +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD--AAVIIKQVL----SGVTYLHKH--- 155
Query: 983 HIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+I+HRD+K N+LL +++ ++ DFG++ + + GT Y+ PE +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK 212
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
+ K DV+S GV+L LL G P
Sbjct: 213 -KYDEKCDVWSIGVILFILLAGYPP 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 48/280 (17%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G +G+V A VA+K + + +E + + H N+V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK----IAIGSARGLAFL 976
G+ + G + L EY G L D + + A+R +A G+ +L
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-----GVVYL 121
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE- 1035
H I HRD+K N+LLDE ++SDFG+A + + ++ + GT YV PE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+ + DV+S G+VL +L G+ P D W + +
Sbjct: 179 LKRREFH----AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-------KKTY 227
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
K D LL + L + P R T+ +
Sbjct: 228 LNPWKKIDSAPL-ALLHKI------LVENPSARITIPDIK 260
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
+G G +G V K + KD G VAIKK S D + A E++ + +++H NLV L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKK-FLESD--DDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
L CK ++R LV+E++ + +L + + L++ +K G+ F H +
Sbjct: 90 LEVCK-KKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPPEY- 1036
+IIHRD+K N+L+ ++ ++ DFG AR ++A V+T Y PE
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-VATRW----YRAPELL 196
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGK 1062
+ DV++ G ++ E+ G+
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 50/261 (19%), Positives = 86/261 (32%), Gaps = 19/261 (7%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
CS+ V + ++ ++PS + K + F +L+++ +S
Sbjct: 9 CSNRV-FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQ 63
Query: 360 NDFTGALP-DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS 418
ND + D SNL L + + N I Q N L+ L + N + +P
Sbjct: 64 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPN-LQYLLISNTGI-KHLPD 121
Query: 419 -TLSNCSQLVSLHLSFNYLTGTIPSSL--GSLSKLQDLKLWLNQLHGEIPPE-LGNIQTL 474
+ Q V L + N TI + G + L L N + EI Q
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFY 533
E D N L + + +S + +P++ L L N
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRARSTYNLK-- 237
Query: 534 GRIPPELGDCRSLIWLDLNTN 554
++P L +L+ L
Sbjct: 238 -KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 55/321 (17%), Positives = 98/321 (30%), Gaps = 42/321 (13%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVS 226
+ L K+ V+ F+G +L+++ + N V I S L + +
Sbjct: 31 NAIELRFVLTKLR---VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 227 SNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVG 284
N + + F + L+YL IS L++ N+ I
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER- 146
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFSGELPI 343
N F G L V L L+ N + ++ + F E +N ELP
Sbjct: 147 -NSFVG--------LSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPN 195
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
++F S L +S L NL L + + L +L
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL-EKL-----VALM 249
Query: 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463
E L S+C + + L + + S L+ ++ Q G+
Sbjct: 250 EASLTYP----------SHCCAFANWRRQISELH-----PICNKSILRQEVDYMTQARGQ 294
Query: 464 IPPELGNIQTLETLFLDFNEL 484
+ ++ + D
Sbjct: 295 RSSLAEDNESSYSRGFDMTYT 315
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 52/348 (14%), Positives = 93/348 (26%), Gaps = 105/348 (30%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSF 433
+ + ++ IP +L PRN EL L I S L + +S
Sbjct: 10 SNRVFLCQESKVT-EIPSDL---PRN-AIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQ 63
Query: 434 NYLTGTIPSS-LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAAL 492
N + I + +L KL ++++ N L P A
Sbjct: 64 NDVLEVIEADVFSNLPKLHEIRI-----------------------EKANNLLYINPEAF 100
Query: 493 SNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLN 552
N NL ++ +SN I L ++ + + LD+
Sbjct: 101 QNLPNLQYLLISNTG--------IKHLPDVHKIHSLQ----------------KVLLDIQ 136
Query: 553 TNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRI 612
N+ +I F G + + I
Sbjct: 137 DNINIHTIERNSF---------------------------VGLSFESVILWLNKNGIQEI 169
Query: 613 STRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNN 671
FN N L +P ++ S IL++
Sbjct: 170 HNS---------------AFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTR 213
Query: 672 LSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718
+ +P+ +L+ L + + +P ++ L L E L
Sbjct: 214 IH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 42/250 (16%), Positives = 75/250 (30%), Gaps = 46/250 (18%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNS 531
L +L A S +L I +S N + I + L L +++ +
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 532 FYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSK 590
I PE + +L +L ++ +P S + + I
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQK--------VLLDI------ 135
Query: 591 ECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSG 650
N+ + I S + + L ++ N +
Sbjct: 136 ----QDNI---------NIHTIERNSFVGLS--------------FESVILWLNKNGIQ- 167
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTL 709
I + + L LNL NN +P +V G ILD+S R+ + +L
Sbjct: 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 227
Query: 710 LNEIDLCNNQ 719
L N +
Sbjct: 228 LRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 8/159 (5%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSF-LSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
L L+ L + N+ I LP + S LD+ NI + S++G +L
Sbjct: 103 LPNLQYLLISNTGIK---HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159
Query: 151 NLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
L+ N + A + E+ N + +P +F+G L + ++
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE---ELPNDVFHGASGPVILDISRTRIH- 215
Query: 211 DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDIS 249
+ +NL+ L S +P+ +AL ++
Sbjct: 216 SLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 42/288 (14%), Positives = 80/288 (27%), Gaps = 69/288 (23%)
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ-----LSNLAILKL 527
+ +++T +P+ L N + L I + +L +++
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKL-----RVIQKGAFSGFGDLEKIEI 61
Query: 528 SNNSFYGRIPPE----LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
S N I + L + N NL I P F+ + +Y+
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKAN-NLL--YINPEAFQNLPNL--------QYLL 110
Query: 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643
I N G + + H+ + LDI
Sbjct: 111 ISNTG--------------------IKHLPDV---------------HKIHSLQKVLLDI 135
Query: 644 SYNMLSGSIPKEI--GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTI 700
N+ +I + G IL L N + I + + +N LE
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLP 748
+ +D+ ++ +P E + + + L LP
Sbjct: 195 NDVFHGASGPVILDISRTRIH-SLPS-YGLENLKKLRARSTYNLKKLP 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 64/252 (25%), Positives = 101/252 (40%), Gaps = 30/252 (11%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AE---METIGKIKHRNLV 919
+IG GGFG+VY + D + A+K L I + E + + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 920 PLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLH 977
+ Y ++L + + M G L L R A I L +H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---MRFYAAEIILG--LEHMH 309
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+ +++RD+K +N+LLDE+ R+SD G+A S H GT GY+ PE
Sbjct: 310 NR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVL 362
Query: 1038 QSFRCSTKG-DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE-- 1094
Q D +S G +L +LL G P D + + + +++ D F PE
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 1095 -----LMKEDPN 1101
L++ D N
Sbjct: 423 SLLEGLLQRDVN 434
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 14/206 (6%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
IG G F V + ++ G A+K K G + E +KH ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
L +V+E+M L + + G + A L + H N
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 982 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+IIHRD+K VLL + + ++ FG+A + ++ L GTP ++ PE +
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPEVVK 206
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRP 1064
DV+ GV+L LL+G P
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 33/269 (12%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
IG G F V A+ + G VAIK + ++ ++ E+ + + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNCIPH 983
+ + L+ EY G + D L ++ K AR K I SA + + H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE---ARSKFRQIVSA--VQYCHQK---R 134
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR-C 1042
I+HRD+K+ N+LLD + +++DFG + + + L G P Y PE +Q +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKL--DAFCGAPPYAAPELFQGKKYD 191
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNI 1102
+ DV+S GV+L L++G P F NL + ++ P M D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP-----FDGQNL---KELRERVLRGKYRIPFYMSTD--- 240
Query: 1103 EIELLQHLHVASACLDDRPWRRPTMIQVM 1131
++L L P +R T+ Q+M
Sbjct: 241 ----CENL--LKRFLVLNPIKRGTLEQIM 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 48/278 (17%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK----------H 915
+G G FG V + G VA+K L +R+ ++ +GKIK H
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLA 974
+++ L + +V EY+ G L D + +V ARR I SA +
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSA--VD 125
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
+ H + ++HRD+K NVLLD + A+++DFG++ +MS L T G+P Y P
Sbjct: 126 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFL--RTSCGSPNYAAP 179
Query: 1035 EYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
E + D++S GV+L LL G P F D ++ K K++ + P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP-----FDDEHVPTLFK---KIRGGVFYIP 231
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
E + LL H+ L P +R T+ +
Sbjct: 232 EYLNRSV---ATLLMHM------LQVDPLKRATIKDIR 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 47/303 (15%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDRE-FTAEMETIGKIKHRNLVPLLG 923
+G G FG+V K K G A+K + + + D+E E++ + ++ H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNCI 981
+ + LV E G L D + ++K+ AAR R++ G+ ++H N
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD--AARIIRQVL----SGITYMHKN-- 145
Query: 982 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
I+HRD+K N+LL ++ R+ DFG++ A + GT Y+ PE
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLH 201
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE---- 1094
K DV+S GV+L LL+G P F N +K+ K K + F+
Sbjct: 202 G-TYDEKCDVWSTGVILYILLSGCPP-----FNGANEYDILKKVEKGKYT--FELPQWKK 253
Query: 1095 -----------LMKEDPNIEI---ELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140
++ P++ I + L H + + + P++ + ++ Q
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT 313
Query: 1141 SGL 1143
L
Sbjct: 314 QKL 316
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
IG G +G V+KAK + VA+K+ + D E +A E+ + ++KH+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
+++L LV+E+ L+ + L+ + +GL F H
Sbjct: 67 HDVL-HSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPPEY- 1036
+++HRD+K N+L++ N E ++++FG+AR + V TL Y PP+
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTL----WYRPPDVL 173
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ + ST D++S G + EL RP
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 30/164 (18%), Positives = 70/164 (42%), Gaps = 11/164 (6%)
Query: 349 MSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-HNLCQGPRNSLKELFL 407
M++L + L+ + T + N++ L +++ + + P L ++L+ L +
Sbjct: 43 MNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNPISGL-----SNLERLRI 95
Query: 408 QNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE 467
+ LS + L L +S + +I + + +L K+ + L N +I P
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP- 154
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE 511
L + L++L + F+ + + + LN + + +GG+
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 32/160 (20%), Positives = 64/160 (40%), Gaps = 10/160 (6%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
+SL + L++ N++ +++ I++ + +SNL+ L +
Sbjct: 44 NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN---YNPISGLSNLERLRIMGK 98
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL 420
D T +LS LT+L LD+S + +I + P + + L N + I L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP--KVNSIDLSYNGAITDI-MPL 155
Query: 421 SNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
+L SL++ F+ + + KL L + +
Sbjct: 156 KTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 28/205 (13%), Positives = 66/205 (32%), Gaps = 33/205 (16%)
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
S K + + + + + +L + L++ N++ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-------------DLTGI---- 62
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
+ L ++ + T + + LS L+ L++ + + P L
Sbjct: 63 -----------EYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
+ +L L + + ++ ++ +N I LS N +I + L L L +
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQF 168
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTN 554
+ + D L L +
Sbjct: 169 DGV-HDYRG-IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 31/192 (16%), Positives = 70/192 (36%), Gaps = 20/192 (10%)
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
L + +I ++ +L ++ +++ N + + ++ L I+ T +
Sbjct: 24 AYLNGLLGQSSTA-NITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHAT-N 80
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
IS +L L + + + +L+ L +SL LD+S +
Sbjct: 81 YN-PISGLSNLERLRIM-----------GKDVTSDKIPNLSGL-TSLTLLDISHSAHDDS 127
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
+ ++ + + S D+S N + I ++ LK L + F+ + + L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITD--IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 377 ETLDLSSNNLSG 388
L S + G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 30/157 (19%), Positives = 58/157 (36%), Gaps = 5/157 (3%)
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457
P ++ K + T + + L + L+ +T + + ++DL +
Sbjct: 18 PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIG 517
P + + LE L + ++T LS T+L + +S++ I T I
Sbjct: 76 IHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 518 QLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
L + + LS N I P L L L++ +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 26/166 (15%), Positives = 60/166 (36%), Gaps = 15/166 (9%)
Query: 92 LDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLN 151
+++L ++L N N++ L + + L ++ ++ + + S+L+ L
Sbjct: 43 MNSLTYITLANINVT---DLTGIEYAHN-IKDLTINNI----HATNYNPISGLSNLERLR 94
Query: 152 LSSNLLDFSGREA-GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
+ + L SL +LD+S++ + + N ++ + L N
Sbjct: 95 IMGKDVTSDKIPNLSGLT-SLTLLDISHSAHDDSILTK---INTLPKVNSIDLSYNGAIT 150
Query: 211 DI-NVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTG 255
DI + L+ L++ + D L L + G
Sbjct: 151 DIMPLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 25/162 (15%), Positives = 59/162 (36%), Gaps = 15/162 (9%)
Query: 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYN 179
L+ + L+ ++D++ + ++K L +++ +++ L +LE L +
Sbjct: 46 LTYITLANI----NVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLS-NLERLRIMGK 98
Query: 180 KISGANVVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVPSF 237
++ + +G L L + + I ++ + +D+S N +
Sbjct: 99 DVTSDKIPN---LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL 155
Query: 238 GDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279
L+ L+I + D I L+ L S G
Sbjct: 156 KTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 21/144 (14%), Positives = 55/144 (38%), Gaps = 7/144 (4%)
Query: 419 TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
S ++ L + T + ++ L + L + ++ + ++ L
Sbjct: 18 PDSTFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLT 72
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538
++ T P +S +NL + + + + + L++L +L +S+++ I
Sbjct: 73 INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 539 ELGDCRSLIWLDLNTNLFNGSIPP 562
++ + +DL+ N I P
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
L I ++ + ++ L +L++ H+ I T++ L +N +DLS N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 701 PSSMSSLTLLNEIDLCNNQLTGMIPV 726
+ +L L +++ + + +
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDYRGI 177
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 22/124 (17%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
+ + L LE L + +++ + +P S +S L+ LD+S + S ++ + +
Sbjct: 82 NPISGLSNLERLRIMGKDVT-SDKIPNLSGLTS-LTLLDISHSAHDD--SILTKINTLPK 137
Query: 147 LKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
+ ++LS N +L L+ L++ ++ + +L QL
Sbjct: 138 VNSIDLSYNGAITDIMPLKTLP-ELKSLNIQFDGVHDYRG-----IEDFPKLNQLYAFSQ 191
Query: 207 KVTG 210
+ G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 19/80 (23%), Positives = 37/80 (46%), Gaps = 2/80 (2%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
L I+ + P I +S L L + +++ + L L +LD+S + + +I
Sbjct: 71 LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 701 PSSMSSLTLLNEIDLCNNQL 720
+ +++L +N IDL N
Sbjct: 129 LTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 24/112 (21%), Positives = 41/112 (36%), Gaps = 5/112 (4%)
Query: 453 LKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEI 512
L L Q + +L + L +T + N+ ++++N H
Sbjct: 26 LNGLLGQSSTA-NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYN 82
Query: 513 PTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
P I LSNL L++ P L SL LD++ + + SI +
Sbjct: 83 P--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 38/213 (17%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE----FTA--EMETIGKIKHRNLVP 920
+G G F VYKA+ VAIKK I + + + + TA E++ + ++ H N++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 921 LLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
LL + + LV+++M LE ++ + + L + + + + +GL +LH +
Sbjct: 77 LLD-AFGHKSNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS----AMDTHLSVSTLAGTPGYVPPE 1035
I+HRD+K +N+LLDEN +++DFG+A+ A TH V T Y PE
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQ-VVTR----WYRAPE 182
Query: 1036 ------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y D+++ G +L ELL
Sbjct: 183 LLFGARMY-----GVGVDMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPLL 922
IG G +G VYKA+ G T A+KK I + + E T E+ + ++KH N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK---IRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
++RL LV+E++ L+ +L + L + + G+A+ H
Sbjct: 67 DVI-HTKKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPPE--- 1035
++HRD+K N+L++ E +++DFG+AR TH + TL Y P+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTL----WYRAPDVLM 173
Query: 1036 ---YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y ST D++S G + E++ G
Sbjct: 174 GSKKY-----STTIDIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
IG G +G V+K + +D G VAIKK D A E+ + ++KH NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
L + LV+EY + VLH + + + I + + + F H +
Sbjct: 68 LEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPPEY-Y 1037
+ IHRD+K N+L+ ++ ++ DFG ARL++ V+T Y PE
Sbjct: 122 -NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATR----WYRSPELLV 175
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGK 1062
+ DV++ G V ELL+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 61/212 (28%), Positives = 83/212 (39%), Gaps = 17/212 (8%)
Query: 323 SCS-SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
S S + + LP ++ + L LS N +L T L L+L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441
L+ + + G L L L +N L S+P L L +SFN LT ++P
Sbjct: 63 DRAELT-KLQVD---GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLP 116
Query: 442 SSL-GSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPA-ALSNCTNL 498
L +LQ+L L N+L +PP L LE L L N LT LPA L+ NL
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENL 174
Query: 499 NWISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530
+ + L N L IP L L N
Sbjct: 175 DTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 15/200 (7%)
Query: 369 SLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVS 428
+S + + ++ NL+ A+P +L P++ L L NLL +TL ++L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL---PKD-TTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 429 LHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTL 488
L+L LT + G+L L L L NQL +P + L L + FN LT +L
Sbjct: 60 LNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 489 PA-ALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDC-RS 545
P AL L + L N L +P + L L L+NN+ +P L + +
Sbjct: 116 PLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLEN 173
Query: 546 LIWLDLNTNLFNGSIPPALF 565
L L L N +IP F
Sbjct: 174 LDTLLLQENSLY-TIPKGFF 192
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 55/219 (25%), Positives = 82/219 (37%), Gaps = 27/219 (12%)
Query: 219 NLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
+ ++ N + A+P D L +S N + L+ LN+
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
+ + V L LDLS N L +P + +L D+S N+
Sbjct: 67 LTK-LQVD-------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL-SNLTNLETLDLSSNNLSGAIPHNLC 395
+ LP+ + L+EL L N+ LP L + LE L L++NNL+ +P L
Sbjct: 112 LT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLL 168
Query: 396 QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
G N L L LQ N L +IP L L N
Sbjct: 169 NGLEN-LDTLLLQEN-SLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 5/94 (5%)
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNI 688
+ LD+S+N L S+P ++ L +L++ N L+ +P L L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQE 128
Query: 689 LDLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLT 721
L L N L+ T+P + + L ++ L NN LT
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 3/81 (3%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700
L +S N+L + + L LNL L+ + + G L L LDLS N+L+ ++
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SL 92
Query: 701 PSSMSSLTLLNEIDLCNNQLT 721
P +L L +D+ N+LT
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 7/99 (7%)
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGD-LRGLN 687
++ LD+S+N L+ S+P + L L L N L +P + L
Sbjct: 94 LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLE 151
Query: 688 ILDLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLTGMIP 725
L L++N L +P+ + + L L+ + L N L IP
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 27/171 (15%)
Query: 94 TLETLSLKNSNISGTISLPAGSRCS-SFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNL 152
L L + + + + + L+ L+L L+ + G+ L L+L
Sbjct: 32 DTTILHLSENLLY---TFSLATLMPYTRLTQLNLDRA----ELTKLQVDGTLPVLGTLDL 84
Query: 153 SSNLLD-----FSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNK 207
S N L A L VLD+S+N+++ +P G EL++L LKGN+
Sbjct: 85 SHNQLQSLPLLGQTLPA------LTVLDVSFNRLT---SLPLGALRGLGELQELYLKGNE 135
Query: 208 VTG-DINV-SKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFT 254
+ + + L+ L +++NN + +P+ L+ L + N
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 47/222 (21%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
IG G FG+V+KA+ K G VA+KK + + ++E TA E++ + +KH N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 922 LGYCKVGEERL--------LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
+ C+ LV+++ + L +L N +K + +++ GL
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGL 137
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD-------THLSVSTLA 1026
++H N I+HRDMK++NVL+ + +++DFG+AR S T+ V TL
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR-VVTL- 192
Query: 1027 GTPGYVPPE------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y PPE Y D++ G ++ E+ T
Sbjct: 193 ---WYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRS 226
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 48/280 (17%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G +G+V A VA+K + + +E + + H N+V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK----IAIGSARGLAFL 976
G+ + G + L EY G L D + + A+R +A G+ +L
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-----GVVYL 121
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE- 1035
H I HRD+K N+LLDE ++SDFG+A + + ++ + GT YV PE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 1036 ----YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
+ + DV+S G+VL +L G+ P D W + +
Sbjct: 179 LKRREFH----AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-------KKTY 227
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
K D LL + L + P R T+ +
Sbjct: 228 LNPWKKIDSAPL-ALLHKI------LVENPSARITIPDIK 260
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-22
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 46/278 (16%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G FG+V K K + A+K + + E+E + K+ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 925 CKVGEERLLVY---EYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHN 979
E+ Y E G L D + +K+ AAR +++ G+ ++H +
Sbjct: 90 L---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHD--AARIIKQVF----SGITYMHKH 140
Query: 980 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
+I+HRD+K N+LL +++ + ++ DFG++ + GT Y+ PE
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEV 194
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096
+ K DV+S GV+L LL+G P F N +K+ K + FD
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLSGTPP-----FYGKNEYDILKRVETGKYA--FDLP-- 244
Query: 1097 KEDPNIEIE---LLQHLHVASACLDDRPWRRPTMIQVM 1131
+ I + L++ + L P R T Q +
Sbjct: 245 -QWRTISDDAKDLIRKM------LTFHPSLRITATQCL 275
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 52/272 (19%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
+GSG FGDV+ + + G IK + Q E AE+E + + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLN--WAAR--RKIAIGSARGLAFLHHNCI 981
+ +V E G L + + + + G L+ + A +++ LA+ H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM----NALAYFHSQ-- 143
Query: 982 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE--- 1035
H++H+D+K N+L + ++ DFG+A L + + + AGT Y+ PE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFK 199
Query: 1036 -YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
+ K D++S GVV+ LLTG P F +L ++ + + + E
Sbjct: 200 RDV-----TFKCDIWSAGVVMYFLLTGCLP-----FTGTSLEEVQQKATYKEPN--YAVE 247
Query: 1095 --------------LMKEDPNIEI---ELLQH 1109
++ +DP ++L H
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE----FTA--EMETIGKIKHRNLVP 920
+G+G + VYK G VA+K+ + + D E TA E+ + ++KH N+V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKE-VKL----DSEEGTPSTAIREISLMKELKHENIVR 67
Query: 921 LLGYCKVGEERL-LVYEYMRYGSLEDVL--HNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
L E +L LV+E+M L+ + L + +GLAF H
Sbjct: 68 LYDVI-HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPP 1034
N I+HRD+K N+L+++ + ++ DFG+AR + V TL Y P
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VVTL----WYRAP 177
Query: 1035 E------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
+ Y ST D++S G +L E++TGK
Sbjct: 178 DVLMGSRTY-----STSIDIWSCGCILAEMITGK 206
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-21
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 48/278 (17%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK----------H 915
+G G FG V K G VA+K L +R+ ++ +GKI+ H
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLA 974
+++ L + +V EY+ G L D + ++ K +RR I S +
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---ESRRLFQQILSG--VD 130
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
+ H + ++HRD+K NVLLD + A+++DFG++ +MS L T G+P Y P
Sbjct: 131 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFL--RTSCGSPNYAAP 184
Query: 1035 EYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
E + D++S GV+L LL G P F D+++ K K+ + P
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP-----FDDDHVPTLFK---KICDGIFYTP 236
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ + I LL+H+ L P +R T+ +
Sbjct: 237 QYLNPSV---ISLLKHM------LQVDPMKRATIKDIR 265
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 79/311 (25%), Positives = 125/311 (40%), Gaps = 83/311 (26%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGY-- 924
IG+G FG V++AKL + VAIKK + D+ F E++ + +KH N+V L +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK-VLQ----DKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 925 ---CKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS--------ARG 972
K E L LV EY+ E V + + ++ + + R
Sbjct: 103 SNGDKKDEVFLNLVLEYVP----ETV----YRA-SRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 973 LAFLH-HNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLS-VSTLAGTP 1029
LA++H I HRD+K N+LLD ++ DFG A+++ A + ++S + +
Sbjct: 154 LAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--- 206
Query: 1030 GYVPPE------YYQSFRCSTKGDVYSYGVVLLELLTGK--------------------R 1063
Y PE Y +T D++S G V+ EL+ G+
Sbjct: 207 -YRAPELIFGATNY-----TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
Query: 1064 PTDSADFGDNNLVGWVK--QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRP 1121
P+ N K Q S VF P P+ I+L+ L L+ P
Sbjct: 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT---PPDA-IDLISRL------LEYTP 310
Query: 1122 WRRPTMIQVMA 1132
R T I+ +
Sbjct: 311 SARLTAIEALC 321
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
+IG G FG+V KLK+ V A+K L + + + E + + + + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
Y + L LV +Y G L + K AR +A + A + +H
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQL- 194
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
H +HRD+K N+L+D N R++DFG + T S S GTP Y+ PE Q+
Sbjct: 195 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAM 251
Query: 1041 RCSTKG-----DVYSYGVVLLELLTGKRP 1064
D +S GV + E+L G+ P
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 30/209 (14%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
+GSG FG V++ K G K I+ D+ E+ + ++ H L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAK-FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 926 KVGEERLLVYEYMRYGSL------EDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLH 977
+ E +L+ E++ G L ED ++ + R+ GL +H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE-------VINYMRQAC----EGLKHMH 166
Query: 978 HNCIPHIIHRDMKSSNVLL--DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
+ I+H D+K N++ + ++ DFG+A + + V T + PE
Sbjct: 167 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPE 220
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
D+++ GV+ LL+G P
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 30/207 (14%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE----FTA--EMETIGKIKHRNLVP 920
+G G + VYK K K + VA+K+ I + + E TA E+ + +KH N+V
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKE-IRL----EHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 921 LLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L E+ L LV+EY+ L+ L + G +N + RGLA+ H
Sbjct: 65 LHDII-HTEKSLTLVFEYLDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD---THLSVSTLAGTPGYVPPEY 1036
++HRD+K N+L++E E +++DFG+AR S + V TL Y PP+
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-VVTL----WYRPPDI 171
Query: 1037 -YQSFRCSTKGDVYSYGVVLLELLTGK 1062
S ST+ D++ G + E+ TG+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 45/230 (19%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
++G G FG V+K + G +A K +I G D+E E+ + ++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 920 PLLGYCKVGEERLLVYEYMRYGSL------EDVLHNQKKVGIKLNWAAR--RKIAIGSAR 971
L + + +LV EY+ G L E + ++I
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-------TILFMKQIC----E 198
Query: 972 GLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHLSVSTLAGTP 1029
G+ +H +I+H D+K N+L ++ DFG+AR + + GTP
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTP 252
Query: 1030 GYVPPE-----YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
++ PE + S D++S GV+ LL+G P F +N
Sbjct: 253 EFLAPEVVNYDFV-----SFPTDMWSVGVIAYMLLSGLSP-----FLGDN 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 52/311 (16%), Positives = 100/311 (32%), Gaps = 42/311 (13%)
Query: 838 INLATFEKPLRKLTF-ADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS 896
I L E K+ L + K + + +
Sbjct: 39 IRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
Query: 897 GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY---EYMRYGSLEDVLHNQKKV 953
A I ++ + +G + ++ +Y + R +L+D ++ + +
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 954 G---IKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010
+ +IA + FLH ++HRD+K SN+ + +V DFG+
Sbjct: 159 EDREHGVCLHIFIQIA----EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 1011 RLM----------SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1060
M + M + + + GT Y+ PE S K D++S G++L ELL
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
Query: 1061 GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDR 1120
+ + ++ P L + E ++Q L
Sbjct: 272 SFSTQME------------RVRIITDVRNLKFPLLFTQKYPQEHMMVQ------DMLSPS 313
Query: 1121 PWRRPTMIQVM 1131
P RP ++
Sbjct: 314 PTERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLV 919
F +G GGFG V++AK K D AIK++ + + RE E++ + K++H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 53/280 (18%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK----------H 915
+G G FG V A K VA+K + R+ + + +++ H
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRY--GSLEDVLHNQKKVGIKLNWAARRKIA-IGSARG 972
+++ L V + + Y G L D + +K++ RR I A
Sbjct: 69 PHIIKLY---DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED---EGRRFFQQIICA-- 120
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ + H + I+HRD+K N+LLD+N +++DFG++ +M+ L T G+P Y
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFL--KTSCGSPNYA 174
Query: 1033 PPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
PE + DV+S G+VL +L G+ P F D + K+
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP-----FDDEFI---PNLFKKVNSCVYV 226
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
P+ + L++ + + P +R T+ ++
Sbjct: 227 MPDFLSPGA---QSLIRRM------IVADPMQRITIQEIR 257
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 300 CS-SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358
C+ + +D SS L+ +PS + + D+ SNK S LP + F ++ L+ L L+
Sbjct: 14 CNNNKNSVDCSSKKLTA-IPS--NIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLN 69
Query: 359 FNDFTGALPDSL-SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP 417
N LP + L NLETL ++ N L A+P + N L EL L N L S+P
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVN-LAELRLDRN-QLKSLP 125
Query: 418 STL-SNCSQLVSLHLSFNYLTGTIPSSL-GSLSKLQDLKLWLNQLHGEIPPEL-GNIQTL 474
+ + ++L L L +N L ++P + L+ L++L+L+ NQL +P + L
Sbjct: 126 PRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTEL 183
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506
+TL LD N+L A + L + L N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
N ++D SS L+ AIP N+ P + K+L LQ+N L ++L L+L+ N
Sbjct: 17 NKNSVDCSSKKLT-AIPSNI---PAD-TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN 71
Query: 435 YLTGTIPSSL-GSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPA-A 491
L T+P+ + L L+ L + N+L +P + + L L LD N+L +LP
Sbjct: 72 KLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV 128
Query: 492 LSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDC-RSLIWL 549
+ T L ++SL N L +P + +L++L L+L NN R+P D L L
Sbjct: 129 FDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTL 186
Query: 550 DLNTNLFNGSIPPALF 565
L+ N +P F
Sbjct: 187 KLDNNQLK-RVPEGAF 201
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 39/230 (16%)
Query: 117 CSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--LSLEVL 174
C++ +S+D S L+ S+I + K L+L SN L S + + L +L
Sbjct: 14 CNNNKNSVDCSSKKLTAIPSNIP-----ADTKKLDLQSNKL--SSLPSKAFHRLTKLRLL 66
Query: 175 DLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG-DINV-SKCKNLQFLDVSSNNFSM 232
L+ NK+ +P +F L+ L + NK+ I V + NL L + N
Sbjct: 67 YLNDNKLQ---TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK- 122
Query: 233 AVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG-----PIPVGY 285
++P F L YL + N+ ++ +F + +
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ----------------SLPKGVFDKLTSLKELRLYN 166
Query: 286 NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSN 335
N+ + +P D + L L L +N L F S L+ + N
Sbjct: 167 NQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 52/220 (23%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
IG+G FG VY+AKL D G VAIKK++ D+ F E++ + K+ H N+V L +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 926 KVGEERL------LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS--------AR 971
E+ LV +Y+ + ++ +V + A++ + + R
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-----PETVY---RV-ARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 972 GLAFLH-HNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLS-VSTLAGT 1028
LA++H I HRD+K N+LLD + ++ DFG A+ + + ++S + +
Sbjct: 168 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 1029 PGYVPPE------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y PE Y ++ DV+S G VL ELL G+
Sbjct: 222 --YRAPELIFGATDY-----TSSIDVWSAGCVLAELLLGQ 254
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKL-IHISGQGDREF--TA--E---METIGKIKHRNL 918
IG G +G VYKA+ G VA+K + + G G + E + + +H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 919 VPLL----GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
V L+ E ++ LV+E++ L L G+ + + RGL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA--ETIKDLMRQFLRGL 133
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS---AMDTHLSVSTLAGTPG 1030
FLH N I+HRD+K N+L+ +++DFG+AR+ S A+ T + V TL
Sbjct: 134 DFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPV-VVTL----W 184
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y PE +T D++S G + E+ K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-20
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL------------IHISGQGDRE-FTAEMETIGKI 913
+GSG +G+V K K S AIK + + + + E E+ + +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 914 KHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSAR 971
H N++ L + + LV E+ G L + + N+ K AA ++I
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD--AANIMKQIL----S 157
Query: 972 GLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
G+ +LH + +I+HRD+K N+LL + ++ DFG++ S + GT
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGT 211
Query: 1029 PGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
Y+ PE + + + K DV+S GV++ LL G P
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
+G+G FG V++ + G+ A K + + D+E E++T+ ++H LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 926 KVGEERLLVYEYMRYGSL------EDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLH 977
+ E +++YE+M G L E ++ + A R++ +GL +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-------AVEYMRQVC----KGLCHMH 272
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
N + +H D+K N++ + DFG+ + D SV GT + PE
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPE 326
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+ D++S GV+ LL+G P FG N
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGEN 360
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 44/230 (19%)
Query: 857 EATNGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKH 915
+ + F + + G G FG V K K G +VAIKK+I +RE M+ + + H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHH 78
Query: 916 RNLVPLLGYCKVGEER-------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
N+V L Y ER +V EY+ D LH + + + +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH---RC-CRNYYRRQVAPPPI 129
Query: 969 S--------ARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTH 1019
R + LH + ++ HRD+K NVL++ + ++ DFG A+ +S + +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 1020 LSVSTLAGTPGYVPPEYYQ-------SFRCSTKGDVYSYGVVLLELLTGK 1062
++ Y+ YY+ + +T D++S G + E++ G+
Sbjct: 189 VA---------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 44/208 (21%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G FG V++ T K + + G E+ + +HRN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 927 VGEERLLVYEYMRYGSL------EDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHH 978
EE ++++E++ + N+++ ++ L FLH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVC----EALQFLHS 120
Query: 979 NCIPHIIHRDMKSSNVLL--DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
+ +I H D++ N++ + ++ +FG AR + + L P Y PE
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEV 174
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+Q ST D++S G ++ LL+G P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 40/225 (17%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
+GSG F V K + K G A K +L RE E+ + +I+H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 921 LLGYCKVGEERLLVYEYMRYGSL-----EDVLHNQKKVGIKLNWAAR--RKIAIGSARGL 973
L + + +L+ E + G L E + + A + ++I G+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFLKQI----LDGV 121
Query: 974 AFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
+LH I H D+K N++L N ++ DFG+A + A + + GTP
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTP 175
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+V PE + D++S GV+ LL+G P F
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGET 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE---FTA--EMETIGKIKHRNLVPL 921
+G G +G+VYKA TVAIK+ I + + E TA E+ + +++HRN++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKR---IRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
RL L++EY L+ + ++ + G+ F H
Sbjct: 99 KSVI-HHNHRLHLIFEYAEN-DLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSR- 151
Query: 981 IPHIIHRDMKSSNVLLDENFEAR-----VSDFGMARLMSAMD---THLSVSTLAGTPGYV 1032
+HRD+K N+LL + + + DFG+AR TH + TL Y
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-IITL----WYR 204
Query: 1033 PPE------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
PPE +Y ST D++S + E+L
Sbjct: 205 PPEILLGSRHY-----STSVDIWSIACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 52/227 (22%), Positives = 99/227 (43%), Gaps = 54/227 (23%)
Query: 868 IGSGGFGDVYKAKLKDGST---VAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLL 922
+G G +G VYKAK KDG A+K++ +A E+ + ++KH N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 923 G-YCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA---------- 970
+ + ++ L+++Y + L ++ + + A ++ + +
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA-----SKANKKPVQLPRGMVKSLLYQIL 138
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR----VSDFGMARLMSAMD---THLS-- 1021
G+ +LH N ++HRD+K +N+L+ R ++D G ARL ++ L
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 1022 VSTLAGTPGYVPPE------YYQSFRCSTKGDVYSYGVVLLELLTGK 1062
V T Y PE +Y + D+++ G + ELLT +
Sbjct: 196 VVTF----WYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G FG+V K K + A+K + + E+E + K+ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNCIP 982
+ +V E G L D + +K+ AAR +++ G+ ++H +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD--AARIIKQVF----SGITYMHKH--- 140
Query: 983 HIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+I+HRD+K N+LL +++ + ++ DFG++ GT Y+ PE +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG 197
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
K DV+S GV+L LL+G P F N
Sbjct: 198 -TYDEKCDVWSAGVILYILLSGTPP-----FYGKN 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-20
Identities = 55/211 (26%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
+IG G F +V K+K V A+K + + +G+ E + + R + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
+ E L LV EY G L + K AR +A I A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLAEIVMA--IDSVHRL- 181
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
+HRD+K N+LLD R++DFG + D + GTP Y+ PE Q+
Sbjct: 182 --GYVHRDIKPDNILLDRCGHIRLADFGSCLKLR-ADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 1041 RCSTKGDVY-------SYGVVLLELLTGKRP 1064
Y + GV E+ G+ P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK--------KLIHISGQGDREFTA-EMETIGKIK-HR 916
+G G V + K A+K Q RE T E++ + K+ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
N++ L + LV++ M+ G L D L + L+ RKI + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICAL 140
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE- 1035
H +I+HRD+K N+LLD++ +++DFG + + + + + GTP Y+ PE
Sbjct: 141 HKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEI 194
Query: 1036 -----YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ D++S GV++ LL G P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-20
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 868 IGSGGFGDVYKAK--LKDGSTVAIKKLIHISGQGD-------REFTAEMETIGKIKHRNL 918
IG G +G V+KA+ G VA+K+ + + + RE + +H N+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKR-VRVQTGEEGMPLSTIREVAVLRH-LETFEHPNV 76
Query: 919 VPLL----GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
V L E +L LV+E++ L L + G+ + + RGL
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLLRGL 133
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA-MD-THLSVSTLAGTPGY 1031
FLH + ++HRD+K N+L+ + + +++DFG+AR+ S M T + V TL Y
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTL----WY 185
Query: 1032 VPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
PE +T D++S G + E+ K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 50/279 (17%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIK-----KLIHISGQGDREF---TAEMETIGKIKHRNL 918
+GSG FG V+ A + V +K K++ D + T E+ + +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 919 VPLLGYCKVGEERLLVYEYMRYGS---LEDVLHNQKKVGIKLNWAARRKIA-IGSARGLA 974
+ +L + LV E +GS L + ++ L A + SA +
Sbjct: 92 IKVLDIFENQGFFQLVMEK--HGSGLDLFAFIDRHPRLDEPL---ASYIFRQLVSA--VG 144
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
+L IIHRD+K N+++ E+F ++ DFG A + T GT Y P
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLF--YTFCGTIEYCAP 198
Query: 1035 EYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
E + +++S GV L L+ + P F + A + +
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENP-----FCELEET----VEAAIHPPYLVSK 249
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
ELM L+ L L P RR T+ +++
Sbjct: 250 ELMS--------LVSGL------LQPVPERRTTLEKLVT 274
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
+IG G FG+V + K V A+K L + + D F E + + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
Y + L +V EYM G D+++ + WA R A + A L +H
Sbjct: 136 -YAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHSM- 187
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
IHRD+K N+LLD++ +++DFG M+ T GTP Y+ PE +S
Sbjct: 188 --GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVLKS- 243
Query: 1041 RCSTKGDVYSY---------GVVLLELLTGKRPTDSADFGDNNLVG 1077
+G Y GV L E+L G P F ++LVG
Sbjct: 244 ----QGGDGYYGRECDWWSVGVFLYEMLVGDTP-----FYADSLVG 280
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 54/345 (15%), Positives = 113/345 (32%), Gaps = 57/345 (16%)
Query: 141 LGSCSSLKVLNLSSNLLDFSGREA-----GSLKLSLEVLDLSYNKIS--GANVVPWILFN 193
+ L+LS N L + S+ L+LS N + ++ + IL
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 194 GCDELKQLALKGNKVTGDINV--------SKCKNLQFLDVSSNNFS-MAVPSFGDCLA-- 242
+ L L GN + + + + LD+ N+FS + F +
Sbjct: 78 IPANVTSLNLSGNFL-SYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 243 ---LEYLDISANKFTGDVGHAISAC-----EHLSFLNVSSNLFSGPIPVGYNEFQGEIPL 294
+ L++ N + +++ LN+ N + ++ E+
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA-------SKNCAELAK 189
Query: 295 HLADLCSSLVKLDLSSNNLSGKVPSRFGSC-----SSLESFDISSNKFSGE---LPIEIF 346
LA + +S+ LDLS+N L K + + + S ++ N G +
Sbjct: 190 FLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLK 249
Query: 347 LSMSNLKELVLSFNDFTG-------ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG-- 397
S+ +L+ + L ++ AL + N+ + +D + + + +
Sbjct: 250 DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIR 309
Query: 398 -PRNSLKELFLQNNLLL-----GSIPSTLSNCSQLVSLHLSFNYL 436
L N L+ + L+ +L + L
Sbjct: 310 ELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 47/254 (18%), Positives = 80/254 (31%), Gaps = 61/254 (24%)
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG---PRNSLKELFLQNNLL--------- 412
+ + S + +LDLS NNL L Q S+ L L N L
Sbjct: 13 PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72
Query: 413 --LGSIPSTL-----------------------SNCSQLVSLHLSFNYLTGTIPSSLGSL 447
L +IP+ + + + L L +N + S
Sbjct: 73 QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA 132
Query: 448 -----SKLQDLKLWLNQLHGEIPPELGNI-----QTLETLFLDFNELTGT----LPAAL- 492
+ + L L N L + EL I + +L L N L L L
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 493 SNCTNLNWISLSNNHLGGEIPTWIGQL-----SNLAILKLSNNSFYG----RIPPELGDC 543
S ++ + LS N LG + + + +++ L L N +G +
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 544 RSLIWLDLNTNLFN 557
+ L + L+ ++
Sbjct: 253 KHLQTVYLDYDIVK 266
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 63/317 (19%), Positives = 103/317 (32%), Gaps = 52/317 (16%)
Query: 169 LSLEVLDLSYNKISGANVVPWILF-NGCDELKQLALKGNKVTGD------INVSKCKNLQ 221
S+E L + I+ + D +K++ L GN + + N++ K+L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 222 FLDVSSNNFS-------MAVPSFGDCLA----LEYLDISANKFTGDVG-----HAISACE 265
+ S A+ L L + +S N F G +S
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFLSKHT 122
Query: 266 HLSFLNVSSNLFSGPIPVGYNEF----QGEIPLHLADLCSSLVKLDLSSNNLSGK----V 317
L L + +N P + Q A L + N L
Sbjct: 123 PLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 318 PSRFGSCSSLESFDISSNKFSGE----LPIEIFLSMSNLKELVLSFNDFTG----ALPDS 369
F S L + + N E L +E LK L L N FT AL +
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 370 LSNLTNLETLDLSSNNLSG----AIPHNLCQGPRNSLKELFLQNNLL----LGSIPSTL- 420
L + NL L L+ LS A+ + L+ L LQ N + + ++ + +
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 421 SNCSQLVSLHLSFNYLT 437
L+ L L+ N +
Sbjct: 300 EKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 65/312 (20%), Positives = 100/312 (32%), Gaps = 58/312 (18%)
Query: 302 SLVKLDLSSNNLSGK----VPSRFGSCSSLESFDISSNKFSGE--LPI-EIFLSMSNLKE 354
S+ L + ++ + V + S++ +S N E + E S +L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 355 LVLSFNDFTG-----------ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN--S 401
S FTG L +L L T+ LS N L
Sbjct: 65 AEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 402 LKELFLQNN-------------LLLGSIPSTLSNCSQLVSLHLSFNYLTG----TIPSSL 444
L+ L+L NN L ++ N L S+ N L +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 445 GSLSKLQDLKLWLNQLHGE-----IPPELGNIQTLETLFLDFNELTGT----LPAALSNC 495
S L +K+ N + E + L Q L+ L L N T L AL +
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 496 TNLNWISLSNNHLGGE----IPTWIGQLSN--LAILKLSNNSFYGRIPPELGD-----CR 544
NL + L++ L + +L N L L+L N L
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 545 SLIWLDLNTNLF 556
L++L+LN N F
Sbjct: 304 DLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-17
Identities = 56/337 (16%), Positives = 104/337 (30%), Gaps = 78/337 (23%)
Query: 85 VASFLLTLDTLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILSGPLSDI---- 138
V + LL D+++ + L + I L L + S +I
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 139 ----SYLGSCSSLKVLNLSSNLLDFSGRE--AGSLKL--SLEVLDLSYNKIS--GANVVP 188
L C L + LS N + +E L LE L L N + +
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI- 142
Query: 189 WILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMA-VPSFGDCLA----L 243
L++LA+ L+ + N + + L
Sbjct: 143 ------ARALQELAVNKKA-------KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189
Query: 244 EYLDISANKFTGD-----VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298
+ + N + + ++ C+ L L++ N F+ +G LA
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT---HLG--------SSALAI 238
Query: 299 L---CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKEL 355
+L +L L+ LS + G+ + +++F N L+ L
Sbjct: 239 ALKSWPNLRELGLNDCLLSAR-----GAAAVVDAFSKLENI--------------GLQTL 279
Query: 356 VLSFNDFTG----ALPDSL-SNLTNLETLDLSSNNLS 387
L +N+ L + + +L L+L+ N S
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 31/186 (16%), Positives = 59/186 (31%), Gaps = 37/186 (19%)
Query: 94 TLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILS--GPLSDISY-LGSCSSLK 148
L ++ + + + L ++ + N + G + L C LK
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 149 VLNLSSNLLDFSGRE--AGSLKL--SLEVLDLSYNKISGANVVPWILFNGCDEL-KQLAL 203
VL+L N G A +LK +L L L+ +S G + +
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR---------GAAAVVDAFSK 270
Query: 204 KGNKVTGDINVSKCKNLQFLDVSSNNFSMA-VPSFGDCLA-----LEYLDISANKFTGDV 257
N LQ L + N + V + + L +L+++ N+F +
Sbjct: 271 LEN-----------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEE 318
Query: 258 GHAISA 263
+
Sbjct: 319 DDVVDE 324
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 49/284 (17%), Positives = 89/284 (31%), Gaps = 66/284 (23%)
Query: 473 TLETLFLDFNELTG----TLPAALSNCTNLNWISLSNNHLGGE----IPTWIGQLSNLAI 524
++E L + +T ++ A L ++ I LS N +G E + I +L I
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 525 LKLSNNSFYGRIPPE-----------LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAA 573
+ S+ F GR+ E L C L + L+ N F G A
Sbjct: 65 AEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF------------GPTAQ 111
Query: 574 NFIVGKKYVYIKNDGS-KECHGAGNLLEFAGIR--AERLSRISTRSPCNFTRVYGGHTQP 630
++ ++ + + N L A L +
Sbjct: 112 EPLID----FLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL--------------AVNK 153
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEIGSM----SYLFILNLGHNNLSGP-IPTEVGDL-- 683
+ + + N L KE L + + N + I + +
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 684 --RGLNILDLSSNRL--EGT--IPSSMSSLTLLNEIDLCNNQLT 721
+ L +LDL N G+ + ++ S L E+ L + L+
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGYC 925
IG G +G+V A K A K I D + F E+E + + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAK-KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNCIPH 983
+ + LV E G L + + +++ AAR + + +A+ H +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESD--AARIMKDVL----SAVAYCHKL---N 126
Query: 984 IIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
+ HRD+K N L + ++ DFG+A T GTP YV P+ +
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG- 182
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP 1064
+ D +S GV++ LL G P
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDRE---FTAEMETIGKIKHRNL 918
+GSG G+V A + VAI+ K S + E+E + K+ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+ + + E +V E M G L D + K+ L A + + +LH
Sbjct: 203 IKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLH 256
Query: 978 HNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
N IIHRD+K NVLL +E+ +++DFG ++++ + TL GTP Y+ P
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAP 310
Query: 1035 EYYQSFRC---STKGDVYSYGVVLLELLTGKRP 1064
E S + D +S GV+L L+G P
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
+GSG F V K + K G A K + RE E+ + +I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 921 LLGYCKVGEERLLVYEYMRYGSL-----EDVLHNQKKVGIKLNWAAR--RKIAIGSARGL 973
L + + +L+ E + G L E +++ A ++I G+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFLKQIL----NGV 127
Query: 974 AFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
+LH I H D+K N++L ++ DFG+A + + + GTP
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 181
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+V PE + D++S GV+ LL+G P
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-19
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 40/225 (17%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
+GSG F V K + K G A K + RE E+ + ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 921 LLGYCKVGEERLLVYEYMRYGSL-----EDVLHNQKKVGIKLNWAAR--RKIAIGSARGL 973
L + + +L+ E + G L + ++++ A ++I G+
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFIKQI----LDGV 128
Query: 974 AFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
+LH I H D+K N++L ++ DFG+A ++ + + GTP
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTP 182
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+V PE + D++S GV+ LL+G P F +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDT 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 23/280 (8%)
Query: 797 VETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINL--ATFEKPLRKLTFAD 854
VET + R++ +A+ D A ++ + + KP ++T +
Sbjct: 90 VETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 855 LLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETI 910
F L+G G FG V K K A+K L I + + T E +
Sbjct: 150 -------FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 911 GKIKHRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS 969
+H L L Y +RL V EY G L H ++ + A I S
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVS 259
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
A L +LH ++++RD+K N++LD++ +++DFG+ + + ++ T GTP
Sbjct: 260 A--LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTP 313
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
Y+ PE + D + GVV+ E++ G+ P + D
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-------KLIHISGQGDREFTA-EMETIGKIK-HRN 917
IG G V + + G A+K +L + RE T E + ++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR---RKIAIGSARGLA 974
++ L+ + LV++ MR G L D L + + K R R + ++
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---ETRSIMRSLL----EAVS 214
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
FLH N +I+HRD+K N+LLD+N + R+SDFG + + + + L GTPGY+ P
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAP 268
Query: 1035 E------YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
E + D+++ GV+L LL G P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 24/214 (11%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGY 924
++G G V A+K + G E+E + + + HRN++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI-AIGSARGLAFLHHNCIPH 983
+ + LV+E MR GS+ +H ++ A + + SA L FLH+
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EASVVVQDVASA--LDFLHNK---G 131
Query: 984 IIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVS-----TLAGTPGYVPPE 1035
I HRD+K N+L ++ ++ DF + + +S T G+ Y+ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 1036 YYQSFRCSTKG-----DVYSYGVVLLELLTGKRP 1064
++F D++S GV+L LL+G P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 59/234 (25%), Positives = 92/234 (39%), Gaps = 39/234 (16%)
Query: 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIG 911
A+L + + I SG +G V +G VAIK++ + G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 912 K-----------IKHRNLVPLLGYCKVGEERL-----LVYEYMRYGSLEDVLHNQKKVGI 955
K H N++ L EE LV E MR L V+H+Q+ I
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR---I 129
Query: 956 KLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015
++ + GL LH ++HRD+ N+LL +N + + DF +AR +A
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 1016 MDTHLSVSTLAGTPGYV------PPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
D + + YV PE F+ TK D++S G V+ E+ K
Sbjct: 187 -DANKT--------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 40/225 (17%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
+GSG F V K + K G A K + RE E+ + ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 921 LLGYCKVGEERLLVYEYMRYGSL-----EDVLHNQKKVGIKLNWAAR--RKIAIGSARGL 973
L + + +L+ E + G L + ++++ A ++I G+
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFIKQI----LDGV 128
Query: 974 AFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
+LH I H D+K N++L ++ DFG+A + + GTP
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTP 182
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+V PE + D++S GV+ LL+G P F +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDT 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 39/300 (13%)
Query: 816 SRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGD 875
+ + G+ S K A+ F +G+G FG
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGR 56
Query: 876 VYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLLGYCKVGEER 931
V K K+ A+K L + E T E + + LV L K
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNCIPHIIHRDMK 990
+V EY+ G + L +++G AR A I +LH +I+RD+K
Sbjct: 117 YMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLT--FEYLHSL---DLIYRDLK 168
Query: 991 SSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYS 1050
N+L+D+ +V+DFG A+ + T TL GTP + PE S + D ++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGR-TW----TLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 1051 YGVVLLELLTGKRPTDSADFGDNNLVGWVKQ--HAKLKISDVFDPE-------LMKEDPN 1101
GV++ E+ G P F + + ++ K++ F + L++ D
Sbjct: 224 LGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIK-----KLIHISGQGDREFTA---EMETIGKIKHRNL 918
+GSG G+V A + VAIK K S + E+E + K+ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 919 VPLLGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI-AIGSARGLAF 975
+ + + + +V E M G L D + K++ + + A + +
Sbjct: 78 IKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEA---TCKLYFYQMLLA--VQY 129
Query: 976 LHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
LH N IIHRD+K NVLL +E+ +++DFG ++++ + TL GTP Y+
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYL 183
Query: 1033 PPEYYQSFRCSTKG---DVYSYGVVLLELLTG 1061
PE S + D +S GV+L L+G
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 6e-18
Identities = 63/250 (25%), Positives = 119/250 (47%), Gaps = 34/250 (13%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
+G+G FG V+ + + A+K L + E T E + + H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
G + +++ ++ +Y+ G L +L +K N A+ A + A L +LH
Sbjct: 73 GTFQD-AQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLA--LEYLHSK- 125
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
II+RD+K N+LLD+N +++DFG A+ + + T+ TL GTP Y+ PE +
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY----TLCGTPDYIAPEVVSTK 178
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ--HAKLKISDVFDPE---- 1094
+ D +S+G+++ E+L G P F D+N + ++ +A+L+ F+ +
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 233
Query: 1095 ---LMKEDPN 1101
L+ D +
Sbjct: 234 LSRLITRDLS 243
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G F V + K G A K + +S + ++ E K++H N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+ LV++ + G L + + ++ + A +A+ H N I
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSN---GI 126
Query: 985 IHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+HR++K N+LL + +++DFG+A ++ + AGTPGY+ PE +
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDP 183
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
S D+++ GV+L LL G P F D +
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP-----FWDED 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 8e-18
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGY 924
++GSG F +V+ K + G A+K I S E+ + KIKH N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKC-IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNCIP 982
+ LV + + G L D + + K A+ +++ + +LH N
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKD--ASLVIQQVL----SAVKYLHEN--- 125
Query: 983 HIIHRDMKSSNVLL---DENFEARVSDFGMARLM--SAMDTHLSVSTLAGTPGYVPPEYY 1037
I+HRD+K N+L +EN + ++DFG++++ M ST GTPGYV PE
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM------STACGTPGYVAPEVL 179
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
S D +S GV+ LL G P F +
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP-----FYEET 211
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 9e-18
Identities = 45/215 (20%), Positives = 76/215 (35%), Gaps = 27/215 (12%)
Query: 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND 361
L + +LS + + S SC L+ + + + I L M L L+
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCL----LTIILLMRALDPLLY---- 400
Query: 362 FTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSL------KELFLQNNLLLGS 415
++L + L+ +D + + L L + L +
Sbjct: 401 ----EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--T 454
Query: 416 IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLE 475
+ L + L LS N L +P +L +L L+ L+ N L E + N+ L+
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQ 511
Query: 476 TLFLDFNELTGTLPA--ALSNCTNLNWISLSNNHL 508
L L N L A L +C L ++L N L
Sbjct: 512 ELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 3e-13
Identities = 41/229 (17%), Positives = 72/229 (31%), Gaps = 22/229 (9%)
Query: 331 DISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAI 390
+++ I+ + KE VL + + L +LS +
Sbjct: 307 ASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKSTVL- 364
Query: 391 PHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS---FNYLTGTIPSSLGSL 447
L+EL +N L +I + L+ + F+ L P L
Sbjct: 365 --QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 448 SKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNH 507
L+ L E + L L +LT + L + + LS+N
Sbjct: 423 DDLRSKFLL------ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474
Query: 508 LGGEIPTWIGQLSNLAILKLSNNSFYGRIP--PELGDCRSLIWLDLNTN 554
L +P + L L +L+ S+N + + + L L L N
Sbjct: 475 L-RALPPALAALRCLEVLQASDN----ALENVDGVANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 8e-13
Identities = 48/265 (18%), Positives = 87/265 (32%), Gaps = 30/265 (11%)
Query: 177 SYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS 236
S N + I + + + LK + + + L ++S ++
Sbjct: 308 SLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSE 367
Query: 237 FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHL 296
C L+ L+ + + A + L + + F + + P+
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF--------STLKAVDPMRA 419
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
A L + + + + ++ + + + + L
Sbjct: 420 AYLDDL-------RSKFLLENSVLKMEYADVRVLHLAHKDLTV---LCHLEQLLLVTHLD 469
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP--HNLCQGPRNSLKELFLQNNLLLG 414
LS N ALP +L+ L LE L S N L + NL L+EL L NN L
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLP-----RLQELLLCNN-RLQ 521
Query: 415 SIPS--TLSNCSQLVSLHLSFNYLT 437
+ L +C +LV L+L N L
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 9e-10
Identities = 38/242 (15%), Positives = 70/242 (28%), Gaps = 15/242 (6%)
Query: 81 DFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSG--PLSDI 138
+L D E ++ S+ L S S L P +
Sbjct: 324 GSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKW 383
Query: 139 SYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198
L ++ L+ + + + + S + +L ++
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
+ L L +T ++ + + LD+S N P+ LE L S N G
Sbjct: 444 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 503
Query: 259 HAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVP 318
++ L L + +N L C LV L+L N+L +
Sbjct: 504 --VANLPRLQELLLCNNRLQQS----------AAIQPLVS-CPRLVLLNLQGNSLCQEEG 550
Query: 319 SR 320
+
Sbjct: 551 IQ 552
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 49/331 (14%), Positives = 96/331 (29%), Gaps = 32/331 (9%)
Query: 391 PHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKL 450
P++ Q + L + +S +S+ S G+ +L +
Sbjct: 223 PND--QSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDE 280
Query: 451 QDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGG 510
L + G P + L L+ T + + L +
Sbjct: 281 APLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC 340
Query: 511 EIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGK 570
L +LS + EL C+ L L+ +I +
Sbjct: 341 WCRD-SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRA---- 394
Query: 571 IAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQP 630
+ ++ + R + +
Sbjct: 395 -------------LDPLLYEK-ETLQYFSTLKAVDPMRAAYLDDLRSKFLL-----ENSV 435
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILD 690
+ L +++ L+ + + + + L+L HN L +P + LR L +L
Sbjct: 436 LKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQ 492
Query: 691 LSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
S N LE + +++L L E+ LCNN+L
Sbjct: 493 ASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 46/337 (13%), Positives = 100/337 (29%), Gaps = 46/337 (13%)
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457
+ + L L+ S++ +L L + ++ + + +WL
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPD-GRNRPSHVWL 301
Query: 458 NQLHGEIPPELGNIQTLETLFLDFNEL---------TGTLPAALSNCTNLNWISLSNNHL 508
L + T ++ + + L LS
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKS 361
Query: 509 GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG--SIPPALFK 566
+ + + L L+ N I + L++ F+ ++ P
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 567 QSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGG 626
+ + F++ + ++ + H A L+ +
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHK----------DLTVL-------------- 456
Query: 627 HTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGL 686
+ LD+S+N L ++P + ++ L +L N L + V +L L
Sbjct: 457 ---CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRL 510
Query: 687 NILDLSSNRLEGTIPS--SMSSLTLLNEIDLCNNQLT 721
L L +NRL+ + + S L ++L N L
Sbjct: 511 QELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKIKHRNLVPLL 922
L+G G FG V + K A+K L I + + T E + +H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 923 GYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNC 980
Y +RL V EY G L H ++ A R A I SA L +LH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERA-RFYGAEIVSA--LEYLHSR- 124
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
+++RD+K N++LD++ +++DFG+ + +S T + T GTP Y+ PE +
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLED 179
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
D + GVV+ E++ G+ P + D
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYC 925
+G G F K K A+K IS + + E+ + + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI-AIGSARGLAFLHHNCIPHI 984
LV E + G L + + +K A + + SA ++ +H +
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSET---EASYIMRKLVSA--VSHMHDV---GV 127
Query: 985 IHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE-----Y 1036
+HRD+K N+L ++N E ++ DFG ARL + L T T Y PE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPELLNQNG 185
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
Y D++S GV+L +L+G+ P
Sbjct: 186 Y-----DESCDLWSLGVILYTMLSGQVP 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 45/247 (18%), Positives = 83/247 (33%), Gaps = 37/247 (14%)
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
+ L VT ++ + +Q + ++N ++ L+ L +S N+ + D
Sbjct: 20 NAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQIS-D 77
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+ + L L+V+ N + + L +L L +N L
Sbjct: 78 LS-PLKDLTKLEELSVNRNRLK------------NLN-GIPSA--CLSRLFLDNNELRD- 120
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
+LE I +NK I + +S L+ L L N+ T L+ L +
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLKS---IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKV 174
Query: 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL--LLGSI--PSTLSNCSQLVSLHLS 432
+DL+ P EL++ N + G P +SN V +
Sbjct: 175 NWIDLTGQKCV--------NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVL 226
Query: 433 FNYLTGT 439
+ T
Sbjct: 227 WELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 36/188 (19%), Positives = 73/188 (38%), Gaps = 17/188 (9%)
Query: 343 IEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSL 402
+ ++N + L T S L+ ++ + ++N+ +L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQFF----TNL 65
Query: 403 KELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG 462
KEL L +N + S S L + ++L L ++ N L + + L L L N+L
Sbjct: 66 KELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELR- 119
Query: 463 EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNL 522
+ L +++ LE L + N+L + L + L + L N + + +L +
Sbjct: 120 DTDS-LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKV 174
Query: 523 AILKLSNN 530
+ L+
Sbjct: 175 NWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 46/309 (14%), Positives = 85/309 (27%), Gaps = 79/309 (25%)
Query: 200 QLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGH 259
+ + + N ++ + + + S + ++ + +
Sbjct: 1 ESIQRPTPINQVFPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSN------- 52
Query: 260 AISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS 319
I + + F +L +L LS N +S S
Sbjct: 53 -IQSLAGMQFFT------------------------------NLKELHLSHNQIS--DLS 79
Query: 320 RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379
+ LE ++ N+ + + + L L L N+ DSL +L NLE L
Sbjct: 80 PLKDLTKLEELSVNRNRLKN---LN-GIPSACLSRLFLDNNELRD--TDSLIHLKNLEIL 133
Query: 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGT 439
+ +N L SI L S+L L L N +T
Sbjct: 134 SIRNNKLK---------------------------SIVM-LGFLSKLEVLDLHGNEITN- 164
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
L L K+ + L + E + T+ P +SN +
Sbjct: 165 -TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYV 221
Query: 500 WISLSNNHL 508
+
Sbjct: 222 DGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 38/197 (19%), Positives = 73/197 (37%), Gaps = 22/197 (11%)
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSS 146
L ++ + NSNI SL ++ L L LS N +SD+S L +
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ---SLAGMQFFTN-LKELHLSHN----QISDLSPLKDLTK 86
Query: 147 LKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKG 205
L+ L+++ N L + +G L L L N++ + L+ L+++
Sbjct: 87 LEELSVNRNRLKNLNGIP----SACLSRLFLDNNELR--DTDS---LIHLKNLEILSIRN 137
Query: 206 NKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACE 265
NK+ + + L+ LD+ N + + ++D++ K + +
Sbjct: 138 NKLKSIVMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQKCVNE---PVKYQP 193
Query: 266 HLSFLNVSSNLFSGPIP 282
L N + I
Sbjct: 194 ELYITNTVKDPDGRWIS 210
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 41/268 (15%), Positives = 85/268 (31%), Gaps = 58/268 (21%)
Query: 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYN 179
+L ++D+ S ++ N ++ + +G + +L+ L LS+N
Sbjct: 21 AVKQNLGKQ----SVTDLVSQKELSGVQNFNGDNSNIQSLAGMQ--FFT-NLKELHLSHN 73
Query: 180 KISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGD 239
+IS ++ P +L++L++ N++ ++N L L + +N S
Sbjct: 74 QIS--DLSP---LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELRD-TDSLIH 126
Query: 240 CLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL 299
LE L I NK + + L FL+
Sbjct: 127 LKNLEILSIRNNK--------LKSIVMLGFLS---------------------------- 150
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
L LDL N ++ + D++ K P++ + +
Sbjct: 151 --KLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPD 205
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLS 387
+ P +SN + +
Sbjct: 206 GRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 38/258 (14%), Positives = 79/258 (30%), Gaps = 67/258 (25%)
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
+ L +T + + + + N+++ + + +NL L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 528 SNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKND 587
S+N + P L D L L +N N
Sbjct: 71 SHNQI-SDLSP-LKDLTKLEELSVNRN--------------------------------- 95
Query: 588 GSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ----PTFNHNGSMMFLDI 643
RL ++ +R++ + + + H ++ L I
Sbjct: 96 --------------------RLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSI 135
Query: 644 SYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSS 703
N L SI +G +S L +L+L N ++ + L+ +N +DL+ +
Sbjct: 136 RNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKY 191
Query: 704 MSSLTLLNEIDLCNNQLT 721
L + N + + +
Sbjct: 192 QPELYITNTVKDPDGRWI 209
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 47/183 (25%), Positives = 69/183 (37%), Gaps = 12/183 (6%)
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA 365
L S L VP S D+S N S ++NL L+LS N
Sbjct: 23 LSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI 79
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCS 424
++ + NL LDLSSN+L + L + L+ L L NN + + + +
Sbjct: 80 SSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA-LEVLLLYNN-HIVVVDRNAFEDMA 136
Query: 425 QLVSLHLSFNYLTGTIP----SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480
QL L+LS N ++ P L KL L L N+L +L + L
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
Query: 481 FNE 483
+
Sbjct: 196 LHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 52/198 (26%), Positives = 75/198 (37%), Gaps = 32/198 (16%)
Query: 365 ALPDSLSNLTNLETLDLSSNNLS----GAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-T 419
+P SL + LDLS NNLS P L +L L L +N L I S
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRL-----TNLHSLLLSHNHL-NFISSEA 83
Query: 420 LSNCSQLVSLHLSFNYLTGTIPS-SLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETL 477
L L LS N+L T+ L L+ L L+ N + + ++ L+ L
Sbjct: 84 FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141
Query: 478 FLDFNELTGTLPA----ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNL--AILKLSNNS 531
+L N+++ P + L + LS+N L T + +L L L NN
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200
Query: 532 FYGRIPPELGDCRSLIWL 549
DC+ L L
Sbjct: 201 L-------ECDCK-LYQL 210
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 43/176 (24%), Positives = 67/176 (38%), Gaps = 15/176 (8%)
Query: 409 NNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPS--SLGSLSKLQDLKLWLNQLHGEIPP 466
+ L ++P +L S L LS N L+ + + + L+ L L L N L+ I
Sbjct: 26 SKQQLPNVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81
Query: 467 E-LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAI 524
E + L L L N L S+ L + L NNH+ + ++ L
Sbjct: 82 EAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQK 140
Query: 525 LKLSNNSFYGRIPPE----LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFI 576
L LS N R P E L+ LDL++N +P ++ N +
Sbjct: 141 LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 47/199 (23%), Positives = 67/199 (33%), Gaps = 46/199 (23%)
Query: 219 NLQFLDVSSNNFSMAVP--SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
LD+S NN S + L L +S N +SS
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN----------------FISSEA 83
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSN 335
F +L LDLSSN+L + F +LE + +N
Sbjct: 84 FVP--------------------VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN 122
Query: 336 KFSGELPIEIFLSMSNLKELVLSFNDFT----GALPDSLSNLTNLETLDLSSNNLSGAIP 391
+ F M+ L++L LS N + + + L L LDLSSN L
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELI-KDGNKLPKLMLLDLSSNKLKKLPL 180
Query: 392 HNLCQGPRNSLKELFLQNN 410
+L + P L+L NN
Sbjct: 181 TDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 45/201 (22%), Positives = 67/201 (33%), Gaps = 51/201 (25%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVS 226
+LDLS+N +S + L L L N + I+ NL++LD+S
Sbjct: 40 YTALLDLSHNNLS--RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 227 SNNFSMAVPS--FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVG 284
SN+ + F D ALE L + N V N F
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV----------------VVDRNAFED----- 134
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR----FGSCSSLESFDISSNKFSGE 340
+ L KL LS N +S + P L D+SSNK +
Sbjct: 135 ---------------MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-K 177
Query: 341 LPIEIFLSMSNLKELVLSFND 361
LP+ + + L ++
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 39/158 (24%), Positives = 59/158 (37%), Gaps = 14/158 (8%)
Query: 124 LDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLK--LSLEVLDLSYNKI 181
LDLS N LS ++ + ++L L LS N L + + + +L LDLS N +
Sbjct: 44 LDLSHNNLSRLRAEWTPTRL-TNLHSLLLSHNHL--NFISSEAFVPVPNLRYLDLSSNHL 100
Query: 182 SGANVVPWILFNGCDELKQLALKGNKVTG-DINV-SKCKNLQFLDVSSNNFSM----AVP 235
+ LF+ L+ L L N + D N LQ L +S N S +
Sbjct: 101 H---TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIK 157
Query: 236 SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVS 273
L LD+S+NK + +
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 640 FLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLE 697
L +S+N L+ I E + L L+L N+L + + DL+ L +L L +N +
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV 125
Query: 698 GTIPSSM-SSLTLLNEIDLCNNQLT 721
+ + + L ++ L NQ++
Sbjct: 126 -VVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 60/282 (21%), Positives = 103/282 (36%), Gaps = 52/282 (18%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIK---KLIHISGQGDREFTAEMETIGKIKHRNLVPLL 922
IGSG FG + VA+K + I RE + ++H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFK 82
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK----IAIGSARGLAFLHH 978
++ EY G L + + N + AR ++ G+++ H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS-----GVSYCHS 134
Query: 979 NCIPHIIHRDMKSSNVLLDENFEAR--VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
I HRD+K N LLD + R + DFG ++ + + + GTP Y+ PE
Sbjct: 135 M---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP--KSTVGTPAYIAPEV 188
Query: 1037 YQSFRCSTKG------DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090
+ DV+S GV L +L G P F D ++ + +S
Sbjct: 189 L-----LRQEYDGKIADVWSCGVTLYVMLVGAYP-----FEDPEEPRDYRKTIQRILSVK 238
Query: 1091 FD-PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ P+ ++ P L+ + P R ++ ++
Sbjct: 239 YSIPDDIRISPECC-HLISRI------FVADPATRISIPEIK 273
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 87/535 (16%), Positives = 166/535 (31%), Gaps = 67/535 (12%)
Query: 6 LLFLVFSSFISLSLLASASSPNK---DLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVS 62
+L VFS S S K ++++ K + N + + + + V
Sbjct: 13 VLEHVFSFIQLDKDRNSVSLVCKSWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVE 72
Query: 63 CKAA-SVSSIDLSPFTLS-VDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSF 120
K + +L P + + + + LE + LK ++ L ++
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDD-CLELIAKSFKN 131
Query: 121 LSSLDLS--LNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSG----REAGSLKLSLEVL 174
L LS + L+ I+ +C +LK L+L + +D SL L
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIA--ATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189
Query: 175 DLS--YNKISGANVVPWILFNGCDELKQLALKGNKVTGDIN--VSKCKNLQFLDVSSNN- 229
++S +++S + + L C LK L L + + + L+ L
Sbjct: 190 NISCLASEVSFSALE--RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247
Query: 230 ------FSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPV 283
+S + C L L + + S C L+ LN+S
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLS---------- 297
Query: 284 GYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP- 342
Y Q + L C L +L + + +C L + ++ P
Sbjct: 298 -YATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPN 356
Query: 343 --------IEIFLSMSNLKELVLSFNDFTGA-LPDSLSNLTNLETLDLSSNNLSGAIPHN 393
+ + + L+ ++ T A L N N+ L
Sbjct: 357 VALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE-------- 408
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSK-LQD 452
+L L + + +C L L LS LT + +G+ +K ++
Sbjct: 409 -------PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKVFEYIGTYAKKMEM 460
Query: 453 LKLWLNQLHGE-IPPELGNIQTLETLFLDFNELTG-TLPAALSNCTNLNWISLSN 505
L + + L +L L + L A S + + +S+
Sbjct: 461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 63/351 (17%), Positives = 125/351 (35%), Gaps = 26/351 (7%)
Query: 57 GFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNS-NISGTISLPAGS 115
S+ S+++S V F + + L++L L + + +L +
Sbjct: 175 WLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRA 234
Query: 116 RCSSFLSSLDLSLNILSGPLSDIS-YLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVL 174
L + + + S +S L C L+ L+ + + S+ L L
Sbjct: 235 PQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTL 294
Query: 175 DLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV----SKCKNLQFLDVSSNNF 230
+LSY + ++V L C +L++L + D + S CK+L+ L V +
Sbjct: 295 NLSYATVQSYDLVK--LLCQCPKLQRLWV--LDYIEDAGLEVLASTCKDLRELRVFPSEP 350
Query: 231 SMAVPSFG-----------DCLALEYLDISANKFTGDVGHAISA-CEHLSFLNVSSNLFS 278
+ P+ C LE + + T I+ +++ +
Sbjct: 351 FVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPK 410
Query: 279 GPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS-CSSLESFDISSNKF 337
P + + + C L +L LS L+ KV G+ +E ++
Sbjct: 411 APDYLTLEPLDIGF-GAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGD 468
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTG-ALPDSLSNLTNLETLDLSSNNLS 387
S + +L++L + F AL + S L + +L +SS ++S
Sbjct: 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-13
Identities = 61/501 (12%), Positives = 140/501 (27%), Gaps = 64/501 (12%)
Query: 90 LTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLS-------LNILSGPLSDISYLG 142
++ + N R + S++L N++ Y
Sbjct: 38 YEIERWCRRKVFIGNCYAVSPATVIRRFPK-VRSVELKGKPHFADFNLVPDGWGGYVYPW 96
Query: 143 ------SCSSLKVLNLSSNLLDFSGREAGSLKL-SLEVLDLSY-NKISGANVVPWILFNG 194
S + L+ + L ++ E + + +VL LS S + +
Sbjct: 97 IEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGL--AAIAAT 154
Query: 195 CDELKQLALKGNKVTGDINVS------KCKNLQFLDVSSNNFSMAVPSFG----DCLALE 244
C LK+L L+ + V +L L++S ++ + C L+
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214
Query: 245 YLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLV 304
L ++ + + L L + P Y+ C L
Sbjct: 215 SLKLNRAVPLEKLATLLQRAPQLEELGTGG-YTAEVRPDVYSGLS-----VALSGCKELR 268
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
L + + +P+ + CS L + ++S +++ L+ L +
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDA 328
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
L S +L L + + + L+ S C
Sbjct: 329 GLEVLASTCKDLRELRVFP-----------SEPFVMEPNVALTEQGLV-----SVSMGCP 372
Query: 425 QLVSLHLSFNYLTGTIPSSLG-SLSKLQDLKLWLNQLHGEIPPELG-----------NIQ 472
+L S+ +T ++ + + +L + + L + +
Sbjct: 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK 432
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ-LSNLAILKLSNNS 531
L L L + + +S++ + +L L++ +
Sbjct: 433 DLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492
Query: 532 FYGR-IPPELGDCRSLIWLDL 551
F + + ++ L +
Sbjct: 493 FGDKALLANASKLETMRSLWM 513
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 55/343 (16%), Positives = 108/343 (31%), Gaps = 40/343 (11%)
Query: 57 GFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETL-SLKNSNISGTISLPAGS 115
+ +A + + +T V + + + L + L L + LPA
Sbjct: 226 KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 116 RCSSFLSSLDLS-LNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVL 174
S L++L+LS + S L + L C L+ L + + D S L L
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKL--LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL 343
Query: 175 DLSYNKISGANVVPWI-------LFNGCDELKQLALKGNKVTGD--INVSK-CKNLQFLD 224
+ ++ + + GC +L+ + ++T I +++ N+
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFR 403
Query: 225 VSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVG 284
+ P D L LE LDI G + C+ L L++S L
Sbjct: 404 LCIIE-----PKAPDYLTLEPLDIG-------FGAIVEHCKDLRRLSLSGLLTDKVF--- 448
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK-VPSRFGSCSSLESFDISSNKFSGELPI 343
++ + L ++ S + C SL +I F + +
Sbjct: 449 ---------EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL 499
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLS-NLTNLETLDLSSNN 385
+ ++ L +S + L + L +
Sbjct: 500 ANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 58/246 (23%), Positives = 98/246 (39%), Gaps = 44/246 (17%)
Query: 839 NLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISG 897
++A ++ + + + N S IG G +G V A + VAIKK+
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH 65
Query: 898 QGD-----REFTAEMETIGKI----KHRNLVPLLGYCKVGEERL-----LVYEYMRYGSL 943
Q RE KI +H N++ + + +V + M L
Sbjct: 66 QTYCQRTLREI--------KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DL 116
Query: 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003
+L Q L+ RGL ++H +++HRD+K SN+LL+ + +
Sbjct: 117 YKLLKTQH-----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYV------PPEYYQSFRCSTKG-DVYSYGVVLL 1056
+ DFG+AR+ H T YV PE + + TK D++S G +L
Sbjct: 169 ICDFGLARVADPDHDHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223
Query: 1057 ELLTGK 1062
E+L+ +
Sbjct: 224 EMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 42/225 (18%)
Query: 857 EATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETI 910
E + + +GSG +G V A + G+ VAIKK + E A E+ +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLL 78
Query: 911 GKIKHRNLVPLLGYCKVGEERL------LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
++H N++ LL E LV +M L ++ ++K L +
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-----LGEDRIQF 132
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ +GL ++H IIHRD+K N+ ++E+ E ++ DFG+AR + T
Sbjct: 133 LVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------ 183
Query: 1025 LAGTPGYVPPEYY-------QSFRCSTKGDVYSYGVVLLELLTGK 1062
GYV +Y R + D++S G ++ E++TGK
Sbjct: 184 -----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
++G G G V + + G A+K L++ S + +E + G ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASG---GPHIVCILDVY 91
Query: 926 ----KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA--IGSARGLAFLHHN 979
L++ E M G L Q++ +I IG+A + FLH +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIGTA--IQFLHSH 147
Query: 980 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
+I HRD+K N+L +++ +++DFG A+ T ++ T TP YV PE
Sbjct: 148 ---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEV 200
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+ D++S GV++ LL G P F N
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNT 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 40/219 (18%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETIGKIKH 915
+ N IGSG G V A VAIKK +S + A E+ + + H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK---LSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 916 RNLVPLL------GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGS 969
+N++ LL + ++ LV E M + L + + ++L+ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHERMSYLLYQM 173
Query: 970 ARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP 1029
G+ LH IIHRD+K SN+++ + ++ DFG+AR + T
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMMT 221
Query: 1030 GYV------PPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
YV PE D++S G ++ E++ K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGK-IKHRNLVPLLGYC 925
IG G + + K A+K +I S + E E+E + + +H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVK-IIDKSKRDPTE---EIEILLRYGQHPNIITLKDVY 85
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI-AIGSARGLAFLHHNCIPHI 984
G+ +V E M+ G L D + QK + A + I + +LH +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSER---EASAVLFTITKT--VEYLHAQ---GV 137
Query: 985 IHRDMKSSNVLL---DENFEA-RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
+HRD+K SN+L N E+ R+ DFG A+ + A + L T T +V PE +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPCYTANFVAPEVLERQ 195
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRP 1064
D++S GV+L +LTG P
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGK-IKHRNLVPL 921
+IG G FG V A+ K A+K L I + + + +E + K +KH LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHN 979
+ ++L V +Y+ G L H Q++ A R A I SA L +LH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRA-RFYAAEIASA--LGYLHSL 158
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+I++RD+K N+LLD ++DFG+ + + T ST GTP Y+ PE
Sbjct: 159 ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLH 212
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
D + G VL E+L G P S +
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 26/217 (11%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHIS--GQGDRE-FTAEMETIGKIKHR-NLVPLL 922
+G G F V + K G A K + GQ R E+ + K ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAK-FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNC 980
+ E +L+ EY G + + + + N R ++I G+ +LH N
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL----EGVYYLHQN- 150
Query: 981 IPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+I+H D+K N+LL + ++ DFGM+R + + + GTP Y+ PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEIL 205
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+T D+++ G++ LLT P F +
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSP-----FVGED 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-17
Identities = 45/206 (21%), Positives = 82/206 (39%), Gaps = 21/206 (10%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G F V + G A + +S + ++ E +KH N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR---RKIAIGSARGLAFLHHNCI 981
L+++ + G L + + ++ A ++I + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEA---DASHCIQQIL----EAVLHCHQM-- 129
Query: 982 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
++HR++K N+LL + +++DFG+A + AGTPGY+ PE +
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSPEVLR 186
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRP 1064
D+++ GV+L LL G P
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G F V + K G A K + +S + ++ E K++H N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR---RKIAIGSARGLAFLHHNCI 981
+ LV++ + G L + + ++ A ++I +A+ H N
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQIL----ESIAYCHSN-- 147
Query: 982 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
I+HR++K N+LL + +++DFG+A ++ + AGTPGY+ PE +
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLK 203
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRP 1064
S D+++ GV+L LL G P
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 40/224 (17%)
Query: 857 EATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETI 910
+ N IGSG G V A VAIKK +S + A E+ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK---LSRPFQNQTHAKRAYRELVLM 78
Query: 911 GKIKHRNLVPLL------GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
+ H+N++ LL + ++ +V E M +L V+ + L+
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME------LDHERMSY 131
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ G+ LH IIHRD+K SN+++ + ++ DFG+AR + T
Sbjct: 132 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGT 179
Query: 1025 LAGTPGYV------PPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
YV PE D++S G ++ E++ G
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-16
Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AE---METIGKIKHRNL 918
++G G FG V ++ K + A+K L + D E T E + GK L
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFL 404
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
L C +RL V EY+ G L + H Q+ K A A A GL FL
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQ 459
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEY 1036
II+RD+K NV+LD +++DFGM + + T T GTP Y+ PE
Sbjct: 460 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEI 513
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
D +++GV+L E+L G+ P + D
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 867 LIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGY 924
+G G VY+ K K A+K + D++ E+ + ++ H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKV---LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR--RKIAIGSARGLAFLHHNCIP 982
+ E LV E + G L D + + + AA ++I +A+LH N
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERD--AADAVKQIL----EAVAYLHEN--- 167
Query: 983 HIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
I+HRD+K N+L + +++DFG+++++ + T+ GTPGY PE +
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRG 224
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRP 1064
+ D++S G++ LL G P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-16
Identities = 67/491 (13%), Positives = 136/491 (27%), Gaps = 88/491 (17%)
Query: 67 SVSSIDLSPFTLSVDFHLVAS------------FLLTLDTLETLSLKNSNISGTISLPAG 114
++ S+ L + F+L+ L L+++ + +S
Sbjct: 74 NLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVS-------- 125
Query: 115 SRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLS--SNLLDFSGREAGSLKLSLE 172
DL L+ L+ L+ L L S + ++
Sbjct: 126 ----------DLDLDRLA--------KARADDLETLKLDKCSGFTTDGLLSIVTHCRKIK 167
Query: 173 VLDLSYNKISGANVVPWI--LFNGCDELKQLALKGNKVTGDIN-------VSKCKNLQFL 223
L + + S W+ L L+ L + I+ C++L +
Sbjct: 168 TLLMEESSFS-EKDGKWLHELAQHNTSLEVLNFYMTEFA-KISPKDLETIARNCRSLVSV 225
Query: 224 DVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPV 283
V V F LE + + L + GP +
Sbjct: 226 KVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM 285
Query: 284 GYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG-KVPSRFGSCSSLESFDISSNKFSGELP 342
L + + KLDL L + C +LE + N
Sbjct: 286 P----------ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRGL 334
Query: 343 IEIFLSMSNLKELVLSFNDFTGALPDSLSNLT------------NLETLDLSSNNLSGAI 390
+ LK L + + D ++ LE + + ++++
Sbjct: 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES 394
Query: 391 PHNLCQGPRN--SLKELFLQNNLLLGSIP------STLSNCSQLVSLHLSFNY--LTGTI 440
++ +N + + L + +P S L C +L LT
Sbjct: 395 LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454
Query: 441 PSSLGSLSK-LQDLKLWLNQLHGE-IPPELGNIQTLETLFLDFNELT-GTLPAALSNCTN 497
S +G S ++ + L E + L+ L + + + AA++ +
Sbjct: 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514
Query: 498 LNWISLSNNHL 508
L ++ +
Sbjct: 515 LRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-12
Identities = 49/339 (14%), Positives = 106/339 (31%), Gaps = 28/339 (8%)
Query: 99 SLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSS-NLL 157
+++ I +P F L GP + ++ L+L L
Sbjct: 247 EFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLE 306
Query: 158 DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKC 217
+LEVL+ N I + +L C +LK+L + +
Sbjct: 307 TEDHCTLIQKCPNLEVLETR-NVIGDRGLE--VLAQYCKQLKRL-----------RIERG 352
Query: 218 KNLQFLDVSSNNFS-MAVPSFGD-CLALEYLDISANKFTGDVGHAISA-CEHLSFLNVSS 274
+ Q ++ S + + C LEY+ + + T + +I ++L +
Sbjct: 353 ADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL 412
Query: 275 NLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSN--NLSGKVPSRFGS-CSSLESFD 331
I + L C L + L+ S G ++
Sbjct: 413 LDREERIT---DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWML 469
Query: 332 ISSNKFSGELPIEIFLSMSNLKELVLSFNDFT-GALPDSLSNLTNLETLDLSSNNLSGAI 390
+ S E +E NL++L + F+ A+ +++ L +L L + S
Sbjct: 470 LGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529
Query: 391 PHNLCQG-PRNSLKELFLQN--NLLLGSIPSTLSNCSQL 426
+ P +++ + + + + + + +
Sbjct: 530 QDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI 568
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 7e-12
Identities = 62/424 (14%), Positives = 118/424 (27%), Gaps = 95/424 (22%)
Query: 184 ANVVPWILFNGCDELKQLALKGNKVTGDINV-----------------SKCKNLQFLDVS 226
P L L+ L LKG N+ + + L+ +
Sbjct: 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFR 120
Query: 227 S---NNFSMAVPSFGDCLALEYLDISANKFTGDVG--HAISACEHLSFLNVSSNLFSGPI 281
++ + + LE L + G ++ C + L + + FS
Sbjct: 121 RMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFS--- 177
Query: 282 PVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG----KVPSRFGSCSSLESFDISSNKF 337
E G+ LA +SL L+ + + + +C SL S + +
Sbjct: 178 -----EKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI 232
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG 397
+ F + +NL+E + +P+ NL L + G
Sbjct: 233 LEL--VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-------- 282
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSF-NYLTGTIPSSLGSLSKLQDLKLW 456
+P +Q+ L L + T + + L+ L+
Sbjct: 283 ----------------NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326
Query: 457 -----------------LNQLHGEIPPELGNIQTLETLFLDFNELT-GTLPAALSNCTNL 498
L +L + + + + ++ L A C L
Sbjct: 327 NVIGDRGLEVLAQYCKQLKRLR------IERGADEQGMEDEEGLVSQRGLIALAQGCQEL 380
Query: 499 NWISLSNNHLGGEIPTWIGQ-LSNLAILKLSNNSFYGRIPPELGD---------CRSLIW 548
++++ + + E IG L NL +L RI D C+ L
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR 440
Query: 549 LDLN 552
Sbjct: 441 FAFY 444
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 867 LIGSGGFGDVY---KAKLKDGSTV-AIKKL--IHISGQGDREFTAEMETIGKIKHRNLVP 920
++G G FG V+ K D + A+K L + + E + + ++ H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 921 LLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHH 978
L Y E +L L+ +++R G L K+V + +A + A L LH
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDV-KFYLAELALA--LDHLHS 144
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
II+RD+K N+LLDE +++DFG+++ ++D + GT Y+ PE
Sbjct: 145 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ D +S+GV++ E+LTG P D
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-16
Identities = 73/247 (29%), Positives = 105/247 (42%), Gaps = 27/247 (10%)
Query: 831 GAREALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTV-AI 889
G +E+ +L + F ++G G FG V A++K+ + A+
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLARVKETGDLYAV 53
Query: 890 KKL--IHISGQGDREFT-AEMETIGKI-KHRNLVPLLGYCKVGEERL-LVYEYMRYGSLE 944
K L I D E T E + H L L C +RL V E++ G L
Sbjct: 54 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL- 111
Query: 945 DVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003
+ H QK A R A I SA L FLH II+RD+K NVLLD +
Sbjct: 112 -MFHIQKSRRFDEARA-RFYAAEIISA--LMFLHDK---GIIYRDLKLDNVLLDHEGHCK 164
Query: 1004 VSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
++DFGM + + T +T GTP Y+ PE Q D ++ GV+L E+L G
Sbjct: 165 LADFGMCKEGICNGVT---TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
Query: 1063 RPTDSAD 1069
P ++ +
Sbjct: 222 APFEAEN 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-16
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AE---METIGKIKHRNLV 919
++G G FG V+ A+ K + AIK L + D E T E + +H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--WEHPFLT 81
Query: 920 PLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
+ +E L V EY+ G L + H Q L+ A A GL FLH
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRA--TFYAAEIILGLQFLHS 136
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYY 1037
I++RD+K N+LLD++ +++DFGM + M +T GTP Y+ PE
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEIL 190
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ + D +S+GV+L E+L G+ P D
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AEMETIGKI-KHRNLVPL 921
+IG G + V +LK + A+K + ++ D ++ E + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 922 LGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLHHN 979
C E RL V EY+ G L + H Q++ + A R A I A L +LH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHA-RFYSAEISLA--LNYLHER 129
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
II+RD+K NVLLD +++D+GM + + DT ST GTP Y+ PE +
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILR 183
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRP 1064
D ++ GV++ E++ G+ P
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 857 EATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETI 910
E + + + +GSG +G V A + G VAIKKL E A E+ +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLL 77
Query: 911 GKIKHRNLVPLL------GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
++H N++ LL + + LV +M+ L+ ++ + + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK------FSEEKIQY 130
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ +GL ++H ++HRD+K N+ ++E+ E ++ DFG+AR A T
Sbjct: 131 LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT------ 181
Query: 1025 LAGTPGYVPPEYY-------QSFRCSTKGDVYSYGVVLLELLTGK 1062
GYV +Y + D++S G ++ E+LTGK
Sbjct: 182 -----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 867 LIGSGGFGDVYKAKLKDGSTV-AIKKL--IHISGQGDREFT-AE---METIGKIKHRNLV 919
++G G FG V ++ K + A+K L + D E T E + GK L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFLT 84
Query: 920 PLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFLH 977
L C +RL V EY+ G L + H Q+ K A A I L FL
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHA-VFYAAEIAIG--LFFLQ 138
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEY 1036
II+RD+K NV+LD +++DFGM + + T T GTP Y+ PE
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEI 192
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
D +++GV+L E+L G+ P + D
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 42/225 (18%)
Query: 857 EATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETI 910
E + N S +GSG +G V A K G VA+KK +S A E+ +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLL 82
Query: 911 GKIKHRNLVPLL------GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRK 964
+KH N++ LL + + LV M L +++ QK L +
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-----LTDDHVQF 136
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ RGL ++H IIHRD+K SN+ ++E+ E ++ DFG+AR + T
Sbjct: 137 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT------ 187
Query: 1025 LAGTPGYVPPEYY-------QSFRCSTKGDVYSYGVVLLELLTGK 1062
GYV +Y + D++S G ++ ELLTG+
Sbjct: 188 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 50/236 (21%), Positives = 91/236 (38%), Gaps = 39/236 (16%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEME-------------TIG 911
+G G F V+ AK + + + VA+K I + E AE E
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTE-AAEDEIKLLQRVNDADNTKED 81
Query: 912 KIKHRNLVPLLGY----CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAI 967
+ +++ LL + G ++V+E + +L ++ + GI L + ++I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYV--KQISK 138
Query: 968 GSARGLAFLHHNCIPHIIHRDMKSSNVLLDE------NFEARVSDFGMARLMSAMDTHLS 1021
GL ++H C IIH D+K NVL++ + +++D G +A
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEH 191
Query: 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKR--PTDSADFGDNNL 1075
+ T Y PE D++S ++ EL+TG D +
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 59/252 (23%), Positives = 100/252 (39%), Gaps = 56/252 (22%)
Query: 837 SINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLI-- 893
S+N+ F+ R + + +G GG G V+ A VAIKK++
Sbjct: 1 SMNIHGFDLGSR-------------YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT 47
Query: 894 -HISGQGDREFTAEMETIGKIKHRNLVPLL----------GYCKVGEERL----LVYEYM 938
S + E++ I ++ H N+V + L +V EYM
Sbjct: 48 DPQSVK--HALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM 104
Query: 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD- 997
L +VL L R RGL ++H +++HRD+K +N+ ++
Sbjct: 105 ET-DLANVLEQGP-----LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINT 155
Query: 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV------PPEYYQSFRCSTKG-DVYS 1050
E+ ++ DFG+AR+M +H + + P S TK D+++
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLS-----EGLVTKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 1051 YGVVLLELLTGK 1062
G + E+LTGK
Sbjct: 211 AGCIFAEMLTGK 222
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 9e-16
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 867 LIGSGGFGDVY---KAKLKDGSTV----AIKKLIHISGQGDREFT-AEMETIGKIKHRNL 918
++G GG+G V+ K + + +KK + + D T AE + ++KH +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 919 VPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAFL 976
V L+ Y +L L+ EY+ G L + +++ + A +A I A L L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTA-CFYLAEISMA--LGHL 137
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H II+RD+K N++L+ +++DFG+ + ++ T GT Y+ PE
Sbjct: 138 HQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYMAPEI 192
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069
+ D +S G ++ ++LTG P +
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 47/252 (18%), Positives = 92/252 (36%), Gaps = 84/252 (33%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTA-EMETIGKIKHRNLVPLLGYC 925
+G+G FG V + + G A+KK++ D + E++ + + H N++ L+ Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 926 KVGEERL--------------------------------------LVYEYMRYGSLEDVL 947
+ ++ EY+ D L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDTL 124
Query: 948 HNQKKVGIKLNWAARRKIAIGS--------ARGLAFLH-HNCIPHIIHRDMKSSNVLLD- 997
H +K + R I + R + F+H I HRD+K N+L++
Sbjct: 125 HKV----LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLVNS 176
Query: 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS----FRC---STKGDVYS 1050
++ ++ DFG A+ + + ++ Y+ +Y++ + D++S
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 1051 YGVVLLELLTGK 1062
G V EL+ GK
Sbjct: 228 IGCVFGELILGK 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 27/239 (11%)
Query: 834 EALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTV-AIKKL 892
E ++N K L D F +IG G + V +LK + A++ +
Sbjct: 33 EKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV 85
Query: 893 --IHISGQGDREFT-AEMETIGKI-KHRNLVPLLGYCKVGEERL-LVYEYMRYGSLEDVL 947
++ D ++ E + H LV L C E RL V EY+ G L +
Sbjct: 86 KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MF 142
Query: 948 HNQKKVGIKLNWAARRKIA-IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006
H Q++ + A R A I A L +LH II+RD+K NVLLD +++D
Sbjct: 143 HMQRQRKLPEEHA-RFYSAEISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 1007 FGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+GM + + DT ST GTP Y+ PE + D ++ GV++ E++ G+ P
Sbjct: 197 YGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 45/239 (18%)
Query: 848 RKLTFADLLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD-----R 901
+++ + ++ F SL+G G +G V A G VAIKK+ R
Sbjct: 3 KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR 58
Query: 902 EFTAEMETIGKI----KHRNLVPLLGYCKVGEERL-----LVYEYMRYGSLEDVLHNQKK 952
E KI KH N++ + + ++ E M+ L V+ Q
Sbjct: 59 EI--------KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM- 108
Query: 953 VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012
L+ + + R + LH + ++IHRD+K SN+L++ N + +V DFG+AR+
Sbjct: 109 ----LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 1013 MSAMDTHLSVSTLAGTP--GYV------PPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
+ S T + +V PE + ++ DV+S G +L EL +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 62/259 (23%), Positives = 105/259 (40%), Gaps = 37/259 (14%)
Query: 867 LIGSGGFGDVY---KAKLKDGSTV-AIK---KLIHISGQGDREFT-AEMETIGKIKHRN- 917
++G+G +G V+ K D + A+K K + E T E + + I+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 918 LVPLLGYCKVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIA-IGSARGLAF 975
LV L Y E +L L+ +Y+ G L H ++ + + + I A L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEV-QIYVGEIVLA--LEH 174
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
LH II+RD+K N+LLD N ++DFG+++ A +T + GT Y+ P+
Sbjct: 175 LHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YDFCGTIEYMAPD 230
Query: 1036 YYQSFRCSTKG-----DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK-QHAKLKISD 1089
+ G D +S GV++ ELLTG P ++ + ++
Sbjct: 231 IVRGGD---SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
Query: 1090 VFDPE-------LMKEDPN 1101
L+ +DP
Sbjct: 288 EMSALAKDLIQRLLMKDPK 306
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKI-KHRNLVPLLGY 924
+G G G V + K A+K + D E+E + + ++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKM---LQ---DCPKARREVELHWRASQCPHIVRIVDV 123
Query: 925 C---KVGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
G + L +V E + G L + ++ A+ +IG A + +LH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSI- 180
Query: 981 IPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+I HRD+K N+L N +++DFG A+ ++ ++ ++T TP YV PE
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVL 235
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
+ D++S GV++ LL G P F N+
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNH 267
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 42/217 (19%), Positives = 85/217 (39%), Gaps = 50/217 (23%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-------HRNLV 919
+G G + +V++A + + V +K L + + + +IK N++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKK-KIKREIKILENLRGGPNII 94
Query: 920 PLLGYCKVGEER--LLVYEYMRYGSLEDVLHNQKKVGIK------LNWAARRKIAIGSAR 971
L K R LV+E++ + + I+ L +
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------K 141
Query: 972 GLAFLH-HNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTH-LSVSTLAGT 1028
L + H I+HRD+K NV++D E+ + R+ D+G+A + + V++
Sbjct: 142 ALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 1029 PGYVPPEYYQSFRCSTKG-DVYSYGVVLLELLTGKRP 1064
+ PE ++ D++S G +L ++ K P
Sbjct: 196 --FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-15
Identities = 54/242 (22%), Positives = 88/242 (36%), Gaps = 43/242 (17%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTA-----EMETIGKIKH 915
+ LIG G +G VY A VAIKK ++ + E+ + ++K
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK---VNRMFEDLIDCKRILREITILNRLKS 84
Query: 916 RNLVPLLGYCKVGEERL-----LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
++ L + +V E + L K I L + I
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTP- 1029
G F+H + IIHRD+K +N LL+++ +V DFG+AR +++ V+ L
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 1030 -------------GYV------PPEYYQSFRCSTKG-DVYSYGVVLLELLTGKRPTDSAD 1069
+V PE TK D++S G + ELL + +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 1070 FG 1071
Sbjct: 257 TN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 53/312 (16%), Positives = 104/312 (33%), Gaps = 71/312 (22%)
Query: 798 ETRKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADLLE 857
++ S + G + ++ + ++ P R
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR--------- 54
Query: 858 ATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEME---TIGKI 913
+ LIG+G +G V +A + VAIKK+ R F ++ + +I
Sbjct: 55 ----YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREI 103
Query: 914 K------HRNLVPLLGYCKVGEERL-----LVYEYMRYGSLEDVLHNQKKVGIKLNWAAR 962
H ++V +L + +V E + + + L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHI 158
Query: 963 RKIAIGSARGLAFLH-HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLS 1021
+ + G+ ++H I+HRD+K +N L++++ +V DFG+AR + + S
Sbjct: 159 KTLLYNLLVGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 1022 VSTLAGTP-------------------GYV------PPEYYQSFRCSTKG-DVYSYGVVL 1055
++ G+V PE T+ DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 1056 LELLTGKRPTDS 1067
ELL + +
Sbjct: 275 AELLNMIKENVA 286
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 49/234 (20%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEME---TIGKIK--- 914
+ +G G +G V+K+ + G VA+KK+ F + T +I
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILT 63
Query: 915 ----HRNLVPLLG--YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
H N+V LL + LV++YM L V+ L ++ +
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI-----LEPVHKQYVVYQ 117
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
+ + +LH ++HRDMK SN+LL+ +V+DFG++R + + L+
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 1029 P-------------GYV------PPEYYQSFRCSTKG-DVYSYGVVLLELLTGK 1062
YV PE TKG D++S G +L E+L GK
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-13
Identities = 59/219 (26%), Positives = 87/219 (39%), Gaps = 45/219 (20%)
Query: 865 DSLIGSGGFGDVYKAK-LKDGSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHR-- 916
+IG G FG V KA K VA+K K H E+ + ++ +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA------EEIRILEHLRKQDK 155
Query: 917 ----NLVPLLGY-------CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI 965
N++ +L C + +E + +L +++ K G L RK
Sbjct: 156 DNTMNVIHMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLP--LVRKF 205
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA--RVSDFGMARLMSAMDTHLSVS 1023
A + L LH N IIH D+K N+LL + + +V DFG S+ H V
Sbjct: 206 AHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVY 257
Query: 1024 TLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
T + Y PE R D++S G +L ELLTG
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 40/195 (20%), Positives = 73/195 (37%), Gaps = 32/195 (16%)
Query: 834 EALSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKD------GSTV 887
E L + + +E P +L +G G FG V +A TV
Sbjct: 8 ERLPYDASKWEFPRDRLKL------------GKPLGRGAFGQVIEADAFGIDKTATCRTV 55
Query: 888 AIKKLIHISGQGDR-EFTAEMETIGKI-KHRNLVPLLGYC-KVGEERLLVYEYMRYGSLE 944
A+K L + + +E++ + I H N+V LLG C K G +++ E+ ++G+L
Sbjct: 56 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115
Query: 945 DVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004
L ++ R + +G F I D+K + + +
Sbjct: 116 TYLRSK-----------RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 1005 SDFGMARLMSAMDTH 1019
S F + +S ++
Sbjct: 165 SGFVEEKSLSDVEEE 179
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 14/136 (10%)
Query: 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNV 994
E +E+ + L + A+G+ FL IHRD+ + N+
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 995 LLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP-----PEYYQSFRCSTKGDVY 1049
LL E ++ DFG+AR + + + +P PE + + DV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVW 279
Query: 1050 SYGVVLLELLT-GKRP 1064
S+GV+L E+ + G P
Sbjct: 280 SFGVLLWEIFSLGASP 295
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 3/130 (2%)
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
++ L N + P F L D+S+N+ S EL + F + +L LVL N T
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
L +L+ L L++N ++ + + Q N L L L +N L T S
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN-LNLLSLYDNKLQTIAKGTFSPLR 152
Query: 425 QLVSLHLSFN 434
+ ++HL+ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 30/138 (21%), Positives = 53/138 (38%), Gaps = 5/138 (3%)
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
++ + N +P F L+ + LS N + PD+ L +L +L L N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIPSS 443
++ +P +L +G + L+ L L N + + + L L L N L +
Sbjct: 91 KIT-ELPKSLFEGLFS-LQLLLLNAN-KINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 444 LGSLSKLQDLKLWLNQLH 461
L +Q + L N
Sbjct: 148 FSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 21/176 (11%)
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST-LSNCSQLVSLHLSFNYL 436
+D L+ IP NL P + E+ L+ N + IP S +L + LS N +
Sbjct: 15 IVDCRGKGLT-EIPTNL---PET-ITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQI 68
Query: 437 TGTIPS-SLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPAALSN 494
+ + + L L L L+ N++ E+P L + +L+ L L+ N++ A +
Sbjct: 69 S-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQD 126
Query: 495 CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR-SLIWL 549
NLN +SL +N L L + + L+ N F C L WL
Sbjct: 127 LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF---------ICDCHLKWL 173
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 3/110 (2%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
L ++DLS+N +S P F SL S + NK + ELP +F + +L+ L+L+ N
Sbjct: 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
D+ +L NL L L N L I P +++ + L N
Sbjct: 115 KINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFS-PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 32/106 (30%), Positives = 44/106 (41%), Gaps = 9/106 (8%)
Query: 463 EIPPELGNI-QTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLS 520
EIP N+ +T+ + L+ N + P A S L I LSNN + E+ L
Sbjct: 25 EIPT---NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLR 80
Query: 521 NLAILKLSNNSFYGRIPPELGDC-RSLIWLDLNTNLFNGSIPPALF 565
+L L L N +P L + SL L LN N N + F
Sbjct: 81 SLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 21/92 (22%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 632 FNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNIL 689
F+ + +D+S N +S + + + L L L N ++ +P + + L L +L
Sbjct: 52 FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLL 109
Query: 690 DLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
L++N++ + L LN + L +N+L
Sbjct: 110 LLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 21/90 (23%), Positives = 39/90 (43%), Gaps = 4/90 (4%)
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNI 688
F S+ L + N ++ +PK + + L +L L N ++ + + L LN+
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNL 132
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718
L L N+L+ + S L + + L N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 59/212 (27%), Positives = 83/212 (39%), Gaps = 31/212 (14%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHRNLV 919
SLIG G FG V KA + VAIK K Q + M +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 920 PLLGY-------CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
L + C LV+E + Y +L D+L N G+ LN RK A
Sbjct: 120 HLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLN--LTRKFAQQMCTA 169
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLL--DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
L FL + IIH D+K N+LL + ++ DFG S+ + +
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIYQYIQSRF 223
Query: 1031 YVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK 1062
Y PE D++S G +L+E+ TG+
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 49/223 (21%), Positives = 80/223 (35%), Gaps = 32/223 (14%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKL---IHISGQGDREF-----TAEMETIGKIKHRN 917
IGSGGFG +Y A A + +G E A+ + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 918 LVPLLG-----YCKVGEERLLVYEYM---RYG-SLEDVLHNQKKVGIKLNWAARRKIAIG 968
+ LG + E + Y +M R G L+ + ++ I
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL----QLGIR 159
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHL-----S 1021
L ++H N +H D+K++N+LL +V +D+G++ H
Sbjct: 160 MLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
GT + + ++ S + DV G +L L GK P
Sbjct: 217 RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 48/157 (30%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
KLDL S L+ + F + L ++ N+ L +F ++ L L L+ N
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA- 96
Query: 365 ALPDSL-SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSN 422
+LP + +LT L+ L L N L ++P + LKEL L N L SIP+
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK-LKELRLNTNQL-QSIPAGAFDK 153
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
+ L +L LS N L + L KLQ + L+ NQ
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 51/184 (27%), Positives = 73/184 (39%), Gaps = 37/184 (20%)
Query: 328 ESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS 387
E D+ S + L F ++ L L L +N +LT L TL L++N L+
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96
Query: 388 GAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSL-HLSFNYLTGTIPSSLGS 446
++P + L +L+L N QL SL F+ LT
Sbjct: 97 -SLPLGVFDHLTQ-LDKLYLGGN--------------QLKSLPSGVFDRLT--------- 131
Query: 447 LSKLQDLKLWLNQLHGEIPP----ELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWIS 502
KL++L+L NQL IP +L N L+TL L N+L A L I+
Sbjct: 132 --KLKELRLNTNQLQ-SIPAGAFDKLTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 503 LSNN 506
L N
Sbjct: 186 LFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGT 699
LD+ L+ ++ L LNL +N L + V D L L L L++N+L +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-S 97
Query: 700 IPSSM-SSLTLLNEIDLCNNQLT 721
+P + LT L+++ L NQL
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK 120
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 36/118 (30%), Positives = 48/118 (40%), Gaps = 7/118 (5%)
Query: 451 QDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLG 509
+ L L L + L L LD+N+L TL A + T L + L+NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL- 95
Query: 510 GEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDC-RSLIWLDLNTNLFNGSIPPALF 565
+P + L+ L L L N +P + D L L LNTN SIP F
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 22/111 (19%), Positives = 37/111 (33%), Gaps = 4/111 (3%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
L + + +L I + + L + + L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
+ PD+ L L+LS N L ++ QG SL+EL L N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL--SLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 23/111 (20%), Positives = 35/111 (31%), Gaps = 3/111 (2%)
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDF 481
L + + L L +L + Q + L + L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 482 NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+ L P A L+ ++LS N L + LS L L LS N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 24/104 (23%), Positives = 42/104 (40%), Gaps = 4/104 (3%)
Query: 383 SNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIP 441
+ + + H+L G N L EL+++N L + L +L +L + + L P
Sbjct: 16 TRDGALDSLHHL-PGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485
+ +L L L N L + + +L+ L L N L
Sbjct: 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 11/72 (15%), Positives = 21/72 (29%), Gaps = 1/72 (1%)
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSMSSLTL 709
+ L L + + + L L L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 710 LNEIDLCNNQLT 721
L+ ++L N L
Sbjct: 82 LSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 5/100 (5%)
Query: 107 GTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGS 166
G + + L+ L + L L L+ L + + L F +A
Sbjct: 19 GALDSLHHLPGAENLTELYIENQQHLQHLELRD-LRGLGELRNLTIVKSGLRFVAPDAFH 77
Query: 167 LKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
L L+LS+N + + W G L++L L GN
Sbjct: 78 FTPRLSRLNLSFNALE---SLSWKTVQGLS-LQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 12/107 (11%)
Query: 151 NLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
+L G E +L L + + + G EL+ L + + +
Sbjct: 19 GALDSLHHLPGAE------NLTELYIENQQHLQH--LELRDLRGLGELRNLTIVKSGLR- 69
Query: 211 DINV---SKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFT 254
+ L L++S N L+L+ L +S N
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 33/225 (14%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHI------SGQGDREFT-----AEMETIGKIKH 915
IG GGFG +Y A + +V + +G E A+ E I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 916 RNLVPLLG-----YCKVGEERLLVYEYM---RYG-SLEDVLHNQKKVGIKLNWAARRKIA 966
+ LG + ++ Y +M R+G L+ + K + + +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK---RFSRKTVLQLS 158
Query: 967 IGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHL---- 1020
+ L ++H + +H D+K+SN+LL+ +V D+G+A H
Sbjct: 159 LRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 1021 -SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
GT + + + S +GD+ G +++ LTG P
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 30/138 (21%), Positives = 59/138 (42%), Gaps = 4/138 (2%)
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
+++N+F+ IF + L+++ S N T + + + + L+SN
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPS-TLSNCSQLVSLHLSFNYLTGTIPSS 443
L + H + +G + LK L L++N + + + + S + L L N +T P +
Sbjct: 92 RLE-NVQHKMFKGLES-LKTLMLRSN-RITCVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148
Query: 444 LGSLSKLQDLKLWLNQLH 461
+L L L L N +
Sbjct: 149 FDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 41/180 (22%), Positives = 76/180 (42%), Gaps = 22/180 (12%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST--LSNCSQLVSLHLS 432
T+D S+ L+ IP ++ P+ EL L NN + +T QL ++ S
Sbjct: 12 EGTTVDCSNQKLN-KIPEHI---PQY-TAELRLNNNEF-TVLEATGIFKKLPQLRKINFS 65
Query: 433 FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLPAA 491
N +T + S + ++ L N+L + ++ +++L+TL L N +T +
Sbjct: 66 NNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDS 124
Query: 492 LSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDCR-SLIWL 549
+++ +SL +N + + L +L+ L L N F +C L WL
Sbjct: 125 FIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLANPF---------NCNCYLAWL 174
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 30/130 (23%), Positives = 53/130 (40%), Gaps = 11/130 (8%)
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIE 344
NEF + L K++ S+N ++ F S + ++SN+ + +
Sbjct: 41 NNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHK 99
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPH----NLCQGPRN 400
+F + +LK L+L N T DS L+++ L L N ++ + L +
Sbjct: 100 MFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL-----H 153
Query: 401 SLKELFLQNN 410
SL L L N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 4/93 (4%)
Query: 631 TFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNI 688
F + ++ S N ++ I + S + + L N L + ++ L L
Sbjct: 52 IFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKT 109
Query: 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721
L L SNR+ S L+ + + L +NQ+T
Sbjct: 110 LMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 39/210 (18%)
Query: 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND 361
+K +L +++ + +S++ +++ I+ + N++ L L N
Sbjct: 20 ETIKANLKKKSVT-DAVT-QNELNSIDQIIANNSDIKSVQGIQ---YLPNVRYLALGGNK 74
Query: 362 FTGALP--DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
+ L TNL L L+ N L ++P+ + N LKEL L N L S+P
Sbjct: 75 LH-DISALKEL---TNLTYLILTGNQLQ-SLPNGVFDKLTN-LKELVLVENQL-QSLPDG 127
Query: 420 LSNC-SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478
+ + + L L+L+ N L L+ L +L L NQL +P +
Sbjct: 128 VFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGV---------- 176
Query: 479 LDFNELTGTLPAALSNCTNLNWISLSNNHL 508
F++LT L + L N L
Sbjct: 177 --FDKLT-----------QLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 43/212 (20%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
+S+ ++ +++++ V ++ + NK I ++NL L+L+ N
Sbjct: 41 NSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH---DISALKELTNLTYLILTGN 95
Query: 361 DFTGALPDSL-SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
+LP+ + LTNL+ L L N L ++P + N L L L +N
Sbjct: 96 QLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN-LTYLNLAHN--------- 143
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSL-GSLSKLQDLKLWLNQLHGEIPP----ELGNIQTL 474
QL SL P + L+ L +L L NQL +P +L L
Sbjct: 144 -----QLQSL-----------PKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ---L 183
Query: 475 ETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506
+ L L N+L T+L +I L +N
Sbjct: 184 KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 46/247 (18%), Positives = 93/247 (37%), Gaps = 57/247 (23%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNN 229
+L ++ A N + + Q+ + + + N+++L + N
Sbjct: 20 ETIKANLKKKSVTDAVT-----QNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNK 74
Query: 230 FSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQ 289
+ + + L YL ++ N+ ++ + +F
Sbjct: 75 LH-DISALKELTNLTYLILTGNQLQ----------------SLPNGVFDKL--------- 108
Query: 290 GEIPLHLADLCSSLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFSGELPIEIFLS 348
++L +L L N L +P F ++L +++ N+ LP +F
Sbjct: 109 -----------TNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDK 155
Query: 349 MSNLKELVLSFNDFTGALPDSL-SNLTNLETLDLSSNNLSGAIPH----NLCQGPRNSLK 403
++NL EL LS+N +LP+ + LT L+ L L N L ++P L SL+
Sbjct: 156 LTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL-----TSLQ 208
Query: 404 ELFLQNN 410
++L +N
Sbjct: 209 YIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 43/197 (21%), Positives = 74/197 (37%), Gaps = 43/197 (21%)
Query: 374 TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL--LGSIPSTLSNCSQLVSLHL 431
+L +++ A+ N NS+ ++ N+ + + I + L L
Sbjct: 19 AETIKANLKKKSVTDAVTQN----ELNSIDQIIANNSDIKSVQGIQYL----PNVRYLAL 70
Query: 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA- 490
N L + +L +L +L L L N+L +LP
Sbjct: 71 GGNKLH-----DISALKELTNL---------------------TYLILTGNQLQ-SLPNG 103
Query: 491 ALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNNSFYGRIPPELGDC-RSLIW 548
TNL + L N L +P + +L+NL L L++N +P + D +L
Sbjct: 104 VFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTE 161
Query: 549 LDLNTNLFNGSIPPALF 565
LDL+ N S+P +F
Sbjct: 162 LDLSYNQLQ-SLPEGVF 177
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 45/226 (19%), Positives = 78/226 (34%), Gaps = 37/226 (16%)
Query: 868 IGSGGFGDVYKAK---------LKDGSTVAIKKLIHISGQGDREF-----TAEMETIGKI 913
G +Y+A ++ KL G+ E A+ + K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSL-KLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 914 KHRNLVPLLGYCKV-------GEERLLVYEYMRYG-SLEDVLHNQKKVGIKLNWAARRKI 965
K PLL + R LV G SL+ L K + + +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLP--SLGRSLQSALDVSPKHVLSERSVLQ--V 164
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHL--- 1020
A L FLH N +H ++ + N+ +D +++V + +G A H+
Sbjct: 165 ACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 1021 --SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
S S G ++ + ++ S + D+ S G +L+ L G P
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 52/254 (20%), Positives = 93/254 (36%), Gaps = 28/254 (11%)
Query: 83 HLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLG 142
+ + ++ + L NS I + S+CS L +L L LS P+ ++ L
Sbjct: 83 DQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK-LQNLSLEGLRLSDPI--VNTLA 139
Query: 143 SCSSLKVLNLS--SNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
S+L LNLS S +F+ + S L+ L+LS+ V + + + + Q
Sbjct: 140 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 199
Query: 201 LALKG-NKVTGDINV----SKCKNLQFLDVSSNNF--SMAVPSFGDCLALEYLDISANKF 253
L L G K ++ +C NL LD+S + + F L++L +S
Sbjct: 200 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259
Query: 254 TGDVG-HAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNN 312
+ L L V + G L L +L L ++ ++
Sbjct: 260 IIPETLLELGEIPTLKTLQVFGIVPDGT---------------LQLLKEALPHLQINCSH 304
Query: 313 LSGKVPSRFGSCSS 326
+ G+ +
Sbjct: 305 FTTIARPTIGNKKN 318
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 41/242 (16%), Positives = 83/242 (34%), Gaps = 24/242 (9%)
Query: 216 KCKNLQFLDVSSNNFS-MAVPSFGD-CLALEYLDISANKFTGDVGHAISACEHLSFLNVS 273
+Q +D+S++ + C L+ L + + + + + ++ +L LN+S
Sbjct: 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150
Query: 274 SNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSS-NNLSGKVPSRF--GSCSSLESF 330
G + F L CS L +L+LS + + K ++
Sbjct: 151 ----------GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL 200
Query: 331 DIS--SNKFSGELPIEIFLSMSNLKELVLSFNDF-TGALPDSLSNLTNLETLDLSS-NNL 386
++S + NL L LS + L L+ L LS ++
Sbjct: 201 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI 260
Query: 387 SGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS 446
L + P +LK L + + G++ L ++ S + T ++G+
Sbjct: 261 IPETLLELGEIP--TLKTLQVFGIVPDGTLQLLKEALPHL-QINCS--HFTTIARPTIGN 315
Query: 447 LS 448
Sbjct: 316 KK 317
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 44/272 (16%), Positives = 81/272 (29%), Gaps = 20/272 (7%)
Query: 243 LEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSS 302
L + ++ C+ L +L+ G N ++ L
Sbjct: 21 FSCLCLP------ELLKVSGVCKRWYRLASDESLWQTLDLTGKN-LHPDVTGRLLSQGVI 73
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
+ S + + S ++ D+S++ I S L+ L L
Sbjct: 74 AFRCPRSFMDQPL---AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 130
Query: 363 TGALPDSLSNLTNLETLDLSS-NNLSGAIPHNLCQGPRNSLKELFLQNNLLL---GSIPS 418
+ + ++L+ +NL L+LS + S L L EL L +
Sbjct: 131 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR-LDELNLSWCFDFTEKHVQVA 189
Query: 419 TLSNCSQLVSLHLS--FNYLTGTIPSSLG-SLSKLQDLKL-WLNQLHGEIPPELGNIQTL 474
+ L+LS L + S+L L L L L + E + L
Sbjct: 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 249
Query: 475 ETLFLDF-NELTGTLPAALSNCTNLNWISLSN 505
+ L L ++ L L + +
Sbjct: 250 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-11
Identities = 32/139 (23%), Positives = 47/139 (33%), Gaps = 12/139 (8%)
Query: 91 TLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVL 150
T ++ L L NS + L L L+ I+ L + LK L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEE-LEFLSTINVGLT----SIANLPKLNKLKKL 69
Query: 151 NLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG 210
LS N + +L L+LS NKI + + + LK L L +VT
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI--EPLKKLENLKSLDLFNCEVTN 127
Query: 211 DIN-----VSKCKNLQFLD 224
+ L +LD
Sbjct: 128 LNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 28/113 (24%), Positives = 45/113 (39%), Gaps = 7/113 (6%)
Query: 300 CSSLVKLDLSSN-NLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358
S + +L L ++ + GK+ LE + + I ++ LK+L LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELS 72
Query: 359 FNDFTGALPDSLSNLTNLETLDLSSNNLSG-AIPHNLCQGPRNSLKELFLQNN 410
N +G L NL L+LS N + + L + +LK L L N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLE--NLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 29/116 (25%), Positives = 48/116 (41%), Gaps = 6/116 (5%)
Query: 372 NLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHL 431
++++ L L N+ S L+ L N L SI + L ++L L L
Sbjct: 15 TPSDVKELVLD-NSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLEL 71
Query: 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQLH--GEIPPELGNIQTLETLFLDFNELT 485
S N ++G + L L L N++ I P L ++ L++L L E+T
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 27/111 (24%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 446 SLSKLQDLKLWLNQL-HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
+ S +++L L ++ G++ + LE L LT ++ A L L + LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYG-RIPPELGDCRSLIWLDLNTN 554
+N + G + + NL L LS N L +L LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 33/126 (26%), Positives = 47/126 (37%), Gaps = 23/126 (18%)
Query: 261 ISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL--CSSLVKLDLSSNNLSGKVP 318
E L FL+ + + +A+L + L KL+LS N +SG +
Sbjct: 38 TDEFEELEFLSTINVGLT----------------SIANLPKLNKLKKLELSDNRVSGGLE 81
Query: 319 SRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPD----SLSNLT 374
C +L ++S NK IE + NLK L L + T L D L
Sbjct: 82 VLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLP 140
Query: 375 NLETLD 380
L LD
Sbjct: 141 QLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 15/120 (12%)
Query: 195 CDELKQLALKGNK---VTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISAN 251
++K+L L ++ + + + L+FL + + ++ + L+ L++S N
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDN 74
Query: 252 KFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSN 311
+ +G + C +L+ LN+S N L L +L LDL +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDL----------STIEPLKKL-ENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 3/89 (3%)
Query: 470 NIQTLETLFLDFNELT-GTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLS 528
++ L LD + G L L ++S N L I + +L+ L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 529 NNSFYGRIPPELGDCRSLIWLDLNTNLFN 557
+N G + C +L L+L+ N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 25/210 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVP-LLG 923
IGSG FGD+Y + G VAIK + Q E + + +P +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG---IPTIRW 72
Query: 924 YCKVGEERLLVYEYMRYG-SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
G+ ++V E + G SLED+ + + K + +A + ++H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK--- 124
Query: 983 HIIHRDMKSSNVLL---DENFEARVSDFGMAR--LMSAMDTHLSVST---LAGTPGYVPP 1034
+ IHRD+K N L+ + + DFG+A+ + H+ L GT Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ S + D+ S G VL+ G P
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 25/141 (17%), Positives = 44/141 (31%), Gaps = 14/141 (9%)
Query: 89 LLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLK 148
L L+ I +L G+ ++D S N + + LK
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENL--GATLDQ-FDAIDFSDN----EIRKLDGFPLLRRLK 67
Query: 149 VLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKV 208
L +++N + G L L L+ N + + L L + N V
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL--DPLASLKSLTYLCILRNPV 125
Query: 209 TGDIN-----VSKCKNLQFLD 224
T + + K ++ LD
Sbjct: 126 TNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 22/112 (19%), Positives = 41/112 (36%), Gaps = 7/112 (6%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+LDL + + + + ++ D S N+ ++ F + LK L+++
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNN 73
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSG-AIPHNLCQGPRNSLKELFLQNN 410
N L +L L L++N+L L SL L + N
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK--SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 25/132 (18%), Positives = 50/132 (37%), Gaps = 14/132 (10%)
Query: 149 VLNLSSNLLDFSGREAGSLK--LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
++ L++ L+ +A + LDL KI V L D+ + N
Sbjct: 1 MVKLTAELI----EQAAQYTNAVRDRELDLRGYKIP----VIENLGATLDQFDAIDFSDN 52
Query: 207 KVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCL-ALEYLDISANKFT--GDVGHAISA 263
++ + L+ L V++N L L L ++ N GD+ +++
Sbjct: 53 EIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LAS 111
Query: 264 CEHLSFLNVSSN 275
+ L++L + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 24/120 (20%), Positives = 45/120 (37%), Gaps = 8/120 (6%)
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLV 427
+N LDL + I NL + +N + + +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIE-NLGATLDQ-FDAIDFSDN-EIRKL-DGFPLLRRLK 67
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH--GEIPPELGNIQTLETLFLDFNELT 485
+L ++ N + +L L +L L N L G++ P L ++++L L + N +T
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 26/154 (16%), Positives = 51/154 (33%), Gaps = 34/154 (22%)
Query: 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438
+ L++ + A + +EL L+ + I + + Q ++ S N +
Sbjct: 2 VKLTAELIEQAAQYTNAV----RDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR- 55
Query: 439 TIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNL 498
L L+ LK TL ++ N + +L
Sbjct: 56 ----KLDGFPLLRRLK---------------------TLLVNNNRICRIGEGLDQALPDL 90
Query: 499 NWISLSNNHLG--GEIPTWIGQLSNLAILKLSNN 530
+ L+NN L G++ + L +L L + N
Sbjct: 91 TELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 18/152 (11%), Positives = 44/152 (28%), Gaps = 24/152 (15%)
Query: 235 PSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPL 294
+ + + LD+ K + + + + ++ S N
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---------------- 55
Query: 295 HLADL--CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL 352
L L L +++N + + L +++N ++ S+ +L
Sbjct: 56 KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 353 KELVLSFNDFTGALPD----SLSNLTNLETLD 380
L + N T + + + LD
Sbjct: 116 TYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 7/107 (6%)
Query: 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSK-CKNLQFLDVSSNNFS 231
++ L+ I A + ++L L+G K+ N+ +D S N
Sbjct: 1 MVKLTAELIEQAAQ-----YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR 55
Query: 232 MAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFS 278
+ F L+ L ++ N+ A L+ L +++N
Sbjct: 56 -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 6e-10
Identities = 36/207 (17%), Positives = 57/207 (27%), Gaps = 48/207 (23%)
Query: 848 RKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD------- 900
+ F+ L T IG G FG+V++ + VAIK I I G
Sbjct: 9 GPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKI-IAIEGPDLVNGSHQK 65
Query: 901 --REFTAE---------METIGKIKHRNLVPLLGYCKV----GEERLLVYEYMR--YGSL 943
E E + + + L V L +++ GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 944 EDVLHNQKKVGI-------------------KLNWAARRKIAIGSARGLAFLHHNCIPHI 984
D K + + A + I LA +
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RF 183
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMAR 1011
HRD+ NVLL + ++ +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 347 LSMSNLKELVL--SFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKE 404
+ + +++ L + +LS L + L LS+NN+ I +L +L+
Sbjct: 20 VVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGME--NLRI 74
Query: 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH--G 462
L L N L+ I + + L L +S+N + ++ S + L L+ L + N++ G
Sbjct: 75 LSLGRN-LIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWG 131
Query: 463 EIPPELGNIQTLETLFLDFNELT 485
EI L + LE L L N L
Sbjct: 132 EIDK-LAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 9/141 (6%)
Query: 393 NLCQGPRNSLKELFLQNNL-LLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQ 451
+++ L + + + +TLS L LS N + I SSL + L+
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLR 73
Query: 452 DLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG-- 509
L L N + +I TLE L++ +N++ +L + + NL + +SNN +
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNW 130
Query: 510 GEIPTWIGQLSNLAILKLSNN 530
GEI + L L L L+ N
Sbjct: 131 GEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 32/155 (20%), Positives = 62/155 (40%), Gaps = 15/155 (9%)
Query: 121 LSSLDLSLNILSGPLSDI-SYLGSCSSLKVLNLSSNLL-DFSGREAGSLKLSLEVLDLSY 178
++L I P+ + + L + + K L LS+N + S ++ +L +L L
Sbjct: 25 AEKVELHGMI--PPIEKMDATLSTLKACKHLALSTNNIEKISSLS--GME-NLRILSLGR 79
Query: 179 NKISGANVVPWILFNGCDELKQLALKGNKVTGDI-NVSKCKNLQFLDVSSNNFS--MAVP 235
N I L D L++L + N++ + + K NL+ L +S+N + +
Sbjct: 80 NLIKKIEN----LDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 236 SFGDCLALEYLDISANKFTGDVGHAISACEHLSFL 270
LE L ++ N D + E+ +
Sbjct: 135 KLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 35/195 (17%), Positives = 65/195 (33%), Gaps = 51/195 (26%)
Query: 197 ELKQLALKGNKVTG-DINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTG 255
E +L + D +S K + L +S+NN + S L L + N
Sbjct: 26 EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNL--- 81
Query: 256 DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG 315
I E+L + +L +L +S N ++
Sbjct: 82 -----IKKIENLD-----------------------------AVADTLEELWISYNQIA- 106
Query: 316 KVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDS------ 369
S +L +S+NK + I+ ++ L++L+L+ N ++
Sbjct: 107 -SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEY 165
Query: 370 ----LSNLTNLETLD 380
+ L NL+ LD
Sbjct: 166 RIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 27/150 (18%)
Query: 89 LLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGS-CSSL 147
L TL + L+L +NI SL S + L L L N+ + I L + +L
Sbjct: 44 LSTLKACKHLALSTNNIEKISSL---SGMEN-LRILSLGRNL----IKKIENLDAVADTL 95
Query: 148 KVLNLSSNLL-DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
+ L +S N + SG E L +L VL +S NKI+ + + D+L+ L L GN
Sbjct: 96 EELWISYNQIASLSGIE--KLV-NLRVLYMSNNKITNWGEIDKL--AALDKLEDLLLAGN 150
Query: 207 KVTGDIN------------VSKCKNLQFLD 224
+ D V + NL+ LD
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/164 (18%), Positives = 58/164 (35%), Gaps = 33/164 (20%)
Query: 298 DLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSN-LKELV 356
+ L LS+NN+ K+ S +L + N IE ++++ L+EL
Sbjct: 45 STLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK---IENLDAVADTLEELW 99
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
+S+N + L NL L +S+N ++ + E+
Sbjct: 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKIT-------------NWGEI----------- 133
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460
L+ +L L L+ N L + + ++ L L
Sbjct: 134 -DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/110 (18%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 446 SLSKLQDLKLWLNQLH-GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
++ + ++L ++ L ++ + L L N + ++LS NL +SL
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLG 78
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
N + +I L L +S N + + +L L ++ N
Sbjct: 79 RNLI-KKIENLDAVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMSNN 125
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 46/241 (19%), Positives = 79/241 (32%), Gaps = 69/241 (28%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISG---QGDREFTAEMETIGKIKH--RNLV 919
+G G FG V + + + A+K + +I E ++ I N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI-LKKIQNDDINNNNIV 99
Query: 920 PLLGY-------CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
G C L++E + SL +++ G + + I +
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIE--DIKLYCIEILKA 149
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEA-------------------------RVSDF 1007
L +L + H D+K N+LLD+ + ++ DF
Sbjct: 150 LNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPE------YYQSFRCSTKGDVYSYGVVLLELLTG 1061
G A ++ T Y PE + D++S+G VL EL TG
Sbjct: 207 G-----CATFKSDYHGSIINTRQYRAPEVILNLGW--DVSS----DMWSFGCVLAELYTG 255
Query: 1062 K 1062
Sbjct: 256 S 256
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 31/140 (22%), Positives = 46/140 (32%), Gaps = 12/140 (8%)
Query: 90 LTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKV 149
T + L L N + + + L L L L +S L LK
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVN-LEFLSLINVGLI----SVSNLPKLPKLKK 75
Query: 150 LNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT 209
L LS N + +L L+LS NK+ + + + LK L L +VT
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL--EPLKKLECLKSLDLFNCEVT 133
Query: 210 GDIN-----VSKCKNLQFLD 224
+ L +LD
Sbjct: 134 NLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 28/135 (20%), Positives = 43/135 (31%), Gaps = 29/135 (21%)
Query: 301 SSLVKLDLSSNNLS-GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
+++ +L L + + GK+ +LE + + + + LK+L LS
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSE 80
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
N G L L NL L+LS N L + L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK-------------DISTL------------EP 115
Query: 420 LSNCSQLVSLHLSFN 434
L L SL L
Sbjct: 116 LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 34/137 (24%), Positives = 53/137 (38%), Gaps = 28/137 (20%)
Query: 350 SNLKELVLSFNDFT-GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQ 408
+ ++ELVL G + + NLE L L + L NL + P+ LK+L L
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPK--LKKLELS 79
Query: 409 NNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL 468
N + G + L L+LS N L + +L L+ L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLE-------------- 120
Query: 469 GNIQTLETLFLDFNELT 485
L++L L E+T
Sbjct: 121 ----CLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 32/134 (23%), Positives = 44/134 (32%), Gaps = 30/134 (22%)
Query: 400 NSLKELFLQNN-LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLN 458
+++EL L N G I + L L L L S+ +L KL LK
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLK---- 74
Query: 459 QLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG--GEIPTWI 516
L L N + G L NL ++LS N L + +
Sbjct: 75 -----------------KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPL 116
Query: 517 GQLSNLAILKLSNN 530
+L L L L N
Sbjct: 117 KKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 31/146 (21%), Positives = 51/146 (34%), Gaps = 24/146 (16%)
Query: 242 ALEYLDISANKFT-GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL- 299
A+ L + K G + + +L FL++ + +++L
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI----------------SVSNLP 68
Query: 300 -CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358
L KL+LS N + G + +L ++S NK +E + LK L L
Sbjct: 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128
Query: 359 FNDFTGALPD----SLSNLTNLETLD 380
+ T L D L L LD
Sbjct: 129 NCEVT-NLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 3/89 (3%)
Query: 470 NIQTLETLFLDFNELT-GTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLS 528
+ L LD + G + + NL ++SL N L + + +L L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 529 NNSFYGRIPPELGDCRSLIWLDLNTNLFN 557
N +G + +L L+L+ N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 2e-09
Identities = 88/581 (15%), Positives = 157/581 (27%), Gaps = 179/581 (30%)
Query: 172 EVLDLSYN----KISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCK-------NL 220
EVL ++Y I P ++ E + N+V NVS+ + L
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 221 QFLDVSSNNFSMAVPSFG-DCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279
L + N V G +AL+ C
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALD------------------VCLSYKVQCK----MDF 182
Query: 280 PI---PVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
I + + L L + S ++ S + R S + + S
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 337 FSGELPI-------EIFLSMSNL--KELVLSFN----DFTGA-------LPDSLSNLTNL 376
+ L + + + + NL K L+ + DF A L LT
Sbjct: 243 YENCLLVLLNVQNAKAWNAF-NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 377 ETLDLSSNNLS---GAIPHNLCQGPRNSLKELFLQNNLLLGSI-------PSTLSNCSQL 426
E L L +P + N L I +T N
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTT-----------NPRRLSIIAESIRDGLATWDN---- 346
Query: 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNI--QTLETLFLDFNEL 484
H++ + LT I SSL L + + ++L + P +I L +
Sbjct: 347 -WKHVNCDKLTTIIESSLNVLEP-AEYRKMFDRL--SVFPPSAHIPTILLSLI------- 395
Query: 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR 544
W + + ++ + +L ++++ IP
Sbjct: 396 ---------------WFDVIKS----DVMVVVNKLHKYSLVEKQPKESTISIP------- 429
Query: 545 SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKEC-----------H 593
I+L+L L N AL + I ++ + K + +D H
Sbjct: 430 -SIYLELKVKLEN---EYALHR---SIVDHYNIPKTFDS--DDLIPPYLDQYFYSHIGHH 480
Query: 594 --GAGN----------LLEF----AGIRAERLSRISTRSPCNFT---RVYGGHTQPTFNH 634
+ L+F IR + + ++ S N + Y + N
Sbjct: 481 LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD--ND 538
Query: 635 NGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGP 675
Y L +I F+ + N +
Sbjct: 539 P--------KYERLVNAILD--------FLPKIEENLICSK 563
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 7e-05
Identities = 97/646 (15%), Positives = 175/646 (27%), Gaps = 198/646 (30%)
Query: 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVG---KKYVYIKNDGSKECH 593
+ L W L + ++ F+ Y ++ + E
Sbjct: 58 KDAVSGTLRLFWT--------------LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ- 102
Query: 594 GAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS----YNMLS 649
R P TR+Y +N N ++S Y L
Sbjct: 103 ---------------------RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141
Query: 650 GSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRG-----LNILDLSSNRLEGTIPSSM 704
++ E+ + I G L G + + S +++ + +
Sbjct: 142 QAL-LELRPAKNVLI----D-----------GVL-GSGKTWVALDVCLSYKVQCKMDFKI 184
Query: 705 SSLTL--LNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGASANS 762
L L N + L ++ + T + N S +
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN---------IKLRIHSIQAELR 235
Query: 763 RHQKSHRRPASL--------AGSIAMGLLFSLFCIFGLIIVVVETRKRRKKKESALDVYI 814
R KS L A + F+L C +++ TR K+ +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNA---FNLSC-----KILLTTR----FKQVTDFLSA 283
Query: 815 DSRSHSGTANTSWKLTGAREALSINLATFEKPLRKLTFADL-LEA--TNGFHNDSLIGSG 871
+ +H + S LT E S+ K L DL E TN S+I
Sbjct: 284 ATTTHISLDHHSMTLT-PDEVKSL----LLKYL-DCRPQDLPREVLTTNPRRL-SIIA-- 334
Query: 872 GFGDVYKAKLKDG-------STVAIKKLIHI-----SGQGDREFTAEMETIG------KI 913
++DG V KL I + E+ + + I
Sbjct: 335 -------ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 914 KHRNLVPLLGYCKVGEERLLVYEYMRYGSLED-------VLHN---QKKVGIKLNWAARR 963
L + + ++V + +Y +E + + + KV ++ +A R
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447
Query: 964 KIAIGSARGL-AFLHHNCIP---------HIIH---------RDMKSSNVLLDENF-EAR 1003
I + F + IP HI H R V LD F E +
Sbjct: 448 SI-VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKR 1063
+ A S + + L ++Y+ + +
Sbjct: 507 IRHDSTAWNASGSILNT-LQQL---------KFYKPY------------------ICDND 538
Query: 1064 PTDSADFGDNNLVGWVKQHA----KLKISDVFDPELMKEDPNIEIE 1105
P ++ ++ + K +D+ LM ED I E
Sbjct: 539 PKYERLVNA--ILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 52/241 (21%), Positives = 80/241 (33%), Gaps = 73/241 (30%)
Query: 866 SLIGSGGFGDVYKA--KLKDGSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHR-- 916
+G G FG V + + S VA+K + + E+ + KIK +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR------LEINVLKKIKEKDK 78
Query: 917 ----NLVPLLGY-------CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI 965
V + + C + +E + + + L L R +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKENNFQPYPLP--HVRHM 128
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA-------------------RVSD 1006
A L FLH N + H D+K N+L + RV+D
Sbjct: 129 AYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPE-----YYQSFRCSTKGDVYSYGVVLLELLTG 1061
FG SA H +T+ T Y PPE + + C DV+S G +L E G
Sbjct: 186 FG-----SATFDHEHHTTIVATRHYRPPEVILELGW-AQPC----DVWSIGCILFEYYRG 235
Query: 1062 K 1062
Sbjct: 236 F 236
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 42/161 (26%), Positives = 60/161 (37%), Gaps = 35/161 (21%)
Query: 350 SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS---GAIPHNLCQGPRNSLKELF 406
+N + L L N T P +L NL+ L L SN L + +L Q L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ-----LTVLD 94
Query: 407 LQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL-GSLSKLQDLKLWLNQLHGEIP 465
L N QL L PS++ L L++L + N+L E+P
Sbjct: 95 LGTN--------------QLTVL-----------PSAVFDRLVHLKELFMCCNKLT-ELP 128
Query: 466 PELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506
+ + L L LD N+L A ++L L N
Sbjct: 129 RGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 45/148 (30%), Positives = 66/148 (44%), Gaps = 16/148 (10%)
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL-SNLTN 375
VP+ G ++ + + N+ + +L +F S+ NLKEL L N ALP + +LT
Sbjct: 34 VPA--GIPTNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 376 LETLDLSSNNLSGAIPH----NLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHL 431
L LDL +N L+ +P L LKELF+ N L +P + + L L L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVH-----LKELFMCCNKL-TELPRGIERLTHLTHLAL 142
Query: 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
N L + LS L L+ N
Sbjct: 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 35/117 (29%), Positives = 52/117 (44%), Gaps = 13/117 (11%)
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
L L N ++ P F S +L+ + SN+ LP+ +F S++ L L L N T
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 365 ALPDSL-SNLTNLETLDLSSNNLSGAIPH---NLCQGPRNSLKELFLQNNLLLGSIP 417
LP ++ L +L+ L + N L+ +P L L L L N L SIP
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH-----LTHLALDQN-QLKSIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 17/148 (11%)
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP----EL 468
S+P+ + +Q L+L N +T P SL L++L L NQL +P L
Sbjct: 31 HASVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSL 87
Query: 469 GNIQTLETLFLDFNELTGTLPAAL-SNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
L L L N+LT LP+A+ +L + + N L E+P I +L++L L L
Sbjct: 88 TQ---LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLAL 142
Query: 528 SNNSFYGRIPPELGD-CRSL--IWLDLN 552
N IP D SL +L N
Sbjct: 143 DQNQL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGT 699
L + N ++ P S+ L L LG N L +P V D L L +LDL +N+L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 700 IPSSMSSLTLLNEIDLCNNQLT 721
+ L L E+ +C N+LT
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT 125
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 38/121 (31%), Positives = 54/121 (44%), Gaps = 20/121 (16%)
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
LDL +N+L F +SL + NK LP +F +++L L LS N
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 365 ALP----DSLSNLTNLETLDLSSNNLSGAIPH----NLCQGPRNSLKELFLQNNLLLGSI 416
+LP D L+ L L L++N L ++P L Q LK+L L N L S+
Sbjct: 90 SLPNGVFDKLTQLKE---LALNTNQLQ-SLPDGVFDKLTQ-----LKDLRLYQN-QLKSV 139
Query: 417 P 417
P
Sbjct: 140 P 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 48/195 (24%), Positives = 72/195 (36%), Gaps = 44/195 (22%)
Query: 318 PSRFGSCS-SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
PSR CS S + + S + +P I + L L N LT+L
Sbjct: 2 PSR---CSCSGTTVECYSQGRTS-VPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSL 54
Query: 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYL 436
L L N L ++P+ + + L L L N QL SL
Sbjct: 55 TQLYLGGNKLQ-SLPNGVFNKLTS-LTYLNLSTN--------------QLQSL------- 91
Query: 437 TGTIPSSL-GSLSKLQDLKLWLNQLHGEIPP----ELGNIQTLETLFLDFNELTGTLPAA 491
P+ + L++L++L L NQL +P +L L+ L L N+L
Sbjct: 92 ----PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQLKSVPDGV 143
Query: 492 LSNCTNLNWISLSNN 506
T+L +I L +N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 14/124 (11%)
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP----EL 468
S+P+ + + L L N L L+ L L L N+L +P +L
Sbjct: 19 RTSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKL 75
Query: 469 GNIQTLETLFLDFNELTGTLPAAL-SNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILK 526
+ L L L N+L +LP + T L ++L+ N L +P + +L+ L L+
Sbjct: 76 TS---LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLR 130
Query: 527 LSNN 530
L N
Sbjct: 131 LYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 38/162 (23%), Positives = 63/162 (38%), Gaps = 17/162 (10%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
+ T++ S + ++P + L L+ N L + L L+L N
Sbjct: 8 SGTTVECYSQGRT-SVPTGI----PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN 62
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP----ELGNIQTLETLFLDFNELTGTLPA 490
L L+ L L L NQL +P +L L+ L L+ N+L +LP
Sbjct: 63 KLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQ---LKELALNTNQLQ-SLPD 117
Query: 491 -ALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKLSNN 530
T L + L N L +P + +L++L + L +N
Sbjct: 118 GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/82 (32%), Positives = 37/82 (45%), Gaps = 2/82 (2%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGT 699
LD+ N L ++ L L LG N L +P V + L L L+LS+N+L+
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 700 IPSSMSSLTLLNEIDLCNNQLT 721
LT L E+ L NQL
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ 113
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 46/217 (21%), Positives = 79/217 (36%), Gaps = 50/217 (23%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDRE-FTAEMETIGKI-KHRNLVPLLGY 924
+G G G V + K A+K + D E+E + + ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKM---LQ---DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 925 CKVGEER----LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
+ L+V E + G L + ++ A+ +IG A + +LH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSI- 136
Query: 981 IPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+I HRD+K N+L N +++DFG A+ E Y
Sbjct: 137 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-------------------TTGEKY 175
Query: 1038 QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074
D++S GV++ LL G P F N+
Sbjct: 176 -----DKSCDMWSLGVIMYILLCGYPP-----FYSNH 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 25/211 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVP-LLG 923
IG G FG +++ L + VAIK + Q E+ + + +P +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTG---IPNVYY 73
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ + G +LV + + SLED+L + K + A + +H
Sbjct: 74 FGQEGLHNVLVIDLLGP-SLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---S 126
Query: 984 IIHRDMKSSNVLLDENFEAR-----VSDFGMAR--LMSAMDTHL---SVSTLAGTPGYVP 1033
+++RD+K N L+ V DFGM + H+ L+GT Y+
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ S + D+ + G V + L G P
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 52/263 (19%), Positives = 85/263 (32%), Gaps = 77/263 (29%)
Query: 866 SLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEME-----TIGKIK----- 914
+G G F V+ + ++ VA+K + S + E TA E ++
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTE-TALDEIRLLKSVRNSDPNDPN 99
Query: 915 HRNLVPLLGYCKV----GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
+V LL K+ G +V+E + + L + G+ L +KI
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCV--KKIIQQVL 156
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLL---------------------------------- 996
+GL +LH C IIH D+K N+LL
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 997 ---------------DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
E + +++D G A + H + T Y E
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHF--TEDIQTRQYRSLEVLIGSG 269
Query: 1042 CSTKGDVYSYGVVLLELLTGKRP 1064
+T D++S + EL TG
Sbjct: 270 YNTPADIWSTACMAFELATGDYL 292
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 23/209 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIK--KLIHISGQGDREFTAEMETIGKIKHRNLVP-LLG 923
IGSG FG++Y ++ VAIK + Q E + +P +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGGTG---IPNVRW 70
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
+ G+ +LV + + SLED+ + + KL+ +A + F+H
Sbjct: 71 FGVEGDYNVLVMDLLGP-SLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---S 123
Query: 984 IIHRDMKSSNVLLDENFEAR---VSDFGMARLMSAMDTHLSVS-----TLAGTPGYVPPE 1035
+HRD+K N L+ A + DFG+A+ TH + L GT Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ S + D+ S G VL+ L G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 43/265 (16%), Positives = 71/265 (26%), Gaps = 39/265 (14%)
Query: 296 LADLCSSLVKLDLSSNNLSGKVPSRFGSC-SSLESFDISSNKFSGE----LPIEIFLSMS 350
L +L +++L+S L + N E L +
Sbjct: 96 LGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQC 155
Query: 351 NLKELVLSFNDFTG----ALPDSLSNLTNLETLDLSSNNLS--GAIPHNLCQGPRN--SL 402
+ L LS N T L + L+ T++ L L L G L L
Sbjct: 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--LLAAQLDRNRQL 213
Query: 403 KELFLQNNLL----LGSIPSTLSNCSQLVSLHLSFNYLTGT-------IPSSLGSLSKLQ 451
+EL + N ++ L LHL FN L+ + + +++
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVV 273
Query: 452 DLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE 511
+ L +Q L A + L L ++
Sbjct: 274 VSLTEGTAVSEYWSVILSEVQR---------NLNSWDRARVQRHLELLLRDLEDSRGATL 324
Query: 512 IPTWIGQL----SNLAILKLSNNSF 532
P QL + L S
Sbjct: 325 NPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 50/313 (15%), Positives = 82/313 (26%), Gaps = 78/313 (24%)
Query: 119 SFLSSLDLSLNILSGPLSDISYLG-----SCSSLKVLNLSSNLLDFSGREA-GSLKLSLE 172
S L L+L+ ++ + + +L +NL+S LD +G + L
Sbjct: 72 SSLRQLNLAGVRMTP--VKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129
Query: 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSM 232
L L N + C +L+ L ++ + L +S+N +
Sbjct: 130 KLGLQLNSLGPE---------ACKDLRD-LLLHDQCQ----------ITTLRLSNNPLTA 169
Query: 233 A-VPSFGDCLA----LEYLDISANKFTGDVG-----HAISACEHLSFLNVSSNLFSGPIP 282
A V + LA + +L + GD G + L LNV+
Sbjct: 170 AGVAVLMEGLAGNTSVTHLSLLHTGL-GDEGLELLAAQLDRNRQLQELNVA--------- 219
Query: 283 VGYNEFQGEIPLHLADL---CSSLVKLDLSSNNLS-------GKVPSRFGSCSSLESFDI 332
YN L LA SL L L N LS + + +
Sbjct: 220 --YNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLT 277
Query: 333 SSNKFSGE--------------LPIEIFLSMSNLKELVLSFNDFT----GALPDSLSNLT 374
S L L + L
Sbjct: 278 EGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEG 337
Query: 375 NLETLDLSSNNLS 387
+ L +
Sbjct: 338 EVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 54/301 (17%), Positives = 94/301 (31%), Gaps = 60/301 (19%)
Query: 145 SSLKVLNLSSNLLDFSGREA-----GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELK 199
SSL+ LNL+ + GS + +L+ ++L+ ++ A + L +
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR--TLLPVFLRAR 129
Query: 200 QLALKGNKVTGD--------INVSKCKNLQFLDVSSNNFSMA-VPSFGDCLA----LEYL 246
+L L+ N + + + +C+ + L +S+N + A V + LA + +L
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQ-ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188
Query: 247 DISANKFTGDVG-----HAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL-- 299
+ GD G + L LNV+ YN L LA
Sbjct: 189 SLLHTGL-GDEGLELLAAQLDRNRQLQELNVA-----------YNGAGDTAALALARAAR 236
Query: 300 -CSSLVKLDLSSNNLS-------GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSN 351
SL L L N LS + + + S + + N
Sbjct: 237 EHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRN 296
Query: 352 LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPR--NSLKELFLQN 409
L + L DL + + P Q R ++ L Q
Sbjct: 297 LNSW----------DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQL 346
Query: 410 N 410
Sbjct: 347 G 347
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 34/187 (18%), Positives = 61/187 (32%), Gaps = 27/187 (14%)
Query: 370 LSNLTNLETLDLSSNNLSGAIPHNLCQG---PRNSLKELFLQNNLL----LGSIPSTLSN 422
L++L L+L+ ++ + R++L E+ L + L L ++
Sbjct: 68 AEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR 127
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSL-----SKLQDLKLWLNQLHGE----IPPELGNIQT 473
L L N L L L ++ L+L N L + L +
Sbjct: 128 AR---KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 474 LETLFLDFNELTGT----LPAALSNCTNLNWISLSNNHLGGE----IPTWIGQLSNLAIL 525
+ L L L L A L L ++++ N G + + +L +L
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELL 244
Query: 526 KLSNNSF 532
L N
Sbjct: 245 HLYFNEL 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 37/256 (14%), Positives = 73/256 (28%), Gaps = 49/256 (19%)
Query: 85 VASFLLTLDTLETLSLKNSNIS--GTISLPAG-SRCSSFLSSLDLSLNILSGP----LSD 137
+ + L L L+ +++ L +++L LS N L+ L +
Sbjct: 118 LRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLME 177
Query: 138 ISYLGSCSSLKVLNLSSNLLDFSGRE--AGSLKL--SLEVLDLSYNKISGANVVPWILFN 193
L +S+ L+L L G E A L L+ L+++YN
Sbjct: 178 G--LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT--------- 226
Query: 194 GCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMA-------VPSFGDCLALEYL 246
L + A + + +L+ L + N S + + A +
Sbjct: 227 AALALAR-AAREH-----------PSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVV 274
Query: 247 DISANKFTGDVGHAISA-----CEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLC- 300
++ + I + V +L + + P A L
Sbjct: 275 SLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLR 334
Query: 301 --SSLVKLDLSSNNLS 314
+ L +
Sbjct: 335 VEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 28/189 (14%), Positives = 52/189 (27%), Gaps = 30/189 (15%)
Query: 94 TLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILSGP----LSDISYLGSCSSL 147
++ LSL ++ + G L A + L L+++ N L+ SL
Sbjct: 184 SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA--RAAREHPSL 241
Query: 148 KVLNLSSNLLDFSG----REAGSLK---LSLEVLDLSYNKISGANVVPWILFNGCDELKQ 200
++L+L N L G R+ G + V +S L +
Sbjct: 242 ELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEY---------WSVILSE 292
Query: 201 LALKGNKVTGDINVSKCKNLQFLDVSSNNFS-MAVPSFGDCLA----LEYLDISANKFTG 255
+ V + L D+ + + + L + L
Sbjct: 293 -VQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGS 351
Query: 256 DVGHAISAC 264
G
Sbjct: 352 PSGSWSHPQ 360
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 47/210 (22%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP-LLGYC 925
IG G FG++ K L VAIK S E ++ + +P + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 926 KVGEERLLVYEYMRYG-SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
G+ +V E + G SLED+ + + IAI + ++H ++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSK---NL 126
Query: 985 IHRDMKSSNVLL--DENFEAR---VSDFGMARLMSAMDTHLSVS-----TLAGTPGYVPP 1034
I+RD+K N L+ N + + DF +A+ +T + +L GT Y+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
+ S + D+ + G + + L G P
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 52/241 (21%), Positives = 84/241 (34%), Gaps = 73/241 (30%)
Query: 866 SLIGSGGFGDVYKAK--LKDGSTVAIK-----KLIHISGQGDREFTAEMETIGKIKHR-- 916
+G G FG V + G VA+K + + +E++ + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR------SEIQVLEHLNTTDP 73
Query: 917 ----NLVPLLGY-------CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKI 965
V +L + C +V+E + S D + + +L+ RK+
Sbjct: 74 NSTFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENGFLPFRLD--HIRKM 123
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA-------------------RVSD 1006
A + + FLH N + H D+K N+L ++ +V D
Sbjct: 124 AYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPE-----YYQSFRCSTKGDVYSYGVVLLELLTG 1061
FG SA STL T Y PE + S C DV+S G +L+E G
Sbjct: 181 FG-----SATYDDEHHSTLVSTRHYRAPEVILALGW-SQPC----DVWSIGCILIEYYLG 230
Query: 1062 K 1062
Sbjct: 231 F 231
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 24/176 (13%), Positives = 59/176 (33%), Gaps = 23/176 (13%)
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
+ +M L L + + L NL++L++ S L ++ ++ +L+
Sbjct: 166 PVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLE 222
Query: 404 ELFL---QNNLLLGSIPSTLS------NCSQLVSLHLSFNYLTGTIPSSLGS---LSKLQ 451
+L L + + L L + + L +L+
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282
Query: 452 DLKLWLNQLHGE----IPPELGNIQTLETLFLDFNELTGT----LPAALSNCTNLN 499
+ + L E + + I+ L+ + + +N L+ L +L +++
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 4e-07
Identities = 31/204 (15%), Positives = 64/204 (31%), Gaps = 27/204 (13%)
Query: 220 LQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVS--SNLF 277
+ + F+ F + E +IS D+ + A L+ L + +NL
Sbjct: 128 ADGIVENKEKFAHFEGLFWGDIDFEEQEISWI-EQVDLSPVLDAMPLLNNLKIKGTNNLS 186
Query: 278 SGPIP--------VGYNEFQGEIPLHLAD-LCSSLVKLDL---SSNNLSGKVPSRF---- 321
G P + + + +L KL L + + F
Sbjct: 187 IGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246
Query: 322 --GSCSSLESFDISSNKFSGELPIEIFLS--MSNLKELVLSFNDFTG----ALPDSLSNL 373
+L+ I + + S + L+ + +S T L D + +
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI 306
Query: 374 TNLETLDLSSNNLSGAIPHNLCQG 397
+L+ +++ N LS + L +
Sbjct: 307 KHLKFINMKYNYLSDEMKKELQKS 330
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 1e-05
Identities = 27/203 (13%), Positives = 60/203 (29%), Gaps = 19/203 (9%)
Query: 25 SPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSC---KAASVSSIDLSPFTLSVD 81
+ ++ K + L + + + L+ +
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 82 FHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLN----ILSGPLSD 137
+L L++L + + + ++ L L L + G ++
Sbjct: 183 NNLSIG-KKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241
Query: 138 ISYL---GSCSSLKVLNLSSNLLDFSGRE--AGSLKL-SLEVLDLSYNKISGANVVPWIL 191
L +LK L + E S L LE +D+S ++ L
Sbjct: 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL--L 299
Query: 192 FNGCDE---LKQLALKGNKVTGD 211
+ D+ LK + +K N ++ +
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 8e-05
Identities = 25/198 (12%), Positives = 54/198 (27%), Gaps = 28/198 (14%)
Query: 358 SFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG-------PRNSLKELFLQNN 410
+D + ++ + E L + + Q L L ++
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS--LSKLQDLKLWL---NQLHGEIP 465
L N L SL + L ++ + L L+ L L++ +
Sbjct: 183 NNLSIGKKPRPN---LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239
Query: 466 PEL------GNIQTLETLFLDFNELTGTLPAALSNC---TNLNWISLSNNHLGGE----I 512
L+ L + E + L + +S L E +
Sbjct: 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL 299
Query: 513 PTWIGQLSNLAILKLSNN 530
+ ++ +L + + N
Sbjct: 300 LDHVDKIKHLKFINMKYN 317
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 13/111 (11%)
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364
+L+L SN L F + L +S N+ LP +F ++ L L L N
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 365 ALPDSL-SNLTNLETLDLSSNNLSGAIPH----NLCQGPRNSLKELFLQNN 410
+LP+ + LT L+ L L +N L ++P L SL++++L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRL-----TSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 33/124 (26%), Positives = 53/124 (42%), Gaps = 14/124 (11%)
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP----EL 468
L S+P+ + + + L L N L L++L L L NQ+ +P +L
Sbjct: 19 LTSVPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKL 75
Query: 469 GNIQTLETLFLDFNELTGTLPA-ALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILK 526
L L+L N+L +LP T L ++L N L +P I +L++L +
Sbjct: 76 TK---LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIW 130
Query: 527 LSNN 530
L N
Sbjct: 131 LHTN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 16/135 (11%)
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST--LSNCSQLVSLHLSFNY 435
T+D + L IP ++ P ++ EL L +N L G I S LV L L N
Sbjct: 12 TVDCTGRGLK-EIPRDI---PLHT-TELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQ 65
Query: 436 LTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP----ELGNIQTLETLFLDFNELTGTLPAA 491
LTG P++ S +Q+L+L N++ EI L L+TL L N+++ +P +
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQ---LKTLNLYDNQISCVMPGS 121
Query: 492 LSNCTNLNWISLSNN 506
+ +L ++L++N
Sbjct: 122 FEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 1/100 (1%)
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIE 344
NE L LVKL+L N L+G P+ F S ++ + NK E+ +
Sbjct: 38 DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNK 96
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
+FL + LK L L N + +P S +L +L +L+L+SN
Sbjct: 97 MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 17/88 (19%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 331 DISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSL-SNLTNLETLDLSSNNLSGA 389
++ N+ +F + +L +L L N T + + ++++ L L N +
Sbjct: 35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-E 92
Query: 390 IPHNLCQGPRNSLKELFLQNNLLLGSIP 417
I + + G LK L L +N + +
Sbjct: 93 ISNKMFLGLHQ-LKTLNLYDN-QISCVM 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 29/126 (23%), Positives = 46/126 (36%), Gaps = 13/126 (10%)
Query: 413 LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP----EL 468
L +P + L+L N T +P L + L + L N++ + +
Sbjct: 22 LKVLPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNM 77
Query: 469 GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI-GQLSNLAILKL 527
L TL L +N L P +L +SL N + +P LS L+ L +
Sbjct: 78 TQ---LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAI 133
Query: 528 SNNSFY 533
N Y
Sbjct: 134 GANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 328 ESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS 387
+ N+F+ L + + +L + LS N + S SN+T L TL LS N L
Sbjct: 34 TELYLDGNQFT--LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 388 GAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHLSFN 434
IP G ++ L+ L L N + +P ++ S L L + N
Sbjct: 92 -CIPPRTFDGLKS-LRLLSLHGN-DISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 39/131 (29%)
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIE 344
N+F +P L++ L +DLS+N +S L +
Sbjct: 40 GNQFT-LVPKELSNY-KHLTLIDLSNNRIS-------------------------TLSNQ 72
Query: 345 IFLSMSNLKELVLSFNDFTGALPDSL-SNLTNLETLDLSSNNLSGAIPH----NLCQGPR 399
F +M+ L L+LS+N +P L +L L L N++S +P +L
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL----- 125
Query: 400 NSLKELFLQNN 410
++L L + N
Sbjct: 126 SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 22/82 (26%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD-LRGLNILDLSSNRLEGT 699
L + N + +PKE+ + +L +++L +N +S + + + L L LS NRL
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 700 IPSSM-SSLTLLNEIDLCNNQL 720
IP L L + L N +
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDI 114
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 40.7 bits (94), Expect = 6e-04
Identities = 12/45 (26%), Positives = 20/45 (44%), Gaps = 16/45 (35%)
Query: 800 RKRRKKKESALDVYIDSRSHSGTANTSWKLTGAREALSINLATFE 844
++ KK +++L +Y D +A AL+I AT E
Sbjct: 19 KQALKKLQASLKLYAD-----DSA----------PALAIK-ATME 47
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1176 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.33 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.73 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.69 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.62 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.28 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.15 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.98 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.92 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.69 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.36 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.34 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.21 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.6 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.92 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.43 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 86.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.74 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.6 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-95 Score=929.82 Aligned_cols=730 Identities=68% Similarity=1.103 Sum_probs=652.3
Q ss_pred CCChHHHHHHHHHHhcCCCCCCCCCCCCCCCCcccceeEeCCCcEEEEecCCccccccchhhhhhhcCcccccccccCCC
Q 046275 24 SSPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNS 103 (1176)
Q Consensus 24 ~~~~~~~~~ll~~k~~~~~~~~l~~w~~~~~cC~W~gv~C~~~~v~~l~L~~~~~~~~~~~~~~~l~~~~~L~~L~L~~n 103 (1176)
.+.++|++|||+||++++||..++||+.++|||+|+||+|+.++|++|||++..+.+....++..+.+++.|+.++++.|
T Consensus 8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~ 87 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTS
T ss_pred cCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCC
Confidence 33578999999999999988889999988999999999999889999999998888765557777888777777766666
Q ss_pred CCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccc-cccccccCCCcEEEccCCCCC
Q 046275 104 NISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSG-REAGSLKLSLEVLDLSYNKIS 182 (1176)
Q Consensus 104 ~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~-~~~~~~~~~L~~LdLs~N~i~ 182 (1176)
.+ .++|..+..+++|++|||++|.+++..+....++.+++|++|+|++|.+.... ...+..+++|++|||++|+++
T Consensus 88 ~~---~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 88 HI---NGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp CE---EECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred Cc---CCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 54 45678889999999999999999987666557899999999999999887543 444477889999999999998
Q ss_pred CCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhh
Q 046275 183 GANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAIS 262 (1176)
Q Consensus 183 ~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~ 262 (1176)
+.....+..+.++++|++|++++|.+++..++..+++|++|++++|++++.++.++++++|++|+|++|++++.+|..+.
T Consensus 165 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~ 244 (768)
T 3rgz_A 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAIS 244 (768)
T ss_dssp EETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHTT
T ss_pred CcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHHh
Confidence 74222222378999999999999999998888999999999999999998777799999999999999999999999999
Q ss_pred ccccCCeEeeccccccCccCCC-----------CccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEE
Q 046275 263 ACEHLSFLNVSSNLFSGPIPVG-----------YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFD 331 (1176)
Q Consensus 263 ~l~~L~~L~Ls~N~l~~~~p~~-----------~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 331 (1176)
++++|++|+|++|.+++.+|.. .+.+++.+|..++..+++|++|+|++|++++.+|..|+++++|++|+
T Consensus 245 ~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 324 (768)
T 3rgz_A 245 TCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324 (768)
T ss_dssp TCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEE
T ss_pred cCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEE
Confidence 9999999999999999877653 22344567777777779999999999999999999999999999999
Q ss_pred ccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCC-CCCEEEccCCcCCCCCCccccCCCCCCccEEEccCc
Q 046275 332 ISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT-NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410 (1176)
Q Consensus 332 Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N 410 (1176)
+++|.++|.+|...|..+++|++|+|++|.+++.+|..+.+++ +|++|+|++|++++.+|..++...+++|++|+|++|
T Consensus 325 L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n 404 (768)
T 3rgz_A 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404 (768)
T ss_dssp CCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSS
T ss_pred CCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCC
Confidence 9999999999999889999999999999999999999999987 999999999999999999887666789999999999
Q ss_pred cccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCcccc
Q 046275 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPA 490 (1176)
Q Consensus 411 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 490 (1176)
.+++.+|..++++++|++|+|++|++++.+|..++.+++|+.|++++|.+.+.+|..++.+++|++|+|++|++++.+|.
T Consensus 405 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 484 (768)
T 3rgz_A 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484 (768)
T ss_dssp EEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred ccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhccc
Q 046275 491 ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGK 570 (1176)
Q Consensus 491 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~ 570 (1176)
.+.++++|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+|.....
T Consensus 485 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~ 564 (768)
T 3rgz_A 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK 564 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTC
T ss_pred HHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987666
Q ss_pred chhhhccccceeeeecCCC-CcccCCCCchhhhhhhhhhccccccCCCCccc-cccCCCCCCCcCCCCCccEEEcccCcC
Q 046275 571 IAANFIVGKKYVYIKNDGS-KECHGAGNLLEFAGIRAERLSRISTRSPCNFT-RVYGGHTQPTFNHNGSMMFLDISYNML 648 (1176)
Q Consensus 571 l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~LdLs~N~l 648 (1176)
.......+..+.++.+... ..|...+...++.++....+..+.....+.+. ..+.+...+.+..+.+|++||||+|++
T Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l 644 (768)
T 3rgz_A 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644 (768)
T ss_dssp BCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCC
T ss_pred hhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcc
Confidence 6555556666777665433 34455566666666666666666655555443 446677788899999999999999999
Q ss_pred ccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCC
Q 046275 649 SGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMG 728 (1176)
Q Consensus 649 ~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~ 728 (1176)
+|.+|.+|+++++|+.|+|++|+|+|.||+.|++|++|++||||+|+|+|.||..++.+++|++|||++|+|+|.||..+
T Consensus 645 ~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~ 724 (768)
T 3rgz_A 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724 (768)
T ss_dssp BSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSS
T ss_pred cccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCccccCCCCCCCCCCCCCCCCC
Q 046275 729 QFETFQPAKFLNNSGLCGLPLPPCEKDS 756 (1176)
Q Consensus 729 ~~~~~~~~~~~~n~~l~~~~~~~c~~~~ 756 (1176)
++.+++..+|.||++|||.|+++|....
T Consensus 725 ~~~~~~~~~~~gN~~Lcg~~l~~C~~~~ 752 (768)
T 3rgz_A 725 QFETFPPAKFLNNPGLCGYPLPRCDPSN 752 (768)
T ss_dssp SGGGSCGGGGCSCTEEESTTSCCCCSCC
T ss_pred hhccCCHHHhcCCchhcCCCCcCCCCCc
Confidence 9999999999999999999999997644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-66 Score=659.53 Aligned_cols=597 Identities=33% Similarity=0.458 Sum_probs=402.1
Q ss_pred hhcCcccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCcccccc---
Q 046275 88 FLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREA--- 164 (1176)
Q Consensus 88 ~l~~~~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~--- 164 (1176)
.+..+++|++|||++|.++|.++....+..+++|++|||++|.+.+..+. ..+..+++|++|+|++|+++......
T Consensus 95 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 173 (768)
T 3rgz_A 95 GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV-SGGLKLNSLEVLDLSANSISGANVVGWVL 173 (768)
T ss_dssp CCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSC-CSCCCCTTCSEEECCSSCCEEETHHHHHH
T ss_pred hhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCH-HHhccCCCCCEEECCCCccCCcCChhhhh
Confidence 35555566666666665554332212445555566666666555543321 12244555555555555554433222
Q ss_pred ccccCCCcEEEccCCCCCCCC--------------------ccccccccCCCCccEEEeCCCcccc--cccCCCCCccce
Q 046275 165 GSLKLSLEVLDLSYNKISGAN--------------------VVPWILFNGCDELKQLALKGNKVTG--DINVSKCKNLQF 222 (1176)
Q Consensus 165 ~~~~~~L~~LdLs~N~i~~~~--------------------~~~~~~f~~~~~L~~L~L~~n~l~~--~~~~~~l~~L~~ 222 (1176)
+..+++|++|++++|++++.. .++. |..+++|++|++++|.+++ ...+..+++|++
T Consensus 174 ~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~ 251 (768)
T 3rgz_A 174 SDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKL 251 (768)
T ss_dssp TTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCE
T ss_pred hccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCE
Confidence 334444444444444444311 1221 4444555555555555443 223444555555
Q ss_pred eeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhcc-ccCCeEeeccccccCccCCCCccccCcchhhhhhcCC
Q 046275 223 LDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISAC-EHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS 301 (1176)
Q Consensus 223 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~ 301 (1176)
|++++|++++..+.. .+++|++|+|++|++++.+|..+... ++|++|+|++|.+++.+|.. +..++
T Consensus 252 L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~------------~~~l~ 318 (768)
T 3rgz_A 252 LNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF------------FGSCS 318 (768)
T ss_dssp EECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG------------GGGCT
T ss_pred EECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH------------HhcCC
Confidence 555555554433333 44455555555555554444444432 55555555555554443332 33468
Q ss_pred CccEEEccCCcccccCCcc-ccCCCCCcEEEccCCcCcccCCHHHHhcCC-CCCEEEccCcccCCCCcccccC--CCCCC
Q 046275 302 SLVKLDLSSNNLSGKVPSR-FGSCSSLESFDISSNKFSGELPIEIFLSMS-NLKELVLSFNDFTGALPDSLSN--LTNLE 377 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~--l~~L~ 377 (1176)
+|++|+|++|++++.+|.. +..+++|++|++++|++++.+|..+ ..++ +|++|++++|.+++.+|..+.. +++|+
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~ 397 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL-TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTH-HHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHH-HhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence 8999999999998888865 8999999999999999988888775 4555 8999999999999888888877 88899
Q ss_pred EEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeeccc
Q 046275 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457 (1176)
Q Consensus 378 ~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 457 (1176)
+|++++|++++.+|..+. .+++|++|+|++|++++.+|..++++++|+.|++++|++++.+|..+..+++|++|++++
T Consensus 398 ~L~L~~n~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 475 (768)
T 3rgz_A 398 ELYLQNNGFTGKIPPTLS--NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475 (768)
T ss_dssp EEECCSSEEEEECCGGGG--GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred EEECCCCccccccCHHHh--cCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecC
Confidence 999999999988888874 467899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCC
Q 046275 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537 (1176)
Q Consensus 458 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 537 (1176)
|++++.+|..++++++|++|+|++|++++.+|.+|+++++|++|+|++|+++|.+|..++.+++|++|+|++|+++|.+|
T Consensus 476 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip 555 (768)
T 3rgz_A 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred CcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998888
Q ss_pred CCCCCCCCCCEEEccCC----------------------CCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCC
Q 046275 538 PELGDCRSLIWLDLNTN----------------------LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGA 595 (1176)
Q Consensus 538 ~~~~~l~~L~~L~L~~N----------------------~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 595 (1176)
..+..+..+..+++..+ .+.|.+|..+.... ......+....+...... .
T Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~l~~~~~~g~~~~---~---- 627 (768)
T 3rgz_A 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS-TRNPCNITSRVYGGHTSP---T---- 627 (768)
T ss_dssp GGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGG-GTCCSCTTSCEEEEECCC---S----
T ss_pred hHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccc-cccccccccceecccCch---h----
Confidence 87766544443332221 01122221111000 000000000000000000 0
Q ss_pred CCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCcccccc
Q 046275 596 GNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGP 675 (1176)
Q Consensus 596 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~ 675 (1176)
+.....+...++ +.+ .+.+.++..+..+.+|+.||||+|+++|.||..|+++++|+.|||++|+++|.
T Consensus 628 --~~~l~~L~~LdL------s~N----~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ 695 (768)
T 3rgz_A 628 --FDNNGSMMFLDM------SYN----MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR 695 (768)
T ss_dssp --CSSSBCCCEEEC------CSS----CCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEC
T ss_pred --hhccccccEEEC------cCC----cccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCc
Confidence 000000000000 001 12233444566677899999999999999999999999999999999999999
Q ss_pred CCccccCcCcccEEEccCccccccCCCCcccccccccccccccc-ccCCC
Q 046275 676 IPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQ-LTGMI 724 (1176)
Q Consensus 676 iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~-l~g~~ 724 (1176)
||+.+++|++|++||||+|+|+|.||.. +.+..+....+.+|+ |+|.+
T Consensus 696 ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 696 IPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp CCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEESTT
T ss_pred CChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCCC
Confidence 9999999999999999999999999975 566777778888884 88864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=579.02 Aligned_cols=568 Identities=23% Similarity=0.221 Sum_probs=452.8
Q ss_pred ccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCc
Q 046275 93 DTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLE 172 (1176)
Q Consensus 93 ~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~ 172 (1176)
+++++|+|++|.+++.. +..+..+++|++|||++|.+++..+ ..++.+++|++|+|++|+|+.++...+..+++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 100 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLP--AANFTRYSQLTSLDVGFNTISKLEP--ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLT 100 (680)
T ss_dssp TTCSEEECCSSCCCCCC--GGGGGGGTTCSEEECCSSCCCCCCT--THHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCS
T ss_pred CCCcEEECCCCCCCCcC--HHHHhCCCcCcEEECCCCccCccCH--HHHhcccCcCEEECCCCccCccChhhhccCCCCC
Confidence 58899999999998632 3456788999999999999987655 3578899999999999999999988899999999
Q ss_pred EEEccCCCCCCCCccccccccCCCCccEEEeCCCccccc--ccCCCCCccceeeccCCcccccCCC-c--cCCCCCcEEE
Q 046275 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD--INVSKCKNLQFLDVSSNNFSMAVPS-F--GDCLALEYLD 247 (1176)
Q Consensus 173 ~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~-l--~~l~~L~~L~ 247 (1176)
+|+|++|++++ ++...|.++++|++|+|++|.+++. ..+..+++|++|++++|++++.++. + ..+++|++|+
T Consensus 101 ~L~L~~n~l~~---~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 177 (680)
T 1ziw_A 101 ELHLMSNSIQK---IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177 (680)
T ss_dssp EEECCSSCCCC---CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEE
T ss_pred EEECCCCccCc---cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEE
Confidence 99999999986 6666789999999999999999863 4577899999999999999887653 3 3568999999
Q ss_pred cCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCC-
Q 046275 248 ISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS- 326 (1176)
Q Consensus 248 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~- 326 (1176)
+++|++++..+..+..+.+|+.|++++|.+.+.... .++..+ ..++|+.|++++|.+++..|..|..++.
T Consensus 178 L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~-------~~~~~l--~~~~L~~L~L~~n~l~~~~~~~~~~l~~~ 248 (680)
T 1ziw_A 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE-------KLCLEL--ANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248 (680)
T ss_dssp CTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHH-------HHHHHH--TTSCCCEEECTTSCCCEECTTTTGGGGGS
T ss_pred CCCCcccccChhhhhhhhhhhhhhccccccChhhHH-------HHHHHh--hhccccEEEccCCcccccChhHhhccCcC
Confidence 999999999999999999999999999887521110 111111 2378999999999999888888988865
Q ss_pred -CcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCC-----CCc--cccCCC
Q 046275 327 -LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGA-----IPH--NLCQGP 398 (1176)
Q Consensus 327 -L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~--~~~~~~ 398 (1176)
|++|++++|+++ .++...|..+++|++|++++|.+++..|..+.++++|++|++++|...+. +|. ......
T Consensus 249 ~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~ 327 (680)
T 1ziw_A 249 NLTMLDLSYNNLN-VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327 (680)
T ss_dssp CCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTT
T ss_pred CCCEEECCCCCcC-ccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhccc
Confidence 999999999998 45555678999999999999999988899999999999999998866542 232 111245
Q ss_pred CCCccEEEccCccccCCCCccccccccCcEEEcCCccccCC--CCccccC--CCccCeeecccccccCCCCCCCCCcccc
Q 046275 399 RNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGT--IPSSLGS--LSKLQDLKLWLNQLHGEIPPELGNIQTL 474 (1176)
Q Consensus 399 ~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L 474 (1176)
+++|++|++++|.+++..+..|.++++|++|++++|.++.. .+..|.. .++|+.|++++|++++..|..|..+++|
T Consensus 328 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp CTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 68899999999999998888999999999999999986532 2223333 3589999999999998889999999999
Q ss_pred ceeecccccccCccc-cccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccc--ccCCCCCCCCCCCCEEEc
Q 046275 475 ETLFLDFNELTGTLP-AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY--GRIPPELGDCRSLIWLDL 551 (1176)
Q Consensus 475 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L 551 (1176)
++|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+. +.+|..+..+++|+.|+|
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~L 487 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEEC
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEEC
Confidence 999999999987665 68999999999999999999888899999999999999999987 578999999999999999
Q ss_pred cCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCC
Q 046275 552 NTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT 631 (1176)
Q Consensus 552 ~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 631 (1176)
++|++++ +|+..|
T Consensus 488 s~N~l~~-i~~~~~------------------------------------------------------------------ 500 (680)
T 1ziw_A 488 SNNNIAN-INDDML------------------------------------------------------------------ 500 (680)
T ss_dssp CSSCCCC-CCTTTT------------------------------------------------------------------
T ss_pred CCCCCCc-CChhhh------------------------------------------------------------------
Confidence 9999984 443322
Q ss_pred cCCCCCccEEEcccCcCccC--------CCccccccccceeeeccCccccccCCc-cccCcCcccEEEccCccccccCCC
Q 046275 632 FNHNGSMMFLDISYNMLSGS--------IPKEIGSMSYLFILNLGHNNLSGPIPT-EVGDLRGLNILDLSSNRLEGTIPS 702 (1176)
Q Consensus 632 ~~~~~~l~~LdLs~N~l~g~--------iP~~~~~l~~L~~L~L~~N~l~g~iP~-~~~~L~~L~~L~Ls~N~l~g~iP~ 702 (1176)
..+.+|++|||++|++++. .+..|+++++|+.|+|++|+++ .+|. .|+++++|+.|||++|+|++..|.
T Consensus 501 -~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 578 (680)
T 1ziw_A 501 -EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPAS 578 (680)
T ss_dssp -TTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred -ccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHh
Confidence 2334567777777777653 1223677777777777777777 4443 577777777777777777754444
Q ss_pred CccccccccccccccccccCCCCCCC--CccccCCccccCCCCCCC
Q 046275 703 SMSSLTLLNEIDLCNNQLTGMIPVMG--QFETFQPAKFLNNSGLCG 746 (1176)
Q Consensus 703 ~l~~l~~L~~l~ls~N~l~g~~p~~~--~~~~~~~~~~~~n~~l~~ 746 (1176)
.+..+++|+.|+|++|+|++.+|..- .+..+....+.+|+..|.
T Consensus 579 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp TTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred HhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 56677777777777777777766421 344555566667776664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=565.13 Aligned_cols=588 Identities=22% Similarity=0.219 Sum_probs=491.2
Q ss_pred cccceeEeCC-----------CcEEEEecCCccccccchhhhhhhcCcccccccccCCCCCCCcccCCCCCccccCcccc
Q 046275 56 CGFKGVSCKA-----------ASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSL 124 (1176)
Q Consensus 56 C~W~gv~C~~-----------~~v~~l~L~~~~~~~~~~~~~~~l~~~~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~L 124 (1176)
|.++.|.|.+ .+++.|+|+++.+.. ..+..+..+++|++|+|++|.+++.. |..+..+++|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~---~~~~~~~~l~~L~~L~Ls~n~l~~~~--~~~~~~l~~L~~L 78 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR---LPAANFTRYSQLTSLDVGFNTISKLE--PELCQKLPMLKVL 78 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC---CCGGGGGGGTTCSEEECCSSCCCCCC--TTHHHHCTTCCEE
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCC---cCHHHHhCCCcCcEEECCCCccCccC--HHHHhcccCcCEE
Confidence 6666677764 258899999877653 34456889999999999999998643 5667788999999
Q ss_pred ccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeC
Q 046275 125 DLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204 (1176)
Q Consensus 125 dLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~ 204 (1176)
||++|.+++.++. .++.+++|++|+|++|+++.++...+..+++|++|+|++|.+++ ++...|..+++|++|+++
T Consensus 79 ~L~~n~l~~l~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~---~~~~~~~~l~~L~~L~L~ 153 (680)
T 1ziw_A 79 NLQHNELSQLSDK--TFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS---TKLGTQVQLENLQELLLS 153 (680)
T ss_dssp ECCSSCCCCCCTT--TTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSC---CCCCSSSCCTTCCEEECC
T ss_pred ECCCCccCccChh--hhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccc---cCchhhcccccCCEEEcc
Confidence 9999999876542 47899999999999999999998889999999999999999987 455667899999999999
Q ss_pred CCccccccc----CCCCCccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhh---ccccCCeEeecccc
Q 046275 205 GNKVTGDIN----VSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAIS---ACEHLSFLNVSSNL 276 (1176)
Q Consensus 205 ~n~l~~~~~----~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~---~l~~L~~L~Ls~N~ 276 (1176)
+|.+++... ...+++|++|++++|++++.++ .+..+.+|+.|++++|.+.......+. ..++|++|++++|.
T Consensus 154 ~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~ 233 (680)
T 1ziw_A 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233 (680)
T ss_dssp SSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSC
T ss_pred CCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCc
Confidence 999986432 3456899999999999998776 488999999999999988643322221 34789999999999
Q ss_pred ccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEE
Q 046275 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356 (1176)
Q Consensus 277 l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~ 356 (1176)
+++..|..+..+. .++|++|+|++|++++..|..|+.+++|++|++++|++++ ++...|..+++|++|+
T Consensus 234 l~~~~~~~~~~l~----------~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 302 (680)
T 1ziw_A 234 LSTTSNTTFLGLK----------WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFNVRYLN 302 (680)
T ss_dssp CCEECTTTTGGGG----------GSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSE-ECTTTTTTCTTCCEEE
T ss_pred ccccChhHhhccC----------cCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCc-cChhhhcCCCCccEEe
Confidence 9987776654331 1469999999999998888999999999999999999985 4445678999999999
Q ss_pred ccCcccCC-----CCcc----cccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCC--CCcccccc--
Q 046275 357 LSFNDFTG-----ALPD----SLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGS--IPSTLSNC-- 423 (1176)
Q Consensus 357 Ls~N~l~~-----~~p~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~--~p~~l~~l-- 423 (1176)
+++|...+ .+|. .+..+++|++|++++|.+++..+..+ ..+++|++|++++|.+... .+..+..+
T Consensus 303 L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~ 380 (680)
T 1ziw_A 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF--TGLINLKYLSLSNSFTSLRTLTNETFVSLAH 380 (680)
T ss_dssp CTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTT--TTCTTCCEEECTTCBSCCCEECTTTTGGGTT
T ss_pred ccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHh--ccccCCcEEECCCCchhhhhcchhhhccccc
Confidence 99886554 2333 78899999999999999998766656 4578999999999986542 22334433
Q ss_pred ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCC-CCCCCccccceeecccccccCccccccccCCCCCeee
Q 046275 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIP-PELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWIS 502 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 502 (1176)
++|+.|++++|++++..|..|..+++|+.|++++|.+.+.+| ..+.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 589999999999999999999999999999999999998776 6899999999999999999999999999999999999
Q ss_pred ccccccC--CCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccc
Q 046275 503 LSNNHLG--GEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKK 580 (1176)
Q Consensus 503 Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~ 580 (1176)
+++|.++ +.+|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++. +...+.
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~-------------- 525 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL-WKHANP-------------- 525 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGG-GSTTST--------------
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCcccc-chhhcc--------------
Confidence 9999987 57899999999999999999999987788899999999999999999742 111000
Q ss_pred eeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccc
Q 046275 581 YVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMS 660 (1176)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~ 660 (1176)
+.....|..+.+|++|||++|+++...+..|++++
T Consensus 526 ---------------------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 560 (680)
T 1ziw_A 526 ---------------------------------------------GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560 (680)
T ss_dssp ---------------------------------------------TSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ---------------------------------------------CCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence 00112355678899999999999954445799999
Q ss_pred cceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcc-ccccccccccccccccCCCCC
Q 046275 661 YLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMS-SLTLLNEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 661 ~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~-~l~~L~~l~ls~N~l~g~~p~ 726 (1176)
+|+.|+|++|++++..|..|+.+++|+.|+|++|+|++..|..+. .+++|+.|+|++|++...-+.
T Consensus 561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999999966666789999999999999999987777777 799999999999999887654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=545.30 Aligned_cols=516 Identities=21% Similarity=0.255 Sum_probs=431.2
Q ss_pred CccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCcc
Q 046275 120 FLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELK 199 (1176)
Q Consensus 120 ~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~ 199 (1176)
++++|||++|.+++..+ ..++.+++|++|+|++|+|+.+....+..+++|++|+|++|++++ ++...|.++++|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~---~~~~~~~~l~~L~ 108 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQN--TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF---MAETALSGPKALK 108 (606)
T ss_dssp TCCEEECTTCCCSEECT--TTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE---ECTTTTSSCTTCC
T ss_pred cCcEEEccCCccCcCCh--hHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc---cChhhhccccccc
Confidence 46667777776665433 246777788888888887777777777777788888888888775 4445677788888
Q ss_pred EEEeCCCcccc--cccCCCCCccceeeccCCcccccC-CCccCCCCCcEEEcCCCcCCCCcChhhhccccCC--eEeecc
Q 046275 200 QLALKGNKVTG--DINVSKCKNLQFLDVSSNNFSMAV-PSFGDCLALEYLDISANKFTGDVGHAISACEHLS--FLNVSS 274 (1176)
Q Consensus 200 ~L~L~~n~l~~--~~~~~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~--~L~Ls~ 274 (1176)
+|++++|.++. ...+..+++|++|++++|+++++. +.+..+++|++|++++|++++..+..++.+++|+ .|++++
T Consensus 109 ~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~ 188 (606)
T 3t6q_A 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188 (606)
T ss_dssp EEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTT
T ss_pred EeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCC
Confidence 88888888876 356788899999999999998753 5566699999999999999988888899999999 899999
Q ss_pred ccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCc----ccCCHHHHhcCC
Q 046275 275 NLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFS----GELPIEIFLSMS 350 (1176)
Q Consensus 275 N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~i~~~~~~~l~ 350 (1176)
|.+++..|..+. ..+|+.|++++|.. ++..+..+.++....+..+.+. ..++...|..+.
T Consensus 189 n~l~~~~~~~~~-------------~~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 189 NDIAGIEPGAFD-------------SAVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp CCCCEECTTTTT-------------TCEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred CccCccChhHhh-------------hccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 999876665432 24789999998872 3445555555555544433332 245555666654
Q ss_pred --CCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcE
Q 046275 351 --NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVS 428 (1176)
Q Consensus 351 --~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 428 (1176)
+|++|++++|.+++..+..|.++++|++|++++|+++ .+|..+ ..+++|++|++++|.+++..|..+.++++|++
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l--~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL--VGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSC--CSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhh--cccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 7999999999999888888999999999999999998 788876 45789999999999999888899999999999
Q ss_pred EEcCCccccCCCCc-cccCCCccCeeecccccccCCC--CCCCCCccccceeecccccccCccccccccCCCCCeeeccc
Q 046275 429 LHLSFNYLTGTIPS-SLGSLSKLQDLKLWLNQLHGEI--PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505 (1176)
Q Consensus 429 L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 505 (1176)
|++++|.+.+.+|. .+..+++|++|++++|.+.+.. |..++.+++|++|++++|++++..|..|.++++|++|++++
T Consensus 330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 409 (606)
T 3t6q_A 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409 (606)
T ss_dssp EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence 99999999877765 5899999999999999999776 88899999999999999999989999999999999999999
Q ss_pred cccCCCCCc-cccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCccc-CChhHHhhcccchhhhccccceee
Q 046275 506 NHLGGEIPT-WIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGS-IPPALFKQSGKIAANFIVGKKYVY 583 (1176)
Q Consensus 506 N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~-ip~~~~~~~~~l~~~~~~~~~~~~ 583 (1176)
|++++..|. .+..+++|++|++++|.+.+..|..+..+++|+.|+|++|++++. +|..
T Consensus 410 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------- 469 (606)
T 3t6q_A 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT-------------------- 469 (606)
T ss_dssp CCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSS--------------------
T ss_pred CcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccc--------------------
Confidence 999987665 489999999999999999999999999999999999999999752 1110
Q ss_pred eecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccce
Q 046275 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLF 663 (1176)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~ 663 (1176)
..+..+.+|++|||++|++++.+|..|+++++|+
T Consensus 470 ----------------------------------------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 503 (606)
T 3t6q_A 470 ----------------------------------------------NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503 (606)
T ss_dssp ----------------------------------------------CGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ----------------------------------------------hhhccCCCccEEECCCCccCccChhhhccccCCC
Confidence 0133456799999999999999999999999999
Q ss_pred eeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCC
Q 046275 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 664 ~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~ 726 (1176)
.|+|++|++++.+|..+++++.| +|+|++|++++.+|..+..+++|+.|++++|++++..+.
T Consensus 504 ~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp EEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred EEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99999999999999999999999 999999999998888899999999999999999987663
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=541.98 Aligned_cols=557 Identities=24% Similarity=0.228 Sum_probs=437.1
Q ss_pred cccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCC-CCCccccccccccCCCcEEEc
Q 046275 98 LSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSN-LLDFSGREAGSLKLSLEVLDL 176 (1176)
Q Consensus 98 L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n-~i~~~~~~~~~~~~~L~~LdL 176 (1176)
.|.++++++ .+|. ..++|++||||+|.+++..+ ..++.+++|++|+|++| .+..++...+..+++|++|+|
T Consensus 9 ~dcs~~~L~---~vP~---lp~~l~~LdLs~N~i~~i~~--~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~L 80 (844)
T 3j0a_A 9 AFYRFCNLT---QVPQ---VLNTTERLLLSFNYIRTVTA--SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80 (844)
T ss_dssp EEESCCCSS---CCCS---SCTTCCEEEEESCCCCEECS--SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEEC
T ss_pred EEccCCCCC---CCCC---CCCCcCEEECCCCcCCccCh--hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEEC
Confidence 455566665 3444 34678888888888876543 34788888888888888 556676777888888888999
Q ss_pred cCCCCCCCCccccccccCCCCccEEEeCCCcccc--cc--cCCCCCccceeeccCCcccccCC--CccCCCCCcEEEcCC
Q 046275 177 SYNKISGANVVPWILFNGCDELKQLALKGNKVTG--DI--NVSKCKNLQFLDVSSNNFSMAVP--SFGDCLALEYLDISA 250 (1176)
Q Consensus 177 s~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~--~~--~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~ 250 (1176)
++|+|++ +....|.++++|++|+|++|.+++ .. .+..+++|++|+|++|.+++..+ .|+++++|++|+|++
T Consensus 81 s~N~l~~---~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~ 157 (844)
T 3j0a_A 81 GSSKIYF---LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157 (844)
T ss_dssp TTCCCCE---ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEES
T ss_pred CCCcCcc---cCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCC
Confidence 8888876 555668888889999999988876 22 27889999999999999987643 589999999999999
Q ss_pred CcCCCCcChhhhcc--ccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCC---C
Q 046275 251 NKFTGDVGHAISAC--EHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSC---S 325 (1176)
Q Consensus 251 N~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l---~ 325 (1176)
|.+++..+..+..+ ++|+.|+++.|.+.+..|..+..... .+.. ..|+.|++++|.+++..+..+... +
T Consensus 158 N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~-----~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~l~~~ 231 (844)
T 3j0a_A 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN-----PFRN-MVLEILDVSGNGWTVDITGNFSNAISKS 231 (844)
T ss_dssp SCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC-----TTTT-CCBSEEBCSSCCSSTTTTSGGGGTSCSC
T ss_pred CcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCC-----cccc-CceeEEecCCCcCchhHHHHHHhhcCcc
Confidence 99999999999888 89999999999999877766544321 1111 359999999999988877776544 6
Q ss_pred CCcEEEccCCcCcc--------cCCHHHHhcC--CCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCcccc
Q 046275 326 SLESFDISSNKFSG--------ELPIEIFLSM--SNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLC 395 (1176)
Q Consensus 326 ~L~~L~Ls~N~l~~--------~i~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 395 (1176)
+++.|.++.+.+.. .+....|.++ ++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..+
T Consensus 232 ~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~- 310 (844)
T 3j0a_A 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF- 310 (844)
T ss_dssp CBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTT-
T ss_pred cccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHh-
Confidence 78888887433321 2233344444 789999999999998888999999999999999999997777666
Q ss_pred CCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccc
Q 046275 396 QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLE 475 (1176)
Q Consensus 396 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 475 (1176)
..+++|++|+|++|.+++..|..|..+++|+.|++++|++++..+..|..+++|+.|+|++|.+++ + ..+++|+
T Consensus 311 -~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i----~~~~~L~ 384 (844)
T 3j0a_A 311 -YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-I----HFIPSIP 384 (844)
T ss_dssp -TTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-C----SSCCSCS
T ss_pred -cCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-c----cCCCCcc
Confidence 456889999999999998889999999999999999999998888889999999999999999983 3 3378899
Q ss_pred eeecccccccCccccccccCCCCCeeeccccccCCCC-CccccCCCCCCeEEccCCcccccCCC-CCCCCCCCCEEEccC
Q 046275 476 TLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEI-PTWIGQLSNLAILKLSNNSFYGRIPP-ELGDCRSLIWLDLNT 553 (1176)
Q Consensus 476 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~ 553 (1176)
.|++++|+++ .+|.. ..+++.|++++|++++.. +..++.+++|++|+|++|++++..+. .+..+++|+.|+|++
T Consensus 385 ~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~ 460 (844)
T 3j0a_A 385 DIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460 (844)
T ss_dssp EEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEES
T ss_pred hhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCC
Confidence 9999999999 55544 467899999999998632 33466899999999999999865443 466789999999999
Q ss_pred CCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcC
Q 046275 554 NLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFN 633 (1176)
Q Consensus 554 N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 633 (1176)
|.+++..+.. .....|.
T Consensus 461 N~l~~~~~~~---------------------------------------------------------------~~~~~~~ 477 (844)
T 3j0a_A 461 NMLQLAWETE---------------------------------------------------------------LCWDVFE 477 (844)
T ss_dssp CCCSSSCCSC---------------------------------------------------------------CCSSCSS
T ss_pred Cccccccccc---------------------------------------------------------------cchhhhc
Confidence 9987422110 0112355
Q ss_pred CCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccccccc
Q 046275 634 HNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEI 713 (1176)
Q Consensus 634 ~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l 713 (1176)
.+.+|+.|||++|+|++.+|..|+++++|+.|+|++|+|++..|..+. ++|+.|||++|+|+|.+|..+. +|+.|
T Consensus 478 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l 552 (844)
T 3j0a_A 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVL 552 (844)
T ss_dssp CBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEE
T ss_pred CcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEE
Confidence 667899999999999999999999999999999999999976666665 8999999999999999998764 68899
Q ss_pred ccccccccCCCCCCCCccccCCccccCCCCCCCCCCC-CCCC
Q 046275 714 DLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLP-PCEK 754 (1176)
Q Consensus 714 ~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~~~~~~-~c~~ 754 (1176)
++++|++....+.. .|.......|..+||.|.. .|..
T Consensus 553 ~l~~Np~~C~c~~~----~f~~~~~~~~~~~~~~~~~~~C~~ 590 (844)
T 3j0a_A 553 DITHNKFICECELS----TFINWLNHTNVTIAGPPADIYCVY 590 (844)
T ss_dssp EEEEECCCCSSSCC----SHHHHHHHTTTTTCCCGGGCCCSS
T ss_pred EecCCCcccccccH----HHHHHHHhcCcccccccccCccCC
Confidence 99999998766532 2222223445566666543 5643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=528.01 Aligned_cols=528 Identities=21% Similarity=0.179 Sum_probs=444.9
Q ss_pred cccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEE
Q 046275 96 ETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLD 175 (1176)
Q Consensus 96 ~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~Ld 175 (1176)
+.++.+++.++ .+|..+. ++|++|||++|.+++..+ ..++++++|++|+|++|+|+.++...+..+++|++|+
T Consensus 14 ~~~~c~~~~l~---~ip~~~~--~~l~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~ 86 (606)
T 3vq2_A 14 ITYQCMDQKLS---KVPDDIP--SSTKNIDLSFNPLKILKS--YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLI 86 (606)
T ss_dssp TEEECTTSCCS---SCCTTSC--TTCCEEECTTSCCCEECT--TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CceEccCCCcc---cCCCCCC--CCcCEEECCCCCcCEeCh--hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeE
Confidence 57889999887 4565443 789999999999987654 2578999999999999999999888899999999999
Q ss_pred ccCCCCCCCCccccccccCCCCccEEEeCCCccccc--ccCCCCCccceeeccCCcccc--cCCCccCCCCCcEEEcCCC
Q 046275 176 LSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD--INVSKCKNLQFLDVSSNNFSM--AVPSFGDCLALEYLDISAN 251 (1176)
Q Consensus 176 Ls~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~--~~~~l~~l~~L~~L~Ls~N 251 (1176)
|++|+|++ ++...|.++++|++|+|++|.++.. ..+..+++|++|++++|.+++ ++..++++++|++|++++|
T Consensus 87 Ls~n~l~~---~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 87 LTGNPIQS---FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp CTTCCCCC---CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred CCCCcccc---cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999987 5556788999999999999999863 468899999999999999985 4567899999999999999
Q ss_pred cCCCCcChhhhccccCC----eEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCccc-ccCCccccCCCC
Q 046275 252 KFTGDVGHAISACEHLS----FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS-GKVPSRFGSCSS 326 (1176)
Q Consensus 252 ~l~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~ 326 (1176)
++++..+..++.+.+|+ +|++++|.+++..+. .+.. .+|+.|++++|.++ +..|..+.++++
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~------------~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~ 230 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ------------AFQG-IKLHELTLRGNFNSSNIMKTCLQNLAG 230 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTT------------TTTT-CEEEEEEEESCCSCHHHHHHHHHTTTT
T ss_pred cceecChhhhhhhhccccccceeeccCCCcceeCcc------------cccC-ceeeeeeccCCccchhHHHHHhccccc
Confidence 99988888888888776 799999998844333 3333 37999999999987 467788899999
Q ss_pred CcEEEccCCcCcc-----cCCHHHHhcCC--CCCEEEc-cCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCC
Q 046275 327 LESFDISSNKFSG-----ELPIEIFLSMS--NLKELVL-SFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGP 398 (1176)
Q Consensus 327 L~~L~Ls~N~l~~-----~i~~~~~~~l~--~L~~L~L-s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 398 (1176)
|+.+++..+.+.+ .++...+..+. .++.+++ ..|.+++.+|. +..+++|+.|++++|.+. .+| .+ ..
T Consensus 231 L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l--~~ 305 (606)
T 3vq2_A 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DV--PK 305 (606)
T ss_dssp CEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CC--CT
T ss_pred cccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hc--cc
Confidence 9998887655532 23333343333 4666777 67888888777 899999999999999997 566 44 45
Q ss_pred CCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC--CCCCCCCccccce
Q 046275 399 RNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE--IPPELGNIQTLET 476 (1176)
Q Consensus 399 ~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~ 476 (1176)
+++|++|++++|.+ +.+| .+ .+++|+.|++++|+..+.+ .+..+++|++|++++|.+++. +|..+..+++|++
T Consensus 306 ~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~ 380 (606)
T 3vq2_A 306 HFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380 (606)
T ss_dssp TCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCE
T ss_pred cccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccE
Confidence 67899999999999 5788 45 8999999999999765444 677899999999999999866 4888899999999
Q ss_pred eecccccccCccccccccCCCCCeeeccccccCCCCC-ccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCC
Q 046275 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIP-TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNL 555 (1176)
Q Consensus 477 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 555 (1176)
|+|++|.+++ +|..|.++++|+.|++++|++.+..| ..+..+++|++|++++|.+.+.+|..+..+++|+.|++++|+
T Consensus 381 L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 459 (606)
T 3vq2_A 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459 (606)
T ss_dssp EECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred eECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCc
Confidence 9999999984 67889999999999999999998877 689999999999999999999999999999999999999999
Q ss_pred Cccc-CChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCC
Q 046275 556 FNGS-IPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNH 634 (1176)
Q Consensus 556 l~g~-ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (1176)
+++. +|. .|..
T Consensus 460 l~~~~~~~--------------------------------------------------------------------~~~~ 471 (606)
T 3vq2_A 460 FKDNTLSN--------------------------------------------------------------------VFAN 471 (606)
T ss_dssp EGGGEECS--------------------------------------------------------------------CCTT
T ss_pred CCCcchHH--------------------------------------------------------------------hhcc
Confidence 8863 232 1334
Q ss_pred CCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccc-ccccc
Q 046275 635 NGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLT-LLNEI 713 (1176)
Q Consensus 635 ~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~-~L~~l 713 (1176)
+.+|++|||++|++++.+|..|+++++|+.|+|++|++++.+|..|+.+++|++|||++|+|+ .+|..+..++ +|+.|
T Consensus 472 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l 550 (606)
T 3vq2_A 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFF 550 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEE
T ss_pred CCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEE
Confidence 567999999999999999999999999999999999999989999999999999999999999 7999899997 59999
Q ss_pred ccccccccCCCCC
Q 046275 714 DLCNNQLTGMIPV 726 (1176)
Q Consensus 714 ~ls~N~l~g~~p~ 726 (1176)
++++|++.+..|.
T Consensus 551 ~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 551 NLTNNSVACICEH 563 (606)
T ss_dssp ECCSCCCCCSSTT
T ss_pred EccCCCcccCCcc
Confidence 9999999987664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=521.94 Aligned_cols=526 Identities=21% Similarity=0.201 Sum_probs=434.9
Q ss_pred ccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEE
Q 046275 123 SLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLA 202 (1176)
Q Consensus 123 ~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~ 202 (1176)
.+|.++..++..+..+ .+.+++|+|++|+|+.++...+..+++|++|+|++|+|++ +....|.++++|++|+
T Consensus 16 ~~~c~~~~l~~iP~~l-----~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~---~~~~~~~~l~~L~~L~ 87 (606)
T 3t6q_A 16 TYNCENLGLNEIPGTL-----PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW---IHEDTFQSQHRLDTLV 87 (606)
T ss_dssp EEECTTSCCSSCCTTS-----CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCE---ECTTTTTTCTTCCEEE
T ss_pred eEECCCCCcccCcCCC-----CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccce---eChhhccCccccCeee
Confidence 4556666665544332 2478999999999999988889999999999999999986 5667789999999999
Q ss_pred eCCCccccc--ccCCCCCccceeeccCCcccccC-CCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccC
Q 046275 203 LKGNKVTGD--INVSKCKNLQFLDVSSNNFSMAV-PSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279 (1176)
Q Consensus 203 L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (1176)
|++|.++.. ..+..+++|++|++++|+++++. ..+.++++|++|++++|++++.....+..+++|++|++++|.+++
T Consensus 88 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 167 (606)
T 3t6q_A 88 LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167 (606)
T ss_dssp CTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred CCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence 999999863 46889999999999999999874 468999999999999999998654555669999999999999874
Q ss_pred ccCCCCccccCcchhhhhhcCCCcc--EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEc
Q 046275 280 PIPVGYNEFQGEIPLHLADLCSSLV--KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVL 357 (1176)
Q Consensus 280 ~~p~~~~~l~~~i~~~~~~~l~~L~--~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~L 357 (1176)
. +...+..+++|+ .|++++|.+++..|..+.. .+|+.|++++|... + ..+..+.++....+
T Consensus 168 ~------------~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~---~-~~~~~l~~~~l~~l 230 (606)
T 3t6q_A 168 L------------SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNL---L-VIFKGLKNSTIQSL 230 (606)
T ss_dssp E------------CHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCH---H-HHHHHTTTCEEEEE
T ss_pred c------------ChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhH---H-HHhhhccccchhhe
Confidence 3 333444567888 8999999999777766654 68999999998732 2 34566766665555
Q ss_pred cCcccCC-----CCcccccCCC--CCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEE
Q 046275 358 SFNDFTG-----ALPDSLSNLT--NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLH 430 (1176)
Q Consensus 358 s~N~l~~-----~~p~~l~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 430 (1176)
..+.+.+ ..+..+..+. +|+.|++++|.+++..+..+ ..+++|++|++++|+++ .+|..+.++++|++|+
T Consensus 231 ~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~ 307 (606)
T 3t6q_A 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF--HCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307 (606)
T ss_dssp ECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTT--TTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEE
T ss_pred echhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHh--ccccCCCEEeccCCccC-CCChhhcccccCCEEE
Confidence 4443332 2223333333 78999999999986655555 45788999999999998 7888899999999999
Q ss_pred cCCccccCCCCccccCCCccCeeecccccccCCCCCC-CCCccccceeecccccccCcc--ccccccCCCCCeeeccccc
Q 046275 431 LSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE-LGNIQTLETLFLDFNELTGTL--PAALSNCTNLNWISLSNNH 507 (1176)
Q Consensus 431 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~ 507 (1176)
+++|++++..|..+..+++|++|++++|.+.+.+|.. +..+++|++|++++|++++.. |..+.++++|++|++++|+
T Consensus 308 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 387 (606)
T 3t6q_A 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387 (606)
T ss_dssp CTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCS
T ss_pred CccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCc
Confidence 9999999888889999999999999999998777664 899999999999999999766 7889999999999999999
Q ss_pred cCCCCCccccCCCCCCeEEccCCcccccCCCC-CCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeec
Q 046275 508 LGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKN 586 (1176)
Q Consensus 508 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (1176)
+++..|..+..+++|++|++++|++.+..|.. +..+++|+.|++++|.+++..|..
T Consensus 388 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------------- 444 (606)
T 3t6q_A 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL----------------------- 444 (606)
T ss_dssp CEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTT-----------------------
T ss_pred CCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHH-----------------------
Confidence 99888999999999999999999999877655 889999999999999998654432
Q ss_pred CCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccC---CCccccccccce
Q 046275 587 DGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGS---IPKEIGSMSYLF 663 (1176)
Q Consensus 587 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~---iP~~~~~l~~L~ 663 (1176)
+..+.+|++|+|++|++++. .+..++.+++|+
T Consensus 445 ---------------------------------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 445 ---------------------------------------------FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp ---------------------------------------------TTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred ---------------------------------------------HhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 23345799999999999973 346799999999
Q ss_pred eeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCC-CCccccCCccccCCC
Q 046275 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM-GQFETFQPAKFLNNS 742 (1176)
Q Consensus 664 ~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~ 742 (1176)
.|+|++|++++.+|..|+.+++|++|||++|++++.+|..+.+++.| .|||++|++++.+|.. +.+..+....+.+|+
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 558 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence 99999999999999999999999999999999999999999999999 9999999999998863 456667777788887
Q ss_pred CCC
Q 046275 743 GLC 745 (1176)
Q Consensus 743 ~l~ 745 (1176)
..|
T Consensus 559 ~~c 561 (606)
T 3t6q_A 559 LDC 561 (606)
T ss_dssp EEC
T ss_pred ccc
Confidence 666
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=536.66 Aligned_cols=444 Identities=19% Similarity=0.230 Sum_probs=286.1
Q ss_pred hHHHHHHHHHHhcCCCCC---------CCCCCCCCCCCccc---ceeEeCC-CcEEEEecCCccccccchhhhhhhcCcc
Q 046275 27 NKDLQQLLSFKAALPNPS---------VLPNWSPNQNPCGF---KGVSCKA-ASVSSIDLSPFTLSVDFHLVASFLLTLD 93 (1176)
Q Consensus 27 ~~~~~~ll~~k~~~~~~~---------~l~~w~~~~~cC~W---~gv~C~~-~~v~~l~L~~~~~~~~~~~~~~~l~~~~ 93 (1176)
..|+.||.+||.++.++. ...+|..++|||.| .||+|+. ++|++|+|++.++.+ .++..++.++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g---~lp~~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASG---RVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEE---EECGGGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCC---cCChHHhcCc
Confidence 579999999999986331 34589999999999 9999987 589999999877764 3445677888
Q ss_pred cccccccCCCCCCCcc----------cCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccc
Q 046275 94 TLETLSLKNSNISGTI----------SLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGRE 163 (1176)
Q Consensus 94 ~L~~L~L~~n~l~g~~----------~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~ 163 (1176)
+|+.|+|++|.+.... .+|.. .+.+|+ +++++|.+.+..+ ..
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~--~~~~l~-l~l~~~~l~~~~~-------------------------~~ 157 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDE--QKQKMR-MHYQKTFVDYDPR-------------------------ED 157 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHH--HHHHHH-THHHHHHTCCCGG-------------------------GG
T ss_pred cceEEECcCCccccCCccccccccccCchHH--HHHHHH-hhHHHhhhccCch-------------------------hh
Confidence 8888888887653110 00100 012233 3333333332111 00
Q ss_pred cccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCC
Q 046275 164 AGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLAL 243 (1176)
Q Consensus 164 ~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L 243 (1176)
....+..+..+++....+.. .....++.+.+.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~-------------------------------~~~~~l~~l~l~----------------- 189 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK-------------------------------SSRITLKDTQIG----------------- 189 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC-------------------------------CCCCCCCTTTTT-----------------
T ss_pred HHHHHHHHhhcCcccccccc-------------------------------ccccchhhhhhc-----------------
Confidence 00011111111111111110 000111111111
Q ss_pred cEEEcCCCcCCCCcChhhhccccCCeEeeccccccCc------cCCCCccccCcchhhhh-hcCCCccEEEccCCccccc
Q 046275 244 EYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGP------IPVGYNEFQGEIPLHLA-DLCSSLVKLDLSSNNLSGK 316 (1176)
Q Consensus 244 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~------~p~~~~~l~~~i~~~~~-~~l~~L~~L~L~~n~l~~~ 316 (1176)
..+|++++ +|..++++++|++|+|++|.+++. +|.....+.+.+|..+. ..+++|++|+|++|++.+.
T Consensus 190 ----~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 190 ----QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp ----CCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred ----cccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 11234444 444444444444444444444432 00000000001222221 1346677777777777777
Q ss_pred CCccccCCCCCcEEEccCCc-Ccc-cCCHHHHhcC------CCCCEEEccCcccCCCCcc--cccCCCCCCEEEccCCcC
Q 046275 317 VPSRFGSCSSLESFDISSNK-FSG-ELPIEIFLSM------SNLKELVLSFNDFTGALPD--SLSNLTNLETLDLSSNNL 386 (1176)
Q Consensus 317 ~p~~~~~l~~L~~L~Ls~N~-l~~-~i~~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l 386 (1176)
+|..|+++++|++|++++|+ ++| .+|..+ ..+ ++|++|+|++|.++ .+|. .++++++|++|+|++|++
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~-~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l 342 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDW-QALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQL 342 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHH-HHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCC
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHH-HhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcC
Confidence 77778888888888888887 776 677665 333 78888888888888 6777 788888888888888888
Q ss_pred CCCCCccccCCCCCCccEEEccCccccCCCCcccccccc-CcEEEcCCccccCCCCccccCCC--ccCeeecccccccCC
Q 046275 387 SGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ-LVSLHLSFNYLTGTIPSSLGSLS--KLQDLKLWLNQLHGE 463 (1176)
Q Consensus 387 ~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~ 463 (1176)
+|.+| .+ ..+++|++|+|++|+++ .+|..+.++++ |++|++++|+++ .+|..+..++ +|+.|++++|.+++.
T Consensus 343 ~g~ip-~~--~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 343 EGKLP-AF--GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp EEECC-CC--EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred ccchh-hh--CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 87777 44 34567888888888888 77778888888 888888888888 7787777655 788888888888888
Q ss_pred CCCCCC-------CccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccC-CC-------CCCeEEcc
Q 046275 464 IPPELG-------NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ-LS-------NLAILKLS 528 (1176)
Q Consensus 464 ~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~-------~L~~L~L~ 528 (1176)
+|..+. .+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+.. +. +|++|+|+
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECC
T ss_pred chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECc
Confidence 888887 7788888888888888544455667888888999988888 56654333 22 88899999
Q ss_pred CCcccccCCCCCC--CCCCCCEEEccCCCCcccCChhH
Q 046275 529 NNSFYGRIPPELG--DCRSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 529 ~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
+|+++ .+|..+. .+++|+.|+|++|++++ +|..+
T Consensus 497 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~ 532 (636)
T 4eco_A 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532 (636)
T ss_dssp SSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGG
T ss_pred CCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhh
Confidence 99888 7888876 88888888888888876 66543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=520.39 Aligned_cols=509 Identities=19% Similarity=0.142 Sum_probs=435.5
Q ss_pred ccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCc
Q 046275 93 DTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLE 172 (1176)
Q Consensus 93 ~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~ 172 (1176)
+.+++|+|++|.+++.. +..+..+++|++|||++|.+++..+. .+.++++|++|+|++|+|+.+....+..+++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~Ls~n~l~~i~~~--~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 107 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILK--SYSFSNFSELQWLDLSRCEIETIEDK--AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE 107 (606)
T ss_dssp TTCCEEECTTSCCCEEC--TTTTTTCTTCCEEECTTCCCCEECTT--TTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCC
T ss_pred CCcCEEECCCCCcCEeC--hhhccCCccCcEEeCCCCcccccCHH--HhhchhhcCEeECCCCcccccChhhcCCcccCC
Confidence 68999999999998543 45678899999999999999876543 478999999999999999999888899999999
Q ss_pred EEEccCCCCCCCCccccccccCCCCccEEEeCCCcccc---cccCCCCCccceeeccCCcccccCC-CccCCCCCc----
Q 046275 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG---DINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALE---- 244 (1176)
Q Consensus 173 ~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~---~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~---- 244 (1176)
+|+|++|++++ ++...|.++++|++|++++|.+++ +..+..+++|++|++++|+++++++ .+..+.+|+
T Consensus 108 ~L~L~~n~l~~---~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~ 184 (606)
T 3vq2_A 108 NLVAVETKLAS---LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184 (606)
T ss_dssp EEECTTSCCCC---SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCC
T ss_pred EEEccCCcccc---ccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccc
Confidence 99999999987 454558999999999999999985 4568999999999999999998765 477776665
Q ss_pred EEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccc------cCC
Q 046275 245 YLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG------KVP 318 (1176)
Q Consensus 245 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~------~~p 318 (1176)
+|++++|.+++..+..+... +|++|++++|.+++ ......+..+++|+.+++..+.+.+ ..+
T Consensus 185 ~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~-----------~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~ 252 (606)
T 3vq2_A 185 SLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSS-----------NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252 (606)
T ss_dssp EEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCH-----------HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCG
T ss_pred eeeccCCCcceeCcccccCc-eeeeeeccCCccch-----------hHHHHHhccccccccccccccccccCCcccccCh
Confidence 89999999998777777665 89999999998863 2223344567889988886555432 111
Q ss_pred ccccCCC--CCcEEEc-cCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCcccc
Q 046275 319 SRFGSCS--SLESFDI-SSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLC 395 (1176)
Q Consensus 319 ~~~~~l~--~L~~L~L-s~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 395 (1176)
..+..+. +++.+++ ..|.+++.+|. |..+++|++|++++|.++ .+| .+..+++|++|++++|.+ +.+|. +
T Consensus 253 ~~~~~l~~l~l~~l~l~~~~~~~~~~~~--~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~-~- 325 (606)
T 3vq2_A 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVK--FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPT-L- 325 (606)
T ss_dssp GGGTTGGGSEEEEEEECCCTTCCGGGGS--CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCC-C-
T ss_pred HHhhhhhhccHhheeccccccccccccc--cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-ccccc-C-
Confidence 2222222 4677777 77888877775 789999999999999997 556 899999999999999999 58883 3
Q ss_pred CCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCC--CCccccCCCccCeeecccccccCCCCCCCCCccc
Q 046275 396 QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGT--IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQT 473 (1176)
Q Consensus 396 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 473 (1176)
.+++|++|++++|...+.. .+..+++|++|++++|++++. +|..+..+++|++|++++|.+. .+|..+..+++
T Consensus 326 --~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~ 400 (606)
T 3vq2_A 326 --DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE 400 (606)
T ss_dssp --CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTT
T ss_pred --CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCC
Confidence 5789999999999765444 677899999999999999865 4889999999999999999998 47789999999
Q ss_pred cceeecccccccCccc-cccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc-cCCCCCCCCCCCCEEEc
Q 046275 474 LETLFLDFNELTGTLP-AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG-RIPPELGDCRSLIWLDL 551 (1176)
Q Consensus 474 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L 551 (1176)
|++|++++|++++..| ..|.++++|++|++++|++++..|..++.+++|++|+|++|++++ .+|..++.+++|+.|+|
T Consensus 401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L 480 (606)
T 3vq2_A 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480 (606)
T ss_dssp CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEEC
Confidence 9999999999998887 789999999999999999999999999999999999999999998 47999999999999999
Q ss_pred cCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCC
Q 046275 552 NTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPT 631 (1176)
Q Consensus 552 ~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 631 (1176)
++|++++..|..
T Consensus 481 s~n~l~~~~~~~-------------------------------------------------------------------- 492 (606)
T 3vq2_A 481 SKCQLEQISWGV-------------------------------------------------------------------- 492 (606)
T ss_dssp TTSCCCEECTTT--------------------------------------------------------------------
T ss_pred CCCcCCccChhh--------------------------------------------------------------------
Confidence 999998755432
Q ss_pred cCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcC-cccEEEccCccccccCC
Q 046275 632 FNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR-GLNILDLSSNRLEGTIP 701 (1176)
Q Consensus 632 ~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~-~L~~L~Ls~N~l~g~iP 701 (1176)
|..+.+|++|+|++|++++.+|..|+++++|+.|+|++|+|+ .+|..+..++ +|++|++++|.+.+..|
T Consensus 493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred hcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 233467999999999999999999999999999999999999 8998899997 69999999999997655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=529.47 Aligned_cols=528 Identities=23% Similarity=0.194 Sum_probs=405.7
Q ss_pred cccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEE
Q 046275 122 SSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQL 201 (1176)
Q Consensus 122 ~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L 201 (1176)
+..|.+++.++..+. ..++|++|+|++|.|+.+....+..+++|++|||++|.+.. .++...|.++++|++|
T Consensus 7 ~~~dcs~~~L~~vP~------lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~--~i~~~~f~~L~~L~~L 78 (844)
T 3j0a_A 7 RIAFYRFCNLTQVPQ------VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL--TIDKEAFRNLPNLRIL 78 (844)
T ss_dssp EEEEESCCCSSCCCS------SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCC--EECTTTTSSCTTCCEE
T ss_pred eEEEccCCCCCCCCC------CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCcc--ccCHHHhcCCCCCCEE
Confidence 357788888876543 34789999999999999988889999999999999996543 3666778999999999
Q ss_pred EeCCCcccc--cccCCCCCccceeeccCCccccc-CCC--ccCCCCCcEEEcCCCcCCCCcC-hhhhccccCCeEeeccc
Q 046275 202 ALKGNKVTG--DINVSKCKNLQFLDVSSNNFSMA-VPS--FGDCLALEYLDISANKFTGDVG-HAISACEHLSFLNVSSN 275 (1176)
Q Consensus 202 ~L~~n~l~~--~~~~~~l~~L~~L~Ls~N~l~~~-~~~--l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N 275 (1176)
+|++|.+.. +..+..+++|++|+|++|.+++. ++. +.++++|++|+|++|.+++..+ ..|+++++|++|+|++|
T Consensus 79 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N 158 (844)
T 3j0a_A 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158 (844)
T ss_dssp ECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred ECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence 999999986 45688999999999999999863 333 8899999999999999987755 67899999999999999
Q ss_pred cccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCC------CcEEEccCCcCcccCCHHHHhc-
Q 046275 276 LFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSS------LESFDISSNKFSGELPIEIFLS- 348 (1176)
Q Consensus 276 ~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~i~~~~~~~- 348 (1176)
.+++..|..+..+. .++|+.|+|++|.+.+..|..+..+++ |++|++++|.+++.++..+...
T Consensus 159 ~i~~~~~~~l~~l~----------~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l 228 (844)
T 3j0a_A 159 QIFLVCEHELEPLQ----------GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228 (844)
T ss_dssp CCCCCCSGGGHHHH----------HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTS
T ss_pred cCCeeCHHHccccc----------CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhc
Confidence 99866555433221 168999999999999888877777665 9999999999887777665433
Q ss_pred -CCCCCEEEccCc---------ccCCCCcccccCC--CCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCC
Q 046275 349 -MSNLKELVLSFN---------DFTGALPDSLSNL--TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416 (1176)
Q Consensus 349 -l~~L~~L~Ls~N---------~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~ 416 (1176)
.++++.|.++.+ .+.+..+..+..+ ++|+.|+|++|.+.+..|..+ ..+++|+.|+|++|++++..
T Consensus 229 ~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~L~~n~i~~~~ 306 (844)
T 3j0a_A 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF--ETLKDLKVLNLAYNKINKIA 306 (844)
T ss_dssp CSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS--SSCCCCCEEEEESCCCCEEC
T ss_pred CcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh--hcCCCCCEEECCCCcCCCCC
Confidence 256888887743 3333333444443 567777887777776555554 34567777777777777777
Q ss_pred CccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCC
Q 046275 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCT 496 (1176)
Q Consensus 417 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 496 (1176)
|..|.++++|++|+|++|++++..|..|..+++|+.|++++|.+.+..+..|..+++|++|+|++|.+++ ++ .++
T Consensus 307 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~ 381 (844)
T 3j0a_A 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIP 381 (844)
T ss_dssp TTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCC
T ss_pred hHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCC
Confidence 7777777777777777777776667777777777777777777776666677777777777777777773 22 266
Q ss_pred CCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccC-CCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhh
Q 046275 497 NLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI-PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANF 575 (1176)
Q Consensus 497 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~ 575 (1176)
+|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+..+++|+.|+|++|++++..+..
T Consensus 382 ~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------ 445 (844)
T 3j0a_A 382 SIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ------------ 445 (844)
T ss_dssp SCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSS------------
T ss_pred CcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccc------------
Confidence 7777777777777 45543 456777777777776421 123456777777777777776422110
Q ss_pred ccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCc-----c
Q 046275 576 IVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS-----G 650 (1176)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~-----g 650 (1176)
.+....+|+.|+|++|.++ +
T Consensus 446 -------------------------------------------------------~~~~~~~L~~L~Ls~N~l~~~~~~~ 470 (844)
T 3j0a_A 446 -------------------------------------------------------TPSENPSLEQLFLGENMLQLAWETE 470 (844)
T ss_dssp -------------------------------------------------------SSCSCTTCCBCEEESCCCSSSCCSC
T ss_pred -------------------------------------------------------ccccCCccccccCCCCccccccccc
Confidence 1223457899999999998 5
Q ss_pred CCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCCCc
Q 046275 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQF 730 (1176)
Q Consensus 651 ~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~~~ 730 (1176)
..|..|.++++|+.|+|++|+|++.+|..|+.+++|+.|+|++|+|++..|..+. ++|+.|||++|+|+|.+|.. +
T Consensus 471 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~ 546 (844)
T 3j0a_A 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--F 546 (844)
T ss_dssp CCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--C
T ss_pred cchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--h
Confidence 5567899999999999999999999999999999999999999999976666665 89999999999999999964 5
Q ss_pred cccCCccccCCCCCCCCCC
Q 046275 731 ETFQPAKFLNNSGLCGLPL 749 (1176)
Q Consensus 731 ~~~~~~~~~~n~~l~~~~~ 749 (1176)
..+....+.+|+..|..++
T Consensus 547 ~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 547 VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SSCCEEEEEEECCCCSSSC
T ss_pred CCcCEEEecCCCccccccc
Confidence 5777788999999997654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=532.53 Aligned_cols=540 Identities=19% Similarity=0.229 Sum_probs=345.1
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCCCCCCC-----CC--ccc------------ceeEeCC-CcEEEEecCCccccccchhh
Q 046275 26 PNKDLQQLLSFKAALPNPSVLPNWSPNQ-----NP--CGF------------KGVSCKA-ASVSSIDLSPFTLSVDFHLV 85 (1176)
Q Consensus 26 ~~~~~~~ll~~k~~~~~~~~l~~w~~~~-----~c--C~W------------~gv~C~~-~~v~~l~L~~~~~~~~~~~~ 85 (1176)
..+|+.||++||+++.+| +|+.++ +| |.| .||+|+. ++|++|+|++.++.+ .+
T Consensus 267 ~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G---~i 339 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG---RV 339 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE---EE
T ss_pred chHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC---cC
Confidence 367999999999999877 887554 55 999 9999995 689999998877763 34
Q ss_pred hhhhcCccccccccc-CCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCcccccc
Q 046275 86 ASFLLTLDTLETLSL-KNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREA 164 (1176)
Q Consensus 86 ~~~l~~~~~L~~L~L-~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~ 164 (1176)
+..++++++|+.|+| ++|.++|...+.. .. + .++++...+. .++..++. .-+...+
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~-~~----~-~~~l~~~~l~-------------~lr~~~~~-~~l~~~~--- 396 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGD-EE----L-TPDMSEERKH-------------RIRMHYKK-MFLDYDQ--- 396 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTT-BC----C-CSSCCHHHHH-------------HHHTHHHH-HHTCCCG---
T ss_pred chHHhccccceEeeecccccccccccccc-cc----c-ccccchhHHH-------------HHHHhhhh-hhhccCc---
Confidence 466777777888888 7777766421110 00 0 1111111100 00000000 0000000
Q ss_pred ccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccC--CcccccCCCccCCCC
Q 046275 165 GSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSS--NNFSMAVPSFGDCLA 242 (1176)
Q Consensus 165 ~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~--N~l~~~~~~l~~l~~ 242 (1176)
...++. +....+...+... .........++.+.+.. |+++++|+.++++++
T Consensus 397 -------------~~~~s~---l~~~~l~~~~~~~-----------~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~ 449 (876)
T 4ecn_A 397 -------------RLNLSD---LLQDAINRNPEMK-----------PIKKDSRISLKDTQIGNLTNRITFISKAIQRLTK 449 (876)
T ss_dssp -------------GGGSCH---HHHHHHHTCTTSC-----------CCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTT
T ss_pred -------------chhhhH---HHHHHhhhCcccc-----------ccccccccchhhceeccccCcccchhHHHhcCCC
Confidence 000000 0000000000000 00001112233333332 555555555666666
Q ss_pred CcEEEcCCCcCCCC-cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccc
Q 046275 243 LEYLDISANKFTGD-VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRF 321 (1176)
Q Consensus 243 L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~ 321 (1176)
|++|+|++|+|++. ++... +..+.|.++|.+|..+. +..+++|++|+|++|++.+.+|..|
T Consensus 450 L~~L~Ls~N~Lsg~~i~~~~--------~~~s~n~~~g~iP~~l~----------f~~L~~L~~L~Ls~N~l~~~iP~~l 511 (876)
T 4ecn_A 450 LQIIYFANSPFTYDNIAVDW--------EDANSDYAKQYENEELS----------WSNLKDLTDVELYNCPNMTQLPDFL 511 (876)
T ss_dssp CCEEEEESCCCCGGGBSSSC--------SCTTSHHHHHHTTSCCC----------GGGCTTCCEEEEESCTTCCSCCGGG
T ss_pred CCEEECcCCcCCCCcccccc--------cccccccccccCChhhh----------hccCCCCCEEECcCCCCCccChHHH
Confidence 66666666666541 11000 01111222223333321 2234677777777777777777777
Q ss_pred cCCCCCcEEEccCCc-Ccc-cCCHHHH------hcCCCCCEEEccCcccCCCCcc--cccCCCCCCEEEccCCcCCCCCC
Q 046275 322 GSCSSLESFDISSNK-FSG-ELPIEIF------LSMSNLKELVLSFNDFTGALPD--SLSNLTNLETLDLSSNNLSGAIP 391 (1176)
Q Consensus 322 ~~l~~L~~L~Ls~N~-l~~-~i~~~~~------~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p 391 (1176)
+++++|++|+|++|+ ++| .+|..+. ..+++|++|+|++|.++ .+|. .++++++|+.|+|++|+++ .+|
T Consensus 512 ~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp 589 (876)
T 4ecn_A 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE 589 (876)
T ss_dssp GGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred hCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence 888888888888887 776 6666532 12347888888888887 6777 7788888888888888887 677
Q ss_pred ccccCCCCCCccEEEccCccccCCCCcccccccc-CcEEEcCCccccCCCCccccCCCc--cCeeecccccccCCCCCC-
Q 046275 392 HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ-LVSLHLSFNYLTGTIPSSLGSLSK--LQDLKLWLNQLHGEIPPE- 467 (1176)
Q Consensus 392 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~- 467 (1176)
.+ ..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|..+..++. |+.|+|++|++.+.+|..
T Consensus 590 -~~--~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~ 664 (876)
T 4ecn_A 590 -AF--GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664 (876)
T ss_dssp -CC--CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCS
T ss_pred -hh--cCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccch
Confidence 44 45677888888888887 77777888887 888888888888 67777776654 888888888887766532
Q ss_pred --CC--CccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCC--------CCCeEEccCCccccc
Q 046275 468 --LG--NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLS--------NLAILKLSNNSFYGR 535 (1176)
Q Consensus 468 --~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--------~L~~L~L~~N~l~~~ 535 (1176)
++ .+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+ .+|..+.... +|++|+|++|+++ .
T Consensus 665 ~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~ 742 (876)
T 4ecn_A 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742 (876)
T ss_dssp SCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-C
T ss_pred hhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-c
Confidence 22 3347888888888888433334457888888888888888 6666554432 7888888888888 7
Q ss_pred CCCCCC--CCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccc
Q 046275 536 IPPELG--DCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613 (1176)
Q Consensus 536 ~p~~~~--~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 613 (1176)
+|..+. .+++|+.|+|++|++++ +|..++
T Consensus 743 lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~------------------------------------------------ 773 (876)
T 4ecn_A 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL------------------------------------------------ 773 (876)
T ss_dssp CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG------------------------------------------------
T ss_pred chHHhhhccCCCcCEEEeCCCCCCc-cchhhh------------------------------------------------
Confidence 888876 88888888888888886 665432
Q ss_pred cCCCCccccccCCCCCCCcCCCCCccEEEccc------CcCccCCCccccccccceeeeccCccccccCCccccCcCccc
Q 046275 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY------NMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLN 687 (1176)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~------N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~ 687 (1176)
.+.+|+.|+|++ |++.+.+|..|+++++|+.|+|++|+| +.||..+. ++|+
T Consensus 774 --------------------~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~ 830 (876)
T 4ecn_A 774 --------------------NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLY 830 (876)
T ss_dssp --------------------GCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSC
T ss_pred --------------------cCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCC
Confidence 123567777765 778888888888888888888888888 58888766 5888
Q ss_pred EEEccCccccccCCCCcccccccccccccccccc
Q 046275 688 ILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721 (1176)
Q Consensus 688 ~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~ 721 (1176)
.|||++|++...-+..+.....+..+.|++|++.
T Consensus 831 ~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp EEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred EEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 8888888887666667767777777777777654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=451.96 Aligned_cols=264 Identities=26% Similarity=0.435 Sum_probs=217.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|++++++++|||||+++|+|.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999874 467899999976655556789999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhcc---------ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 934 VYEYMRYGSLEDVLHNQK---------KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
|||||++|+|.++++..+ .....++|.+++.++.|||+||+|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999998653 1234699999999999999999999999 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||...+ ..+......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-----~~~~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----NNEVIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence 99999987655444333345679999999999999999999999999999999999 999997543 222333333
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
.+... ......|. ++.+++.+||+.||++|||+++|.+.|+++.+.++
T Consensus 245 ~~~~~-----~~p~~~~~------~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 QGRVL-----QRPRTCPQ------EVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HTCCC-----CCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred cCCCC-----CCCccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 32211 11112221 35569999999999999999999999999987654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=484.45 Aligned_cols=492 Identities=21% Similarity=0.182 Sum_probs=330.3
Q ss_pred cCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCc
Q 046275 119 SFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198 (1176)
Q Consensus 119 ~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L 198 (1176)
+++++|||++|.+++..+ ..+..+++|++|+|++|+|+.++...+..+++|++|+|++|++++ ++...
T Consensus 28 ~~l~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~---~~~~~------- 95 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGS--YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS---LALGA------- 95 (570)
T ss_dssp SSCCEEECCSCCCCEECT--TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE---ECTTT-------
T ss_pred ccccEEEccCCccCccCh--hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc---cCHhh-------
Confidence 345556666665554322 134555555555555555555555555555555555555555543 33333
Q ss_pred cEEEeCCCcccccccCCCCCccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCC-cChhhhccccCCeEeecccc
Q 046275 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGD-VGHAISACEHLSFLNVSSNL 276 (1176)
Q Consensus 199 ~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~ 276 (1176)
+..+++|++|++++|+++.+++ .++++++|++|++++|.+++. +|..++++++|++|++++|.
T Consensus 96 ---------------~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~ 160 (570)
T 2z63_A 96 ---------------FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (570)
T ss_dssp ---------------TTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred ---------------hcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCc
Confidence 4445555555555555554443 355555555555555555542 35555555555555555555
Q ss_pred ccCccCCCCccccCcchhhhhhcCCCc----cEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCC
Q 046275 277 FSGPIPVGYNEFQGEIPLHLADLCSSL----VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL 352 (1176)
Q Consensus 277 l~~~~p~~~~~l~~~i~~~~~~~l~~L----~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L 352 (1176)
+++..|..+ ..+++| +.|++++|.+++..|..+..+ +|+.|++++|..........+..++++
T Consensus 161 l~~~~~~~~------------~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l 227 (570)
T 2z63_A 161 IQSIYCTDL------------RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGL 227 (570)
T ss_dssp CCEECGGGG------------HHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTC
T ss_pred cceecHHHc------------cchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCcccc
Confidence 553322221 112233 556666666655555555444 566666666544322222334555555
Q ss_pred CEEEccCcccCC------CCcccccCCC--CCCEEEccCC-cCCCCCCccccCCCCCCccEEEccCccccCCCCcccccc
Q 046275 353 KELVLSFNDFTG------ALPDSLSNLT--NLETLDLSSN-NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC 423 (1176)
Q Consensus 353 ~~L~Ls~N~l~~------~~p~~l~~l~--~L~~L~Ls~N-~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l 423 (1176)
+.+.+..+.+.. .....+..+. .++.+++++| .+.+.+|..+ ..+++|+.|++++|.++ .+|..+..+
T Consensus 228 ~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~--~~l~~L~~L~l~~~~l~-~l~~~~~~~ 304 (570)
T 2z63_A 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF--NCLTNVSSFSLVSVTIE-RVKDFSYNF 304 (570)
T ss_dssp EEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTT--GGGTTCSEEEEESCEEC-SCCBCCSCC
T ss_pred ceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhh--cCcCcccEEEecCccch-hhhhhhccC
Confidence 555544322211 1111222222 2456666666 5555556555 23567777777777777 567777777
Q ss_pred ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCcc--ccccccCCCCCee
Q 046275 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTL--PAALSNCTNLNWI 501 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L 501 (1176)
+|++|++++|+++ .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|
T Consensus 305 -~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L 378 (570)
T 2z63_A 305 -GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378 (570)
T ss_dssp -CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEE
T ss_pred -CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEE
Confidence 8888888888887 5555 4678888888888888766655 67888999999999988654 7788899999999
Q ss_pred eccccccCCCCCccccCCCCCCeEEccCCcccccCC-CCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccc
Q 046275 502 SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP-PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKK 580 (1176)
Q Consensus 502 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~ 580 (1176)
++++|++++. |..+..+++|++|++++|.+.+..| ..+..+++|+.|++++|.+.+.+|..
T Consensus 379 ~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------- 440 (570)
T 2z63_A 379 DLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI----------------- 440 (570)
T ss_dssp ECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTT-----------------
T ss_pred ECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhh-----------------
Confidence 9999999854 4448899999999999999987766 56888999999999999887654432
Q ss_pred eeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCc-cCCCcccccc
Q 046275 581 YVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS-GSIPKEIGSM 659 (1176)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~-g~iP~~~~~l 659 (1176)
|..+.+|++|+|++|+++ +.+|..++.+
T Consensus 441 ---------------------------------------------------~~~l~~L~~L~l~~n~l~~~~~p~~~~~l 469 (570)
T 2z63_A 441 ---------------------------------------------------FNGLSSLEVLKMAGNSFQENFLPDIFTEL 469 (570)
T ss_dssp ---------------------------------------------------TTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred ---------------------------------------------------hhcCCcCcEEECcCCcCccccchhhhhcc
Confidence 233457889999999998 6899999999
Q ss_pred ccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCC
Q 046275 660 SYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMG 728 (1176)
Q Consensus 660 ~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~ 728 (1176)
++|+.|+|++|++++..|..|+.+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|...
T Consensus 470 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred cCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 999999999999998889999999999999999999998888889999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=452.76 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=208.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|.+.+.||+|+||+||+|+++ +++.||||++........++|.+|++++++++|||||+++|+|.++...|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999874 478899999976655556789999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhcccc-----------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 934 VYEYMRYGSLEDVLHNQKKV-----------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
|||||++|+|.++++..... ..+++|.+++.|+.|||+||+|||+. +||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 99999999999999865321 23699999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-----~~~~~~~ 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-----NTEAIDC 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-----HHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Confidence 9999999987655444434455689999999999999999999999999999999999 999997543 1222222
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
...+. .+......+. .+.+++.+||+.||++|||++||+++|+.+.+..
T Consensus 273 i~~g~-----~~~~p~~~~~------~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 273 ITQGR-----ELERPRACPP------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHTC-----CCCCCTTCCH------HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHcCC-----CCCCcccccH------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 22221 1111122221 3556999999999999999999999999998754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=479.19 Aligned_cols=492 Identities=21% Similarity=0.162 Sum_probs=359.9
Q ss_pred ccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCc
Q 046275 93 DTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLE 172 (1176)
Q Consensus 93 ~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~ 172 (1176)
+.++.|+|++|.+++.. +..+..+++|++|||++|.+++..+ ..++.+++|++|+|++|+++.++...+..+++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~Ls~n~i~~i~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLG--SYSFFSFPELQVLDLSRCEIQTIED--GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103 (570)
T ss_dssp SSCCEEECCSCCCCEEC--TTTTTTCSSCCEEECTTCCCCEECT--TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred ccccEEEccCCccCccC--hhHhhCCCCceEEECCCCcCCccCc--ccccCchhCCEEeCcCCcCCccCHhhhcCccccc
Confidence 57999999999998543 4466788999999999999986544 3578999999999999999999989999999999
Q ss_pred EEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCc
Q 046275 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANK 252 (1176)
Q Consensus 173 ~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~ 252 (1176)
+|++++|+++.+ +...|.++++|++|++++|.++.. .++..+.++++|++|++++|+
T Consensus 104 ~L~L~~n~l~~l---~~~~~~~l~~L~~L~L~~n~l~~~--------------------~lp~~~~~l~~L~~L~l~~n~ 160 (570)
T 2z63_A 104 KLVAVETNLASL---ENFPIGHLKTLKELNVAHNLIQSF--------------------KLPEYFSNLTNLEHLDLSSNK 160 (570)
T ss_dssp EEECTTSCCCCS---TTCSCTTCTTCCEEECCSSCCCCC--------------------CCCGGGGGCTTCCEEECTTSC
T ss_pred cccccccccccC---CCccccccccccEEecCCCcccee--------------------cChhhhcccCCCCEEeCcCCc
Confidence 999999999874 333345555555555555544430 023345555555555555555
Q ss_pred CCCCcChhhhccccC----CeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCccc-ccCCccccCCCCC
Q 046275 253 FTGDVGHAISACEHL----SFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS-GKVPSRFGSCSSL 327 (1176)
Q Consensus 253 l~~~~~~~l~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L 327 (1176)
+++..+..++.+++| +.|++++|.+++..|..+. . .+|+.|++++|... ..++..+..++++
T Consensus 161 l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~------------~-~~L~~L~l~~n~~~~~~~~~~~~~l~~l 227 (570)
T 2z63_A 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK------------E-IRLHKLTLRNNFDSLNVMKTCIQGLAGL 227 (570)
T ss_dssp CCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT------------T-CEEEEEEEESCCSCTTHHHHHHHTTTTC
T ss_pred cceecHHHccchhccchhhhhcccCCCCceecCHHHhc------------c-CcceeEecccccccccchhhhhcCcccc
Confidence 555555555555555 5555555555543332221 1 14555555555332 1233444555555
Q ss_pred cEEEccCCcCc-----ccCCHHHHhcCC--CCCEEEccCc-ccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCC
Q 046275 328 ESFDISSNKFS-----GELPIEIFLSMS--NLKELVLSFN-DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPR 399 (1176)
Q Consensus 328 ~~L~Ls~N~l~-----~~i~~~~~~~l~--~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 399 (1176)
+.+.+..+.+. ..++...|..++ .++.++++++ .+.+..|..+..+++|+.|++++|.++ .+|..+. ..
T Consensus 228 ~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~--~~ 304 (570)
T 2z63_A 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY--NF 304 (570)
T ss_dssp EEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCS--CC
T ss_pred ceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhc--cC
Confidence 55544332221 123333333333 2566677766 666677777777888888888888777 5666553 23
Q ss_pred CCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCC--CCCCCCcccccee
Q 046275 400 NSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI--PPELGNIQTLETL 477 (1176)
Q Consensus 400 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L 477 (1176)
+|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|.+++.. |..+..+++|++|
T Consensus 305 -~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L 378 (570)
T 2z63_A 305 -GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378 (570)
T ss_dssp -CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEE
T ss_pred -CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEE
Confidence 7888888888877 4554 4677888888888888766554 67788888888888887554 6778888899999
Q ss_pred ecccccccCccccccccCCCCCeeeccccccCCCCC-ccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCC
Q 046275 478 FLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIP-TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLF 556 (1176)
Q Consensus 478 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 556 (1176)
++++|++++..+. +.++++|+.|++++|++++..| ..+..+++|++|++++|.+.+.+|..+..+++|+.|+|++|++
T Consensus 379 ~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 457 (570)
T 2z63_A 379 DLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457 (570)
T ss_dssp ECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcC
Confidence 9999999855444 9999999999999999987666 5788999999999999999988999999999999999999988
Q ss_pred c-ccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCC
Q 046275 557 N-GSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHN 635 (1176)
Q Consensus 557 ~-g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (1176)
+ +.+|. .+..+
T Consensus 458 ~~~~~p~--------------------------------------------------------------------~~~~l 469 (570)
T 2z63_A 458 QENFLPD--------------------------------------------------------------------IFTEL 469 (570)
T ss_dssp GGGEECS--------------------------------------------------------------------CCTTC
T ss_pred ccccchh--------------------------------------------------------------------hhhcc
Confidence 6 34442 12344
Q ss_pred CCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCC
Q 046275 636 GSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPS 702 (1176)
Q Consensus 636 ~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~ 702 (1176)
.+|++|||++|++++.+|..|+++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|.
T Consensus 470 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 6789999999999999999999999999999999999988888899999999999999999998875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=443.27 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=210.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++++.+.||+|+||+||+|++. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556789999999999999863 46789999986533 3345789999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccc------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 046275 934 VYEYMRYGSLEDVLHNQKK------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE 1001 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 1001 (1176)
|||||++|+|.++++.... ....++|.++..|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999975431 123689999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHH
Q 046275 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1002 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~ 1080 (1176)
+||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..+...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~~~~~~ 258 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVVE 258 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----HHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----HHHHHH
Confidence 99999999987755444444456789999999999999999999999999999999999 899997543 222233
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
....+... ......|. .+.+++.+||+.||++||||+||+++|+.+
T Consensus 259 ~i~~~~~~-----~~p~~~~~------~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQVL-----PCPDDCPA------WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCCC-----CCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCCC-----CCcccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33222211 11122222 355699999999999999999999999864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=480.55 Aligned_cols=485 Identities=20% Similarity=0.197 Sum_probs=386.9
Q ss_pred CcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccccc--ccCCCCCccceee
Q 046275 147 LKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD--INVSKCKNLQFLD 224 (1176)
Q Consensus 147 L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 224 (1176)
.-+.++++|+++.+|...+ ++|++|||++|+|++ ++...|.++++|++|+|++|.+++. ..+..+++|++|+
T Consensus 7 ~~~c~~~~~~l~~ip~~~~---~~L~~L~Ls~n~l~~---~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 7 SGVCDGRSRSFTSIPSGLT---AAMKSLDLSFNKITY---IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp TSEEECTTSCCSSCCSCCC---TTCCEEECCSSCCCE---ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CceEECCCCccccccccCC---CCccEEECcCCccCc---cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 3345666666666665443 466777777777764 3444566777777777777777653 3477888899999
Q ss_pred ccCCcccccCCC-ccCCCCCcEEEcCCCcCCCC-cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCC
Q 046275 225 VSSNNFSMAVPS-FGDCLALEYLDISANKFTGD-VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSS 302 (1176)
Q Consensus 225 Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~ 302 (1176)
+++|++++.++. ++++++|++|+|++|++++. .+..+.++++|++|++++|.+.+.+| ...+..+++
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~-----------~~~~~~l~~ 149 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR-----------RIDFAGLTS 149 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC-----------TTTTTTCCE
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC-----------Hhhhhcccc
Confidence 999998888775 88899999999999999864 56778899999999999998443332 223344678
Q ss_pred ccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCC--c-ccccCCCCCCEE
Q 046275 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL--P-DSLSNLTNLETL 379 (1176)
Q Consensus 303 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~l~~l~~L~~L 379 (1176)
|++|++++|++++..|..+..+++|++|++++|.+. .+|...+..+++|++|++++|.+++.. | .....+++|+.|
T Consensus 150 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L 228 (549)
T 2z81_A 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228 (549)
T ss_dssp EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred cCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence 999999999999889999999999999999999986 778777788999999999999998742 2 223467899999
Q ss_pred EccCCcCCCCCCccccC--CCCCCccEEEccCccccCCC------CccccccccCcEEEcCCccccCC-----CCccccC
Q 046275 380 DLSSNNLSGAIPHNLCQ--GPRNSLKELFLQNNLLLGSI------PSTLSNCSQLVSLHLSFNYLTGT-----IPSSLGS 446 (1176)
Q Consensus 380 ~Ls~N~l~~~~p~~~~~--~~~~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~ 446 (1176)
++++|.+++..+..+.. ..+.+|+.|++++|.+.+.. ...+..+.+|+.|++.++.+... ++..+..
T Consensus 229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~ 308 (549)
T 2z81_A 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308 (549)
T ss_dssp EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHH
T ss_pred eccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhh
Confidence 99999988655544321 23568999999999987632 23456788999999999887632 2223344
Q ss_pred CCccCeeecccccccCCCCCCC-CCccccceeecccccccCccc---cccccCCCCCeeeccccccCCCCC--ccccCCC
Q 046275 447 LSKLQDLKLWLNQLHGEIPPEL-GNIQTLETLFLDFNELTGTLP---AALSNCTNLNWISLSNNHLGGEIP--TWIGQLS 520 (1176)
Q Consensus 447 l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~ 520 (1176)
..+|+.|++++|.+. .+|..+ ..+++|++|+|++|++++.+| ..++.+++|++|+|++|++++..+ ..+..++
T Consensus 309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~ 387 (549)
T 2z81_A 309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387 (549)
T ss_dssp STTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred cccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence 578999999999998 777766 579999999999999998775 347899999999999999986432 5689999
Q ss_pred CCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchh
Q 046275 521 NLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLE 600 (1176)
Q Consensus 521 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (1176)
+|++|+|++|+++ .+|..+..+++|++|++++|++++ +|..+
T Consensus 388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~------------------------------------ 429 (549)
T 2z81_A 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI------------------------------------ 429 (549)
T ss_dssp TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS------------------------------------
T ss_pred CCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh------------------------------------
Confidence 9999999999998 799999999999999999999872 33211
Q ss_pred hhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccc
Q 046275 601 FAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV 680 (1176)
Q Consensus 601 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~ 680 (1176)
..+|++|||++|+|++.+ +.+++|+.|+|++|+|+ .||+ .
T Consensus 430 ----------------------------------~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~ 469 (549)
T 2z81_A 430 ----------------------------------PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-A 469 (549)
T ss_dssp ----------------------------------CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-G
T ss_pred ----------------------------------cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-c
Confidence 025889999999999753 58899999999999999 8997 5
Q ss_pred cCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCC
Q 046275 681 GDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMG 728 (1176)
Q Consensus 681 ~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~ 728 (1176)
+.+++|++|||++|+|++.+|..+..+++|+.|+|++|++++..|...
T Consensus 470 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 517 (549)
T 2z81_A 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 517 (549)
T ss_dssp GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHH
T ss_pred ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHH
Confidence 789999999999999999888889999999999999999999988543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=438.12 Aligned_cols=262 Identities=29% Similarity=0.434 Sum_probs=202.4
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|.+.+.||+|+||+||+|+++ ..||||++.... ....+.|.+|+.++++++|||||+++|++.+ +..|+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 46778899999999999999875 469999885432 2334679999999999999999999998864 568999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
|++|+|.++++..+ .+++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999998653 2699999999999999999999999 99999999999999999999999999998765544
Q ss_pred ccccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
........+||+.|||||++.+ ..|+.++|||||||++|||+||+.||...+. ................ .+.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~~~~~~~~~~~~~~p~-~~~ 261 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----RDQIIFMVGRGYASPD-LSK 261 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHTTCCCCC-STT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcCCCCCC-ccc
Confidence 4334456789999999999853 4689999999999999999999999975431 1111122211111100 011
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.....|. .+.+++.+||+.||++|||+.||+++|+.++...
T Consensus 262 ~~~~~~~------~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 262 LYKNCPK------AMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp SCTTSCH------HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ccccchH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1222221 3556999999999999999999999999987554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=435.48 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=217.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999986 6999999999643 2344567999999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||++||+|.+++...+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998765 699999999999999999999999 999999999999999999999999999998765
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
..........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ .......+...... +++.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~~~--~p~~- 256 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKIIKLEYD--FPEK- 256 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--CCTT-
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCC--CCcc-
Confidence 444444467789999999999999999999999999999999999999996543 22333333333221 1111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhCCCCC
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAGSGLD 1144 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~~~~~ 1144 (1176)
.+ .++.+++.+||+.||++|||++|++.+ +.++....+.+
T Consensus 257 ---~s------~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 257 ---FF------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp ---CC------HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---cC------HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 11 135679999999999999999998544 55555554443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=437.70 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=209.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999987 69999999997666666677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+||+|.+++... .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 589999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+ ..+....+........ ..+..
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~~~~~---~~~~~ 295 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDNLPPRL---KNLHK 295 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSSCCCC---SCGGG
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCCCCCC---Ccccc
Confidence 2356789999999999999999999999999999999999999996532 2222222222111110 01111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+|+.+||+.||++|||++|+++|
T Consensus 296 ~s------~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 VS------PSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 135679999999999999999999886
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=471.77 Aligned_cols=466 Identities=23% Similarity=0.233 Sum_probs=352.8
Q ss_pred cCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCc
Q 046275 119 SFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198 (1176)
Q Consensus 119 ~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L 198 (1176)
++|++|||++|.+++..+ ..+..+++|++|+|++|+|+.++...+..+++|++|||++|++++ ++...|.++++|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~---~~~~~~~~l~~L 100 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGH--GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS---LSSSWFGPLSSL 100 (549)
T ss_dssp TTCCEEECCSSCCCEECS--STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCS---CCHHHHTTCTTC
T ss_pred CCccEEECcCCccCccCh--hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCc---cCHHHhccCCCC
Confidence 456666666666654433 236677777777777777777777777777778888888887775 555557777888
Q ss_pred cEEEeCCCcccc---cccCCCCCccceeeccCCc-ccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeec
Q 046275 199 KQLALKGNKVTG---DINVSKCKNLQFLDVSSNN-FSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVS 273 (1176)
Q Consensus 199 ~~L~L~~n~l~~---~~~~~~l~~L~~L~Ls~N~-l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls 273 (1176)
++|++++|.++. ...+..+++|++|++++|+ ++.+++ .+.++++|++|++++|++++..|..+..+++|++|+++
T Consensus 101 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 180 (549)
T 2z81_A 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180 (549)
T ss_dssp CEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEE
T ss_pred cEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecc
Confidence 888888887764 2357788889999999888 555553 58889999999999999998888889999999999999
Q ss_pred cccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccC--C-ccccCCCCCcEEEccCCcCcccCCHHH---Hh
Q 046275 274 SNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKV--P-SRFGSCSSLESFDISSNKFSGELPIEI---FL 347 (1176)
Q Consensus 274 ~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~--p-~~~~~l~~L~~L~Ls~N~l~~~i~~~~---~~ 347 (1176)
.|.+. .++...+..+++|++|++++|++++.. | .....+++|+.|++++|.+++..+..+ +.
T Consensus 181 ~n~~~------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~ 248 (549)
T 2z81_A 181 LSESA------------FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248 (549)
T ss_dssp CSBST------------THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGG
T ss_pred cCccc------------ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhh
Confidence 88875 445555566788999999999988642 1 234557889999999998876544433 24
Q ss_pred cCCCCCEEEccCcccCCCC------cccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcccc
Q 046275 348 SMSNLKELVLSFNDFTGAL------PDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS 421 (1176)
Q Consensus 348 ~l~~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~ 421 (1176)
.+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+... ... ..++..+.
T Consensus 249 ~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~----~~~-----------------~~l~~~~~ 307 (549)
T 2z81_A 249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF----YLF-----------------YDLSTVYS 307 (549)
T ss_dssp GCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCG----GGS-----------------CCCCHHHH
T ss_pred hhccccccccccccccccccccccchhhhhhhcccccccccccccchh----hhc-----------------ccchhhhh
Confidence 5778888888888876531 12345556666666666654311 000 01222233
Q ss_pred ccccCcEEEcCCccccCCCCccc-cCCCccCeeecccccccCCCC---CCCCCccccceeecccccccCccc--cccccC
Q 046275 422 NCSQLVSLHLSFNYLTGTIPSSL-GSLSKLQDLKLWLNQLHGEIP---PELGNIQTLETLFLDFNELTGTLP--AALSNC 495 (1176)
Q Consensus 422 ~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l 495 (1176)
...+|+.|++++|+++ .+|..+ ..+++|++|++++|++.+.+| ..++.+++|++|+|++|++++..+ ..+..+
T Consensus 308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 4567888888888877 666665 468888888888888887663 347788899999999999986543 568899
Q ss_pred CCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhh
Q 046275 496 TNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANF 575 (1176)
Q Consensus 496 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~ 575 (1176)
++|++|++++|+++ .+|..++.+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++.+
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~--------------- 447 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS--------------- 447 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC---------------
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc---------------
Confidence 99999999999998 68888999999999999999997 5665553 68999999999987521
Q ss_pred ccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcc
Q 046275 576 IVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE 655 (1176)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~ 655 (1176)
..+.+|++|||++|+|+ .||.
T Consensus 448 ---------------------------------------------------------~~l~~L~~L~Ls~N~l~-~ip~- 468 (549)
T 2z81_A 448 ---------------------------------------------------------LFLPRLQELYISRNKLK-TLPD- 468 (549)
T ss_dssp ---------------------------------------------------------CCCTTCCEEECCSSCCS-SCCC-
T ss_pred ---------------------------------------------------------ccCChhcEEECCCCccC-cCCC-
Confidence 11246889999999999 7887
Q ss_pred ccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCC
Q 046275 656 IGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIP 701 (1176)
Q Consensus 656 ~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP 701 (1176)
.+.+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++..|
T Consensus 469 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 5789999999999999999888899999999999999999998766
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=436.38 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=207.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+.|++.++||+|+||+||+|+++ +|+.||||++.... ...+|+.++++++|||||++++++.+++..|+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46788889999999999999986 69999999986432 2247999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeecccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~ 1017 (1176)
+||+|.++++..+ ++++..++.++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999998765 699999999999999999999999 999999999999999987 69999999998765432
Q ss_pred ccc---cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1018 THL---SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1018 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||....... -+... ...... ...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i----~~~~~~---~~~ 277 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKI----ASEPPP---IRE 277 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHH----HHSCCG---GGG
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHH----HcCCCC---chh
Confidence 211 2234679999999999999999999999999999999999999997654322 11111 111110 011
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
++...+ ..+.+++.+||+.||++|||+.|+++++.......+
T Consensus 278 ~~~~~s------~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 278 IPPSCA------PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cCccCC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 111111 134569999999999999999999999988765543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=439.94 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=203.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999986 699999999865322 234568999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
||+||+|.+++...+ +..+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997654 23679999999999999999999999 9999999999999999999999999999876432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ ..+....+...... ...
T Consensus 179 ~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~~-----~~~ 246 (350)
T 4b9d_A 179 VE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISGSFP-----PVS 246 (350)
T ss_dssp HH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCCC-----CCC
T ss_pred cc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCCCC-----CCC
Confidence 21 2245679999999999999999999999999999999999999996543 33333333333321 111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~s------~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 LHYS------YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112 135679999999999999999999885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=424.24 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=197.9
Q ss_pred CCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCeeEEEE
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEERLLVY 935 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 935 (1176)
.+.+.||+|+||+||+|++. +++.||+|++.... ....+.|.+|++++++++|||||+++++|.+ +...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999986 58999999986532 2234568999999999999999999999865 34579999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeeccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMS 1014 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~ 1014 (1176)
|||++|+|.+++++.+ ++++..++.++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998764 6899999999999999999999981 13999999999999984 7899999999998643
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. .....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.... +.............+ +.
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~~~~~----~~ 250 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKP----AS 250 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCCC----GG
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHcCCCC----CC
Confidence 22 2345689999999999875 69999999999999999999999996432 222333333222211 11
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+ .++.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~------~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 FDKVAI------PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGCCC------HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCccCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 135679999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=439.27 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=210.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999987 69999999997666666677999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+||+|.++++.. .+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999754 589999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+ .......+........ ..+..
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~~~~~---~~~~~ 372 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDNLPPRL---KNLHK 372 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCC---SCTTS
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCCCCCC---ccccc
Confidence 2356789999999999999999999999999999999999999996532 2222222222111110 01111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+|+.+||+.||++|||++|+++|
T Consensus 373 ~s------~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VS------PSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 135679999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=416.65 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=192.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||+|++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999976 69999999986432 233457899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+ +|+|.+++...+ ++++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999998664 699999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+ .......+...... ++
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~~~--~p-- 232 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGVYT--LP-- 232 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--CC--
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCC--CC--
Confidence 22 2345689999999999998876 579999999999999999999996532 33333333332211 11
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||++|+++|
T Consensus 233 --~~~s------~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 --KFLS------PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --TTSC------HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCC------HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 134569999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=438.00 Aligned_cols=268 Identities=22% Similarity=0.356 Sum_probs=214.8
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCC-CCcccceeEEee
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQ-GDREFTAEMETIGKIKH-RNLVPLLGYCKV 927 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 927 (1176)
+...++|++.+.||+|+||+||+|++.. ++.||||++...... ..+.|.+|++++.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3445789999999999999999998752 357999998654332 34568999999999965 899999999866
Q ss_pred C-CeeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 046275 928 G-EERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNV 994 (1176)
Q Consensus 928 ~-~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 994 (1176)
. ...|+|||||++|+|.++++..+.. ...+++.+++.++.|||+||+|||++ +||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccce
Confidence 4 5689999999999999999865321 23589999999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 046275 995 LLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDN 1073 (1176)
Q Consensus 995 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~ 1073 (1176)
|+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-~ 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-E 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-H
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-H
Confidence 999999999999999987755444444456789999999999999999999999999999999998 99999764322 1
Q ss_pred cHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1074 NLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1074 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.+..... .+. .+......+. ++.+++.+||+.||++|||+.||+++|+++.+..
T Consensus 296 ~~~~~i~---~g~-----~~~~p~~~~~------~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 EFCRRLK---EGT-----RMRAPDYTTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHH---HTC-----CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHH---cCC-----CCCCCccCCH------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 1222221 111 1111111221 3456999999999999999999999999987654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=466.67 Aligned_cols=454 Identities=20% Similarity=0.199 Sum_probs=265.1
Q ss_pred EEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccccc--ccCCCCCccceeecc
Q 046275 149 VLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD--INVSKCKNLQFLDVS 226 (1176)
Q Consensus 149 ~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls 226 (1176)
+|++++|+|+.++.... ++|++|||++|+|++ ++...|.++++|++|+|++|++++. ..+..+++|++|+|+
T Consensus 4 ~l~ls~n~l~~ip~~~~---~~L~~L~Ls~n~i~~---~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 77 (520)
T 2z7x_B 4 LVDRSKNGLIHVPKDLS---QKTTILNISQNYISE---LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77 (520)
T ss_dssp EEECTTSCCSSCCCSCC---TTCSEEECCSSCCCC---CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECC
T ss_pred eEecCCCCccccccccc---ccccEEECCCCcccc---cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecC
Confidence 45555555555554333 455666666666554 3334455666666666666666543 346677777777777
Q ss_pred CCcccccCCCccCCCCCcEEEcCCCcCCCC-cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCc--
Q 046275 227 SNNFSMAVPSFGDCLALEYLDISANKFTGD-VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSL-- 303 (1176)
Q Consensus 227 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L-- 303 (1176)
+|+++.++.. .+++|++|+|++|++++. .|..++++++|++|++++|.+++. .+..+++|
T Consensus 78 ~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---------------~~~~l~~L~L 140 (520)
T 2z7x_B 78 HNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---------------SVLPIAHLNI 140 (520)
T ss_dssp SSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---------------GGGGGTTSCE
T ss_pred CCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh---------------hcccccccee
Confidence 7777766555 677888888888887763 567788888888888888877631 11223455
Q ss_pred cEEEccCCcc--cccCCccccCCC-CCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcc-------cCCCCcccccCC
Q 046275 304 VKLDLSSNNL--SGKVPSRFGSCS-SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFND-------FTGALPDSLSNL 373 (1176)
Q Consensus 304 ~~L~L~~n~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~-------l~~~~p~~l~~l 373 (1176)
++|++++|.+ .+..|..+..+. +...+++++|.+.+.++...+..+++|+.|++++|. +.+.+| .+..+
T Consensus 141 ~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l 219 (520)
T 2z7x_B 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTN 219 (520)
T ss_dssp EEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGC
T ss_pred eEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccc
Confidence 8888888877 666777776665 344567777777777776667777888888888776 554444 67777
Q ss_pred CCCCEEEccCCcCCCCCCccccCC-CCCCccEEEccCccccCCCCccc-----cccccCcEEEcCCccccCCCC-ccccC
Q 046275 374 TNLETLDLSSNNLSGAIPHNLCQG-PRNSLKELFLQNNLLLGSIPSTL-----SNCSQLVSLHLSFNYLTGTIP-SSLGS 446 (1176)
Q Consensus 374 ~~L~~L~Ls~N~l~~~~p~~~~~~-~~~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 446 (1176)
++|+.|++++|.+++..+..+... ..++|++|++++|.++|.+|..+ +++++|+.+++++|.+ .+| ..+..
T Consensus 220 ~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~ 297 (520)
T 2z7x_B 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYE 297 (520)
T ss_dssp TTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHH
T ss_pred cchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhc
Confidence 778888887777664332221100 01245555555555555555554 5555555555555555 233 23332
Q ss_pred C---CccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCC
Q 046275 447 L---SKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523 (1176)
Q Consensus 447 l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 523 (1176)
+ .+|+.|++++|. +.+.. .+..+++|++|++++|++++.+|.+++.+++|+
T Consensus 298 ~~~~~~L~~L~l~~n~------------------------l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 351 (520)
T 2z7x_B 298 IFSNMNIKNFTVSGTR------------------------MVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351 (520)
T ss_dssp HHHTCCCSEEEEESSC------------------------CCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCC
T ss_pred ccccCceeEEEcCCCc------------------------ccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCC
Confidence 2 344444444444 43211 113444555555555555544555555555555
Q ss_pred eEEccCCcccc--cCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhh
Q 046275 524 ILKLSNNSFYG--RIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEF 601 (1176)
Q Consensus 524 ~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (1176)
+|+|++|++++ .+|..++.+++|+.|+|++|++++.+|...
T Consensus 352 ~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~------------------------------------- 394 (520)
T 2z7x_B 352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD------------------------------------- 394 (520)
T ss_dssp EEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCS-------------------------------------
T ss_pred EEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccch-------------------------------------
Confidence 55555555553 334445555555555555555554333211
Q ss_pred hhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCcccc
Q 046275 602 AGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVG 681 (1176)
Q Consensus 602 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~ 681 (1176)
+..+.+|++|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..+.
T Consensus 395 ------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~ 441 (520)
T 2z7x_B 395 ------------------------------CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV 441 (520)
T ss_dssp ------------------------------CCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred ------------------------------hccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence 11123455556666666555555543 55666666666666 6666666
Q ss_pred CcCcccEEEccCccccccCCCC-ccccccccccccccccccCCCC
Q 046275 682 DLRGLNILDLSSNRLEGTIPSS-MSSLTLLNEIDLCNNQLTGMIP 725 (1176)
Q Consensus 682 ~L~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~l~ls~N~l~g~~p 725 (1176)
.+++|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++..+
T Consensus 442 ~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 442 KLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 6666666666666666 45554 6666666677777776666554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=472.48 Aligned_cols=452 Identities=19% Similarity=0.287 Sum_probs=283.2
Q ss_pred ccceeeccCCccccc-CCCccCCCCCcEEEcCCCcC------CC------CcChhhhccccCCeEeeccccccCccCCCC
Q 046275 219 NLQFLDVSSNNFSMA-VPSFGDCLALEYLDISANKF------TG------DVGHAISACEHLSFLNVSSNLFSGPIPVGY 285 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~N~l------~~------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 285 (1176)
+++.|+|++|+++|. ++.++++++|++|+|++|.+ .+ .+|... +.+|+ ++++.|.+.+.+|..+
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~ 158 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDF 158 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGS
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhH
Confidence 455566666666543 33466666666666666644 11 223222 44555 6666666665555443
Q ss_pred ccccCcchh-hh------hhcCCCccEEEcc--CCcccccCCccccCCCCCcEEEccCCcCccc----------------
Q 046275 286 NEFQGEIPL-HL------ADLCSSLVKLDLS--SNNLSGKVPSRFGSCSSLESFDISSNKFSGE---------------- 340 (1176)
Q Consensus 286 ~~l~~~i~~-~~------~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---------------- 340 (1176)
..+...... .. ......++.+.+. .|++++ +|..|+++++|++|+|++|.++|.
T Consensus 159 ~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~ 237 (636)
T 4eco_A 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237 (636)
T ss_dssp CHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred HHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcc
Confidence 311000000 00 0000122222222 567776 777777777788888887777764
Q ss_pred -CCHHHHh--cCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCc-CCC-CCCccccCC----CCCCccEEEccCcc
Q 046275 341 -LPIEIFL--SMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN-LSG-AIPHNLCQG----PRNSLKELFLQNNL 411 (1176)
Q Consensus 341 -i~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~~----~~~~L~~L~L~~N~ 411 (1176)
+|..+ . ++++|++|+|++|.+.+.+|..++++++|++|+|++|+ ++| .+|..+... .+++|++|+|++|+
T Consensus 238 ~ip~~l-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~ 316 (636)
T 4eco_A 238 YKTEDL-KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316 (636)
T ss_dssp HTTSCC-CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred cCchhh-hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence 66653 4 67778888888777777777777777778888888777 776 677665321 12567778888887
Q ss_pred ccCCCCc--cccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccc-cceeecccccccCcc
Q 046275 412 LLGSIPS--TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQT-LETLFLDFNELTGTL 488 (1176)
Q Consensus 412 l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~ 488 (1176)
++ .+|. .++++++|++|++++|+++|.+| .++.+++|++|++++|+++ .+|..++.+++ |++|+|++|+++ .+
T Consensus 317 l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~l 392 (636)
T 4eco_A 317 LK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YI 392 (636)
T ss_dssp CS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SC
T ss_pred CC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-cc
Confidence 77 6777 77777778888888887777777 7777777888888877777 77777777777 888888888777 66
Q ss_pred ccccccCC--CCCeeeccccccCCCCCcccc-------CCCCCCeEEccCCcccccCCCC-CCCCCCCCEEEccCCCCcc
Q 046275 489 PAALSNCT--NLNWISLSNNHLGGEIPTWIG-------QLSNLAILKLSNNSFYGRIPPE-LGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 489 p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~g 558 (1176)
|..+..++ +|++|++++|++++.+|..|. .+++|++|+|++|+++ .+|.. +..+++|+.|+|++|+++
T Consensus 393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~- 470 (636)
T 4eco_A 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT- 470 (636)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-
T ss_pred chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-
Confidence 77666654 777788888887777777777 6777778888888777 45554 345777778888887777
Q ss_pred cCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCc
Q 046275 559 SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSM 638 (1176)
Q Consensus 559 ~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 638 (1176)
.+|...|.... +.+..+.+|
T Consensus 471 ~i~~~~~~~~~------------------------------------------------------------~~~~~l~~L 490 (636)
T 4eco_A 471 EIPKNSLKDEN------------------------------------------------------------ENFKNTYLL 490 (636)
T ss_dssp BCCSSSSEETT------------------------------------------------------------EECTTGGGC
T ss_pred CcCHHHhcccc------------------------------------------------------------ccccccCCc
Confidence 67765443110 001112245
Q ss_pred cEEEcccCcCccCCCcccc--ccccceeeeccCccccccCCccccCcCcccEEEc------cCccccccCCCCccccccc
Q 046275 639 MFLDISYNMLSGSIPKEIG--SMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDL------SSNRLEGTIPSSMSSLTLL 710 (1176)
Q Consensus 639 ~~LdLs~N~l~g~iP~~~~--~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~L------s~N~l~g~iP~~l~~l~~L 710 (1176)
++|||++|+++ .+|..++ .+++|+.|+|++|++++ +|..++++++|++|+| ++|++.+.+|..+..+++|
T Consensus 491 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 66666666666 5666665 66666666666666664 6666666666666666 3455666666666666666
Q ss_pred cccccccccccCCCCCCCCccccCCccccCCCCCC
Q 046275 711 NEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLC 745 (1176)
Q Consensus 711 ~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~ 745 (1176)
+.|+|++|++ +.+|..- ...+....+.+|+-.|
T Consensus 569 ~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 569 TQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNIS 601 (636)
T ss_dssp CEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred CEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcc
Confidence 6666666666 4555431 1344444445554443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=423.25 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=202.2
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHH--HHHHHHHHhcCCCCcccceeEEeeCC----eeEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREF--TAEMETIGKIKHRNLVPLLGYCKVGE----ERLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 934 (1176)
+|.+.+.||+|+||+||+|+++ |+.||||++... ..+.+ ..|+..+.+++|||||++++++.++. ..|+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 5777899999999999999985 899999998542 23333 34566667889999999999997653 57999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC-----IPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
|||+++|+|.++++.. +++|..+.+++.|+++||+|||+++ .++||||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999864 5899999999999999999999862 45899999999999999999999999999
Q ss_pred ccccccccccc--cccccccCCcccCccccCCC------CCCchhhhHHHHHHHHHHHcCCCCCCCCCCC----------
Q 046275 1010 ARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSF------RCSTKGDVYSYGVVLLELLTGKRPTDSADFG---------- 1071 (1176)
Q Consensus 1010 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~P~~~~~~~---------- 1071 (1176)
|+......... .....+||+.|||||++.+. .++.++|||||||++|||+||+.||......
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98765433221 22346799999999998754 4678999999999999999998876543211
Q ss_pred CccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1072 DNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
......+...... +.++|.+....+. ......+.+++.+||+.||++||||.||++.|+++.+..+
T Consensus 235 ~~~~~~~~~~~~~----~~~rp~~p~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 235 DPSVEEMRKVVCE----QKLRPNIPNRWQS-CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCCHHHHHHHHTT----SCCCCCCCGGGGS-SHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred cchHHHHHHHHhc----ccCCCCCCccccc-hHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 1122222222222 2233333222111 1123456679999999999999999999999999986543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=421.77 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=193.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||+||+|+.. +++.||+|++.+.. ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999873 47899999986432 2233468889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||++||+|.+++.+.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998765 699999999999999999999999 9999999999999999999999999999865
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ ..+....+...... +
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~~--~-- 245 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RKETMTMILKAKLG--M-- 245 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--C--
T ss_pred cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HHHHHHHHHcCCCC--C--
Confidence 43222 2345789999999999999999999999999999999999999997543 22333333332211 1
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM 1127 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~ 1127 (1176)
+...+ ..+.+++.+||+.||++|||+
T Consensus 246 --p~~~s------~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 --PQFLS------PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CTTSC------HHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCcCC------HHHHHHHHHHcccCHHHCCCC
Confidence 11111 135569999999999999985
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=450.24 Aligned_cols=509 Identities=22% Similarity=0.182 Sum_probs=340.5
Q ss_pred cCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCc
Q 046275 119 SFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198 (1176)
Q Consensus 119 ~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L 198 (1176)
+++++||||+|.|++.++ ..+.++++|++|+|++|+|+.++..+|..+++|++|+|++|+|+. ++..+|.++++|
T Consensus 52 ~~~~~LdLs~N~i~~l~~--~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~---l~~~~f~~L~~L 126 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGS--YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS---LALGAFSGLSSL 126 (635)
T ss_dssp TTCCEEECTTSCCCEECT--TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE---ECGGGGTTCTTC
T ss_pred cCCCEEEeeCCCCCCCCH--HHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC---CCHHHhcCCCCC
Confidence 467777888877775543 246778888888888888888888888888888888888888875 666777778888
Q ss_pred cEEEeCCCcccccc--cCCCCCccceeeccCCccccc--CCCccCCCCCcEEEcCCCcCCCCcChhhhccccCC----eE
Q 046275 199 KQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMA--VPSFGDCLALEYLDISANKFTGDVGHAISACEHLS----FL 270 (1176)
Q Consensus 199 ~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l~~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~----~L 270 (1176)
++|+|++|+++... .++.+++|++|+|++|.++.+ +..+..+++|++|+|++|++++..+..+..+.+++ .+
T Consensus 127 ~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~ 206 (635)
T 4g8a_A 127 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 206 (635)
T ss_dssp CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEE
T ss_pred CEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhh
Confidence 88888777777633 467777888888888877643 33467778888888888888777777777665544 56
Q ss_pred eeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccc-cCCccccCCCCCcEEEccCCcCcc-----cCCHH
Q 046275 271 NVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSG-KVPSRFGSCSSLESFDISSNKFSG-----ELPIE 344 (1176)
Q Consensus 271 ~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~-----~i~~~ 344 (1176)
+++.|.++...+..+. ...++.+++.+|.... ..+..+..+..++...+..+...+ .....
T Consensus 207 ~ls~n~l~~i~~~~~~-------------~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 273 (635)
T 4g8a_A 207 DLSLNPMNFIQPGAFK-------------EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 273 (635)
T ss_dssp ECTTCCCCEECTTTTT-------------TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred hcccCcccccCccccc-------------chhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence 6777776643332221 1245666666665542 233455666666666554332211 12222
Q ss_pred HHhcCCCCCEEEccCcccCC---CCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcccc
Q 046275 345 IFLSMSNLKELVLSFNDFTG---ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS 421 (1176)
Q Consensus 345 ~~~~l~~L~~L~Ls~N~l~~---~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~ 421 (1176)
.+..+..+..+.+..+.... ..+..+..+.+++.+++.+|.+....+. ....+++.|++.+|.+.+..+.
T Consensus 274 ~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~----~~~~~L~~L~l~~~~~~~~~~~--- 346 (635)
T 4g8a_A 274 ALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDF----SYNFGWQHLELVNCKFGQFPTL--- 346 (635)
T ss_dssp TTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGG----GSCCCCSEEEEESCEESSCCCC---
T ss_pred ccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccccc----ccchhhhhhhcccccccCcCcc---
Confidence 33444555555555443322 1233445566777777777766532221 1234577777777777644332
Q ss_pred ccccCcEEEcCCccccCCCCccccCCCccCeeecccccccC--CCCCCCCCccccceeecccccccCccccccccCCCCC
Q 046275 422 NCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG--EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499 (1176)
Q Consensus 422 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 499 (1176)
.+..|+.++++.|.+... .....+++|+.|+++.|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+
T Consensus 347 ~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~ 423 (635)
T 4g8a_A 347 KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLE 423 (635)
T ss_dssp BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCC
T ss_pred cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-ccccccccccccc
Confidence 345677777777776532 234456777777777777642 34455556677777777777776 4555677777777
Q ss_pred eeeccccccCCCCC-ccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccc
Q 046275 500 WISLSNNHLGGEIP-TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVG 578 (1176)
Q Consensus 500 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~ 578 (1176)
.+++++|++....+ ..+..+++++.++++.|.+.+..|..+..+++|+.|+|++|.+...+++
T Consensus 424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~---------------- 487 (635)
T 4g8a_A 424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP---------------- 487 (635)
T ss_dssp EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEEC----------------
T ss_pred chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCc----------------
Confidence 77777776654433 4466777778888888887777777777777888888877765432211
Q ss_pred cceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccc
Q 046275 579 KKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGS 658 (1176)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~ 658 (1176)
..|..+.+|++|||++|+|++.+|..|++
T Consensus 488 ---------------------------------------------------~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~ 516 (635)
T 4g8a_A 488 ---------------------------------------------------DIFTELRNLTFLDLSQCQLEQLSPTAFNS 516 (635)
T ss_dssp ---------------------------------------------------SCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ---------------------------------------------------hhhhhccccCEEECCCCccCCcChHHHcC
Confidence 12334457888888888888888888888
Q ss_pred cccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccc-ccccccccccccccC
Q 046275 659 MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL-TLLNEIDLCNNQLTG 722 (1176)
Q Consensus 659 l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l-~~L~~l~ls~N~l~g 722 (1176)
+++|+.|+|++|+|++..|..|+.+++|++|||++|+|++.+|..+..+ ++|+.|+|++|+++.
T Consensus 517 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 517 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 8888888888888887777788888888888888888888888888877 678888888888763
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=445.84 Aligned_cols=432 Identities=20% Similarity=0.211 Sum_probs=360.8
Q ss_pred CccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhh
Q 046275 218 KNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHL 296 (1176)
Q Consensus 218 ~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~ 296 (1176)
++|++|++++|+++++++ .|.++++|++|+|++|++++..|..|+++++|++|+|++|+|++ +| ..
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp-----------~~- 87 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-IS-----------CH- 87 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EE-----------CC-
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cC-----------cc-
Confidence 678888888888887764 58889999999999999998888899999999999999999872 22 22
Q ss_pred hhcCCCccEEEccCCcccc-cCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCC--CEEEccCccc--CCCCccccc
Q 046275 297 ADLCSSLVKLDLSSNNLSG-KVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL--KELVLSFNDF--TGALPDSLS 371 (1176)
Q Consensus 297 ~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L--~~L~Ls~N~l--~~~~p~~l~ 371 (1176)
.+++|++|+|++|++++ .+|..|+++++|++|++++|.+++ ..|..+++| ++|++++|.+ ++..|..+.
T Consensus 88 --~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~ 161 (520)
T 2z7x_B 88 --PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161 (520)
T ss_dssp --CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTT
T ss_pred --ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeeccccccccccccccc
Confidence 36899999999999987 478999999999999999999984 346778888 9999999999 778888887
Q ss_pred CCC-CCCEEEccCCcCCCCCCccccCCCCCCccEEEccCcc-------ccCCCCccccccccCcEEEcCCccccCCCCcc
Q 046275 372 NLT-NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL-------LLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSS 443 (1176)
Q Consensus 372 ~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 443 (1176)
.+. +...+++++|.+.+.++.... ..+++|+.|++++|. +.+.+| .++.+++|+.|++++|.+++..+..
T Consensus 162 ~l~~~~l~l~l~~n~~~~~~~~~~~-~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~ 239 (520)
T 2z7x_B 162 DFNTESLHIVFPTNKEFHFILDVSV-KTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIR 239 (520)
T ss_dssp TCCEEEEEEECCSSSCCCCCCCCCC-TTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHH
T ss_pred ccccceEEEEeccCcchhhhhhhhh-hcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHH
Confidence 776 344678899999887776543 357889999999998 776666 7889999999999999988543332
Q ss_pred cc---CCCccCeeecccccccCCCCCCC-----CCccccceeecccccccCccc-cccccC---CCCCeeeccccccCCC
Q 046275 444 LG---SLSKLQDLKLWLNQLHGEIPPEL-----GNIQTLETLFLDFNELTGTLP-AALSNC---TNLNWISLSNNHLGGE 511 (1176)
Q Consensus 444 ~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~ 511 (1176)
+. ..++|++|++++|+++|.+|..+ +++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+...
T Consensus 240 ~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~ 317 (520)
T 2z7x_B 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317 (520)
T ss_dssp HHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC
T ss_pred HHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc
Confidence 21 24689999999999999999999 9999999999999999 455 566665 7899999999998743
Q ss_pred CCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcc--cCChhHHhhcccchhhhccccceeeeecCCC
Q 046275 512 IPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG--SIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589 (1176)
Q Consensus 512 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g--~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 589 (1176)
+ .+..+++|++|++++|++++.+|..++.+++|+.|+|++|++++ .+|..
T Consensus 318 -~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~-------------------------- 369 (520)
T 2z7x_B 318 -L-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM-------------------------- 369 (520)
T ss_dssp -C-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHH--------------------------
T ss_pred -c-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHH--------------------------
Confidence 2 13689999999999999999999999999999999999999985 22221
Q ss_pred CcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcc-ccccccceeeecc
Q 046275 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE-IGSMSYLFILNLG 668 (1176)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~-~~~l~~L~~L~L~ 668 (1176)
+..+.+|++|||++|++++.+|.. +..+++|+.|+|+
T Consensus 370 ------------------------------------------~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls 407 (520)
T 2z7x_B 370 ------------------------------------------TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407 (520)
T ss_dssp ------------------------------------------HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECC
T ss_pred ------------------------------------------HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECc
Confidence 223457999999999999878865 8899999999999
Q ss_pred CccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCC-CCCccccCCccccCCCCCC
Q 046275 669 HNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV-MGQFETFQPAKFLNNSGLC 745 (1176)
Q Consensus 669 ~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~ 745 (1176)
+|++++.+|..+. ++|++|||++|+|+ .+|..+..+++|+.|+|++|++++.++. ...+..+......+|+.-|
T Consensus 408 ~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 408 SNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp SSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence 9999999998776 79999999999999 8999999999999999999999965554 4556666667777886555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=463.86 Aligned_cols=415 Identities=20% Similarity=0.295 Sum_probs=309.6
Q ss_pred CCCcEEEcCCCcCCCCcChhhhccccCCeEee-ccccccCccCCCCcccc-----------------------------C
Q 046275 241 LALEYLDISANKFTGDVGHAISACEHLSFLNV-SSNLFSGPIPVGYNEFQ-----------------------------G 290 (1176)
Q Consensus 241 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L-s~N~l~~~~p~~~~~l~-----------------------------~ 290 (1176)
..++.|+|++|.++|.+|..++++++|++|+| ++|.++|..|....... +
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46899999999999999999999999999999 89988877443311110 0
Q ss_pred cchhhhh----------hcCCCccEEEccC--CcccccCCccccCCCCCcEEEccCCcCcc-----------------cC
Q 046275 291 EIPLHLA----------DLCSSLVKLDLSS--NNLSGKVPSRFGSCSSLESFDISSNKFSG-----------------EL 341 (1176)
Q Consensus 291 ~i~~~~~----------~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----------------~i 341 (1176)
.++..+. .....++.+.+.. |++++ +|..|+++++|++|+|++|+++| .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0000000 0112334444443 78887 88889999999999999999987 37
Q ss_pred CHHH-HhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCc-CCC-CCCccccC-----CCCCCccEEEccCcccc
Q 046275 342 PIEI-FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNN-LSG-AIPHNLCQ-----GPRNSLKELFLQNNLLL 413 (1176)
Q Consensus 342 ~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~-----~~~~~L~~L~L~~N~l~ 413 (1176)
|..+ |.++++|++|+|++|.+.+.+|..++++++|+.|+|++|+ +++ .+|..+.. ..+++|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 8775 4588999999999999888999999999999999999998 887 77775532 12458999999999998
Q ss_pred CCCCc--cccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccc-cceeecccccccCcccc
Q 046275 414 GSIPS--TLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQT-LETLFLDFNELTGTLPA 490 (1176)
Q Consensus 414 ~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~ 490 (1176)
.+|. .++++++|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+.++++ |++|+|++|+++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 7888 8889999999999999998 788 8888999999999999988 88888988988 999999999998 7788
Q ss_pred ccccCCC--CCeeeccccccCCCCCccc---c--CCCCCCeEEccCCcccccCCCCCC-CCCCCCEEEccCCCCcccCCh
Q 046275 491 ALSNCTN--LNWISLSNNHLGGEIPTWI---G--QLSNLAILKLSNNSFYGRIPPELG-DCRSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 491 ~~~~l~~--L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~ip~ 562 (1176)
.+..+.. |+.|+|++|++++.+|... + .+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+++ .+|.
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~ 714 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPE 714 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence 8877654 9999999999988766432 2 3458899999999998 6676654 7889999999999888 7777
Q ss_pred hHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEE
Q 046275 563 ALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLD 642 (1176)
Q Consensus 563 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Ld 642 (1176)
.+|.... +.+..+.+|+.|+
T Consensus 715 ~~~~~~~------------------------------------------------------------~~l~nl~~L~~L~ 734 (876)
T 4ecn_A 715 NSLKPKD------------------------------------------------------------GNYKNTYLLTTID 734 (876)
T ss_dssp TSSSCTT------------------------------------------------------------SCCTTGGGCCEEE
T ss_pred HHhcccc------------------------------------------------------------ccccccCCccEEE
Confidence 6543210 0111223566677
Q ss_pred cccCcCccCCCcccc--ccccceeeeccCccccccCCccccCcCcccEEEccC------ccccccCCCCccccccccccc
Q 046275 643 ISYNMLSGSIPKEIG--SMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSS------NRLEGTIPSSMSSLTLLNEID 714 (1176)
Q Consensus 643 Ls~N~l~g~iP~~~~--~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~------N~l~g~iP~~l~~l~~L~~l~ 714 (1176)
|++|+|+ .+|..++ .+++|+.|+|++|+|++ +|..++.+++|+.|+|++ |++.+.+|..+.++++|+.|+
T Consensus 735 Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~ 812 (876)
T 4ecn_A 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812 (876)
T ss_dssp CCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred CCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEE
Confidence 7777776 5666665 66677777777777765 666666777777776654 666666777777777777777
Q ss_pred cccccccCCCCC
Q 046275 715 LCNNQLTGMIPV 726 (1176)
Q Consensus 715 ls~N~l~g~~p~ 726 (1176)
|++|+| +.+|.
T Consensus 813 Ls~N~L-~~Ip~ 823 (876)
T 4ecn_A 813 IGSNDI-RKVDE 823 (876)
T ss_dssp CCSSCC-CBCCS
T ss_pred CCCCCC-CccCH
Confidence 777776 56665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=410.00 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=189.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCC--------
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGE-------- 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 929 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++...... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999986 6999999998654332 2356889999999999999999999986543
Q ss_pred ----eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 046275 930 ----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVS 1005 (1176)
Q Consensus 930 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 1005 (1176)
..|+||||+++|+|.+++...... ...++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999876432 2356778899999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccc----------cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccH
Q 046275 1006 DFGMARLMSAMDTHL----------SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNL 1075 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~ 1075 (1176)
|||+|+......... .....+||+.|||||++.+..|+.++||||+||++|||++ ||... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MER 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHH
Confidence 999998765432211 1234579999999999999999999999999999999996 76421 111
Q ss_pred HHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1076 VGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
............ ++.. ......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~----p~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLTDVRNLKF----PPLF-------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHTTCC----CHHH-------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCCC----CCCC-------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111122222111 1111 1112234569999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=448.09 Aligned_cols=461 Identities=20% Similarity=0.193 Sum_probs=268.8
Q ss_pred CcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccccc--ccCCCCCccceee
Q 046275 147 LKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD--INVSKCKNLQFLD 224 (1176)
Q Consensus 147 L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 224 (1176)
.+++++++|+++.+|.... ++|++|||++|+|++ ++...|.++++|++|+|++|.+++. ..+..+++|++|+
T Consensus 33 ~~~l~ls~~~L~~ip~~~~---~~L~~L~Ls~N~i~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 106 (562)
T 3a79_B 33 ESMVDYSNRNLTHVPKDLP---PRTKALSLSQNSISE---LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD 106 (562)
T ss_dssp CCEEECTTSCCCSCCTTSC---TTCCEEECCSSCCCC---CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CcEEEcCCCCCccCCCCCC---CCcCEEECCCCCccc---cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence 3555555555555544332 455555555555554 3344455555566666666655542 3356666777777
Q ss_pred ccCCcccccCCCccCCCCCcEEEcCCCcCCCC-cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCc
Q 046275 225 VSSNNFSMAVPSFGDCLALEYLDISANKFTGD-VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSL 303 (1176)
Q Consensus 225 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L 303 (1176)
|++|+++.++.. .+++|++|+|++|++++. .|..|+++++|++|++++|.+++. .+ ..+++|
T Consensus 107 Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~------------~~l~~L 169 (562)
T 3a79_B 107 VSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DL------------LPVAHL 169 (562)
T ss_dssp CTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TT------------GGGTTS
T ss_pred CCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---ch------------hhhhhc
Confidence 777777655554 677777777777777653 356677777777777777776531 11 112333
Q ss_pred --cEEEccCCcc--cccCCccccCCC-CCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCC----CCcccccCCC
Q 046275 304 --VKLDLSSNNL--SGKVPSRFGSCS-SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG----ALPDSLSNLT 374 (1176)
Q Consensus 304 --~~L~L~~n~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~ 374 (1176)
++|++++|.+ ++..|..+..+. ..-.+++++|.+.+.++...+..+++|+.|++++|.... .....+..++
T Consensus 170 ~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~ 249 (562)
T 3a79_B 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249 (562)
T ss_dssp CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCS
T ss_pred eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccC
Confidence 7777777777 666666666554 122456677777666666556667777777777764110 1123455666
Q ss_pred CCCEEEccCCcCCCCCCccccC-CCCCCccEEEccCccccCCCCccc-----cccccCcEEEcCCccccCCCC-ccccCC
Q 046275 375 NLETLDLSSNNLSGAIPHNLCQ-GPRNSLKELFLQNNLLLGSIPSTL-----SNCSQLVSLHLSFNYLTGTIP-SSLGSL 447 (1176)
Q Consensus 375 ~L~~L~Ls~N~l~~~~p~~~~~-~~~~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l 447 (1176)
+|+.|+++++.+++.....+.. ....+|++|++++|.++|.+|..+ .+++.|+.++++.|.+ .+| ..+..+
T Consensus 250 ~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~ 327 (562)
T 3a79_B 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV 327 (562)
T ss_dssp SCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH
T ss_pred cceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh
Confidence 6777766666554321111000 001245555555555554444444 3444444444444443 222 111111
Q ss_pred CccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEc
Q 046275 448 SKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527 (1176)
Q Consensus 448 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 527 (1176)
....+|++|++++|.+.... ....+++|++|++++|++++.+|.+++.+++|++|+|
T Consensus 328 ---------------------~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 384 (562)
T 3a79_B 328 ---------------------FAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384 (562)
T ss_dssp ---------------------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEEC
T ss_pred ---------------------hccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEEC
Confidence 00134555666666554211 1245666666666666666666666666666666666
Q ss_pred cCCcccc--cCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhh
Q 046275 528 SNNSFYG--RIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIR 605 (1176)
Q Consensus 528 ~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (1176)
++|++++ .+|..+..+++|+.|+|++|++++.+|...|
T Consensus 385 ~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~---------------------------------------- 424 (562)
T 3a79_B 385 QRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC---------------------------------------- 424 (562)
T ss_dssp CSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCC----------------------------------------
T ss_pred CCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhh----------------------------------------
Confidence 6666664 2345566677777777777776655553221
Q ss_pred hhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCc
Q 046275 606 AERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRG 685 (1176)
Q Consensus 606 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~ 685 (1176)
..+.+|++|+|++|+++|.+|..+. ++|+.|+|++|+++ .||..++.+++
T Consensus 425 ---------------------------~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~ 474 (562)
T 3a79_B 425 ---------------------------AWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA 474 (562)
T ss_dssp ---------------------------CCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCC
T ss_pred ---------------------------cCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCC
Confidence 1234566777777777766666554 57777888888777 67777778888
Q ss_pred ccEEEccCccccccCCCC-ccccccccccccccccccCCCCC
Q 046275 686 LNILDLSSNRLEGTIPSS-MSSLTLLNEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 686 L~~L~Ls~N~l~g~iP~~-l~~l~~L~~l~ls~N~l~g~~p~ 726 (1176)
|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++..|.
T Consensus 475 L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 475 LQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp CSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 888888888887 56666 77788888888888888776663
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=430.83 Aligned_cols=513 Identities=20% Similarity=0.156 Sum_probs=410.4
Q ss_pred CCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccccc--ccCCCCCccce
Q 046275 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGD--INVSKCKNLQF 222 (1176)
Q Consensus 145 ~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 222 (1176)
+++++|+|++|+|+.++...|..+++|++|||++|+|+. ++..+|.++++|++|+|++|+++.. ..+..+++|++
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~---i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~ 128 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT---IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 128 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE---ECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC---cChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCE
Confidence 489999999999999999999999999999999999986 7778899999999999999999974 35889999999
Q ss_pred eeccCCcccccCC-CccCCCCCcEEEcCCCcCCCC-cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcC
Q 046275 223 LDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGD-VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLC 300 (1176)
Q Consensus 223 L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l 300 (1176)
|+|++|+++++++ .|+++++|++|+|++|++++. .|..+..+++|++|+|++|+|++..|..+..+. ...
T Consensus 129 L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~--------~l~ 200 (635)
T 4g8a_A 129 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH--------QMP 200 (635)
T ss_dssp EECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH--------TCT
T ss_pred EECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchh--------hhh
Confidence 9999999998887 489999999999999999865 678899999999999999999976665543321 112
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCccc------CCCCcccccCCC
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF------TGALPDSLSNLT 374 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l------~~~~p~~l~~l~ 374 (1176)
..+..++++.|.++...+..+ ....++.+++++|.....++...+..+..++...+..+.. .......+..+.
T Consensus 201 ~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~ 279 (635)
T 4g8a_A 201 LLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 279 (635)
T ss_dssp TCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGG
T ss_pred hhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccccccc
Confidence 345689999999996555444 4567889999999887667777788899998887765433 223344555666
Q ss_pred CCCEEEccCCcCCCCCCccc-cCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCee
Q 046275 375 NLETLDLSSNNLSGAIPHNL-CQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453 (1176)
Q Consensus 375 ~L~~L~Ls~N~l~~~~p~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 453 (1176)
.+..+++..+.......... ......+++.+.+.+|.+.... .+....+|+.|++++|.+.+..+. .+..|+.+
T Consensus 280 ~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l 354 (635)
T 4g8a_A 280 NLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRL 354 (635)
T ss_dssp GSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEE
T ss_pred chhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhc
Confidence 67777766654432211111 0123457889999998887532 355667899999999998855443 45678889
Q ss_pred ecccccccCCCCCCCCCccccceeecccccccC--ccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCc
Q 046275 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELTG--TLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNS 531 (1176)
Q Consensus 454 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 531 (1176)
++..|.+.. +.....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|.
T Consensus 355 ~l~~n~~~~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~ 431 (635)
T 4g8a_A 355 TFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 431 (635)
T ss_dssp EEESCCSCC--BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSE
T ss_pred ccccccCCC--Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcc
Confidence 999888763 3345678999999999999863 45667778899999999999887 456678889999999999988
Q ss_pred ccccCC-CCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhcc
Q 046275 532 FYGRIP-PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS 610 (1176)
Q Consensus 532 l~~~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 610 (1176)
.....+ ..+..+++++.++++.|.+.+..|..
T Consensus 432 ~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~----------------------------------------------- 464 (635)
T 4g8a_A 432 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI----------------------------------------------- 464 (635)
T ss_dssp EESTTSSCTTTTCTTCCEEECTTSCCEECCTTT-----------------------------------------------
T ss_pred ccccccccccccccccccccccccccccccccc-----------------------------------------------
Confidence 876655 45788999999999999987644321
Q ss_pred ccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcC-ccCCCccccccccceeeeccCccccccCCccccCcCcccEE
Q 046275 611 RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNML-SGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNIL 689 (1176)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l-~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L 689 (1176)
+....+++.|+|++|++ .+.+|..|+.+++|+.|+|++|+|++.+|..|+++++|++|
T Consensus 465 ---------------------~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 465 ---------------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp ---------------------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ---------------------cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 22345788999999985 55678999999999999999999999999999999999999
Q ss_pred EccCccccccCCCCccccccccccccccccccCCCCCC-CCc-cccCCccccCCCCCC
Q 046275 690 DLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVM-GQF-ETFQPAKFLNNSGLC 745 (1176)
Q Consensus 690 ~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~-~~~-~~~~~~~~~~n~~l~ 745 (1176)
+|++|+|++..|..+..+++|+.|||++|+|++.+|.. ..+ ..+......+|+.-|
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 99999999888888999999999999999999999964 233 356667778898777
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=402.95 Aligned_cols=202 Identities=27% Similarity=0.427 Sum_probs=173.0
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
....++|++.+.||+|+||+||+|+++ +++.||+|++... ....++.+|+++++.+ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999864 4678999988643 3456788999999998 69999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeecc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGM 1009 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 1009 (1176)
.|+||||+++|+|.++++ .+++.+++.++.|++.||+|||++ +||||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999984 488999999999999999999999 99999999999999876 7999999999
Q ss_pred cccccccccc--------------------------ccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCC
Q 046275 1010 ARLMSAMDTH--------------------------LSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGK 1062 (1176)
Q Consensus 1010 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~ 1062 (1176)
|+........ ......+||+.|||||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9765432110 112345799999999999775 5899999999999999999999
Q ss_pred CCCCCCC
Q 046275 1063 RPTDSAD 1069 (1176)
Q Consensus 1063 ~P~~~~~ 1069 (1176)
.||....
T Consensus 245 ~Pf~~~~ 251 (361)
T 4f9c_A 245 YPFYKAS 251 (361)
T ss_dssp SSSSCCS
T ss_pred CCCCCCC
Confidence 9996543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=405.06 Aligned_cols=265 Identities=23% Similarity=0.343 Sum_probs=200.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEee------CC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKV------GE 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 929 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999986 699999999864322 223568899999999999999999998754 35
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+|||||+ |+|.+++...+ ++++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 68999998654 699999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc--ccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1010 ARLMSAMD--THLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1010 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+ .+...........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~ 283 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPS 283 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence 98664322 12223567899999999998775 56999999999999999999999997643111 0111111110000
Q ss_pred cccccC-----------cccccCCCchHHH-----HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFD-----------PELMKEDPNIEIE-----LLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~-----------~~~~~~~~~~~~~-----~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+... ..+....+..... -..+.+|+.+||+.||++|||++|+++|
T Consensus 284 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 -PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000100000 1245679999999999999999999987
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=427.29 Aligned_cols=454 Identities=22% Similarity=0.228 Sum_probs=300.9
Q ss_pred cccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEE
Q 046275 122 SSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQL 201 (1176)
Q Consensus 122 ~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L 201 (1176)
+++|+++|.+++.+..+ .++|++|+|++|+|+.++...+..+++|++|+|++|+|++ ++...|.++++|++|
T Consensus 34 ~~l~ls~~~L~~ip~~~-----~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDL-----PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS---LDFHVFLFNQDLEYL 105 (562)
T ss_dssp CEEECTTSCCCSCCTTS-----CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE---ECTTTTTTCTTCCEE
T ss_pred cEEEcCCCCCccCCCCC-----CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc---CCHHHhCCCCCCCEE
Confidence 55666666555443322 1566666666666666666666666666666666666664 444556666667777
Q ss_pred EeCCCcccccccCCCCCccceeeccCCcccccC--CCccCCCCCcEEEcCCCcCCCCcChhhhccccC--CeEeeccccc
Q 046275 202 ALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAV--PSFGDCLALEYLDISANKFTGDVGHAISACEHL--SFLNVSSNLF 277 (1176)
Q Consensus 202 ~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~~L~Ls~N~l 277 (1176)
+|++|.++..... .+++|++|++++|++++++ ..++++++|++|+|++|++++. .+..+++| ++|++++|.+
T Consensus 106 ~Ls~N~l~~lp~~-~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 106 DVSHNRLQNISCC-PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp ECTTSCCCEECSC-CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred ECCCCcCCccCcc-ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 7777766653333 6778888888888887654 4678888888888888888753 34555555 8888888888
Q ss_pred --cCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCc-cccCCCCCcEEEccCCcC-----cccCCHHHHhcC
Q 046275 278 --SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPS-RFGSCSSLESFDISSNKF-----SGELPIEIFLSM 349 (1176)
Q Consensus 278 --~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l-----~~~i~~~~~~~l 349 (1176)
++..|..+..+. .....+++++|.+.+.++. .+..+++|+.|++++|+. .+.+ ..|..+
T Consensus 182 ~~~~~~~~~l~~l~-----------~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~--~~l~~l 248 (562)
T 3a79_B 182 HIKGGETESLQIPN-----------TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL--SELTRG 248 (562)
T ss_dssp CCCSSSCCEEEECC-----------EEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH--HHHHSC
T ss_pred cccccCcccccccC-----------cceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH--HHHhcc
Confidence 666555443321 0122567788887765543 566778888888888852 2222 235778
Q ss_pred CCCCEEEccCcccCCC----CcccccCCCCCCEEEccCCcCCCCCCccccCCC---CCCccEEEccCccccCCCC-cccc
Q 046275 350 SNLKELVLSFNDFTGA----LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGP---RNSLKELFLQNNLLLGSIP-STLS 421 (1176)
Q Consensus 350 ~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~---~~~L~~L~L~~N~l~~~~p-~~l~ 421 (1176)
++|+.|+++++.+++. ++..+ ..++|++|++++|.++|.+|..++... ++.|+.++++.|.+ .+| ..+.
T Consensus 249 ~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~ 325 (562)
T 3a79_B 249 PTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALY 325 (562)
T ss_dssp SSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHH
T ss_pred CcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhh
Confidence 8888888888777642 12222 235889999999999888888765432 34444455555555 334 2222
Q ss_pred cc---ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCC
Q 046275 422 NC---SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNL 498 (1176)
Q Consensus 422 ~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 498 (1176)
.+ .+|+.|++++|.+.... + .+.+++|++|+|++|++++.+|..+.++++|
T Consensus 326 ~~~~~~~L~~L~l~~n~~~~~~---~-----------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 379 (562)
T 3a79_B 326 SVFAEMNIKMLSISDTPFIHMV---C-----------------------PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379 (562)
T ss_dssp HHHHTCCCSEEEEESSCCCCCC---C-----------------------CSSCCCCCEEECCSSCCCTTTTTTCCSCSSC
T ss_pred hhhccCcceEEEccCCCccccc---C-----------------------ccCCCCceEEECCCCccccchhhhhcccCCC
Confidence 22 45777777777664211 1 1334555555555555555555566666666
Q ss_pred CeeeccccccCC--CCCccccCCCCCCeEEccCCcccccCCC-CCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhh
Q 046275 499 NWISLSNNHLGG--EIPTWIGQLSNLAILKLSNNSFYGRIPP-ELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANF 575 (1176)
Q Consensus 499 ~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~ 575 (1176)
++|+|++|++++ .+|..++.+++|++|+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+
T Consensus 380 ~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l----------- 448 (562)
T 3a79_B 380 QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL----------- 448 (562)
T ss_dssp CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC-----------
T ss_pred CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh-----------
Confidence 666666666654 2235567777777777777777764554 46777888888888888875433210
Q ss_pred ccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcc
Q 046275 576 IVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE 655 (1176)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~ 655 (1176)
. .+|++|||++|+|+ .+|..
T Consensus 449 ---------------------------------------------------------~--~~L~~L~L~~N~l~-~ip~~ 468 (562)
T 3a79_B 449 ---------------------------------------------------------P--PKVKVLDLHNNRIM-SIPKD 468 (562)
T ss_dssp ---------------------------------------------------------C--TTCSEEECCSSCCC-CCCTT
T ss_pred ---------------------------------------------------------c--CcCCEEECCCCcCc-ccChh
Confidence 0 25788999999998 78888
Q ss_pred ccccccceeeeccCccccccCCcc-ccCcCcccEEEccCccccccCC
Q 046275 656 IGSMSYLFILNLGHNNLSGPIPTE-VGDLRGLNILDLSSNRLEGTIP 701 (1176)
Q Consensus 656 ~~~l~~L~~L~L~~N~l~g~iP~~-~~~L~~L~~L~Ls~N~l~g~iP 701 (1176)
++.+++|+.|+|++|+|+ .+|.. ++.+++|++|+|++|.+++..|
T Consensus 469 ~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred hcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 889999999999999999 67776 9999999999999999997655
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=419.91 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=201.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHH---HHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAE---METIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.++||+|+||+||+|+++ +|+.||+|++.+. .......+.+| +.+++.++|||||+++++|.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999987 6999999998642 12233334444 56667779999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999998765 699999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccccccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
..... ....+||+.|||||++. +..|+.++||||+||++|||++|+.||......+ .............
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~~---- 411 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAV---- 411 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCCC----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCCC----
Confidence 65432 24568999999999996 4579999999999999999999999997543222 2222222222111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
..+...+ ..+.+|+.+||+.||.+|++ ++||++|
T Consensus 412 --~~p~~~S------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 --ELPDSFS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --CCCTTSC------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --CCCccCC------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1111111 13557999999999999998 7888765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=415.56 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=210.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||+||+|+++ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.++...|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999986 69999999987655555667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC--CcEEEEeeccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN--FEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~~~~~~ 1016 (1176)
+||+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999997543 2689999999999999999999999 99999999999999854 88999999999877543
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+ .......+..... .+++..+
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-----~~~~~~~i~~~~~--~~~~~~~ 380 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCDW--NMDDSAF 380 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTCC--CCCSGGG
T ss_pred Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHhCCC--CCCcccc
Confidence 22 345689999999999999999999999999999999999999997543 2222222222221 1222222
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+|+.+||+.||++|||+.|+++|
T Consensus 381 ~~~s------~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SGIS------EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222 135679999999999999999999885
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=390.11 Aligned_cols=287 Identities=37% Similarity=0.613 Sum_probs=237.1
Q ss_pred cCHHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 850 LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 850 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
+++.++..++++|++.+.||+|+||.||+|++++|+.||+|++........+.+.+|+.++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445566788999999999999999999998889999999987665556678999999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..++||||+++|+|.+++.........+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976654445699999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC-CccHHHHHH-Hhhcccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG-DNNLVGWVK-QHAKLKI 1087 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~-~~~~~~~~~-~~~~~~~ 1087 (1176)
++...............||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......|.. .......
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654433332334456899999999998889999999999999999999999999765432 234455542 2333444
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
...+++......+ ......+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 266 ~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 266 EQIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSSSSSSCTTCSC--HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhcChhhccccC--HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 4555555443332 234456778999999999999999999999999987643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=402.56 Aligned_cols=362 Identities=22% Similarity=0.223 Sum_probs=305.8
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
++|++|+|++|.+++..|..|.++++|++|++++|.+.+.++...|.++++|++|+|++|.+++..|..+.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 67888888888888777888889999999999999887778777788899999999999999888888899999999999
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcc-ccccccCcEEEcCCccccCCCCccccCC--CccCeeeccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST-LSNCSQLVSLHLSFNYLTGTIPSSLGSL--SKLQDLKLWL 457 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~ 457 (1176)
|++|++++.+|.......+++|++|+|++|.+++..|.. +.++++|++|++++|++++..|..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 999998876555422355778999999999998877766 7889999999999999998888888766 7889999999
Q ss_pred ccccCCCCCCC--------CCccccceeecccccccCccccccccC---CCCCeeeccccccCCC----------CCccc
Q 046275 458 NQLHGEIPPEL--------GNIQTLETLFLDFNELTGTLPAALSNC---TNLNWISLSNNHLGGE----------IPTWI 516 (1176)
Q Consensus 458 N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~----------~p~~~ 516 (1176)
|.+.+..+..+ ..+++|++|+|++|++++..|..+..+ ++|+.|++++|.+.+. .+..+
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 99886555443 366889999999999998888887765 8899999999866542 22223
Q ss_pred cC--CCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccC
Q 046275 517 GQ--LSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHG 594 (1176)
Q Consensus 517 ~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 594 (1176)
.. .++|++|++++|.+++.+|..++.+++|+.|+|++|++++..|..
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~------------------------------- 318 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA------------------------------- 318 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT-------------------------------
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH-------------------------------
Confidence 22 368999999999999999999999999999999999998644432
Q ss_pred CCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccc
Q 046275 595 AGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG 674 (1176)
Q Consensus 595 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g 674 (1176)
|..+.+|++|+|++|++++..|..|+++++|+.|+|++|++++
T Consensus 319 -------------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 361 (455)
T 3v47_A 319 -------------------------------------FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361 (455)
T ss_dssp -------------------------------------TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred -------------------------------------hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence 2334579999999999999889999999999999999999998
Q ss_pred cCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCCCc
Q 046275 675 PIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQF 730 (1176)
Q Consensus 675 ~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~~~ 730 (1176)
..|..|+.+++|++|+|++|+|++..|..+..+++|+.|+|++|++++.+|....+
T Consensus 362 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l 417 (455)
T 3v47_A 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 417 (455)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred cChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHH
Confidence 88999999999999999999999766667899999999999999999999975444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=386.03 Aligned_cols=288 Identities=43% Similarity=0.746 Sum_probs=237.4
Q ss_pred ccccCHHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEE
Q 046275 847 LRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYC 925 (1176)
Q Consensus 847 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 925 (1176)
...+++.++..+.++|++.+.||+|+||+||+|++.+|+.||||++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999865332 2334689999999999999999999999
Q ss_pred eeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 046275 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVS 1005 (1176)
Q Consensus 926 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 1005 (1176)
......++||||+++|+|.+++........++++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998876555569999999999999999999999877789999999999999999999999
Q ss_pred eeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CCCCccHHHHHHHh
Q 046275 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSA---DFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~---~~~~~~~~~~~~~~ 1082 (1176)
|||+++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||... .........|....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876543322 224456999999999998888999999999999999999999999631 12334455555333
Q ss_pred h-ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1083 A-KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1083 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
. ........+.......+ ......+.+++.+||+.||++|||++||+++|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYK--DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCC--HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccC--HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2 23333444444433332 33556778899999999999999999999999863
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=396.23 Aligned_cols=376 Identities=26% Similarity=0.271 Sum_probs=243.9
Q ss_pred CccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhcccc-------------CCeEeeccccccCccCCC
Q 046275 218 KNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEH-------------LSFLNVSSNLFSGPIPVG 284 (1176)
Q Consensus 218 ~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-------------L~~L~Ls~N~l~~~~p~~ 284 (1176)
++|++|++++|+++.+|++++++++|++|++++|++++..|..++++.+ |++|++++|.+++. |.
T Consensus 11 ~~L~~L~l~~n~l~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~- 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE- 88 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS-
T ss_pred ccchhhhcccCchhhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC-
Confidence 4445555555555444444555555555555555555444544444443 58888888887742 11
Q ss_pred CccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCC
Q 046275 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364 (1176)
Q Consensus 285 ~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~ 364 (1176)
..++|++|++++|++++ +|.. +++|++|++++|+++ .+|. ..++|++|++++|.+++
T Consensus 89 --------------~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~----~~~~L~~L~L~~n~l~~ 145 (454)
T 1jl5_A 89 --------------LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQLEK 145 (454)
T ss_dssp --------------CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCCSS
T ss_pred --------------CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccC----CCCCCCEEECcCCCCCC
Confidence 12578888888888886 5643 378888888888887 4442 12688888888888885
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccc
Q 046275 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL 444 (1176)
Q Consensus 365 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 444 (1176)
+| .++++++|++|++++|++++ +|... .+|++|++++|++++ +| .++++++|++|++++|++++ +|...
T Consensus 146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~ 214 (454)
T 1jl5_A 146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP 214 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSC-CCCCC-----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC
T ss_pred -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc
Confidence 66 58888888888888888884 55432 478888888888886 55 58888888888888888885 55433
Q ss_pred cCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCe
Q 046275 445 GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAI 524 (1176)
Q Consensus 445 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 524 (1176)
++|++|++++|.++ .+| .++.+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|++
T Consensus 215 ---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~ 281 (454)
T 1jl5_A 215 ---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTF 281 (454)
T ss_dssp ---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCE
T ss_pred ---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCE
Confidence 47888888888888 677 48888888888888888885 4443 3788888888888885 5553 378888
Q ss_pred EEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhh
Q 046275 525 LKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGI 604 (1176)
Q Consensus 525 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (1176)
|++++|++++ +|.. .++|+.|++++|++++ +|.
T Consensus 282 L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~------------------------------------------ 314 (454)
T 1jl5_A 282 LDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCD------------------------------------------ 314 (454)
T ss_dssp EECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECC------------------------------------------
T ss_pred EECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccC------------------------------------------
Confidence 8888888886 2221 1578888888888764 110
Q ss_pred hhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcC
Q 046275 605 RAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR 684 (1176)
Q Consensus 605 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~ 684 (1176)
...+|++|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .++
T Consensus 315 -----------------------------~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~ 357 (454)
T 1jl5_A 315 -----------------------------LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQ 357 (454)
T ss_dssp -----------------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCT
T ss_pred -----------------------------CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhh
Confidence 00257788888888886 6765 477888888888888 5776 478
Q ss_pred cccEEEccCccccc--cCCCCcccc-------------ccccccccccccccC--CCCC
Q 046275 685 GLNILDLSSNRLEG--TIPSSMSSL-------------TLLNEIDLCNNQLTG--MIPV 726 (1176)
Q Consensus 685 ~L~~L~Ls~N~l~g--~iP~~l~~l-------------~~L~~l~ls~N~l~g--~~p~ 726 (1176)
+|++|+|++|+++| .+|.++.+| ++|+.||+++|+++| .+|.
T Consensus 358 ~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 358 NLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp TCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------
T ss_pred hccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh
Confidence 88888888888888 788888888 889999999999998 7775
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=394.83 Aligned_cols=386 Identities=19% Similarity=0.182 Sum_probs=292.2
Q ss_pred ceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcC
Q 046275 221 QFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLC 300 (1176)
Q Consensus 221 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l 300 (1176)
+.+++++++++.++. + .++|++|+|++|++++..+..|.++++|++|+|++|.+.+.++ ...+..+
T Consensus 13 ~~~~c~~~~l~~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~-----------~~~~~~l 78 (455)
T 3v47_A 13 YNAICINRGLHQVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR-----------NNTFRGL 78 (455)
T ss_dssp TEEECCSSCCSSCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC-----------TTTTTTC
T ss_pred cccCcCCCCcccCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC-----------ccccccc
Confidence 346666677666655 2 2667777777777777777777777777777777777654332 2223345
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCH-HHHhcCCCCCEEEccCcccCCCCccc-ccCCCCCCE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPI-EIFLSMSNLKELVLSFNDFTGALPDS-LSNLTNLET 378 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~ 378 (1176)
++|++|+|++|++++..|..|+++++|++|+|++|++++.++. ..|..+++|++|+|++|.+++..|.. +.++++|++
T Consensus 79 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 158 (455)
T 3v47_A 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158 (455)
T ss_dssp TTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCE
T ss_pred ccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccE
Confidence 6788888888888777777788888888888888888753332 23567788888888888887766665 677888888
Q ss_pred EEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcc--------ccccccCcEEEcCCccccCCCCccccCC---
Q 046275 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST--------LSNCSQLVSLHLSFNYLTGTIPSSLGSL--- 447 (1176)
Q Consensus 379 L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~--------l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--- 447 (1176)
|+|++|++++..|..+......+|+.|++++|.+.+..+.. +..+++|++|++++|++++..|..+..+
T Consensus 159 L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 238 (455)
T 3v47_A 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238 (455)
T ss_dssp EECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTT
T ss_pred EeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccc
Confidence 88888888777676665444467788888888887654433 3356788888888888887777766544
Q ss_pred CccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccC--CCCCeeeccccccCCCCCccccCCCCCCeE
Q 046275 448 SKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC--TNLNWISLSNNHLGGEIPTWIGQLSNLAIL 525 (1176)
Q Consensus 448 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 525 (1176)
++|+.|++++|.+.+.. +..+.+.+..+..+.++ ++|++|++++|++++.+|..++.+++|++|
T Consensus 239 ~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 304 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQL 304 (455)
T ss_dssp CCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEE
Confidence 77888888888765331 22333333334444443 689999999999999899999999999999
Q ss_pred EccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhh
Q 046275 526 KLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIR 605 (1176)
Q Consensus 526 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (1176)
+|++|++++..|..|.++++|+.|+|++|.+++..|..
T Consensus 305 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------------------------------------ 342 (455)
T 3v47_A 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM------------------------------------------ 342 (455)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG------------------------------------------
T ss_pred ECCCCcccccChhHhcCcccCCEEECCCCccCCcChhH------------------------------------------
Confidence 99999999888999999999999999999997533321
Q ss_pred hhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCc
Q 046275 606 AERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRG 685 (1176)
Q Consensus 606 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~ 685 (1176)
|..+.+|++|||++|++++.+|..|+.+++|+.|+|++|++++..+..++.+++
T Consensus 343 --------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 396 (455)
T 3v47_A 343 --------------------------FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTS 396 (455)
T ss_dssp --------------------------GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred --------------------------hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCc
Confidence 223457899999999999999999999999999999999999766667899999
Q ss_pred ccEEEccCccccccCCC
Q 046275 686 LNILDLSSNRLEGTIPS 702 (1176)
Q Consensus 686 L~~L~Ls~N~l~g~iP~ 702 (1176)
|++|+|++|++++.+|.
T Consensus 397 L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 397 LQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCEEECCSSCBCCCTTT
T ss_pred ccEEEccCCCcccCCCc
Confidence 99999999999998874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=394.30 Aligned_cols=242 Identities=21% Similarity=0.195 Sum_probs=143.3
Q ss_pred CcccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCC
Q 046275 91 TLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLS 170 (1176)
Q Consensus 91 ~~~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~ 170 (1176)
..+.|+.|++++|++ | .+|..+..+++|++|++++|.+.+..+. .++.+.+|+.+++++|.. .+
T Consensus 9 ~~~~L~~L~l~~n~l-~--~iP~~i~~L~~L~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~c~~-----------~~ 72 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-T--EMPVEAENVKSKTEYYNAWSEWERNAPP--GNGEQREMAVSRLRDCLD-----------RQ 72 (454)
T ss_dssp ----------------------------CCHHHHHHHHHHHHHTSCT--TSCCCHHHHHHHHHHHHH-----------HT
T ss_pred ccccchhhhcccCch-h--hCChhHhcccchhhhhccCCcccccCCc--ccccchhcchhhhhhhhc-----------cC
Confidence 357888999999999 4 5677888999999999999998865443 366777776666665521 35
Q ss_pred CcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCC
Q 046275 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISA 250 (1176)
Q Consensus 171 L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~ 250 (1176)
+++|++++|.+++++.+ .++|++|++++|.+++... .+++|++|++++|++++++.. .++|++|++++
T Consensus 73 l~~L~l~~~~l~~lp~~-------~~~L~~L~l~~n~l~~lp~--~~~~L~~L~l~~n~l~~l~~~---~~~L~~L~L~~ 140 (454)
T 1jl5_A 73 AHELELNNLGLSSLPEL-------PPHLESLVASCNSLTELPE--LPQSLKSLLVDNNNLKALSDL---PPLLEYLGVSN 140 (454)
T ss_dssp CSEEECTTSCCSCCCSC-------CTTCSEEECCSSCCSSCCC--CCTTCCEEECCSSCCSCCCSC---CTTCCEEECCS
T ss_pred CCEEEecCCccccCCCC-------cCCCCEEEccCCcCCcccc--ccCCCcEEECCCCccCcccCC---CCCCCEEECcC
Confidence 67777777777763322 2466677777766665322 246777777777777765432 15778888888
Q ss_pred CcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEE
Q 046275 251 NKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESF 330 (1176)
Q Consensus 251 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 330 (1176)
|++++ +| .++++++|++|++++|++++ +|.. ..+|++|++++|++++ +| .++++++|++|
T Consensus 141 n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~---------------~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L 200 (454)
T 1jl5_A 141 NQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---------------PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAI 200 (454)
T ss_dssp SCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC---------------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred CCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC---------------cccccEEECcCCcCCc-Cc-cccCCCCCCEE
Confidence 88876 44 47777888888888887764 2221 1367777777777775 44 47777777777
Q ss_pred EccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCC
Q 046275 331 DISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS 387 (1176)
Q Consensus 331 ~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 387 (1176)
++++|+++ .+|. ..++|++|++++|.++ .+| .++.+++|++|++++|+++
T Consensus 201 ~l~~N~l~-~l~~----~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 201 YADNNSLK-KLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp ECCSSCCS-SCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCC-cCCC----CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCC
Confidence 77777776 3442 1246677777777666 455 3666666666666666665
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=371.46 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=208.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 357999999999999999999875 6899999999776666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 489999999999999999999999 99999999999999999999999999998665432
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .................+ .
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~---~ 240 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTPELQNP---E 240 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSCCCSCG---G
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCCCc---c
Confidence 2 23456799999999999999999999999999999999999999965431 111111111111111111 1
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~------~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLS------AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccC------HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111 135579999999999999999999886
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=373.68 Aligned_cols=262 Identities=25% Similarity=0.437 Sum_probs=211.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|.+.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46888999999999999999986 58999999986655556678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.++++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998643 2689999999999999999999999 999999999999999999999999999987643322
Q ss_pred cc------------cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1019 HL------------SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1019 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 11 112457999999999999999999999999999999999999998654322111000000000001
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.....+. .+.+++.+||+.||++|||++++++.|++++...
T Consensus 244 --------~~~~~~~------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 --------CPPNCPP------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --------CCTTCCT------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111121 2456999999999999999999999999997653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=363.59 Aligned_cols=283 Identities=38% Similarity=0.635 Sum_probs=226.9
Q ss_pred ccccCHHHHHHHhcCCCCC------ceEeEeCceEEEEEEECCCCEEEEEEeeccC----CcCHHHHHHHHHHHHhcCCC
Q 046275 847 LRKLTFADLLEATNGFHND------SLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS----GQGDREFTAEMETIGKIKHR 916 (1176)
Q Consensus 847 ~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 916 (1176)
...+++.++..++++|... +.||+|+||.||+|+. +++.||+|++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999998877 8999999999999987 58999999986432 22346788999999999999
Q ss_pred CcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 917 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
||+++++++.+.+..++||||+++|+|.+++..... ..++++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999976432 23689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 1076 (1176)
+.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHH
Confidence 9999999999999987654333333345679999999999876 5789999999999999999999999765432 2222
Q ss_pred HHHHHhhc--cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1077 GWVKQHAK--LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1077 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.+...... ..+.+.+++.+.... ......+.+++.+||+.||.+|||+++++++|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCC---HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccccc---hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 33322211 112222333332211 2234456779999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=370.24 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=206.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++|++.+.||+|+||.||+|++. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457999999999999999999985 799999999865422 23456889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998764 689999999999999999999999 999999999999999999999999999986643
Q ss_pred ccccccccccccCCcccCccccCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCS-TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. .....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+ .............. ++
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~--~p-- 234 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLRGKYR--IP-- 234 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CC--
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--CC--
Confidence 32 23556899999999999887765 79999999999999999999996543 23333333222211 11
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||.+|||++|++++
T Consensus 235 --~~~s------~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 --FYMS------TDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --TTSC------HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 135569999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=377.74 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=211.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC--------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVG 928 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 928 (1176)
.++|++.+.||+|+||+||+|++. ++..||||++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357889999999999999999863 345799998864322 2345688999999999 899999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
+..|+||||+++|+|.+++...+.. ...+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999875421 23589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNL 1075 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~ 1075 (1176)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 9999999999999987654433333344567889999999999999999999999999999999 99999764321 12
Q ss_pred HHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1076 VGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
... ...... +......+ ..+.+++.+||+.||++|||+.|++++|+++...
T Consensus 315 ~~~---~~~~~~-----~~~~~~~~------~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 FKL---LKEGHR-----MDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHH---HHTTCC-----CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HhcCCC-----CCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 221 111111 11111111 1355699999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=364.72 Aligned_cols=263 Identities=30% Similarity=0.494 Sum_probs=201.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++ +|+.||||++...... ..+.+.+|++++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45789999999999999999987 4889999998654322 23568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH--IIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 115 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred cCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999986532 12489999999999999999999999 7 9999999999999999999999999997543
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .............. ..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~~~----~~ 259 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-----PAQVVAAVGFKCKR----LE 259 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHHSCCC----CC
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCC----CC
Confidence 321 12245679999999999999999999999999999999999999997543 11122111111110 11
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.....+ ..+.+++.+||+.||++|||++++++.|+.+.+....
T Consensus 260 ~~~~~~------~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 260 IPRNLN------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 111111 1355699999999999999999999999999866433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.95 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=214.0
Q ss_pred cccCHHHHHHHhcC----------CCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCC
Q 046275 848 RKLTFADLLEATNG----------FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHR 916 (1176)
Q Consensus 848 ~~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 916 (1176)
..++++++..+++. |...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777777654 667789999999999999987 6999999999766666677899999999999999
Q ss_pred CcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 917 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998753 589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 1076 (1176)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-----~~ 247 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-----PV 247 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HH
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH
Confidence 9999999999999986654322 1245679999999999999999999999999999999999999996532 12
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
................ ....+ ..+.+++.+||+.||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~---~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRDSPPPKLKN---SHKVS------PVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSSCCCCTT---GGGSC------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCCCcCc---cccCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222222211111000 00111 135569999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=369.95 Aligned_cols=270 Identities=27% Similarity=0.326 Sum_probs=210.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC----eeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE----ERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 57889999999999999999986 8999999985432 23345667899999999999999999998744 469999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC-------IPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999764 4899999999999999999999861 2379999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc----------
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN---------- 1073 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~---------- 1073 (1176)
+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987655443333345679999999999976 3566789999999999999999999976543211
Q ss_pred -cHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1074 -NLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1074 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
....+......... .+.+....+ .......+.+++.+||+.||++|||++|+++.|+++++..
T Consensus 257 ~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 257 PSLEDMQEVVVHKKK----RPVLRDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGG-SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CchhhhhhhhhcccC----CCCcccccc-ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11122221111111 111111111 1113345778999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=370.88 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=205.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999987 789999999854332 223568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999987554 589999999999999999999999 9999999999999999999999999999866543
Q ss_pred cccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
..........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.........+..+.... .. .++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~---~~~-- 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TY---LNP-- 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC---TT---STT--
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc---cc---CCc--
Confidence 33333356689999999999977665 7789999999999999999999976553333222222111 10 010
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+...+ ..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~------~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKID------SAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCC------HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111 134569999999999999999999876
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=379.47 Aligned_cols=308 Identities=20% Similarity=0.193 Sum_probs=193.1
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
++|++|++++|++++. + ++++++|++|++++|+++ .+| +..+++|++|++++|.+++. .++++++|++|+
T Consensus 85 ~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~ 154 (457)
T 3bz5_A 85 TNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLT-KLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELD 154 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCS-CCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEE
T ss_pred CCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCC-eec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEE
Confidence 3444444444444432 2 445555555555555554 233 34455555555555555542 144555555555
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 460 (1176)
+++|+..+.++ + ..+++|++|++++|++++ +| ++.+++|+.|++++|++++. .++.+++|+.|++++|++
T Consensus 155 l~~n~~~~~~~--~--~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l 224 (457)
T 3bz5_A 155 CHLNKKITKLD--V--TPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKL 224 (457)
T ss_dssp CTTCSCCCCCC--C--TTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCC
T ss_pred CCCCCcccccc--c--ccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcc
Confidence 55554333332 1 234555555555555554 23 55566666666666666643 256666666666666666
Q ss_pred cCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCC
Q 046275 461 HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPEL 540 (1176)
Q Consensus 461 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 540 (1176)
++ +| ++.+++|++|++++|++++.. ++.+++|+.|++++| +|+.|++++|.+.|.+| +
T Consensus 225 ~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~ 282 (457)
T 3bz5_A 225 TE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--A 282 (457)
T ss_dssp SC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--C
T ss_pred cc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--c
Confidence 65 44 666667777777777776543 345566666666655 34556677777666666 4
Q ss_pred CCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCcc
Q 046275 541 GDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNF 620 (1176)
Q Consensus 541 ~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 620 (1176)
+.|++|+.|++++|++.|.+|... ..+ ..
T Consensus 283 ~~l~~L~~L~Ls~n~~l~~l~~~~----~~L--------------------------------------~~--------- 311 (457)
T 3bz5_A 283 EGCRKIKELDVTHNTQLYLLDCQA----AGI--------------------------------------TE--------- 311 (457)
T ss_dssp TTCTTCCCCCCTTCTTCCEEECTT----CCC--------------------------------------SC---------
T ss_pred cccccCCEEECCCCcccceeccCC----Ccc--------------------------------------eE---------
Confidence 566777777777777666555210 000 00
Q ss_pred ccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccC
Q 046275 621 TRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI 700 (1176)
Q Consensus 621 ~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~i 700 (1176)
-.+.++.+|++|+|++|+|+| +| ++++++|+.|++++|+|+| ++.|+.|++++|+++|.
T Consensus 312 ---------L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~- 370 (457)
T 3bz5_A 312 ---------LDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE- 370 (457)
T ss_dssp ---------CCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-
T ss_pred ---------echhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-
Confidence 012334578999999999998 44 9999999999999999996 34677789999999987
Q ss_pred CCCccccccccccccccccccCCCCC
Q 046275 701 PSSMSSLTLLNEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 701 P~~l~~l~~L~~l~ls~N~l~g~~p~ 726 (1176)
.++..|..+++++|+|+|.||.
T Consensus 371 ----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 371 ----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp ----EEEEECCCBCCBTTBEEEECCT
T ss_pred ----ceeeecCccccccCcEEEEcCh
Confidence 4778899999999999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=368.05 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=208.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
.++|.+.+.||+|+||.||+|+++ +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999987 6899999998654322 246789999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEee
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF----EARVSDF 1007 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 1007 (1176)
|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997654 689999999999999999999999 999999999999998876 7999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
|++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+ .......+.....
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~ 235 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANITAVSY 235 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTCC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCC
Confidence 9998765432 2245679999999999999999999999999999999999999996543 2222222222211
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+++..+...+. .+.+++.+||+.||++|||+.|+++|
T Consensus 236 --~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 --DFDEEFFSQTSE------LAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCCHHHHTTSCH------HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCCchhccCCCH------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122222222222 35679999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=359.82 Aligned_cols=265 Identities=22% Similarity=0.347 Sum_probs=208.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357999999999999999999986 68999999986543333 35688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++...+ ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998764 689999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .............. .....
T Consensus 163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~-~~~~~ 235 (294)
T 4eqm_A 163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-----AVSIAIKHIQDSVP-NVTTD 235 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-----HHHHHHHHHSSCCC-CHHHH
T ss_pred cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhhccCC-Ccchh
Confidence 3222 12244579999999999999999999999999999999999999996543 11111111111111 01111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhhCCCC
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRP-TMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~~~ 1143 (1176)
.....|. .+.+++.+||+.||++|| +++++.+.|+++......
T Consensus 236 ~~~~~~~------~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 236 VRKDIPQ------SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp SCTTSCH------HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cccCCCH------HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 1122221 355699999999999999 999999999988655443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.36 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=211.7
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|++.+++.||+|++... ....+++.+|++++++++||||+++++++.++...++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 468889999999999999999988999999998643 3345779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999997653 2589999999999999999999999 999999999999999999999999999986643221
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.... ............ .+.....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~~ 231 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTGF-----RLYKPRL 231 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTC-----CCCCCTT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhcCc-----cCCCCCc
Confidence 12234567888999999998899999999999999999999 999987543 122222222111 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.+ ..+.+++.+||+.||++|||+++++++|+++...
T Consensus 232 ~~------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 232 AS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp SC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11 1355699999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=365.03 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=206.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999987 6899999998653 3344567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999998654 689999999999999999999999 999999999999999999999999999975432
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .............. ++
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~--~p--- 225 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIR--FP--- 225 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CC---
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCCC--CC---
Confidence 22 12345689999999999999999999999999999999999999996543 22222222222110 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|| +++|+++|
T Consensus 226 -~~~s------~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 -RTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -TTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCC------HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111 1355699999999999999 89999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=367.25 Aligned_cols=262 Identities=25% Similarity=0.384 Sum_probs=208.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|.+.+.||+|+||.||+|++. .+..||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 57889999999999999999985 34569999986532 23345689999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.++++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999997553 2689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccc-ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTH-LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~~~~-----~ 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-----NRDVISSVEEGY-----R 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHHTTC-----C
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHcCC-----C
Confidence 43221 12233456788999999998899999999999999999999 999986543 112222221111 1
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.......+ ..+.+++.+||+.||++|||+.++++.|+++....+.
T Consensus 273 ~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 273 LPAPMGCP------HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCcC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 11111111 1355699999999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=355.19 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=211.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|++.+.||+|+||.||+|+++++..||+|++... ....+++.+|++++++++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3578899999999999999999998889999988643 334577999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++...+ ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998754 2589999999999999999999999 999999999999999999999999999986654322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ........... ....+..
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~--~~~~~~~-- 229 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----SEVVLKVSQGH--RLYRPHL-- 229 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHTTC--CCCCCTT--
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----HHHHHHHHcCC--CCCCCCc--
Confidence 2 2234456788999999998889999999999999999999 9999865431 11221111111 0111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.+ ..+.+++.+||+.||++|||+++++++|++++..
T Consensus 230 -~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 -AS------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -SC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -Ch------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11 1355699999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=377.93 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=208.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|.+.+.||+|+||.||+|+++ +++.||||.+..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 56888999999999999999987 689999998864322 2234588999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.++++..+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 194 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 194 VQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998653 2589999999999999999999999 99999999999999999999999999998644322
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.........+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ............ .....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~ 337 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----NQQTREFVEKGG-----RLPCP 337 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----HHHHHHHHHTTC-----CCCCC
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC-----CCCCC
Confidence 1111122345778999999998889999999999999999998 999986543 111111111111 01111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
...|. .+.+++.+||+.||++|||++++++.|+++++.
T Consensus 338 ~~~~~------~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ELCPD------AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCH------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11221 355699999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=373.53 Aligned_cols=271 Identities=25% Similarity=0.350 Sum_probs=216.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC--------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVG 928 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 928 (1176)
.++|.+.+.||+|+||+||+|++. .+..||+|++..... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357889999999999999999863 235799998865322 2235688999999999 999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
+..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999999999999876421 23589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNL 1075 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~ 1075 (1176)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----~ 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence 9999999999999987655443333345567899999999999999999999999999999999 999986543 2
Q ss_pred HHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCCCCc
Q 046275 1076 VGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQST 1148 (1176)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~ 1148 (1176)
............. ......+ ..+.+++.+||+.||++|||++|++++|+++.+.........
T Consensus 300 ~~~~~~~~~~~~~-----~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 300 EELFKLLKEGHRM-----DKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp HHHHHHHHTTCCC-----CCCSSCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred HHHHHHHHcCCCC-----CCCccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 2222222222111 1111111 135569999999999999999999999999987665444333
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=375.04 Aligned_cols=270 Identities=22% Similarity=0.369 Sum_probs=212.8
Q ss_pred HHHHHHHhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCccccee
Q 046275 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLG 923 (1176)
Q Consensus 852 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~ 923 (1176)
..+.....++|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3344455678999999999999999999842 457899999865332 2235689999999999 7999999999
Q ss_pred EEeeCCe-eEEEEeeccCCCHHHHHhhcccc-------------------------------------------------
Q 046275 924 YCKVGEE-RLLVYEYMRYGSLEDVLHNQKKV------------------------------------------------- 953 (1176)
Q Consensus 924 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------- 953 (1176)
++.+.+. .++||||+++|+|.++++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9877554 89999999999999999865421
Q ss_pred -------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 954 -------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 954 -------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 11289999999999999999999999 99999999999999999999999999998665443333
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .............. ....
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~--------~~~~ 321 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRA--------PDYT 321 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCCCC--------CTTC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCCCC--------CCCC
Confidence 3455678999999999999899999999999999999998 999997654221 11111111111111 1111
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
+ ..+.+++.+||+.||++|||++|++++|+++..
T Consensus 322 ~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 322 T------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1 135569999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=357.30 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=204.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHh--cCCCCcccceeEEee----CCeeE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGK--IKHRNLVPLLGYCKV----GEERL 932 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~ 932 (1176)
.++|++.+.||+|+||+||+|++ +++.||||++.. ...+.+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45799999999999999999998 589999999853 334556677777776 799999999998654 34579
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--------HNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
+||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999643 5899999999999999999999 76 9999999999999999999999
Q ss_pred Eeeccccccccccccc--cccccccCCcccCccccCCC------CCCchhhhHHHHHHHHHHHcC----------CCCCC
Q 046275 1005 SDFGMARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSF------RCSTKGDVYSYGVVLLELLTG----------KRPTD 1066 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~P~~ 1066 (1176)
+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997654433221 12345799999999999876 455799999999999999999 88886
Q ss_pred CCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1067 SADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
........................+++... .......+.+++.+||+.||++|||++++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWF-----SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGG-----GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhc-----cCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 654343333333332222211111111111 112334567899999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=358.47 Aligned_cols=265 Identities=23% Similarity=0.407 Sum_probs=204.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-----CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-----DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 932 (1176)
++|++.+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 56889999999999999999852 588999999876555555678999999999999999999999854 35589
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++...+. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999987642 589999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---------CCccH-H-HHHH
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF---------GDNNL-V-GWVK 1080 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~---------~~~~~-~-~~~~ 1080 (1176)
........ ......+++.|+|||++.+..++.++||||||+++|||++|..||..... ..... . ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 65432221 12344577889999999988999999999999999999999999864210 00000 0 0001
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
...... ........+ ..+.+++.+||+.||++|||++|+++.|++++...
T Consensus 244 ~~~~~~-----~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNG-----RLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTC-----CCCCCTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccC-----cCCCCcCcC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111110 111111112 24566999999999999999999999999998654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=371.62 Aligned_cols=360 Identities=23% Similarity=0.236 Sum_probs=211.4
Q ss_pred cccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCC
Q 046275 164 AGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLAL 243 (1176)
Q Consensus 164 ~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L 243 (1176)
.+..+++|++||+++|.+++. | .|..+++|++|+|++|.+++. ++..+++|++|++++|++++++ ++.+++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~---~--~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM---T--GIEKLTGLTKLICTSNNITTL-DLSQNTNLTYLACDSNKLTNLD--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC---T--TGGGCTTCSEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSCCC--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC---h--hhcccCCCCEEEccCCcCCeE-ccccCCCCCEEECcCCCCceee--cCCCCcC
Confidence 344556777777777777653 2 244555555555555555543 2444455555555555544432 4444445
Q ss_pred cEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccC
Q 046275 244 EYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS 323 (1176)
Q Consensus 244 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 323 (1176)
++|++++|++++. + ++.++ +|++|++++|++++. + ++.
T Consensus 109 ~~L~L~~N~l~~l-~--~~~l~------------------------------------~L~~L~l~~N~l~~l-~--l~~ 146 (457)
T 3bz5_A 109 TYLNCDTNKLTKL-D--VSQNP------------------------------------LLTYLNCARNTLTEI-D--VSH 146 (457)
T ss_dssp CEEECCSSCCSCC-C--CTTCT------------------------------------TCCEEECTTSCCSCC-C--CTT
T ss_pred CEEECCCCcCCee-c--CCCCC------------------------------------cCCEEECCCCcccee-c--ccc
Confidence 5555555544432 1 44444 444444444444432 1 445
Q ss_pred CCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCcc
Q 046275 324 CSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403 (1176)
Q Consensus 324 l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~ 403 (1176)
+++|++|++++|+..+.++ +..+++|++|++++|++++ +| +..+++|+.|++++|++++. + + ..+++|+
T Consensus 147 l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l--~~l~~L~ 215 (457)
T 3bz5_A 147 NTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--L--NQNIQLT 215 (457)
T ss_dssp CTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--C--TTCTTCS
T ss_pred CCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--c--ccCCCCC
Confidence 5555555555553333442 3445555555555555554 22 45555555555555555532 1 1 2345566
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 483 (1176)
+|+|++|++++ +| ++.+++|+.|++++|++++.. ++.+++|+.|+++.| +|+.|++++|.
T Consensus 216 ~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~ 275 (457)
T 3bz5_A 216 FLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNT 275 (457)
T ss_dssp EEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCT
T ss_pred EEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCc
Confidence 66666666654 34 556666777777777766532 345566666666554 34566777777
Q ss_pred ccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChh
Q 046275 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPA 563 (1176)
Q Consensus 484 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~ 563 (1176)
+.+.+| ++++++|+.|++++|.+.+.+|. ..++|+.|++++| ++|+.|++++|+++| +|
T Consensus 276 ~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~-- 334 (457)
T 3bz5_A 276 QLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTE-LD-- 334 (457)
T ss_dssp TCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--
T ss_pred cCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCcccc-cc--
Confidence 766666 46677777777777777666663 3455666655555 577888888888775 21
Q ss_pred HHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEc
Q 046275 564 LFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643 (1176)
Q Consensus 564 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdL 643 (1176)
+..+.+|+.||+
T Consensus 335 --------------------------------------------------------------------l~~l~~L~~L~l 346 (457)
T 3bz5_A 335 --------------------------------------------------------------------VSHNTKLKSLSC 346 (457)
T ss_dssp --------------------------------------------------------------------CTTCTTCSEEEC
T ss_pred --------------------------------------------------------------------cccCCcCcEEEC
Confidence 122346778888
Q ss_pred ccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccc
Q 046275 644 SYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSS 706 (1176)
Q Consensus 644 s~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~ 706 (1176)
++|+|+| ++.|..|++++|+++|. +.+..|+.+||++|+|+|.||..+..
T Consensus 347 ~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 347 VNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp CSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred CCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 8888886 24567778888888876 46677888899999999999887644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=359.35 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=205.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|.+.+.||+|+||.||+|+++ +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46889999999999999999987 5899999998653322 3567899999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEeec
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF----EARVSDFG 1008 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 1008 (1176)
+||||+++|+|.+++...+ .+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999997653 689999999999999999999999 999999999999999887 79999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .............
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~~- 234 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVNY- 234 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHTCC-
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHHhcCC-
Confidence 9987643222 245679999999999999999999999999999999999999996542 1122222111111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.+......+ ..+.+++.+||+.||++|||+.|++++
T Consensus 235 -~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -EFEDEYFSNTS------ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCCHHHHTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CcCccccccCC------HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111122 235579999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=365.29 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=206.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-----CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-----SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46999999999999999999986 6899999988532 12245779999999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEeeccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE---ARVSDFGMA 1010 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla 1010 (1176)
||||+++|+|.+++......+..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999998876654455689999999999999999999999 9999999999999986554 999999999
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
+....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ............ .
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~i~~~~~--~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFEGIIKGKY--K 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHHHHHHTCC--C
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHHHHHcCCC--C
Confidence 87654322 2245679999999999999999999999999999999999999996532 112222222211 1
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++..+...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~s------~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 MNPRQWSHIS------ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCHHHHTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccccccCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1222222222 235679999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=366.80 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=200.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||+|++.+. .....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999987 5899999998643 223445678899999988 79999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998764 689999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+...... ++.
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~--~p~ 245 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDEVV--YPT 245 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CCT
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCC--CCC
Confidence 3222 22345689999999999999899999999999999999999999997543 22222322222211 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM------IQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~------~evl~~ 1133 (1176)
. .+ ..+.+++.+||+.||++||++ +|+++|
T Consensus 246 ~----~~------~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 246 W----LH------EDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp T----SC------HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C----CC------HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 11 135569999999999999998 777764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=367.23 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=201.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.++||+|+||+||+|+++ +++.||+|++.+... ...+.+.+|..++.++ +|||||++++++.+....|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57899999999999999999987 578899999875422 2234578899999887 899999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 132 ~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998764 689999999999999999999999 99999999999999999999999999997532
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC---c-cHHHHHHHhhccccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD---N-NLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~---~-~~~~~~~~~~~~~~~~~ 1090 (1176)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ . .............. .
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~ 280 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--R 280 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--C
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--C
Confidence 221 22356789999999999999999999999999999999999999997543211 1 11111122222111 0
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM------IQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~------~evl~~ 1133 (1176)
+++ ..+ ..+.+++.+||+.||++||++ +|+++|
T Consensus 281 ~p~----~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 IPR----SLS------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCT----TSC------HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCC----cCC------HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111 111 135579999999999999995 566554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=368.08 Aligned_cols=266 Identities=27% Similarity=0.439 Sum_probs=212.0
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
..++|++.+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999885 347899998865332 224568999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc--------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV--------------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMK 990 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 990 (1176)
.++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+. +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999864311 14689999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCC
Q 046275 991 SSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSAD 1069 (1176)
Q Consensus 991 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~ 1069 (1176)
|+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654333233345678999999999988899999999999999999999 999986543
Q ss_pred CCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1070 FGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
.............. ......+ ..+.+++.+||+.||++|||+.+++++|+++....+
T Consensus 282 -----~~~~~~~~~~~~~~-----~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 282 -----HEEVIYYVRDGNIL-----ACPENCP------LELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp -----HHHHHHHHHTTCCC-----CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred -----hHHHHHHHhCCCcC-----CCCCCCC------HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 12222222222211 1111112 135569999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=366.84 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=203.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.+++.++|||||++++++.+....|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46889999999999999999987 5889999998642 2344567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+.+|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999998654 689999999999999999999999 999999999999999999999999999987643
Q ss_pred ccccccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............. .++
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~--~~p 240 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTVV--TYP 240 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHHCCC--CCC
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhhccc--CCC
Confidence 22 2356689999999999864 45899999999999999999999999754322 22222222222111 011
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-MIQVMA 1132 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-~~evl~ 1132 (1176)
. ..+ ..+.+++.+||+.||.+||+ ++++.+
T Consensus 241 ~----~~s------~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 S----AWS------QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp T----TSC------HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred C----cCC------HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 111 14566999999999999998 666654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=356.23 Aligned_cols=271 Identities=22% Similarity=0.278 Sum_probs=211.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC--eeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE--ERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999987 48999999986533 234567889999999999999999999987765 779999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEeecccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMAR 1011 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla~ 1011 (1176)
||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999987643 22489999999999999999999999 99999999999999 788889999999998
Q ss_pred ccccccccccccccccCCcccCccccC--------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQ--------SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........... ......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE-VMYKII 240 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH-HHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH-HHHHHh
Confidence 7654332 23457999999999985 56789999999999999999999999976543222222 222211
Q ss_pred ccccccc-------------cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1084 KLKISDV-------------FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1084 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
....... +.+...............+.+++.+||+.||++|||++|++++..+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111100 001111111122233445678999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=361.76 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=212.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
.++|.+.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 457889999999999999999872 35789999886432 22345688999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhcccc--------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKV--------------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKS 991 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 991 (1176)
++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 9999999999999999875431 13489999999999999999999999 999999999
Q ss_pred CCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCC
Q 046275 992 SNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADF 1070 (1176)
Q Consensus 992 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~ 1070 (1176)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333345567889999999998889999999999999999999 9999976442
Q ss_pred CCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1071 GDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
........ .... +......+ ..+.+++.+||+.||++|||+.+++++|+++...
T Consensus 259 --~~~~~~~~---~~~~-----~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 --ERLFNLLK---TGHR-----MERPDNCS------EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp --GGHHHHHH---TTCC-----CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHHhh---cCCc-----CCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 12222211 1111 11111111 1355699999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=360.81 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=202.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|++. +++.||+|++... .......+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999985 6899999998642 2233457889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+ +|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 679999997654 689999999999999999999999 999999999999999999999999999986643
Q ss_pred ccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... ....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........ ...+... ...
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------~~~i~~~-~~~ 226 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------FKKVNSC-VYV 226 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------BCCCCSS-CCC
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------HHHHHcC-CCC
Confidence 322 245679999999999988776 7899999999999999999999975432210 0000000 001
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+ ..+.+++.+||+.||.+|||++|++++
T Consensus 227 ~p~~~s------~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 MPDFLS------PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCTTSC------HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CcccCC------HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111 134569999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=373.34 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=211.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||+||+|++. +++.||||++... ......++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56889999999999999999853 4668999998543 2233456889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhcccc---CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEEe
Q 046275 933 LVYEYMRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF---EARVSD 1006 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~D 1006 (1176)
+||||+++|+|.+++...+.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999876422 23589999999999999999999999 999999999999999554 599999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcc
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.... ...........
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-----~~~~~~~i~~~ 302 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVTSG 302 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHTT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC
Confidence 999986544333333345678999999999988899999999999999999998 999986543 12222222221
Q ss_pred ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
... ......+ ..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 303 ~~~-----~~~~~~~------~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRM-----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCC-----CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCC-----CCCccCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 111 1111111 13556999999999999999999999999997653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=362.99 Aligned_cols=257 Identities=24% Similarity=0.415 Sum_probs=200.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCE----EEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGST----VAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||+||+|++. +++. ||+|++... .....+.+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46889999999999999999975 3443 577776432 2344567999999999999999999999998754 788
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998753 2689999999999999999999999 9999999999999999999999999999877
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ............... +
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~----~ 241 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQ----P 241 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCC----C
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHcCCCCCC----C
Confidence 65444333345567889999999999999999999999999999999 9999976432 122222211111010 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
...+ ..+.+++.+||+.||++|||+.+++++|+++..
T Consensus 242 ----~~~~------~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 ----PICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----TTBC------HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ----ccCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111 145569999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=368.87 Aligned_cols=274 Identities=18% Similarity=0.223 Sum_probs=208.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECC------CCEEEEEEeeccCCcC-----------HHHHHHHHHHHHhcCCCCccc
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKD------GSTVAIKKLIHISGQG-----------DREFTAEMETIGKIKHRNLVP 920 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 920 (1176)
..++|++.+.||+|+||.||+|++.. ++.||||.+....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999998864 4789999876432111 112344556677778999999
Q ss_pred ceeEEeeC----CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 921 LLGYCKVG----EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 921 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
+++++... ...|+||||+ +|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4579999999 999999998652 3699999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEEeecccccccccccccc-----ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 997 D--ENFEARVSDFGMARLMSAMDTHLS-----VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 997 ~--~~~~~kl~DfGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
+ .++.+||+|||+++.+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 889999999999987654332211 134459999999999999999999999999999999999999997533
Q ss_pred CCCccHHHHHHHhhccccccccCcccc-cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1070 FGDNNLVGWVKQHAKLKISDVFDPELM-KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
................+.+.+++.+. ...| ..+.+++..||+.||++||++.++++.|+++....+...
T Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 266 -KDPKYVRDSKIRYRENIASLMDKCFPAANAP------GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp -TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred -cCHHHHHHHHHHhhhhHHHHHHHhcccccCH------HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 22222222222222222222222221 1112 145569999999999999999999999999987655443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=370.60 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=198.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|+++ ++..||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57999999999999999999875 57789999986432 22345789999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.++++..+ ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999998653 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccc-ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTH-LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... .............
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-----~~~~~~~i~~~~~----- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIKAVDEGYR----- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-----HHHHHHHHHTTEE-----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC-----
Confidence 43221 11123345788999999998899999999999999999998 999986543 1122222211110
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.......+ ..+.+++.+||+.||++||++.++++.|+++....
T Consensus 269 ~~~~~~~~------~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 LPPPMDCP------AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CCCCTTCB------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCcccc------HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00111111 24566999999999999999999999999997653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.68 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=208.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|++.+.||+|+||.||+|++.++..||+|++... ....+++.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3568889999999999999999998889999998643 334577999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999986432 689999999999999999999999 999999999999999999999999999986643222
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ........... ....+ .
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~~~~~--~~~~~---~ 244 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEHIAQGL--RLYRP---H 244 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHTTC--CCCCC---T
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----hHHHHHHhccc--CCCCC---C
Confidence 12234457888999999998899999999999999999998 9999875431 12222221111 00111 1
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
..+ ..+.+++.+||+.||++|||+++++++|+++...
T Consensus 245 ~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 245 LAS------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111 1355699999999999999999999999998743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=357.49 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=206.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||+||+|+++ +++.||+|.+.. .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec-CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467999999999999999999987 578899998753 233445688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCcEEEEeecccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE--NFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~ 1015 (1176)
+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999997543 3689999999999999999999999 9999999999999987 78999999999987654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ............. .+++..
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~--~~~~~~ 226 (321)
T 1tki_A 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEY--TFDEEA 226 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCC--CCCHHH
T ss_pred CCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHcCCC--CCChhh
Confidence 322 245679999999999999889999999999999999999999996543 1222222222221 112222
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~s------~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FKEIS------IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22222 235679999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=361.39 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=203.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCE----EEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGST----VAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||+||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46888999999999999999976 3444 7777764332 233356788999999999999999999986 456889
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+.+|+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998653 2688999999999999999999999 9999999999999999999999999999887
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ...................+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHTTCBCCCCTTBC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHcCCCCCCCCcCc
Confidence 65444434455678889999999998899999999999999999999 9999976432 22222222111111111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
+ .+.+++.+||+.||++|||+.+++++|+++..
T Consensus 244 ~--------------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 244 I--------------DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp T--------------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred H--------------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 23459999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=359.44 Aligned_cols=266 Identities=26% Similarity=0.450 Sum_probs=213.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEE------CCCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL------KDGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
.++|++.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788999999999999999986 2467899999864332 2346688999999999 99999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc--------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV--------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
.++||||+++|+|.+++...... ..++++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999999999999865421 22589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNL 1075 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~ 1075 (1176)
+.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HH
Confidence 9999999999999987655443333345567889999999988899999999999999999999 999997654221 11
Q ss_pred HHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1076 VGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
....... . .+......+ ..+.+++.+||+.||.+|||+.|++++|+++.....
T Consensus 258 ~~~~~~~----~----~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 258 YKMIKEG----F----RMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHT----C----CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHhccC----C----CCCCcccCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111111 1 011111111 235669999999999999999999999999886544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=365.08 Aligned_cols=266 Identities=23% Similarity=0.370 Sum_probs=209.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHIS-GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
.++|.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 467899999999999999999872 35689999986432 23446789999999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc-------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV-------------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKS 991 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 991 (1176)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 99999999999999999865321 12479999999999999999999999 999999999
Q ss_pred CCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCC
Q 046275 992 SNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADF 1070 (1176)
Q Consensus 992 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~ 1070 (1176)
+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654433333345567889999999988899999999999999999998 9999976542
Q ss_pred CCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1071 GDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
. ..+..... .. . .+......+ ..+.+++.+||+.||.+|||+.+++++|+.+.+...
T Consensus 281 ~-~~~~~~~~---~~-~----~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 D-ANFYKLIQ---NG-F----KMDQPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp S-HHHHHHHH---TT-C----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred H-HHHHHHHh---cC-C----CCCCCCCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 2 11211111 11 1 111111111 135569999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=355.95 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=204.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56889999999999999999987 6899999998643 2234567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999998654 689999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+..... .+++
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~--~~p~-- 224 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAEL--RFPP-- 224 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCC--CCCT--
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC--CCCC--
Confidence 2 235679999999999999999999999999999999999999996532 2222222222211 0111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++|| +++++++|
T Consensus 225 --~~~------~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 225 --FFN------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --TSC------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCC------HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111 1355699999999999999 88998865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=362.86 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=205.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++|++.+.||+|+||.||+|+++ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999986 689999999865332 23356889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN---FEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~ 1012 (1176)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||+++.+ +.+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999997654 689999999999999999999999 99999999999999865 4599999999986
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+ .............. ++
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~~--~~ 250 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQIKAGAYD--YP 250 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--CC
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCC--CC
Confidence 653322 245679999999999999899999999999999999999999986543 12222222222211 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~------~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPEWDTVT------PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTGGGGSC------HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccCCC------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111122 135569999999999999999999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=359.89 Aligned_cols=267 Identities=21% Similarity=0.339 Sum_probs=195.7
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECC-C---CEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKD-G---STVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
..++|++.+.||+|+||.||+|++.. + ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999998764 3 27999988643 233456789999999999999999999999877665
Q ss_pred ------EEEEeeccCCCHHHHHhhccc--cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 932 ------LLVYEYMRYGSLEDVLHNQKK--VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 932 ------~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 999999999999999976532 223589999999999999999999999 999999999999999999999
Q ss_pred EEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHh
Q 046275 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1004 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~---~ 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNY---L 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH---H
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHH---H
Confidence 999999987654433333334567889999999999899999999999999999999 99999764321 11111 1
Q ss_pred hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
...... ......+ ..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 253 ~~~~~~-----~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 253 IGGNRL-----KQPPECM------EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HTTCCC-----CCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcCCCC-----CCCCccC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 111110 0111111 2456799999999999999999999999999865433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=348.53 Aligned_cols=253 Identities=32% Similarity=0.482 Sum_probs=193.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC----cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG----QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|++. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57889999999999999999986 89999998864322 22467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--------CCcEEEEee
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE--------NFEARVSDF 1007 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df 1007 (1176)
||+++++|.+++... .+++..++.++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999998643 5899999999999999999999993333999999999999986 678999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
|+++....... ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...+. ............
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~ 231 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----LAVAYGVAMNKL 231 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHHHHTSCC
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHhhhcCCC
Confidence 99986543222 245789999999999988999999999999999999999999975431 111111111111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
. .......+ ..+.+++.+||+.||++|||+.|++++|+++
T Consensus 232 ~----~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A----LPIPSTCP------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C----CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C----CCCCcccC------HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1 11111112 1356699999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=364.53 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=207.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||.||+|+++ +|+.||+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999987 6889999988655444556789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCcEEEEeecccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE--NFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~ 1015 (1176)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997543 3689999999999999999999999 9999999999999974 57799999999987654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ............. .+++..
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~i~~~~~--~~~~~~ 273 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCDW--EFDEDA 273 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCCC--CCCSST
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC--CCCccc
Confidence 322 234579999999999999999999999999999999999999997543 1222222222211 112222
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|||+.|++++
T Consensus 274 ~~~~s------~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSSVS------PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCC------HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 22222 135579999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=354.26 Aligned_cols=265 Identities=24% Similarity=0.314 Sum_probs=202.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++.+|+.||+|++..... ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367999999999999999999998899999999864322 223568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 8888887653 2589999999999999999999999 9999999999999999999999999999876432
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc---ccccC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI---SDVFD 1092 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 1092 (1176)
.. ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .+............ ....+
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTT
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhc
Confidence 22 2244578999999999876 568999999999999999999999997654322 22222221111100 00000
Q ss_pred c--------ccccCCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 P--------ELMKEDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~--------~~~~~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ......+... ....++.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000000000 001245679999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=369.79 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=205.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
..++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3457999999999999999999886 688999998865332 2345688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEeecccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMAR 1011 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~ 1011 (1176)
|||+++|+|.+.+...+ .+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998764 689999999999999999999999 999999999999998 46789999999998
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+ .............. +
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~--~ 232 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----QHRLYQQIKAGAYD--F 232 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCCC--C
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHhCCCC--C
Confidence 6654322 2245679999999999999999999999999999999999999996533 22222222222211 1
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+...+...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~s------~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWDTVT------PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CccccccCC------HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111111122 135569999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=373.12 Aligned_cols=258 Identities=26% Similarity=0.328 Sum_probs=206.5
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
++....++|++.+.||+|+||+||+|+++ +++.||+|++.+. .....+.+.+|+.+++.++|||||++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44455678999999999999999999987 5889999998642 2233445889999999999999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+++|+|.++++.. .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999754 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCC----CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR----CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
|+....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+ .......+...
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNH 288 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTH
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-----hhhHHHHHHhc
Confidence 987654322 1234668999999999997655 7889999999999999999999997543 22222222211
Q ss_pred ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 046275 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAM 1133 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~ 1133 (1176)
...-.++. ....+ ..+.+++.+||+.+|.+ ||+++||++|
T Consensus 289 ~~~~~~p~--~~~~s------~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 KNSLTFPD--DNDIS------KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHCCCCT--TCCCC------HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccccCCC--ccccc------HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 10000110 00111 13556999999999988 9999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=358.64 Aligned_cols=266 Identities=20% Similarity=0.228 Sum_probs=213.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++. +|+.||||.+.... ..+.+.+|+++++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 357899999999999999999975 68899999886432 234688999999999 99999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-----EEEEeecccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE-----ARVSDFGMAR 1011 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~ 1011 (1176)
|+ +|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 899999998652 2699999999999999999999999 9999999999999998887 9999999998
Q ss_pred ccccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1012 LMSAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1012 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~ 236 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQKIGDTK 236 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHHHHhhh
Confidence 764433211 124567999999999999999999999999999999999999999865422 2222222221111
Q ss_pred cccccCcc-cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1087 ISDVFDPE-LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1087 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
.. .... .....| .+.+++.+||+.||.+||+++++++.|+++....+..
T Consensus 237 ~~--~~~~~~~~~~p-------~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 237 RA--TPIEVLCENFP-------EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HH--SCHHHHTTTCH-------HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cc--CCHHHHhccCh-------HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 10 0001 111111 4567999999999999999999999999998765543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=362.42 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=204.3
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
...++|.+.+.||+|+||+||+|+++ +|+.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999987 58899999986532 33456678899999887 999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+||||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999998754 689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+..... .+
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~--~~ 237 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFHSIRMDNP--FY 237 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC--CC
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHhCCC--CC
Confidence 5432221 2345689999999999999999999999999999999999999997543 1222222222111 01
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMI-QVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~-evl~~ 1133 (1176)
+ ...+ ..+.+++.+||+.||++||++. ++++|
T Consensus 238 p----~~~s------~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 238 P----RWLE------KEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp C----TTSC------HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred C----cccC------HHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1 1111 1355699999999999999997 66543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=377.67 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=211.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|.+.+.||+|+||.||+|+++++..||||++... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 3568888999999999999999988899999998653 345678999999999999999999999986 66789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999986532 2578999999999999999999999 999999999999999999999999999987643221
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.......+|+.|+|||++....++.++|||||||++|||+| |+.||...+ ..+......... ......
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~-----~~~~~~ 408 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALERGY-----RMPRPE 408 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHHTC-----CCCCCT
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC-----CCCCCC
Confidence 11233456789999999998899999999999999999999 999997543 112222222111 011111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
..+ ..+.+++.+||+.||++|||+++|++.|+++....+.
T Consensus 409 ~~~------~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 409 NCP------EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp TSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCC------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 112 1355699999999999999999999999998765443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=360.40 Aligned_cols=270 Identities=21% Similarity=0.307 Sum_probs=208.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 933 (1176)
.++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 357899999999999999999984 789999999876555556678999999999999999999999863 347799
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++.........+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999987544445799999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccc-------cccccccCCcccCccccCCCC---CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1014 SAMDTHL-------SVSTLAGTPGYVPPEYYQSFR---CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1014 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 3211110 112345799999999987543 6889999999999999999999985421111111111111
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
.... ......+ ..+.+++.+||+.||.+|||+.+++++|+++........
T Consensus 263 ~~~~------~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 263 QLSI------PQSPRHS------SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp C--C------CCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred cCCC------CccccCC------HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 0000 0001111 135669999999999999999999999999986655443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=362.10 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=195.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|.+.+.||+|+||+||+|+++ +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999987 78999999986533 3346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--EEEEeecccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE--ARVSDFGMARLMSA 1015 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~~~ 1015 (1176)
+++|+|.+++...+ ++++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999997654 689999999999999999999999 9999999999999987765 99999999974332
Q ss_pred ccccccccccccCCcccCccccCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTK-GDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...... ..+............. ++..
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~--~~~~ 244 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYS--IPDD 244 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTCCC--CCTT
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCCCC--CCCc
Confidence 21 2244579999999999988777665 89999999999999999999765432 2233333222222111 1110
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ..+ ..+.+++.+||+.||++|||+.|+++|
T Consensus 245 ~--~~s------~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 I--RIS------PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp S--CCC------HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C--CCC------HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 011 235679999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=349.92 Aligned_cols=267 Identities=19% Similarity=0.194 Sum_probs=212.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+|++. +|+.||+|++... ...+.+.+|+.+++++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 357999999999999999999975 6899999988543 2334678899999999 79999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-----EEEEeecccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE-----ARVSDFGMAR 1011 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGla~ 1011 (1176)
|+ +++|.+++...+ .++++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 899999998653 2589999999999999999999999 9999999999999987766 9999999998
Q ss_pred cccccccc-----ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1012 LMSAMDTH-----LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1012 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 237 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEKK 237 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHHHHHhhc
Confidence 76543221 112456799999999999999999999999999999999999999986543221 11111111110
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.. ...+......+ ..+.+++.+||+.||++|||++++++.|+++....+.
T Consensus 238 ~~-~~~~~~~~~~~------~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 238 QS-TPLRELCAGFP------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HH-SCHHHHTTTSC------HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cC-ccHHHHHhhCc------HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00 00011111112 1355699999999999999999999999999876544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=348.73 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=211.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4688899999999999999999888999999986533 345779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999997653 2589999999999999999999999 999999999999999999999999999986543221
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......|++.|+|||++.+..++.++||||+|+++|+|++ |+.||.... ............ .......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~i~~~~-----~~~~~~~ 229 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTGF-----RLYKPRL 229 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTC-----CCCCCTT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HHHHHHHHhcCC-----cCCCCcc
Confidence 12234567889999999988889999999999999999999 899986543 222222222211 0111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.+ ..+.+++.+||+.||++|||+++++++|+++.++
T Consensus 230 ~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 230 AS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp SC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred Cc------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11 1355699999999999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=359.33 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=202.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|+++ +++.||+|++.+..... .+.+.+|..+++++ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46889999999999999999987 58899999987543222 34578899999988 899999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998654 689999999999999999999999 99999999999999999999999999997543
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC----ccHHHHHHHhhccccccc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD----NNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~ 1090 (1176)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............... .
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~ 237 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--R 237 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--C
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--C
Confidence 222 12345689999999999999999999999999999999999999997532211 111111122222111 0
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM------IQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~------~evl~~ 1133 (1176)
++ ...+ ..+.+++.+||+.||++||++ +|+++|
T Consensus 238 ~p----~~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 IP----RSLS------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CC----TTSC------HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CC----CCCC------HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11 1111 135569999999999999995 566654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=374.80 Aligned_cols=263 Identities=24% Similarity=0.277 Sum_probs=207.4
Q ss_pred HHHHHHHhcCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEee
Q 046275 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927 (1176)
Q Consensus 852 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 927 (1176)
+.++....++|++.++||+|+||+||+|+++. ++.||+|++.+. .....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34445567889999999999999999999874 788999988642 12223348899999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
.+..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +||||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999998642 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
|+|+........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+ ..+....+
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-----~~~~~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKI 293 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-----hhHHHHhh
Confidence 999766443322 224468999999999986 5678999999999999999999999997543 11122111
Q ss_pred hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 046275 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWR--RPTMIQVMAM 1133 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--RPt~~evl~~ 1133 (1176)
......-.++ ......+ ..+.+++.+||..+|++ ||+++|+++|
T Consensus 294 ~~~~~~~~~p-~~~~~~s------~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERFQFP-TQVTDVS------ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHCCCC-SSCCCSC------HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccccccCC-cccccCC------HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1110000011 1111111 13556999999988888 9999999886
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=352.63 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=195.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--------------------------CHHHHHHHHHHHHh
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--------------------------GDREFTAEMETIGK 912 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~ 912 (1176)
++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57899999999999999999986 5889999988643211 12468899999999
Q ss_pred cCCCCcccceeEEee--CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 046275 913 IKHRNLVPLLGYCKV--GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMK 990 (1176)
Q Consensus 913 l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 990 (1176)
++||||+++++++.+ ....|+||||+++|+|.+++.. .++++.+++.++.|++.||+|||+. +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999986 5688999999999999876542 2689999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCC---CCchhhhHHHHHHHHHHHcCCCCCCC
Q 046275 991 SSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR---CSTKGDVYSYGVVLLELLTGKRPTDS 1067 (1176)
Q Consensus 991 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~P~~~ 1067 (1176)
|+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 224567999999999997655 47889999999999999999999864
Q ss_pred CCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1068 ADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ...+........... +. ....+ ..+.+++.+||+.||++|||++|++++
T Consensus 243 ~~-----~~~~~~~~~~~~~~~---~~-~~~~~------~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ER-----IMCLHSKIKSQALEF---PD-QPDIA------EDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SS-----HHHHHHHHHHCCCCC---CS-SSCCC------HHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cc-----HHHHHHHHhcccCCC---CC-ccccC------HHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 32 222222222221110 00 01111 135569999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=354.69 Aligned_cols=267 Identities=23% Similarity=0.375 Sum_probs=204.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||.||+|++. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999985 689999999865322 2245688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999986544445789999999999999999999999 99999999999999999999999999997654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .................
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~---- 258 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCDYPPL---- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHHHTTCSCCC----
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHhhcccCCCC----
Confidence 3222 12345689999999999999999999999999999999999999975432 22333333322222111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.....+ ..+.+++.+||+.||++|||+.++++.|+++++....
T Consensus 259 ~~~~~~------~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 PSDHYS------EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CTTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cccccC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 111111 1355699999999999999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=351.78 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=202.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-C-------CEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-G-------STVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
++|.+.+.||+|+||+||+|++.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568889999999999999998763 3 47999998766666667899999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------EE
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE--------AR 1003 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 1003 (1176)
++||||+++|+|.+++...+. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999987542 489999999999999999999999 9999999999999988877 99
Q ss_pred EEeeccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1004 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.... .........
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----DSQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----chHHHHHHh
Confidence 9999998754322 23457899999999987 678999999999999999999655543221 111111111
Q ss_pred -hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1083 -AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1083 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
......... +. .+.+++.+||+.||++|||+.+++++|+++..+.+.+
T Consensus 232 ~~~~~~~~~~--------~~------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 232 EDRHQLPAPK--------AA------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HTTCCCCCCS--------SC------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred hccCCCCCCC--------CH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 111111111 11 2446999999999999999999999999997655443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=358.57 Aligned_cols=245 Identities=23% Similarity=0.256 Sum_probs=205.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+++ +|+.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999987 6899999998643 2234567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998764 689999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+...... ++
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~--~p--- 258 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGKVR--FP--- 258 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CC---
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHHcCCCC--CC---
Confidence 2 234579999999999999999999999999999999999999996532 22233333222211 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||.+||+ ++|+++|
T Consensus 259 -~~~~------~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 -SHFS------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -TTCC------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCC------HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1111 13556999999999999998 8888765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.35 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=199.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||+||+|++. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999986 5899999998654322 23668899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++ ++.+.+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 6666665432 2689999999999999999999999 9999999999999999999999999999866432
Q ss_pred cccccccccccCCcccCccccCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC---
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD--- 1092 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1092 (1176)
.. ......||+.|+|||++.+.. ++.++||||+||++|||++|..||.........+........... .+..+
T Consensus 155 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~ 231 (292)
T 3o0g_A 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT-EEQWPSMT 231 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC-TTTCTTGG
T ss_pred cc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC-hhhhhhhc
Confidence 22 224567899999999997765 799999999999999999999886443211111111111111000 00000
Q ss_pred --------------cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 --------------PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 --------------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.......+.. -..+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKL---NATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhccccc---ChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000111 1235579999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.99 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=200.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|++. ++.||+|++.. ....+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46888999999999999999986 78899998853 2345678999999999999999999998873 4799999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-EEEEeeccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE-ARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~~~ 1018 (1176)
+|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999986542 124788999999999999999999943228999999999999988876 799999999755322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .+.....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~-----~~~~~~~ 228 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---AFRIMWAVHNGT-----RPPLIKN 228 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---HHHHHHHHHTTC-----CCCCBTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---HHHHHHHHhcCC-----CCCcccc
Confidence 13346899999999999999999999999999999999999999754321 111111111111 1111122
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
.+. .+.+++.+||+.||++|||+++++++|+++.+.....
T Consensus 229 ~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 229 LPK------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred cCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 221 3556999999999999999999999999998765443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=351.36 Aligned_cols=273 Identities=25% Similarity=0.375 Sum_probs=208.7
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc--CCCCcccceeEEeeC----C
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI--KHRNLVPLLGYCKVG----E 929 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 929 (1176)
....++|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++... +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344568999999999999999999986 899999998532 334455666666655 899999999999887 7
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCCCcEEE
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC-----IPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
..++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 889999999999999999754 5899999999999999999999862 347999999999999999999999
Q ss_pred Eeeccccccccccccc--cccccccCCcccCccccCCCCCCch------hhhHHHHHHHHHHHcC----------CCCCC
Q 046275 1005 SDFGMARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSFRCSTK------GDVYSYGVVLLELLTG----------KRPTD 1066 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg----------~~P~~ 1066 (1176)
+|||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997664432221 1234579999999999987766554 9999999999999999 66765
Q ss_pred CCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1067 SADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
...........+............++..... ......+.+++.+||+.||++|||+.+++++|+++.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSS-----DECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGG-----SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchh-----hHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 5443333333333333222222222111111 1223456779999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=364.18 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=195.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCC--CCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIKH--RNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||.||+|.+.+++.||||++..... ...+.+.+|+.++++++| |||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356899999999999999999998899999999864332 223568899999999976 9999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
||+ .+|+|.+++...+ .+++.++..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 88 ~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp ECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 995 5789999998754 689999999999999999999999 999999999999997 5789999999998765
Q ss_pred cccccccccccccCCcccCccccCC-----------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQS-----------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... . .........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~-~~~~~~~~~ 234 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---N-QISKLHAII 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC---S-HHHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh---h-HHHHHHHHh
Confidence 4433333345679999999999854 678999999999999999999999996432 1 111111111
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
...... ......+ ..+.+++.+||+.||.+|||+.|++++-
T Consensus 235 ~~~~~~----~~~~~~~------~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 DPNHEI----EFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CTTSCC----CCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCccc----CCcccCC------HHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111 1111111 1355799999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.57 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=194.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++. ..||+|++..... ...+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 357999999999999999999864 4699998864332 2235688999999999999999999965 5566899999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999997553 3689999999999999999999999 9999999999999999999999999999866543
Q ss_pred cccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..........||+.|+|||++. +..++.++||||+|+++|+|++|+.||..... ..................
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~- 248 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMVGRGSLSPDLS- 248 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC----HHHHHHHHHHTSCCCCTT-
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch----HHHHHHHhcccccCcchh-
Confidence 3333334567999999999986 66788899999999999999999999975431 122222222222111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
......+ ..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 249 ~~~~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 KVRSNCP------KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hccccCC------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111122 245679999999999999999999999998864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.55 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=204.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||+|++.+. .....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999987 4789999998653 234456688899999988 89999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998654 689999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+...... +++
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~~--~p~ 242 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEHNVA--YPK 242 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CCT
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhCCCC--CCC
Confidence 3221 12345689999999999999999999999999999999999999997543 22222222222211 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++||+ ++++++|
T Consensus 243 ----~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 243 ----SMS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----TSC------HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 13556999999999999995 5777665
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.71 Aligned_cols=252 Identities=29% Similarity=0.545 Sum_probs=202.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCH-------HHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGD-------REFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
++|++.+.||+|+||+||+|++. +++.||+|++........ +.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57899999999999999999985 689999999865333221 56889999999999999999999986655
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCc-----EEE
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH--IIHRDMKSSNVLLDENFE-----ARV 1004 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl 1004 (1176)
++||||+++|+|.+++.... .++++..++.++.|++.||+|||+. + |+||||||+||+++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999887553 3689999999999999999999999 7 999999999999988776 999
Q ss_pred EeeccccccccccccccccccccCCcccCcccc--CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY--QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
+|||+++.... ......||+.|+|||++ ....++.++||||+|+++|||++|+.||....... ..+....
T Consensus 171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~ 242 (287)
T 4f0f_A 171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---IKFINMI 242 (287)
T ss_dssp CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---HHHHHHH
T ss_pred CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---HHHHHHH
Confidence 99999975432 12456799999999998 45567899999999999999999999997654322 1222222
Q ss_pred hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
...... +......+ ..+.+++.+||+.||++|||++++++.|+++
T Consensus 243 ~~~~~~----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLR----PTIPEDCP------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCC----CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCC----CCCCcccC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 221111 11212222 1355699999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=358.61 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=211.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC--------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVG 928 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 928 (1176)
.++|++.+.||+|+||.||+|++. ++..||+|++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357899999999999999999873 467899999864322 2345688999999999 899999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 996 (1176)
+..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999865421 22489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccH
Q 046275 997 DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNL 1075 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~ 1075 (1176)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~ 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-----H
Confidence 9999999999999987654433333344567889999999988889999999999999999999 999986543 2
Q ss_pred HHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1076 VGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1076 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
............ +......+ ..+.+++.+||+.||.+|||+.+++++|+++.....
T Consensus 266 ~~~~~~~~~~~~-----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 EELFKLLKEGHR-----MDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHTCC-----CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcCCC-----CCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 222222222111 11111111 135569999999999999999999999999976533
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=349.18 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=206.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+|+++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356899999999999999999987 689999999864332 334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999887543 689999999999999999999999 9999999999999999999999999999866443
Q ss_pred cccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
..........||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||.........+..+... .. ... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---~~~--~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KT---YLN--P 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT---CT---TST--T
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc---cc---ccC--c
Confidence 32223345679999999999987665 779999999999999999999997655333222222211 00 000 0
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 WKKID------SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GGGSC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhhcC------HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11111 134569999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=353.42 Aligned_cols=275 Identities=23% Similarity=0.339 Sum_probs=216.9
Q ss_pred CHHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHh--cCCCCcccceeEEeeC
Q 046275 851 TFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGK--IKHRNLVPLLGYCKVG 928 (1176)
Q Consensus 851 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 928 (1176)
+........++|.+.+.||+|+||.||+|++. |+.||+|++.. ...+.+.+|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 33334455678999999999999999999985 89999999853 345667889999887 7899999999999877
Q ss_pred C----eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCCEEE
Q 046275 929 E----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--------HNCIPHIIHRDMKSSNVLL 996 (1176)
Q Consensus 929 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll 996 (1176)
. ..++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+||++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 6 789999999999999999754 5899999999999999999999 66 89999999999999
Q ss_pred CCCCcEEEEeeccccccccccccc--cccccccCCcccCccccCCC------CCCchhhhHHHHHHHHHHHcC-------
Q 046275 997 DENFEARVSDFGMARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSF------RCSTKGDVYSYGVVLLELLTG------- 1061 (1176)
Q Consensus 997 ~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg------- 1061 (1176)
+.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999998665433221 22455799999999999765 334789999999999999999
Q ss_pred ---CCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1062 ---KRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1062 ---~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
+.||............+............++... . .......+.+++.+||+.||++|||+.+++++|+++.
T Consensus 261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW----Q-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG----G-TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc----c-chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 7888765544444444444333322221111111 0 1123345677999999999999999999999999998
Q ss_pred hCCC
Q 046275 1139 AGSG 1142 (1176)
Q Consensus 1139 ~~~~ 1142 (1176)
...+
T Consensus 336 ~~~~ 339 (342)
T 1b6c_B 336 QQEG 339 (342)
T ss_dssp HTTC
T ss_pred HHhc
Confidence 6543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=369.71 Aligned_cols=253 Identities=29% Similarity=0.429 Sum_probs=206.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-eeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE-ERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 937 (1176)
.++|++.+.||+|+||.||+|+++ |+.||||++... ...+.+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356888999999999999999986 789999998643 24567999999999999999999999987665 78999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++...+. ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999999987642 2478999999999999999999999 9999999999999999999999999999854321
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ....... .+. .....
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~---~~~-----~~~~p 408 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE---KGY-----KMDAP 408 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHH---TTC-----CCCCC
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---cCC-----CCCCC
Confidence 123367889999999999999999999999999999998 99999765422 2222221 111 11111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
...+. .+.+++.+||+.||++|||+.++++.|+++...
T Consensus 409 ~~~~~------~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 DGCPP------AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12221 355699999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=344.12 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=206.7
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||.||+|+++ ++..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356999999999999999999987 4789999999876666778899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeeccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~ 1014 (1176)
+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999998654 589999999999999999999999 99999999999999 788999999999998665
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... .....||+.|+|||++.+. ++.++||||+|+++|+|++|+.||.... ............. ..+..
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--~~~~~ 229 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-----DSEVMLKIREGTF--TFPEK 229 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC--CCCHH
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCC--CCCch
Confidence 4322 2456799999999998764 8999999999999999999999997543 1122222222111 11111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~------~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 230 DWLNVS------PQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHTTSC------HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhcCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 245569999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=350.13 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=194.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|++.+.||+|+||.||+|++.. +..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578899999999999999998753 45689998754322 23456889999999999999999999984 567899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997653 2689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ....... ....
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~---~~~~----- 235 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE---NGER----- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH---TTCC-----
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHH---cCCC-----
Confidence 443221 2234457889999999988899999999999999999997 99999764321 2222211 1111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.......+ ..+.+++.+||+.||++|||+.+++++|+++..
T Consensus 236 ~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01111112 135569999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.64 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=199.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||+||+|++.+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999985432 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++ +|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 9999987653 2689999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc---cc-----
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK---IS----- 1088 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~----- 1088 (1176)
. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.. ..+........... ..
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhcc
Confidence 1 1234578999999999876 45899999999999999999999999754311 11111111111000 00
Q ss_pred cccCcccccC--------CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELMKE--------DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+++..... .+... ..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLD---ESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcC---HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111111100 01111 235579999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=357.67 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=190.0
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|++++++++||||+++++++......++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999987 58899999986432 34568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeecccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARLM 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~ 1013 (1176)
|+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999997654 589999999999999999999999 9999999999999975 889999999999865
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............. ...
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~i~~~~~~--~~~ 272 (349)
T 2w4o_A 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD----QFMFRRILNCEYY--FIS 272 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH----HHHHHHHHTTCCC--CCT
T ss_pred Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc----HHHHHHHHhCCCc--cCC
Confidence 4322 124567999999999999999999999999999999999999999654311 1111222221111 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 273 ~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PWWDEVS------LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhhhCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111122 135579999999999999999999885
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=354.40 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=194.6
Q ss_pred cCCCCCceEeEeCceEEEEEEE----CCCCEEEEEEeeccC----CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL----KDGSTVAIKKLIHIS----GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5789999999999999999998 368999999986532 22345578899999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998654 689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ............. .+
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~--~~ 240 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-----RKKTIDKILKCKL--NL 240 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCC--CC
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCC--CC
Confidence 5432221 2245679999999999999899999999999999999999999997543 1222222222111 11
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
++. .+ ..+.+++.+||+.||++|| ++.++++|
T Consensus 241 p~~----~~------~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 PPY----LT------QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CTT----SC------HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCC----CC------HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111 11 1355699999999999999 78888775
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=350.20 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=199.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|.+.+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46889999999999999999986 58999999986543 33457789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeeccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~ 1014 (1176)
+++|+|.+++......+..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999976644445799999999999999999999999 99999999999999 456789999999997654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... .....||+.|+|||++.+ .++.++||||+|+++|||++|+.||.... .............. ....
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~--~~~~ 247 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEEVQQKATYKEPN--YAVE 247 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CCC-
T ss_pred Cccc---CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHHHHhhhccCCcc--cccc
Confidence 3222 245679999999999864 68999999999999999999999997543 11222111111110 0000
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ...+ ..+.+++.+||+.||++|||++|++++
T Consensus 248 ~-~~~~------~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 C-RPLT------PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CCCC------HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred c-CcCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0011 135569999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=369.80 Aligned_cols=262 Identities=22% Similarity=0.229 Sum_probs=205.9
Q ss_pred HHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEee
Q 046275 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927 (1176)
Q Consensus 852 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 927 (1176)
+.+.....++|++.+.||+|+||+||+|+++ +|+.||+|++.+.. ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455678999999999999999999986 69999999986422 1223457889999999999999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
.+..|+||||+++|+|.+++...+ ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999998653 2689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccC-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-------SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
|+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+ ......
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~ 280 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-----TAETYG 280 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHH
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 999876543221 223468999999999987 4578999999999999999999999997543 112221
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRR---PTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---Pt~~evl~~ 1133 (1176)
.+......-.+ +......+ ..+.+++.+||+ +|.+| |+++|+++|
T Consensus 281 ~i~~~~~~~~~-p~~~~~~s------~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYKEHLSL-PLVDEGVP------EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHHHHCCC-C----CCC------HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcccCcCC-CccccCCC------HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111000000 11111111 135669999999 99998 689999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.57 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=199.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCE----EEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGST----VAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||+||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57999999999999999999975 4544 567766432 3345678999999999999999999999998654 788
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998653 2689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..............
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~~~----- 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERLPQ----- 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCC-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCCC-----
Confidence 54443333344567889999999999999999999999999999999 99999765322 22222211111110
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
....+ ..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 241 ---~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 241 ---PPICT------IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---CTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---CccCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01111 1355699999999999999999999999998743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=357.66 Aligned_cols=270 Identities=22% Similarity=0.353 Sum_probs=212.5
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhc-CCCCcccceeEE
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKI-KHRNLVPLLGYC 925 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~ 925 (1176)
......++|++.+.||+|+||+||+|++. +++.||+|.+...... ..+.+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 33344578999999999999999999852 4678999998653322 335688999999999 799999999998
Q ss_pred eeCC-eeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 046275 926 KVGE-ERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSS 992 (1176)
Q Consensus 926 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 992 (1176)
...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccc
Confidence 7654 589999999999999999875421 11288999999999999999999999 9999999999
Q ss_pred CEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 046275 993 NVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFG 1071 (1176)
Q Consensus 993 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 1071 (1176)
||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999987654433333345668899999999998899999999999999999998 99999765422
Q ss_pred CccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1072 DNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
. .+ ......... .......+ ..+.+++.+||+.||.+|||+.+++++|+++.+..
T Consensus 258 ~-~~---~~~~~~~~~-----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 258 E-EF---CRRLKEGTR-----MRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp H-HH---HHHHHHTCC-----CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H-HH---HHHhccCcc-----CCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1 11 111111111 01111111 13556999999999999999999999999987543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=366.28 Aligned_cols=300 Identities=27% Similarity=0.338 Sum_probs=144.9
Q ss_pred CCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhh
Q 046275 217 CKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHL 296 (1176)
Q Consensus 217 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~ 296 (1176)
+++|+.|++++|.++.++ .+..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..+
T Consensus 45 l~~l~~L~l~~~~i~~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-------------- 107 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-------------- 107 (466)
T ss_dssp HHTCCEEECCSSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--------------
T ss_pred hccccEEecCCCCCccCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--------------
Confidence 345555555555554432 34455555555555555554433 5555555555555555542211
Q ss_pred hhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCC
Q 046275 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376 (1176)
Q Consensus 297 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 376 (1176)
+..+++|++|++++|.+++..+ +.++++|++|++++|.++ .++. +..+++|++|+++ |.+.+.. .+.++++|
T Consensus 108 ~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L 179 (466)
T 1o6v_A 108 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISA--LSGLTSLQQLSFG-NQVTDLK--PLANLTTL 179 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEEC-CCGG--GTTCTTCSEEEEE-ESCCCCG--GGTTCTTC
T ss_pred hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccC-CChh--hccCCcccEeecC-CcccCch--hhccCCCC
Confidence 1223455555555555553321 555666666666666655 3332 4556666666664 3333221 25556666
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecc
Q 046275 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456 (1176)
Q Consensus 377 ~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 456 (1176)
++|++++|.+++ ++. + ..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|+.|+++
T Consensus 180 ~~L~l~~n~l~~-~~~-l--~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~ 251 (466)
T 1o6v_A 180 ERLDISSNKVSD-ISV-L--AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 251 (466)
T ss_dssp CEEECCSSCCCC-CGG-G--GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred CEEECcCCcCCC-Chh-h--ccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECC
Confidence 666666665542 211 1 123445555555555544333 44455555555555555432 234444555555555
Q ss_pred cccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccC
Q 046275 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536 (1176)
Q Consensus 457 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 536 (1176)
+|.+.+..| +..+++|++|++++|++++..+ +..+++|+.|++++|++++..| ++.+++|++|+|++|++++..
T Consensus 252 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~ 325 (466)
T 1o6v_A 252 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCG
T ss_pred CCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCch
Confidence 555443322 4444455555555555543322 4444555555555555543222 444445555555555444333
Q ss_pred CCCCCCCCCCCEEEccCCCCc
Q 046275 537 PPELGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 537 p~~~~~l~~L~~L~L~~N~l~ 557 (1176)
| +..+++|+.|++++|+++
T Consensus 326 ~--~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 326 P--VSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp G--GGGCTTCCEEECCSSCCC
T ss_pred h--hccCccCCEeECCCCccC
Confidence 3 344444444444444443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=354.16 Aligned_cols=271 Identities=24% Similarity=0.364 Sum_probs=202.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCe----
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEE---- 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 930 (1176)
.++|++.+.||+|+||.||+|++. +++.||||++....... ...+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 357999999999999999999985 68899999986543332 2468899999999999999999999876543
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||+++|+|.++++..+ ++++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999998654 689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccc-ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1011 RLMSAMDTH-LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1011 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----~~~~~~~~~~~~~-- 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDP-- 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCC--
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCCC--
Confidence 866443221 12234578999999999999999999999999999999999999996543 1111111111110
Q ss_pred ccCcc-cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HHHHHHhhCCCCCCCCccc
Q 046275 1090 VFDPE-LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM-AMFKEIQAGSGLDSQSTIA 1150 (1176)
Q Consensus 1090 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl-~~L~~i~~~~~~~~~~~~~ 1150 (1176)
..+. .....+ ..+.+++.+||+.||++||++.+++ +.+.++......+.+....
T Consensus 237 -~~~~~~~~~~~------~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~ 292 (311)
T 3ork_A 237 -IPPSARHEGLS------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT 292 (311)
T ss_dssp -CCHHHHSTTCC------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCCC
T ss_pred -CCcccccCCCC------HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcccc
Confidence 1111 111111 1355699999999999999666655 5577776665555544433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=350.26 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=206.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||.||+|+++ +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46899999999999999999987 6899999998654322 3567899999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEeec
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF----EARVSDFG 1008 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 1008 (1176)
+||||+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999997653 689999999999999999999999 999999999999999887 79999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
++........ .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ............
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~-- 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANITSVS-- 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTC--
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcc--
Confidence 9986654322 244579999999999999999999999999999999999999996532 122222222211
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+++......+ ..+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDEEFFSHTS------ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCHHHHTTCC------HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccChhhhcccC------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112222222222 135679999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=360.03 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=197.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHH-HHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMET-IGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||+||+|+++ +++.||+|++.+... ...+.+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56999999999999999999987 588999999865432 223456667766 5678999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998754 688999999999999999999999 99999999999999999999999999998543
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+..... .+++.
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~~--~~~~~ 261 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNKPL--QLKPN 261 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHSCC--CCCSS
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhccc--CCCCC
Confidence 222 12346689999999999999999999999999999999999999996533 2222222222211 11111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.+ ..+.+++.+||+.||.+||++.+.++.+.++..
T Consensus 262 ----~~------~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 262 ----IT------NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp ----SC------HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred ----CC------HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 11 135569999999999999998755555554443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=363.00 Aligned_cols=206 Identities=22% Similarity=0.292 Sum_probs=177.6
Q ss_pred hcCCCCCceEeEe--CceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSG--GFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|++.+.||+| +||+||+|+++ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 99999999987 699999999865432 223567889999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986532 2589999999999999999999999 9999999999999999999999999988654
Q ss_pred cccccc-----ccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1014 SAMDTH-----LSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1014 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 322111 11133478999999999987 678999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=359.76 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=197.5
Q ss_pred CceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 865 DSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
.+.||+|+||.||+|++. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999986 6899999998765545567799999999999999999999999999999999999999999
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE--CCCCcEEEEeecccccccccccccc
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL--DENFEARVSDFGMARLMSAMDTHLS 1021 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~ 1021 (1176)
.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.......
T Consensus 174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 99987543 2689999999999999999999999 99999999999999 6678999999999987654322
Q ss_pred ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCc
Q 046275 1022 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101 (1176)
Q Consensus 1022 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1101 (1176)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+..... .+.+..+...+
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~--~~~~~~~~~~~- 316 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----DAETLNNILACRW--DLEDEEFQDIS- 316 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCC--CSCSGGGTTSC-
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccC--CCChhhhccCC-
Confidence 234579999999999999999999999999999999999999997543 1122222222111 11111111112
Q ss_pred hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1102 IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1102 ~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.+++.+||+.||++|||+.|++++
T Consensus 317 -----~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 317 -----EEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 245679999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.23 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=203.1
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|+++ ++.||+|++..... ...+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46889999999999999999986 88999999865332 2345689999999999999999999999877 7789999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH--IIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.++++|||++...
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999998654 23589999999999999999999998 7 999999999999999999999999987543
Q ss_pred ccccccccccccccCCcccCccccCCCCCCc---hhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCST---KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
.. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||.... ............
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~---- 227 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-----NMEIGMKVALEG---- 227 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-----HHHHHHHHHHSC----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----hHHHHHHHHhcC----
Confidence 21 2346899999999997655444 8999999999999999999996543 111111111111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
..+......+. .+.+++.+||+.||++|||++++++.|+++..
T Consensus 228 ~~~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LRPTIPPGISP------HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112222221 35569999999999999999999999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=373.03 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=207.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|.+.+.||+|+||.||+|+++ +|+.||+|++.+. .......+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357889999999999999999986 6999999998643 233456788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||++||+|.+++...+. ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986542 2589999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............. ..++
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~~~~--~~~p-- 409 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVKEVP--EEYS-- 409 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHHHCC--CCCC--
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhhccc--ccCC--
Confidence 4322 234589999999999999999999999999999999999999997654322 1222222221111 1111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||.+|| +++|+++|
T Consensus 410 --~~~s------~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 --ERFS------PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --TTSC------HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCC------HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1111 1355699999999999999 78998876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=348.67 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=208.6
Q ss_pred cCCCCCc-eEeEeCceEEEEEEEC---CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDS-LIGSGGFGDVYKAKLK---DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|.+.+ .||+|+||.||+|++. ++..||+|++..... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 9999999999999864 577899999865322 2345688999999999999999999999 55678999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999997543 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... . ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~---~~~~~i~~~~~----- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--P---EVMAFIEQGKR----- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--H---HHHHHHHTTCC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--H---HHHHHHhcCCc-----
Confidence 433221 1233457899999999988889999999999999999998 9999975431 1 12222222111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
+......+ ..+.+++.+||+.||++||++.+++++|+++..+.+...
T Consensus 232 ~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 232 MECPPECP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp CCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCcC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 11111112 135569999999999999999999999999987655444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=357.72 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=210.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC-C-----CEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD-G-----STVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
.++|.+.+.||+|+||.||+|++.. + ..||+|.+..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678999999999999999999753 2 4799998865332 2345688999999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhcccc----------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKV----------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF 1000 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 1000 (1176)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 99999999999999999865321 23579999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHH
Q 046275 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWV 1079 (1176)
Q Consensus 1001 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~ 1079 (1176)
.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |..||...... .......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHHH
Confidence 999999999986654333333345567889999999988899999999999999999999 99998754322 1111111
Q ss_pred HHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1080 KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1080 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
..... .......+ ..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 281 ~~~~~--------~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 281 KDGYQ--------MAQPAFAP------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHTCC--------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCC--------CCCCCCCC------HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11111 11111111 135569999999999999999999999998864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=350.15 Aligned_cols=268 Identities=24% Similarity=0.308 Sum_probs=190.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999876 689999999865432 334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccc--cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 937 YMRYGSLEDVLHNQKK--VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|++ |+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599999976532 123589999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc---c---
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK---I--- 1087 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~--- 1087 (1176)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+... .+........... .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence 3221 1234578999999999976 468999999999999999999999997543111 1111111110000 0
Q ss_pred --ccccCcccccCCCchHH----------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 --SDVFDPELMKEDPNIEI----------ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 --~~~~~~~~~~~~~~~~~----------~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+.+......+.... .-..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000111000000000 01246679999999999999999999886
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=365.53 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=196.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcC--CCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIK--HRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.+|++.+.||+|+||.||+|.+.+++.||||++..... ...+.+.+|+.++++++ ||||+++++++..++..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45899999999999999999988899999999864332 23456899999999996 599999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
| +.+++|.+++.... .+++.+++.++.||+.||.|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56789999998654 688999999999999999999999 999999999999996 57899999999987654
Q ss_pred ccccccccccccCCcccCccccCC-----------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQS-----------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~~~~~ 282 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAIID 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh----HHHHHHHHHhC
Confidence 333323345679999999999864 368899999999999999999999996432 11111222211
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
......++ ...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 283 ~~~~~~~~----~~~~------~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEIEFP----DIPE------KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCCCCC----CCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCCC----ccch------HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111 1111 135679999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=353.37 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=182.6
Q ss_pred CceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 865 DSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
.+.||+|+||+||+|+++ +++.||||++.. .....+.+|+.+++.+. ||||+++++++.++...|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 689999999854 34567889999999997 9999999999999999999999999999
Q ss_pred HHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEEeecccccccccccc
Q 046275 943 LEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF---EARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 943 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~ 1019 (1176)
|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 999998754 689999999999999999999999 999999999999997665 799999999986543222
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC--CccHHHHHHHhhccccccccCccccc
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG--DNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.. ................. ++...+.
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~ 241 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEGEAWK 241 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCSHHHH
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCccccc
Confidence 234567899999999999999999999999999999999999999765422 12223333333332211 1111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~s------~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVS------QEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSC------HHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCC------HHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111 245679999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.29 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=201.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457899999999999999999887 57799999885422 23356788999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998664 689999999999999999999999 99999999999999999999999999986543
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...+ ............. .
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~------~ 225 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF------T 225 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCC------C
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HHHHHHHHHhCCC------C
Confidence 322 234578999999999999999999999999999999999999997543 2222222222111 1
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+ ..+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 FPDFVT------EGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCTTSC------HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCcCC------HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111 134569999999999999999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=371.68 Aligned_cols=260 Identities=27% Similarity=0.392 Sum_probs=204.9
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|+++.+..||||++.... ...+++.+|++++++++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 5678889999999999999999888889999986533 346789999999999999999999999876 67899999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... +..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 262 ~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 262 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 999999997543 22589999999999999999999999 999999999999999999999999999986643221
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.......+. .......
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~-----~~~~~~~ 405 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGY-----RMPCPPE 405 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC-----CCCCCTT
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC-----CCCCCCC
Confidence 11234457889999999998899999999999999999999 999986543 112222221111 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.+ ..+.+++.+||+.||++|||++++++.|+++....+.
T Consensus 406 ~~------~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 406 CP------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp SC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 12 1355699999999999999999999999998765443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.79 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=205.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee---------
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--------- 927 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 927 (1176)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999987 79999999986432 456789999999999999999998854
Q ss_pred -------CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 046275 928 -------GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF 1000 (1176)
Q Consensus 928 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 1000 (1176)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 445799999999999999998653 23689999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1001 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+... ..+..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~ 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT 229 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH
Confidence 999999999987654322 23457999999999999889999999999999999999999886321 11222
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
......+...+ + ..+.+++.+||+.||++|||+.|++++++.+.+..+...
T Consensus 230 ~~~~~~~~~~~--------~------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 230 DLRDGIISDIF--------D------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHHTTCCCTTS--------C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred HhhcccccccC--------C------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 22222211111 1 124569999999999999999999999999987665543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=351.26 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=193.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.++||+|+||+||+|++. +|+.||||++...... .......|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 7999999987543222 223445566655555 8999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+ +++|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 679999987654 3699999999999999999999999 999999999999999999999999999986643
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..+.. ..... ..+..
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~-~~~~~----~~~~~ 273 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQQ-LRQGY----LPPEF 273 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHHH-HTTTC----CCHHH
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHH-HhccC----CCccc
Confidence 222 244579999999999876 7899999999999999999997765321 11111 11111 11222
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|||++|++++
T Consensus 274 ~~~~~------~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 TAGLS------SELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCC------HHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 22222 245679999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.87 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=209.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||.||+|++.+++.||+|++... ....+.+.+|++++++++||||+++++++. ++..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 568889999999999999999988889999988643 334678999999999999999999999986 456899999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+++|.+++.... +..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 91 ~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 91 NGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 999999997643 22589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~~ 234 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLERGY-----RMVRPDN 234 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC-----CCCCCTT
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-----HHHHHHHHhccc-----CCCCccc
Confidence 12234457889999999988889999999999999999999 999986543 112222221111 1111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
.+ ..+.+++.+|++.||++|||+.++++.|+++.....
T Consensus 235 ~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 235 CP------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cc------HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11 245569999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=351.18 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=199.7
Q ss_pred cCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
+.|.+. +.||+|+||+||+|++. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 78999999999999875 6899999999766656677899999999985 79999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEeecccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE---ARVSDFGMARLM 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~ 1013 (1176)
|+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998764 689999999999999999999999 9999999999999988766 999999998765
Q ss_pred ccccc-----cccccccccCCcccCccccCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc---------
Q 046275 1014 SAMDT-----HLSVSTLAGTPGYVPPEYYQS-----FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN--------- 1074 (1176)
Q Consensus 1014 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~--------- 1074 (1176)
..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111234569999999999865 56889999999999999999999999765432210
Q ss_pred -HHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1075 -LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1075 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
............. .++...+...+ ..+.+++.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~i~~~~~--~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY--EFPDKDWAHIS------CAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC--CCCHHHHTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc--ccCchhcccCC------HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111122221111 11111111111 245679999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=361.61 Aligned_cols=273 Identities=22% Similarity=0.273 Sum_probs=213.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC--eeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE--ERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46889999999999999999987 58999999986533 234567889999999999999999999988755 679999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEEeecccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL----DENFEARVSDFGMAR 1011 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGla~ 1011 (1176)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999987543 22389999999999999999999999 99999999999999 778889999999998
Q ss_pred ccccccccccccccccCCcccCccccCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQS--------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... ..
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~-~~ 240 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK-II 240 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH-HH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH-Hh
Confidence 7654322 245679999999999864 56788999999999999999999999765433332222222 21
Q ss_pred ccccccc-------------cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1084 KLKISDV-------------FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1084 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
....... +.................+.+++.+||+.||++|||++++++.++++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111110 00111111122233444566899999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=349.35 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=205.0
Q ss_pred cCCCCCceEeEeCceEEEEEEE-----CCCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC--Cee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL-----KDGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 931 (1176)
++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588899999999999999984 36889999998643 333457789999999999999999999999876 668
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996553 2589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccc-ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----------CCCccHHHHHH
Q 046275 1012 LMSAMDTH-LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD----------FGDNNLVGWVK 1080 (1176)
Q Consensus 1012 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~----------~~~~~~~~~~~ 1080 (1176)
........ .......||..|+|||++.+..++.++||||+|+++|+|++|+.|+.... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76543322 12245568889999999998889999999999999999999999864321 00111111111
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
...... ........+ ..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 255 ~~~~~~-----~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK-----RLPCPPNCP------DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC-----CCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC-----CCCCCCCCC------HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 111111111 24567999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.61 Aligned_cols=268 Identities=22% Similarity=0.324 Sum_probs=208.0
Q ss_pred cCCCCCceEeEeCceEEEEEEE-----CCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEe--eCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL-----KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK--VGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 932 (1176)
++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4688999999999999999985 358899999987655555567899999999999999999999886 456689
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++...+. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999986532 589999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC----------CccHHHHHHH
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG----------DNNLVGWVKQ 1081 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~----------~~~~~~~~~~ 1081 (1176)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65433221 223456888999999999888999999999999999999999998642210 0011111111
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
..... ........+ ..+.+++.+||+.||++|||+++++++|+++.......
T Consensus 257 ~~~~~-----~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 257 LEEGQ-----RLPAPPACP------AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHTTC-----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred hhccc-----CCCCCCccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 11111 111111111 23556999999999999999999999999987655433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=357.47 Aligned_cols=268 Identities=15% Similarity=0.157 Sum_probs=209.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC---------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCccc---------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD---------GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP--------- 920 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 920 (1176)
.++|.+.+.||+|+||.||+|++.. ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999874 789999988642 46789999999999999988
Q ss_pred ------ceeEEee-CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 046275 921 ------LLGYCKV-GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSN 993 (1176)
Q Consensus 921 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 993 (1176)
+++++.. +...|+||||+ +|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5667665 77889999999 899999998652 23699999999999999999999999 99999999999
Q ss_pred EEECCCC--cEEEEeeccccccccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Q 046275 994 VLLDENF--EARVSDFGMARLMSAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTD 1066 (1176)
Q Consensus 994 Ill~~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~ 1066 (1176)
|+++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 89999999998765432211 1134579999999999999999999999999999999999999997
Q ss_pred CCCCCCccHHHHHHHhhccccccccCccc-ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1067 SADFGDNNLVGWVKQHAKLKISDVFDPEL-MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
................. .......+... +...+ ..+.+++.+||+.||++|||++++++.|+++....+..
T Consensus 270 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFV-DKPGPFVGPCGHWIRPS------ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCHHHHHHHHHHHH-HSCCCEECTTSCEECCC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCHHHHHHHHHhcc-CChhhhhhhccccCCCc------HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 65422222222222111 11111111110 01111 24566999999999999999999999999998776543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.84 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=204.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999986 589999999865332 23356889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE---ARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~ 1012 (1176)
||+++|+|.+.+...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999987664 689999999999999999999999 9999999999999976655 99999999976
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...+ .............. .+
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~--~~ 227 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQIKAGAYD--YP 227 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--CC
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----hhHHHHHHHhcccc--CC
Confidence 643322 244679999999999999999999999999999999999999986533 12222222222111 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.......+ ..+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPEWDTVT------PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTTTSC------HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chhhcccC------HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111 135569999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=354.82 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=202.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+|+++ +|+.||+|.+..... ...+|++++.++ +||||+++++++.++...|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457999999999999999999987 588999999865332 235688888888 79999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEEeeccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN----FEARVSDFGMARL 1012 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 1012 (1176)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+||++.++ +.+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999998654 689999999999999999999999 99999999999998543 3599999999986
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ................. +.
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~~~~i~~~~~~--~~ 243 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--DDTPEEILARIGSGKFS--LS 243 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--TSCHHHHHHHHHHCCCC--CC
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--cCCHHHHHHHHccCCcc--cC
Confidence 643322 2245678999999999988889999999999999999999999997542 22233333333333221 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~s------~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 244 GGYWNSVS------DTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp STTTTTSC------HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccccccCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11112122 135569999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=358.26 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=212.9
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeC
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVG 928 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 928 (1176)
....++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345578999999999999999999865 367899998864332 2234688999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhcccc------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKV------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
...++||||+++|+|.+++...+.. ..++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence 9999999999999999999865321 13578999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||+++...............||+.|+|||++.+..++.++||||+|+++|+|++ |+.||.... .......
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~ 252 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVLRF 252 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----HHHHHHH
Confidence 9999999986654433333344567899999999998899999999999999999999 899986543 1222222
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
........ .....+ ..+.+++.+||+.||++|||+.|++++|+++...
T Consensus 253 ~~~~~~~~-----~~~~~~------~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VMEGGLLD-----KPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTTCCCC-----CCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCcCC-----CCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 22222111 111111 1355699999999999999999999999988653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=371.32 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=195.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999986 6899999998643 233345678899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999998654 68999999999999999999998 7 8999999999999999999999999999754
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .............. +++
T Consensus 300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~--~p~ 370 (446)
T 4ejn_A 300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEEIR--FPR 370 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CCT
T ss_pred cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHHhCCCC--CCc
Confidence 3222 22345789999999999999999999999999999999999999996543 22222222221110 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||.+|| |++|+++|
T Consensus 371 ----~~~------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 371 ----TLG------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----TSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----cCC------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111 1355699999999999999 99999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.63 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=202.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|.+.+.||+|+||+||+|++.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3578899999999999999998653 2359999886532 2334678899999999999999999999865 45689
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++++|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999997653 2589999999999999999999999 9999999999999999999999999999866
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ...............
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~~~~~~----- 235 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKGDRLPK----- 235 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHTCCCCC-----
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcCCCCCC-----
Confidence 443221 2234567889999999988899999999999999999998 9999975432 122222211111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
....+ ..+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 236 ---~~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 ---PDLCP------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11111 135569999999999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=354.76 Aligned_cols=263 Identities=25% Similarity=0.287 Sum_probs=202.5
Q ss_pred HHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-----CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC
Q 046275 855 LLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-----SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG 928 (1176)
Q Consensus 855 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 928 (1176)
+....++|.+.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456678999999999999999999986 6889999988643 234456789999999999999999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhcccc------------------------------------CcccCHHHHHHHHHHHHHH
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKV------------------------------------GIKLNWAARRKIAIGSARG 972 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~ 972 (1176)
...++||||+++|+|.+++...... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999632110 1235678889999999999
Q ss_pred HHHHHhcCCCCeeeCCCCCCCEEECCCC--cEEEEeecccccccccccc--ccccccccCCcccCccccCC--CCCCchh
Q 046275 973 LAFLHHNCIPHIIHRDMKSSNVLLDENF--EARVSDFGMARLMSAMDTH--LSVSTLAGTPGYVPPEYYQS--FRCSTKG 1046 (1176)
Q Consensus 973 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 1046 (1176)
|+|||+. +|+||||||+||+++.++ .+||+|||+++........ .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 8999999999865432221 12345679999999999865 6788999
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC
Q 046275 1047 DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126 (1176)
Q Consensus 1047 DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt 1126 (1176)
|||||||++|||++|+.||..... ............. +........+ ..+.+++.+||+.||.+|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLC--FENPNYNVLS------PLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCC--TTSGGGGGSC------HHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcccc--cCCcccccCC------HHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999965431 1112221111110 1111111111 23557999999999999999
Q ss_pred HHHHHHH
Q 046275 1127 MIQVMAM 1133 (1176)
Q Consensus 1127 ~~evl~~ 1133 (1176)
+.+++++
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=367.57 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=205.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57899999999999999999987 79999999986432 233467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997654 689999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.... .............. . +
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~~--~-p- 236 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKKICDGIFY--T-P- 236 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHHHHTTCCC--C-C-
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCCcC--C-C-
Confidence 32 2245679999999999988765 689999999999999999999997543 12222222222110 0 1
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||++|++++
T Consensus 237 --~~~s------~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 --QYLN------PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --TTCC------HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --ccCC------HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111 135669999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=358.36 Aligned_cols=267 Identities=16% Similarity=0.172 Sum_probs=201.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCCc-----------CHHHHHHHHHHHHhcCCCCccccee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISGQ-----------GDREFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
.++|.+.+.||+|+||.||+|++. ++..||+|+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999986 5788999988654321 1123667888899999999999999
Q ss_pred EEee----CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 046275 924 YCKV----GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN 999 (1176)
Q Consensus 924 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 999 (1176)
++.. ....|+||||+ +++|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 77899999999 899999998664 689999999999999999999999 99999999999999887
Q ss_pred C--cEEEEeeccccccccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 046275 1000 F--EARVSDFGMARLMSAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD 1072 (1176)
Q Consensus 1000 ~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~ 1072 (1176)
+ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 99999999998764332211 1244579999999999999899999999999999999999999996432111
Q ss_pred ccHHHHHHHhhccccccccCccccc-CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1073 NNLVGWVKQHAKLKISDVFDPELMK-EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
. ............+...+...... ..+ ..+.+++.+||+.||++|||++++++.|++....
T Consensus 268 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 268 V-AVQTAKTNLLDELPQSVLKWAPSGSSC------CEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp H-HHHHHHHHHHHTTTHHHHHHSCTTSCC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred H-HHHHHHHhhcccccHHHHhhccccccH------HHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1 11111111111111111110000 111 1456699999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=376.83 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=210.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||.||+|+++. +..||||++... ....+++.+|+.++++++||||+++++++......|+||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 457888999999999999999874 889999998643 345678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 299 ~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 299 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 99999999986532 3589999999999999999999999 99999999999999999999999999998764322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.. ........ . .......
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~---~-----~~~~~~~ 442 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK---D-----YRMERPE 442 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT---T-----CCCCCCT
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc---C-----CCCCCCC
Confidence 112234456789999999998899999999999999999999 99998765422 22222211 1 1111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
..+ ..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 443 ~~~------~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 443 GCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCC------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 112 1355699999999999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=369.71 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=207.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||+||+|+++ +|+.||+|++.+.. ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57889999999999999999986 69999999986432 234567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||++||+|.+++.........+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999987654344699999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .............. .++
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~~--~~p--- 413 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQAV--TYP--- 413 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCCC--CCC---
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhccc--CCC---
Confidence 322 1234589999999999999999999999999999999999999997654221 22233322222211 111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTM-----IQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~-----~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++||++ +++++|
T Consensus 414 -~~~s------~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 414 -DKFS------PASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -TTSC------HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -cccC------HHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1111 134569999999999999975 666653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=345.62 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=202.5
Q ss_pred cCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEE-eeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYC-KVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 933 (1176)
.+|.+.+.||+|+||+||+|++.+ +..||+|++..... ...+.+.+|+.++++++||||+++++++ ..+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998753 23578888764332 2345688999999999999999999985 45567899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997643 3589999999999999999999999 9999999999999999999999999999866
Q ss_pred cccccc--ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1014 SAMDTH--LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1014 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
...... .......||+.|+|||.+.+..++.++||||+|+++|+|++ |.+||...... ............
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~----- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL----- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCCC-----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCCC-----
Confidence 443221 12234567889999999998899999999999999999999 55555443321 122111111110
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
..+ ...+ ..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 252 ~~~---~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 252 LQP---EYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCC---TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCC---ccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111 1111 1356699999999999999999999999999876443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=348.95 Aligned_cols=42 Identities=36% Similarity=0.701 Sum_probs=38.7
Q ss_pred CCChHHHHHHHHHHhcCCCCCCCCCCCCCCCCcc--cceeEeCC
Q 046275 24 SSPNKDLQQLLSFKAALPNPSVLPNWSPNQNPCG--FKGVSCKA 65 (1176)
Q Consensus 24 ~~~~~~~~~ll~~k~~~~~~~~l~~w~~~~~cC~--W~gv~C~~ 65 (1176)
+|.++|+.||++||+++.||..+++|..++|||. |.||+|+.
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~ 45 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDT 45 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECC
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCC
Confidence 5789999999999999998888999998899998 99999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=353.97 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=198.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC-------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------- 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 929 (1176)
.++|++.+.||+|+||.||+|+++ +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356899999999999999999987 799999999865433 33467899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeeccCCCHHHHHhhccccCcccCH
Q 046275 930 --------------------------------------------------ERLLVYEYMRYGSLEDVLHNQKKVGIKLNW 959 (1176)
Q Consensus 930 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~ 959 (1176)
..++||||+++|+|.+++...... ...++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhh
Confidence 379999999999999999876532 34677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc----------ccccccccCC
Q 046275 960 AARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH----------LSVSTLAGTP 1029 (1176)
Q Consensus 960 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~ 1029 (1176)
..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 9999999999999999999999999999876543221 1123457999
Q ss_pred cccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHH
Q 046275 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQH 1109 (1176)
Q Consensus 1030 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1109 (1176)
.|+|||++.+..++.++||||+||++|||++|..|+.. .............. .. .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~~~~-----~~------~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNLKFP-----LL------FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTTCCC-----HH------HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhccCCC-----cc------cccCChhH
Confidence 99999999999999999999999999999998776321 11111111111111 10 01112244
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1110 LHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1110 ~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+++.+||+.||++|||++|++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 679999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=350.63 Aligned_cols=264 Identities=27% Similarity=0.445 Sum_probs=207.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEE--EEEEeecc-CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTV--AIKKLIHI-SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||.||+|++. ++..+ |+|++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56899999999999999999876 45544 88887642 233456789999999999 899999999999999999999
Q ss_pred EeeccCCCHHHHHhhcc------------ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 935 YEYMRYGSLEDVLHNQK------------KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
|||+++|+|.+++...+ .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999998654 2234689999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK 253 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HHHHHHH
Confidence 999999987433211 1234457889999999988889999999999999999998 999996543 2222222
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
..... ........+ ..+.+++.+||+.||++|||+++++++|+++........
T Consensus 254 ~~~~~-----~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 254 LPQGY-----RLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp GGGTC-----CCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred hhcCC-----CCCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 22211 111111111 135669999999999999999999999999987755444
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=344.89 Aligned_cols=263 Identities=28% Similarity=0.391 Sum_probs=205.0
Q ss_pred CCCCCceEeEeCceEEEEEEECC-C---CEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee-EEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKD-G---STVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER-LLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 934 (1176)
.|...+.||+|+||+||+|++.+ + ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998642 2 2689998864332 2345688999999999999999999999776655 999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 3689999999999999999999999 99999999999999999999999999998654
Q ss_pred cccc--cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDT--HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.... ........+|+.|+|||.+.+..++.++||||+|+++|+|++|..|+.... .................
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~----- 249 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQ----- 249 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCCCC-----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCCCC-----
Confidence 3321 112234568899999999999999999999999999999999666643322 12222222221111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
....+ ..+.+++.+||+.||.+|||++++++.|+++......+
T Consensus 250 ---~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 250 ---PEYCP------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ---CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ---Cccch------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11111 13566999999999999999999999999998765443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=347.03 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=199.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|.+.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999986 68889999886543222 35688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++...+ ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998654 689999999999999999999999 99999999999999999999999999997654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .. ............ ...
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~-~~~~~~~~~~~~--~~~ 256 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LS-VMGAHINQAIPR--PST 256 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-----HH-HHHHHHHSCCCC--GGG
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-----HH-HHHHHhccCCCC--ccc
Confidence 3221 12235578999999999999899999999999999999999999996532 11 111111111110 011
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhhCC
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRP-TMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-t~~evl~~L~~i~~~~ 1141 (1176)
.....+. .+.+++.+||+.||++|| |++++++.|++..+..
T Consensus 257 ~~~~~~~------~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VRPGIPV------AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TSTTCCT------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCCCCCH------HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1112222 345699999999999999 9999999999876544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=350.12 Aligned_cols=264 Identities=20% Similarity=0.352 Sum_probs=197.6
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe-
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE- 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 930 (1176)
..++|.+.+.||+|+||.||+|++. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567899999999999999999865 245899998864322 223568899999999999999999999877553
Q ss_pred ----eEEEEeeccCCCHHHHHhhcc--ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 931 ----RLLVYEYMRYGSLEDVLHNQK--KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 931 ----~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
.++||||+++|+|.+++.... .....+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 499999999999999995432 2234699999999999999999999999 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... .
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~---~ 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL---L 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH---H
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH---H
Confidence 99999987654333223344567889999999999899999999999999999999 88998754321 121111 1
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.... +......+ ..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 264 ~~~~-----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 264 HGHR-----LKQPEDCL------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp TTCC-----CCCBTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCC-----CCCCcccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 11111111 1356699999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=340.38 Aligned_cols=266 Identities=23% Similarity=0.314 Sum_probs=209.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEE-eeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC-KVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+|++. +|+.||+|++.... ..+++.+|+.++++++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 468999999999999999999984 78999999876433 335688999999999988877766655 66778899999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeecccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLM 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 1013 (1176)
|+ +++|.+++.... .++++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 899999997543 2689999999999999999999999 99999999999999 47889999999999876
Q ss_pred ccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC-ccHH-HHHHHhhccc
Q 046275 1014 SAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-NNLV-GWVKQHAKLK 1086 (1176)
Q Consensus 1014 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~-~~~~-~~~~~~~~~~ 1086 (1176)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5433211 1245679999999999999999999999999999999999999998644221 1111 1111111110
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
. +......+ ..+.+++.+||+.||++|||+.++++.|+++....+..
T Consensus 239 ~-----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 239 I-----EVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp H-----HHHTTTSC------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred h-----HHHHhhCC------HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 0 01111112 13556999999999999999999999999998776553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=358.16 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=191.6
Q ss_pred cCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHh-cCCCCcccceeEEee----CCeeE
Q 046275 860 NGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGK-IKHRNLVPLLGYCKV----GEERL 932 (1176)
Q Consensus 860 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 932 (1176)
++|.+. ++||+|+||+||+|+++ +|+.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999987 689999999852 3467788888754 589999999999875 56789
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeecc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGM 1009 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl 1009 (1176)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998653 23589999999999999999999999 9999999999999997 78899999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc--cHHHHHHHhhcccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN--NLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~ 1087 (1176)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .....
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQY 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTCC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCcc
Confidence 98654322 23456789999999999999999999999999999999999999976542211 111111 11111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMF 1134 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L 1134 (1176)
. ++...+...+ ..+.+++.+||+.||++|||+.|++++-
T Consensus 285 ~--~~~~~~~~~s------~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 E--FPNPEWSEVS------EEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C--CCTTTTTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c--CCCcccccCC------HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 1111111111 1356799999999999999999999973
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.13 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=206.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEE-eeCCeeEEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC-KVGEERLLVY 935 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 935 (1176)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+.+++.++|++++..++++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999985 68899999865432 224578899999999988877777665 6677889999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 1012 (1176)
||+ +|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 899999998543 2689999999999999999999999 99999999999999 7889999999999987
Q ss_pred cccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc-cH-HHHHHHhhcc
Q 046275 1013 MSAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-NL-VGWVKQHAKL 1085 (1176)
Q Consensus 1013 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~-~~-~~~~~~~~~~ 1085 (1176)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 65433211 12356799999999999999999999999999999999999999976543221 11 1111111111
Q ss_pred ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCC
Q 046275 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLD 1144 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~ 1144 (1176)
.. +......+ ..+.+++.+||+.||++|||++++++.|+++....+.+
T Consensus 238 ~~-----~~~~~~~~------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 238 PI-----EVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CH-----HHHTTTSC------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hh-----hhhhccCC------HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 00 00111111 14566999999999999999999999999998765543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=368.29 Aligned_cols=347 Identities=23% Similarity=0.233 Sum_probs=257.9
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccC
Q 046275 304 VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSS 383 (1176)
Q Consensus 304 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 383 (1176)
+.++.++++++ .+|..+. ++|++|+|++|+++ .++...|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 45555555555 3444332 35555555555555 33333445555555555555555544455555555555555555
Q ss_pred CcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC
Q 046275 384 NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463 (1176)
Q Consensus 384 N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 463 (1176)
|++ ++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+.+.
T Consensus 90 n~l--------------------------~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 143 (477)
T 2id5_A 90 NRL--------------------------KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143 (477)
T ss_dssp SCC--------------------------CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred CcC--------------------------CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcccee
Confidence 544 434445567778888888888888877777888888888888888888877
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCC
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 543 (1176)
.|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+.+|..+...
T Consensus 144 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~ 223 (477)
T 2id5_A 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223 (477)
T ss_dssp CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTT
T ss_pred ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccC
Confidence 78888888889999999999887777788899999999999999988878888899999999999998888888888877
Q ss_pred CCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccc
Q 046275 544 RSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRV 623 (1176)
Q Consensus 544 ~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 623 (1176)
.+|+.|+|++|.++ .+|...|.
T Consensus 224 ~~L~~L~l~~n~l~-~~~~~~~~--------------------------------------------------------- 245 (477)
T 2id5_A 224 LNLTSLSITHCNLT-AVPYLAVR--------------------------------------------------------- 245 (477)
T ss_dssp CCCSEEEEESSCCC-SCCHHHHT---------------------------------------------------------
T ss_pred ccccEEECcCCccc-ccCHHHhc---------------------------------------------------------
Confidence 89999999999987 46654332
Q ss_pred cCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCC
Q 046275 624 YGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSS 703 (1176)
Q Consensus 624 ~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~ 703 (1176)
.+.+|++|||++|++++..+..|+++++|+.|+|++|++++..|..|+.+++|++|+|++|+|++..|..
T Consensus 246 ----------~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 315 (477)
T 2id5_A 246 ----------HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315 (477)
T ss_dssp ----------TCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGG
T ss_pred ----------CccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhH
Confidence 2346889999999999888888999999999999999999888999999999999999999999766667
Q ss_pred ccccccccccccccccccCCCCCCCCccccCCccccCCCCCCCCC
Q 046275 704 MSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLP 748 (1176)
Q Consensus 704 l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~~~~ 748 (1176)
+..+++|+.|+|++|+++...+....+.......+.++...|..|
T Consensus 316 ~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 316 FHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp BSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred cCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 889999999999999998765532222222334455665566544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.51 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=206.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC------cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG------QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||.||+|++. +|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999987 689999998865322 13567899999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEeec
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF----EARVSDFG 1008 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 1008 (1176)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999997654 689999999999999999999999 999999999999998877 79999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ............
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-- 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----KQETLTNISAVN-- 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTC--
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----hHHHHHHhHhcc--
Confidence 9986543222 234568999999999999999999999999999999999999996543 112222221111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhhC
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQAG 1140 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~~ 1140 (1176)
...++......+ ..+.+++.+||+.||++|||+.+++++ ++.++..
T Consensus 228 ~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 228 YDFDEEYFSNTS------ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CCCCHHHHTTCC------HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred cCCcchhcccCC------HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 111222222222 235679999999999999999999985 6666544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=352.85 Aligned_cols=248 Identities=29% Similarity=0.393 Sum_probs=199.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
+.|...+.||+|+||+||+|++. +|+.||||++....... .+.+.+|++++++++||||+++++++..+...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888999999999999999975 68899999986533222 346889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+. |++.+++.... .++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888886543 2689999999999999999999999 999999999999999999999999999976543
Q ss_pred ccccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..................
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~ 275 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNESPALQS 275 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCCCC
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCCCC
Confidence 2 3457999999999984 5678999999999999999999999986543 112222222211111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
...+ ..+.+++.+||+.||++|||+++++++--
T Consensus 276 ----~~~~------~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 276 ----GHWS------EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----TTSC------HHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----CCCC------HHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1111 13556999999999999999999998743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=357.67 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=196.7
Q ss_pred CCCCCceEeEeCceEEEEEEEC--CC--CEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEee-CCeeEEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK--DG--STVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKV-GEERLLV 934 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 934 (1176)
.|.+.+.||+|+||+||+|++. ++ ..||+|.+..... ...+++.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999864 22 3578888754322 334678999999999999999999998654 5678999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997653 2588999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccc--cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1015 AMDTHL--SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1015 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||...... ........ ... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~---~~~--~~ 316 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ---GRR--LL 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHT---TCC--CC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHc---CCC--CC
Confidence 322211 1234467889999999999899999999999999999999 67777654322 22222211 110 01
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCC
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDS 1145 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~ 1145 (1176)
.+ ...+ ..+.+++.+||+.||++|||+.+++++|+++......+.
T Consensus 317 ~p---~~~~------~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 317 QP---EYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp CC---TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CC---CCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 11 1111 135569999999999999999999999999987765443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=356.70 Aligned_cols=210 Identities=23% Similarity=0.339 Sum_probs=181.2
Q ss_pred cccCHHHHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-----CCCcccc
Q 046275 848 RKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-----HRNLVPL 921 (1176)
Q Consensus 848 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 921 (1176)
..+++.+.....++|.+.+.||+|+||+||+|++. +++.||||++.. .....+.+..|+.+++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34455555556789999999999999999999985 689999998853 2233456788999999996 9999999
Q ss_pred eeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---
Q 046275 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE--- 998 (1176)
Q Consensus 922 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 998 (1176)
++++...+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 99999999999999999 8899999986642 2589999999999999999999999 9999999999999975
Q ss_pred ----------------------CCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHH
Q 046275 999 ----------------------NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLL 1056 (1176)
Q Consensus 999 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ 1056 (1176)
++.+||+|||+|+...... ....||+.|+|||++.+..++.++||||+||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7889999999998644322 3457899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 046275 1057 ELLTGKRPTDSAD 1069 (1176)
Q Consensus 1057 elltg~~P~~~~~ 1069 (1176)
+|++|+.||...+
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=360.34 Aligned_cols=204 Identities=25% Similarity=0.436 Sum_probs=164.1
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCC--e
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGE--E 930 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 930 (1176)
...++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999986 68999999985432 223456788999999997 999999999997544 6
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 5999999753 589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccc-------------------ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1011 RLMSAMD-------------------THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1011 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
+...... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8653211 1112244679999999999976 678999999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=354.65 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=175.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57899999999999999999987 68999999886532 22345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999998764 5899999999999999999999842 79999999999999999999999999997553221
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 187 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 187 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp --------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=343.82 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=203.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|.+.+.||+|+||.||+|++. +|+.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356899999999999999999986 6899999998765444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeeccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~~ 1014 (1176)
+++|+|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999997654 689999999999999999999999 99999999999999 788999999999987543
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.. ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .............. ++..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~--~~~~ 229 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----ESKLFEKIKEGYYE--FESP 229 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHCCCC--CCTT
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCC--CCcc
Confidence 22 1234568999999999999999999999999999999999999986543 12222222222110 1111
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+ ..+.+++.+||+.||++|||+++++++
T Consensus 230 ~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FWDDIS------ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTSC------HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111112 235679999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=364.63 Aligned_cols=258 Identities=24% Similarity=0.315 Sum_probs=195.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 929 (1176)
.++|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999886 5889999998653 223345688999999999999999999999654 4
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 57666642 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc----
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---- 1085 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1085 (1176)
|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.. ..+.......
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~----~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCC
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCC
Confidence 98664322 234568999999999999999999999999999999999999999764311 1111110000
Q ss_pred ------------------------ccccccCcccccCCCch-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 ------------------------KISDVFDPELMKEDPNI-EIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ------------------------~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+........... ......+.+++.+||+.||++|||++|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001111111111111 1123457789999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=346.47 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=199.3
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-----cCHHHHHHHHHHHHhcC---CCCcccceeEEeeC
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-----QGDREFTAEMETIGKIK---HRNLVPLLGYCKVG 928 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 928 (1176)
..++|++.+.||+|+||+||+|++. +++.||+|++..... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999975 689999999864321 22346778888887775 99999999999775
Q ss_pred C-----eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 929 E-----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 929 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
. ..++||||+. |+|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 4799999997 599999987642 2489999999999999999999999 999999999999999999999
Q ss_pred EEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1004 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
|+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+........
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 236 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG 236 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 999999986543222 245678999999999998899999999999999999999999997543111 1111111111
Q ss_pred cc---ccccccC--c-ccccCCCchHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KL---KISDVFD--P-ELMKEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~---~~~~~~~--~-~~~~~~~~~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. .+..... . ......+.... ....+.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 0000000 0 00000000000 11245679999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=339.98 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=198.1
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 933 (1176)
.|.+.+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777889999999999999886 58889999886432 2234568899999999999999999998865 456899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEC-CCCcEEEEeeccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH--IIHRDMKSSNVLLD-ENFEARVSDFGMA 1010 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGla 1010 (1176)
||||+++|+|.+++...+ .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999998754 689999999999999999999999 7 99999999999998 7899999999999
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ................
T Consensus 180 ~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~- 249 (290)
T 1t4h_A 180 TLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKPA- 249 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCCCG-
T ss_pred ccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC----cHHHHHHHHhccCCcc-
Confidence 7543322 234579999999998875 58999999999999999999999996532 2222222222221111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
......+ ..+.+++.+||+.||.+|||+.|++++
T Consensus 250 ---~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 ---SFDKVAI------PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGGCCC------HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCCCCC------HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111 135679999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=346.55 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=203.6
Q ss_pred hcCCCCCc-eEeEeCceEEEEEEEC---CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 859 TNGFHNDS-LIGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 859 ~~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
.++|.+.+ .||+|+||.||+|.+. +++.||||++...... ..+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999653 4678999988654322 246789999999999999999999998 567789
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999998654 589999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||..... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~--- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGER--- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC---
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC---
Confidence 65433221 1233456789999999988889999999999999999999 9999875431 112222222111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+......+ ..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 239 --~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 --MGCPAGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --CCCCTTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 1355699999999999999999999999998654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=353.93 Aligned_cols=256 Identities=17% Similarity=0.199 Sum_probs=207.3
Q ss_pred HhcCCCCCceEeEeCceEEEEEE------ECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC---CCCcccceeEEeeC
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAK------LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK---HRNLVPLLGYCKVG 928 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 928 (1176)
..++|.+.+.||+|+||+||+|+ ..+++.||+|++.. ....++.+|++++++++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34679999999999999999994 34689999999853 34567888999988887 99999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhccc-cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---------
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKK-VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE--------- 998 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------- 998 (1176)
+..|+||||+++|+|.++++..+. ....+++..++.++.|+++||+|||+. +||||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999986432 234699999999999999999999999 9999999999999998
Q ss_pred --CCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHH
Q 046275 999 --NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 999 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~ 1076 (1176)
++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999976554333334456789999999999999999999999999999999999999985432110
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHhhC
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRR-PTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R-Pt~~evl~~L~~i~~~ 1140 (1176)
......+ ...+. . ..+.+++..|++.+|.+| |+++++.+.|+++...
T Consensus 293 --------~~~~~~~-----~~~~~-~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 --------CKPEGLF-----RRLPH-L---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------EEECSCC-----TTCSS-H---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------eeechhc-----cccCc-H---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0011111 11111 1 133468999999999998 5788888888888654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=352.04 Aligned_cols=275 Identities=23% Similarity=0.324 Sum_probs=201.1
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHH--HHhcCCCCcccceeEEee-----CCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMET--IGKIKHRNLVPLLGYCKV-----GEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~ 932 (1176)
++|++.+.||+|+||.||+|++ +++.||||++... ....+..|.++ +..++||||+++++++.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5789999999999999999987 5899999998542 23444455554 445899999999985532 33568
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC------IPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
+||||+++|+|.+++... ..++..+..++.|+++||+|||+.. .++|+||||||+||+++.++.+||+|
T Consensus 89 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 999999999999999765 3588999999999999999999872 23799999999999999999999999
Q ss_pred eccccccccccc------cccccccccCCcccCccccCC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 046275 1007 FGMARLMSAMDT------HLSVSTLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN 1073 (1176)
Q Consensus 1007 fGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~ 1073 (1176)
||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987643221 111234579999999999987 4567899999999999999999887654322111
Q ss_pred -------------cHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1074 -------------NLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1074 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
....+........ ..+.+....+........+.+++.+||+.||++|||++|+++.|+++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0111111111111 11122221112112333567799999999999999999999999999977
Q ss_pred CCCCCCC
Q 046275 1141 SGLDSQS 1147 (1176)
Q Consensus 1141 ~~~~~~~ 1147 (1176)
...+...
T Consensus 320 ~~~~~~~ 326 (336)
T 3g2f_A 320 WERNKSV 326 (336)
T ss_dssp CCC----
T ss_pred HHhcccC
Confidence 7665543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.29 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=205.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEe--eCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCK--VGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 933 (1176)
.++|++.+.||+|+||.||+|+++ +++.||+|++..... ...+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357899999999999999999987 689999999864322 23456889999999999999999999874 3678899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCCEEECCCCcEEEEeec
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH-----IIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987654445699999999999999999999999 6 9999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
.++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+ ..............
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~~~~ 234 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELAGKIREGKFR 234 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----HHHHHHHHhhcccc
Confidence 9986543221 1234568999999999998899999999999999999999999987543 12222222222211
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+....+ ..+.+++.+||+.||++|||+.|++++...-
T Consensus 235 -----~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 -----RIPYRYS------DELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -----CCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -----cCCcccC------HHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 1111111 1355699999999999999999999876533
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.93 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=205.8
Q ss_pred CCCCceEeEeCceEEEEEEEC-----CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeC--CeeEE
Q 046275 862 FHNDSLIGSGGFGDVYKAKLK-----DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVG--EERLL 933 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 933 (1176)
|++.+.||+|+||+||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998653 578899999865432 2345689999999999999999999999874 67899
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC--------Cc--cHHHHHHHh
Q 046275 1014 SAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG--------DN--NLVGWVKQH 1082 (1176)
Q Consensus 1014 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~--------~~--~~~~~~~~~ 1082 (1176)
....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .. .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 5433221 223456888999999999888999999999999999999999998643210 00 000111111
Q ss_pred hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
.... ........+ ..+.+++.+||+.||++|||++++++.|+++......
T Consensus 265 ~~~~-----~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 265 ERGE-----RLPRPDKCP------AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HTTC-----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hccc-----CCCCCcccc------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 1111 111111111 2456799999999999999999999999998765433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=351.98 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=195.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEe--------eCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCK--------VGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~ 929 (1176)
.+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47889999999999999999986 68999999986655555667899999999996 999999999984 344
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEEee
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH--IIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
..++||||+. |+|.+++..... ..++++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred eEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 5799999996 699999876432 23699999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccccccccc----------cccccccCCcccCcccc---CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 046275 1008 GMARLMSAMDTHL----------SVSTLAGTPGYVPPEYY---QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074 (1176)
Q Consensus 1008 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~ 1074 (1176)
|+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998765432211 11244689999999998 5667899999999999999999999998643211
Q ss_pred HHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCCCCCCccccc
Q 046275 1075 LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIATD 1152 (1176)
Q Consensus 1075 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~ 1152 (1176)
..... .. ........+. .+.+++.+||+.||++|||+.|++++|+++.+....+....+...
T Consensus 260 --~~~~~----~~----~~~~~~~~~~------~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~~~ 321 (337)
T 3ll6_A 260 --RIVNG----KY----SIPPHDTQYT------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321 (337)
T ss_dssp ------------C----CCCTTCCSSG------GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCHHH
T ss_pred --HhhcC----cc----cCCcccccch------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHHHH
Confidence 11110 00 0000111111 245699999999999999999999999999887666555444433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=349.59 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=201.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-----GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.+.||+|+||.||+|++.. +..||+|++..... .....+.+|+.++++++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467788999999999999998753 23599998864322 234468899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999997643 2689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccccc-ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1014 SAMDTH-LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1014 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .............
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~~~~~~~---- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAINDGFR---- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTCC----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHCCCc----
Confidence 543221 11223456889999999998899999999999999999999 999986543 1122222221110
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.......+ ..+.+++.+||+.||++||++.+++++|+++....
T Consensus 269 -~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 -LPTPMDCP------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -CCCCTTCB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -CCCcccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 01111111 13556999999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=344.45 Aligned_cols=261 Identities=27% Similarity=0.371 Sum_probs=196.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC--HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG--DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||+||+|++. +|+.||+|++....... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999987 58999999886543222 3557889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887554 589999999999999999999999 9999999999999999999999999999876532
Q ss_pred cccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh-----------c
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA-----------K 1084 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-----------~ 1084 (1176)
.. ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+ .......... .
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHT
T ss_pred cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhccccccccccccc
Confidence 22 1244578999999999865 678999999999999999999999997643211 0111001000 0
Q ss_pred cccc---cccCcccc----cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKIS---DVFDPELM----KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~---~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ...++... ...+.. ...+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNI---SYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTC---CHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccCcCCCccccchhhhhcccc---cHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000000 000111 1235679999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=352.48 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=205.8
Q ss_pred hcCCCCCceEeEeCceEEEEEEE------CCCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL------KDGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 931 (1176)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... .....++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35799999999999999999983 257899999986432 23345688999999999999999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhcccc---CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEE
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKV---GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVS 1005 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 1005 (1176)
|+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999876422 13589999999999999999999999 9999999999999984 4569999
Q ss_pred eeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||.... ..........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~ 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVTS 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----HHHHHHHHhc
Confidence 9999976544333223345568999999999988899999999999999999998 999986543 1222222222
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.... ......+ ..+.+++.+||+.||.+|||+.+++++++.+....
T Consensus 261 ~~~~-----~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 261 GGRM-----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp TCCC-----CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCC-----CCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1111 1111111 13556999999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=344.95 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=212.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||+||+|+++. +..||+|++.. .....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4578889999999999999999874 78899998864 333456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999986542 3689999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
. .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...+.. ........... ....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~ 234 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR--------MERP 234 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC--------CCCC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCC--------CCCC
Confidence 2 22234567889999999998899999999999999999999 99998765422 12222211111 1111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
...+ ..+.+++.+||+.||++|||++++++.|+++...
T Consensus 235 ~~~~------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 235 EGCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC------HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 1355699999999999999999999999988754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.46 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=203.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56899999999999999999987 5778999988543 2233567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998764 589999999999999999999999 999999999999999999999999999875543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.. .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ............. ..
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~------~~ 231 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----HTETHRRIVNVDL------KF 231 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCC------CC
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----HhHHHHHHhcccc------CC
Confidence 22 234578999999999999999999999999999999999999996543 1112222221111 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|||+++++++
T Consensus 232 ~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 PPFLS------DGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCcCC------HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11111 134569999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=356.75 Aligned_cols=348 Identities=26% Similarity=0.350 Sum_probs=220.4
Q ss_pred CCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCcccee
Q 046275 144 CSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFL 223 (1176)
Q Consensus 144 l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L 223 (1176)
+++|+.|++++|.+..++. +..+++|++|||++|.+++. +. |..+++| ++|
T Consensus 45 l~~l~~L~l~~~~i~~l~~--~~~l~~L~~L~Ls~n~l~~~---~~--~~~l~~L----------------------~~L 95 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDI---TP--LKNLTKL----------------------VDI 95 (466)
T ss_dssp HHTCCEEECCSSCCCCCTT--GGGCTTCCEEECCSSCCCCC---GG--GTTCTTC----------------------CEE
T ss_pred hccccEEecCCCCCccCcc--hhhhcCCCEEECCCCccCCc---hh--hhccccC----------------------CEE
Confidence 4566666666666665542 44555666666666666552 21 3444444 445
Q ss_pred eccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCc
Q 046275 224 DVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSL 303 (1176)
Q Consensus 224 ~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L 303 (1176)
++++|.+++.++ +.++++|++|++++|++++..+ +.++++|++|++++|.+++. + .+..+++|
T Consensus 96 ~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~------------~--~~~~l~~L 158 (466)
T 1o6v_A 96 LMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI------------S--ALSGLTSL 158 (466)
T ss_dssp ECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC------------G--GGTTCTTC
T ss_pred ECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC------------h--hhccCCcc
Confidence 555554444443 4555555555555555554432 55555555555555555421 1 01223455
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccC
Q 046275 304 VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSS 383 (1176)
Q Consensus 304 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 383 (1176)
++|+++ |.+.+.. .+.++++|++|++++|.++ .++ .+..+++|++|++++|.+++..| ++.+++|++|++++
T Consensus 159 ~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 230 (466)
T 1o6v_A 159 QQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS-DIS--VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 230 (466)
T ss_dssp SEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred cEeecC-CcccCch--hhccCCCCCEEECcCCcCC-CCh--hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCC
Confidence 555554 3333221 2566666666666666665 333 24566666666666666665433 55566666666666
Q ss_pred CcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC
Q 046275 384 NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463 (1176)
Q Consensus 384 N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 463 (1176)
|++++ ++ .+ ..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++.+.
T Consensus 231 n~l~~-~~-~l--~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~ 302 (466)
T 1o6v_A 231 NQLKD-IG-TL--ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302 (466)
T ss_dssp SCCCC-CG-GG--GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC
T ss_pred CCccc-ch-hh--hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc
Confidence 66653 22 22 234567777777777765443 6777788888888888875433 77788888888888888754
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCC
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 543 (1176)
.| ++.+++|+.|+|++|++++..| +..+++|+.|++++|++++. ..+..+++|++|++++|++++..| +..+
T Consensus 303 ~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 374 (466)
T 1o6v_A 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANL 374 (466)
T ss_dssp GG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred hh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcC
Confidence 44 7778888888888888887665 77888888888888888854 468888888888888888887766 7888
Q ss_pred CCCCEEEccCCCCcccCCh
Q 046275 544 RSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 544 ~~L~~L~L~~N~l~g~ip~ 562 (1176)
++|+.|++++|++++ +|.
T Consensus 375 ~~L~~L~l~~n~~~~-~p~ 392 (466)
T 1o6v_A 375 TRITQLGLNDQAWTN-APV 392 (466)
T ss_dssp TTCCEEECCCEEEEC-CCB
T ss_pred CCCCEEeccCCcccC-Cch
Confidence 888888888888886 443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.17 Aligned_cols=247 Identities=21% Similarity=0.360 Sum_probs=199.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|++.+.||+|+||+||+|++. +++.||+|++.... .....++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457999999999999999999987 79999999986532 23345688899999999 999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---------------
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN--------------- 999 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--------------- 999 (1176)
|||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999987654334689999999999999999999999 99999999999999844
Q ss_pred ----CcEEEEeeccccccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 046275 1000 ----FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074 (1176)
Q Consensus 1000 ----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~ 1074 (1176)
..+|++|||.+...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 47999999999865432 234589999999999765 56689999999999999999988754221
Q ss_pred HHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1075 LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1075 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+. ....... +......+ ..+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~-~~~~~~~-----~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 --QWH-EIRQGRL-----PRIPQVLS------QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HHH-HHHTTCC-----CCCSSCCC------HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --HHH-HHHcCCC-----CCCCcccC------HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1111111 11111111 135569999999999999999999876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=360.48 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=193.6
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--------cCHHHHHHHHHHHHhcCCCCcccceeEEee
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--------QGDREFTAEMETIGKIKHRNLVPLLGYCKV 927 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 927 (1176)
...++|.+.+.||+|+||+||+|++. +++.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999886 589999999864321 11234789999999999999999999975
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEE
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN---FEARV 1004 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 1004 (1176)
.+..|+||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999999887654 689999999999999999999999 99999999999999754 45999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+.....
T Consensus 284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~- 358 (419)
T 3i6u_A 284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT- 358 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHH-
T ss_pred eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHh-
Confidence 9999998764322 2345679999999999853 567889999999999999999999997643222 2222211
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ...+..+...+ ..+.+++.+||+.||++|||++|++++
T Consensus 359 --~~~~--~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 --SGKY--NFIPEVWAEVS------EKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --TTCC--CCCHHHHTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --cCCC--CCCchhhcccC------HHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111 11122222222 245679999999999999999999885
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=354.92 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=200.9
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--------CHHHHHHHHHHHHhcCCCCcccceeEEeeC
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--------GDREFTAEMETIGKIKHRNLVPLLGYCKVG 928 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 928 (1176)
..++|++.+.||+|+||+||+|++. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467999999999999999999976 6889999988653221 233577899999999999999999999999
Q ss_pred CeeEEEEeeccCC-CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEee
Q 046275 929 EERLLVYEYMRYG-SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDF 1007 (1176)
Q Consensus 929 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 1007 (1176)
+..++||||+.+| +|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
|+++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .....
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~ 240 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TVEAA 240 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GTTTC
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HHhhc
Confidence 99987654322 234679999999999988776 7899999999999999999999864210 00000
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ..+. ..+ ..+.+++.+||+.||++|||+++++++
T Consensus 241 ~---~~~~---~~~------~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 I---HPPY---LVS------KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C---CCSS---CCC------HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred c---CCCc---ccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 011 135569999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=341.30 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=182.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|++. +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56889999999999999999985 68999999986432 223467889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++.... .++++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998653 3689999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ....... +...
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~------~~~~ 231 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLA------DYEM 231 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSS------CCCC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhc------ccCC
Confidence 222 12345789999999999988899999999999999999999999976542210 1111000 0011
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|||+++++++
T Consensus 232 ~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSFLS------IEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTTSC------HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccC------HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11111 135569999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=341.93 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=198.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC-CeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG-EERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||+||+|+++ |+.||+|.+... ...+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 56889999999999999999885 889999988542 3456789999999999999999999987554 4789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++...+. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999986542 2478999999999999999999999 99999999999999999999999999987554321
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .. ....... ..+....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~---~~~~~~~-----~~~~~~~ 237 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VPRVEKG-----YKMDAPD 237 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GH---HHHHTTT-----CCCCCCT
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHHhcC-----CCCCCcc
Confidence 23467889999999988899999999999999999998 99999754321 11 1111111 1111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
..+ ..+.+++.+||+.||++|||+.++++.|++++..
T Consensus 238 ~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 238 GCP------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC------HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 122 1355699999999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.86 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=198.6
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
+|....+||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3555669999999999999985 688999999876655556779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeeccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~ 1018 (1176)
+++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999986532 23567899999999999999999999 9999999999999987 89999999999986543221
Q ss_pred cccccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
......||+.|+|||++.+. .++.++||||||+++|+|++|+.||....... ......... . ..+.+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~----~~~~~~ 248 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMF-K----VHPEIP 248 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHH-C----CCCCCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhccc-c----cccccc
Confidence 12355789999999998764 37899999999999999999999986432111 111111110 1 111121
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 249 ~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ESMS------AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TTSC------HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccCC------HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112 134569999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=374.68 Aligned_cols=261 Identities=27% Similarity=0.390 Sum_probs=210.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++|++.+.||+|+||.||+|+++.+..||||++.... ...+++.+|++++++++||||+++++++.+ +..|+||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35688889999999999999999888889999986533 345789999999999999999999999876 6789999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.++++... +..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999997543 22589999999999999999999999 999999999999999999999999999986643211
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+......... ......
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~-----~~~~~~ 487 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGY-----RMPCPP 487 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-----HHHHHHHHHTTC-----CCCCCT
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC-----CCCCCC
Confidence 11233457789999999998899999999999999999999 999986543 112222221111 111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
..+ ..+.+++.+||+.||++|||++++++.|+++....+.
T Consensus 488 ~~~------~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 488 ECP------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 112 1355699999999999999999999999988755443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=353.21 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=202.8
Q ss_pred cCCCCCceEeEeCceEEEEEEE----CCCCEEEEEEeeccC----CcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL----KDGSTVAIKKLIHIS----GQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 930 (1176)
++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999998 368999999885422 23345677899999999 69999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++||||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+........
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE-- 282 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCC--
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhccC--
Confidence 865433222 2244679999999999985 457899999999999999999999997654322 2222322222111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAMF 1134 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~L 1134 (1176)
+......+ ..+.+++.+||+.||++|| |++|++++.
T Consensus 283 ----~~~~~~~~------~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PPYPQEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCTTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCcccC------HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111111 1345699999999999999 999998863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=348.07 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=205.6
Q ss_pred HHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--------CHHHHHHHHHHHHhc-CCCCcccceeE
Q 046275 855 LLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--------GDREFTAEMETIGKI-KHRNLVPLLGY 924 (1176)
Q Consensus 855 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~ 924 (1176)
.....++|.+.+.||+|+||.||+|+++ +|+.||||++...... ..+.+.+|+++++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999986 6999999988653321 134578899999999 79999999999
Q ss_pred EeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 925 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
+......|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998654 689999999999999999999999 9999999999999999999999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCC------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHH
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGW 1078 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~ 1078 (1176)
+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~~~ 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----QILM 313 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----HHHH
Confidence 99999987654322 245679999999999853 358889999999999999999999996532 1112
Q ss_pred HHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1079 VKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1079 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.......... .....+...+ ..+.+++.+||+.||++|||+++++++
T Consensus 314 ~~~i~~~~~~--~~~~~~~~~~------~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIMEGQYQ--FSSPEWDDRS------STVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHTCCC--CCHHHHSSSC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCC--CCCcccccCC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2222221111 1111111111 235679999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.44 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=204.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|.+.+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999987 578899998865422 2345688899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987654 689999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ............. .
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~------~ 233 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIKKNEY------S 233 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCC------C
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhhccC------C
Confidence 3222 1244678999999999999899999999999999999999999996543 1112222111111 0
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+ ..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 IPKHIN------PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccccC------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111 135569999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.03 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=198.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEee--CCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKV--GEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|++. +++.||+|++.. ...+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57999999999999999999875 689999998853 34577899999999997 9999999999987 66789999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLMS 1014 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~ 1014 (1176)
||+++++|.+++. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999885 478899999999999999999999 999999999999999776 89999999998665
Q ss_pred cccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc----
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD---- 1089 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 1089 (1176)
.... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.........+.............+
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4332 245578999999999877 67899999999999999999999999654322111111111110000000
Q ss_pred ---ccCcc----------------cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 ---VFDPE----------------LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ---~~~~~----------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..++. .....+. .--..+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQH--LVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGG--GCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0000000 011245679999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=347.68 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=206.7
Q ss_pred cCCCCCceEeEeCceEEEEEEE-----CCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC--eeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKL-----KDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE--ERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 932 (1176)
++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688899999999999999984 368899999987655555667999999999999999999999886544 679
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++...+ ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998653 2589999999999999999999999 999999999999999999999999999987
Q ss_pred ccccccccc-ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---------CCccH-H-HHHH
Q 046275 1013 MSAMDTHLS-VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADF---------GDNNL-V-GWVK 1080 (1176)
Q Consensus 1013 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~---------~~~~~-~-~~~~ 1080 (1176)
......... .....++..|+|||++.+..++.++||||||+++|||+||..||..... ..... . ....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 654332211 2334577889999999888899999999999999999999999753210 00000 0 0001
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
...... ........+ ..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 275 ~~~~~~-----~~~~~~~~~------~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 275 LLKNNG-----RLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHTTC-----CCCCCTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCC-----CCCCCCccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111100 011111111 245669999999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.05 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=204.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
.++|.+.+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457899999999999999999987 478899998865322 2345688999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++++|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987654 689999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .............. ++
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~--~~-- 261 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIKKNEYS--IP-- 261 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCCC--CC--
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHhcCCCC--CC--
Confidence 3222 1245679999999999998889999999999999999999999996543 11222211111110 11
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||++|++++
T Consensus 262 --~~~~------~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 --KHIN------PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --TTSC------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 134569999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=335.89 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=196.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|.+.+.||+|+||.||+|+++ +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57899999999999999999987 7999999998643 2234567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998664 589999999999999999999999 999999999999999999999999999986643
Q ss_pred ccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... .....||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||.... ............. .++
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--~~~-- 231 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFKKIRGGVF--YIP-- 231 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC--CCC--
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhhcCcc--cCc--
Confidence 221 234578999999999988765 689999999999999999999986532 2222222222111 011
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 232 --~~~~------~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 --EYLN------RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --TTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhcC------HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 135569999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=374.73 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=201.1
Q ss_pred CCCCCc-eEeEeCceEEEEEEEC---CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 861 GFHNDS-LIGSGGFGDVYKAKLK---DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 861 ~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++.+.+ .||+|+||.||+|.++ ++..||||++.... ....+++.+|++++++++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999874 45679999986543 3356789999999999999999999999876 5689999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999997543 3689999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1016 MDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1016 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+. .... .....+.. .
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~---~~i~~~~~-----~ 558 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVM---AFIEQGKR-----M 558 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHH---HHHHTTCC-----C
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHH---HHHHcCCC-----C
Confidence 33221 1123346789999999998899999999999999999998 9999976432 1122 22222111 1
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
......+ ..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 559 ~~p~~~~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 559 ECPPECP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCCTTCC------HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1111122 13556999999999999999999999999986553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=340.64 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=206.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
+.|++.+.||+|+||.||+|++. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888999999999999999876 68999999986543 33457789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++... ++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999753 589999999999999999999999 99999999999999999999999999997664332
Q ss_pred ccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ............ .+....
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~~~~ 241 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNN-----PPTLEG 241 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC-----CCCCCS
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-----HHHHHHHhhcCC-----CCCCcc
Confidence 1 2245678999999999999999999999999999999999999986532 111211111111 111111
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
..+. .+.+++.+||+.||++|||+.+++++.-
T Consensus 242 ~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 242 NYSK------PLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp SCCH------HHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ccCH------HHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 2221 3556999999999999999999998743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=362.49 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=204.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++|.+.+.||+|+||+||+|+++ +++.||||++... .......+.+|++++++++||||+++++++.+....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356999999999999999999986 6899999998642 2345677899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~ 1012 (1176)
||+.+|+|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999997664 689999999999999999999999 999999999999995 456799999999986
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .............. ++
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~--~~ 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDILKRVETGKYA--FD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--SC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--CC
Confidence 64322 2345679999999999876 58999999999999999999999996543 22222222222211 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~s------~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQWRTIS------DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGGGGSC------HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CcccCCCC------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111 135579999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=363.25 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=200.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++|++.+.||+|+||+||+|+++ ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346999999999999999999987 68999999986532 334567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~ 1012 (1176)
||+++|+|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999987654 689999999999999999999999 9999999999999976 45599999999987
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .............. ++
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~--~~ 257 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT-----DQEILRKVEKGKYT--FD 257 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--CC
T ss_pred CCCCc---cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--CC
Confidence 65432 2345679999999999874 68999999999999999999999997543 22222222222211 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+...+. .+.+++.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEWKNVSE------GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGGTTSCH------HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhcccCCH------HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 222222221 35579999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=346.00 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=203.5
Q ss_pred HHHHHHhcCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhc-CCCCcccceeEEee
Q 046275 853 ADLLEATNGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKI-KHRNLVPLLGYCKV 927 (1176)
Q Consensus 853 ~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 927 (1176)
.......++|.+. +.||+|+||+||+|++. +++.||+|++.... ......+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344555678777 89999999999999987 58999999886532 23356789999999999 46999999999999
Q ss_pred CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEE
Q 046275 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARV 1004 (1176)
Q Consensus 928 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 1004 (1176)
....++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999986542 23689999999999999999999999 9999999999999987 789999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...+. .........
T Consensus 176 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~ 247 (327)
T 3lm5_A 176 VDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----QETYLNISQ 247 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH
T ss_pred eeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHHHh
Confidence 99999986643222 2445799999999999999999999999999999999999999965431 111111111
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... ..........+ ..+.+++.+||+.||++|||+++++++
T Consensus 248 ~~~--~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 VNV--DYSEETFSSVS------QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TCC--CCCTTTTTTSC------HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccc--ccCchhhcccC------HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111 11111111111 135569999999999999999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=360.03 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=167.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----Ce
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 930 (1176)
.++|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999986 578899999864322 2345688999999999999999999998766 56
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||++ |+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 59999997653 689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccc--------------------ccccccccCCcccCcccc-CCCCCCchhhhHHHHHHHHHHHcCCCCCC
Q 046275 1011 RLMSAMDTH--------------------LSVSTLAGTPGYVPPEYY-QSFRCSTKGDVYSYGVVLLELLTGKRPTD 1066 (1176)
Q Consensus 1011 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~P~~ 1066 (1176)
+........ .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 123567899999999986 56679999999999999999998655553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=343.48 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=187.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-CH-HHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-GD-REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.++|++.+.||+|+||+||+|++. +|+.||+|++...... .. +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 357889999999999999999985 6889999998643222 12 23444555578889999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++ +|.+++.........+++..++.++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 998888764444457999999999999999999999953 799999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCcccc----CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYY----QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
... .....||+.|+|||++ .+..++.++||||+|+++|+|++|+.||..... ........... ......
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~-~~~~~~ 235 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---PFQQLKQVVEE-PSPQLP 235 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---HHHHHHHHHHS-CCCCCC
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---hHHHHHHHhcc-CCCCcc
Confidence 222 2345799999999996 566789999999999999999999999975321 11222221111 111111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~----~~~~------~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 A----DKFS------AEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp T----TTSC------HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred c----ccCC------HHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1 1111 135679999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=360.15 Aligned_cols=244 Identities=17% Similarity=0.183 Sum_probs=188.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHH---HHHhcCCCCcccce-------eE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEME---TIGKIKHRNLVPLL-------GY 924 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 924 (1176)
.++|.+.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+. .+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 457888999999999999999974 6999999998643 2233467889994 55556899999998 55
Q ss_pred EeeCC-----------------eeEEEEeeccCCCHHHHHhhccccC---cccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046275 925 CKVGE-----------------ERLLVYEYMRYGSLEDVLHNQKKVG---IKLNWAARRKIAIGSARGLAFLHHNCIPHI 984 (1176)
Q Consensus 925 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 984 (1176)
+.+.+ ..|+||||+ +|+|.+++...+... ..+++..++.++.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 579999998754221 1345688999999999999999999 99
Q ss_pred eeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCC-----------CCCchhhhHHHHH
Q 046275 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-----------RCSTKGDVYSYGV 1053 (1176)
Q Consensus 985 vH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv 1053 (1176)
+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985332 2245567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1054 VLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1054 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
++|||++|+.||........ ...... . ....+ ..+.+++.+||+.||++|||+.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~-------------~~~~~~-~-~~~~~------~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-------------SEWIFR-S-CKNIP------QPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CC-------------SGGGGS-S-CCCCC------HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccc-------------hhhhhh-h-ccCCC------HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999965432110 000000 0 01111 135569999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=350.63 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=194.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC-HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG-DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|.+.+.||+|+||+||+|++. +++.||+|++....... ...+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999987 68999999885432221 22355799999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
++ |+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 59999987654 2689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc--
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE-- 1094 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1094 (1176)
. ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+.. ...............+.++..
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhc
Confidence 1 2244578999999999876 56899999999999999999999999764321 111111111111111111000
Q ss_pred ----------------cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 ----------------LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ----------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+.. -..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRL---DSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCC---CHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000011 1235679999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=361.47 Aligned_cols=195 Identities=24% Similarity=0.388 Sum_probs=154.7
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEee-----CCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKV-----GEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 930 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+++.++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999886 689999999865322 234568899999999999999999999843 356
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||+. |+|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 69999997653 689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccc-------------------------ccccccccCCcccCcccc-CCCCCCchhhhHHHHHHHHHHHcC
Q 046275 1011 RLMSAMDTH-------------------------LSVSTLAGTPGYVPPEYY-QSFRCSTKGDVYSYGVVLLELLTG 1061 (1176)
Q Consensus 1011 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg 1061 (1176)
+........ ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876432211 123456789999999986 566799999999999999999993
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=340.99 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=199.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457999999999999999999987 5899999998766666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999987643 2589999999999999999999999 99999999999999999999999999876432211
Q ss_pred ccccccccccCCcccCcccc-----CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1018 THLSVSTLAGTPGYVPPEYY-----QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.......||+.|+|||++ ....++.++||||||+++|+|++|+.||...+ ..................
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCCSS
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHHHHhccCCcccCC
Confidence 112345789999999998 46678999999999999999999999987543 112222222222111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.. .+ ..+.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~---~~------~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 PSK---WS------VEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GGG---SC------HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccc---cC------HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 11 135579999999999999999999875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=346.77 Aligned_cols=260 Identities=33% Similarity=0.540 Sum_probs=229.8
Q ss_pred ccCcEEEcCCccccC--CCCccccCCCccCeeeccc-ccccCCCCCCCCCccccceeecccccccCccccccccCCCCCe
Q 046275 424 SQLVSLHLSFNYLTG--TIPSSLGSLSKLQDLKLWL-NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNW 500 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 500 (1176)
.+++.|+|++|.+++ .+|..+.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 467778888888877 7788888888888888884 8888888888888888888888888888888888888999999
Q ss_pred eeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCC-CCCEEEccCCCCcccCChhHHhhcccchhhhcccc
Q 046275 501 ISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR-SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGK 579 (1176)
Q Consensus 501 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~ 579 (1176)
|+|++|++++.+|..++.+++|++|+|++|+++|.+|..++.++ +|+.|+|++|+++|.+|..+..
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~------------- 196 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN------------- 196 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG-------------
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC-------------
Confidence 99999999888898899999999999999999888999999887 8999999999998877764321
Q ss_pred ceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcccccc
Q 046275 580 KYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSM 659 (1176)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l 659 (1176)
+ .|++|||++|++++.+|..|+.+
T Consensus 197 -------------------------------------------------------l-~L~~L~Ls~N~l~~~~~~~~~~l 220 (313)
T 1ogq_A 197 -------------------------------------------------------L-NLAFVDLSRNMLEGDASVLFGSD 220 (313)
T ss_dssp -------------------------------------------------------C-CCSEEECCSSEEEECCGGGCCTT
T ss_pred -------------------------------------------------------C-cccEEECcCCcccCcCCHHHhcC
Confidence 1 27789999999999999999999
Q ss_pred ccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCCCCCccccCCcccc
Q 046275 660 SYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFL 739 (1176)
Q Consensus 660 ~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~ 739 (1176)
++|+.|+|++|++++.+|. ++.+++|++|+|++|+|+|.+|..+..+++|+.|+|++|+++|.+|..+++..+....+.
T Consensus 221 ~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~ 299 (313)
T 1ogq_A 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299 (313)
T ss_dssp SCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTC
T ss_pred CCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhc
Confidence 9999999999999987776 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCC
Q 046275 740 NNSGLCGLPLPPCE 753 (1176)
Q Consensus 740 ~n~~l~~~~~~~c~ 753 (1176)
+|+++||.|+++|.
T Consensus 300 ~N~~lc~~p~~~C~ 313 (313)
T 1ogq_A 300 NNKCLCGSPLPACT 313 (313)
T ss_dssp SSSEEESTTSSCCC
T ss_pred CCCCccCCCCCCCC
Confidence 99999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=364.72 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=205.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46999999999999999999987 78999999986432 344677999999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeeccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARL 1012 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~ 1012 (1176)
||+.+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 106 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999997654 689999999999999999999999 99999999999999 5678999999999987
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+ .............. ++
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~--~~ 247 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-----EYDILKKVEKGKYT--FE 247 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CC
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCC--CC
Confidence 654322 244579999999999876 68999999999999999999999997543 22222222222211 11
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+...+ ..+.+++.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~s------~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 LPQWKKVS------ESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SGGGGGSC------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CcccccCC------HHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11111111 135579999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=347.88 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=192.9
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
..++|++.+.||+|+||+||+|++. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.++...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4468999999999999999999876 6889999988643322 234577899999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-----CCCCcEEEEeecc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL-----DENFEARVSDFGM 1009 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfGl 1009 (1176)
|||+++ +|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 9999998664 589999999999999999999999 99999999999999 4555699999999
Q ss_pred ccccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc--
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK-- 1086 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 1086 (1176)
++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+...........
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchh
Confidence 986643222 22445789999999999774 4899999999999999999999999754311 11111111110000
Q ss_pred -cccc-----cCcccccCCCc-hHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 -ISDV-----FDPELMKEDPN-IEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 -~~~~-----~~~~~~~~~~~-~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ........... ... .-..+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 00000000000 000 01345679999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=361.79 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=203.4
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-------------cCHHHHHHHHHHHHhcCCCCccccee
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-------------QGDREFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
..++|.+.+.||+|+||+||+|+++ +++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4568999999999999999999987 588999999864321 23467889999999999999999999
Q ss_pred EEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---
Q 046275 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF--- 1000 (1176)
Q Consensus 924 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 1000 (1176)
++.+....|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999997654 689999999999999999999999 999999999999998775
Q ss_pred cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1001 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ......
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN-----DQDIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 69999999998765432 2345679999999999875 68999999999999999999999997543 222333
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........ ++...+...+ ..+.+++.+||+.||.+|||++|++++
T Consensus 258 ~i~~~~~~--~~~~~~~~~s------~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYY--FDFNDWKNIS------DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCC--CCHHHHTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC--CCccccCCCC------HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 33222211 1111122222 235679999999999999999999886
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=354.46 Aligned_cols=270 Identities=21% Similarity=0.289 Sum_probs=200.7
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee--------
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV-------- 927 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 927 (1176)
...++|++.+.||+|+||+||+|++. +|+.||+|++.... +...+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 45678999999999999999999885 69999999986432 223479999999999999999999844
Q ss_pred ------------------------------CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHH
Q 046275 928 ------------------------------GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977 (1176)
Q Consensus 928 ------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH 977 (1176)
....++||||++ |+|.+.+......+..+++..++.++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334789999998 5888888765444457999999999999999999999
Q ss_pred hcCCCCeeeCCCCCCCEEEC-CCCcEEEEeeccccccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHH
Q 046275 978 HNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVL 1055 (1176)
Q Consensus 978 ~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil 1055 (1176)
+. +|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99 999999999999997 688999999999986644332 2445789999999998765 489999999999999
Q ss_pred HHHHcCCCCCCCCCCCCccHHHHHHHhhcc---------------ccccccCcccccCCCchHHHHHHHHHHHHHhccCC
Q 046275 1056 LELLTGKRPTDSADFGDNNLVGWVKQHAKL---------------KISDVFDPELMKEDPNIEIELLQHLHVASACLDDR 1120 (1176)
Q Consensus 1056 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 1120 (1176)
|||++|+.||...+.. ..+.......... ..............+.. .-..+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG--TPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTT--CCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCC--CCHHHHHHHHHHccCC
Confidence 9999999999764311 1111111110000 00000000000000000 0123567999999999
Q ss_pred CCCCCCHHHHHHH--HHHHhhC
Q 046275 1121 PWRRPTMIQVMAM--FKEIQAG 1140 (1176)
Q Consensus 1121 p~~RPt~~evl~~--L~~i~~~ 1140 (1176)
|++|||+.|+++| +++++..
T Consensus 310 P~~R~t~~e~l~hp~f~~~~~~ 331 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHLRNS 331 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHHHHC
T ss_pred hhhCCCHHHHhcCHHHHHHHhh
Confidence 9999999999976 6666553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=348.42 Aligned_cols=269 Identities=23% Similarity=0.300 Sum_probs=199.0
Q ss_pred CHHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC-----------HHHHHHHHHHHHhcCCCCcc
Q 046275 851 TFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG-----------DREFTAEMETIGKIKHRNLV 919 (1176)
Q Consensus 851 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv 919 (1176)
.+.++....++|.+.+.||+|+||.||+|++.+|+.||||++....... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567788899999999999999999999999889999999985432221 26789999999999999999
Q ss_pred cceeEEee-----CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 046275 920 PLLGYCKV-----GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNV 994 (1176)
Q Consensus 920 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 994 (1176)
++++++.. ....|+||||++ |+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999844 336799999998 58988887543 3689999999999999999999999 999999999999
Q ss_pred EECCCCcEEEEeeccccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 046275 995 LLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN 1073 (1176)
Q Consensus 995 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~ 1073 (1176)
+++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN- 241 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999999999975433222 244578999999999876 678999999999999999999999997643110
Q ss_pred cHHHHHHHhhccc------------------cccccCcc-cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1074 NLVGWVKQHAKLK------------------ISDVFDPE-LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1074 ~~~~~~~~~~~~~------------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+........... ........ .....+.. -..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA---DPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCC---CHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0111111000000 00000000 00000011 1235679999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=343.88 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=197.6
Q ss_pred HHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEee-----
Q 046275 855 LLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKV----- 927 (1176)
Q Consensus 855 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 927 (1176)
+....++|++.+.||+|+||.||+|++. +|+.||+|++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3345678999999999999999999985 6899999988643 34456789999999999 89999999999976
Q ss_pred -CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 928 -GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 928 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999998653 23689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||..... ......
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~ 245 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALFL 245 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHH
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHH
Confidence 999876543211 123457899999999986 56788999999999999999999999864331 111111
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........... ...+ ..+.+++.+||+.||++|||+++++++
T Consensus 246 ~~~~~~~~~~~----~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 246 IPRNPAPRLKS----KKWS------KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSCCCCCSC----SCSC------HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhcCccccCCc----cccC------HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111111 1111 145569999999999999999999885
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=349.50 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=197.5
Q ss_pred cCHHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcC--CCCcccceeEE
Q 046275 850 LTFADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--QGDREFTAEMETIGKIK--HRNLVPLLGYC 925 (1176)
Q Consensus 850 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 925 (1176)
+.++.+....++|++.+.||+|+||.||+|++.+++.||+|++..... ...+.+.+|+.++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 333334445567999999999999999999998899999999864322 23456889999999997 59999999999
Q ss_pred eeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 046275 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVS 1005 (1176)
Q Consensus 926 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 1005 (1176)
..+...++||| +.+++|.+++...+ .+++..++.++.|+++||.|||+. +|+||||||+||++++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 55789999998654 689999999999999999999999 9999999999999965 799999
Q ss_pred eeccccccccccccccccccccCCcccCccccCC-----------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 046275 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-----------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN 1074 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~ 1074 (1176)
|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~ 245 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---Q 245 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---H
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---H
Confidence 9999987654333222345579999999999875 4788899999999999999999999965321 1
Q ss_pred HHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1075 LVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1075 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. ............ .......+ ..+.+++.+||+.||++|||++|++++
T Consensus 246 ~-~~~~~~~~~~~~----~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 I-SKLHAIIDPNHE----IEFPDIPE------KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H-HHHHHHHCTTSC----CCCCCCSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHHHHHHhcccc----cCCcccch------HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 111111111111 11111111 135569999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=346.23 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=196.9
Q ss_pred HHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-----CHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 857 EATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-----GDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 857 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
...++|++.+.||+|+||.||+|++. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34568999999999999999999986 5899999988643221 12467899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 8998887653 3588899999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---c
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---K 1086 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~ 1086 (1176)
+....... ......||+.|+|||++.+. .++.++||||+||++|||++|..||...... ..+.......... .
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTT
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhh
Confidence 87643222 22456789999999998654 5899999999999999999999998654311 1111111111110 0
Q ss_pred cccccC--cc-cccCCCch-H-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFD--PE-LMKEDPNI-E-----IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~--~~-~~~~~~~~-~-----~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.+... .. .....+.. . ..-..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00 00000000 0 001346679999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=372.91 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=197.2
Q ss_pred ceEeEeCceEEEEEEEC---CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLK---DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||.||+|.+. .++.||||++..... ...+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999663 467899999865332 235679999999999999999999999864 568899999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+||+++.++.+||+|||+++.........
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997654 689999999999999999999999 99999999999999999999999999998765433221
Q ss_pred -cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1021 -SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1021 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ............ ......
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~~-----~~~p~~ 596 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGER-----MGCPAG 596 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC-----CCCCTT
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCC-----CCCCCC
Confidence 2234457889999999999899999999999999999998 9999975431 122222222211 111111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.+ ..+.+++.+||+.||++|||+++|++.|+++..
T Consensus 597 ~~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 597 CP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22 235569999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.77 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=196.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC--CCC--EEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK--DGS--TVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||+||+|++. +++ .||+|++.... ....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46889999999999999999864 333 68999875432 233467889999999999999999999987655 88
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999998653 2589999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+ ..............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~-- 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGER-- 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HHHHHHHHHccCCC--
Confidence 65433221 1234567889999999988889999999999999999999 999997543 12222222221111
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.......+ ..+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus 244 --~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 --LPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --CCCCcCcC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11111111 2356699999999999999999999999988754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=353.17 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=208.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC-CCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKH-RNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|.+.+.||+|+||.||+|++. +++.||||++..... ..++.+|+++++.++| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999985 689999998754332 3457899999999987 556666666778888999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---CCCCcEEEEeecccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLM 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla~~~ 1013 (1176)
|+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +||||||||+|||+ +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 899999998543 2699999999999999999999999 99999999999999 58899999999999876
Q ss_pred ccccccc-----cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1014 SAMDTHL-----SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1014 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYEKISEKKVA 234 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHHHHHHHHHHHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHHHHHHhhcccc
Confidence 5433221 1235679999999999999999999999999999999999999997654221 11111111111111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
... ..+....+ .++.+++.+||+.||++||++.+|++.|+++....+.
T Consensus 235 ~~~-~~l~~~~p------~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 235 TSI-EALCRGYP------TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp SCH-HHHHTTSC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccH-HHHhcCCc------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 100 01111112 1456799999999999999999999999999765443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=341.93 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=199.8
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
..++|++.+.||+|+||.||+|++. +|+.||+|++... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467999999999999999999987 5899999998643 345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999997432 3689999999999999999999999 9999999999999999999999999999765432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .................+..
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~- 250 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MRAIFMIPTNPPPTFRKPEL- 250 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCCCCCSSGGG-
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCcccCCccc-
Confidence 21 22445789999999999999999999999999999999999999965431 11111111111111111111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||++|||+.+++++
T Consensus 251 --~~------~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 251 --WS------DNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --SC------HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CC------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 235679999999999999999999886
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.39 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=200.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC----CcCHHHHHHHHHHHHhcCCCCcccceeEE--eeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS----GQGDREFTAEMETIGKIKHRNLVPLLGYC--KVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 931 (1176)
.++|.+.+.||+|+||.||+|++. +++.||+|.+.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999986 68999999986432 23456789999999999999999999998 445678
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||++++ +.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 778776543 23689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccCCcccCccccCCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFR--CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
...............||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...+ .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~~~-- 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGKGSY-- 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhcCCC--
Confidence 765433333334567999999999987644 4789999999999999999999987532 2222222222211
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
......+ ..+.+++.+||+.||++|||++|++++
T Consensus 231 ----~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----AIPGDCG------PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCSSSC------HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCCccC------HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 134569999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=347.35 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=193.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 929 (1176)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357899999999999999999986 699999999854322 22356889999999999999999999997653
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 78999999753 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--- 1085 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 1085 (1176)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+ .+..........
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAE 248 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 9865432 234578999999999876 678999999999999999999999997643211 010000000000
Q ss_pred ---------------ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 ---------------KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+..........+... ..+.+++.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCC---HHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000011111111111 245679999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=353.30 Aligned_cols=266 Identities=26% Similarity=0.325 Sum_probs=196.1
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------eeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 933 (1176)
.+|++.+.||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46889999999999999999998777899999864322 2236999999999999999999985543 3789
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEEeeccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARL 1012 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~ 1012 (1176)
||||+++ ++.+.+.........+++..++.++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||+|+.
T Consensus 116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999987 55555443333344799999999999999999999999 999999999999998 799999999999987
Q ss_pred cccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-------
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK------- 1084 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 1084 (1176)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.. ..+....+....
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 644332 2345789999999998764 5899999999999999999999999764311 111111111000
Q ss_pred ---cccccccCcccccCCCchH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHh
Q 046275 1085 ---LKISDVFDPELMKEDPNIE----IELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138 (1176)
Q Consensus 1085 ---~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 1138 (1176)
....+..-+.... .+... ..-..+.+++.+||+.||++|||+.|+++| +++++
T Consensus 268 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRP-HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHCGGGSSSCCCCCCC-CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhChhhhhhccccccC-CcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0000000000000 00000 001246679999999999999999999987 55444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=346.27 Aligned_cols=257 Identities=24% Similarity=0.303 Sum_probs=191.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------e
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------E 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 930 (1176)
++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57999999999999999999886 688999999864322 22356889999999999999999999997654 7
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 8999999975 78888852 488999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc---
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI--- 1087 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 1087 (1176)
+...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+. ...+.........
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 8654321 22446799999999999999999999999999999999999999976431 1111111110000
Q ss_pred -------------------------ccccCcccccCCCc-hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 -------------------------SDVFDPELMKEDPN-IEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 -------------------------~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.+.......... .......+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000010 11123457789999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=373.95 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=204.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 933 (1176)
.++|++.+.||+|+||+||+|+++ +++.||||++.+. .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999987 5889999998642 233456678899999987 79999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 420 V~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998765 689999999999999999999999 9999999999999999999999999999854
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+..... .+++
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~~--~~p~ 563 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEHNV--AYPK 563 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHSSCC--CCCT
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhCCC--CCCc
Confidence 32221 2356789999999999999999999999999999999999999997543 2223333322221 1111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTM-----IQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~-----~evl~~ 1133 (1176)
. .+ ..+.+++.+||+.||++||++ +||++|
T Consensus 564 ~----~s------~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 564 S----MS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp T----SC------HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred c----CC------HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 11 135669999999999999997 666553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=343.26 Aligned_cols=265 Identities=23% Similarity=0.354 Sum_probs=200.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEee--------C
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKV--------G 928 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 928 (1176)
++|++.+.||+|+||+||+|++. +|+.||+|++..... .....+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57899999999999999999985 789999998854332 234568899999999999999999999877 3
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
+..++||||+++ ++.+.+.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 8888876543 2589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccc--cccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc
Q 046275 1009 MARLMSAMDT--HLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1009 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ............
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCC
Confidence 9987653222 112345678999999999876 45799999999999999999999999764311 111111111111
Q ss_pred ccccccCc----c-------cccCCCchHHHH------HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 KISDVFDP----E-------LMKEDPNIEIEL------LQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ~~~~~~~~----~-------~~~~~~~~~~~~------~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+..+. . ...........+ ..+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00010000 0 000111111111 236689999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=344.25 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=198.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC--HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG--DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|++. +|+.||+|++....... .+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57889999999999999999987 58999999986543322 3457889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999988876543 589999999999999999999999 9999999999999999999999999999765432
Q ss_pred cccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh-----------hc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH-----------AK 1084 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~ 1084 (1176)
.. ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||......+ .+....... ..
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHH
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhh
Confidence 22 22445789999999999775 78999999999999999999999997643211 111111000 00
Q ss_pred c-ccccccCcccccCCCchH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 L-KISDVFDPELMKEDPNIE---IELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. .......+......+... .....+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000111111111111100 011245679999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=341.47 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=196.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--------cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--------QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 929 (1176)
.++|.+.+.||+|+||.||+|++. +++.||||.+..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457999999999999999999986 578999998854221 12234789999999999999999999987655
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEe
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE---ARVSD 1006 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 1006 (1176)
.|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999997654 689999999999999999999999 9999999999999987654 99999
Q ss_pred eccccccccccccccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... .+.....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~--- 233 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQIT--- 233 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHH---
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHH---
Confidence 99998664322 123457899999999973 5678899999999999999999999997654222 2222221
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ...+..+...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~--~~~~~~~~~~~------~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKY--NFIPEVWAEVS------EKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCC--CCCHHHHTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCcc--ccCchhhhhcC------HHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1111 11122222222 245679999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.05 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=186.4
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
..++|.+.+.||+|+||.||+|++. +++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4568999999999999999999865 68999999875432 233456889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccc----cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 936 EYMRYGSLEDVLHNQKK----VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999975311 123589999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccc---cccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1012 LMSAMDT---HLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1012 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLTLQNDPPSL 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHTSSCCCT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHhccCCCcc
Confidence 6543221 111234579999999999865 568999999999999999999999997643211 1111110000001
Q ss_pred cc-ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 SD-VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.. ..++......+ ..+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYG------KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCC------HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhh------HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 11111212222 135569999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=354.14 Aligned_cols=264 Identities=27% Similarity=0.346 Sum_probs=196.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------CeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------EERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 932 (1176)
.+|++.+.||+|+||.||+|++. +|+.||||++.... +...+|++++++++|||||++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888999999999999999986 59999999986432 2234799999999999999999988532 2357
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEEeecccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMAR 1011 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~ 1011 (1176)
+||||+++ ++.+.+.........+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 77777765433345799999999999999999999999 99999999999999965 568999999998
Q ss_pred ccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc------
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK------ 1084 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 1084 (1176)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. ..+....+....
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 6643322 2345789999999998764 7899999999999999999999999764311 112222111100
Q ss_pred ----cccccccCcccccC------CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHh
Q 046275 1085 ----LKISDVFDPELMKE------DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138 (1176)
Q Consensus 1085 ----~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 1138 (1176)
....+...+.+... .+.. -..+.+++.+||+.||++|||+.|+++| +++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRT---PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCC---CHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00001101111000 0000 1246679999999999999999999986 44443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=333.48 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=202.9
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---------cCHHHHHHHHHHHHhcC-CCCcccceeEEe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---------QGDREFTAEMETIGKIK-HRNLVPLLGYCK 926 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 926 (1176)
..++|.+.+.||+|+||.||+|+++ +|+.||+|.+..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999986 588999999864321 11345788999999995 999999999999
Q ss_pred eCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 927 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
.....++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998654 689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccC------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ------SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||.... ......
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLMLR 239 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----HHHHHH
Confidence 999986643322 24557899999999984 4568899999999999999999999986532 112222
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........ .........+ ..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~--~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQ--FGSPEWDDYS------DTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCC--CCTTTGGGSC------HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcc--cCcccccccC------HHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 22222111 1111111111 235679999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=350.96 Aligned_cols=253 Identities=10% Similarity=0.037 Sum_probs=180.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhc--CCCCcccce-------eEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKI--KHRNLVPLL-------GYCK 926 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 926 (1176)
.+|.+.+.||+|+||.||+|++. +|+.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35888999999999999999986 689999999976433 2234577785555444 699988755 4443
Q ss_pred eC-----------------CeeEEEEeeccCCCHHHHHhhccccCcccCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 046275 927 VG-----------------EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAAR------RKIAIGSARGLAFLHHNCIPH 983 (1176)
Q Consensus 927 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ 983 (1176)
.. ...|+||||++ |+|.+++...+. .+++..+ ..++.|++.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 32 33799999998 799999987542 3455566 78889999999999999 9
Q ss_pred eeeCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcC
Q 046275 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTG 1061 (1176)
Q Consensus 984 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg 1061 (1176)
|+||||||+||+++.++.+||+|||+|+...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 13456799999999987 7899999999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHhhccccccccCcccc-cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1062 KRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM-KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1062 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.||......... ................ ...+... ..+.+++.+||+.||++|||+.+++++
T Consensus 290 ~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 290 FLPFGLVTPGIKG------SWKRPSLRVPGTDSLAFGSCTPLP---DFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCSTTBCCTTCTT------CCCBCCTTSCCCCSCCCTTSSCCC---HHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCcCccccc------chhhhhhhhccccccchhhccCCC---HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999765322110 0000000000000000 0001111 245569999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=343.50 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=200.2
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeC-----Ce
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 930 (1176)
..++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999986 6888999998643322 235688999999999999999999998654 36
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||++ |+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 4999999754 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccc-cccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc--
Q 046275 1011 RLMSAMDTHL-SVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK-- 1086 (1176)
Q Consensus 1011 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 1086 (1176)
+......... ......||+.|+|||++. ...++.++||||+||++|+|++|+.||...+..+ .+...........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQE 254 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence 8765433221 124568999999999865 4458999999999999999999999997654221 1111111000000
Q ss_pred ----------------cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ----------------ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....-........+.. -..+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNA---DSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC---CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000011 1245679999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=344.18 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=203.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCH-----------------HHHHHHHHHHHhcCCCCcccc
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGD-----------------REFTAEMETIGKIKHRNLVPL 921 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~niv~l 921 (1176)
.++|++.+.||+|+||.||+|++ +|+.||+|++........ +.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35799999999999999999999 899999999864322111 779999999999999999999
Q ss_pred eeEEeeCCeeEEEEeeccCCCHHHH------HhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCE
Q 046275 922 LGYCKVGEERLLVYEYMRYGSLEDV------LHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNV 994 (1176)
Q Consensus 922 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NI 994 (1176)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 54321 2368999999999999999999999 8 999999999999
Q ss_pred EECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCC-CCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 046275 995 LLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCST-KGDVYSYGVVLLELLTGKRPTDSADFGD 1072 (1176)
Q Consensus 995 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~~P~~~~~~~~ 1072 (1176)
+++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||+|+++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence 9999999999999999865432 22456799999999999877 5666 999999999999999999999764321
Q ss_pred ccHHHHHHHhhccccccccCc-----ccccC-----CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1073 NNLVGWVKQHAKLKISDVFDP-----ELMKE-----DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1073 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
................+. ..... .+.. -..+.+++.+||+.||++|||+.|++++
T Consensus 259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL---SNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CC---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHhccCcCCccchhhhhccccccccccchhhc---CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122222222211100000 00000 0011 1245679999999999999999999885
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=327.82 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=203.5
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999987 68999999986532 33456789999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEEeecccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN---FEARVSDFGMAR 1011 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~ 1011 (1176)
|||+++++|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999987654 689999999999999999999999 99999999999999754 469999999998
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... .............. .
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~--~ 241 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDILKRVETGKYA--F 241 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--C
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCC--C
Confidence 6543222 233468999999999876 48999999999999999999999986543 22222222222211 1
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+.......+ ..+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DLPQWRTIS------DDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSGGGTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CchhhhhcC------HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111111111 135569999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=354.65 Aligned_cols=327 Identities=22% Similarity=0.167 Sum_probs=261.8
Q ss_pred ceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcC
Q 046275 221 QFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLC 300 (1176)
Q Consensus 221 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l 300 (1176)
+.+++++++++.+|..+. +++++|+|++|++++..+..|.++++|++|+|++|.+++..|..+. .+
T Consensus 14 ~~v~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~------------~l 79 (477)
T 2id5_A 14 RAVLCHRKRFVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN------------NL 79 (477)
T ss_dssp TEEECCSCCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT------------TC
T ss_pred CEEEeCCCCcCcCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhh------------CC
Confidence 456777777776666543 5677778888877777777777777888888887777755454433 34
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
++|++|+|++|++++..+..|.++++|++|+|++|+++ .++...|..+++|++|+|++|.+++..+..|.++++|+.|+
T Consensus 80 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 158 (477)
T 2id5_A 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT 158 (477)
T ss_dssp TTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccc-cCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEE
Confidence 67888888888877655566778888888888888887 44445567788888888888888877777888888888888
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 460 (1176)
|++|++++..+..+ ..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..+....+|+.|+|++|++
T Consensus 159 l~~n~l~~~~~~~l--~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l 236 (477)
T 2id5_A 159 LEKCNLTSIPTEAL--SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236 (477)
T ss_dssp EESCCCSSCCHHHH--TTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCC
T ss_pred CCCCcCcccChhHh--cccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcc
Confidence 88888875443334 3467788888888888877777888899999999999888878888777777999999999999
Q ss_pred cCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCC
Q 046275 461 HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPEL 540 (1176)
Q Consensus 461 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 540 (1176)
++..+..+..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..|
T Consensus 237 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 316 (477)
T 2id5_A 237 TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316 (477)
T ss_dssp CSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGB
T ss_pred cccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHc
Confidence 85555678899999999999999998888889999999999999999998889999999999999999999997777788
Q ss_pred CCCCCCCEEEccCCCCcccCChhH
Q 046275 541 GDCRSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 541 ~~l~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
..+++|+.|+|++|++.+.++..+
T Consensus 317 ~~l~~L~~L~l~~N~l~c~c~~~~ 340 (477)
T 2id5_A 317 HSVGNLETLILDSNPLACDCRLLW 340 (477)
T ss_dssp SCGGGCCEEECCSSCEECSGGGHH
T ss_pred CCCcccCEEEccCCCccCccchHh
Confidence 999999999999999998765443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=347.99 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=157.0
Q ss_pred CCCC-CceEeEeCceEEEEEEEC---CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeEEE
Q 046275 861 GFHN-DSLIGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERLLV 934 (1176)
Q Consensus 861 ~y~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 934 (1176)
.|.+ .++||+|+||+||+|+++ +++.||+|++... .....+.+|+.++++++||||+++++++.. +...|+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3555 568999999999999976 5789999988542 234568899999999999999999999954 6789999
Q ss_pred EeeccCCCHHHHHhhcccc-----CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEE
Q 046275 935 YEYMRYGSLEDVLHNQKKV-----GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL----DENFEARVS 1005 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 1005 (1176)
|||+.+ +|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 888888644321 22489999999999999999999999 99999999999999 678899999
Q ss_pred eeccccccccccc-cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1006 DFGMARLMSAMDT-HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1006 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
|||+|+....... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987653221 1223456799999999999874 58999999999999999999999997654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=341.86 Aligned_cols=276 Identities=23% Similarity=0.287 Sum_probs=193.1
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe--
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE-- 930 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 930 (1176)
......++|++.+.||+|+||+||+|++. +|+.||||++.... .......+|++.++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999986 68999999886432 333456778888899999999999999865433
Q ss_pred -----eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeCCCCCCCEEECC-CCcE
Q 046275 931 -----RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--HNCIPHIIHRDMKSSNVLLDE-NFEA 1002 (1176)
Q Consensus 931 -----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~ 1002 (1176)
.++||||+++ ++.+.+.........+++..+..++.|++.|+.||| +. +|+||||||+||+++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999986 666655543333447899999999999999999999 77 9999999999999996 8999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. ..+......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHH
Confidence 9999999987654332 2345789999999998654 4899999999999999999999999764311 111111111
Q ss_pred hhcc--cc-----ccccCccccc--CCCch-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHh
Q 046275 1082 HAKL--KI-----SDVFDPELMK--EDPNI-------EIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138 (1176)
Q Consensus 1082 ~~~~--~~-----~~~~~~~~~~--~~~~~-------~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 1138 (1176)
.... .. ....+..... ..+.. ......+.+++.+||+.||++|||+.|+++| ++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0000 00 0000000000 00000 0012356779999999999999999999987 55554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=346.19 Aligned_cols=260 Identities=26% Similarity=0.325 Sum_probs=180.7
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeC------C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVG------E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 929 (1176)
.++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367999999999999999999876 688999999864322 2345688999999999999999999998654 5
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 67999988753 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc--c
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--K 1086 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~ 1086 (1176)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+ .+.......... .
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAE 252 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 9865422 234578999999999877 678999999999999999999999997643110 011111110000 0
Q ss_pred cccccCc--------ccccCCCchHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFDP--------ELMKEDPNIEI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~~--------~~~~~~~~~~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+.. .+......... .-..+.+++.+||+.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 00000000000 01245679999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=334.02 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=199.4
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC--CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhc---CCCCcccceeEEe----
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK--DGSTVAIKKLIHISG--QGDREFTAEMETIGKI---KHRNLVPLLGYCK---- 926 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 926 (1176)
+.++|++.+.||+|+||.||+|++. +|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4568999999999999999999984 578899998864322 2234567788877776 8999999999987
Q ss_pred -eCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEE
Q 046275 927 -VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVS 1005 (1176)
Q Consensus 927 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 1005 (1176)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 599999986542 2589999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-
Q 046275 1006 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK- 1084 (1176)
Q Consensus 1006 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~- 1084 (1176)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .+.........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLP 238 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCC
Confidence 999998654322 2345678999999999999899999999999999999999999997543110 01111111100
Q ss_pred --ccccccc-----------CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 --LKISDVF-----------DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 --~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.... ........+... ..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCC---HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 000000011111 234569999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=346.56 Aligned_cols=199 Identities=27% Similarity=0.337 Sum_probs=172.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc------CCCCcccceeEEeeCCee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI------KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 931 (1176)
..+|++.+.||+|+||+||+|++. +++.||||++... ....+++.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999887 5889999988532 22345677888888887 577999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--EEEEeecc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE--ARVSDFGM 1009 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl 1009 (1176)
++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 699999987542 2589999999999999999999999 9999999999999999887 99999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9754321 234579999999999999999999999999999999999999997653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=329.41 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=192.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee----------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV---------- 927 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 927 (1176)
.++|++.+.||+|+||.||+|++. +|+.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457899999999999999999986 6899999988542 2334678899999999999999999998865
Q ss_pred ---CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 046275 928 ---GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARV 1004 (1176)
Q Consensus 928 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 1004 (1176)
....|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 356799999999999999998643 3578899999999999999999999 9999999999999999999999
Q ss_pred Eeeccccccccccc------------cccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046275 1005 SDFGMARLMSAMDT------------HLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFG 1071 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~ 1071 (1176)
+|||++........ ........||+.|+|||++.+. .++.++||||+||++|||++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 99999976542210 1122345789999999999764 68999999999999999998 54321
Q ss_pred CccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1072 DNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.............. ..+++......+ ..+.+++.+||+.||++|||+++++++
T Consensus 232 -~~~~~~~~~~~~~~--~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -MERVNILKKLRSVS--IEFPPDFDDNKM------KVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHHHHHSTT--CCCCTTCCTTTS------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhHHHHHHhccccc--cccCccccccch------HHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11112222222111 112222222111 234569999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=366.94 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=202.3
Q ss_pred HhcCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
..++|++.+.||+|+||.||+|++.. +..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678899999999999999998753 45789998754322 22356889999999999999999999985 45689
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997653 3689999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .............
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERL--- 611 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHHTCCC---
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHcCCCC---
Confidence 643322 12234567889999999988899999999999999999997 9999875431 1222222221111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
......+ ..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 612 --~~~~~~~------~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 612 --PMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp --CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCcccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111112 135569999999999999999999999998864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=335.85 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=171.9
Q ss_pred hcCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCeeE
Q 046275 859 TNGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEERL 932 (1176)
Q Consensus 859 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 932 (1176)
.++|.+. ++||+|+||+||+|+++ +|+.||+|++... .....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4578885 46999999999999987 6899999998532 2222223334566799999999999876 44589
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeecc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGM 1009 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl 1009 (1176)
+||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986542 3689999999999999999999999 9999999999999976 45599999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
++...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... ............
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~-- 250 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKRRIRLGQY-- 250 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHHhhhcccc--
Confidence 97654322 23457899999999998889999999999999999999999999754322110 000011100000
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++...+...+ ..+.+++.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 GFPNPEWSEVS------EDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCCTTTSTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCchhhccCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111111111 135569999999999999999999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=339.16 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=198.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||.||+|+++. .||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678999999999999999999863 48999885432 2233557789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++++|.+++...+ ..+++..++.++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999997653 3589999999999999999999999 999999999999998 679999999998755322
Q ss_pred cc---cccccccccCCcccCccccCC---------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc
Q 046275 1017 DT---HLSVSTLAGTPGYVPPEYYQS---------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084 (1176)
Q Consensus 1017 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1084 (1176)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..........
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AEAIIWQMGT 257 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----HHHHHHHHHT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHhcc
Confidence 11 112234568999999999864 457889999999999999999999996543 1122222222
Q ss_pred cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1085 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
......... ..+. .+.+++.+||+.||++|||+.++++.|+++....
T Consensus 258 ~~~~~~~~~----~~~~------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNLSQI----GMGK------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCCCCS----SCCT------THHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCcC----CCCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 211111111 1111 2456999999999999999999999999987653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=339.88 Aligned_cols=202 Identities=27% Similarity=0.324 Sum_probs=170.9
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CC-----CcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HR-----NLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 930 (1176)
..++|++.+.||+|+||+||+|++. +++.||||++... ....+++.+|+.+++.++ |+ +|+++++++.....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3568999999999999999999987 5788999988532 223456778999988885 55 49999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEEeec
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD--ENFEARVSDFG 1008 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG 1008 (1176)
.++||||++ |+|.+++..... ..+++..++.++.|++.||.|||+. ..+|+||||||+||+++ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999996 599999986542 2589999999999999999999952 12899999999999994 57889999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99866432 234678999999999999999999999999999999999999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=338.94 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=193.7
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCee----
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEER---- 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 931 (1176)
.++|.+.+.||+|+||.||+|++. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357899999999999999999986 6889999998653222 245688999999999999999999999877654
Q ss_pred --EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 932 --LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 932 --~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588887742 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL--- 1085 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 1085 (1176)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+ .+..........
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTE 264 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHH
Confidence 9865432 234578999999999877 688999999999999999999999997643111 011111100000
Q ss_pred ---------------ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 ---------------KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..............+.. -..+.+++.+||+.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA---SPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTS---CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhcccc---ChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000000 1245679999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=336.08 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=196.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeC-----Cee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVG-----EER 931 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 931 (1176)
.++|.+.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999987 688999999854322 2234678999999999999999999987654 678
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
++||||+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 5999998753 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccc--------cccccccCCcccCccccC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1012 LMSAMDTHL--------SVSTLAGTPGYVPPEYYQ-SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1012 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
......... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+... .+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 239 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGII 239 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHh
Confidence 764322111 123357899999999875 4678999999999999999999999997643111 011111100
Q ss_pred hccc-------------------cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1083 AKLK-------------------ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1083 ~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... .............+.. -..+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV---NPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccC---CHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000000000011 1235679999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=335.50 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=190.1
Q ss_pred HHHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhc----CCCCccccee
Q 046275 855 LLEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKI----KHRNLVPLLG 923 (1176)
Q Consensus 855 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~ 923 (1176)
.....++|++.+.||+|+||.||+|++. +++.||+|++...... ....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999875 6889999998643321 223356799999998 8999999999
Q ss_pred EEeeCCeeEEEEee-ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCc
Q 046275 924 YCKVGEERLLVYEY-MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFE 1001 (1176)
Q Consensus 924 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 1001 (1176)
++...+..++|||| +.+++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 78999999998754 689999999999999999999999 999999999999999 8899
Q ss_pred EEEEeeccccccccccccccccccccCCcccCccccCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1002 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS-TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1002 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
+||+|||+++...... .....||+.|+|||++.+..+. .++||||+|+++|||++|+.||.... ....
T Consensus 179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~ 247 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILE 247 (312)
T ss_dssp EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH
T ss_pred EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhh
Confidence 9999999998765422 2445789999999998766654 58999999999999999999986321 1111
Q ss_pred HhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1081 QHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... +. ...+ ..+.+++.+||+.||++|||++|++++
T Consensus 248 --~~~~----~~----~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 --AELH----FP----AHVS------PDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --TCCC----CC----TTSC------HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hccC----Cc----ccCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 11 1111 135569999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=335.01 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=191.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEe-----------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK----------- 926 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 926 (1176)
.++|.+.+.||+|+||.||+|++. +|+.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357899999999999999999987 48999999987655555667899999999999999999999873
Q ss_pred ---eCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcE
Q 046275 927 ---VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFEA 1002 (1176)
Q Consensus 927 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 1002 (1176)
+....++||||++ |+|.+++... ++++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 5999999743 589999999999999999999999 999999999999997 56799
Q ss_pred EEEeeccccccccccc-cccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDT-HLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVK 1080 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~ 1080 (1176)
||+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~ 239 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILE 239 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9999999986643211 112234567999999998755 678999999999999999999999997643110 0100000
Q ss_pred Hhhc------cccccccC----cc-------cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1081 QHAK------LKISDVFD----PE-------LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1081 ~~~~------~~~~~~~~----~~-------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ......+. .. .....+.. -..+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI---SREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTC---CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchh---hHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 00000000 00 00000001 1245679999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=358.98 Aligned_cols=336 Identities=20% Similarity=0.196 Sum_probs=216.4
Q ss_pred CCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCcc
Q 046275 324 CSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403 (1176)
Q Consensus 324 l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~ 403 (1176)
+++++.|++++|.+. .+|..+|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..+ ..+++|+
T Consensus 50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~ 126 (597)
T 3oja_B 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--QNVPLLT 126 (597)
T ss_dssp GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT--TTCTTCC
T ss_pred CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHH--cCCCCCC
Confidence 345555566655554 5555555556666666666666655555556666666666666666654444333 2345566
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 483 (1176)
+|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++. .++.+++|+.|++++|.
T Consensus 127 ~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNL 203 (597)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSC
T ss_pred EEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCc
Confidence 666666666644444456666666666666666666666666666666666666666643 24455666677777776
Q ss_pred ccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChh
Q 046275 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPA 563 (1176)
Q Consensus 484 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~ 563 (1176)
+++ +....+|+.|++++|.++. +|..+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..
T Consensus 204 l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 273 (597)
T 3oja_B 204 LST-----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP 273 (597)
T ss_dssp CSE-----EECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred ccc-----ccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHH
Confidence 653 2234467777777777663 23222 2567777777777764 356667777777777777776544432
Q ss_pred HHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEc
Q 046275 564 LFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643 (1176)
Q Consensus 564 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdL 643 (1176)
+ ..+.+|++|+|
T Consensus 274 ~--------------------------------------------------------------------~~l~~L~~L~L 285 (597)
T 3oja_B 274 F--------------------------------------------------------------------VKMQRLERLYI 285 (597)
T ss_dssp G--------------------------------------------------------------------TTCSSCCEEEC
T ss_pred h--------------------------------------------------------------------cCccCCCEEEC
Confidence 2 22345677777
Q ss_pred ccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCC
Q 046275 644 SYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGM 723 (1176)
Q Consensus 644 s~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~ 723 (1176)
++|++++ +|..++.+++|+.|+|++|+++ .+|..++.+++|++|+|++|+|++ +| +..+++|+.|+|++|++++.
T Consensus 286 s~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 286 SNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp TTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC-cC--hhhcCCCCEEEeeCCCCCCh
Confidence 7777775 5667777888888888888888 678888888888888888888874 44 66777888888888888876
Q ss_pred CCCCCCccccCCccccCCCCCCCCCC
Q 046275 724 IPVMGQFETFQPAKFLNNSGLCGLPL 749 (1176)
Q Consensus 724 ~p~~~~~~~~~~~~~~~n~~l~~~~~ 749 (1176)
.+. ..+..+....+.++...|+.+.
T Consensus 361 ~~~-~~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 361 SLR-ALFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp HHH-HHTTTCCTTTBCCCCCCCCTTC
T ss_pred hHH-HHHHHHhhhccccccccCCcch
Confidence 432 3455666677888888998743
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=342.73 Aligned_cols=264 Identities=21% Similarity=0.229 Sum_probs=199.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC--------CCCcccceeEEe---
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK--------HRNLVPLLGYCK--- 926 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 926 (1176)
.++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999876 5788999988532 233456889999999985 788999999987
Q ss_pred -eCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-----
Q 046275 927 -VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF----- 1000 (1176)
Q Consensus 927 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----- 1000 (1176)
.....++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+||+++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 456789999999 567777776543 236899999999999999999999964 799999999999999775
Q ss_pred --------------------------------------------cEEEEeeccccccccccccccccccccCCcccCccc
Q 046275 1001 --------------------------------------------EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036 (1176)
Q Consensus 1001 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 1036 (1176)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999865432 234578999999999
Q ss_pred cCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCcc--HHHHH---HHhhc--------cccc-cccCc-----ccc-
Q 046275 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNN--LVGWV---KQHAK--------LKIS-DVFDP-----ELM- 1096 (1176)
Q Consensus 1037 ~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~--~~~~~---~~~~~--------~~~~-~~~~~-----~~~- 1096 (1176)
+.+..++.++|||||||++|||++|+.||...+..... ..... ..... .... +.+.. .+.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99989999999999999999999999999765432211 11110 10000 0000 00000 000
Q ss_pred -----------cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 -----------KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 -----------~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
............+.+++.+||+.||++|||++|+++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0001112334567789999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=332.27 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=200.2
Q ss_pred hcCCCCCceEeEeCceEEEEEEE-C-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCC------CcccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL-K-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHR------NLVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 930 (1176)
.++|++.+.||+|+||+||+|.+ + +++.||+|++... ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35799999999999999999987 3 5788999988532 23345688899999998765 49999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE------------ 998 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------ 998 (1176)
.++||||+ +++|.+++...+. .++++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 8899999986542 3688999999999999999999999 9999999999999987
Q ss_pred -------CCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046275 999 -------NFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG 1071 (1176)
Q Consensus 999 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~ 1071 (1176)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764332 23457899999999999999999999999999999999999999754321
Q ss_pred CccHHHHHHHhhcccccc----------ccC--------------------cccccCCCchHHHHHHHHHHHHHhccCCC
Q 046275 1072 DNNLVGWVKQHAKLKISD----------VFD--------------------PELMKEDPNIEIELLQHLHVASACLDDRP 1121 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~----------~~~--------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dp 1121 (1176)
........... ..+. .+. ................+.+++.+||+.||
T Consensus 241 --~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 241 --EHLAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp --HHHHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred --HHHHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11111111000 0000 000 00000000011123456789999999999
Q ss_pred CCCCCHHHHHHH
Q 046275 1122 WRRPTMIQVMAM 1133 (1176)
Q Consensus 1122 ~~RPt~~evl~~ 1133 (1176)
++|||++|++++
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.94 Aligned_cols=244 Identities=24% Similarity=0.398 Sum_probs=198.3
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcC--CCCcccceeEEe
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKIK--HRNLVPLLGYCK 926 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 926 (1176)
....++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344568999999999999999999876 6889999998654322 2245678999999996 599999999999
Q ss_pred eCCeeEEEEeeccC-CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEE
Q 046275 927 VGEERLLVYEYMRY-GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARV 1004 (1176)
Q Consensus 927 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 1004 (1176)
..+..++||||+.+ ++|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999986 89999998754 689999999999999999999999 999999999999999 7889999
Q ss_pred EeeccccccccccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh
Q 046275 1005 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA 1083 (1176)
Q Consensus 1005 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~ 1083 (1176)
+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~----~ 256 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI----I 256 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH----H
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh----h
Confidence 9999998764322 234579999999999877665 678999999999999999999985421 11 1
Q ss_pred ccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1084 KLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1084 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... .+. ...+ ..+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~--~~~----~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 RGQV--FFR----QRVS------SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HCCC--CCS----SCCC------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccc--ccc----ccCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 011 1111 135569999999999999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=337.16 Aligned_cols=334 Identities=20% Similarity=0.197 Sum_probs=186.3
Q ss_pred CCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccE
Q 046275 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKE 404 (1176)
Q Consensus 325 ~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~ 404 (1176)
++|++|++++|.++ .+|..+|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..+ ..+++|++
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~ 121 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF--QNVPLLTV 121 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT--TTCTTCCE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh--cCCCCCCE
Confidence 44555555555554 4455545555555555555555554444455555555555555555554333333 22444555
Q ss_pred EEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccc
Q 046275 405 LFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNEL 484 (1176)
Q Consensus 405 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 484 (1176)
|+|++|.++...+..|.++++|++|++++|++++..|..+..+++|++|++++|++++. .++.+++|+.|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 55555555533333345555555555555555555555555555555555555555532 234455556666666655
Q ss_pred cCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhH
Q 046275 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 485 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
++. ....+|+.|++++|+++. +|.. ..++|++|+|++|.+++. ..+..+++|+.|+|++|.+++..|..
T Consensus 199 ~~~-----~~~~~L~~L~l~~n~l~~-~~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~- 267 (390)
T 3o6n_A 199 STL-----AIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP- 267 (390)
T ss_dssp SEE-----ECCSSCSEEECCSSCCCE-EECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGG-
T ss_pred ccc-----CCCCcceEEECCCCeeee-cccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhH-
Confidence 521 223456666666666653 2322 235566666666666532 35556666666666666665433321
Q ss_pred HhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcc
Q 046275 565 FKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDIS 644 (1176)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs 644 (1176)
|..+.+|++|+|+
T Consensus 268 -------------------------------------------------------------------~~~l~~L~~L~L~ 280 (390)
T 3o6n_A 268 -------------------------------------------------------------------FVKMQRLERLYIS 280 (390)
T ss_dssp -------------------------------------------------------------------GTTCSSCCEEECC
T ss_pred -------------------------------------------------------------------ccccccCCEEECC
Confidence 1122346666666
Q ss_pred cCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCC
Q 046275 645 YNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMI 724 (1176)
Q Consensus 645 ~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~ 724 (1176)
+|++++ +|..++.+++|+.|+|++|+++ .+|..++.+++|++|+|++|+++ .+| +..+++|+.|++++|++++.-
T Consensus 281 ~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~--~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 281 NNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp SSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc-eeC--chhhccCCEEEcCCCCccchh
Confidence 666664 4555666777777777777777 56667777777777777777777 344 566777777777777777542
Q ss_pred CCCCCccccCCccccCCCCCCCCC
Q 046275 725 PVMGQFETFQPAKFLNNSGLCGLP 748 (1176)
Q Consensus 725 p~~~~~~~~~~~~~~~n~~l~~~~ 748 (1176)
. ...+..+....+.++...|..+
T Consensus 356 ~-~~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 356 L-RALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp H-HHHTTTCCTTTBCCCCSCCCTT
T ss_pred H-HHHHHHHHhhcccccCceeccc
Confidence 2 1233444555566777777654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=332.76 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=192.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc--CHHHHHHHHHHHHhcCCCCcccceeEEeeCCe------
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ--GDREFTAEMETIGKIKHRNLVPLLGYCKVGEE------ 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 930 (1176)
++|.+.+.||+|+||.||+|+++ +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999986 6899999998643222 23568899999999999999999999987654
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588877642 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-----
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK----- 1084 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~----- 1084 (1176)
+..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+ .+.........
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEF 247 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 764322 234578999999999877 678999999999999999999999997643211 01111010000
Q ss_pred -------------cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 -------------LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+......+.. -..+.+++.+||+.||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA---SPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTS---CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCc---CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000001111111111 1245679999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=344.48 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=185.4
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeecc
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +|||||++++++.++...|+||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45567899999999998877778999999998542 245678899999886 89999999999999999999999996
Q ss_pred CCCHHHHHhhccccCcc---cCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-------------CcEE
Q 046275 940 YGSLEDVLHNQKKVGIK---LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDEN-------------FEAR 1003 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k 1003 (1176)
|+|.+++......... .++..++.++.||+.||+|||+. +|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 5999999876432211 13345678999999999999999 99999999999999654 4899
Q ss_pred EEeeccccccccccccc--cccccccCCcccCccccCC-------CCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 046275 1004 VSDFGMARLMSAMDTHL--SVSTLAGTPGYVPPEYYQS-------FRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDN 1073 (1176)
Q Consensus 1004 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~ 1073 (1176)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-- 246 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-- 246 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence 99999998765432211 1234579999999999965 678999999999999999999 99998643211
Q ss_pred cHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1074 NLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1074 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....... ..... .... . ........+.+++.+||+.||++|||+.+++++
T Consensus 247 -~~~i~~~--~~~~~-----~~~~-~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 -ESNIIRG--IFSLD-----EMKC-L-HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -HHHHHHT--CCCCC-----CCTT-C-CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHhcC--CCCcc-----cccc-c-ccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111111 00100 0000 0 011122356679999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=329.97 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=177.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHH-HHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEME-TIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|.+.+.||+|+||.||+|+++ +|+.||||++..... ....++..|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57889999999999999999986 689999999865322 22344556665 6777899999999999999999999999
Q ss_pred eccCCCHHHHHhhccc-cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 937 YMRYGSLEDVLHNQKK-VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|+++ +|.+++..... ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 88888764221 1336899999999999999999999962 799999999999999999999999999976543
Q ss_pred ccccccccccccCCcccCcccc----CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYY----QSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
... .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... ............ .+
T Consensus 179 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~-~~ 250 (327)
T 3aln_A 179 SIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGDPP-QL 250 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCC-CC
T ss_pred ccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCCCC-CC
Confidence 221 2334799999999998 45678999999999999999999999997532110 111111111100 11
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+ ..+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEEREFS------PSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCCCC------HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCC------HHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111111 145669999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=337.59 Aligned_cols=263 Identities=18% Similarity=0.222 Sum_probs=196.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-----------CCCcccceeEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-----------HRNLVPLLGYCKV 927 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 927 (1176)
++|++.+.||+|+||+||+|++. +++.||||++.. .....+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57999999999999999999985 688999998853 2223456888999999886 8999999999876
Q ss_pred CC----eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC------
Q 046275 928 GE----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD------ 997 (1176)
Q Consensus 928 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~------ 997 (1176)
.+ ..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+||+++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 54 789999999 8899999986542 25899999999999999999999963 799999999999994
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc--cH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN--NL 1075 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~--~~ 1075 (1176)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999865432 2345789999999999998999999999999999999999999976432110 00
Q ss_pred HHHHHHhh-cccccc--------------------ccCc--------ccccCCCchHHHHHHHHHHHHHhccCCCCCCCC
Q 046275 1076 VGWVKQHA-KLKISD--------------------VFDP--------ELMKEDPNIEIELLQHLHVASACLDDRPWRRPT 1126 (1176)
Q Consensus 1076 ~~~~~~~~-~~~~~~--------------------~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt 1126 (1176)
........ .+..+. .+.. ...............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 01100000 000000 0000 000000111223445678999999999999999
Q ss_pred HHHHHHH
Q 046275 1127 MIQVMAM 1133 (1176)
Q Consensus 1127 ~~evl~~ 1133 (1176)
++|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=324.89 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=177.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC-H-HHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG-D-REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||.||+|+++ +|+.||||++....... . +.+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888999999999999999986 68999999986543221 2 234445556788899999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
|+ ++.+..+..... ..+++..++.++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 556665554332 368999999999999999999998 5 899999999999999999999999999976543
Q ss_pred ccccccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
... .....||+.|+|||++. ...++.++||||||+++|||++|+.||..... .. ............ .
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~-~~~~~~~~~~~~-~ 249 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DF-EVLTKVLQEEPP-L 249 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HH-HHHHHHHHSCCC-C
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cH-HHHHHHhccCCC-C
Confidence 222 23457899999999984 55788999999999999999999999975321 11 111111111111 0
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
++ . ....+ ..+.+++.+||+.||.+|||+++++++
T Consensus 250 ~~-~-~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LP-G-HMGFS------GDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CC-S-SSCCC------HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC-c-cCCCC------HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0 00111 135569999999999999999999886
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=329.20 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=198.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CC-CEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC------cccceeEEeeCCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DG-STVAIKKLIHISGQGDREFTAEMETIGKIKHRN------LVPLLGYCKVGEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 930 (1176)
.++|++.+.||+|+||+||+|++. ++ +.||+|.+... ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 367999999999999999999986 34 68999988532 233456888999999997665 8999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE--------------
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLL-------------- 996 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-------------- 996 (1176)
.++||||+ ++++.+++..... .++++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 5678887765432 3689999999999999999999999 99999999999999
Q ss_pred -----CCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCC
Q 046275 997 -----DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFG 1071 (1176)
Q Consensus 997 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~ 1071 (1176)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56788999999999764332 23457999999999999999999999999999999999999999754311
Q ss_pred CccHHHHHHHhhccccccc-----------cCcc-cc------------------cCCCchHHHHHHHHHHHHHhccCCC
Q 046275 1072 DNNLVGWVKQHAKLKISDV-----------FDPE-LM------------------KEDPNIEIELLQHLHVASACLDDRP 1121 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~-----------~~~~-~~------------------~~~~~~~~~~~~~~~li~~cl~~dp 1121 (1176)
.......... ...+.. .... .+ ............+.+++.+||+.||
T Consensus 246 --~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 --EHLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp --HHHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred --HHHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1111111110 000000 0000 00 0000111123456789999999999
Q ss_pred CCCCCHHHHHHH
Q 046275 1122 WRRPTMIQVMAM 1133 (1176)
Q Consensus 1122 ~~RPt~~evl~~ 1133 (1176)
++|||++|++++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=341.25 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=186.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.+|.+.++||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +|||||++++++.+....|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4588889999999999776666689999999985422 23356899999999 7999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCcEEEEeecccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-----NFEARVSDFGMARLM 1013 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~~~ 1013 (1176)
. |+|.+++..... ...+..++.++.||+.||+|||+. +|+||||||+||+++. ...+||+|||+|+..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999986542 345556778999999999999999 9999999999999953 335889999999876
Q ss_pred cccccc-ccccccccCCcccCccccC---CCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1014 SAMDTH-LSVSTLAGTPGYVPPEYYQ---SFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1014 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
...... .......||+.|+|||++. ...++.++||||+||++|||++ |..||..... ............
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~~ 247 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQANILLGACSL 247 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HHHHHHTTCCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HHHHHHhccCCc
Confidence 543221 1234567999999999997 4567889999999999999999 9999854321 111111111111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ +. ..-..+.+++.+||+.||++|||++++++|
T Consensus 248 ~~~~~------~~--~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCLHP------EK--HEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTSCT------TC--HHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCc------cc--cccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11111 01 122235679999999999999999999854
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=329.85 Aligned_cols=315 Identities=22% Similarity=0.248 Sum_probs=196.4
Q ss_pred CCCccEEEeCCCccccccc--CCCCCccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEe
Q 046275 195 CDELKQLALKGNKVTGDIN--VSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLN 271 (1176)
Q Consensus 195 ~~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 271 (1176)
+++++.|++++|.++.... +..+++|++|++++|.++.+++ .+..+++|++|+|++|++++..+..+.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 3456666666666655332 4555666666666666665544 456666666666666666665555566666666666
Q ss_pred eccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCC
Q 046275 272 VSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSN 351 (1176)
Q Consensus 272 Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~ 351 (1176)
|++|.++. +|..++..+++|++|++++|++++..|..|..+++|++|++++|+++ .++ +..+++
T Consensus 124 L~~n~l~~------------l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~---~~~l~~ 187 (390)
T 3o6n_A 124 LERNDLSS------------LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD---LSLIPS 187 (390)
T ss_dssp CCSSCCCC------------CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS-BCC---GGGCTT
T ss_pred CCCCccCc------------CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC-ccc---cccccc
Confidence 66665552 22222333455555555555555544555555555555555555554 233 233455
Q ss_pred CCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEc
Q 046275 352 LKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHL 431 (1176)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 431 (1176)
|++|++++|.+++. ...++ |++|++++|.++.. |... .++|+.|++
T Consensus 188 L~~L~l~~n~l~~~-----~~~~~--------------------------L~~L~l~~n~l~~~-~~~~--~~~L~~L~l 233 (390)
T 3o6n_A 188 LFHANVSYNLLSTL-----AIPIA--------------------------VEELDASHNSINVV-RGPV--NVELTILKL 233 (390)
T ss_dssp CSEEECCSSCCSEE-----ECCSS--------------------------CSEEECCSSCCCEE-ECCC--CSSCCEEEC
T ss_pred cceeeccccccccc-----CCCCc--------------------------ceEEECCCCeeeec-cccc--cccccEEEC
Confidence 55555555544421 12234 55555555555432 2211 256666777
Q ss_pred CCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCC
Q 046275 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGE 511 (1176)
Q Consensus 432 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 511 (1176)
++|++++. ..+..+++|++|++++|.+++..|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .
T Consensus 234 ~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~ 309 (390)
T 3o6n_A 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 309 (390)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-C
T ss_pred CCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-e
Confidence 77766642 45666777777777777777666777777777777788888777 35666677888888888888888 5
Q ss_pred CCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 512 IPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 512 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
+|..+..+++|++|+|++|++++ +| +..+++|+.|++++|++++.....++.
T Consensus 310 ~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~ 361 (390)
T 3o6n_A 310 VERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFR 361 (390)
T ss_dssp CGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred cCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHHHHHH
Confidence 77778888889999999998874 44 777889999999999998765555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.66 Aligned_cols=231 Identities=15% Similarity=0.119 Sum_probs=181.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||.||+|++. +|+.||+|.+....... .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999987 48999999986543322 256889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++++|.++++.. ....++..++.|++.||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999542 34557888999999999999999 99999999999999999999997443
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC-c-
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD-P- 1093 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 1093 (1176)
|++ .++.++|||||||++|||+||+.||...+....-. ........... +
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------PAERDTAGQPIEPA 226 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------ECCBCTTSCBCCHH
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------HHHHHhccCCCChh
Confidence 333 36889999999999999999999998654321100 00000000000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
......+ ..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 227 ~~~~~~~------~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 DIDRDIP------FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSC------HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hcccCCC------HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 1111111 135569999999999999 9999999999988543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=347.78 Aligned_cols=271 Identities=24% Similarity=0.317 Sum_probs=200.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEee------CCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKV------GEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 930 (1176)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999885 6899999988643 22334568899999999999999999998765 667
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc---EEEEee
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFE---ARVSDF 1007 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 1007 (1176)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986542 23588899999999999999999999 9999999999999987665 999999
Q ss_pred ccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc---
Q 046275 1008 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK--- 1084 (1176)
Q Consensus 1008 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~--- 1084 (1176)
|++........ .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ....|......
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC----
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccc
Confidence 99987654322 245679999999999999999999999999999999999999996532 11122110000
Q ss_pred ------ccccc--ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHHHHhhC
Q 046275 1085 ------LKISD--VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQ-----VMAMFKEIQAG 1140 (1176)
Q Consensus 1085 ------~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~e-----vl~~L~~i~~~ 1140 (1176)
..... .+.................+.+++.+||+.||++|||+++ ..+.++++...
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 0011100000001112234567999999999999999988 45666666644
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=317.69 Aligned_cols=306 Identities=25% Similarity=0.356 Sum_probs=169.4
Q ss_pred cCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEee
Q 046275 193 NGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNV 272 (1176)
Q Consensus 193 ~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 272 (1176)
..+++|++|++++|.+.....+..+++|++|++++|+++.+++ +..+++|++|++++|.+++. ..+.++++|++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~~~~~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l 117 (347)
T 4fmz_A 41 EELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYL 117 (347)
T ss_dssp HHHTTCSEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred hhcccccEEEEeCCccccchhhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEEC
Confidence 3455566666666666555555555666666666665555444 55555566666666555543 23555555555555
Q ss_pred ccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCC
Q 046275 273 SSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL 352 (1176)
Q Consensus 273 s~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L 352 (1176)
++|.+++..+ +..+++|++|++++|.....+ ..+..+++|++|++++|.+. .++. +..+++|
T Consensus 118 ~~n~i~~~~~--------------~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~-~~~~--~~~l~~L 179 (347)
T 4fmz_A 118 NEDNISDISP--------------LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK-DVTP--IANLTDL 179 (347)
T ss_dssp TTSCCCCCGG--------------GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTC
T ss_pred cCCcccCchh--------------hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcC-Cchh--hccCCCC
Confidence 5555542111 122344555555555333222 22444455555555555444 2222 3444444
Q ss_pred CEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcC
Q 046275 353 KELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS 432 (1176)
Q Consensus 353 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 432 (1176)
++|++++|.+++..+ +..++ +|+.|++++|.+++..+ +..+++|++|+++
T Consensus 180 ~~L~l~~n~l~~~~~--~~~l~--------------------------~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 229 (347)
T 4fmz_A 180 YSLSLNYNQIEDISP--LASLT--------------------------SLHYFTAYVNQITDITP--VANMTRLNSLKIG 229 (347)
T ss_dssp SEEECTTSCCCCCGG--GGGCT--------------------------TCCEEECCSSCCCCCGG--GGGCTTCCEEECC
T ss_pred CEEEccCCccccccc--ccCCC--------------------------ccceeecccCCCCCCch--hhcCCcCCEEEcc
Confidence 444444444442211 44444 45555555555543322 5555666666666
Q ss_pred CccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCC
Q 046275 433 FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEI 512 (1176)
Q Consensus 433 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 512 (1176)
+|++++..+ +..+++|++|++++|.+++. +.+..+++|++|++++|++++. ..+..+++|+.|++++|++++..
T Consensus 230 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 230 NNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGG
T ss_pred CCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcC
Confidence 666663322 56666666666666666532 3466666777777777777643 34667777777777777777666
Q ss_pred CccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCc
Q 046275 513 PTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 513 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 557 (1176)
|..++.+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 6777777777777777777775444 666777777777777664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=344.57 Aligned_cols=314 Identities=22% Similarity=0.244 Sum_probs=195.6
Q ss_pred CCccEEEeCCCccccccc--CCCCCccceeeccCCcccccCC-CccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEee
Q 046275 196 DELKQLALKGNKVTGDIN--VSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNV 272 (1176)
Q Consensus 196 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 272 (1176)
.+++.|++++|.+..... +..+++|++|+|++|.++++++ .|..+++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 455666666666554322 4455566666666666655544 4555666666666666665555555555555666666
Q ss_pred ccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCC
Q 046275 273 SSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNL 352 (1176)
Q Consensus 273 s~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L 352 (1176)
++|.|++. |..++..+++|++|+|++|.+++..|..|..+++|++|+|++|.++ .++ +..+++|
T Consensus 131 ~~n~l~~l------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~---~~~l~~L 194 (597)
T 3oja_B 131 ERNDLSSL------------PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD---LSLIPSL 194 (597)
T ss_dssp CSSCCCCC------------CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS-BCC---GGGCTTC
T ss_pred eCCCCCCC------------CHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC-CcC---hhhhhhh
Confidence 55555522 2222223345555555555555554555555555555555555554 233 2334455
Q ss_pred CEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcC
Q 046275 353 KELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLS 432 (1176)
Q Consensus 353 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 432 (1176)
++|++++|.+++ +...+ +|+.|++++|.++.. +..+ .++|+.|+|+
T Consensus 195 ~~L~l~~n~l~~-----l~~~~--------------------------~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~ 240 (597)
T 3oja_B 195 FHANVSYNLLST-----LAIPI--------------------------AVEELDASHNSINVV-RGPV--NVELTILKLQ 240 (597)
T ss_dssp SEEECCSSCCSE-----EECCT--------------------------TCSEEECCSSCCCEE-ECSC--CSCCCEEECC
T ss_pred hhhhcccCcccc-----ccCCc--------------------------hhheeeccCCccccc-cccc--CCCCCEEECC
Confidence 555555554442 11223 355555555555422 2111 1466777777
Q ss_pred CccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCC
Q 046275 433 FNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEI 512 (1176)
Q Consensus 433 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 512 (1176)
+|.+++ +..+..+++|+.|+|++|.+.+..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+
T Consensus 241 ~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i 316 (597)
T 3oja_B 241 HNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HV 316 (597)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CC
T ss_pred CCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-cc
Confidence 777764 3566777777777777777777777777777888888888888874 5667777888999999999888 67
Q ss_pred CccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 513 PTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 513 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
|..++.+++|++|+|++|.+++. | +..+++|+.|+|++|+++|..+..++.
T Consensus 317 ~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~ 367 (597)
T 3oja_B 317 ERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFR 367 (597)
T ss_dssp GGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred CcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHH
Confidence 88888899999999999998743 3 677889999999999999876555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=315.04 Aligned_cols=308 Identities=21% Similarity=0.289 Sum_probs=236.1
Q ss_pred cccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCC
Q 046275 164 AGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLAL 243 (1176)
Q Consensus 164 ~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L 243 (1176)
.+..+++|++|++++|.++.+ +. +..+++|++|++++|.+++...+..+++|++|++++|.++.+ +.+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~~---~~--~~~~~~L~~L~l~~n~i~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVASI---QG--IEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDI-SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCCC---TT--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-GGGTTCTTC
T ss_pred cchhcccccEEEEeCCccccc---hh--hhhcCCccEEEccCCccccchhhhcCCcCCEEEccCCcccCc-hHHcCCCcC
Confidence 345678999999999999874 32 678999999999999999877799999999999999999976 468999999
Q ss_pred cEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccC
Q 046275 244 EYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS 323 (1176)
Q Consensus 244 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 323 (1176)
++|++++|++++..+ +..+++|++|++++|.....++. +..+++|++|++++|.+.+..+ +..
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-------------~~~l~~L~~L~l~~~~~~~~~~--~~~ 175 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-------------LSNMTGLNYLTVTESKVKDVTP--IAN 175 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-------------GTTCTTCCEEECCSSCCCCCGG--GGG
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-------------hhhCCCCcEEEecCCCcCCchh--hcc
Confidence 999999999997655 89999999999999965432221 3456899999999999985543 889
Q ss_pred CCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCcc
Q 046275 324 CSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403 (1176)
Q Consensus 324 l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~ 403 (1176)
+++|++|++++|.++ .++. +..+++|++|++++|.+++..+ +..+++|++|++++|++++. +.
T Consensus 176 l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~----------- 238 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP----------- 238 (347)
T ss_dssp CTTCSEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-----------
T ss_pred CCCCCEEEccCCccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-----------
Confidence 999999999999998 5554 6889999999999999996544 78888888888888888732 22
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 483 (1176)
+..+++|++|++++|++++. +.+..+++|++|++++|.+++. +.+..+++|++|+|++|+
T Consensus 239 ----------------~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~ 298 (347)
T 4fmz_A 239 ----------------LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQ 298 (347)
T ss_dssp ----------------GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred ----------------hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCc
Confidence 33444555555555555432 2455555566666666655532 245666777777777777
Q ss_pred ccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccc
Q 046275 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 484 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 533 (1176)
+++..|..|.++++|++|++++|++++..| +..+++|++|++++|.|+
T Consensus 299 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 777777777777778888888887775544 677778888888887764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=329.74 Aligned_cols=243 Identities=16% Similarity=0.158 Sum_probs=180.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC---cCHHHHHHHHHHHHhcCC-CCccccee-----------
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG---QGDREFTAEMETIGKIKH-RNLVPLLG----------- 923 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~----------- 923 (1176)
.+|...++||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.++| ++......
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45777889999999999999976 699999998863322 225678999999999987 32221111
Q ss_pred ----------EEee-----CCeeEEEEeeccCCCHHHHHhhc---cccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 046275 924 ----------YCKV-----GEERLLVYEYMRYGSLEDVLHNQ---KKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985 (1176)
Q Consensus 924 ----------~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 985 (1176)
++.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111 12346777766 57999998532 11233688999999999999999999999 999
Q ss_pred eCCCCCCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCcccc----------CCCCCCchhhhHHHHHHH
Q 046275 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY----------QSFRCSTKGDVYSYGVVL 1055 (1176)
Q Consensus 986 H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil 1055 (1176)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998765432 245567 999999999 666788999999999999
Q ss_pred HHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1056 LELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1056 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
|||++|+.||........ ....+.. ....| ..+.+++.+||+.||++|||+.+++++
T Consensus 308 ~elltg~~Pf~~~~~~~~-------------~~~~~~~--~~~~~------~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-------------SEWIFRS--CKNIP------QPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-------------SGGGGSS--CCCCC------HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhhh-------------HHHHHhh--cccCC------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999975431110 0000110 01112 235669999999999999998888654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=309.91 Aligned_cols=229 Identities=21% Similarity=0.255 Sum_probs=176.8
Q ss_pred cCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHH-HhcCCCCcccceeEEee----CCeeE
Q 046275 860 NGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETI-GKIKHRNLVPLLGYCKV----GEERL 932 (1176)
Q Consensus 860 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 932 (1176)
++|.+. +.||+|+||.||+|++. +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 78999999999999985 689999999853 34677899888 55699999999999877 67789
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeecc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGM 1009 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl 1009 (1176)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998754 23689999999999999999999999 9999999999999998 78899999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc-cccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK-LKIS 1088 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~ 1088 (1176)
+.... +..++.++||||+||++|||++|+.||....... ....... ....
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~ 217 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIRMG 217 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSCTT
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----hhHHHHHHHhhc
Confidence 86432 1346789999999999999999999996543111 0000000 0000
Q ss_pred c-ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 D-VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
. .++...+...+ ..+.+++.+||+.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~------~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 QYEFPNPEWSEVS------EEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCHHHHTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCchhcccCC------HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00100001111 245679999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=349.24 Aligned_cols=238 Identities=21% Similarity=0.347 Sum_probs=189.6
Q ss_pred cCCCCCceEeEeCceEEEEEEEC--CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCe-----e
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK--DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEE-----R 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 931 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999986 588999998864322 233468899999999999999999999987655 6
Q ss_pred EEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
|+||||+++++|.+++.. .+++.+++.++.||+.||.|||+. +||||||||+||+++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999987653 589999999999999999999999 99999999999999986 89999999998
Q ss_pred ccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1012 LMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1012 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||....... +
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------~---- 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------L---- 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------C----
T ss_pred hcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------c----
Confidence 65432 345799999999998765 4899999999999999999998875421110 0
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-MIQVMAMFKEI 1137 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-~~evl~~L~~i 1137 (1176)
. ... ........+.+++.+||+.||++||+ ++++.+.+..+
T Consensus 285 ~----~~~-~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 P----EDD-PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp C----TTC-HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c----ccc-cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 000 00111234567999999999999995 55566666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=318.64 Aligned_cols=238 Identities=16% Similarity=0.182 Sum_probs=180.4
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--------cCHHHHHHHHHHHHhcC---------CCCcccc-
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--------QGDREFTAEMETIGKIK---------HRNLVPL- 921 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l- 921 (1176)
++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.++++++ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5688999999999999999998 689999999975422 22367899999999886 5555554
Q ss_pred ----------------eeEEee-------------CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHH
Q 046275 922 ----------------LGYCKV-------------GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972 (1176)
Q Consensus 922 ----------------~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 972 (1176)
++++.+ ....|+||||+++|++.+.+.+. .+++..++.++.||+.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHHH
Confidence 444443 67899999999999777666432 58999999999999999
Q ss_pred HHHHH-hcCCCCeeeCCCCCCCEEECCCC--------------------cEEEEeeccccccccccccccccccccCCcc
Q 046275 973 LAFLH-HNCIPHIIHRDMKSSNVLLDENF--------------------EARVSDFGMARLMSAMDTHLSVSTLAGTPGY 1031 (1176)
Q Consensus 973 L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 1031 (1176)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+.... ....||+.|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 88 999999999999999887 899999999986543 234799999
Q ss_pred cCccccCCCCCCchhhhHHHHHH-HHHHHcCCCCCCCCCCCCccHHHHHHHh----h-ccccccccCcccccCCCchHHH
Q 046275 1032 VPPEYYQSFRCSTKGDVYSYGVV-LLELLTGKRPTDSADFGDNNLVGWVKQH----A-KLKISDVFDPELMKEDPNIEIE 1105 (1176)
Q Consensus 1032 ~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~P~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~ 1105 (1176)
+|||++.+.. +.++||||+|++ .+++++|..||.. ..|.... . .........+. ....-
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 308 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTDKMLKQMTFKTKCNTP------AMKQI 308 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHHHHHHTCCCSSCCCSH------HHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHHhhhhhhccCcccchh------hhhhc
Confidence 9999998766 899999998777 7888999999732 1121111 1 11111110111 11112
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHH-HH
Q 046275 1106 LLQHLHVASACLDDRPWRRPTMIQVM-AM 1133 (1176)
Q Consensus 1106 ~~~~~~li~~cl~~dp~~RPt~~evl-~~ 1133 (1176)
-..+.+|+.+||+.| |++|++ +|
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred CHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 345678999999976 999988 54
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=302.93 Aligned_cols=246 Identities=28% Similarity=0.355 Sum_probs=211.6
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
+++.++++++.++ .+|..+. ++|++|++++|.++ .++...|..+++|++|+|++|.+++..|..+.++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 6888888888887 5666553 68899999999987 566666788899999999999998877888999999999999
Q ss_pred cCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCcccc--CCCCccccCCCccCeeeccccc
Q 046275 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT--GTIPSSLGSLSKLQDLKLWLNQ 459 (1176)
Q Consensus 382 s~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~ 459 (1176)
++|+++ .+|..++ ++|++|++++|++++..+..+.++++|++|++++|+++ +..|..+..+ +|+.|++++|+
T Consensus 110 ~~n~l~-~l~~~~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp CSSCCC-SCCSSCC----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB
T ss_pred CCCcCC-ccCcccc----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC
Confidence 999988 6776553 67999999999999777778899999999999999996 4678888888 99999999999
Q ss_pred ccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 460 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
+++ +|..+. ++|++|+|++|++++..|..|.++++|+.|+|++|++++..|.++..+++|++|+|++|+++ .+|..
T Consensus 184 l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 184 LTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp CSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred CCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 984 676665 78999999999999888889999999999999999999888888999999999999999998 88989
Q ss_pred CCCCCCCCEEEccCCCCcccCCh
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~ 562 (1176)
+..+++|+.|++++|++++ +|.
T Consensus 260 l~~l~~L~~L~l~~N~l~~-~~~ 281 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITK-VGV 281 (332)
T ss_dssp GGGCTTCCEEECCSSCCCB-CCT
T ss_pred hhcCccCCEEECCCCCCCc-cCh
Confidence 9999999999999999974 443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=299.39 Aligned_cols=295 Identities=19% Similarity=0.265 Sum_probs=196.8
Q ss_pred CccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhh
Q 046275 218 KNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLA 297 (1176)
Q Consensus 218 ~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~ 297 (1176)
.+++.++++++.++.++..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..+.
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----------- 97 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA----------- 97 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT-----------
T ss_pred CCCeEEEecCCCccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc-----------
Confidence 467777888877776666543 5778888888888877777788888888888888887755554433
Q ss_pred hcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCC--CCcccccCCCC
Q 046275 298 DLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG--ALPDSLSNLTN 375 (1176)
Q Consensus 298 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~ 375 (1176)
.+++|++|+|++|+++ .+|..+. ++|++|++++|+++ .++...|..+++|++|++++|.++. ..+..+.++++
T Consensus 98 -~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~ 172 (330)
T 1xku_A 98 -PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172 (330)
T ss_dssp -TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT
T ss_pred -CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCC
Confidence 2467888888888887 4555544 78888888888887 6777778888889999998888864 56777888888
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeec
Q 046275 376 LETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 376 L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 455 (1176)
|++|++++|.++ .+|..+ .++|++|+|++|.+++..|..+..+++|++|+|++|++++..+..+..+++|++|+|
T Consensus 173 L~~L~l~~n~l~-~l~~~~----~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 247 (330)
T 1xku_A 173 LSYIRIADTNIT-TIPQGL----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247 (330)
T ss_dssp CCEEECCSSCCC-SCCSSC----CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cCEEECCCCccc-cCCccc----cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEEC
Confidence 888888888887 455543 246777777777776666666666777777777777766555556666666666666
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc-
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG- 534 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~- 534 (1176)
++|+++ .+|..+..+++|++|+|++|+|++..+..|.... .....+.|+.|++++|.+..
T Consensus 248 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGG
T ss_pred CCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCccccc
Confidence 666666 5555566666666666666666654444443220 00012445555555555532
Q ss_pred -cCCCCCCCCCCCCEEEccCC
Q 046275 535 -RIPPELGDCRSLIWLDLNTN 554 (1176)
Q Consensus 535 -~~p~~~~~l~~L~~L~L~~N 554 (1176)
..|..|..+.+|+.++|++|
T Consensus 309 ~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 309 EIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp GSCGGGGTTCCCGGGEEC---
T ss_pred ccCccccccccceeEEEeccc
Confidence 33445555556666666555
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-35 Score=351.31 Aligned_cols=354 Identities=21% Similarity=0.203 Sum_probs=210.9
Q ss_pred CCccEEEccCCcccc----cCCccccCCCCCcEEEccCCcCcccCCHHHHhcCC----CCCEEEccCcccCC----CCcc
Q 046275 301 SSLVKLDLSSNNLSG----KVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS----NLKELVLSFNDFTG----ALPD 368 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~----~L~~L~Ls~N~l~~----~~p~ 368 (1176)
++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..++..++ +|++|+|++|.++. .++.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 344444444444432 23445555666666666666665333334444454 57777777776663 3466
Q ss_pred cccCCCCCCEEEccCCcCCCCCCccccC---CCCCCccEEEccCccccCC----CCccccccccCcEEEcCCccccCCCC
Q 046275 369 SLSNLTNLETLDLSSNNLSGAIPHNLCQ---GPRNSLKELFLQNNLLLGS----IPSTLSNCSQLVSLHLSFNYLTGTIP 441 (1176)
Q Consensus 369 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p 441 (1176)
.+..+++|++|+|++|.+++..+..++. ....+|++|+|++|++++. ++..+..+++|++|++++|++++..+
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 187 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence 6667777777777777765433332221 1234577777777777653 24555666777788888777765433
Q ss_pred cccc-----CCCccCeeecccccccCC----CCCCCCCccccceeecccccccCcc-----ccccccCCCCCeeeccccc
Q 046275 442 SSLG-----SLSKLQDLKLWLNQLHGE----IPPELGNIQTLETLFLDFNELTGTL-----PAALSNCTNLNWISLSNNH 507 (1176)
Q Consensus 442 ~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~ 507 (1176)
..+. ..++|++|++++|.+++. ++..+..+++|++|+|++|++++.. +..+..+++|++|++++|+
T Consensus 188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~ 267 (461)
T 1z7x_W 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267 (461)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence 3332 255777777777777653 4555666677777777777776432 2223356777777777777
Q ss_pred cCCC----CCccccCCCCCCeEEccCCcccccCCCCCC-----CCCCCCEEEccCCCCcccCChhHHhhcccchhhhccc
Q 046275 508 LGGE----IPTWIGQLSNLAILKLSNNSFYGRIPPELG-----DCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVG 578 (1176)
Q Consensus 508 l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~ 578 (1176)
+++. ++..+..+++|++|+|++|.+.+..+..+. ..++|+.|+|++|.+++.-...+..
T Consensus 268 l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~------------ 335 (461)
T 1z7x_W 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS------------ 335 (461)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH------------
T ss_pred CCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH------------
Confidence 7643 566666677777777777777543333222 2257777777777776431111100
Q ss_pred cceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccc
Q 046275 579 KKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGS 658 (1176)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~ 658 (1176)
.+..+.+|++|||++|.+++..+..++.
T Consensus 336 ----------------------------------------------------~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 336 ----------------------------------------------------VLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp ----------------------------------------------------HHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ----------------------------------------------------HHhhCCCccEEEccCCccccccHHHHHH
Confidence 0112245677777777777655555543
Q ss_pred -----cccceeeeccCccccc----cCCccccCcCcccEEEccCcccccc--------CCCCccccccccccccccc
Q 046275 659 -----MSYLFILNLGHNNLSG----PIPTEVGDLRGLNILDLSSNRLEGT--------IPSSMSSLTLLNEIDLCNN 718 (1176)
Q Consensus 659 -----l~~L~~L~L~~N~l~g----~iP~~~~~L~~L~~L~Ls~N~l~g~--------iP~~l~~l~~L~~l~ls~N 718 (1176)
.++|+.|+|++|++++ .+|..+..+++|++|||++|++++. +|.....|..|..+|++.|
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 5577777888877775 6777777777788888888877754 4544444444444444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=299.15 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=204.4
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
+++.++++++.++ .+|..+. ++|++|++++|+++ .++...|..+++|++|+|++|.+++..|..+.++++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 5666666666666 4555443 57777888888877 566556677888888888888888777888888888888888
Q ss_pred cCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCcccc--CCCCccccCCCccCeeeccccc
Q 046275 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT--GTIPSSLGSLSKLQDLKLWLNQ 459 (1176)
Q Consensus 382 s~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~ 459 (1176)
++|+++ .+|..++ ++|++|++++|.+++..+..+.++++|++|++++|+++ +..+..+..+++|++|++++|.
T Consensus 108 s~n~l~-~l~~~~~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 108 SKNQLK-ELPEKMP----KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp CSSCCS-BCCSSCC----TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred CCCcCC-ccChhhc----ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence 888887 5666542 57888999999888777778889999999999999986 3677888999999999999999
Q ss_pred ccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 460 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..+.++..+++|++|+|++|+++ .+|..
T Consensus 183 l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 258 (330)
T 1xku_A 183 IT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258 (330)
T ss_dssp CC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh
Confidence 98 5666654 78999999999999888899999999999999999999888888999999999999999998 88999
Q ss_pred CCCCCCCCEEEccCCCCcccCChh
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPPA 563 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~~ 563 (1176)
+..+++|++|+|++|++++ +|..
T Consensus 259 l~~l~~L~~L~l~~N~i~~-~~~~ 281 (330)
T 1xku_A 259 LADHKYIQVVYLHNNNISA-IGSN 281 (330)
T ss_dssp TTTCSSCCEEECCSSCCCC-CCTT
T ss_pred hccCCCcCEEECCCCcCCc-cChh
Confidence 9999999999999999984 5543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=301.70 Aligned_cols=289 Identities=23% Similarity=0.274 Sum_probs=163.8
Q ss_pred CccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhh
Q 046275 218 KNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLA 297 (1176)
Q Consensus 218 ~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~ 297 (1176)
.+++.++++++.++.++..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..+
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~------------ 98 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF------------ 98 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGS------------
T ss_pred ccCCEEECCCCCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHh------------
Confidence 356677777777766665542 567777777777776666667777777777777776664333322
Q ss_pred hcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCC--CCcccccCCCC
Q 046275 298 DLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG--ALPDSLSNLTN 375 (1176)
Q Consensus 298 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~ 375 (1176)
..+++|++|+|++|+++ .+|..+. ++|++|++++|+++ .+|...|..+++|++|++++|.++. ..+..+..+ +
T Consensus 99 ~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~ 173 (332)
T 2ft3_A 99 SPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-K 173 (332)
T ss_dssp TTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-C
T ss_pred hCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-c
Confidence 22356666666666666 3444433 56777777777776 5565556667777777777776642 455666666 6
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeec
Q 046275 376 LETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 376 L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 455 (1176)
|+.|++++|++++ +|..+. ++|++|+|++|.+++..+..+.++++|++|+|++|++++..+..+..+
T Consensus 174 L~~L~l~~n~l~~-l~~~~~----~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-------- 240 (332)
T 2ft3_A 174 LNYLRISEAKLTG-IPKDLP----ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL-------- 240 (332)
T ss_dssp CSCCBCCSSBCSS-CCSSSC----SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC--------
T ss_pred cCEEECcCCCCCc-cCcccc----CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC--------
Confidence 7777777777663 444331 345555555555554444445555555555555555554444444444
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccC------CCCCCeEEccC
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ------LSNLAILKLSN 529 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~ 529 (1176)
++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|.. ..+|+.|++++
T Consensus 241 ----------------~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~ 303 (332)
T 2ft3_A 241 ----------------PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303 (332)
T ss_dssp ----------------TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCS
T ss_pred ----------------CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeec
Confidence 44444555555444 44444555555555555555555433333332 24566666666
Q ss_pred Cccc--ccCCCCCCCCCCCCEEEccCCC
Q 046275 530 NSFY--GRIPPELGDCRSLIWLDLNTNL 555 (1176)
Q Consensus 530 N~l~--~~~p~~~~~l~~L~~L~L~~N~ 555 (1176)
|.+. +..|..|..+++|+.+++++|+
T Consensus 304 N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CcccccccCcccccccchhhhhhccccc
Confidence 6655 4455556666666666666653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-34 Score=344.29 Aligned_cols=385 Identities=19% Similarity=0.146 Sum_probs=252.2
Q ss_pred CCCcEEecCCCCCCcccc-ccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCcccee
Q 046275 145 SSLKVLNLSSNLLDFSGR-EAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFL 223 (1176)
Q Consensus 145 ~~L~~L~Ls~n~i~~~~~-~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L 223 (1176)
++|++|+|++|+++..+. ..+..+++|++|+|++|++++...-.. ...+..+++|++|
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l---------------------~~~l~~~~~L~~L 61 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI---------------------SSALRVNPALAEL 61 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHH---------------------HHHHHTCTTCCEE
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHH---------------------HHHHHhCCCcCEE
Confidence 345556666555554442 224445555555555555542100000 1123345566666
Q ss_pred eccCCcccccC-CC-ccCCC----CCcEEEcCCCcCCC----CcChhhhccccCCeEeeccccccCccCCCCccccCcch
Q 046275 224 DVSSNNFSMAV-PS-FGDCL----ALEYLDISANKFTG----DVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIP 293 (1176)
Q Consensus 224 ~Ls~N~l~~~~-~~-l~~l~----~L~~L~Ls~N~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~ 293 (1176)
++++|.++... .. ...+. +|++|+|++|++++ .++..+..+++|++|+|++|.+++..+. .+.
T Consensus 62 ~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~-------~l~ 134 (461)
T 1z7x_W 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQ-------LLC 134 (461)
T ss_dssp ECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHH-------HHH
T ss_pred eCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHH-------HHH
Confidence 66666654321 11 12222 57777777777764 3466677777777777777776532111 111
Q ss_pred hhhhhcCCCccEEEccCCccccc----CCccccCCCCCcEEEccCCcCcccCCHHHH----hcCCCCCEEEccCcccCCC
Q 046275 294 LHLADLCSSLVKLDLSSNNLSGK----VPSRFGSCSSLESFDISSNKFSGELPIEIF----LSMSNLKELVLSFNDFTGA 365 (1176)
Q Consensus 294 ~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~----~~l~~L~~L~Ls~N~l~~~ 365 (1176)
..+....++|++|+|++|++++. ++..+..+++|++|++++|.+++..+..+. ...++|++|+|++|.+++.
T Consensus 135 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 214 (461)
T 1z7x_W 135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD 214 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT
T ss_pred HHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHH
Confidence 12222245688888888877753 355666778888888888887633222221 2356888888888888763
Q ss_pred ----CcccccCCCCCCEEEccCCcCCCCCCccccC---CCCCCccEEEccCccccCC----CCccccccccCcEEEcCCc
Q 046275 366 ----LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ---GPRNSLKELFLQNNLLLGS----IPSTLSNCSQLVSLHLSFN 434 (1176)
Q Consensus 366 ----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N 434 (1176)
++..+..+++|++|+|++|.+++.....++. ...++|++|+|++|.+++. ++..+.++++|++|+|++|
T Consensus 215 ~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n 294 (461)
T 1z7x_W 215 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294 (461)
T ss_dssp HHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred HHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCC
Confidence 4667777888888888888876432211111 2356788999999988864 5677778899999999999
Q ss_pred cccCCCCccccC-----CCccCeeecccccccCC----CCCCCCCccccceeecccccccCcccccccc-----CCCCCe
Q 046275 435 YLTGTIPSSLGS-----LSKLQDLKLWLNQLHGE----IPPELGNIQTLETLFLDFNELTGTLPAALSN-----CTNLNW 500 (1176)
Q Consensus 435 ~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~ 500 (1176)
++++..+..+.. .++|++|++++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|++
T Consensus 295 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~ 374 (461)
T 1z7x_W 295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374 (461)
T ss_dssp CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred CCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEE
Confidence 987544444432 36899999999998865 4666777899999999999998766665553 679999
Q ss_pred eeccccccCC----CCCccccCCCCCCeEEccCCccccc--------CCCCCCCCCCCCEEEccCCCCcccC
Q 046275 501 ISLSNNHLGG----EIPTWIGQLSNLAILKLSNNSFYGR--------IPPELGDCRSLIWLDLNTNLFNGSI 560 (1176)
Q Consensus 501 L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~--------~p~~~~~l~~L~~L~L~~N~l~g~i 560 (1176)
|+|++|++++ .+|..+..+++|++|+|++|++++. +|.. ..+|+.|++.++.+....
T Consensus 375 L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~---~~~L~~L~~~~~~~~~~~ 443 (461)
T 1z7x_W 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP---GCLLEQLVLYDIYWSEEM 443 (461)
T ss_dssp EECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTST---TCCCCEEECTTCCCCHHH
T ss_pred EECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccC---CcchhheeecccccCHHH
Confidence 9999999986 7788888999999999999998754 3332 346888888888776433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=293.71 Aligned_cols=280 Identities=21% Similarity=0.209 Sum_probs=196.6
Q ss_pred CCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCee
Q 046275 374 TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453 (1176)
Q Consensus 374 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 453 (1176)
+.....++++|.++ .+|..+. ++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|.++++|++|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT----EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC----TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCeEeeCCCCCcc-ccccccc----ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 33444566666665 4555432 356677777777665555567777777777777777776666677777777777
Q ss_pred ecccccccCCCCCCCCCccccceeecccccccCccc-cccccCCCCCeeecccc-ccCCCCCccccCCCCCCeEEccCCc
Q 046275 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLP-AALSNCTNLNWISLSNN-HLGGEIPTWIGQLSNLAILKLSNNS 531 (1176)
Q Consensus 454 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~ 531 (1176)
+|++|++++..+..++++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..|..++.+++|++|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 777777775444447777777777777777774433 46777788888888877 4665556677778888888888888
Q ss_pred ccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccc
Q 046275 532 FYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSR 611 (1176)
Q Consensus 532 l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 611 (1176)
+++..|..+..+++|+.|++++|.+. .+|..++.
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~--------------------------------------------- 219 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD--------------------------------------------- 219 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCST-THHHHHHH---------------------------------------------
T ss_pred cCccCHHHHhccccCCeecCCCCccc-cchhhhhh---------------------------------------------
Confidence 87777888888888888888888774 34433321
Q ss_pred cccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcccc---ccccceeeeccCccccc----cCCccccCcC
Q 046275 612 ISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIG---SMSYLFILNLGHNNLSG----PIPTEVGDLR 684 (1176)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~---~l~~L~~L~L~~N~l~g----~iP~~~~~L~ 684 (1176)
...+|+.|+|++|++++..+..+. ....++.++|++|.+++ .+|+.++.++
T Consensus 220 ----------------------~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~ 277 (353)
T 2z80_A 220 ----------------------VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQIS 277 (353)
T ss_dssp ----------------------HTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCT
T ss_pred ----------------------hcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhccc
Confidence 123577788888888876555443 34566677777777665 4788888888
Q ss_pred cccEEEccCccccccCCCCc-cccccccccccccccccCCCCCC
Q 046275 685 GLNILDLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLTGMIPVM 727 (1176)
Q Consensus 685 ~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~l~ls~N~l~g~~p~~ 727 (1176)
+|++|||++|+|+ .+|..+ ..+++|+.|+|++|++++..|..
T Consensus 278 ~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l 320 (353)
T 2z80_A 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 320 (353)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred CCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCCc
Confidence 8888999888888 677764 78888888999999888888743
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=281.70 Aligned_cols=225 Identities=24% Similarity=0.255 Sum_probs=148.5
Q ss_pred ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeec
Q 046275 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL 503 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 503 (1176)
++++.|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..|.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 34455555555554 44444555555555555555555 45555555555555555555555 44555555555555555
Q ss_pred cccccCCCCCcccc---------CCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhh
Q 046275 504 SNNHLGGEIPTWIG---------QLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAAN 574 (1176)
Q Consensus 504 s~N~l~~~~p~~~~---------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~ 574 (1176)
++|++.+.+|..++ .+++|++|+|++|+++ .+|..++.+++|+.|+|++|++++ +|+.+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l---------- 225 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI---------- 225 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGG----------
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhh----------
Confidence 55555555555444 3777777777777776 677777777777777777777763 44321
Q ss_pred hccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCc
Q 046275 575 FIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPK 654 (1176)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~ 654 (1176)
..+.+|++|+|++|++.+.+|.
T Consensus 226 ----------------------------------------------------------~~l~~L~~L~Ls~n~~~~~~p~ 247 (328)
T 4fcg_A 226 ----------------------------------------------------------HHLPKLEELDLRGCTALRNYPP 247 (328)
T ss_dssp ----------------------------------------------------------GGCTTCCEEECTTCTTCCBCCC
T ss_pred ----------------------------------------------------------ccCCCCCEEECcCCcchhhhHH
Confidence 1224577777888777778888
Q ss_pred cccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccccccccccccccc
Q 046275 655 EIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721 (1176)
Q Consensus 655 ~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~ 721 (1176)
.++.+++|+.|+|++|++.+.+|..++++++|++|+|++|++.|.+|.++.+|++|+.++++.|.+.
T Consensus 248 ~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred HhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 8888888888888888888888888888888888888888888888888888888888888766554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=276.39 Aligned_cols=237 Identities=25% Similarity=0.255 Sum_probs=169.2
Q ss_pred CCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCC--CcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCcc
Q 046275 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGA--LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403 (1176)
Q Consensus 326 ~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~ 403 (1176)
+|++|+|++|+++ .+|..+|..+++|++|+|++|.++.. .+..+..+++|++|+|++|.++ .+|..+ ..+++|+
T Consensus 29 ~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~--~~l~~L~ 104 (306)
T 2z66_A 29 SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF--LGLEQLE 104 (306)
T ss_dssp TCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEE--ETCTTCC
T ss_pred CCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhc--CCCCCCC
Confidence 4444444444443 34444444444444444444444311 1333334444444455444444 233333 1234455
Q ss_pred EEEccCccccCCCC-ccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccC-CCCCCCCCccccceeeccc
Q 046275 404 ELFLQNNLLLGSIP-STLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG-EIPPELGNIQTLETLFLDF 481 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~ 481 (1176)
+|++++|.+++..+ ..+..+++|++|++++|++++..|..+..+++|++|++++|.+.+ .+|..+..+++|++|+|++
T Consensus 105 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 184 (306)
T 2z66_A 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184 (306)
T ss_dssp EEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred EEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCC
Confidence 55555555554333 467778888888888888887788888888888888888888876 5788899999999999999
Q ss_pred ccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCC-CCCCEEEccCCCCcccC
Q 046275 482 NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC-RSLIWLDLNTNLFNGSI 560 (1176)
Q Consensus 482 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~g~i 560 (1176)
|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..|..+..+ ++|+.|+|++|+++|..
T Consensus 185 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 99998888999999999999999999998777789999999999999999999999999998 49999999999999876
Q ss_pred ChhHHh
Q 046275 561 PPALFK 566 (1176)
Q Consensus 561 p~~~~~ 566 (1176)
+...|.
T Consensus 265 ~~~~~~ 270 (306)
T 2z66_A 265 EHQSFL 270 (306)
T ss_dssp GGHHHH
T ss_pred ChHHHH
Confidence 654443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=323.50 Aligned_cols=440 Identities=16% Similarity=0.101 Sum_probs=288.8
Q ss_pred ccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCccc--ccCCCccCCCCCcEEEcCCCcCCCCcChhhhcc-
Q 046275 188 PWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFS--MAVPSFGDCLALEYLDISANKFTGDVGHAISAC- 264 (1176)
Q Consensus 188 ~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l- 264 (1176)
+...+..+++|++|+|++|......... + .....+. .+......+++|++|+|++|.+++..+..+...
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~--~------~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 136 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLI--P------ENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKAR 136 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCS--C------TTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHH
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccc--c------ccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhc
Confidence 3445666778888888876543211100 0 0001100 011112367788888888888776666666653
Q ss_pred c-cCCeEeecccc-ccCccCCCCccccCcchhhhhhcCCCccEEEccCCccccc----CCccccCCCCCcEEEccCCcCc
Q 046275 265 E-HLSFLNVSSNL-FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK----VPSRFGSCSSLESFDISSNKFS 338 (1176)
Q Consensus 265 ~-~L~~L~Ls~N~-l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 338 (1176)
+ +|++|+|++|. ++ + .....+...+++|++|+|++|.+++. ++..+..+++|++|++++|.++
T Consensus 137 ~~~L~~L~L~~~~~~~---~--------~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~ 205 (592)
T 3ogk_B 137 ADDLETLKLDKCSGFT---T--------DGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA 205 (592)
T ss_dssp GGGCCEEEEESCEEEE---H--------HHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCS
T ss_pred cccCcEEECcCCCCcC---H--------HHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCC
Confidence 3 48888888776 21 0 11122334568888888888887654 3344566788888888888886
Q ss_pred ccCC----HHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCC---CCCCccccCCCCCCccEEEccCcc
Q 046275 339 GELP----IEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLS---GAIPHNLCQGPRNSLKELFLQNNL 411 (1176)
Q Consensus 339 ~~i~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~---~~~p~~~~~~~~~~L~~L~L~~N~ 411 (1176)
+ +. ..++.++++|++|++++|.+.+ +|..+.++++|+.|+++.+... +..+..+ ..+++|+.|+++++.
T Consensus 206 ~-~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l--~~~~~L~~L~l~~~~ 281 (592)
T 3ogk_B 206 K-ISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL--VFPRKLCRLGLSYMG 281 (592)
T ss_dssp S-CCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCC--CCCTTCCEEEETTCC
T ss_pred c-cCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHh--hccccccccCccccc
Confidence 2 22 2334678888888888888874 6677888888888888764322 1122222 345678888888764
Q ss_pred ccCCCCccccccccCcEEEcCCccccCCCC-ccccCCCccCeeecccccccCCCCCCCCCccccceeecc----------
Q 046275 412 LLGSIPSTLSNCSQLVSLHLSFNYLTGTIP-SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD---------- 480 (1176)
Q Consensus 412 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~---------- 480 (1176)
. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++-..+.++..+..+++|++|+|+
T Consensus 282 ~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~ 360 (592)
T 3ogk_B 282 P-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMED 360 (592)
T ss_dssp T-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSS
T ss_pred h-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCcccccccc
Confidence 3 3677788888999999999998764433 346788899999998443333344444667889999998
Q ss_pred -cccccCcc-ccccccCCCCCeeeccccccCCCCCccccC-CCCCCeEEcc----CCccccc-----CCCCCCCCCCCCE
Q 046275 481 -FNELTGTL-PAALSNCTNLNWISLSNNHLGGEIPTWIGQ-LSNLAILKLS----NNSFYGR-----IPPELGDCRSLIW 548 (1176)
Q Consensus 481 -~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~ 548 (1176)
.|.+++.. +..+.++++|++|+++.|++++..+..++. +++|+.|+++ .|.+++. ++..+..+++|+.
T Consensus 361 ~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~ 440 (592)
T 3ogk_B 361 EEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR 440 (592)
T ss_dssp TTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCE
T ss_pred ccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCE
Confidence 36676443 333556889999999888888777777776 8889999996 6777643 2333566888999
Q ss_pred EEccCCC--CcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCC
Q 046275 549 LDLNTNL--FNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGG 626 (1176)
Q Consensus 549 L~L~~N~--l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 626 (1176)
|+|++|. +++..+..+.
T Consensus 441 L~L~~~~~~l~~~~~~~~~------------------------------------------------------------- 459 (592)
T 3ogk_B 441 FAFYLRQGGLTDLGLSYIG------------------------------------------------------------- 459 (592)
T ss_dssp EEEECCGGGCCHHHHHHHH-------------------------------------------------------------
T ss_pred EEEecCCCCccHHHHHHHH-------------------------------------------------------------
Confidence 9987543 4332111110
Q ss_pred CCCCCcCCCCCccEEEcccCcCcc-CCCccccccccceeeeccCcccccc-CCccccCcCcccEEEccCccccccCCCCc
Q 046275 627 HTQPTFNHNGSMMFLDISYNMLSG-SIPKEIGSMSYLFILNLGHNNLSGP-IPTEVGDLRGLNILDLSSNRLEGTIPSSM 704 (1176)
Q Consensus 627 ~~~~~~~~~~~l~~LdLs~N~l~g-~iP~~~~~l~~L~~L~L~~N~l~g~-iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l 704 (1176)
....+|++|+|++|.+++ .+|..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|++++.--..+
T Consensus 460 ------~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l 533 (592)
T 3ogk_B 460 ------QYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLM 533 (592)
T ss_dssp ------HSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGG
T ss_pred ------HhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHH
Confidence 112468899999999886 4566678889999999999998755 45556778999999999999886533333
Q ss_pred -cccccccccccccc
Q 046275 705 -SSLTLLNEIDLCNN 718 (1176)
Q Consensus 705 -~~l~~L~~l~ls~N 718 (1176)
..++.+....+..+
T Consensus 534 ~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 534 QMARPYWNIELIPSR 548 (592)
T ss_dssp GGCCTTEEEEEECCC
T ss_pred HHhCCCcEEEEecCc
Confidence 24455544444433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=277.75 Aligned_cols=174 Identities=24% Similarity=0.305 Sum_probs=84.9
Q ss_pred EEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccC--CCCccccCCCccCeeec
Q 046275 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG--TIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 378 ~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L 455 (1176)
.++++++.++ .+|..+ .++|++|+|++|+++...+..|.++++|++|+|++|+++. ..|..+..+++|++|++
T Consensus 11 ~l~c~~~~l~-~ip~~~----~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGI----PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEECCSSCCS-SCCSCC----CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred EEEcCCCCcc-cCCCCC----CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 4555555554 444432 1345555555555553333345556666666666666552 22344444555555555
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccc-cccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLP-AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 534 (1176)
++|.+. .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|++++..|..+..+++|++|+|++|.+.+
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 555554 334444445555555555555543332 344444455555555555444444444444555555555554443
Q ss_pred -cCCCCCCCCCCCCEEEccCCCCc
Q 046275 535 -RIPPELGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 535 -~~p~~~~~l~~L~~L~L~~N~l~ 557 (1176)
.+|..+..+++|+.|+|++|.++
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~ 188 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLE 188 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcC
Confidence 34444444444444444444444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-29 Score=286.66 Aligned_cols=246 Identities=26% Similarity=0.253 Sum_probs=200.5
Q ss_pred CccEEEccCccccCCCCccccccccCcEEEcCCcccc-CCCCcccc-------CCCccCeeecccccccCCCCCCC--CC
Q 046275 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT-GTIPSSLG-------SLSKLQDLKLWLNQLHGEIPPEL--GN 470 (1176)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~--~~ 470 (1176)
+|++|++++|.+ .+|..+... |+.|+|++|+++ ..+|..+. ++++|++|+|++|++++.+|..+ +.
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 455566666666 455544433 777888888884 45666665 78889999999999988888876 88
Q ss_pred ccccceeecccccccCccccccccC-----CCCCeeeccccccCCCCCccccCCCCCCeEEccCCccccc--CCCCC--C
Q 046275 471 IQTLETLFLDFNELTGTLPAALSNC-----TNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR--IPPEL--G 541 (1176)
Q Consensus 471 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~ 541 (1176)
+++|++|+|++|++++. |..+.++ ++|++|+|++|++++..|..|+.+++|++|+|++|++.|. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 99999999999999976 8888877 8999999999999988889999999999999999998765 34444 8
Q ss_pred CCCCCCEEEccCCCCcc--cCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCc
Q 046275 542 DCRSLIWLDLNTNLFNG--SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCN 619 (1176)
Q Consensus 542 ~l~~L~~L~L~~N~l~g--~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 619 (1176)
.+++|++|+|++|++++ .+|..+|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~------------------------------------------------------ 224 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALA------------------------------------------------------ 224 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHH------------------------------------------------------
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHH------------------------------------------------------
Confidence 89999999999999873 2222221
Q ss_pred cccccCCCCCCCcCCCCCccEEEcccCcCccCCC-ccccccccceeeeccCccccccCCccccCcCcccEEEccCccccc
Q 046275 620 FTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIP-KEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEG 698 (1176)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP-~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g 698 (1176)
..+.+|++|||++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+. ++|++|||++|+|++
T Consensus 225 -------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~ 288 (312)
T 1wwl_A 225 -------------AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR 288 (312)
T ss_dssp -------------HTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCS
T ss_pred -------------hcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCC
Confidence 123568999999999999886 56677999999999999999 8999888 899999999999996
Q ss_pred cCCCCccccccccccccccccccCC
Q 046275 699 TIPSSMSSLTLLNEIDLCNNQLTGM 723 (1176)
Q Consensus 699 ~iP~~l~~l~~L~~l~ls~N~l~g~ 723 (1176)
. |. +..+++|+.|+|++|++++.
T Consensus 289 ~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 289 N-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred C-hh-HhhCCCCCEEeccCCCCCCC
Confidence 5 77 99999999999999999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=275.98 Aligned_cols=234 Identities=21% Similarity=0.277 Sum_probs=164.9
Q ss_pred CCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCee
Q 046275 374 TNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453 (1176)
Q Consensus 374 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 453 (1176)
+.++.|+|++|.++ .+|..++. +++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~--l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFR--LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGG--GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cceeEEEccCCCch-hcChhhhh--CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 55667777777666 55555532 456666666666666 55666666666666666666666 556666666666666
Q ss_pred ecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccc
Q 046275 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 454 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 533 (1176)
+|++|++.+.+|..++.. ..+..|.++++|++|+|++|+++ .+|..++.+++|++|+|++|+++
T Consensus 156 ~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred ECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 666666555555554430 11223445778888888888877 67777888888888888888887
Q ss_pred ccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccc
Q 046275 534 GRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613 (1176)
Q Consensus 534 ~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 613 (1176)
.+|..++.+++|+.|+|++|++.+.+|..+
T Consensus 220 -~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~------------------------------------------------- 249 (328)
T 4fcg_A 220 -ALGPAIHHLPKLEELDLRGCTALRNYPPIF------------------------------------------------- 249 (328)
T ss_dssp -CCCGGGGGCTTCCEEECTTCTTCCBCCCCT-------------------------------------------------
T ss_pred -cCchhhccCCCCCEEECcCCcchhhhHHHh-------------------------------------------------
Confidence 466677778888888888887777665422
Q ss_pred cCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccC
Q 046275 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSS 693 (1176)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~ 693 (1176)
..+.+|++|+|++|++.+.+|..++++++|+.|+|++|++.|.+|+.+++|++|+.++++.
T Consensus 250 -------------------~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~ 310 (328)
T 4fcg_A 250 -------------------GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310 (328)
T ss_dssp -------------------TCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCG
T ss_pred -------------------cCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCH
Confidence 2234677888888888888888888899999999999999889999999999999999888
Q ss_pred cccc
Q 046275 694 NRLE 697 (1176)
Q Consensus 694 N~l~ 697 (1176)
|.+.
T Consensus 311 ~~~~ 314 (328)
T 4fcg_A 311 HLQA 314 (328)
T ss_dssp GGSC
T ss_pred HHHH
Confidence 8776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=284.63 Aligned_cols=227 Identities=21% Similarity=0.148 Sum_probs=135.2
Q ss_pred cCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecc
Q 046275 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 425 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 504 (1176)
+|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 44444444444444444444555555555555555554444555555555555555555554444455555555555555
Q ss_pred ccccCCCCCccccCCCCCCeEEccCCcccccCC-CCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceee
Q 046275 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP-PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583 (1176)
Q Consensus 505 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~ 583 (1176)
+|+++...+..|..+++|++|+|++|+..+.+| ..|.++++|+.|+|++|++++ +|.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~--------------------- 213 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN--------------------- 213 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCC---------------------
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-ccc---------------------
Confidence 555554444455556666666666533222333 346666666666666666652 221
Q ss_pred eecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccce
Q 046275 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLF 663 (1176)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~ 663 (1176)
+..+.+|++|||++|+|++..|..|+++++|+
T Consensus 214 ------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 245 (452)
T 3zyi_A 214 ------------------------------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245 (452)
T ss_dssp ------------------------------------------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCC
T ss_pred ------------------------------------------------ccccccccEEECcCCcCcccCcccccCccCCC
Confidence 12234566777777777776677777777777
Q ss_pred eeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccccccccccccccc
Q 046275 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721 (1176)
Q Consensus 664 ~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~ 721 (1176)
.|+|++|++++..|..|+.+++|+.|||++|+|++..|..+..+++|+.|+|++|++.
T Consensus 246 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred EEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 7777777777666777777777777777777777555566677777777777777765
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=282.43 Aligned_cols=282 Identities=22% Similarity=0.213 Sum_probs=184.2
Q ss_pred cCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccC
Q 046275 238 GDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKV 317 (1176)
Q Consensus 238 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 317 (1176)
..|+.....++++|.++.+ |..+. ++|++|++++|.+++..+. .+..+++|++|+|++|++++..
T Consensus 28 ~~C~~~~~c~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~~~~~------------~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNS------------DLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp CEECTTSEEECCSTTCSSC-CTTCC--TTCCEEECTTSCCCEECTT------------TTTTCTTCCEEECTTSCCCEEC
T ss_pred CCCCCCeEeeCCCCCcccc-ccccc--ccCcEEECCCCcCcccCHH------------HhccCCCCCEEECCCCccCccC
Confidence 3455556678888888854 43333 4788888888887743332 2334577888888888888777
Q ss_pred CccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCc-ccccCCCCCCEEEccCCc-CCCCCCcccc
Q 046275 318 PSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP-DSLSNLTNLETLDLSSNN-LSGAIPHNLC 395 (1176)
Q Consensus 318 p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~ 395 (1176)
|..|.++++|++|++++|+++ .+|...|..+++|++|+|++|.+++..+ ..+.++++|++|++++|. +++..+..+
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~- 170 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF- 170 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTT-
T ss_pred HhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHc-
Confidence 777888888888888888887 6777777778888888888888874333 367777777777777774 442222222
Q ss_pred CCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccc
Q 046275 396 QGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLE 475 (1176)
Q Consensus 396 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 475 (1176)
..+++|++|++++|.+++..|..+.++++|++|++++|+++. +|. ..+..+++|+
T Consensus 171 -~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~-----------------------~~~~~~~~L~ 225 (353)
T 2z80_A 171 -AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLE-----------------------IFVDVTSSVE 225 (353)
T ss_dssp -TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHH-----------------------HHHHHTTTEE
T ss_pred -cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chh-----------------------hhhhhccccc
Confidence 223445555555555554444555555555555555555442 222 1222344555
Q ss_pred eeecccccccCccccccc---cCCCCCeeeccccccCC----CCCccccCCCCCCeEEccCCcccccCCCC-CCCCCCCC
Q 046275 476 TLFLDFNELTGTLPAALS---NCTNLNWISLSNNHLGG----EIPTWIGQLSNLAILKLSNNSFYGRIPPE-LGDCRSLI 547 (1176)
Q Consensus 476 ~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~ 547 (1176)
+|+|++|++++..+..+. ....++.++|++|.+++ .+|.++..+++|++|+|++|+++ .+|.. |..+++|+
T Consensus 226 ~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~ 304 (353)
T 2z80_A 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQ 304 (353)
T ss_dssp EEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred EEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCC
Confidence 555555555543333222 34556666666666654 47888999999999999999998 66766 58999999
Q ss_pred EEEccCCCCcccCCh
Q 046275 548 WLDLNTNLFNGSIPP 562 (1176)
Q Consensus 548 ~L~L~~N~l~g~ip~ 562 (1176)
.|+|++|+++|.+|.
T Consensus 305 ~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 305 KIWLHTNPWDCSCPR 319 (353)
T ss_dssp EEECCSSCBCCCHHH
T ss_pred EEEeeCCCccCcCCC
Confidence 999999999998873
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=282.57 Aligned_cols=247 Identities=21% Similarity=0.187 Sum_probs=141.5
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeec
Q 046275 376 LETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 376 L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 455 (1176)
.+.++.+++.++ .+|..+ .++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 45 ~~~v~c~~~~l~-~iP~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGI----STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp SCEEECCSCCCS-SCCSCC----CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCEEEeCCCCcC-cCCCCC----CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 455666666665 455433 234555555555555444455555555555555555555444444554555555554
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccccc
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR 535 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 535 (1176)
++|+|++..+..|.++++|++|+|++|+++...+..|..+++|++|+|++|+..+.
T Consensus 120 ------------------------~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~ 175 (440)
T 3zyj_A 120 ------------------------FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY 175 (440)
T ss_dssp ------------------------CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE
T ss_pred ------------------------CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcce
Confidence 44444444444455555555555555555544444555555555555555332223
Q ss_pred CC-CCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhcccccc
Q 046275 536 IP-PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST 614 (1176)
Q Consensus 536 ~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 614 (1176)
+| ..|.++++|+.|+|++|.++ .+|.
T Consensus 176 i~~~~~~~l~~L~~L~L~~n~l~-~~~~---------------------------------------------------- 202 (440)
T 3zyj_A 176 ISEGAFEGLSNLRYLNLAMCNLR-EIPN---------------------------------------------------- 202 (440)
T ss_dssp ECTTTTTTCSSCCEEECTTSCCS-SCCC----------------------------------------------------
T ss_pred eCcchhhcccccCeecCCCCcCc-cccc----------------------------------------------------
Confidence 32 34556666666666666554 2221
Q ss_pred CCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCc
Q 046275 615 RSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSN 694 (1176)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N 694 (1176)
+..+.+|++|||++|+|++..|..|.++++|+.|+|++|++++..|..|+++++|+.|||++|
T Consensus 203 -----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 265 (440)
T 3zyj_A 203 -----------------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265 (440)
T ss_dssp -----------------CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTS
T ss_pred -----------------cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCC
Confidence 112235666777777777666777777777777777777777666677777777777777777
Q ss_pred cccccCCCCcccccccccccccccccc
Q 046275 695 RLEGTIPSSMSSLTLLNEIDLCNNQLT 721 (1176)
Q Consensus 695 ~l~g~iP~~l~~l~~L~~l~ls~N~l~ 721 (1176)
+|++..|..+..+++|+.|+|++|++.
T Consensus 266 ~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 266 NLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCccChhHhccccCCCEEEcCCCCcc
Confidence 777555556677777777777777764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=268.11 Aligned_cols=231 Identities=26% Similarity=0.272 Sum_probs=162.2
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccC
Q 046275 304 VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSS 383 (1176)
Q Consensus 304 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 383 (1176)
+.++.+++.++ .+|..+ .++|++|++++|.++ .++...|..+++|++|+|++|.+++..|..+.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 45666666665 334332 245666666666665 44444455555666666666655555455555555555555555
Q ss_pred CcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC
Q 046275 384 NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463 (1176)
Q Consensus 384 N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 463 (1176)
|.. ++...|..+..+++|++|++++|++++..|..+..+++|++|++++|++++.
T Consensus 90 n~~-------------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 144 (285)
T 1ozn_A 90 NAQ-------------------------LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144 (285)
T ss_dssp CTT-------------------------CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCC-------------------------ccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccccc
Confidence 541 3333355666677777777777777766677777777888888888887766
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCC
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 543 (1176)
.+..++.+++|++|+|++|++++..+..|.++++|++|+|++|++++..|.++..+++|++|+|++|++++..+..+..+
T Consensus 145 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 66667888888888888888886666678888888888888888888778888888888888888888886655668888
Q ss_pred CCCCEEEccCCCCcccCChh
Q 046275 544 RSLIWLDLNTNLFNGSIPPA 563 (1176)
Q Consensus 544 ~~L~~L~L~~N~l~g~ip~~ 563 (1176)
++|+.|+|++|++.+..+..
T Consensus 225 ~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp TTCCEEECCSSCEECSGGGH
T ss_pred cccCEEeccCCCccCCCCcH
Confidence 89999999999988766543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=265.76 Aligned_cols=233 Identities=22% Similarity=0.190 Sum_probs=118.3
Q ss_pred cCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc-ccCccccccccCCCCCeeec
Q 046275 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE-LTGTLPAALSNCTNLNWISL 503 (1176)
Q Consensus 425 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 503 (1176)
+|++|++++|++++..+..|..+++|++|++++|.+++..|..|.++++|++|+|++|+ ++...|..|.++++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 34444444444443333334444444444444444443334444444444444444444 44333444555555555555
Q ss_pred cccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceee
Q 046275 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583 (1176)
Q Consensus 504 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~ 583 (1176)
++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++ +|+..
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~------------------- 172 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERA------------------- 172 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTT-------------------
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-cCHHH-------------------
Confidence 5555554444555555555555555555554444445555555555555555542 11110
Q ss_pred eecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccce
Q 046275 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLF 663 (1176)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~ 663 (1176)
|..+.+|++|+|++|++++..|..|+++++|+
T Consensus 173 ------------------------------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 204 (285)
T 1ozn_A 173 ------------------------------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204 (285)
T ss_dssp ------------------------------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred ------------------------------------------------hcCccccCEEECCCCcccccCHhHccCccccc
Confidence 11223455566666666655566666666666
Q ss_pred eeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCC
Q 046275 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 664 ~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~ 726 (1176)
.|+|++|++++..|..++.+++|++|+|++|++....+.. .-+..++.+..+.|.+.+..|.
T Consensus 205 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESG
T ss_pred EeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCch
Confidence 6666666666544455666666666666666666433321 2223455556666666666664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=284.61 Aligned_cols=268 Identities=28% Similarity=0.331 Sum_probs=158.7
Q ss_pred CCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEE
Q 046275 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKEL 405 (1176)
Q Consensus 326 ~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L 405 (1176)
+++.|++++|.++ .+|..++ ++|++|+|++|.|+ .+|. .+++|++|+|++|+++ .+|. .+++|++|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~-----~l~~L~~L 106 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV-----LPPGLLEL 106 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC-----CCTTCCEE
T ss_pred CCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC-----CCCCCCEE
Confidence 4777888888877 7776543 67788888888777 4454 4577777777777776 4554 24567777
Q ss_pred EccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccccc
Q 046275 406 FLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485 (1176)
Q Consensus 406 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 485 (1176)
+|++|.+++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|.. +.+|+.|++++|+|+
T Consensus 107 ~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~ 174 (622)
T 3g06_A 107 SIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT 174 (622)
T ss_dssp EECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred ECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCC
Confidence 777777764 333 45667777777777763 4443 3566666666666663 3332 345666666666666
Q ss_pred CccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHH
Q 046275 486 GTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565 (1176)
Q Consensus 486 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~ 565 (1176)
+ +| ..+++|+.|++++|+|++ +|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|++++ +|.
T Consensus 175 ~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp~--- 238 (622)
T 3g06_A 175 S-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPV--- 238 (622)
T ss_dssp C-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCC---
T ss_pred C-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CCC---
Confidence 3 34 334566666666666663 3332 355666666666665 34432 2456666666665553 220
Q ss_pred hhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEccc
Q 046275 566 KQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY 645 (1176)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~ 645 (1176)
...+|+.|+|++
T Consensus 239 --------------------------------------------------------------------~l~~L~~L~Ls~ 250 (622)
T 3g06_A 239 --------------------------------------------------------------------LPSELKELMVSG 250 (622)
T ss_dssp --------------------------------------------------------------------CCTTCCEEECCS
T ss_pred --------------------------------------------------------------------CCCcCcEEECCC
Confidence 012355566666
Q ss_pred CcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccc
Q 046275 646 NMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLT 708 (1176)
Q Consensus 646 N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~ 708 (1176)
|+|+ .+|. .+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+++|.+|..+..++
T Consensus 251 N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 251 NRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 6665 3444 3455556666666666 5555566666666666666666655555554443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=284.07 Aligned_cols=268 Identities=26% Similarity=0.316 Sum_probs=200.4
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
+++.|++++|.++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 4667777777776 5555554 67777777777776 5664 4567777777777776 3444 5577777777
Q ss_pred cCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeeccccccc
Q 046275 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH 461 (1176)
Q Consensus 382 s~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 461 (1176)
++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|.++
T Consensus 109 s~N~l~~-l~~-----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~ 174 (622)
T 3g06_A 109 FSNPLTH-LPA-----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLT 174 (622)
T ss_dssp CSCCCCC-CCC-----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred cCCcCCC-CCC-----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCC
Confidence 7777763 443 23567777777777774 4443 3778888888888874 444 2457888888888888
Q ss_pred CCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCC
Q 046275 462 GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELG 541 (1176)
Q Consensus 462 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 541 (1176)
+ +| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++ .+|.. +++|++|+|++|++++ +| .
T Consensus 175 ~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~ 238 (622)
T 3g06_A 175 S-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---V 238 (622)
T ss_dssp C-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---C
T ss_pred C-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---C
Confidence 4 55 446788889999999885 4443 478999999999998 56643 5789999999999985 66 4
Q ss_pred CCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccc
Q 046275 542 DCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFT 621 (1176)
Q Consensus 542 ~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 621 (1176)
.+++|+.|+|++|+++ .+|.
T Consensus 239 ~l~~L~~L~Ls~N~L~-~lp~----------------------------------------------------------- 258 (622)
T 3g06_A 239 LPSELKELMVSGNRLT-SLPM----------------------------------------------------------- 258 (622)
T ss_dssp CCTTCCEEECCSSCCS-CCCC-----------------------------------------------------------
T ss_pred CCCcCcEEECCCCCCC-cCCc-----------------------------------------------------------
Confidence 5689999999999987 3543
Q ss_pred cccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcC
Q 046275 622 RVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR 684 (1176)
Q Consensus 622 ~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~ 684 (1176)
...+|+.|+|++|+|+ .+|..|+++++|+.|+|++|.++|.+|..+..++
T Consensus 259 ------------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 259 ------------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ------------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ------------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 1135889999999999 8899999999999999999999999999888776
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=279.57 Aligned_cols=267 Identities=22% Similarity=0.185 Sum_probs=167.2
Q ss_pred CcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEE
Q 046275 327 LESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELF 406 (1176)
Q Consensus 327 L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~ 406 (1176)
++.++++.+.+. ..+..++..+++|++|+|++|.+++..|..+.++++|++|+|++|++++..+
T Consensus 12 l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--------------- 75 (317)
T 3o53_A 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--------------- 75 (317)
T ss_dssp EEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---------------
T ss_pred eeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---------------
Confidence 445566666665 5555666666677777777777776666667777777777777776653221
Q ss_pred ccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccC
Q 046275 407 LQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTG 486 (1176)
Q Consensus 407 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 486 (1176)
+..+++|++|+|++|++++. | ..++|++|++++|++++..+.. +++|++|+|++|++++
T Consensus 76 -------------~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 76 -------------LESLSTLRTLDLNNNYVQEL-L----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITM 134 (317)
T ss_dssp -------------ETTCTTCCEEECCSSEEEEE-E----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCS
T ss_pred -------------hhhcCCCCEEECcCCccccc-c----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCC
Confidence 33344455555555554421 1 1134444444444444332222 2345555555555555
Q ss_pred ccccccccCCCCCeeeccccccCCCCCcccc-CCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHH
Q 046275 487 TLPAALSNCTNLNWISLSNNHLGGEIPTWIG-QLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565 (1176)
Q Consensus 487 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~ 565 (1176)
..|..+.++++|++|+|++|++++..|..+. .+++|++|+|++|++++. |. ...
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~----------------------- 189 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVV----------------------- 189 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCC-----------------------
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccc-----------------------
Confidence 5455555555555555555555544444332 344444444444444321 11 111
Q ss_pred hhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEccc
Q 046275 566 KQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY 645 (1176)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~ 645 (1176)
+.+|++|||++
T Consensus 190 ---------------------------------------------------------------------l~~L~~L~Ls~ 200 (317)
T 3o53_A 190 ---------------------------------------------------------------------FAKLKTLDLSS 200 (317)
T ss_dssp ---------------------------------------------------------------------CTTCCEEECCS
T ss_pred ---------------------------------------------------------------------cccCCEEECCC
Confidence 23466777777
Q ss_pred CcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCcccc-ccCCCCccccccccccccc-cccccCC
Q 046275 646 NMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLE-GTIPSSMSSLTLLNEIDLC-NNQLTGM 723 (1176)
Q Consensus 646 N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~-g~iP~~l~~l~~L~~l~ls-~N~l~g~ 723 (1176)
|++++ +|..++.+++|+.|+|++|+++ .+|..++.+++|+.|+|++|+++ +.+|..+..++.|+.++++ .+.++|.
T Consensus 201 N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~ 278 (317)
T 3o53_A 201 NKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278 (317)
T ss_dssp SCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSS
T ss_pred CcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCC
Confidence 77774 4556888889999999999999 68889999999999999999999 8899999999999999999 6688888
Q ss_pred CCC
Q 046275 724 IPV 726 (1176)
Q Consensus 724 ~p~ 726 (1176)
.|.
T Consensus 279 ~~~ 281 (317)
T 3o53_A 279 NEE 281 (317)
T ss_dssp SSC
T ss_pred chh
Confidence 775
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=277.32 Aligned_cols=257 Identities=21% Similarity=0.213 Sum_probs=188.4
Q ss_pred cCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHH
Q 046275 266 HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI 345 (1176)
Q Consensus 266 ~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~ 345 (1176)
..+.++.+++.++ .+|..+ .++++.|+|++|++++..+..|.++++|++|+|++|.++ .++...
T Consensus 44 ~~~~v~c~~~~l~------------~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~ 107 (440)
T 3zyj_A 44 QFSKVICVRKNLR------------EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGA 107 (440)
T ss_dssp TSCEEECCSCCCS------------SCCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGG
T ss_pred CCCEEEeCCCCcC------------cCCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhh
Confidence 3566777776665 222222 146777777777777666667777777777777777776 555556
Q ss_pred HhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcccccccc
Q 046275 346 FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ 425 (1176)
Q Consensus 346 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~ 425 (1176)
|.++++|++|+|++|+++...+..|..+++|++|+|++|+++ +..+..|.++++
T Consensus 108 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--------------------------~~~~~~~~~l~~ 161 (440)
T 3zyj_A 108 FNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE--------------------------SIPSYAFNRIPS 161 (440)
T ss_dssp GTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC--------------------------EECTTTTTTCTT
T ss_pred ccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCccc--------------------------ccCHHHhhhCcc
Confidence 667777777777777776555556666666666666666665 233345556667
Q ss_pred CcEEEcCCc-cccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecc
Q 046275 426 LVSLHLSFN-YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 426 L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 504 (1176)
|++|+|++| .+....+..|..+++|++|+|++|+++ .+| .+..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 162 L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 239 (440)
T 3zyj_A 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239 (440)
T ss_dssp CCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred cCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECC
Confidence 777777763 344333346677777777777777777 445 47788889999999999998888999999999999999
Q ss_pred ccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 505 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
+|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+...-.+|.
T Consensus 240 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~ 301 (440)
T 3zyj_A 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLS 301 (440)
T ss_dssp TCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHH
T ss_pred CCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHH
Confidence 99999888889999999999999999999777778899999999999999999877655543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=277.62 Aligned_cols=237 Identities=20% Similarity=0.210 Sum_probs=174.6
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
+++++|+|++|++++..|..|.++++|++|+|++|+++ .++...|.++++|++|+|++|.+++..+..|.++++|++|+
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 45666666666666555666666666666666666665 34444455566666666666666644444555555555555
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCc-cccCCCCccccCCCccCeeeccccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN-YLTGTIPSSLGSLSKLQDLKLWLNQ 459 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~ 459 (1176)
|++|+++ +..+..|.++++|+.|++++| .+....+..|..+++|++|+|++|+
T Consensus 154 L~~N~l~--------------------------~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 154 LRNNPIE--------------------------SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp CCSCCCC--------------------------EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCCCcc--------------------------eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 5555554 333445666777777777773 4443334467778888888888888
Q ss_pred ccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 460 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
+++ +| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..
T Consensus 208 l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 208 IKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred ccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 874 34 4788899999999999999888999999999999999999999888999999999999999999999777778
Q ss_pred CCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
+..+++|+.|+|++|++.+.+.-.++.
T Consensus 286 ~~~l~~L~~L~L~~Np~~CdC~~~~l~ 312 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPWNCDCDILWLA 312 (452)
T ss_dssp STTCTTCCEEECCSSCEECSTTTHHHH
T ss_pred hccccCCCEEEccCCCcCCCCCchHHH
Confidence 899999999999999999877655543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-29 Score=281.72 Aligned_cols=204 Identities=22% Similarity=0.221 Sum_probs=129.0
Q ss_pred ccccCcEEEcCCccccCCCCccc--cCCCccCeeecccccccCCCCCCCCCc-----cccceeecccccccCcccccccc
Q 046275 422 NCSQLVSLHLSFNYLTGTIPSSL--GSLSKLQDLKLWLNQLHGEIPPELGNI-----QTLETLFLDFNELTGTLPAALSN 494 (1176)
Q Consensus 422 ~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~ 494 (1176)
++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|++
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 45555666666666655555544 5556666666666666544 5555555 56666666666666555566666
Q ss_pred CCCCCeeeccccccCCC--CCccc--cCCCCCCeEEccCCcccc--cCC-CCCCCCCCCCEEEccCCCCcccCChhHHhh
Q 046275 495 CTNLNWISLSNNHLGGE--IPTWI--GQLSNLAILKLSNNSFYG--RIP-PELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567 (1176)
Q Consensus 495 l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~ 567 (1176)
+++|++|+|++|++.+. +|..+ +.+++|++|+|++|++++ .++ ..+..+++|+.|+|++|++++.+|...
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--- 248 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS--- 248 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSC---
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhh---
Confidence 66666666666665543 22333 566667777777776652 122 223456677777777777765443111
Q ss_pred cccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCc
Q 046275 568 SGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNM 647 (1176)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~ 647 (1176)
+..+.+|++|||++|+
T Consensus 249 ----------------------------------------------------------------~~~l~~L~~L~Ls~N~ 264 (312)
T 1wwl_A 249 ----------------------------------------------------------------CDWPSQLNSLNLSFTG 264 (312)
T ss_dssp ----------------------------------------------------------------CCCCTTCCEEECTTSC
T ss_pred ----------------------------------------------------------------hhhcCCCCEEECCCCc
Confidence 1123457778888888
Q ss_pred CccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccc
Q 046275 648 LSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEG 698 (1176)
Q Consensus 648 l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g 698 (1176)
|+ .+|..+. ++|+.|+|++|+|++. |. ++.+++|++|+|++|+|++
T Consensus 265 l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 265 LK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 87 6777776 7888888888888854 66 8888888888888888875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-29 Score=311.36 Aligned_cols=465 Identities=16% Similarity=0.092 Sum_probs=256.3
Q ss_pred cccccccccCCCcEEEccCCCC-CCCCccccc-----------cccCCCCccEEEeCCCcccccccCCCCCccceeeccC
Q 046275 160 SGREAGSLKLSLEVLDLSYNKI-SGANVVPWI-----------LFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSS 227 (1176)
Q Consensus 160 ~~~~~~~~~~~L~~LdLs~N~i-~~~~~~~~~-----------~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~ 227 (1176)
.+...+..+++|++|+|+++.- .+.+.+|.. .+..+++|++|+|++|.+++..
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~--------------- 128 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLD--------------- 128 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHH---------------
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHH---------------
Confidence 3455667788999999988643 211112210 1113445555555554443211
Q ss_pred CcccccCCCccC-CCC-CcEEEcCCCc-CCCC-cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCc
Q 046275 228 NNFSMAVPSFGD-CLA-LEYLDISANK-FTGD-VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSL 303 (1176)
Q Consensus 228 N~l~~~~~~l~~-l~~-L~~L~Ls~N~-l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L 303 (1176)
+..+.. +++ |++|+|++|. ++.. .+.....+++|++|+|++|.+++... .....+...+++|
T Consensus 129 ------~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~--------~~l~~~~~~~~~L 194 (592)
T 3ogk_B 129 ------LDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDG--------KWLHELAQHNTSL 194 (592)
T ss_dssp ------HHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCS--------HHHHHHHHHCCCC
T ss_pred ------HHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcch--------hHHHHHHhcCCCc
Confidence 111222 222 5555555543 1111 11222345555555555555442110 0011223334566
Q ss_pred cEEEccCCccc----ccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccC---CCCcccccCCCCC
Q 046275 304 VKLDLSSNNLS----GKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT---GALPDSLSNLTNL 376 (1176)
Q Consensus 304 ~~L~L~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~---~~~p~~l~~l~~L 376 (1176)
++|++++|.++ +.++..+.++++|++|++++|.+. .++ ..+..+++|++|+++..... ...+..+..+++|
T Consensus 195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~-~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L 272 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272 (592)
T ss_dssp CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGH-HHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTC
T ss_pred cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHH-HHHhhhhHHHhhcccccccccchHHHHHHhhccccc
Confidence 66666666654 233344455666777777776665 344 34566677777777643222 2334556666777
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCC-ccccccccCcEEEcCCcccc-CCCCccccCCCccCeee
Q 046275 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHLSFNYLT-GTIPSSLGSLSKLQDLK 454 (1176)
Q Consensus 377 ~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ 454 (1176)
+.|+++++... .+|..+ ..+++|++|+|++|.+++... ..+.++++|++|+++ |.+. +.++..+..+++|++|+
T Consensus 273 ~~L~l~~~~~~-~l~~~~--~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 273 CRLGLSYMGPN-EMPILF--PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp CEEEETTCCTT-TGGGGG--GGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEE
T ss_pred cccCccccchh-HHHHHH--hhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEE
Confidence 77777765332 444433 234567777777777654332 335677788888887 4333 33444445677788888
Q ss_pred cc-----------cccccCCC-CCCCCCccccceeecccccccCcccccccc-CCCCCeeecc----ccccCCC-----C
Q 046275 455 LW-----------LNQLHGEI-PPELGNIQTLETLFLDFNELTGTLPAALSN-CTNLNWISLS----NNHLGGE-----I 512 (1176)
Q Consensus 455 L~-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~ 512 (1176)
++ .|.+++.. +.....+++|++|+++.|++++..+..+.. +++|+.|+++ .|++++. +
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~ 428 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHH
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHH
Confidence 87 35555332 222345678888888888888777777665 8888888886 6677753 3
Q ss_pred CccccCCCCCCeEEccCCc--ccccCCCCCCC-CCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCC
Q 046275 513 PTWIGQLSNLAILKLSNNS--FYGRIPPELGD-CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589 (1176)
Q Consensus 513 p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~-l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 589 (1176)
+..+..+++|++|+|++|. +++..+..+.. +++|+.|+|++|++++.-.+.+
T Consensus 429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~------------------------- 483 (592)
T 3ogk_B 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF------------------------- 483 (592)
T ss_dssp HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH-------------------------
T ss_pred HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH-------------------------
Confidence 3346668888888887533 55554444443 7788888888888764211110
Q ss_pred CcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccC-CCccccccccceeeecc
Q 046275 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGS-IPKEIGSMSYLFILNLG 668 (1176)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~-iP~~~~~l~~L~~L~L~ 668 (1176)
+..+.+|++|||++|.+++. +|..+..+++|+.|+|+
T Consensus 484 ------------------------------------------~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls 521 (592)
T 3ogk_B 484 ------------------------------------------SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521 (592)
T ss_dssp ------------------------------------------HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEE
T ss_pred ------------------------------------------HhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECc
Confidence 11234688888888888755 44555678889999999
Q ss_pred CccccccCCccc-cCcCcccEEEccCccccccCCCCc-cccccccccccccccccCCCCCC
Q 046275 669 HNNLSGPIPTEV-GDLRGLNILDLSSNRLEGTIPSSM-SSLTLLNEIDLCNNQLTGMIPVM 727 (1176)
Q Consensus 669 ~N~l~g~iP~~~-~~L~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~l~ls~N~l~g~~p~~ 727 (1176)
+|++++.-...+ ..++.|....+..++-....|..- ......+.+. .+|.+.|..|..
T Consensus 522 ~n~it~~~~~~l~~~~p~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~g~~~~~ 581 (592)
T 3ogk_B 522 GYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHIL-AYYSLAGQRTDC 581 (592)
T ss_dssp SCBCCTTCTTGGGGCCTTEEEEEECCC---------------CCCEEE-EEECTTCSCSCC
T ss_pred CCcCCHHHHHHHHHhCCCcEEEEecCccccccccccCCcCCcchhheE-eeeecCCCccCC
Confidence 999886533333 356777666666543321111110 1111222232 356677777654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-28 Score=275.69 Aligned_cols=218 Identities=25% Similarity=0.243 Sum_probs=100.3
Q ss_pred CCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEE
Q 046275 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379 (1176)
Q Consensus 300 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 379 (1176)
+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ |..+++|++|+|++|.+++. + ..++|++|
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L 104 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQEL-L----VGPSIETL 104 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEE-E----ECTTCCEE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccc-c----CCCCcCEE
Confidence 3444444444444444444445555555555555555542222 34445555555555554421 1 12445555
Q ss_pred EccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeeccccc
Q 046275 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459 (1176)
Q Consensus 380 ~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 459 (1176)
++++|++++..+. .+++|++|++++|++++..+..+..+++|++|+|++|++++..|..+.
T Consensus 105 ~l~~n~l~~~~~~-----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-------------- 165 (317)
T 3o53_A 105 HAANNNISRVSCS-----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA-------------- 165 (317)
T ss_dssp ECCSSCCSEEEEC-----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGG--------------
T ss_pred ECCCCccCCcCcc-----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHh--------------
Confidence 5555554432211 123344444444444444444444444444444444444433333331
Q ss_pred ccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 460 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
..+++|++|+|++|+|++. |. ...+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..
T Consensus 166 ---------~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~ 232 (317)
T 3o53_A 166 ---------ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA 232 (317)
T ss_dssp ---------GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTT
T ss_pred ---------hccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhH
Confidence 2344444444444444432 11 1224555555555555552 3333555555555555555555 34555
Q ss_pred CCCCCCCCEEEccCCCCc
Q 046275 540 LGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~ 557 (1176)
+..+++|+.|+|++|+++
T Consensus 233 ~~~l~~L~~L~l~~N~~~ 250 (317)
T 3o53_A 233 LRFSQNLEHFDLRGNGFH 250 (317)
T ss_dssp CCCCTTCCEEECTTCCCB
T ss_pred hhcCCCCCEEEccCCCcc
Confidence 555555555555555555
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-27 Score=281.85 Aligned_cols=234 Identities=25% Similarity=0.183 Sum_probs=167.5
Q ss_pred CccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecc
Q 046275 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480 (1176)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 480 (1176)
+|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|++|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45555555555555555566666666666666666665444 6666667777777776663322 2677777777
Q ss_pred cccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCC-CCCCCCEEEccCCCCccc
Q 046275 481 FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELG-DCRSLIWLDLNTNLFNGS 559 (1176)
Q Consensus 481 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~ 559 (1176)
+|.|++..+.. +++|+.|+|++|.+++..|..++.+++|++|+|++|.+++.+|..+. .+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 77777655543 46677777777777777777777777788888888887777777765 677888888888877642
Q ss_pred CChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCcc
Q 046275 560 IPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMM 639 (1176)
Q Consensus 560 ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 639 (1176)
|. ...+++|+
T Consensus 185 -~~---------------------------------------------------------------------~~~l~~L~ 194 (487)
T 3oja_A 185 -KG---------------------------------------------------------------------QVVFAKLK 194 (487)
T ss_dssp -EC---------------------------------------------------------------------CCCCTTCC
T ss_pred -cc---------------------------------------------------------------------cccCCCCC
Confidence 10 01134678
Q ss_pred EEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCcccc-ccCCCCccccccccccccc
Q 046275 640 FLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLE-GTIPSSMSSLTLLNEIDLC 716 (1176)
Q Consensus 640 ~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~-g~iP~~l~~l~~L~~l~ls 716 (1176)
+|||++|+|++ +|..++.+++|+.|+|++|+|++ +|..++.+++|+.|+|++|.+. +.+|..+..++.|+.++++
T Consensus 195 ~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 195 TLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp EEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred EEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 88888888886 44558888888899999998884 7888888888999999999888 7788888888888888886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=289.38 Aligned_cols=185 Identities=19% Similarity=0.091 Sum_probs=130.5
Q ss_pred eEeEeCceEEEEEEE-CCCCEEEEEEeeccCC----------cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 867 LIGSGGFGDVYKAKL-KDGSTVAIKKLIHISG----------QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 867 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
..+.|++|.+..++. -.|+.+++|.+.+... ...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 345667776666543 3589999999864321 1224689999999999 799999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||++||+|.+++...+ +++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998765 45553 4889999999999999 99999999999999999999999999998665
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCC
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 1064 (1176)
.... .....+||+.|||||++.+ .+..++|+||+|++.+++.++..|
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 2345689999999999976 467789999999998887666544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=279.36 Aligned_cols=216 Identities=26% Similarity=0.246 Sum_probs=123.7
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|++|+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 366777777777766656667777777777777777664433 5566666666666666663221 25566666
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 460 (1176)
+++|.+++..+. .+++|+.|+|++|.+++..|..++++++|++|+|++|.++
T Consensus 106 L~~N~l~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~----------------------- 157 (487)
T 3oja_A 106 AANNNISRVSCS-----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID----------------------- 157 (487)
T ss_dssp CCSSCCCCEEEC-----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC-----------------------
T ss_pred CcCCcCCCCCcc-----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC-----------------------
Confidence 666666543222 1234555555555555444444444455555555555544
Q ss_pred cCCCCCCCC-CccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 461 HGEIPPELG-NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 461 ~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
+..|..+. .+++|++|+|++|.|++..+ +..+++|+.|+|++|+|++ +|..++.+++|+.|+|++|.+++ +|..
T Consensus 158 -~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~ 232 (487)
T 3oja_A 158 -TVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA 232 (487)
T ss_dssp -EEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred -CcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchh
Confidence 44444443 45555555555555554322 2235666666666666664 33346666666666666666663 5666
Q ss_pred CCCCCCCCEEEccCCCCc
Q 046275 540 LGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~ 557 (1176)
+..+++|+.|++++|++.
T Consensus 233 l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 233 LRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CCCCTTCCEEECTTCCBC
T ss_pred hccCCCCCEEEcCCCCCc
Confidence 666667777777777766
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-29 Score=309.50 Aligned_cols=453 Identities=17% Similarity=0.162 Sum_probs=215.3
Q ss_pred CCcccceeEeCCCcEEEEecCCccccccchhhhhhhcCcccccccccCCCCCCCcccC-C------------CCCccccC
Q 046275 54 NPCGFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNSNISGTISL-P------------AGSRCSSF 120 (1176)
Q Consensus 54 ~cC~W~gv~C~~~~v~~l~L~~~~~~~~~~~~~~~l~~~~~L~~L~L~~n~l~g~~~~-~------------~~~~~~~~ 120 (1176)
-|++|.++ ....+..+++..... ......+..++.|++|+|+++.......+ | .....+++
T Consensus 33 vck~W~~~--~~~~~~~l~~~~~~~----~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~ 106 (594)
T 2p1m_B 33 VCKSWYEI--ERWCRRKVFIGNCYA----VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTW 106 (594)
T ss_dssp SCHHHHHH--HHHHCCEEEESSTTS----SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHHHHHHh--hhhhceEEeeccccc----cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCC
Confidence 46799998 222455666654221 12345577888999999998763321111 1 11234566
Q ss_pred ccccccCCcccCCCCCcccccC-CCCCCcEEecCCC-CCCccc-cccccccCCCcEEEccCCCCCCCCcc-ccccccCCC
Q 046275 121 LSSLDLSLNILSGPLSDISYLG-SCSSLKVLNLSSN-LLDFSG-REAGSLKLSLEVLDLSYNKISGANVV-PWILFNGCD 196 (1176)
Q Consensus 121 L~~LdLs~N~l~~~~~~~~~l~-~l~~L~~L~Ls~n-~i~~~~-~~~~~~~~~L~~LdLs~N~i~~~~~~-~~~~f~~~~ 196 (1176)
|++|+|++|.+++... ..+. .+++|++|+|++| .++... ......+++|++|+|++|.+++...- -......++
T Consensus 107 L~~L~L~~~~~~~~~~--~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 107 LEEIRLKRMVVTDDCL--ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp CCEEEEESCBCCHHHH--HHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCeEEeeCcEEcHHHH--HHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 7777777776653211 1232 5667777777776 444322 23334566777777777766542211 011223555
Q ss_pred CccEEEeCCCc--ccc--ccc-CCCCCccceeeccCC-cccccCCCccCCCCCcEEEcCCCc-------CCCCcChhhhc
Q 046275 197 ELKQLALKGNK--VTG--DIN-VSKCKNLQFLDVSSN-NFSMAVPSFGDCLALEYLDISANK-------FTGDVGHAISA 263 (1176)
Q Consensus 197 ~L~~L~L~~n~--l~~--~~~-~~~l~~L~~L~Ls~N-~l~~~~~~l~~l~~L~~L~Ls~N~-------l~~~~~~~l~~ 263 (1176)
+|++|++++|. +.. ... +..+++|++|++++| .+++++..+..+++|++|+++.+. +.+ .+..+.+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhc
Confidence 66666666664 111 000 123456666666655 333333334555556666544332 111 2224455
Q ss_pred cccCCeE-eeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccC-CccccCCCCCcEEEccCCcCcccC
Q 046275 264 CEHLSFL-NVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKV-PSRFGSCSSLESFDISSNKFSGEL 341 (1176)
Q Consensus 264 l~~L~~L-~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~i 341 (1176)
+++|+.| .+...... .++ .+...+++|++|+|++|.+++.. +..+..+++|++|++++| +++..
T Consensus 264 ~~~L~~Ls~~~~~~~~------------~l~-~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~ 329 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPA------------YLP-AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAG 329 (594)
T ss_dssp CTTCCEEECCBTCCGG------------GGG-GGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHH
T ss_pred CCCcccccCCcccchh------------hHH-HHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHH
Confidence 5555555 22211100 111 11223455555565555544321 122345555555555555 32111
Q ss_pred CHHHHhcCCCCCEEEccC---------cccCCCCccccc-CCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCcc
Q 046275 342 PIEIFLSMSNLKELVLSF---------NDFTGALPDSLS-NLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL 411 (1176)
Q Consensus 342 ~~~~~~~l~~L~~L~Ls~---------N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~ 411 (1176)
...+...+++|++|++++ +.+++.....+. ++++|+.|+++ .|.
T Consensus 330 l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~--------------------------~~~ 383 (594)
T 2p1m_B 330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYF--------------------------CRQ 383 (594)
T ss_dssp HHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEE--------------------------ESC
T ss_pred HHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHh--------------------------cCC
Confidence 222223455555555522 223221111111 24444444444 444
Q ss_pred ccCCCCcccc-ccccCcEEEcC--C----ccccCC-----CCccccCCCccCeeecccccccCCCCCCCCC-ccccceee
Q 046275 412 LLGSIPSTLS-NCSQLVSLHLS--F----NYLTGT-----IPSSLGSLSKLQDLKLWLNQLHGEIPPELGN-IQTLETLF 478 (1176)
Q Consensus 412 l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~ 478 (1176)
+++..+..+. .+++|+.|+++ + |.+++. ++..+..+++|+.|+|++ .+++..+..++. +++|+.|+
T Consensus 384 l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~ 462 (594)
T 2p1m_B 384 MTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLS 462 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEE
T ss_pred cCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEee
Confidence 4433333332 34555555555 2 333311 111234455566666644 444333333333 55666666
Q ss_pred cccccccCcccccc-ccCCCCCeeeccccccCCCCCc-cccCCCCCCeEEccCCcccccCCCCC-CCCCCCCEEEccCCC
Q 046275 479 LDFNELTGTLPAAL-SNCTNLNWISLSNNHLGGEIPT-WIGQLSNLAILKLSNNSFYGRIPPEL-GDCRSLIWLDLNTNL 555 (1176)
Q Consensus 479 L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~ 555 (1176)
|++|.+++..+..+ .++++|++|+|++|.+++..+. .+..+++|++|++++|+++......+ ..+++|+...+..+.
T Consensus 463 L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 463 VAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp EESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred ccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 66666654444443 4566666666666666433222 23346666666666666643222222 334566555555554
Q ss_pred C
Q 046275 556 F 556 (1176)
Q Consensus 556 l 556 (1176)
.
T Consensus 543 ~ 543 (594)
T 2p1m_B 543 A 543 (594)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-28 Score=299.90 Aligned_cols=449 Identities=18% Similarity=0.161 Sum_probs=241.0
Q ss_pred cEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCC-CccCCCCCcEEEcCC
Q 046275 172 EVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISA 250 (1176)
Q Consensus 172 ~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~ 250 (1176)
..++++.+... .+...+..+++|++|++++|....+..+..- +. ...+....+ ....+++|++|+|++
T Consensus 46 ~~l~~~~~~~~----~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~------~~-~~~~~~~l~~l~~~~~~L~~L~L~~ 114 (594)
T 2p1m_B 46 RKVFIGNCYAV----SPATVIRRFPKVRSVELKGKPHFADFNLVPD------GW-GGYVYPWIEAMSSSYTWLEEIRLKR 114 (594)
T ss_dssp CEEEESSTTSS----CHHHHHHHCTTCCEEEEECSCGGGGGTCSCT------TS-CCBCHHHHHHHHHHCTTCCEEEEES
T ss_pred eEEeecccccc----CHHHHHhhCCCceEEeccCCCchhhcccccc------cc-cchhhHHHHHHHHhCCCCCeEEeeC
Confidence 45666554332 3445567778888888887754322111000 00 000000001 123566777777777
Q ss_pred CcCCCCcChhhh-ccccCCeEeeccc-cccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccc----cCC
Q 046275 251 NKFTGDVGHAIS-ACEHLSFLNVSSN-LFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRF----GSC 324 (1176)
Q Consensus 251 N~l~~~~~~~l~-~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~----~~l 324 (1176)
|.+++..+..+. .+++|++|+|++| .+++ .....+...+++|++|+|++|.+++..+..+ ..+
T Consensus 115 ~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~-----------~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 115 MVVTDDCLELIAKSFKNFKVLVLSSCEGFST-----------DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CBCCHHHHHHHHHHCTTCCEEEEESCEEEEH-----------HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred cEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH-----------HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 777665555554 5677777777776 3331 1122334456777777777777664333322 355
Q ss_pred CCCcEEEccCCc--CcccCCHHHHhcCCCCCEEEccCc-ccCCCCcccccCCCCCCEEEccCCc-------CCCCCCccc
Q 046275 325 SSLESFDISSNK--FSGELPIEIFLSMSNLKELVLSFN-DFTGALPDSLSNLTNLETLDLSSNN-------LSGAIPHNL 394 (1176)
Q Consensus 325 ~~L~~L~Ls~N~--l~~~i~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N~-------l~~~~p~~~ 394 (1176)
++|++|++++|. ++......++..+++|++|+|++| .+++ ++..+.++++|+.|+++.+. +.+ ++..+
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l 261 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVAL 261 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHH
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHH
Confidence 677777777776 221111222344677888888777 4443 56666777777777765443 221 22222
Q ss_pred cCCCCCCccEE-EccCccccCCCCccccccccCcEEEcCCccccCCC-CccccCCCccCeeecccccccCC-CCCCCCCc
Q 046275 395 CQGPRNSLKEL-FLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTI-PSSLGSLSKLQDLKLWLNQLHGE-IPPELGNI 471 (1176)
Q Consensus 395 ~~~~~~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l 471 (1176)
..+++|+.| .+.+... +.++..+..+++|++|+|++|.+++.. +..+..+++|+.|++++| +... ++.....+
T Consensus 262 --~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~ 337 (594)
T 2p1m_B 262 --SGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTC 337 (594)
T ss_dssp --HTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHC
T ss_pred --hcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhC
Confidence 234556666 2332222 234444456677777777777765332 223456677777777766 3321 22222245
Q ss_pred cccceeec---------ccccccCccccccc-cCCCCCeeeccccccCCCCCcccc-CCCCCCeEEcc--C----Ccccc
Q 046275 472 QTLETLFL---------DFNELTGTLPAALS-NCTNLNWISLSNNHLGGEIPTWIG-QLSNLAILKLS--N----NSFYG 534 (1176)
Q Consensus 472 ~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~ 534 (1176)
++|++|++ +.+.+++.....+. ++++|+.|+++.|++++..+..+. .+++|+.|+|+ + |.+++
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 66777766 33455543333333 467777777777777655555554 46777777777 3 44441
Q ss_pred c-----CCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhc
Q 046275 535 R-----IPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERL 609 (1176)
Q Consensus 535 ~-----~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 609 (1176)
. ++..+..+++|+.|+|++ .+++..+..+..
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~------------------------------------------- 453 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT------------------------------------------- 453 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH-------------------------------------------
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHH-------------------------------------------
Confidence 1 111144566777777755 333211111100
Q ss_pred cccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccc-cccccceeeeccCccccccCCc-cccCcCccc
Q 046275 610 SRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSGPIPT-EVGDLRGLN 687 (1176)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~-~~l~~L~~L~L~~N~l~g~iP~-~~~~L~~L~ 687 (1176)
...+|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+
T Consensus 454 ------------------------~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~ 509 (594)
T 2p1m_B 454 ------------------------YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509 (594)
T ss_dssp ------------------------HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSS
T ss_pred ------------------------hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCC
Confidence 12346777777777765544444 5567777777777777544333 344577777
Q ss_pred EEEccCccccccCCCCc-cccccccccccc
Q 046275 688 ILDLSSNRLEGTIPSSM-SSLTLLNEIDLC 716 (1176)
Q Consensus 688 ~L~Ls~N~l~g~iP~~l-~~l~~L~~l~ls 716 (1176)
+|+|++|+++..-...+ ..++.|+...+.
T Consensus 510 ~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~ 539 (594)
T 2p1m_B 510 SLWMSSCSVSFGACKLLGQKMPKLNVEVID 539 (594)
T ss_dssp EEEEESSCCBHHHHHHHHHHCTTEEEEEEC
T ss_pred EEeeeCCCCCHHHHHHHHHhCCCCEEEEec
Confidence 77777777753322222 333444443333
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=241.03 Aligned_cols=152 Identities=24% Similarity=0.214 Sum_probs=91.3
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 483 (1176)
..+..+..++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 3455555555 4454443 456677777777665555566666666666666666665555566666666666666666
Q ss_pred ccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccccc-CCCCCCCCCCCCEEEccCCCCcc
Q 046275 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR-IPPELGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 484 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g 558 (1176)
+++..+..|.++++|++|++++|++++..+..++.+++|++|+|++|++.+. +|..+..+++|+.|+|++|++++
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc
Confidence 6655556666666666666666666655454566666666666666666542 45555555556666665555553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=238.62 Aligned_cols=227 Identities=23% Similarity=0.221 Sum_probs=157.0
Q ss_pred EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC
Q 046275 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384 (1176)
Q Consensus 305 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 384 (1176)
..+..+.++. .+|..+. ++|++|++++|+++ .++...|..+++|++|+|++|.+++..+..+.++++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 3445555554 3444432 35666666666665 444444555666666666666665444445555555555555555
Q ss_pred cCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC-
Q 046275 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE- 463 (1176)
Q Consensus 385 ~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~- 463 (1176)
+++ +..+..|.++++|++|++++|++++..+..++.+++|++|++++|.+++.
T Consensus 87 ~l~--------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 140 (276)
T 2z62_A 87 PIQ--------------------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140 (276)
T ss_dssp CCC--------------------------EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC
T ss_pred ccC--------------------------ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec
Confidence 554 44445566677777777777777765555677777777777777777653
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCC----eeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN----WISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
+|..++++++|++|+|++|++++..+..|..+.+|+ .|++++|++++..+..+ ...+|++|+|++|++++..+..
T Consensus 141 l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~ 219 (276)
T 2z62_A 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGI 219 (276)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTT
T ss_pred CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhH
Confidence 577788888888888888888877777777777777 88999999986555444 4458999999999999666667
Q ss_pred CCCCCCCCEEEccCCCCcccCCh
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~ 562 (1176)
+..+++|+.|+|++|+++|.+|.
T Consensus 220 ~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 220 FDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp TTTCCSCCEEECCSSCBCCCTTT
T ss_pred hcccccccEEEccCCcccccCCc
Confidence 88999999999999999998873
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=238.62 Aligned_cols=139 Identities=24% Similarity=0.231 Sum_probs=74.1
Q ss_pred ccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCC
Q 046275 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499 (1176)
Q Consensus 420 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 499 (1176)
+.++++|++|+|++|++++..+..+..+++|++|++++|++++..+..++.+++|++|+|++|++++..+..|.++++|+
T Consensus 81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 160 (272)
T 3rfs_A 81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160 (272)
T ss_dssp GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence 33444444455554444444444444444555555555555444444455555555555555555544444555555555
Q ss_pred eeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcc
Q 046275 500 WISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 500 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 558 (1176)
+|++++|++++..|..++.+++|++|+|++|++++..|..+..+++|+.|+|++|++.|
T Consensus 161 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 55555555555545555555666666666666655555555556666666666665554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-23 Score=226.14 Aligned_cols=206 Identities=26% Similarity=0.291 Sum_probs=158.0
Q ss_pred CCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEE
Q 046275 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKEL 405 (1176)
Q Consensus 326 ~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L 405 (1176)
+++++++++++++ .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------ 74 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ------------------ 74 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS------------------
T ss_pred CCCEEEccCCCCC-ccCCCC---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC------------------
Confidence 4567777777776 566443 245677777777776555556666666666666666665
Q ss_pred EccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccccc
Q 046275 406 FLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELT 485 (1176)
Q Consensus 406 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 485 (1176)
...+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..|..|+.+++|++|+|++|+|+
T Consensus 75 --------~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 146 (270)
T 2o6q_A 75 --------TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146 (270)
T ss_dssp --------CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred --------eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC
Confidence 223344566677777777777777666666777788888888888888777777888888888888888888
Q ss_pred CccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 486 GTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 486 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
+..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++.+..+
T Consensus 147 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7777778899999999999999997777778899999999999999997666678899999999999999988765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=262.48 Aligned_cols=186 Identities=17% Similarity=0.203 Sum_probs=148.0
Q ss_pred CCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcC--------HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 863 HNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQG--------DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
...+.||+|+||.||+|+. .++.+++|+........ .+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 48899999875432211 23478999999999999999777777788888999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+|+...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 9999999999999999 99999999999775
Q ss_pred cccccc-----cccccccCCcccCccccCC--CCCCchhhhHHHHHHHHHHHcCCCCCC
Q 046275 1015 AMDTHL-----SVSTLAGTPGYVPPEYYQS--FRCSTKGDVYSYGVVLLELLTGKRPTD 1066 (1176)
Q Consensus 1015 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~P~~ 1066 (1176)
..+... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 433211 1235679999999999976 567888999999999999888877763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-23 Score=229.47 Aligned_cols=211 Identities=26% Similarity=0.264 Sum_probs=163.3
Q ss_pred ccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCC
Q 046275 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN 400 (1176)
Q Consensus 321 ~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 400 (1176)
+.++++|+++++++|+++ .+|..++ +++++|+|++|.+++..+..|.++++|++|+|++|.+++ ++
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~--------- 71 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ--------- 71 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE---------
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-cc---------
Confidence 566777888888888876 6775542 567777777777776666777777777777777777652 11
Q ss_pred CccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecc
Q 046275 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480 (1176)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 480 (1176)
. .+.+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 72 -----------------~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~ 132 (290)
T 1p9a_G 72 -----------------V-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (290)
T ss_dssp -----------------C-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred -----------------C-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECC
Confidence 1 145566777777777776 566677777778888888888876666778888888888888
Q ss_pred cccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccC
Q 046275 481 FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSI 560 (1176)
Q Consensus 481 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i 560 (1176)
+|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|++.+..
T Consensus 133 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 88888777778888999999999999999766667788999999999999998 78999999999999999999998765
Q ss_pred ChhHH
Q 046275 561 PPALF 565 (1176)
Q Consensus 561 p~~~~ 565 (1176)
.-..|
T Consensus 212 ~~~~l 216 (290)
T 1p9a_G 212 EILYF 216 (290)
T ss_dssp GGHHH
T ss_pred ccHHH
Confidence 43333
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=233.57 Aligned_cols=205 Identities=21% Similarity=0.248 Sum_probs=98.5
Q ss_pred cCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCC
Q 046275 322 GSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNS 401 (1176)
Q Consensus 322 ~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 401 (1176)
..+++|+.|++++|.++ .++. +..+++|++|++++|.+++. ..+.++++|++|+|++|.+++
T Consensus 38 ~~l~~L~~L~l~~~~i~-~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~------------- 99 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIK-SVQG--IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQS------------- 99 (272)
T ss_dssp HHHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCC-------------
T ss_pred ccccceeeeeeCCCCcc-cccc--cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCc-------------
Confidence 34455555555555554 3321 34455555555555555432 244444555555555554442
Q ss_pred ccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccc
Q 046275 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDF 481 (1176)
Q Consensus 402 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 481 (1176)
..+..+.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..++.+++|++|+|++
T Consensus 100 -------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 166 (272)
T 3rfs_A 100 -------------LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166 (272)
T ss_dssp -------------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred -------------cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCC
Confidence 2223334444444444444444433333444444444444444444444444444455555555555
Q ss_pred ccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 482 NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 482 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
|++++..+..|.++++|++|++++|++++..|..+..+++|++|+|++|.+.+. +++|+.|+++.|.++|.+|
T Consensus 167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 167 NQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBB
T ss_pred CCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCccc
Confidence 555544444445555555555555555544444455555555555555554432 2345555555555555555
Q ss_pred hhH
Q 046275 562 PAL 564 (1176)
Q Consensus 562 ~~~ 564 (1176)
.++
T Consensus 240 ~~~ 242 (272)
T 3rfs_A 240 NSA 242 (272)
T ss_dssp CTT
T ss_pred Ccc
Confidence 544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=9e-24 Score=239.30 Aligned_cols=205 Identities=22% Similarity=0.192 Sum_probs=161.3
Q ss_pred CccCeeecccccccCCCCCCC--CCccccceeecccccccCccc----cccccCCCCCeeeccccccCCCCCccccCCCC
Q 046275 448 SKLQDLKLWLNQLHGEIPPEL--GNIQTLETLFLDFNELTGTLP----AALSNCTNLNWISLSNNHLGGEIPTWIGQLSN 521 (1176)
Q Consensus 448 ~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 521 (1176)
++|++|++++|.+.+..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..++.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 457777777777777777766 777777788888887776544 34567889999999999998888888999999
Q ss_pred CCeEEccCCccccc--C--CCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCC
Q 046275 522 LAILKLSNNSFYGR--I--PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGN 597 (1176)
Q Consensus 522 L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (1176)
|++|+|++|++.+. + +..++.+++|++|+|++|+++. +|.....
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~------------------------------- 218 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAA------------------------------- 218 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHH-------------------------------
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHH-------------------------------
Confidence 99999999988652 2 3345788999999999999862 2221100
Q ss_pred chhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCcccccc---ccceeeeccCccccc
Q 046275 598 LLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSM---SYLFILNLGHNNLSG 674 (1176)
Q Consensus 598 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l---~~L~~L~L~~N~l~g 674 (1176)
.+..+.+|++||||+|+|++.+|..++.+ ++|+.|+|++|+|+
T Consensus 219 ---------------------------------l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~- 264 (310)
T 4glp_A 219 ---------------------------------LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE- 264 (310)
T ss_dssp ---------------------------------HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-
T ss_pred ---------------------------------HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-
Confidence 01123468899999999999889988887 69999999999999
Q ss_pred cCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccC
Q 046275 675 PIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTG 722 (1176)
Q Consensus 675 ~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g 722 (1176)
.+|..+. ++|++|||++|+|++ +|. +..+++|+.|+|++|+|+.
T Consensus 265 ~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 265 QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence 8898885 899999999999995 454 6788999999999999974
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-24 Score=252.65 Aligned_cols=255 Identities=22% Similarity=0.187 Sum_probs=130.6
Q ss_pred EEccCCcccccCCccccCCCCCcEEEccCCcCcccCCH----HHHhcCC-CCCEEEccCcccCCCCcccccCC-----CC
Q 046275 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPI----EIFLSMS-NLKELVLSFNDFTGALPDSLSNL-----TN 375 (1176)
Q Consensus 306 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 375 (1176)
++++.|++++.+|..+...++|++|+|++|.++ .++. +.|..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 445555555555555555555666666666655 3443 3445555 56666666666655544444443 55
Q ss_pred CCEEEccCCcCCCCCCccccCC--CC-CCccEEEccCccccCCCCcccc----c-cccCcEEEcCCccccCCC----Ccc
Q 046275 376 LETLDLSSNNLSGAIPHNLCQG--PR-NSLKELFLQNNLLLGSIPSTLS----N-CSQLVSLHLSFNYLTGTI----PSS 443 (1176)
Q Consensus 376 L~~L~Ls~N~l~~~~p~~~~~~--~~-~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~Ls~N~l~~~~----p~~ 443 (1176)
|++|+|++|.+++..+..++.. .. ++|++|+|++|.+++..+..+. . .++|++|+|++|++++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 6666666666554443322111 11 3455555555555544333322 2 246666666666665322 222
Q ss_pred ccCCC-ccCeeecccccccCCCCCCCCC----c-cccceeecccccccCc----ccccccc-CCCCCeeeccccccCCCC
Q 046275 444 LGSLS-KLQDLKLWLNQLHGEIPPELGN----I-QTLETLFLDFNELTGT----LPAALSN-CTNLNWISLSNNHLGGEI 512 (1176)
Q Consensus 444 ~~~l~-~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~ 512 (1176)
+..++ +|++|+|++|++++..+..+.. + ++|++|+|++|+|++. ++..+.. .++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 33333 5666666666555444433332 2 3566666666666532 3344444 236666666666666443
Q ss_pred C----ccccCCCCCCeEEccCCcccc-------cCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 513 P----TWIGQLSNLAILKLSNNSFYG-------RIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 513 p----~~~~~l~~L~~L~L~~N~l~~-------~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
+ ..+..+++|++|+|++|.+.+ .++..+..+++|+.||+++|++.+..|
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3 223445566666666665322 223355556666666666666654433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=227.40 Aligned_cols=202 Identities=27% Similarity=0.294 Sum_probs=139.5
Q ss_pred hcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCC
Q 046275 298 DLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE 377 (1176)
Q Consensus 298 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 377 (1176)
..+++++++++++|+++ .+|..+. ++|++|+|++|.++ .++...|..+++|++|+|++|.+++. +. ...+++|+
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~ 80 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLG 80 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCC
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCC-ccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCC
Confidence 34678999999999999 5676654 78999999999998 66667789999999999999999964 33 27788888
Q ss_pred EEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeeccc
Q 046275 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457 (1176)
Q Consensus 378 ~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 457 (1176)
+|+|++|+++ .+|. .+..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 81 ~L~Ls~N~l~-~l~~--------------------------~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPL--------------------------LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp EEECCSSCCS-SCCC--------------------------CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred EEECCCCcCC-cCch--------------------------hhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 8888888876 4443 334445555555555555544445555555555555555
Q ss_pred ccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccc
Q 046275 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 458 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 533 (1176)
|++++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 5555444455556666666666666666544555566666666666666666 55666666666666777666664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-22 Score=221.98 Aligned_cols=204 Identities=28% Similarity=0.340 Sum_probs=152.8
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD 380 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 380 (1176)
.+.+.+++++++++ .+|..+. ++|++|+|++|+++ .++...|..+++|++|+|++|.++...+..|.++++|++|+
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~ 91 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW 91 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence 46899999999999 5776654 68999999999998 77877789999999999999999976666678899999999
Q ss_pred ccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccc
Q 046275 381 LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQL 460 (1176)
Q Consensus 381 Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 460 (1176)
|++|++++..+ ..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+
T Consensus 92 l~~n~l~~~~~--------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 92 VTDNKLQALPI--------------------------GVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp CCSSCCCCCCT--------------------------TTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcCCcCCH--------------------------hHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcC
Confidence 99988873222 2344455666666666666655555566666666666666666
Q ss_pred cCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc
Q 046275 461 HGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534 (1176)
Q Consensus 461 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 534 (1176)
++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.+..
T Consensus 146 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 146 QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 65555556677777777777777776666667777777777777777776656667777888888888887753
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-24 Score=250.83 Aligned_cols=177 Identities=23% Similarity=0.234 Sum_probs=96.7
Q ss_pred EEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCC----ccccccc-cCcEEEcCCccccCCCCccccCC-----C
Q 046275 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP----STLSNCS-QLVSLHLSFNYLTGTIPSSLGSL-----S 448 (1176)
Q Consensus 379 L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~ 448 (1176)
++|++|.+++.+|..+ ....+|++|+|++|.+++..+ ..+.+++ +|++|+|++|++++..+..+..+ +
T Consensus 3 ~~ls~n~~~~~~~~~~--~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFT--SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EECCCCTTCCHHHHHH--TSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred cccccccchHHHHHHH--hCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 5666666666665544 223446666666666665544 4555555 66666666666665555555443 5
Q ss_pred ccCeeecccccccCCCCCCCCCc-----cccceeecccccccCcccccccc-----CCCCCeeeccccccCCCCCc----
Q 046275 449 KLQDLKLWLNQLHGEIPPELGNI-----QTLETLFLDFNELTGTLPAALSN-----CTNLNWISLSNNHLGGEIPT---- 514 (1176)
Q Consensus 449 ~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~---- 514 (1176)
+|++|+|++|.+++..+..+... ++|++|+|++|+|++..+..+.. .++|++|+|++|++++..+.
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 66666666666665544433332 55666666666665544444332 24566666666666543222
Q ss_pred cccCCC-CCCeEEccCCcccccCCCCCC----CC-CCCCEEEccCCCCc
Q 046275 515 WIGQLS-NLAILKLSNNSFYGRIPPELG----DC-RSLIWLDLNTNLFN 557 (1176)
Q Consensus 515 ~~~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~ 557 (1176)
.+..++ +|++|+|++|++++..+..+. .+ ++|+.|||++|.++
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCC
Confidence 223333 566666666666544443222 22 35666666666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.8e-25 Score=255.95 Aligned_cols=248 Identities=21% Similarity=0.184 Sum_probs=178.7
Q ss_pred CCCccccccccCcEEEcCCccccCCCC----ccccCCCccCeeecccc---cccCCCCCCC-------CCccccceeecc
Q 046275 415 SIPSTLSNCSQLVSLHLSFNYLTGTIP----SSLGSLSKLQDLKLWLN---QLHGEIPPEL-------GNIQTLETLFLD 480 (1176)
Q Consensus 415 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~ 480 (1176)
.++..+..+++|++|+|++|++++..+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 345556666777777777777765422 33556777777777764 3444555444 567788888888
Q ss_pred cccccC----ccccccccCCCCCeeeccccccCCCCCccccC----C---------CCCCeEEccCCccc-ccCC---CC
Q 046275 481 FNELTG----TLPAALSNCTNLNWISLSNNHLGGEIPTWIGQ----L---------SNLAILKLSNNSFY-GRIP---PE 539 (1176)
Q Consensus 481 ~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~l~-~~~p---~~ 539 (1176)
+|.+++ .+|..+.++++|++|+|++|.+++..+..+.. + ++|++|+|++|+++ +.+| ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 888876 46777788888888888888876444433333 3 78888888888886 3444 45
Q ss_pred CCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCc
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCN 619 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 619 (1176)
+..+++|+.|+|++|+++..=-..+.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~------------------------------------------------------ 208 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLL------------------------------------------------------ 208 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHH------------------------------------------------------
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHH------------------------------------------------------
Confidence 66788888888888887620000000
Q ss_pred cccccCCCCCCCcCCCCCccEEEcccCcCc----cCCCccccccccceeeeccCcccccc----CCccc--cCcCcccEE
Q 046275 620 FTRVYGGHTQPTFNHNGSMMFLDISYNMLS----GSIPKEIGSMSYLFILNLGHNNLSGP----IPTEV--GDLRGLNIL 689 (1176)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~----g~iP~~~~~l~~L~~L~L~~N~l~g~----iP~~~--~~L~~L~~L 689 (1176)
...+..+.+|++|+|++|.++ +.+|..+..+++|+.|+|++|++++. +|..+ +.+++|++|
T Consensus 209 ---------~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L 279 (386)
T 2ca6_A 209 ---------LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279 (386)
T ss_dssp ---------HTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEE
T ss_pred ---------HHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEE
Confidence 001234457888999999986 67888899999999999999999876 67777 458999999
Q ss_pred EccCccccc----cCCCCc-cccccccccccccccccCCCC
Q 046275 690 DLSSNRLEG----TIPSSM-SSLTLLNEIDLCNNQLTGMIP 725 (1176)
Q Consensus 690 ~Ls~N~l~g----~iP~~l-~~l~~L~~l~ls~N~l~g~~p 725 (1176)
+|++|++++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 280 ~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp ECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred ECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 999999997 588888 668999999999999998776
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=229.49 Aligned_cols=227 Identities=22% Similarity=0.226 Sum_probs=178.8
Q ss_pred CCcEEEccCCcCcccCCHHH--HhcCCCCCEEEccCcccCCCCcccc--cCCCCCCEEEccCCcCCCCCCc--cccCCCC
Q 046275 326 SLESFDISSNKFSGELPIEI--FLSMSNLKELVLSFNDFTGALPDSL--SNLTNLETLDLSSNNLSGAIPH--NLCQGPR 399 (1176)
Q Consensus 326 ~L~~L~Ls~N~l~~~i~~~~--~~~l~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p~--~~~~~~~ 399 (1176)
.++.|.+.++.++...-..+ +..+++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+. ......+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 46667777766642111111 2235679999999999988888887 8889999999999998876552 1111346
Q ss_pred CCccEEEccCccccCCCCccccccccCcEEEcCCccccCC--C--CccccCCCccCeeecccccccCCCCC----CCCCc
Q 046275 400 NSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGT--I--PSSLGSLSKLQDLKLWLNQLHGEIPP----ELGNI 471 (1176)
Q Consensus 400 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 471 (1176)
++|++|+|++|++++..|..++++++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .+|. .++.+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 7899999999999888888999999999999999998642 2 234578899999999999997 3333 25678
Q ss_pred cccceeecccccccCccccccccC---CCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCE
Q 046275 472 QTLETLFLDFNELTGTLPAALSNC---TNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIW 548 (1176)
Q Consensus 472 ~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 548 (1176)
++|++|+|++|+|++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|++++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 999999999999998878888777 69999999999999 7788775 7999999999999953 44 678899999
Q ss_pred EEccCCCCcc
Q 046275 549 LDLNTNLFNG 558 (1176)
Q Consensus 549 L~L~~N~l~g 558 (1176)
|+|++|+++.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=217.35 Aligned_cols=131 Identities=17% Similarity=0.174 Sum_probs=77.4
Q ss_pred cCcEEEcCCccccCCCCccccCCCccCeeeccccc-ccCCCCCCCCCccccceeeccc-ccccCccccccccCCCCCeee
Q 046275 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ-LHGEIPPELGNIQTLETLFLDF-NELTGTLPAALSNCTNLNWIS 502 (1176)
Q Consensus 425 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 502 (1176)
+|++|++++|++++..+..|..+++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 55566666666654444455555666666666654 5544444555666666666665 666655555666666666666
Q ss_pred ccccccCCCCCccccCCCCCC---eEEccCC-cccccCCCCCCCCCCCC-EEEccCCCCc
Q 046275 503 LSNNHLGGEIPTWIGQLSNLA---ILKLSNN-SFYGRIPPELGDCRSLI-WLDLNTNLFN 557 (1176)
Q Consensus 503 Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~ 557 (1176)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 66666663 444 55566665 6666666 66544445566666666 6666666655
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.6e-22 Score=216.15 Aligned_cols=205 Identities=22% Similarity=0.268 Sum_probs=154.6
Q ss_pred ccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc-ccCccccccccCCCCCeeeccc-cccCCCCC
Q 046275 436 LTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE-LTGTLPAALSNCTNLNWISLSN-NHLGGEIP 513 (1176)
Q Consensus 436 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p 513 (1176)
++ .+|. +. ++|++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 55 5666 43 378889999998887777788888888999998887 8866667888888888888888 88887666
Q ss_pred ccccCCCCCCeEEccCCcccccCCCCCCCCCCCC---EEEccCC-CCcccCChhHHhhcccchhhhccccceeeeecCCC
Q 046275 514 TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI---WLDLNTN-LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589 (1176)
Q Consensus 514 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 589 (1176)
..|..+++|++|++++|++++ +|. +..+++|+ .|++++| .+++ +|+..
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~-i~~~~------------------------- 150 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTS-IPVNA------------------------- 150 (239)
T ss_dssp TSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCE-ECTTT-------------------------
T ss_pred HHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhh-cCccc-------------------------
Confidence 788888888888888888885 666 77888887 8888888 6653 33221
Q ss_pred CcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCcc-EEEcccCcCccCCCccccccccceeeecc
Q 046275 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMM-FLDISYNMLSGSIPKEIGSMSYLFILNLG 668 (1176)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~LdLs~N~l~g~iP~~~~~l~~L~~L~L~ 668 (1176)
|..+.+|+ +|+|++|+++ .+|......++|+.|+|+
T Consensus 151 ------------------------------------------~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 151 ------------------------------------------FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp ------------------------------------------TTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred ------------------------------------------ccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 22345677 8888888888 566554444788888888
Q ss_pred Ccc-ccccCCccccCc-CcccEEEccCccccccCCCCccccccccccccccc
Q 046275 669 HNN-LSGPIPTEVGDL-RGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNN 718 (1176)
Q Consensus 669 ~N~-l~g~iP~~~~~L-~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N 718 (1176)
+|+ +++..|..|+.+ ++|+.|||++|+|+ .+|.. .+.+|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 884 885556678888 88888888888887 56655 5667777777765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-21 Score=211.83 Aligned_cols=182 Identities=23% Similarity=0.245 Sum_probs=160.1
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeee
Q 046275 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLK 454 (1176)
Q Consensus 375 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 454 (1176)
..++++++++.++ .+|..+ .++++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 89 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGI----PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG 89 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCC----CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCeEEecCCCCcc-ccCCCC----CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEE
Confidence 4567777777776 566544 24688888888888877788889999999999999999988888899999999999
Q ss_pred cccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc
Q 046275 455 LWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534 (1176)
Q Consensus 455 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 534 (1176)
|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+.+++|++|+|++|++++
T Consensus 90 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 169 (251)
T 3m19_A 90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS 169 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence 99999998888889999999999999999998778889999999999999999997777789999999999999999998
Q ss_pred cCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 535 RIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 535 ~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
..|..+..+++|+.|+|++|++++..+
T Consensus 170 ~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 170 VPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred cCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 777889999999999999999998733
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-23 Score=236.53 Aligned_cols=230 Identities=17% Similarity=0.233 Sum_probs=155.2
Q ss_pred ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC-CCCCCCCccccceeecccccccCccccccccCCCCCeee
Q 046275 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE-IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWIS 502 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 502 (1176)
++++.|++++|.+++..+. +..+++|++|++++|.+++. +|..+..+++|++|+|++|++++..|..+.++++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4555666666665544333 34556666666666665544 555566666667777777766666666677777777777
Q ss_pred cccc-ccCCC-CCccccCCCCCCeEEccCC-ccccc-CCCCCCCCC-CCCEEEccCCC--Cc-ccCChhHHhhcccchhh
Q 046275 503 LSNN-HLGGE-IPTWIGQLSNLAILKLSNN-SFYGR-IPPELGDCR-SLIWLDLNTNL--FN-GSIPPALFKQSGKIAAN 574 (1176)
Q Consensus 503 Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~L~~N~--l~-g~ip~~~~~~~~~l~~~ 574 (1176)
|++| .+++. +|..+..+++|++|++++| .+++. +|..+..++ +|+.|+|++|. ++ +.+|..
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~----------- 217 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL----------- 217 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHH-----------
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHH-----------
Confidence 7777 55542 5555667777777777777 77643 455666777 78888887773 33 122211
Q ss_pred hccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCc-CccCCC
Q 046275 575 FIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNM-LSGSIP 653 (1176)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~-l~g~iP 653 (1176)
+..+++|+.|+|++|. +++..|
T Consensus 218 ---------------------------------------------------------~~~~~~L~~L~l~~~~~l~~~~~ 240 (336)
T 2ast_B 218 ---------------------------------------------------------VRRCPNLVHLDLSDSVMLKNDCF 240 (336)
T ss_dssp ---------------------------------------------------------HHHCTTCSEEECTTCTTCCGGGG
T ss_pred ---------------------------------------------------------HhhCCCCCEEeCCCCCcCCHHHH
Confidence 1122468888999888 777788
Q ss_pred ccccccccceeeeccCcc-ccccCCccccCcCcccEEEccCccccccCCC-Cccccc-cccccccccccccCCCCCC
Q 046275 654 KEIGSMSYLFILNLGHNN-LSGPIPTEVGDLRGLNILDLSSNRLEGTIPS-SMSSLT-LLNEIDLCNNQLTGMIPVM 727 (1176)
Q Consensus 654 ~~~~~l~~L~~L~L~~N~-l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~-~l~~l~-~L~~l~ls~N~l~g~~p~~ 727 (1176)
..++.+++|+.|+|++|. ++......++++++|+.|+|++| +|. .+..+. .|..|++++|+++|..|..
T Consensus 241 ~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-----i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 241 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-----VPDGTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp GGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-----SCTTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred HHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-----cCHHHHHHHHhhCcceEEecccCccccCCc
Confidence 888999999999999995 32222236888999999999998 443 456664 4889999999999998853
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.7e-24 Score=249.73 Aligned_cols=241 Identities=25% Similarity=0.277 Sum_probs=163.8
Q ss_pred cCCCccEEEccCCccccc----CCccccCCCCCcEEEccCC---cCcccCCHHH------HhcCCCCCEEEccCcccCC-
Q 046275 299 LCSSLVKLDLSSNNLSGK----VPSRFGSCSSLESFDISSN---KFSGELPIEI------FLSMSNLKELVLSFNDFTG- 364 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~i~~~~------~~~l~~L~~L~Ls~N~l~~- 364 (1176)
.+++|++|+|++|++++. ++..+..+++|++|+|++| ++++.+|..+ +..+++|++|+|++|.+++
T Consensus 30 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 109 (386)
T 2ca6_A 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 109 (386)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHH
Confidence 356777777777777654 3334666777777777774 3344455443 3456666666666666665
Q ss_pred ---CCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcccccc---------ccCcEEEcC
Q 046275 365 ---ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNC---------SQLVSLHLS 432 (1176)
Q Consensus 365 ---~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l---------~~L~~L~Ls 432 (1176)
.+|..+.++++|++|+|++|.+++..+..+ +..+..+ ++|++|+|+
T Consensus 110 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l----------------------~~~l~~l~~~~~~~~~~~L~~L~L~ 167 (386)
T 2ca6_A 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI----------------------ARALQELAVNKKAKNAPPLRSIICG 167 (386)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHH----------------------HHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred HHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHH----------------------HHHHHHHhhhhhcccCCCCcEEECC
Confidence 245556666666666666666643222222 1222222 677777777
Q ss_pred Ccccc-CCCC---ccccCCCccCeeecccccccC-----CCCCCCCCccccceeeccccccc----CccccccccCCCCC
Q 046275 433 FNYLT-GTIP---SSLGSLSKLQDLKLWLNQLHG-----EIPPELGNIQTLETLFLDFNELT----GTLPAALSNCTNLN 499 (1176)
Q Consensus 433 ~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~ 499 (1176)
+|+++ +.+| ..+..+++|+.|+|++|+++. ..|..+..+++|++|+|++|.|+ +.+|..+..+++|+
T Consensus 168 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~ 247 (386)
T 2ca6_A 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247 (386)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred CCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence 77775 3344 355667777777777777762 34447778888888888888885 56788888888999
Q ss_pred eeeccccccCCC----CCccc--cCCCCCCeEEccCCcccc----cCCCCC-CCCCCCCEEEccCCCCcccCC
Q 046275 500 WISLSNNHLGGE----IPTWI--GQLSNLAILKLSNNSFYG----RIPPEL-GDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 500 ~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~g~ip 561 (1176)
+|+|++|++++. +|..+ +.+++|++|+|++|.+++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 999999988765 56666 348899999999999987 477777 568999999999999987665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-21 Score=209.64 Aligned_cols=89 Identities=24% Similarity=0.206 Sum_probs=51.1
Q ss_pred CccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccc
Q 046275 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLC 716 (1176)
Q Consensus 637 ~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls 716 (1176)
+|++|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+..+++|+.|+|+
T Consensus 108 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 187 (251)
T 3m19_A 108 QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187 (251)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 44555555555554444445556666666666666664444456666666666666666665545556666666666666
Q ss_pred cccccCCCC
Q 046275 717 NNQLTGMIP 725 (1176)
Q Consensus 717 ~N~l~g~~p 725 (1176)
+|++++..+
T Consensus 188 ~N~~~c~~~ 196 (251)
T 3m19_A 188 GNQFDCSRC 196 (251)
T ss_dssp SCCBCTTST
T ss_pred CCceeCCcc
Confidence 666665533
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=237.51 Aligned_cols=189 Identities=27% Similarity=0.335 Sum_probs=121.5
Q ss_pred cCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecc
Q 046275 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 425 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 504 (1176)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+++ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 56666666666664 454442 55666666666666 455 335666666666666664 444 444 67777777
Q ss_pred ccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeee
Q 046275 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYI 584 (1176)
Q Consensus 505 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~ 584 (1176)
+|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|++++ +|. |
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~--l------------------- 178 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE--L------------------- 178 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--C-------------------
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch--h-------------------
Confidence 777764 554 46677777777777764 554 45667777777777664 443 1
Q ss_pred ecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccc--
Q 046275 585 KNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYL-- 662 (1176)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L-- 662 (1176)
. .+|++|||++|+|+ .+|. |+. +|
T Consensus 179 ------------------------------------------------~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~ 204 (571)
T 3cvr_A 179 ------------------------------------------------P--ESLEALDVSTNLLE-SLPA-VPV--RNHH 204 (571)
T ss_dssp ------------------------------------------------C--TTCCEEECCSSCCS-SCCC-CC-------
T ss_pred ------------------------------------------------h--CCCCEEECcCCCCC-chhh-HHH--hhhc
Confidence 0 24666777777777 5666 554 56
Q ss_pred -----eeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccc
Q 046275 663 -----FILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTL 709 (1176)
Q Consensus 663 -----~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~ 709 (1176)
+.|+|++|+|+ .||..++.+++|+.|+|++|+|+|.+|..+..++.
T Consensus 205 ~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp ---CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred ccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 77888888887 67877777888888888888888888877776654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=218.63 Aligned_cols=193 Identities=19% Similarity=0.264 Sum_probs=98.0
Q ss_pred CCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccc
Q 046275 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQ 221 (1176)
Q Consensus 142 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~ 221 (1176)
..+++|++|++++|.|+.++ .+..+++|++|+|++|+++++ +. |..+++|++|+|++|.+++...+..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~---~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~ 110 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDL---AP--LKNLTKITELELSGNPLKNVSAIAGLQSIK 110 (308)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC---GG--GTTCCSCCEEECCSCCCSCCGGGTTCTTCC
T ss_pred HHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCC---hh--HccCCCCCEEEccCCcCCCchhhcCCCCCC
Confidence 34445555555555555443 234445555555555555542 21 344444444444444444433344444555
Q ss_pred eeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCC
Q 046275 222 FLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS 301 (1176)
Q Consensus 222 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~ 301 (1176)
+|++++|+++++++ +..+++|++|++++|++++..+ +..++
T Consensus 111 ~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~------------------------------------ 151 (308)
T 1h6u_A 111 TLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLT------------------------------------ 151 (308)
T ss_dssp EEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCT------------------------------------
T ss_pred EEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCC------------------------------------
Confidence 55555555544322 4445555555555555544332 44444
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
+|++|+|++|++++.. . +..+++|++|++++|+++ .++. +..+++|++|+|++|.+++.. .+..+++|+.|+|
T Consensus 152 ~L~~L~l~~n~l~~~~-~-l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l 224 (308)
T 1h6u_A 152 NLQYLSIGNAQVSDLT-P-LANLSKLTTLKADDNKIS-DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTL 224 (308)
T ss_dssp TCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEE
T ss_pred CccEEEccCCcCCCCh-h-hcCCCCCCEEECCCCccC-cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEc
Confidence 4444555555444322 2 555566666666666665 3332 455666666666666666433 2566666666666
Q ss_pred cCCcCC
Q 046275 382 SSNNLS 387 (1176)
Q Consensus 382 s~N~l~ 387 (1176)
++|+++
T Consensus 225 ~~N~i~ 230 (308)
T 1h6u_A 225 TNQTIT 230 (308)
T ss_dssp EEEEEE
T ss_pred cCCeee
Confidence 666665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=222.05 Aligned_cols=223 Identities=18% Similarity=0.200 Sum_probs=125.0
Q ss_pred cCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCC-CCCCCccccce-eecccccccCccccccccCCCCCeee
Q 046275 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIP-PELGNIQTLET-LFLDFNELTGTLPAALSNCTNLNWIS 502 (1176)
Q Consensus 425 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~ 502 (1176)
++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|.+ +.++.|+|++..|..|.++++|++|+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence 44444455554443223344455555555555555443333 23455555443 44455666655566666666666666
Q ss_pred ccccccCCCCCccccCCCCCCeEEccC-CcccccCCCCCCCCC-CCCEEEccCCCCcccCChhHHhhcccchhhhccccc
Q 046275 503 LSNNHLGGEIPTWIGQLSNLAILKLSN-NSFYGRIPPELGDCR-SLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKK 580 (1176)
Q Consensus 503 Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~ 580 (1176)
+++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+++ .||+..|.
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~-------------- 175 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN-------------- 175 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSST--------------
T ss_pred ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhcc--------------
Confidence 666666655555555555666666644 445544444555553 4667777777776 34433321
Q ss_pred eeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEccc-CcCccCCC-ccccc
Q 046275 581 YVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY-NMLSGSIP-KEIGS 658 (1176)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~-N~l~g~iP-~~~~~ 658 (1176)
..+|+.|++++ |.++ .|| ..|++
T Consensus 176 ------------------------------------------------------~~~L~~l~l~~~n~l~-~i~~~~f~~ 200 (350)
T 4ay9_X 176 ------------------------------------------------------GTQLDELNLSDNNNLE-ELPNDVFHG 200 (350)
T ss_dssp ------------------------------------------------------TEEEEEEECTTCTTCC-CCCTTTTTT
T ss_pred ------------------------------------------------------ccchhHHhhccCCccc-CCCHHHhcc
Confidence 12356677764 4444 455 45677
Q ss_pred cccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccccccccccccccc
Q 046275 659 MSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721 (1176)
Q Consensus 659 l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~ 721 (1176)
+++|+.|+|++|+|+ .+|.. .+.+|+.|.+.++.--..+|. +.++++|+.++++++.-+
T Consensus 201 l~~L~~LdLs~N~l~-~lp~~--~~~~L~~L~~l~~~~l~~lP~-l~~l~~L~~l~l~~~~~c 259 (350)
T 4ay9_X 201 ASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYPSHC 259 (350)
T ss_dssp EECCSEEECTTSCCC-CCCSS--SCTTCCEEECTTCTTCCCCCC-TTTCCSCCEEECSCHHHH
T ss_pred CcccchhhcCCCCcC-ccChh--hhccchHhhhccCCCcCcCCC-chhCcChhhCcCCCCccc
Confidence 788888888888887 55542 244555555444333336773 777778888888766543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.4e-21 Score=202.88 Aligned_cols=135 Identities=22% Similarity=0.204 Sum_probs=80.0
Q ss_pred ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeec
Q 046275 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL 503 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 503 (1176)
++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 35555666666555444444555555556665555555444444555666666666666666555555666666666666
Q ss_pred cccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcc
Q 046275 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 504 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 558 (1176)
++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++.|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 6666665555556666666666666666664444446666666666666666554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-22 Score=229.55 Aligned_cols=253 Identities=17% Similarity=0.182 Sum_probs=119.8
Q ss_pred CcEEEcCCCcCCCCcChhhhcc--ccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCcc
Q 046275 243 LEYLDISANKFTGDVGHAISAC--EHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320 (1176)
Q Consensus 243 L~~L~Ls~N~l~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 320 (1176)
++.|++++|.+. +..+..+ ++++.|++++|.+++..+ .
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~------------------------------------~- 88 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA------------------------------------E- 88 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC------------------------------------S-
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccch------------------------------------h-
Confidence 567777777665 3445555 556666666555553322 2
Q ss_pred ccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC-cCCCC-CCccccCCC
Q 046275 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN-NLSGA-IPHNLCQGP 398 (1176)
Q Consensus 321 ~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~ 398 (1176)
+..+++|++|++++|.+++......+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+ ..
T Consensus 89 ~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~--~~ 166 (336)
T 2ast_B 89 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL--SS 166 (336)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH--HH
T ss_pred hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH--hc
Confidence 2334445555555554442211122344455555555555544444444444555555555555 33321 22211 11
Q ss_pred CCCccEEEccCc-cccCC-CCccccccc-cCcEEEcCCc--ccc-CCCCccccCCCccCeeeccccc-ccCCCCCCCCCc
Q 046275 399 RNSLKELFLQNN-LLLGS-IPSTLSNCS-QLVSLHLSFN--YLT-GTIPSSLGSLSKLQDLKLWLNQ-LHGEIPPELGNI 471 (1176)
Q Consensus 399 ~~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l 471 (1176)
+++|++|++++| .+++. ++..+..++ +|++|++++| .++ +.+|..+..+++|+.|++++|. +++..+..+..+
T Consensus 167 ~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l 246 (336)
T 2ast_B 167 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246 (336)
T ss_dssp CTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred CCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence 233444444444 44332 344455556 6666666666 333 3344455555555555555555 444445555555
Q ss_pred cccceeeccccc-ccCccccccccCCCCCeeeccccccCCCCCccccCC-CCCCeEEccCCcccccCCCCCC
Q 046275 472 QTLETLFLDFNE-LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQL-SNLAILKLSNNSFYGRIPPELG 541 (1176)
Q Consensus 472 ~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~ 541 (1176)
++|++|+|++|. ++......+.++++|+.|++++| ++.. .+..+ ..|..|++++|++++..|+.++
T Consensus 247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCccc
Confidence 555555555553 22111123455555555555555 2211 12222 1244444555555555554444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=7.7e-21 Score=214.63 Aligned_cols=210 Identities=25% Similarity=0.370 Sum_probs=127.7
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccC
Q 046275 304 VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSS 383 (1176)
Q Consensus 304 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 383 (1176)
..+.+..+.+++.+ .+..+++|++|++++|.++ .++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++
T Consensus 22 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (308)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccC
Confidence 33455566665432 2445677777777777776 555 25667777777777777774433 67777777777777
Q ss_pred CcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCC
Q 046275 384 NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463 (1176)
Q Consensus 384 N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 463 (1176)
|++++ ++ .+..+++|++|++++|++++ ++. +..+++|++|++++|.+++.
T Consensus 95 n~l~~-~~---------------------------~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~ 144 (308)
T 1h6u_A 95 NPLKN-VS---------------------------AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI 144 (308)
T ss_dssp CCCSC-CG---------------------------GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred CcCCC-ch---------------------------hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC
Confidence 76653 22 24444555555555555553 222 55555555555555555533
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCC
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 543 (1176)
.+ ++.+++|++|+|++|++++..+ +.++++|+.|++++|++++..+ +..+++|++|+|++|++++..| +..+
T Consensus 145 ~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l 216 (308)
T 1h6u_A 145 SP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANT 216 (308)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTC
T ss_pred cc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCC
Confidence 22 5566666666666666664333 6666677777777777764332 6667777777777777764332 6677
Q ss_pred CCCCEEEccCCCCcc
Q 046275 544 RSLIWLDLNTNLFNG 558 (1176)
Q Consensus 544 ~~L~~L~L~~N~l~g 558 (1176)
++|+.|+|++|++++
T Consensus 217 ~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 217 SNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCCEEEEEEEEEEC
T ss_pred CCCCEEEccCCeeec
Confidence 777777777777753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.1e-21 Score=219.28 Aligned_cols=244 Identities=20% Similarity=0.206 Sum_probs=151.8
Q ss_pred CeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHh
Q 046275 268 SFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFL 347 (1176)
Q Consensus 268 ~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~ 347 (1176)
++++.++++++ ++|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|...|.
T Consensus 12 ~~v~C~~~~Lt------------~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~ 76 (350)
T 4ay9_X 12 RVFLCQESKVT------------EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 76 (350)
T ss_dssp TEEEEESTTCC------------SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBC
T ss_pred CEEEecCCCCC------------ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhh
Confidence 56777777776 233222 257888888888888555567888888999999988887678888888
Q ss_pred cCCCCCE-EEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccC
Q 046275 348 SMSNLKE-LVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL 426 (1176)
Q Consensus 348 ~l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L 426 (1176)
+++++++ +.++.|+++...|..|.++++|++|++++|+++...+..+ ....++..|++.++
T Consensus 77 ~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~--~~~~~l~~l~l~~~---------------- 138 (350)
T 4ay9_X 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK--IHSLQKVLLDIQDN---------------- 138 (350)
T ss_dssp SCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT--CCBSSCEEEEEESC----------------
T ss_pred cchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhh--cccchhhhhhhccc----------------
Confidence 8888765 5666788887777888888888888888888874332222 11223444444321
Q ss_pred cEEEcCCccccCCCCccccCCC-ccCeeecccccccCCCCCCCCCccccceeeccc-ccccCccccccccCCCCCeeecc
Q 046275 427 VSLHLSFNYLTGTIPSSLGSLS-KLQDLKLWLNQLHGEIPPELGNIQTLETLFLDF-NELTGTLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 427 ~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls 504 (1176)
|+++...+..|..+. .++.|+|++|+++ .+|.......+|++|++++ |.++...+..|.++++|++|||+
T Consensus 139 -------~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs 210 (350)
T 4ay9_X 139 -------INIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210 (350)
T ss_dssp -------TTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECT
T ss_pred -------cccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcC
Confidence 233322223333332 3455555555555 3333333445666666653 55554444566777777777777
Q ss_pred ccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCC
Q 046275 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLF 556 (1176)
Q Consensus 505 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 556 (1176)
+|+|+. +|.. .+.+|+.|.+.++.-...+| .+.++++|+.++++++.-
T Consensus 211 ~N~l~~-lp~~--~~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 211 RTRIHS-LPSY--GLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp TSCCCC-CCSS--SCTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred CCCcCc-cChh--hhccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 777773 3332 24455555544443333666 477788888888875543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=213.81 Aligned_cols=153 Identities=15% Similarity=0.099 Sum_probs=123.0
Q ss_pred HHHHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCc------------------CHHHHHHHHHHHHhc
Q 046275 852 FADLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQ------------------GDREFTAEMETIGKI 913 (1176)
Q Consensus 852 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l 913 (1176)
...+......|.+.+.||+|+||.||+|++.+|+.||+|.+...... ....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 44455566678888999999999999999977999999988532211 234588999999999
Q ss_pred CCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 046275 914 KHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSN 993 (1176)
Q Consensus 914 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 993 (1176)
+ | +++.+++.. +..|+||||++||+|.+ +.. .....++.|++.||+|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 9 5 777776544 55699999999999988 421 12346999999999999999 99999999999
Q ss_pred EEECCCCcEEEEeeccccccccccccccccccccCCcccCccccC
Q 046275 994 VLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038 (1176)
Q Consensus 994 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 1038 (1176)
|+++ ++.+||+|||+|+. +..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999 99999999999862 34578999874
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.6e-20 Score=223.25 Aligned_cols=186 Identities=27% Similarity=0.341 Sum_probs=138.1
Q ss_pred CCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEE
Q 046275 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLH 430 (1176)
Q Consensus 351 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 430 (1176)
+|++|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| . .+++|+.|+|++|+|++ +|. +.+ +|++|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~----~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~ 126 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-E----LPASLEYLDACDNRLST-LPE-LPA--SLKHLD 126 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-C----CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEE
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-c----ccCCCCEEEccCCCCCC-cch-hhc--CCCEEE
Confidence 67777777777764 555442 56777777777776 555 2 24567777777777775 555 544 778888
Q ss_pred cCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCC
Q 046275 431 LSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGG 510 (1176)
Q Consensus 431 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 510 (1176)
|++|+|++ +|. .+++|+.|+|++|.+++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+
T Consensus 127 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~- 193 (571)
T 3cvr_A 127 VDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE- 193 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-
T ss_pred CCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-
Confidence 88888775 555 56778888888888875 555 46788888888888886 555 65 78888899998888
Q ss_pred CCCccccCCCCC-------CeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 511 EIPTWIGQLSNL-------AILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 511 ~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
.+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+++|.+|..+..
T Consensus 194 ~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 194 SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 6676 554 67 99999999998 78998889999999999999999988887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-20 Score=194.98 Aligned_cols=128 Identities=20% Similarity=0.212 Sum_probs=64.8
Q ss_pred cEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecccc
Q 046275 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506 (1176)
Q Consensus 427 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 506 (1176)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 35566666665 344333 235555555555555444444555555555555555555444444555555555555555
Q ss_pred ccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCc
Q 046275 507 HLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 507 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 557 (1176)
++++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|+++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 137 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc
Confidence 555444444455555555555555554333333444444444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.7e-19 Score=188.18 Aligned_cols=160 Identities=19% Similarity=0.171 Sum_probs=130.8
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCC-ccccCCCccCeeecccccccCCCCCCCCCccccceeecccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP-SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 482 (1176)
.+++++|.++ .+|..+. ..+++|+|++|++++..| ..|..+++|+.|+|++|++++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5555555555 3444442 345677777777776544 34677888888888888888777778888899999999999
Q ss_pred cccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCCh
Q 046275 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 483 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~ 562 (1176)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+++|.++-
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 99988888899999999999999999988899999999999999999999988899999999999999999999998876
Q ss_pred hHHh
Q 046275 563 ALFK 566 (1176)
Q Consensus 563 ~~~~ 566 (1176)
..+.
T Consensus 172 ~~l~ 175 (220)
T 2v70_A 172 AWLG 175 (220)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=186.30 Aligned_cols=160 Identities=19% Similarity=0.226 Sum_probs=126.8
Q ss_pred cEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccc
Q 046275 403 KELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482 (1176)
Q Consensus 403 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 482 (1176)
+.++++++.++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 34555555555 3444443 56777777777777666667777778888888888887777888888888888888888
Q ss_pred cccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCCh
Q 046275 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 483 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~ 562 (1176)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+..+-
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 88866667788899999999999999988888899999999999999999977777899999999999999999886654
Q ss_pred hHH
Q 046275 563 ALF 565 (1176)
Q Consensus 563 ~~~ 565 (1176)
.++
T Consensus 171 ~~l 173 (220)
T 2v9t_B 171 KWL 173 (220)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.8e-18 Score=182.77 Aligned_cols=156 Identities=24% Similarity=0.197 Sum_probs=128.5
Q ss_pred ccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccc
Q 046275 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDF 481 (1176)
Q Consensus 402 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 481 (1176)
.+.++++++.++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345666666665 4454443 6778888888888877777788888888888888888765566778888899999999
Q ss_pred ccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 482 NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 482 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+.++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9998777778899999999999999998 788889999999999999999997666789999999999999999998876
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.7e-21 Score=233.42 Aligned_cols=85 Identities=27% Similarity=0.341 Sum_probs=37.9
Q ss_pred ccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccC-CCCccccccccccccc
Q 046275 638 MMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTI-PSSMSSLTLLNEIDLC 716 (1176)
Q Consensus 638 l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~i-P~~l~~l~~L~~l~ls 716 (1176)
|+.|||++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+.|++|+.|+|++|+|++.+ |..++.+++|+.|+|+
T Consensus 465 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~ 541 (567)
T 1dce_A 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541 (567)
T ss_dssp CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECT
T ss_pred CcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEec
Confidence 334444444444 344444444444444444444442 33 4444444444444444444333 4444444444444444
Q ss_pred cccccCCCC
Q 046275 717 NNQLTGMIP 725 (1176)
Q Consensus 717 ~N~l~g~~p 725 (1176)
+|+|++.+|
T Consensus 542 ~N~l~~~~~ 550 (567)
T 1dce_A 542 GNSLCQEEG 550 (567)
T ss_dssp TSGGGGSSS
T ss_pred CCcCCCCcc
Confidence 444444444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.7e-19 Score=215.65 Aligned_cols=200 Identities=22% Similarity=0.325 Sum_probs=116.9
Q ss_pred ccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeec
Q 046275 424 SQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL 503 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 503 (1176)
..+..+.++.+.+.+..+ +..+++|+.|++++|.+. .+| .+..+++|+.|+|++|+|++..| +.++++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 344455555555553322 345556666666666665 233 35666666666666666665444 666666666666
Q ss_pred cccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceee
Q 046275 504 SNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583 (1176)
Q Consensus 504 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~ 583 (1176)
++|+|++ +| .+..+++|+.|+|++|++.+ + +.+..|++|+.|+|++|.+++. +
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~---------------------- 147 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-T---------------------- 147 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-G----------------------
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-h----------------------
Confidence 6666663 33 46666666666666666663 2 3466666666666666666531 0
Q ss_pred eecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccce
Q 046275 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLF 663 (1176)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~ 663 (1176)
.+..+.+|+.|+|++|+|++.+| ++.+++|+
T Consensus 148 -----------------------------------------------~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~ 178 (605)
T 1m9s_A 148 -----------------------------------------------VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 178 (605)
T ss_dssp -----------------------------------------------GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred -----------------------------------------------hhcccCCCCEEECcCCcCCCchh--hccCCCCC
Confidence 01223456666777777665545 66667777
Q ss_pred eeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccc
Q 046275 664 ILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL 707 (1176)
Q Consensus 664 ~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l 707 (1176)
.|+|++|+|++ +| .++.|++|+.|+|++|++++.....+..+
T Consensus 179 ~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 179 NLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp EEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred EEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCCcccccccE
Confidence 77777777764 33 46667777777777777765433333333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.3e-19 Score=225.56 Aligned_cols=131 Identities=25% Similarity=0.275 Sum_probs=99.9
Q ss_pred EcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccC
Q 046275 430 HLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG 509 (1176)
Q Consensus 430 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 509 (1176)
+++.|++. ..|..+..++.|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 44555555 55667777777777777777777 66767777888888888888888 78888899999999999999998
Q ss_pred CCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHH
Q 046275 510 GEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565 (1176)
Q Consensus 510 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~ 565 (1176)
.+|..|+.+++|++|+|++|.|+ .+|..|+.|++|+.|+|++|+|+|.+|..++
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHh
Confidence 78989999999999999999997 8888899999999999999999988777654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.5e-19 Score=203.68 Aligned_cols=180 Identities=24% Similarity=0.197 Sum_probs=141.5
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCcccc-ccccCcEEEcCCccccCCCCccccCCCccCeeec
Q 046275 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLS-NCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 377 ~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 455 (1176)
+.+++++|.++ .+|..+ ...++.|+|++|++++..+..+. ++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 21 ~~l~c~~~~l~-~iP~~~----~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSL----PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp TEEECCSSCCS-SCCSSC----CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEEEeCCCCcC-ccCccC----CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 56777777776 466544 23577788888888776667776 8888888888888888777778888888888888
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccc---cCCCCCCeEEccCCcc
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI---GQLSNLAILKLSNNSF 532 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l 532 (1176)
++|++++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 8888887777788888999999999999988778889999999999999999985444444 5688999999999999
Q ss_pred cccCCCCCCCCCC--CCEEEccCCCCcccCC
Q 046275 533 YGRIPPELGDCRS--LIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 533 ~~~~p~~~~~l~~--L~~L~L~~N~l~g~ip 561 (1176)
++..+..+..++. |+.|+|++|++.+...
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 8555566777776 4889999999987543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=210.10 Aligned_cols=187 Identities=22% Similarity=0.290 Sum_probs=98.9
Q ss_pred EEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccC
Q 046275 200 QLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSG 279 (1176)
Q Consensus 200 ~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 279 (1176)
.+.+..+.+.+...+..+++|+.|++++|.+..++ .+..+++|++|+|++|+|++..+ +..+++|+.|+|++|.|+
T Consensus 25 ~l~l~~~~i~~~~~~~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~- 100 (605)
T 1m9s_A 25 KDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK- 100 (605)
T ss_dssp HHHTTCSCTTSEECHHHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-
T ss_pred HHhccCCCcccccchhcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC-
Confidence 33444444444444445556666666666655443 35555666666666666555443 555555555555555544
Q ss_pred ccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccC
Q 046275 280 PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359 (1176)
Q Consensus 280 ~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~ 359 (1176)
+ + +.+..+++|++|+|++|+++ .++ .+..+++|+.|+|++
T Consensus 101 -----------------------------------~-l-~~l~~l~~L~~L~Ls~N~l~-~l~--~l~~l~~L~~L~Ls~ 140 (605)
T 1m9s_A 101 -----------------------------------D-L-SSLKDLKKLKSLSLEHNGIS-DIN--GLVHLPQLESLYLGN 140 (605)
T ss_dssp -----------------------------------C-C-TTSTTCTTCCEEECTTSCCC-CCG--GGGGCTTCSEEECCS
T ss_pred -----------------------------------C-C-hhhccCCCCCEEEecCCCCC-CCc--cccCCCccCEEECCC
Confidence 2 1 24555555666666666555 232 245556666666666
Q ss_pred cccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccC
Q 046275 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438 (1176)
Q Consensus 360 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 438 (1176)
|.+++. ..+..+++|+.|+|++|.+++..| + ..+++|+.|+|++|++++. ..+..+++|+.|+|++|++.+
T Consensus 141 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l--~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 141 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L--AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp SCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G--TTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CccCCc--hhhcccCCCCEEECcCCcCCCchh--h--ccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 665543 445555666666666665554333 2 2344455555555555432 235566666666666666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=182.85 Aligned_cols=154 Identities=23% Similarity=0.278 Sum_probs=123.9
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCC-ccccccccCcEEEcCCccccCCCCccccCCCccCeeec
Q 046275 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP-STLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 377 ~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 455 (1176)
+.+++++|.++ .+|..+ ...+++|+|++|++++..| ..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 14 ~~l~~s~n~l~-~iP~~~----~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 88 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHI----PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL 88 (220)
T ss_dssp TEEECCSSCCS-SCCSCC----CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEeEeCCCCcc-cCccCC----CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEEC
Confidence 46677777766 456544 2346777777777776544 45778888888888888888777778888888888888
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccccc
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR 535 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 535 (1176)
++|++++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+.
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 88888877777788888899999999999888888888899999999999999888888888899999999999988754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-19 Score=224.03 Aligned_cols=225 Identities=23% Similarity=0.233 Sum_probs=119.2
Q ss_pred CccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecc
Q 046275 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480 (1176)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 480 (1176)
.++.|.|.+|.+.. .+. ..|+.++|+.|.|.+ ++++.|.+. ..|..+..++.|+.|+|+
T Consensus 174 ~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls 232 (727)
T 4b8c_D 174 LTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDLS 232 (727)
T ss_dssp ---------------------------------------------------------------------CCCCCCEEECT
T ss_pred ccceEEeeCCCCCc-chh-----hHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEECC
Confidence 35555665555553 121 235556666666652 345566666 678888899999999999
Q ss_pred cccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccC
Q 046275 481 FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSI 560 (1176)
Q Consensus 481 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i 560 (1176)
+|+++ .+|..+.++++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+.|++|++|+|++|.|+ .|
T Consensus 233 ~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~l 308 (727)
T 4b8c_D 233 NLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TL 308 (727)
T ss_dssp TSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CC
T ss_pred CCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-cc
Confidence 99998 67777778999999999999998 88888999999999999999998 78999999999999999999886 56
Q ss_pred ChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccE
Q 046275 561 PPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMF 640 (1176)
Q Consensus 561 p~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 640 (1176)
|.. |..+.+|++
T Consensus 309 p~~--------------------------------------------------------------------~~~l~~L~~ 320 (727)
T 4b8c_D 309 PWE--------------------------------------------------------------------FGNLCNLQF 320 (727)
T ss_dssp CSS--------------------------------------------------------------------TTSCTTCCC
T ss_pred Chh--------------------------------------------------------------------hhcCCCccE
Confidence 643 223456888
Q ss_pred EEcccCcCccCCCccccccccc-eeeeccCccccccCCccccCcCcccEEEccCc--------cccccCCCCcccccccc
Q 046275 641 LDISYNMLSGSIPKEIGSMSYL-FILNLGHNNLSGPIPTEVGDLRGLNILDLSSN--------RLEGTIPSSMSSLTLLN 711 (1176)
Q Consensus 641 LdLs~N~l~g~iP~~~~~l~~L-~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N--------~l~g~iP~~l~~l~~L~ 711 (1176)
|+|++|.|+|.+|..++.+... ..|+|++|.++|.+|.. |+.|++++| .|.+.++..+.++..+.
T Consensus 321 L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~ 394 (727)
T 4b8c_D 321 LGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRT 394 (727)
T ss_dssp EECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------------------------
T ss_pred EeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccc
Confidence 9999999999888888765433 35789999999888864 456667777 44444555556677777
Q ss_pred ccccccccccCCC
Q 046275 712 EIDLCNNQLTGMI 724 (1176)
Q Consensus 712 ~l~ls~N~l~g~~ 724 (1176)
...+++|-+++..
T Consensus 395 ~~~ls~Nil~~~~ 407 (727)
T 4b8c_D 395 FTVLSYNTLCQHY 407 (727)
T ss_dssp -------CCCGGG
T ss_pred eeeeecccccccc
Confidence 7777777776543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-20 Score=227.76 Aligned_cols=214 Identities=20% Similarity=0.150 Sum_probs=130.2
Q ss_pred CCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceee-
Q 046275 400 NSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF- 478 (1176)
Q Consensus 400 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~- 478 (1176)
++|+.|+|++|+++ .+|..++++++|+.|++++|.....+|.. +..+.+.+.+|..++.+++|+.|+
T Consensus 349 ~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~L~~ 416 (567)
T 1dce_A 349 EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKAVDP 416 (567)
T ss_dssp TTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHHHCG
T ss_pred ccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcccCcc
Confidence 34444444444444 44555555555555555444311011100 001123445566666666666666
Q ss_pred cccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcc
Q 046275 479 LDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 479 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 558 (1176)
++.|.+. +|..+.+++|.++. +|. ..|+.|+|++|.|++ +|. ++.+++|+.|+|++|.++
T Consensus 417 l~~n~~~-----------~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~- 476 (567)
T 1dce_A 417 MRAAYLD-----------DLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR- 476 (567)
T ss_dssp GGHHHHH-----------HHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-
T ss_pred hhhcccc-----------hhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-
Confidence 5555443 44555666666652 221 247777777777774 565 777777777777777776
Q ss_pred cCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCc
Q 046275 559 SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSM 638 (1176)
Q Consensus 559 ~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 638 (1176)
.+|..+. .+.+|
T Consensus 477 ~lp~~~~--------------------------------------------------------------------~l~~L 488 (567)
T 1dce_A 477 ALPPALA--------------------------------------------------------------------ALRCL 488 (567)
T ss_dssp CCCGGGG--------------------------------------------------------------------GCTTC
T ss_pred ccchhhh--------------------------------------------------------------------cCCCC
Confidence 5664321 22457
Q ss_pred cEEEcccCcCccCCCccccccccceeeeccCccccccC-CccccCcCcccEEEccCccccccCCCC---ccccccccccc
Q 046275 639 MFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPI-PTEVGDLRGLNILDLSSNRLEGTIPSS---MSSLTLLNEID 714 (1176)
Q Consensus 639 ~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~i-P~~~~~L~~L~~L~Ls~N~l~g~iP~~---l~~l~~L~~l~ 714 (1176)
+.|||++|+|++ +| .|+++++|+.|+|++|+|++.+ |..|+.|++|+.|+|++|+|++.+|.. +..+++|+.||
T Consensus 489 ~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 489 EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp CEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 778888888876 66 7888888888888888888766 888888888888888888888654432 23367777775
Q ss_pred c
Q 046275 715 L 715 (1176)
Q Consensus 715 l 715 (1176)
+
T Consensus 567 l 567 (567)
T 1dce_A 567 T 567 (567)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.7e-18 Score=180.36 Aligned_cols=153 Identities=24% Similarity=0.340 Sum_probs=130.1
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecc
Q 046275 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456 (1176)
Q Consensus 377 ~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 456 (1176)
+.+++++|.++ .+|..+ .++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 14 ~~v~c~~~~l~-~iP~~l----~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 88 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNL----PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88 (220)
T ss_dssp TEEECTTSCCS-SCCSSC----CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECC
T ss_pred CEEEcCCCCcC-cCCCcc----CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECC
Confidence 56777777776 566544 2568888888888887667788888999999999999998888899999999999999
Q ss_pred cccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc
Q 046275 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534 (1176)
Q Consensus 457 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 534 (1176)
+|+++...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 999996666678889999999999999998888999999999999999999998878889999999999999998864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.3e-18 Score=188.44 Aligned_cols=172 Identities=20% Similarity=0.199 Sum_probs=86.2
Q ss_pred CCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccc
Q 046275 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQ 221 (1176)
Q Consensus 142 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~ 221 (1176)
+.+++|+.|++++|.|+.++ .+..+++|++|+|++|++++. +. +..+++|++|++++|.+++...+
T Consensus 43 ~~l~~L~~L~l~~~~i~~~~--~~~~l~~L~~L~L~~n~l~~~---~~--l~~l~~L~~L~l~~n~l~~~~~l------- 108 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI---KP--LANLKNLGWLFLDENKVKDLSSL------- 108 (291)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC---GG--GTTCTTCCEEECCSSCCCCGGGG-------
T ss_pred hhcCcccEEEccCCCcccCh--hHhcCCCCCEEEccCCccCCC---cc--cccCCCCCEEECCCCcCCCChhh-------
Confidence 34455555555555555442 134445555555555555542 11 33444444444444444433333
Q ss_pred eeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCC
Q 046275 222 FLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS 301 (1176)
Q Consensus 222 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~ 301 (1176)
..+++|++|+|++|++++. ..+..+++|++|++++|.+++. ..+..++
T Consensus 109 ----------------~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--------------~~l~~l~ 156 (291)
T 1h6t_A 109 ----------------KDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--------------TVLSRLT 156 (291)
T ss_dssp ----------------TTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--------------GGGGGCT
T ss_pred ----------------ccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--------------hhhccCC
Confidence 4444444444444444432 2344444444455544444421 0112234
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCC
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG 364 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~ 364 (1176)
+|++|+|++|++++..+ +..+++|++|++++|.++ .++. +..+++|++|++++|.++.
T Consensus 157 ~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~-~l~~--l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 157 KLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRA--LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCGG--GTTCTTCSEEEEEEEEEEC
T ss_pred CCCEEEccCCccccchh--hcCCCccCEEECCCCcCC-CChh--hccCCCCCEEECcCCcccC
Confidence 55555555555554333 666667777777777666 4442 5667777777777777664
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.1e-18 Score=190.49 Aligned_cols=62 Identities=11% Similarity=0.134 Sum_probs=28.8
Q ss_pred CCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecccccc
Q 046275 214 VSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 278 (1176)
+..+++|+.|++++|.++.+ +.+..+++|++|+|++|++++..+ +.++++|++|+|++|.++
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 103 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred hhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC
Confidence 33444455555555544433 224444555555555555544333 444444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.2e-18 Score=187.31 Aligned_cols=173 Identities=23% Similarity=0.255 Sum_probs=142.0
Q ss_pred CccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEE
Q 046275 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549 (1176)
Q Consensus 470 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 549 (1176)
.+.++..+++++|.+++ ++ .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++. |. +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence 56777888888888884 33 6788889999999999888 456 688889999999999999854 44 8889999999
Q ss_pred EccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCC
Q 046275 550 DLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629 (1176)
Q Consensus 550 ~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 629 (1176)
+|++|++++ +|..
T Consensus 91 ~L~~N~l~~-l~~~------------------------------------------------------------------ 103 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI------------------------------------------------------------------ 103 (263)
T ss_dssp ECCSSCCSC-CTTC------------------------------------------------------------------
T ss_pred ECCCCccCC-cCcc------------------------------------------------------------------
Confidence 999998874 3210
Q ss_pred CCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccc
Q 046275 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTL 709 (1176)
Q Consensus 630 ~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~ 709 (1176)
.. .+|+.|+|++|++++ +| .++.+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++. ..+..+++
T Consensus 104 ---~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~ 173 (263)
T 1xeu_A 104 ---PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKK 173 (263)
T ss_dssp ---CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCC
T ss_pred ---cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCC
Confidence 01 368889999999996 44 68999999999999999995 55 799999999999999999965 77899999
Q ss_pred ccccccccccccCCCC
Q 046275 710 LNEIDLCNNQLTGMIP 725 (1176)
Q Consensus 710 L~~l~ls~N~l~g~~p 725 (1176)
|+.|++++|++++.+.
T Consensus 174 L~~L~l~~N~~~~~~~ 189 (263)
T 1xeu_A 174 VNWIDLTGQKCVNEPV 189 (263)
T ss_dssp CCEEEEEEEEEECCCE
T ss_pred CCEEeCCCCcccCCcc
Confidence 9999999999988754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=9.4e-18 Score=193.93 Aligned_cols=176 Identities=23% Similarity=0.198 Sum_probs=119.5
Q ss_pred cEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCccccc-CCCCCCEEEccCCcCCCCCCccccCCCCCCccEEE
Q 046275 328 ESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLS-NLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELF 406 (1176)
Q Consensus 328 ~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~ 406 (1176)
+.+++++|+++ .+|..+ .+.+++|+|++|.|++..+..+. ++++|++|+|
T Consensus 21 ~~l~c~~~~l~-~iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L------------------------- 71 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLL------------------------- 71 (361)
T ss_dssp TEEECCSSCCS-SCCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEEC-------------------------
T ss_pred CEEEeCCCCcC-ccCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEEC-------------------------
Confidence 45666666665 555432 13355555555555544444444 4444555554
Q ss_pred ccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccC
Q 046275 407 LQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTG 486 (1176)
Q Consensus 407 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 486 (1176)
++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++
T Consensus 72 -~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 72 -SHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp -CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred -CCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 4455544445566777777788888887776666677778888888888888877777788888888888888888886
Q ss_pred cccccc---ccCCCCCeeeccccccCCCCCccccCCCC--CCeEEccCCccc
Q 046275 487 TLPAAL---SNCTNLNWISLSNNHLGGEIPTWIGQLSN--LAILKLSNNSFY 533 (1176)
Q Consensus 487 ~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~ 533 (1176)
..+..| .++++|+.|+|++|+|++..+..+..++. |+.|+|++|.+.
T Consensus 151 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 555555 56888888888888888666667777776 488999999886
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.1e-17 Score=176.49 Aligned_cols=154 Identities=25% Similarity=0.288 Sum_probs=132.9
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeec
Q 046275 376 LETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455 (1176)
Q Consensus 376 L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 455 (1176)
.+.++++++.++ .+|..+ .++|++|+|++|++++..|..|.++++|++|+|++|+++...+..|..+++|+.|+|
T Consensus 21 ~~~v~c~~~~l~-~ip~~~----~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGI----PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TTEEECTTSCCS-SCCSCC----CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEeEccCCCcC-ccCCCC----CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 566788888776 666654 367888888888888888888999999999999999998666677889999999999
Q ss_pred ccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCccccc
Q 046275 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR 535 (1176)
Q Consensus 456 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 535 (1176)
++|++++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..+..+++|+.|+|++|.+.+.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999777777899999999999999999 7888899999999999999999977777899999999999999998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-17 Score=180.39 Aligned_cols=139 Identities=17% Similarity=0.170 Sum_probs=107.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEE-CCCCE--EEEEEeeccCCc------------------------CHHHHHHHHHHHH
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKL-KDGST--VAIKKLIHISGQ------------------------GDREFTAEMETIG 911 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~ 911 (1176)
..-|.+.+.||+|+||.||+|++ .+|+. ||||.+...... ....+.+|+.++.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 33467889999999999999998 67888 999986432111 0125788999999
Q ss_pred hcCCCCc--ccceeEEeeCCeeEEEEeeccC-C----CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHH-hcCCCC
Q 046275 912 KIKHRNL--VPLLGYCKVGEERLLVYEYMRY-G----SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH-HNCIPH 983 (1176)
Q Consensus 912 ~l~h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ 983 (1176)
+++|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. +
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---g 191 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---E 191 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---C
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9988864 333332 356899999942 4 67766432 224467789999999999999 87 9
Q ss_pred eeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 984 IIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 984 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=183.62 Aligned_cols=168 Identities=28% Similarity=0.336 Sum_probs=103.8
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
++..+++++|.+++.. .+..+++|++|++++|+++ .++ .+..+++|++|+|++|.+++..+ +.++++|+.|+|
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 4555566666666332 4566677777777777776 555 25667777777777777775433 677777777777
Q ss_pred cCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeeccccccc
Q 046275 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH 461 (1176)
Q Consensus 382 s~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 461 (1176)
++|++++ +|... . .+|++|+|++|++++. ..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|+++
T Consensus 93 ~~N~l~~-l~~~~---~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 93 NRNRLKN-LNGIP---S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CSSCCSC-CTTCC---C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred CCCccCC-cCccc---c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 7777763 33321 1 4566666666666642 2466666777777777776643 3 4566666666666666666
Q ss_pred CCCCCCCCCccccceeecccccccCc
Q 046275 462 GEIPPELGNIQTLETLFLDFNELTGT 487 (1176)
Q Consensus 462 ~~~p~~~~~l~~L~~L~L~~N~l~~~ 487 (1176)
+. ..+..+++|+.|++++|.+++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 44 4555566666666666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.8e-17 Score=169.49 Aligned_cols=86 Identities=22% Similarity=0.277 Sum_probs=51.6
Q ss_pred CCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCE
Q 046275 469 GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIW 548 (1176)
Q Consensus 469 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 548 (1176)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44556666666666666 344 4666666666666666554 2235666666666666666666555666666666666
Q ss_pred EEccCCCCcc
Q 046275 549 LDLNTNLFNG 558 (1176)
Q Consensus 549 L~L~~N~l~g 558 (1176)
|+|++|.+++
T Consensus 117 L~Ls~n~i~~ 126 (197)
T 4ezg_A 117 LDISHSAHDD 126 (197)
T ss_dssp EECCSSBCBG
T ss_pred EEecCCccCc
Confidence 6666665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.1e-17 Score=169.36 Aligned_cols=150 Identities=18% Similarity=0.212 Sum_probs=107.8
Q ss_pred CccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecc
Q 046275 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480 (1176)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 480 (1176)
+|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 3444444444444 333 4566677777777777654 23467777788888888888877777778888888888888
Q ss_pred cccccCccccccccCCCCCeeeccccc-cCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcc
Q 046275 481 FNELTGTLPAALSNCTNLNWISLSNNH-LGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558 (1176)
Q Consensus 481 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 558 (1176)
+|++++..|..+.++++|++|++++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|++.+
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888887777888888888888888887 54 555 57888888888888888874 44 67788888888888888753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=2.7e-17 Score=171.66 Aligned_cols=89 Identities=24% Similarity=0.340 Sum_probs=51.2
Q ss_pred CccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccc
Q 046275 637 SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLC 716 (1176)
Q Consensus 637 ~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls 716 (1176)
+|++|||++|+|++.+|..|+++++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++.+|..+..+++|+.|+|+
T Consensus 55 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 134 (192)
T 1w8a_A 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134 (192)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECT
T ss_pred CCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeC
Confidence 45555555555555555555555555555555555555555555555556666666666555555555555556666666
Q ss_pred cccccCCCC
Q 046275 717 NNQLTGMIP 725 (1176)
Q Consensus 717 ~N~l~g~~p 725 (1176)
+|++++..|
T Consensus 135 ~N~l~c~c~ 143 (192)
T 1w8a_A 135 SNPFNCNCH 143 (192)
T ss_dssp TCCBCCSGG
T ss_pred CCCccCcCc
Confidence 665555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=166.47 Aligned_cols=137 Identities=25% Similarity=0.271 Sum_probs=116.0
Q ss_pred cEEEcCCccccCCCCccccCCCccCeeecccccccCCCCC-CCCCccccceeecccccccCccccccccCCCCCeeeccc
Q 046275 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP-ELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505 (1176)
Q Consensus 427 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 505 (1176)
+.+++++|+++ .+|..+.. +|++|++++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777776 56665543 778888888888765554 478888999999999999988888999999999999999
Q ss_pred cccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 506 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
|+|++..|..|..+++|++|+|++|++++.+|..+..+++|+.|+|++|+|+|.++-..+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~ 148 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH
Confidence 9999888888999999999999999999999999999999999999999999988765543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=2e-17 Score=188.76 Aligned_cols=103 Identities=14% Similarity=0.031 Sum_probs=72.2
Q ss_pred CCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCC-eeeccccccCCCCCccccCCCCCCeE
Q 046275 447 LSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN-WISLSNNHLGGEIPTWIGQLSNLAIL 525 (1176)
Q Consensus 447 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 525 (1176)
+++|+.|+|++|+++...+..|.++++|+.|+|.+| ++.+.+.+|.++++|+ .|++.+ +++...+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 566666666666666555556777777777777776 6655666777777777 777777 5665556777777777777
Q ss_pred EccCCcccccCCCCCCCCCCCCEEEc
Q 046275 526 KLSNNSFYGRIPPELGDCRSLIWLDL 551 (1176)
Q Consensus 526 ~L~~N~l~~~~p~~~~~l~~L~~L~L 551 (1176)
++++|+++...+..|.+|++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 77777777666667777777777753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=9.6e-17 Score=183.03 Aligned_cols=260 Identities=20% Similarity=0.208 Sum_probs=150.6
Q ss_pred ccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccc--------cCCCcEEEccCCCCCCCCcccc
Q 046275 118 SSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSL--------KLSLEVLDLSYNKISGANVVPW 189 (1176)
Q Consensus 118 ~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~--------~~~L~~LdLs~N~i~~~~~~~~ 189 (1176)
+++|++||||+|++...... -+.++.+..+.+..| .++..+|.. +.+|++|+|++ +++. ++.
T Consensus 48 l~~L~~LdLs~n~i~~~~~~---~~~~~~~~~~~~~~~---~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~---I~~ 117 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGK---AGTYPNGKFYIYMAN---FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKN---IED 117 (329)
T ss_dssp CTTCCEEEEEEEEECCEEES---SSSSGGGCCEEECTT---EECTTTTEEEETTEEEECTTCCC-CBCT-TCCE---ECT
T ss_pred hccCeEEecCcceeEEecCc---ccccccccccccccc---ccCHHHhcccccccccccCCCcEEECCc-cccc---hhH
Confidence 55677777777776521111 111222334444444 344556666 66666666666 5553 555
Q ss_pred ccccCCCCccEEEeCCCcccc--cccCCCCCccceeeccCCcc----cccC-CCccCCCCCc-EEEcCCCcCCCCcChhh
Q 046275 190 ILFNGCDELKQLALKGNKVTG--DINVSKCKNLQFLDVSSNNF----SMAV-PSFGDCLALE-YLDISANKFTGDVGHAI 261 (1176)
Q Consensus 190 ~~f~~~~~L~~L~L~~n~l~~--~~~~~~l~~L~~L~Ls~N~l----~~~~-~~l~~l~~L~-~L~Ls~N~l~~~~~~~l 261 (1176)
.+|.+|++|+.|++.+|.+.. ...+..+.++..+.+..+.. ..+. ..|.++..|+ .+.+.... .++..+
T Consensus 118 ~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~ 194 (329)
T 3sb4_A 118 AAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEI 194 (329)
T ss_dssp TTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHH
T ss_pred HHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHH
Confidence 666666666666666666553 33455556666655554322 1111 2355666666 55554321 111111
Q ss_pred ----hccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcC
Q 046275 262 ----SACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKF 337 (1176)
Q Consensus 262 ----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 337 (1176)
....+++.+.+.++-.. .-...+...+++|+.++|++|+++.+.+.+|.++++|+.|+|.+| +
T Consensus 195 ~~~~~~~~~~~~l~~~~~l~~------------~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i 261 (329)
T 3sb4_A 195 MKAGLQPRDINFLTIEGKLDN------------ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-L 261 (329)
T ss_dssp HHTTCCGGGCSEEEEEECCCH------------HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-C
T ss_pred hhcccCccccceEEEeeeecH------------HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-c
Confidence 13455666666654221 111223334677888888887777666667888888888888777 6
Q ss_pred cccCCHHHHhcCCCCC-EEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEc
Q 046275 338 SGELPIEIFLSMSNLK-ELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFL 407 (1176)
Q Consensus 338 ~~~i~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L 407 (1176)
+ .|+...|.++++|+ .|++.+ .++.+.+.+|.++++|+.|++++|.++ .++...+ ..+++|+.++.
T Consensus 262 ~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~aF-~~~~~L~~ly~ 328 (329)
T 3sb4_A 262 K-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDELF-GNGVPSKLIYK 328 (329)
T ss_dssp C-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTTT-CTTCCCCEEEC
T ss_pred c-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhhh-cCCcchhhhcc
Confidence 5 67777788888887 888877 666566677888888888888777777 4444332 33566777653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=158.67 Aligned_cols=137 Identities=23% Similarity=0.224 Sum_probs=111.3
Q ss_pred cEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecccc
Q 046275 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506 (1176)
Q Consensus 427 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 506 (1176)
+.+++++|.++ .+|..+. ++|++|+|++|.++ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46777777776 5565443 46777788888777 66777888888888888888888777788889999999999999
Q ss_pred ccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhh
Q 046275 507 HLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567 (1176)
Q Consensus 507 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~ 567 (1176)
+|++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+...-.+|..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~ 149 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSD 149 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHH
Confidence 9998888889999999999999999996666678999999999999999998776555543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=155.26 Aligned_cols=131 Identities=24% Similarity=0.181 Sum_probs=64.4
Q ss_pred CccEEEccCcccc-CCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeec
Q 046275 401 SLKELFLQNNLLL-GSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479 (1176)
Q Consensus 401 ~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 479 (1176)
+|++|+|++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 4555555555554 34455555555555555555555533 44455555555555555555444444444555555555
Q ss_pred ccccccCcc-ccccccCCCCCeeeccccccCCCCC---ccccCCCCCCeEEccCCccc
Q 046275 480 DFNELTGTL-PAALSNCTNLNWISLSNNHLGGEIP---TWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 480 ~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 533 (1176)
++|+|++.. +..+.++++|++|++++|++++..+ ..+..+++|++|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 555554321 1444455555555555555543322 24444555555555555444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=155.36 Aligned_cols=137 Identities=22% Similarity=0.137 Sum_probs=122.8
Q ss_pred cccCcEEEcCCcccc-CCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCee
Q 046275 423 CSQLVSLHLSFNYLT-GTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501 (1176)
Q Consensus 423 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 501 (1176)
.++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 478999999999998 78899999999999999999999965 889999999999999999998789889999999999
Q ss_pred eccccccCCCC-CccccCCCCCCeEEccCCcccccCC---CCCCCCCCCCEEEccCCCCcccCCh
Q 046275 502 SLSNNHLGGEI-PTWIGQLSNLAILKLSNNSFYGRIP---PELGDCRSLIWLDLNTNLFNGSIPP 562 (1176)
Q Consensus 502 ~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~g~ip~ 562 (1176)
+|++|++++.. +..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+. ++|.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999999542 2789999999999999999995444 38999999999999999986 4553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=5e-15 Score=152.31 Aligned_cols=133 Identities=22% Similarity=0.205 Sum_probs=109.2
Q ss_pred CcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccc
Q 046275 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505 (1176)
Q Consensus 426 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 505 (1176)
.+.+++++|+++ .+|..+. ++|+.|++++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 456777777776 4554433 5778888888888766666778888888899999988877777788999999999999
Q ss_pred cccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 506 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
|+|++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|+++|.+|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99997777778999999999999999996656667889999999999999999877
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5.2e-14 Score=163.84 Aligned_cols=265 Identities=11% Similarity=0.120 Sum_probs=156.9
Q ss_pred CCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccc--cccCCCCCc
Q 046275 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG--DINVSKCKN 219 (1176)
Q Consensus 142 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~--~~~~~~l~~ 219 (1176)
..+..++.+.+.+ .++.++..+|..+ +|+.+++..| ++. +...+|.++ +|+.+.+.. .++. ..+|..|++
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~---I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~ 181 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKS---IGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYN 181 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCE---ECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTT
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccE---ECHHhcCCC-CceEEEeCC-CccEehHHHhhCccc
Confidence 3456777777764 4777777777775 6888887766 443 666677774 577777765 4443 345667777
Q ss_pred cceeeccCCcccccCCC-ccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhh
Q 046275 220 LQFLDVSSNNFSMAVPS-FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298 (1176)
Q Consensus 220 L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~ 298 (1176)
|+.+++++|+++.++.. |. +.+|+.+.|..+ ++.+...+|.++++|+.+++..| ++ .++...|.
T Consensus 182 L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~------------~I~~~aF~ 246 (401)
T 4fdw_A 182 LKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS------------TIGQEAFR 246 (401)
T ss_dssp CCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC------------EECTTTTT
T ss_pred CCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc------------Cccccccc
Confidence 77777777777766554 43 567777777643 66566667777777777777654 22 23333343
Q ss_pred cCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCc----ccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCC
Q 046275 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFS----GELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLT 374 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 374 (1176)
. .+|+.+.+ .+.++.....+|.++++|+.+++.+|.+. ..++...|.++++|+.++|. +.++.....+|.+++
T Consensus 247 ~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~ 323 (401)
T 4fdw_A 247 E-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNR 323 (401)
T ss_dssp T-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCC
T ss_pred c-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCC
Confidence 3 46666666 34455445566666666666666665542 13555566666666666666 335444445555556
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCC-ccCee
Q 046275 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLS-KLQDL 453 (1176)
Q Consensus 375 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L 453 (1176)
+|+.++|..| ++ ...+.+|.++ +|+.+++++|.+....+..|..++ +++.|
T Consensus 324 ~L~~l~lp~~-l~--------------------------~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l 375 (401)
T 4fdw_A 324 KVTQLTIPAN-VT--------------------------QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVI 375 (401)
T ss_dssp SCCEEEECTT-CC--------------------------EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEE
T ss_pred CccEEEECcc-cc--------------------------EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEE
Confidence 6666655433 32 2333455555 566666666655544444555553 45566
Q ss_pred ecccccc
Q 046275 454 KLWLNQL 460 (1176)
Q Consensus 454 ~L~~N~l 460 (1176)
++..+.+
T Consensus 376 ~vp~~~~ 382 (401)
T 4fdw_A 376 RVPAESV 382 (401)
T ss_dssp EECGGGH
T ss_pred EeCHHHH
Confidence 6555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-14 Score=165.42 Aligned_cols=269 Identities=12% Similarity=0.123 Sum_probs=162.1
Q ss_pred CCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCcc
Q 046275 241 LALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSR 320 (1176)
Q Consensus 241 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 320 (1176)
..++.+.+.+ .++.+...+|.++ +|+.+.+..| ++ .++...|.. .+|+.+.+.. .++...+.+
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~------------~I~~~aF~~-~~L~~i~lp~-~l~~I~~~a 175 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK------------SIGDMAFFN-STVQEIVFPS-TLEQLKEDI 175 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC------------EECTTTTTT-CCCCEEECCT-TCCEECSST
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc------------EECHHhcCC-CCceEEEeCC-CccEehHHH
Confidence 3444444443 2443444455553 4555555544 33 222333333 2466666654 455455567
Q ss_pred ccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCC
Q 046275 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRN 400 (1176)
Q Consensus 321 ~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 400 (1176)
|.++++|+.+++++|+++ .++...|. ..+|+.+.|..+ ++.....+|.++++|+.+++..| ++ .++...+.. .
T Consensus 176 F~~c~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~--~ 248 (401)
T 4fdw_A 176 FYYCYNLKKADLSKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE--S 248 (401)
T ss_dssp TTTCTTCCEEECTTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT--C
T ss_pred hhCcccCCeeecCCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc--C
Confidence 777777777777777776 67777775 477777777644 55455667777777777777664 33 333333322 3
Q ss_pred CccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecc
Q 046275 401 SLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480 (1176)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 480 (1176)
+|+.+.+. +.++.....+|.++++|+.+++.+|.+.. +.+....+..|.++++|+.++|.
T Consensus 249 ~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~ 308 (401)
T 4fdw_A 249 GITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP 308 (401)
T ss_dssp CCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC
T ss_pred CccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC
Confidence 45666552 33443445566666666666666555430 01112344566677777777777
Q ss_pred cccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCC-CCCEEEccCCCC
Q 046275 481 FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR-SLIWLDLNTNLF 556 (1176)
Q Consensus 481 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l 556 (1176)
+.++.+...+|.+|++|+.++|.+| ++..-+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..|.+
T Consensus 309 -~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 309 -ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp -TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred -CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 3466556677888888888888655 554556677777 888888888887755666777774 678888776654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-15 Score=150.98 Aligned_cols=127 Identities=23% Similarity=0.213 Sum_probs=72.0
Q ss_pred ccCcEEEcCCcccc-CCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeee
Q 046275 424 SQLVSLHLSFNYLT-GTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWIS 502 (1176)
Q Consensus 424 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 502 (1176)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555554 44555555555555555555555533 4555556666666666666655555555566666666
Q ss_pred ccccccCCC-CCccccCCCCCCeEEccCCcccccCC---CCCCCCCCCCEEEcc
Q 046275 503 LSNNHLGGE-IPTWIGQLSNLAILKLSNNSFYGRIP---PELGDCRSLIWLDLN 552 (1176)
Q Consensus 503 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 552 (1176)
+++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666542 23556666666666666666664333 245566666666654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.8e-14 Score=163.08 Aligned_cols=326 Identities=17% Similarity=0.207 Sum_probs=168.0
Q ss_pred ccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccc-ccccCCCCC
Q 046275 140 YLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT-GDINVSKCK 218 (1176)
Q Consensus 140 ~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~-~~~~~~~l~ 218 (1176)
++.+|.+|+.+.|.. .++.|+..+|..|.+|+.+++..+ ++. +...+|.+|.+|+.+.+..+-.. +..++..+.
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~---I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM---IGRCTFSGCYALKSILLPLMLKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE---ECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCC
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE---ccchhhcccccchhhcccCceeeecceeeeccc
Confidence 466777777777764 377777777777777777777654 332 56666777777777666544222 233444444
Q ss_pred ccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhh
Q 046275 219 NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~ 298 (1176)
.+......... .-...+|.++.+|+.+.+.++. ..+...+|.++.+|+.+++..| ++ .++...+.
T Consensus 141 ~~~~~~~~~~~-~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~------------~I~~~~F~ 205 (394)
T 4fs7_A 141 FKEITIPEGVT-VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK------------IIRDYCFA 205 (394)
T ss_dssp CSEEECCTTCC-EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC------------EECTTTTT
T ss_pred ccccccCcccc-ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce------------EeCchhhc
Confidence 33322222211 1112346667777777776542 3345556666777776666544 22 23334444
Q ss_pred cCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCE
Q 046275 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLET 378 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 378 (1176)
.+..|+.+.+..+... +...+....+|+.+.+..+ ++ .++...|..+..|+.+.+..+... .....+..+..++.
T Consensus 206 ~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~ 280 (394)
T 4fs7_A 206 ECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKK 280 (394)
T ss_dssp TCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCE
T ss_pred cccccceeecCCCceE--eehhhcccCCCceEEECCC-ce-ecccccccccccceeEEcCCCcce-eeccccccccccce
Confidence 5556666655544332 2233334456666666433 22 344455566666666666655333 34455555666665
Q ss_pred EEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccc
Q 046275 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLN 458 (1176)
Q Consensus 379 L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 458 (1176)
+....+.+ +. ..|..+.+|+.+.+..+ ++.+-..+|.++++|+.++|..+
T Consensus 281 ~~~~~~~i----~~-------------------------~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~ 330 (394)
T 4fs7_A 281 VIYGSVIV----PE-------------------------KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL 330 (394)
T ss_dssp EEECSSEE----CT-------------------------TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred eccCceee----cc-------------------------ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc
Confidence 55544422 11 22333444444444332 33223334444444555444322
Q ss_pred cccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCe
Q 046275 459 QLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAI 524 (1176)
Q Consensus 459 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 524 (1176)
++..-...|.++++|+.+++..| ++.+...+|.++.+|+.+++..+ ++ .+..+|.+.++|+.
T Consensus 331 -v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 331 -VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred -ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 33233445555555555555544 44344555666666666666544 22 23344555555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=151.47 Aligned_cols=108 Identities=25% Similarity=0.333 Sum_probs=63.4
Q ss_pred cCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecc
Q 046275 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 425 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 504 (1176)
+|++|+|++|+++ .+|..|..+++|+.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4555555555554 444555555555555555555555555555556666666666666665555566666666666666
Q ss_pred ccccCCCCCccccCCCCCCeEEccCCccc
Q 046275 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 505 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 533 (1176)
+|+|+...+..|..+++|+.|+|++|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66666444445666666666666666664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.2e-15 Score=148.95 Aligned_cols=128 Identities=23% Similarity=0.196 Sum_probs=102.3
Q ss_pred CCccEEEccCcccc-CCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceee
Q 046275 400 NSLKELFLQNNLLL-GSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLF 478 (1176)
Q Consensus 400 ~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 478 (1176)
++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..++.+++|++|++++|.+++.+|..++.+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45777777777777 66777777888888888888888755 6778888888888888888877777777788888888
Q ss_pred cccccccCc-cccccccCCCCCeeeccccccCCCCC---ccccCCCCCCeEEccC
Q 046275 479 LDFNELTGT-LPAALSNCTNLNWISLSNNHLGGEIP---TWIGQLSNLAILKLSN 529 (1176)
Q Consensus 479 L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~ 529 (1176)
+++|++++. .+..+.++++|++|++++|++++..+ ..++.+++|++|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888863 34788888999999999999886655 4788889999988864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=147.70 Aligned_cols=131 Identities=22% Similarity=0.254 Sum_probs=86.7
Q ss_pred cEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccc
Q 046275 403 KELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482 (1176)
Q Consensus 403 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 482 (1176)
+.+++++|+++ .+|..+. ++|+.|++++|++++..+..|..+++|++|++++|++++..+..++.+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34455555554 2333222 45666666666666555555666667777777777776555556677777777777777
Q ss_pred cccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccC
Q 046275 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536 (1176)
Q Consensus 483 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 536 (1176)
+|++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++.+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 777666666777778888888888877655555677788888888888777543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=4.2e-15 Score=168.43 Aligned_cols=143 Identities=13% Similarity=0.081 Sum_probs=101.9
Q ss_pred HHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC--------------cCHHH--------HHHHHHHHHh
Q 046275 855 LLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG--------------QGDRE--------FTAEMETIGK 912 (1176)
Q Consensus 855 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~ 912 (1176)
+.....=|++.+.||+|+||.||+|...+|+.||||.+..... ..... ..+|...+.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3333345899999999999999999999999999997642110 00011 2346667777
Q ss_pred cCCCCcccceeEEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 046275 913 IKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSS 992 (1176)
Q Consensus 913 l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 992 (1176)
+.+.++....-+.. ...++||||++|++|.++.. . .....++.|++.+|.|||+. +||||||||.
T Consensus 170 L~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~ 234 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEF 234 (397)
T ss_dssp HHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred HHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence 75544432222211 23479999999988765432 1 12356789999999999998 9999999999
Q ss_pred CEEECCCC----------cEEEEeeccccc
Q 046275 993 NVLLDENF----------EARVSDFGMARL 1012 (1176)
Q Consensus 993 NIll~~~~----------~~kl~DfGla~~ 1012 (1176)
|||+++++ .+.|+||+.+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998776 389999997753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-13 Score=160.18 Aligned_cols=334 Identities=17% Similarity=0.190 Sum_probs=209.2
Q ss_pred CCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccc--ccccCCCCCccceeeccCCccccc
Q 046275 156 LLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT--GDINVSKCKNLQFLDVSSNNFSMA 233 (1176)
Q Consensus 156 ~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~--~~~~~~~l~~L~~L~Ls~N~l~~~ 233 (1176)
.++.|+..+|..|.+|+.+++..+ ++. +...+|.+|.+|+.+++..+ ++ +...+..+.+|+.+.+..+--.-.
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~---I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~ 132 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VRE---IGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIG 132 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCE---ECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEEC
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccC---cchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeec
Confidence 467788899999999999999754 554 77788999988888888655 33 245567777777766654422211
Q ss_pred CCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcc
Q 046275 234 VPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNL 313 (1176)
Q Consensus 234 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l 313 (1176)
..+|.++..++....... ..+...+|.++++|+.+.+..+.. .++
T Consensus 133 ~~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~-------------~I~-------------------- 177 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSME-------------TLH-------------------- 177 (394)
T ss_dssp TTTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCC-------------EEC--------------------
T ss_pred ceeeecccccccccCccc--cccchhhhcccCCCcEEecCCccc-------------eec--------------------
Confidence 224555543333322222 223334566666666665543321 122
Q ss_pred cccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCcc
Q 046275 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHN 393 (1176)
Q Consensus 314 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 393 (1176)
...|.++.+|+.+++..| ++ .++...|.++..|+.+.+..+... +.+......+|+.+.+..+. + .+...
T Consensus 178 ----~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~-~i~~~ 247 (394)
T 4fs7_A 178 ----NGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-T-ELGKS 247 (394)
T ss_dssp ----TTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-C-EECSS
T ss_pred ----cccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-e-ecccc
Confidence 334444444444444433 22 344444455555555544443221 12222333455555554321 1 12211
Q ss_pred ccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccc
Q 046275 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQT 473 (1176)
Q Consensus 394 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 473 (1176)
.+ .....|+.+.+..+... .....|..+..++.+....+.+. ...|..+.+|+.+.+..+ ++..-...|.++.+
T Consensus 248 ~f-~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~ 321 (394)
T 4fs7_A 248 VF-YGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTS 321 (394)
T ss_dssp TT-TTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTT
T ss_pred cc-cccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCC
Confidence 11 12345666666555433 44567788888888888776543 346788999999999765 66566778999999
Q ss_pred cceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEE
Q 046275 474 LETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549 (1176)
Q Consensus 474 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 549 (1176)
|+.++|..+ ++.+...+|.++++|+.+++..| ++.....+|.++++|+.+++..+ +. .+...|.++++|+.+
T Consensus 322 L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 322 LVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 999999754 77666889999999999999887 76566788999999999999876 33 456789999998865
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=3.4e-16 Score=164.29 Aligned_cols=155 Identities=23% Similarity=0.254 Sum_probs=105.1
Q ss_pred cccCCCCCeeeccccccCCCCCc------cccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHH
Q 046275 492 LSNCTNLNWISLSNNHLGGEIPT------WIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALF 565 (1176)
Q Consensus 492 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~ 565 (1176)
+.....++.+++++|.++|.+|. .++.+++|++|+|++|++++ +| .+..+++|+.|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 33444555555555555555554 66666777777777777664 55 6666677777777777665 4553221
Q ss_pred hhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEccc
Q 046275 566 KQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY 645 (1176)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~ 645 (1176)
. +.+|++|||++
T Consensus 91 ~--------------------------------------------------------------------~~~L~~L~L~~ 102 (198)
T 1ds9_A 91 V--------------------------------------------------------------------ADTLEELWISY 102 (198)
T ss_dssp H--------------------------------------------------------------------HHHCSEEEEEE
T ss_pred c--------------------------------------------------------------------CCcCCEEECcC
Confidence 1 12467788888
Q ss_pred CcCccCCCccccccccceeeeccCccccccCC--ccccCcCcccEEEccCccccccCCCC----------cccccccccc
Q 046275 646 NMLSGSIPKEIGSMSYLFILNLGHNNLSGPIP--TEVGDLRGLNILDLSSNRLEGTIPSS----------MSSLTLLNEI 713 (1176)
Q Consensus 646 N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP--~~~~~L~~L~~L~Ls~N~l~g~iP~~----------l~~l~~L~~l 713 (1176)
|++++ +| .++.+++|+.|+|++|++++ +| ..++.+++|++|++++|++++.+|.. +..+++|+.|
T Consensus 103 N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~L 179 (198)
T 1ds9_A 103 NQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179 (198)
T ss_dssp EECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEE
T ss_pred CcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEE
Confidence 88875 55 67888888888888888884 33 47888888888888888888777764 7788888877
Q ss_pred ccccccccC
Q 046275 714 DLCNNQLTG 722 (1176)
Q Consensus 714 ~ls~N~l~g 722 (1176)
| +|.++.
T Consensus 180 d--~~~i~~ 186 (198)
T 1ds9_A 180 D--GMPVDV 186 (198)
T ss_dssp C--CGGGTT
T ss_pred C--CcccCH
Confidence 6 666653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=5e-16 Score=162.98 Aligned_cols=135 Identities=26% Similarity=0.301 Sum_probs=113.8
Q ss_pred CCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccC
Q 046275 416 IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC 495 (1176)
Q Consensus 416 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 495 (1176)
+|..+..+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+..+++|++|+|++|++++ +| .+.++
T Consensus 40 l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l 114 (198)
T 1ds9_A 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHH
T ss_pred hhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccC
Confidence 44578888999999999999985 67 8888999999999999998 678888888999999999999995 55 68899
Q ss_pred CCCCeeeccccccCCCCC-ccccCCCCCCeEEccCCcccccCCCC----------CCCCCCCCEEEccCCCCc
Q 046275 496 TNLNWISLSNNHLGGEIP-TWIGQLSNLAILKLSNNSFYGRIPPE----------LGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 496 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~L~~N~l~ 557 (1176)
++|++|++++|++++..+ ..+..+++|++|++++|++.+.+|.. +..+++|+.|| +|+++
T Consensus 115 ~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 999999999999985322 47889999999999999998877764 78889999887 66665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=2.8e-14 Score=146.49 Aligned_cols=133 Identities=17% Similarity=0.142 Sum_probs=101.4
Q ss_pred ccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCC
Q 046275 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499 (1176)
Q Consensus 420 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 499 (1176)
+.++++|+.|++++|+++ .+|......++|++|++++|.+++. ..++.+++|++|+|++|+|++..+..|.++++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 455667777777777777 3444333333777788877777754 5777888888888888888865556668888899
Q ss_pred eeeccccccCCCCCc--cccCCCCCCeEEccCCcccccCCCC----CCCCCCCCEEEccCCCCc
Q 046275 500 WISLSNNHLGGEIPT--WIGQLSNLAILKLSNNSFYGRIPPE----LGDCRSLIWLDLNTNLFN 557 (1176)
Q Consensus 500 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 557 (1176)
+|+|++|+++ .+|. .+..+++|++|++++|.++ .+|.. +..+++|+.||+++|...
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999886 5665 7888899999999999987 56664 888899999999988765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=141.65 Aligned_cols=59 Identities=19% Similarity=0.119 Sum_probs=33.1
Q ss_pred ccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecccccc
Q 046275 219 NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 278 (1176)
+|++|++++|.++++ +.+..+++|++|+|++|+|++..+..+..+++|++|+|++|+|+
T Consensus 43 ~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 101 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101 (176)
T ss_dssp CCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred CCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC
Confidence 555555555555544 44555666666666666665444444455555555555555553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=4e-13 Score=136.79 Aligned_cols=108 Identities=21% Similarity=0.250 Sum_probs=86.6
Q ss_pred CeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCC
Q 046275 451 QDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530 (1176)
Q Consensus 451 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 530 (1176)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45555555555 3554443 67788888888888777888888888899999999988777777888999999999999
Q ss_pred cccccCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 531 SFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 531 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
+|++..|..|..+++|+.|+|++|++++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9987666679999999999999999998765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=133.78 Aligned_cols=108 Identities=19% Similarity=0.239 Sum_probs=81.7
Q ss_pred CeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCC
Q 046275 451 QDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530 (1176)
Q Consensus 451 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 530 (1176)
+.+++++|++. .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34555555554 4555443 66777888888888777778888888888888888888666666788888889999999
Q ss_pred cccccCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 531 SFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 531 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
+|++..+..|..+++|+.|+|++|+|.+..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 8886555568889999999999999986544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-12 Score=133.31 Aligned_cols=106 Identities=25% Similarity=0.252 Sum_probs=78.0
Q ss_pred CcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccc
Q 046275 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505 (1176)
Q Consensus 426 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 505 (1176)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456677777776 4555443 6677777777777766677777777777888888887766666777888888888888
Q ss_pred cccCCCCCccccCCCCCCeEEccCCcccc
Q 046275 506 NHLGGEIPTWIGQLSNLAILKLSNNSFYG 534 (1176)
Q Consensus 506 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 534 (1176)
|+|++..+..|..+++|++|+|++|++.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 88886666677788888888888887764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-12 Score=131.34 Aligned_cols=104 Identities=23% Similarity=0.288 Sum_probs=74.2
Q ss_pred cEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeecccc
Q 046275 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506 (1176)
Q Consensus 427 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 506 (1176)
+.+++++|+++ .+|..+. ++|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666665 4555443 56777777777777666777777777777777777777665666777778888888888
Q ss_pred ccCCCCCccccCCCCCCeEEccCCccc
Q 046275 507 HLGGEIPTWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 507 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 533 (1176)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 887655556777888888888888776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.33 E-value=4.6e-11 Score=139.53 Aligned_cols=330 Identities=14% Similarity=0.177 Sum_probs=150.3
Q ss_pred cCCCC-CCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCc
Q 046275 141 LGSCS-SLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKN 219 (1176)
Q Consensus 141 l~~l~-~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~ 219 (1176)
+.+|. .|+.+.+..+ ++.|+..+|..|.+|+.+.++.|.-+.+..+...+|.+|.+|+.+.+..+
T Consensus 59 F~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~------------- 124 (394)
T 4gt6_A 59 FCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS------------- 124 (394)
T ss_dssp TTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-------------
T ss_pred ccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-------------
Confidence 44553 4777777643 67777777777777777777766533333455566666666555544332
Q ss_pred cceeeccCCcccccC-CCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhh
Q 046275 220 LQFLDVSSNNFSMAV-PSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298 (1176)
Q Consensus 220 L~~L~Ls~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~ 298 (1176)
++.+. ..|..+.+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ ++ .+....+.
T Consensus 125 ----------~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~------------~I~~~aF~ 180 (394)
T 4gt6_A 125 ----------VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VT------------AIEERAFT 180 (394)
T ss_dssp ----------CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CC------------EECTTTTT
T ss_pred ----------cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-ee------------Eecccccc
Confidence 22122 23455555555555432 23344445555555555555433 11 11122222
Q ss_pred cCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCE
Q 046275 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLET 378 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 378 (1176)
. .+|+.+.+..+-.. ....+|.++.+|+......+... .+....+........-.. .+.....+..
T Consensus 181 ~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~ 246 (394)
T 4gt6_A 181 G-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYALI-----------RYPSQREDPA 246 (394)
T ss_dssp T-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEE-----------ECCTTCCCSE
T ss_pred c-cceeEEEECCcccc-cccchhhhccccceecccccccc-cccceeeccccccccccc-----------ccccccccce
Confidence 1 34455544433222 33345555555555555444332 111111111110000000 0001111111
Q ss_pred EEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccc
Q 046275 379 LDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLN 458 (1176)
Q Consensus 379 L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 458 (1176)
+.+ . +.++.....+|.++..|+.+.+..+..+ .....|.++++|+.+.+. +
T Consensus 247 ~~i--------------------------p-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~ 297 (394)
T 4gt6_A 247 FKI--------------------------P-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-S 297 (394)
T ss_dssp EEC--------------------------C-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-T
T ss_pred EEc--------------------------C-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-C
Confidence 111 1 0111122334455555555555443322 333445555555555553 2
Q ss_pred cccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCC
Q 046275 459 QLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPP 538 (1176)
Q Consensus 459 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 538 (1176)
.++......|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.... .
T Consensus 298 ~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~ 372 (394)
T 4gt6_A 298 RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---N 372 (394)
T ss_dssp TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---H
T ss_pred cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---h
Confidence 333333445556666666666543 44344556666666776666544 443445566666777777776665431 3
Q ss_pred CCCCCCCCCEEEccCCCC
Q 046275 539 ELGDCRSLIWLDLNTNLF 556 (1176)
Q Consensus 539 ~~~~l~~L~~L~L~~N~l 556 (1176)
.+..+.+|+.+.+..|.+
T Consensus 373 ~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 373 AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCBCCCCC----------
T ss_pred hhhccCCCCEEEeCCCCE
Confidence 455566676666655543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.31 E-value=5.9e-11 Score=138.61 Aligned_cols=284 Identities=14% Similarity=0.184 Sum_probs=175.3
Q ss_pred ccCCCCCcEEEcCCCc---CCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcc
Q 046275 237 FGDCLALEYLDISANK---FTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNL 313 (1176)
Q Consensus 237 l~~l~~L~~L~Ls~N~---l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l 313 (1176)
|.+|++|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++ .++...+..+.+|+.+.+..+ +
T Consensus 83 F~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~------------~I~~~aF~~c~~L~~i~lp~~-~ 148 (394)
T 4gt6_A 83 FYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT------------EIDSEAFHHCEELDTVTIPEG-V 148 (394)
T ss_dssp TTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS------------EECTTTTTTCTTCCEEECCTT-C
T ss_pred hhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc------------eehhhhhhhhcccccccccce-e
Confidence 4445555555544432 33344455555555555544332 11 233344455566666666533 2
Q ss_pred cccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCcc
Q 046275 314 SGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHN 393 (1176)
Q Consensus 314 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 393 (1176)
.......|..+.+|+.+.+..+ ++ .+....|.. ..|+.+.+..+-.. ....++.++.+++......+... .+...
T Consensus 149 ~~I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~-~~~~~ 223 (394)
T 4gt6_A 149 TSVADGMFSYCYSLHTVTLPDS-VT-AIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYP-AIDNV 223 (394)
T ss_dssp CEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSC-BSSSC
T ss_pred eeecccceecccccccccccce-ee-Eeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccc-cccce
Confidence 3244556777777777777654 33 555566643 56777777654332 44566677777777766655443 12111
Q ss_pred ccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccc
Q 046275 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQT 473 (1176)
Q Consensus 394 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 473 (1176)
++.. +.........+.....+..+.+. +.++..-...|.++..|+.+.+..+... .....|.++.+
T Consensus 224 ~~~~------------~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~ 289 (394)
T 4gt6_A 224 LYEK------------SANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPA 289 (394)
T ss_dssp EEEE------------CTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTT
T ss_pred eecc------------cccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccc
Confidence 1110 00000000111222344555554 3344345667889999999999766544 66678899999
Q ss_pred cceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccC
Q 046275 474 LETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNT 553 (1176)
Q Consensus 474 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 553 (1176)
|+.+.+. +.++.+...+|.++.+|+.++|.++ ++.....+|.++.+|+.+.|..+ ++..-..+|.+|++|+.+++.+
T Consensus 290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred cccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 9999996 5676567788999999999999876 66456778999999999999765 6644567899999999999998
Q ss_pred CCC
Q 046275 554 NLF 556 (1176)
Q Consensus 554 N~l 556 (1176)
|..
T Consensus 367 ~~~ 369 (394)
T 4gt6_A 367 SRS 369 (394)
T ss_dssp CHH
T ss_pred cee
Confidence 754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=3e-11 Score=138.63 Aligned_cols=113 Identities=18% Similarity=0.122 Sum_probs=86.8
Q ss_pred eeecccc-cccCCCCCCCCCccccceeeccc-ccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccC
Q 046275 452 DLKLWLN-QLHGEIPPELGNIQTLETLFLDF-NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529 (1176)
Q Consensus 452 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 529 (1176)
.++++++ .|+ .+|. +..+++|++|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|+.|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455555 566 4666 77777888888885 888877778888888888888888888888888888888888899999
Q ss_pred CcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhh
Q 046275 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQ 567 (1176)
Q Consensus 530 N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~ 567 (1176)
|+|++..|..+..++ |+.|+|++|+|.+...-..|..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~ 126 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQR 126 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHH
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHH
Confidence 888855555565555 9999999999987766555543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=6.8e-13 Score=152.87 Aligned_cols=86 Identities=16% Similarity=0.219 Sum_probs=38.0
Q ss_pred CCccEEEccCCcccccCCccc-----cCCCCCcEEEccCCcCcccCCHH----HHhcCCCCCEEEccCcccCCC----Cc
Q 046275 301 SSLVKLDLSSNNLSGKVPSRF-----GSCSSLESFDISSNKFSGELPIE----IFLSMSNLKELVLSFNDFTGA----LP 367 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~i~~~----~~~~l~~L~~L~Ls~N~l~~~----~p 367 (1176)
++|++|+|++|.++......+ ...++|++|+|++|.|++ .... .+..+++|++|+|++|.|++. ++
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~-~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~ 204 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTA-AGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA 204 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHH-HHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCCh-HHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence 345555555555543222222 233455555555555541 1111 123445555555555555431 13
Q ss_pred ccccCCCCCCEEEccCCcCC
Q 046275 368 DSLSNLTNLETLDLSSNNLS 387 (1176)
Q Consensus 368 ~~l~~l~~L~~L~Ls~N~l~ 387 (1176)
..+...++|++|+|++|.++
T Consensus 205 ~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 205 AQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp HHGGGCSCCCEEECCSSCCC
T ss_pred HHHhcCCCcCeEECCCCCCC
Confidence 33444445555555555544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.2e-13 Score=157.03 Aligned_cols=63 Identities=17% Similarity=0.224 Sum_probs=29.4
Q ss_pred CCccEEEccCCcccccCCccc----c-CCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccC
Q 046275 301 SSLVKLDLSSNNLSGKVPSRF----G-SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT 363 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~ 363 (1176)
+.|+.|+|++|.++......+ . ..++|++|+|++|.+++.-...++..+++|++|+|++|.++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~ 139 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence 445555555555543222221 1 12456666666666642222222233445555555555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.7e-09 Score=125.48 Aligned_cols=126 Identities=13% Similarity=0.097 Sum_probs=71.3
Q ss_pred cCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCccc--ccccCCCCC
Q 046275 141 LGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT--GDINVSKCK 218 (1176)
Q Consensus 141 l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~--~~~~~~~l~ 218 (1176)
.....+|+.+.+.. .++.|+..+|..|.+|+.++|..+ ++. +...+|.++ +|+.+.+..+ ++ +..++..+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~---Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~- 113 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTS---IGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT- 113 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCE---ECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceE---echhhhcCC-CCceEECCce-eeEeccceeccC-
Confidence 44455666666653 467777777777777777777643 443 566667766 5666665543 22 23334433
Q ss_pred ccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecccc
Q 046275 219 NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 276 (1176)
+|+.+.+..+-..-....|.++ +|+.+.+..+ ++.+...++..+.+++.+.+..+.
T Consensus 114 ~L~~i~lp~~~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~ 169 (379)
T 4h09_A 114 DLDDFEFPGATTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNN 169 (379)
T ss_dssp CCSEEECCTTCCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTC
T ss_pred CcccccCCCccccccccccccc-eeeeeeccce-eeccccchhccccccccccccccc
Confidence 6777777654222112234443 4555555543 444455567777777777766544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=127.60 Aligned_cols=146 Identities=12% Similarity=0.020 Sum_probs=114.8
Q ss_pred HHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEE
Q 046275 856 LEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 856 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 934 (1176)
.....+|++...++.|+.+.||++... ++.+++|............+.+|+.+++.+. +..+.++++++...+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344467888888899999999999754 7899999886432233456889999999984 67788999999998999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC---------------------------------- 980 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 980 (1176)
|||++|.++.+.+.. ......++.+++++++.||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999998876321 1223467889999999999810
Q ss_pred ----------------------CCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 981 ----------------------IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 981 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667899998764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.11 E-value=9.6e-11 Score=134.35 Aligned_cols=102 Identities=24% Similarity=0.208 Sum_probs=49.6
Q ss_pred EEccCc-cccCCCCccccccccCcEEEcCC-ccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccc
Q 046275 405 LFLQNN-LLLGSIPSTLSNCSQLVSLHLSF-NYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482 (1176)
Q Consensus 405 L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 482 (1176)
++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455554 454 2444 55555555555553 5555444444555555555555555555444444445555555555555
Q ss_pred cccCccccccccCCCCCeeeccccccC
Q 046275 483 ELTGTLPAALSNCTNLNWISLSNNHLG 509 (1176)
Q Consensus 483 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 509 (1176)
+|++..+..|..++ |+.|+|++|.|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 55433333333333 444444444444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=7.2e-10 Score=121.32 Aligned_cols=136 Identities=13% Similarity=0.060 Sum_probs=99.2
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC--cccceeEEeeCCeeEEEEeec
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN--LVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+|.+..+.+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333455669999998777888999986532 2345788999999986544 566888888778899999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC-------------------------------------- 980 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 980 (1176)
+|.++. ... .+ ...++.++++.++.||+..
T Consensus 98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998874 211 11 2256677778888888642
Q ss_pred -----------------CCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 981 -----------------IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 981 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
...++|+|++|.||++++++.+.++|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667899999875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.88 E-value=7.5e-08 Score=111.57 Aligned_cols=290 Identities=16% Similarity=0.163 Sum_probs=146.3
Q ss_pred ccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccc-cccCCCCC
Q 046275 140 YLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTG-DINVSKCK 218 (1176)
Q Consensus 140 ~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~-~~~~~~l~ 218 (1176)
++.+|.+|+.++|..+ ++.++..+|..+ +|+.+.+..+ ++. +...+|.++ +|+.+.+..+-..- ...+..+
T Consensus 64 aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~---I~~~aF~~~-~L~~i~lp~~~~~i~~~~F~~~- 135 (379)
T 4h09_A 64 NFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKK---FGDYVFQGT-DLDDFEFPGATTEIGNYIFYNS- 135 (379)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCE---ECTTTTTTC-CCSEEECCTTCCEECTTTTTTC-
T ss_pred HhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeE---eccceeccC-CcccccCCCccccccccccccc-
Confidence 4677788888888644 777777788777 6777776543 332 566677665 68888877653332 2334333
Q ss_pred ccceeeccCCccccc-CCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhh
Q 046275 219 NLQFLDVSSNNFSMA-VPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLA 297 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~-~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~ 297 (1176)
+|+.+.+..+ ++.+ ...+..+..++.+.+..+.........+. .........+ +
T Consensus 136 ~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----------------------~ 190 (379)
T 4h09_A 136 SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-YNKNKTILES-----------------------Y 190 (379)
T ss_dssp CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE-EETTSSEEEE-----------------------C
T ss_pred eeeeeeccce-eeccccchhcccccccccccccccceeeccccee-cccccceecc-----------------------c
Confidence 4555555443 3322 23467777888777776543311111000 0000000000 0
Q ss_pred hcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCC
Q 046275 298 DLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE 377 (1176)
Q Consensus 298 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 377 (1176)
..+..+..+.+....-. .....+....+|+.+.+..+ +. .++...|.++..|+.+.+..+ ++.....+|.++.+|+
T Consensus 191 ~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 191 PAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred cccccccccccccceeE-Eeecccccccccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 01122333333222111 23334444455555555433 22 344444555555555555443 3323344455555555
Q ss_pred EEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeeccc
Q 046275 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457 (1176)
Q Consensus 378 ~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 457 (1176)
.+.+..+ ++ .++...+ ..+.+|+.+.+.++.++.....+|.++.+|+.++|..+ ++.+-..+|.++++|+.+.+..
T Consensus 267 ~i~l~~~-i~-~i~~~aF-~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 267 TLNFYAK-VK-TVPYLLC-SGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEEECCC-CS-EECTTTT-TTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccc-ce-ecccccc-ccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 5555433 22 2222222 22445666666555555444566777777777777643 5534455677777777777654
Q ss_pred ccccCCCCCCCCCc
Q 046275 458 NQLHGEIPPELGNI 471 (1176)
Q Consensus 458 N~l~~~~p~~~~~l 471 (1176)
+ ++..-...|.+.
T Consensus 343 ~-v~~I~~~aF~~c 355 (379)
T 4h09_A 343 S-ITLIESGAFEGS 355 (379)
T ss_dssp T-CCEECTTTTTTS
T ss_pred c-cCEEchhHhhCC
Confidence 3 443344455554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=4.8e-09 Score=117.65 Aligned_cols=187 Identities=19% Similarity=0.204 Sum_probs=122.6
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCC--cccceeEEeeCC---eeEEEEeec
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRN--LVPLLGYCKVGE---ERLLVYEYM 938 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~ 938 (1176)
.+.++.|....||++. ..+++|.... ......+.+|..+++.+. +.. +.+++.+..... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4579999999999874 5688887532 123467889999999884 333 344544433333 348999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN--------------------------------------- 979 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------- 979 (1176)
+|.++.+.... .++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99888653321 467778888889999999988861
Q ss_pred ----------------CCCCeeeCCCCCCCEEECC--CCcEEEEeecccccccccccccccccc---c---------cCC
Q 046275 980 ----------------CIPHIIHRDMKSSNVLLDE--NFEARVSDFGMARLMSAMDTHLSVSTL---A---------GTP 1029 (1176)
Q Consensus 980 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~---~---------gt~ 1029 (1176)
..+.++|+|++|.||++++ +..+.++||+.+........-...... . ...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1135899999999999988 556899999988654321100000000 0 000
Q ss_pred cccC-ccccCCCCCCchhhhHHHHHHHHHHHcCCCCC
Q 046275 1030 GYVP-PEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT 1065 (1176)
Q Consensus 1030 ~y~a-PE~~~~~~~~~~~DvwSlGvil~elltg~~P~ 1065 (1176)
++.. |+.... .....+.|++|.++|.+.+|+.+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1112 222111 122368999999999999998775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.73 E-value=1e-08 Score=117.96 Aligned_cols=143 Identities=15% Similarity=0.172 Sum_probs=106.8
Q ss_pred CCceEeEeCceEEEEEEECCCCEEEEEEee--ccC-CcCHHHHHHHHHHHHhcC--CCCcccceeEEeeC---CeeEEEE
Q 046275 864 NDSLIGSGGFGDVYKAKLKDGSTVAIKKLI--HIS-GQGDREFTAEMETIGKIK--HRNLVPLLGYCKVG---EERLLVY 935 (1176)
Q Consensus 864 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 935 (1176)
..+.++.|.++.||+++.. +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999875 5678888764 221 122356888999999997 45688888888766 4589999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC----------------------------------- 980 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 980 (1176)
||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997764311 113678888999999999999999831
Q ss_pred --------------------CCCeeeCCCCCCCEEECCCCc--EEEEeecccccc
Q 046275 981 --------------------IPHIIHRDMKSSNVLLDENFE--ARVSDFGMARLM 1013 (1176)
Q Consensus 981 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~~ 1013 (1176)
.+.++|||+++.||+++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999987653 699999988753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.69 E-value=9e-09 Score=117.31 Aligned_cols=62 Identities=13% Similarity=0.201 Sum_probs=29.3
Q ss_pred CCccEEEcccCcCccCCCcccc---ccccceeeeccCcccccc----CCccccCcCcccEEEccCcccc
Q 046275 636 GSMMFLDISYNMLSGSIPKEIG---SMSYLFILNLGHNNLSGP----IPTEVGDLRGLNILDLSSNRLE 697 (1176)
Q Consensus 636 ~~l~~LdLs~N~l~g~iP~~~~---~l~~L~~L~L~~N~l~g~----iP~~~~~L~~L~~L~Ls~N~l~ 697 (1176)
++|++|+|++|.+++..+..+. .+++|+.|+|+.|++++. ++..+..+++|+.|+|++|.|+
T Consensus 252 p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 3455555555555533322222 344555555555555432 3333344455555555555544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.68 E-value=5.3e-09 Score=119.20 Aligned_cols=83 Identities=18% Similarity=0.222 Sum_probs=47.4
Q ss_pred CCccCeeecccccccCCCCCCC---CCccccceeecccccccCc----cccccccCCCCCeeeccccccCCCCCccccC-
Q 046275 447 LSKLQDLKLWLNQLHGEIPPEL---GNIQTLETLFLDFNELTGT----LPAALSNCTNLNWISLSNNHLGGEIPTWIGQ- 518 (1176)
Q Consensus 447 l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~- 518 (1176)
+++|+.|+|.+|.+.+..+..+ ..+++|++|+|+.|.|++. ++..+.++++|+.|+|++|.++...-..+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 4555555555555543222111 2356777777777777653 3344456677888888888776443333332
Q ss_pred CCCCCeEEccCCc
Q 046275 519 LSNLAILKLSNNS 531 (1176)
Q Consensus 519 l~~L~~L~L~~N~ 531 (1176)
+ ...+++++|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 3567777776
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.62 E-value=3e-09 Score=114.88 Aligned_cols=19 Identities=11% Similarity=-0.213 Sum_probs=13.7
Q ss_pred CcccceeEeCCC--cEEEEec
Q 046275 55 PCGFKGVSCKAA--SVSSIDL 73 (1176)
Q Consensus 55 cC~W~gv~C~~~--~v~~l~L 73 (1176)
.|+|.|+.|+.. +|+.+..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~ 97 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIIN 97 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEE
T ss_pred HHhcCcEEECCCCCEEEEEEe
Confidence 489999999864 5654444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=2.2e-08 Score=103.06 Aligned_cols=99 Identities=21% Similarity=0.229 Sum_probs=58.1
Q ss_pred hhhhhcCcccccccccCCC-CCC--CcccCCCCCccccCccccccCCcccCCCC--CcccccCCCCCCcEEecCCCCCCc
Q 046275 85 VASFLLTLDTLETLSLKNS-NIS--GTISLPAGSRCSSFLSSLDLSLNILSGPL--SDISYLGSCSSLKVLNLSSNLLDF 159 (1176)
Q Consensus 85 ~~~~l~~~~~L~~L~L~~n-~l~--g~~~~~~~~~~~~~L~~LdLs~N~l~~~~--~~~~~l~~l~~L~~L~Ls~n~i~~ 159 (1176)
++..+...+.|++|+|++| .++ |...+...+...++|++|||++|.+.... .-...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 5677888888999999988 887 33333344445566777777777665211 111234455666666666666665
Q ss_pred cc----cccccccCCCcEEEc--cCCCCCC
Q 046275 160 SG----REAGSLKLSLEVLDL--SYNKISG 183 (1176)
Q Consensus 160 ~~----~~~~~~~~~L~~LdL--s~N~i~~ 183 (1176)
.+ ...+...++|++|+| ++|.|++
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 43 223334445666666 5555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.28 E-value=1e-07 Score=97.97 Aligned_cols=118 Identities=14% Similarity=0.077 Sum_probs=60.7
Q ss_pred ccCCCCCCcEEecCCC-CCCcccc----ccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccC
Q 046275 140 YLGSCSSLKVLNLSSN-LLDFSGR----EAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINV 214 (1176)
Q Consensus 140 ~l~~l~~L~~L~Ls~n-~i~~~~~----~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~ 214 (1176)
.+..+++|++|+|++| .|+..+. ..+...++|++|+|++|.|.+...... ...+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l---------------------~~~L 89 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFAL---------------------AEML 89 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHH---------------------HHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHH---------------------HHHH
Confidence 3556677777777777 6665431 222334455555555555543111000 0112
Q ss_pred CCCCccceeeccCCcccc-----cCCCccCCCCCcEEEc--CCCcCCCCc----ChhhhccccCCeEeecccccc
Q 046275 215 SKCKNLQFLDVSSNNFSM-----AVPSFGDCLALEYLDI--SANKFTGDV----GHAISACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 215 ~~l~~L~~L~Ls~N~l~~-----~~~~l~~l~~L~~L~L--s~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~ 278 (1176)
...++|++|+|++|.|+. +...+...++|++|+| ++|.|++.. ...+...++|++|+|++|.+.
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 234455666666665542 2334555566666666 666666432 233444456666666666554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.28 E-value=3.4e-07 Score=98.80 Aligned_cols=66 Identities=29% Similarity=0.385 Sum_probs=32.5
Q ss_pred ccccceeeeccCccccc--cCCccccCcCcccEEEccCccccccCCCCccccc--cccccccccccccCCCC
Q 046275 658 SMSYLFILNLGHNNLSG--PIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLT--LLNEIDLCNNQLTGMIP 725 (1176)
Q Consensus 658 ~l~~L~~L~L~~N~l~g--~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~--~L~~l~ls~N~l~g~~p 725 (1176)
++++|+.|+|++|+|++ .+|..++.+++|+.|+|++|+|++. ..+..+. +|++|+|++|++++.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 34445555555555554 3444445555555555555555532 2233333 55555555555555444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=9.3e-06 Score=88.94 Aligned_cols=135 Identities=18% Similarity=0.151 Sum_probs=98.0
Q ss_pred eEeEeCce-EEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 867 LIGSGGFG-DVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 867 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
.+..|.-| .||+.... ++..+++|+-.. ....++.+|...++.+. +--+.++++++.+.+..|+|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68988765 456788887532 23456888999999884 44477889999999999999999999888
Q ss_pred HHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 046275 944 EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC------------------------------------------- 980 (1176)
Q Consensus 944 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------- 980 (1176)
.+...... .....+..++++.++.||...
T Consensus 108 ~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 77654321 223445666677777777430
Q ss_pred ------------CCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 981 ------------IPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 981 ------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887778999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1e-05 Score=90.24 Aligned_cols=136 Identities=18% Similarity=0.164 Sum_probs=93.2
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCC---CcccceeEEe-eCCeeEEEEeeccC
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHR---NLVPLLGYCK-VGEERLLVYEYMRY 940 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~ 940 (1176)
.+.++.|....||+. |+.+++|... .......+.+|..+++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999998 5778888742 222345788999999999752 3566666664 45567899999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN----------------------------------------- 979 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------- 979 (1176)
.++.+..-. .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 887663211 233444444555555555555532
Q ss_pred ----------------CCCCeeeCCCCCCCEEECC---CCc-EEEEeeccccc
Q 046275 980 ----------------CIPHIIHRDMKSSNVLLDE---NFE-ARVSDFGMARL 1012 (1176)
Q Consensus 980 ----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~ 1012 (1176)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 58999997754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.92 E-value=1.4e-06 Score=88.78 Aligned_cols=122 Identities=18% Similarity=0.159 Sum_probs=63.3
Q ss_pred ccceeEeCCCcEEEEecCCccccccchhhhhhhcCcccccccccCCC-CCC--CcccCCCCCccccCccccccCCcccCC
Q 046275 57 GFKGVSCKAASVSSIDLSPFTLSVDFHLVASFLLTLDTLETLSLKNS-NIS--GTISLPAGSRCSSFLSSLDLSLNILSG 133 (1176)
Q Consensus 57 ~W~gv~C~~~~v~~l~L~~~~~~~~~~~~~~~l~~~~~L~~L~L~~n-~l~--g~~~~~~~~~~~~~L~~LdLs~N~l~~ 133 (1176)
.|.||..........+-.++..+++. .++..+.+.+.|++|+|++| .|+ |...+..++...+.|++|+|++|.|..
T Consensus 6 ~~~~~~k~~~~~~~~~e~~N~t~v~~-~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd 84 (197)
T 1pgv_A 6 TFNGIMQSYVPRIVPDEPDNDTDVES-CINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD 84 (197)
T ss_dssp ---------------------CCHHH-HHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH
T ss_pred cccceecccccccCCCCCCCCCCHHH-HHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCCh
Confidence 36776654432222333333333221 26677788899999999985 786 444445555666778888888887762
Q ss_pred --CCCcccccCCCCCCcEEecCCCCCCcccc----ccccccCCCcEEEccCC
Q 046275 134 --PLSDISYLGSCSSLKVLNLSSNLLDFSGR----EAGSLKLSLEVLDLSYN 179 (1176)
Q Consensus 134 --~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~----~~~~~~~~L~~LdLs~N 179 (1176)
...-...|...+.|+.|+|++|.|+..+. .+++....|++|+|++|
T Consensus 85 ~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 85 SEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence 22222445566777777777777776552 23344445666666654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=2.4e-05 Score=89.52 Aligned_cols=79 Identities=8% Similarity=-0.013 Sum_probs=54.7
Q ss_pred ceE-eEeCceEEEEEEEC-------CCCEEEEEEeeccC---CcCHHHHHHHHHHHHhcC-C--CCcccceeEEeeC---
Q 046275 866 SLI-GSGGFGDVYKAKLK-------DGSTVAIKKLIHIS---GQGDREFTAEMETIGKIK-H--RNLVPLLGYCKVG--- 928 (1176)
Q Consensus 866 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 928 (1176)
+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 466 77888999998754 26678888654322 112245788999998884 3 3577788877654
Q ss_pred CeeEEEEeeccCCCHH
Q 046275 929 EERLLVYEYMRYGSLE 944 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~ 944 (1176)
+..|+||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00016 Score=81.92 Aligned_cols=141 Identities=20% Similarity=0.273 Sum_probs=81.1
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC--CCCccccee------EEeeCCeeEEEEee
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK--HRNLVPLLG------YCKVGEERLLVYEY 937 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lV~E~ 937 (1176)
+.|+.|..+.||++...+| .+++|+... ...++..|..+++.+. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3456677899999987654 588887753 2344555666666553 113344443 22356778999999
Q ss_pred ccCCCHH--------------HHHhhccc-c--C-------cccCHHHH-------------------------------
Q 046275 938 MRYGSLE--------------DVLHNQKK-V--G-------IKLNWAAR------------------------------- 962 (1176)
Q Consensus 938 ~~~gsL~--------------~~l~~~~~-~--~-------~~l~~~~~------------------------------- 962 (1176)
++|.++. ..+|.... . . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11222111 0 0 00122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 963 RKIAIGSARGLAFLHH----------NCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 963 ~~i~~~ia~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
..+...+.+++.+|+. .....++|+|+.+.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666663 123489999999999999888889999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.69 E-value=1.2e-05 Score=80.40 Aligned_cols=84 Identities=12% Similarity=0.108 Sum_probs=55.0
Q ss_pred cCccccccCCcccCCCCCcccccCCCCCCcEEecCCC-CCCccccccccc----cCCCcEEEccCC-CCCCCCccccccc
Q 046275 119 SFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSN-LLDFSGREAGSL----KLSLEVLDLSYN-KISGANVVPWILF 192 (1176)
Q Consensus 119 ~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n-~i~~~~~~~~~~----~~~L~~LdLs~N-~i~~~~~~~~~~f 192 (1176)
.+|++||||+|.++.. .+..+.+|++|+.|+|++| .|++-+...... +++|++|+|++| +||+... ..+
T Consensus 61 ~~L~~LDLs~~~Itd~--GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl---~~L 135 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSI--GFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI---IAL 135 (176)
T ss_dssp CCEEEEEEESCCCCGG--GGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH---HHG
T ss_pred ceEeEEeCcCCCccHH--HHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH---HHH
Confidence 4688888888887632 3355788888888888888 477665444333 346888888887 4765321 223
Q ss_pred cCCCCccEEEeCCCc
Q 046275 193 NGCDELKQLALKGNK 207 (1176)
Q Consensus 193 ~~~~~L~~L~L~~n~ 207 (1176)
..+++|++|++++|.
T Consensus 136 ~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 136 HHFRNLKYLFLSDLP 150 (176)
T ss_dssp GGCTTCCEEEEESCT
T ss_pred hcCCCCCEEECCCCC
Confidence 456666666666664
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.66 E-value=6e-06 Score=84.13 Aligned_cols=120 Identities=16% Similarity=0.102 Sum_probs=89.8
Q ss_pred eCCCcEEEEecCCc-cccccchh-hhhhhcCcccccccccCCCCCC--CcccCCCCCccccCccccccCCcccCCC--CC
Q 046275 63 CKAASVSSIDLSPF-TLSVDFHL-VASFLLTLDTLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILSGP--LS 136 (1176)
Q Consensus 63 C~~~~v~~l~L~~~-~~~~~~~~-~~~~l~~~~~L~~L~L~~n~l~--g~~~~~~~~~~~~~L~~LdLs~N~l~~~--~~ 136 (1176)
..+..++.|+|+.. .++..+.. ++..|...+.|+.|+|++|.|+ |+..+..++...+.|++|+|++|.|+.. ..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34457899999874 66654443 8888999999999999999999 5556666677789999999999999743 22
Q ss_pred cccccCCCCCCcEEecCCC---CCCccc----cccccccCCCcEEEccCCCCC
Q 046275 137 DISYLGSCSSLKVLNLSSN---LLDFSG----REAGSLKLSLEVLDLSYNKIS 182 (1176)
Q Consensus 137 ~~~~l~~l~~L~~L~Ls~n---~i~~~~----~~~~~~~~~L~~LdLs~N~i~ 182 (1176)
-...|...+.|++|+|++| .|..-. ..+++..+.|++|+++.|.+.
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2256778889999999976 444322 234555678888888877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00024 Score=82.39 Aligned_cols=75 Identities=13% Similarity=0.059 Sum_probs=49.7
Q ss_pred CceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-------cCHHHHHHHHHHHHhcCC--CC-cccceeEEeeCCeeEE
Q 046275 865 DSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-------QGDREFTAEMETIGKIKH--RN-LVPLLGYCKVGEERLL 933 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 933 (1176)
.+.||.|..+.||+++.. +++.+++|....... .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 478899997642211 123456789999988742 33 4455543 3455689
Q ss_pred EEeeccCC
Q 046275 934 VYEYMRYG 941 (1176)
Q Consensus 934 V~E~~~~g 941 (1176)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.51 E-value=3.6e-05 Score=76.85 Aligned_cols=85 Identities=9% Similarity=0.067 Sum_probs=51.5
Q ss_pred CCCcEEEcCCCcCCCCcChhhhccccCCeEeecccc-ccCccCCCCccccCcchhhhhh---cCCCccEEEccCCc-ccc
Q 046275 241 LALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL-FSGPIPVGYNEFQGEIPLHLAD---LCSSLVKLDLSSNN-LSG 315 (1176)
Q Consensus 241 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~~i~~~~~~---~l~~L~~L~L~~n~-l~~ 315 (1176)
.+|++|||++|.|++..-..+..+++|++|+|++|. |++ ..-..+.. .+++|++|+|++|. ++.
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD-----------~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD 129 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED-----------GCLERLSQLENLQKSMLEMEIISCGNVTD 129 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH-----------HHHHHHHTCHHHHHHCCEEEEESCTTCCH
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH-----------HHHHHHHhcccccCCCCEEEcCCCCcCCH
Confidence 467777777777776665666777777777777774 442 11111221 12356777777663 654
Q ss_pred cCCccccCCCCCcEEEccCCc
Q 046275 316 KVPSRFGSCSSLESFDISSNK 336 (1176)
Q Consensus 316 ~~p~~~~~l~~L~~L~Ls~N~ 336 (1176)
..-..+..+++|++|+|+++.
T Consensus 130 ~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 130 KGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHHHGGGCTTCCEEEEESCT
T ss_pred HHHHHHhcCCCCCEEECCCCC
Confidence 333456667777777777764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00076 Score=74.28 Aligned_cols=79 Identities=19% Similarity=0.209 Sum_probs=58.5
Q ss_pred CCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC---CCcccceeEEeeCCeeEEEEee
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKH---RNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
...-.+.+|.|..+.||+.+..+|+.|++|+...........|.+|...|+.+.. --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3444678999999999999999999999998654444445678899999998842 2345555542 34789999
Q ss_pred ccCCCH
Q 046275 938 MRYGSL 943 (1176)
Q Consensus 938 ~~~gsL 943 (1176)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00059 Score=75.71 Aligned_cols=139 Identities=18% Similarity=0.205 Sum_probs=92.6
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC---CCCcccceeEEeeCCeeEEEEeeccCC
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK---HRNLVPLLGYCKVGEERLLVYEYMRYG 941 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~g 941 (1176)
.+.|+.|....+|+... +++.+++|.... .....+.+|...++.+. ...+++++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999875 477888887643 23567889999998884 367889999888888899999999987
Q ss_pred CHH--------H---HHhhccc---cCc---------------ccCHHHHH---HHHH----------------HHHH-H
Q 046275 942 SLE--------D---VLHNQKK---VGI---------------KLNWAARR---KIAI----------------GSAR-G 972 (1176)
Q Consensus 942 sL~--------~---~l~~~~~---~~~---------------~l~~~~~~---~i~~----------------~ia~-~ 972 (1176)
.+. + .+|.... .+. .-+|.... ++.. .++. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 2233211 110 12454322 1111 1111 1
Q ss_pred HHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 973 LAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 973 L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
...|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2246799999999999999887 8889974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00027 Score=82.57 Aligned_cols=78 Identities=13% Similarity=0.115 Sum_probs=49.5
Q ss_pred CCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccccccccccc--CCcccCccccCCC---CCCchhhhHHHHHHH
Q 046275 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAG--TPGYVPPEYYQSF---RCSTKGDVYSYGVVL 1055 (1176)
Q Consensus 981 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGvil 1055 (1176)
.+.++|+|++|.||+++.++ ++++||+.+......-. ...... ...|.+|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34799999999999998876 99999998875432111 111111 2346666655321 112345666888888
Q ss_pred HHHHcCC
Q 046275 1056 LELLTGK 1062 (1176)
Q Consensus 1056 ~elltg~ 1062 (1176)
|+.++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0033 Score=70.34 Aligned_cols=159 Identities=12% Similarity=0.107 Sum_probs=88.4
Q ss_pred cCHHHHHHHhcCCCCC-----ceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC--cccce
Q 046275 850 LTFADLLEATNGFHND-----SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN--LVPLL 922 (1176)
Q Consensus 850 ~~~~~~~~~~~~y~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 922 (1176)
++.+++......|.+. +.|+.|....+|+....+| .+++|..... ....++..|+.+++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4555555555556542 3466688899999987655 6778876532 12345667888877774212 33444
Q ss_pred eE------EeeCCeeEEEEeeccCCCHHH--------------HHhhcc-ccCcc-------cCHHHHHH----------
Q 046275 923 GY------CKVGEERLLVYEYMRYGSLED--------------VLHNQK-KVGIK-------LNWAARRK---------- 964 (1176)
Q Consensus 923 ~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~-~~~~~-------l~~~~~~~---------- 964 (1176)
.. ....+..++||+|++|..+.. .+|... ....+ ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123466789999998854310 122110 00000 11222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 965 --IAIGSARGLAFLHHN----CIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 965 --i~~~ia~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
+...+.+.+++++.. ....++|+|+.+.||+++++..+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455556532 13469999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0066 Score=68.02 Aligned_cols=143 Identities=13% Similarity=0.111 Sum_probs=83.3
Q ss_pred ceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCC--CcccceeE-----EeeCCeeEEEEeec
Q 046275 866 SLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHR--NLVPLLGY-----CKVGEERLLVYEYM 938 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~E~~ 938 (1176)
..++ |....||+....+|+.+++|..... ......+..|..+++.+... .+++++.. ...++..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 8888999988777778999987522 12456677888888877422 24445443 22355678899999
Q ss_pred cCCCHH-----HH---------Hhhcccc-----CcccCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 046275 939 RYGSLE-----DV---------LHNQKKV-----GIKLNWAAR----RKI---------------AIGSARGLAFLHHN- 979 (1176)
Q Consensus 939 ~~gsL~-----~~---------l~~~~~~-----~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~- 979 (1176)
+|..+. .. +|..... ....++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 11 1211100 001222211 001 11111223333321
Q ss_pred ---CCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 980 ---CIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 980 ---~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0062 Score=67.38 Aligned_cols=71 Identities=10% Similarity=0.016 Sum_probs=44.8
Q ss_pred CceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCc-ccceeEEeeCCeeEEEEeec-cCCC
Q 046275 865 DSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNL-VPLLGYCKVGEERLLVYEYM-RYGS 942 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 942 (1176)
.+.|+.|....+|+. +.+++|........ .....+|+.+++.+...++ .+++++ +.+.-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 56788876432111 1123568888887743333 455544 334457899999 6544
Q ss_pred H
Q 046275 943 L 943 (1176)
Q Consensus 943 L 943 (1176)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.013 Score=65.75 Aligned_cols=143 Identities=13% Similarity=0.109 Sum_probs=74.5
Q ss_pred ceEeEeCceE-EEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC--CCcccceeEEeeCCeeEEEEeeccCCC
Q 046275 866 SLIGSGGFGD-VYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKH--RNLVPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 866 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
+.|+.|+... +|+....+|+.+++|...... ..++..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455554444 667665447777777543211 1334567777777642 23556666543333 78999998777
Q ss_pred HHHHHhhccc---------------------cCc-ccCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 046275 943 LEDVLHNQKK---------------------VGI-KLNWAARR-------K-------------IAIGSARGLAFLHH-- 978 (1176)
Q Consensus 943 L~~~l~~~~~---------------------~~~-~l~~~~~~-------~-------------i~~~ia~~L~~LH~-- 978 (1176)
+.+++..... ... .++..... . ....+.+.++.+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 7655432110 000 11111100 0 00011122222211
Q ss_pred -cCCCCeeeCCCCCCCEEECCC----CcEEEEeecccccc
Q 046275 979 -NCIPHIIHRDMKSSNVLLDEN----FEARVSDFGMARLM 1013 (1176)
Q Consensus 979 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~~ 1013 (1176)
.....++|||+.+.||+++.+ +.+.++||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 67999999988653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0054 Score=71.43 Aligned_cols=72 Identities=17% Similarity=0.158 Sum_probs=49.0
Q ss_pred CceEeEeCceEEEEEEECC--------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC-cccceeEEeeCCeeEEEE
Q 046275 865 DSLIGSGGFGDVYKAKLKD--------GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN-LVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 935 (1176)
.+.|+.|....||++...+ ++.+++|+.... .....+.+|..+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 478888876321 22255668999998885333 3566665532 3899
Q ss_pred eeccCCC
Q 046275 936 EYMRYGS 942 (1176)
Q Consensus 936 E~~~~gs 942 (1176)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0094 Score=67.84 Aligned_cols=142 Identities=13% Similarity=0.115 Sum_probs=82.3
Q ss_pred ceEeEeCceEEEEEEEC--------CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEEe
Q 046275 866 SLIGSGGFGDVYKAKLK--------DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 936 (1176)
+.+..|-...+|++... +++.+++|+.-. .......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45667888889999864 247888887532 2234556779999998884 3334566666543 38999
Q ss_pred eccCCCHHH--------------H---Hhhccc-cCcccC--HHHHHHHHHHHHH-------------------HHHHHH
Q 046275 937 YMRYGSLED--------------V---LHNQKK-VGIKLN--WAARRKIAIGSAR-------------------GLAFLH 977 (1176)
Q Consensus 937 ~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~ia~-------------------~L~~LH 977 (1176)
|++|.++.. . +|.... .+.... +.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998855431 1 111110 011122 3444445443321 223332
Q ss_pred ----hc-CCCCeeeCCCCCCCEEECCC----CcEEEEeeccccc
Q 046275 978 ----HN-CIPHIIHRDMKSSNVLLDEN----FEARVSDFGMARL 1012 (1176)
Q Consensus 978 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~ 1012 (1176)
.. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 22368999999999999876 7899999998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0063 Score=57.77 Aligned_cols=66 Identities=17% Similarity=0.152 Sum_probs=48.8
Q ss_pred CeeeccccccC-CCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHh
Q 046275 499 NWISLSNNHLG-GEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 499 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 566 (1176)
..++.+++.|+ ..+|..+ .++|++|+|++|+|+...+..|..+++|+.|+|++|++.+..--..|.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~ 77 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLR 77 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHH
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHH
Confidence 36777888776 3456443 246899999999998655667888999999999999998765444443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.93 E-value=0.011 Score=56.13 Aligned_cols=56 Identities=14% Similarity=0.185 Sum_probs=43.1
Q ss_pred ceeeccCCccc--ccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeecccccc
Q 046275 221 QFLDVSSNNFS--MAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 221 ~~L~Ls~N~l~--~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 278 (1176)
..++.++++++ .+|..+. .+|++|+|++|+|+.+.+..|..+++|++|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36788888887 6665432 46888888888888887788888888888888888764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.017 Score=64.92 Aligned_cols=32 Identities=22% Similarity=0.313 Sum_probs=27.9
Q ss_pred CCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 982 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
..++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999877643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.034 Score=65.00 Aligned_cols=74 Identities=14% Similarity=0.020 Sum_probs=46.8
Q ss_pred CceEeEeCceEEEEEEECC-CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCc-ccceeEEeeCCeeEEEEeeccCCC
Q 046275 865 DSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNL-VPLLGYCKVGEERLLVYEYMRYGS 942 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 942 (1176)
.+.|+.|-...+|++...+ +..+++|...... ...-+..+|..+++.+...++ .++++++. . .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998865 4678887663322 111123589999998865444 56666652 2 35999998744
Q ss_pred H
Q 046275 943 L 943 (1176)
Q Consensus 943 L 943 (1176)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.53 E-value=0.012 Score=67.12 Aligned_cols=72 Identities=15% Similarity=0.088 Sum_probs=42.9
Q ss_pred ceEeEeCceEEEEEEECC---------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC-cccceeEEeeCCeeEEEE
Q 046275 866 SLIGSGGFGDVYKAKLKD---------GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN-LVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 935 (1176)
+.++.|....+|+....+ ++.+++|....... ...+...|..+++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 456778888999998754 26788886543211 1112467888888875333 44666543 2 37899
Q ss_pred eeccCCC
Q 046275 936 EYMRYGS 942 (1176)
Q Consensus 936 E~~~~gs 942 (1176)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.48 E-value=0.088 Score=53.70 Aligned_cols=103 Identities=16% Similarity=0.123 Sum_probs=67.8
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
-||.+++...+ .+++++++|.++.|.+.+|.-.-.... + ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 38999998775 489999999999999998876622111 1 1233457899999999887763 1110
Q ss_pred cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCC
Q 046275 1021 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064 (1176)
Q Consensus 1021 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 1064 (1176)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888764 3557889999999999999874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.92 E-value=0.13 Score=59.12 Aligned_cols=74 Identities=8% Similarity=0.009 Sum_probs=48.0
Q ss_pred CceEeEeCceEEEEEEECC--------CCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEE
Q 046275 865 DSLIGSGGFGDVYKAKLKD--------GSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.+.+..|-...+|+....+ ++.+++++..... ...-+..+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3467778889999998763 5788888753322 11223467888888884 333455555332 27899
Q ss_pred eeccCCCH
Q 046275 936 EYMRYGSL 943 (1176)
Q Consensus 936 E~~~~gsL 943 (1176)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.43 E-value=1.3 Score=50.81 Aligned_cols=29 Identities=28% Similarity=0.452 Sum_probs=24.7
Q ss_pred eeeCCCCCCCEEE------CCCCcEEEEeeccccc
Q 046275 984 IIHRDMKSSNVLL------DENFEARVSDFGMARL 1012 (1176)
Q Consensus 984 ivH~Dlkp~NIll------~~~~~~kl~DfGla~~ 1012 (1176)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.72 E-value=0.57 Score=34.22 Aligned_cols=11 Identities=27% Similarity=0.428 Sum_probs=4.7
Q ss_pred ccchhhhhHHH
Q 046275 774 LAGSIAMGLLF 784 (1176)
Q Consensus 774 l~~~i~~~~~~ 784 (1176)
++++++.|+++
T Consensus 13 IA~gVVgGv~~ 23 (44)
T 2ks1_B 13 IATGMVGALLL 23 (44)
T ss_dssp STHHHHHHHHH
T ss_pred EEeehhHHHHH
Confidence 44444444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.74 E-value=2.3 Score=43.26 Aligned_cols=115 Identities=6% Similarity=0.092 Sum_probs=77.9
Q ss_pred CCCCcccceeEEeeCCeeEEEEeeccCC-CHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 046275 914 KHRNLVPLLGYCKVGEERLLVYEYMRYG-SLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSS 992 (1176)
Q Consensus 914 ~h~niv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 992 (1176)
.||+++.. .+-.+++...+.|+.-+.+ ++.. ++ ..+...+++++..|+....++++. +|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68888866 4555666666666654422 2222 22 478899999999999888666655 68889999
Q ss_pred CEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Q 046275 993 NVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTD 1066 (1176)
Q Consensus 993 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~ 1066 (1176)
|++++.++.+++.=.|+-..+ +|. ..+...=.-.+=+++..++++++.|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877653222 222 11222233456678899999998863
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.60 E-value=0.83 Score=33.27 Aligned_cols=10 Identities=50% Similarity=0.770 Sum_probs=3.8
Q ss_pred hhhhHHHHhh
Q 046275 778 IAMGLLFSLF 787 (1176)
Q Consensus 778 i~~~~~~~~~ 787 (1176)
|+.|.+.+++
T Consensus 12 IA~gVVgGv~ 21 (44)
T 2l2t_A 12 IAAGVIGGLF 21 (44)
T ss_dssp HHHHHHHHHH
T ss_pred EEEeehHHHH
Confidence 3333333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1176 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-14 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-12 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-14 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-13 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-10 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-07 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 8e-73
Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 21/276 (7%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
IGSG FG VYK K V + + + Q + F E+ + K +H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
+ +V ++ SL LH + K IA +A+G+ +LH I IH
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKSI---IH 127
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC---S 1043
RD+KS+N+ L E+ ++ DFG+A + S L+G+ ++ PE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
+ DVY++G+VL EL+TG+ P + + N + P+L K N
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVG---RGYLSPDLSKVRSNCP 239
Query: 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
+ + + + CL + RP Q++A + +
Sbjct: 240 KAMKR---LMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 6e-66
Identities = 65/271 (23%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G+G FG+V+ + VA+K + F AE + +++H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
E ++ EYM GSL D L GIKL +A A G+AF+ + IH
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKG 1046
RD++++N+L+ + +++DFG+ARL+ + + PE + K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKS 191
Query: 1047 DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIEL 1106
DV+S+G++L E++T R + ++ +++ ++ D EL
Sbjct: 192 DVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGYRMVRPDNCPEEL----------- 239
Query: 1107 LQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ C +RP RPT + ++ ++
Sbjct: 240 ---YQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 5e-65
Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 24/274 (8%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
IGSG FG V+ + VAIK I + +F E E + K+ H LV L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
LV+E+M +G L D L Q+ + + + G + + +IHR
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEG---MAYLEEACVIHR 125
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGD 1047
D+ + N L+ EN +VSDFGM R + S T + PE + R S+K D
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSD 184
Query: 1048 VYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELL 1107
V+S+GV++ E+ + + + ++ +V + +L + +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGFRLYKPRLASTHV------------ 231
Query: 1108 QHLHVASACLDDRPWRRPTMIQVMAMFKEI-QAG 1140
+ + C +RP RP +++ EI ++G
Sbjct: 232 --YQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-63
Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 31/299 (10%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC-- 925
IG G FG+V++ K + G VA+K + AE+ ++H N++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 926 --KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI-- 981
+ LV +Y +GSL D L+ + K+A+ +A GLA LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 982 ---PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV--STLAGTPGYVPPEY 1036
P I HRD+KS N+L+ +N ++D G+A + + + + GT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 1037 YQS------FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV------KQHAK 1084
F + D+Y+ G+V E+ + V ++ K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143
+ P + + E L + C R T +++ ++ G+
Sbjct: 244 VVCEQKLRPNIPNRWQSCE-ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 5e-63
Identities = 56/270 (20%), Positives = 112/270 (41%), Gaps = 23/270 (8%)
Query: 868 IGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV 927
+G+G FG V K + VAIK I + EF E + + + H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 928 GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHR 987
++ EYM G L + L + + ++ + +L +HR
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 988 DMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGD 1047
D+ + N L+++ +VSDFG++R + + SV + + PPE + S+K D
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSKSD 183
Query: 1048 VYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELL 1107
++++GV++ E+ + + F ++ + Q +L + ++
Sbjct: 184 IWAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQGLRLYRPHLASEKV------------ 230
Query: 1108 QHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ +C ++ RPT +++ ++
Sbjct: 231 --YTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 4e-62
Identities = 72/305 (23%), Positives = 129/305 (42%), Gaps = 40/305 (13%)
Query: 851 TFADLLEATNGFHN---------DSLIGSGGFGDVYKAKLK----DGSTVAIKKL-IHIS 896
TF D EA F + +IG+G FG+V LK VAIK L +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 897 GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIK 956
+ R+F +E +G+ H N++ L G +++ E+M GSL+ L +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---Q 124
Query: 957 LNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM--- 1013
+ G A G+ +L +HRD+ + N+L++ N +VSDFG++R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGD 1072
++ T+ S + PE Q + ++ DV+SYG+V+ E+++ G+RP D +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMTN 239
Query: 1073 NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+++ ++Q +L L + C RP Q++
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSAL--------------HQLMLDCWQKDRNHRPKFGQIVN 285
Query: 1133 MFKEI 1137
++
Sbjct: 286 TLDKM 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-61
Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 867 LIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
IG G FGDV + G+ VA+K + + + + F AE + +++H NLV LLG
Sbjct: 14 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 927 VGEERL-LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ L +V EYM GSL D L ++ + L K ++ + +L N + +
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFV 125
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+ + NVL+ E+ A+VSDFG+ + S+ T + PE + + STK
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTK 180
Query: 1046 GDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIE 1105
DV+S+G++L E+ + R ++V V++ K+ D P +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAPDGCPPAV---------- 229
Query: 1106 LLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
V C RP+ +Q+ + I+
Sbjct: 230 ----YEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (534), Expect = 2e-61
Identities = 76/329 (23%), Positives = 133/329 (40%), Gaps = 57/329 (17%)
Query: 836 LSINLATFEKPLRKLTFADLLEATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAI 889
L+ L + E P + + IG G FG V++A+ + VA+
Sbjct: 1 LNPKLLSLEYPRNNIEYVRD------------IGEGAFGRVFQARAPGLLPYEPFTMVAV 48
Query: 890 KKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLH 948
K L S +F E + + + N+V LLG C VG+ L++EYM YG L + L
Sbjct: 49 KMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 108
Query: 949 NQKKVGI--------------------KLNWAARRKIAIGSARGLAFLHHNCIPHIIHRD 988
+ + L+ A + IA A G+A+L +HRD
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRD 165
Query: 989 MKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDV 1048
+ + N L+ EN +++DFG++R + + D + + A ++PPE R +T+ DV
Sbjct: 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 1049 YSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQ 1108
++YGVVL E+ + ++ +V+ L + EL
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGM-AHEEVIYYVRDGNILACPENCPLEL------------- 271
Query: 1109 HLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
++ C P RP+ + + + +
Sbjct: 272 -YNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 6e-61
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 23/276 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPL 921
+ +G G FG+V+ + VAIK + F E + + K++H LV L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
E +V EYM GSL D L + G L +A A G+A++
Sbjct: 78 YAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+HRD++++N+L+ EN +V+DFG+ARL+ + + PE R
Sbjct: 135 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGR 190
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101
+ K DV+S+G++L EL T R + ++ V++ ++ L
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYRMPCPPECPESL------ 243
Query: 1102 IEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ C P RPT + A ++
Sbjct: 244 --------HDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 8e-61
Identities = 64/279 (22%), Positives = 123/279 (44%), Gaps = 29/279 (10%)
Query: 865 DSLIGSGGFGDVYKAKLK---DGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVP 920
D +G G FG V + + VAIK L + + D E E + + ++ + +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
L+G C+ E +LV E G L L +++ ++ + ++ + G+ +L
Sbjct: 74 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK- 128
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV-STLAGTPGYVPPEYYQS 1039
+ +HRD+ + NVLL A++SDFG+++ + A D++ + S + PE
Sbjct: 129 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 1040 FRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098
+ S++ DV+SYGV + E L+ G++P ++ +++Q +++ PEL
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRMECPPECPPEL--- 241
Query: 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ S C + RP + V +
Sbjct: 242 -----------YALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 867 LIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDRE-FTAEMETIGKIK-HRNL 918
+G+G FG V +A TVA+K L + +RE +E++ + + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKK--------------VGIKLNWAARRK 964
V LLG C +G L++ EY YG L + L ++ + L+
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
+ A+G+AFL + IHRD+ + N+LL ++ DFG+AR + ++
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
++ PE + + + DV+SYG+ L EL + D+ +K+ +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141
+ + E+ + C D P +RPT Q++ + ++ + S
Sbjct: 267 MLSPEHAPAEM--------------YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-59
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 863 HNDSLIGSGGFGDVYKAKLKDGST----VAIKKLIHISGQGD-REFTAEMETIGKIKHRN 917
H + +IG G FG VY L D A+K L I+ G+ +F E + H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 918 LVPLLGYCKVGEER-LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
++ LLG C E L+V YM++G L + + N+ + A+G+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGM--- 143
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM--SAMDTHLSVSTLAGTPGYVPP 1034
+HRD+ + N +LDE F +V+DFG+AR M D+ + + ++
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
E Q+ + +TK DV+S+GV+L EL+T P D ++ ++ Q +L +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVYLLQGRRLLQPEYCPDP 262
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
L V C + RP+ ++++ I +
Sbjct: 263 L--------------YEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-58
Identities = 67/313 (21%), Positives = 119/313 (38%), Gaps = 41/313 (13%)
Query: 858 ATNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKH 915
+ F S +G+G G V+K K G +A K + R E++ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
+V G E + E+M GSL+ VL + + K++I +GL +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
L I+HRD+K SN+L++ E ++ DFG++ + + + GT Y+ PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPE 173
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD-------------------------F 1070
Q S + D++S G+ L+E+ G+ P D
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 1071 GDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELL--QHLHVASACLDDRPWRRPTMI 1128
G + + I ++ D + + P + + + + CL P R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 1129 QVMAM--FKEIQA 1139
Q+M K A
Sbjct: 294 QLMVHAFIKRSDA 306
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-58
Identities = 58/280 (20%), Positives = 114/280 (40%), Gaps = 31/280 (11%)
Query: 865 DSLIGSGGFGDVYKAKLKDGST---VAIKKLIHISGQGD--REFTAEMETIGKIKHRNLV 919
D +GSG FG V K + VA+K L + + E AE + ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
++G C+ E +LV E G L L + + ++ + G+ +L +
Sbjct: 72 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 126
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST-LAGTPGYVPPEYYQ 1038
+ +HRD+ + NVLL A++SDFG+++ + A + + T + PE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 1039 SFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097
++ S+K DV+S+GV++ E + G++P + + +++ ++ E+
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGERMGCPAGCPREM-- 239
Query: 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ + C RP V +
Sbjct: 240 ------------YDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-58
Identities = 63/294 (21%), Positives = 115/294 (39%), Gaps = 44/294 (14%)
Query: 867 LIGSGGFGDVYKAKLKDGS------TVAIKKLIHISGQGDRE-FTAEMETIGKI-KHRNL 918
++GSG FG V A S VA+K L + +RE +E++ + ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKK-------------------VGIKLNW 959
V LLG C + L++EY YG L + L ++++ L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 960 AARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019
A A+G+ FL +HRD+ + NVL+ ++ DFG+AR + + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWV 1079
+ ++ PE + K DV+SYG++L E+ + D N +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 1080 KQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133
+ K+ E+ + +C +RP+ + +
Sbjct: 281 QNGFKMDQPFYATEEIY--------------IIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-57
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 25/272 (9%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNLVPLLG 923
IG+G +G K + K DG + K+L ++ + +E+ + ++KH N+V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 924 YCKVGEERLL--VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH--HN 979
L V EY G L V+ K L+ ++ L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
++HRD+K +NV LD ++ DFG+AR+++ + GTP Y+ PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNR 188
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099
+ K D++S G +L EL P F L G +++ +I + EL
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIREGKFRRIPYRYSDEL---- 242
Query: 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
E++ L+ + + RP++ +++
Sbjct: 243 ----NEIITR------MLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-57
Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 28/271 (10%)
Query: 868 IGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCK 926
+G G FG VYKA+ K+ A K + S + ++ E++ + H N+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 927 VGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIH 986
++ E+ G+++ V+ ++ L + + + + L +LH N IIH
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 987 RDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC---- 1042
RD+K+ N+L + + +++DFG++ + + GTP ++ PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRP 191
Query: 1043 -STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101
K DV+S G+ L+E+ + P + N + + + AK +P + +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLKIAK------SEPPTLAQPSR 240
Query: 1102 IEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
CL+ R T Q++
Sbjct: 241 WSSNF---KDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 2e-57
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 23/277 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G +G+VY+ K TVA+K + EF E + +IKH NLV
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
LLG C ++ E+M YG+L D L + +++ +A + + +L
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
+ IHRD+ + N L+ EN +V+DFG++RLM+ + PE
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYN 191
Query: 1041 RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100
+ S K DV+++GV+L E+ T + + +++ +++ + ++
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERPEGCPEKV----- 245
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ AC P RP+ ++ F+ +
Sbjct: 246 ---------YELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-57
Identities = 63/296 (21%), Positives = 124/296 (41%), Gaps = 30/296 (10%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGS-----TVAIKKLIHISGQGDR-EFTAEMETIGKIKH 915
+IG+G FG+VYK LK S VAIK L + R +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
N++ L G + +++ EYM G+L+ L + + + + G A G+
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGM-- 123
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST-LAGTPGYVPP 1034
+ + +HRD+ + N+L++ N +VSDFG++R++ ++ + P
Sbjct: 124 -KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
E + ++ DV+S+G+V+ E++T + ++ ++ + +L
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGFRLPTPMDCPSA 241
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGLDSQSTIA 1150
+ + C RRP ++++ ++ DS T+A
Sbjct: 242 I--------------YQLMMQCWQQERARRPKFADIVSILDKLIRAP--DSLKTLA 281
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-57
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 38/295 (12%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKDGST---VAIKKL-IHISGQGDREFTAEMETIGKI-K 914
N +IG G FG V KA++K AIK++ + S R+F E+E + K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 915 HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQ------------KKVGIKLNWAAR 962
H N++ LLG C+ L EY +G+L D L L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 963 RKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSV 1022
A ARG+ + IHRD+ + N+L+ EN+ A+++DFG++R
Sbjct: 130 LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 1023 STLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082
+ ++ E +T DV+SYGV+L E+++ L + Q
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-PYCGMTCAELYEKLPQG 242
Query: 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+L+ D E+ + C ++P+ RP+ Q++ +
Sbjct: 243 YRLEKPLNCDDEV--------------YDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 7e-57
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 24/268 (8%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKL-IHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
+G G +G+V A + VA+K + + + E+ + H N+V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+ G + L EY G L D + + ++ G+ +LH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGI---GI 124
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST 1044
HRD+K N+LLDE ++SDFG+A + + ++ + GT YV PE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 1045 KG-DVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
+ DV+S G+VL +L G+ P D W ++ L D
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-------- 236
Query: 1104 IELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ LL L + P R T+ +
Sbjct: 237 LALLHK------ILVENPSARITIPDIK 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-56
Identities = 64/275 (23%), Positives = 103/275 (37%), Gaps = 32/275 (11%)
Query: 865 DSLIGSGGFGDVYKAKLKD-GSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNLVPL 921
D IG G F VYK + VA +L ++ + F E E + ++H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 922 LGYC----KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
K + +LV E M G+L+ L K + R +GL FLH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 978 HNCIPHIIHRDMKSSNVLL-DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
P IIHRD+K N+ + ++ D G+A L A + GTP ++ PE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM 184
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096
Y+ + DVY++G+ +LE+ T + P V PE+
Sbjct: 185 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ C+ R ++ ++
Sbjct: 244 --------------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 6e-56
Identities = 68/277 (24%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD---REFTAEMETIGKIKHRN 917
F + IG G FG VY A+ +++ VAIKK+ + Q + ++ E+ + K++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
+ G LV EY + + + ++K L + G+ +GLA+LH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 132
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
+ ++IHRD+K+ N+LL E ++ DFG A +M+ ++ GTP ++ PE
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYWMAPEVI 183
Query: 1038 QSF---RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
+ + K DV+S G+ +EL K P + N + + A+ + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQSGH 238
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ ++ +CL P RPT ++
Sbjct: 239 WSEY--------FRNF--VDSCLQKIPQDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 62/279 (22%), Positives = 105/279 (37%), Gaps = 29/279 (10%)
Query: 868 IGSGGFGDVYKAKLK----DGSTVAIKKL---IHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G FG V + + +VA+K L + + +F E+ + + HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
L G ++ V E GSL D L + + A+ A G+ +L
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST-LAGTPGYVPPEYYQS 1039
IHRD+ + N+LL ++ DFG+ R + D H + + PE ++
Sbjct: 132 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 1040 FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099
S D + +GV L E+ T + G L K+ +L + ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI---- 244
Query: 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138
+V C +P RPT + + E Q
Sbjct: 245 ----------YNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-55
Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 25/266 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG G G VY A + G VAI+++ E+ + + K+ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
VG+E +V EY+ GSL DV+ + + + L FLH N +I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 986 HRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTK 1045
HRD+KS N+LL + +++DFG ++ + ST+ GTP ++ PE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 1046 GDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIE 1105
D++S G++ +E++ G+ P + + N + + A ++ +PE + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPP-----YLNENPLRALYLIATNGTPELQNPEKLSAIF---RD 248
Query: 1106 LLQHLHVASACLDDRPWRRPTMIQVM 1131
L CLD +R + +++
Sbjct: 249 FLNR------CLDMDVEKRGSAKELL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-55
Identities = 67/271 (24%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKL---IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G G FG+VY A+ K +A+K L + + E+E ++H N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
GY L+ EY G++ L K + A L++ H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK--- 125
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
+IHRD+K N+LL E +++DFG + + TL GT Y+PPE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMH 181
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ--HAKLKISDVFDPELMKEDP 1100
K D++S GV+ E L GK P F N K+ + D
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGA----- 231
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+L+ L P +RP + +V+
Sbjct: 232 ---RDLISR------LLKHNPSQRPMLREVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-54
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 31/283 (10%)
Query: 868 IGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGDR-EFTAEMETIGKIKHRNLVP 920
+G G FG VY+ K + VAIK + + +R EF E + + ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKK------VGIKLNWAARRKIAIGSARGLA 974
LLG G+ L++ E M G L+ L + + V + + ++A A G+A
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 975 FLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
+L+ N +HRD+ + N ++ E+F ++ DFGM R + D + ++ P
Sbjct: 148 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 1035 EYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
E + +T DV+S+GVVL E+ T + ++ +V + L D
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRFVMEGGLLDKPDNCPDM 263
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
L + C P RP+ +++++ KE
Sbjct: 264 L--------------FELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-54
Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 30/283 (10%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGST-----VAIKKLIHI-SGQGDREFTAEMETIGKIKH 915
F ++GSG FG VYK VAIK+L S + ++E E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
++ LLG C + L+ + M +G L D + K + + A+G+ +
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNY 126
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
L ++HRD+ + NVL+ +++DFG+A+L+ A + ++ E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094
+ + DV+SYGV + EL+T G +P D + + +++ +L + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLPQPPICTID 241
Query: 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ + C RP +++ F ++
Sbjct: 242 VY--------------MIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-54
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 30/277 (10%)
Query: 867 LIGSGGFGDVYKAKLKD----GSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPL 921
IG G FGDV++ VAIK + + RE F E T+ + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+G ++ E G L L +K L+ A+ A + LA+L
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK-- 127
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
+HRD+ + NVL+ N ++ DFG++R M + + S ++ PE R
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRR 185
Query: 1042 CSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDP 1100
++ DV+ +GV + E+L G +P +N+++G ++ +L + P L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERLPMPPNCPPTL----- 238
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
+ + C P RRP ++ A I
Sbjct: 239 ---------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 40/295 (13%)
Query: 867 LIGSGGFGDVYKAKLK--------DGSTVAIKKL-IHISGQGDREFTAEMETIGKI-KHR 916
+G G FG V A+ + VA+K L + + + +EME + I KH+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 917 NLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGI------------KLNWAARRK 964
N++ LLG C ++ EY G+L + L ++ G+ +L+
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 965 IAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVST 1024
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR + +D + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 1025 LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
++ PE + + DV+S+GV+L E+ T L +K+ +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEELFKLLKEGHR 255
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139
+ EL + C P +RPT Q++ I A
Sbjct: 256 MDKPSNCTNEL--------------YMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 39/297 (13%)
Query: 867 LIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQGD-REFTAEMETIGKIKHR-NL 918
+G G FG V +A TVA+K L + + R +E++ + I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 919 VPLLGYC-KVGEERLLVYEYMRYGSLEDVLHNQKKVGIK------------LNWAARRKI 965
V LLG C K G +++ E+ ++G+L L +++ + L
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 966 AIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTL 1025
+ A+G+ FL IHRD+ + N+LL E ++ DFG+AR + ++
Sbjct: 140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 1026 AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL 1085
++ PE + + DV+S+GV+L E+ + D +K+ ++
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256
Query: 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI-QAGS 1141
+ D PE+ C P +RPT +++ + QA +
Sbjct: 257 RAPDYTTPEM--------------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (471), Expect = 3e-52
Identities = 54/269 (20%), Positives = 105/269 (39%), Gaps = 25/269 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G+G FG V++ G+ A K ++ E++T+ ++H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ E +++YE+M G L + + ++ K++ + +GL +H N + +
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 986 HRDMKSSNVLL--DENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
H D+K N++ + E ++ DFG+ + + GT + PE +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVG 203
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
D++S GV+ LL+G P FG N ++ + D
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP-----FGGENDDETLRNVKSCDWN--MDDSAFSGISEDG 256
Query: 1104 IELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ ++ L P R T+ Q +
Sbjct: 257 KDFIRK------LLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-52
Identities = 59/271 (21%), Positives = 102/271 (37%), Gaps = 32/271 (11%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKL---IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
++G G F V A+ L AIK L I T E + + ++ H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
+ E+ Y + G L + + R L +LH I
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGI- 129
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
IHRD+K N+LL+E+ +++DFG A+++S ++ GT YV PE
Sbjct: 130 --IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS--DVFDPELMKEDP 1100
D+++ G ++ +L+ G P F N ++ KL+ + F P+
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYDFPEKFFPKA----- 237
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+L++ L +R ++
Sbjct: 238 ---RDLVEK------LLVLDATKRLGCEEME 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (457), Expect = 2e-50
Identities = 50/269 (18%), Positives = 101/269 (37%), Gaps = 25/269 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+GSG FG V++ G K + E+ + ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ E +L+ E++ G L D + + K++ A + GL +H + I+
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 986 HRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
H D+K N++ + + V DFG+A ++ + + T + PE
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
D+++ GV+ LL+G P F + + ++ + FD +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQNVKRCDWE--FDEDAFSSVSPEA 259
Query: 1104 IELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ +++ L P +R T+ +
Sbjct: 260 KDFIKN------LLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (449), Expect = 6e-50
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 22/268 (8%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGKIKHRNLVPLLGY 924
++G+G F +V A+ + VAIK + + +G E+ + KIKH N+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
+ G L+ + + G L D + + ++ + +LH I H
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCST 1044
+ LDE+ + +SDFG++++ ST GTPGYV PE S
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSK 188
Query: 1045 KGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEI 1104
D +S GV+ LL G P F D N +Q K + FD + +
Sbjct: 189 AVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILKAEYE--FDSPYWDDISDSAK 241
Query: 1105 ELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+ ++H ++ P +R T Q +
Sbjct: 242 DFIRH------LMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-49
Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 28/275 (10%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G G FG V++ T K + + G E+ + +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
+ EE ++++E++ + + ++ +LN L FLH + +I
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 986 HRDMKSSNVLLDENFEARV--SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
H D++ N++ + + +FG AR + D L P Y PE +Q S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVS 181
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
T D++S G ++ LL+G P F ++ + + FD E KE
Sbjct: 182 TATDMWSLGTLVYVLLSGINP-----FLAETNQQIIENIMNAEYT--FDEEAFKEISIEA 234
Query: 1104 IELLQHLHVASACLDDRPWRRPTMIQVMAM--FKE 1136
++ + L R T + + K+
Sbjct: 235 MDFVDR------LLVKERKSRMTASEALQHPWLKQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (434), Expect = 2e-48
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 30/292 (10%)
Query: 859 TNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGD---REFTAEMETIGKIK 914
++ + ++G GG +V+ A+ L+ VA+K L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 915 HRNLVPLLGYC----KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
H +V + G +V EY+ +L D++H + + ++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LMSAMDTHLSVSTLAGTP 1029
+ L F H N IIHRD+K +N+++ +V DFG+AR + + ++ + + GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 1030 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089
Y+ PE + + DVYS G VL E+LTG+ P F ++ V QH +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHVREDP-- 231
Query: 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-TMIQVMAMFKEIQAG 1140
+ + ++ L P R T ++ A + G
Sbjct: 232 IPPSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 3e-46
Identities = 73/281 (25%), Positives = 111/281 (39%), Gaps = 33/281 (11%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIH---ISGQGDREFTAE---METIGK 912
N F +IG GGFG+VY + D G A+K L QG+ E + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 913 IKHRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+V + ++ + + M G L L + A R A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
L +H+ +++RD+K +N+LLDE+ R+SD G+A S H SV GT GY+
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 172
Query: 1033 PPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091
PE Q + D +S G +L +LL G P D + + + +++ D F
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
PEL LL+ L RR + A
Sbjct: 233 SPEL--------RSLLEG------LLQRDVNRRLGCLGRGA 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 1e-45
Identities = 57/281 (20%), Positives = 99/281 (35%), Gaps = 28/281 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IGSG FGD+Y + G VAIK + E + ++ +P + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 926 KV-GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
G+ ++V E + + +K + +A + ++H +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 985 IHRDMKSSNVL---LDENFEARVSDFGMARLMSAMDTHLSV-----STLAGTPGYVPPEY 1036
IHRD+K N L + + DFG+A+ TH + L GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096
+ S + D+ S G VL+ G P ++ ++ K+S L
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQ--GLKAATKRQKYERISEKKMSTP-IEVLC 241
Query: 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
K P+ L C R +P + +F+ +
Sbjct: 242 KGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 2e-45
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 42/294 (14%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKL--------IHISGQGDRE-FTAEMETIG 911
+ ++G G V + A+K + Q RE E++ +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 912 KIK-HRNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
K+ H N++ L + LV++ M+ G L D L + L+ RKI
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALL 120
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPG 1030
+ LH +I+HRD+K N+LLD++ +++DFG + + + + GTP
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPS 174
Query: 1031 YVPPEYYQSFRC------STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK 1084
Y+ PE + + D++S GV++ LL G P F + ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIMS 229
Query: 1085 LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKE 1136
F + + +L+ L +P +R T + +A F++
Sbjct: 230 GNYQ--FGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-45
Identities = 61/306 (19%), Positives = 119/306 (38%), Gaps = 32/306 (10%)
Query: 855 LLEATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE-FTAEMETIGK 912
+ + + N S IG G +G V A + VAIKK+ Q + E++ + +
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 913 IKHRNLVPLLGYCKVGE----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
+H N++ + + + + + ++ L +L Q L+
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQ 117
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM-SAMDTHLSVSTLAG 1027
RGL ++H +++HRD+K SN+LL+ + ++ DFG+AR+ D ++
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 1028 TPGYVPPEY-YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-----NLVGWVKQ 1081
T Y PE S + D++S G +L E+L+ + + D ++G Q
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 1082 HAKLKISDVFDPELMKEDPNIEIELLQHL---------HVASACLDDRPWRRPTMIQVMA 1132
I ++ + P+ L + L P +R + Q +A
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
Query: 1133 M--FKE 1136
++
Sbjct: 295 HPYLEQ 300
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 2e-44
Identities = 58/272 (21%), Positives = 115/272 (42%), Gaps = 37/272 (13%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKL---IHISGQGDREFTAEMETIGKIKHRNLVPLL 922
+G+G FG V+ + + +G A+K L I + + E + + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 923 GYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIP 982
G + ++ ++ +Y+ G L +K A + L +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFS--LLRKSQRFPNPVAKFYAAEV-----CLALEYLHSK 123
Query: 983 HIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC 1042
II+RD+K N+LLD+N +++DFG A+ + + TL GTP Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPY 178
Query: 1043 STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ--HAKLKISDVFDPELMKEDP 1100
+ D +S+G+++ E+L G P F D+N + ++ +A+L+ F+ ++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFPPFFNEDV----- 228
Query: 1101 NIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+LL + +R +Q
Sbjct: 229 ---KDLLSR------LITRDLSQRLGNLQNGT 251
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 29/290 (10%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKL-----IHISGQGDREFTAEMETIGKIKHRNLVP 920
+G G F VYKA+ K VAIKK+ +R E++ + ++ H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 921 LLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC 980
LL LV+++M + N L + + + + +GL +LH +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 981 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSF 1040
I +HRD+K +N+LLDEN +++DFG+A+ + + + T Y PE
Sbjct: 121 I---LHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGA 175
Query: 1041 RC-STKGDVYSYGVVLLELLTGKRPTDSADFGDN-----NLVGWVKQHAKLKISDVFDPE 1094
R D+++ G +L ELL D +G + + + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 1095 LMKEDPNIEIELLQH------LHVASACLDDRPWRRPTMIQVMAM--FKE 1136
K P I + + L + P R T Q + M F
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 55/294 (18%), Positives = 118/294 (40%), Gaps = 27/294 (9%)
Query: 866 SLIGSGGFGDVYKAKLK--DGSTVAIKKLIHISGQGDREFT-----AEMETIGKIKHRNL 918
+ IG G +G V+KA+ G VA+K++ +G+ + A + + +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSL--EDVLHNQKKVGIKLNWAARRKIAIGSARGLAFL 976
V L C V + + + + + K + + + RGL FL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 977 HHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
H + ++HRD+K N+L+ + + +++DFG+AR+ S +++ T Y PE
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEV 186
Query: 1037 YQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-----NLVGWVKQHAKLKISDVF 1091
+T D++S G + E+ K + D +++G + + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 1092 DPELMKEDPNIEIELLQHL-----HVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138
+ + + + + CL P +R + ++ F++++
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (403), Expect = 4e-44
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 26/292 (8%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNLV 919
+H IG G +G VYKA+ G T A+KK+ E+ + ++KH N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L + +LV+E++ + + + L + + G+A+ H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR 119
Query: 980 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQS 1039
++HRD+K N+L++ E +++DFG+AR + T Y P+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMG 174
Query: 1040 F-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-----NLVGWVKQHAKLKISDV--F 1091
+ ST D++S G + E++ G D ++G ++++ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 1092 DPELMKEDPNIEIELLQHL-----HVASACLDDRPWRRPTMIQVMAM--FKE 1136
DP +P L+ L + S L P +R T Q + FKE
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 34/280 (12%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDRE---FTAEMETIGK-IKHRNLVPL 921
++G G FG V+ A+ K AIK L D + E + +H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 922 LGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ E V EY+ G L + + K + + A GL FLH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK-- 122
Query: 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR 1041
I++RD+K N+LLD++ +++DFGM + D +T GTP Y+ PE +
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQK 179
Query: 1042 CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPN 1101
+ D +S+GV+L E+L G+ P D + L ++ + E
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMD-NPFYPRWLEKEA------ 230
Query: 1102 IEIELLQHLHVASACLDDRPWRRPTMIQVM---AMFKEIQ 1138
+LL P +R + + +F+EI
Sbjct: 231 --KDLLVK------LFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 34/298 (11%)
Query: 862 FHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNL 918
F IG G +G VYKA+ K G VA+KK+ + E+ + ++ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
V LL + LV+E++ + + + + + +GLAF H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHS 120
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+ ++HRD+K N+L++ +++DFG+AR + T Y PE
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILL 175
Query: 1039 SFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097
+ ST D++S G + E++T + GD+ + + L D +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFP----GDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 1098 EDPNIEIELLQH----------------LHVASACLDDRPWRRPTMIQVMAM--FKEI 1137
P+ + + + S L P +R + +A F+++
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (393), Expect = 1e-42
Identities = 51/282 (18%), Positives = 90/282 (31%), Gaps = 28/282 (9%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
IG G FG +++ L + VAIK + E T + +P + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 926 KVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHII 985
++ + SLED+L + K + A + +H ++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 986 HRDMKSSNVLLDENFE-----ARVSDFGMARLMSAMDTHLSV-----STLAGTPGYVPPE 1035
+RD+K N L+ V DFGM + T + L+GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ S + D+ + G V + L G P N + K EL
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---QKYERIGEKKQSTPLREL 240
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137
P + + + + P + +F ++
Sbjct: 241 CAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFSKV 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-42
Identities = 52/273 (19%), Positives = 103/273 (37%), Gaps = 29/273 (10%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
++G G G V + + A+K + + RE + ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKM-LQDCPKARREVELHWRAS---QCPHIVRIVDVY 74
Query: 926 KVGEER----LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCI 981
+ L+V E + G L + ++ +I + +LH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 982 PHIIHRDMKSSNVLLDENFE---ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
+I HRD+K N+L +++DFG A+ ++ ++ +T TP YV PE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLG 186
Query: 1039 SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098
+ D++S GV++ LL G P + ++ L ++++ P E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPF----YSNHGLAISPGMKTRIRMGQYEFPN--PE 240
Query: 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVM 1131
+ E+ + L P +R T+ + M
Sbjct: 241 WSEVSEEVKM---LIRNLLKTEPTQRMTITEFM 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-42
Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 32/299 (10%)
Query: 862 FHNDSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP 920
+ + +IG+G FG VY+AKL D G VAIKK++ Q R E++ + K+ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 921 LLGYCKVGEER------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLA 974
L + E+ LV +Y+ H + L + R LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 975 FLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1033
++H I HRD+K N+LLD + ++ DFG A+ + + + VS + P
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAP 191
Query: 1034 PEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD------NNLVGWVKQHAKLKI 1087
+ + ++ DV+S G VL ELL G+ D L ++ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 1088 SDVFDPELMKEDPNIEIELLQH------LHVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138
+ + + + + ++ + + + S L+ P R T ++ A F E++
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-42
Identities = 60/284 (21%), Positives = 105/284 (36%), Gaps = 46/284 (16%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDRE------FTAEMETIGKIK--HRN 917
L+GSGGFG VY + D VAIK + E E+ + K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
++ LL + + + +L+ E ++ L R + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 978 HNCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEY 1036
+ ++HRD+K N+L+D N E ++ DFG L+ GT Y PPE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEW 180
Query: 1037 YQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ R V+S G++L +++ G P + D ++ ++ E
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDEEII-----RGQVFFRQRVSSEC 231
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEI 1137
L++ CL RP RPT ++ +++
Sbjct: 232 --------QHLIRW------CLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 36/284 (12%)
Query: 867 LIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDR------EFTAEMETIGKIKHRNLV 919
+GSG F V K + K G A K + + R + E+ + +I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 920 PLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHN 979
L + + +L+ E + G L D L ++ L + G+ +LH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSL 132
Query: 980 CIPHIIHRDMKSSNVLLDENFEAR----VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
I H D+K N++L + + + DFG+A + + + GTP +V PE
Sbjct: 133 QI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ D++S GV+ LL+G P F + + + + F+ E
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTKQETLANVSAVNYE--FEDEY 239
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEI 1137
+ + ++ L P +R T+ + K
Sbjct: 240 FSNTSALAKDFIRR------LLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-39
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 36/300 (12%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNL 918
+ + IG G FG+V+KA+ K G VA+KK++ + E++ + +KH N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 919 VPLLGYCKVGEER--------LLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSA 970
V L+ C+ LV+++ + + + K + +++
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 127
Query: 971 RGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT--HLSVSTLAGT 1028
GL ++H N I+HRDMK++NVL+ + +++DFG+AR S + T
Sbjct: 128 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 1029 PGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGD-----NNLVGWVKQH 1082
Y PPE R D++ G ++ E+ T + L G +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVA----------SACLDDRPWRRPTMIQVMA 1132
+ + E ++ + ++ L L P +R +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-37
Identities = 64/297 (21%), Positives = 117/297 (39%), Gaps = 28/297 (9%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLI--HISGQGDREFTAEMETIGKIKHRNL 918
+ + +GSG +G V A + G+ VAIKKL S + E+ + ++H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 919 VPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHH 978
+ LL E ++ + KL + + +GL ++H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 979 NCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1038
IIHRD+K N+ ++E+ E ++ DFG+AR + T T Y PE
Sbjct: 140 A---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAPEVIL 191
Query: 1039 SF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-----NNLVGWVKQHAKLKISDVFD 1092
++ R + D++S G ++ E++TGK +D D + G ++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 1093 PELMKEDPNIEIELLQHL---------HVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138
MK P +E + + ++ L +R T + +A F+ +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 59/288 (20%), Positives = 110/288 (38%), Gaps = 28/288 (9%)
Query: 868 IGSGGFGDVYKAKLK-DGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNLVPLLGY 924
IG G +G V+KAK + VA+K++ E+ + ++KH+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 925 CKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHI 984
++ LV+E+ + + + + +GL F H ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDL----DPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 985 IHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-S 1043
+HRD+K N+L++ N E ++++FG+AR S T Y PP+ + S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYS 180
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDV--------FDPEL 1095
T D++S G + EL RP + D+ L + + P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 1096 MKEDPNIEIELLQHLHVA-----SACLDDRPWRRPTMIQVMAM--FKE 1136
M + ++ L+ L P +R + + + F +
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-37
Identities = 60/292 (20%), Positives = 100/292 (34%), Gaps = 41/292 (14%)
Query: 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKL---IHISGQGDREFTAEMETIGKIKH 915
N F L+G G FG V + K G A+K L + I+ E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
L L + + V EY G L L + R L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSAL-- 118
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPE 1035
+ +++RD+K N++LD++ +++DFG+ + + + T GTP Y+ PE
Sbjct: 119 -EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 1036 YYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH--AKLKISDVFDP 1093
+ D + GVV+ E++ G+ P F + + + +++ P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILMEEIRFPRTLSP 230
Query: 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM-------FKEIQ 1138
E LL L P +R A F I
Sbjct: 231 EA--------KSLLAG------LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 3e-36
Identities = 59/278 (21%), Positives = 102/278 (36%), Gaps = 32/278 (11%)
Query: 868 IGSGGFGDVYKAK-LKDGSTVAIKKLIH---ISGQGDREFTAEMETIGKIKHRNLVPLLG 923
+G+G FG V K + G+ A+K L + + E + + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPH 983
K +V EY+ G + L + + R A +LH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---D 161
Query: 984 IIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCS 1043
+I+RD+K N+L+D+ +V+DFG A+ + TL GTP + PE S +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-----TLCGTPEALAPEIILSKGYN 216
Query: 1044 TKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIE 1103
D ++ GV++ E+ G P F + + ++ K+ F + ++
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLL 269
Query: 1104 IELLQHLHVASACLDDR-PWRRPTMIQVMAM--FKEIQ 1138
LLQ L R + + + F
Sbjct: 270 RNLLQV------DLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 3e-35
Identities = 54/307 (17%), Positives = 107/307 (34%), Gaps = 45/307 (14%)
Query: 860 NGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRN 917
+ + +G G + +V++A + + V +K + ++ E++ + ++ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 918 LVPLLGYCKVGEERL--LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
++ L K R LV+E++ + + L R + L +
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 976 LHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1034
H I H RD+K NV++D E+ + R+ D+G+A + + + + P
Sbjct: 145 CHSMGIMH---RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 198
Query: 1035 EYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093
E ++ D++S G +L ++ K P + LV K + D D
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 1094 ELMKEDPNIEIELLQH---------------------LHVASACLDDRPWRRPTMIQVMA 1132
++ DP L +H L L R T + M
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 1133 M--FKEI 1137
F +
Sbjct: 319 HPYFYTV 325
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-34
Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 867 LIGSGGFGDVYKAKL----KDGSTVAIKKL----IHISGQGDREFTAEMETIGKIKHR-N 917
++G+G +G V+ + G A+K L I + E + + I+
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 918 LVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLH 977
LV L + + L+ +Y+ G L L +++ +I + L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-------LE 143
Query: 978 HNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYY 1037
H II+RD+K N+LLD N ++DFG+++ A +T + GT Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYMAPDIV 202
Query: 1038 QSFR--CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095
+ D +S GV++ ELLTG P F + + ++ + +P
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-----FTVDGEKNSQAEISRRILK--SEPPY 255
Query: 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMA 1132
+E + +L+Q L P +R A
Sbjct: 256 PQEMSALAKDLIQR------LLMKDPKKRLGCGPRDA 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-33
Identities = 73/305 (23%), Positives = 119/305 (39%), Gaps = 38/305 (12%)
Query: 857 EATNGFHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKL--IHISGQGDREFTAEMETIGKI 913
E + N S +GSG +G V A K G VA+KKL S + E+ + +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 914 KHRNLVPLLGYCKVGE-----ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIG 968
KH N++ LL + + ++ L +++ Q KL + +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQ 129
Query: 969 SARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGT 1028
RGL ++H IIHRD+K SN+ ++E+ E ++ DFG+AR T T
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVAT 181
Query: 1029 PGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDN-----NLVGWVKQH 1082
Y PE ++ + D++S G ++ ELLTG+ D D LVG
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVA---------SACLDDRPWRRPTMIQVMAM 1133
KIS ++ + ++ + L +R T Q +A
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 1134 --FKE 1136
F +
Sbjct: 302 AYFAQ 306
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-32
Identities = 61/305 (20%), Positives = 101/305 (33%), Gaps = 47/305 (15%)
Query: 862 FHNDSLIGSGGFGDVYKAK-LKDGSTVAIKKL--IHISGQGDREFTAEMETIGKIKHRNL 918
+ N IGSG G V A VAIKKL + + E+ + + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 919 VPLLGYCKV------GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARG 972
+ LL ++ LV E M + + + + G
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCG 131
Query: 973 LAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
+ LH I IHRD+K SN+++ + ++ DFG+AR + T Y
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYR 185
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-------------------- 1072
PE D++S G ++ E++ K D+ D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 1073 ----NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQH-LHVASACLDDRPWRRPTM 1127
N V ++A L +F L D + S L P +R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 1128 IQVMA 1132
+
Sbjct: 306 DDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 2e-28
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 17/212 (8%)
Query: 867 LIGSGGFGDVYKAK-LKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYC 925
+G G F V+ AK + + + VA+K + E++ + ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 926 KVGEERLLVYEY------------MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGL 973
+LL + + +K + ++I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 974 AFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1032
++H C IIH D+K NVL++ + + +A L +A + T Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 1033 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRP 1064
PE D++S ++ EL+TG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 108 bits (271), Expect = 8e-26
Identities = 69/363 (19%), Positives = 134/363 (36%), Gaps = 26/363 (7%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNN 229
+ L I + + L Q+ N++T + L + +++N
Sbjct: 45 QVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQ 99
Query: 230 FSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQ 289
+ P + D ++ L + + + S + +
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 290 GEIPLHLAD--LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFL 347
L + L ++ S ++LES ++N+ S P+ I
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI-- 217
Query: 348 SMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFL 407
++NL EL L+ N +L++LTNL LDL++N +S P + L EL L
Sbjct: 218 -LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGL----TKLTELKL 270
Query: 408 QNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE 467
N + P + L+ + I + L L L L+ N + P
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISN----LKNLTYLTLYFNNISDISP-- 324
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
+ ++ L+ LF N+++ ++L+N TN+NW+S +N + P + L+ + L L
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380
Query: 528 SNN 530
++
Sbjct: 381 NDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (268), Expect = 2e-25
Identities = 73/378 (19%), Positives = 135/378 (35%), Gaps = 37/378 (9%)
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
E + L VT ++ + + L ++ L ++ S N+ T
Sbjct: 23 EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDI 81
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+ L + +++N + P+ + L + +L++ N
Sbjct: 82 T--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
+ S+L G ++ + L + + L+ LTNL
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYL 436
E+L ++N +S P + +L EL L N L TL++ + L L L+ N +
Sbjct: 200 ESLIATNNQISDITPLGIL----TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 437 TGTIPSSLGSLSKLQDLKLWLNQLHGEIP--------------------PELGNIQTLET 476
+ P L L+KL +LKL NQ+ P + N++ L
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536
L L FN ++ P +S+ T L + +NN + + + L+N+ L +N
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 537 PPELGDCRSLIWLDLNTN 554
P L + + L LN
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (253), Expect = 1e-23
Identities = 79/409 (19%), Positives = 145/409 (35%), Gaps = 52/409 (12%)
Query: 98 LSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL 157
L +N++ T+S + L + +L + I + ++L +N S+N L
Sbjct: 27 TVLGKTNVTDTVSQ-------TDLDQVT-TLQADRLGIKSIDGVEYLNNLTQINFSNNQL 78
Query: 158 DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKC 217
+ L + ++ N + L L L N++T +
Sbjct: 79 --TDITPLKNLTKLVDILMNNN-----QIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 218 KNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
NL L++SSN S G + + + + + N
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK----- 186
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKF 337
+ + ++L L ++N +S P ++L+ ++ N+
Sbjct: 187 -------------VSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQL 231
Query: 338 SGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQG 397
I S++NL +L L+ N + P LS LT L L L +N +S P
Sbjct: 232 KD---IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 286
Query: 398 PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWL 457
N + S +SN L L L FN ++ P + SL+KLQ L
Sbjct: 287 LTNLELNENQLED------ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNN 506
N++ L N+ + L N+++ P L+N T + + L++
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.2 bits (238), Expect = 1e-21
Identities = 77/431 (17%), Positives = 140/431 (32%), Gaps = 82/431 (19%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
+ +K L N++ V + + I+ ++NL ++ S N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSNN 76
Query: 361 DFTGALPDSLSNLTNLETLDLSS-------------NNLSGAIPHNLCQGPRNSLKELFL 407
T P L NLT L + +++ N + +N L
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 408 QNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPE 467
L + S +S S L SL T L +L+ L+ L + N++
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL- 193
Query: 468 LGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
+ LE+L N+++ P TNL+ +SL+ N L + L+NL L L
Sbjct: 194 -AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 528 SNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKND 587
+NN P L L L L N + P A
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGL---------------------- 284
Query: 588 GSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNM 647
T ++ ++ +L + +N
Sbjct: 285 --------------------------TALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 648 LSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL 707
+S P + S++ L L +N +S + + +L +N L N++ P +++L
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANL 372
Query: 708 TLLNEIDLCNN 718
T + ++ L +
Sbjct: 373 TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.3 bits (194), Expect = 4e-16
Identities = 71/411 (17%), Positives = 134/411 (32%), Gaps = 57/411 (13%)
Query: 284 GYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPI 343
G + DL + L + K ++L + S+N+ + P+
Sbjct: 30 GKTNVTDTVSQ--TDL-DQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITPL 84
Query: 344 EIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403
+ +++ L +++++ N P + + I +L
Sbjct: 85 K---NLTKLVDILMNNNQIADITPLANLTNLTGL------TLFNNQITDIDPLKNLTNLN 135
Query: 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGE 463
L L +N + S +S S L SL T L +L+ L+ L + N++
Sbjct: 136 RLELSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523
+ LE+L N+++ P TNL+ +SL+ N L + L+NL
Sbjct: 191 SVL--AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 524 ILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
L L+NN P L L L L N + P A + +
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL---------ELN 293
Query: 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643
L + + +S I + + L
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDI-----------------SPVSSLTKLQRLFF 336
Query: 644 SYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSN 694
+ N +S + +++ + L+ GHN +S P + +L + L L+
Sbjct: 337 ANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 1e-12
Identities = 53/284 (18%), Positives = 102/284 (35%), Gaps = 21/284 (7%)
Query: 446 SLSKLQDLKLWLNQLHGEIPP-ELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
+L++ L + + +L + TL+ L + G + NL I+ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564
NN L P + L+ L + ++NN P + + L N +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 565 FKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVY 624
++++N I + + + L+ ++T + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSF------GNQVTDLKPLANLTTLERLDISSNK 186
Query: 625 GGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLR 684
++ L + N +S P I ++ L L+L N L + L
Sbjct: 187 VSDISVLAKLT-NLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLT 241
Query: 685 GLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMG 728
L LDL++N++ P +S LT L E+ L NQ++ + P+ G
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG 283
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 3e-10
Identities = 35/177 (19%), Positives = 66/177 (37%), Gaps = 34/177 (19%)
Query: 95 LETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSS 154
L+ LSL + + +L + + L+ LDL+ N +S ++ L + L L L +
Sbjct: 221 LDELSLNGNQLKDIGTLASLTN----LTDLDLANNQISN----LAPLSGLTKLTELKLGA 272
Query: 155 NLLDFSGREAGSLKLS--------------------LEVLDLSYNKISGANVVPWILFNG 194
N + AG L+ L L L +N IS +
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-----ISPVSS 327
Query: 195 CDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISAN 251
+L++L NKV+ +++ N+ +L N S + + + L ++
Sbjct: 328 LTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS-DLTPLANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (248), Expect = 2e-23
Identities = 60/277 (21%), Positives = 106/277 (38%), Gaps = 15/277 (5%)
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
DL LDL +N ++ F + +L + + +NK S P F + L+ L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLY 85
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
LS N LP+ + L+ L + N ++ + + EL G
Sbjct: 86 LSKNQLKE-LPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
+L + ++ +T TIP L L +L L N++ L + L
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG-- 534
L L FN ++ +L+N +L + L+NN L ++P + + ++ L NN+
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIG 258
Query: 535 ----RIPPELGDCRSLIWLDLNTN-LFNGSIPPALFK 566
P S + L +N + I P+ F+
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.6 bits (218), Expect = 2e-19
Identities = 54/349 (15%), Positives = 104/349 (29%), Gaps = 62/349 (17%)
Query: 375 NLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFN 434
+L + S L +P +L P + L LQNN + N L +L L N
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL---PPD-TALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65
Query: 435 YLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN 494
++ P + L KL+ L L NQL +Q L + ++ ++ L+
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 495 CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554
+ + + G + L+ +++++ + IP L SL L L+ N
Sbjct: 126 MIVVELGT-NPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGN 181
Query: 555 LFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIST 614
+L L+++
Sbjct: 182 KITKVDAASLKGL---------------------------------------NNLAKLGL 202
Query: 615 RSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG 674
G + + P + Y+ ++ L +NN+S
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKV------PGGLADHKYIQVVYLHNNNISA 256
Query: 675 ------PIPTEVGDLRGLNILDLSSNRLEGT--IPSSMSSLTLLNEIDL 715
P + + L SN ++ PS+ + + + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 26/272 (9%)
Query: 243 LEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSS 302
LD+ NK T ++L L + +N S P F
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP---GAFAP---------LVK 80
Query: 303 LVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDF 362
L +L LS N L + L + K + L+ + EL +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKS--VFNGLNQMIVVELGTNPLKS 138
Query: 363 TGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSN 422
+G + + L + ++ N++ IP L SL EL L N + ++L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP----SLTELHLDGNKITKVDAASLKG 193
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482
+ L L LSFN ++ SL + L++L L N+L ++P L + + ++ ++L N
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 252
Query: 483 ELTG------TLPAALSNCTNLNWISLSNNHL 508
++ P + + + +SL +N +
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 48/319 (15%), Positives = 94/319 (29%), Gaps = 57/319 (17%)
Query: 409 NNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL 468
++L L +P L L L N +T +L L L L N++ P
Sbjct: 18 SDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 469 GNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLS 528
+ LE L+L N+L L + + + Q+ + L +
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTN 134
Query: 529 NNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDG 588
G + L ++ + +IP L
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL-------------------- 173
Query: 589 SKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNML 648
E H GN + + ++ L +S+N +
Sbjct: 174 -TELHLDGNKIT-------------------------KVDAASLKGLNNLAKLGLSFNSI 207
Query: 649 SGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEG------TIPS 702
S + + +L L+L +N L +P + D + + ++ L +N + P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 703 SMSSLTLLNEIDLCNNQLT 721
+ + + L +N +
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.4 bits (158), Expect = 8e-12
Identities = 49/280 (17%), Positives = 90/280 (32%), Gaps = 50/280 (17%)
Query: 463 EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNL 522
++P +L L L N++T N NL+ + L NN + P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 523 AILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYV 582
L LS N +P ++ + + N + ++F
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQELRVHEN---EITKVRKSVFNG--------------- 122
Query: 583 YIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLD 642
L+++ G F + ++
Sbjct: 123 --------------------------LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156
Query: 643 ISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPS 702
I+ ++ +IP+ G L L+L N ++ + L L L LS N +
Sbjct: 157 IADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213
Query: 703 SMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNS 742
S+++ L E+ L NN+L + + + Q NN+
Sbjct: 214 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.1 bits (157), Expect = 1e-11
Identities = 45/301 (14%), Positives = 101/301 (33%), Gaps = 36/301 (11%)
Query: 121 LSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNK 180
+ LDL N ++ + +L L L +N + A + + LE L LS N+
Sbjct: 33 TALLDLQNNKITEIKDGD--FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 181 ISGANVVPWILFNGCDELKQLALKGNKVTGDI--NVSKCKNLQFLDVSSNNFSMAVPSFG 238
+ +P + EL+ + KV + +++ ++ + + +F
Sbjct: 91 LKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 239 DCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298
L Y+ I+ T L+ L++ N +
Sbjct: 148 GMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKG----------- 193
Query: 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358
++L KL LS N++S + L +++NK ++ + L
Sbjct: 194 -LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK--VPGGLADHKYIQVVYLH 250
Query: 359 FNDFTG------ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL 412
N+ + P + + + L SN + + ++ + ++++ +
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV------QYWEIQPSTFRCVYVRAAVQ 304
Query: 413 L 413
L
Sbjct: 305 L 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.4 bits (137), Expect = 3e-09
Identities = 46/264 (17%), Positives = 74/264 (28%), Gaps = 54/264 (20%)
Query: 487 TLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSL 546
+P L + + L NN + L NL L L NN P L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 547 IWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRA 606
L L+ N +P + K
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKT--------------------------------------- 101
Query: 607 ERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNML--SGSIPKEIGSMSYLFI 664
+ + FN M+ +++ N L SG M L
Sbjct: 102 -------LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
Query: 665 LNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMI 724
+ + N++ IP G L L L N++ +S+ L L ++ L N ++ +
Sbjct: 155 IRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211
Query: 725 PVMGQFETFQPAKFLNNSGLCGLP 748
LNN+ L +P
Sbjct: 212 NGSLANTPHLRELHLNNNKLVKVP 235
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.8 bits (120), Expect = 4e-07
Identities = 18/102 (17%), Positives = 40/102 (39%), Gaps = 2/102 (1%)
Query: 651 SIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLL 710
+PK++ +L+L +N ++ + +L+ L+ L L +N++ P + + L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 711 NEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPC 752
+ L NQL + M + + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 1e-22
Identities = 26/156 (16%), Positives = 52/156 (33%), Gaps = 21/156 (13%)
Query: 866 SLIGSGGFGDVYKAKLKDGSTVAIK----------KLIHISGQGDREFTAEMETIGKIKH 915
L+G G V+ + +K K+ GD F+ + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 916 RNLVPLLGYCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAF 975
R L L G Y + L +++ ++ +++ ++ +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118
Query: 976 LHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011
+H I+H D+ NVL+ E + DF +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (237), Expect = 3e-22
Identities = 49/262 (18%), Positives = 88/262 (33%), Gaps = 6/262 (2%)
Query: 297 ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELV 356
+ ++ ++ L N +S + F +C +L + SN + + +
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
P + L L TL L +L+ L+LQ+N L
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLD--RCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLET 476
T + L L L N ++ + L L L L N++ P ++ L T
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536
L+L N L+ AL+ L ++ L++N + + L + S++ +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSL 264
Query: 537 PPELGDCRSLIWLDLNTNLFNG 558
P L L N G
Sbjct: 265 PQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (212), Expect = 6e-19
Identities = 53/246 (21%), Positives = 79/246 (32%), Gaps = 5/246 (2%)
Query: 323 SCSSLESFDIS-SNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381
C + S + +P+ I + + + L N + S NL L L
Sbjct: 7 VCYNEPKVTTSCPQQGLQAVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWL 63
Query: 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIP 441
SN L+ + N L P+T +L +LHL L P
Sbjct: 64 HSNVLARIDAAAFTGLALLE-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 442 SSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWI 501
L+ LQ L L N L ++ L LFL N ++ A +L+ +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 502 SLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIP 561
L N + P L L L L N+ L R+L +L LN N +
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242
Query: 562 PALFKQ 567
Sbjct: 243 ARPLWA 248
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 6e-15
Identities = 57/270 (21%), Positives = 87/270 (32%), Gaps = 19/270 (7%)
Query: 218 KNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
Q + + N S SF C L L + +N A + L L++S N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
+ P L L L L L P F ++L+ + N
Sbjct: 92 QLRSVD----------PATFHGLG-RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
LP + F + NL L L N + + L +L+ L L N ++ PH
Sbjct: 141 LQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
R LF N L L+ L L L+ N + + LQ +
Sbjct: 200 LGRLMTLYLF--ANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGS 256
Query: 457 LNQLHGEIPPELGNIQTLETLFLDFNELTG 486
+++ +P L L N+L G
Sbjct: 257 SSEVPCSLPQRLAGRDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 7e-15
Identities = 55/315 (17%), Positives = 85/315 (26%), Gaps = 51/315 (16%)
Query: 409 NNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPEL 468
L ++P + SQ + L N ++ +S + L L L N L
Sbjct: 19 PQQGLQAVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 469 GNIQTLETLFLDFNELTGTL-PAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKL 527
+ LE L L N ++ PA L+ + L L P L+ L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 528 SNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKND 587
+N+ D +L L L+ N + A
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH------------------- 177
Query: 588 GSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNM 647
S F G +M L + N
Sbjct: 178 -------------------------SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 648 LSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSL 707
LS + + + L L L N L SS+ + ++P ++
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 708 TLLNEIDLCNNQLTG 722
L L N L G
Sbjct: 272 DLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (158), Expect = 6e-12
Identities = 47/273 (17%), Positives = 84/273 (30%), Gaps = 26/273 (9%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNN 229
+ + + L N+IS VP F C L L L N + + + ++
Sbjct: 33 ASQRIFLHGNRISH---VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 230 FSM----AVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGY 285
+ +F L L + L +L + N
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD--- 146
Query: 286 NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI 345
+L L L N +S F SL+ + N+ + P
Sbjct: 147 ---------DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HA 196
Query: 346 FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKEL 405
F + L L L N+ + ++L+ L L+ L L+ N + L++
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA---RPLWAWLQKF 253
Query: 406 FLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438
++ + S+P L+ L+ N L G
Sbjct: 254 RGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 1e-08
Identities = 39/203 (19%), Positives = 69/203 (33%), Gaps = 22/203 (10%)
Query: 140 YLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELK 199
L L+L L G +L+ L L N + +P F L
Sbjct: 100 TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA---LPDDTFRDLGNLT 156
Query: 200 QLALKGNKVTGDINVS--KCKNLQFLDVSSNNFSMAVP-SFGDCLALEYLDISANKFTGD 256
L L GN+++ + +L L + N + P +F D L L + AN +
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
A++ L +L ++ N + L + L K SS+ +
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDC-------------RARPLWAWLQKFRGSSSEVPCS 263
Query: 317 VPSRFGSCSSLESFDISSNKFSG 339
+P R + + +++N G
Sbjct: 264 LPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 4e-08
Identities = 49/273 (17%), Positives = 84/273 (30%), Gaps = 22/273 (8%)
Query: 476 TLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGR 535
T L +P + I L N + NL IL L +N
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 536 IPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGA 595
L LDL+ N S+ PA F G++ + + +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA- 130
Query: 596 GNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKE 655
L++ ++ L + + F G++ L + N +S +
Sbjct: 131 ---LQYLYLQDNALQALPDDT---------------FRDLGNLTHLFLHGNRISSVPERA 172
Query: 656 IGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDL 715
+ L L L N ++ P DL L L L +N L +++ L L + L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 716 CNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLP 748
+N + Q + ++ C LP
Sbjct: 233 NDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 95.2 bits (235), Expect = 1e-21
Identities = 62/319 (19%), Positives = 115/319 (36%), Gaps = 48/319 (15%)
Query: 437 TGTIPSSLGSLSKLQDLKLWLNQLHG--EIPPELGNIQTLETLFLDFNE-LTGTLPAALS 493
G + + ++ +L L L IP L N+ L L++ L G +P A++
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 494 NCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNT 553
T L+++ +++ ++ G IP ++ Q+ L L S N+ G +PP + +L+ + +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 554 NLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRIS 613
N +G+IP + S + I + +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-------------------- 198
Query: 614 TRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLS 673
+ + +R + ++G L L+L +N +
Sbjct: 199 -LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 674 GPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETF 733
G +P + L+ L+ L++S N L G IP G + F
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQG------------------------GNLQRF 293
Query: 734 QPAKFLNNSGLCGLPLPPC 752
+ + NN LCG PLP C
Sbjct: 294 DVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.5 bits (215), Expect = 5e-19
Identities = 62/373 (16%), Positives = 107/373 (28%), Gaps = 73/373 (19%)
Query: 29 DLQQLLSFKAALPNPSVLPNWSPNQNPCG--FKGVSCKAASVSSIDLSPFTLSVDFHLVA 86
D Q LL K L NP+ L +W P + C + GV C + +
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY---------------- 50
Query: 87 SFLLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGS--- 143
+ L L N+ +P SS + L+ + G + + +
Sbjct: 51 -------RVNNLDLSGLNLPKPYPIP-----SSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 144 -CSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLA 202
+ L L ++ + + + S +L LD SYN + + + L +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL---SGTLPPSISSLPNLVGIT 155
Query: 203 LKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAIS 262
GN+++G I S + + L +S
Sbjct: 156 FDGNRISGAIPDSYG----------SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFG 322
+V + + L L +L LDL +N + G +P
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
L S ++S N GE+P NL + +
Sbjct: 266 QLKFLHSLNVSFNNLCGEIP--------------------------QGGNLQRFDVSAYA 299
Query: 383 SNNLSGAIPHNLC 395
+N P C
Sbjct: 300 NNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 4e-13
Identities = 64/268 (23%), Positives = 95/268 (35%), Gaps = 20/268 (7%)
Query: 171 LEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNK---VTGDINVSKCKNLQFLDVSS 227
+ LDLS + +P L N L L + G ++K L +L ++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 228 NNFSMAVPS-FGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYN 286
N S A+P L LD S N +G + +IS+ +L + N SG IP Y
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 287 EFQG----------EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
F + + ++L + + + + S + I K
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
S + NL L L N G LP L+ L L +L++S NNL G IP
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--- 287
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCS 424
G NN L P L C+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 3e-11
Identities = 64/277 (23%), Positives = 99/277 (35%), Gaps = 37/277 (13%)
Query: 213 NVSKCKNLQFLDVSSNNFSMAVP---SFGDCLALEYLDISAN-KFTGDVGHAISACEHLS 268
++ + LD+S N P S + L +L I G + AI+ L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 269 FLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE 328
+L ++ SG IP ++ +LV LD S N LSG +P S +L
Sbjct: 105 YLYITHTNVSGAIPDFLSQ------------IKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 329 SFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLD-------- 380
N+ SG +P + +S N TG +P + +NL
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212
Query: 381 ------------LSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVS 428
+ G +L L L+NN + G++P L+ L S
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 429 LHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIP 465
L++SFN L G IP G+L + N+ P
Sbjct: 273 LNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (180), Expect = 3e-14
Identities = 58/411 (14%), Positives = 114/411 (27%), Gaps = 16/411 (3%)
Query: 326 SLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTG----ALPDSLSNLTNLETLDL 381
++S DI + S E+ + + + L T + +L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 382 SSNNLSGAIPHNLCQG---PRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG 438
SN L H + QG P +++L LQN L G+ LS+ + + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 439 TIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNL 498
+ + L L ++ + + E L +SN
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182
Query: 499 NWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558
+ P + L + S+N + L N G
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242
Query: 559 SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPC 618
+ + + I G + E + + +
Sbjct: 243 -MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301
Query: 619 NFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPT 678
+ + S+ + + L I N + +G
Sbjct: 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED-AGVREL 360
Query: 679 EVGDLRG---LNILDLSSNRLEGT----IPSSMSSLTLLNEIDLCNNQLTG 722
G + L +L L+ + + + +++ + L E+DL NN L
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.9 bits (161), Expect = 6e-12
Identities = 56/442 (12%), Positives = 99/442 (22%), Gaps = 19/442 (4%)
Query: 302 SLVKLDLSSNNLSGK-VPSRFGSCSSLESFDISSNKFSGELPIEI---FLSMSNLKELVL 357
+ LD+ LS + + + +I L EL L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 358 SFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIP 417
N+ + + + +L G +S L S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 418 STLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETL 477
QL+ L + + L + + + +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182
Query: 478 FLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIP 537
L L + L S I ++ G +
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242
Query: 538 PELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGN 597
L L+ GA
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302
Query: 598 LLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIG 657
L + C+FT H N ++ L IS N L + +E+
Sbjct: 303 LC-ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361
Query: 658 -----SMSYLFILNLGHNNLSG----PIPTEVGDLRGLNILDLSSNRLEGTIPSSMSS-- 706
S L +L L ++S + + L LDLS+N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 707 ---LTLLNEIDLCNNQLTGMIP 725
LL ++ L + + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 4e-09
Identities = 24/108 (22%), Positives = 35/108 (32%), Gaps = 25/108 (23%)
Query: 346 FLSMSNLKELVLSFNDFTG----ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNS 401
S L+ L L+ D + +L +L +L LDLS+N L A L + R
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ- 423
Query: 402 LKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSK 449
L L L Y + + L +L K
Sbjct: 424 --------------------PGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 9/91 (9%)
Query: 391 PHNLCQGPRNSLKELFLQNNLL----LGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGS 446
P + L+ L+L + + S+ +TL L L LS N L L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 447 -----LSKLQDLKLWLNQLHGEIPPELGNIQ 472
L+ L L+ E+ L ++
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 4e-07
Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 9/82 (10%)
Query: 470 NIQTLETLFLDFNELTGT----LPAALSNCTNLNWISLSNNHLGGEIPTWIGQ-----LS 520
L L+L +++ + L A L +L + LSNN LG + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 521 NLAILKLSNNSFYGRIPPELGD 542
L L L + + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 7e-07
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 8/97 (8%)
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS----CSSLESFDISSNKFSGE 340
+ E+ L S L L L+ ++S S + SL D+S+N
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 341 LPIEIFLSM----SNLKELVLSFNDFTGALPDSLSNL 373
+++ S+ L++LVL ++ + D L L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 20/103 (19%), Positives = 31/103 (30%), Gaps = 16/103 (15%)
Query: 318 PSRFGSCSSLESFDISSNKFSGELPIEI---FLSMSNLKELVLSFNDFTG----ALPDSL 370
S L ++ S + L+ +L+EL LS N L +S+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 371 -SNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLL 412
LE L L S + + L+ L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME--------DRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 14/93 (15%)
Query: 169 LSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDI------NVSKCKNLQF 222
L ++ LD+ ++S A L + + + L +T + L
Sbjct: 2 LDIQSLDIQCEELSDARWAE--LLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 223 LDVSSNNFS-MAVPSFGDCLA-----LEYLDIS 249
L++ SN + V L ++ L +
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 20/93 (21%), Positives = 40/93 (43%), Gaps = 9/93 (9%)
Query: 121 LSSLDLSLNILS-GPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKL----SLEVLD 175
+ SLD+ LS +++ L +V+ L L + + S L +L L+
Sbjct: 4 IQSLDIQCEELSDARWAEL--LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 176 LSYNKIS--GANVVPWILFNGCDELKQLALKGN 206
L N++ G + V L ++++L+L+
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 16/117 (13%), Positives = 36/117 (30%), Gaps = 27/117 (23%)
Query: 417 PSTLSNCSQLVSLHLSFNYLTGT----IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQ 472
S L L L+ ++ + + ++L + L++L L N L +L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-- 419
Query: 473 TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLS----NLAIL 525
+ L + L + + E+ + L +L ++
Sbjct: 420 -----------------SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 13/85 (15%), Positives = 26/85 (30%), Gaps = 9/85 (10%)
Query: 489 PAALSNCTNLNWISLSNNHLGGE----IPTWIGQLSNLAILKLSNNSFYGRIPPELGD-- 542
+ L + L++ + + + +L L LSNN +L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 543 ---CRSLIWLDLNTNLFNGSIPPAL 564
L L L ++ + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 19/80 (23%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 139 SYLGSCSSLKVLNLSSNLLDFSGREAGSLKL----SLEVLDLSYNKIS--GANVVPWILF 192
S L+VL L+ + S + + L SL LDLS N + G + +
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 193 NGCDELKQLALKGNKVTGDI 212
L+QL L + ++
Sbjct: 423 QPGCLLEQLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 20/79 (25%), Positives = 29/79 (36%), Gaps = 7/79 (8%)
Query: 112 PAGSRCSSFLSSLDLSLNILS--GPLSDISYLGSCSSLKVLNLSSNLLDFSGREA----- 164
+ S L L L+ +S S + L + SL+ L+LS+N L +G
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 165 GSLKLSLEVLDLSYNKISG 183
LE L L S
Sbjct: 422 RQPGCLLEQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 16/92 (17%), Positives = 28/92 (30%), Gaps = 8/92 (8%)
Query: 95 LETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILS--GPLSDISYLGSCSSLKVLNL 152
+++L ++ +S + L L+ S L +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQ-CQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 153 SSNLLDFSGREA-----GSLKLSLEVLDLSYN 179
SN L G + ++ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 12/82 (14%), Positives = 27/82 (32%), Gaps = 11/82 (13%)
Query: 243 LEYLDISANKFTGD----VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298
L L ++ + + + A L L++S+N + ++ +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL-------QLVESVRQ 423
Query: 299 LCSSLVKLDLSSNNLSGKVPSR 320
L +L L S ++ R
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 6e-04
Identities = 12/103 (11%), Positives = 29/103 (28%), Gaps = 14/103 (13%)
Query: 241 LALEYLDISANKFT-GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADL 299
L ++ LDI + + + + + + + +I L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT-------EARCKDISSALRV- 53
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGS-----CSSLESFDISSNKF 337
+L +L+L SN L ++ + +
Sbjct: 54 NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 0.001
Identities = 16/99 (16%), Positives = 27/99 (27%), Gaps = 5/99 (5%)
Query: 641 LDISYNMLSGSIPKEI-GSMSYLFILNLGHNNLSG----PIPTEVGDLRGLNILDLSSNR 695
LDI LS + E+ + ++ L L+ I + + L L+L SN
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 696 LEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQ 734
L + + L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 16/94 (17%), Positives = 34/94 (36%), Gaps = 12/94 (12%)
Query: 182 SGANVVPWILFNGCDELKQLALKGNKVTGDI------NVSKCKNLQFLDVSSNNFSMA-V 234
+G + L L+ L L V+ + +L+ LD+S+N A +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 235 PSFGDCL-----ALEYLDISANKFTGDVGHAISA 263
+ + LE L + ++ ++ + A
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.004
Identities = 13/94 (13%), Positives = 28/94 (29%), Gaps = 9/94 (9%)
Query: 627 HTQPTFNHNGSMMFLDISYNMLSG----SIPKEIGSMSYLFILNLGHNNLSGPIPTEVGD 682
Q + L ++ +S S+ + + L L+L +N L ++ +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 683 -----LRGLNILDLSSNRLEGTIPSSMSSLTLLN 711
L L L + + +L
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.5 bits (171), Expect = 9e-14
Identities = 50/213 (23%), Positives = 71/213 (33%), Gaps = 10/213 (4%)
Query: 320 RFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379
+S + + LP ++ + L LS N +L T L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGT 439
+L L + ++ L S+P L L +SFN LT
Sbjct: 61 NLDRAE-----LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
+L L +LQ+L L N+L P L LE L L N LT L+ NL+
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 500 WISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+ L N IP L L N +
Sbjct: 176 TLLLQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (159), Expect = 3e-12
Identities = 29/205 (14%), Positives = 52/205 (25%), Gaps = 5/205 (2%)
Query: 493 SNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLN 552
S + ++ +L +P + + IL LS N Y L L L+L+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 553 TNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRI 612
G + + + + + + L +
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 613 STRSPCNFTRVYGGHTQPTFNHNG-SMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNN 671
P + L ++ N L+ + + L L L N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 672 LSGPIPTEVGDLRGLNILDLSSNRL 696
L IP L L N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 41/192 (21%), Positives = 55/192 (28%), Gaps = 10/192 (5%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
+P DL L LS N L + + L ++ +
Sbjct: 24 ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL------TKLQVDG 74
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
L L L T L + L+EL+L+ N
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGN 470
L P L+ +L L L+ N LT L L L L L N L+ IP
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 471 IQTLETLFLDFN 482
L FL N
Sbjct: 194 SHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 1e-06
Identities = 44/206 (21%), Positives = 71/206 (34%), Gaps = 15/206 (7%)
Query: 214 VSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVS 273
VSK + ++ N + A+P L +S N + L+ LN+
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 274 SNLFSGPIP---------VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSC 324
+ + + Q + L +L LD+S N L+
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
L+ + N+ LP + L++L L+ N+ T L+ L NL+TL L N
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNN 410
+L IP L FL N
Sbjct: 183 SLY-TIPKGFFGSH--LLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 25/193 (12%), Positives = 47/193 (24%), Gaps = 16/193 (8%)
Query: 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALK 204
+L+LS NLL L L+L + L L
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--------LTKLQVDGTLPVLGTL 82
Query: 205 GNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISAC 264
++ + +L + ++ +
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFN------RLTSLPLGALRGLGELQELYLKGNEL 136
Query: 265 EHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSC 324
+ L ++ + + N L L +L L L N+L +P F
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE-NLDTLLLQENSLY-TIPKGFFGS 194
Query: 325 SSLESFDISSNKF 337
L + N +
Sbjct: 195 HLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 14/65 (21%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 655 EIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEID 714
E+ ++ +N NL+ +P ++ + IL LS N L +++ T L +++
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 715 LCNNQ 719
L +
Sbjct: 62 LDRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (165), Expect = 7e-13
Identities = 40/272 (14%), Positives = 88/272 (32%), Gaps = 15/272 (5%)
Query: 286 NEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI 345
++ L L ++ + + + F S ++ D+S++ I
Sbjct: 10 KNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGI 66
Query: 346 FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKEL 405
S L+ L L + + ++L+ +NL L+LS + + L EL
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 406 ------FLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
+ ++ +QL N + + + L L L +
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 460 LH-GEIPPELGNIQTLETLFLDF-NELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIG 517
+ + E + L+ L L ++ L L + + G +
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 518 QLSNLAILKLSNNSFYGRIPPELGDCRSL-IW 548
L + L+++ + F P +G+ ++ IW
Sbjct: 247 ALPH---LQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 3e-11
Identities = 46/303 (15%), Positives = 87/303 (28%), Gaps = 39/303 (12%)
Query: 123 SLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKIS 182
+LDL+ L + L S + + +D E S ++ +DLS + I
Sbjct: 4 TLDLTGKNLHPDV--TGRLLS-QGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIE 59
Query: 183 GANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVP-SFGDCL 241
+ + IL S+C LQ L + S + +
Sbjct: 60 V-STLHGIL-----------------------SQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
Query: 242 ALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS 301
L L++S + ++ + + + L
Sbjct: 96 NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 155
Query: 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF-N 360
S N + + C +L D+S + + F ++ L+ L LS
Sbjct: 156 S----GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL 420
D L + L+TL + G + +L L + + T+
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK-----EALPHLQINCSHFTTIARPTI 266
Query: 421 SNC 423
N
Sbjct: 267 GNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 7/133 (5%)
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
TLDL+ NL + L + + + + S ++ + LS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLL---SQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIE 59
Query: 438 G-TIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD--FNELTGTLPAALSN 494
T+ L SKLQ+L L +L I L L L L L LS+
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 495 CTNLNWISLSNNH 507
C+ L+ ++LS
Sbjct: 120 CSRLDELNLSWCF 132
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 43/284 (15%), Positives = 79/284 (27%), Gaps = 24/284 (8%)
Query: 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLH-GEIPPELGNIQTLETLFLDFNELTG 486
+L L+ L P G L + + + E + ++ + L + +
Sbjct: 4 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 487 -TLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAIL--KLSNNSFYGRIPPELGDC 543
TL LS C+ L +SL L I + + SNL L + + L C
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 544 RSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAG 603
L L+L+ F + K + + + S
Sbjct: 121 SRLDELNLSWC----------FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 170
Query: 604 IRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISY-NMLSGSIPKEIGSMSYL 662
+R S F + L +S + E+G + L
Sbjct: 171 VRRCPNLVHLDLSDSVM---LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227
Query: 663 FILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSS 706
L + G + L L I + + ++ +
Sbjct: 228 KTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 6e-07
Identities = 50/284 (17%), Positives = 96/284 (33%), Gaps = 24/284 (8%)
Query: 201 LALKGNKVTGDINVSKCK-NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGH 259
L L G + D+ + + + ++++D+S + H
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 260 AI-SACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLS--SNNLSGK 316
I S C L L++ I LA S+LV+L+LS S
Sbjct: 65 GILSQCSKLQNLSLE-----------GLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFA 112
Query: 317 VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
+ + SCS L+ ++S E +++ ++ + L+ + + L S +
Sbjct: 113 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 172
Query: 377 ETLDLSSNNLSGAIPHN----LCQGPRNSLKELFLQN-NLLLGSIPSTLSNCSQLVSLHL 431
+L +LS ++ N L+ L L ++ L L +L +
Sbjct: 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 232
Query: 432 SFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLE 475
GT+ +L LQ + + P +GN + E
Sbjct: 233 FGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 2e-04
Identities = 46/250 (18%), Positives = 88/250 (35%), Gaps = 28/250 (11%)
Query: 89 LLTLDTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLK 148
+ ++ + L NS I + S+CS L +L L LS P+ ++ L S+L
Sbjct: 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSK-LQNLSLEGLRLSDPI--VNTLAKNSNLV 98
Query: 149 VLNLS--SNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGN 206
LNLS S +F+ + S L+ L+LS+ V + + + + QL L G
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 207 KVTGDINVSKCKNLQFLDVSSNNFSM-------AVPSFGDCLALEYLDISANKFTGDVG- 258
+ + + ++ + S F L++L +S
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 259 HAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVP 318
+ L L V + G + + L +L L ++ ++ +
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQL---------------LKEALPHLQINCSHFTTIAR 263
Query: 319 SRFGSCSSLE 328
G+ + E
Sbjct: 264 PTIGNKKNQE 273
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 65.6 bits (158), Expect = 1e-11
Identities = 58/348 (16%), Positives = 94/348 (27%), Gaps = 26/348 (7%)
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453
L EL L N L S+P + L SL S N LT +P SL L
Sbjct: 32 LRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVD 86
Query: 454 KLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIP 513
L L P +L + L N + L I + NN L
Sbjct: 87 NNNLKALSDLPP---------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPD 137
Query: 514 TWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAA 573
A + P L + S+ + +
Sbjct: 138 LPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL 197
Query: 574 NFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFN 633
+ ++ + +L R + ++ + + ++ F+
Sbjct: 198 PELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 257
Query: 634 HNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSS 693
+ N S I L LN+ +N L +P L L S
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASF 313
Query: 694 NRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNN 741
N L +P +L L + N L + E + +N+
Sbjct: 314 NHLA-EVPELPQNLKQL---HVEYNPLREFPDIPESVEDLR----MNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 3e-09
Identities = 22/95 (23%), Positives = 35/95 (36%), Gaps = 11/95 (11%)
Query: 357 LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI 416
N + + +LE L++S+N L +P L+ L N L +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP-----RLERLIASFN-HLAEV 319
Query: 417 PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQ 451
P N L LH+ +N L P S+ L+
Sbjct: 320 PELPQN---LKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 6e-08
Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 15/102 (14%)
Query: 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALP 367
N S ++ S SLE ++S+NK E+ L+ L+ SFN +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLA-EVP 320
Query: 368 DSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
+ NL+ L + N L P S+++L + +
Sbjct: 321 ELPQ---NLKQLHVEYNPLRE-FPDIP-----ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 2e-07
Identities = 25/97 (25%), Positives = 41/97 (42%), Gaps = 10/97 (10%)
Query: 280 PIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSG 339
P + Y L DL SL +L++S+N L ++P+ LE S N +
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA- 317
Query: 340 ELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNL 376
E+ NLK+L + +N PD ++ +L
Sbjct: 318 ----EVPELPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 4e-07
Identities = 44/326 (13%), Positives = 89/326 (27%), Gaps = 22/326 (6%)
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN 482
Q L L+ L+ ++P L + L N L E+P ++++L +
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 483 ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGD 542
L+ L ++ +SNN E + S L I+ + NNS
Sbjct: 92 ALS-------DLPPLLEYLGVSNNQ--LEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 543 CRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFA 602
+ L P L + + + +++ +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202
Query: 603 GIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYL 662
+ + ++ + + +S L
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 663 FILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTG 722
N S I + L L++S+N+L +P+ L L N L
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE 318
Query: 723 MIPVMGQFETFQPAKFLNNSGLCGLP 748
+ + + + + L P
Sbjct: 319 VPELPQNLKQLH----VEYNPLREFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 62/338 (18%), Positives = 105/338 (31%), Gaps = 32/338 (9%)
Query: 144 CSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLAL 203
L L++ L L LE L S N ++ +P + + LK L +
Sbjct: 37 DRQAHELELNNLGL----SSLPELPPHLESLVASCNSLT---ELPELPQS----LKSLLV 85
Query: 204 KGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISA 263
N + +S L SNN +P + L+ +D+ N S
Sbjct: 86 DNNNL---KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 264 CEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGS 323
+ N L + L + + N + +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202
Query: 324 CSSLESFDISSNKFSGELPIEIFLSMSNLKEL-------VLSFNDFTGALPDSLSNLTNL 376
L + +N + L N+++ + F + S L+ L
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYL 436
N S I P SL+EL + NN L+ +P+ L L SFN+L
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPP--SLEELNVSNNKLI-ELPALPPR---LERLIASFNHL 316
Query: 437 TGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTL 474
+P + L+ L + N L E P +++ L
Sbjct: 317 A-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 24/84 (28%), Positives = 43/84 (51%), Gaps = 13/84 (15%)
Query: 144 CSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLAL 203
SL+ LN+S+N L E +L LE L S+N ++ VP + N LKQL +
Sbjct: 283 PPSLEELNVSNNKL----IELPALPPRLERLIASFNHLAE---VPELPQN----LKQLHV 331
Query: 204 KGNKVTGDINVSKCKNLQFLDVSS 227
+ N + ++ ++++ L ++S
Sbjct: 332 EYNPLREFPDIP--ESVEDLRMNS 353
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.7 bits (145), Expect = 2e-10
Identities = 44/247 (17%), Positives = 76/247 (30%), Gaps = 10/247 (4%)
Query: 318 PSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLE 377
R CS+ F +K + E+P ++ N EL + S +LE
Sbjct: 2 HHRICHCSN-RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLE 56
Query: 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT 437
+++S N++ I ++ + + N LL P N L L +S +
Sbjct: 57 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116
Query: 438 GTIPSSLGSLSKLQDLKLWL--NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNC 495
+ L + N E +G L+L+ N + A +
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 496 TNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNL 555
NN+L S IL +S + L + + L NL
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-NL 235
Query: 556 FNGSIPP 562
+P
Sbjct: 236 --KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (118), Expect = 4e-07
Identities = 26/234 (11%), Positives = 60/234 (25%), Gaps = 12/234 (5%)
Query: 494 NCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNT 553
+C+N + + EIP+ + N L+ L ++++
Sbjct: 7 HCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62
Query: 554 NLFNGSIPPALFKQSGKIAANF--------IVGKKYVYIKNDGSKECHGAGNLLEFAGIR 605
N I +F K+ + + + + +
Sbjct: 63 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122
Query: 606 AERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFIL 665
+ + ++ + + L ++ N + +
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 666 NLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQ 719
+NNL G ILD+S R+ + +L L N +
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 37/245 (15%), Positives = 60/245 (24%), Gaps = 15/245 (6%)
Query: 143 SCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLA 202
CS+ L S + + L + L K+ + F+G +L+++
Sbjct: 7 HCSNRVFLCQESKVTEI----PSDLPRNAIELRFVLTKLRV---IQKGAFSGFGDLEKIE 59
Query: 203 LKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAIS 262
+ N V I NL + + + +
Sbjct: 60 ISQNDVLEVIEADVFSNLPK-----LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 114
Query: 263 ACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFG 322
+ S L V L L+ N + F
Sbjct: 115 IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN 174
Query: 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
E +N ELP ++F S L +S L NL L
Sbjct: 175 GTQLDELNLSDNNNL-EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST- 232
Query: 383 SNNLS 387
NL
Sbjct: 233 -YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (110), Expect = 4e-06
Identities = 40/225 (17%), Positives = 74/225 (32%), Gaps = 7/225 (3%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
EIP +DL + ++L L F LE +IS N + ++F ++
Sbjct: 22 EIP---SDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78
Query: 351 NLKELVLSFNDFT-GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQN 409
L E+ + + P++ NL NL+ L +S+ + + + L ++
Sbjct: 79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138
Query: 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELG 469
N+ S + + V L L+ N + + + N L
Sbjct: 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH 198
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPT 514
L + + L N L S N ++PT
Sbjct: 199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 12/58 (20%), Positives = 20/58 (34%), Gaps = 3/58 (5%)
Query: 285 YNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP 342
N E+P + S V LD+S + + L + + K +LP
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 35/212 (16%), Positives = 64/212 (30%), Gaps = 13/212 (6%)
Query: 174 LDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMA 233
+ + ++ + D + L+ G VT V NL L++ N +
Sbjct: 24 IAAGKSNVTDT-----VTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDL 78
Query: 234 VPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIP 293
P E + + + L + + + +
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 294 LHL---ADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
+ + L LS N + + S L + NK S I S+
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD---ISPLASLP 195
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382
NL E+ L N + P L+N +NL + L+
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 3e-09
Identities = 44/229 (19%), Positives = 82/229 (35%), Gaps = 21/229 (9%)
Query: 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFN 360
++ +K+ +N++ V + + + IE ++NL L L N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKDN 73
Query: 361 DFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL 420
T P NL + + + + G ++ + + L
Sbjct: 74 QITDLAPLK-----NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ---ITDVTPL 125
Query: 421 SNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLD 480
+ S L L+L N +T P + + + + L N+ L TL D
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA----QVSDLTPLANLSKLTTLKAD 181
Query: 481 FNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
N+++ P L++ NL + L NN + P + SNL I+ L+N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 4e-08
Identities = 27/223 (12%), Positives = 71/223 (31%), Gaps = 14/223 (6%)
Query: 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSN 529
+ + + +T T+ ++ + +S + + L+NL L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 530 NSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGS 589
N P + + + L N +I ++ + + I + ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 590 KECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS 649
+ + + + + + + + L N +S
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD------LTPLANLSKLTTLKADDNKIS 186
Query: 650 GSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLS 692
P + S+ L ++L +N +S P + + L I+ L+
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 31/228 (13%), Positives = 68/228 (29%), Gaps = 17/228 (7%)
Query: 490 AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549
AL+N + +++ + L + L + +LI L
Sbjct: 16 PALANAIKIA---AGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 550 DLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERL 609
+L N + + +KN + + L+ + +
Sbjct: 69 ELKDNQITD------LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 610 SRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGH 669
+ ++ S + G +S S + ++S L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 670 NNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCN 717
N +S P + L L + L +N++ P +++ + L + L N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 33/228 (14%), Positives = 68/228 (29%), Gaps = 27/228 (11%)
Query: 342 PI-EIF--LSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGP 398
I IF +++N ++ ++ T + + ++L + TL ++
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGVQYLN-- 63
Query: 399 RNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPS--------------SL 444
+L L L++N + P + L + I +
Sbjct: 64 --NLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 445 GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
+ L +I +L + L+N + L +
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLN 552
+N + P + L NL + L NN P L + +L + L
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 36/223 (16%), Positives = 69/223 (30%), Gaps = 22/223 (9%)
Query: 283 VGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP 342
G + + ADL + L ++ ++L ++ N
Sbjct: 26 AGKSNVTDTVTQ--ADL-DGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN------Q 74
Query: 343 IEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSL 402
I + NL ++ S ++ + L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 403 KELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG 462
Q I + +LS + + L +LSKL LK N++
Sbjct: 135 YLDLNQ-------ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 463 EIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSN 505
P L ++ L + L N+++ P L+N +NL ++L+N
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 35/236 (14%), Positives = 76/236 (32%), Gaps = 34/236 (14%)
Query: 98 LSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLL 157
++ SN++ T++ + L + +L+ ++ I + ++L L L N +
Sbjct: 24 IAAGKSNVTDTVTQ-------ADLDGIT-TLSAFGTGVTTIEGVQYLNNLIGLELKDNQI 75
Query: 158 DFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKC 217
K++ L + K A + ++T ++
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDL-------TSTQITDVTPLAGL 128
Query: 218 KNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLF 277
NLQ L + N + P G +S ++ L+ L N
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLT---NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 278 SGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDIS 333
S P+ +L+++ L +N +S P + S+L ++
Sbjct: 186 SDISPLAS--------------LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.4 bits (134), Expect = 9e-09
Identities = 45/336 (13%), Positives = 93/336 (27%), Gaps = 24/336 (7%)
Query: 94 TLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILS--GPLSDISYLGSCSSLKV 149
++E SLK I+ S+ A + + LS N + + S L++
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 150 LNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVT 209
S E L L K+ + E L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 210 GDINVSKCKNLQFL---DVSSNNFSMAVPSFGDCLALEYLDISANKFT-GDVGHAISACE 265
+ + + + L + N+ G + +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 266 HLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCS 325
L+ + +G P G E + +L ++ + ++ S + S
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 326 SLESFDISSNKFSGELPIEI-----FLSMSNLKELVLSFNDFTGALPDSL-----SNLTN 375
+L ++ S + L L+ L L +N+ +L + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 376 LETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNL 411
L L+L+ N S + ++E+F
Sbjct: 304 LLFLELNGNRFSEEDDV------VDEIREVFSTRGR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 55.3 bits (131), Expect = 2e-08
Identities = 41/357 (11%), Positives = 88/357 (24%), Gaps = 40/357 (11%)
Query: 351 NLKELVLSFNDFTG----ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELF 406
+++ L + T ++ L +++ + LS N + L +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--------- 54
Query: 407 LQNNLLLGSIPSTLSNCSQLVSLHLSFNY---LTGTIPSSLGSLSKLQDLKLWLNQLHGE 463
+++ L S + + IP +L L + L+ +
Sbjct: 55 -------------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101
Query: 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523
Q FL + L + ++ + L
Sbjct: 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 161
Query: 524 ILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVY 583
+ N + L+T + + + + V
Sbjct: 162 SIICGRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL 220
Query: 584 IKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDI 643
D + G+ L + + N + L +
Sbjct: 221 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280
Query: 644 SYNMLSGSIPKEIGS-----MSYLFILNLGHNNLS--GPIPTEVGDL---RGLNILD 690
YN + + + + M L L L N S + E+ ++ RG LD
Sbjct: 281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 54.9 bits (130), Expect = 2e-08
Identities = 41/331 (12%), Positives = 91/331 (27%), Gaps = 31/331 (9%)
Query: 401 SLKELFLQNNLL----LGSIPSTLSNCSQLVSLHLSFNYLTG----TIPSSLGSLSKLQD 452
S++ L+ + + S+ + L + + LS N + + ++ S L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 453 LKLWLNQLH---GEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLG 509
+ EIP L + + + + A LS +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 510 GEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSG 569
+ L A K++ + + + L + N K
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 570 KIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629
V I+ +G + G+ + ++ FT +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLL-------LEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSM------SYLFILNLGHNNLSGPIPTEVGD- 682
++ L ++ +LS + L L L +N + +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 683 ----LRGLNILDLSSNRL--EGTIPSSMSSL 707
+ L L+L+ NR E + + +
Sbjct: 297 IDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.0 bits (125), Expect = 1e-07
Identities = 39/331 (11%), Positives = 88/331 (26%), Gaps = 39/331 (11%)
Query: 450 LQDLKLWLNQLHGE----IPPELGNIQTLETLFLDFNELTG----TLPAALSNCTNLNWI 501
++ L L+ + E + L +++ + L N + L +++ +L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 502 SLSNNH---LGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNG 558
S+ + EIP + L + ++ + + L+ +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 559 SIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGA-----GNLLEFAGIRAER----- 608
+ + A + + + N LE ++
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 609 LSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLS-------GSIPKEIGSMSY 661
+ T G L + + ++ + S
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 662 LFILNLGHNNLSGPIPTEVGD------LRGLNILDLSSNRLEGTIPSSMSS-----LTLL 710
L L L LS V D GL L L N +E ++ + + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 711 NEIDLCNNQLTGMIPVMGQFETFQPAKFLNN 741
++L N+ + V+ + +
Sbjct: 305 LFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 37/310 (11%), Positives = 74/310 (23%), Gaps = 15/310 (4%)
Query: 81 DFHLVASFLLTLDTLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILSGPLSDI 138
D V + LL D+++ + L + I L L + S +I
Sbjct: 19 DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI 78
Query: 139 SYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDEL 198
+L A ++D ++ G
Sbjct: 79 PEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS--FGDCLALEYLDISANKFTGD 256
++A ++ + L+ + N + L G
Sbjct: 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 198
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
I + +L +L L+ LS +
Sbjct: 199 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258
Query: 317 VPSRFGSC------SSLESFDISSNKFSGE----LPIEIFLSMSNLKELVLSFNDFTGAL 366
+ L++ + N+ + L I M +L L L+ N F
Sbjct: 259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEE 317
Query: 367 PDSLSNLTNL 376
D + + +
Sbjct: 318 DDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 37/326 (11%), Positives = 93/326 (28%), Gaps = 27/326 (8%)
Query: 218 KNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD----VGHAISACEHLSFLNVS 273
K+L+ +++ + + +++ + +S N + + I++ + L S
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 274 SNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLE--SFD 331
+ L KL + + P+
Sbjct: 68 DIFTGRVKDEIPEALR-----LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 332 ISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP 391
+ + L+ N P S + L+ S
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 392 HNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL----VSLHLSFNYLTGTIPSSLGSL 447
+ + + ++ + + L+ C +L + + + + + +L S
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 448 SKLQDLKLWLNQLHGEIPPELGNI------QTLETLFLDFNELTGTLPAAL-----SNCT 496
L++L L L + + L+TL L +NE+ L
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 497 NLNWISLSNNHLGGEIPTWIGQLSNL 522
+L ++ L+ N E + ++ +
Sbjct: 303 DLLFLELNGNRFSEE-DDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 45/332 (13%), Positives = 85/332 (25%), Gaps = 32/332 (9%)
Query: 146 SLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKIS--GANVVPWILFNGCDELKQLAL 203
SLK+ +++ S++ + LS N I A + + + +L+
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDD-SVKEIVLSGNTIGTEAARWLSENIAS-KKDLEIAEF 66
Query: 204 KGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISA 263
+ L + D +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN------AFGPTAQEPLIDFLSKH 120
Query: 264 CEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLS----GKVPS 319
++ L Q A L + N L +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 320 RFGSCSSLESFDISSNKFSGELPIEIFLS--------MSNLKELVLSFNDFTGALPDSLS 371
F S L + + N E + L + + + AL +L
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 372 NLTNLETLDLSSNNLSG----AIPHNLCQGPRNSLKELFLQNNLLLGSIPSTL-----SN 422
+ NL L L+ LS A+ + L+ L LQ N + TL
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 423 CSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLK 454
L+ L L+ N + + + ++ +
Sbjct: 301 MPDLLFLELNGNRFSE-EDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.003
Identities = 50/304 (16%), Positives = 79/304 (25%), Gaps = 52/304 (17%)
Query: 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEI---FLSMSNLKELVLSFN- 360
KLD + V + S++ +S N E + S +L+ S
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 361 ---------DFTGALPDSLSNLTNLETLDLSSNNLSGAIPH---------------NLCQ 396
+ L +L L T+ LS N L
Sbjct: 71 TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 130
Query: 397 GPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456
+ L ++ N L S+ N L + L
Sbjct: 131 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190
Query: 457 LNQLHGEIPPELGNIQTLETL-------------FLDFNELTGTLPAALSNCTNLNWISL 503
+ + I PE LE L + + L AL + NL + L
Sbjct: 191 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250
Query: 504 SNNHLGGEIPTWIGQ------LSNLAILKLSNNSFYGRIPPELGD-----CRSLIWLDLN 552
++ L + L L+L N L L++L+LN
Sbjct: 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 310
Query: 553 TNLF 556
N F
Sbjct: 311 GNRF 314
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 34/188 (18%), Positives = 66/188 (35%), Gaps = 4/188 (2%)
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
E + LK VT + ++ ++ + ++++ V + L ++ NK T
Sbjct: 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDI 83
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
A FL+ + + + + + LV L + G
Sbjct: 84 KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGN 143
Query: 317 -VPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTN 375
+ S L D S + + I ++ L+ L LS N + +L+ L N
Sbjct: 144 NKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKN 201
Query: 376 LETLDLSS 383
L+ L+L S
Sbjct: 202 LDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 29/199 (14%), Positives = 61/199 (30%), Gaps = 19/199 (9%)
Query: 331 DISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAI 390
++ + + ++++ +++ + +D + L N+ L L+ N L+
Sbjct: 30 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLTDIK 84
Query: 391 PHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKL 450
P + L S L L S + L L
Sbjct: 85 PLANLK-----------NLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 451 QDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGG 510
L+ + + + T + + L+ T L + LS NH+
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD 192
Query: 511 EIPTWIGQLSNLAILKLSN 529
+ L NL +L+L +
Sbjct: 193 --LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 29/197 (14%), Positives = 57/197 (28%), Gaps = 22/197 (11%)
Query: 369 SLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVS 428
S +L +++ A+ Q NS+ ++ N+ + + +
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT----QNELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 429 LHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPP------------ELGNIQTLET 476
L L+ N LT P + L + + + +I L
Sbjct: 73 LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 477 LFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWI--GQLSNLAILKLSNNSFYG 534
L + G + + + +I + L+ L L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI-- 190
Query: 535 RIPPELGDCRSLIWLDL 551
L ++L L+L
Sbjct: 191 SDLRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 27/203 (13%), Positives = 61/203 (30%), Gaps = 15/203 (7%)
Query: 491 ALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLD 550
A + N L + + +L+++ + +N+ + ++ L
Sbjct: 22 AFAETIKDN---LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74
Query: 551 LNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLS 610
LN N P A K G + + K +K+ + ++
Sbjct: 75 LNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------SLEHNGISDIN 128
Query: 611 RISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHN 670
+ + + +S S + ++ L L L N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188
Query: 671 NLSGPIPTEVGDLRGLNILDLSS 693
++S + L+ L++L+L S
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 37/227 (16%), Positives = 76/227 (33%), Gaps = 56/227 (24%)
Query: 271 NVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESF 330
+ S + P P+ + D + +K +L +++ V +S++
Sbjct: 2 PLGSETITVPTPIKQ--------IFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQI 51
Query: 331 DISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN------ 384
+++ I+ + N+ +L L+ N T L+NL NL L L N
Sbjct: 52 IANNSDIKSVQGIQ---YLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLS 106
Query: 385 ----------------------NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSI------ 416
L N + ++ + + L
Sbjct: 107 SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDN 166
Query: 417 ----PSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQ 459
L+ ++L +L+LS N+++ +L L L L+L+ +Q
Sbjct: 167 QISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 25/170 (14%), Positives = 52/170 (30%), Gaps = 12/170 (7%)
Query: 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNN 229
S++ + + + I + +L L GNK+T ++ KNL +L + N
Sbjct: 47 SIDQIIANNSDIKS-----VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101
Query: 230 FSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQ 289
+ + E L N + + +
Sbjct: 102 VKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL 161
Query: 290 GEIPLHLADL-----CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISS 334
++D+ + L L LS N++S +L+ ++ S
Sbjct: 162 SLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 10/79 (12%), Positives = 33/79 (41%), Gaps = 10/79 (12%)
Query: 651 SIPKEIG------SMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSM 704
++P I + + NL +++ + +L ++ + +++ ++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 705 SSLTLLNEIDLCNNQLTGM 723
L + ++ L N+LT +
Sbjct: 65 QYLPNVTKLFLNGNKLTDI 83
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 23/139 (16%), Positives = 46/139 (33%), Gaps = 19/139 (13%)
Query: 221 QFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGP 280
+ L ++ + ++ + L + +LD+S N+ A++A L L S N
Sbjct: 1 RVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 281 IPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNL-SGKVPSRFGSCSSLESFDISSNKFSG 339
V E L L +N L SC L ++ N
Sbjct: 59 DGVANLPRLQE--------------LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
Query: 340 E--LPIEIFLSMSNLKELV 356
E + + + ++ ++
Sbjct: 105 EEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 4e-07
Identities = 30/118 (25%), Positives = 41/118 (34%), Gaps = 23/118 (19%)
Query: 353 KELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIP-----HNLC------------ 395
+ L L+ D T L L + LDLS N L P L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 396 --QGPRNSLKELFLQNNLLLG-SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKL 450
L+EL L NN L + L +C +LV L+L N L L+++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 5e-07
Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 23/104 (22%)
Query: 306 LDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELP--------------------IEI 345
L L+ +L+ V + D+S N+ P ++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 346 FLSMSNLKELVLSFNDFTG-ALPDSLSNLTNLETLDLSSNNLSG 388
++ L+EL+L N A L + L L+L N+L
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 28/120 (23%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 429 LHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTL 488
LHL+ LT + L L + L L N+L +PP L ++ LE L ++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL--QASDNALEN 57
Query: 489 PAALSNCTNLNWISLSNNHL-GGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLI 547
++N L + L NN L + L +L L NS ++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 25/118 (21%), Positives = 38/118 (32%), Gaps = 13/118 (11%)
Query: 199 KQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVG 258
+ L L +T ++ + + LD+S N P+ LE L S N G
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 259 HAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
A L L + +N L LV L+L N+L +
Sbjct: 61 VAN--LPRLQELLLCNNRLQQ----------SAAIQPLVSC-PRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 26/118 (22%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNI------------ 688
L +++ L+ + + + + L+L HN L P + LR L +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 689 ----------LDLSSNRLEGT-IPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQP 735
L L +NRL+ + + S L ++L N L + + P
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 13/111 (11%)
Query: 124 LDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISG 183
L L+ L+ + +L + L+LS N L +L+ L + S
Sbjct: 3 LHLAHK----DLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALR------CLEVLQASD 52
Query: 184 ANVVPWILFNGCDELKQLALKGNKVTGDINV---SKCKNLQFLDVSSNNFS 231
+ L++L L N++ + C L L++ N+
Sbjct: 53 NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 3e-04
Identities = 25/103 (24%), Positives = 33/103 (32%), Gaps = 6/103 (5%)
Query: 453 LKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEI 512
L L L + L + + L L N L PA L+ L + S+N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 513 PTWIGQLSNLAILKLSNNSF-YGRIPPELGDCRSLIWLDLNTN 554
L L NN L C L+ L+L N
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 100
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (118), Expect = 2e-07
Identities = 29/164 (17%), Positives = 53/164 (32%), Gaps = 6/164 (3%)
Query: 307 DLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL 366
+L + ++ + ++ + L + L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS---DPDLVAQNIDVVLNRR-SSMAATL 57
Query: 367 PDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQL 426
N+ L +L+LS+N L + +LK L L N L +L
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 427 VSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHG-EIPPELG 469
L L N L+ T +S +++ L +L G E+PP +
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 2e-06
Identities = 30/126 (23%), Positives = 50/126 (39%), Gaps = 7/126 (5%)
Query: 366 LPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQ 425
L +S + L L +L +N L ++++ ++ N +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVA--QNIDVVLNRRSSMA-ATLRIIEENIPE 66
Query: 426 LVSLHLSFNYLTGT--IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483
L+SL+LS N L + S + L+ L L N+L E + LE L+LD N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 484 LTGTLP 489
L+ T
Sbjct: 127 LSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 4e-06
Identities = 26/124 (20%), Positives = 42/124 (33%), Gaps = 5/124 (4%)
Query: 440 IPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499
+ + L L L P+L L + + TL N L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELL 68
Query: 500 WISLSNNHLGG--EIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFN 557
++LSNN L ++ + + + NL IL LS N + L L L+ N +
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 558 GSIP 561
+
Sbjct: 129 DTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 24/137 (17%), Positives = 41/137 (29%), Gaps = 5/137 (3%)
Query: 415 SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTL 474
+ +S L L L + + L + + + NI L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 475 ETLFLDFNELTGT--LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
+L L N L + + + NL ++LS N L E + L L L NS
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 533 YGRIPPELGDCRSLIWL 549
+ ++
Sbjct: 128 SDTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 3/127 (2%)
Query: 627 HTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSG--PIPTEVGDLR 684
+ P + L+ +M + ++ ++ L LNL +N L + + V
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 685 GLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGL 744
L IL+LS N L+ L E+ L N L+ + + +F L
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
Query: 745 CGLPLPP 751
G LPP
Sbjct: 152 DGHELPP 158
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.6 bits (119), Expect = 2e-07
Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 7/168 (4%)
Query: 365 ALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS 424
+P + + L L+ N L L + L +L L+ N L G P+ S
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPH-LVKLELKRNQLTGIEPNAFEGAS 78
Query: 425 QLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNEL 484
+ L L N + L +L+ L L+ NQ+ +P ++ +L +L +
Sbjct: 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNP 137
Query: 485 TGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSF 532
L SL+ P+ ++ ++ I L ++ F
Sbjct: 138 FNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 6e-05
Identities = 33/170 (19%), Positives = 58/170 (34%), Gaps = 19/170 (11%)
Query: 219 NLQFLDVSSNNFSMAVPSF--GDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNL 276
+ L ++ N G L L++ N+ TG +A H+ L + N
Sbjct: 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89
Query: 277 FSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNK 336
F G L L+L N +S +P F +SL S +++SN
Sbjct: 90 IKEISN---KMFLG---------LHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137
Query: 337 FSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNL 386
F+ + F L++ L+ P + ++ DL +
Sbjct: 138 FNCNCHLAWFAE--WLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 28/163 (17%), Positives = 49/163 (30%), Gaps = 7/163 (4%)
Query: 291 EIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMS 350
EIP D+ +L L+ N L + F S
Sbjct: 22 EIP---RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 351 NLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNN 410
+++EL L N L L+TL+L N +S +P + + L
Sbjct: 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
Query: 411 LLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDL 453
+ + L+ PS + + +++DL
Sbjct: 139 NCNCHLAWFAEWLRK---KSLNGGAARCGAPSKVRDV-QIKDL 177
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 31/186 (16%), Positives = 65/186 (34%), Gaps = 10/186 (5%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
C +D + L ++P ++ N+ +F + +L +L L
Sbjct: 8 CEGTT-VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKR 63
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
N TG P++ ++++ L L N + + LK L L +N + +P +
Sbjct: 64 NQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQ--LKTLNLYDNQISCVMPGS 121
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFL 479
+ + L SL+ + L+ L P ++ ++Q + L
Sbjct: 122 FEHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKD---L 177
Query: 480 DFNELT 485
+E
Sbjct: 178 PHSEFK 183
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (116), Expect = 2e-07
Identities = 20/152 (13%), Positives = 36/152 (23%), Gaps = 3/152 (1%)
Query: 300 CSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF 359
L + + +L I + + L + + L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 360 NDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPST 419
+ PD+ L L+LS N L + L N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELV--LSGNPLHCSCALRW 123
Query: 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQ 451
L + + L L +
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 19/139 (13%), Positives = 38/139 (27%), Gaps = 4/139 (2%)
Query: 641 LDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEV-GDLRGLNILDLSSNRLEGT 699
L + + + L L + + + L L L + + L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 700 IPSSMSSLTLLNEIDLCNNQLTGMIPVMGQFETFQPAKFLNNSGLCGLPLPPCEKDSGAS 759
P + L+ ++L N L + Q + Q N C L ++
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 760 ANSRHQKSHR--RPASLAG 776
++ + LA
Sbjct: 132 LGGVPEQKLQCHGQGPLAH 150
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (115), Expect = 5e-07
Identities = 32/154 (20%), Positives = 54/154 (35%), Gaps = 9/154 (5%)
Query: 336 KFSGELPIEI--FLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHN 393
K + EL + + + +EL L + + + L + +D S N +
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 60
Query: 394 LCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTG-TIPSSLGSLSKLQD 452
L + LK L + NN + L L L+ N L L SL L
Sbjct: 61 LLR----RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116
Query: 453 LKLWLNQLHGEIPPELGNIQTLETL-FLDFNELT 485
L + N + + L I + + LDF ++
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK 150
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 5e-04
Identities = 17/121 (14%), Positives = 30/121 (24%), Gaps = 3/121 (2%)
Query: 466 PELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAIL 525
+ N L L ++ + + + I S+N + L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 526 KLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIK 585
++NN L L L N + I+ K
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 586 N 586
+
Sbjct: 129 H 129
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 5e-04
Identities = 16/90 (17%), Positives = 28/90 (31%), Gaps = 3/90 (3%)
Query: 665 LNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMI 724
L+L + I L + +D S N + L L + + NN++ +
Sbjct: 23 LDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIG 79
Query: 725 PVMGQFETFQPAKFLNNSGLCGLPLPPCEK 754
+ Q L N+ L L
Sbjct: 80 EGLDQALPDLTELILTNNSLVELGDLDPLA 109
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 29/184 (15%), Positives = 58/184 (31%), Gaps = 4/184 (2%)
Query: 197 ELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGD 256
E + L VT ++ + + L ++ L ++ S N+ T
Sbjct: 19 EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDI 77
Query: 257 VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK 316
+N + P+ N + + L L +
Sbjct: 78 TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 137
Query: 317 VPSRFGSCSSLESFDISSNKFSGELP-IEIFLSMSNLKELVLSFNDFTGALPDSLSNLTN 375
S S + N S ++ ++ +++ L+ L +S N + L+ LTN
Sbjct: 138 NTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTN 195
Query: 376 LETL 379
LE+L
Sbjct: 196 LESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 28/201 (13%), Positives = 65/201 (32%), Gaps = 19/201 (9%)
Query: 325 SSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384
+ + + + + + L D + L NL ++ S+N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSL 444
L+ L + + + + + + + + + ++L
Sbjct: 73 QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 445 GSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504
L L+ L + +L+ L N++T P L+N T L + +S
Sbjct: 131 NRL--------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 505 NNHLGGEIPTWIGQLSNLAIL 525
+N + + + +L+NL L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 37/214 (17%), Positives = 75/214 (35%), Gaps = 23/214 (10%)
Query: 340 ELPIEIFLSMSNLKELV---LSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQ 396
+ PI + + L E + L + T + S ++L + TL +
Sbjct: 5 DTPINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK--------- 53
Query: 397 GPRNSLKEL-FLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKL 455
S+ + +L N + + L++ + L +L + L + +
Sbjct: 54 ----SIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLT 109
Query: 456 WLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTW 515
L + +I L+ + T + +ALS T+L ++ S+N + P
Sbjct: 110 GLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-- 167
Query: 516 IGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549
+ L+ L L +S+N L +L L
Sbjct: 168 LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1176 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.64 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.17 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.1 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.23 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.66 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.18 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.83 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=425.86 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=204.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999986 689999999865332 2345689999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+++|+|.+++...+ .+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997554 699999999999999999999999 99999999999999999999999999998775544
Q ss_pred ccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
........+||+.|||||++.+..+ +.++||||+||++|||+||+.||.........+..+ ....... ..+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~~~~~-----~~~ 229 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYL-----NPW 229 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTTCTTS-----TTG
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCCCCC-----Ccc
Confidence 4333456789999999999988776 578999999999999999999997654332211111 1111100 001
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~s------~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 230 KKID------SAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGSC------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 134569999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=420.57 Aligned_cols=263 Identities=28% Similarity=0.426 Sum_probs=203.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|+++ ..||||++... .....+.|.+|++++++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357899999999999999999864 46999998543 33345678999999999999999999998754 56899999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.++++..+ .++++..+..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999997654 2699999999999999999999999 9999999999999999999999999999876654
Q ss_pred cccccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..........||+.|||||++.+ ..++.++|||||||++|||+||+.||..... ................ .+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~p~-~~ 232 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPD-LS 232 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHHTSCCCC-GG
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcCCCCCc-ch
Confidence 44444456789999999999864 3579999999999999999999999975431 1111122222111100 01
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
......|. .+.+++.+||+.||++|||++|++++|+.++++.
T Consensus 233 ~~~~~~~~------~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 233 KVRSNCPK------AMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GSCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hccccchH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11122221 3556999999999999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=420.23 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=201.7
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|++++++.||||++.. .....+++.+|++++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46888999999999999999999889999999864 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++.... ..+++..++.++.|||+||+|||+. +|+||||||+||++++++.+||+|||+|+........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987653 3689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
......||+.|+|||++.+..++.++|||||||++|||+|+..|+... .+..+.......... ...|. ..
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~----~~~~~~~~~i~~~~~--~~~p~---~~ 227 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVEDISTGFR--LYKPR---LA 227 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS----CCHHHHHHHHHHTCC--CCCCT---TS
T ss_pred -eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC----CCHHHHHHHHHhcCC--CCCcc---cc
Confidence 223457899999999999999999999999999999999954444321 122223322222211 11111 11
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+ .++.+++.+||+.||++|||++||+++|++++.+
T Consensus 228 ~------~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 228 S------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1 1456799999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=422.02 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=208.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999975 69999999997666666778999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++... .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 589999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......||+.|+|||++.+..++.++||||+||++|||+||+.||...+ ................ .....
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~~~~~~---~~~~~ 241 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PLRALYLIATNGTPEL---QNPEK 241 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHHCSCCC---SSGGG
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-----HHHHHHHHHhCCCCCC---CCccc
Confidence 2345689999999999999999999999999999999999999996533 1111211111111111 11111
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+ ..+.+++.+||+.||++|||++|+++|
T Consensus 242 ~s------~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 LS------AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SC------HHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 135579999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=413.47 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=206.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999986 6899999998642 2344567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ ++++..++.++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998765 689999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||...+ ..+.......... ..
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~------~~ 223 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRVEF------TF 223 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTCC------CC
T ss_pred Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCC------CC
Confidence 22 245679999999999999999999999999999999999999996532 2223333222221 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
....+ ..+.+++.+||+.||++|||++|+++|
T Consensus 224 p~~~s------~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 PDFVT------EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CccCC------HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11111 135569999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=413.91 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=208.7
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 468888999999999999999998889999998643 3456789999999999999999999998754 56799999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++..... .++++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||+|+.......
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 9999998876542 3689999999999999999999999 999999999999999999999999999987754332
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
.......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ............. .+......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~~~i~~~~-----~~~~p~~~ 235 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNLERGY-----RMVRPDNC 235 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTTC-----CCCCCTTC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----CHHHHHHHHHhcC-----CCCCcccC
Confidence 22345678999999999998899999999999999999999766653321 1222222222211 11111122
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+. .+.+++.+||+.||++|||+++|++.|+.+..+
T Consensus 236 ~~------~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PE------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hH------HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 21 355699999999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=417.11 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=195.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEee--CCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKV--GEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 934 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+ +...|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56999999999999999999986 689999999865432 223568899999999999999999998864 4567999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC--IPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
|||+++|+|.+++.........+++..++.++.|++.||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999876544557999999999999999999999972 12499999999999999999999999999987
Q ss_pred cccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||...+ ..+....+.......
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----~~~~~~~i~~~~~~~--- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELAGKIREGKFRR--- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTCCCC---
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCCC---
Confidence 654222 2245689999999999999999999999999999999999999996533 222233333322211
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+....+ .++.+++.+||+.||++|||++|+++|
T Consensus 234 --~~~~~s------~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 --IPYRYS------DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCcccC------HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111 135569999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=417.04 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=206.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
+.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35888999999999999999986 68999999987666666678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++...+ .++++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999987543 2699999999999999999999999 99999999999999999999999999997654321
Q ss_pred cccccccccCCcccCccccC-----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQ-----SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
.......||+.|+|||++. ...|+.++||||+||++|||+||+.||...+... ...............+
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~ 238 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLLKIAKSEPPTLAQP 238 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHHHHHSCCCCCSSG
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCCCCCcc
Confidence 1234568999999999983 4568999999999999999999999997643211 1122222221111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||++|+++|
T Consensus 239 ---~~~s------~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 239 ---SRWS------SNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---GGSC------HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---ccCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 145679999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=405.18 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=212.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|++++++.||||++... ....+++.+|+.++++++|||||+++|++.++...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578999999999999999999988889999998753 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++..... .+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+|+........
T Consensus 83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999876543 689999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+.......+. ....| ..
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----~~~~~~~i~~~~--~~~~p---~~ 225 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQGL--RLYRP---HL 225 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHHTTC--CCCCC---TT
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-----HHHHHHHHHhCC--CCCCc---cc
Confidence 2345678999999999999999999999999999999998 899987543 122222222211 11111 11
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+ ..+.+++.+||+.||++|||+++++++|.+|
T Consensus 226 ~~------~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 AS------EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cc------HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12 2456799999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-46 Score=418.04 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=197.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CC---EEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GS---TVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.++||+|+||+||+|+++. ++ .||||++.... ....++|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778999999999999999863 32 58888875432 23345799999999999999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++.... ..+++.++..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999887653 2689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccccc---ccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1015 AMDTHLS---VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1015 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
....... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+.........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-----~~~~~~~i~~~~---- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----NQDVINAIEQDY---- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTC----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC----
Confidence 4332211 123467999999999999999999999999999999998 899986543 122222222211
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.+......+. .+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 251 -~~~~~~~~~~------~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 251 -RLPPPMDCPS------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -CCCCCTTCCH------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCccchH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111111221 355699999999999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=414.73 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=205.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999986 6899999998642 2344567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +||||||||+||++++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988765 699999999999999999999999 999999999999999999999999999987765
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+..... .++.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~--~~p~-- 231 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIKLEY--DFPE-- 231 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCC--CCCT--
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHHHHcCCC--CCCc--
Confidence 444333456689999999999999999999999999999999999999997542 2222233322221 1111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++|||++|++++
T Consensus 232 --~~s------~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 232 --KFF------PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --TCC------HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --cCC------HHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111 135679999999999999999998765
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=404.11 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=196.8
Q ss_pred CCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEee----CCeeEEEE
Q 046275 863 HNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKV----GEERLLVY 935 (1176)
Q Consensus 863 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 935 (1176)
++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999986 68899999986532 2234568899999999999999999999865 34679999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEEeeccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~ 1014 (1176)
||+++|+|.+++...+ .+++..++.++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998764 6899999999999999999999981 1299999999999996 57899999999998643
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
... .....||+.|||||++.+ +++.++||||+||++|||++|+.||.... +.............. +.
T Consensus 167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~~~~~~~i~~~~~~----~~ 233 (270)
T d1t4ha_ 167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGVKP----AS 233 (270)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTCCC----GG
T ss_pred CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cHHHHHHHHHcCCCC----cc
Confidence 321 245689999999999876 69999999999999999999999996432 222222222222111 11
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.....+. ++.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~------~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FDKVAIP------EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGCCCH------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCccCCH------HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111111 35579999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-46 Score=415.88 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=212.4
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.. .....+++.+|++++++++|||||+++++|.+++..|+||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC-ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 56888899999999999999987 588999998854 3445678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999997653 23689999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.... +........... ..+.....
T Consensus 171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~~~~~i~~~-----~~~~~~~~ 240 (287)
T d1opja_ 171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKD-----YRMERPEG 240 (287)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHTT-----CCCCCCTT
T ss_pred -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHHHHHHHhcC-----CCCCCCcc
Confidence 22344568999999999999999999999999999999999877764322 222222222221 11122222
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.+. .+.+++.+||+.||++|||++||++.|+.+....
T Consensus 241 ~~~------~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 241 CPE------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred chH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 221 3567999999999999999999999999886543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=420.30 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=178.0
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC-CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS-GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+++.+|+.++++++|||||+++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999986 68899999986543 2334678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+++|+|.+++.+.+ .+++..++.++.|++.||.|||+++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999998765 6899999999999999999999732 7999999999999999999999999999866432
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSAD 1069 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~ 1069 (1176)
. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 245689999999999999999999999999999999999999997654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=417.15 Aligned_cols=258 Identities=23% Similarity=0.397 Sum_probs=206.2
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-C-----CEEEEEEeecc-CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-G-----STVAIKKLIHI-SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
++|++.+.||+|+||+||+|++.. + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999998753 2 26899988543 333445789999999998 899999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhcccc-------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 046275 932 LLVYEYMRYGSLEDVLHNQKKV-------------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSS 992 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 992 (1176)
|+||||+++|+|.++++..+.. ...+++..++.++.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 9999999999999999765321 12589999999999999999999999 9999999999
Q ss_pred CEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 046275 993 NVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFG 1071 (1176)
Q Consensus 993 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~ 1071 (1176)
||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987665544444456678999999999999999999999999999999998 89999764322
Q ss_pred CccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 046275 1072 DNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFK 1135 (1176)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~ 1135 (1176)
..+..... .. ..+......+ ..+.+++.+||+.||++|||++||+++|.
T Consensus 274 -~~~~~~~~---~~-----~~~~~p~~~~------~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 -ANFYKLIQ---NG-----FKMDQPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -HHHHHHHH---TT-----CCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHHh---cC-----CCCCCCCcCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11222211 11 1111111122 13567999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=406.36 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=206.4
Q ss_pred cCCCCCce-EeEeCceEEEEEEEC---CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSL-IGSGGFGDVYKAKLK---DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|.+.+. ||+|+||+||+|.++ ++..||||++..... ...++|.+|++++++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999875 345799999865332 334679999999999999999999999865 568999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.+++...+ ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999986543 2689999999999999999999999 99999999999999999999999999998775
Q ss_pred cccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1015 AMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1015 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .. +.......+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~---~~~~~i~~~~~----- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GP---EVMAFIEQGKR----- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--TH---HHHHHHHTTCC-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HH---HHHHHHHcCCC-----
Confidence 543322 2234578999999999998999999999999999999998 999997543 21 22222222211
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
++.....|. .+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 231 ~~~p~~~~~------~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 MECPPECPP------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCCCTTCCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcCCH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 112222221 355699999999999999999999999887643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=404.18 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=200.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECCC-----CEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDG-----STVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
+.|+..++||+|+||+||+|+++.+ ..||||++..... ....+|.+|++++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987642 3699999864332 234468899999999999999999999999999999
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
||||+.+|++.+++.... ..+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999887653 2699999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
....... ......||+.|||||++.+..++.++|||||||++|||++|..|+.... +..+.......+. .
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~~~i~~~~-----~ 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAINDGF-----R 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTC-----C
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHHHHHHHhccC-----C
Confidence 5432221 2234568999999999999999999999999999999999766654321 1222222222211 1
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+......+ ..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 232 ~~~~~~~~------~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 LPTPMDCP------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCTTCB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCchhhH------HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112222 2356799999999999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-45 Score=409.57 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=191.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.+.|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999986 689999999865432 234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEEeecccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARLM 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGla~~~ 1013 (1176)
|++||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997654 699999999999999999999999 999999999999994 5789999999999865
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..... ....+||+.|||||++.+..++.++||||+||++|||++|+.||.... .......+...... ++.
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~--~~~ 230 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQILKAEYE--FDS 230 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHTTCCC--CCT
T ss_pred cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHhccCCC--CCC
Confidence 43322 245679999999999999999999999999999999999999996532 12222222222211 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
......+ ..+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~s------~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 PYWDDIS------DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCCC------HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111122 135679999999999999999999886
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-45 Score=413.40 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=208.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.++++++|||||++++++.+++..|+||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999986 68999999997655555667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEEeeccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD--ENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~ 1016 (1176)
++|+|.+++.... .++++..++.++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999996543 2699999999999999999999999 999999999999995 4678999999999876543
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||...+ ..+....+...... +++...
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~--~~~~~~ 249 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCDWN--MDDSAF 249 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCC--SCCGGG
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--CCcccc
Confidence 32 245689999999999999999999999999999999999999996543 22223322222211 111111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||++|||++|+++|
T Consensus 250 ~~~s------~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGIS------EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCC------HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 135679999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=403.68 Aligned_cols=259 Identities=26% Similarity=0.375 Sum_probs=204.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeecc
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMR 939 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 939 (1176)
++|++.+.||+|+||+||+|+++++++||||++.. .....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 46889999999999999999999888999999854 44556789999999999999999999999854 56899999999
Q ss_pred CCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccccc
Q 046275 940 YGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTH 1019 (1176)
Q Consensus 940 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 1019 (1176)
+|+|.+++..... ..++|.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 ~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 95 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 9999999876542 2589999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccccCC
Q 046275 1020 LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKED 1099 (1176)
Q Consensus 1020 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1099 (1176)
.......||+.|+|||++....++.++|||||||++|||++|..||.... ...+......... .+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~~~~~~~~i~~~~-----~~~~~~~~ 239 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGY-----RMPCPPEC 239 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTTC-----CCCCCTTS
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----CHHHHHHHHHhcC-----CCCCCccc
Confidence 22345679999999999999999999999999999999999777654332 1222222222211 11111222
Q ss_pred CchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1100 PNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1100 ~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
+. ++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 240 ~~------~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PE------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CH------HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 21 3556999999999999999999999999876544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-45 Score=406.16 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=200.0
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
.|+..+.||+|+||+||+|++. +|+.||||++....... .+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999986 68889999986543322 3458899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+.+|++..++...+ ++++.+++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999987765543 699999999999999999999999 9999999999999999999999999999865432
Q ss_pred cccccccccccCCcccCccccCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQS---FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... .................+.
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNESPALQSG 237 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCCCCCSCT
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCCCCCCCC
Confidence 34579999999999864 468999999999999999999999986432 1122222222221111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+ ..+.+++.+||+.||++|||++|+++|
T Consensus 238 ----~~s------~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 238 ----HWS------EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----TSC------HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCC------HHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 145679999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=400.22 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=197.9
Q ss_pred ceEeEeCceEEEEEEECC---CCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeeccC
Q 046275 866 SLIGSGGFGDVYKAKLKD---GSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMRY 940 (1176)
Q Consensus 866 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 940 (1176)
+.||+|+||+||+|.++. ++.||||++..... ...+++.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998653 46899999854322 234579999999999999999999999865 457899999999
Q ss_pred CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccccc
Q 046275 941 GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDTHL 1020 (1176)
Q Consensus 941 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 1020 (1176)
|+|.++++... ++++..++.++.||+.||+|||+. +||||||||+||+++.++.+|++|||+|+.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998654 699999999999999999999999 99999999999999999999999999998765433322
Q ss_pred -cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCcccccC
Q 046275 1021 -SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMKE 1098 (1176)
Q Consensus 1021 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1098 (1176)
......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+.......+.. +.....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~~i~~~~~-----~~~p~~ 234 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLEKGER-----MGCPAG 234 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTCC-----CCCCTT
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHHHHHHHHcCCC-----CCCCcc
Confidence 2234678999999999999999999999999999999998 899997543 1222222222211 111122
Q ss_pred CCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1099 DPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1099 ~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
.|. .+.+++.+||+.||++|||+++|++.|+...
T Consensus 235 ~~~------~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 235 CPR------EMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCH------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCH------HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 221 3556999999999999999999999887753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-44 Score=411.41 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=208.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999986 69999999987654445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEEeeccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD--ENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~ 1016 (1176)
++|+|.+++...+ .++++.+++.++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999886543 3699999999999999999999999 999999999999998 5789999999999877543
Q ss_pred cccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+ .......+...... +++...
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~~~--~~~~~~ 252 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCDWE--FDEDAF 252 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCCCC--CCSSTT
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCCC--CCcccc
Confidence 32 245679999999999999999999999999999999999999996543 12222222222211 111222
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...+. .+.+++.+||+.||.+|||++|+++|
T Consensus 253 ~~~s~------~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVSP------EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSCH------HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 21221 35579999999999999999999886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=399.82 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=206.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC------cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG------QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+... ...+.+.+|++++++++|||||++++++.++...|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999986 699999999864322 23467999999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEEeec
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF----EARVSDFG 1008 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 1008 (1176)
+||||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998764 699999999999999999999999 999999999999998776 49999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+ ..+....+.....
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~- 233 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVNY- 233 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTCC-
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcCC-
Confidence 9987654322 245679999999999999999999999999999999999999997543 1222222222211
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+.+......+ ..+.+++.+||+.||++|||++|+++|
T Consensus 234 -~~~~~~~~~~s------~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 -EFEDEYFSNTS------ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CCCHHHHTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCchhcCCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112222222 135679999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=403.81 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=208.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56999999999999999999986 6999999998643 3344577899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +||||||||+|||++++|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999998765 689999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+ .....+......+. ++
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~~i~~~~~~--~p--- 225 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEEIR--FP--- 225 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CC---
T ss_pred CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----HHHHHHHHhcCCCC--CC---
Confidence 222 2345789999999999999999999999999999999999999997643 22233333222211 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||.+||+ ++|+++|
T Consensus 226 -~~~s------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 -RTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -TTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -ccCC------HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1111 13567999999999999994 8888875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=394.30 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=198.0
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEee-CCeeEEEEeec
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKV-GEERLLVYEYM 938 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 938 (1176)
++|++.+.||+|+||.||+|+++ |+.||||++.. ....+.+.+|++++++++|||||+++|++.+ ....|+||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45778899999999999999986 78999999854 3345779999999999999999999998854 45689999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.+++...+. ..+++..+++++.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999976542 2589999999999999999999999 99999999999999999999999999998654322
Q ss_pred cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCccccc
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELMK 1097 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1097 (1176)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+ ..+...++ ..+ ..++...
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i---~~~-----~~~~~~~ 223 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRV---EKG-----YKMDAPD 223 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHH---TTT-----CCCCCCT
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHH---HcC-----CCCCCCc
Confidence 34568999999999999999999999999999999998 687776543 22222222 221 1122222
Q ss_pred CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1098 EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1098 ~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
..+. ++.+++.+||+.||.+|||+.+++++|++++.
T Consensus 224 ~~~~------~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 224 GCPP------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCH------HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2221 35579999999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-44 Score=403.76 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=210.8
Q ss_pred HhcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCe
Q 046275 858 ATNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 858 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 930 (1176)
.+++|++.+.||+|+||+||+|+++ +++.||||++...... ..+++.+|++++++++||||+++++++.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4568999999999999999999874 3578999998643322 24569999999999999999999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccc--------------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKK--------------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMK 990 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 990 (1176)
.++||||+++|+|.++++.... ....+++.+++.++.|++.||+|||++ +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 9999999999999999975321 122489999999999999999999999 99999999
Q ss_pred CCCEEECCCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCC-CCCCCCC
Q 046275 991 SSNVLLDENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK-RPTDSAD 1069 (1176)
Q Consensus 991 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~~~~ 1069 (1176)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765544444445678999999999999999999999999999999999986 5665432
Q ss_pred CCCccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHh
Q 046275 1070 FGDNNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQ 1138 (1176)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~ 1138 (1176)
..+.......+... ......+. .+.+++.+||+.||++||||.||++.|+++.
T Consensus 248 -----~~e~~~~v~~~~~~-----~~p~~~~~------~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 -----HEEVIYYVRDGNIL-----ACPENCPL------ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -----HHHHHHHHHTTCCC-----CCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----HHHHHHHHHcCCCC-----CCCccchH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22233333332221 11122221 3556999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=402.03 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=202.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCC----EEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGS----TVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 933 (1176)
++|++.++||+|+||+||+|++. +|+ +||+|++... .....+++.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 36899999999999999999876 344 5888887543 334567899999999999999999999999764 5678
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLM 1013 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~ 1013 (1176)
|+||+.+|+|.+++.... ..+++..++.++.|||.||+|||++ +||||||||+||+++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887653 3689999999999999999999999 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccC
Q 046275 1014 SAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFD 1092 (1176)
Q Consensus 1014 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1092 (1176)
.............||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+...........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~------ 233 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLP------ 233 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCCCC------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCC------
Confidence 65444444445678999999999999999999999999999999999 7888875432 22222222111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1093 PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1093 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.....+ ..+.+++.+||+.||++|||+.|++++++++..
T Consensus 234 --~p~~~~------~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 --QPPICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --CCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcccC------HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111111 135569999999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-43 Score=398.42 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=206.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999999999999986 6999999998642 2344567899999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||++||++.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999998765 678899999999999999999999 999999999999999999999999999987643
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. ....+||+.|||||++.+..++.++||||+||++|||+||+.||...+ .......+..... .+++.+
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~--~~p~~~ 224 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNAEL--RFPPFF 224 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHCCC--CCCTTS
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHcCCC--CCCCCC
Confidence 2 235689999999999999999999999999999999999999996533 2223333322221 111111
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
+ ..+.+++.+||+.||.+|| |++++++|
T Consensus 225 ----s------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 ----N------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----C------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----C------HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 1355699999999999996 89999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=400.27 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=199.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeC-C
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVG-E 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 929 (1176)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|..++.++ +|+|||.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357899999999999999999864 246899999864332 2345677888888777 689999999987654 4
Q ss_pred eeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
..++||||+++|+|.++++..+.. ...+++.+++.++.||++||+|||++ +||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 689999999999999999765421 23589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCC-CCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK-RPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~ 1076 (1176)
+++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||..... ...+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHHHH
Confidence 99999999999998765544444445678999999999999999999999999999999999975 56654432 21222
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
.... .+.. +......+. .+.+++.+||+.||++|||++|++++|+++.+
T Consensus 248 ~~~~---~~~~-----~~~~~~~~~------~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 RRLK---EGTR-----MRAPDYTTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHH---HTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh---cCCC-----CCCCccCCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222 1111 111111111 35679999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=393.82 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=195.3
Q ss_pred cCCCCCceEeEeCceEEEEEEECC----CCEEEEEEeeccCCc-CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD----GSTVAIKKLIHISGQ-GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||+||+|++.. +..||||++...... ..+.+.+|++++++++|||||++++++. ++..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578899999999999999998753 346888887543332 2356899999999999999999999985 4678999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|++.+++.... .++++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 ~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999887553 2689999999999999999999999 99999999999999999999999999998765
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccccCc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDVFDP 1093 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1093 (1176)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |++||..... ..+...+ ..+.. +
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i---~~~~~-----~ 228 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRI---ENGER-----L 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH---HTTCC-----C
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHH---HcCCC-----C
Confidence 43222 2345678999999999999999999999999999999998 8999875432 2222222 22111 1
Q ss_pred ccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1094 ELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1094 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
..+...+. .+.+++.+||+.||++|||+.||+++|+++..
T Consensus 229 ~~~~~~~~------~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 229 PMPPNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11222221 35569999999999999999999999998863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-43 Score=390.09 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=202.1
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---HHHHHHHHHHHHhcCCCCcccceeEEeeCC----e
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---DREFTAEMETIGKIKHRNLVPLLGYCKVGE----E 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 930 (1176)
.++|++.+.||+|+||+||+|++. +|+.||||++....... .+.+.+|++++++++|||||++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999985 68999999986543322 346889999999999999999999987643 4
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||++||+|.+++...+ ++++.+++.++.||+.||+|||+. +||||||||+||+++.++.++++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987765 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccc-cccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1011 RLMSAMDT-HLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1011 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
........ ........||+.|+|||++.+..++.++||||+||++|||+||+.||...+ ..+...........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~~~~~~~~- 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDPI- 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCCC-
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----HHHHHHHHHhcCCC-
Confidence 75543222 222345689999999999999999999999999999999999999996532 12222222211110
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHhh
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-TMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-t~~evl~~L~~i~~ 1139 (1176)
.+.......+. .+.+++.+||+.||++|| |++++++.|.+++.
T Consensus 233 -~~~~~~~~~s~------~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 -PPSARHEGLSA------DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -CGGGTSSSCCH------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -CCchhccCCCH------HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 01111111221 355699999999999999 89999999998863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-43 Score=405.89 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=199.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC---CcCHHHHHHH---HHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS---GQGDREFTAE---METIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ......+.+| +++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999987 69999999985421 2223334444 66677778999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998764 688999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccccc
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVF 1091 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1091 (1176)
..... .....||+.|+|||++.. ..++.++||||+||++|||+||+.||....... ............
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~----- 225 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMA----- 225 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCC-----
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCC-----
Confidence 65432 245679999999999864 568999999999999999999999997654322 222221111111
Q ss_pred CcccccCCCchHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 046275 1092 DPELMKEDPNIEIELLQHLHVASACLDDRPWRRPT-----MIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt-----~~evl~~ 1133 (1176)
...+...+. .+.+++.+||+.||++||| ++|+++|
T Consensus 226 -~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -VELPDSFSP------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCSSSCH------HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCCCCCH------HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111111111 3567999999999999999 6888765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-43 Score=385.11 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=203.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcC---------HHHHHHHHHHHHhcC-CCCcccceeEEeeC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQG---------DREFTAEMETIGKIK-HRNLVPLLGYCKVG 928 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 928 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++....... .+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999986 68999999986543221 235788999999997 99999999999999
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
+..|+||||+++|+|.++++..+ ++++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999998664 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccCccccC------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQ------SFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH 1082 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~ 1082 (1176)
+|+....... .....||+.|+|||++. ...++.++||||+||++|||++|+.||...+ .......+
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~~~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLMLRMI 227 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----HHHHHHHH
Confidence 9987654322 24567999999999985 3357889999999999999999999997543 11112222
Q ss_pred hccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1083 AKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1083 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
...... .........+ .++.+++.+||+.||++|||++||++|
T Consensus 228 ~~~~~~--~~~~~~~~~s------~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ--FGSPEWDDYS------DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC--CCTTTGGGSC------HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC--CCCcccccCC------HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 222211 1111111111 145679999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-43 Score=399.30 Aligned_cols=245 Identities=23% Similarity=0.256 Sum_probs=205.9
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999986 6999999998542 2334567889999999999999999999999999999999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~ 1015 (1176)
||+.+|+|.+++...+ .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998765 689999999999999999999999 999999999999999999999999999987643
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||...+ .......+...... ++
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~~~~--~p--- 258 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSGKVR--FP--- 258 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC--CC---
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHHhcCCCC--CC---
Confidence 2 235679999999999999999999999999999999999999996532 22233333222211 11
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
...+ ..+.+++.+||+.||.+|+ |++|+++|
T Consensus 259 -~~~s------~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 -SHFS------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -TTCC------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -ccCC------HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1111 1355699999999999994 89999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=395.52 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=205.9
Q ss_pred cCCCCCceEeEeCceEEEEEEECC-CC--EEEEEEeecc-CCcCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD-GS--TVAIKKLIHI-SGQGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||+||+|++++ |. .||||++... .....+.+.+|+++++++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568889999999999999998864 44 4778877543 333456799999999998 799999999999999999999
Q ss_pred EeeccCCCHHHHHhhcc------------ccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 046275 935 YEYMRYGSLEDVLHNQK------------KVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEA 1002 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 1002 (1176)
|||+++|+|.++++... .....+++.++..++.|||+||.|+|+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 2234699999999999999999999999 99999999999999999999
Q ss_pred EEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCC-CCCCCCCCCccHHHHHHH
Q 046275 1003 RVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKR-PTDSADFGDNNLVGWVKQ 1081 (1176)
Q Consensus 1003 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-P~~~~~~~~~~~~~~~~~ 1081 (1176)
||+|||+|+....... .....||+.|+|||.+.+..++.++|||||||++|||++|.. ||...+ ..+....
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence 9999999976543222 234568999999999999999999999999999999999765 554332 2233333
Q ss_pred hhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCC
Q 046275 1082 HAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSG 1142 (1176)
Q Consensus 1082 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~ 1142 (1176)
...+. .+......+ .++.+++.+||+.||++||||+||+++|+++.....
T Consensus 239 i~~~~-----~~~~~~~~~------~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 239 LPQGY-----RLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp GGGTC-----CCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHhcC-----CCCCCccCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 22221 112211111 145679999999999999999999999999986543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=396.09 Aligned_cols=263 Identities=25% Similarity=0.433 Sum_probs=211.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCCee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGEER 931 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 931 (1176)
++|++.+.||+|+||.||+|++. +++.||||++..... ....++.+|+.+++++ +|||||++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888999999999999999863 356899999865332 2344688999999999 699999999999999999
Q ss_pred EEEEeeccCCCHHHHHhhccc--------------cCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 932 LLVYEYMRYGSLEDVLHNQKK--------------VGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 932 ~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
++||||+++|+|.++++.... ....+++..+..++.||++|++|||++ +||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 999999999999999986532 123589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcC-CCCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTG-KRPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~P~~~~~~~~~~~~ 1076 (1176)
.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+ .+||.... ....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-VDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-SSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence 9999999999999977655544444567899999999999999999999999999999999995 44454332 222222
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
....... .+......+ ..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 259 ~~i~~~~--------~~~~~~~~~------~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGF--------RMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTC--------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCC--------CCCCccccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222111 111111111 1356799999999999999999999999887543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=390.16 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=203.4
Q ss_pred CceEeEeCceEEEEEEECCC----CEEEEEEeecc-CCcCHHHHHHHHHHHHhcCCCCcccceeEEee-CCeeEEEEeec
Q 046275 865 DSLIGSGGFGDVYKAKLKDG----STVAIKKLIHI-SGQGDREFTAEMETIGKIKHRNLVPLLGYCKV-GEERLLVYEYM 938 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 938 (1176)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|++++++++|||||+++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 25899988643 33334679999999999999999999999865 56889999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
++|+|.++++... ...++..++.++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999988654 2578899999999999999999999 999999999999999999999999999987654332
Q ss_pred cc--cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcccc
Q 046275 1019 HL--SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPELM 1096 (1176)
Q Consensus 1019 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1096 (1176)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.... .......+. ..+... ..|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i---~~g~~~--~~p--- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL---LQGRRL--LQP--- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH---HTTCCC--CCC---
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHH---HcCCCC--CCc---
Confidence 21 2234578999999999999999999999999999999999888876432 111222222 222111 111
Q ss_pred cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCCCC
Q 046275 1097 KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGSGL 1143 (1176)
Q Consensus 1097 ~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~~~ 1143 (1176)
...+ ..+.+++.+||+.||++|||+.||+++|+++......
T Consensus 257 ~~~~------~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 257 EYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ccCc------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1111 1355699999999999999999999999999876443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=387.61 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=196.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC--CC--CEEEEEEeeccC---CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK--DG--STVAIKKLIHIS---GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||.||+|++. ++ ..||||++.... ....++|.+|+.++++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46888999999999999999864 23 368999875432 2234578999999999999999999999965 4678
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
+||||+++|++.+++..... .+++..++.++.|+|+||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998876542 699999999999999999999999 999999999999999999999999999997
Q ss_pred cccccccc-cccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHHHHHHHhhccccccc
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLVGWVKQHAKLKISDV 1090 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1090 (1176)
........ ......|++.|+|||++.+..++.++|||||||++|||+| |+.||...+ ..+..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----~~~~~~~i~~~~~--- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGE--- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----HHHHHHHHHhCCC---
Confidence 75543322 2234567889999999999999999999999999999998 899986543 2222222222211
Q ss_pred cCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 046275 1091 FDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEI 1137 (1176)
Q Consensus 1091 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i 1137 (1176)
.+......|. .+.+++.+||+.||++|||+.+|++.|++.
T Consensus 233 -~~~~~~~~~~------~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 -RLPRPEDCPQ------DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCcccccH------HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111122221 355799999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=393.70 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=206.6
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||||.+... ......+.+|+++++.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999987 6889999988643 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--CCcEEEEeecccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE--NFEARVSDFGMARLMSA 1015 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~ 1015 (1176)
++||+|.+++...+ .++++.+++.++.||+.||+|||++ +|+||||||+|||++. ...+|++|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999997653 3689999999999999999999999 9999999999999985 45799999999987643
Q ss_pred ccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCccc
Q 046275 1016 MDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPEL 1095 (1176)
Q Consensus 1016 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1095 (1176)
... .....||+.|+|||.+.+..++.++||||+||++|+|++|+.||...+ .......+..... .++...
T Consensus 157 ~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~~~~~~i~~~~~--~~~~~~ 226 (321)
T d1tkia_ 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEY--TFDEEA 226 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCC--CCCHHH
T ss_pred CCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC--CCChhh
Confidence 322 245678999999999999999999999999999999999999997543 2222222222221 122222
Q ss_pred ccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1096 MKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1096 ~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
+...+ ..+.+++.+||+.||++|||++|+++|
T Consensus 227 ~~~~s------~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 FKEIS------IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22221 135679999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=392.41 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=207.1
Q ss_pred cCCCCCceEeEeCceEEEEEEECC--------CCEEEEEEeeccCC-cCHHHHHHHHHHHHhc-CCCCcccceeEEeeCC
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKD--------GSTVAIKKLIHISG-QGDREFTAEMETIGKI-KHRNLVPLLGYCKVGE 929 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 929 (1176)
++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 468889999999999999998642 24799998865333 2346688899999888 8999999999999999
Q ss_pred eeEEEEeeccCCCHHHHHhhcccc------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKV------------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLD 997 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 997 (1176)
..++||||+++|+|.+++...+.. ...+++.+++.++.|++.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 999999999999999999765421 23589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCCCccHH
Q 046275 998 ENFEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT-GKRPTDSADFGDNNLV 1076 (1176)
Q Consensus 998 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~P~~~~~~~~~~~~ 1076 (1176)
.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |+.||.... ..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-----~~ 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VE 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-----HH
Confidence 999999999999987765544444456679999999999999999999999999999999998 688876433 11
Q ss_pred HHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1077 GWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1077 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
+.......+. .+......+. .+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 245 ~~~~~i~~~~-----~~~~p~~~~~------~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ELFKLLKEGH-----RMDKPSNCTN------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHTTC-----CCCCCSSCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCC-----CCCCCccchH------HHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2222222211 1111122221 356799999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=393.67 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=203.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc---CCcCHHHHHHHHHHHH-hcCCCCcccceeEEeeCCeeEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI---SGQGDREFTAEMETIG-KIKHRNLVPLLGYCKVGEERLLV 934 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 934 (1176)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999987 6899999998642 2334456677777665 68999999999999999999999
Q ss_pred EeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccc
Q 046275 935 YEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMS 1014 (1176)
Q Consensus 935 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~ 1014 (1176)
|||+++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+|++|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998765 689999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccccccCcc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDPE 1094 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1094 (1176)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+ .......+..... .
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~------~ 221 (320)
T d1xjda_ 155 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFHSIRMDNP------F 221 (320)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC------C
T ss_pred cccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCC------C
Confidence 3322 2345689999999999999999999999999999999999999997543 2222222222211 1
Q ss_pred cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 046275 1095 LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMI-QVMAM 1133 (1176)
Q Consensus 1095 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~-evl~~ 1133 (1176)
.....+ ..+.+++.+||+.||++|||+. ++++|
T Consensus 222 ~p~~~s------~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 YPRWLE------KEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCTTSC------HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCccCC------HHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 111111 1356799999999999999996 67653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=392.40 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=201.6
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHH--HHHHHHhcCCCCcccceeEEeeCC----eeEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTA--EMETIGKIKHRNLVPLLGYCKVGE----ERLL 933 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 933 (1176)
++|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+.+ |+..+..++|||||++++++.+++ ..|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3567788999999999999997 4899999988532 2334444 444556789999999999997643 5799
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC-----IPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
||||+++|+|.+++++. +++|..+++++.|+|.||+|+|+.. .++||||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999864 5899999999999999999999741 2489999999999999999999999999
Q ss_pred cccccccccccc--cccccccCCcccCccccCCC------CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCC--------
Q 046275 1009 MARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSF------RCSTKGDVYSYGVVLLELLTGKRPTDSADFGD-------- 1072 (1176)
Q Consensus 1009 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~P~~~~~~~~-------- 1072 (1176)
+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||..||.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 998765433222 23456899999999998754 36779999999999999999998875433211
Q ss_pred --ccHHHHHHHhhccccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1073 --NNLVGWVKQHAKLKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1073 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.......... ..+.++|.+..... .......+.+++.+||+.||++|||+.||+++|+++....
T Consensus 234 ~~~~~~~~~~~~----~~~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVV----CEQKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHH----TTSCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHH----hccccCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1111121211 11222333322111 1113345677999999999999999999999999997643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-43 Score=394.22 Aligned_cols=252 Identities=21% Similarity=0.247 Sum_probs=197.2
Q ss_pred cCCCCC-ceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhc-CCCCcccceeEEee----CCeeE
Q 046275 860 NGFHND-SLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKI-KHRNLVPLLGYCKV----GEERL 932 (1176)
Q Consensus 860 ~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~ 932 (1176)
++|.+. ++||+|+||+||+|++. +|+.||||++.. ...+.+|+.++.++ +|||||+++++|.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 578776 46999999999999985 689999999853 35678899987655 89999999999865 45689
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeecc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGM 1009 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl 1009 (1176)
+|||||+||+|.+++...+ ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. .+.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999998653 23699999999999999999999999 9999999999999985 56799999999
Q ss_pred ccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccccc
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISD 1089 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1089 (1176)
|+....... .....||+.|||||++.+..|+.++||||+||++|+|+||+.||....... ..............
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~i~~~~~-- 234 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQY-- 234 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSS--
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHHHHhcCCC--
Confidence 987654332 345689999999999999999999999999999999999999997543211 01111111111110
Q ss_pred ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1090 VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1090 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.++...+. .--..+.+++.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWS------EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHH------HSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccc------cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111111 111246679999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=392.21 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=211.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC------CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK------DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 932 (1176)
++|++.+.||+|+||+||+|+++ +++.||||++..... .....+.+|++++++++|||||++++++..+...+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56888999999999999999874 357899999864332 22345889999999999999999999999999999
Q ss_pred EEEeeccCCCHHHHHhhcccc------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 933 LVYEYMRYGSLEDVLHNQKKV------GIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
+||||+++|+|.+++...+.. -..+++..+..++.|+|+||.|||++ +|+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999999765321 12478999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCC-CCCCCCCCCCccHHHHHHHhhcc
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGK-RPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
||+|+...............||+.|+|||.+.+..++.++||||||+++|||+||. .||... +..++.......
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRFVMEG 251 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHHHHTT
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhC
Confidence 99998776555544445567899999999999999999999999999999999985 666432 233333333332
Q ss_pred ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhh
Q 046275 1086 KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQA 1139 (1176)
Q Consensus 1086 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~ 1139 (1176)
... ......+ ..+.+++.+||+.+|++|||+.+|+++|++..+
T Consensus 252 ~~~-----~~p~~~~------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLL-----DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCC-----CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCC-----CCcccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 211 1111122 145679999999999999999999999987754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=383.26 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=195.8
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc------CHHHHHHHHHHHHhcC--CCCcccceeEEeeCCe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ------GDREFTAEMETIGKIK--HRNLVPLLGYCKVGEE 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 930 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++...... ...++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999986 6899999998643221 1234678999999996 8999999999999999
Q ss_pred eEEEEeeccC-CCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEEeec
Q 046275 931 RLLVYEYMRY-GSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-NFEARVSDFG 1008 (1176)
Q Consensus 931 ~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 1008 (1176)
.|+||||+.+ +++.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 68888887654 689999999999999999999999 9999999999999985 4789999999
Q ss_pred cccccccccccccccccccCCcccCccccCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcccc
Q 046275 1009 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRC-STKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKI 1087 (1176)
Q Consensus 1009 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1176)
+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .......
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~~ 221 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQV 221 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCCC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhccc
Confidence 99865432 2245689999999999987665 567899999999999999999986421 1111111
Q ss_pred ccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1088 SDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1088 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.+++. .+ .++.+++.+||+.||++|||++|+++|
T Consensus 222 --~~~~~----~s------~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 --FFRQR----VS------SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCSSC----CC------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCCC----CC------HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111 11 135669999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=386.13 Aligned_cols=259 Identities=25% Similarity=0.296 Sum_probs=193.5
Q ss_pred CceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCc-----CHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEeec
Q 046275 865 DSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQ-----GDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYM 938 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 938 (1176)
.++||+|+||+||+|+++ +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999986 6899999988543221 1346889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccccc
Q 046275 939 RYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMDT 1018 (1176)
Q Consensus 939 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 1018 (1176)
.++++..+..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9887776655433 688899999999999999999999 999999999999999999999999999986644322
Q ss_pred cccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc---ccccccc---
Q 046275 1019 HLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK---LKISDVF--- 1091 (1176)
Q Consensus 1019 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 1091 (1176)
......||+.|+|||++.. ..++.++||||+||++|||+||+.||......+ .+....+.... .......
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccc
Confidence 2245679999999999865 467999999999999999999999997543111 11111111100 0000000
Q ss_pred CcccccCCCch-HH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1092 DPELMKEDPNI-EI-----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1092 ~~~~~~~~~~~-~~-----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........+.. .. .-..+.+|+.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000000 00 01246789999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=380.59 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccC--CcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHIS--GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999985 69999999985432 2335678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
|+.+ ++.+++.... ...+++..++.++.|++.||+|||++ +||||||||+|||++.++.+|++|||.|+.....
T Consensus 82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976 4555554332 23689999999999999999999999 9999999999999999999999999999876432
Q ss_pred cccccccccccCCcccCccccCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhh-ccccccccCc-
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHA-KLKISDVFDP- 1093 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~- 1093 (1176)
.. ......||+.|+|||++.... ++.++||||+||++|+|++|+.||...+. ...+..... .+...+...+
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTT
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCCchhhccc
Confidence 22 234567999999999877655 57899999999999999999999975431 111111110 0000000000
Q ss_pred ---------cccc-CCCchHH----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1094 ---------ELMK-EDPNIEI----ELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1094 ---------~~~~-~~~~~~~----~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ....... ....+.+++.+||+.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 0000000 01345679999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-41 Score=373.69 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=198.8
Q ss_pred cCCCCCceEeEeCceEEEEEEECCCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEee
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 937 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 937 (1176)
++|++.+.||+|+||+||+|++++|+.||||++... .....+.+.+|+.++++++|||||++++++..++..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 579999999999999999999999999999998543 223356799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecccccccccc
Q 046275 938 MRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAMD 1017 (1176)
Q Consensus 938 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~ 1017 (1176)
+.++.+..+....+ .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877766665443 699999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc---cc-----
Q 046275 1018 THLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK---IS----- 1088 (1176)
Q Consensus 1018 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~----- 1088 (1176)
. ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+ .+........... ..
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhh
Confidence 2 2234568999999999865 456899999999999999999999997543111 0111111100000 00
Q ss_pred cccCcccc-------c-CCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1089 DVFDPELM-------K-EDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~-------~-~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
........ . ..+.. ...+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGL---DESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSC---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 0 00111 1245679999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=374.05 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=195.3
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-C-CCEEEEEEeeccC--CcCHHHHHHHHHHHHhc---CCCCcccceeEEee----
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-D-GSTVAIKKLIHIS--GQGDREFTAEMETIGKI---KHRNLVPLLGYCKV---- 927 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 927 (1176)
.++|++.+.||+|+||+||+|++. + ++.||||++.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999984 4 5678999986432 22234566788877766 79999999999853
Q ss_pred -CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEe
Q 046275 928 -GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSD 1006 (1176)
Q Consensus 928 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 1006 (1176)
....+++|||++++.+........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 346799999999876655444332 3689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc--
Q 046275 1007 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK-- 1084 (1176)
Q Consensus 1007 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~-- 1084 (1176)
||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+ .+.........
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG 235 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCc
Confidence 99987654322 2356789999999999999999999999999999999999999997543111 11111111100
Q ss_pred -ccccc-----------ccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 -LKISD-----------VFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 -~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+.. ..........+... ..+.+|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCC---HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000000011111 235579999999999999999999886
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.1e-41 Score=379.41 Aligned_cols=196 Identities=34% Similarity=0.571 Sum_probs=147.5
Q ss_pred cccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCC-CEEEccCCCCcccCChhHHh
Q 046275 488 LPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSL-IWLDLNTNLFNGSIPPALFK 566 (1176)
Q Consensus 488 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~g~ip~~~~~ 566 (1176)
.|..+..+.+|+.+++++|++.+.+|.++++++.|+.+++++|.+.|.+|..+..+.++ +.+++++|+++|..|..+..
T Consensus 117 ~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred ccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccc
Confidence 33334444445555555555555555555555566666666666666666665555554 66666777766655543211
Q ss_pred hcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccC
Q 046275 567 QSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYN 646 (1176)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N 646 (1176)
....++++++|
T Consensus 197 ---------------------------------------------------------------------l~~~~l~l~~~ 207 (313)
T d1ogqa_ 197 ---------------------------------------------------------------------LNLAFVDLSRN 207 (313)
T ss_dssp ---------------------------------------------------------------------CCCSEEECCSS
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 02336888888
Q ss_pred cCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCccccccccccccccccccCCCCC
Q 046275 647 MLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLTGMIPV 726 (1176)
Q Consensus 647 ~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~g~~p~ 726 (1176)
.+.|.+|..++.+++|+.|++++|+++|.+| .++.+++|+.|||++|+|+|.+|.+|++|++|+.|||++|+|+|.||.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 8888999999999999999999999997766 688899999999999999999999999999999999999999999999
Q ss_pred CCCccccCCccccCCCCCCCCCCCCCC
Q 046275 727 MGQFETFQPAKFLNNSGLCGLPLPPCE 753 (1176)
Q Consensus 727 ~~~~~~~~~~~~~~n~~l~~~~~~~c~ 753 (1176)
.+.+..+....+.+|+++||.|+|+|.
T Consensus 287 ~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp STTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cccCCCCCHHHhCCCccccCCCCCCCC
Confidence 888999999999999999999999995
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-39 Score=358.69 Aligned_cols=265 Identities=20% Similarity=0.202 Sum_probs=208.5
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCC-CCcccceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKH-RNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++. +|+.||||.+.... ....+.+|+++++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999986 68899999875432 23457889999999965 899999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-----CCcEEEEeecccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE-----NFEARVSDFGMAR 1011 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGla~ 1011 (1176)
|+ +|+|.+++...+ ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+|++|||+|+
T Consensus 82 ~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 679999987654 2689999999999999999999999 9999999999999974 5679999999998
Q ss_pred cccccccc-----ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccc
Q 046275 1012 LMSAMDTH-----LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLK 1086 (1176)
Q Consensus 1012 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1086 (1176)
.+...... .......||+.|||||++.+..++.++|||||||++|||+||+.||........ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~--~~~~~~i~~~~ 232 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEKK 232 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH--HHHHHHHHhcc
Confidence 76543221 122456799999999999999999999999999999999999999976543322 11111111111
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhCC
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAGS 1141 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~~ 1141 (1176)
.. ...+++....|. ++.+++..|++.+|++||+++.+.+.++++....
T Consensus 233 ~~-~~~~~l~~~~p~------~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 233 QS-TPLRELCAGFPE------EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HH-SCHHHHTTTSCH------HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CC-CChHHhcCCCCH------HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00 001112122221 3456889999999999999999999999886544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=367.33 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=195.1
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeecc--CCcCHHHHHHHHHHHHhcCCCCcccceeEEee--------C
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHI--SGQGDREFTAEMETIGKIKHRNLVPLLGYCKV--------G 928 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 928 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999986 7999999988543 23345678899999999999999999998855 3
Q ss_pred CeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeec
Q 046275 929 EERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFG 1008 (1176)
Q Consensus 929 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 1008 (1176)
...|+||||+.++.+........ .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+|++|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 45789999998876655444332 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccc--cccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc
Q 046275 1009 MARLMSAMDTHL--SVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL 1085 (1176)
Q Consensus 1009 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1085 (1176)
+++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+. ........... +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~-~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLC-G 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH-C
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhc-C
Confidence 998665432211 22345799999999998765 689999999999999999999999975431 11111111111 1
Q ss_pred cccc----ccC--------cccccCCCchHHH------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 KISD----VFD--------PELMKEDPNIEIE------LLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 ~~~~----~~~--------~~~~~~~~~~~~~------~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
.... ..+ ............. ...+++|+.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 000 0000111111111 1234679999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=372.01 Aligned_cols=264 Identities=27% Similarity=0.334 Sum_probs=195.2
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCcccceeEEeeC------CeeEE
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVPLLGYCKVG------EERLL 933 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 933 (1176)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++|||||+++++|... ...|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999986 699999999865332 234799999999999999999998543 34689
Q ss_pred EEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccc
Q 046275 934 VYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARL 1012 (1176)
Q Consensus 934 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~ 1012 (1176)
||||++++ +.+.+.........+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999875 4444433323344799999999999999999999999 999999999999999775 899999999987
Q ss_pred cccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH----------
Q 046275 1013 MSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ---------- 1081 (1176)
Q Consensus 1013 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~---------- 1081 (1176)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+ .+....+.
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhh
Confidence 654332 245679999999998764 578999999999999999999999997543111 11111110
Q ss_pred -hh----ccccccccCcccc-cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhh
Q 046275 1082 -HA----KLKISDVFDPELM-KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQA 1139 (1176)
Q Consensus 1082 -~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 1139 (1176)
.. ............. ...+.. -..+.+|+.+||+.||++|||+.|+++| +++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRT---PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhccchhhccccccccCchhhhcccCC---CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00 0000000000000 001111 1235679999999999999999999986 566543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-39 Score=360.69 Aligned_cols=262 Identities=22% Similarity=0.270 Sum_probs=199.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCCccc-ceeEEeeCCeeEEEEe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRNLVP-LLGYCKVGEERLLVYE 936 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~E 936 (1176)
.++|++.+.||+|+||+||+|++. +|+.||||.+.... ...++.+|+++++.++|++++. +.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999986 68899999876432 2345788999999998776555 4556677888999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEEeecccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARLM 1013 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla~~~ 1013 (1176)
|+. |++.+.+.... ..+++..+..++.|++.||+|||++ +||||||||+||+++. +..+|++|||+|+.+
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 994 57777665443 2689999999999999999999999 9999999999999864 557999999999876
Q ss_pred cccccc-----ccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccH--HHHHHHhhccc
Q 046275 1014 SAMDTH-----LSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNL--VGWVKQHAKLK 1086 (1176)
Q Consensus 1014 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~ 1086 (1176)
...... .......||+.|||||++.+..++.++|||||||++|||+||+.||.......... ..+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 543322 12245679999999999999999999999999999999999999997654322111 11111100100
Q ss_pred cccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHhhC
Q 046275 1087 ISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAMFKEIQAG 1140 (1176)
Q Consensus 1087 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~L~~i~~~ 1140 (1176)
.+......|. ++.+++.+||+.+|++||++.++.+.|+++...
T Consensus 237 -----~~~~~~~~p~------~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 -----IEVLCKGYPS------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----HHHHTTTSCH------HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----hhHhccCCCH------HHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0111111221 355699999999999999999999999887543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=368.90 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=197.7
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC-cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC----eeE
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG-QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE----ERL 932 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 932 (1176)
+.+|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999875 799999999865332 22456889999999999999999999986643 335
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566677799999999754 589999999999999999999999 999999999999999999999999999987
Q ss_pred cccccccc-cccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc-----
Q 046275 1013 MSAMDTHL-SVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL----- 1085 (1176)
Q Consensus 1013 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~----- 1085 (1176)
........ ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+..+ ...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQED 236 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhhccCCChhh
Confidence 65433322 2345679999999999854 467889999999999999999999997543211 00000000000
Q ss_pred --------------ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHh
Q 046275 1086 --------------KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQ 1138 (1176)
Q Consensus 1086 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~ 1138 (1176)
..............+... .++.+++.+||+.||++|||++|+++| +++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCC---HHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 000000000000000000 245679999999999999999999987 55443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=367.54 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=202.2
Q ss_pred cCCCCCceEeEeCceEEEEEEEC----CCCEEEEEEeecc----CCcCHHHHHHHHHHHHhcCC-CCcccceeEEeeCCe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK----DGSTVAIKKLIHI----SGQGDREFTAEMETIGKIKH-RNLVPLLGYCKVGEE 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 930 (1176)
++|++.+.||+|+||+||+|+.. +|+.||||.+... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999863 4789999988542 22335668899999999976 899999999999999
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++||||+.+|+|.+++...+ .+++..++.++.|++.|++|+|++ +||||||||+||+++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998775 578899999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCcccCccccCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhccccc
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSF--RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKIS 1088 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1176)
+.+...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ ............
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE-- 252 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC--
T ss_pred hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCC--
Confidence 876543332 23456799999999999754 468899999999999999999999977653332 222222221111
Q ss_pred cccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 046275 1089 DVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRP-----TMIQVMAM 1133 (1176)
Q Consensus 1089 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RP-----t~~evl~~ 1133 (1176)
+......+ .++.+++.+||+.||++|| |++|+++|
T Consensus 253 ----~~~~~~~s------~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 ----PPYPQEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----CCCCTTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----CCCcccCC------HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11111111 2456699999999999999 58888764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=369.40 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=194.4
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCC------
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGE------ 929 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 929 (1176)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357999999999999999999986 699999999864322 22356889999999999999999999997654
Q ss_pred eeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeecc
Q 046275 930 ERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1009 (1176)
Q Consensus 930 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 1009 (1176)
..|+||||+ +++|.++.+.. ++++..++.++.|++.||+|||++ +||||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 56888877643 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCcccCccccCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhc----
Q 046275 1010 ARLMSAMDTHLSVSTLAGTPGYVPPEYYQS-FRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAK---- 1084 (1176)
Q Consensus 1010 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~---- 1084 (1176)
|+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+... .+.........
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAE 241 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHH
Confidence 9865432 245679999999999865 456899999999999999999999997643110 00000000000
Q ss_pred --------------cccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHhh
Q 046275 1085 --------------LKISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM--FKEIQA 1139 (1176)
Q Consensus 1085 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~--L~~i~~ 1139 (1176)
....+..........+... ..+.+|+.+||+.||++|||++|+++| ++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCC---HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000111111111111 235679999999999999999999997 665543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=360.03 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=202.3
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEeeCCeeEEEEe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 936 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 936 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++..... ....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999986 689999999854332 234678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccccccccc
Q 046275 937 YMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLMSAM 1016 (1176)
Q Consensus 937 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~ 1016 (1176)
++.++++..++...+ .+++..++.++.|++.||+|||++ +||||||||+||+++.++.+|++|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988887654 688999999999999999999999 9999999999999999999999999999876543
Q ss_pred cccccccccccCCcccCccccCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc---c------
Q 046275 1017 DTHLSVSTLAGTPGYVPPEYYQSFR-CSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---K------ 1086 (1176)
Q Consensus 1017 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~------ 1086 (1176)
... .....+++.|+|||++.... ++.++||||+||++|||++|+.||.........+.......... .
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Ccc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 322 23456788999999987654 68999999999999999999999754331111111111111100 0
Q ss_pred cccccC-------cccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1087 ISDVFD-------PELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1087 ~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..+..+ .......+.. -..+.+|+.+||+.||.+|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKL---NATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTC---CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000001111 1245679999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-39 Score=364.25 Aligned_cols=258 Identities=19% Similarity=0.274 Sum_probs=195.0
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeC--CeeEEEE
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVG--EERLLVY 935 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 935 (1176)
++|++.+.||+|+||+||+|++. +|+.||||++.. ...+++.+|++++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999985 689999999853 34567899999999995 99999999998743 5689999
Q ss_pred eeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEEeeccccccc
Q 046275 936 EYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLMS 1014 (1176)
Q Consensus 936 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~ 1014 (1176)
||+++|+|.++.+ .+++..++.++.||+.||+|||++ +||||||||+|||++.++ .+|++|||+|+...
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999876532 589999999999999999999999 999999999999998654 69999999998765
Q ss_pred cccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHH---------hhc
Q 046275 1015 AMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQ---------HAK 1084 (1176)
Q Consensus 1015 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~---------~~~ 1084 (1176)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 4332 2456799999999998765 47999999999999999999999997543211111110000 000
Q ss_pred ccc------ccccCcc---cc---cCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1085 LKI------SDVFDPE---LM---KEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1085 ~~~------~~~~~~~---~~---~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
... ....... .. ...+....--.++.+|+.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000000 00 0000000011245679999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=361.89 Aligned_cols=260 Identities=24% Similarity=0.288 Sum_probs=188.5
Q ss_pred cCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEee------CCe
Q 046275 860 NGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKV------GEE 930 (1176)
Q Consensus 860 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 930 (1176)
++|++.++||+|+||+||+|+++ +|+.||||++..... .....+.+|+.++++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999987 699999999865332 223468899999999999999999999864 367
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.|+||||+.++ +.+.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999764 4454432 589999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHh--------
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQH-------- 1082 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~-------- 1082 (1176)
+...... ......||+.|+|||++.+..+++++||||+||++|||++|+.||...+... .........
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHH
Confidence 7654322 2345679999999999999999999999999999999999999997543110 000000000
Q ss_pred ----------hcccc-------ccccCcccccCCC-chHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1083 ----------AKLKI-------SDVFDPELMKEDP-NIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1083 ----------~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..... ...+......... ........+.+|+.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0001111111111 111233456789999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=360.34 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=192.9
Q ss_pred hcCCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCC--cCHHHHHHHHHHHHhcCCCCcccceeEEee-----CCe
Q 046275 859 TNGFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISG--QGDREFTAEMETIGKIKHRNLVPLLGYCKV-----GEE 930 (1176)
Q Consensus 859 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 930 (1176)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++++|||||++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457999999999999999999986 699999999864332 223468899999999999999999999864 334
Q ss_pred eEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEEeeccc
Q 046275 931 RLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1010 (1176)
Q Consensus 931 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla 1010 (1176)
.++|++|+.+|+|.+++... ++++..++.++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.|
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 57778888899999999654 589999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccCCcccCccccCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCccHHHHHHHhhcc----
Q 046275 1011 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSF-RCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKL---- 1085 (1176)
Q Consensus 1011 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 1085 (1176)
..... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+... ............
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAEL 242 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHH
Confidence 75432 22456789999999987665 46889999999999999999999997543110 000000000000
Q ss_pred --------------ccccccCcccccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 046275 1086 --------------KISDVFDPELMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQVMAM 1133 (1176)
Q Consensus 1086 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~evl~~ 1133 (1176)
..............+.. -..+.+|+.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGA---NPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCC---CHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000000 1235679999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-34 Score=328.70 Aligned_cols=269 Identities=18% Similarity=0.198 Sum_probs=189.3
Q ss_pred CCCCCceEeEeCceEEEEEEEC-CCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-----------CCCcccceeEEee-
Q 046275 861 GFHNDSLIGSGGFGDVYKAKLK-DGSTVAIKKLIHISGQGDREFTAEMETIGKIK-----------HRNLVPLLGYCKV- 927 (1176)
Q Consensus 861 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~- 927 (1176)
+|++.++||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999999999999986 69999999986432 22456788999888875 5789999998754
Q ss_pred -CCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC------
Q 046275 928 -GEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENF------ 1000 (1176)
Q Consensus 928 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------ 1000 (1176)
....++||+++..+.......... ....+++..++.++.|++.|++|||+.. +|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 455667777665544333332221 2336889999999999999999999832 899999999999998654
Q ss_pred cEEEEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCCCc--c---H
Q 046275 1001 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDN--N---L 1075 (1176)
Q Consensus 1001 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P~~~~~~~~~--~---~ 1075 (1176)
.+|++|||.|...... .....||+.|+|||++....++.++||||+||++++|++|+.||...+.... . .
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999998754332 2456799999999999999999999999999999999999999975432110 0 1
Q ss_pred HHHHHHhhc------------------cccccccCcc--------cccCCCchHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 046275 1076 VGWVKQHAK------------------LKISDVFDPE--------LMKEDPNIEIELLQHLHVASACLDDRPWRRPTMIQ 1129 (1176)
Q Consensus 1076 ~~~~~~~~~------------------~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dp~~RPt~~e 1129 (1176)
......... ......+... ..............+.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111110000 0000000000 00111112234456788999999999999999999
Q ss_pred HHHH--HHHHh
Q 046275 1130 VMAM--FKEIQ 1138 (1176)
Q Consensus 1130 vl~~--L~~i~ 1138 (1176)
+++| +++..
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 9986 55443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=5.5e-27 Score=271.74 Aligned_cols=357 Identities=23% Similarity=0.292 Sum_probs=196.9
Q ss_pred cccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEe
Q 046275 124 LDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLAL 203 (1176)
Q Consensus 124 LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L 203 (1176)
.+++.+.+++... ...+.+|++|++++|+|+.+. -+..+++|++|||++|+|+++ +. |.++++|++|++
T Consensus 27 ~~l~~~~~~~~~~----~~~l~~l~~L~l~~~~I~~l~--gl~~L~nL~~L~Ls~N~l~~l---~~--l~~L~~L~~L~L 95 (384)
T d2omza2 27 TVLGKTNVTDTVS----QTDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDI---TP--LKNLTKLVDILM 95 (384)
T ss_dssp HHTTCSSTTSEEC----HHHHTTCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCC---GG--GTTCTTCCEEEC
T ss_pred HHhCCCCCCCccC----HHHhCCCCEEECCCCCCCCcc--ccccCCCCCEEeCcCCcCCCC---cc--ccCCcccccccc
Confidence 3455555543221 234456666666666666552 233455666666666666552 21 344444554444
Q ss_pred CCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCC
Q 046275 204 KGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPV 283 (1176)
Q Consensus 204 ~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 283 (1176)
++|.+.+..++ +.+++|+.|++++|.+++..+ ......+..+....|.+....+.
T Consensus 96 ~~n~i~~i~~l-----------------------~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~ 150 (384)
T d2omza2 96 NNNQIADITPL-----------------------ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL 150 (384)
T ss_dssp CSSCCCCCGGG-----------------------TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGG
T ss_pred ccccccccccc-----------------------ccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence 44444443344 444555555555555443322 22334444444444444321111
Q ss_pred CCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccC
Q 046275 284 GYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT 363 (1176)
Q Consensus 284 ~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~ 363 (1176)
... ............. ....+...+.........|.... . ..+..+++++.+++++|.++
T Consensus 151 ~~~------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~l~~~~~l~l~~n~i~ 210 (384)
T d2omza2 151 SGL------------TSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVSD--I-SVLAKLTNLESLIATNNQIS 210 (384)
T ss_dssp TTC------------TTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCCC
T ss_pred ccc------------ccccccccccccc-----hhhhhcccccccccccccccccc--c-cccccccccceeeccCCccC
Confidence 000 0011111111111 11223333444444444444431 1 12345556666666666655
Q ss_pred CCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCcc
Q 046275 364 GALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSS 443 (1176)
Q Consensus 364 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 443 (1176)
+..| +...++|++|++++|.++. ++ .+ ..+++|+.|++++|.+++.. .++.+++|++|++++|++++.. .
T Consensus 211 ~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l--~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~ 280 (384)
T d2omza2 211 DITP--LGILTNLDELSLNGNQLKD-IG-TL--ASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--P 280 (384)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCC-CG-GG--GGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--G
T ss_pred CCCc--ccccCCCCEEECCCCCCCC-cc-hh--hcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--c
Confidence 4332 3344556666666666552 22 12 22355666666666665432 2566677777777777776432 3
Q ss_pred ccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCC
Q 046275 444 LGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLA 523 (1176)
Q Consensus 444 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 523 (1176)
+..++.++.++++.|.+++ +..+..+++++.|++++|++++..+ +..+++|++|++++|+|++ +| .++.+++|+
T Consensus 281 ~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~ 354 (384)
T d2omza2 281 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNIN 354 (384)
T ss_dssp GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCC
T ss_pred ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCC
Confidence 6667777777777777764 2346777788888888888886433 7778888888888888873 44 578888888
Q ss_pred eEEccCCcccccCCCCCCCCCCCCEEEccCC
Q 046275 524 ILKLSNNSFYGRIPPELGDCRSLIWLDLNTN 554 (1176)
Q Consensus 524 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 554 (1176)
+|++++|++++..| +.++++|+.|+|++|
T Consensus 355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred EEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88888888886544 778888888888877
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=5.9e-27 Score=271.49 Aligned_cols=358 Identities=23% Similarity=0.308 Sum_probs=215.9
Q ss_pred cccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCcEEE
Q 046275 96 ETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLD 175 (1176)
Q Consensus 96 ~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~Ld 175 (1176)
...+++.+++++.+. ...+.+|++|++++|.|+.. +.+..+++|++|+|++|+|+.++. ++.+++|++|+
T Consensus 25 ~~~~l~~~~~~~~~~----~~~l~~l~~L~l~~~~I~~l----~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~ 94 (384)
T d2omza2 25 MKTVLGKTNVTDTVS----QTDLDQVTTLQADRLGIKSI----DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94 (384)
T ss_dssp HHHHTTCSSTTSEEC----HHHHTTCCEEECCSSCCCCC----TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHhCCCCCCCccC----HHHhCCCCEEECCCCCCCCc----cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccc
Confidence 345777777876542 23567899999999999743 347789999999999999999864 77889999999
Q ss_pred ccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCC-ccCCCCCcEEEcCCCcCC
Q 046275 176 LSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPS-FGDCLALEYLDISANKFT 254 (1176)
Q Consensus 176 Ls~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~ 254 (1176)
+++|+|+++ + .+.++++|+.|++++|.+++.........+..+....|.+...... ................+
T Consensus 95 L~~n~i~~i---~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~- 168 (384)
T d2omza2 95 MNNNQIADI---T--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL- 168 (384)
T ss_dssp CCSSCCCCC---G--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-
T ss_pred ccccccccc---c--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh-
Confidence 999999874 2 2578999999999999998877777777788888877777644332 11122222222221111
Q ss_pred CCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccC
Q 046275 255 GDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISS 334 (1176)
Q Consensus 255 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 334 (1176)
..+.............|.... ......+++++.+++++|.+++..| +...++|++|++++
T Consensus 169 ----~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~ 228 (384)
T d2omza2 169 ----KPLANLTTLERLDISSNKVSD--------------ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 228 (384)
T ss_dssp ----GGGTTCTTCCEEECCSSCCCC--------------CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred ----hhhcccccccccccccccccc--------------ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCC
Confidence 223333444444444443221 0111223455555555555554322 33345555555555
Q ss_pred CcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccC
Q 046275 335 NKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLG 414 (1176)
Q Consensus 335 N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~ 414 (1176)
|+++ .++ .+..+++|++|++++|.+++.. .+..+++|++|++++|+++ +
T Consensus 229 n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~--------------------------~ 277 (384)
T d2omza2 229 NQLK-DIG--TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQIS--------------------------N 277 (384)
T ss_dssp SCCC-CCG--GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCC--------------------------C
T ss_pred CCCC-Ccc--hhhcccccchhccccCccCCCC--cccccccCCEeeccCcccC--------------------------C
Confidence 5554 332 2344555555555555555332 2444455555555555444 3
Q ss_pred CCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCcccccccc
Q 046275 415 SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN 494 (1176)
Q Consensus 415 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 494 (1176)
.. .+..++.++.++++.|++++ +..+..+++++.|++++|++++.. .+..+++|++|+|++|+|++ ++ .|.+
T Consensus 278 ~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~ 349 (384)
T d2omza2 278 IS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLAN 349 (384)
T ss_dssp CG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred CC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence 21 24445555666666666553 223555566666666666666432 25666677777777777763 33 4677
Q ss_pred CCCCCeeeccccccCCCCCccccCCCCCCeEEccCC
Q 046275 495 CTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNN 530 (1176)
Q Consensus 495 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 530 (1176)
+++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 350 l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7777777777777775433 677777777777776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=8.5e-27 Score=262.01 Aligned_cols=220 Identities=29% Similarity=0.480 Sum_probs=140.2
Q ss_pred ccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccc
Q 046275 410 NLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLP 489 (1176)
Q Consensus 410 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 489 (1176)
|+++|.+|..|+++++|++|+|++|++.+..|..+..+.+|+.+++++|.+. +.+|
T Consensus 87 N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~------------------------~~~p 142 (313)
T d1ogqa_ 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS------------------------GTLP 142 (313)
T ss_dssp TTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE------------------------SCCC
T ss_pred cccccccccccccccccchhhhccccccccccccccchhhhccccccccccc------------------------ccCc
Confidence 4455566666666666666666666666555555555555555555555544 4445
Q ss_pred cccccCCCCCeeeccccccCCCCCccccCCCCC-CeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhc
Q 046275 490 AALSNCTNLNWISLSNNHLGGEIPTWIGQLSNL-AILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQS 568 (1176)
Q Consensus 490 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~ 568 (1176)
..+.++++|+.+++++|.+++.+|..++.+..+ +.+++++|+++|..|..+..+..+ .+++++|.+.|.+|..+
T Consensus 143 ~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~---- 217 (313)
T d1ogqa_ 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLF---- 217 (313)
T ss_dssp GGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGC----
T ss_pred hhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc----
Confidence 555555555555555555555555555555443 555555555555555555554333 46666665555444321
Q ss_pred ccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcC
Q 046275 569 GKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNML 648 (1176)
Q Consensus 569 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l 648 (1176)
....+++.+++++|.+
T Consensus 218 ----------------------------------------------------------------~~~~~l~~l~~~~~~l 233 (313)
T d1ogqa_ 218 ----------------------------------------------------------------GSDKNTQKIHLAKNSL 233 (313)
T ss_dssp ----------------------------------------------------------------CTTSCCSEEECCSSEE
T ss_pred ----------------------------------------------------------------cccccccccccccccc
Confidence 1113455666677777
Q ss_pred ccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccccccccccccc-ccCCC
Q 046275 649 SGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQ-LTGMI 724 (1176)
Q Consensus 649 ~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~-l~g~~ 724 (1176)
+|.+| .++.+++|+.|+|++|+|+|.+|++|++|++|++|||++|+|+|.||. +++|++|+.+++++|+ ++|.+
T Consensus 234 ~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTT
T ss_pred ccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCC
Confidence 66554 577778888888888888888888888888888888888888888884 6788889999999886 78763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=3e-25 Score=248.25 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=186.2
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDL 381 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 381 (1176)
.++.++-++++++ .+|..+. +++++|+|++|+|+ .+|...|.++++|++|++++|.++...|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 3455666666666 4555543 56777777777776 666666677777777777777777666677777777777777
Q ss_pred cCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCcccc--CCCCccccCCCccCeeeccccc
Q 046275 382 SSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLT--GTIPSSLGSLSKLQDLKLWLNQ 459 (1176)
Q Consensus 382 s~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~ 459 (1176)
++|+++ .+|..+ ...+..|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.
T Consensus 87 ~~n~l~-~l~~~~----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~ 161 (305)
T d1xkua_ 87 SKNQLK-ELPEKM----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161 (305)
T ss_dssp CSSCCS-BCCSSC----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred cCCccC-cCccch----hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCC
Confidence 777776 455433 245777778887777666666666777778888777543 3445667778888888888888
Q ss_pred ccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 460 LHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 460 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
+. .+|..+ .++|++|++++|.+++..+..|.+++.+++|++++|.+++..|.++..+++|++|+|++|+|+ .+|.+
T Consensus 162 l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 162 IT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp CC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred cc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc
Confidence 87 455543 578888888888888888888888888999999999888877888888889999999999887 67888
Q ss_pred CCCCCCCCEEEccCCCCcccCChhHH
Q 046275 540 LGDCRSLIWLDLNTNLFNGSIPPALF 565 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~N~l~g~ip~~~~ 565 (1176)
|.++++|++|+|++|+++ .|+...|
T Consensus 238 l~~l~~L~~L~Ls~N~i~-~i~~~~f 262 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNIS-AIGSNDF 262 (305)
T ss_dssp TTTCSSCCEEECCSSCCC-CCCTTSS
T ss_pred cccccCCCEEECCCCccC-ccChhhc
Confidence 888889999999988887 4555443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.9e-24 Score=241.62 Aligned_cols=244 Identities=22% Similarity=0.343 Sum_probs=179.0
Q ss_pred ccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhh
Q 046275 219 NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~ 298 (1176)
.++.+|.++++++.+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..| .
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f------------~ 76 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF------------A 76 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT------------T
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh------------h
Confidence 56778888888888877663 678999999999987777788888999999999998885444433 3
Q ss_pred cCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccC--CCCcccccCCCCC
Q 046275 299 LCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFT--GALPDSLSNLTNL 376 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L 376 (1176)
.+++|++|++++|+++ .+|..+ ...++.|++++|.+. .++...|.....+..++...|... ...+..+..+++|
T Consensus 77 ~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L 152 (305)
T d1xkua_ 77 PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152 (305)
T ss_dssp TCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTC
T ss_pred CCCccCEecccCCccC-cCccch--hhhhhhhhccccchh-hhhhhhhhccccccccccccccccccCCCcccccccccc
Confidence 4578889999988888 455443 357889999999987 778888888888889988887554 2345667788888
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecc
Q 046275 377 ETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW 456 (1176)
Q Consensus 377 ~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 456 (1176)
+.+++++|.++ .+|..+ .++|++|++++|..++..+..+.+++.+++|++++|++++..+.++.++++|++|+|+
T Consensus 153 ~~l~l~~n~l~-~l~~~~----~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 153 SYIRIADTNIT-TIPQGL----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp CEEECCSSCCC-SCCSSC----CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred CccccccCCcc-ccCccc----CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence 89999888887 455433 3567777777777776666777777777777777777776666666666666666666
Q ss_pred cccccCCCCCCCCCccccceeecccccccC
Q 046275 457 LNQLHGEIPPELGNIQTLETLFLDFNELTG 486 (1176)
Q Consensus 457 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 486 (1176)
+|+++ .+|..|.++++|++|+|++|+|+.
T Consensus 228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccccc-ccccccccccCCCEEECCCCccCc
Confidence 66665 455566666666666666666663
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.2e-25 Score=243.43 Aligned_cols=231 Identities=25% Similarity=0.267 Sum_probs=172.6
Q ss_pred EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC
Q 046275 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384 (1176)
Q Consensus 305 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 384 (1176)
.++.++++++ .+|..+. +++++|+|++|+|+ .+|...|.++++|++|++++|.+....+..+.++..++.++..
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~-- 88 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS-- 88 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC--
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccc--
Confidence 3455555555 4454332 34566666666665 5555555555556666665555555444444444444444433
Q ss_pred cCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCC
Q 046275 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464 (1176)
Q Consensus 385 ~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 464 (1176)
..|.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|++++..
T Consensus 89 -----------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~ 145 (284)
T d1ozna_ 89 -----------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (284)
T ss_dssp -----------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred -----------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccC
Confidence 233444445667788888888888888888667777888888888888888888777
Q ss_pred CCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCC
Q 046275 465 PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCR 544 (1176)
Q Consensus 465 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 544 (1176)
+..|..+++|+.|+|++|++++..+.+|.++++|+++++++|++++..|.+|..+++|++|++++|++.+..|..|++++
T Consensus 146 ~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~ 225 (284)
T d1ozna_ 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred hhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence 77888889999999999999988888999999999999999999988899999999999999999999988888899999
Q ss_pred CCCEEEccCCCCcccCChhH
Q 046275 545 SLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 545 ~L~~L~L~~N~l~g~ip~~~ 564 (1176)
+|++|+|++|++.|.++...
T Consensus 226 ~L~~L~l~~N~l~C~C~~~~ 245 (284)
T d1ozna_ 226 ALQYLRLNDNPWVCDCRARP 245 (284)
T ss_dssp TCCEEECCSSCEECSGGGHH
T ss_pred ccCEEEecCCCCCCCccchH
Confidence 99999999999988766443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-24 Score=240.31 Aligned_cols=269 Identities=23% Similarity=0.243 Sum_probs=175.3
Q ss_pred EEEccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecc-
Q 046275 378 TLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLW- 456 (1176)
Q Consensus 378 ~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~- 456 (1176)
.++.++++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|++++|++.+..+..+..+..+..+...
T Consensus 15 ~v~c~~~~L~-~iP~~i----p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGI----PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp EEECCSSCCS-SCCTTC----CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCCC-ccCCCC----CCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 3455666665 555544 2456777777777765555667777777777777777776666666777777776553
Q ss_pred cccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccC
Q 046275 457 LNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRI 536 (1176)
Q Consensus 457 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 536 (1176)
.|.++...|..|.++++|++|++++|.+....+..+..+.+|+.+++++|+|++..+.+|..+++|+.|+|++|++++..
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 55566555666777777777777777776666666777777777777777777655666777777777777777777666
Q ss_pred CCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCC
Q 046275 537 PPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRS 616 (1176)
Q Consensus 537 p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 616 (1176)
|..|.++++|+.+++++|++++..|..
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~----------------------------------------------------- 196 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHA----------------------------------------------------- 196 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTT-----------------------------------------------------
T ss_pred hhhhccccccchhhhhhccccccChhH-----------------------------------------------------
Confidence 667777777777777777776433321
Q ss_pred CCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccc
Q 046275 617 PCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRL 696 (1176)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l 696 (1176)
|..+.+|++||+++|++++..|..|+++.+|+.|+|++|.+.+.-+ ...-...++.+....+++
T Consensus 197 ---------------f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~ 260 (284)
T d1ozna_ 197 ---------------FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEV 260 (284)
T ss_dssp ---------------TTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCC
T ss_pred ---------------hhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCce
Confidence 2223456677777777776666677777777777777777765433 122223456666666676
Q ss_pred cccCCCCccccccccccccccccccCC
Q 046275 697 EGTIPSSMSSLTLLNEIDLCNNQLTGM 723 (1176)
Q Consensus 697 ~g~iP~~l~~l~~L~~l~ls~N~l~g~ 723 (1176)
....|.++.. ....+++.|.|+|+
T Consensus 261 ~C~~p~~l~g---~~l~~l~~~~l~gc 284 (284)
T d1ozna_ 261 PCSLPQRLAG---RDLKRLAANDLQGC 284 (284)
T ss_dssp BEEESGGGTT---CBGGGSCGGGSCCC
T ss_pred EeCCchHHcC---CccccCCHHHCCCc
Confidence 6666665543 44556666666663
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.7e-22 Score=220.46 Aligned_cols=208 Identities=26% Similarity=0.269 Sum_probs=145.2
Q ss_pred CCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCCcCCCCCCccccCCCCCCcc
Q 046275 324 CSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSNNLSGAIPHNLCQGPRNSLK 403 (1176)
Q Consensus 324 l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~ 403 (1176)
...+.+++.++++++ .+|.++. +++++|+|++|.|++..+..|.++++|++|+|++|+|+ .+|
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~------------ 71 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ------------ 71 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE------------
T ss_pred cCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc------------
Confidence 344444555555555 4553321 34555555555555444445555555555555555554 121
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 483 (1176)
.++.+++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.
T Consensus 72 ---------------~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 72 ---------------VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp ---------------CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred ---------------ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccc
Confidence 1234555666666666665 345556666677777777777766666777778888888888888
Q ss_pred ccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChh
Q 046275 484 LTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPA 563 (1176)
Q Consensus 484 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~ 563 (1176)
++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+..--.
T Consensus 136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred cceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence 88777788888999999999999999888888999999999999999998 89999999999999999999998765433
Q ss_pred HH
Q 046275 564 LF 565 (1176)
Q Consensus 564 ~~ 565 (1176)
.|
T Consensus 215 ~l 216 (266)
T d1p9ag_ 215 YF 216 (266)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.8e-22 Score=220.39 Aligned_cols=198 Identities=26% Similarity=0.244 Sum_probs=132.0
Q ss_pred ccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEcc
Q 046275 449 KLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLS 528 (1176)
Q Consensus 449 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 528 (1176)
.+.+.+.+++.++ .+|..+. +++++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 3344444445554 3444443 35666666677666555566677777777777777766 333 24567777777777
Q ss_pred CCcccccCCCCCCCCCCCCEEEccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhh
Q 046275 529 NNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAER 608 (1176)
Q Consensus 529 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (1176)
+|+++ .+|..+..+++|+.|++++|.+.+ ++..
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~-~~~~--------------------------------------------- 118 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLG--------------------------------------------- 118 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCC-CCSS---------------------------------------------
T ss_pred ccccc-ccccccccccccccccccccccce-eecc---------------------------------------------
Confidence 77776 456667777777777777776652 2211
Q ss_pred ccccccCCCCccccccCCCCCCCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccE
Q 046275 609 LSRISTRSPCNFTRVYGGHTQPTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNI 688 (1176)
Q Consensus 609 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~ 688 (1176)
.+..+.++++|++++|.+++..|..+..++.|+.|++++|+|++..|..|+.+++|++
T Consensus 119 ----------------------~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~ 176 (266)
T d1p9ag_ 119 ----------------------ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176 (266)
T ss_dssp ----------------------TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred ----------------------ccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccce
Confidence 1122345667777777777666666777788888888888888666677788888888
Q ss_pred EEccCccccccCCCCcccccccccccccccccc
Q 046275 689 LDLSSNRLEGTIPSSMSSLTLLNEIDLCNNQLT 721 (1176)
Q Consensus 689 L~Ls~N~l~g~iP~~l~~l~~L~~l~ls~N~l~ 721 (1176)
|||++|+|+ .||.++..+++|+.|+|++|++.
T Consensus 177 L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred eecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 888888887 78888778888888888877764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=4e-19 Score=202.00 Aligned_cols=295 Identities=23% Similarity=0.260 Sum_probs=141.5
Q ss_pred CCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceee
Q 046275 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLD 224 (1176)
Q Consensus 145 ~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~ 224 (1176)
++|++|+|++|+|+.++.. ..+|++|++++|+++.+..+| +.|++|++++|.+.....+..+++|+.|+
T Consensus 58 ~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~l~~lp-------~~L~~L~L~~n~l~~lp~~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKALSDLP-------PLLEYLGVSNNQLEKLPELQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSCCCSCC-------TTCCEEECCSSCCSSCCCCTTCTTCCEEE
T ss_pred CCCCEEECCCCCCcccccc----hhhhhhhhhhhcccchhhhhc-------cccccccccccccccccchhhhccceeec
Confidence 3445555555555544321 234555555555555432221 23455555555554444445566666666
Q ss_pred ccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCcc
Q 046275 225 VSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLV 304 (1176)
Q Consensus 225 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~ 304 (1176)
+++|.+...+.. ...+..+.+..+.... ...+..++.++.|++++|.+...... ....+
T Consensus 127 l~~~~~~~~~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~~~----------------~~~~~ 185 (353)
T d1jl5a_ 127 VDNNSLKKLPDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPDL----------------PLSLE 185 (353)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCCCC----------------CTTCC
T ss_pred cccccccccccc---cccccchhhccccccc--cccccccccceecccccccccccccc----------------ccccc
Confidence 666666544432 2345555655554432 22355566666666666655421100 12234
Q ss_pred EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC
Q 046275 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384 (1176)
Q Consensus 305 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 384 (1176)
.+..+++.+. .++ .+..++.|+.+++++|... .++ ....++..+.+.++.+.. .+. ....+...++..+
T Consensus 186 ~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~----~~~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~ 254 (353)
T d1jl5a_ 186 SIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLP----DLPPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSEN 254 (353)
T ss_dssp EEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCC----SCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred cccccccccc-ccc-ccccccccccccccccccc-ccc----cccccccccccccccccc-ccc---ccccccccccccc
Confidence 4444444443 222 2445566666666666554 333 123445555555555442 111 1233444444444
Q ss_pred cCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCC
Q 046275 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI 464 (1176)
Q Consensus 385 ~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 464 (1176)
.+.+ ++. .. ......++..|.+.+. ...+++|++|+|++|+++ .+
T Consensus 255 ~~~~-l~~-----l~------------------------~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~l 299 (353)
T d1jl5a_ 255 IFSG-LSE-----LP------------------------PNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-EL 299 (353)
T ss_dssp CCSE-ESC-----CC------------------------TTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CC
T ss_pred cccc-ccc-----cc------------------------chhcccccccCccccc----cccCCCCCEEECCCCccC-cc
Confidence 3331 110 00 1223344444444321 122345566666666655 44
Q ss_pred CCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEcc
Q 046275 465 PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLS 528 (1176)
Q Consensus 465 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 528 (1176)
|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.. ..+|+.|.+.
T Consensus 300 p~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~---~~~L~~L~~~ 352 (353)
T d1jl5a_ 300 PAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI---PESVEDLRMN 352 (353)
T ss_dssp CCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECC
T ss_pred ccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc---ccccCeeECc
Confidence 433 345666677777766 45532 346777777777776 55543 2346666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=7.2e-19 Score=199.89 Aligned_cols=313 Identities=27% Similarity=0.273 Sum_probs=185.2
Q ss_pred CCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceee
Q 046275 145 SSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLD 224 (1176)
Q Consensus 145 ~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~ 224 (1176)
.++++|+|++|.|+.+|. ..++|++|+|++|+|+. +|. ... +|+.|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~~---lp~----~~~----------------------~L~~L~ 84 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE----LPPHLESLVASCNSLTE---LPE----LPQ----------------------SLKSLL 84 (353)
T ss_dssp HTCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSS---CCC----CCT----------------------TCCEEE
T ss_pred cCCCEEEeCCCCCCCCCC----CCCCCCEEECCCCCCcc---ccc----chh----------------------hhhhhh
Confidence 367778888888777763 24577777777777775 332 123 444455
Q ss_pred ccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCcc
Q 046275 225 VSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLV 304 (1176)
Q Consensus 225 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~ 304 (1176)
+++|+++.+... .+.|++|++++|.++... .++.+++|++|++++|.+....+ ....+.
T Consensus 85 l~~n~l~~l~~l---p~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~~~~~~~~~~----------------~~~~l~ 143 (353)
T d1jl5a_ 85 VDNNNLKALSDL---PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVDNNSLKKLPD----------------LPPSLE 143 (353)
T ss_dssp CCSSCCSCCCSC---CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSCCCC----------------CCTTCC
T ss_pred hhhcccchhhhh---cccccccccccccccccc--chhhhccceeecccccccccccc----------------cccccc
Confidence 555544433211 134666666666666432 24556666666666666542211 124566
Q ss_pred EEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC
Q 046275 305 KLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN 384 (1176)
Q Consensus 305 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 384 (1176)
.+.+..+... .+..+..++.++.|++++|.+. .++. .....+.+...++.+. .++ .+..++.|+.+++++|
T Consensus 144 ~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~-~~~~----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n 214 (353)
T d1jl5a_ 144 FIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNN 214 (353)
T ss_dssp EEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS-SCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSS
T ss_pred chhhcccccc--ccccccccccceeccccccccc-cccc----cccccccccccccccc-ccc-cccccccccccccccc
Confidence 6666666554 2345677788888888888876 3332 2334566777666665 333 3567888888888888
Q ss_pred cCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCC-CccCeeecccccccCC
Q 046275 385 NLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSL-SKLQDLKLWLNQLHGE 463 (1176)
Q Consensus 385 ~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~ 463 (1176)
... .++.. ..++..+.+.+|.+.. .+. ....+...++..|.+.+. ..+ ......++..|.+.+
T Consensus 215 ~~~-~~~~~-----~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~- 278 (353)
T d1jl5a_ 215 LLK-TLPDL-----PPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRS- 278 (353)
T ss_dssp CCS-SCCSC-----CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSE-
T ss_pred ccc-ccccc-----cccccccccccccccc-ccc---cccccccccccccccccc-----ccccchhcccccccCcccc-
Confidence 776 34432 3457778888887763 222 234566677766665521 111 233455555555542
Q ss_pred CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCC
Q 046275 464 IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDC 543 (1176)
Q Consensus 464 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 543 (1176)
++ ..+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+++ .+|....
T Consensus 279 ~~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~-- 344 (353)
T d1jl5a_ 279 LC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE-- 344 (353)
T ss_dssp EC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT--
T ss_pred cc---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc--
Confidence 22 23467778888888777 45543 456777777777777 55542 456777777777776 5665332
Q ss_pred CCCCEEEc
Q 046275 544 RSLIWLDL 551 (1176)
Q Consensus 544 ~~L~~L~L 551 (1176)
+|+.|.+
T Consensus 345 -~L~~L~~ 351 (353)
T d1jl5a_ 345 -SVEDLRM 351 (353)
T ss_dssp -TCCEEEC
T ss_pred -ccCeeEC
Confidence 4555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=2.7e-21 Score=199.34 Aligned_cols=169 Identities=15% Similarity=0.106 Sum_probs=119.7
Q ss_pred CCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCC-----cC-------------HHHHHHHHHHHHhcCCCCccccee
Q 046275 862 FHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISG-----QG-------------DREFTAEMETIGKIKHRNLVPLLG 923 (1176)
Q Consensus 862 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~-------------~~~~~~E~~~l~~l~h~niv~l~~ 923 (1176)
+.+++.||+|+||+||+|++.+|+.||||.+..... .. .....+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999999999999997642110 00 122456888999999999998876
Q ss_pred EEeeCCeeEEEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 046275 924 YCKVGEERLLVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNCIPHIIHRDMKSSNVLLDENFEAR 1003 (1176)
Q Consensus 924 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 1003 (1176)
+. ..++||||++++.+. .++......++.|++++++|||+. +|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence 53 237999999875432 244455678999999999999999 99999999999999965 589
Q ss_pred EEeeccccccccccccccccccccCCcccCccccCCCCCCchhhhHHHHHH
Q 046275 1004 VSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVV 1054 (1176)
Q Consensus 1004 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 1054 (1176)
++|||.|............. ..... -.|.+ ...|+.++|+||..--
T Consensus 143 liDFG~a~~~~~~~~~~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILE---RDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 99999997553221110000 00000 01122 3567889999997543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1e-21 Score=232.42 Aligned_cols=160 Identities=25% Similarity=0.256 Sum_probs=71.4
Q ss_pred CccEEEccCCccccc----CCccccCCCCCcEEEccCCcCccc----CCHHHHhcCCCCCEEEccCcccCCC----Cccc
Q 046275 302 SLVKLDLSSNNLSGK----VPSRFGSCSSLESFDISSNKFSGE----LPIEIFLSMSNLKELVLSFNDFTGA----LPDS 369 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----i~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 369 (1176)
....+++..+.+... ....+...+.++.+++++|.+... .....+.....++.|++++|.+... ....
T Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~ 278 (460)
T d1z7xw1 199 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 278 (460)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccc
Confidence 444555555544311 112233445566666666654311 1112223345566666666655432 1223
Q ss_pred ccCCCCCCEEEccCCcCCCCCCcccc---CCCCCCccEEEccCccccCCCCc----cccccccCcEEEcCCccccCC---
Q 046275 370 LSNLTNLETLDLSSNNLSGAIPHNLC---QGPRNSLKELFLQNNLLLGSIPS----TLSNCSQLVSLHLSFNYLTGT--- 439 (1176)
Q Consensus 370 l~~l~~L~~L~Ls~N~l~~~~p~~~~---~~~~~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~--- 439 (1176)
+...+.++.+++++|.+++.....++ ......|+.+++++|.++..... .+...++|++|+|++|++++.
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~ 358 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 358 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred ccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccc
Confidence 34455666666666655432111111 01123456666666655543222 223334566666666666431
Q ss_pred -CCcccc-CCCccCeeeccccccc
Q 046275 440 -IPSSLG-SLSKLQDLKLWLNQLH 461 (1176)
Q Consensus 440 -~p~~~~-~l~~L~~L~L~~N~l~ 461 (1176)
++..+. ..+.|++|+|++|.++
T Consensus 359 ~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 359 ELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhhhhhhcccCCCCEEECCCCCCC
Confidence 222222 2334555555555443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.2e-21 Score=226.98 Aligned_cols=161 Identities=17% Similarity=0.094 Sum_probs=100.3
Q ss_pred CCccEEEccCccccCC----CCccccccccCcEEEcCCccccCCCCcc----c-cCCCccCeeecccccccCCCCCCC--
Q 046275 400 NSLKELFLQNNLLLGS----IPSTLSNCSQLVSLHLSFNYLTGTIPSS----L-GSLSKLQDLKLWLNQLHGEIPPEL-- 468 (1176)
Q Consensus 400 ~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~----~-~~l~~L~~L~L~~N~l~~~~p~~~-- 468 (1176)
..++.|++++|.+... ....+...+.++.+++++|.++...... + .....|+.+++++|.++......+
T Consensus 255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~ 334 (460)
T d1z7xw1 255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 334 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccc
Confidence 4466666666655432 1223445566777777777765321111 1 233567777777777764432222
Q ss_pred --CCccccceeecccccccCc----cccccc-cCCCCCeeeccccccCCC----CCccccCCCCCCeEEccCCcccccCC
Q 046275 469 --GNIQTLETLFLDFNELTGT----LPAALS-NCTNLNWISLSNNHLGGE----IPTWIGQLSNLAILKLSNNSFYGRIP 537 (1176)
Q Consensus 469 --~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p 537 (1176)
...++|++|+|++|+|+.. ++..+. ..+.|++|+|++|+|+.. ++..+...++|++|+|++|+|+....
T Consensus 335 ~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~ 414 (460)
T d1z7xw1 335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414 (460)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHH
T ss_pred ccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHH
Confidence 3445788888888888643 333333 456789999999988742 44456677889999999998864322
Q ss_pred CC----CC-CCCCCCEEEccCCCCcccC
Q 046275 538 PE----LG-DCRSLIWLDLNTNLFNGSI 560 (1176)
Q Consensus 538 ~~----~~-~l~~L~~L~L~~N~l~g~i 560 (1176)
.. +. +...|+.|++++|.+....
T Consensus 415 ~~l~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 415 LQLVESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred HHHHHHHHhCCCccCEEECCCCCCCHHH
Confidence 22 22 3357999999999887533
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.6e-18 Score=181.03 Aligned_cols=201 Identities=18% Similarity=0.141 Sum_probs=119.4
Q ss_pred CCccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccC-cccCCCCcccccCCCCCCEE
Q 046275 301 SSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSF-NDFTGALPDSLSNLTNLETL 379 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L 379 (1176)
+++++|+|++|+++...+..|.++++|++|++++|.+...++...|.+++++++|.+.. |.+....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 46788888888887555567888888888888888887667777778888888888764 67776677778888888888
Q ss_pred EccCCcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccc-cCcEEEcCCccccCCCCccccCCCccCee-eccc
Q 046275 380 DLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCS-QLVSLHLSFNYLTGTIPSSLGSLSKLQDL-KLWL 457 (1176)
Q Consensus 380 ~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~ 457 (1176)
++++|.+.. .+.......+..+..+...++.+....+..+..++ .++.|++++|+++. ++.......+++.+ .+++
T Consensus 109 ~l~~~~l~~-~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~ 186 (242)
T d1xwdc1 109 LISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDN 186 (242)
T ss_dssp EEESCCCCS-CCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTC
T ss_pred ccchhhhcc-cccccccccccccccccccccccccccccccccccccceeeecccccccc-cccccccchhhhccccccc
Confidence 888888763 33222112234455555566666544445554443 55666666666663 22222223333222 3344
Q ss_pred ccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeec
Q 046275 458 NQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISL 503 (1176)
Q Consensus 458 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 503 (1176)
|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 187 n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4444222333444555555555555554333334444444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.5e-17 Score=174.50 Aligned_cols=188 Identities=18% Similarity=0.237 Sum_probs=108.4
Q ss_pred CCCCCCcEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccc
Q 046275 142 GSCSSLKVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQ 221 (1176)
Q Consensus 142 ~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~ 221 (1176)
+.+.+|+.|++++|+|+.+. .+..+++|++|++++|+|++.. .|..+++|+++++++|.++....+..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~~-----~l~~l~~l~~l~~~~n~~~~i~~l~~l~~L~ 110 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLA-----PLKNLTKITELELSGNPLKNVSAIAGLQSIK 110 (227)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-----GGTTCCSCCEEECCSCCCSCCGGGTTCTTCC
T ss_pred HHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeeccc-----ccccccccccccccccccccccccccccccc
Confidence 34445555555555555442 2344555555555555554421 1345555555555555555555555666666
Q ss_pred eeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCC
Q 046275 222 FLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCS 301 (1176)
Q Consensus 222 ~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~ 301 (1176)
.++++++...... .+...+.++.+.++++.+.... .+.++++|++|++++|.+++..+ +..++
T Consensus 111 ~l~l~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~--------------l~~l~ 173 (227)
T d1h6ua2 111 TLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP--------------LANLS 173 (227)
T ss_dssp EEECTTSCCCCCG-GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--------------GTTCT
T ss_pred ccccccccccccc-hhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh--------------hcccc
Confidence 6666666555332 2445566666666666665433 25566667777776666652211 22346
Q ss_pred CccEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEcc
Q 046275 302 SLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLS 358 (1176)
Q Consensus 302 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls 358 (1176)
+|++|+|++|++++. + .++++++|++|+|++|+++ .++. +.++++|++|+++
T Consensus 174 ~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt-~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 174 KLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS-DVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp TCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC-BCGG--GTTCTTCCEEEEE
T ss_pred cceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCC-CCcc--cccCCCCCEEEee
Confidence 677777777777642 2 3677777888888888777 4543 5677788888776
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.1e-17 Score=172.00 Aligned_cols=136 Identities=24% Similarity=0.241 Sum_probs=108.8
Q ss_pred CcEEEcCCccccCCCCccccCCCccCeeecccccccCCC-CCCCCCccccceeecccccccCccccccccCCCCCeeecc
Q 046275 426 LVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEI-PPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLS 504 (1176)
Q Consensus 426 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 504 (1176)
.+.++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 346677777777 5666553 56777777777776533 5567788888888888888888888888888899999999
Q ss_pred ccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEEEccCCCCcccCChhH
Q 046275 505 NNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWLDLNTNLFNGSIPPAL 564 (1176)
Q Consensus 505 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 564 (1176)
+|+|+...|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|++.+..+..+
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~ 146 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH
Confidence 999987778888899999999999999998788889999999999999999987554433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=5.2e-17 Score=171.98 Aligned_cols=204 Identities=18% Similarity=0.213 Sum_probs=134.7
Q ss_pred cEEecCCCCCCccccccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccC
Q 046275 148 KVLNLSSNLLDFSGREAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSS 227 (1176)
Q Consensus 148 ~~L~Ls~n~i~~~~~~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~ 227 (1176)
..++++.++++++. ....+.+|++|++++|.|+++.. +..+++|++|++++|.+++..++..+++|+++++++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l~~-----l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCTT-----GGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcchh-----HhcCCCCcEeecCCceeecccccccccccccccccc
Confidence 34455556555442 33456678888888888876322 466788888888888887776777778888888887
Q ss_pred CcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEE
Q 046275 228 NNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLD 307 (1176)
Q Consensus 228 N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~ 307 (1176)
|.++.+ +.+.++++|+++++++|...+.. .+...+.++.+.++.+.+....+ +..+++|++|+
T Consensus 95 n~~~~i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~--------------~~~~~~L~~L~ 157 (227)
T d1h6ua2 95 NPLKNV-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--------------LAGLTNLQYLS 157 (227)
T ss_dssp CCCSCC-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--------------GGGCTTCCEEE
T ss_pred cccccc-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhhh--------------hcccccccccc
Confidence 777643 34667777888888777766543 35666777777777776652211 12346677777
Q ss_pred ccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEcc
Q 046275 308 LSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLS 382 (1176)
Q Consensus 308 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 382 (1176)
+++|.+++. ..++++++|++|+|++|+++ .++. |..+++|++|+|++|++++. + .+.++++|+.|+++
T Consensus 158 l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~-~l~~--l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 158 IGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISP--LASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred ccccccccc--hhhcccccceecccCCCccC-CChh--hcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 777776633 23667777777777777776 4443 56677777777777777643 2 26677777777765
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=6.4e-18 Score=173.88 Aligned_cols=177 Identities=23% Similarity=0.251 Sum_probs=140.8
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCccEEEccCccccCC-CCccccccccCcEEEcCCccccCCCCccccCCCccCeee
Q 046275 376 LETLDLSSNNLSGAIPHNLCQGPRNSLKELFLQNNLLLGS-IPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLK 454 (1176)
Q Consensus 376 L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 454 (1176)
.++++.++++++ .+|..+ .+++++|+|++|+|++. .+..|.++++|+.|+|++|++++..+..+..+++|++|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~l----p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~ 84 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDI----PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TTEEECTTSCCS-SCCSCC----CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEEEEeCCCcC-ccCCCC----CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceee
Confidence 346777777777 667654 25688888888888753 456778899999999999999988888999999999999
Q ss_pred cccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccc
Q 046275 455 LWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYG 534 (1176)
Q Consensus 455 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 534 (1176)
|++|+++...|..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|.+....+.. .-...++.+.+..|.+..
T Consensus 85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBB
T ss_pred eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEe
Confidence 9999999888888999999999999999999888888999999999999999998543321 112346677788888887
Q ss_pred cCCCCCCCCCCCCEEEccCCCCcccCC
Q 046275 535 RIPPELGDCRSLIWLDLNTNLFNGSIP 561 (1176)
Q Consensus 535 ~~p~~~~~l~~L~~L~L~~N~l~g~ip 561 (1176)
..|..+ ..++.++|+.|.|.+.-+
T Consensus 164 ~~p~~l---~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 164 GAPSKV---RDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp CSSTTT---TTSBGGGSCTTTCCCCCC
T ss_pred CCChhh---cCCEeeecCHhhCcCCCC
Confidence 777655 456778899999986544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.9e-17 Score=172.82 Aligned_cols=166 Identities=22% Similarity=0.308 Sum_probs=107.5
Q ss_pred CccccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCCCCCCCCCCEE
Q 046275 470 NIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPELGDCRSLIWL 549 (1176)
Q Consensus 470 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 549 (1176)
.+.+|++|++++|.++.. + .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+++ .+| .+.++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccc
Confidence 345566666666666532 2 25666667777777776664 33 2566677777777777766 344 46667777777
Q ss_pred EccCCCCcccCChhHHhhcccchhhhccccceeeeecCCCCcccCCCCchhhhhhhhhhccccccCCCCccccccCCCCC
Q 046275 550 DLNTNLFNGSIPPALFKQSGKIAANFIVGKKYVYIKNDGSKECHGAGNLLEFAGIRAERLSRISTRSPCNFTRVYGGHTQ 629 (1176)
Q Consensus 550 ~L~~N~l~g~ip~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 629 (1176)
++++|.+.. ++
T Consensus 118 ~l~~~~~~~-~~-------------------------------------------------------------------- 128 (210)
T d1h6ta2 118 SLEHNGISD-IN-------------------------------------------------------------------- 128 (210)
T ss_dssp ECTTSCCCC-CG--------------------------------------------------------------------
T ss_pred ccccccccc-cc--------------------------------------------------------------------
Confidence 777766541 11
Q ss_pred CCcCCCCCccEEEcccCcCccCCCccccccccceeeeccCccccccCCccccCcCcccEEEccCccccccCCCCcccccc
Q 046275 630 PTFNHNGSMMFLDISYNMLSGSIPKEIGSMSYLFILNLGHNNLSGPIPTEVGDLRGLNILDLSSNRLEGTIPSSMSSLTL 709 (1176)
Q Consensus 630 ~~~~~~~~l~~LdLs~N~l~g~iP~~~~~l~~L~~L~L~~N~l~g~iP~~~~~L~~L~~L~Ls~N~l~g~iP~~l~~l~~ 709 (1176)
.+.++..++.+++++|.+++ +..++.+++|+.+++++|++++ ++ .++++++|+.|+|++|+|+ .+| .+..|++
T Consensus 129 -~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~ 201 (210)
T d1h6ta2 129 -GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKN 201 (210)
T ss_dssp -GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTT
T ss_pred -cccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCC
Confidence 01122356677777777764 3456777788888888888874 44 3778888888888888887 565 5778888
Q ss_pred cccccccc
Q 046275 710 LNEIDLCN 717 (1176)
Q Consensus 710 L~~l~ls~ 717 (1176)
|++|+|++
T Consensus 202 L~~L~Ls~ 209 (210)
T d1h6ta2 202 LDVLELFS 209 (210)
T ss_dssp CSEEEEEE
T ss_pred CCEEEccC
Confidence 88888764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3.2e-17 Score=175.58 Aligned_cols=220 Identities=17% Similarity=0.118 Sum_probs=117.6
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCC-cccccCCCCCCEEEcc
Q 046275 304 VKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGAL-PDSLSNLTNLETLDLS 382 (1176)
Q Consensus 304 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls 382 (1176)
+.++.++++++ .+|..+. +++++|+|++|+|+ .+|...|.++++|++|++++|.+...+ +..|.+++.+++|++.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 55666666666 4554432 45666666666665 566555666666666666666665433 3345556666666554
Q ss_pred C-CcCCCCCCccccCCCCCCccEEEccCccccCCCCccccccccCcEEEcCCccccCCCCc-cccCCCccCeeecccccc
Q 046275 383 S-NNLSGAIPHNLCQGPRNSLKELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPS-SLGSLSKLQDLKLWLNQL 460 (1176)
Q Consensus 383 ~-N~l~~~~p~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l 460 (1176)
. |++. ...+..|.++++|++|++++|+++...+. .+..+..+..+..+++.+
T Consensus 87 ~~n~l~--------------------------~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l 140 (242)
T d1xwdc1 87 KANNLL--------------------------YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140 (242)
T ss_dssp CCTTCC--------------------------EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTC
T ss_pred cccccc--------------------------ccccccccccccccccccchhhhccccccccccccccccccccccccc
Confidence 3 3343 33344455555555555555555422111 223334444444455555
Q ss_pred cCCCCCCCCCcc-ccceeecccccccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC
Q 046275 461 HGEIPPELGNIQ-TLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE 539 (1176)
Q Consensus 461 ~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 539 (1176)
....+..+.+++ .++.|++++|+++...+..|.....++.+++++|+++...+..|.++++|++|+|++|+|+...+..
T Consensus 141 ~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 220 (242)
T d1xwdc1 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220 (242)
T ss_dssp CEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred ccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence 544444454443 5666666666666433333333222333455666666433344666777777777777776333344
Q ss_pred CCCCCCCCEEEccC
Q 046275 540 LGDCRSLIWLDLNT 553 (1176)
Q Consensus 540 ~~~l~~L~~L~L~~ 553 (1176)
|.++++|+.+++.+
T Consensus 221 ~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 221 LENLKKLRARSTYN 234 (242)
T ss_dssp CTTCCEEESSSEES
T ss_pred HcCCcccccCcCCC
Confidence 66666666555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=3.2e-16 Score=163.39 Aligned_cols=101 Identities=21% Similarity=0.234 Sum_probs=49.5
Q ss_pred CCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcC
Q 046275 170 SLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDIS 249 (1176)
Q Consensus 170 ~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls 249 (1176)
+|++|++++|.|+++.. ++.+++|++|+|++|++++..+++.+++|++|++++|+++.++ .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~~-----l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQG-----IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCTT-----GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCchh-----HhhCCCCCEEeCCCccccCccccccCccccccccccccccccc-cccccccccccccc
Confidence 44444444444443211 2334444444444444444334445555555666555555433 35555666666666
Q ss_pred CCcCCCCcChhhhccccCCeEeecccccc
Q 046275 250 ANKFTGDVGHAISACEHLSFLNVSSNLFS 278 (1176)
Q Consensus 250 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 278 (1176)
+|.+... ..+..+++|+.+++++|.++
T Consensus 121 ~~~~~~~--~~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 121 HNGISDI--NGLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred ccccccc--cccccccccccccccccccc
Confidence 6655432 23555555555555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=3e-16 Score=162.14 Aligned_cols=167 Identities=22% Similarity=0.184 Sum_probs=85.3
Q ss_pred ccccccccCCCCCCCcccCCCCCccccCccccccCCcccCCCCCcccccCCCCCCcEEecCCCCCCccccccccccCCCc
Q 046275 93 DTLETLSLKNSNISGTISLPAGSRCSSFLSSLDLSLNILSGPLSDISYLGSCSSLKVLNLSSNLLDFSGREAGSLKLSLE 172 (1176)
Q Consensus 93 ~~L~~L~L~~n~l~g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~~~~~~~L~ 172 (1176)
.+...+.++.+++++.... ..+.++++|++++|.+.. ++.++.+++|++|+|++|+|+.++. +..+++|+
T Consensus 18 ~~~i~~~l~~~~~~~~~~~----~~l~~l~~L~l~~~~i~~----l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~ 87 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVSQ----TDLDQVTTLQADRLGIKS----IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 87 (199)
T ss_dssp HHHHHHHTTCSSTTSEECH----HHHTTCCEEECTTSCCCC----CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred HHHHHHHhCCCCCCCccCH----HHhcCCCEEECCCCCCCC----ccccccCCCcCcCccccccccCccc--ccCCcccc
Confidence 3444566667766654321 234566667777766653 2234556666666666666665542 44555666
Q ss_pred EEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCc
Q 046275 173 VLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANK 252 (1176)
Q Consensus 173 ~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~ 252 (1176)
+|++++|.+..+ + .+.++++|+.|++++|.+.....+..+++|+.|++++|++..+ +.+..+++|++|++++|+
T Consensus 88 ~L~l~~n~~~~~---~--~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 88 DILMNNNQIADI---T--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp EEECCSSCCCCC---G--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSC
T ss_pred cccccccccccc---c--ccccccccccccccccccccccccchhhhhHHhhhhhhhhccc-cccccccccccccccccc
Confidence 666666655542 1 1344555555555555555444444455555555555554432 234444455555555554
Q ss_pred CCCCcChhhhccccCCeEeeccccc
Q 046275 253 FTGDVGHAISACEHLSFLNVSSNLF 277 (1176)
Q Consensus 253 l~~~~~~~l~~l~~L~~L~Ls~N~l 277 (1176)
+++.. .++++++|++|++++|++
T Consensus 162 l~~l~--~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 162 VTDLK--PLANLTTLERLDISSNKV 184 (199)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCC
T ss_pred ccCCc--cccCCCCCCEEECCCCCC
Confidence 44332 144444444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.64 E-value=1.2e-15 Score=157.66 Aligned_cols=54 Identities=31% Similarity=0.518 Sum_probs=24.0
Q ss_pred ccCCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEE
Q 046275 321 FGSCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETL 379 (1176)
Q Consensus 321 ~~~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 379 (1176)
+..+++|+.|++++|+++ .++. +.++++|++|++++|++++ ++ .++++++|++|
T Consensus 146 l~~~~~L~~L~l~~n~l~-~l~~--l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVT-DLKP--LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCSEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccccccccc-CCcc--ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 444444445555444444 2221 3444555555555555443 21 34444444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=9.3e-15 Score=159.74 Aligned_cols=162 Identities=20% Similarity=0.224 Sum_probs=101.0
Q ss_pred CCCccceeeccCCcccc--cCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccc-cccCccCCCCccccCcc
Q 046275 216 KCKNLQFLDVSSNNFSM--AVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSN-LFSGPIPVGYNEFQGEI 292 (1176)
Q Consensus 216 ~l~~L~~L~Ls~N~l~~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~~i 292 (1176)
...+|++||++++.++. +...+..+++|++|+|++|.+++..+..++.+++|++|+++++ .+++ ..
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd-----------~~ 112 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE-----------FA 112 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCH-----------HH
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccc-----------cc
Confidence 44567777777776653 2223567778888888888777666677777788888888774 3331 11
Q ss_pred hhhhhhcCCCccEEEccCC-ccccc-CCccccC-CCCCcEEEccCC--cCcccCCHHHHhcCCCCCEEEccCc-ccCCCC
Q 046275 293 PLHLADLCSSLVKLDLSSN-NLSGK-VPSRFGS-CSSLESFDISSN--KFSGELPIEIFLSMSNLKELVLSFN-DFTGAL 366 (1176)
Q Consensus 293 ~~~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~i~~~~~~~l~~L~~L~Ls~N-~l~~~~ 366 (1176)
-..+...+++|++|+++++ .++.. +...+.. .++|+.|+++++ .+++.--..++.++++|++|++++| .+++..
T Consensus 113 l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~ 192 (284)
T d2astb2 113 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192 (284)
T ss_dssp HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGG
T ss_pred cchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchh
Confidence 2234455677888888775 34321 1222222 367888888764 3442222334456788888888775 466666
Q ss_pred cccccCCCCCCEEEccCC-cCCC
Q 046275 367 PDSLSNLTNLETLDLSSN-NLSG 388 (1176)
Q Consensus 367 p~~l~~l~~L~~L~Ls~N-~l~~ 388 (1176)
...+.++++|++|+|++| .+++
T Consensus 193 ~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 193 FQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp GGGGGGCTTCCEEECTTCTTCCG
T ss_pred hhhhcccCcCCEEECCCCCCCCh
Confidence 667777777777777774 4543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=5.9e-15 Score=161.35 Aligned_cols=183 Identities=19% Similarity=0.164 Sum_probs=92.4
Q ss_pred CCCCCcEEEccCCcCcccCCHHHHhcCCCCCEEEccCcccCCCCcccccCCCCCCEEEccCC-cCCCCCCccccCCCCCC
Q 046275 323 SCSSLESFDISSNKFSGELPIEIFLSMSNLKELVLSFNDFTGALPDSLSNLTNLETLDLSSN-NLSGAIPHNLCQGPRNS 401 (1176)
Q Consensus 323 ~l~~L~~L~Ls~N~l~~~i~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~~~~ 401 (1176)
...+|++||++++.+++.....++..+++|++|+|++|.+++..+..++.+++|++|+|+++ .+++..-..+. ..+++
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~-~~~~~ 122 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SSCSR 122 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH-HHCTT
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhh-HHHHh
Confidence 33466666666666653333445566666666666666666555566666666666666664 33321111111 12345
Q ss_pred ccEEEccCc-cccCC-CCccccc-cccCcEEEcCCc--cccCC-CCccccCCCccCeeecccc-cccCCCCCCCCCcccc
Q 046275 402 LKELFLQNN-LLLGS-IPSTLSN-CSQLVSLHLSFN--YLTGT-IPSSLGSLSKLQDLKLWLN-QLHGEIPPELGNIQTL 474 (1176)
Q Consensus 402 L~~L~L~~N-~l~~~-~p~~l~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L 474 (1176)
|++|+++++ .+++. +...+.. .++|+.|+++++ .++.. +...+.++++|++|++++| .+++..+..+.++++|
T Consensus 123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L 202 (284)
T d2astb2 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202 (284)
T ss_dssp CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence 555555553 23211 1112222 245666666653 23211 2222234555666666553 3444444555555556
Q ss_pred ceeecccc-cccCccccccccCCCCCeeecccc
Q 046275 475 ETLFLDFN-ELTGTLPAALSNCTNLNWISLSNN 506 (1176)
Q Consensus 475 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N 506 (1176)
++|+|+++ .+++.....++++++|+.|+++++
T Consensus 203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66666553 455444445555566666666555
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=4.5e-15 Score=167.65 Aligned_cols=260 Identities=20% Similarity=0.214 Sum_probs=127.5
Q ss_pred hhhhhcCcccccccccCCCCCC--CcccCCCCCccccCccccccCCcccCCCCCc--------ccccCCCCCCcEEecCC
Q 046275 85 VASFLLTLDTLETLSLKNSNIS--GTISLPAGSRCSSFLSSLDLSLNILSGPLSD--------ISYLGSCSSLKVLNLSS 154 (1176)
Q Consensus 85 ~~~~l~~~~~L~~L~L~~n~l~--g~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~--------~~~l~~l~~L~~L~Ls~ 154 (1176)
+...+.+...|+.|+|++|.|+ |...+...+...++|+.|+++++........ ...+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 4555667777777777777775 2233334455556667777766654321110 12234556666666666
Q ss_pred CCCCcccc----ccccccCCCcEEEccCCCCCCCCccccccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcc
Q 046275 155 NLLDFSGR----EAGSLKLSLEVLDLSYNKISGANVVPWILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNF 230 (1176)
Q Consensus 155 n~i~~~~~----~~~~~~~~L~~LdLs~N~i~~~~~~~~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l 230 (1176)
|.++.... ..+..+++|+.|++++|.++..... ..... |..+.. .......+.|+.|++++|++
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~--~l~~~---l~~~~~-------~~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA--KIARA---LQELAV-------NKKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH--HHHHH---HHHHHH-------HHHHHTCCCCCEEECCSSCC
T ss_pred cccccccccchhhhhcccccchheecccccccccccc--ccccc---cccccc-------ccccccCcccceeecccccc
Confidence 66554321 1223345566666666555321000 00000 000000 00011234555555555555
Q ss_pred cc-----cCCCccCCCCCcEEEcCCCcCCCC-----cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcC
Q 046275 231 SM-----AVPSFGDCLALEYLDISANKFTGD-----VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLC 300 (1176)
Q Consensus 231 ~~-----~~~~l~~l~~L~~L~Ls~N~l~~~-----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l 300 (1176)
+. +...+..++.|++|+|++|+++.. ....+..+++|+.|+|++|.++..... .+ ......+
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~-------~L-~~~l~~~ 242 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS-------AL-AIALKSW 242 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH-------HH-HHHGGGC
T ss_pred cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc-------cc-ccccccc
Confidence 41 111234455666666666666532 223345566666666666665421000 01 1122334
Q ss_pred CCccEEEccCCccccc----CCccccC--CCCCcEEEccCCcCccc----CCHHHHhcCCCCCEEEccCcccCC
Q 046275 301 SSLVKLDLSSNNLSGK----VPSRFGS--CSSLESFDISSNKFSGE----LPIEIFLSMSNLKELVLSFNDFTG 364 (1176)
Q Consensus 301 ~~L~~L~L~~n~l~~~----~p~~~~~--l~~L~~L~Ls~N~l~~~----i~~~~~~~l~~L~~L~Ls~N~l~~ 364 (1176)
++|++|+|++|.+++. +...+.. .+.|++|++++|+|+.. +...+..++++|++|+|++|.+..
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 6666777777766543 2222222 35678888888877532 222222356778888888888763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=4.9e-15 Score=167.32 Aligned_cols=267 Identities=18% Similarity=0.154 Sum_probs=159.8
Q ss_pred CcccCCCCCccccCccccccCCcccCCCC--CcccccCCCCCCcEEecCCCCCCcccc----------ccccccCCCcEE
Q 046275 107 GTISLPAGSRCSSFLSSLDLSLNILSGPL--SDISYLGSCSSLKVLNLSSNLLDFSGR----------EAGSLKLSLEVL 174 (1176)
Q Consensus 107 g~~~~~~~~~~~~~L~~LdLs~N~l~~~~--~~~~~l~~l~~L~~L~Ls~n~i~~~~~----------~~~~~~~~L~~L 174 (1176)
+..++...+.....|++|+|++|.++... .-...+..+++|+.|+++++.+..... ..+..+++|++|
T Consensus 19 ~~~~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L 98 (344)
T d2ca6a1 19 DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98 (344)
T ss_dssp HHHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEE
T ss_pred HHHHHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccc
Confidence 33344444556677888888888775321 111346677788888887775543321 122334566666
Q ss_pred EccCCCCCCCCccc-cccccCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcC
Q 046275 175 DLSYNKISGANVVP-WILFNGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKF 253 (1176)
Q Consensus 175 dLs~N~i~~~~~~~-~~~f~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 253 (1176)
||++|.++...... ...+..+++|++|++++|.+.......-...|..+... ......+.|+.|++++|++
T Consensus 99 ~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~--------~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 99 RLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN--------KKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp ECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHH--------HHHHTCCCCCEEECCSSCC
T ss_pred cccccccccccccchhhhhcccccchheecccccccccccccccccccccccc--------cccccCcccceeecccccc
Confidence 66666665421110 01123344444444444444321000000001111000 0123567899999999999
Q ss_pred CCC----cChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhhcCCCccEEEccCCccccc----CCccccCCC
Q 046275 254 TGD----VGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLADLCSSLVKLDLSSNNLSGK----VPSRFGSCS 325 (1176)
Q Consensus 254 ~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~ 325 (1176)
+.. +...+..++.|++|+|++|.|+... +. .+.......+++|+.|+|++|.++.. +...+..++
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g---~~----~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~ 243 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG---IE----HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHH---HH----HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred cccccccccchhhhhhhhcccccccccccccc---cc----cchhhhhcchhhhcccccccccccccccccccccccccc
Confidence 854 3344667899999999999986310 00 11122344568999999999998742 456678899
Q ss_pred CCcEEEccCCcCcccCCHHH---Hhc--CCCCCEEEccCcccCCC----Cccccc-CCCCCCEEEccCCcCCC
Q 046275 326 SLESFDISSNKFSGELPIEI---FLS--MSNLKELVLSFNDFTGA----LPDSLS-NLTNLETLDLSSNNLSG 388 (1176)
Q Consensus 326 ~L~~L~Ls~N~l~~~i~~~~---~~~--l~~L~~L~Ls~N~l~~~----~p~~l~-~l~~L~~L~Ls~N~l~~ 388 (1176)
+|++|+|++|.|++.-...+ +.. .+.|++|++++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 99999999999974322222 222 36799999999998753 233443 57899999999999974
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=6.1e-14 Score=138.68 Aligned_cols=123 Identities=18% Similarity=0.136 Sum_probs=51.7
Q ss_pred ccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhhhhh
Q 046275 219 NLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLHLAD 298 (1176)
Q Consensus 219 ~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~~~~ 298 (1176)
+|++|+|++|+|+.++..+..+++|++|+|++|+|+.. ..+..+++|++|++++|+++ .++..++.
T Consensus 19 ~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~------------~l~~~~~~ 84 (162)
T d1a9na_ 19 RDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC------------RIGEGLDQ 84 (162)
T ss_dssp SCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC------------EECSCHHH
T ss_pred cCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc------------CCCccccc
Confidence 34444444444443332233344444444444444422 12344444444444444443 11222222
Q ss_pred cCCCccEEEccCCcccccC-CccccCCCCCcEEEccCCcCcccCC---HHHHhcCCCCCEEE
Q 046275 299 LCSSLVKLDLSSNNLSGKV-PSRFGSCSSLESFDISSNKFSGELP---IEIFLSMSNLKELV 356 (1176)
Q Consensus 299 ~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~i~---~~~~~~l~~L~~L~ 356 (1176)
.+++|++|++++|+++... ...+..+++|++|++++|.++ ..| ..++..+++|++||
T Consensus 85 ~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 85 ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp HCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 3344444444444443211 023455555555555555554 333 12344555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=7.6e-14 Score=137.98 Aligned_cols=127 Identities=17% Similarity=0.162 Sum_probs=89.1
Q ss_pred ccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCC
Q 046275 420 LSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLN 499 (1176)
Q Consensus 420 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 499 (1176)
+.+..+|++|||++|+|+ .+|..+..+++|+.|+|++|+++ .++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 445566777777777776 44555566777777777777776 333 467777888888888888755555567788888
Q ss_pred eeeccccccCCCCC--ccccCCCCCCeEEccCCcccccCCC----CCCCCCCCCEEEc
Q 046275 500 WISLSNNHLGGEIP--TWIGQLSNLAILKLSNNSFYGRIPP----ELGDCRSLIWLDL 551 (1176)
Q Consensus 500 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L 551 (1176)
.|++++|+++. ++ ..+..+++|++|++++|.++ ..|. .+..+++|++||-
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 88888888873 33 35677888888888888886 4443 4666788887763
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=3.1e-13 Score=126.86 Aligned_cols=101 Identities=28% Similarity=0.348 Sum_probs=52.9
Q ss_pred EEEccCccccCCCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeeccccc
Q 046275 404 ELFLQNNLLLGSIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNE 483 (1176)
Q Consensus 404 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 483 (1176)
.|+|++|+++ .++ .+.++++|++|++++|+|+ .+|..++.+++|+.|++++|+++. +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555554 222 2555566666666666665 345555555555555555555552 22 25555555555555555
Q ss_pred ccCcc-ccccccCCCCCeeeccccccC
Q 046275 484 LTGTL-PAALSNCTNLNWISLSNNHLG 509 (1176)
Q Consensus 484 l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 509 (1176)
|+... ...+..+++|++|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55322 134555555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.39 E-value=2.3e-13 Score=127.77 Aligned_cols=101 Identities=30% Similarity=0.370 Sum_probs=49.8
Q ss_pred EEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCccccccccCCCCCeeeccccc
Q 046275 428 SLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNH 507 (1176)
Q Consensus 428 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 507 (1176)
+|||++|+++ .++ .+..+++|++|++++|+++ .+|..++.+++|++|++++|+|++ +| .+.++++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4566666665 333 2455555555555555554 344445555555555555555552 22 24555555555555555
Q ss_pred cCCCC-CccccCCCCCCeEEccCCccc
Q 046275 508 LGGEI-PTWIGQLSNLAILKLSNNSFY 533 (1176)
Q Consensus 508 l~~~~-p~~~~~l~~L~~L~L~~N~l~ 533 (1176)
|+... +..++.+++|++|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 54221 123444455555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=8.9e-14 Score=142.56 Aligned_cols=130 Identities=27% Similarity=0.341 Sum_probs=102.5
Q ss_pred CCCccccccccCcEEEcCCccccCCCCccccCCCccCeeecccccccCCCCCCCCCccccceeecccccccCcccccccc
Q 046275 415 SIPSTLSNCSQLVSLHLSFNYLTGTIPSSLGSLSKLQDLKLWLNQLHGEIPPELGNIQTLETLFLDFNELTGTLPAALSN 494 (1176)
Q Consensus 415 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 494 (1176)
.++..++.+++|++|+|++|+|+ .++ .+..+++|+.|+|++|.++ .+|..+..+++|++|++++|+|+. + ..+.+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 45567888888999999999988 444 5888888999999999887 566656666789999999999984 3 34888
Q ss_pred CCCCCeeeccccccCCCCC--ccccCCCCCCeEEccCCcccccCCCC----------CCCCCCCCEEE
Q 046275 495 CTNLNWISLSNNHLGGEIP--TWIGQLSNLAILKLSNNSFYGRIPPE----------LGDCRSLIWLD 550 (1176)
Q Consensus 495 l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~ 550 (1176)
+++|+.|++++|+++. ++ ..+..+++|++|+|++|++....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 8999999999999984 33 46888999999999999887554443 45678888876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=4.2e-11 Score=117.03 Aligned_cols=109 Identities=18% Similarity=0.093 Sum_probs=85.0
Q ss_pred cCeeecccccccCCCCCCCCCccccceeecccc-cccCccccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEcc
Q 046275 450 LQDLKLWLNQLHGEIPPELGNIQTLETLFLDFN-ELTGTLPAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLS 528 (1176)
Q Consensus 450 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 528 (1176)
...++.+++.+. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+...|.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555666555 45666777778888888765 4876667788999999999999999987778889999999999999
Q ss_pred CCcccccCCCCCCCCCCCCEEEccCCCCcccC
Q 046275 529 NNSFYGRIPPELGDCRSLIWLDLNTNLFNGSI 560 (1176)
Q Consensus 529 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i 560 (1176)
+|+|+ .+|.......+|+.|+|++|+|.+..
T Consensus 89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 89 FNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SSCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCCc-ccChhhhccccccccccCCCcccCCc
Confidence 99998 56655555557999999999997644
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.15 E-value=1.1e-12 Score=134.40 Aligned_cols=84 Identities=25% Similarity=0.185 Sum_probs=40.5
Q ss_pred cCCCCccEEEeCCCcccccccCCCCCccceeeccCCcccccCCCccCCCCCcEEEcCCCcCCCCcChhhhccccCCeEee
Q 046275 193 NGCDELKQLALKGNKVTGDINVSKCKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISANKFTGDVGHAISACEHLSFLNV 272 (1176)
Q Consensus 193 ~~~~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 272 (1176)
..+++|++|+|++|+|+...++..+++|++|+|++|.|+.+++.+..+++|++|++++|+++.. ..+..+++|++|++
T Consensus 45 ~~L~~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L 122 (198)
T d1m9la_ 45 STLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYM 122 (198)
T ss_dssp HHTTTCCEEECSEEEESCCCCHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEEE
T ss_pred hcccccceeECcccCCCCcccccCCccccChhhccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 3344444444444444443334445555555555555554433333344555555555555532 23455555555555
Q ss_pred cccccc
Q 046275 273 SSNLFS 278 (1176)
Q Consensus 273 s~N~l~ 278 (1176)
++|+|+
T Consensus 123 ~~N~i~ 128 (198)
T d1m9la_ 123 SNNKIT 128 (198)
T ss_dssp SEEECC
T ss_pred ccchhc
Confidence 555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=1.4e-10 Score=113.16 Aligned_cols=109 Identities=15% Similarity=0.066 Sum_probs=69.6
Q ss_pred CCccceeeccCCcccccCCCccCCCCCcEEEcCCC-cCCCCcChhhhccccCCeEeeccccccCccCCCCccccCcchhh
Q 046275 217 CKNLQFLDVSSNNFSMAVPSFGDCLALEYLDISAN-KFTGDVGHAISACEHLSFLNVSSNLFSGPIPVGYNEFQGEIPLH 295 (1176)
Q Consensus 217 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~i~~~ 295 (1176)
+...+.++++++++...+..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+. ++..
T Consensus 7 c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~------------i~~~ 74 (156)
T d2ifga3 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF------------VAPD 74 (156)
T ss_dssp CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE------------ECTT
T ss_pred cCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC------------cccc
Confidence 34455677777777777777777778888888655 4776666677777777777777777762 3333
Q ss_pred hhhcCCCccEEEccCCcccccCCccccCCCCCcEEEccCCcCc
Q 046275 296 LADLCSSLVKLDLSSNNLSGKVPSRFGSCSSLESFDISSNKFS 338 (1176)
Q Consensus 296 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 338 (1176)
.+..+++|++|+|++|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 75 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 75 AFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred cccccccccceeccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 3444566666666666666333333333 35667777766664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=2.4e-08 Score=97.72 Aligned_cols=83 Identities=27% Similarity=0.178 Sum_probs=45.5
Q ss_pred CCCccccceeecccccccCcc--ccccccCCCCCeeeccccccCCCCCccccCCCCCCeEEccCCcccccCCCC------
Q 046275 468 LGNIQTLETLFLDFNELTGTL--PAALSNCTNLNWISLSNNHLGGEIPTWIGQLSNLAILKLSNNSFYGRIPPE------ 539 (1176)
Q Consensus 468 ~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~------ 539 (1176)
+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+++...+-.+....+|+.|++++|.+.......
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 344556666666666666432 344556666666666666666332223334445666666666665433321
Q ss_pred -CCCCCCCCEEE
Q 046275 540 -LGDCRSLIWLD 550 (1176)
Q Consensus 540 -~~~l~~L~~L~ 550 (1176)
+..+++|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 44556666654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=1.8e-06 Score=91.50 Aligned_cols=148 Identities=12% Similarity=0.052 Sum_probs=103.3
Q ss_pred HHHHHhcCCCCCceEeEeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeE
Q 046275 854 DLLEATNGFHNDSLIGSGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERL 932 (1176)
Q Consensus 854 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 932 (1176)
++.+..+.|++.+..+-++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555556776655544455578998864 57778888876554445556788999888774 444678888888889999
Q ss_pred EEEeeccCCCHHHHHhhccccCcccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 046275 933 LVYEYMRYGSLEDVLHNQKKVGIKLNWAARRKIAIGSARGLAFLHHNC-------------------------------- 980 (1176)
Q Consensus 933 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------- 980 (1176)
+||++++|.++.+..... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998876544321 112234555556666666421
Q ss_pred ------------------------CCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 981 ------------------------IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 981 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
.+.++|+|+.|.||++++++.+-+.||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137999999999999987667799999775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=4.2e-08 Score=95.93 Aligned_cols=90 Identities=19% Similarity=0.135 Sum_probs=58.0
Q ss_pred CccccCCCccCeeecccccccCC--CCCCCCCccccceeecccccccCccccccccCCCCCeeeccccccCCCCCc----
Q 046275 441 PSSLGSLSKLQDLKLWLNQLHGE--IPPELGNIQTLETLFLDFNELTGTLPAALSNCTNLNWISLSNNHLGGEIPT---- 514 (1176)
Q Consensus 441 p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---- 514 (1176)
+..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+.+..+|+.|++++|.+......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 33344566666777777766643 234456677888888888888744443444556788888888888755442
Q ss_pred ---cccCCCCCCeEEccCCcc
Q 046275 515 ---WIGQLSNLAILKLSNNSF 532 (1176)
Q Consensus 515 ---~~~~l~~L~~L~L~~N~l 532 (1176)
.+..+|+|+.|| ++.+
T Consensus 138 ~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 138 ISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHHCCCCCEEC--cCCC
Confidence 255688888775 4444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.66 E-value=3.4e-06 Score=82.36 Aligned_cols=98 Identities=19% Similarity=0.197 Sum_probs=49.1
Q ss_pred hhhhhcCcccccccccCCC-CCCC--cccCCCCCccccCccccccCCcccCCC--CCcccccCCCCCCcEEecCCCCCCc
Q 046275 85 VASFLLTLDTLETLSLKNS-NISG--TISLPAGSRCSSFLSSLDLSLNILSGP--LSDISYLGSCSSLKVLNLSSNLLDF 159 (1176)
Q Consensus 85 ~~~~l~~~~~L~~L~L~~n-~l~g--~~~~~~~~~~~~~L~~LdLs~N~l~~~--~~~~~~l~~l~~L~~L~Ls~n~i~~ 159 (1176)
+.....+.+.|++|+|+++ .++. ...+...+...++|++|+|++|.+... ..-...+...+.|++|+|++|.|+.
T Consensus 7 l~~l~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 7 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence 3444455677777777764 4542 122222334445566666666665421 1111234455566666666666554
Q ss_pred cc----cccccccCCCcEEEccCCCCC
Q 046275 160 SG----REAGSLKLSLEVLDLSYNKIS 182 (1176)
Q Consensus 160 ~~----~~~~~~~~~L~~LdLs~N~i~ 182 (1176)
.+ ..+++..++|++|+|++|.+.
T Consensus 87 ~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 87 ELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 33 122333445556666555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.54 E-value=1.6e-05 Score=77.41 Aligned_cols=59 Identities=19% Similarity=0.084 Sum_probs=27.4
Q ss_pred CCccceeeccCCcccc-----cCCCccCCCCCcEEEcCCCcCCCC-------cChhhhccccCCeEeeccc
Q 046275 217 CKNLQFLDVSSNNFSM-----AVPSFGDCLALEYLDISANKFTGD-------VGHAISACEHLSFLNVSSN 275 (1176)
Q Consensus 217 l~~L~~L~Ls~N~l~~-----~~~~l~~l~~L~~L~Ls~N~l~~~-------~~~~l~~l~~L~~L~Ls~N 275 (1176)
.+.|++|+|++|.++. +...+...++|++|+|++|.+... +...+...+.|+.|+++.+
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 3455555555555541 122344455555666655544322 2233334455555555443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.53 E-value=2.5e-05 Score=81.91 Aligned_cols=73 Identities=11% Similarity=0.055 Sum_probs=52.4
Q ss_pred EeEeC-ceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcC--CCCcccceeEEeeCCeeEEEEeeccCCCH
Q 046275 868 IGSGG-FGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIK--HRNLVPLLGYCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 868 lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL 943 (1176)
+..|. -+.||+....++..+++|..... ....+..|...++.+. .-.+.+++++..+++..++||+|++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 33444 36799998877888888865432 2335678888888774 33467788888888889999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.18 E-value=0.00059 Score=75.91 Aligned_cols=76 Identities=14% Similarity=0.060 Sum_probs=48.8
Q ss_pred CceEeEeCceEEEEEEECC-CCEEEEEEeecc-------CCcCHHHHHHHHHHHHhcC-C--CCcccceeEEeeCCeeEE
Q 046275 865 DSLIGSGGFGDVYKAKLKD-GSTVAIKKLIHI-------SGQGDREFTAEMETIGKIK-H--RNLVPLLGYCKVGEERLL 933 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 933 (1176)
.+.||.|....||++...+ ++.|+||.-... .+....+...|.+.++.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998754 678999865321 1112334567888888763 3 345555544 4556689
Q ss_pred EEeeccCCC
Q 046275 934 VYEYMRYGS 942 (1176)
Q Consensus 934 V~E~~~~gs 942 (1176)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.96 E-value=5.8e-05 Score=73.27 Aligned_cols=61 Identities=18% Similarity=0.163 Sum_probs=30.7
Q ss_pred CCCccceeeccCCccc-----ccCCCccCCCCCcEEEc--CCCcCCCC----cChhhhccccCCeEeecccc
Q 046275 216 KCKNLQFLDVSSNNFS-----MAVPSFGDCLALEYLDI--SANKFTGD----VGHAISACEHLSFLNVSSNL 276 (1176)
Q Consensus 216 ~l~~L~~L~Ls~N~l~-----~~~~~l~~l~~L~~L~L--s~N~l~~~----~~~~l~~l~~L~~L~Ls~N~ 276 (1176)
..+.++.+++++|.++ .+...+...++|+.++| ++|.+++. +...+...++|+.|+++.+.
T Consensus 72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 3455556666655553 12234455566665444 34455432 33344455666666665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.91 E-value=9.9e-05 Score=71.57 Aligned_cols=60 Identities=17% Similarity=0.128 Sum_probs=33.5
Q ss_pred CCCCccEEEeCCCccccc------ccCCCCCcccee--eccCCcccc-----cCCCccCCCCCcEEEcCCCcC
Q 046275 194 GCDELKQLALKGNKVTGD------INVSKCKNLQFL--DVSSNNFSM-----AVPSFGDCLALEYLDISANKF 253 (1176)
Q Consensus 194 ~~~~L~~L~L~~n~l~~~------~~~~~l~~L~~L--~Ls~N~l~~-----~~~~l~~l~~L~~L~Ls~N~l 253 (1176)
..+.++.|++++|.+... ..+...++|+.+ ++++|.+.. +...+...++|++|+++.+..
T Consensus 72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 334455555555544431 234556667654 345566642 233456778888888877654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.15 E-value=0.0071 Score=64.95 Aligned_cols=139 Identities=11% Similarity=0.091 Sum_probs=80.1
Q ss_pred eCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC--ccccee-----EEeeCCeeEEEEeeccCCCH
Q 046275 871 GGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN--LVPLLG-----YCKVGEERLLVYEYMRYGSL 943 (1176)
Q Consensus 871 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~-----~~~~~~~~~lV~E~~~~gsL 943 (1176)
+..-.||+++.++|+.|++|.... .....+++..|...+..+.... ++..+. .+..++..+.|+++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 334689999999999999997643 2345677888999888874222 222221 23456678899999876321
Q ss_pred -----HHH---------Hhhcc----cc-CcccCH-------------------HHHHHHHHHHHHHHHHHHhc----CC
Q 046275 944 -----EDV---------LHNQK----KV-GIKLNW-------------------AARRKIAIGSARGLAFLHHN----CI 981 (1176)
Q Consensus 944 -----~~~---------l~~~~----~~-~~~l~~-------------------~~~~~i~~~ia~~L~~LH~~----~~ 981 (1176)
..+ +|... .. ....++ ..+..+...+.+.++.+... ..
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 111 11100 00 001111 11112222223333333322 23
Q ss_pred CCeeeCCCCCCCEEECCCCcEEEEeeccccc
Q 046275 982 PHIIHRDMKSSNVLLDENFEARVSDFGMARL 1012 (1176)
Q Consensus 982 ~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~ 1012 (1176)
.++||+|+.+.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 468999999999999754 45899997753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.14 E-value=0.018 Score=61.25 Aligned_cols=160 Identities=12% Similarity=0.040 Sum_probs=84.8
Q ss_pred ccCHHHHHHHhcCCCCCceEe-----EeCceEEEEEEECCCCEEEEEEeeccCCcCHHHHHHHHHHHHhcCCCC--cccc
Q 046275 849 KLTFADLLEATNGFHNDSLIG-----SGGFGDVYKAKLKDGSTVAIKKLIHISGQGDREFTAEMETIGKIKHRN--LVPL 921 (1176)
Q Consensus 849 ~~~~~~~~~~~~~y~~~~~lG-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 921 (1176)
.++.+|+.....+|.+++... .|---+.|+.+..+|+ +++|..... ...+++..|++++..+...+ +...
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence 356677888888888765543 5556788999877654 788876432 23345666777777764222 2222
Q ss_pred ee------EEeeCCeeEEEEeeccCCCHH--------------HHHhhcccc-----Cc------------------ccC
Q 046275 922 LG------YCKVGEERLLVYEYMRYGSLE--------------DVLHNQKKV-----GI------------------KLN 958 (1176)
Q Consensus 922 ~~------~~~~~~~~~lV~E~~~~gsL~--------------~~l~~~~~~-----~~------------------~l~ 958 (1176)
+. +.........++.++.+.... ..++..... .. ...
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 21 122344556667766553221 001100000 00 001
Q ss_pred HHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEEeecccc
Q 046275 959 WAARRKIAIGSARGLAFLHH-NCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1011 (1176)
Q Consensus 959 ~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~ 1011 (1176)
.......+......+...+. ..+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11111222222222222222 123479999999999999988777899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.83 E-value=0.0076 Score=66.72 Aligned_cols=73 Identities=16% Similarity=0.133 Sum_probs=49.3
Q ss_pred CceEeEeCceEEEEEEECCC--------CEEEEEEeeccCCcCHHHHHHHHHHHHhcC-CCCcccceeEEeeCCeeEEEE
Q 046275 865 DSLIGSGGFGDVYKAKLKDG--------STVAIKKLIHISGQGDREFTAEMETIGKIK-HRNLVPLLGYCKVGEERLLVY 935 (1176)
Q Consensus 865 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 935 (1176)
.+.|+.|-.-.+|++...++ +.|+++..- .........+|..+++.+. +.-..++++++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC--CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35788888899999987643 445555443 2334456678999998884 4444577776642 6899
Q ss_pred eeccCCCH
Q 046275 936 EYMRYGSL 943 (1176)
Q Consensus 936 E~~~~gsL 943 (1176)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|